PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fasana, E; Fossati, M; Ruggiano, A; Brambillasca, S; Hoogenraad, CC; Navone, F; Francolini, M; Borgese, N				Fasana, Elisa; Fossati, Matteo; Ruggiano, Annamaria; Brambillasca, Silvia; Hoogenraad, Casper C.; Navone, Francesca; Francolini, Maura; Borgese, Nica			A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum	FASEB JOURNAL			English	Article						inclusion bodies; neurodegenerative diseases; post-translational insertion; tail-anchored membrane proteins	PROTEIN-ASSOCIATED PROTEIN; LIPID-BINDING PROTEINS; TAIL-ANCHORED PROTEINS; MOTOR-NEURON DISEASE; LOSS-OF-FUNCTION; MEMBRANE-PROTEIN; FFAT MOTIF; ER; MUTATION; TRANSPORT	VAPB (vesicle-associated membrane protein-associated protein B) is an endoplasmic reticulum (ER)-resident tail-anchored adaptor protein involved in lipid transport. A dominantly inherited mutant, P56S-VAPB, causes a familial form of amyotrophic lateral sclerosis (ALS) and forms poorly characterized inclusion bodies in cultured cells. To provide a cell biological basis for the understanding of mutant VAPB pathogenicity, we investigated its biogenesis and the inclusions that it generates. Translocation assays in cell-free systems and in cultured mammalian cells were used to investigate P56S-VAPB membrane insertion, and the inclusions were characterized by confocal imaging and electron microscopy. We found that mutant VAPB inserts post-translationally into ER membranes in a manner indistinguishable from the wild-type protein but that it rapidly clusters to form inclusions that remain continuous with the rest of the ER. Inclusions were induced by the mutant also when it was expressed at levels comparable to the endogenous wild-type protein. Ultrastructural analysis revealed that the inclusions represent a novel form of organized smooth ER (OSER) consisting in a limited number of parallel cisternae (usually 2 or 3) interleaved by a similar to 30 nm-thick electron-dense cytosolic layer. Our results demonstrate that the ALS-linked VAPB mutant causes dramatic ER restructuring that may underlie its pathogenicity in motoneurons.-Fasana, E., Fossati, M., Ruggiano, A., Brambillasca, S., Hoogenraad, C. C., Navone, F., Francolini, M., Borgese, N. A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J. 24, 1419-1430 (2010). www.fasebj.org	[Fasana, Elisa; Fossati, Matteo; Ruggiano, Annamaria; Brambillasca, Silvia; Navone, Francesca; Francolini, Maura; Borgese, Nica] Inst Neurosci, CNR, I-20129 Milan, Italy; [Fasana, Elisa; Fossati, Matteo; Ruggiano, Annamaria; Brambillasca, Silvia; Navone, Francesca; Francolini, Maura; Borgese, Nica] Univ Milan, Dept Pharmacol, Milan, Italy; [Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Borgese, Nica] Univ Catanzaro, Dept Pharmacobiol Sci, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Erasmus University Rotterdam; Erasmus MC; Magna Graecia University of Catanzaro	Borgese, N (corresponding author), Inst Neurosci, CNR, Via Vanvitelli 32, I-20129 Milan, Italy.	n.borgese@in.cnr.it	Hoogenraad, Casper/B-8866-2011; Fossati, Matteo/J-4131-2018; Fossati, Matteo/AAB-6081-2019; Borgese, Nica/GWZ-8895-2022	Hoogenraad, Casper/0000-0002-2666-0758; Fossati, Matteo/0000-0002-9210-5242; Fossati, Matteo/0000-0002-9210-5242; Borgese, Nica/0000-0002-7537-3974; FRANCOLINI, MAURA/0000-0002-3126-1575; Ruggiano, Annamaria/0000-0003-4514-7922	Telethon [GGP07010]; CAR-IPLO Foundation; University of Milan	Telethon(Fondazione Telethon); CAR-IPLO Foundation(Fondazione Cariplo); University of Milan	In addition to the people who kindly supplied reagents (listed in Materials and Methods and in Supplemental Table 2), the authors thank Paolo Ronchi for helpful discussions. Special thanks are extended to the Monzino Foundation (Milan, Italy), for its generous gift of the Zeiss LSM 510 Meta confocal microscope. This work was supported by Telethon (grant GGP07010) and by the CAR-IPLO Foundation. E. F. was a doctoral student supported by the University of Milan.	Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BASSETTI M, 1995, ENDOCRINOLOGY, V136, P1168, DOI 10.1210/en.136.3.1168; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; BORGESE N, 2009, PROTEIN TRANSPORT EN, P91; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; DESILVESTRIS M, 1995, FEBS LETT, V370, P69, DOI 10.1016/0014-5793(95)00797-D; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Sprocati T, 2006, J CELL SCI, V119, P3249, DOI 10.1242/jcs.03058; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	40	75	78	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2010	24	5					1419	1430		10.1096/fj.09-147850	http://dx.doi.org/10.1096/fj.09-147850			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20008544				2022-12-25	WOS:000277158900015
J	Petersen, M; Pardali, E; van der Horst, G; Cheung, H; van den Hoogen, C; van der Pluijm, G; ten Dijke, P				Petersen, M.; Pardali, E.; van der Horst, G.; Cheung, H.; van den Hoogen, C.; van der Pluijm, G.; ten Dijke, P.			Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis	ONCOGENE			English	Article						angiogenesis; breast cancer; metastasis; Smad; TGF-beta	BETA TYPE-I; TGF-BETA; SUPPRESSES METASTASIS; ENHANCES TUMORIGENESIS; MESENCHYMAL TRANSITION; KINASE INHIBITOR; VEGF PRODUCTION; MAMMARY-TUMOR; GROWTH; TGF-BETA-1	Transforming growth factor (TGF)-beta can suppress and promote breast cancer progression. How TGF-beta elicits these dichotomous functions and which roles the principle intracellular effector proteins Smad2 and Smad3 have therein, is unclear. Here, we investigated the specific functions of Smad2 and Smad3 in TGF-beta-induced responses in breast cancer cells in vitro and in a mouse model for breast cancer metastasis. We stably knocked down Smad2 or Smad3 expression in MDA-MB-231 breast cancer cells. The TGF-beta-induced Smad3-mediated transcriptional response was mitigated and enhanced by Smad3 and Smad2 knockdown, respectively. This response was also seen for TGF-beta-induced vascular endothelial growth factor (VEGF) expression. TGF-beta induction of key target genes involved in bone metastasis, were found to be dependent on Smad3 but not Smad2. Strikingly, whereas knockdown of Smad3 in MDA-MB-231 resulted in prolonged latency and delayed growth of bone metastasis, Smad2 knockdown resulted in a more aggressive phenotype compared with control MDA-MB-231 cells. Consistent with differential effects of Smad knockdown on TGF-beta-induced VEGF expression, these opposing effects of Smad2 versus Smad3 could be directly correlated with divergence in the regulation of tumor angiogenesis in vivo. Thus, Smad2 and Smad3 differentially affect breast cancer bone metastasis formation in vivo. Oncogene (2010) 29, 1351-1361; doi:10.1038/onc.2009.426; published online 14 December 2009	[Petersen, M.; Pardali, E.; ten Dijke, P.] Dept Mol Cell Biol, Leiden, Netherlands; [Petersen, M.; Pardali, E.; ten Dijke, P.] Ctr Biomed Genet, Leiden, Netherlands; [Petersen, M.; van der Horst, G.; Cheung, H.; van den Hoogen, C.; van der Pluijm, G.] Leiden Univ, Med Ctr, Dept Urol, NL-2300 RC Leiden, Netherlands; [van der Pluijm, G.] Leiden Univ, Med Ctr, Dept Endocrinol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Pluijm, G (corresponding author), Leiden Univ, Med Ctr, Dept Urol & Endocrinol, J3-100,POB 9600, NL-2300 RC Leiden, Netherlands.	G.van_der_Pluijm@lumc.nl	Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; van der Horst, Geertje/0000-0003-1696-160X	Dutch Cancer Society [UL 2005-3371]; Ludwig Institute for Cancer Research; European Union [005428, 504743, 503224, 518198]	Dutch Cancer Society(KWF Kankerbestrijding); Ludwig Institute for Cancer Research; European Union(European Commission)	We thank Martine Deckers and Maarten van Dinther for their initial studies and members of our research group for help and suggestions during the course of this work. We are grateful to Lukas Hawinkels and Hein Verspaget for assistance with VEGF ELISA measurements, Kuber Sampath (Genzyme) for BMP6, Ken Iwata (OSI Pharmaceuticals) for TGF-beta 3 and Dr Philippe Clezardin for the MDA-MB-231 subclone BO2. This work was supported by the Dutch Cancer Society (UL 2005-3371), Ludwig Institute for Cancer Research and grants from the Sixth European Union Framework Programme, that is, the EpiplastCarcinoma Marie Curie RTN (project 005428), Angiotargeting (project 504743), BRECOSM (project 503224) and Tumor-Host Genomics (project 518198).	Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Buijs JT, 2009, CANCER LETT, V273, P177, DOI 10.1016/j.canlet.2008.05.044; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Desruisseau S, 2006, BRIT J CANCER, V94, P239, DOI 10.1038/sj.bjc.6602920; Donovan D, 1997, ANN SURG ONCOL, V4, P621, DOI 10.1007/BF02303745; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Ghellal A, 2000, ANTICANCER RES, V20, P4413; Heffelfinger SC, 1999, CLIN CANCER RES, V5, P2867; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Isogai C, 2001, CANCER RES, V61, P5587; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kirkbride KC, 2003, EXPERT OPIN BIOL TH, V3, P251; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V327, P393, DOI 10.1016/j.bbrc.2004.12.032; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; LaGamba D, 2005, DEV DYNAM, V234, P132, DOI 10.1002/dvdy.20489; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsui J, 2008, CLIN CANCER RES, V14, P5459, DOI 10.1158/1078-0432.CCR-07-5270; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sheen-Chen SM, 2001, ARCH SURG-CHICAGO, V136, P937, DOI 10.1001/archsurg.136.8.937; Tannehill-Gregg SH, 2004, VET PATHOL, V41, P278, DOI 10.1354/vp.41-3-278; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tian F, 2004, CANCER RES, V64, P4523, DOI 10.1158/0008-5472.CAN-04-0030; Tian F, 2003, CANCER RES, V63, P8284; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Xie W, 2002, CANCER RES, V62, P497; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	51	137	140	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1351	1361		10.1038/onc.2009.426	http://dx.doi.org/10.1038/onc.2009.426			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	20010874				2022-12-25	WOS:000275170600010
J	Koehl, GE; Spitzner, M; Ousingsawat, J; Schreiber, R; Geissler, EK; Kunzelmann, K				Koehl, G. E.; Spitzner, M.; Ousingsawat, J.; Schreiber, R.; Geissler, E. K.; Kunzelmann, K.			Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice	ONCOGENE			English	Article						mTOR; familial adenomatous polyposis; ion channels; APCMin/ plus mice; rapamycin; Sirolimus	GATED POTASSIUM CHANNELS; K+ CHANNELS; ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER; COLONIC-CARCINOMA; APC GENE; CELLS; PROLIFERATION; MTOR; COMBINATION	The adenomatous polyposis coli (APC) gene is mutated in familial adenomatous polyposis. Mice with a heterozygous APC(Min) mutation develop multiple intestinal neoplasia (Min) leading to premature death. Early in colorectal carcinogenesis, APC(Min/+) mice show enhanced Akt-mammalian target of rapamycin (mTOR) signaling, which is paralleled by upregulation of oncogenic K+ channels. In this study, we tested the effect of mTOR inhibition with rapamycin on tumor formation in APC(Min/+) mice and evaluated ion channel regulation. We found that continuous long-term rapamycin treatment of APC(Min/+) mice dramatically inhibits intestinal neoplasia. Moreover, although untreated APC(Min/+) mice lose weight, experience intestinal bleeding and succumb to multiple neoplasia by 22.3 +/- 1.4 weeks of age, mice treated with rapamycin maintain stable weight and survive long term (39.6 +/- 3.4 weeks), with more than 30% surviving > 1 year. Impressively, abnormalities in colonic electrolyte transport typical for APC(Min/+) mice are abolished, along with the suppression of epithelial Na+ channel (ENaC) and oncogenic K+ ion channels BK, Elk1 and Erg1, both functionally and at mRNA levels. These results show that continuous prophylaxis by rapamycin markedly inhibits the development of APC mutation-related polyposis, and suggest a novel contributing mechanism of action through the blockade of intestinal oncogenic ion channels. Oncogene (2010) 29, 1553-1560; doi:10.1038/onc.2009.435; published online 7 December 2009	[Koehl, G. E.; Geissler, E. K.] Univ Regensburg, Univ Hosp Regensburg, Dept Surg, Regensburg, Bavaria, Germany; [Spitzner, M.; Ousingsawat, J.; Schreiber, R.; Kunzelmann, K.] Univ Regensburg, Dept Physiol, Regensburg, Germany	University of Regensburg; University of Regensburg	Koehl, GE (corresponding author), Univ Regensburg, Univ Hosp Regensburg, Dept Surg, Franz Josef Str Allee 11,H4, Regensburg, Bavaria, Germany.	gudrun.koehl@klinik.uni-regensburg.de	Geissler, Edward/R-4131-2016; Schreiber, Robert/Q-7550-2019	Kunzelmann, Karl/0000-0002-4583-7037; Spitzner, Melanie/0000-0002-3673-0625	Deutsche Forschungsgemeinschaft [SCHR 752/2-2, SFB699, KU 756/8-2]; Wilhelm Sander-Stiftung [2005.063.1]; Roche Organ Transplant Research Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; Roche Organ Transplant Research Foundation	We thank Anna Hoehn, Astrid Schwend and Ernestine Tartler for their excellent technical assistance. This study was supported by grants from the Deutsche Forschungsgemeinschaft to RS and KK (SCHR 752/2-2, SFB699, KU 756/8-2), the Wilhelm Sander-Stiftung (2005.063.1; to KK) and the Roche Organ Transplant Research Foundation (to EKG).	Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gaber AO, 2008, TRANSPLANTATION, V86, P1187, DOI 10.1097/TP.0b013e318187bab0; Guba M, 2005, TRANSPL INT, V18, P89, DOI 10.1111/j.1432-2277.2004.00026.x; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; KOEHL GE, 2005, TRANSPLANT REV, V19, P20; Koehl GE, 2006, TRANSPLANTATION, V82, P741, DOI 10.1097/01.tp.0000233852.75162.74; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Moran AE, 2004, J BIOL CHEM, V279, P43261, DOI 10.1074/jbc.M404276200; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; Otulakowski G, 2007, AM J RESP CELL MOL, V37, P457, DOI 10.1165/rcmb.2007-0055OC; Ousingsawat J, 2008, PFLUG ARCH EUR J PHY, V456, P847, DOI 10.1007/s00424-008-0451-3; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2005, J MEMBRANE BIOL, V205, P115, DOI 10.1007/s00232-005-0776-1; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Puntheeranurak S, 2007, CELL PHYSIOL BIOCHEM, V19, P77, DOI 10.1159/000099194; Schreiber R, 2005, J MEMBRANE BIOL, V205, P129, DOI 10.1007/s00232-005-0778-z; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Swamy MV, 2006, CANCER RES, V66, P7370, DOI 10.1158/0008-5472.CAN-05-4619; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Yao XQ, 1999, LIFE SCI, V65, P55, DOI 10.1016/S0024-3205(99)00218-0; Zhang YQ, 2003, FEBS LETT, V534, P125, DOI 10.1016/S0014-5793(02)03804-8	32	43	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2010	29	10					1553	1560		10.1038/onc.2009.435	http://dx.doi.org/10.1038/onc.2009.435			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19966863				2022-12-25	WOS:000275392400013
J	Yao, HW; Hwang, JW; Moscat, J; Diaz-Meco, MT; Leitges, M; Kishore, N; Li, X; Rahman, I				Yao, Hongwei; Hwang, Jae-Woong; Moscat, Jorge; Diaz-Meco, Maria T.; Leitges, Michael; Kishore, Nandini; Li, Xiong; Rahman, Irfan			Protein Kinase C zeta Mediates Cigarette Smoke/Aldehyde- and Lipopolysaccharide-induced Lung Inflammation and Histone Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; HUMAN ALVEOLAR MACROPHAGES; PKC-ZETA; PHOSPHATIDYLINOSITOL 3-KINASE; EPITHELIAL-CELLS; GENE-EXPRESSION; MOUSE LUNG; IKK-ALPHA	Atypical protein kinase C (PKC) zeta is an important regulator of inflammation through activation of the nuclear factor-kappa B (NF-kappa B) pathway. Chromatin remodeling on pro-inflammatory genes plays a pivotal role in cigarette smoke (CS)- and lipopolysaccharide (LPS)-induced abnormal lung inflammation. However, the signaling mechanism whereby chromatin remodeling occurs in CS-and LPS-induced lung inflammation is not known. We hypothesized that PKC zeta is an important regulator of chromatin remodeling, and down-regulation of PKC zeta ameliorates lung inflammation by CS and LPS exposures. We determined the role and molecular mechanism of PKC zeta in abnormal lung inflammatory response to CS and LPS exposures in PKC zeta-deficient (PKC zeta(-/-)) and wild-type mice. Lung inflammatory response was decreased in PKC zeta(-/-) mice compared with WT mice exposed to CS and LPS. Moreover, inhibition of PKC zeta by a specific pharmacological PKC zeta inhibitor attenuated CS extract-, reactive aldehydes (present in CS)-, and LPS-mediated pro-inflammatory mediator release from macrophages. The mechanism underlying these findings is associated with decreased RelA/p65 phosphorylation (Ser311) and translocation of the RelA/p65 subunit of NF-kappa B into the nucleus. Furthermore, CS/reactive aldehydes and LPS exposures led to activation and translocation of PKC zeta into the nucleus where it forms a complex with CREB-binding protein (CBP) and acetylated RelA/p65 causing histone phosphorylation and acetylation on promoters of pro-inflammatory genes. Taken together, these data suggest that PKC zeta plays an important role in CS/aldehyde-and LPS-induced lung inflammation through acetylation of RelA/p65 and histone modifications via CBP. These data provide new insights into the molecular mechanisms underlying the pathogenesis of chronic inflammatory lung diseases.	[Yao, Hongwei; Hwang, Jae-Woong; Rahman, Irfan] Univ Rochester, Med Ctr, Lung Biol & Dis Program, Dept Environm Med, Rochester, NY 14642 USA; [Moscat, Jorge; Diaz-Meco, Maria T.; Leitges, Michael] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45237 USA; [Kishore, Nandini; Li, Xiong] Pfizer Res Labs, Dept Biol Sci, St Louis, MO 63167 USA	University of Rochester; University System of Ohio; University of Cincinnati; Pfizer	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Lung Biol & Dis Program, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Leitges, Michael/AAN-1953-2021; Yao, Hongwei/G-6444-2010	Leitges, Michael/0000-0003-4203-6995; Diaz-Meco, Maria/0000-0003-0147-0998	NIEHS Environmental Health Science Center [R01-HL085613, R01-HL097751, P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097751, R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIEHS Environmental Health Science Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL085613 and R01-HL097751 and Grant P30-ES01247 from the NIEHS Environmental Health Science Center.	BARNES PJ, 2004, J COPD, V1, P59; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Calcerrada MC, 2002, FEBS LETT, V514, P361, DOI 10.1016/S0014-5793(02)02401-8; Carnevali S, 1998, AM J PHYSIOL-LUNG C, V274, pL591, DOI 10.1152/ajplung.1998.274.4.L591; Chakrabarti S, 2008, MICROCIRCULATION, V15, P555, DOI 10.1080/10739680801949732; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cockerill PN, 1996, CELL GROWTH DIFFER, V7, P917; Corradi M, 2003, AM J RESP CRIT CARE, V167, P1380, DOI 10.1164/rccm.200210-1253OC; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; Dallot E, 2005, BIOCHIMIE, V87, P513, DOI 10.1016/j.biochi.2005.02.009; de Kozak Y, 2007, AM J PATHOL, V170, P1241, DOI 10.2353/ajpath.2007.060236; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Engdahl R, 2007, BIOCHEM BIOPH RES CO, V359, P88, DOI 10.1016/j.bbrc.2007.05.057; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Fujioka K, 2006, ENVIRON TOXICOL, V21, P47, DOI 10.1002/tox.20153; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Garrett S, 2008, INFLAMMATION, V31, P235, DOI 10.1007/s10753-008-9070-6; Guo H, 2009, J LEUKOCYTE BIOL, V85, P911, DOI 10.1189/jlb.0708429; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Koch A, 2004, AM J RESP CELL MOL, V30, P342, DOI 10.1165/rcmb.2003-0122OC; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Lapperre TS, 2007, CHEST, V131, P53, DOI 10.1378/chest.06-0796; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Marchisio M, 2005, J CELL PHYSIOL, V205, P32, DOI 10.1002/jcp.20364; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Mauderly JL, 2004, TOXICOL SCI, V81, P280, DOI 10.1093/toxsci/kfh203; Monick MM, 2000, J IMMUNOL, V165, P4632, DOI 10.4049/jimmunol.165.8.4632; Monick MM, 1999, J IMMUNOL, V162, P3005; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Najjar I, 2005, J VIROL, V79, P4936, DOI 10.1128/JVI.79.8.4936-4943.2005; Neri LM, 1999, FASEB J, V13, P2299, DOI 10.1096/fasebj.13.15.2299; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Samten B, 2008, J IMMUNOL, V181, P2056, DOI 10.4049/jimmunol.181.3.2056; Savkovic SD, 2003, AM J PHYSIOL-CELL PH, V285, pC512, DOI 10.1152/ajpcell.00444.2002; Sethi JM, 2000, CLIN CHEST MED, V21, P67, DOI 10.1016/S0272-5231(05)70008-3; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P637, DOI 10.1016/S0278-6915(00)00051-X; STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314; Syed DN, 2007, ONCOGENE, V26, P673, DOI 10.1038/sj.onc.1209829; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Thatcher TH, 2005, AM J PHYSIOL-LUNG C, V289, pL322, DOI 10.1152/ajplung.00039.2005; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; van Houwelingen AH, 2008, FASEB J, V22, P3403, DOI 10.1096/fj.07-096230; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Xin MG, 2007, J BIOL CHEM, V282, P21268, DOI 10.1074/jbc.M701613200; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	76	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5405	5416		10.1074/jbc.M109.041418	http://dx.doi.org/10.1074/jbc.M109.041418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007975	Green Published, hybrid			2022-12-25	WOS:000275327200034
J	Zhang, H; Verkman, AS				Zhang, Hua; Verkman, A. S.			Aquaporin-1 Tunes Pain Perception by Interaction with Na(v)1.8 Na+ Channels in Dorsal Root Ganglion Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOCICEPTIVE SENSORY NEURONS; WATER CHANNELS; INFLAMMATORY PAIN; SLOW INACTIVATION; SODIUM-CHANNELS; DRG NEURONS; DEPENDENT INHIBITION; FUNCTIONAL-ANALYSIS; ACTION-POTENTIALS; TRANSGENIC MICE	Aquaporin-1 (AQP1) water channels are expressed in the plasma membrane of dorsal root ganglion (DRG) neurons. We found reduced osmotic water permeability in freshly isolated DRG neurons from AQP1(-/-) versus AQP1(-/-) mice. Behavioral studies showed greatly reduced thermal inflammatory pain perception in AQP1(-/-) mice evoked by bradykinin, prostaglandin E-2, and capsaicin as well as reduced cold pain perception. Patch clamp of freshly isolated DRG neurons showed reduced action potential firing in response to current injections. Single action potentials after pulse current injections showed reduced maximum inward current, suggesting impaired Na(v)1.8 Na+ function. Whole-cell Na(v)1.8 Na+ currents in Na(v)1.8-expressing ND7-23 cells showed slowed frequency-dependent inactivation after AQP1 transfection. Immunoprecipitation studies showed AQP1-Na(v)1.8 Na+ interaction, which was verified in live cells by single-particle tracking of quantum dot-labeled AQP1. Our results implicate the involvement of AQP1 in DRG neurons for the perception of inflammatory thermal pain and cold pain, whose molecular basis is accounted for, in part, by reduced Na(v)1.8-dependent membrane Na+ current. AQP1 is, thus, a novel target for pain management.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [DK35124, EY13574, EB00415, DK86125, DK72517, HL73856]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, RC1DK086125, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK35124, EY13574, EB00415, DK86125, DK72517, and HL73856. This work was also supported by a grant from the Guthy-Jackson Charitable Foundation.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Blair NT, 2002, J NEUROSCI, V22, P10277; Blair NT, 2003, J NEUROSCI, V23, P10338; Chahine M, 2005, TRENDS PHARMACOL SCI, V26, P496, DOI 10.1016/j.tips.2005.08.002; Choi JS, 2007, J NEUROPHYSIOL, V97, P1258, DOI 10.1152/jn.01033.2006; Choi JS, 2006, J NEUROPHYSIOL, V96, P97, DOI 10.1152/jn.00854.2005; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Foulkes T, 2007, CHANNELS, V1, P154, DOI 10.4161/chan.4692; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; John VH, 2004, NEUROPHARMACOLOGY, V46, P425, DOI 10.1016/j.neuropharm.2003.09.018; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KOSTYUK PG, 1977, NATURE, V267, P70, DOI 10.1038/267070a0; Lariviere RC, 2002, J NEUROCHEM, V81, P525, DOI 10.1046/j.1471-4159.2002.00853.x; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Liu CJ, 2005, MOL CELL NEUROSCI, V28, P636, DOI 10.1016/j.mcn.2004.11.007; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Oshio K, 2006, BIOCHEM BIOPH RES CO, V341, P1022, DOI 10.1016/j.bbrc.2006.01.062; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; QUANDT FN, 1988, MOL PHARMACOL, V34, P557; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Shields SD, 2007, PAIN, V131, P8, DOI 10.1016/j.pain.2006.11.018; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Solenov EI, 2002, J NEUROSCI METH, V113, P85, DOI 10.1016/S0165-0270(01)00481-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Wang XD, 2009, J NEUROSCI, V29, P5508, DOI 10.1523/JNEUROSCI.4288-08.2009; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zador Z, 2008, FASEB J, V22, P870, DOI 10.1096/fj.07-9468com; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	50	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5896	5906		10.1074/jbc.M109.090233	http://dx.doi.org/10.1074/jbc.M109.090233			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018876	Green Published, hybrid			2022-12-25	WOS:000275327200080
J	Graham, JR; Tullai, JW; Cooper, GM				Graham, Julie R.; Tullai, John W.; Cooper, Geoffrey M.			GSK-3 Represses Growth Factor-inducible Genes by Inhibiting NF-kappa B in Quiescent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FACTOR-BINDING SITES; PHOSPHATIDYLINOSITOL 3-KINASE; IKK-BETA; TRANSCRIPTION; ACTIVATION; SURVIVAL; APOPTOSIS; INSULIN; P65	GSK-3 is active in the absence of growth factor stimulation and generally acts to induce apoptosis or inhibit cell proliferation. We previously identified a subset of growth factor-inducible genes that can also be induced in quiescent T98G cells solely by inhibition of GSK-3 in the absence of growth factor stimulation. Computational predictions verified by chromatin immunoprecipitation assays identified NF-kappa B binding sites in the upstream regions of 75% of the genes regulated by GSK-3. p50 bound to most of these sites in quiescent cells, and for one-third of the genes, binding of p65 to the predicted sites increased upon inhibition of GSK-3. The functional role of p65 in gene induction following inhibition of GSK-3 was demonstrated by RNA interference experiments. Furthermore, inhibition of GSK-3 in quiescent cells resulted in activation of I kappa B kinase, leading to phosphorylation and degradation of I kappa B alpha and nuclear translocation of p65 and p50. Taken together, these results indicate that the high levels of GSK-3 activity in quiescent cells repress gene expression by negatively regulating NF-kappa B through inhibition of I kappa B kinase. This inhibition of NF-kappa B is consistent with the role of GSK-3 in the induction of apoptosis or cell cycle arrest in cells deprived of growth factors.	[Graham, Julie R.; Cooper, Geoffrey M.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA USA; [Tullai, John W.; Cooper, Geoffrey M.] Boston Univ, Dept Biol, Boston, MA USA	Boston University; Boston University	Cooper, GM (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			National Institutes of Health [R01 CA18689]; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA18689.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hurel SJ, 1996, BIOCHEM J, V320, P871, DOI 10.1042/bj3200871; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Sauer T, 2006, BIOINFORMATICS, V22, P430, DOI 10.1093/bioinformatics/bti819; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Terragni J, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-6; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	48	26	26	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4472	4480		10.1074/jbc.M109.053785	http://dx.doi.org/10.1074/jbc.M109.053785			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018891	Green Published, hybrid			2022-12-25	WOS:000275274800025
J	He, YX; Huang, L; Xue, YY; Fei, X; Teng, YB; Rubin-Pitel, SB; Zhao, HM; Zhou, CZ				He, Yong-Xing; Huang, Liang; Xue, Yanyan; Fei, Xue; Teng, Yan-Bin; Rubin-Pitel, Sheryl B.; Zhao, Huimin; Zhou, Cong-Zhao			Crystal Structure and Computational Analyses Provide Insights into the Catalytic Mechanism of 2,4-Diacetylphloroglucinol Hydrolase PhlG from Pseudomonas fluorescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC 2,4-DIACETYLPHLOROGLUCINOL; BIOLOGICAL-CONTROL; BINDING; FOLD; SUPPRESSION; VALIDATION; RESISTANCE; PATHOGENS; SEQUENCE; PROTEIN	2,4-Diacetylphloroglucinol hydrolase PhlG from Pseudomonas fluorescens catalyzes hydrolytic carbon-carbon (C-C) bond cleavage of the antibiotic 2,4-diacetylphloroglucinol to form monoacetylphloroglucinol, a rare class of reactions in chemistry and biochemistry. To investigate the catalytic mechanism of this enzyme, we determined the three-dimensional structure of PhlG at 2.0 angstrom resolution using x-ray crystallography and MAD methods. The overall structure includes a small N-terminal domain mainly involved in dimerization and a C-terminal domain of Bet v1-like fold, which distinguishes PhlG from the classical alpha/beta-fold hydrolases. A dumbbell-shaped substrate access tunnel was identified to connect a narrow interior amphiphilic pocket to the exterior solvent. The tunnel is likely to undergo a significant conformational change upon substrate binding to the active site. Structural analysis coupled with computational docking studies, site-directed mutagenesis, and enzyme activity analysis revealed that cleavage of the 2,4-diacetylphloroglucinol C-C bond proceeds via nucleophilic attack by a water molecule, which is coordinated by a zinc ion. In addition, residues Tyr(121), Tyr(229), and Asn(132), which are predicted to be hydrogen-bonded to the hydroxyl groups and unhydrolyzed acetyl group, can finely tune and position the bound substrate in a reactive orientation. Taken together, these results revealed the active sites and zinc-dependent hydrolytic mechanism of PhlG and explained its substrate specificity as well.	[Rubin-Pitel, Sheryl B.; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [He, Yong-Xing; Huang, Liang; Xue, Yanyan; Fei, Xue; Teng, Yan-Bin; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [He, Yong-Xing; Huang, Liang; Xue, Yanyan; Fei, Xue; Teng, Yan-Bin; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhao, Huimin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhao, HM (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@illinois.edu; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011	Zhou, Cong-Zhao/0000-0002-6881-7151; Fei, Xue/0000-0003-3378-7447				Abbas A, 2004, MICROBIOL-SGM, V150, P2443, DOI 10.1099/mic.0.27033-0; Abbas A, 2002, J BACTERIOL, V184, P3008, DOI 10.1128/JB.184.11.3008-3016.2002; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200; Bottiglieri M, 2006, APPL ENVIRON MICROB, V72, P418, DOI 10.1128/AEM.72.1.418-427.2006; BROADBENT D, 1976, PHYTOCHEMISTRY, V15, P1785, DOI 10.1016/S0031-9422(00)97487-9; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delany I, 2000, MICROBIOL-UK, V146, P537, DOI 10.1099/00221287-146-2-537; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grogan G, 2005, BIOCHEM J, V388, P721, DOI 10.1042/BJ20042038; Grogan G, 2002, J MOL CATAL B-ENZYM, V19, P73, DOI 10.1016/S1381-1177(02)00153-4; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Hermann JC, 2006, ORG BIOMOL CHEM, V4, P206, DOI 10.1039/b512969a; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; KEEL C, 1990, SYMBIOSIS, V9, P327; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Liu SP, 2008, P NATL ACAD SCI USA, V105, P13309, DOI 10.1073/pnas.0708850105; Makinen M W, 1984, Adv Inorg Biochem, V6, P1; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Schleberger C, 2007, J MOL BIOL, V367, P409, DOI 10.1016/j.jmb.2006.12.068; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Schoefer L, 2004, APPL ENVIRON MICROB, V70, P6131, DOI 10.1128/AEM.70.10.6131-6137.2004; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822	46	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4603	4611		10.1074/jbc.M109.044180	http://dx.doi.org/10.1074/jbc.M109.044180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018877	hybrid, Green Published			2022-12-25	WOS:000275274800038
J	Zhao, ML; Zhang, NY; Zurawel, A; Hansen, KC; Liu, CW				Zhao, Minglian; Zhang, Nan-Yan; Zurawel, Ashley; Hansen, Kirk C.; Liu, Chang-Wei			Degradation of Some Polyubiquitinated Proteins Requires an Intrinsic Proteasomal Binding Element in the Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; REGULATORY PARTICLE; TRANSCRIPTION FACTOR; 20S PROTEASOME; ATP BINDING; RECOGNITION; DEUBIQUITINATION; TRANSLOCATION; ASSOCIATION; MECHANISM	Lysine 48-linked polyubiquitin chains usually target proteins for 26 S proteasomal degradation; however, this modification is not a warrant for destruction. Here, we found that efficient degradation of a physiological substrate UbcH10 requires not only an exogenous polyubiquitin chain modification but also its unstructured N-terminal region. Interestingly, the unstructured N-terminal region of UbcH10 directly binds the 19 S regulatory complex of the 26 S proteasome, and it mediates the initiation of substrate translocation. To promote ubiquitin-dependent degradation of the folded domains of UbcH10, its N-terminal region can be displaced by exogenous proteasomal binding elements. Moreover, the unstructured N-terminal region can initiate substrate translocation even when UbcH10 is artificially cyclized without a free terminus. Polyubiquitinated circular UbcH10 is completely degraded by the 26 S proteasome. Accordingly, we propose that degradation of some polyubiquitinated proteins requires two binding interactions: a polyubiquitin chain and an intrinsic proteasomal binding element in the substrates (likely an unstructured region); moreover, the intrinsic proteasomal binding element initiates substrate translocation regardless of its location in the substrates.	[Zhao, Minglian; Zhang, Nan-Yan; Liu, Chang-Wei] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Zurawel, Ashley; Hansen, Kirk C.] Univ Colorado, Denver Sch Med, Prote Core Facil, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, CW (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, POB 6511,Mail Stop 8101,12801 E 17th Ave, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu			American Heart Association; Basil O'Conner Starter Scholar Research Award; American Cancer Society	American Heart Association(American Heart Association); Basil O'Conner Starter Scholar Research Award(March of Dimes); American Cancer Society(American Cancer Society)	This work was supported by grants from the American Heart Association, the Basil O'Conner Starter Scholar Research Award, and the American Cancer Society (to C.-W.L.).	Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoskins JR, 2002, ADV PROTEIN CHEM, V59, P413; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kwok SC, 2003, J BIOL CHEM, V278, P35248, DOI 10.1074/jbc.M305306200; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOETSCHER P, 1991, J BIOL CHEM, V266, P11213; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	43	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4771	4780		10.1074/jbc.M109.060095	http://dx.doi.org/10.1074/jbc.M109.060095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007692	Green Published, hybrid			2022-12-25	WOS:000275274800055
J	Song, YQ; Selak, MA; Watson, CT; Coutts, C; Scherer, PC; Panzer, JA; Gibbs, S; Scott, MO; Willer, G; Gregg, RG; Ali, DW; Bennett, MJ; Balice-Gordon, RJ				Song, Yuanquan; Selak, Mary A.; Watson, Corey T.; Coutts, Christopher; Scherer, Paul C.; Panzer, Jessica A.; Gibbs, Sarah; Scott, Marion O.; Willer, Gregory; Gregg, Ronald G.; Ali, Declan W.; Bennett, Michael J.; Balice-Gordon, Rita J.			Mechanisms Underlying Metabolic and Neural Defects in Zebrafish and Human Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; ACIDURIA TYPE-II; ELECTRON-TRANSFER FLAVOPROTEIN; OXIDATION DISORDERS; RESPIRATORY-CHAIN; BETA-OXIDATION; PPAR-GAMMA; MITOCHONDRIA; DISEASES; ACIDS	In humans, mutations in electron transfer flavoprotein (ETF) or electron transfer flavoprotein dehydrogenase (ETFDH) lead to MADD/glutaric aciduria type II, an autosomal recessively inherited disorder characterized by a broad spectrum of devastating neurological, systemic and metabolic symptoms. We show that a zebrafish mutant in ETFDH, xavier, and fibroblast cells from MADD patients demonstrate similar mitochondrial and metabolic abnormalities, including reduced oxidative phosphorylation, increased aerobic glycolysis, and upregulation of the PPARG-ERK pathway. This metabolic dysfunction is associated with aberrant neural proliferation in xav, in addition to other neural phenotypes and paralysis. Strikingly, a PPARG antagonist attenuates aberrant neural proliferation and alleviates paralysis in xav, while PPARG agonists increase neural proliferation in wild type embryos. These results show that mitochondrial dysfunction, leading to an increase in aerobic glycolysis, affects neurogenesis through the PPARG-ERK pathway, a potential target for therapeutic intervention.	[Song, Yuanquan; Scherer, Paul C.; Panzer, Jessica A.; Gibbs, Sarah; Scott, Marion O.; Balice-Gordon, Rita J.] Univ Penn, Dept Neurosci, Sch Med, Philadelphia, PA 19104 USA; [Selak, Mary A.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Watson, Corey T.; Willer, Gregory; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Coutts, Christopher; Ali, Declan W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bennett, Michael J.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Louisville; University of Alberta; University of Pennsylvania	Song, YQ (corresponding author), Univ Penn, Dept Neurosci, Sch Med, Philadelphia, PA 19104 USA.	rbaliceg@mail.med.upenn.edu	Song, Yuanquan/E-2603-2012	Balice-Gordon, Rita/0000-0002-9950-7965; Gregg, Ronald/0000-0001-5805-224X	NIH [NS050524]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant NS050524 to R. B.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; BENNETT MJ, 1992, ANN CLIN BIOCHEM, V29, P541, DOI 10.1177/000456329202900509; BOHM N, 1982, EUR J PEDIATR, V139, P60, DOI 10.1007/BF00442082; Bonham JR, 1999, J INHERIT METAB DIS, V22, P174, DOI 10.1023/A:1005406205548; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; BROWN CW, 1992, ADV NEAR INFRARED ME, V1, P1; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Fajas L, 2001, NUTR METAB CARDIOVAS, V11, P64; Frerman F. E., 2001, METABOLIC MOL BASES, P2357, DOI DOI 10.1036/OMMBID.131; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Mueller T, 2002, MECH DEVELOP, V117, P123, DOI 10.1016/S0925-4773(02)00194-6; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nam DH, 2007, MOL HUM REPROD, V13, P829, DOI 10.1093/molehr/gam071; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Russell AP, 2003, J CLIN ENDOCR METAB, V88, P5921, DOI 10.1210/jc.2003-030885; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009; Shen JJ, 2000, J INHERIT METAB DIS, V23, P27, DOI 10.1023/A:1005694712583; SHEVELL MI, 1995, PEDIATR NEUROL, V12, P350, DOI 10.1016/0887-8994(95)00049-L; STOCKLER S, 1994, J PEDIATR-US, V124, P601, DOI 10.1016/S0022-3476(05)83142-7; Takanashi J, 1999, PEDIATR NEUROL, V20, P142, DOI 10.1016/S0887-8994(98)00118-0; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Van Hove JLK, 2003, LANCET, V361, P1433, DOI 10.1016/S0140-6736(03)13105-4; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Zannino DA, 2009, J NEUROSCI, V29, P2322, DOI 10.1523/JNEUROSCI.3755-08.2009	40	44	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8329	10.1371/journal.pone.0008329	http://dx.doi.org/10.1371/journal.pone.0008329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020044	Green Submitted, Green Published, gold			2022-12-25	WOS:000272834200004
J	Chung, E; Yamashita, H; Au, P; Tannous, BA; Fukumura, D; Jain, RK				Chung, Euiheon; Yamashita, Hiroshi; Au, Patrick; Tannous, Bakhos A.; Fukumura, Dai; Jain, Rakesh K.			Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases	PLOS ONE			English	Article							BREAST-CANCER CELLS; IN-VIVO; GENE-EXPRESSION; GROWTH; BRAIN; OUTGROWTH; CULTURE; VITRO	Background: Currently, only few techniques are available for quantifying systemic metastases in preclinical model. Thus techniques that can sensitively detect metastatic colonization and assess treatment response in real-time are urgently needed. To this end, we engineered tumor cells to express a naturally secreted Gaussia luciferase (Gluc), and investigated its use as a circulating biomarker for monitoring viable metastatic or primary tumor growth and their treatment responses. Methodology/Principal Findings: We first developed orthotopic primary and metastatic breast tumors with derivative of MDA-MB-231 cells expressing Gluc. We then correlated tumor burden with Gluc activity in the blood and urine along with bioluminescent imaging (BLI). Second, we utilized blood Gluc assay to monitor treatment response to lapatinib in an experimental model of systemic metastasis. We observed good correlation between the primary tumor volume and Gluc concentration in blood (R(2) = 0.84) and urine (R(2) = 0.55) in the breast tumor model. The correlation deviated as a primary tumor grew due to a reduction in viable tumor fraction. This was also supported by our mathematical models for tumor growth to compare the total and viable tumor burden in our model. In the experimental metastasis model, we found numerous brain metastases as well as systemic metastases including bone and lungs. Importantly, blood Gluc assay revealed early growth of metastatic tumors before BLI could visualize their presence. Using secreted Gluc, we localized systemic metastases by BLI and quantitatively monitored the total viable metastatic tumor burden by blood Gluc assay during the course of treatment with lapatinib, a dual tyrosine kinase inhibitor of EGFR and HER2. Conclusion/Significance: We demonstrated secreted Gluc assay accurately reflects the amount of viable cancer cells in primary and metastatic tumors. Blood Gluc activity not only tracks metastatic tumor progression but also serves as a longitudinal biomarker for tumor response to treatments.	[Chung, Euiheon; Yamashita, Hiroshi; Au, Patrick; Fukumura, Dai; Jain, Rakesh K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Edwin L Steele Lab,Dept Radiat Oncol, Boston, MA 02115 USA; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurogenet Unit,Dept Neurol, Boston, MA USA; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Ctr Mol Imaging Res, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chung, E (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Edwin L Steele Lab,Dept Radiat Oncol, Boston, MA 02115 USA.	btannous@hms.harvard.edu; dai@steele.mgh.harvard.edu; jain@steele.mgh.harvard.edu	Chung, Euiheon/A-1801-2009; Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548; Chung, Euiheon/0000-0002-3326-6927	National Cancer Institute [R01-CA96915, R01-CA85140, R01-CA115767, R01-CA126642, P01-CA80124]; Federal Share/National Cancer Institute Proton Beam Program Income;  [R00CA126839];  [P50CA86355-07]; NATIONAL CANCER INSTITUTE [R00CA126839, P01CA080124, T32CA073479, R01CA115767, R01CA085140, P50CA086355, R24CA085140, R01CA126642, R01CA096915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064983] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal Share/National Cancer Institute Proton Beam Program Income; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by R00CA126839 and P50CA86355-07 (BAT), National Cancer Institute grants R01-CA96915 (DF), and R01-CA85140, R01-CA115767, R01-CA126642, P01-CA80124, and Federal Share/National Cancer Institute Proton Beam Program Income grant (RKJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Bao R, 2000, GYNECOL ONCOL, V78, P373, DOI 10.1006/gyno.2000.5925; Bao RD, 2002, J NATL CANCER I, V94, P522; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hiramatsu N, 2006, J IMMUNOL METHODS, V315, P202, DOI 10.1016/j.jim.2006.07.003; Kim HJ, 2008, J NUCL MED, V49, P1686, DOI 10.2967/jnumed.108.052894; Korpal M, 2009, NAT MED, V15, P960, DOI 10.1038/nm.1943; Meng YM, 2005, LAB INVEST, V85, P1429, DOI 10.1038/labinvest.3700341; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	21	68	79	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8316	10.1371/journal.pone.0008316	http://dx.doi.org/10.1371/journal.pone.0008316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016816	gold, Green Submitted, Green Published			2022-12-25	WOS:000272833800012
J	Ruiz, S; Santos, E; Bustelo, XR				Ruiz, Sergio; Santos, Eugenio; Bustelo, Xose R.			The Use of Knockout Mice Reveals a Synergistic Role of the Vav1 and Rasgrf2 Gene Deficiencies in Lymphomagenesis and Metastasis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; EXPRESSION SIGNATURE; RECEPTOR; ONCOGENE; RAS; OVEREXPRESSION; PROGRESSION; MOLECULES	Background: Vav1 and RasGRF2 are GDP/GTP exchange factors for Ras superfamily GTPases with roles in the development and/or effector functions of T-lymphocytes. Methodology/Principal Findings: Given that the phenotype of Vav1(-/-), Rasgrf2(-/-) and Vav1(-/-); Rasgrf2(-/-) mice has been studied so far in young animals, we decided to explore the long-term consequences of the inactivation of those loci in the immune system. Unexpectedly, our studies revealed that the inactivation of the Vav1 proto-oncogene favors the formation of lymphoblastic lymphoma-like tumors in aging mice. Those tumors, that can be found either localized exclusively inside the thymus or widely disseminated in hematopoietic and non-hematopoietic tissues, are composed of CD3(+) lymphoblasts that display heterogeneous combinations of CD4 and CD8 surface markers. Interestingly, the additional deletion of the Rasgrf2 gene induces a shortening in the latency period for the development of those tumors, an increase in the percentage of disseminated tumors outside the thymus and, as a result, higher mortality rates. Conclusions/Significance: These data reveal unexpected negative roles for Vav1 and RasGRF2 in different stages of T-cell lymphoma progression. They also suggest that the inactivation of Vav1 function may represent an inadequate strategy to treat T-cell lymphomas, especially those associated with low levels of Rasgrf2 gene expression.	Univ Salamanca, CSIC, Ctr Invest Canc, E-37008 Salamanca, Spain; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Ruiz, S (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xbustelo@usal.es	Bustelo, Xose R./A-9526-2010; Bustelo, Xose R./AAD-2081-2022; Ruiz, Sergio/G-1561-2016	Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072; Ruiz, Sergio/0000-0002-0177-6965	NIH [5R01-CA73735-13]; Spanish Ministry of Science and Innovation [SAF2006-01789]; Red Tematica de Investigacion Cooperativa en Cancer [RD06/0020/0001]; Castilla y Leon Autonomous Government [SA053A05, GR97]; Spanish Ministry of Science and Innovation; Ramon Areces Foundation; Foundation for Cancer Research at the University of Salamanca; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer; Castilla y Leon Autonomous Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon Areces Foundation; Foundation for Cancer Research at the University of Salamanca; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	X. R. B. work is supported by grants from the NIH (5R01-CA73735-13), the Spanish Ministry of Science and Innovation (SAF2006-01789), the Red Tematica de Investigacion Cooperativa en Cancer (RD06/0020/0001), and the Castilla y Leon Autonomous Government (SA053A05 and GR97). S. R. was supported by a Juan de la Cierva postdoctoral position funded by the Spanish Ministry of Science and Innovation. The activities of the Centro de Investigacion del Cancer are partially supported by the Ramon Areces Foundation and by the Foundation for Cancer Research at the University of Salamanca. X. R. B. lab has been recognized as a Consolidated Cancer Research Group by the Spanish Association against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhojwani D, 2008, J CLIN ONCOL, V26, P4376, DOI 10.1200/JCO.2007.14.4519; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Chen H, 2006, ONCOL REP, V15, P1281; Cleverley SC, 2000, ONCOGENE, V19, P13, DOI 10.1038/sj.onc.1203259; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; DUMONT C, 2008, BLOOD; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Lee KW, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-158; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Prieto-Sanchez RM, 2006, BRIT J HAEMATOL, V133, P642, DOI 10.1111/j.1365-2141.2006.06094.x; Qiu CP, 2003, ONCOGENE, V22, P1253, DOI 10.1038/sj.onc.1206233; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Ruiz S, 2007, MOL CELL BIOL, V27, P8127, DOI 10.1128/MCB.00912-07; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Sauzeau V, 2007, MOL BIOL CELL, V18, P943, DOI 10.1091/mbc.E06-09-0877; Saveliev A, 2009, NAT IMMUNOL, V10, P361, DOI 10.1038/ni.1709; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	49	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8229	10.1371/journal.pone.0008229	http://dx.doi.org/10.1371/journal.pone.0008229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011522	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300011
J	Gonzalez, MJ; Plummer, EM; Rae, CS; Manchester, M				Gonzalez, Maria J.; Plummer, Emily M.; Rae, Chris S.; Manchester, Marianne			Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RESPIRATORY SYNCYTIAL VIRUS; MEMBRANE PROTEIN F; PLANT-VIRUS; T-CELLS; PSEUDOMONAS-AERUGINOSA; SUBEPITHELIAL DOME; PEYERS PATCH; BONE-MARROW; FLT3 LIGAND	Background: Plant viruses such as Cowpea mosaic virus (CPMV) are increasingly being developed for applications in nanobiotechnology including vaccine development because of their potential for producing large quantities of antigenic material in plant hosts. In order to improve efficacy of viral nanoparticles in these types of roles, an investigation of the individual cell types that interact with the particles is critical. In particular, it is important to understand the interactions of a potential vaccine with antigen presenting cells (APCs) of the immune system. CPMV was previously shown to interact with vimentin displayed on cell surfaces to mediate cell entry, but the expression of surface vimentin on APCs has not been characterized. Methodology: The binding and internalization of CPMV by several populations of APCs was investigated both in vitro and in vivo by flow cytometry and fluorescence confocal microscopy. The association of the particles with mouse gastrointestinal epithelium and Peyer's patches was also examined by confocal microscopy. The expression of surface vimentin on APCs was also measured. Conclusions: We found that CPMV is bound and internalized by subsets of several populations of APCs both in vitro and in vivo following intravenous, intraperitoneal, and oral administration, and also by cells isolated from the Peyer's patch following gastrointestinal delivery. Surface vimentin was also expressed on APC populations that could internalize CPMV. These experiments demonstrate that APCs capture CPMV particles in vivo, and that further tuning the interaction with surface vimentin may facilitate increased uptake by APCs and priming of antibody responses. These studies also indicate that CPMV particles likely access the systemic circulation following oral delivery via the Peyer's patch.	[Gonzalez, Maria J.; Plummer, Emily M.; Rae, Chris S.; Manchester, Marianne] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Gonzalez, MJ (corresponding author), Anaphore Inc, La Jolla, CA USA.	mmanchester@ucsd.edu		Manchester, Marianne/0000-0002-7143-5744	 [R01CA112075]; NATIONAL CANCER INSTITUTE [R01CA112075] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work has been supported by grant number R01CA112075 (http://www.nih.gov/). Extra funding includes the Gustavus and Louise Pfeiffer Research Foundation Grant (http://foundationcenter.org/grantmaker/pfeiffer/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bachtarzi H, 2008, EXPERT OPIN DRUG DEL, V5, P1231, DOI [10.1517/17425240802507636, 10.1517/17425240802507636 ]; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; Brennan FR, 1999, MICROBIOL-SGM, V145, P211, DOI 10.1099/13500872-145-1-211; Brennan FR, 1999, MICROBIOL-SGM, V145, P2061, DOI 10.1099/13500872-145-8-2061; Butz EA, 1998, J IMMUNOL, V160, P2139; Canizares MC, 2005, EXPERT REV VACCINES, V4, P687, DOI 10.1586/14760584.4.5.687; Canizares MC, 2005, IMMUNOL CELL BIOL, V83, P263, DOI 10.1111/j.1440-1711.2005.01339.x; Chatterji A, 2004, CHEM BIOL, V11, P855, DOI 10.1016/j.chembiol.2004.04.011; Christen U, 2004, J CLIN INVEST, V114, P1290, DOI 10.1172/JCI200422557; Coester C, 2006, EUR J PHARM BIOPHARM, V62, P306, DOI 10.1016/j.ejpb.2005.09.009; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dalsgaard K, 1997, NAT BIOTECHNOL, V15, P248, DOI 10.1038/nbt0397-248; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; HAHN K, 1994, VIROLOGY, V201, P330, DOI 10.1006/viro.1994.1298; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jiang LB, 2006, VACCINE, V24, P109, DOI 10.1016/j.vaccine.2005.09.060; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Koudelka KJ, 2007, J VIROL, V81, P1632, DOI 10.1128/JVI.00960-06; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Lin TW, 2003, ADV VIRUS RES, V62, P167, DOI 10.1016/S0065-3527(03)62004-X; Liu L, 2005, VACCINE, V23, P1788, DOI 10.1016/j.vaccine.2004.11.006; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McCormick AA, 2008, EXPERT REV VACCINES, V7, P33, DOI 10.1586/14760584.7.1.33; MCLAIN L, 1995, AIDS RES HUM RETROV, V11, P327, DOI 10.1089/aid.1995.11.327; McLain L, 1996, VACCINE, V14, P799, DOI 10.1016/0264-410X(95)00229-T; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Nuzzaci M, 2007, ARCH VIROL, V152, P915, DOI 10.1007/s00705-006-0916-7; Piazzolla G, 2005, J CLIN IMMUNOL, V25, P142, DOI 10.1007/s10875-005-2820-4; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Porta C, 2003, VIROLOGY, V310, P50, DOI 10.1016/S0042-6822(03)00140-5; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rae CS, 2005, VIROLOGY, V343, P224, DOI 10.1016/j.virol.2005.08.017; Rennermalm A, 2001, VACCINE, V19, P3376, DOI 10.1016/S0264-410X(01)00080-9; Sapsford KE, 2006, BIOSENS BIOELECTRON, V21, P1668, DOI 10.1016/j.bios.2005.09.003; Sedlik C, 1997, P NATL ACAD SCI USA, V94, P7503, DOI 10.1073/pnas.94.14.7503; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Singh P., 2006, DRUG DEVELOP RES, V67, P1; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; STEINMETZ NF, 2009, CURR TOP MICROBIOL I, P23; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tsunetsugu-Yokota Y, 2003, J VIROL, V77, P10250, DOI 10.1128/JVI.77.19.10250-10259.2003; Wang Q, 2002, CHEM BIOL, V9, P805, DOI 10.1016/S1074-5521(02)00165-5; Wang X, 2005, IMMUNOL LETT, V98, P123, DOI 10.1016/j.imlet.2004.10.028; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Yusibov V, 2005, VACCINE, V23, P2261, DOI 10.1016/j.vaccine.2005.01.039	58	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7981	10.1371/journal.pone.0007981	http://dx.doi.org/10.1371/journal.pone.0007981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956734	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827300023
J	Liang, LM; Meng, ZH; Ye, FP; Yang, JK; Liu, SQ; Sun, YN; Guo, Y; Mi, QL; Huang, XW; Zou, CG; Rao, ZH; Lou, ZY; Zhang, KQ				Liang, Lianming; Meng, Zhaohui; Ye, Fengping; Yang, Jinkui; Liu, Shuqun; Sun, Yuna; Guo, Yu; Mi, Qili; Huang, Xiaowei; Zou, Chenggang; Rao, Zihe; Lou, Zhiyong; Zhang, Ke-Qin			The crystal structures of two cuticle-degrading proteases from nematophagous fungi and their contribution to infection against nematodes	FASEB JOURNAL			English	Article						Ver112; PL646; serine protease; nematocidal virulence	EXTRACELLULAR SERINE-PROTEASE; PAECILOMYCES-LILACINUS; MELOIDOGYNE-INCOGNITA; ARTHROBOTRYS-OLIGOSPORA; TRAPPING FUNGUS; PROTEINASE-K; LECANICILLIUM-PSALLIOTAE; CAENORHABDITIS-ELEGANS; NEMATOCIDAL ACTIVITY; BIOLOGICAL-ACTIVITY	Cuticle-degrading proteases are involved in the breakdown of cuticle/eggshells of nematodes or insects, a hard physical barrier against fungal infections. Understanding the 3-dimensional structures of these proteins can provide crucial information for improving the effectiveness of these fungi in biocontrol applications, e. g., by targeted protein engineering. However, the structures of these proteases remain unknown. Here, we report the structures of two cuticle-degrading proteases from two species of nematophagous fungi. The two structures were solved with X-ray crystallography to resolutions of 1.65 angstrom (Ver112) and 2.1 angstrom (PL646), respectively. Crystal structures of PL646 and Ver112 were found to be very similar to each other, and similar to that of proteinase K from another fungus Tritirachium album. Differences between the structures were found among residues of the substrate binding sites (S1 and S4). Experimental studies showed that the enzymes differed in hydrolytic activity to synthetic peptide substrates. Our analyses of the hydrophobic/hydrophilic and electrostatic features of these two proteins suggest that their surfaces likely play important roles during fungal infection against nematodes. The two crystal structures provide a solid basis for investigating the relationship between structure and function of cuticle-degrading proteases.-Liang, L., Lou, Z., Ye, F., Yang, J., Liu, S., Sun, Y., Guo, Y., Mi, Q., Huang, X., Zou, C., Meng, Z., Rao, Z., Zhang, K.-Q. The crystal structures of two cuticle-degrading proteases from nematophagous fungi and their contribution to infection against nematodes. FASEB J. 24, 1391-1400 (2010). www.fasebj.org	[Liang, Lianming; Meng, Zhaohui; Ye, Fengping; Yang, Jinkui; Liu, Shuqun; Mi, Qili; Huang, Xiaowei; Zou, Chenggang; Zhang, Ke-Qin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Liang, Lianming; Meng, Zhaohui; Ye, Fengping; Yang, Jinkui; Liu, Shuqun; Mi, Qili; Huang, Xiaowei; Zou, Chenggang; Zhang, Ke-Qin] Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming 650091, Peoples R China; [Meng, Zhaohui] Kunming Med Univ, Affiliated Hosp 1, Dept Cardiol, Mol Cardiol Lab, Kunming, Peoples R China; [Sun, Yuna; Guo, Yu; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Tsinghua Nankai Inst Biophys Joint Res Grp Struct, Beijing 100084, Peoples R China	Yunnan University; Yunnan University; Kunming Medical University; Tsinghua University	Zhang, KQ (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, 2 N Cuihu Rd, Kunming 650091, Peoples R China.	louzy@xtal.tsinghua.edu.cn; kqzhang111@yahoo.com.cn	zhang, ke/AAH-8217-2019; Liang, Lian-Ming/AAL-3861-2021; Rao, Zihe/HCH-6944-2022	Yang, Jinkui/0000-0002-3106-2189	National Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [30630003, 30660107, 30960229, 30860011, 30860278, 30221003]; Department of Science and Technology of Yunnan Province [2007C007Z, 2006C0071M, 2007C0001R, 2009CI052]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province	The authors are grateful to Prof. Jianping Xu (Department of Biology, McMaster University, Hamilton, ON, Canada), for valuable comments and critical discussion. This work was funded by the National Basic Research Program of China (2007CB411600), by projects from the National Natural Science Foundation of China (30630003, 30660107, 30960229, 30860011, 30860278, and 30221003), and the Department of Science and Technology of Yunnan Province (2007C007Z, 2006C0071M, 2007C0001R, and 2009CI052).	Agarwala S. P., 1999, Journal of Communicable Diseases, V31, P193; Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basualdo JA, 2000, PARASITOL RES, V86, P854, DOI 10.1007/PL00008513; BETZEL C, 1988, EUR J BIOCHEM, V178, P155, DOI 10.1111/j.1432-1033.1988.tb14440.x; BETZEL C, 1990, PROTEIN ENG, V3, P161, DOI 10.1093/protein/3.3.161; Bidochka MJ, 2000, CAN J MICROBIOL, V46, P1138, DOI 10.1139/cjm-46-12-1138; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; BONANTS PJM, 1995, MICROBIOL-UK, V141, P775, DOI 10.1099/13500872-141-4-775; Brand D, 2004, APPL BIOCHEM BIOTECH, V118, P81, DOI 10.1385/ABAB:118:1-3:081; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CABANILLAS E, 1989, J NEMATOL, V21, P164; CABANILLAS E, 1989, J NEMATOL, V21, P115; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Dong LQ, 2007, NEMATOLOGY, V9, P743, DOI 10.1163/156854107782024802; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunasekera TS, 2000, CAN J MICROBIOL, V46, P775, DOI 10.1139/cjm-46-9-775; HIMMELHOCH S, 1978, EXP PARASITOL, V45, P208, DOI 10.1016/0014-4894(78)90061-9; Huang XW, 2004, RES MICROBIOL, V155, P811, DOI 10.1016/j.resmic.2004.07.003; JATALA P, 1980, J NEMATOL, V12, P226; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOSHI L, 1995, FEMS MICROBIOL LETT, V125, P211, DOI 10.1111/j.1574-6968.1995.tb07360.x; Kalele D N, 2007, Commun Agric Appl Biol Sci, V72, P209; Khan A, 2004, BIOL CONTROL, V31, P346, DOI 10.1016/j.biocontrol.2004.07.011; Khan A, 2003, PROTEIN EXPRES PURIF, V32, P210, DOI 10.1016/j.pep.2003.07.007; Khan A, 2003, FEMS MICROBIOL LETT, V227, P107, DOI 10.1016/S0378-1097(03)00654-2; Kiewnick S., 2004, Communications in Agricultural and Applied Biological Sciences, V69, P373; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2006, PROCESS BIOCHEM, V41, P925, DOI 10.1016/j.procbio.2005.10.006; Liu SQ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-33; Lott Mary Elizabeth, 2007, J Drugs Dermatol, V6, P436; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendoza A., 2004, Communications in Agricultural and Applied Biological Sciences, V69, P365; Morton CO, 2003, MYCOL RES, V107, P38, DOI 10.1017/S0953756202007050; MURRELL KD, 1983, EXP PARASITOL, V55, P331, DOI 10.1016/0014-4894(83)90030-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JO, 2004, LETT APPL MICROBIOL, V38, P271, DOI 10.1111/j.1472-765X.2004.01488.x; Pastor FJ, 2006, CLIN MICROBIOL INFEC, V12, P948, DOI 10.1111/j.1469-0691.2006.01481.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Saberhagen C, 1997, CLIN INFECT DIS, V25, P1411, DOI 10.1086/516136; Sasser J. N., 1987, Vistas on Nematology: A Commemoration of the Twenty-fifth Anniversary of the Society of Nematologists, P7; SEGERS R, 1994, MICROBIOL-SGM, V140, P2715, DOI 10.1099/00221287-140-10-2715; Siddiqui ZA, 1996, BIORESOURCE TECHNOL, V58, P229, DOI 10.1016/S0960-8524(96)00122-8; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; STLEGER RJ, 1987, ARCH BIOCHEM BIOPHYS, V253, P221, DOI 10.1016/0003-9861(87)90655-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUNLID A, 1991, APPL ENVIRON MICROB, V57, P2868, DOI 10.1128/AEM.57.10.2868-2872.1991; TUNLID A, 1994, MICROBIOL-UK, V140, P1687, DOI 10.1099/13500872-140-7-1687; Walter H.E., 1984, METHOD ENZYMAT AN, P270; WOLF WM, 1991, J BIOL CHEM, V266, P17695; Yang JK, 2007, APPL MICROBIOL BIOT, V75, P21, DOI 10.1007/s00253-007-0881-4; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Ye FP, 2009, ACTA CRYSTALLOGR F, V65, P271, DOI 10.1107/S1744309109003595; Zhao ML, 2004, MYCOLOGIA, V96, P16, DOI 10.2307/3761982; [No title captured]	59	29	43	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1391	1400		10.1096/fj.09-136408	http://dx.doi.org/10.1096/fj.09-136408			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20007510				2022-12-25	WOS:000277158900012
J	Zentilin, L; Puligadda, U; Lionetti, V; Zacchigna, S; Collesi, C; Pattarini, L; Ruozi, G; Camporesi, S; Sinagra, G; Pepe, M; Recchia, FA; Giacca, M				Zentilin, Lorena; Puligadda, Uday; Lionetti, Vincenzo; Zacchigna, Serena; Collesi, Chiara; Pattarini, Lucia; Ruozi, Giulia; Camporesi, Silvia; Sinagra, Gianfranco; Pepe, Martino; Recchia, Fabio A.; Giacca, Mauro			Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction	FASEB JOURNAL			English	Article						apoptosis; adeno-associated virus; angiogenesis; gene therapy; gene expression	ENDOTHELIAL GROWTH-FACTOR; SKELETAL-MUSCLE REGENERATION; IN-VIVO; STEM-CELLS; MOLECULAR-BASIS; ADULT-MOUSE; ANGIOGENESIS; MICE; EXPRESSION; RECEPTOR	Mounting evidence indicates that the function of members of the vascular endothelial growth factor (VEGF) family extends beyond blood vessel formation. Here, we show that the prolonged intramyocardial expression of VEGF-A165 and VEGF-B167 on adeno-associated virus-mediated gene delivery determined a marked improvement in cardiac function after myocardial infarction in rats, by promoting cardiac contractility, preserving viable cardiac tissue, and preventing remodeling of the left ventricle (LV) over time. Consistent with this functional outcome, animals treated with both factors showed diminished fibrosis and increased contractile myocardium, which were more pronounced after expression of the selective VEGF receptor-1 (VEGFR-1) ligand VEGF-B, in the absence of significant induction of angiogenesis. We found that cardiomyocytes expressed VEGFR-1, VEGFR-2, and neuropilin-1 and that, in particular, VEGFR-1 was specifically up-regulated in hypoxia and on exposure to oxidative stress. VEGF-B exerted powerful antiapoptotic effect in both cultured cardiomyocytes and after myocardial infarction in vivo. Finally, VEGFR-1 activation by VEGF-B was found to elicit a peculiar gene expression profile proper of the compensatory, hypertrophic response, consisting in activation of alpha MHC and repression of beta MHC and skeletal alpha-actin, and an increase in SERCA2a, RYR, PGC1 alpha, and cardiac natriuretic peptide transcripts, both in cultured cardiomyocytes and in infarcted hearts. The finding that VEGFR-1 activation by VEGF-B prevents loss of cardiac mass and promotes maintenance of cardiac contractility over time has obvious therapeutic implications.-Zentilin, L., Puligadda, U., Lionetti, V., Zacchigna, S., Collesi, C., Pattarini, L., Ruozi, G., Camporesi, S., Sinagra, G., Pepe, M., Recchia, F. A., Giacca, M. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J. 24, 1467-1478 (2010). www.fasebj.org	[Zentilin, Lorena; Puligadda, Uday; Zacchigna, Serena; Collesi, Chiara; Pattarini, Lucia; Ruozi, Giulia; Camporesi, Silvia; Giacca, Mauro] ICGEB, Mol Med Lab, Trieste, Italy; [Lionetti, Vincenzo; Recchia, Fabio A.] Scuola Super Sant Anna, Sector Med, Pisa, Italy; [Sinagra, Gianfranco] Osped Cattinara, Azienda Osped Univ Osped Riuniti Trieste, SC Cardiol, Trieste, Italy; [Pepe, Martino; Recchia, Fabio A.] New York Med Coll, New York, NY USA; [Giacca, Mauro] Univ Trieste, Fac Med, Dept Biomed, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); Scuola Superiore Sant'Anna; New York Medical College; University of Trieste	Giacca, M (corresponding author), CGEB Trieste, Mol Med Lab, Padriciano 99, I-34012 Trieste, Italy.	giacca@icgeb.org	sinagra, gianfranco gs/P-7643-2014; Lionetti, Vincenzo/AAH-9503-2020; Recchia, Fabio/F-2315-2010; Sinagra, Gianfranco/AAE-3943-2020; Lionetti, Vincenzo/AAN-1994-2020; Giacca, Mauro/J-9287-2016; Collesi, Chiara/AAB-8979-2019; Lionetti, Vincenzo/G-9528-2014; ZACCHIGNA, SERENA/E-9496-2017	Lionetti, Vincenzo/0000-0002-0640-8651; Giacca, Mauro/0000-0003-2927-7225; SINAGRA, GIANFRANCO/0000-0003-2700-8478; ZACCHIGNA, SERENA/0000-0001-6705-3076; COLLESI, CHIARA/0000-0003-3909-422X	Fondazione CR Trieste, Trieste, Italy; Regione Friuli Venezia Giulia, Italy; World Anti-Doping Agency (WADA), Montreal, Canada	Fondazione CR Trieste, Trieste, Italy; Regione Friuli Venezia Giulia, Italy(Regione Friuli Venezia Giulia); World Anti-Doping Agency (WADA), Montreal, Canada	The authors are grateful to Marina Dapas and Michela Zotti for superb technical support in AAV production, to Mauro Sturnega for help in animal experimentation, and to Suzanne Kerbavcic for editorial assistance. This work was supported by a grant from the Fondazione CR Trieste, Trieste, Italy; by grants from the Regione Friuli Venezia Giulia, Italy; and by a grant from the World Anti-Doping Agency (WADA), Montreal, Canada. F. A. R. is an Established Investigator of the American Heart Association.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bhardwaj S, 2003, HUM GENE THER, V14, P1451, DOI 10.1089/104303403769211664; BRENT GA, 1994, NEW ENGL J MED, V331, P847; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; DILLMANN W, 2009, HEART FAIL REV; Eble DM, 1998, AM J PHYSIOL-CELL PH, V274, pC1226, DOI 10.1152/ajpcell.1998.274.5.C1226; Favre D, 2001, MOL THER, V4, P559, DOI 10.1006/mthe.2001.0494; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Lagercrantz J, 1998, BBA-GENE STRUCT EXPR, V1398, P157, DOI 10.1016/S0167-4781(98)00040-2; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Li X, 2008, ARTERIOSCL THROM VAS, V28, P1614, DOI 10.1161/ATVBAHA.107.158725; Li Y, 2008, J CLIN INVEST, V118, P913, DOI 10.1172/JCI33673; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Messina S, 2007, FASEB J, V21, P3737, DOI 10.1096/fj.07-8459com; Mould AW, 2005, CIRC RES, V97, P60, DOI 10.1161/01.RES.0000182631.33638.77; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARK JE, 1994, J BIOL CHEM, V269, P25646; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Poesen K, 2008, J NEUROSCI, V28, P10451, DOI 10.1523/JNEUROSCI.1092-08.2008; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rottbauer W, 2005, GENE DEV, V19, P1624, DOI 10.1101/gad.1319405; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; Silvestre JS, 2003, CIRC RES, V93, P114, DOI 10.1161/01.RES.0000081594.21764.44; SIMPSON PC, 1991, MOL CELL BIOCHEM, V104, P35; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Tardiff JC, 2000, AM J PHYSIOL-HEART C, V278, pH412, DOI 10.1152/ajpheart.2000.278.2.H412; Tirziu D, 2007, J CLIN INVEST, V117, P3188, DOI 10.1172/JCI32024; Trivieri MG, 2006, P NATL ACAD SCI USA, V103, P6043, DOI 10.1073/pnas.0601072103; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200; Zacchigna S, 2008, J CLIN INVEST, V118, P2062, DOI 10.1172/JCI32832; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	54	123	135	2	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1467	1478		10.1096/fj.09-143180	http://dx.doi.org/10.1096/fj.09-143180			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20019242				2022-12-25	WOS:000277158900019
J	Rattan, R; Narita, K; Chien, J; Maguire, JL; Shridhar, R; Giri, S; Shridhar, V				Rattan, R.; Narita, K.; Chien, J.; Maguire, J. L.; Shridhar, R.; Giri, S.; Shridhar, V.			TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappa B pathway	ONCOGENE			English	Article						TCEAL7; NF-kappa B; ovarian cancer; tumor suppressor gene	HUMAN OVARIAN-CARCINOMA; RNA-POLYMERASE-II; INDUCED APOPTOSIS; CANCER MODELS; EARLY-STAGE; IN-VITRO; EXPRESSION; CELLS; CHEMORESISTANCE; IDENTIFICATION	We have previously shown that a frequently downregulated gene, transcription elongation factor A-like 7 (TCEAL7), promoted anchorage-independent growth and modulated Myc activity in ovarian surface epithelial cells immortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OSEtsT/hTERT). Analysis of protein/DNA array showed that TCEAL7 downregulation resulted in an approximately twofold increase in nuclear factor (NF)-kappa B binding to its target DNA sequence. In this study we showed that short hairpin RNA (shRNA)-mediated downregulation of TCEAL7 in two different immortalized OSE cells showed higher NF-kappa B activity, as determined using reporter and gel-shift assays. Transient transfection of TCEAL7 inhibited the activation of NF-kappa B in TCEAL7-downregulated clones, IOSE-523 and in other ovarian cancer cell lines (OVCAR8, SKOV3ip and DOV13), suggesting that TCEAL7 negatively regulates NF-kappa B pathway. Consistent with this observation, TCEAL7-downregulated clones showed higher levels of NF-kappa B targets, such as pro-proliferative (cyclin-D1 and cMyc), pro-angiogenic (interleukin (IL)-6, IL-8 and vascular endothelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxygenase-2 (Cox-2)) and antiapoptotic (B-cell lymphoma-extra large (Bcl-xl)) genes when compared with vector controls. Inhibition of NF-kappa B by I kappa B kinase (IKK) inhibitor (BMS 345541) attenuated cell survival and proliferation of TCEAL-knockdown clones. Although TCEAL7 inhibited p65 transcriptional activity, it did not modulate the cytoplasmic signaling of the NF-kappa B pathway, by itself or by tumor necrosis factor alpha (TNF-alpha). Chromatin immunoprecipitation (ChIP) assays revealed increased recruitment of p65 and p300 to the promoters of IL-8 and IL-6 in TCEAL7-downregulated clones. Collectively, these results indicate a novel role for TCEAL7 in the negative regulation of NF-kappa B signaling at the basal level by modulating transcriptional activity of NF-kappa B on its target gene promoters, potentially providing a novel mechanism by which NF-kappa B activity may be deregulated in ovarian cancer cells. Oncogene (2010) 29, 1362-1373; doi:10.1038/onc.2009.431; published online 7 December 2009	[Rattan, R.; Chien, J.; Maguire, J. L.; Giri, S.; Shridhar, V.] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN 55905 USA; [Narita, K.] Univ Yamanashi, Fac Med, Dept Anat & Cell Biol, Chuo Ku, Yamanashi, Japan; [Shridhar, R.] Barbara Ann Karmanos Canc Inst, Gershenson Radiat Oncol Ctr, Detroit, MI USA	Mayo Clinic; University of Yamanashi; Barbara Ann Karmanos Cancer Institute	Shridhar, V (corresponding author), Mayo Clin, Coll Med, Dept Lab Med & Expt Pathol, Rochester, MN 55905 USA.	shridhar.vijayalakshmi@mayo.edu	Narita, Keishi/E-3539-2010; Chien, Jeremy/AID-8939-2022; Seal, Sudipta/A-7698-2012	Narita, Keishi/0000-0002-7602-8523; Chien, Jeremy/0000-0003-4744-8374	Ovarian Cancer Research Fund; Mayo Foundation; Bernard and Edith Waterman Foundation	Ovarian Cancer Research Fund; Mayo Foundation; Bernard and Edith Waterman Foundation	This work was supported by Ovarian Cancer Research Fund to RR as a Program of Excellence grant and with funds from Mayo Foundation and Bernard and Edith Waterman Foundation to VS.	Abdollahi T, 2003, CANCER RES, V63, P4521; Aggarwal BB, 2004, EXPERT OPIN INV DRUG, V13, P1327, DOI 10.1517/13543784.13.10.1327; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahn KS, 2007, CURR MOL MED, V7, P619, DOI 10.2174/156652407782564363; Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Camp ER, 2004, J AM COLL SURGEONS, V199, P249, DOI 10.1016/j.jamcollsurg.2004.04.015; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Chien J, 2005, ONCOGENE, V24, P5089, DOI 10.1038/sj.onc.1208700; Chien J, 2008, ONCOGENE, V27, P7223, DOI 10.1038/onc.2008.360; Collinson FJ, 2008, EXPERT REV ANTICANC, V8, P21, DOI 10.1586/14737140.8.1.21; Ferrandina G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-182; Friedlander ML, 1998, SEMIN ONCOL, V25, P305; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GIAVAZZI R, 1994, EUR J CANCER, V30A, P1865, DOI 10.1016/0959-8049(94)00345-6; Giri S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0798com; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kalli KR, 2002, ENDOCRINOLOGY, V143, P3259, DOI 10.1210/en.2001-211408; Kar R, 2007, CANCER BIOL THER, V6, P1101, DOI 10.4161/cbt.6.7.4329; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Nilsson MB, 2007, J BIOL CHEM, V282, P29919, DOI 10.1074/jbc.M611539200; Opala T, 2003, EUR J GYNAECOL ONCOL, V24, P255; RAPP G, 1990, DNA CELL BIOL, V9, P479, DOI 10.1089/dna.1990.9.479; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Shridhar V, 2002, CANCER RES, V62, P262; Shridhar V, 2001, CANCER RES, V61, P5895; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toutirais O, 2003, EUR CYTOKINE NETW, V14, P246; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; YEH CH, 1994, P NATL ACAD SCI USA, V91, P11002, DOI 10.1073/pnas.91.23.11002	35	33	36	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1362	1373		10.1038/onc.2009.431	http://dx.doi.org/10.1038/onc.2009.431			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19966855				2022-12-25	WOS:000275170600011
J	Geoghegan, JA; Ganesh, VK; Smeds, E; Liang, XW; Hook, M; Foster, TJ				Geoghegan, Joan A.; Ganesh, Vannakambadi K.; Smeds, Emanuel; Liang, Xiaowen; Hook, Magnus; Foster, Timothy J.			Molecular Characterization of the Interaction of Staphylococcal Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) ClfA and Fbl with Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUMPING FACTOR-A; BINDING MSCRAMM; LIGAND-BINDING; EXPERIMENTAL ENDOCARDITIS; AUREUS; PROTEIN; LUGDUNENSIS; IDENTIFICATION; IMMUNOGLOBULIN; PATHOGENESIS	The ligand-binding domain of Fbl (the fibrinogen binding protein from Staphylococcus lugdunensis) shares 60% sequence identity with ClfA (clumping factor A) of Staphylococcus aureus. Recombinant Fbl corresponding to the minimum fibrinogenbinding region (subdomains N2N3) was compared with ClfA for binding to fibrinogen. Fbl and ClfA had very similar affinities for fibrinogen by surface plasmon resonance. The binding site for Fbl in fibrinogen was localized to the extreme C terminus of the fibrinogen gamma-chain at the same site recognized by ClfA. Isothermal titration calorimetry showed that Fbl and ClfA had very similar affinities for a peptide mimicking the C-terminal segment of the fibrinogen gamma-chain. The peptide also inhibited binding of Fbl and ClfA to fibrinogen. Aseries of substituted gamma-chain variant peptides behaved very similarly when used to inhibit ClfA and Fbl binding to immobilized fibrinogen. Both ClfA and Fbl bound to bovine fibrinogen with a lower affinity compared with human fibrinogen and did not bind detectably to ovine fibrinogen. The structure of the N2N3 subdomains of Fbl in complex with the fibrinogen gamma-chain peptide was modeled based on the crystal structure of the N2N3 subdomains of the ClfA-gamma-chain peptide complex. Residues in the putative binding trench likely to be involved in fibrinogen binding were identified. Fbl variant proteins with alanine substitutions in key residues had reduced affinities for fibrinogen. Thus Fbl and ClfA bind the same site in fibrinogen by similar mechanisms.	[Geoghegan, Joan A.; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland; [Ganesh, Vannakambadi K.; Smeds, Emanuel; Liang, Xiaowen; Hook, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA	Trinity College Dublin; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Foster, TJ (corresponding author), Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland.	tfoster@tcd.ie		Liang, Xiaowen/0000-0002-6174-2951; Geoghegan, Joan/0000-0002-3788-0668	National Institutes of Health [AI20624]; Health Research Board of Ireland project; Science Foundation Ireland Programme Investigator; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624, R56AI020624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Board of Ireland project; Science Foundation Ireland Programme Investigator(Science Foundation Ireland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI20624 (to M.H.). This work was also supported by a Health Research Board of Ireland project grant and a Science Foundation Ireland Programme Investigator grant (to T.J F.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; CARSON MJ, 1997, J MOL GRAPHICS, V5, P103; Deivanayagam CCS, 1999, ACTA CRYSTALLOGR D, V55, P554, DOI 10.1107/S0907444998012426; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Mitchell J, 2004, MICROBIOL-SGM, V150, P3831, DOI 10.1099/mic.0.27337-0; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Nilsson M, 2004, FEMS MICROBIOL LETT, V241, P87, DOI 10.1016/j.femsle.2004.10.008; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863	26	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6208	6216		10.1074/jbc.M109.062208	http://dx.doi.org/10.1074/jbc.M109.062208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20007717	Green Published, hybrid			2022-12-25	WOS:000275367500025
J	Whelan, SA; Dias, WB; Thiruneelakantapillai, L; Lane, MD; Hart, GW				Whelan, Stephen A.; Dias, Wagner B.; Thiruneelakantapillai, Lakshmanan; Lane, M. Daniel; Hart, Gerald W.			Regulation of Insulin Receptor Substrate 1 (IRS-1)/AKT Kinase-mediated Insulin Signaling by O-Linked beta-N-Acetylglucosamine in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GLCNAC TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; PHOSPHATIDYLINOSITOL 3-KINASE; NUCLEOCYTOPLASMIC PROTEIN; DEPENDENT PHOSPHORYLATION; FULL ACTIVATION; TERMINAL DOMAIN; AKT ACTIVATION; OKADAIC ACID	Increased O-linked beta-N-acetylglucosamine (O-GlcNAc) is associated with insulin resistance in muscle and adipocytes. Upon insulin treatment of insulin-responsive adipocytes, O-GlcNAcylation of several proteins is increased. Key insulin signaling proteins, including IRS-1, IRS-2, and PDK1, are substrates for OGT, suggesting potential O-GlcNAc control points within the pathway. To elucidate the roles of O-GlcNAc in dampening insulin signaling (Vosseller, K., Wells, L., Lane, M. D., and Hart, G. W. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 5313-5318), we focused on the pathway upstream of AKT. Increasing O-GlcNAc in 3T3-L1 adipocytes decreases phosphoinositide 3-kinase (PI3K) interactions with both IRS-1 and IRS-2. Elevated O-GlcNAc also reduces phosphorylation of the PI3K p85 binding motifs (YXXM) of IRS-1 and results in a concomitant reduction in tyrosine phosphorylation of (YXXM)-X-608 in IRS-1, one of the two main PI3K p85 binding motifs. Additionally, insulin signaling stimulates the interaction of OGT with PDK1. We conclude that one of the steps at which O-GlcNAc contributes to insulin resistance is by inhibiting phosphorylation at the (YXXM)-X-608 PI3K p85 binding motif in IRS-1 and possibly at PDK1 as well.	[Whelan, Stephen A.; Dias, Wagner B.; Thiruneelakantapillai, Lakshmanan; Lane, M. Daniel; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Whelan, Stephen A/I-9502-2012; Dias, Wagner/B-1401-2016	Whelan, Stephen A/0000-0002-4740-0795; Dias, Wagner/0000-0002-8378-8846; Whelan, Stephen A/0000-0002-5439-6501; Hart, Gerald/0000-0001-7812-4351	National Institutes of Health (NIH) [DK61671, N01-HV-28180]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant DK61671 and NIH Contract N01-HV-28180. G. W. H. receives a share of royalty received by the university on sales of the CTD 110.6 antibody. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict of interest policies.	Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; HORSCH M, 1991, EUR J BIOCHEM, V197, P815, DOI 10.1111/j.1432-1033.1991.tb15976.x; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Kupriyanova TA, 1999, J BIOL CHEM, V274, P1458, DOI 10.1074/jbc.274.3.1458; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; LIMA FB, 1991, ENDOCRINOLOGY, V128, P2415, DOI 10.1210/endo-128-5-2415; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Standaert ML, 1999, J BIOL CHEM, V274, P14074, DOI 10.1074/jbc.274.20.14074; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tao GZ, 2006, BIOCHEM BIOPH RES CO, V351, P708, DOI 10.1016/j.bbrc.2006.10.092; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	58	117	120	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5204	5211		10.1074/jbc.M109.077818	http://dx.doi.org/10.1074/jbc.M109.077818			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018868	hybrid, Green Published			2022-12-25	WOS:000275327200013
J	Chiu, FY; Chen, YR; Tu, SL				Chiu, Fang-Yi; Chen, Yu-Rong; Tu, Shih-Long			Electrostatic Interaction of Phytochromobilin Synthase and Ferredoxin for Biosynthesis of Phytochrome Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; GLUTAMATE SYNTHASE; 2FE-2S FERREDOXIN; NITRITE REDUCTASE; SULFITE REDUCTASE; OXIDOREDUCTASE; COMPLEX; ARABIDOPSIS; PHYCOCYANOBILIN; BINDING	In plants, phytochromobilin synthase (HY2) synthesize the open chain tetrapyrrole chromophore for light-sensing phytochromes. It catalyzes the double bond reduction of a heme-derived tetrapyrrole intermediate biliverdin IX alpha (BV) at the A-ring diene system. HY2 is a member of ferredoxin-dependent bilin reductases (FDBRs), which require ferredoxins (Fds) as the electron donors for double bond reductions. In this study, we investigated the interaction mechanism of FDBRs and Fds by using HY2 and Fd from Arabidopsis thaliana as model proteins. We found that one of the six Arabidopsis Fds, AtFd2, was the preferred electron donor for HY2. HY2 and AtFd2 formed a heterodimeric complex that was stabilized by chemical cross-linking. Surface-charged residues on HY2 and AtFd2 were important in the protein-protein interaction as well as BV reduction activity of HY2. These surface residues are close to the iron-sulfur center of Fd and the HY2 active site, implying that the interaction promotes direct electron transfer from the Fd to HY2-bound BV. In addition, the C12 propionate group of BV is important for HY2-catalyzed BV reduction. A possible role for this functional group is to mediate the electron transfer by interacting directly with AtFd2. Together, our biochemical data suggest a docking mechanism for HY2: BV and AtFd2.	[Chiu, Fang-Yi; Chen, Yu-Rong; Tu, Shih-Long] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tu, SL (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	tsl@gate.sinica.edu.tw	Tu, Shih-Long/ABF-5446-2021	Tu, Shih-Long/0000-0001-9436-278X	National Science Council [96-2311-B-001-019-MY2]; Academia Sinica of Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica of Taiwan(Academia Sinica - Taiwan)	This work was supported by Grant 96-2311-B-001-019-MY2 ( to S.-L. T.) from the National Science Council and the Summit Team Project from Academia Sinica of Taiwan.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; BEALE SI, 1991, J BIOL CHEM, V266, P22328; Binda C, 1998, ACTA CRYSTALLOGR D, V54, P1353, DOI 10.1107/S0907444998005137; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; Dose MM, 1997, PLANT PHYSIOL, V114, P1047, DOI 10.1104/pp.114.3.1047; ELICH TD, 1989, J BIOL CHEM, V264, P183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg N.F., 2003, PORPHYRIN HDB CHLORO; Garcia-Sanchez MI, 2000, J BIOL INORG CHEM, V5, P713, DOI 10.1007/s007750000160; GarciaSanchez MI, 1997, EUR J BIOCHEM, V250, P364, DOI 10.1111/j.1432-1033.1997.0364a.x; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hanke GT, 2005, PLANT CELL ENVIRON, V28, P1146, DOI 10.1111/j.1365-3040.2005.01352.x; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; HUISMAN JG, 1978, BIOCHEM BIOPH RES CO, V82, P1121, DOI 10.1016/0006-291X(78)90303-0; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Martinez-Julvez M, 1998, BIOCHEMISTRY-US, V37, P17680, DOI 10.1021/bi981718i; McDowell MT, 2001, PLANT PHYSIOL, V126, P1546, DOI 10.1104/pp.126.4.1546; Okada K, 2009, FEBS LETT, V583, P1251, DOI 10.1016/j.febslet.2009.03.052; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; SCHLUCHTER WM, 1994, CHARACTERIZATION PHO; Sevrioukova IF, 2005, J MOL BIOL, V347, P607, DOI 10.1016/j.jmb.2005.01.047; Tu SL, 2008, J BIOL CHEM, V283, P27555, DOI 10.1074/jbc.M803761200; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; Yonekura-Sakakibara K, 2000, PLANT PHYSIOL, V122, P887, DOI 10.1104/pp.122.3.887; ZANETTI G, 1988, BIOCHEMISTRY-US, V27, P3753, DOI 10.1021/bi00410a035; ZANETTI G, 1984, J BIOL CHEM, V259, P6153	33	12	20	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5056	5065		10.1074/jbc.M109.075747	http://dx.doi.org/10.1074/jbc.M109.075747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996315	Green Published, hybrid			2022-12-25	WOS:000275274800081
J	Del Cid, N; Jeffery, E; Rizvi, SM; Stamper, E; Peters, LR; Brown, WC; Provoda, C; Raghavan, M				Del Cid, Natasha; Jeffery, Elise; Rizvi, Syed Monem; Stamper, Ericca; Peters, Larry Robert; Brown, William Clay; Provoda, Chester; Raghavan, Malini			Modes of Calreticulin Recruitment to the Major Histocompatibility Complex Class I Assembly Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; PEPTIDE-LOADING COMPLEX; CHAPERONE CALRETICULIN; MOLECULAR CHAPERONE; MUTATIONAL ANALYSIS; LISTERIOLYSIN-O; REDOX ACTIVITY; ERP57; TAPASIN; CALNEXIN	Major histocompatibility complex (MHC) class I molecules are ligands for T-cell receptors of CD8(+) T cells and inhibitory receptors of natural killer cells. Assembly of the heavy chain, light chain, and peptide components of MHC class I molecules occurs in the endoplasmic reticulum (ER). Specific assembly factors and generic ER chaperones, collectively called the MHC class I peptide loading complex (PLC), are required for MHC class I assembly. Calreticulin has an important role within the PLC and induces MHC class I cell surface expression, but the interactions and mechanisms involved are incompletely understood. We show that interactions with the thiol oxidoreductase ERp57 and substrate glycans are important for the recruitment of calreticulin into the PLC and for its functional activities in MHC class I assembly. The glycan and ERp57 binding sites of calreticulin contribute directly or indirectly to complexes between calreticulin and the MHC class I assembly factor tapasin and are important for maintaining steady-state levels of both tapasin and MHC class I heavy chains. A number of destabilizing conditions and mutations induce generic polypeptide binding sites on calreticulin and contribute to calreticulin-mediated suppression of misfolded protein aggregation in vitro. We show that generic polypeptide binding sites per se are insufficient for stable recruitment of calreticulin to PLC substrates in cells. However, such binding sites could contribute to substrate stabilization in a step that follows the glycan and ERp57-dependent recruitment of calreticulin to the PLC.	[Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Del Cid, Natasha; Peters, Larry Robert] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Brown, William Clay] Univ Michigan, Struct Biol Ctr, Ann Arbor, MI 48109 USA; [Provoda, Chester] Univ Michigan, Ctr Drug Targeting, Ann Arbor, MI 48109 USA; [Provoda, Chester] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu		Stamper, Ericca/0000-0003-2230-7911	University of Michigan Diabetes Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044115, R01AI066131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	University of Michigan Diabetes Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Drs. Marek Michalak and Tim Elliott for providing calreticulin-deficient K42 cells and to Drs. Ted Hansen and Jon Yewdell for antibodies used in these studies. We thank James Delproposto of the University of Michigan high throughput protein laboratory for assistance with expression of recombinant truncated proteins, the University of Michigan DNA sequencing core for DNA sequence data, the University of Michigan Hybridoma Core for ascites production, the University of Michigan Microarray core for Sypro Orange binding analyses, and the University of Michigan Diabetes Research and Training Center for financial support. We thank Ramkumar Nandkumar and Kalpana Krishnaswamy (Metaome) for assistance with supplemental Fig. S1, and Ben Schwartz, Rachael Sturtevant, and Laura Weiser for assistance with the project.	Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Gopalakrishnapai J, 2006, BIOCHEM BIOPH RES CO, V351, P14, DOI 10.1016/j.bbrc.2006.09.164; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Harris MR, 1998, J IMMUNOL, V160, P5404; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Malawski GA, 2006, PROTEIN SCI, V15, P2718, DOI 10.1110/ps.062491906; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Silvennoinen L, 2004, J BIOL CHEM, V279, P13607, DOI 10.1074/jbc.M313054200; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Thammavongsa V, 2009, IMMUNOGENETICS, V61, P703, DOI 10.1007/s00251-009-0399-2; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VANPARIJS L, 2009, IMMUNITY, V30, P611; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	40	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4520	4535		10.1074/jbc.M109.085407	http://dx.doi.org/10.1074/jbc.M109.085407			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959473	Green Published, hybrid			2022-12-25	WOS:000275274800029
J	Kemp, MG; Mason, AC; Carreira, A; Reardon, JT; Haring, SJ; Borgstahl, GEO; Kowalczykowski, SC; Sancar, A; Wold, MS				Kemp, Michael G.; Mason, Aaron C.; Carreira, Aura; Reardon, Joyce T.; Haring, Stuart J.; Borgstahl, Gloria E. O.; Kowalczykowski, Stephen C.; Sancar, Aziz; Wold, Marc S.			An Alternative Form of Replication Protein A Expressed in Normal Human Tissues Supports DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; BINDING-PROTEIN; PHYSICAL INTERACTION; COMPLEX-FORMATION; DAMAGED DNA; RPA; RAD51; XPA; RECOGNITION	Replication protein A (RPA) is a heterotrimeric protein complex required for a large number of DNA metabolic processes, including DNA replication and repair. An alternative form of RPA (aRPA) has been described in which the RPA2 subunit (the 32-kDa subunit of RPA and product of the RPA2 gene) of canonical RPA is replaced by a homologous subunit, RPA4. The normal function of aRPA is not known; however, previous studies have shown that it does not support DNA replication in vitro or S-phase progression in vivo. In this work, we show that the RPA4 gene is expressed in normal human tissues and that its expression is decreased in cancerous tissues. To determine whether aRPA plays a role in cellular physiology, we investigated its role in DNA repair. aRPA interacted with both Rad52 and Rad51 and stimulated Rad51 strand exchange. We also showed that, by using a reconstituted reaction, aRPA can support the dual incision/excision reaction of nucleotide excision repair. aRPA is less efficient in nucleotide excision repair than canonical RPA, showing reduced interactions with the repair factor XPA and no stimulation of XPF-ERCC1 endonuclease activity. In contrast, aRPA exhibits higher affinity for damaged DNA than canonical RPA, which may explain its ability to substitute for RPA in the excision step of nucleotide excision repair. Our findings provide the first direct evidence for the function of aRPA in human DNA metabolism and support a model for aRPA functioning in chromosome maintenance functions in nonproliferating cells.	[Mason, Aaron C.; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Kemp, Michael G.; Reardon, Joyce T.] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [Kemp, Michael G.; Sancar, Aziz] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Haring, Stuart J.] N Dakota State Univ, Dept Chem & Mol Biol, Fargo, ND 58105 USA; [Borgstahl, Gloria E. O.] Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA	University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Davis; University of California System; University of California Davis; North Dakota State University Fargo; University of Nebraska System; University of Nebraska Medical Center	Wold, MS (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu	Haring, Stuart/E-7481-2012; Borgstahl, Gloria/AAZ-4114-2020; Wold, Marc/F-5806-2010; Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745; Wold, Marc/0000-0002-4580-1624; Carreira, Aura/0000-0001-5489-4343	National Institutes of Health Research [GM32833, GM62653, GM44721]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R01GM032833, R01GM062653, R01GM044721] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants GM32833 (to A. S.), GM62653 (to S. C. K.), and GM44721 (to M. S. W.).	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; KESHAV KF, 1995, MOL CELL BIOL, V15, P3119; LI L, 1995, MOL CELL BIOL, V15, P5396; Mason AC, 2009, J BIOL CHEM, V284, P5324, DOI 10.1074/jbc.M808963200; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Stigger E, 1998, J BIOL CHEM, V273, P9337, DOI 10.1074/jbc.273.15.9337; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tomkiel JE, 2002, CLIN CANCER RES, V8, P752; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wang M, 2000, BIOCHEMISTRY-US, V39, P6433, DOI 10.1021/bi000472q; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	53	20	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4788	4797		10.1074/jbc.M109.079418	http://dx.doi.org/10.1074/jbc.M109.079418			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996105	Green Published, hybrid			2022-12-25	WOS:000275274800057
J	Wang, XS; Zhang, SJ; Zhang, JH; Huang, XJ; Xu, C; Wang, WW; Liu, ZJ; Wu, JH; Shi, Y				Wang, Xingsheng; Zhang, Shaojie; Zhang, Jiahai; Huang, Xiaojuan; Xu, Chao; Wang, Weiwei; Liu, Zhijun; Wu, Jihui; Shi, Yunyu			A Large Intrinsically Disordered Region in SKIP and Its Disorder-Order Transition Induced by PPIL1 Binding Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; D-MEDIATED TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; CIRCULAR-DICHROISM; BACKBONE DYNAMICS; SPLICING FACTORS; GENE-EXPRESSION; CHEMICAL-SHIFTS; SPLICEOSOME; INTERACTS	Intrinsically disordered proteins or protein regions play an important role in fundamental biological processes. During spliceosome activation, a large structural rearrangement occurs. The Prp19 complex and related factors are involved in the catalytic activation of the spliceosome. Recent mass spectrometric analyses have shown that Ski interaction protein (SKIP) and peptidylprolyl isomerase-like protein 1 (PPIL1) are Prp19-related factors that constitute the spliceosome B, B*, and C complexes. Here, we report that a highly flexible region of SKIP (SKIPN, residues 59-129) is intrinsically disordered. Upon binding to PPIL1, SKIPN undergoes a disorder-order transition. A highly conserved fragment of SKIP (residues 59-79) called the PPIL1-binding fragment (PBF) was sufficient to bind PPIL1. The structure of PBF.PPIL1 complex, solved by NMR, shows that PBF exhibits an ordered structure and interacts with PPIL1 through electrostatic and hydrophobic interactions. Three subfragments in the PBF (residues 59-67, 68-73, and 74-79) show hook-like backbone structure, and interactions between these subfragments are necessary for PBF.PPIL1 complex formation. PPIL1 is a cyclophilin family protein. It is recruited by SKIP into the spliceosome by a region other than the peptidylprolyl isomerase active site. This enables the active site of PPIL1 to remain open in the complex and still function as a peptidylprolyl cis/trans-isomerase or molecular chaperon to facilitate the folding of other proteins in the spliceosomes. The large disordered region in SKIP provides an interaction platform. Its disorder-order transition, induced by PPIL1 binding, may adapt the requirement for a large structural rearrangement occurred in the activation of spliceosome.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Xu, Chao/G-3885-2010	Xu, Chao/0000-0003-0444-7080; Wang, Weiwei/0000-0002-0215-9467	Chinese National Fundamental Research [2006CB806507, 2006CB910201, 2002CB713806, 2006AA02A315]; Chinese National Natural Science Foundation [30121001, 30570361, 30830031]	Chinese National Fundamental Research; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National Fundamental Research Project (Grants 2006CB806507, 2006CB910201, 2002CB713806, and 2006AA02A315) and the Chinese National Natural Science Foundation (Grants 30121001, 30570361, and 30830031).	AIYAR A, 1993, BIOTECHNIQUES, V14, P366; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Ambrozkova M, 2001, BIOCHEM BIOPH RES CO, V284, P1148, DOI 10.1006/bbrc.2001.5108; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bourquin JP, 1997, NUCLEIC ACIDS RES, V25, P2055, DOI 10.1093/nar/25.11.2055; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIEHL BE, 1991, GENETICS, V127, P287; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; Jung JW, 2005, J BIOCHEM MOL BIOL, V38, P550; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; MacDonald PN, 2004, J STEROID BIOCHEM, V89-90, P179, DOI 10.1016/j.jsbmb.2004.03.097; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Mesa A, 2008, FEBS LETT, V582, P2345, DOI 10.1016/j.febslet.2008.06.006; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Nagai K, 2004, BIOCHEM BIOPH RES CO, V316, P512, DOI 10.1016/j.bbrc.2004.02.077; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Reidt U, 2003, J MOL BIOL, V331, P45, DOI 10.1016/S0022-2836(03)00684-3; Romero P, 1998, Pac Symp Biocomput, P437; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Skruzny M, 2001, BBA-GENE STRUCT EXPR, V1521, P146, DOI 10.1016/S0167-4781(01)00301-3; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200	53	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4951	4963		10.1074/jbc.M109.087528	http://dx.doi.org/10.1074/jbc.M109.087528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007319	Green Published, hybrid			2022-12-25	WOS:000275274800072
J	Kuhn, H; Hierlmeier, T; Merl, J; Jakob, S; Aguissa-Toure, AH; Milkereit, P; Tschochner, H				Kuehn, Holger; Hierlmeier, Thomas; Merl, Juliane; Jakob, Steffen; Aguissa-Toure, Almass-Houd; Milkereit, Philipp; Tschochner, Herbert			The Noc-Domain Containing C-Terminus of Noc4p Mediates Both Formation of the Noc4p-Nop14p Submodule and Its Incorporation into the SSU Processome	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; PROTEIN; SUBUNITS; COMPLEXES; BIOGENESIS; EXPRESSION; CYTOPLASM; YEAST	Noc1p, Noc3p and Noc4p are eukaryotic proteins which play essential roles in yeast ribosome biogenesis and contain a homologous stretch of about 45 aminoacids (Noc-domain) of unknown function. Yeast Noc4p is a component of the small ribosomal subunit (SSU) processome, can be isolated as a stable Noc4p-Nop14p SSU-processome submodule from yeast cells, and is required for nuclear steps of small ribosomal subunit rRNA maturation. We expressed a series of mutated alleles of NOC4 in yeast cells and analysed whether the corresponding protein variants support vegetative growth, interact with Nop14p, and are incorporated into the SSU-processome. The data reveal that the essential C-terminus of Noc4p which contains 237 aminoacids including the Noc-domain represents a protein-protein interaction module. It is required and sufficient for its association with Nop14p and several nuclear precursors of the small ribosomal subunit. The N-terminal Noc4-part seems to be targeted to pre-ribosomes via the C-terminus of Noc4p and plays there an essential role in SSU-processome function. Replacement of the Noc4p-Noc-domain by its homologues Noc1p-counterpart results in a hybrid Noc4p variant which fails to associate with Nop14p and pre-ribosomes. On the other hand, exchange of 6 amino acids in the Noc1-Noc-domain of this hybrid Noc4p protein is sufficient to restore its essential in vivo functions. These data suggest that Noc-domains of Noc1p and Noc4p share a common structural backbone in which diverging amino acids play crucial roles in mediating specific regulated interactions. Our analysis allows us to distinguish between different functions of certain domains within Noc4p and contribute to the understanding of how incorporation of Noc4p into ribosomal precursors is coupled to rRNA processing and maturation of the small ribosomal subunit.	[Kuehn, Holger; Hierlmeier, Thomas; Merl, Juliane; Jakob, Steffen; Milkereit, Philipp; Tschochner, Herbert] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Regensburg, Germany; [Aguissa-Toure, Almass-Houd] Univ Toulouse UPS, Lab Biol Mol Eucaryote, Toulouse, France	University of Regensburg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE)	Kuhn, H (corresponding author), Univ Regensburg, Inst Biochem Genet & Mikrobiol, Regensburg, Germany.	philipp.milkereit@vkl.uni-regensburg.de; herbert.tschochner@vkl.uni-regensburg.de	Merl-Pham, Juliane/N-7258-2014	Merl-Pham, Juliane/0000-0002-3422-4083	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bax R, 2006, RNA, V12, P2005, DOI 10.1261/rna.159406; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Dez C, 2007, RNA, V13, P1516, DOI 10.1261/rna.609807; Dlakic M, 2004, RNA, V10, P351, DOI 10.1261/rna.5184704; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Granneman S, 2003, NUCLEIC ACIDS RES, V31, P1877, DOI 10.1093/nar/gkg300; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vos HR, 2004, EUKARYOT CELL, V3, P1504, DOI 10.1128/EC.3.6.1504-1512.2004; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Wery M, 2009, RNA, V15, P406, DOI 10.1261/rna.1402709; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018	43	19	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8370	10.1371/journal.pone.0008370	http://dx.doi.org/10.1371/journal.pone.0008370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20019888	Green Published, gold, Green Submitted			2022-12-25	WOS:000272870600010
J	Horovitz, I; Martin, T; Bloch, J; Ladeveze, S; Kurz, C; Sanchez-Villagra, MR				Horovitz, Ines; Martin, Thomas; Bloch, Jonathan; Ladeveze, Sandrine; Kurz, Cornelia; Sanchez-Villagra, Marcelo R.			Cranial Anatomy of the Earliest Marsupials and the Origin of Opossums	PLOS ONE			English	Article							FUNCTIONAL-ADAPTIVE ANATOMY; MAYULESTES-FEROX; EXTANT MARSUPIALS; INNER-EAR; PALEOBIOLOGY; SEQUENCES; HERPETOTHERIUM; PHYLOGENY	Background: The early evolution of living marsupials is poorly understood in part because the early offshoots of this group are known almost exclusively from jaws and teeth. Filling this gap is essential for a better understanding of the phylogenetic relationships among living marsupials, the biogeographic pathways that led to their current distribution as well as the successive evolutionary steps that led to their current diversity, habits and various specializations that distinguish them from placental mammals. Methodology/Principal Findings: Here we report the first skull of a 55 million year old peradectid marsupial from the early Eocene of North America and exceptionally preserved skeletons of an Oligocene herpetotheriid, both representing critical groups to understand early marsupial evolution. A comprehensive phylogenetic cladistic analysis of Marsupialia including the new findings and close relatives of marsupials show that peradectids are the sister group of living opossums and herpetotheriids are the sister group of all living marsupials. Conclusions/Significance: The results imply that North America played an important role in early Cenozoic marsupial evolutionary history and may have even been the center of origin of living marsupials and opossums. New data from the herpetotheriid postcranium support the view that the ancestral morphotype of Marsupialia was more terrestrial than opossums are. The resolution of the phylogenetic position of peradectids reveals an older calibration point for molecular estimates of divergence times among living marsupials than those currently used.	[Horovitz, Ines] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA; [Martin, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-5300 Bonn, Germany; [Bloch, Jonathan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Ladeveze, Sandrine; Sanchez-Villagra, Marcelo R.] Palaeontol Inst & Museum, Zurich, Switzerland; [Kurz, Cornelia] Nat Kundemuseum Ottoneum Kassel, Kassel, Germany	University of California System; University of California Los Angeles; University of Bonn; State University System of Florida; University of Florida	Horovitz, I (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	horovitz@ucla.edu; m.sanchez@pim.uzh.ch		Bloch, Jonathan/0000-0003-1484-6931; Sanchez-Villagra, Marcelo Ricardo/0000-0001-7587-3648	University of Zurich; Swiss National Fond [3100A0-116013]	University of Zurich; Swiss National Fond(Swiss National Science Foundation (SNSF))	University of Zurich and Swiss National Fond (3100A0-116013) gave Financial support to Marcelo R. Sanchez-Villagra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; Archibald J.D., 1987, P24; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Asher RJ, 2004, MOL PHYLOGENET EVOL, V33, P240, DOI 10.1016/j.ympev.2004.05.004; Beck RMD, 2008, J MAMMAL, V89, P175, DOI 10.1644/06-MAMM-A-437.1; Beck RMD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001858; Bowen GJ, 2002, J SEDIMENT RES, V72, P46, DOI 10.1306/061901720046; BOWN T M, 1979, Contributions from the Museum of Paleontology University of Michigan, V25, P89; CASE JA, 2005, J MAMM EVOL, V12, P223; Cifelli RL, 2004, B AM MUS NAT HIST, P62; Cifelli RL, 1996, NATURE, V379, P715, DOI 10.1038/379715a0; Clemens WA, 2006, PALAEONTOGR ABT A, V277, P19; de Muizon Christian, 2003, P43; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Forasiepi AM, 2009, J ZOOL SYST EVOL RES, V47, P391, DOI 10.1111/j.1439-0469.2008.00519.x; FOX RC, 1983, CAN J EARTH SCI, V20, P1565, DOI 10.1139/e83-146; GINGERICH P D, 1987, Contributions from the Museum of Paleontology University of Michigan, V27, P275; GINGERICH PD, 2001, U MICHIGAN PAPERS PA, V33, P37; Horovitz I, 2008, PALAEONTOGR ABT A, V284, P109; Johanson Z, 1996, J PALEONTOL, V70, P1023, DOI 10.1017/S0022336000038725; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Koenigswald W von, 1992, MESSEL INSIGHT HIST, P155; KORTH WW, 2007, EVOLUTION TERTIARY M, V2, P39; Kurz Conny, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P21; Kurz Conny, 2007, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V15, P3; Lofgren Donald L., 2004, P43; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Marshall L.G., 1990, Current Mammalogy, V2, P433; MARSHALL LG, 1988, NATL GEOGR RES, V4, P23; MENG J, 1995, ZOOL J LINN SOC-LOND, V115, P47, DOI 10.1006/zjls.1995.0033; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; OLIVEIRA EV, 2006, MARSUPIAIS BRASIL BI, P607; Phillips MJ, 2006, SYST BIOL, V55, P122, DOI 10.1080/10635150500481614; REIG OA, 1987, POSSUMS OPOSSUMS STU, V1, P1; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Sanchez-Villagra M, 2007, BIOL LETTERS, V3, P318, DOI 10.1098/rsbl.2007.0090; Sánchez-Villagra Marcelo R., 2007, Mastozool. neotrop., V14, P53; SWOFFORD D, 2002, PAUP 4 0 B10 PROGRAM; Szalay F. S., 1994, EVOLUTIONARY HIST MA; VULLO R, 2009, P NATL ACAD SCI US	44	72	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8278	10.1371/journal.pone.0008278	http://dx.doi.org/10.1371/journal.pone.0008278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016823	Green Published, gold			2022-12-25	WOS:000272834000009
J	Lu, DS; Liu, JX; Endo, T; Zhou, HW; Yao, SY; Willert, K; Schmidt-Wolf, IGH; Kipps, TJ; Carson, DA				Lu, Desheng; Liu, Jerry X.; Endo, Tomoyuki; Zhou, Haowen; Yao, Shiyin; Willert, Karl; Schmidt-Wolf, Ingo G. H.; Kipps, Thomas J.; Carson, Dennis A.			Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CATENIN; SIGNALING PATHWAY; MULTIPLE-MYELOMA; WNT PROTEINS; COLON-CANCER; CYCLIN D1; EXPRESSION; APOPTOSIS; LEF-1	Background: Aberrant activation of Wnt/beta-catenin signaling promotes the development of several cancers. It has been demonstrated that the Wnt signaling pathway is activated in chronic lymphocytic leukemia (CLL) cells, and that uncontrolled Wnt/beta-catenin signaling may contribute to the defect in apoptosis that characterizes this malignancy. Thus, the Wnt signaling pathway is an attractive candidate for developing targeted therapies for CLL. Methodology/Principal Findings: The diuretic agent ethacrynic acid (EA) was identified as a Wnt inhibitor using a cell-based Wnt reporter assay. In vitro assays further confirmed the inhibitory effect of EA on Wnt/beta-catenin signaling. Cell viability assays showed that EA selectively induced cell death in primary CLL cells. Exposure of CLL cells to EA decreased the expression of Wnt/beta-catenin target genes, including LEF-1, cyclin D1 and fibronectin. Immune co-precipitation experiments demonstrated that EA could directly bind to LEF-1 protein and destabilize the LEF-1/beta-catenin complex. N-acetyl-L-cysteine (NAC), which can react with the a, beta-unsaturated ketone in EA, but not other anti-oxidants, prevented the drug's inhibition of Wnt/beta-catenin activation and its ability to induce apoptosis in CLL cells. Conclusions/Significance: Our studies indicate that EA selectively suppresses CLL survival due to inhibition of Wnt/beta-catenin signaling. Antagonizing Wnt signaling in CLL with EA or related drugs may represent an effective treatment of this disease.	[Lu, Desheng; Liu, Jerry X.; Endo, Tomoyuki; Zhou, Haowen; Yao, Shiyin; Kipps, Thomas J.; Carson, Dennis A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Schmidt-Wolf, Ingo G. H.] Univ Bonn, Ctr Integrated Oncol, D-5300 Bonn, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Bonn	Lu, DS (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	delu@ucsd.edu; decarson@ucsd.edu	Lu, Deheng/AAK-5216-2020; Lu, desheng/E-4822-2013	Lu, desheng/0000-0002-3616-6657; Lu, Desheng/0000-0002-0314-5649	Leukemia and Lymphoma Society SCOR [CA81534-06]; National Cancer Institute-Drug Development Group [CA113318-01]; National Institutes of Health [PO1-CA081534]; Vassiliadis Family Fellowship; NATIONAL CANCER INSTITUTE [P20CA081534, U19CA113318, P01CA081534] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); National Cancer Institute-Drug Development Group; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vassiliadis Family Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Leukemia and Lymphoma Society SCOR grant (CA81534-06), a National Cancer Institute-Drug Development Group grant (CA113318-01) and a National Institutes of Health Grant PO1-CA081534. J.X.L is the recipient of the Vassiliadis Family Fellowship for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 2003, CANCER SCI, V94, P886, DOI 10.1111/j.1349-7006.2003.tb01371.x; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Caligaris-Cappio F, 1999, J CLIN ONCOL, V17, P399, DOI 10.1200/JCO.1999.17.1.399; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Han YS, 2005, SHOCK, V23, P45, DOI 10.1097/01.shk.0000150629.53699.3f; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, P467; Horie R, 2006, LEUKEMIA, V20, P800, DOI 10.1038/sj.leu.2404167; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Howe D, 2006, LEUKEMIA RES, V30, P29, DOI 10.1016/j.leukres.2005.06.004; Jin GY, 2009, BIOORG MED CHEM LETT, V19, P606, DOI 10.1016/j.bmcl.2008.12.067; Kay Neil E, 2002, Hematology Am Soc Hematol Educ Program, P193, DOI 10.1182/asheducation-2002.1.193; Keating Michael J, 2003, Hematology Am Soc Hematol Educ Program, P153, DOI 10.1182/asheducation-2003.1.153; KIPPS TJ, 1995, WILLIAMS HEMATOLOGY, P1017; LACRETA FP, 1994, J PHARMACOL EXP THER, V270, P1186; LAMBERT E, 1992, LEUKEMIA, V6, P1063; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lu DS, 2005, P NATL ACAD SCI USA, V102, P18567, DOI 10.1073/pnas.0509316102; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; ODWYER PJ, 1991, CANCER RES, V51, P6059; Polakis P, 2000, GENE DEV, V14, P1837; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Schultz M, 1997, ADV DRUG DELIVER REV, V26, P91, DOI 10.1016/S0169-409X(97)00029-X; Sercan HO, 2007, ONCOL REP, V18, P1563; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SILBER R, 1992, BLOOD, V80, P2038; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TEW KD, 1988, CANCER RES, V48, P3622; TWENTYMAN PR, 1992, LEUKEMIA, V6, P726; Wang R, 2007, CANCER RES, V67, P7856, DOI 10.1158/0008-5472.CAN-07-0151; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2	46	88	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8294	10.1371/journal.pone.0008294	http://dx.doi.org/10.1371/journal.pone.0008294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011538	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300043
J	Sachs, AJ; David, SA; Haider, NB; Nystuen, AM				Sachs, Andrew J.; David, Samuel A.; Haider, Neena B.; Nystuen, Arne M.			Patterned Neuroprotection in the Inpp4a(wbl) Mutant Mouse Cerebellum Correlates with the Expression of Eaat4	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 4-PHOSPHATASE; METABOTROPIC GLUTAMATE RECEPTORS; PURKINJE-CELL DEGENERATION; G-ALPHA-Q; ZEBRIN-II; PHOSPHOLIPASE-C-BETA-4 EXPRESSION; 1,4,5-TRISPHOSPHATE RECEPTOR; SYNAPTIC PLASTICITY; MOTOR COORDINATION; NULL MUTATION	The weeble mutant mouse has a frame shift mutation in inositol polyphosphate 4-phosphatase type I (Inpp4a). The phenotype is characterized by an early onset cerebellar ataxia and neurodegeneration, especially apparent in the Purkinje cells. Purkinje cell loss is a common pathological finding in many human and mouse ataxic disorders. Here we show that in the Inpp4a(wbl) mutant, Purkinje cells are lost in a specific temporal and spatial pattern. Loss occurs early in postnatal development; however, prior to the appearance of climbing fibers in the developing molecular layer, the mutant has a normal complement of Purkinje cells and they are properly positioned. Degeneration and reactive gliosis are present at postnatal day 5 and progress rapidly in a defined pattern of patches; however, Inpp4a is expressed uniformly across Purkinje cells. In late stage mutants, patches of surviving Purkinje cells appear remarkably normal with the exception that the climbing fibers have been excessively eliminated. Surviving Purkinje cells express Eaat4, a glutamate transporter that is differentially expressed in subsets of Purkinje cells during development and into adult stages. Prior to Purkinje cell loss, reactive gliosis and dendritic atrophy can be seen in Eaat4 negative stripes. Our data suggest that Purkinje cell loss in the Inpp4a(wbl) mutant is due to glutamate excitotoxicity initiated by the climbing fiber, and that Eaat4 may exert a protective effect.	[Sachs, Andrew J.; David, Samuel A.; Haider, Neena B.; Nystuen, Arne M.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68182 USA; [Haider, Neena B.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sachs, AJ (corresponding author), Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68182 USA.	nhaidern@unmc.edu; anystuen@unmc.edu			The Nebraska Tobacco Settlement Biomedical Research Fund	The Nebraska Tobacco Settlement Biomedical Research Fund	This work was funded by The Nebraska Tobacco Settlement Biomedical Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Chung SH, 2008, NEUROSCIENCE, V153, P721, DOI 10.1016/j.neuroscience.2008.01.090; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; EDWARDS MA, 1994, ANAT EMBRYOL, V190, P417; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Marzban H, 2007, J COMP NEUROL, V502, P857, DOI 10.1002/cne.21352; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Nagao S, 1997, NEUROSCIENCE, V78, P929; Nikkuni O, 2007, NEUROSCI RES, V59, P296, DOI 10.1016/j.neures.2007.07.006; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Nystuen A, 2001, NEURON, V32, P203, DOI 10.1016/S0896-6273(01)00468-8; Nystuen AM, 2007, NEUROGENETICS, V8, P1, DOI 10.1007/s10048-006-0068-7; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; Sachs AJ, 2007, MAMM GENOME, V18, P749, DOI 10.1007/s00335-007-9064-y; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Street VA, 1997, J NEUROSCI, V17, P635; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Tanaka J, 2000, EUR J NEUROSCI, V12, P781, DOI 10.1046/j.1460-9568.2000.00959.x; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Welsh JP, 2002, ADV NEUROL, V89, P331; Williams BL, 2007, J VIROL, V81, P2675, DOI 10.1128/JVI.02245-06; Yamada K, 1997, NEUROSCI RES, V27, P191, DOI 10.1016/S0168-0102(96)01148-0; Yamashita A, 2006, NEUROSCI RES, V55, P264, DOI 10.1016/j.neures.2006.03.007	42	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8270	10.1371/journal.pone.0008270	http://dx.doi.org/10.1371/journal.pone.0008270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011524	gold, Green Submitted, Green Published			2022-12-25	WOS:000272830300026
J	Geib, T; Hertel, KJ				Geib, Till; Hertel, Klemens J.			Restoration of Full-Length SMN Promoted by Adenoviral Vectors Expressing RNA Antisense Oligonucleotides Embedded in U7 snRNAs	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; PRE-MESSENGER-RNA; RECOMBINANT ADENOVIRUS; PROTEIN; GENE; COMPLEX; MODULATION; RESCUE; MODEL; SITE	Background: Spinal Muscular Atrophy (SMA) is an autosomal recessive disease that leads to specific loss of motor neurons. It is caused by deletions or mutations of the survival of motor neuron 1 gene (SMN1). The remaining copy of the gene, SMN2, generates only low levels of the SMN protein due to a mutation in SMN2 exon 7 that leads to exon skipping. Methodology/Principal Findings: To correct SMN2 splicing, we use Adenovirus type 5-derived vectors to express SMN2-antisense U7 snRNA oligonucleotides targeting the SMN intron 7/exon 8 junction. Infection of SMA type I-derived patient fibroblasts with these vectors resulted in increased levels of exon 7 inclusion, upregulating the expression of SMN to similar levels as in non-SMA control cells. Conclusions/Significance: These results show that Adenovirus type 5-derived vectors delivering U7 antisense oligonucleotides can efficiently restore full-length SMN protein and suggest that the viral vector-mediated oligonucleotide application may be a suitable therapeutic approach to counteract SMA.	[Geib, Till; Hertel, Klemens J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Sch Med, Irvine, CA 92717 USA	University of California System; University of California Irvine	Geib, T (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Sch Med, Irvine, CA 92717 USA.	khertel@uci.edu		Hertel, Klemens/0000-0002-7560-9529	NIH [GM62287]; Muscular Dystrophy [MDA4043]; Families of SMA [HER0607]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004043] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy; Families of SMA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grant GM62287 (KJH), a Muscular Dystrophy grant MDA4043 ( KJH), and a Families of SMA grant HER0607 ( KJH). TG was supported by a fellowship from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Brun C, 2003, CELL MOL LIFE SCI, V60, P557, DOI 10.1007/s000180300047; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Chari A, 2009, CURR OPIN CELL BIOL, V21, P387, DOI 10.1016/j.ceb.2009.02.004; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Driesse MJ, 1999, HUM GENE THER, V10, P2347, DOI 10.1089/10430349950016997; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fox-Walsh KL, 2009, P NATL ACAD SCI USA, V106, P1766, DOI 10.1073/pnas.0813128106; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; GRIMM C, 1993, EMBO J, V12, P1229, DOI 10.1002/j.1460-2075.1993.tb05764.x; Lai CM, 2002, DNA CELL BIOL, V21, P895, DOI 10.1089/104454902762053855; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Navarro V, 1999, GENE THER, V6, P1884, DOI 10.1038/sj.gt.3301008; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Rubinchik S, 2000, GENE THER, V7, P875, DOI 10.1038/sj.gt.3301172; Schumperli D, 2004, CELL MOL LIFE SCI, V61, P2560, DOI 10.1007/s00018-004-4190-0; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Vacek M, 2003, CELL MOL LIFE SCI, V60, P825, DOI 10.1007/s00018-003-3042-7; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	33	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8204	10.1371/journal.pone.0008204	http://dx.doi.org/10.1371/journal.pone.0008204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997596	Green Published, gold			2022-12-25	WOS:000272829700004
J	Gill, KZ; Purves, D				Gill, Kamraan Z.; Purves, Dale			A Biological Rationale for Musical Scales	PLOS ONE			English	Article							CONSONANCE THEORY; EVOLUTION; PITCH	Scales are collections of tones that divide octaves into specific intervals used to create music. Since humans can distinguish about 240 different pitches over an octave in the mid-range of hearing [1], in principle a very large number of tone combinations could have been used for this purpose. Nonetheless, compositions in Western classical, folk and popular music as well as in many other musical traditions are based on a relatively small number of scales that typically comprise only five to seven tones [2-6]. Why humans employ only a few of the enormous number of possible tone combinations to create music is not known. Here we show that the component intervals of the most widely used scales throughout history and across cultures are those with the greatest overall spectral similarity to a harmonic series. These findings suggest that humans prefer tone combinations that reflect the spectral characteristics of conspecific vocalizations. The analysis also highlights the spectral similarity among the scales used by different cultures.	[Gill, Kamraan Z.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA; Duke Univ, Dept Neurobiol, Durham, NC USA	Duke University; Duke University	Gill, KZ (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA.	kzg2101@columbia.edu; purves@neuro.duke.edu			NSF; Duke University	NSF(National Science Foundation (NSF)); Duke University	NSF (www.nsf.gov) and Duke University (www.duke.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldwell Edward, 2011, HARMONY VOICE LEADIN; AOYAGI T, 1996, P 4 INT C MUS PERC C, P65; ARNOLD B, 2002, ESSENTIALS CHORD CHA; Atcherson W, 1973, J MUSIC THEORY, V17, P204, DOI 10.2307/843342; Bagchee Sandeep, 1998, NAD UNDERSTANDING RA; BERNSTEIN L., 1976, UNANSWERED QUESTION; BROUGHTON S, 2000, WORLD MUSIC ROUGH GU; Brown S, 2000, ORIGINS OF MUSIC, P271; Burkholder James Peter, 2006, HIST W MUSIC; BURNS EM, 1982, PSYCHOL MUSIC, P215; Butterfield E. C, 1970, 3 S OR SENS PERC MOU, P313; Day-O'Connell Jeremy, 2007, PENTATONICISM 18 CEN; DEBEER A, 1969, SONORUM SPECULUM, V38, P26; Duffin Ross W., 2007, EQUAL TEMPERAMENT RU; FERGUSON J, 2000, ALL BLUES SCALE JAZZ; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; GOLD L, 2007, MUSIC BALI EXPERIENC; Gunde Richard, 2002, CULTURE CUSTOMS CHIN; HARRISON M, 2003, BLUES PIANO HAL LEON; Helmholtz H., 1877, SENSATIONS TONE; Isacoff Stuart., 2001, TEMPERAMENT; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1460, DOI 10.1121/1.1911624; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1451, DOI 10.1121/1.1911623; Kostka Stefan, 2000, TONAL HARMONY; LEHRDAHL F, 1996, GEN THEORY TONAL MUS; LENTZ DA, 1961, TONE INTERVALS HINDU; MANDELBAUM MJ, 1961, THESIS INDIANA U BLO; McDermott J, 2005, MUSIC PERCEPT, V23, P29, DOI 10.1525/mp.2005.23.1.29; McPhee C., 1966, MUSIC BALI; MUKHERJEE P, 2004, SCALES INDIAN MUSIC; Parncutt R., 1989, HARMONY PSYCHOACOUST; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; PIERCE JR, 2000, SCI MUSICAL SOUND; PLOMP R, 1964, J ACOUST SOC AM, V36, P1628, DOI 10.1121/1.1919256; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Samson Jim, 1977, MUSIC TRANSITION STU; SATYANARAYANA NC, 2005, SCI INDIAN MUSIC; Schellenberg EG, 1996, PSYCHOL SCI, V7, P272, DOI 10.1111/j.1467-9280.1996.tb00373.x; Schwartz DA, 2004, HEARING RES, V194, P31, DOI 10.1016/j.heares.2004.01.019; SETHARES WA, 1993, J ACOUST SOC AM, V94, P1218, DOI 10.1121/1.408175; SETHARES WA, 1998, TIMBRE TUNING SPECTR; SNOWDON CT, 2009, AFFECTIVE RESPONSES; TERHARDT E, 1984, MUSIC PERCEPT, V1, P276; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; Touma Habib Hassan, 1996, MUSIC ARABS; von Hoerner Sebastian, 1974, PSYCHOL MUSIC, V2, P18, DOI DOI 10.1177/030573567422003; VONHOERNER S, 1976, PSYCHOL MUSIC, V4, P12; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Wright Owen, 1978, MODAL SYSTEM ARAB PE; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2; Zwicker E., 1999, PSYCHOACOUSTICS, DOI [10.1007/978-3-662-09562-1, DOI 10.1007/978-3-662-09562-1]	51	64	66	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8144	10.1371/journal.pone.0008144	http://dx.doi.org/10.1371/journal.pone.0008144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997506	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829000005
J	Guo, L; Sun, BL; Sang, F; Wang, W; Lu, ZH				Guo, Li; Sun, Beili; Sang, Fei; Wang, Wei; Lu, Zuhong			Haplotype Distribution and Evolutionary Pattern of miR-17 and miR-124 Families Based on Population Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING-SITES; MICRORNAS; IDENTIFICATION; RNAS; NETWORKS; SEQUENCE	Background: MicroRNAs (miRNAs) are small, endogenously expressed non-coding RNAs that regulate mRNAs post-transcriptionally. Previous studies have explored miRNA evolutionary trend, but evolutionary history and pattern in the miRNA world are still not fully clear. In the paper, we intended to analyze miRNA haplotype distribution and evolutionary network by analyzing miRNA sequences of miR-17 and miR-124 families across animal species as special populations. Principal Findings: 31 haplotypes were detected in miR-17 family while only 9 haplotypes were defined in miR-124 family. The complex miR-17 family was mainly distributed in vertebrates, but miR-124 was shared by more animal species from Caenorhabditis to Homo and had a wide distribution spectrum. Some haplotypes of the two miRNA families appeared discontinuous distributions across animals. Compared with a simple phylogenetic network in miR-124 family, miR-17 family indicated a complex network with some median vectors that might be lost ancestral or potential miRNA haplotypes. By analyzing different miRNAs across 12 animal species, we found these small RNAs showed different haplotype diversities, haplotype distributions and phylogenetic networks. Conclusions: Different miRNAs had quite different haplotype distributions and evolutionary patterns. Discontinuous distributions of miRNAs and median vectors in phylogenetic networks implied more members in the miRNA world. miRNA may be an excellent phylogenetic marker to discover its evolutionary history and pattern across the animal kingdom.	[Guo, Li; Sun, Beili; Wang, Wei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Sang, Fei; Lu, Zuhong] Southeast Univ, Key Lab Child Dev, Nanjing, Peoples R China; [Sang, Fei; Lu, Zuhong] Southeast Univ, Learning Sci Minist Educ, Nanjing, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	zhlu@seu.edu.cn	Lu, Zuhong/A-5448-2013	Sang, Fei/0000-0002-8746-5868; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the project 30871393 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Fu XH, 2008, MOL BIOL EVOL, V25, P1067, DOI 10.1093/molbev/msn060; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; HE L, 2004, NATURE REV GENETICS, V5, P522; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wittkopp PJ, 2005, CELL MOL LIFE SCI, V62, P1779, DOI 10.1007/s00018-005-5064-9; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006	40	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7944	10.1371/journal.pone.0007944	http://dx.doi.org/10.1371/journal.pone.0007944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956752	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827300004
J	Li, J; Yang, TL; Wang, L; Yan, H; Zhang, YP; Guo, Y; Pan, F; Zhang, ZX; Peng, YM; Zhou, Q; He, LN; Zhu, XZ; Deng, HY; Levy, S; Papasian, CJ; Drees, BM; Hamilton, JJ; Recker, RR; Cheng, J; Deng, HW				Li, Jian; Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Yinping; Guo, Yan; Pan, Feng; Zhang, Zhixin; Peng, Yumei; Zhou, Qi; He, Lina; Zhu, Xuezhen; Deng, Hongyi; Levy, Shawn; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Recker, Robert R.; Cheng, Jing; Deng, Hong-Wen			Whole Genome Distribution and Ethnic Differentiation of Copy Number Variation in Caucasian and Asian Populations	PLOS ONE			English	Article							AFFYMETRIX SNP ARRAYS; COMPREHENSIVE ANALYSIS; STRUCTURAL VARIATION; DNA; GENE; WIDE; HETEROZYGOSITY; POLYMORPHISM; NUCLEOTIDE; SUSCEPTIBILITY	Although copy number variation (CNV) has recently received much attention as a form of structure variation within the human genome, knowledge is still inadequate on fundamental CNV characteristics such as occurrence rate, genomic distribution and ethnic differentiation. In the present study, we used the Affymetrix GeneChip(R) Mapping 500K Array to discover and characterize CNVs in the human genome and to study ethnic differences of CNVs between Caucasians and Asians. Three thousand and nineteen CNVs, including 2381 CNVs in autosomes and 638 CNVs in X chromosome, from 985 Caucasian and 692 Asian individuals were identified, with a mean length of 296 kb. Among these CNVs, 190 had frequencies greater than 1% in at least one ethnic group, and 109 showed significant ethnic differences in frequencies (p<0.01). After merging overlapping CNVs, 1135 copy number variation regions (CNVRs), covering approximately 439 Mb (14.3%) of the human genome, were obtained. Our findings of ethnic differentiation of CNVs, along with the newly constructed CNV genomic map, extend our knowledge on the structural variation in the human genome and may furnish a basis for understanding the genomic differentiation of complex traits across ethnic groups.	[Li, Jian; Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Zhixin; Deng, Hongyi; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Yinping; Guo, Yan; Pan, Feng; Zhang, Zhixin; Peng, Yumei; Zhou, Qi; He, Lina; Zhu, Xuezhen; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn Minist Educ, Xian 710049, Shanxi, Peoples R China; [Yang, Tielin; Wang, Liang; Yan, Han; Zhang, Yinping; Guo, Yan; Pan, Feng; Zhang, Zhixin; Peng, Yumei; Zhou, Qi; He, Lina; Zhu, Xuezhen; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shanxi, Peoples R China; [Levy, Shawn] Vanderbilt Univ, Nashville, TN USA; [Recker, Robert R.] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA; [Cheng, Jing] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China	University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; Xi'an Jiaotong University; Vanderbilt University; Creighton University; Hunan Normal University	Li, J (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu	Yang, Tie-Lin/G-8365-2014; Li, Jian/G-4445-2015; Guo, Yan/G-8742-2014	Yang, Tie-Lin/0000-0001-7062-3025; Guo, Yan/0000-0002-7364-2392; Levy, Shawn/0000-0002-1369-5740; Deng, Hong-Wen/0000-0002-0387-8818	NIH [R01 AR050496-01, R21 AG027110, R01 AG026564, P50 AR055081]; National Science Foundation of China; Huo Ying Dong Education Foundation, Xi'an Jiaotong University; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation, Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Investigators of this work were partially supported by grants from NIH (R01 AR050496-01, R21 AG027110, R01 AG026564, and P50 AR055081). The study also benefited from grants from National Science Foundation of China, Huo Ying Dong Education Foundation, Xi'an Jiaotong University, and the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hegele RA, 2007, CAN MED ASSOC J, V176, P441, DOI 10.1503/cmaj.061689; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hu N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-299; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacobs S, 2007, CANCER RES, V67, P2544, DOI 10.1158/0008-5472.CAN-06-3597; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Lo KC, 2008, GENE CHROMOSOME CANC, V47, P221, DOI 10.1002/gcc.20524; Madrigal I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-443; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Muller A, 2007, BIOINFORMATICS, V23, P496, DOI 10.1093/bioinformatics/btl608; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selvarajah S, 2007, CANCER GENET CYTOGEN, V179, P52, DOI 10.1016/j.cancergencyto.2007.08.003; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	28	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7958	10.1371/journal.pone.0007958	http://dx.doi.org/10.1371/journal.pone.0007958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956714	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827300015
J	Eliyahu, E; Shtraizent, N; Martinuzzi, K; Barritt, J; He, XX; Wei, H; Chaubal, S; Copperman, AB; Schuchman, EH				Eliyahu, Efrat; Shtraizent, Nataly; Martinuzzi, Kurt; Barritt, Jason; He, Xingxuan; Wei, Hong; Chaubal, Sanjeev; Copperman, Alan B.; Schuchman, Edward H.			Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization	FASEB JOURNAL			English	Article						reproduction; apoptosis; ceramide	ENRICHED MEMBRANE DOMAINS; REPRODUCTIVE TECHNOLOGIES; APOPTOSIS; SPHINGOSINE; MATURATION; REGULATORS; CATTLE	A major challenge of assisted reproduction technologies (ARTs) is to mimic the natural environment required to sustain oocyte and embryo survival. Herein, we show that the ceramide-metabolizing enzyme, acid ceramidase (AC), is expressed in human cumulus cells and follicular fluid, essential components of this environment, and that the levels of this enzyme are positively correlated with the quality of human embryos formed in vitro. These observations led us to develop a new approach for oocyte and embryo culture that markedly improved the outcome of in vitro fertilization (IVF). The addition of recombinant AC (rAC) to human and mouse oocyte culture medium maintained their healthy morphology in vitro. Following fertilization, the number of mouse embryos formed in the presence of rAC also was improved (from similar to 40 to 88%), leading to similar to 5-fold more healthy births. To confirm these observations, immature bovine oocytes were matured in vitro and subjected to IVF in the presence of rAC. Significantly more high-grade blastocysts were formed, and the number of morphologically intact, hatched embryos was increased from similar to 24 to 70%. Overall, these data identify AC as an important component of the in vivo oocyte and embryo environment, and provide a novel technology for enhancing the outcome of assisted fertilization. Eliyahu, E., Shtraizent, N., Martinuzzi, K., Barritt, J., He, X., Wei, H., Chaubal, S., Copperman, A. B., Schuchman, E. H. Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization. FASEB J. 24, 1229-1238 (2010). www.fasebj.org	[Eliyahu, Efrat; Shtraizent, Nataly; He, Xingxuan; Schuchman, Edward H.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Martinuzzi, Kurt; Barritt, Jason; Copperman, Alan B.] Mt Sinai Sch Med, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Schuchman, EH (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, 1425 Madison Ave,Rm 14-20A, New York, NY 10029 USA.	edward.schuchman@mssm.edu			U.S. National Institutes of Health [R01 DK 54830]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054830] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in part, by a grant from the U.S. National Institutes of Health to E. H. S. (R01 DK 54830). The authors also acknowledge the Mouse Genetics Shared Resource Facility at the Mount Sinai School of Medicine for assistance with the mouse surgeries. E. H. S., E. E., N.S. and X. H. are coinventors on a patent application describing the use of AC for cell survival.	Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BENYOSEF D, 1995, MOL REPROD DEV, V42, P122, DOI 10.1002/mrd.1080420116; Caperton L, 2007, P NATL ACAD SCI USA, V104, P5085, DOI 10.1073/pnas.0611642104; Chaube SK, 2005, APOPTOSIS, V10, P863, DOI 10.1007/s10495-005-0367-8; De La Fuente R, 2006, DEV BIOL, V292, P1, DOI 10.1016/j.ydbio.2006.01.008; De Sutter P, 2003, FERTIL STERIL, V79, P1294, DOI 10.1016/S0015-0282(03)00264-4; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Ferlinz K, 2001, J BIOL CHEM, V276, P35352, DOI 10.1074/jbc.M103066200; Galli C, 2008, REPROD DOMEST ANIM, V43, P1, DOI 10.1111/j.1439-0531.2008.01136.x; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Kolialexi A, 2008, MASS SPECTROM REV, V27, P624, DOI 10.1002/mas.20181; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Meng QG, 2007, ACTA VET HUNG, V55, P369, DOI 10.1556/AVet.55.2007.3.11; Ogretmen B, 2001, J BIOL CHEM, V276, P32506, DOI 10.1074/jbc.M101350200; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Scherzer J, 2008, REPROD DOMEST ANIM, V43, P371, DOI 10.1111/j.1439-0531.2007.00921.x; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Swanson WR, 2006, THERIOGENOLOGY, V66, P49, DOI 10.1016/j.theriogenology.2006.03.024; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; WRIGHT JM, 1981, THERIOGENOLOGY, V15, P43, DOI 10.1016/S0093-691X(81)80017-9; Wright Victoria C, 2003, MMWR Surveill Summ, V52, P1; Wu J, 2000, FERTIL STERIL, V74, P1137, DOI 10.1016/S0015-0282(00)01597-1; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zhang Y, 2009, BBA-BIOMEMBRANES, V1788, P178, DOI 10.1016/j.bbamem.2008.07.030; Zheng P, 2007, ANIM REPROD SCI, V98, P56, DOI 10.1016/j.anireprosci.2006.10.005	30	22	31	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1229	1238		10.1096/fj.09-145508	http://dx.doi.org/10.1096/fj.09-145508			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	20007509	Green Published			2022-12-25	WOS:000276462300029
J	Varani, K; Caramori, G; Vincenzi, F; Tosi, A; Barczyk, A; Contoli, M; Casolari, P; Triggiani, M; Hansel, T; Leung, E; MacLennan, S; Barnes, PJ; Chung, KF; Adcock, I; Papi, A; Borea, PA				Varani, Katia; Caramori, Gaetano; Vincenzi, Fabrizio; Tosi, Alice; Barczyk, Adam; Contoli, Marco; Casolari, Paolo; Triggiani, Massimo; Hansel, Trevor; Leung, Edward; MacLennan, Stephen; Barnes, Peter J.; Chung, Kian Fan; Adcock, Ian; Papi, Alberto; Borea, Pier Andrea			Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease	FASEB JOURNAL			English	Article						COPD; macrophages; proliferation; alveolar macrophages; proinflammatory cytokines; U937 cells	HISTONE DEACETYLASE; OXIDATIVE STRESS; AIRWAY INFLAMMATION; EXPRESSION; ASTHMA; BINDING	The primary aim of this study was to investigate adenosine receptors (ARs) in bronchoalveolar lavage (BAL) macrophages from patients with chronic obstructive pulmonary disease (COPD) and age-matched healthy smokers. A(2B)ARs were significantly decreased in BAL macrophages from patients with COPD when compared with healthy smokers. The effect of proinflammatory cytokines and oxidative/nitrosative stress on AR expression and function in U937 cells before and after PMA treatment was evaluated. IL-1 beta and TNF-alpha treatment up-regulated A(2A)- and A(3)ARs but not A(1)- or A(2B)ARs, whereas IL-6 did not modify AR expression. In contrast, oxidative/nitrosative stress selectively decreased A(2B)AR expression, which was associated with a reduction in the potency of the adenosine agonist 5'-N-ethylcarboxamideadenosine (NECA) to induce cAMP. Further, the ability of NECA to enhance cell proliferation was increased after oxidative/nitrosative stress. The specific involvement of A(2B)ARs was investigated by using potent and selective A(2B)AR antagonist and by A(2B)AR knockdown using siRNA and demonstrated responses similar to those obtained with oxidative/nitrosative stress. N-acetylcysteine (NAC), an antioxidant agent, counteracted the decrease in A(2B)AR expression, as well as the altered NECA effects on cAMP and cell proliferation. These findings highlight the central role of A(2B)ARs in alveolar macrophages, suggesting that their modulation could represent an innovative pharmacological strategy to manage COPD.-Varani, K., Caramori, G., Vincenzi, F., Tosi, A., Barczyk, A., Contoli, M., Casolari, P., Triggiani, M., Hansel, T., Leung, E., MacLennan, S., Barnes, P. J., Fan Chung, K., Adcock, I., Papi, A., Borea, P. A. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease. FASEB J. 24, 1192-1204 (2010). www.fasebj.org	[Borea, Pier Andrea] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Unit, Pharmacol Sect, I-44100 Ferrara, Italy; [Caramori, Gaetano; Contoli, Marco; Casolari, Paolo; Papi, Alberto] Univ Ferrara, Dept Clin & Expt Med, Resp Dis Sect, I-44100 Ferrara, Italy; [Barczyk, Adam] Slaskiej Akad Medycznej, Katedra & Klin Pneumonol, Katowice, Poland; [Leung, Edward; MacLennan, Stephen] King Pharmaceut, Cary, NC USA; [Triggiani, Massimo] Univ Naples Federico II, Div Clin Immunol & Allergy, Naples, Italy; [Hansel, Trevor; Barnes, Peter J.; Chung, Kian Fan; Adcock, Ian] Univ London Imperial Coll Sci Technol & Med, Airways Dis Sect, Natl Heart & Lung Inst, London SW7 2AZ, England	University of Ferrara; University of Ferrara; Pfizer; University of Naples Federico II; Imperial College London	Borea, PA (corresponding author), Univ Ferrara, Dept Clin & Expt Med, Pharmacol Unit, Pharmacol Sect, Via Fossato Mortara 17-19, I-44100 Ferrara, Italy.	bpa@unife.it	Contoli, Marco/K-3947-2018; Vincenzi, Fabrizio/E-7925-2013; Chung, Kian Fan/B-1872-2012; Adcock, Ian/L-3217-2019; Triggiani, Massimo/K-8271-2016; Caramori, Gaetano/AAS-8611-2020; Chung, Kian Fan/I-8456-2019; Papi, alberto/AAC-1888-2019; Barczyk, Adam/GYV-4487-2022	Contoli, Marco/0000-0002-2731-5809; Chung, Kian Fan/0000-0001-7101-1426; Triggiani, Massimo/0000-0001-7318-2093; Caramori, Gaetano/0000-0002-9807-327X; Chung, Kian Fan/0000-0001-7101-1426; Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018; Vincenzi, Fabrizio/0000-0002-5027-1699; Barczyk, Adam/0000-0002-6567-9208; PAPI, ALBERTO/0000-0002-6924-4500	GlaxoSmithKline (Brentford, UK); Wellcome Trust; Associazione per la Ricerca e la Cura dell'Asma (ARCA; Padova, Italy); King Pharmaceuticals (Cary, NC, USA)	GlaxoSmithKline (Brentford, UK)(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission); Associazione per la Ricerca e la Cura dell'Asma (ARCA; Padova, Italy); King Pharmaceuticals (Cary, NC, USA)	This work was supported by GlaxoSmithKline (Brentford, UK), Wellcome Trust, Associazione per la Ricerca e la Cura dell'Asma (ARCA; Padova, Italy), and King Pharmaceuticals (Cary, NC, USA). None of authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Anderson GP, 2003, TRENDS PHARMACOL SCI, V24, P71, DOI 10.1016/S0165-6147(02)00052-4; Barnes Peter J., 2005, Current Drug Targets - Inflammation and Allergy, V4, P675, DOI 10.2174/156801005774912833; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brozyna S, 2009, COPD, V6, P4, DOI 10.1080/15412550902724164; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Caramori G, 2005, CURR OPIN ALLERGY CL, V5, P77, DOI 10.1097/00130832-200502000-00014; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6; Di Stefano A, 2004, CLIN EXP ALLERGY, V34, P1156, DOI 10.1111/j.1365-2222.2004.02030.x; GESSI S, 2005, MOL PHARM, V67, P1; Global Initiative for Chronic Obstructive Lung Disease, 2001, NIH PUBL, V2701, P1; Ham J., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P244, DOI 10.2174/187153008786848303; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Martinet W, 2003, BIOTECHNOL LETT, V25, P1025, DOI 10.1023/A:1024157508492; Merighi S, 2005, J BIOL CHEM, V280, P19516, DOI 10.1074/jbc.M413772200; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Ochs-Balcom HM, 2006, EUR J CLIN NUTR, V60, P991, DOI 10.1038/sj.ejcn.1602410; Papi A, 2000, AM J RESP CRIT CARE, V162, P1773, DOI 10.1164/ajrccm.162.5.9910112; Paschen W, 2001, J NEUROCHEM, V76, P1916, DOI 10.1046/j.1471-4159.2001.00206.x; Pinho RA, 2007, RESP MED, V101, P1830, DOI 10.1016/j.rmed.2007.02.004; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Psarras S, 2005, CURR PHARM DESIGN, V11, P2053, DOI 10.2174/1381612054065774; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Ricciardolo FLM, 2005, J ALLERGY CLIN IMMUN, V116, P1028, DOI 10.1016/j.jaci.2005.06.034; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Tomita K, 2002, AM J RESP CRIT CARE, V166, P724, DOI 10.1164/rccm.2104010; Varani K, 2000, MOL PHARMACOL, V57, P968; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Varani K, 2005, BIOCHEM PHARMACOL, V70, P1601, DOI 10.1016/j.bcp.2005.08.018; Varani K, 2003, FASEB J, V17, P2148, DOI 10.1096/fj.03-0079fje; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	44	15	17	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1192	1204		10.1096/fj.09-139485	http://dx.doi.org/10.1096/fj.09-139485			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	20008542				2022-12-25	WOS:000276462300026
J	Mascanfroni, ID; Montesinos, MD; Alamino, VA; Susperreguy, S; Nicola, JP; Ilarregui, JM; Masini-Repiso, AM; Rabinovich, GA; Pellizas, CG				Mascanfroni, Ivan D.; del Mar Montesinos, Maria; Alamino, Vanina A.; Susperreguy, Sebastian; Nicola, Juan P.; Ilarregui, Juan M.; Masini-Repiso, Ana M.; Rabinovich, Gabriel A.; Pellizas, Claudia G.			Nuclear Factor (NF)-kappa B-dependent Thyroid Hormone Receptor beta(1) Expression Controls Dendritic Cell Function via Akt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NONGENOMIC ACTIONS; ACTIVATION; PROTEIN; KINASE; IMMUNOPRECIPITATION; PATHWAY; GENE; MECHANISMS; MATURATION	Despite considerable progress in our understanding of the interplay between immune and endocrine systems, the role of thyroid hormones and their receptors in the control of adaptive immunity is still uncertain. Here, we investigated the role of thyroid hormone receptor (TR) beta(1) signaling in modulating dendritic cell (DC) physiology and the intracellular mechanisms underlying these immunoregulatory effects. Exposure of DCs to triiodothyronine (T-3) resulted in a rapid and sustained increase in Akt phosphorylation independently of phosphatidylinositol 3-kinase activation, which was essential for supporting T-3-induced DC maturation and interleukin (IL)-12 production. This effect was dependent on intact TR beta(1) signaling as small interfering RNA-mediated silencing of TR beta(1) expression prevented T-3-induced DC maturation and IL-12 secretion as well as Akt activation and I kappa B-epsilon degradation. In turn, T-3 up-regulated TR beta(1) expression through mechanisms involving NF-kappa B, suggesting an autocrine regulatory loop to control hormone-dependent TR beta(1) signaling. These findings were confirmed by chromatin immunoprecipitation analysis, which disclosed a new functional NF-kappa B consensus site in the promoter region of the TRB1 gene. Thus, a T-3-induced NF-kappa B-dependent mechanism controls TR beta(1) expression, which in turn signals DCs to promote maturation and function via an Akt-dependent but PI3K-independent pathway. These results underscore a novel unrecognized target that regulates DC maturation and function with critical implications in immunopathology at the crossroads of the immune-endocrine circuits.	[Mascanfroni, Ivan D.; del Mar Montesinos, Maria; Alamino, Vanina A.; Susperreguy, Sebastian; Nicola, Juan P.; Masini-Repiso, Ana M.; Pellizas, Claudia G.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Consejo Nacl Invest Cient & Tecn,Ctr Invest Bioqu, RA-5000 Cordoba, Argentina; [Ilarregui, Juan M.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Inmunopatol, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Pellizas, CG (corresponding author), Ciudad Univ, RA-5000 Cordoba, Argentina.	claudia@fcq.unc.edu.ar	Pellizas, Claudia Gabriela/U-5241-2019	Ilarregui, Juan Martin/0000-0002-6871-6764	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-5325]; Agencia Nacional de Promocion Ciencia y Tecnica [PICT 2005-33139, 2006-603]; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba; Cancer Research Institute; Fundacion Sales	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Ciencia y Tecnica(ANPCyT); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Cancer Research Institute; Fundacion Sales	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP-5325 (to C. G. P.), Agencia Nacional de Promocion Ciencia y Tecnica Grants PICT 2005-33139 (to A. M. M.) and 2006-603 (to G. A. R.), and grants from Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (to C. G. P.), Cancer Research Institute (to G. A. R.), and Fundacion Sales (to G. A. R.).	Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Davis PJ, 2008, STEROIDS, V73, P1013, DOI 10.1016/j.steroids.2007.12.030; Davis PJ, 2008, FRONT NEUROENDOCRIN, V29, P211, DOI 10.1016/j.yfrne.2007.09.003; Dhodapkar MV, 2008, CELL DEATH DIFFER, V15, P39, DOI 10.1038/sj.cdd.4402247; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; HODIN RA, 1990, J CLIN INVEST, V85, P101, DOI 10.1172/JCI114398; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; ISSEMANN I, 1991, J STEROID BIOCHEM, V40, P263, DOI 10.1016/0960-0760(91)90191-7; Kemenade LVV, 2007, GEN COMP ENDOCR, V152, P352, DOI 10.1016/j.ygcen.2007.05.025; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Klecha AJ, 2006, J ENDOCRINOL, V189, P45, DOI 10.1677/joe.1.06137; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Laderach D, 2003, J IMMUNOL, V171, P1750, DOI 10.4049/jimmunol.171.4.1750; Lam QLK, 2007, J BIOL CHEM, V282, P27587, DOI 10.1074/jbc.M704579200; Lei J, 2008, AM J PHYSIOL-LUNG C, V294, pL749, DOI 10.1152/ajplung.00335.2007; Mascanfroni I, 2008, FASEB J, V22, P1032, DOI 10.1096/fj.07-8652com; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Refetoff S, 2007, BEST PRACT RES CL EN, V21, P277, DOI 10.1016/j.beem.2007.03.005; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Storey NM, 2006, P NATL ACAD SCI USA, V103, P5197, DOI 10.1073/pnas.0600089103; Straw AD, 2003, J IMMUNOL, V170, P727, DOI 10.4049/jimmunol.170.2.727; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; WOOD WM, 1994, MOL ENDOCRINOL, V8, P1605, DOI 10.1210/me.8.12.1605; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang TY, 2007, J IMMUNOL, V178, P2517, DOI 10.4049/jimmunol.178.4.2517	43	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9569	9582		10.1074/jbc.M109.071241	http://dx.doi.org/10.1074/jbc.M109.071241			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20018842	Green Published, hybrid			2022-12-25	WOS:000276165900030
J	Kim, YH; Kwei, KA; Girard, L; Salari, K; Kao, J; Pacyna-Gengelbach, M; Wang, P; Hernandez-Boussard, T; Gazdar, AF; Petersen, I; Minna, JD; Pollack, JR				Kim, Y. H.; Kwei, K. A.; Girard, L.; Salari, K.; Kao, J.; Pacyna-Gengelbach, M.; Wang, P.; Hernandez-Boussard, T.; Gazdar, A. F.; Petersen, I.; Minna, J. D.; Pollack, J. R.			Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer	ONCOGENE			English	Article						CRKL; lung cancer; DNA amplification; genomic profiling; adapter protein	BRONCHIAL EPITHELIAL-CELLS; HUMAN BREAST-CANCER; ADAPTER PROTEIN; HOMOZYGOUS DELETIONS; TYROSINE KINASE; GENE; MUTATIONS; LINES; MET; AMPLIFICATIONS	DNA amplifications, leading to the overexpression of oncogenes, are a cardinal feature of lung cancer and directly contribute to its pathogenesis. To uncover such novel alterations, we performed an array-based comparative genomic hybridization survey of 128 non-small-cell lung cancer cell lines and tumors. Prominent among our findings, we identified recurrent high-level amplification at cytoband 22q11.21 in 3% of lung cancer specimens, with another 11% of specimens exhibiting low-level gain spanning that locus. The 22q11.21 amplicon core contained eight named genes, only four of which were overexpressed (by transcript pro. ling) when amplified. Among these, CRKL encodes an adapter protein functioning in signal transduction, best known as a substrate of the BCR-ABL kinase in chronic myelogenous leukemia. RNA-interference-mediated knockdown of CRKL in lung cancer cell lines with (but not without) amplification led to significantly decreased cell proliferation, cell-cycle progression, cell survival, and cell motility and invasion. In addition, overexpression of CRKL in immortalized human bronchial epithelial cells led to enhanced growth factor-independent cell growth. Our findings indicate that amplification and resultant overexpression of CRKL contribute to diverse oncogenic phenotypes in lung cancer, with implications for targeted therapy, and highlight a role of adapter proteins as primary genetic drivers of tumorigenesis. Oncogene (2010) 29, 1421-1430; doi:10.1038/onc.2009.437; published online 7 December 2009	[Kim, Y. H.; Kwei, K. A.; Salari, K.; Kao, J.; Pollack, J. R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Girard, L.; Gazdar, A. F.; Minna, J. D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Salari, K.; Hernandez-Boussard, T.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pacyna-Gengelbach, M.] Univ Hosp Charite, Inst Pathol, Berlin, Germany; [Wang, P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Petersen, I.] Univ Klinikum Jena, Inst Pathol, Jena, Germany	Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fred Hutchinson Cancer Center; Friedrich Schiller University of Jena	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, CCSR Bldg,Room 3245A,269 Campus Dr, Stanford, CA 94305 USA.	pollack1@stanford.edu			NIH [R01 CA97139, SPORE P50CA70907, EDRN U01CA084971]; DOD VITAL; Longenbaugh Foundations; TRDRP [17FT-0062]; Deutsche Krebshilfe [108003]; Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [R01CA097139, T32CA009151, U01CA084971, P50CA070907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD VITAL; Longenbaugh Foundations; TRDRP; Deutsche Krebshilfe(Deutsche Krebshilfe); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the SFGF for fabrication of microarrays and the SMD for database support. We thank Eon Rios for assistance with flow cytometry analysis. We also thank the members of the Pollack lab for helpful discussion. This work was supported in part by grants from the NIH: R01 CA97139 (JRP), SPORE P50CA70907 (JDM), EDRN U01CA084971 (AFG); DOD VITAL (JDM); Longenbaugh Foundations (JDM); TRDRP (17FT-0062; KAK) and the Deutsche Krebshilfe: 108003 (IP). KS was supported by the Medical Scientist Training Program and is a Paul & Daisy Soros fellow.	Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; DALY RJ, 1994, ONCOGENE, V9, P2723; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Gay B, 1999, INT J CANCER, V83, P235, DOI 10.1002/(SICI)1097-0215(19991008)83:2<235::AID-IJC15>3.0.CO;2-B; Hemmeryckx B, 2001, CANCER RES, V61, P1398; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kardinal C, 2000, FASEB J, V14, P1529, DOI 10.1096/fj.14.11.1529; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2003, CANCER RES, V63, P6272; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Singer CF, 2006, ONCOL REP, V15, P353; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; TENHOEVE J, 1994, CANCER RES, V54, P2563; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	33	54	54	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1421	1430		10.1038/onc.2009.437	http://dx.doi.org/10.1038/onc.2009.437			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19966867	Green Accepted			2022-12-25	WOS:000275392400002
J	De Groot, CO; Jelesarov, I; Damberger, FF; Bjelic, S; Scharer, MA; Bhavesh, NS; Grigoriev, I; Buey, RM; Wuthrich, K; Capitani, G; Akhmanova, A; Steinmetz, MO				De Groot, Christian O.; Jelesarov, Ilian; Damberger, Fred F.; Bjelic, Sasa; Schaerer, Martin A.; Bhavesh, Neel S.; Grigoriev, Ilia; Buey, Ruben M.; Wuethrich, Kurt; Capitani, Guido; Akhmanova, Anna; Steinmetz, Michel O.			Molecular Insights into Mammalian End-binding Protein Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS-END; CAP-GLY DOMAINS; HYDROGEN-EXCHANGE; IN-VITRO; EB1; DYNAMICS; TRACKING; APC; PLASTICITY; STABILITY	Microtubule plus-end tracking proteins (+TIPs) are involved in many microtubule-based processes. End binding (EB) proteins constitute a highly conserved family of +TIPs. They play a pivotal role in regulating microtubule dynamics and in the recruitment of diverse +TIPs to growing microtubule plus ends. Here we used a combination of methods to investigate the dimerization properties of the three human EB proteins EB1, EB2, and EB3. Based on Forster resonance energy transfer, we demonstrate that the C-terminal dimerization domains of EBs (EBc) can readily exchange their chains in solution. We further document that EB1c and EB3c preferentially form heterodimers, whereas EB2c does not participate significantly in the formation of heterotypic complexes. Measurements of the reaction thermodynamics and kinetics, homology modeling, and mutagenesis provide details of the molecular determinants of homo-versus heterodimer formation of EBc domains. Fluorescence spectroscopy and nuclear magnetic resonance studies in the presence of the cytoskeleton-associated protein-glycine-rich domains of either CLIP-170 or p150(glued) or of a fragment derived from the adenomatous polyposis coli tumor suppressor protein show that chain exchange of EBc domains can be controlled by binding partners. Extension of these studies of the EBc domains to full-length EBs demonstrate that heterodimer formation between EB1 and EB3, but not between EB2 and the other two EBs, occurs both in vitro and in cells as revealed by live cell imaging. Together, our data provide molecular insights for rationalizing the dominant negative control by C-terminal EB domains and form a basis for understanding the functional role of heterotypic chain exchange by EBs in cells.	[De Groot, Christian O.; Bjelic, Sasa; Schaerer, Martin A.; Buey, Ruben M.; Capitani, Guido; Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Jelesarov, Ilian] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Damberger, Fred F.; Bhavesh, Neel S.; Wuethrich, Kurt] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Grigoriev, Ilia; Akhmanova, Anna] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Wuethrich, Kurt] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Erasmus University Rotterdam; Erasmus MC; Scripps Research Institute; Scripps Research Institute	Steinmetz, MO (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	michel.steinmetz@psi.ch	Akhmanova, Anna S/B-8896-2011; Martinez-Buey, Ruben/K-4296-2014; Bjelic, Sasa/G-6849-2011; Bhavesh, Neel Sarovar/F-3127-2015; Steinmetz, Michel O/AAA-3349-2022; Bjelic, Sasa/N-1348-2019; Damberger, Fred F/A-8938-2011	Akhmanova, Anna S/0000-0002-9048-8614; Martinez-Buey, Ruben/0000-0003-1263-0221; Bjelic, Sasa/0000-0002-9805-3201; Bhavesh, Neel Sarovar/0000-0002-7248-4978; Steinmetz, Michel O/0000-0001-6157-3687; Bjelic, Sasa/0000-0002-9805-3201; Damberger, Fred F/0000-0002-8457-3409; Wuthrich, Kurt/0000-0001-8739-6965	Swiss National Science Foundation; Netherlands Organization for Scientific Research NWO-ALW-VICI; ZonMW-TOP; Federation of European Biochemical Societies; NCCR Structural Biology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research NWO-ALW-VICI(Netherlands Organization for Scientific Research (NWO)); ZonMW-TOP; Federation of European Biochemical Societies; NCCR Structural Biology(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (to M. O. S. and I. J.), by Netherlands Organization for Scientific Research NWO-ALW-VICI and ZonMW-TOP grants (to A. A.), by a Federation of European Biochemical Societies fellowship (to R. M. B.), and by the Swiss National Science Foundation and the ETH Zurich through the NCCR Structural Biology (to I. J. and K. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Ban R, 2009, J BIOL CHEM, V284, P28367, DOI 10.1074/jbc.M109.000273; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Durr E, 1999, BIOCHEMISTRY-US, V38, P870, DOI 10.1021/bi981891e; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Keller R., 2004, COMPUTER AIDED RESON, V1; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kronja I, 2009, MOL BIOL CELL, V20, P2684, DOI 10.1091/mbc.E08-10-1051; Lee T, 2008, ONCOGENE, V27, P2494, DOI 10.1038/sj.onc.1210867; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Niethammer P, 2007, PLOS BIOL, V5, P190, DOI 10.1371/journal.pbio.0050029; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schroder JM, 2007, CURR BIOL, V17, P1134, DOI 10.1016/j.cub.2007.05.055; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WAGNER G, 1979, J MOL BIOL, V134, P75, DOI 10.1016/0022-2836(79)90414-5; Wang FB, 2008, EXP CELL RES, V314, P213, DOI 10.1016/j.yexcr.2007.09.022; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	51	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5802	5814		10.1074/jbc.M109.068130	http://dx.doi.org/10.1074/jbc.M109.068130			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20008324	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000275327200071
J	Cai, Y; Jin, JJ; Swanson, SK; Cole, MD; Choi, SH; Florens, L; Washburn, MP; Conaway, JW; Conaway, RC				Cai, Yong; Jin, Jingji; Swanson, Selene K.; Cole, Michael D.; Choi, Seung Hyuk; Florens, Laurence; Washburn, Michael P.; Conaway, Joan W.; Conaway, Ronald C.			Subunit Composition and Substrate Specificity of a MOF-containing Histone Acetyltransferase Distinct from the Male-specific Lethal (MSL) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; PROTEIN IDENTIFICATION TECHNOLOGY; DOSAGE COMPENSATION; PROTEOMIC ANALYSIS; TRANSCRIPTION; DROSOPHILA; INO80; ACETYLATION; H4; ACTIVATION	Human MOF (MYST1), a member of the MYST (Moz-Ybf2/Sas3-Sas2-Tip60) family of histone acetyltransferases (HATs), is the human ortholog of the Drosophila males absent on the first (MOF) protein. MOF is the catalytic subunit of the male-specific lethal (MSL) HAT complex, which plays a key role in dosage compensation in the fly and is responsible for a large fraction of histone H4 lysine 16 (H4K16) acetylation in vivo. MOF was recently reported to be a component of a second HAT complex, designated the non-specific lethal (NSL) complex (Mendjan, S., Taipale, M., Kind, J., Holz, H., Gebhardt, P., Schelder, M., Vermeulen, M., Buscaino, A., Duncan, K., Mueller, J., Wilm, M., Stunnenberg, H. G., Saumweber, H., and Akhtar, A. (2006) Mol. Cell 21, 811-823). Here we report an analysis of the subunit composition and substrate specificity of the NSL complex. Proteomic analyses of complexes purified through multiple candidate subunits reveal that NSL is composed of nine subunits. Two of its subunits, WD repeat domain 5 (WDR5) and host cell factor 1 (HCF1), are shared with members of the MLL/SET family of histone H3 lysine 4 (H3K4) methyltransferase complexes, and a third subunit, MCRS1, is shared with the human INO80 chromatin-remodeling complex. In addition, we show that assembly of the MOF HAT into MSL or NSL complexes controls its substrate specificity. Although MSL-associated MOF acetylates nucleosomal histone H4 almost exclusively on lysine 16, NSL-associated MOF exhibits a relaxed specificity and also acetylates nucleosomal histone H4 on lysines 5 and 8.	[Cai, Yong; Jin, Jingji; Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Cole, Michael D.; Choi, Seung Hyuk] Dartmouth Med Sch, Dept Pharmacol, Hanover, NH 03756 USA; [Cole, Michael D.; Choi, Seung Hyuk] Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Dartmouth College; Dartmouth College; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org		Conaway, Joan/0000-0002-2786-0663; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	NIGMS, National Institutes of Health [R37 GM41628]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R01CA055248, P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant R37 GM41628 from the NIGMS, National Institutes of Health Grant (to R. C. C.), and by funds from the Stowers Institute for Medical Research.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Owen-Hughes T, 1999, METH MOL B, V119, P319; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pillus L, 2008, CURR OPIN CELL BIOL, V20, P326, DOI 10.1016/j.ceb.2008.04.009; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	38	162	177	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4268	4272		10.1074/jbc.C109.087981	http://dx.doi.org/10.1074/jbc.C109.087981			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018852	Green Published, hybrid			2022-12-25	WOS:000275274800002
J	Desai, LP; White, SR; Waters, CM				Desai, Leena P.; White, Steven R.; Waters, Christopher M.			Cyclic Mechanical Stretch Decreases Cell Migration by Inhibiting Phosphatidylinositol 3-Kinase-and Focal Adhesion Kinase-mediated JNK1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; PLECKSTRIN HOMOLOGY DOMAIN; WOUND CLOSURE; IN-VITRO; PHOSPHOINOSITIDE 3-KINASE; BASEMENT-MEMBRANE; DNA-SYNTHESIS; SEVERE ASTHMA	Epithelial cell migration during wound healing requires coordinated signaling pathways that direct polarization of the leading and trailing ends of the cells, cytoskeletal organization, and remodeling of focal adhesions. These inherently mechanical processes are disrupted by cyclic stretch (CS), but the specific signaling molecules involved in this disruption are not well understood. In this study, we demonstrate that inhibition of phosphatidylinositol 3-kinase (PI3K) or expression of a dominant-negative form of PI3K caused inhibition of airway epithelial cell wound closure. CS caused a sustained decrease in activation of PI3K and inhibited wound healing. Expression of constitutively active PI3K stimulated translocation of Tiam1 to the membrane, increased Rac1 activity, and increased wound healing of airway epithelial cells. Increased Rac1 activity resulted in increased phosphorylation of JNK1. PI3K activation was not regulated by association with focal adhesion kinase. Restoration of efficient cell migration during CS required coexpression of constitutively active PI3K, focal adhesion kinase, and JIP3.	[Desai, Leena P.; Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Biomed Engn, Memphis, TN 38163 USA; [White, Steven R.] Univ Chicago, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago	Waters, CM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave,426 Nash, Memphis, TN 38163 USA.	cwaters2@uthsc.edu	Waters, Christopher/V-2759-2019		National Institutes of Health [HL-094366, HL-080417]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094366, R01HL080417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-094366 (to C. M. W.) and HL-080417 (to S. R. W.).	Adam RM, 2003, J UROLOGY, V169, P2388, DOI 10.1097/01.ju.0000063980.99368.35; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Avvisato CL, 2007, J CELL SCI, V120, P2672, DOI 10.1242/jcs.03476; Baba Y, 2008, BRIT J CANCER, V98, P974, DOI 10.1038/sj.bjc.6604252; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bryant P, 2006, MOL CELL BIOL, V26, P4201, DOI 10.1128/MCB.01612-05; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Chartier NT, 2006, J CELL SCI, V119, P31, DOI 10.1242/jcs.02698; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chu HW, 1998, AM J RESP CRIT CARE, V158, P1936, DOI 10.1164/ajrccm.158.6.9712073; Coon M, 2002, J CELL BIOCHEM, V84, P655, DOI 10.1002/jcb.10078; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Desai LP, 2008, AM J PHYSIOL-LUNG C, V295, pL958, DOI 10.1152/ajplung.90218.2008; Desai LP, 2009, AM J PHYSIOL-LUNG C, V297, pL520, DOI 10.1152/ajplung.00076.2009; Desai LP, 2004, AM J PHYSIOL-LUNG C, V287, pL1134, DOI 10.1152/ajplung.00022.2004; El-Assal ON, 2005, GASTROENTEROLOGY, V129, P609, DOI 10.1053/j.gastro.2005.05.054; ERJEFALT JS, 1995, CELL TISSUE RES, V281, P305, DOI 10.1007/BF00583399; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hammerschmidt S, 2007, AM J RESP CELL MOL, V37, P699, DOI 10.1165/rcmb.2006-0429OC; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hwang SY, 2006, INT J CANCER, V118, P2056, DOI 10.1002/ijc.21574; Ikeda M, 1999, BIOCHEM BIOPH RES CO, V257, P668, DOI 10.1006/bbrc.1999.0532; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Kallergi G, 2003, EXP CELL RES, V288, P94, DOI 10.1016/S0014-4827(03)00210-6; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Kodama K, 2005, INT J CANCER, V116, P876, DOI 10.1002/ijc.21136; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; RICKARD KA, 1993, AM J RESP CELL MOL, V8, P63, DOI 10.1165/ajrcmb/8.1.63; ROCHE WR, 1989, LANCET, V1, P520; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Savla U, 2004, J APPL PHYSIOL, V96, P566, DOI 10.1152/japplphysiol.00510.2003; Savla U, 1998, AM J PHYSIOL-LUNG C, V274, pL883, DOI 10.1152/ajplung.1998.274.6.L883; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Song JJ, 2005, J BIOL CHEM, V280, P26845, DOI 10.1074/jbc.M502318200; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Tetreault MP, 2008, J CELL PHYSIOL, V214, P545, DOI 10.1002/jcp.21239; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Tscharntke M, 2005, FASEB J, V19, P1836, DOI 10.1096/fj.04-3327fje; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; White SR, 1999, AM J RESP CELL MOL, V20, P787, DOI 10.1165/ajrcmb.20.4.3318; Wiggs BR, 1997, J APPL PHYSIOL, V83, P1814, DOI 10.1152/jappl.1997.83.6.1814; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P4277, DOI 10.1167/iovs.04-0119; Zhang Y, 1999, INVEST OPHTH VIS SCI, V40, P2819; Zou L, 2004, SHOCK, V22, P453, DOI 10.1097/01.shk.0000142255.15759.de	76	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4511	4519		10.1074/jbc.M109.084335	http://dx.doi.org/10.1074/jbc.M109.084335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018857	Green Published, hybrid			2022-12-25	WOS:000275274800028
J	Gros, Y; Schuldiner, S				Gros, Yael; Schuldiner, Shimon			Directed Evolution Reveals Hidden Properties of VMAT, a Neurotransmitter Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR MONOAMINE TRANSPORTER; SACCHAROMYCES-CEREVISIAE; SUBSTRATE RECOGNITION; CHROMAFFIN GRANULE; AMINE TRANSPORTER; MULTIDRUG TRANSPORTERS; TETRABENAZINE BINDING; RESIDUES CONTRIBUTE; LIGAND RECOGNITION; RESERPINE BINDING	The vesicular neurotransmitter transporter VMAT2 is responsible for the transport of monoamines into synaptic and storage vesicles. VMAT2 is the target of many psychoactive drugs and is essential for proper neurotransmission and survival. Here we describe a new expression system in Saccharomyces cerevisiae that takes advantage of the polyspecificity of VMAT2. Expression of rVMAT2 confers resistance to acriflavine and to the parkinsonian toxin 1-methyl-4-phenylpyridinium (MPP+) by their removal into the yeast vacuole. This expression system allowed identification of a new substrate, acriflavine, and isolation of mutants with modified affinity to tetrabenazine (TBZ), a non-competitive inhibitor of VMAT2 that is used in the treatment of various movement disorders including Tourette syndrome and Huntington chorea. Whereas one type of mutant obtained displayed decreased affinity to TBZ, a second type showed only a slight decrease in the affinity to TBZ, displayed a higher K-m to the neurotransmitter serotonin, but conferred increased resistance to acriflavine and MPP+. A protein where both types of mutations were combined (with only three amino acid replacements) lost most of the properties of the neurotransmitter transporter (TBZ-insensitive, no transport of neurotransmitter) but displayed enhanced resistance to the above toxicants. The work described here shows that in the case of rVMAT2, loss of traits acquired in evolution of function (such as serotonin transport and TBZ binding) bring about an improvement in older functions such as resistance to toxic compounds. A process that has taken millions of years of evolution can be reversed by three mutations.	[Gros, Yael; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	National Institutes of Health [NS16708]; Center for Innovation in Membrane Protein Production [P50 GM73210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Innovation in Membrane Protein Production; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grant NS16708 from the National Institutes of Health. This work was also supported by The Center for Innovation in Membrane Protein Production (P50 GM73210).	Adam Y, 2008, AM J PHYSIOL-CELL PH, V294, pC1004, DOI 10.1152/ajpcell.00348.2007; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; DARCHEN F, 1989, BIOCHEMISTRY-US, V28, P1692, DOI 10.1021/bi00430a040; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Eiden LE, 2000, FASEB J, V14, P2396, DOI 10.1096/fj.00-0817rev; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Erickson JD, 2000, FASEB J, V14, P2450, DOI 10.1096/fj.00-0206rev; Finn JP, 1998, J BIOL CHEM, V273, P3943, DOI 10.1074/jbc.273.7.3943; Finn JP, 1997, J BIOL CHEM, V272, P16301, DOI 10.1074/jbc.272.26.16301; FREIS ED, 1954, NEW ENGL J MED, V251, P1006, DOI 10.1056/NEJM195412162512504; Friedmann Y, 2006, MOL PHARMACOL, V70, P1395, DOI 10.1124/mol.106.022962; GUTHRIE C, 1991, METHOD ENZYMOL, pR17; Kenney Christopher, 2006, Expert Rev Neurother, V6, P7, DOI 10.1586/14737175.6.1.7; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; MERICKEL A, 1995, NEUROPHARMACOLOGY, V34, P1543, DOI 10.1016/0028-3908(95)00148-Y; PETER D, 1994, J BIOL CHEM, V269, P7231; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; SCHERMAN D, 1984, MOL PHARMACOL, V25, P113; SCHERMAN D, 1983, P NATL ACAD SCI-BIOL, V80, P584, DOI 10.1073/pnas.80.2.584; SCHULDINER S, 1993, MOL PHARMACOL, V44, P1227; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; SteinerMordoch S, 1996, J BIOL CHEM, V271, P13048, DOI 10.1074/jbc.271.22.13048; STERNBACH Y, 1990, J BIOL CHEM, V265, P3961; STITZEL RE, 1976, PHARMACOL REV, V28, P179; Thiriot DS, 2001, J BIOL CHEM, V276, P27304, DOI 10.1074/jbc.M103947200; Vardy E, 2005, J BACTERIOL, V187, P7518, DOI 10.1128/JB.187.21.7518-7525.2005; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yelin R, 1995, FEBS LETT, V377, P201, DOI 10.1016/0014-5793(95)01346-6; Yelin R, 2001, BBA-BIOMEMBRANES, V1510, P426, DOI 10.1016/S0005-2736(00)00374-6; Yelin R, 1999, J BACTERIOL, V181, P949, DOI 10.1128/JB.181.3.949-956.1999; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	39	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5076	5084		10.1074/jbc.M109.081216	http://dx.doi.org/10.1074/jbc.M109.081216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007701	Green Published, hybrid			2022-12-25	WOS:000275274800083
J	Naganuma, T; Nomura, N; Yao, M; Mochizuki, M; Uchiumi, T; Tanaka, I				Naganuma, Takao; Nomura, Naoko; Yao, Min; Mochizuki, Masahiro; Uchiumi, Toshio; Tanaka, Isao			Structural Basis for Translation Factor Recruitment to the Eukaryotic/Archaeal Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ASSOCIATED CENTER; ESCHERICHIA-COLI RIBOSOMES; ELONGATION-FACTOR-G; C-TERMINAL DOMAIN; PROTEIN L7/L12; P2 PROTEINS; FACTOR-BINDING; STALK; P1; REFINEMENT	The archaeal ribosomal stalk complex has been shown to have an apparently conserved functional structure with eukaryotic pentameric stalk complex; it provides access to eukaryotic elongation factors at levels comparable to that of the eukaryotic stalk. The crystal structure of the archaeal heptameric (P0(P1)(2)(P1)(2)(P1)(2)) stalk complex shows that the rRNA anchor protein P0 consists of an N-terminal rRNA-anchoring domain followed by three separated spine helices on which three P1 dimers bind. Based on the structure, we have generated P0 mutants depleted of any binding site(s) for P1 dimer(s). Factor-dependent GTPase assay of such mutants suggested that the first P1 dimer has higher activity than the others. Furthermore, we constructed a model of the archaeal 50 S with stalk complex by superposing the rRNA-anchoring domain of P0 on the archaeal 50 S. This model indicates that the C termini of P1 dimers where translation factors bind are all localized to the region between the stalk base of the 50 S and P0 spine helices. Together with the mutational experiments we infer that the functional significance of multiple copies of P1 is in creating a factor pool within a limited space near the stalk base of the ribosome.	[Naganuma, Takao; Mochizuki, Masahiro; Uchiumi, Toshio] Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; [Naganuma, Takao; Nomura, Naoko; Yao, Min; Tanaka, Isao] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Niigata University; Hokkaido University	Uchiumi, T (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Ikarashi 2,Machi 8050, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp; tanaka@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011	yao, min/0000-0003-1687-5904	National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Grants-in-Aid for Scientific Research [20247007] Funding Source: KAKEN	National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan and the Naito Foundation (to T. U.).	Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Briceno V, 2009, INT J BIOCHEM CELL B, V41, P1315, DOI 10.1016/j.biocel.2008.11.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gomez-Lorenzo MG, 1998, J BIOL CHEM, V273, P25041, DOI 10.1074/jbc.273.39.25041; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Guarinos E, 2001, J BIOL CHEM, V276, P32474, DOI 10.1074/jbc.M103229200; Gudkov AT, 1997, FEBS LETT, V407, P253, DOI 10.1016/S0014-5793(97)00361-X; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Iwasaki K, 1979, Methods Enzymol, V60, P657; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Lalioti VS, 2002, MOL MICROBIOL, V46, P719, DOI 10.1046/j.1365-2958.2002.03179.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIAO DQ, 1994, J MOL EVOL, V38, P405, DOI 10.1007/BF00163157; MAASSEN JA, 1985, EUR J BIOCHEM, V149, P609, DOI 10.1111/j.1432-1033.1985.tb08968.x; Maki Y, 2007, J BIOL CHEM, V282, P32827, DOI 10.1074/jbc.M705412200; Moller W., 1986, STRUCTURE FUNCTION G, P309; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naganuma T, 2007, GENES CELLS, V12, P501, DOI 10.1111/j.1365-2443.2007.01067.x; Nomura T, 2006, BIOCHEM J, V396, P565, DOI 10.1042/BJ20060038; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; Santos C, 2004, ANTIMICROB AGENTS CH, V48, P2930, DOI 10.1128/AAC.48.8.2930-2936.2004; Sanyal SC, 2000, CURR OPIN STRUC BIOL, V10, P633, DOI 10.1016/S0959-440X(00)00143-3; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Traut RR, 1995, BIOCHEM CELL BIOL, V73, P949, DOI 10.1139/o95-102; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; ZHONG DG, 1993, BIOTECHNIQUES, V15, P874	48	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4747	4756		10.1074/jbc.M109.068098	http://dx.doi.org/10.1074/jbc.M109.068098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007716	Green Published, hybrid			2022-12-25	WOS:000275274800053
J	Jung, YS; Cai, ML; Clore, GM				Jung, Young-Sang; Cai, Mengli; Clore, G. Marius			Solution Structure of the IIA(Chitobiose)-IIBChitobiose Complex of the N,N '-Diacetylchitobiose Branch of the Escherichia coli Phosphotransferase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYL TRANSFER COMPLEX; RESIDUAL DIPOLAR COUPLINGS; MANNITOL TRANSPORTER IIMANNITOL; PHOSPHOCARRIER PROTEIN HPR; N-TERMINAL DOMAIN; MACROMOLECULAR STRUCTURE DETERMINATION; POTATO CARBOXYPEPTIDASE INHIBITOR; MOLECULAR-STRUCTURE DETERMINATION; CYTOPLASMIC B-DOMAIN; ENZYME-I	The solution structure of the IIA-IIB complex of the N,N '-diacetylchitobiose (Chb) transporter of the Escherichia coli phosphotransferase system has been solved by NMR. The active site His-89 of IIA(Chb) was mutated to Glu to mimic the phosphorylated state and the active site Cys-10 of IIBChb was substituted by serine to prevent intermolecular disulfide bond formation. Binding is weak with a K-D of similar to 1.3mM. The two complementary interaction surfaces are largely hydrophobic, with the protruding active site loop (residues 9-16) of IIBChb buried deep within the active site cleft formed at the interface of two adjacent subunits of the IIA(Chb) trimer. The central hydrophobic portion of the interface is surrounded by a ring of polar and charged residues that provide a relatively small number of electrostatic intermolecular interactions that serve to correctly align the two proteins. The conformation of the active site loop in unphosphorylated IIBChb is inconsistent with the formation of a phosphoryl transition state intermediate because of steric hindrance, especially from the methyl group of Ala-12 of IIBChb. Phosphorylation of IIBChb is accompanied by a conformational change within the active site loop such that its path from residues 11-13 follows a mirror-like image relative to that in the unphosphorylated state. This involves a transition of the phi/psi angles of Gly-13 from the right to left alpha-helical region, as well as smaller changes in the backbone torsion angles of Ala-12 and Met-14. The resulting active site conformation is fully compatible with the formation of the His-89-P-Cys-10 phosphoryl transition state without necessitating any change in relative translation or orientation of the two proteins within the complex.	[Jung, Young-Sang; Cai, Mengli; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm B1-301, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G. Marius/A-3511-2008; Jung, Young-Sang/H-1169-2011; Clore, G Marius/L-2546-2018; Jung, Young-Sang/L-5068-2013	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Jung, Young-Sang/0000-0003-0817-0664	NIDDK; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of NIDDK, National Institutes of Health and the Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G. M. C.).	AB E, 1997, PROTEIN SCI, V6, P304; AB E, 2001, J MOL BIOL, V308, P993, DOI 10.1006/jmbi.2001.4623; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Eberstadt M, 1996, BIOCHEMISTRY-US, V35, P11286, DOI 10.1021/bi960492l; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; HERZBERG O, 1992, P NATL ACAD SCI USA, V89, P2499, DOI 10.1073/pnas.89.6.2499; Hu J, 2008, J BIOL CHEM, V283, P11024, DOI 10.1074/jbc.M800312200; JIA ZC, 1993, J BIOL CHEM, V268, P22490; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KALBITZER HR, 1993, EUR J BIOCHEM, V216, P205, DOI 10.1111/j.1432-1033.1993.tb18134.x; Keyhani NO, 2000, J BIOL CHEM, V275, P33102, DOI 10.1074/jbc.M001045200; Keyhani NO, 2000, J BIOL CHEM, V275, P33091, DOI 10.1074/jbc.M001044200; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; Keyhani NO, 1997, P NATL ACAD SCI USA, V94, P14367, DOI 10.1073/pnas.94.26.14367; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; KUSZEWSKI J, 1995, J MAGN RESON SER B, V106, P92, DOI 10.1006/jmrb.1995.1017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; LIAO DI, 1991, BIOCHEMISTRY-US, V30, P9583, DOI 10.1021/bi00104a004; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Ortega-Roldan JL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp211; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Oberholzer AE, 2009, J BIOL CHEM, V284, P33169, DOI 10.1074/jbc.M109.057612; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Schwieters CD, 2008, J PHYS CHEM B, V112, P6070, DOI 10.1021/jp076244o; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; Sliz P, 1997, STRUCTURE, V5, P775, DOI 10.1016/S0969-2126(97)00232-3; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200; Suh JY, 2005, J MOL BIOL, V353, P1129, DOI 10.1016/j.jmb.2005.09.033; Tang C, 2005, J BIOL CHEM, V280, P11770, DOI 10.1074/jbc.M414300200; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; vanMontfort RLM, 1997, STRUCTURE, V5, P217, DOI 10.1016/S0969-2126(97)00180-9; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; WITTEKIND M, 1992, PROTEIN SCI, V1, P1363, DOI 10.1002/pro.5560011016; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006	80	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4173	4184		10.1074/jbc.M109.080937	http://dx.doi.org/10.1074/jbc.M109.080937			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959833	Green Published, hybrid			2022-12-25	WOS:000275254000069
J	Samuvel, DJ; Sundararaj, KP; Li, YC; Lopes-Virella, MF; Huang, Y				Samuvel, Devadoss J.; Sundararaj, Kamala P.; Li, Yanchun; Lopes-Virella, Maria F.; Huang, Yan			Adipocyte-Mononuclear Cell Interaction, Toll-like Receptor 4 Activation, and High Glucose Synergistically Up-regulate Osteopontin Expression via an Interleukin 6-mediated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-GRADE INFLAMMATION; DIET-INDUCED OBESITY; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; HUMAN MONOCYTES; DISEASE; FIBROBLASTS; CYTOKINE; ADHESION	Although it has been reported that osteopontin, a matrix glycoprotein and proinflammatory cytokine, mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance, it remains unclear how osteopontin is up-regulated in adipose tissue in obese humans and animals. In this study, we incubated U937 mononuclear cells with adipocytes in a transwell system and studied how cell interaction regulated osteopontin expression. Results showed that coculture of U937 cells with adipocytes led to a marked increase in osteopontin production when compared with that released by independent cultures of U937 cells. Moreover, lipopolysaccharide or palmitic acid-induced TLR4 activation and high glucose further augmented the coculture-stimulated osteopontin secretion. Similar observations were made in the coculture of human primary monocytes and adipocytes. Real time PCR studies showed that coculture of U937 cells and adipocytes increased osteopontin mRNA in U937 cells, but not adipocytes, suggesting that adipocyte-derived soluble factor may stimulate osteopontin expression by U937 cells. In our studies to explore the underlying mechanism, we found that the neutralizing antibodies against interleukin (IL)-6 or IL-6 small interfering RNA transfection in adipocytes effectively inhibited coculture-stimulated osteopontin expression, suggesting that IL-6 released by adipocytes plays an essential role in the coculture-stimulated osteopontin expression by U937 cells. In conclusion, this study has demonstrated that cell interaction, TLR4 activation, and high glucose up-regulate osteopontin expression, and adipocyte-derived IL-6 played a major role in the up-regulation.	[Lopes-Virella, Maria F.; Huang, Yan] Med Univ S Carolina, Dept Med, Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA; [Samuvel, Devadoss J.; Sundararaj, Kamala P.; Li, Yanchun; Lopes-Virella, Maria F.; Huang, Yan] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Huang, Y (corresponding author), 114 Doughty St, Charleston, SC 29403 USA.	huangyan@musc.edu	li, yan/GTI-4638-2022		National Institutes of Health [DE16353]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grant DE16353 (to Y.H.). This work was also supported by a Merit Review grant from the Department of Veterans Affairs (to Y.H.).	Agnholt J, 2007, SCAND J IMMUNOL, V65, P453, DOI 10.1111/j.1365-3083.2007.01908.x; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Caceres-Cortes JR, 2008, ANTI-CANCER AGENT ME, V8, P717, DOI 10.2174/187152008785914752; Cammisotto PG, 2003, AM J PHYSIOL-ENDOC M, V285, pE521, DOI 10.1152/ajpendo.00052.2003; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim S, 2008, J LIPID RES, V49, P2571, DOI 10.1194/jlr.M800112-JLR200; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kitahara K, 2003, ENDOCRINOLOGY, V144, P2132, DOI 10.1210/en.2002-220996; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; Naldini A, 2006, J IMMUNOL, V177, P4267, DOI 10.4049/jimmunol.177.7.4267; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Ohmori R, 2003, ATHEROSCLEROSIS, V170, P333, DOI 10.1016/S0021-9150(03)00298-3; Permana PA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1076, DOI 10.1152/ajpendo.91013.2008; Serlin DM, 2006, J CELL BIOCHEM, V97, P519, DOI 10.1002/jcb.20661; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Syed MA, 2002, DIABETES NUTR METAB, V15, P68; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xie ZL, 2004, J CELL PHYSIOL, V198, P399, DOI 10.1002/jcp.10419; Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305	33	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3916	3927		10.1074/jbc.M109.033951	http://dx.doi.org/10.1074/jbc.M109.033951			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007708	Green Published, hybrid			2022-12-25	WOS:000275254000045
J	Hirrlinger, J; Requardt, RP; Winkler, U; Wilhelm, F; Schulze, C; Hirrlinger, PG				Hirrlinger, Johannes; Requardt, Robert P.; Winkler, Ulrike; Wilhelm, Franziska; Schulze, Christine; Hirrlinger, Petra G.			Split-CreERT2: Temporal Control of DNA Recombination Mediated by Split-Cre Protein Fragment Complementation	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; TRANSGENIC MICE; SOMATIC MUTAGENESIS; NEONATAL TREATMENT; RADIAL GLIA; STEM-CELLS; MOUSE; TAMOXIFEN; EXPRESSION; GENERATION	Background: DNA recombination technologies such as the Cre/LoxP system advance modern biological research by allowing conditional gene regulation in vivo. However, the precise targeting of a particular cell type at a given time point has remained challenging since spatial specificity has so far depended exclusively on the promoter driving Cre recombinase expression. We have recently established split-Cre that allows DNA recombination to be controlled by coincidental activity of two promoters, thereby increasing spatial specificity of Cre-mediated DNA recombination. To allow temporal control of split-Cre-mediated DNA recombination we have now extended split-Cre by fusing split-Cre proteins with the tamoxifen inducible ERT2 domain derived from CreERT2. Methodology/Principal Findings: In the split-CreERT2 system, Cre-mediated DNA recombination is controlled by two expression cassettes as well as the time of tamoxifen application. By using two independent Cre-dependent reporters in cultured cells, the combination of NCre-ERT2+ERT2-CCre was identified as having the most favorable properties of all constructs tested, showing an induction ratio of about 10 and EC50-values for 4-hydroxy-tamoxifen of 10 nM to 70 nM. Conclusions/Significance: These characteristics of split-CreERT2 in vitro indicate that split-CreERT2 will be well suited for inducing DNA recombination in living mice harboring LoxP-flanked alleles. In this way, split-CreERT2 will provide a new tool of modern genetics allowing spatial and temporal precise genetic access to cell populations defined by the simultaneous activity of two promoters.	[Hirrlinger, Johannes; Requardt, Robert P.; Winkler, Ulrike; Wilhelm, Franziska; Schulze, Christine] Univ Leipzig, Interdisciplinary Ctr Clin Res, IZKF, Leipzig, Germany; [Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Hirrlinger, Petra G.] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Hirrlinger, J (corresponding author), Univ Leipzig, Interdisciplinary Ctr Clin Res, IZKF, N05 Neural Plast, Leipzig, Germany.	johannes.hirrlinger@medizin.uni-leipzig.de	Hirrlinger, Johannes/F-5984-2010		Interdisciplinary Centre for Clinical Research (IZKF) [N05]; Deutsche Forschungsgemeinschaft DFG [HI1414/1-1, RE849/10-3]	Interdisciplinary Centre for Clinical Research (IZKF); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Interdisciplinary Centre for Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig [N05 to JH] and the Deutsche Forschungsgemeinschaft DFG [HI1414/1-1 to JH; RE849/10-3 to A. Reichenbach, Paul-Flechsig-Institute for Brain Research, Leipzig, Germany]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Casper K. B., 2006, MOL CELL NEUROSCI; Csaba G, 2001, PHARMACOL RES, V43, P531, DOI 10.1006/phrs.2001.0818; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; Doring B, 2006, J CELL SCI, V119, P1715, DOI 10.1242/jcs.02892; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Vancutsem PM, 1997, TERATOLOGY, V56, P220, DOI 10.1002/(SICI)1096-9926(199709)56:3<220::AID-TERA5>3.3.CO;2-D; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhu HZ, 2003, WORLD J GASTROENTERO, V9, P1844, DOI 10.3748/wjg.v9.i8.1844	35	42	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8354	10.1371/journal.pone.0008354	http://dx.doi.org/10.1371/journal.pone.0008354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016782	Green Submitted, Green Published, gold			2022-12-25	WOS:000272834000025
J	Jerke, U; Tkachuk, S; Kiyan, J; Stepanova, V; Kusch, A; Hinz, M; Dietz, R; Haller, H; Fuhrman, B; Dumler, I				Jerke, Uwe; Tkachuk, Sergey; Kiyan, Julia; Stepanova, Victoria; Kusch, Angelika; Hinz, Michael; Dietz, Rainer; Haller, Hermann; Fuhrman, Bianca; Dumler, Inna			Stat1 Nuclear Translocation by Nucleolin upon Monocyte Differentiation	PLOS ONE			English	Article							FAMILY TRANSCRIPTION FACTORS; SMOOTH-MUSCLE-CELLS; HEMATOPOIETIC-CELLS; SIGNAL TRANSDUCER; BINDING-PROTEIN; GENE-EXPRESSION; LEUKEMIA-CELLS; FACTOR PU.1; IMPORT; PHOSPHORYLATION	Background: Members of the signal transducer and activator of transcription (Stat) family of transcription factors traverse the nuclear membrane through a specialized structure, called the nuclear pore complex (NPC), which represents a selective filter for the import of proteins. Karyophilic molecules can bind directly to a subset of proteins of the NPC, collectively called nucleoporins. Alternatively, the transport is mediated via a carrier molecule belonging to the importin/karyopherin superfamily, which transmits the import into the nucleus through the NPC. Methodology/Principal Findings: In this study, we provide evidence for an alternative Stat1 nuclear import mechanism, which is mediated by the shuttle protein nucleolin. We observed Stat1-nucleolin association, nuclear translocation and specific binding to the regulatory DNA element GAS. Using expression of nucleolin transgenes, we found that the nuclear localization signal (NLS) of nucleolin is responsible for Stat1 nuclear translocation. We show that this mechanism is utilized upon differentiation of myeloid cells and is specific for the differentiation step from monocytes to macrophages. Conclusions/Significance: Our data add the nucleolin-Stat1 complex as a novel functional partner for the cell differentiation program, which is uniquely poised to regulate the transcription machinery via Stat1 and nuclear metabolism via nucleolin.	[Jerke, Uwe; Tkachuk, Sergey; Kiyan, Julia; Haller, Hermann; Dumler, Inna] Hannover Med Sch, D-3000 Hannover, Germany; [Jerke, Uwe; Kusch, Angelika; Dietz, Rainer; Dumler, Inna] Max Delbruck Ctr, ECRC, Berlin, Germany; [Stepanova, Victoria] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fuhrman, Bianca] Technion Israel Inst Technol, Fac Med, Lipid Res Lab, Rappaport Inst Med Sci, Haifa, Israel; [Fuhrman, Bianca] Rambam Med Ctr, Haifa, Israel	Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Pennsylvania; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Jerke, U (corresponding author), Hannover Med Sch, D-3000 Hannover, Germany.	uwe.jerke@charite.de	Hinz, Michael/HCI-0550-2022; Kiyan, Yulia/D-7284-2011	Kiyan, Yulia/0000-0002-2063-6327; Hinz, Michael/0000-0003-2611-4121; Jerke, Uwe/0000-0001-6887-8010	Deutsche Forschungsgemeinschaft [Du 344/2-4]; North Atlantic Treaty Organization [CLG.978262]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); North Atlantic Treaty Organization(NATO (North Atlantic Treaty Organisation))	This work was supported by grant Du 344/2-4 from the Deutsche Forschungsgemeinschaft and in part by grant CLG.978262 from the North Atlantic Treaty Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Barahmandpour F, 1996, CURR TOP MICROBIOL, V211, P121; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; CAIZERGUESFERRER M, 1989, GENE DEV, V3, P324, DOI 10.1101/gad.3.3.324; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Coccia EM, 1999, INT IMMUNOL, V11, P1075, DOI 10.1093/intimm/11.7.1075; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; DEVERDUGO UR, 1995, J VIROL, V69, P6751, DOI 10.1128/JVI.69.11.6751-6757.1995; Dimberg A, 2000, BLOOD, V96, P2870; Dimberg A, 2006, SCAND J IMMUNOL, V64, P271, DOI 10.1111/j.1365-3083.2006.01827.x; Dumler I, 1999, J BIOL CHEM, V274, P24059, DOI 10.1074/jbc.274.34.24059; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; EILERS A, 1995, IMMUNOBIOLOGY, V193, P328, DOI 10.1016/S0171-2985(11)80562-0; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Galdiero M, 2006, CYTOKINE, V36, P218, DOI 10.1016/j.cyto.2006.12.003; GILLET G, 1993, ONCOGENE, V8, P565; Ginisty H, 1999, J CELL SCI, V112, P761; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JORDAN G, 1987, NATURE, V329, P489, DOI 10.1038/329489a0; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kiyan J, 2005, EMBO J, V24, P1787, DOI 10.1038/sj.emboj.7600669; KURATA S, 1990, EXP CELL RES, V191, P89, DOI 10.1016/0014-4827(90)90040-H; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Martinet W, 2003, BIOTECHNOL LETT, V25, P1025, DOI 10.1023/A:1024157508492; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Meyer J, 2002, MAR ENVIRON RES, V54, P621, DOI 10.1016/S0141-1136(02)00170-8; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; PASTERNACK MS, 1991, J BIOL CHEM, V266, P14703; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; SAXENA A, 2006, ONCOGENE; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; SRIVASTAVA M, 1989, FEBS LETT, V250, P99, DOI 10.1016/0014-5793(89)80692-1; Stephanou A, 2004, J CELL MOL MED, V8, P519, DOI 10.1111/j.1582-4934.2004.tb00476.x; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Tu X, 2003, EXP CELL RES, V288, P119, DOI 10.1016/S0014-4827(03)00178-2; TUTEJA N, 1995, NUCLEIC ACIDS RES, V23, P2457, DOI 10.1093/nar/23.13.2457; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Tuyt LML, 1998, BLOOD, V92, P1364, DOI 10.1182/blood.V92.4.1364.416k34_1364_1373; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wincewicz A, 2007, EUR J INTERN MED, V18, P267, DOI 10.1016/j.ejim.2006.12.007; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	69	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8302	10.1371/journal.pone.0008302	http://dx.doi.org/10.1371/journal.pone.0008302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011528	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000272830300049
J	Wu, SW; Dal Martello, MF; Maloney, LT				Wu, Shih-Wei; Dal Martello, Maria F.; Maloney, Laurence T.			Sub-Optimal Allocation of Time in Sequential Movements	PLOS ONE			English	Article							STATISTICAL DECISION-THEORY; TRADE-OFFS; MOTOR; ACCURACY; INFORMATION; LIMITS; GAIN	The allocation of limited resources such as time or energy is a core problem that organisms face when planning complex actions. Most previous research concerning planning of movement has focused on the planning of single, isolated movements. Here we investigated the allocation of time in a pointing task where human subjects attempted to touch two targets in a specified order to earn monetary rewards. Subjects were required to complete both movements within a limited time but could freely allocate the available time between the movements. The time constraint presents an allocation problem to the subjects: the more time spent on one movement, the less time is available for the other. In different conditions we assigned different rewards to the two tokens. How the subject allocated time between movements affected their expected gain on each trial. We also varied the angle between the first and second movements and the length of the second movement. Based on our results, we developed and tested a model of speed-accuracy tradeoff for sequential movements. Using this model we could predict the time allocation that would maximize the expected gain of each subject in each experimental condition. We compared human performance with predicted optimal performance. We found that all subjects allocated time sub-optimally, spending more time than they should on the first movement even when the reward of the second target was five times larger than the first. We conclude that the movement planning system fails to maximize expected reward in planning sequences of as few as two movements and discuss possible interpretations drawn from economic theory.	[Wu, Shih-Wei; Maloney, Laurence T.] NYU, Dept Psychol, New York, NY 10003 USA; [Wu, Shih-Wei] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Dal Martello, Maria F.] Univ Padua, Dept Gen Psychol, Padua, Italy; [Maloney, Laurence T.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; California Institute of Technology; University of Padua; New York University	Wu, SW (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	shihwei@caltech.edu		DAL MARTELLO, Maria/0000-0003-0647-1332	NIH [EY08266]; NATIONAL EYE INSTITUTE [R01EY008266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH EY08266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivar MP, 2005, PSICOLOGICA, V26, P61; Baron J., 2000, THINKING DECIDING; Battaglia PW, 2007, J NEUROSCI, V27, P6984, DOI 10.1523/JNEUROSCI.1309-07.2007; Berger J. O., 2013, STAT DECISION THEORY; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Dean M, 2007, J VISION, V7, DOI 10.1167/7.5.10; DiDonato A. R., 1961, MATH COMPUT, V15, P375, DOI [10.1090/S0025-5718-1961-0129116-8, DOI 10.1090/S0025-5718-1961-0129116-8]; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hudson TE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000130; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kreps D. M, 1990, COURSE MICROECONOMIC; LOEWENSTEIN GF, 1993, PSYCHOL REV, V100, P91, DOI 10.1037/0033-295X.100.1.91; Maloney L. T., 2002, PERCEPTION PHYS WORL, P145; Maloney L.T., 2007, INTEGRATED MODELS CO, P297, DOI [10.1093/acprof:oso/9780195189193.003.0021, DOI 10.1093/ACPROF:OSO/9780195189193.003.0021, https://doi.org/10.1093/acprof:oso/9780195189193.003.0021]; Mamassian P, 2008, PSYCHOL SCI, V19, P601, DOI 10.1111/j.1467-9280.2008.02129.x; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; Roy EA, 2004, MOTOR CONTROL, V8, P121, DOI 10.1123/mcj.8.2.121; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schmidt RA., 1978, INFORM PROCESSING MO, P183, DOI DOI 10.1016/B978-0-12-665960-3.50014-1; Simon, 1957, MODELS MAN SOCIAL RA; Stephens D.W., 1986, pi; STONE LD, 2007, THEORY OPTIMAL SEARC; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Trommershauser J, 2006, EXP BRAIN RES, V175, P276, DOI 10.1007/s00221-006-0546-z; Trommershauser J, 2006, PSYCHOL SCI, V17, P981, DOI 10.1111/j.1467-9280.2006.01816.x; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; WRIGHT CE, 1983, Q J EXP PSYCHOL-A, V35, P279, DOI 10.1080/14640748308402134; Wu SW, 2006, J VISION, V6, P53, DOI 10.1167/6.1.5	40	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8228	10.1371/journal.pone.0008228	http://dx.doi.org/10.1371/journal.pone.0008228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533NE	20011047	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000272829800016
J	Qian, XN; Yoon, BJ				Qian, Xiaoning; Yoon, Byung-Jun			Effective Identification of Conserved Pathways in Biological Networks Using Hidden Markov Models	PLOS ONE			English	Article							PROTEIN-INTERACTION; ALIGNMENT; TOOL; YEAST	Background: The advent of various high-throughput experimental techniques for measuring molecular interactions has enabled the systematic study of biological interactions on a global scale. Since biological processes are carried out by elaborate collaborations of numerous molecules that give rise to a complex network of molecular interactions, comparative analysis of these biological networks can bring important insights into the functional organization and regulatory mechanisms of biological systems. Methodology/Principal Findings: In this paper, we present an effective framework for identifying common interaction patterns in the biological networks of different organisms based on hidden Markov models (HMMs). Given two or more networks, our method efficiently finds the top k matching paths in the respective networks, where the matching paths may contain a flexible number of consecutive insertions and deletions. Conclusions/Significance: Based on several protein-protein interaction (PPI) networks obtained from the Database of Interacting Proteins (DIP) and other public databases, we demonstrate that our method is able to detect biologically significant pathways that are conserved across different organisms. Our algorithm has a polynomial complexity that grows linearly with the size of the aligned paths. This enables the search for very long paths with more than 10 nodes within a few minutes on a desktop computer. The software program that implements this algorithm is available upon request from the authors.	[Qian, Xiaoning] Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA; [Yoon, Byung-Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA	State University System of Florida; University of South Florida; Texas A&M University System; Texas A&M University College Station	Qian, XN (corresponding author), Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA.	bjyoon@ece.tamu.edu	Malwad, Govind V/F-4682-2010; Qian, Huiping/E-8264-2010; Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101	National Cancer Institute [R25CA090301-06]; NATIONAL CANCER INSTITUTE [R25CA090301] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute under 2 R25CA090301-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T., 1998, P 9 ANN ACM SIAM S D, P695; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Dost B, 2008, J COMPUT BIOL, V15, P913, DOI 10.1089/cmb.2007.0172; FLANNICK J, 2008, P 10 ANN INT C RES C; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; KALAEV M, 2008, P 10 ANN INT C RES C; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Koyuturk M, 2004, BIOINFORMATICS, V20, P200, DOI 10.1093/bioinformatics/bth919; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Pagni M, 2001, Brief Bioinform, V2, P51, DOI 10.1093/bib/2.1.51; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pinter RY, 2005, BIOINFORMATICS, V21, P3401, DOI 10.1093/bioinformatics/bti554; Qian XN, 2009, J COMPUT BIOL, V16, P145, DOI 10.1089/cmb.2008.02TT; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; SRINIVASAN B, 2006, P 10 ANN INT C RES C; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Tian WH, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P99; Uetz P, 2004, GENOME RES, V14, P2029, DOI 10.1101/gr.2583304; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yang QW, 2007, J COMPUT BIOL, V14, P56, DOI 10.1089/cmb.2006.0076; Zaslavskiy M, 2009, BIOINFORMATICS, V25, pI259, DOI 10.1093/bioinformatics/btp196; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	31	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8070	10.1371/journal.pone.0008070	http://dx.doi.org/10.1371/journal.pone.0008070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997609	Green Published, gold			2022-12-25	WOS:000272829500004
J	Becher, D; Hempel, K; Sievers, S; Zuhlke, D; Pane-Farre, J; Otto, A; Fuchs, S; Albrecht, D; Bernhardt, J; Engelmann, S; Volker, U; van Dijl, JM; Hecker, M				Becher, Doerte; Hempel, Kristina; Sievers, Susanne; Zuehlke, Daniela; Pane-Farre, Jan; Otto, Andreas; Fuchs, Stephan; Albrecht, Dirk; Bernhardt, Joerg; Engelmann, Susanne; Voelker, Uwe; van Dijl, Jan Maarten; Hecker, Michael			A Proteomic View of an Important Human Pathogen - Towards the Quantification of the Entire Staphylococcus aureus Proteome	PLOS ONE			English	Article								The genome sequence is the "blue-print of life,'' but proteomics provides the link to the actual physiology of living cells. Because of their low complexity bacteria are excellent model systems to identify the entire protein assembly of a living organism. Here we show that the majority of proteins expressed in growing and non-growing cells of the human pathogen Staphylococcus aureus can be identified and even quantified by a metabolic labeling proteomic approach. S. aureus has been selected as model for this proteomic study, because it poses a major risk to our health care system by combining high pathogenicity with an increasing frequency of multiple antibiotic resistance, thus requiring the development of new antistaphylococcal therapy strategies. Since such strategies will likely have to target extracellular and surface-exposed virulence factors as well as staphylococcal survival and adaptation capabilities, we decided to combine four subproteomic fractions: cytosolic proteins, membrane-bound proteins, cell surface-associated and extracellular proteins, to comprehensively cover the entire proteome of S. aureus. This quantitative proteomics approach integrating data ranging from gene expression to subcellular localization in growing and non-growing cells is a proof of principle for whole-cell physiological proteomics that can now be extended to address physiological questions in infection-relevant settings. Importantly, with more than 1700 identified proteins (and 1450 quantified proteins) corresponding to a coverage of about three-quarters of the expressed proteins, our model study represents the most comprehensive quantification of a bacterial proteome reported to date. It thus paves the way towards a new level in understanding of cell physiology and pathophysiology of S. aureus and related pathogenic bacteria, opening new avenues for infection-related research on this crucial pathogen.	[Becher, Doerte; Hempel, Kristina; Sievers, Susanne; Zuehlke, Daniela; Pane-Farre, Jan; Otto, Andreas; Fuchs, Stephan; Albrecht, Dirk; Bernhardt, Joerg; Engelmann, Susanne; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [van Dijl, Jan Maarten] Univ Groningen, Groningen, Netherlands	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Groningen; University of Groningen	Becher, D (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany.	hecker@uni-greifswald.de	Sievers, Susanne/Q-9261-2017; Becher, Doerte/B-4454-2015; van Dijl, Jan Maarten/G-1205-2013; Bernhardt, Jörg/AGQ-8765-2022	Sievers, Susanne/0000-0002-5457-2552; Becher, Doerte/0000-0002-9630-5735; Volker, Uwe/0000-0002-5689-3448; Fuchs, Stephan/0000-0002-1338-2699	Deutsche Forschungsgemeinschaft [SFB/TR34]; Bundesministerium fAf1/4r Bildung und Forschung [0313812C, 03ZIK011]; EU [LSHG-CT-2006-037469]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fAf1/4r Bildung und Forschung; EU(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB/TR34), the Bundesministerium fAf1/4r Bildung und Forschung (0313812C and 03ZIK011) and the EU ( BaSysBio LSHG-CT-2006-037469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2008, APPL ENVIRON MICROB, V74, P594, DOI 10.1128/AEM.01921-07; Balzer M, 2005, INFOVIS 05: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P49, DOI 10.1109/INFVIS.2005.1532128; BANDOW JE, 2007, PROG DRUG RES, V79, P81; Batzilla CF, 2006, PROTEOMICS, V6, P3602, DOI 10.1002/pmic.200500732; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dreisbach A, 2008, PROTEOMICS, V8, P2062, DOI 10.1002/pmic.200701081; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; Gerth U, 2008, J BACTERIOL, V190, P321, DOI 10.1128/JB.01233-07; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hecker M, 2008, PROTEOMICS, V8, P4958, DOI 10.1002/pmic.200800278; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Loevenich SN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-59; Lorenz U, 2000, ADV EXP MED BIOL, V485, P273; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101; SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Tjalsma H, 2005, PROTEOMICS, V5, P4472, DOI 10.1002/pmic.200402080; WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185; Wolff S, 2008, MOL CELL PROTEOMICS, V7, P1460, DOI 10.1074/mcp.M700554-MCP200; Ziebandt AK, 2004, PROTEOMICS, V4, P3034, DOI 10.1002/pmic.200400937	38	124	124	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8176	10.1371/journal.pone.0008176	http://dx.doi.org/10.1371/journal.pone.0008176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997597	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829200012
J	Wussow, F; Fickenscher, H; Tischer, BK				Wussow, Felix; Fickenscher, Helmut; Tischer, B. Karsten			Red-Mediated Transposition and Final Release of the Mini-F Vector of a Cloned Infectious Herpesvirus Genome	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; VARICELLA-ZOSTER-VIRUS; ESCHERICHIA-COLI; IN-VITRO; DNA; RECOMBINATION; REPLICATION; CELLS; BAC; CLONING	Bacterial artificial chromosomes ( BACs) are well-established cloning vehicles for functional genomics and for constructing targeting vectors and infectious viral DNA clones. Red-recombination-based mutagenesis techniques have enabled the manipulation of BACs in Escherichia coli without any remaining operational sequences. Here, we describe that the F-factor-derived vector sequences can be inserted into a novel position and seamlessly removed from the present location of the BAC-cloned DNA via synchronous Red-recombination in E. coli in an en passant mutagenesis-based procedure. Using this technique, the mini-F elements of a cloned infectious varicella zoster virus (VZV) genome were specifically transposed into novel positions distributed over the viral DNA to generate six different BAC variants. In comparison to the other constructs, a BAC variant with mini-F sequences directly inserted into the junction of the genomic termini resulted in highly efficient viral DNA replication-mediated spontaneous vector excision upon virus reconstitution in transfected VZV-permissive eukaryotic cells. Moreover, the derived vector-free recombinant progeny exhibited virtually indistinguishable genome properties and replication kinetics to the wild-type virus. Thus, a sequence-independent, efficient, and easy-to-apply mini-F vector transposition procedure eliminates the last hurdle to perform virtually any kind of imaginable targeted BAC modifications in E. coli. The herpesviral terminal genomic junction was identified as an optimal mini-F vector integration site for the construction of an infectious BAC, which allows the rapid generation of mutant virus without any unwanted secondary genome alterations. The novel mini-F transposition technique can be a valuable tool to optimize, repair or restructure other established BACs as well and may facilitate the development of gene therapy or vaccine vectors.	[Wussow, Felix; Fickenscher, Helmut; Tischer, B. Karsten] Univ Kiel, Inst Infect Med, Kiel, Germany; [Wussow, Felix; Fickenscher, Helmut; Tischer, B. Karsten] Univ Med Ctr Schleswig Holstein, Kiel, Germany; [Tischer, B. Karsten] Free Univ Berlin, Inst Virol, D-1000 Berlin, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin	Wussow, F (corresponding author), Univ Kiel, Inst Infect Med, Kiel, Germany.	fickenscher@infmed.uni-kiel.de; k.tischer@fu-berlin.de	Fickenscher, Helmut/J-9655-2019; Fickenscher, Helmut/A-3004-2010	Fickenscher, Helmut/0000-0003-0043-1153; 	Varicella Zoster Virus Foundation ( New York); Medical Faculty of the Christian-Albrechts University of Kiel ( Research Center Integrative Neurobiology); Excellence Cluster Inflammation at Interfaces	Varicella Zoster Virus Foundation ( New York); Medical Faculty of the Christian-Albrechts University of Kiel ( Research Center Integrative Neurobiology); Excellence Cluster Inflammation at Interfaces	This work was supported by an award grant from the Varicella Zoster Virus Foundation ( New York) and by an intramural grant from the Medical Faculty of the Christian-Albrechts University of Kiel ( Research Center Integrative Neurobiology), as well as by the Excellence Cluster Inflammation at Interfaces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Ben Wang J, 2008, J VIROL, V82, P2394, DOI 10.1128/JVI.00063-07; BENPORAT T, 1977, VIROLOGY, V79, P292, DOI 10.1016/0042-6822(77)90356-7; Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Brune W, 2000, TRENDS GENET, V16, P254, DOI 10.1016/S0168-9525(00)02015-1; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Cohen J. I., 2007, VIROLOGY, P2773; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; GARBER DA, 1993, VIROLOGY, V197, P459, DOI 10.1006/viro.1993.1612; Horsburgh BC, 1999, METHOD ENZYMOL, V306, P337; Kress M, 2001, FASEB J, V15, P1037, DOI 10.1096/fj.00-0440com; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Loparev VN, 2004, J VIROL, V78, P8349, DOI 10.1128/jvi.78.15.8349-8358.2004; McVoy MA, 2000, J VIROL, V74, P4882, DOI 10.1128/JVI.74.10.4882-4887.2000; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Patel AH, 1996, VIROLOGY, V217, P111, DOI 10.1006/viro.1996.0098; Ristevski S, 2005, MOL BIOTECHNOL, V29, P153, DOI 10.1385/MB:29:2:153; Sato B, 2003, J VIROL, V77, P5607, DOI 10.1128/JVI.77.10.5607-5620.2003; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Schmidt Michaela, 2003, Journal of Medical Virology, V70, pS82, DOI 10.1002/jmv.10327; Schynts F, 2003, VIROLOGY, V314, P326, DOI 10.1016/S0042-6822(03)00437-9; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Shizuya Hiroaki, 2001, Keio Journal of Medicine, V50, P26, DOI 10.2302/kjm.50.26; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Sparwasser T, 2007, IMMUNOLOGY, V121, P308, DOI 10.1111/j.1365-2567.2007.02605.x; Stavropoulos TA, 1998, J VIROL, V72, P7137, DOI 10.1128/JVI.72.9.7137-7143.1998; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Tischer BK, 2007, J VIROL, V81, P13200, DOI 10.1128/JVI.01148-07; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; TISCHER BK, 2009, IN VITRO MU IN PRESS; Umene K, 1999, REV MED VIROL, V9, P171, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;171::AID-RMV243&gt;3.0.CO;2-A; VARMUZA SL, 1985, CELL, V41, P793, DOI 10.1016/S0092-8674(85)80060-X; Wagner M, 2002, TRENDS MICROBIOL, V10, P318, DOI 10.1016/S0966-842X(02)02394-6; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WELLER TH, 1953, P SOC EXP BIOL MED, V83, P340, DOI 10.3181/00379727-83-20354; Yamagishi Y, 2008, J VIROL, V82, P795, DOI 10.1128/JVI.01722-07; Yang XW, 2005, CURR PROTOC NEUROSCI, DOI [DOI 10.1002/0471142301.NS0520S31.CHAPTER, 10.1002/0471142301.ns0520s31, DOI 10.1002/0471142301.NS0520S31]; Zhou FC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn890	47	13	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8178	10.1371/journal.pone.0008178	http://dx.doi.org/10.1371/journal.pone.0008178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997639	gold, Green Submitted, Green Published			2022-12-25	WOS:000272829200013
J	Deng, KW; Gao, Y; Cao, ZX; Graziani, EI; Wood, A; Doherty, P; Walsh, FS				Deng, Kangwen; Gao, Ying; Cao, Zixuan; Graziani, Edmund I.; Wood, Andrew; Doherty, Patrick; Walsh, Frank S.			Overcoming Amino-Nogo-induced Inhibition of Cell Spreading and Neurite Outgrowth by 12-O-Tetradecanoylphorbol-13-acetate-type Tumor Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CHONDROITIN SULFATE PROTEOGLYCANS; MYELIN-ASSOCIATED GLYCOPROTEIN; PHORBOL ESTER; AXONAL REGENERATION; ACTIVATION; RECEPTOR; GROWTH; DOMAIN; GTPASES	The N-terminal domain of NogoA, called amino-Nogo, inhibits axonal outgrowth and cell spreading via a largely unknown mechanism. In the present study, we show that amino-Nogo decreases Rac1 activity and inhibits fibroblast spreading. 12-O-Tetradecanoylphorbol-13-acetate-type tumor promoters, such as phorbol 12-myristate 13-acetate (PMA) and teleocidin, increase Rac1 activity and overcome the amino-Nogo-induced inhibition of cell spreading. The stimulating effect of tumor promoters on cell spreading requires activation of protein kinase D and the subsequent activation of Akt1. Furthermore, we identified Akt1 as a new signaling component of the amino-Nogo pathway. Akt1 phosphorylation is decreased by amino-Nogo. Activation of Akt1 with a cell-permeable peptide, TAT-TCL1, blocks the amino-Nogo inhibition. Finally, we provide evidence that these signaling pathways operate in neurons in addition to fibroblasts. Our results suggest that activation of protein kinase D and Akt1 are approaches to promote axonal regeneration after injury.	[Doherty, Patrick; Walsh, Frank S.] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 9RT, England; [Deng, Kangwen; Gao, Ying; Cao, Zixuan; Wood, Andrew] Pfizer Global Res & Dev, Neurosci Res, Princeton, NJ 08543 USA; [Graziani, Edmund I.] Pfizer Global Res & Dev, Pearl River, NY 10965 USA	University of London; King's College London; Pfizer; Pfizer	Walsh, FS (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 9RT, England.	frank.s.walsh@kcl.ac.uk	Doherty, Patrick/A-8752-2008	Doherty, Patrick/0000-0002-0407-5689				AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Cao ZX, 2010, MOL CELL NEUROSCI, V43, P1, DOI 10.1016/j.mcn.2009.07.008; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Dergham P, 2002, J NEUROSCI, V22, P6570; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; FUJIKI H, 1984, BIOCHEM BIOPH RES CO, V120, P339, DOI 10.1016/0006-291X(84)91259-2; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hasegawa Y, 2004, J NEUROSCI, V24, P6826, DOI 10.1523/JNEUROSCI.1856-04.2004; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hiromura M, 2004, J BIOL CHEM, V279, P53407, DOI 10.1074/jbc.M403775200; HSU L, 1984, MUSCLE NERVE, V7, P211, DOI 10.1002/mus.880070305; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kubo Takekazu, 2007, Recent Pat CNS Drug Discov, V2, P173, DOI 10.2174/157488907782411738; LEACH KL, 1983, P NATL ACAD SCI-BIOL, V80, P4208, DOI 10.1073/pnas.80.14.4208; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; McDunn JE, 2008, FASEB J, V22, P561, DOI 10.1096/fj.07-8283com; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Niederost B, 2002, J NEUROSCI, V22, P10368; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Obara Y, 2007, LIFE SCI, V80, P1669, DOI 10.1016/j.lfs.2007.01.057; Oertle T, 2003, J NEUROSCI, V23, P5393; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Rozengurt E, 1995, MUTAT RES-FUND MOL M, V333, P153, DOI 10.1016/0027-5107(95)00141-7; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	46	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6425	6433		10.1074/jbc.M109.071548	http://dx.doi.org/10.1074/jbc.M109.071548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018888	Green Published, hybrid			2022-12-25	WOS:000275367500047
J	Tobisawa, Y; Imai, Y; Fukuda, M; Kawashima, H				Tobisawa, Yuki; Imai, Yasuyuki; Fukuda, Minoru; Kawashima, Hiroto			Sulfation of Colonic Mucins by N-Acetylglucosamine 6-O-Sulfotransferase-2 and Its Protective Function in Experimental Colitis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGANDS; HISTONE DEACETYLASE; HEPARAN-SULFATE; MUC2 MUCIN; SULFOTRANSFERASES; EXPRESSION; ROLES; SPECIFICITIES; LOCALIZATION; RECOGNITION	N-Acetylglucosamine 6-O-sulfotransferase-2 (GlcNAc6ST-2) catalyzes the sulfation of mucin-like glycoproteins, which function as ligands for a lymphocyte homing receptor, L-selectin, in the lymph node high endothelial venules (HEVs). We previously showed that GlcNAc6ST-2 is expressed not only in lymph node HEVs but also in the colonic epithelial cells in mice. Here we investigated the regulatory mechanism and physiological significance of colonic expression of GlcNAc6ST-2 in mice. Treatment of a mouse colonic epithelial cell line with butyrate, a short-chain fatty acid produced by anaerobic bacteria, induced GlcNAc6ST-2 expression in the presence of epidermal growth factor. Administration of butyrate in the drinking water stimulated GlcNAc6ST-2 expression in the mouse intestine, indicating that butyrate could serve as a regulatory molecule for the GlcNAc6ST-2 expression in vivo. Immunohistochemical analysis indicated that the sulfation of colonic mucins was greatly diminished in GlcNAc6ST-2-deficient mice. Liquid chromatography coupled to electrospray ionization tandem mass spectrometry of the colonic-mucin O-glycans from wild-type and GlcNAc6ST-2-deficient mice showed that GlcNAc-6-O-sulfation was the predominant sulfate modification of these mucins, and it was exclusively mediated by GlcNAc6ST-2. After colitis induction by dextran sulfate sodium, significantly more leukocyte infiltration was observed in the colon of GlcNAc6ST-2-deficient mice than in that of wild-type mice, indicating that the sulfation of colonic mucins by GlcNAc6ST-2 has a protective function in experimental colitis. These findings indicate that GlcNAc6ST-2, whose expression is regulated by butyrate, is a major sulfotransferase in the biosynthesis of sulfomucins in the mouse colon, where they serve as a mucosal barrier against colonic inflammation.	[Tobisawa, Yuki; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Tobisawa, Yuki; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Global COE Program, Shizuoka 4228526, Japan; [Fukuda, Minoru] Burnham Inst Med Res, Tumor Microenvironm Program, Canc Res Ctr, La Jolla, CA 92037 USA; [Kawashima, Hiroto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Shizuoka; University of Shizuoka; Sanford Burnham Prebys Medical Discovery Institute; Japan Science & Technology Agency (JST)	Kawashima, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan.	kawashih@u-shizuoka-ken.ac.jp	Tobisawa, Yuki/G-3802-2014; Imai, Yasuyuki/E-8701-2010	Tobisawa, Yuki/0000-0001-8026-9541; Imai, Yasuyuki/0000-0002-8937-0221	National Institutes of Health [P01CA71932]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21390023, 20057022]; Takeda Science Foundation; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant P01CA71932 (to M.F.), Grants-in-aid for Scientific Research, Category (B) and Grants-in-aid for Scientific Research on Priority Areas, Dynamics of Extracellular Environments, from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21390023 and 20057022, respectively, to H.K.), and the Takeda Science Foundation (to H.K.).	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; de Graffenried CL, 2003, J BIOL CHEM, V278, P40282, DOI 10.1074/jbc.M304928200; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Honke K, 2004, GLYCOCONJUGATE J, V21, P59, DOI 10.1023/B:GLYC.0000043749.06556.3d; Hurd EA, 2005, GLYCOBIOLOGY, V15, P1002, DOI 10.1093/glycob/cwi089; IRIMURA T, 1991, CANCER RES, V51, P5728; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima H, 2006, BIOL PHARM BULL, V29, P2343, DOI 10.1248/bpb.29.2343; Kawashima H, 2009, J IMMUNOL, V182, P5461, DOI 10.4049/jimmunol.0802327; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Naldi M, 2006, J CHROMATOGR A, V1129, P73, DOI 10.1016/j.chroma.2006.06.100; RAOUF AH, 1992, CLIN SCI, V83, P623, DOI 10.1042/cs0830623; Sanderson IR, 2007, J NUTR, V137, p2557S, DOI 10.1093/jn/137.11.2557S; Seko A, 2002, GLYCOBIOLOGY, V12, P379, DOI 10.1093/glycob/12.6.379; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPICER SS, 1981, J HISTOCHEM CYTOCHEM, V29, P994, DOI 10.1177/29.9.6169762; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Tsuiji H, 1998, BIOCHEM BIOPH RES CO, V253, P374, DOI 10.1006/bbrc.1998.9726; TSUKADA T, 1993, ONCOGENE, V8, P3313; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; YAMORI T, 1987, CANCER RES, V47, P2741; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	46	64	67	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6750	6760		10.1074/jbc.M109.067082	http://dx.doi.org/10.1074/jbc.M109.067082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018871	hybrid, Green Published			2022-12-25	WOS:000275367500078
J	Jones, L; Tedrick, K; Baier, A; Logan, MR; Eitzen, G				Jones, Lynden; Tedrick, Kelly; Baier, Alicia; Logan, Michael R.; Eitzen, Gary			Cdc42p Is Activated during Vacuole Membrane Fusion in a Sterol-dependent Subreaction of Priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; ACTIN POLYMERIZATION; GRANULE EXOCYTOSIS; HUMAN NEUTROPHILS; CELL POLARITY; YEAST; TRANSFORMATION; TRAFFICKING; HYDROLYSIS; BINDING	Cdc42p is a Rho GTPase that initiates signaling cascades at spatially defined intracellular sites for many cellular functions. We have previously shown that Cdc42p is localized to the yeast vacuole where it initiates actin polymerization during membrane fusion. Here we examine the activation cycle of Cdc42p during vacuole membrane fusion. Expression of either GTP- or GDP-locked Cdc42p mutants caused several morphological defects including enlarged cells and fragmented vacuoles. Stimulation of multiple rounds of fusion enhanced vacuole fragmentation, suggesting that cycles of Cdc42p activation, involving rounds of GTP binding and hydrolysis, are required to propagate Cdc42p signaling. We developed an assay to directly examine Cdc42p activation based on affinity to a probe derived from the p21-activated kinase effector, Ste20p. Cdc42p was rapidly activated during vacuole membrane fusion, which kinetically coincided with priming subreaction. During priming, Sec18p ATPase activity dissociates SNARE complexes and releases Sec17p, however, priming inhibitors such as Sec17p and Sec18p ligands did not block Cdc42p activation. Therefore, Cdc42p activation seems to be a parallel subreaction of priming, distinct from Sec18p activity. Specific mutants in the ergosterol synthesis pathway block both Sec17p release and Cdc42p activation. Taken together, our results define a novel sterol-dependent subreaction of vacuole priming that activates cycles of Cdc42p activity to facilitate membrane fusion.	[Jones, Lynden; Tedrick, Kelly; Baier, Alicia; Logan, Michael R.; Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Eitzen, G (corresponding author), Univ Alberta, Dept Cell Biol, 5-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	gary.eitzen@ualberta.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR).	Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Davis CR, 1998, J BIOL CHEM, V273, P849, DOI 10.1074/jbc.273.2.849; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fidyk N, 2006, BIOCHEMISTRY-US, V45, P7750, DOI 10.1021/bi060365h; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Isgandarova S, 2007, J BIOL CHEM, V282, P30466, DOI 10.1074/jbc.M704117200; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Merz AJ, 2004, P NATL ACAD SCI USA, V101, P11548, DOI 10.1073/pnas.0404583101; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Pruyne D, 2000, J CELL SCI, V113, P365; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Tedrick K, 2004, MOL BIOL CELL, V15, P4609, DOI 10.1091/mbc.E04-03-0194; Vanni C, 2005, CELL CYCLE, V4, P1675, DOI 10.4161/cc.4.11.2170; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007	34	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4298	4306		10.1074/jbc.M109.074609	http://dx.doi.org/10.1074/jbc.M109.074609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007700	Green Published, hybrid			2022-12-25	WOS:000275274800006
J	Sohma, Y; Hua, QX; Liu, M; Phillips, NB; Hu, SQ; Whittaker, J; Whittaker, LJ; Ng, A; Roberts, CT; Arvan, P; Kent, SBH; Weiss, MA				Sohma, Youhei; Hua, Qing-xin; Liu, Ming; Phillips, Nelson B.; Hu, Shi-Quan; Whittaker, Jonathan; Whittaker, Linda J.; Ng, Aubree; Roberts, Charles T., Jr.; Arvan, Peter; Kent, Stephen B. H.; Weiss, Michael A.			Contribution of Residue B5 to the Folding and Function of Insulin and IGF-I CONSTRAINTS AND FINE-TUNING IN THE EVOLUTION OF A PROTEIN FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; 3-DIMENSIONAL SOLUTION STRUCTURE; PANCREATIC TRYPSIN-INHIBITOR; TOTAL CHEMICAL-SYNTHESIS; ENDOPLASMIC-RETICULUM; RECEPTOR-BINDING; BIOLOGICAL-ACTIVITY; DIABETES-MELLITUS; CRYSTAL-STRUCTURE; DISULFIDE BONDS	Proinsulin exhibits a single structure, whereas insulin-like growth factors refold as two disulfide isomers in equilibrium. Native insulin-related growth factor (IGF)-I has canonical cystines (A6-A11, A7-B7, and A20-B19) maintained by IGF-binding proteins; IGF-swap has alternative pairing (A7-A11, A6-B7, and A20-B19) and impaired activity. Studies of mini-domain models suggest that residue B5 (His in insulin and Thr in IGFs) governs the ambiguity or uniqueness of disulfide pairing. Residue B5, a site of mutation in proinsulin causing neonatal diabetes, is thus of broad biophysical interest. Here, we characterize reciprocal B5 substitutions in the two proteins. In insulin, His(B5)-> Thr markedly destabilizes the hormone (Delta Delta G(u) 2.0 +/- 0.2 kcal/mol), impairs chain combination, and blocks cellular secretion of proinsulin. The reciprocal IGF-I substitution Thr(B5)-> His (residue 4) specifies a unique structure with native H-1 NMR signature. Chemical shifts and nuclear Overhauser effects are similar to those of native IGF-I. Whereas wild-type IGF-I undergoes thiol-catalyzed disulfide exchange to yield IGF-swap, His(B5)-IGF-I retains canonical pairing. Chemical denaturation studies indicate that His(B5) does not significantly enhance thermodynamic stability (Delta Delta Gu 0.2 +/- 0.2 kcal/mol), implying that the substitution favors canonical pairing by destabilizing competing folds. Whereas the activity of Thr(B5)-insulin is decreased 5-fold, His(B5)-IGF-I exhibits 2-fold increased affinity for the IGF receptor and augmented post-receptor signaling. We propose that conservation of Thr(B5) in IGF-I, rescued from structural ambiguity by IGF-binding proteins, reflects fine-tuning of signal transduction. In contrast, the conservation of HisB5 in insulin highlights its critical role in insulin biosynthesis.	[Hua, Qing-xin; Phillips, Nelson B.; Hu, Shi-Quan; Whittaker, Jonathan; Whittaker, Linda J.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Sohma, Youhei; Kent, Stephen B. H.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sohma, Youhei; Kent, Stephen B. H.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Liu, Ming; Arvan, Peter] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Ng, Aubree; Roberts, Charles T., Jr.] Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Roberts, Charles T., Jr.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA	Case Western Reserve University; University of Chicago; University of Chicago; University of Michigan System; University of Michigan; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	maw21@case.edu	Roberts, Charles/K-6953-2017	Roberts, Charles/0000-0003-1756-5772	National Institutes of Health [DK48280, R01 DK069764, R01 DK40949]; Department of Energy [DE-FG02-04ER63786]; American Diabetes Association [ADA 1-08-RA-218]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK048280, R01DK040949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK48280 (to P. A.), Department of Energy Grant DE-FG02-04ER63786 (to S. B. H. K.), and National Institutes of Health Grants R01 DK069764 and R01 DK40949 (to M. A. W.). This work was also supported by American Diabetes Association Grant ADA 1-08-RA-218 (to M. A. W.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology and Institute for Biophysical Dynamics at the University of Chicago.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BRYANT C, 1992, BIOCHEMISTRY-US, V31, P5692, DOI 10.1021/bi00140a002; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURKHARDT E, 1994, HUM GENET, V94, P91, DOI 10.1007/BF02272850; CHASSIN D, 1995, GENOMICS, V29, P465, DOI 10.1006/geno.1995.9980; Chen Y, 2004, BIOCHEMISTRY-US, V43, P9225, DOI 10.1021/bi049710y; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; CREIGHTON T, 1995, PHILOS T ROY SOC B, V348, P5, DOI 10.1098/rstb.1995.0039; Creighton TE, 1997, BIOL CHEM, V378, P731; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Denley A, 2006, ENDOCRINOLOGY, V147, P1029, DOI 10.1210/en.2005-0736; DEVROEDE MA, 1986, DIABETES, V35, P355, DOI 10.2337/diabetes.35.3.355; DeWolf E, 1996, PROTEIN SCI, V5, P2193; DiMarchi RD, 1992, PEPTIDES CHEM BIOL, P26; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Guo ZY, 2002, BIOCHEMISTRY-US, V41, P1556, DOI 10.1021/bi011166v; Guo ZY, 2002, BIOCHEMISTRY-US, V41, P10585, DOI 10.1021/bi020165f; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; HEJNAES KR, 1992, PROTEIN ENG, V5, P797, DOI 10.1093/protein/5.8.797; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; Hober S, 1999, FEBS LETT, V443, P271, DOI 10.1016/S0014-5793(98)01737-2; HOBER S, 1994, BIOCHEMISTRY-US, V33, P6758, DOI 10.1021/bi00188a003; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang QL, 2007, BIOCHEMISTRY-US, V46, P218, DOI 10.1021/bi0616798; HUDSON P, 1984, EMBO J, V3, P2333, DOI 10.1002/j.1460-2075.1984.tb02135.x; HUDSON P, 1983, NATURE, V301, P628, DOI 10.1038/301628a0; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jansson M, 1998, J BIOL CHEM, V273, P24701, DOI 10.1074/jbc.273.38.24701; Johnson ECB, 2007, TETRAHEDRON LETT, V48, P1795, DOI 10.1016/j.tetlet.2007.01.030; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Katugampola S, 2003, TRENDS PHARMACOL SCI, V24, P30, DOI 10.1016/S0165-6147(02)00007-X; Liu AZ, 2007, J MAGN RESON, V186, P319, DOI 10.1016/j.jmr.2007.02.008; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Magee BA, 1999, BIOCHEMISTRY-US, V38, P15863, DOI 10.1021/bi9910070; MARKUSSEN J, 1985, INT J PEPT PROT RES, V25, P431; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; Milner SJ, 1999, BIOTECHNOL BIOENG, V62, P693; NAGATA K, 1995, J MOL BIOL, V253, P749, DOI 10.1006/jmbi.1995.0588; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; NARHI LO, 1993, BIOCHEMISTRY-US, V32, P5214, DOI 10.1021/bi00070a033; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; SATO A, 1992, J BIOCHEM-TOKYO, V111, P529, DOI 10.1093/oxfordjournals.jbchem.a123791; SATO A, 1993, INT J PEPT PROT RES, V41, P433; Sato A, 2000, J PEPT RES, V56, P218, DOI 10.1034/j.1399-3011.2000.00769.x; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SCHWARZ RT, 1991, BEHRING I MITT, V89, P198; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SMITH MC, 1989, J BIOL CHEM, V264, P9314; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; WEISSMAN JS, 1992, P NATL ACAD SCI USA, V89, P9900, DOI 10.1073/pnas.89.20.9900; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yan H, 2003, PROTEIN SCI, V12, P768, DOI 10.1110/ps.0237203; Yun CH, 2005, BIOCHEM BIOPH RES CO, V326, P52, DOI 10.1016/j.bbrc.2004.10.203; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	108	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5040	5055		10.1074/jbc.M109.062992	http://dx.doi.org/10.1074/jbc.M109.062992			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959476	hybrid, Green Published			2022-12-25	WOS:000275274800080
J	Mayoral, R; Valverde, AM; Izquierdo, CL; Gonzalez-Rodriguez, A; Bosca, L; Martin-Sanz, P				Mayoral, Rafael; Valverde, Angela M.; Llorente Izquierdo, Cristina; Gonzalez-Rodriguez, Agueda; Bosca, Lisardo; Martin-Sanz, Paloma			Impairment of Transforming Growth Factor beta Signaling in Caveolin-1-deficient Hepatocytes ROLE IN LIVER REGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD PROTEINS; ONCOGENIC TRANSFORMATION; HEPATOCELLULAR-CARCINOMA; FIBROBLAST CELLS; RAT HEPATOCYTES; HEPATIC CELLS; EXPRESSION; RECEPTOR; SNON; SKI	Caveolin-1 (Cav-1) is the main structural protein of caveolae and plays an important role in various cellular processes such as vesicular transport, cholesterol homeostasis, and signal transduction pathways. The expression and functional role of Cav-1 have been reported in liver and in hepatocyte cell lines, in human cirrhotic liver, and in hepatocellular carcinomas. Previous studies demonstrated that Cav-1 was dispensable for liver regeneration, because Cav-1(-/-) animals survived and fully regenerated liver function and size after partial hepatectomy. In this study, we have investigated the mechanisms by which the lack of Cav-1 accelerates liver regeneration after partial hepatectomy. The data show that transforming growth factor beta (TGF-beta) signaling is impaired in regenerating liver of Cav-1(-/-) mice and in hepatocytes derived from these animals. TGF-beta receptors I and II do not colocalize in the same membrane fraction in the hepatocytes derived from Cav-1(-/-) mice, as Smad2/3 signaling decreased in the absence of Cav-1 at the time that the transcriptional corepressor SnoN accumulates. Accordingly, the expression of TGF-beta target genes, such as plasminogen activator inhibitor-1, is decreased due to the presence of the high levels of SnoN. Moreover, hepatocyte growth factor inhibited TGF-beta signaling in the absence of Cav-1 by increasing SnoN expression. Taken together, these data might help to unravel why Cav-1-deficient mice exhibit an accelerated liver regeneration after partial hepatectomy and add new insights on the molecular mechanisms controlling the initial commitment to hepatocyte proliferation.	[Mayoral, Rafael; Valverde, Angela M.; Llorente Izquierdo, Cristina; Gonzalez-Rodriguez, Agueda; Bosca, Lisardo; Martin-Sanz, Paloma] CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Mayoral, Rafael; Bosca, Lisardo; Martin-Sanz, Paloma] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona 08036, Spain; [Valverde, Angela M.; Gonzalez-Rodriguez, Agueda] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Martin-Sanz, P (corresponding author), CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	pmartins@iib.uam.es	González-Rodróguez, Águeda/D-7651-2012; Bosca, Lisardo/A-2059-2008; Martín-Sanz, Paloma/K-1303-2014; Mayoral Monibas, Rafael/B-3563-2013	González-Rodróguez, Águeda/0000-0001-6559-0847; Bosca, Lisardo/0000-0002-0253-5469; Mayoral Monibas, Rafael/0000-0002-6645-7172	MICINN [SAF2007-60551, BFU2008-02161]; Comunidad de Madrid [S-BIO-0283/2006]; FIS-RECAVA [RD06/0014/0025]; Instituto de Salud Carlos III	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); FIS-RECAVA; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Grants SAF2007-60551 and BFU2008-02161 from MICINN, S-BIO-0283/2006 from Comunidad de Madrid, and FIS-RECAVA RD06/0014/0025. Red tematica Enfermedades Cardiovasculares, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, and Centro de Investigacion Biome dica en Red de Diabetes y Enfermedades Metabolicas Asociadas are funded by the Instituto de Salud Carlos III.	Bouzahzah B, 2000, CANCER RES, V60, P4531; Calvo M, 2001, HEPATOLOGY, V33, P1259, DOI 10.1053/jhep.2001.23937; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kim S, 2008, CELL SIGNAL, V20, P1313, DOI 10.1016/j.cellsig.2008.02.020; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Lee EK, 2007, BIOCHEM BIOPH RES CO, V359, P385, DOI 10.1016/j.bbrc.2007.05.121; Liu YH, 2004, AM J PHYSIOL-RENAL, V287, pF7, DOI 10.1152/ajprenal.00451.2003; Longerich T, 2004, VIRCHOWS ARCH, V445, P589, DOI 10.1007/s00428-004-1118-x; Macias-Silva M, 2002, J BIOL CHEM, V277, P28483, DOI 10.1074/jbc.M202403200; Martin-Sanz P, 1998, BRIT J PHARMACOL, V125, P1313, DOI 10.1038/sj.bjp.0702196; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nishikawa Y, 1998, J CELL PHYSIOL, V176, P612, DOI 10.1002/(SICI)1097-4652(199809)176:3<612::AID-JCP18>3.0.CO;2-0; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; STAVNEZER E, 1986, J VIROL, V57, P1073, DOI 10.1128/JVI.57.3.1073-1083.1986; Tan RY, 2007, J AM SOC NEPHROL, V18, P2340, DOI 10.1681/ASN.2007010128; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Wang SJ, 2008, IUBMB LIFE, V60, P693, DOI 10.1002/iub.104; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yerian LM, 2004, AM J SURG PATHOL, V28, P357, DOI 10.1097/00000478-200403000-00008; Yokomori H, 2002, LIVER, V22, P150, DOI 10.1034/j.1600-0676.2002.01588.x; Zhang F, 2003, CANCER RES, V63, P5005; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	44	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3633	3642		10.1074/jbc.M109.072900	http://dx.doi.org/10.1074/jbc.M109.072900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19966340	Green Published, hybrid			2022-12-25	WOS:000275254000015
J	Fujimoto, Y; Shiraki, T; Horiuchi, Y; Waku, T; Shigenaga, A; Otaka, A; Ikura, T; Igarashi, K; Aimoto, S; Tate, S; Morikawa, K				Fujimoto, Yoshito; Shiraki, Takuma; Horiuchi, Yuji; Waku, Tsuyoshi; Shigenaga, Akira; Otaka, Akira; Ikura, Tsuyoshi; Igarashi, Kazuhiko; Aimoto, Saburo; Tate, Shin-ichi; Morikawa, Kosuke			Proline cis/trans-Isomerase Pin1 Regulates Peroxisome Proliferator-activated Receptor gamma Activity through the Direct Binding to the Activation Function-1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; PROTEIN AP2; PHOSPHORYLATION; GENE; DIFFERENTIATION; INHIBITION; EXPRESSION; ADIPOGENESIS; METABOLISM; LIGANDS	The important roles of a nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) are widely accepted in various biological processes as well as metabolic diseases. Despite the worldwide quest for pharmaceutical manipulation of PPAR gamma activity through the ligand-binding domain, very little information about the activation mechanism of the N-terminal activation function-1 (AF-1) domain. Here, we demonstrate the molecular and structural basis of the phosphorylation-dependent regulation of PPAR gamma activity by a peptidyl-prolyl isomerase, Pin1. Pin1 interacts with the phosphorylated AF-1 domain, thereby inhibiting the polyubiquitination of PPAR gamma. The interaction and inhibition are dependent upon the WW domain of Pin1 but are independent of peptidyl-prolyl cis/trans-isomerase activity. Gene knockdown experiments revealed that Pin1 inhibits the PPAR gamma-dependent gene expression in THP-1 macrophage-like cells. Thus, our results suggest that Pin1 regulates macrophage function through the direct binding to the phosphorylated AF-1 domain of PPAR gamma.	[Fujimoto, Yoshito; Shiraki, Takuma; Waku, Tsuyoshi; Morikawa, Kosuke] Osaka Univ, Open Labs Adv Biosci & Biotechnol, Takara Bio Endowed Div, Dept Biomol Recognit,Inst Prot Res, Osaka 5650874, Japan; [Shiraki, Takuma; Ikura, Tsuyoshi; Igarashi, Kazuhiko] Tohoku Univ, Dept Biochem, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Horiuchi, Yuji; Tate, Shin-ichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Shigenaga, Akira; Otaka, Akira] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708505, Japan; [Shigenaga, Akira; Otaka, Akira] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Aimoto, Saburo] Osaka Univ, Inst Prot Res, Div Prot Chem, Lab Prot Organ Chem, Suita, Osaka 5650871, Japan	Osaka University; Tohoku University; Hiroshima University; Tokushima University; Tokushima University; Osaka University	Shiraki, T (corresponding author), Osaka Univ, Open Labs Adv Biosci & Biotechnol, Takara Bio Endowed Div, Dept Biomol Recognit,Inst Prot Res, 6-2-3 Furuedai, Osaka 5650874, Japan.	tshiraki@m.tains.tohoku.ac.jp; morikako@protein.osaka-u.ac.jp	Fujimoto, Yukari/M-7282-2014; Tate, Shin-ichi/E-3057-2015	Fujimoto, Yukari/0000-0001-5320-3192; Tate, Shin-ichi/0000-0002-5556-7712; Igarashi, Kazuhiko/0000-0002-2470-2475	Japan Society for the Promotion of Science [18GS0316]; Grants-in-Aid for Scientific Research [21390031] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a donation from Takara Bio, Inc. and by a Grant-in-aid for Creative Scientific Research Program (18GS0316) from the Japan Society for the Promotion of Science.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bluher M, 2003, EXP CLIN ENDOCR DIAB, V111, P85, DOI 10.1055/s-2003-39235; Cavanagh John, 1996, P410; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glass CK, 2000, GENE DEV, V14, P121; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Siegrist R, 2007, HELV CHIM ACTA, V90, P217, DOI 10.1002/hlca.200790028; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; Smet C, 2005, FEBS LETT, V579, P4159, DOI 10.1016/j.febslet.2005.06.048; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044	30	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3126	3132		10.1074/jbc.M109.055095	http://dx.doi.org/10.1074/jbc.M109.055095			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996102	Green Published, hybrid			2022-12-25	WOS:000273829000028
J	Bansal, D; Herbert, F; Lim, P; Deshpande, P; Becavin, C; Guiyedi, V; de Maria, I; Rousselle, JC; Namane, A; Jain, R; Cazenave, PA; Mishra, GC; Ferlini, C; Fesel, C; Benecke, A; Pied, S				Bansal, Devendra; Herbert, Fabien; Lim, Pharath; Deshpande, Prakash; Becavin, Christophe; Guiyedi, Vincent; de Maria, Ilaria; Rousselle, Jean Claude; Namane, Abdelkader; Jain, Rajendra; Cazenave, Pierre-Andre; Mishra, Gyan Chandra; Ferlini, Cristiano; Fesel, Constantin; Benecke, Arndt; Pied, Sylviane			IgG Autoantibody to Brain Beta Tubulin III Associated with Cytokine Cluster-II Discriminate Cerebral Malaria in Central India	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTICARDIOLIPIN ANTIBODIES; INFECTED PATIENTS; GLOBAL ANALYSIS; T-CELLS; PATHOGENESIS; REPERTOIRES; SPECIFICITY; RESPONSES; CORRELATE	Background: The main processes in the pathogenesis of cerebral malaria caused by Plasmodium falciparum involved sequestration of parasitized red blood cells and immunopathological responses. Among immune factors, IgG autoantibodies to brain antigens are increased in P. falciparum infected patients and correlate with disease severity in African children. Nevertheless, their role in the pathophysiology of cerebral malaria (CM) is not fully defined. We extended our analysis to an Indian population with genetic backgrounds and endemic and environmental status different from Africa to determine if these autoantibodies could be either a biomarker or a risk factor of developing CM. Methods/Principal Findings: We investigated the significance of these self-reactive antibodies in clinically well-defined groups of P. falciparum infected patients manifesting mild malaria (MM), severe non-cerebral malaria (SM), or cerebral malaria (CM) and in control subjects from Gondia, a malaria epidemic site in central India using quantitative immunoprinting and multivariate statistical analyses. A two-fold complete-linkage hierarchical clustering allows classifying the different patient groups and to distinguish the CM from the others on the basis of their profile of IgG reactivity to brain proteins defined by PANAMA Blot. We identified beta tubulin III (TBB3) as a novel discriminant brain antigen in the prevalence of CM. In addition, circulating IgG from CM patients highly react with recombinant TBB3. Overall, correspondence analyses based on singular value decomposition show a strong correlation between IgG anti-TBB3 and elevated concentration of cluster-II cytokine (IFN gamma, IL1 beta, TNF alpha, TGF beta) previously demonstrated to be a predictor of CM in the same population. Conclusions/Significance: Collectively, these findings validate the relationship between antibody response to brain induced by P. falciparum infection and plasma cytokine patterns with clinical outcome of malaria. They also provide significant insight into the immune mechanisms associated to CM by the identification of TBB3 as a new disease-specific marker and potential therapeutic target.	[Bansal, Devendra; Herbert, Fabien; Lim, Pharath; Guiyedi, Vincent; Cazenave, Pierre-Andre; Pied, Sylviane] Pole Univ Nord, Inst Pasteur Lille, INSERM, Equipe PIME,CNRS,U547, Lille, France; [Deshpande, Prakash; Mishra, Gyan Chandra] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Becavin, Christophe; Benecke, Arndt] Univ Lille 1, CNRS, USR3078, Inst Rech Interdisciplinaire, Bures Sur Yvette, France; [Becavin, Christophe; Benecke, Arndt] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [de Maria, Ilaria; Ferlini, Cristiano] Univ Cattolica Sacro Cuore, Lab Antineoplast Pharmacol, Rome, Italy; [Rousselle, Jean Claude; Namane, Abdelkader] Inst Pasteur, CNRS, URA 2185, Paris, France; [Cazenave, Pierre-Andre] Univ Paris 06, CNRS, U7087, Paris, France; [Fesel, Constantin] Inst Gulbenkian Ciencias, Oeiras, Portugal	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Saclay; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Instituto Gulbenkian de Ciencia	Bansal, D (corresponding author), Pole Univ Nord, Inst Pasteur Lille, INSERM, Equipe PIME,CNRS,U547, Lille, France.	sylviane.pied@pasteur-lille.fr	Ferlini, Cristiano/K-1339-2013; Namane, Abdelkader/O-1857-2013; Lim, Pharath/AAF-6699-2020; Benecke, Arndt G./T-1079-2019; Bécavin, Christophe/AAA-2046-2020; HERBERT, Fabien/I-3069-2018	Ferlini, Cristiano/0000-0003-3886-9134; Namane, Abdelkader/0000-0001-7180-7619; Bécavin, Christophe/0000-0003-1555-3153; Lim, Pharath/0000-0002-1012-2461; Bansal, Devendra/0000-0002-1387-4335; Cazenave, Pierre-Andre/0000-0002-1345-8526; Fesel, Constantin/0000-0003-3537-5243; Pied, Sylviane/0000-0003-0642-1423; HERBERT, Fabien/0000-0001-7988-3819	Indo-French Centre for Promotion of Advanced Research [2103-3, 3703-2]; Institut Pasteur and Pasteur-Genopole-Ile-de-France; "Fondation des Treilles''; Genopole Evry; Agence Nationale pour la Recherche (ANR); Agence Nationale de Recherches sur le SIDA (ANRS) et les hepatites virales; Fundation para a Ciencia e Tecnologia (Portugal)	Indo-French Centre for Promotion of Advanced Research(French National Research Agency (ANR)); Institut Pasteur and Pasteur-Genopole-Ile-de-France; "Fondation des Treilles''; Genopole Evry; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Agence Nationale de Recherches sur le SIDA (ANRS) et les hepatites virales(ANRS); Fundation para a Ciencia e Tecnologia (Portugal)	This work was part of the Centre National de la Recherche Scientifique (CNRS)-Programme d'Incitation a la Mobilite d'Equipe (PIME): Malaria Immunopathophysiology. It was supported by the Indo-French Centre for Promotion of Advanced Research (grant 2103-3 and 3703-2). This work was also supported by grants from the Institut Pasteur and Pasteur-Genopole-Ile-de-France and "Fondation des Treilles''. Work in the Benecke group is funded by grants from the Genopole Evry, the Agence Nationale pour la Recherche (ANR), and the Agence Nationale de Recherches sur le SIDA (ANRS) et les hepatites virales. CB is recipient of a Ph. D. fellowship from the ANRS. CF received a post-doctoral fellowship from the Fundation para a Ciencia e Tecnologia (Portugal).	Adams S, 2002, TRENDS PARASITOL, V18, P360, DOI 10.1016/S1471-4922(02)02353-X; ADU D, 1982, CLIN EXP IMMUNOL, V49, P310; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Consigny PH, 2002, CLIN EXP IMMUNOL, V127, P158, DOI 10.1046/j.1365-2249.2002.01722.x; DANIELRIBEIRO C, 1983, T ROY SOC TROP MED H, V77, P185, DOI 10.1016/0035-9203(83)90064-0; Duarte J, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-1; FREEMAN RR, 1978, CLIN EXP IMMUNOL, V32, P41; GALLIEN S, 2007, J INFECTION, V54, P1; GENDREL D, 1992, PRESSE MED, V21, P1805; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Greenwood BM, 1997, ANN TROP MED PARASIT, V91, P763, DOI 10.1080/00034989760518; GREENWOOD BM, 1974, LANCET, V1, P435; Guiyedi V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000389; HAURY M, 1994, SCAND J IMMUNOL, V39, P79, DOI 10.1111/j.1365-3083.1994.tb03343.x; HOWARD MK, 1987, CLIN EXP IMMUNOL, V68, P78; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; JAKOBSEN PH, 1993, IMMUNOLOGY, V79, P653; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; KORENROMP E, 2004, WORLD MALARIA REPORT; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Lang B, 2005, J INFECT DIS, V191, P117, DOI 10.1086/426512; Lima MRD, 1996, SCAND J IMMUNOL, V43, P263; Mazier D, 2000, PARASITE IMMUNOL, V22, P613, DOI 10.1046/j.1365-3024.2000.00342.x; Medana IM, 2007, J INFECT DIS, V195, P921, DOI 10.1086/512089; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Minoprio P, 2001, INT J PARASITOL, V31, P588, DOI 10.1016/S0020-7519(01)00171-0; NOBREGA A, 1993, EUR J IMMUNOL, V23, P2851, DOI 10.1002/eji.1830231119; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; SHAPER AG, 1968, LANCET, V1, P1342; SONI PN, 1993, S AFR MED J, V83, P660; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; TRIPATHI AK, 2009, BLOOD           0827; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004	41	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8245	10.1371/journal.pone.0008245	http://dx.doi.org/10.1371/journal.pone.0008245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011600	gold, Green Published			2022-12-25	WOS:000272830300017
J	Jones, HE; Harris, KA; Azizia, M; Bank, L; Carpenter, B; Hartley, JC; Klein, N; Peebles, D				Jones, Hannah E.; Harris, Kathryn A.; Azizia, Malika; Bank, Lindsay; Carpenter, Bernadette; Hartley, John C.; Klein, Nigel; Peebles, Donald			Differing Prevalence and Diversity of Bacterial Species in Fetal Membranes from Very Preterm and Term Labor	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; TOLL-LIKE RECEPTORS; UREAPLASMA-UREALYTICUM; INTRAUTERINE INFECTION; MONOCYTE DEACTIVATION; PREMATURE RUPTURE; AMNIOTIC-FLUID; COLONIZATION; INFLAMMATION; ASSOCIATION	Background: Intrauterine infection may play a role in preterm delivery due to spontaneous preterm labor (PTL) and preterm prolonged rupture of membranes (PPROM). Because bacteria previously associated with preterm delivery are often difficult to culture, a molecular biology approach was used to identify bacterial DNA in placenta and fetal membranes. Methodology/Principal findings: We used broad-range 16S rDNA PCR and species-specific, real-time assays to amplify bacterial DNA from fetal membranes and placenta. 74 women were recruited to the following groups: PPROM,32 weeks (n = 26; 11 caesarean); PTL with intact membranes,32 weeks ( n = 19; all vaginal birth); indicated preterm delivery,32 weeks ( n = 8; all caesarean); term ( n = 21; 11 caesarean). 50% (5/10) of term vaginal deliveries were positive for bacterial DNA. However, little spread was observed through tissues and species diversity was restricted. Minimal bacteria were detected in term elective section or indicated preterm deliveries. Bacterial prevalence was significantly increased in samples from PTL with intact membranes [89% (17/19) versus 50% (5/10) in term vaginal delivery p = 0.03] and PPROM ( CS) [55% (6/11) versus 0% (0/11) in term elective CS, p = 0.01]. In addition, bacterial spread and diversity was greater in the preterm groups with 68% (13/19) PTL group having 3 or more positive samples and over 60% (12/19) showing two or more bacterial species ( versus 20% (2/10) in term vaginal deliveries). Blood monocytes from women with PTL with intact membranes and PPROM who were 16S bacterial positive showed greater level of immune paresis ( p = 0.03). A positive PCR result was associated with histological chorioamnionitis in preterm deliveries. Conclusion/Significance: Bacteria are found in both preterm and term fetal membranes. A greater spread and diversity of bacterial species were found in tissues of women who had very preterm births. It is unclear to what extent the greater bacterial prevalence observed in all vaginal delivery groups reflects bacterial contamination or colonization of membranes during labor. Bacteria positive preterm tissues are associated with histological chorioamnionitis and a pronounced maternal immune paresis.	[Jones, Hannah E.; Bank, Lindsay; Carpenter, Bernadette; Klein, Nigel] Inst Child Hlth, Infect Dis & Microbiol Unit, London, England; [Jones, Hannah E.; Azizia, Malika; Peebles, Donald] UCL, Dept Obstet & Gynecol, Inst Womens Hlth, London, England; [Harris, Kathryn A.; Hartley, John C.] Great Ormond St Hosp Sick Children, Dept Microbiol, Camelia Botner Labs, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Jones, HE (corresponding author), Inst Child Hlth, Infect Dis & Microbiol Unit, London, England.	h.jones@ich.ucl.ac.uk		Harris, Kathryn/0000-0003-3807-9749; Klein, Nigel/0000-0003-3925-9258	SPARKS [06UCL01]; University College London Hospital/University College London; Great Ormond Street Hospital Microbiology Department; Department of Health NIHR Biomedical Research Centres	SPARKS; University College London Hospital/University College London; Great Ormond Street Hospital Microbiology Department; Department of Health NIHR Biomedical Research Centres(National Institute for Health Research (NIHR))	This work was funded by project grant 06UCL01 from SPARKS ( Sport Aiding medical Research for Kids, www.SPARKS.org.UK) charity. The study was undertaken at University College London Hospital/University College London and Great Ormond Street Hospital Microbiology Department. University College London Hospital/University College London received a proportion of funding from the Department of Health NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2002, CRIT CARE MED, V30, P1140, DOI 10.1097/00003246-200205000-00031; Alvarez-de-la-Rosa M, 2000, EUR J OBSTET GYN R B, V88, P57, DOI 10.1016/S0301-2115(99)00129-3; Bergseng H, 2007, J MED MICROBIOL, V56, P223, DOI 10.1099/jmm.0.46731-0; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Boutaga K, 2005, FEMS IMMUNOL MED MIC, V45, P191, DOI 10.1016/j.femsim.2005.03.011; Cahill RJ, 2005, MOL HUM REPROD, V11, P761, DOI 10.1093/molehr/gah234; Cao X, 2007, DIAGN MICR INFEC DIS, V57, P373, DOI 10.1016/j.diagmicrobio.2006.09.006; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dubicke A, 2008, MOL HUM REPROD, V14, P641, DOI 10.1093/molehr/gan060; Feikin DR, 2001, AM J OBSTET GYNECOL, V184, P427, DOI 10.1067/mob.2001.109936; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.033; Gomez R, 2007, J MATERN-FETAL NEO M, V20, P167, DOI 10.1080/14767050601135485; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Greig PC, 1997, OBSTET GYNECOL, V90, P465, DOI 10.1016/S0029-7844(97)00294-9; Guaschino S, 2006, BJOG-INT J OBSTET GY, V113, P46, DOI 10.1111/j.1471-0528.2006.01122.x; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Hobel CJ, 1999, ANN NY ACAD SCI, V897, P54, DOI 10.1111/j.1749-6632.1999.tb07878.x; Hutzal CE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.008; Kataoka S, 2006, J CLIN MICROBIOL, V44, P51, DOI 10.1128/JCM.44.1.51-55.2006; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; King J, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000246; Lloyd J, 2007, OBSTET GYNECOL, V110, P1335, DOI 10.1097/01.AOG.0000289226.08442.e1; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Nguyen DP, 2004, J PERINAT MED, V32, P323, DOI 10.1515/JPM.2004.060; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.044; Patni S, 2007, BJOG-INT J OBSTET GY, V114, P1326, DOI 10.1111/j.1471-0528.2007.01488.x; Patni S, 2009, BIOL REPROD, V80, P243, DOI 10.1095/biolreprod.108.069252; Pretorius C, 2007, J PERINAT MED, V35, P93, DOI 10.1515/JPM.2007.039; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Shobokshi A, 2002, INT J GYNECOL OBSTET, V79, P209, DOI 10.1016/S0020-7292(02)00238-2; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Steinborn A, 1996, J PERINAT MED, V24, P381, DOI 10.1515/jpme.1996.24.4.381; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Witt A, 2005, AM J OBSTET GYNECOL, V193, P1663, DOI 10.1016/j.ajog.2005.03.067; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/mob.2000.109036	45	105	109	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8205	10.1371/journal.pone.0008205	http://dx.doi.org/10.1371/journal.pone.0008205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997613	gold, Green Submitted, Green Published			2022-12-25	WOS:000272829700005
J	Lock, FE; Hotchin, NA				Lock, Frances E.; Hotchin, Neil A.			Distinct Roles for ROCK1 and ROCK2 in the Regulation of Keratinocyte Differentiation	PLOS ONE			English	Article							VENTRAL BODY-WALL; RHO-KINASE-II; MYOSIN PHOSPHATASE; TERMINAL DIFFERENTIATION; IN-VIVO; ADHESION; PROTEIN; PHOSPHORYLATION; EXPRESSION; MECHANISM	Background: The human epidermis is comprised of several layers of specialized epithelial cells called keratinocytes. Normal homoeostasis of the epidermis requires that the balance between keratinocyte proliferation and terminal differentiation be tightly regulated. The mammalian serine/threonine kinases (ROCK1 and ROCK2) are well-characterised downstream effectors of the small GTPase RhoA. We have previously demonstrated that the RhoA/ROCK signalling pathway plays an important role in regulation of human keratinocyte proliferation and terminal differentiation. In this paper we addressed the question of which ROCK isoform was involved in regulation of keratinocyte differentiation. Methodology and Principal Findings: We used RNAi to specifically knockdown ROCK1 or ROCK2 expression in cultured human keratinocytes. ROCK1 depletion results in decreased keratinocyte adhesion to fibronectin and an increase in terminal differentiation. Conversely, ROCK2 depletion results in increased keratinocyte adhesion to fibronectin and inhibits terminal differentiation. Conclusion: These data suggest that ROCK1 and ROCK2 play distinct roles in regulating keratinocyte adhesion and terminal differentiation.	[Lock, Frances E.; Hotchin, Neil A.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Lock, FE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	n.a.hotchin@bham.ac.uk		Hotchin, Neil/0000-0002-1844-7607	Cancer Research UK project [C20692]	Cancer Research UK project(Cancer Research UK)	This work was funded by a Cancer Research UK project grant (C20692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Croft DR, 2006, METHOD ENZYMOL, V406, P541, DOI 10.1016/S0076-6879(06)06042-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Leung T, 1996, MOL CELL BIOL, V16, P5313; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684	30	72	80	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8190	10.1371/journal.pone.0008190	http://dx.doi.org/10.1371/journal.pone.0008190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997641	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829200019
J	Aragam, KG; Tamhane, UU; Kline-Rogers, E; Li, J; Fox, KAA; Goodman, SG; Eagle, KA; Gurm, HS				Aragam, Krishna G.; Tamhane, Umesh U.; Kline-Rogers, Eva; Li, Jin; Fox, Keith A. A.; Goodman, Shaun G.; Eagle, Kim A.; Gurm, Hitinder S.			Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROME; STRATIFICATION; THROMBOLYSIS; ASSOCIATION; MANAGEMENT; MORTALITY; REGISTRY; DEATH; TRIAL	Background: The Thrombolysis in Myocardial Infarction (TIMI) risk scores for Unstable Angina/Non-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) and the Global Registry of Acute Coronary Events (GRACE) risk scores for in-hospital and 6-month mortality are established tools for assessing risk in Acute Coronary Syndrome (ACS) patients. The objective of our study was to compare the discriminative abilities of the TIMI and GRACE risk scores in a broad-spectrum, unselected ACS population and to assess the relative contributions of model simplicity and model composition to any observed differences between the two scoring systems. Methodology/Principal Findings: ACS patients admitted to the University of Michigan between 1999 and 2005 were divided into UA/NSTEMI (n = 2753) and STEMI (n = 698) subpopulations. The predictive abilities of the TIMI and GRACE scores for in-hospital and 6-month mortality were assessed by calibration and discrimination. There were 137 in-hospital deaths (4%), and among the survivors, 234 (7.4%) died by 6 months post-discharge. In the UA/NSTEMI population, the GRACE risk scores demonstrated better discrimination than the TIMI UA/NSTEMI score for in-hospital (C = 0.85, 95% CI: 0.81-0.89, versus 0.54, 95% CI: 0.48-0.60; p, 0.01) and 6-month (C = 0.79, 95% CI: 0.76-0.83, versus 0.56, 95% CI: 0.52-0.60; p, 0.01) mortality. Among STEMI patients, the GRACE and TIMI STEMI scores demonstrated comparably excellent discrimination for in-hospital (C = 0.84, 95% CI: 0.78-0.90 versus 0.83, 95% CI: 0.78-0.89; p = 0.83) and 6-month (C = 0.72, 95% CI: 0.63-0.81, versus 0.71, 95% CI: 0.64-0.79; p = 0.79) mortality. An analysis of refitted multivariate models demonstrated a marked improvement in the discriminative power of the TIMI UA/NSTEMI model with the incorporation of heart failure and hemodynamic variables. Study limitations included unaccounted for confounders inherent to observational, single institution studies with moderate sample sizes. Conclusions/Significance: The GRACE scores provided superior discrimination as compared with the TIMI UA/NSTEMI score in predicting in-hospital and 6-month mortality in UA/NSTEMI patients, although the GRACE and TIMI STEMI scores performed equally well in STEMI patients. The observed discriminative deficit of the TIMI UA/NSTEMI score likely results from the omission of key risk factors rather than from the relative simplicity of the scoring system.	[Aragam, Krishna G.; Tamhane, Umesh U.; Kline-Rogers, Eva; Li, Jin; Eagle, Kim A.; Gurm, Hitinder S.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Fox, Keith A. A.] Univ Edinburgh, Div Med & Radiol Sci, Edinburgh, Midlothian, Scotland; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Div Cardiol, Canadian Heart Res Ctr, Toronto, ON M5B 1W8, Canada; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada	University of Michigan System; University of Michigan; University of Edinburgh; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Aragam, KG (corresponding author), Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	hgurm@med.umich.edu	Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Gurm, Hitinder/0000-0002-1646-0218	Sanofiaventis; Pfizer; Blue Cross Blue Shield Foundation; Mardigian Foundation; University of Michigan Health System	Sanofiaventis(Sanofi-Aventis); Pfizer(Pfizer); Blue Cross Blue Shield Foundation; Mardigian Foundation; University of Michigan Health System(University of Michigan System)	The present work was supported in part by unrestricted grants from: Sanofiaventis, Pfizer, the Blue Cross Blue Shield Foundation, the Mardigian Foundation, and the University of Michigan Health System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Brilakis ES, 2003, AM HEART J, V146, P811, DOI 10.1016/S0002-8703(03)00455-1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Harrell FEJr, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P2174, DOI 10.1001/jama.290.16.2174; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; Morrow DA, 2003, AM HEART J, V146, P754, DOI 10.1016/S0002-8703(03)00460-5; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Ramsay G, 2007, QJM-INT J MED, V100, P11, DOI 10.1093/qjmed/hcl133; Sabatine MS, 2004, CIRCULATION, V109, P874, DOI 10.1161/01.CIR.0000112604.74713.35; Singh M, 2002, CIRCULATION, V106, P2309, DOI 10.1161/01.CIR.0000036598.12888.DE; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Van de Werf F, 2005, BRIT MED J, V330, P441, DOI 10.1136/bmj.38335.390718.82; Weiner DE, 2007, J AM COLL CARDIOL, V50, P217, DOI 10.1016/j.jacc.2007.03.037; Weintraub WS, 2002, CIRCULATION, V106, P2292, DOI 10.1161/01.CIR.0000035925.23046.0B; Yan AT, 2007, EUR HEART J, V28, P1072, DOI 10.1093/eurheartj/ehm004; Yan AT, 2005, AM J CARDIOL, V96, P913, DOI 10.1016/j.amjcard.2005.05.046; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	25	101	110	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7947	10.1371/journal.pone.0007947	http://dx.doi.org/10.1371/journal.pone.0007947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956773	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827300006
J	Tjellstrom, H; Hellgren, LI; Wieslander, A; Sandelius, AS				Tjellstrom, Henrik; Hellgren, Lars I.; Wieslander, Ake; Sandelius, Anna Stina			Lipid asymmetry in plant plasma membranes: phosphate deficiency-induced phospholipid replacement is restricted to the cytosolic leaflet	FASEB JOURNAL			English	Article						detergent-resistant membrane; digalactosyldiacyl-glycerol; liposome; raft; sterol derivative	DETERGENT-RESISTANT MEMBRANES; LATERAL PRESSURE PROFILE; BIOLOGICAL-MEMBRANES; SPHINGOLIPID CLASSES; CELL-MEMBRANES; RAFTS; ARABIDOPSIS; LEAVES; MODEL; BIOSYNTHESIS	As in other eukaryotes, plant plasma membranes contain sphingolipids, phospholipids, and free sterols. In addition, plant plasma membranes also contain sterol derivatives and usually <5 mol% of a galactolipid, digalactosyldiacylglycerol (DGDG). We earlier reported that compared to fully fertilized oats (Avena sativa), oats cultivated without phosphate replaced up to 70 mol% of the root plasma membrane phospholipids with DGDG. Here, we investigated the implications of a high DGDG content on membrane properties. The phospholipid-to-DGDG replacement almost exclusively occurred in the cytosolic leaflet, where DGDG constituted up to one-third of the lipids. In the apoplastic (exoplasmic) leaflet, as well as in rafts, phospholipids were not replaced by DGDG, but by acylated sterol glycosides. Liposome studies revealed that the chain ordering in free sterol/phospholipid mixtures clearly decreased when > 5mol% DGDG was included. As both the apoplastic plasma membrane leaflet (probably the major water permeability barrier) and rafts both contain only trace amounts of DGDG, we conclude that this lipid class is not compatible with membrane functions requiring a high degree of lipid order. By not replacing phospholipids site specifically with DGDG, negative functional effects of this lipid in the plasma membrane are avoided.-Tjellstrom, H., Hellgren, L. I., Wieslander, A., Sandelius, A. S. Lipid asymmetry in plant plasma membranes: phosphate deficiency-induced phospholipid replacement is restricted to the cytosolic leaflet. FASEB J. 24, 1128-1138 (2010). www.fasebj.org	[Tjellstrom, Henrik; Sandelius, Anna Stina] Univ Gothenburg, Dept Plant & Environmen Sci, SE-40530 Gothenburg, Sweden; [Hellgren, Lars I.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Hellgren, Lars I.] Tech Univ Denmark, Ctr Adv Food Studies, DK-2800 Lyngby, Denmark; [Wieslander, Ake] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden	University of Gothenburg; Technical University of Denmark; Technical University of Denmark; Stockholm University	Tjellstrom, H (corresponding author), Univ Gothenburg, Dept Plant & Environmen Sci, POB 461, SE-40530 Gothenburg, Sweden.	henrik.tjellstrom@dpes.gu.se	Hellgren, Lars/B-5137-2010	Hellgren, Lars/0000-0001-9215-4880	Swedish Council for Forestry and Agricultural Research (FORMAS); The Royal Society of Arts and Sciences in Goteborg (KVVS); Carl Trygger's Science Foundation	Swedish Council for Forestry and Agricultural Research (FORMAS)(Swedish Research Council Formas); The Royal Society of Arts and Sciences in Goteborg (KVVS); Carl Trygger's Science Foundation	The authors thank Professors Maryse Block and Eric Marechal (CNRS, Grenoble, France), for generously supplying the DGDG primary antibody. The Centre for Cellular Imaging at the University of Gothenburg is acknowledged for the use of imaging equipment and for the support from the staff. Financial support was from the Swedish Council for Forestry and Agricultural Research (FORMAS), The Royal Society of Arts and Sciences in Goteborg (KVVS), and Carl Trygger's Science Foundation.	Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Bodennec J, 2000, METHOD ENZYMOL, V312, P101; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Bose R, 1998, J BIOL CHEM, V273, P28852, DOI 10.1074/jbc.273.44.28852; Brade L, 2000, GLYCOBIOLOGY, V10, P629, DOI 10.1093/glycob/10.6.629; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; CARLSSON AS, 1994, PHYSIOL PLANTARUM, V91, P754, DOI 10.1111/j.1399-3054.1994.tb03016.x; Christie W.W, 2003, LIPID ANAL ISOLATION, V3rd; Contreras FX, 2003, J BIOL CHEM, V278, P37169, DOI 10.1074/jbc.M303206200; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; EFRATI H, 1986, ARCH BIOCHEM BIOPHYS, V248, P282, DOI 10.1016/0003-9861(86)90425-X; EGGER A, 1992, PHYSIOL PLANTARUM, V84, P121, DOI 10.1111/j.1399-3054.1992.tb08774.x; FREDRICKSON GH, 1989, PHYS FLUIDS A-FLUID, V1, P3, DOI 10.1063/1.857546; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Hedfalk K, 2006, CURR OPIN STRUC BIOL, V16, P447, DOI 10.1016/j.sbi.2006.06.009; HEINZ E, 1975, Z PFLANZENPHYSIOL, V75, P78, DOI 10.1016/S0044-328X(75)80077-8; Hill WG, 1999, J GEN PHYSIOL, V114, P405, DOI 10.1085/jgp.114.3.405; HOEKSTRA D, 1992, BIOCHIM BIOPHYS ACTA, V1113, P227; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; KADOWAKI H, 1983, J LIPID RES, V24, P1389; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; KLEINSCHMIDT MG, 1972, PLANT PHYSIOL, V49, P852, DOI 10.1104/pp.49.5.852; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Larsson C., 1990, The plant plasma membrane., P1; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Morel J, 2006, MOL CELL PROTEOMICS, V5, P1396, DOI 10.1074/mcp.M600044-MCP200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; NORBERG P, 1991, PLANT PHYSIOL, V96, P1136, DOI 10.1104/pp.96.4.1136; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; ROCHESTER CP, 1987, ARCH BIOCHEM BIOPHYS, V255, P385, DOI 10.1016/0003-9861(87)90406-1; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Shangguan T, 1998, BBA-BIOMEMBRANES, V1368, P171, DOI 10.1016/S0005-2736(97)00151-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2001, NAT REV MOL CELL BIO, V2, P216; SOMMARIN M, 1988, BIOCHIM BIOPHYS ACTA, V958, P268, DOI 10.1016/0005-2760(88)90185-3; Sperling P, 2005, PLANT PHYSIOL BIOCH, V43, P1031, DOI 10.1016/j.plaphy.2005.10.004; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; SUNAMOTO J, 1980, J BIOCHEM-TOKYO, V88, P1219, DOI 10.1093/oxfordjournals.jbchem.a133089; Takeda Y, 2001, BBA-BIOMEMBRANES, V1513, P38, DOI 10.1016/S0005-2736(01)00342-X; Templer RH, 1998, FARADAY DISCUSS, V111, P41; Tjellstrom H, 2008, PLANT CELL ENVIRON, V31, P1388, DOI 10.1111/j.1365-3040.2008.01851.x; TOLEDO MS, 1995, J MED VET MYCOL, V33, P247; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; XIANG TX, 1993, BIOPHYS J, V65, P1108, DOI 10.1016/S0006-3495(93)81156-1; YOSHIDA S, 1986, PLANT PHYSIOL, V82, P807, DOI 10.1104/pp.82.3.807	59	53	56	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2010	24	4					1128	1138		10.1096/fj.09-139410	http://dx.doi.org/10.1096/fj.09-139410			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19966136				2022-12-25	WOS:000276462300020
J	Meng, JM; Lien, E; Golenbock, DT				Meng, Jianmin; Lien, Egil; Golenbock, Douglas T.			MD-2-mediated Ionic Interactions between Lipid A and TLR4 Are Essential for Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED DOCKING; HUMAN MD-2; LIPOPOLYSACCHARIDE; COMPLEX; MALARIA; VACCINE; SEPSIS	Lipopolysaccharide (LPS) activates innate immune responses through TLR4.MD-2. LPS binds to the MD-2 hydrophobic pocket and bridges the dimerization of two TLR4.MD-2 complexes to activate intracellular signaling. However, exactly how lipid A, the endotoxic moiety of LPS, activates myeloid lineage cells remains unknown. Lipid IVA, a tetra-acylated lipid A precursor, has been used widely as a model for lipid A activation. For unknown reasons, lipid IVA activates proinflammatory responses in rodent cells but inhibits the activity of LPS in human cells. Using stable TLR4-expressing cell lines and purified monomeric MD-2, as well as MD-2-deficient bone marrow-derived macrophages, we found that both mouse TLR4 and mouse MD-2 are required for lipid IVA activation. Computational studies suggested that unique ionic interactions exist between lipid IVA and TLR4 at the dimerization interface in the mouse complex only. The negatively charged 4'-phosphate on lipid IVA interacts with two positively charged residues on the opposing mouse, but not human, TLR4 (Lys(367) and Arg(434)) at the dimerization interface. When replaced with their negatively charged human counterparts Glu(369) and Gln(436), mouse TLR4 was no longer responsive to lipid IVA. In contrast, human TLR4 gained lipid IVA responsiveness when ionic interactions were enabled by charge reversal at the dimerization interface, defining the basis of lipid IVA species specificity. Thus, using lipid IVA as a selective lipid A agonist, we successfully decoupled and coupled two sequential events required for intracellular signaling: receptor engagement and dimerization, underscoring the functional role of ionic interactions in receptor activation.	[Meng, Jianmin; Lien, Egil; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	egil.lien@umassmed.edu; douglas.golenbock@umassmed.edu			National Institutes of Health [GM54060, AI057588]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075318, R01AI057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060, R37GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54060 (to D. T. G.) and AI057588 ( to E. L.).	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fujimoto Yukari, 2005, J Endotoxin Res, V11, P341, DOI 10.1179/096805105X76841; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOMMA JY, 1990, ADV EXP MED BIOL, V256, P101; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Moitessier N, 2004, J MED CHEM, V47, P4178, DOI 10.1021/jm0311386; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; PARK BS, 2009, NATURE; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; RIETSCHEL ET, 1987, EUR J BIOCHEM, V169, P27, DOI 10.1111/j.1432-1033.1987.tb13576.x; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; TAKADA H, 1989, CRIT REV MICROBIOL, V16, P477, DOI 10.3109/10408418909104475; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	37	73	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8695	8702		10.1074/jbc.M109.075127	http://dx.doi.org/10.1074/jbc.M109.075127			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20018893	Green Published, hybrid			2022-12-25	WOS:000275553700022
J	Fan, YJ; Dickman, KG; Zong, WX				Fan, Yongjun; Dickman, Kathleen G.; Zong, Wei-Xing			Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDEPENDENT SURVIVAL; CANCER-CELLS; FATTY-ACID; IN-VIVO; MITOCHONDRIAL BIOGENESIS; GLUCOSE-METABOLISM; TUMOR-CELLS; GROWTH; EXPRESSION; HEXOKINASE	The high glucose consumption of tumor cells even in an oxygen-rich environment, referred to as the Warburg effect, has been noted as a nearly universal biochemical characteristic of cancer cells. Targeting the glycolysis pathway has been explored as an anti-cancer therapeutic strategy to eradicate cancer based on this fundamental biochemical property of cancer cells. Oncoproteins such as Akt and c-Myc regulate cell metabolism. Accumulating studies have uncovered various molecular mechanisms by which oncoproteins affect cellular metabolism, raising a concern as to whether targeting glycolysis will be equally effective in treating cancers arising from different oncogenic activities. Here, we established a dual-regulatable FL5.12 pre-B cell line in which myristoylated Akt is expressed under the control of doxycycline, and c-Myc, fused to the hormone-binding domain of the human estrogen receptor, is activated by 4-hydroxytamoxifen. Using this system, we directly compared the effect of these oncoproteins on cell metabolism in an isogenic background. Activation of either Akt or c-Myc leads to the Warburg effect as indicated by increased cellular glucose uptake, glycolysis, and lactate generation. When cells are treated with glycolysis inhibitors, Akt sensitizes cells to apoptosis, whereas c-Myc does not. In contrast, c-Myc but not Akt sensitizes cells to the inhibition of mitochondrial function. This is correlated with enhanced mitochondrial activities in c-Myc cells. Hence, although both Akt and c-Myc promote aerobic glycolysis, they differentially affect mitochondrial functions and render cells susceptible to the perturbation of cellular metabolic programs.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Dickman, Kathleen G.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook		wzong@notes.cc.sunysb.edu			NCI [CA129536, CA098092]; Susan Komen for the Cure [KG081538]; Long Island League Against Cancer; NATIONAL CANCER INSTITUTE [R01CA129536, K01CA098092] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Long Island League Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129536 and CA098092 from NCI. This work was also supported by Susan Komen for the Cure Grant KG081538 and Long Island League Against Cancer.	Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Birnbaum MJ, 2004, DEV CELL, V7, P781, DOI 10.1016/j.devcel.2004.11.016; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Dickman KG, 2000, AM J PHYSIOL-GASTR L, V279, pG757, DOI 10.1152/ajpgi.2000.279.4.G757; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Gogvadze V, 2009, SEMIN CANCER BIOL, V19, P57, DOI 10.1016/j.semcancer.2008.11.007; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lewis BC, 2000, CANCER RES, V60, P6178; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wechatekar K, 2005, CLIN RADIOL, V60, P1143, DOI 10.1016/j.crad.2005.05.018; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu RH, 2005, CANCER RES, V65, P613; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	52	95	98	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7324	7333		10.1074/jbc.M109.035584	http://dx.doi.org/10.1074/jbc.M109.035584			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20018866	Green Published, hybrid			2022-12-25	WOS:000275415600044
J	Bardswell, SC; Cuello, F; Rowland, AJ; Sadayappan, S; Robbins, J; Gautel, M; Walker, JW; Kentish, JC; Avkiran, M				Bardswell, Sonya C.; Cuello, Friederike; Rowland, Alexandra J.; Sadayappan, Sakthivel; Robbins, Jeffrey; Gautel, Mathias; Walker, Jeffery W.; Kentish, Jonathan C.; Avkiran, Metin			Distinct Sarcomeric Substrates Are Responsible for Protein Kinase D-mediated Regulation of Cardiac Myofilament Ca2+ Sensitivity and Cross-bridge Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-BINDING; TROPONIN-I; C PHOSPHORYLATION; VENTRICULAR MYOCYTES; A PHOSPHORYLATION; ATPASE ACTIVITY; MYOCARDIUM; CONTRACTION; VELOCITY; MUSCLE	Protein kinase D (PKD), a serine/threonine kinase with emerging cardiovascular functions, phosphorylates cardiac troponin I (cTnI) at Ser(22)/Ser(23), reduces myofilament Ca2+ sensitivity, and accelerates cross-bridge cycle kinetics. Whether PKD regulates cardiac myofilament function entirely through cTnI phosphorylation at Ser(22)/Ser(23) remains to be established. To determine the role of cTnI phosphorylation at Ser(22)/Ser(23) in PKD-mediated regulation of cardiac myofilament function, we used transgenic mice that express cTnI in which Ser(22)/Ser(23) are substituted by nonphosphorylatable Ala (cTnI-Ala(2)). In skinned myocardium from wild-type (WT) mice, PKD-increased cTnI phosphorylation at Ser(22)/Ser(23) and decreased the Ca2+ sensitivity of force. In contrast, PKD had no effect on the Ca2+ sensitivity of force in myocardium from cTnI-Ala(2) mice, in which Ser(22)/Ser(23) were unavailable for phosphorylation. Surprisingly, PKD accelerated cross-bridge cycle kinetics similarly in myocardium from WT and cTnI-Ala(2) mice. Because cardiac myosin-binding protein C (cMyBP-C) phosphorylation underlies cAMP-dependent protein kinase (PKA)-mediated acceleration of cross-bridge cycle kinetics, we explored whether PKD phosphorylates cMyBP-C at its PKA sites, using recombinant C1C2 fragments with or without site-specific Ser/Ala substitutions. Kinase assays confirmed that PKA phosphorylates Ser(273), Ser(282), and Ser(302), and revealed that PKD phosphorylates only Ser(302). Furthermore, PKD phosphorylated Ser(302) selectively and to a similar extent in native cMyBP-C of skinned myocardium from WT and cTnI-Ala(2) mice, and this phosphorylation occurred throughout the C-zones of sarcomeric A-bands. In conclusion, PKD reduces myofilament Ca2+ sensitivity through cTnI phosphorylation at Ser(22)/Ser(23) but accelerates cross-bridge cycle kinetics by a distinct mechanism. PKD phosphorylates cMyBP-C at Ser(302), which may mediate the latter effect.	[Avkiran, Metin] St Thomas Hosp, Rayne Inst, Kings Coll London, Div Cardiovasc, London SE1 7EH, England; [Sadayappan, Sakthivel; Robbins, Jeffrey] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Walker, Jeffery W.] Univ Arizona, Mol Cardiovasc Res Program, Tucson, AZ 85724 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cincinnati Children's Hospital Medical Center; University of Arizona	Avkiran, M (corresponding author), St Thomas Hosp, Rayne Inst, Kings Coll London, Div Cardiovasc, London SE1 7EH, England.	metin.avkiran@kcl.ac.uk	Gautel, Mathias/AAB-9860-2019; Cuello, Friederike/A-9642-2016	Sadayappan, Sakthivel/0000-0003-2006-7678; Gautel, Mathias/0000-0003-4027-9803; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation [PG/07/056/23150]; King's British Heart Foundation Centre of Research Excellence; Medical Research Council [G0001112, G0600251] Funding Source: researchfish; MRC [G0001112, G0600251] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); King's British Heart Foundation Centre of Research Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Project Grant PG/07/056/23150 and in part by the King's British Heart Foundation Centre of Research Excellence.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GE Y, 2009, P NATL ACAD SCI US; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2007, J MOL CELL CARDIOL, V43, P686, DOI 10.1016/j.yjmcc.2007.09.013; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Herron TJ, 2001, CIRC RES, V89, P1184, DOI 10.1161/hh2401.101908; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; HOFMANN PA, 1994, CIRC RES, V74, P718, DOI 10.1161/01.RES.74.4.718; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kulikovskaya I, 2007, J GEN PHYSIOL, V129, P419, DOI 10.1085/jgp.200609714; McDonald KS, 1998, J PHYSIOL-LONDON, V511, P519, DOI 10.1111/j.1469-7793.1998.519bh.x; MESSERLI JM, 1993, HISTOCHEMISTRY, V100, P193, DOI 10.1007/BF00269092; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; SCHWINGER RHG, 1994, CIRC RES, V74, P959, DOI 10.1161/01.RES.74.5.959; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004	38	85	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5674	5682		10.1074/jbc.M109.066456	http://dx.doi.org/10.1074/jbc.M109.066456			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018870	Green Published, hybrid			2022-12-25	WOS:000275327200060
J	Pankiv, S; Lamark, T; Bruun, JA; Overvatn, A; Bjorkoy, G; Johansen, T				Pankiv, Serhiy; Lamark, Trond; Bruun, Jack-Ansgar; Overvatn, Aud; Bjorkoy, Geir; Johansen, Terje			Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-INDEPENDENT LIGAND; SIGNALING ADAPTER P62; A170 STRESS-PROTEIN; KAPPA-B ACTIVATION; BINDING-PROTEIN; LOCALIZATION SIGNALS; SELECTIVE AUTOPHAGY; EXPORT SIGNALS; KINASE-C; SUBCELLULAR-LOCALIZATION	p62, also known as sequestosome1 (SQSTM1), A170, or ZIP, is a multifunctional protein implicated in several signal transduction pathways. p62 is induced by various forms of cellular stress, is degraded by autophagy, and acts as a cargo receptor for autophagic degradation of ubiquitinated targets. It is also suggested to shuttle ubiquitinated proteins for proteasomal degradation. p62 is commonly found in cytosolic protein inclusions in patients with protein aggregopathies, it is up-regulated in several forms of human tumors, and mutations in the gene are linked to classical adult onset Paget disease of the bone. To this end, p62 has generally been considered to be a cytosolic protein, and little attention has been paid to possible nuclear roles of this protein. Here, we present evidence that p62 shuttles continuously between nuclear and cytosolic compartments at a high rate. The protein is also found in nuclear promyelocytic leukemia bodies. We show that p62 contains two nuclear localization signals and a nuclear export signal. Our data suggest that the nucleocytoplasmic shuttling of p62 is modulated by phosphorylations at or near the most important nuclear localization signal, NLS2. The aggregation of p62 in cytosolic bodies also regulates the transport of p62 between the compartments. We found p62 to be essential for accumulation of polyubiquitinated proteins in promyelocytic leukemia bodies upon inhibition of nuclear protein export. Furthermore, p62 contributed to the assembly of proteasome-containing degradative compartments in the vicinity of nuclear aggregates containing polyglutamine-expanded Ataxin1Q84 and to the degradation of Ataxin1Q84.	[Pankiv, Serhiy; Lamark, Trond; Bruun, Jack-Ansgar; Overvatn, Aud; Bjorkoy, Geir; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Bjorkoy, Geir] Univ Coll Sor Trondelag, Dept Biosci, N-7006 Trondheim, Norway	UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU)	Johansen, T (corresponding author), Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/AAY-1753-2021; Johansen, Terje/N-2971-2015	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Pankiv, Serhiy/0000-0001-7953-2445; Lamark, Trond/0000-0001-6338-3342; Bruun, Jack-Ansgar/0000-0003-0614-2790; Bjorkoy, Geir/0000-0003-0031-8361	Top Research Programme; Norwegian Research Council; Norwegian Cancer Society; Blix Foundation	Top Research Programme; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Blix Foundation	This work was supported in part by grants from the Top Research Programme and the FUGE Programme of the Norwegian Research Council, the Norwegian Cancer Society, and the Blix Foundation (to T. J.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen M, 2008, J CELL BIOL, V180, P697, DOI 10.1083/jcb.200708131; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hinton CV, 2007, EXP CELL RES, V313, P1735, DOI 10.1016/j.yexcr.2007.03.008; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nilsen T, 2007, J BIOL CHEM, V282, P26245, DOI 10.1074/jbc.M611234200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pikkarainen M, 2008, J NEUROPATH EXP NEUR, V67, P280, DOI 10.1097/NEN.0b013e31816a1da2; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sudo T, 2000, BIOCHEM BIOPH RES CO, V269, P521, DOI 10.1006/bbrc.2000.2333; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Thullberg M, 2000, ONCOGENE, V19, P2870, DOI 10.1038/sj.onc.1203579; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wooten MW, 2000, MOL CELL BIOL, V20, P4494, DOI 10.1128/MCB.20.13.4494-4504.2000; Yanagawa T, 1997, BIOCHEM BIOPH RES CO, V241, P157, DOI 10.1006/bbrc.1997.7783; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	66	170	177	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5941	5953		10.1074/jbc.M109.039925	http://dx.doi.org/10.1074/jbc.M109.039925			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018885	Green Published, hybrid			2022-12-25	WOS:000275327200084
J	Saxena, M; Abhyankar, M; Bastia, D				Saxena, Mukesh; Abhyankar, Mayuresh; Bastia, Deepak			Replication Initiation at a Distance DETERMINATION OF THE CIS- AND TRANS-ACTING ELEMENTS OF REPLICATION ORIGIN alpha OF PLASMID R6K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; R-PLASMID RSF1040; ESCHERICHIA-COLI; DNA-REPLICATION; IN-VIVO; PURIFIED PROTEINS; COPY NUMBER; R6K DNA; GAMMA; PRIMASE	Plasmid R6K, which contains 3 replication origins called alpha, gamma, and beta, is a favorable system to investigate the molecular mechanism(s) of action at a distance, i.e. replication initiation at a considerable distance from the primary initiator protein binding sites (iterons). The centrally located gamma origin contains 7 iterons that bind to the plasmid-encoded initiator protein, pi. Ori alpha, located at a distance of similar to 4 kb from gamma, contains a single iteron that does not directly bind to pi but is believed to access the protein by pi-mediated alpha-gamma iteron-iteron interaction that loops out the intervening similar to 3.7 kb of DNA. Although the cis-acting components and the trans-acting proteins required for ori gamma function have been analyzed in detail, such information was lacking for ori alpha. Here, we have identified both the sequence elements located at alpha and those at gamma, that together promoted alpha activity. The data support the conclusion that besides the single iteron, a neighboring DNA primase recognition element called G site is essential for alpha-directed plasmid maintenance. Sequences preceding the iteron and immediately following the G site, although not absolutely necessary, appear to play a role in efficient plasmid maintenance. In addition, while both dnaA1 and dnaA2 boxes that bind to DnaA protein and are located at gamma were essential for alpha activity, only dnaA2 was required for initiation at gamma. Mutations in the AT-rich region of gamma also abolished alpha function. These results are consistent with the interpretation that a protein-DNA complex consisting of pi and DnaA forms at gamma and activates alpha at a distance by DNA looping.	[Saxena, Mukesh; Abhyankar, Mayuresh; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Bastia, D (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	bastia@musc.edu			NIAID [RO1GM049264]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM049264 from the NIAID (to D. B.).	Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; Abhyankar MM, 2003, J BIOL CHEM, V278, P45476, DOI 10.1074/jbc.M308516200; Avila P, 1996, J MOL BIOL, V261, P135, DOI 10.1006/jmbi.1996.0447; BOUCHE JP, 1978, J BIOL CHEM, V253, P765; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; CROSA JH, 1978, J MOL BIOL, V124, P443, DOI 10.1016/0022-2836(78)90181-X; CROSA JH, 1980, J BIOL CHEM, V255, P1075; CROSA JH, 1976, J BACTERIOL, V126, P454, DOI 10.1128/JB.126.1.454-466.1976; Datta HJ, 1999, P NATL ACAD SCI USA, V96, P73, DOI 10.1073/pnas.96.1.73; de Laat W, 2007, CURR OPIN CELL BIOL, V19, P317, DOI 10.1016/j.ceb.2007.04.004; FILUTOWICZ M, 1988, NUCLEIC ACIDS RES, V16, P3829, DOI 10.1093/nar/16.9.3829; FLASHNER Y, 1990, P NATL ACAD SCI USA, V87, P9123, DOI 10.1073/pnas.87.23.9123; Flashner Y, 1996, MOL MICROBIOL, V19, P985, DOI 10.1046/j.1365-2958.1996.428960.x; GERMINO J, 1983, CELL, V34, P125, DOI 10.1016/0092-8674(83)90142-3; Gondor A, 2009, NAT REV GENET, V10, P269, DOI 10.1038/nrg2555; INUZUKA N, 1980, J BIOL CHEM, V255, P1071; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KELLEY WL, 1991, J BIOL CHEM, V266, P15924; KELLEY WL, 1992, NEW BIOL, V4, P569; KELLEY WL, 1992, P NATL ACAD SCI USA, V89, P5078, DOI 10.1073/pnas.89.11.5078; KOLTER R, 1978, PLASMID, V1, P571, DOI 10.1016/0147-619X(78)90014-8; Kornberg A., 1992, DNA REPLICATION; KUBOTA Y, 1993, GENE, V126, P9; LOBELL RB, 1991, J MOL BIOL, V218, P45, DOI 10.1016/0022-2836(91)90872-4; Loscha K, 2004, PROTEIN EXPRES PURIF, V33, P304, DOI 10.1016/j.pep.2003.10.001; LOVETT MA, 1975, P NATL ACAD SCI USA, V72, P2905, DOI 10.1073/pnas.72.8.2905; Lu YB, 1998, EMBO J, V17, P5192, DOI 10.1093/emboj/17.17.5192; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; MACALLISTER TW, 1991, J BIOL CHEM, V266, P16056; MASAI H, 1990, J BIOL CHEM, V265, P15124; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; NASH HA, 1987, J BACTERIOL, V169, P4124, DOI 10.1128/jb.169.9.4124-4127.1987; Nunez B, 1997, MOL MICROBIOL, V24, P1157, DOI 10.1046/j.1365-2958.1997.4111778.x; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; Park K, 2001, J MOL BIOL, V310, P69, DOI 10.1006/jmbi.2001.4741; Pritchard AE, 1996, J BIOL CHEM, V271, P10291, DOI 10.1074/jbc.271.17.10291; PTASHNE M, 2004, GENETIC SWITCH; ROWEN L, 1978, J BIOL CHEM, V253, P758; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; SHAFFERMAN A, 1987, MOL GEN GENET, V208, P263, DOI 10.1007/BF00330452; Sharma R, 2001, EMBO J, V20, P4577, DOI 10.1093/emboj/20.16.4577; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; SIMS J, 1980, P NATL ACAD SCI-BIOL, V77, P900, DOI 10.1073/pnas.77.2.900; STAYTON MM, 1983, J BIOL CHEM, V258, P3205; Swan MK, 2006, P NATL ACAD SCI USA, V103, P18481, DOI 10.1073/pnas.0609046103; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Zzaman S, 2004, J BIOL CHEM, V279, P17404, DOI 10.1074/jbc.M400021200	51	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5705	5712		10.1074/jbc.M109.067348	http://dx.doi.org/10.1074/jbc.M109.067348			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018882	Green Published, hybrid			2022-12-25	WOS:000275327200063
J	Suzuki, N; Yamamoto, K				Suzuki, Noriko; Yamamoto, Kazuo			Molecular Cloning of Pigeon UDP-galactose:beta-D-Galactoside alpha 1,4-Galactosyltransferase and UDP-galactose:beta-D-Galactoside beta 1,4-Galactosyltransferase, Two Novel Enzymes Catalyzing the Formation of Gal alpha 1-4Gal beta 1-4Gal beta 1-4GlcNAc Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED DOMAIN DATABASE; STRUCTURAL-ANALYSIS; OVIDUCAL MUCINS; EGG-WHITE; N-GLYCANS; CARBOHYDRATE CHAINS; UNFERTILIZED EGGS; FERTILIZED-EGGS; SHIGA TOXIN; GLYCOPROTEINS	We previously found that pigeon IgG possesses unique N-glycan structures that contain the Gal alpha 1-4Gal beta 1-4Gal beta 1-4GlcNAc sequence at their nonreducing termini. This sequence is most likely produced by putative alpha 1,4- and beta 1,4-galactosyltransferases (GalTs), which are responsible for the biosynthesis of the Gal alpha 1-4Gal and Gal beta 1-4Gal sequences on the N-glycans, respectively. Because no such glycan structures have been found in mammalian glycoproteins, the biosynthetic enzymes that produce these glycans are likely to have distinct substrate specificities from the known mammalian GalTs. To study these enzymes, we cloned the pigeon liver cDNAs encoding alpha 4GalT and beta 4GalT by expression cloning and characterized these enzymes using the recombinant proteins. The deduced amino acid sequence of pigeon alpha 4GalT has 58.2% identity to human beta 4GalT and 68.0 and 66.6% identity to putative alpha 4GalTs from chicken and zebra finch, respectively. Unlike human and putative chicken alpha 4GalTs, which possess globotriosylceramide synthase activity, pigeon alpha 4GalT preferred to catalyze formation of the Gal alpha 1-4Gal sequence on glycoproteins. In contrast, the sequence of pigeon beta 4GalT revealed a type II transmembrane protein consisting of 438 amino acid residues, with no significant homology to the glycosyltransferases so far identified from mammals and chicken. However, hypothetical proteins from zebra finch (78.8% identity), frogs (58.9-60.4%), zebrafish (37.1-43.0%), and spotted green pufferfish (43.3%) were similar to pigeon beta 4GalT, suggesting that the pigeon beta 4GalT gene was inherited from the common ancestors of these vertebrates. The sequence analysis revealed that pigeon beta 4GalT and its homologs form a new family of glycosyltransferases.	[Suzuki, Noriko; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	University of Tokyo	Suzuki, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	nrsuzuki@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [18770081]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 18770081 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Bouhours D, 2000, GLYCOBIOLOGY, V10, P857, DOI 10.1093/glycob/10.9.857; Brown S, 2008, NATURE, V453, P138, DOI 10.1038/453138a; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Coppin A, 2003, BIOCHIMIE, V85, P53, DOI 10.1016/S0300-9084(03)00021-X; Coppin A, 1999, EUR J BIOCHEM, V266, P94, DOI 10.1046/j.1432-1327.1999.00823.x; COSSEY A, 1979, EUR J BIOCHEM, V98, P53, DOI 10.1111/j.1432-1033.1979.tb13159.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Florea D, 2002, BIOCHIMIE, V84, P611, DOI 10.1016/S0300-9084(02)01432-3; Fujii Y, 2005, GLYCOBIOLOGY, V15, P1257, DOI 10.1093/glycob/cwj015; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GARRED O, 1995, J BIOL CHEM, V270, P10817; Guerardel Y, 2006, GLYCOBIOLOGY, V16, P244, DOI 10.1093/glycob/cwj062; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; INOUE S, 1989, J BIOL CHEM, V264, P18520; Iwamura K, 2003, J BIOL CHEM, V278, P44429, DOI 10.1074/jbc.M301609200; IWASAKI M, 1992, J BIOL CHEM, V267, P24287; IWASAKI M, 1984, BIOCHEMISTRY-US, V23, P305, DOI 10.1021/bi00297a020; Iwasaki M., 1985, GLYCOCONJUGATE J, V2, P209, DOI [10.1007/BF01049269, DOI 10.1007/BF01049269]; JOHNSON JR, 1994, AM J MED SCI, V307, P335, DOI 10.1097/00000441-199405000-00004; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; Khoo KH, 1997, MOL BIOCHEM PARASIT, V86, P237, DOI 10.1016/S0166-6851(97)00036-4; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Maes E, 1997, GLYCOCONJUGATE J, V14, P127, DOI 10.1023/A:1018577302255; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Moriguchi K, 2007, J BIOCHEM, V142, P213, DOI 10.1093/jb/mvm128; Mourad R, 2001, EUR J BIOCHEM, V268, P1990, DOI 10.1046/j.1432-1327.2001.02071.x; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SHIMAMURA M, 1983, BIOCHEMISTRY-US, V22, P959, DOI 10.1021/bi00273a039; Sibley CG, 1990, PHYLOGENY CLASSIFICA; SLOMIANY A, 1974, J BIOL CHEM, V249, P1225; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Suzuki N, 2006, BBA-GEN SUBJECTS, V1760, P538, DOI 10.1016/j.bbagen.2005.10.005; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Suzuki N, 2003, J BIOL CHEM, V278, P46293, DOI 10.1074/jbc.M307132200; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; Suzuki N, 2009, GLYCOBIOLOGY, V19, P693, DOI 10.1093/glycob/cwp025; Taguchi T, 1996, EUR J BIOCHEM, V238, P357, DOI 10.1111/j.1432-1033.1996.0357z.x; TAGUCHI T, 1993, J BIOL CHEM, V268, P2353; TAGUCHI T, 1994, J BIOL CHEM, V269, P8762; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650; [No title captured]; [No title captured]; [No title captured]	50	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5178	5187		10.1074/jbc.M109.018663	http://dx.doi.org/10.1074/jbc.M109.018663			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19959475	Green Published, hybrid			2022-12-25	WOS:000275327200010
J	Tsai, AC; Pan, SL; Sun, HL; Wang, CY; Peng, CY; Wang, SW; Chang, YL; Kuo, SC; Lee, KH; Teng, CM				Tsai, An-Chi; Pan, Shiow-Lin; Sun, Hui-Lung; Wang, Chih-Ya; Peng, Chieh-Yu; Wang, Shih-Wei; Chang, Ya-Ling; Kuo, Sheng-Chu; Lee, Kuo-Hsiung; Teng, Che-Ming			CHM-1, a New Vascular Targeting Agent, Induces Apoptosis of Human Umbilical Vein Endothelial Cells via p53-mediated Death Receptor 5 Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMITOTIC ANTITUMOR AGENTS; IN-VITRO; TUBULIN POLYMERIZATION; DISRUPTING AGENTS; GENE-EXPRESSION; GROWTH-FACTOR; DNA-DAMAGE; ANGIOGENESIS; ACTIVATION; CANCER	CHM-1 (2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone) has been identified as a potent antitumor agent in human hepatocellular carcinoma; however, its role in tumor angiogenesis is unclear. This study investigated the effects of CHM-1 and the mechanisms by which it exerts its antiangiogenic and vascular disrupting properties. Using a xenograft model antitumor assay, we found that CHM-1 significantly inhibits tumor growth and microvessel formation. Flow cytometry, immunofluorescence microscopy, and cell death enzyme-linked immunosorbent assay kit revealed that CHM-1 inhibits growth of human umbilical vein endothelial cells (HUVEC) by induction of apoptotic cell death in a concentration-dependent manner. CHM-1 also suppresses HUVEC migration and capillary-like tube formation. We were able to correlate CHM-1-induced apoptosis in HUVEC with the cleavage of procaspase-3, -7, and -8, as well as with the cleavage of poly(ADP-ribose) polymerase by Western blotting assay. Such sensitization was achieved through up-regulation of death receptor 5 (DR5) but not DR4 or Fas. CHM-1 was also capable of increasing the expression level of p53, and most importantly, the induction of DR5 by CHM-1 was abolished by p53 small interfering RNA. Taken together, the results of this study indicate that CHM-1 exhibits vascular targeting activity associated with the induction of DR5-mediated endothelial cell apoptosis through p53 up-regulation, which suggests its potential as an antivascular and antitumor therapeutic agent.	[Tsai, An-Chi; Pan, Shiow-Lin; Sun, Hui-Lung; Wang, Chih-Ya; Peng, Chieh-Yu; Wang, Shih-Wei; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Inst Pharmacol, Coll Med, Taipei 10051, Taiwan; [Pan, Shiow-Lin] Taipei Med Univ, Grad Inst Pharmacol, Taipei 10051, Taiwan; [Kuo, Sheng-Chu] China Med Univ, Grad Inst Pharmaceut Chem, Taichung 40402, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	National Taiwan University; Taipei Medical University; China Medical University Taiwan; University of North Carolina; University of North Carolina Chapel Hill	Pan, SL (corresponding author), Natl Taiwan Univ, Inst Pharmacol, Coll Med, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan.	psl0826@ms13.hinet.net; cmteng@ntu.edu.tw	Pan, Shiow-Lin/C-1372-2010; Wang, Shih-Wei/AAH-1967-2020	Wang, Shih-Wei/0000-0001-7522-6352; WANG, CHIH-YUAN/0000-0002-6742-3935; TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan [96-2628-B002-109-MY3, 96-2321-B-002-031-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Research Grants 96-2628-B002-109-MY3 and 96-2321-B-002-031-MY2.	Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Cao L, 2006, TRANSPL P, V38, P2207, DOI 10.1016/j.transproceed.2006.06.014; Chen TH, 2008, CLIN CANCER RES, V14, P4250, DOI 10.1158/1078-0432.CCR-07-4578; Chen YC, 2007, BIOCHEM PHARMACOL, V74, P10, DOI 10.1016/j.bcp.2007.03.015; Cooney MM, 2006, NAT CLIN PRACT ONCOL, V3, P682, DOI 10.1038/ncponc0663; Dimmeler S, 2000, CIRC RES, V87, P434; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Ferlin MG, 2005, J MED CHEM, V48, P3417, DOI 10.1021/jm049387x; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2008, J BIOL CHEM, V283, P30273, DOI 10.1074/jbc.M804196200; Hsu SC, 2009, J ORTHOP RES, V27, P1637, DOI 10.1002/jor.20937; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; KUO SC, 1993, J MED CHEM, V36, P1146, DOI 10.1021/jm00061a005; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; LI L, 1994, J MED CHEM, V37, P1126, DOI 10.1021/jm00034a010; Lippert JW, 2007, BIOORGAN MED CHEM, V15, P605, DOI 10.1016/j.bmc.2006.10.020; MacFarlane M, 2003, TOXICOL LETT, V139, P89, DOI 10.1016/S0378-4274(02)00422-8; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Meng FY, 2008, CANCER CHEMOTH PHARM, V61, P953, DOI 10.1007/s00280-007-0549-x; Pasquier E, 2004, MOL CANCER THER, V3, P1301; Peng CY, 2008, CANCER LETT, V263, P114, DOI 10.1016/j.canlet.2007.12.028; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Sakamaki K, 2004, CURR NEUROVASC RES, V1, P305, DOI 10.2174/1567202043362072; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Sheikh MS, 1998, CANCER RES, V58, P1593; SIEGEL RM, 2002, CURRENT PROTOCOLS CY; Taatjes DJ, 2008, HISTOCHEM CELL BIOL, V129, P33, DOI 10.1007/s00418-007-0356-9; Tas F, 2008, CANCER CHEMOTH PHARM, V61, P721, DOI 10.1007/s00280-007-0526-4; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang SW, 2008, MOL CANCER THER, V7, P350, DOI 10.1158/1535-7163.MCT-07-2000; Wang SW, 2007, CANCER LETT, V257, P87, DOI 10.1016/j.canlet.2007.07.002; Wu GS, 2000, ADV EXP MED BIOL, V465, P143; Xia Y, 1998, J MED CHEM, V41, P1155, DOI 10.1021/jm9707479; Xia Y, 2001, J MED CHEM, V44, P3932, DOI 10.1021/jm0101085	43	24	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5497	5506		10.1074/jbc.M109.036277	http://dx.doi.org/10.1074/jbc.M109.036277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007968	Green Published, hybrid			2022-12-25	WOS:000275327200043
J	Fujii, M; Kanematsu, T; Ishibashi, H; Fukami, K; Takenawa, T; Nakayama, KI; Moss, SJ; Nabekura, J; Hirata, M				Fujii, Makoto; Kanematsu, Takashi; Ishibashi, Hitoshi; Fukami, Kiyoko; Takenawa, Tadaomi; Nakayama, Keiichi I.; Moss, Stephen J.; Nabekura, Junichi; Hirata, Masato			Phospholipase C-related but Catalytically Inactive Protein Is Required for Insulin-induced Cell Surface Expression of gamma-Aminobutyric Acid Type A Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE BINDING-PROTEIN; INHIBITORY SYNAPTIC-TRANSMISSION; CLATHRIN AP2 ADAPTER; GABA(A) RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT BINDING; ANCHORING PROTEIN; BETA SUBUNITS; BREFELDIN-A; RAT-BRAIN	The gamma-aminobutyric acid type A (GABA(A)) receptors play a pivotal role in fast synaptic inhibition in the central nervous system. One of the key factors for determining synaptic strength is the number of receptors on the postsynaptic membrane, which is maintained by the balance between cell surface insertion and endocytosis of the receptors. In this study, we investigated whether phospholipase C-related but catalytically inactive protein (PRIP) is involved in insulin-induced GABA(A) receptor insertion. Insulin potentiated the GABA-induced Cl- current (I-GABA) by about 30% in wild-type neurons, but not in PRIP1 and PRIP2 double-knock-out (DKO) neurons, suggesting that PRIP is involved in insulin-induced potentiation. The phosphorylation level of the GABA(A) receptor beta-subunit was increased by about 30% in the wild-type neurons but not in the mutant neurons, which were similar to the changes observed in I-GABA. We also revealed that PRIP recruited active Akt to the GABA(A) receptors by forming a ternary complex under insulin stimulation. The disruption of the binding between PRIP and the GABA(A) receptor beta-subunit by PRIP interference peptide attenuated the insulin potentiation of I-GABA. Taken together, these results suggest that PRIP is involved in insulin-induced GABA(A) receptor insertion by recruiting active Akt to the receptor complex.	[Fujii, Makoto; Kanematsu, Takashi; Hirata, Masato] Kyushu Univ, Lab Mol & Cellular Biochem, Fac Dent Sci, Fukuoka 8128582, Japan; [Fujii, Makoto; Kanematsu, Takashi; Hirata, Masato] Kyushu Univ, Stn Collaborat Res, Fukuoka 8128582, Japan; [Ishibashi, Hitoshi; Nabekura, Junichi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo 1920392, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Kyushu University; Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo University of Pharmacy & Life Sciences; Kobe University; Kyushu University; Tufts University	Hirata, M (corresponding author), Kyushu Univ, Lab Mol & Cellular Biochem, Fac Dent Sci, Fukuoka 8128582, Japan.	hirata1@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute for Physiological Sciences; Japan Diabetes Foundation; Pharmacological Research Foundation, Tokyo; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Physiological Sciences(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Physiological Sciences (NIPS)); Japan Diabetes Foundation; Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. F., T. K., and M. H.), the Cooperative Study Program of the National Institute for Physiological Sciences (to T. K., J. N., and M. H.), the Japan Diabetes Foundation (to T. K.), and the Pharmacological Research Foundation, Tokyo (to T. K.).; Research Fellow supported by the Japan Society for the Promotion of Science.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chen GJ, 2006, J NEUROSCI, V26, P2513, DOI 10.1523/JNEUROSCI.4712-05.2006; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Coyle JE, 2003, NEUROSCIENTIST, V9, P205, DOI 10.1177/1073858403009003013; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fujii M, 2005, J BIOL CHEM, V280, P1156, DOI 10.1074/jbc.M412006200; Goto H, 2005, MOL CELL NEUROSCI, V30, P197, DOI 10.1016/j.mcn.2005.07.006; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kittler JT, 2008, P NATL ACAD SCI USA, V105, P3616, DOI 10.1073/pnas.0707920105; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Matsuda M, 1998, NEUROSCI LETT, V257, P97, DOI 10.1016/S0304-3940(98)00810-6; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Mielke JG, 2005, J NEUROCHEM, V92, P103, DOI 10.1111/j.1471-4159.2004.02841.x; Mizoguchi Y, 2003, J PHYSIOL-LONDON, V548, P703, DOI 10.1113/jphysiol.2003.038935; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Smith KR, 2008, NEUROPHARMACOLOGY, V55, P844, DOI 10.1016/j.neuropharm.2008.06.072; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Vetiska SM, 2007, NEUROPHARMACOLOGY, V52, P146, DOI 10.1016/j.neuropharm.2006.06.023; Vicini S, 2004, PHARMACOL THERAPEUT, V103, P109, DOI 10.1016/j.pharmthera.2004.06.001; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200	50	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4837	4846		10.1074/jbc.M109.070045	http://dx.doi.org/10.1074/jbc.M109.070045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996098	hybrid, Green Published			2022-12-25	WOS:000275274800062
J	Hou, ZJ; Cherian, C; Drews, J; Wu, JM; Matherly, LH				Hou, Zhanjun; Cherian, Christina; Drews, Joseph; Wu, Jianmei; Matherly, Larry H.			Identification of the Minimal Functional Unit of the Homo-oligomeric Human Reduced Folate Carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; NHAA NA+/H+ ANTIPORTER; MEMBRANE-TRANSPORT; ESCHERICHIA-COLI; OLIGOMERIC STRUCTURE; ACCESSIBILITY METHODS; CELLS; METHOTREXATE; COTRANSPORTER; LOCALIZATION	The reduced folate carrier (RFC) is the major transport system for folates in mammals. We previously demonstrated the existence of human RFC (hRFC) homo-oligomers and established the importance of these higher order structures to intracellular trafficking and carrier function. In this report, we examined the operational significance of hRFC oligomerization and the minimal functional unit for transport. In negative dominance experiments, multimeric transporters composed of different ratios of active (either wild type (WT) or cysteine-less (CLFL)) and inactive (either inherently inactive (Y281L and R373A) due to mutation, or resulting from inactivation of the Y126C mutant by (2-sulfonatoethyl) methanethiosulfonate (MTSES)) hRFC monomers were expressed in hRFC-null HeLa (R5) cells, and residual WT or CLFL activity was measured. In either case, residual transport activity with increasing levels of inactive mutant correlated linearly with the fraction of WT or CLFL hRFC in plasma membranes. When active covalent hRFC dimers, generated by fusing CLFL and Y126C monomers, were expressed in R5 cells and treated with MTSES, transport activity of the CLFL-CLFL dimer was unaffected, whereas Y126C-Y126C was potently (64%) inhibited; heterodimeric CLFL-Y126C and Y126C-CLFL were only partly (27 and 23%, respectively) inhibited by MTSES. In contrast to Y126C-Y126C, trans-stimulation of methotrexate uptake by intracellular folates for Y126C-CLFL and CLFL-Y126C was nominally affected by MTSES. Collectively, these results strongly support the notion that each hRFC monomer comprises a single translocation pathway for anionic folate substrates and functions independently of other monomers (i.e. despite an oligomeric structure, hRFC functions as a monomer).	[Hou, Zhanjun; Cherian, Christina; Drews, Joseph; Wu, Jianmei; Matherly, Larry H.] Wayne State Univ, Sch Med, Dev Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Grad Program Canc Biol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Matherly, LH (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	matherly@kci.wayne.edu	/S-1117-2019		National Institutes of Health, NCI [CA53535]; NATIONAL CANCER INSTITUTE [R01CA053535] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA53535.	Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bossi E, 2007, AM J PHYSIOL-CELL PH, V292, pC1379, DOI 10.1152/ajpcell.00473.2006; Cao W, 2003, BIOCHEM J, V374, P27, DOI 10.1042/BJ20030301; Drori S, 2000, EUR J BIOCHEM, V267, P690, DOI 10.1046/j.1432-1327.2000.01049.x; EMERICK MC, 1993, J BIOL CHEM, V268, P23455; FRY DW, 1982, J BIOL CHEM, V257, P1890; Geertsma ER, 2005, J MOL BIOL, V350, P102, DOI 10.1016/j.jmb.2005.04.047; GOLDMAN ID, 1971, BIOCHIM BIOPHYS ACTA, V233, P624, DOI 10.1016/0005-2736(71)90162-3; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Hou ZJ, 2006, J BIOL CHEM, V281, P33588, DOI 10.1074/jbc.M607049200; Hou ZJ, 2009, J BIOL CHEM, V284, P3285, DOI 10.1074/jbc.M807206200; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kitayama S, 1999, J BIOL CHEM, V274, P10731, DOI 10.1074/jbc.274.16.10731; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loo TW, 2005, J BIOENERG BIOMEMBR, V37, P501, DOI 10.1007/s10863-005-9499-3; LOO TW, 1994, J BIOL CHEM, V269, P28683; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly Larry H., 2004, Current Pharmacogenomics, V2, P287, DOI 10.2174/1570160043377547; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Stokstad ELR, 1990, FOLIC ACID METABOLIS, P1; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Wong SC, 1999, J BIOL CHEM, V274, P10388, DOI 10.1074/jbc.274.15.10388; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2003, ONCOGENE, V22, P7431, DOI 10.1038/sj.onc.1206946	42	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4732	4740		10.1074/jbc.M109.086033	http://dx.doi.org/10.1074/jbc.M109.086033			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018840	Green Published, hybrid			2022-12-25	WOS:000275274800051
J	Korsgren, C; Peters, LL; Lux, SE				Korsgren, Catherine; Peters, Luanne L.; Lux, Samuel E.			Protein 4.2 Binds to the Carboxyl-terminal EF-hands of Erythroid alpha-Spectrin in a Calcium- and Calmodulin-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; MEMBRANE SKELETON; HEREDITARY SPHEROCYTOSIS; CYTOPLASMIC DOMAIN; ANION TRANSPORT; BETA-SPECTRIN; ACTIN-BINDING; BAND-3; ANKYRIN; COMPLEX	Spectrin and protein 4.1 cross-link F-actin protofilaments into a network called the membrane skeleton. Actin and 4.1 bind to one end of beta-spectrin. The adjacent end of alpha-spectrin, called the EF-domain, is calmodulin-like, with calcium-dependent and calcium-independent EF-hands. It has no known function. However, the sph(1J)/sph(1J) mouse has very fragile red cells and lacks the last 13 amino acids in the EF-domain, suggesting the domain is critical for skeletal integrity. Using pulldown binding assays, we find the alpha-spectrin EF-domain either alone or incorporated into a mini-spectrin binds native and recombinant protein 4.2 at a previously identified region of 4.2 (G(3) peptide). Native 4.2 binds with an affinity comparable with other membrane skeletal interactions (K-d = 0.30 mu M). EF-domains bearing the sph(1J) mutation are inactive. Binding of protein 4.2 to band 3 (K-d = 0.45 mu M) does not interfere with the spectrin-4.2 interaction. Spectrin-4.2 binding is amplified by micromolar concentrations of Ca2+ (but not Mg2+) by three to five times. Calmodulin also binds to the EF-domain (K-d = 17 mu M), and Ca2+-calmodulin blocks Ca2+-dependent binding of protein 4.2 but not Ca2+-independent binding. The data suggest that protein 4.2 is located near protein 4.1 at the spectrin-actin junctions. Because proteins 4.1 and 4.2 also bind to band 3, the erythrocyte anion channel, we suggest that one or both of these proteins cause a portion of band 3 to localize near the spectrin-actin junctions and provide another point of attachment between the membrane skeleton and the lipid bilayer.	[Lux, Samuel E.] Harvard Univ, Dept Med, Childrens Hosp, Div Hematol Oncol,Sch Med, Boston, MA 02115 USA; [Korsgren, Catherine; Lux, Samuel E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Peters, Luanne L.; Lux, Samuel E.] Jackson Lab, Bar Harbor, ME 04609 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Jackson Laboratory	Lux, SE (corresponding author), Harvard Univ, Dept Med, Childrens Hosp, Div Hematol Oncol,Sch Med, HU260-1,300 Longwood Ave, Boston, MA 02115 USA.	lux@enders.tch.harvard.edu		Peters, Luanne/0000-0002-0784-0534	National Institutes of Health [RO1 HL081608, RO1 HL088468]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081608, R01HL088468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL081608 (to S. E. L.) and RO1 HL088468 (to L. L. P.).	An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; An XL, 1996, J BIOL CHEM, V271, P33187, DOI 10.1074/jbc.271.52.33187; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Begg GE, 2000, J BIOL CHEM, V275, P3279, DOI 10.1074/jbc.275.5.3279; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BERGLUND A, 1986, FEBS LETT, V201, P306, DOI 10.1016/0014-5793(86)80629-9; Bhattacharyya R, 1999, BIOCHEM J, V340, P505, DOI 10.1042/0264-6021:3400505; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; BURGER D, 1984, BIOCHEMISTRY-US, V23, P1966, DOI 10.1021/bi00304a013; BURNS NR, 1985, BIOCHEMISTRY-US, V24, P3070, DOI 10.1021/bi00333a040; Calderon-Salinas JV, 1999, HUM EXP TOXICOL, V18, P327, DOI 10.1191/096032799678840138; Cherry R J, 1981, Prog Clin Biol Res, V51, P59; COUSIN JL, 1979, J MEMBRANE BIOL, V46, P125, DOI 10.1007/BF01961377; Dahl KN, 2004, BLOOD, V103, P1131, DOI 10.1182/blood-2003-04-1331; Dahl KN, 2003, BLOOD, V101, P1194, DOI 10.1182/blood-2002-04-1187; DERICK LH, 1992, EUR J CELL BIOL, V57, P317; FERREIRA HG, 1976, NATURE, V259, P47, DOI 10.1038/259047a0; FRIEDRICHS B, 1989, EUR J CELL BIOL, V48, P121; FUNDER J, 1978, J GEN PHYSIOL, V71, P721, DOI 10.1085/jgp.71.6.721; Galluzzi L, 1999, BLOOD, V93, P2421, DOI 10.1182/blood.V93.7.2421; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; GHANEM A, 1990, BRIT J HAEMATOL, V75, P414, DOI 10.1111/j.1365-2141.1990.tb04357.x; GILLIGAN DM, 1993, SEMIN HEMATOL, V30, P74; Golan DE, 1996, BIOPHYS J, V70, P1534, DOI 10.1016/S0006-3495(96)79717-5; GRACE RF, 2009, NATHAN OSKIS HEMATOL, V1, P659; HALESTRAP AP, 1976, BIOCHEM J, V156, P193, DOI 10.1042/bj1560193; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HARGREAVES WR, 1980, J BIOL CHEM, V255, P1965; Harper SL, 2001, BIOCHEMISTRY-US, V40, P9935, DOI 10.1021/bi0107795; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HARRIS AS, 1989, J BIOL CHEM, V264, P17401; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; IDEGUCHI H, 1990, BRIT J HAEMATOL, V74, P347, DOI 10.1111/j.1365-2141.1990.tb02594.x; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; KORSGREN C, 1990, P NATL ACAD SCI USA, V87, P613, DOI 10.1073/pnas.87.2.613; KORSGREN C, 1988, J BIOL CHEM, V263, P10212; Li XL, 1996, J BIOL CHEM, V271, P15695, DOI 10.1074/jbc.271.26.15695; LINDBERG FP, 1994, J BIOL CHEM, V269, P1567; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; LUNDBERG S, 1992, BIOCHEMISTRY-US, V31, P5665, DOI 10.1021/bi00139a034; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1979, SEMIN HEMATOL, V16, P21; MACARA IG, 1981, BIOCHEMISTRY-US, V20, P5095, DOI 10.1021/bi00521a001; Mandal D, 2002, BIOCHEM J, V364, P841, DOI 10.1042/BJ20020195; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; OREAR EA, 1981, AM J HEMATOL, V11, P283, DOI 10.1002/ajh.2830110309; Pei XH, 2007, J BIOL CHEM, V282, P26754, DOI 10.1074/jbc.M701612200; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Peters LL, 1999, J CLIN INVEST, V103, P1527, DOI 10.1172/JCI5766; RISINGER MA, 1992, J BIOL CHEM, V267, P5680; RYBICKI AC, 1995, BLOOD, V86, P3583, DOI 10.1182/blood.V86.9.3583.bloodjournal8693583; SAHR KE, 1990, J BIOL CHEM, V265, P4434; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; SATO Y, 1986, BIOCHIM BIOPHYS ACTA, V856, P11, DOI 10.1016/0005-2736(86)90003-9; SAVVIDES P, 1993, BLOOD, V82, P2953; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SHIP S, 1977, J MEMBRANE BIOL, V33, P311, DOI 10.1007/BF01869522; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; SIMONS TJB, 1982, J MEMBRANE BIOL, V66, P235, DOI 10.1007/BF01868498; STROMQVIST M, 1988, BIOCHEMISTRY-US, V27, P1104, DOI 10.1021/bi00404a004; Su Y, 2006, MOL CELL BIOCHEM, V289, P159, DOI 10.1007/s11010-006-9159-x; Taylor AM, 1999, BIOCHEMISTRY-US, V38, P11172, DOI 10.1021/bi990618p; Toye AM, 2005, BLOOD, V105, P4088, DOI 10.1182/blood-2004-05-1895; TRAVE G, 1995, EMBO J, V14, P4922, DOI 10.1002/j.1460-2075.1995.tb00175.x; TRAVE G, 1995, EUR J BIOCHEM, V227, P35, DOI 10.1111/j.1432-1033.1995.tb20357.x; URSITTI JA, 1991, CELL MOTIL CYTOSKEL, V19, P227, DOI 10.1002/cm.970190402; Van Dort HM, 1998, J BIOL CHEM, V273, P14819, DOI 10.1074/jbc.273.24.14819; Wandersee NJ, 2003, BLOOD, V101, P325, DOI 10.1182/blood-2002-01-0113; WIETH JO, 1979, J PHYSIOL-LONDON, V294, P521, DOI 10.1113/jphysiol.1979.sp012944; WILEY JS, 1977, J CLIN INVEST, V59, P1113, DOI 10.1172/JCI108735; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; Workman RF, 1998, J BIOL CHEM, V273, P6171, DOI 10.1074/jbc.273.11.6171; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966	83	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4757	4770		10.1074/jbc.M109.056200	http://dx.doi.org/10.1074/jbc.M109.056200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007969	Green Published, hybrid			2022-12-25	WOS:000275274800054
J	Ogundare, M; Theofilopoulos, S; Lockhart, A; Hall, LJ; Arenas, E; Sjovall, J; Brenton, AG; Wang, YQ; Griffiths, WJ				Ogundare, Michael; Theofilopoulos, Spyridon; Lockhart, Andrew; Hall, Leslie J.; Arenas, Ernest; Sjovall, Jan; Brenton, A. Gareth; Wang, Yuqin; Griffiths, William J.			Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; CDNA CLONING; CHOLESTEROL HOMEOSTASIS; ELECTROSPRAY-IONIZATION; 7-ALPHA-HYDROXY-3-OXO-4-CHOLESTENOIC ACID; ALZHEIMERS-DISEASE; RAT-BRAIN; OXYSTEROLS; IDENTIFICATION; 24S-HYDROXYCHOLESTEROL	In this study we have profiled the free sterol content of cerebrospinal fluid by a combination of charge tagging and liquid chromatography-tandem mass spectrometry. Surprisingly, the most abundant cholesterol metabolites were found to be C-27 and C-24 intermediates of the bile acid biosynthetic pathways with structures corresponding to 7 alpha-hydroxy-3-oxocholest-4-en-26- oic acid (7.170 +/- 2.826 ng/ml, mean +/- S. D., six subjects), 3 beta-hydroxycholest-5-en-26-oic acid (0.416 +/- 0.193 ng/ml), 7 alpha,x-dihydroxy-3-oxocholest-4-en-26-oic acid (1.330 +/- 0.543 ng/ml), and 7 alpha-hydroxy-3-oxochol-4-en-24-oic acid (0.172 +/- k0.085 ng/ml), and the C-26 sterol 7 alpha-hydroxy-26-norcholest-4ene- 3,x-dione (0.204 +/- 0.083 ng/ml), where x is an oxygen atom either on the CD rings or more likely on the C-17 side chain. The ability of intermediates of the bile acid biosynthetic pathways to activate the liver X receptors (LXRs) and the farnesoid X receptor was also evaluated. The acidic cholesterol metabolites 3 beta-hydroxycholest-5-en-26-oic acid and 3 beta,7 alpha-dihydroxycholest-5- en-26-oic acid were found to activate LXR in a luciferase assay, but the major metabolite identified in this study, i.e. 7 alpha-hydroxy-3-oxocholest-4-en-26-oic acid, was not an LXR ligand. 7 alpha-Hydroxy-3-oxocholest-4-en-26-oic acid is formed from 3 beta,7 alpha-dihydroxycholest-5-en-26-oic acid in a reaction catalyzed by 3 beta-hydroxy-Delta(5)-C-27-steroid dehydrogenase (HSD3B7), which may thus represent a deactivation pathway of LXR ligands in brain. Significantly, LXR activation has been found to reduce the symptoms of Alzheimer disease (Fan, J., Donkin, J., and Wellington C. (2009) Biofactors 35, 239-248); thus, cholesterol metabolites may play an important role in the etiology of Alzheimer disease.	[Ogundare, Michael; Brenton, A. Gareth; Wang, Yuqin; Griffiths, William J.] Swansea Univ, Inst Mass Spectrometry, Sch Med, Swansea SA2 8PP, W Glam, Wales; [Theofilopoulos, Spyridon; Arenas, Ernest; Sjovall, Jan] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Lockhart, Andrew] Addenbrookes Hosp, GlaxoSmithKline R&D China, Cambridge CB2 2GG, England; [Hall, Leslie J.] GlaxoSmithKline, Strateg & External Alliances Genet, Res Triangle Pk, NC 27709 USA	Swansea University; Karolinska Institutet; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge; GlaxoSmithKline	Griffiths, WJ (corresponding author), Swansea Univ, Inst Mass Spectrometry, Sch Med, Grove Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	w.j.griffiths@swansea.ac.uk	Theofilopoulos, Spyridon/B-2075-2015; Arenas, Ernest/AAO-5231-2020; Theofilopoulos, Spyridon/E-1508-2011; Griffiths, William/N-4641-2016	Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Griffiths, William/0000-0002-4129-6616; wang, yuqin/0000-0002-3063-3066	United Kingdom Research Councils, Biotechnology and Biological Sciences Research Council [BBC5157712, BBC5113561]; Engineering and Physical Sciences Research Council [EP/F014341/1]; EPSRC [EP/F014341/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515771/2, BB/C511356/1] Funding Source: researchfish	United Kingdom Research Councils, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Research Councils, Biotechnology and Biological Sciences Research Council Grants BBC5157712 and BBC5113561, and Engineering and Physical Sciences Research Council Grant EP/F014341/1.	Alvelius G, 2001, J LIPID RES, V42, P1571; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AXELSON M, 1988, J LIPID RES, V29, P629; Baumgart E, 1996, P NATL ACAD SCI USA, V93, P13748, DOI 10.1073/pnas.93.24.13748; Berger J, 1998, FEBS LETT, V425, P305, DOI 10.1016/S0014-5793(98)00255-5; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Bjorkhem I, 2001, J BIOL CHEM, V276, P37004, DOI 10.1074/jbc.M103828200; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bun-ya M, 1998, J BIOCHEM-TOKYO, V123, P347; Cowan DA, 2008, STEROIDS, V73, P621, DOI 10.1016/j.steroids.2008.01.026; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Ebner MJ, 2006, ENDOCRINOLOGY, V147, P179, DOI 10.1210/en.2005-1065; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; Ferdinandusse S, 2009, J LIPID RES, V50, P2139, DOI 10.1194/jlr.R900009-JLR200; Fine JM, 2008, J CHEM ECOL, V34, P1259, DOI 10.1007/s10886-008-9535-y; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Furster C, 1996, J BIOL CHEM, V271, P20903, DOI 10.1074/jbc.271.34.20903; Gilardi F, 2009, NEUROSCIENCE, V164, P530, DOI 10.1016/j.neuroscience.2009.08.003; Griffiths WJ, 2008, J PROTEOME RES, V7, P3602, DOI 10.1021/pr8001639; Griffiths WJ, 2010, J LIPID RES, V51, P23, DOI 10.1194/jlr.R001941-JLR200; Griffiths WJ, 2009, J CHROMATOGR B, V877, P2778, DOI 10.1016/j.jchromb.2009.05.017; Griffiths WJ, 2006, J AM SOC MASS SPECTR, V17, P341, DOI 10.1016/j.jasms.2005.10.012; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Higashi T, 2007, CHEM PHARM BULL, V55, P662, DOI 10.1248/cpb.55.662; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ikeda H, 2003, LAB INVEST, V83, P349, DOI 10.1097/01.LAB.0000059933.35157.40; Itoh M, 2000, BRAIN RES, V858, P40, DOI 10.1016/S0006-8993(99)02423-3; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KARLAGANIS G, 1984, J LIPID RES, V25, P693; KARLAGANIS G, 1981, J STEROID BIOCHEM, V14, P341, DOI 10.1016/0022-4731(81)90152-7; Karu K, 2007, J LIPID RES, V48, P976, DOI 10.1194/jlr.M600497-JLR200; Kirk JM, 2006, RAPID COMMUN MASS SP, V20, P1247, DOI 10.1002/rcm.2442; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Leoni V, 2006, NEUROSCI LETT, V397, P83, DOI 10.1016/j.neulet.2005.11.046; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Leoni V, 2009, SCAND J CLIN LAB INV, V69, P22, DOI 10.1080/00365510802651858; LI WM, 1995, J GEN PHYSIOL, V105, P569, DOI 10.1085/jgp.105.5.569; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200; Liu SY, 2003, ANAL CHEM, V75, P5835, DOI 10.1021/ac0346297; Lutjohann D, 2006, ACTA NEUROL SCAND, V114, P33, DOI 10.1111/j.1600-0404.2006.00683.x; Lund E, 1996, ARTERIOSCL THROM VAS, V16, P208, DOI 10.1161/01.ATV.16.2.208; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mano N, 2004, J LIPID RES, V45, P1741, DOI 10.1194/jlr.M400157-JLR200; Mano N, 2004, J LIPID RES, V45, P295, DOI 10.1194/jlr.M300369-JLR200; Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200; Meng LJ, 1997, J LIPID RES, V38, P926; MICKAN H, 1972, STEROIDS, V19, P659, DOI 10.1016/S0039-128X(72)80031-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; NAGATA K, 1992, BIOCHIM BIOPHYS ACTA, V1126, P229; Nagata Kazuya, 1995, Neurologia Medico-Chirurgica, V35, P294, DOI 10.2176/nmc.35.294; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ruan BF, 2001, J LIPID RES, V42, P799; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Schonknecht P, 2002, NEUROSCI LETT, V324, P83, DOI 10.1016/S0304-3940(02)00164-7; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SEEDORF U, 1991, J BIOL CHEM, V266, P630; Shafaati M, 2009, BIOCHEM BIOPH RES CO, V378, P689, DOI 10.1016/j.bbrc.2008.11.103; Siciliano M, 1986, Quad Sclavo Diagn, V22, P355; Song C, 2000, ENDOCRINOLOGY, V141, P4180, DOI 10.1210/en.141.11.4180; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Wang YQ, 2008, J PROTEOME RES, V7, P1606, DOI 10.1021/pr7006076; Wang YQ, 2009, MOL BIOSYST, V5, P529, DOI 10.1039/b819502a; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Woo HK, 2009, RAPID COMMUN MASS SP, V23, P1849, DOI 10.1002/rcm.4076; Yang Y, 1997, BIOMED CHROMATOGR, V11, P240, DOI 10.1002/(SICI)1099-0801(199707)11:4<240::AID-BMC686>3.0.CO;2-6; YURI M, 1993, CHEM PHARM BULL, V41, P1327; Zhang J, 1997, BIOCHEM J, V322, P175, DOI 10.1042/bj3220175	77	87	90	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4666	4679		10.1074/jbc.M109.086678	http://dx.doi.org/10.1074/jbc.M109.086678			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996111	Green Published, hybrid			2022-12-25	WOS:000275274800045
J	Srikanth, S; Jung, HJ; Ribalet, B; Gwack, Y				Srikanth, Sonal; Jung, Hea-Jin; Ribalet, Bernard; Gwack, Yousang			The Intracellular Loop of Orai1 Plays a Central Role in Fast Inactivation of Ca2+ Release-activated Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; CRAC CHANNELS; CA(V)1.2 CHANNELS; CALCIUM-CHANNEL; PLASMA-MEMBRANE; STORE; STIM1; ENTRY; SENSOR; BLOCK	Store-operated Ca2+ entry (SOCE) due to activation of Ca2+ release-activated Ca2+ (CRAC) channels leads to sustained elevation of cytoplasmic Ca2+ and activation of lymphocytes. CRAC channels consisting of four pore-forming Orai1 subunits are activated by STIM1, an endoplasmic reticulum Ca2+ sensor that senses intracellular store depletion and migrates to plasma membrane proximal regions to mediate SOCE. One of the fundamental properties of CRAC channels is their Ca2+-dependent fast inactivation. To identify the domains of Orai1 involved in fast inactivation, we have mutated residues in the Orai1 intracellular loop linking transmembrane segment II to III. Mutation of four residues, (VSNV154)-S-151, at the center of the loop (MutA) abrogated fast inactivation, leading to increased SOCE as well as higher CRAC currents. Point mutation analysis identified five key amino acids, (NVHNL157)-V-153, that increased SOCE in Orai1 null murine embryonic fibroblasts. Expression or direct application of a peptide comprising the entire intracellular loop or the sequence (NVHNL157)-V-153 blocked CRAC currents from both wild type (WT) and MutA Orai1. A peptide incorporating the MutA mutations had no blocking effect. Concatenated Orai1 constructs with four MutA monomers exhibited high CRAC currents lacking fast inactivation. Reintroduction of a single WT monomer (MutA-MutA-MutA-WT) was sufficient to fully restore fast inactivation, suggesting that only a single intracellular loop can block the channel. These data suggest that the intracellular loop of Orai1 acts as an inactivation particle, which is stabilized in the ion permeation pathway by the (NVHNL157)-V-153 residues. These results along with recent reports support a model in which the N terminus and the selectivity filter of Orai1 as well as STIM1 act in concert to regulate the movement of the intracellular loop and evoke fast inactivation.	[Ribalet, Bernard] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Ribalet, Bernard] Univ Calif Los Angeles, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Ribalet, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 53-364 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	bribalet@mednet.ucla.edu; ygwack@mednet.ucla.edu			National Institutes of Health [AI083432]; Cancer Research Coordinating Committee (University of California); American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Coordinating Committee (University of California)(University of California System); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083432. This work was also supported by a grant from the Cancer Research Coordinating Committee (University of California) ( to Y.G.) and a fellowship from the American Heart Association ( to S. S.).	Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; Babich O, 2007, J GEN PHYSIOL, V129, P461, DOI 10.1085/jgp.200709733; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	46	63	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5066	5075		10.1074/jbc.M109.072736	http://dx.doi.org/10.1074/jbc.M109.072736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007711	Green Published, hybrid			2022-12-25	WOS:000275274800082
J	Takagi, S; Nakajima, M; Kida, K; Yamaura, Y; Fukami, T; Yokoi, T				Takagi, Shingo; Nakajima, Miki; Kida, Katsuhiko; Yamaura, Yu; Fukami, Tatsuki; Yokoi, Tsuyoshi			MicroRNAs Regulate Human Hepatocyte Nuclear Factor 4 alpha, Modulating the Expression of Metabolic Enzymes and Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACIDS; GENE-EXPRESSION; APOPTOSIS; LIVER; NUCLEAR-FACTOR-4-ALPHA; TRANSACTIVATION; TRANSCRIPTION; CHOLESTASIS; REPRESSION; PROMOTER	Hepatocyte nuclear factor (HNF) 4 alpha is a key transcription factor regulating endo/xenobiotic-metabolizing enzymes and transporters. We investigated whether microRNAs are involved in the regulation of human HNF4 alpha. Potential recognition elements for miR-24 (MRE24) were identified in the coding region and the 3'-untranslated region (3'-UTR), and those for miR-34a (MRE34a) were identified in the 3'-UTR in HNF4 alpha mRNA. The HNF4 alpha protein level in HepG2 cells was markedly decreased by the overexpression of miR-24 and miR-34a. The HNF4 alpha mRNA level was significantly decreased by the overexpression of miR-24 but not by miR-34a. In luciferase analyses in HEK293 cells, the reporter activity of plasmid containing the 3'-UTR of HNF4 alpha was significantly decreased by miR-34a. The reporter activity of plasmid containing the HNF4 alpha coding region downstream of the luciferase gene was significantly decreased by miR24. These results suggest that the MRE24 in the coding region and MRE34a in the 3'-UTR are functional in the negative regulation by mRNA degradation and translational repression, respectively. The down-regulation of HNF4 alpha by these microRNAs resulted in the decrease of various target genes such as cytochrome P450 7A1 and 8B1 as well as morphological changes and the decrease of the S phase population in HepG2 cells. We also clarified that the expressions of miR-24 and miR-34a were regulated by protein kinase C/mitogen-activated protein kinase and reactive oxygen species pathways, respectively. In conclusion, we found that human HNF4 alpha was down-regulated by miR-24 and miR-34a, the expression of which are regulated by cellular stress, affecting the metabolism and cellular biology.	[Takagi, Shingo; Nakajima, Miki; Kida, Katsuhiko; Yamaura, Yu; Fukami, Tatsuki; Yokoi, Tsuyoshi] Kanazawa Univ, Fac Pharmaceut Sci, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yokoi, T (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan.	tyokoi@kenroku.kanazawa-u.ac.jp	yokoi, tsuyoshi/I-7115-2014; Nakajima, Miki/C-3990-2015; Fukami, Tatsuki/C-8907-2015	Fukami, Tatsuki/0000-0003-2416-5988; Yokoi, Tsuyoshi/0000-0002-3239-2817	Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [21390174] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research (B) from the Japan Society for the Promotion of Science and in part by a Health and Labor Science Research Grant from the Ministry of Health, Labor and Welfare of Japan.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Day CP, 2002, GUT, V50, P585, DOI 10.1136/gut.50.5.585; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Geier A, 2005, HEPATOLOGY, V41, P470, DOI 10.1002/hep.20594; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kubitz R, 2004, J BIOL CHEM, V279, P10323, DOI 10.1074/jbc.M306242200; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Popowski K, 2005, MOL PHARMACOL, V67, P1629, DOI 10.1124/mol.104.010223; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Stanger BZ, 2008, DIABETES, V57, P1461, DOI 10.2337/db08-0454; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; YUE HY, 2009, GUT IN PRESS	34	127	135	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4415	4422		10.1074/jbc.M109.085431	http://dx.doi.org/10.1074/jbc.M109.085431			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018894	Green Published, hybrid			2022-12-25	WOS:000275274800018
J	van de Wijngaart, DJ; Molier, M; Lusher, SJ; Hersmus, R; Jenster, G; Trapman, J; Dubbink, HJ				van de Wijngaart, Dennis J.; Molier, Michel; Lusher, Scott J.; Hersmus, Remko; Jenster, Guido; Trapman, Jan; Dubbink, Hendrikus J.			Systematic Structure-Function Analysis of Androgen Receptor Leu(701) Mutants Explains the Properties of the Prostate Cancer Mutant L701H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; NUCLEAR RECEPTOR; GENE-MUTATIONS; THERAPEUTIC IMPLICATIONS; MOLECULAR-MECHANISMS; LXXLL MOTIFS; FXXLF; INSENSITIVITY; BICALUTAMIDE; RECOGNITION	One mechanism of prostate tumors for escape from androgen ablation therapies is mutation of the androgen receptor (AR). We investigated the unique properties of the ARL701H mutant, which is strongly stimulated by cortisol, by a systematic structure-function analysis. Most amino acid substitutions at position 701 did not affect AR activation by 5 alpha-dihydrotestosterone. Further analysis of the AR Leu(701) variants showed that AR L701M and AR L701Q, like AR L701H, had changed ligand responsiveness. AR L701M was strongly activated by progesterone but not by cortisol, whereas the opposite was observed for AR L701Q and AR L701H. Next, we analyzed a panel of structurally related steroids to study which of the OH groups at positions 11 beta, 17 alpha, and 21, which discriminate cortisol from progesterone, underlie the differential responses to both hormones. The results showed that the 17 alpha-OH group was essential for activation of AR L701H and AR L701Q, whereas its absence was important for activation of AR L701M. Modeling indicated a conserved H-bonding network involving the steroidal 17 alpha-OH group, His(701) or Gln(701), and the backbone of Ser(778). This network is absent in Leu701 and in other mutants. A hydrophobic leucine or methionine at position 701 is unfavorable for the 17 alpha-OH group. Our results indicate that the specific amino acid residue at position 701, its interaction with the backbone of Ser778, and the steroidal 17 alpha-hydroxyl group of the ligand are all important for the distinct transcriptional responses to progesterone and cortisol of AR mutants, including the prostate cancer mutant L701H.	[van de Wijngaart, Dennis J.; Molier, Michel; Hersmus, Remko; Trapman, Jan; Dubbink, Hendrikus J.] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, NL-3000 CA Rotterdam, Netherlands; [van de Wijngaart, Dennis J.; Jenster, Guido] Erasmus MC, Josephine Nefkens Inst, Dept Urol, NL-3000 CA Rotterdam, Netherlands; [Lusher, Scott J.] Schering Plough Corp, Mol Design & Informat, NL-5340 BH Oss, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Merck & Company	Dubbink, HJ (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	h.dubbink@erasmusmc.nl	Hersmus, Remko/AAE-9953-2019	Hersmus, Remko/0000-0001-5250-3572	Dutch Cancer Society [DDHK2001-2402]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by Grant DDHK2001-2402 from the Dutch Cancer Society.	Ahmed SF, 2000, J CLIN ENDOCR METAB, V85, P658, DOI 10.1210/jc.85.2.658; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Brinkmann AO, 2001, MOL CELL ENDOCRINOL, V179, P105, DOI 10.1016/S0303-7207(01)00466-X; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Buchanan G, 2001, CLIN CANCER RES, V7, P1273; Chavez B, 2001, CLIN GENET, V59, P185, DOI 10.1034/j.1399-0004.2001.590307.x; Dubbink HJ, 2006, MOL ENDOCRINOL, V20, P1742, DOI 10.1210/me.2005-0348; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Hara T, 2003, CANCER RES, V63, P149; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krishnan AV, 2002, ENDOCRINOLOGY, V143, P1889, DOI 10.1210/en.143.5.1889; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marcelli M, 2000, CANCER RES, V60, P944; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Matias PM, 2002, J MED CHEM, V45, P1439, DOI 10.1021/jm011072j; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Navone NM, 1997, CLIN CANCER RES, V3, P2493; Ozers MS, 2007, BIOCHEMISTRY-US, V46, P683, DOI 10.1021/bi061321b; Poujol N, 2000, J BIOL CHEM, V275, P24022, DOI 10.1074/jbc.M001999200; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Steketee K, 2002, EUR J BIOCHEM, V269, P5780, DOI 10.1046/j.1432-1033.2002.03276.x; SUZUKI H, 1993, J STEROID BIOCHEM, V46, P759, DOI 10.1016/0960-0760(93)90316-O; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Trapman J, 2001, EUR J CANCER, V37, pS119; van de Wijngaart DJ, 2006, J BIOL CHEM, V281, P19407, DOI 10.1074/jbc.M602567200; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Watanabe M, 1997, JPN J CLIN ONCOL, V27, P389, DOI 10.1093/jjco/27.6.389; Zhao XY, 1999, J UROLOGY, V162, P2192, DOI 10.1016/S0022-5347(05)68158-X; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	44	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5097	5105		10.1074/jbc.M109.039958	http://dx.doi.org/10.1074/jbc.M109.039958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007693	Green Published, hybrid			2022-12-25	WOS:000275274800085
J	Juranic, N; Atanasova, E; Filoteo, AG; Macura, S; Prendergast, FG; Penniston, JT; Strehler, EE				Juranic, Nenad; Atanasova, Elena; Filoteo, Adelaida G.; Macura, Slobodan; Prendergast, Franklyn G.; Penniston, John T.; Strehler, Emanuel E.			Calmodulin Wraps around Its Binding Domain in the Plasma Membrane Ca2+ Pump Anchored by a Novel 18-1 Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; TARGET RECOGNITION; PEPTIDE COMPLEX; MULTIDIMENSIONAL NMR; CRYSTAL-STRUCTURE; CALCIUM-BINDING; ISOFORM 4B; KINASE; ACTIVATION; PROTEINS	Using solution NMR spectroscopy, we obtained the structure of Ca2+-calmodulin (holoCaM) in complex with peptide C28 from the binding domain of the plasma membrane Ca2+-ATPase (PMCA) pump isoform 4b. This provides the first atomic resolution insight into the binding mode of holoCaM to the full-length binding domain of PMCA. Structural comparison of the previously determined holoCaM.C20 complex with this holoCaM.C28 complex supports the idea that the initial binding step is represented by (holoCaM.C20) and the final bound complex by (holoCaM.C28). This affirms the existing multi-step kinetic model of PMCA4b activation by CaM. The complex exhibits a new binding motif in which holoCaM is wrapped around helical C28 peptide using two anchoring residues from the peptide at relative positions 18 and 1. The anchors correspond to Phe-1110 and Trp-1093, respectively, in full-length PMCA4b, and the peptide and CaM are oriented in an anti-parallel manner. This is a greater sequence distance between anchors than in any of the known holoCaM complexes with a helical peptide. Analysis of the geometry of holoCaM-peptide binding for the cases where the target peptide adopts an alpha(D)-helix with its anchors buried in the main hydrophobic pockets of the two CaM lobes establishes that only relative sequential positions of 10, 14, 17, and 18 are allowed for the second anchor.	[Juranic, Nenad; Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Prendergast, Franklyn G.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Penniston, John T.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Mayo Clinic; Mayo Clinic; Harvard University; Massachusetts General Hospital	Juranic, N (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	juranic.nenad@mayo.edu			National Institutes of Health [NS51769]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769. Portions of this work have been presented in abstract form at the Keystone Conference on Frontiers of NMR in Biology, February 15-20, 2009 in Santa Fe, NM.	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BAX A, 1994, METHOD ENZYMOL, V239, P79; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; COX JA, 1985, J BIOL CHEM, V260, P2527; DEGRADO WF, 1985, J CELL BIOCHEM, V29, P83, DOI 10.1002/jcb.240290204; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; GUERINI D, 1984, J BIOL CHEM, V259, P5172; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KATAOKA M, 1991, BIOCHEMISTRY-US, V30, P6247, DOI 10.1021/bi00239a024; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Mirzoeva S, 1999, BIOCHEMISTRY-US, V38, P14117, DOI 10.1021/bi9950894; Mirzoeva S, 1999, BIOCHEMISTRY-US, V38, P3936, DOI 10.1021/bi9821263; Neal S, 2006, MAGN RESON CHEM, V44, pS158, DOI 10.1002/mrc.1832; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Permi P, 2000, J BIOMOL NMR, V17, P43, DOI 10.1023/A:1008372624615; Project E, 2006, BIOPHYS J, V90, P3842, DOI 10.1529/biophysj.105.077792; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Scheschonka A, 2008, J BIOL CHEM, V283, P5577, DOI 10.1074/jbc.M709505200; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Slaughter BD, 2007, BIOCHEMISTRY-US, V46, P4045, DOI 10.1021/bi602481u; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Sun HY, 2000, J BIOL CHEM, V275, P1731, DOI 10.1074/jbc.275.3.1731; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VERMA AK, 1988, J BIOL CHEM, V263, P14152; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682	45	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4015	4024		10.1074/jbc.M109.060491	http://dx.doi.org/10.1074/jbc.M109.060491			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996092	Green Published, hybrid			2022-12-25	WOS:000275254000055
J	Liu, YW; Huang, HD; Zhou, BO; Wang, SS; Hu, YX; Li, X; Liu, JP; Zang, JY; Niu, LW; Wu, JH; Zhou, JQ; Teng, MK; Shi, YY				Liu, Yiwei; Huang, Hongda; Zhou, Bo O.; Wang, Shan-Shan; Hu, Yingxia; Li, Xu; Liu, Jianping; Zang, Jianye; Niu, Liwen; Wu, Jihui; Zhou, Jin-Qiu; Teng, Maikun; Shi, Yunyu			Structural Analysis of Rtt106p Reveals a DNA Binding Role Required for Heterochromatin Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE CHAPERONE ACTIVITY; ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; MAMMALIAN-CELLS; CHROMATIN; PROTEIN; YEAST; FACT; INHERITANCE	Rtt106p is a Saccharomyces cerevisiae histone chaperone with roles in heterochromatin silencing and nucleosome assembly. The molecular mechanism by which Rtt106p engages in chromatin dynamics remains unclear. Here, we report the 2.5 angstrom crystal structure of the core domain of Rtt106p, which adopts an unusual "double pleckstrin homology" domain architecture that represents a novel structural mode for histone chaperones. A histone H3-H4-binding region and a novel double-stranded DNA-binding region have been identified. Mutagenesis studies reveal that the histone and DNA binding activities of Rtt106p are involved in Sir protein-mediated heterochromatin formation. Our results uncover the structural basis of the diverse functions of Rtt106p and provide new insights into its cellular roles.	[Niu, Liwen; Wu, Jihui; Teng, Maikun; Shi, Yunyu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Niu, Liwen; Wu, Jihui; Teng, Maikun; Shi, Yunyu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhou, Bo O.; Wang, Shan-Shan; Zhou, Jin-Qiu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Teng, MK (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	mkteng@ustc.edu.cn; yyshi@ustc.edu.cn	Zang, Jianye/E-5228-2013; Shi, Yunyu/B-3240-2009; Huang, Hongda/G-8962-2015	Shi, Yunyu/0000-0002-1348-4759; Li, Xu/0000-0001-5221-0817	Chinese National Fundamental Research Project [2006CB806500, 2006CB910200]; Chinese National Natural Science Foundation [30670426, 30830031]; National High-Tech RD Program [2006AA02A315, 2006AA02A318]; Chinese Academy of Sciences [KSCX2-YW-R-60]; Chinese Ministry of Education [20070358025]	Chinese National Fundamental Research Project; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High-Tech RD Program(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by Chinese National Fundamental Research Project Grants 2006CB806500 and 2006CB910200, Chinese National Natural Science Foundation Grants 30670426 and 30830031, National High-Tech R&D Program Grants 2006AA02A315 and 2006AA02A318, Chinese Academy of Sciences Grant KSCX2-YW-R-60, and Chinese Ministry of Education Grant 20070358025.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CY, 2005, NUCLEIC ACIDS RES, V33, P430, DOI 10.1093/nar/gki191; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; ISHIMI Y, 1984, EUR J BIOCHEM, V142, P431, DOI 10.1111/j.1432-1033.1984.tb08305.x; ISHIMI Y, 1983, J BIOCHEM-TOKYO, V94, P735, DOI 10.1093/oxfordjournals.jbchem.a134414; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Monson EK, 1997, P NATL ACAD SCI USA, V94, P13081, DOI 10.1073/pnas.94.24.13081; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Scholes DT, 2001, GENETICS, V159, P1449; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200	49	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4251	4262		10.1074/jbc.M109.055996	http://dx.doi.org/10.1074/jbc.M109.055996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007951	Green Published, hybrid			2022-12-25	WOS:000275254000077
J	Xie, JZ; Yin, HF; Nichols, TD; Yoder, JA; Horowitz, JM				Xie, Jianzhen; Yin, Haifeng; Nichols, Teresa D.; Yoder, Jeffrey A.; Horowitz, Jonathan M.			Sp2 Is a Maternally Inherited Transcription Factor Required for Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING-PROTEINS; SP-FAMILY MEMBERS; MICE LACKING; DNA-BINDING; SEGMENTATION GENE; LIMB OUTGROWTH; CELL-GROWTH; RB PROTEIN; WILD-TYPE; EXPRESSION	The Sp family of transcription factors is required for the expression of cell cycle- and developmentally regulated genes, and the deregulated expression of a handful of family members is associated with human tumorigenesis. Sp2 is a relatively poorly characterized member of the Sp family that, although widely expressed, exhibits little or no DNA binding or transcriptional activity in human and mouse cell lines. To begin to address the role(s) played by Sp2 in early metazoan development we have cloned and characterized Sp2 from zebrafish (Danio rerio). We report that 1) the intron/exon organization and amino acid sequence of zebrafish Sp2 is closely conserved with its mammalian orthologues, 2) zebrafish Sp2 weakly stimulates an Sp-dependent promoter in vitro and associates with the nuclear matrix in a DNA-independent fashion, 3) zebrafish Sp2 is inherited as a maternal transcript, is transcribed in zebrafish embryos and adult tissues, and is required for completion of gastrulation, and 4) zebrafish lines carrying transgenes regulated by the Sp2 promoter recapitulate patterns of endogenous Sp2 expression.	[Horowitz, Jonathan M.] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA; N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27606 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Horowitz, JM (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, 4700 Hillsborough St, Raleigh, NC 27606 USA.	jon_horowitz@ncsu.edu	Yin, Haifeng/E-8787-2012; Yoder, Jeffrey A./I-5329-2019	Yoder, Jeffrey A./0000-0002-6083-1311	National Institutes of Health [GM065405, CA105313]; Jimmy V-NCSU Cancer Therapeutics Training Program; NATIONAL CANCER INSTITUTE [R01CA105313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jimmy V-NCSU Cancer Therapeutics Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065405 and CA105313 (to J.M.H.). This work was also supported by the Jimmy V-NCSU Cancer Therapeutics Training Program.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; BRONNER G, 1994, NATURE, V369, P664, DOI 10.1038/369664a0; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; Griesel G, 2006, DEVELOPMENT, V133, P1779, DOI 10.1242/dev.02326; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Hertveldt V, 2008, DEV DYNAM, V237, P883, DOI 10.1002/dvdy.21355; Horsfield J, 2002, MECH DEVELOP, V115, P15, DOI 10.1016/S0925-4773(02)00094-1; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kawakami Y, 2004, DEVELOPMENT, V131, P4763, DOI 10.1242/dev.01331; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Moorefield KS, 2006, MOL BIOL CELL, V17, P1711, DOI 10.1091/mbc.E05-11-1063; Moorefield KS, 2004, J BIOL CHEM, V279, P13911, DOI 10.1074/jbc.M313589200; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Penberthy WT, 2004, DEV BIOL, V275, P225, DOI 10.1016/j.ydbio.2004.08.007; Phan D, 2004, CANCER RES, V64, P3072, DOI 10.1158/0008-5472.CAN-03-3730; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Prince VE, 1998, DEVELOPMENT, V125, P393; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHI YG, 1995, CHEM BIOL, V2, P83, DOI 10.1016/1074-5521(95)90280-5; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Sun ZH, 2006, DEV DYNAM, V235, P2999, DOI 10.1002/dvdy.20945; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tallafuss A, 2001, DEVELOPMENT, V128, P4021; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Treichel D, 2001, MECH DEVELOP, V101, P175, DOI 10.1016/S0925-4773(00)00544-X; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; van Loo PF, 2003, BLOOD, V102, P858, DOI 10.1182/blood-2002-06-1848; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; WIMMER EA, 1993, NATURE, V366, P690, DOI 10.1038/366690a0; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593	50	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4153	4164		10.1074/jbc.M109.078881	http://dx.doi.org/10.1074/jbc.M109.078881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959469	hybrid, Green Published			2022-12-25	WOS:000275254000067
J	Kumphune, S; Bassi, R; Jacquet, S; Sicard, P; Clark, JE; Verma, S; Avkiran, M; O'Keefe, SJ; Marber, MS				Kumphune, Sarawut; Bassi, Rekha; Jacquet, Sebastien; Sicard, Pierre; Clark, James E.; Verma, Sharwari; Avkiran, Metin; O'Keefe, Stephen J.; Marber, Michael S.			A Chemical Genetic Approach Reveals That p38 alpha MAPK Activation by Diphosphorylation Aggravates Myocardial Infarction and Is Prevented by the Direct Binding of SB203580	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; IN-VIVO; LOOP AUTOPHOSPHORYLATION; INDEPENDENT ACTIVATION; SUBSTRATE-SPECIFICITY; ISCHEMIA-REPERFUSION; PHOSPHORYLATION; INHIBITORS; MYOCYTES; INJURY	The use of nonselective pharmacological inhibitors has resulted in controversy regarding the mechanism and consequences of p38 activation during myocardial infarction. Classic p38 inhibitors such as SB203580 rely on a critical "gatekeeper" threonine residue for binding. We addressed these controversies by using mice in which the p38 alpha alleles were targeted to cause substitution of the gatekeeper residue and resistance to inhibition. In homozygous drug-resistant compared with wildtype hearts, SB203580 failed to inhibit the activating phosphorylation of p38 or to reduce the infarction caused by myocardial ischemia. However, BIRB796, a p38 inhibitor not reliant on the gatekeeper for binding, similarly reduced p38-activating phosphorylation and infarction in both wild-type and knock-in mice, thereby excluding a nonspecific inhibitor-dependent phenotype resulting from the targeting strategy. Furthermore, the activation during myocardial ischemia involved phosphorylation of both the threonine and tyrosine residues in the activation loop of p38 despite the phosphorylation of the threonine alone being sufficient to create the epitope for dual phosphospecific antibody binding. Finally, SB203580 failed to reduce infarction in heterozygous drug-resistant hearts, suggesting that near complete inhibition of p38 alpha kinase activity is necessary to elicit protection. These results indicate that, during myocardial ischemia, p38 alpha (i) is the dominant-active p38 isoform, (ii) contributes to infarction, (iii) is responsible for the cardioprotective effect of SB203580, and (iv) is activated by a mechanism consistent with autodiphosphorylation despite this necessitating the phosphorylation of a tyrosine residue by an archetypal serine/threonine kinase.	[Kumphune, Sarawut; Bassi, Rekha; Jacquet, Sebastien; Sicard, Pierre; Clark, James E.; Verma, Sharwari; Avkiran, Metin; Marber, Michael S.] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, Rayne Inst, London SE1 7EH, England; [Kumphune, Sarawut; Bassi, Rekha; Jacquet, Sebastien; Sicard, Pierre; Clark, James E.; Verma, Sharwari; Avkiran, Metin; Marber, Michael S.] St Thomas Hosp, London SE1 7EH, England; [O'Keefe, Stephen J.] Merck Res Labs, Dept Immunol, Rahway, NJ 07065 USA	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Merck & Company	Marber, MS (corresponding author), Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, Rayne Inst, London SE1 7EH, England.	mike.marber@kcl.ac.uk	Sicard, Pierre/N-7310-2018; Sicard, Pierre/B-1637-2010; marber, michael/AAW-7916-2021; Clark, James/H-7786-2019; Kumphune, Sarawut/AAH-9060-2019; KUMPHUNE, SARAWUT/AAA-9278-2021	Sicard, Pierre/0000-0001-5837-3916; Sicard, Pierre/0000-0001-8100-9792; KUMPHUNE, SARAWUT/0000-0003-4940-7103; Avkiran, Metin/0000-0003-2392-6343; Marber, Michael/0000-0002-3463-7128; Clark, James/0000-0001-7574-2162	Royal Thai Government scholarship and Medical Research Council [G0802033]; British Heart Foundation [07/073/23432]; MRC [G0802033] Funding Source: UKRI; Medical Research Council [G0802033] Funding Source: researchfish	Royal Thai Government scholarship and Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Royal Thai Government scholarship (to S. K.) and by Medical Research Council Project Grant G0802033 and British Heart Foundation Project Grant 07/073/23432.	Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Clark JE, 2007, PHARMACOL THERAPEUT, V116, P192, DOI 10.1016/j.pharmthera.2007.06.013; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Hart SL, 1997, GENE THER, V4, P1225, DOI 10.1038/sj.gt.3300513; Jacquet S, 2008, J BIOL CHEM, V283, P11964, DOI 10.1074/jbc.M707750200; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Otsu K, 2003, BIOCHEM BIOPH RES CO, V302, P56, DOI 10.1016/S0006-291X(03)00096-2; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Saurin AT, 2000, FASEB J, V14, P2237, DOI 10.1096/fj.99-0671com; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200	25	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2968	10.1074/jbc.M109.079228	http://dx.doi.org/10.1074/jbc.M109.079228			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996096	Green Published, hybrid			2022-12-25	WOS:000273829000011
J	Naresh, R; Song, Y; Hampson, DJ				Naresh, Ram; Song, Yong; Hampson, David J.			The Intestinal Spirochete Brachyspira pilosicoli Attaches to Cultured Caco-2 Cells and Induces Pathological Changes	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; SERPULINA-PILOSICOLI; EXPERIMENTAL-INFECTION; ESCHERICHIA-COLI; PREVALENCE; PORCINE; HUMANS; PIGS; PATHOGENICITY; ASSOCIATION	Background: Brachyspira pilosicoli is an anaerobic spirochete that has received relatively little study, partly due to its specialized culture requirements and slow growth. This bacterium colonizes the large intestine of various species, including humans; typically, a dense layer of spirochete cells may be found intimately attached by one cell end to the surface of colonic enterocytes. Colonized individuals may develop colitis, but the mechanisms involved are not understood. The current study aimed to develop an in vitro model to investigate this process. Methodology/Principal Findings: Four strains of B. pilosicoli were incubated at a high multiplicity of infection with monolayers of a human colonic adenocarcinoma cell line (Caco-2 cells). One strain isolated from a pig (95/1000) and one from a human (WesB) attached to the monolayers. Colonization increased with time, with the Caco-2 cell junctions being the initial targets of attachment. By electron microscopy, individual spirochete cells could be seen to have one cell end invaginated into the Caco-2 cell membranes, with the rest of the spirochete draped over the Caco-2 cell surface. After 6 h incubation, the monolayer was covered with a layer of spirochetes. Colonized monolayers demonstrated a time-dependent series of changes: staining with labelled phalloidin identified accumulation of actin at the cell junctions; ZO-1 staining revealed a loss of Caco-2 tight junction integrity; and Hoechst staining showed condensation and fragmentation of nuclear material consistent with apoptosis. Using quantitative reverse transcription PCR, the colonized monolayers demonstrated a significant up-regulation of interleukin-1 beta (IL-1 beta) and IL-8 expression. B. pilosicoli sonicates caused significant up-regulation of IL-1 beta, TNF-alpha, and IL-6, but culture supernatants and non-pathogenic Brachyspira innocens did not alter cytokine expression. Conclusions/Significance: The changes induced in the Caco-2 cells provide evidence that B. pilosicoli has pathogenic potential, and give insights into the likely in vivo pathogenesis.	[Naresh, Ram; Song, Yong; Hampson, David J.] Murdoch Univ, Anim Res Inst, Murdoch, WA 6150, Australia	Murdoch University	Naresh, R (corresponding author), Murdoch Univ, Anim Res Inst, Murdoch, WA 6150, Australia.	d.hampson@murdoch.edu.au	Hampson, David J/A-9464-2008; Song, Yong/C-2407-2013; Hampson, David/AAE-3666-2019	Hampson, David J/0000-0002-7729-0427; Song, Yong/0000-0002-8178-5641	Murdoch University; Australian Research Council; Novartis Animal Vaccines through Linkage [LP0348441]	Murdoch University; Australian Research Council(Australian Research Council); Novartis Animal Vaccines through Linkage	Ram Naresh was in receipt of a postgraduate scholarship from Murdoch University. This study was supported by the Australian Research Council and Novartis Animal Vaccines through Linkage grant number LP0348441. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Dassanayake RP, 2004, J MED MICROBIOL, V53, P319, DOI 10.1099/jmm.0.45549-0; Duhamel Gerald E., 2001, Animal Health Research Reviews, V2, P3; Goosney DL, 1999, EMERG INFECT DIS, V5, P216, DOI 10.3201/eid0502.990205; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hampson DJ, 2006, EMERG INFECT DIS, V12, P869, DOI 10.3201/eid1205.051180; HAMPSON DJ, 2006, DIS SWINE, P755; HARLAND WA, 1967, BRIT MED J, V3, P718, DOI 10.1136/bmj.3.5567.718; Hartland EL, 1998, FEMS MICROBIOL LETT, V165, P59, DOI 10.1111/j.1574-6968.1998.tb13127.x; HOVINDHOUGEN K, 1982, J CLIN MICROBIOL, V16, P1127, DOI 10.1128/JCM.16.6.1127-1136.1982; Jensen TK, 2000, VET PATHOL, V37, P22, DOI 10.1354/vp.37-1-22; KUNKLE RA, 1986, J CLIN MICROBIOL, V24, P669, DOI 10.1128/JCM.24.4.669-671.1986; LAW CLH, 1994, GENITOURIN MED, V70, P26; LEE JI, 1994, J MED MICROBIOL, V40, P365, DOI 10.1099/00222615-40-5-365; LEE JI, 1993, J CLIN MICROBIOL, V31, P16, DOI 10.1128/JCM.31.1.16-21.1993; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margawani KR, 2004, J MED MICROBIOL, V53, P325, DOI 10.1099/jmm.0.05415-0; MIKOSZA ASJ, 2001, ANIM HLTH RES REV, V2, P83; Muniappa N, 1996, VET PATHOL, V33, P542, DOI 10.1177/030098589603300509; Muniappa N, 1998, J SPIROCHETAL TICK B, V5, P44; Naresh R, 2010, MICROBIOL-SGM, V156, P191, DOI 10.1099/mic.0.030262-0; Nelson EJ, 2009, EMERG INFECT DIS, V15, P571, DOI 10.3201/eid1504.081214; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Obiso RJ, 1997, INFECT IMMUN, V65, P1431, DOI 10.1128/IAI.65.4.1431-1439.1997; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Sacco RE, 1997, INFECT IMMUN, V65, P5349, DOI 10.1128/IAI.65.12.5349-5353.1997; SARAK M, 2004, MICROBES INFECT, V6, P676; Song Y, 2009, VET MICROBIOL, V137, P129, DOI 10.1016/j.vetmic.2008.12.020; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Stephens C. P., 2001, Animal Health Research Reviews, V2, P83; TAYLOR DJ, 1980, VET REC, V106, P326, DOI 10.1136/vr.106.15.326; Thomson JR, 1997, INFECT IMMUN, V65, P3693, DOI 10.1128/IAI.65.9.3693-3700.1997; Trivett-Moore NL, 1998, J CLIN MICROBIOL, V36, P261, DOI 10.1128/JCM.36.1.261-265.1998; Trott Darren J., 2001, Animal Health Research Reviews, V2, P19; Trott DJ, 1997, J CLIN MICROBIOL, V35, P482, DOI 10.1128/JCM.35.2.482-485.1997; TROTT DJ, 1995, INFECT IMMUN, V63, P3705, DOI 10.1128/IAI.63.9.3705-3710.1995; Trott DJ, 1997, EPIDEMIOL INFECT, V119, P369, DOI 10.1017/S0950268897008194; Trott DJ, 1996, INFECT IMMUN, V64, P4648, DOI 10.1128/IAI.64.11.4648-4654.1996; Varon C, 2009, GUT, V58, P629, DOI 10.1136/gut.2007.144501; Vernal R, 2008, ARCH ORAL BIOL, V53, P910, DOI 10.1016/j.archoralbio.2008.04.004	42	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8352	10.1371/journal.pone.0008352	http://dx.doi.org/10.1371/journal.pone.0008352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020053	Green Published, gold			2022-12-25	WOS:000272834200016
J	Li, XF; Kinsey-Jones, JS; Cheng, YS; Knox, AMI; Lin, YS; Petrou, NA; Roseweir, A; Lightman, SL; Milligan, SR; Millar, RP; O'Byrne, KT				Li, Xiao-Feng; Kinsey-Jones, James S.; Cheng, Yewsong; Knox, Alice M. I.; Lin, Yuanshao; Petrou, Nikoletta A.; Roseweir, Antonia; Lightman, Stafford L.; Milligan, Stuart R.; Millar, Robert P.; O'Byrne, Kevin T.			Kisspeptin Signalling in the Hypothalamic Arcuate Nucleus Regulates GnRH Pulse Generator Frequency in the Rat	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MONKEY MACACA-MULATTA; PITUITARY-GONADAL AXIS; PULSATILE LH-RELEASE; LUTEINIZING-HORMONE; RHESUS-MONKEY; MEDIAN-EMINENCE; HYPOGONADOTROPIC HYPOGONADISM; OVARIECTOMIZED RATS; ELECTRICAL-ACTIVITY	Background: Kisspeptin and its G protein-coupled receptor (GPR) 54 are essential for activation of the hypothalamo-pituitary-gonadal axis. In the rat, the kisspeptin neurons critical for gonadotropin secretion are located in the hypothalamic arcuate (ARC) and anteroventral periventricular (AVPV) nuclei. As the ARC is known to be the site of the gonadotropin-releasing hormone (GnRH) pulse generator we explored whether kisspeptin-GPR54 signalling in the ARC regulates GnRH pulses. Methodology/Principal Findings: We examined the effects of kisspeptin-10 or a selective kisspeptin antagonist administration intra-ARC or intra-medial preoptic area (mPOA), (which includes the AVPV), on pulsatile luteinizing hormone (LH) secretion in the rat. Ovariectomized rats with subcutaneous 17 beta-estradiol capsules were chronically implanted with bilateral intra-ARC or intra-mPOA cannulae, or intra-cerebroventricular (icv) cannulae and intravenous catheters. Blood samples were collected every 5 min for 5-8 h for LH measurement. After 2 h of control blood sampling, kisspeptin-10 or kisspeptin antagonist was administered via pre-implanted cannulae. Intranuclear administration of kisspeptin-10 resulted in a dose-dependent increase in circulating levels of LH lasting approximately 1 h, before recovering to a normal pulsatile pattern of circulating LH. Both icv and intra-ARC administration of kisspeptin antagonist suppressed LH pulse frequency profoundly. However, intra-mPOA administration of kisspeptin antagonist did not affect pulsatile LH secretion. Conclusions/Significance: These data are the first to identify the arcuate nucleus as a key site for kisspeptin modulation of LH pulse frequency, supporting the notion that kisspeptin-GPR54 signalling in this region of the mediobasal hypothalamus is a critical neural component of the hypothalamic GnRH pulse generator.	[Li, Xiao-Feng; Kinsey-Jones, James S.; Cheng, Yewsong; Knox, Alice M. I.; Lin, Yuanshao; Petrou, Nikoletta A.; Milligan, Stuart R.; O'Byrne, Kevin T.] Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England; [Roseweir, Antonia; Millar, Robert P.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Lightman, Stafford L.] Univ Bristol, Henry Wellcome Lab Integrat Neurosci & Endocrinol, Bristol, Avon, England; [Millar, Robert P.] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa	University of London; King's College London; University of Edinburgh; University of Bristol; University of Cape Town	Li, XF (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England.	r.millar@hrsu.mrc.ac.uk	Millar, Robert P/A-4853-2012	Petrou, Nikoletta/0000-0001-6295-2451; Roseweir, Antonia K./0000-0001-6158-1564; Lightman, Stafford/0000-0002-8546-9646; Millar, Robert P/0000-0003-3606-2708	Wellcome Trust; Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council (BBSRC); Society for Reproduction and Fertility (UK); MRC [MC_EX_G0701682] Funding Source: UKRI; Medical Research Council [MC_EX_G0701682] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Society for Reproduction and Fertility (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust, Medical Research Council (MRC) and Biotechnology and Biological Sciences Research Council (BBSRC) UK. YSC is a Vacation Scholar funded by the Society for Reproduction and Fertility (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE CA, 1974, ENDOCRINOLOGY, V94, P730, DOI 10.1210/endo-94-3-730; CAGAMPANG FRA, 1991, J ENDOCRINOL, V129, P321, DOI 10.1677/joe.0.1290321; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Tassigny XD, 2008, ENDOCRINOLOGY, V149, P3926, DOI 10.1210/en.2007-1487; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; HALASZ B, 1965, ENDOCRINOLOGY, V77, P553, DOI 10.1210/endo-77-3-553; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Keen KL, 2008, ENDOCRINOLOGY, V149, P4151, DOI 10.1210/en.2008-0231; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kinsey-Jones JS, 2009, J NEUROENDOCRINOL, V21, P20, DOI 10.1111/j.1365-2826.2008.01807.x; Kinsey-Jones JS, 2008, ENDOCRINOLOGY, V149, P1004, DOI 10.1210/en.2007-1505; KIRILOV MJ, 2009, ANN M SOC NEUR CHIC; Maeda KI, 2007, REV ENDOCR METAB DIS, V8, P21, DOI 10.1007/s11154-007-9032-6; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; NISHIHARA M, 1994, NEUROENDOCRINOLOGY, V59, P513, DOI 10.1159/000126700; O'Byrne KT, 1994, METHODS NEUROSCIENCE, P100; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Patterson M, 2006, J NEUROENDOCRINOL, V18, P349, DOI 10.1111/j.1365-2826.2006.01420.x; PELLETIER G, 1975, CELL TISSUE RES, V156, P521; Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365; PLANT TM, 1978, ENDOCRINOLOGY, V102, P52, DOI 10.1210/endo-102-1-52; Plant TM, 2009, PEPTIDES, V30, P67, DOI 10.1016/j.peptides.2008.06.029; Pompolo S, 2006, ENDOCRINOLOGY, V147, P804, DOI 10.1210/en.2005-1123; Ramaswamy S, 2008, ENDOCRINOLOGY, V149, P4387, DOI 10.1210/en.2008-0438; RASMUSSEN DD, 1993, NEUROENDOCRINOLOGY, V58, P511, DOI 10.1159/000126584; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; SILVERMAN AJ, 1986, NEUROENDOCRINOLOGY, V44, P168, DOI 10.1159/000124641; Smith JT, 2006, REPRODUCTION, V131, P623, DOI 10.1530/rep.1.00368; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Suter KJ, 2000, ENDOCRINOLOGY, V141, P3731, DOI 10.1210/en.141.10.3731; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tenenbaum-Rakover Y, 2007, J CLIN ENDOCR METAB, V92, P1137, DOI 10.1210/jc.2006-2147; Terasawa E, 1999, J NEUROSCI, V19, P5898, DOI 10.1523/JNEUROSCI.19-14-05898.1999; Thompson JS, 2004, BIOL BLOOD MARROW TR, V10, P858, DOI 10.1016/j.bbmt.2004.09.006; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; Yamada S, 2007, ENDOCRINOLOGY, V148, P2226, DOI 10.1210/en.2006-1529	46	151	155	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8334	10.1371/journal.pone.0008334	http://dx.doi.org/10.1371/journal.pone.0008334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016824	Green Published, Green Submitted, gold			2022-12-25	WOS:000272834000020
J	Payne, RJH; Grierson, CS				Payne, Robert J. H.; Grierson, Claire Suzanne			A Theoretical Model for ROP Localisation by Auxin in Arabidopsis Root Hair Cells	PLOS ONE			English	Article							PLANAR POLARITY; ETHYLENE; GROWTH; BIOSYNTHESIS; TRANSPORT; MECHANISM; PATTERN; GTPASES; INITIATION; EPIDERMIS	Background: Local activation of Rho GTPases is important for many functions including cell polarity, morphology, movement, and growth. Although a number of molecules affecting Rho-of-Plants small GTPase (ROP) signalling are known, it remains unclear how ROP activity becomes spatially organised. Arabidopsis root hair cells produce patches of ROP at consistent and predictable subcellular locations, where root hair growth subsequently occurs. Methodology/Principal Findings: We present a mathematical model to show how interaction of the plant hormone auxin with ROPs could spontaneously lead to localised patches of active ROP via a Turing or Turing-like mechanism. Our results suggest that correct positioning of the ROP patch depends on the cell length, low diffusion of active ROP, a gradient in auxin concentration, and ROP levels. Our theory provides a unique explanation linking the molecular biology to the root hair phenotypes of multiple mutants and transgenic lines, including OX-ROP, CA-rop, aux1, axr3, tip1, eto1, etr1, and the triple mutant aux1 ein2 gnom(eb). Conclusions/Significance: We show how interactions between Rho GTPases (in this case ROPs) and regulatory molecules (in this case auxin) could produce characteristic subcellular patterning that subsequently affects cell shape. This has important implications for research on the morphogenesis of plants and other eukaryotes. Our results also illustrate how gradient-regulated Turing systems provide a particularly robust and flexible mechanism for pattern formation.	[Payne, Robert J. H.; Grierson, Claire Suzanne] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Payne, RJH (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	robert.payne@bristol.ac.uk; claire.grierson@bristol.ac.uk			Royal Society; Biotechnology and Biological Sciences Research Council [BB/F011709/1] Funding Source: researchfish; BBSRC [BB/F011709/1] Funding Source: UKRI	Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RJHP is funded by the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; Benson DL, 1998, J MATH BIOL, V37, P381, DOI 10.1007/s002850050135; Bouyer D, 2008, PLOS BIOL, V6, P1166, DOI 10.1371/journal.pbio.0060141; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Crampin E.J., 2001, Comments on Theoretical Biology, V6, P229; De Cnodder T, 2005, NEW PHYTOL, V168, P541, DOI 10.1111/j.1469-8137.2005.01540.x; Digiuni S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.54; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Ikeda Y, 2009, NAT CELL BIOL, V11, P731, DOI 10.1038/ncb1879; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jilkine A, 2007, B MATH BIOL, V69, P1943, DOI 10.1007/s11538-007-9200-6; Jones AR, 2009, NAT CELL BIOL, V11, P78, DOI 10.1038/ncb1815; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; LACALLI TC, 1988, DEVELOPMENT, V104, P105; Le J, 2001, PLANT PHYSIOL, V125, P519, DOI 10.1104/pp.125.2.519; LEAVITT RG, 2004, P BOSTON SOC NAT HIS, P274; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Maini PK, 2006, SCIENCE, V314, P1397, DOI 10.1126/science.1136396; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Masucci JD, 1996, PLANT CELL, V8, P1505, DOI 10.1105/tpc.8.9.1505; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; MURRAY JD, 1982, J THEOR BIOL, V98, P143, DOI 10.1016/0022-5193(82)90063-7; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Page KM, 2005, PHYSICA D, V202, P95, DOI 10.1016/j.physd.2005.01.022; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Passey S, 2004, BIOCHEM SOC T, V32, P1115, DOI 10.1042/BST0321115; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; Savage NS, 2008, PLOS BIOL, V6, P1899, DOI 10.1371/journal.pbio.0060235; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Singh SK, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-57; Sorek N, 2007, MOL CELL BIOL, V27, P2144, DOI 10.1128/MCB.02347-06; Strier DE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001053; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x; Yalovsky S, 2008, PLANT PHYSIOL, V147, P1527, DOI 10.1104/pp.108.122150; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005	51	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8337	10.1371/journal.pone.0008337	http://dx.doi.org/10.1371/journal.pone.0008337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016781	Green Published, Green Submitted, gold			2022-12-25	WOS:000272834000023
J	Gushiken, FC; Han, HJ; Pradhan, S; Langlois, KW; Alrehani, N; Cruz, MA; Rumbaut, RE; Vijayan, KV				Gushiken, Francisca C.; Han Hyojeong; Pradhan, Subhashree; Langlois, Kimberly W.; Alrehani, Nawaf; Cruz, Miguel A.; Rumbaut, Rolando E.; Vijayan, K. Vinod			The Catalytic Subunit of Protein Phosphatase 1 Gamma Regulates Thrombin-Induced Murine Platelet alpha(IIb)beta(3) Function	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INTEGRIN ALPHA(IIB)BETA(3); OKADAIC ACID; P-SELECTIN; ACTIVATION; PHOSPHORYLATION; AGGREGATION; SECRETION; MICE; INHIBITORS	Background: Hemostasis and thrombosis are regulated by agonist-induced activation of platelet integrin alpha(IIb)beta(3). Integrin activation, in turn is mediated by cellular signaling via protein kinases and protein phosphatases. Although the catalytic subunit of protein phosphatase 1 (PP1c) interacts with alpha(IIb)beta(3), the role of PP1c in platelet reactivity is unclear. Methodology/Principal Findings: Using c isoform of PP1c deficient mice (PP1c gamma(-/-)), we show that the platelets have moderately decreased soluble fibrinogen binding and aggregation to low concentrations of thrombin or protease-activated receptor 4 (PAR4)-activating peptide but not to adenosine diphosphate (ADP), collagen or collagen-related peptide (CRP). Thrombin-stimulated PP1c gamma(-/-) platelets showed decreased alpha(IIb)beta(3) activation despite comparable levels of alpha(IIb)beta(3), PAR3, PAR4 expression and normal granule secretion. Functions regulated by outside-in integrin alpha(IIb)beta(3) signaling like adhesion to immobilized fibrinogen and clot retraction were not altered in PP1c gamma(-/-) platelets. Thrombus formation induced by a light/dye injury in the cremaster muscle venules was significantly delayed in PP1c gamma(-/-) mice. Phosphorylation of glycogen synthase kinase (GSK3) beta-serine 9 that promotes platelet function, was reduced in thrombin-stimulated PP1c gamma(-/-) platelets by an AKT independent mechanism. Inhibition of GSK3 beta partially abolished the difference in fibrinogen binding between thrombin-stimulated wild type and PP1c gamma(-/-) platelets. Conclusions/Significance: These studies illustrate a role for PP1c gamma in maintaining GSK3 beta-serine9 phosphorylation downstream of thrombin signaling and promoting thrombus formation via fibrinogen binding and platelet aggregation.	[Gushiken, Francisca C.; Han Hyojeong; Pradhan, Subhashree; Alrehani, Nawaf; Cruz, Miguel A.; Rumbaut, Rolando E.; Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Langlois, Kimberly W.; Rumbaut, Rolando E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Gushiken, FC (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	vvijayan@bcm.tmc.edu		Rumbaut, Rolando/0000-0002-8486-1013	National Institutes of Health (NIH) [HL081613, HL079368, T-32HL072754]; American Heart Association (AHA) [09GRNT2260224, 060180N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, T32HL072754, R01HL079368] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health (NIH) HL081613 (K. V. V), HL079368 (R. E. R) and a Grant-In Aid 09GRNT2260224 from the American Heart Association (AHA) to K. V. V. F. C. G. is supported by the Scientist Development Grant 060180N from the AHA. S. P. was supported in part by NIH grant T-32HL072754. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bynagari YS, 2009, J BIOL CHEM, V284, P13413, DOI 10.1074/jbc.M808970200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Cohen PTW, 2002, J CELL SCI, V115, P241; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DE ML, 1991, J BIOL CHEM, V266, P23776; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; HIGASHIHARA M, 1992, FEBS LETT, V307, P206, DOI 10.1016/0014-5793(92)80768-C; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; LASNE D, 1995, THROMB HAEMOSTASIS, V74, P1323; LAU LF, 1994, BIOCHEM J, V303, P391, DOI 10.1042/bj3030391; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Li ZY, 2006, BLOOD, V107, P965, DOI 10.1182/blood-2005-03-1308; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2004, J BIOL CHEM, V279, P42469, DOI 10.1074/jbc.M401532200; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Rumbaut RE, 2004, MICROCIRCULATION, V11, P239, DOI 10.1080/10739680490425949; Satoh K, 1996, BIOCHEM BIOPH RES CO, V225, P1084, DOI 10.1006/bbrc.1996.1299; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Watanabe Y, 2001, BLOOD, V97, P3798, DOI 10.1182/blood.V97.12.3798; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8304	10.1371/journal.pone.0008304	http://dx.doi.org/10.1371/journal.pone.0008304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016849	Green Published, gold, Green Submitted			2022-12-25	WOS:000272833800006
J	Franklin, DC; Whelan, PI				Franklin, Donald C.; Whelan, Peter I.			Tropical Mosquito Assemblages Demonstrate 'Textbook' Annual Cycles	PLOS ONE			English	Article							COMMUNITY STRUCTURE; AUSTRALIA; CULICIDAE; ESTUARY; DIPTERA; SURVIVAL; DURATION; SEASON; DARWIN	Background: Annual biological rhythms are often depicted as predictably cyclic, but quantitative evaluations are few and rarely both cyclic and constant among years. In the monsoon tropics, the intense seasonality of rainfall frequently drives fluctuations in the populations of short-lived aquatic organisms. However, it is unclear how predictably assemblage composition will fluctuate because the intensity, onset and cessation of the wet season varies greatly among years. Methodology/Principal Findings: Adult mosquitoes were sampled using EVS suction traps baited with carbon dioxide around swamplands adjacent to the city of Darwin in northern Australia. Eleven sites were sampled weekly for five years, and one site weekly for 24 years, the sample of c. 1.4 million mosquitoes yielding 63 species. Mosquito abundance, species richness and diversity fluctuated seasonally, species richness being highly predictable. Ordination of assemblage composition demonstrated striking annual cycles that varied little from year to year. The mosquito assemblage was temporally structured by a succession of species peaks in abundance. Conclusion/Significance: Ordination provided strong visual representation of annual rhythms in assemblage composition and the means to evaluate variability among years. Because most mosquitoes breed in shallow freshwater which fluctuates with rainfall, we did not anticipate such repeatability; we conclude that mosquito assemblage composition appears adapted to predictable elements of the rainfall.	[Franklin, Donald C.] Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia; [Whelan, Peter I.] Ctr Dis Control, NT Dept Hlth & Families, Darwin, NT, Australia	Charles Darwin University	Franklin, DC (corresponding author), Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia.	don.franklin@cdu.edu.au	Franklin, Don/F-1171-2014	Franklin, Don/0000-0002-9813-0959	Australian Research Council [LP0667619]; government of the Northern Territory	Australian Research Council(Australian Research Council); government of the Northern Territory	The study was funded by an Australian Research Council grant (LP0667619) and the government of the Northern Territory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat, 2008, STUDENTS APPEAL RULI; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Bisevac L, 2009, J AM MOSQUITO CONTR, V25, P58, DOI 10.2987/08-5814.1; Bowman D. M. J. S., 2002, AUSTR GEOGRAPHICAL S, V40, P261, DOI DOI 10.1111/1467-8470.00179; Campos RE, 2006, MEM I OSWALDO CRUZ, V101, P47, DOI 10.1590/S0074-02762006000100009; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cook GD, 2001, INT J CLIMATOL, V21, P1723, DOI 10.1002/joc.704; Cuesta JA, 2006, HYDROBIOLOGIA, V557, P85, DOI 10.1007/s10750-005-1311-1; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; Heckman CW, 1997, GLOBAL ECOL BIOGEOGR, V6, P97, DOI 10.2307/2997567; Jacups SP, 2008, TROP MED INT HEALTH, V13, P943, DOI 10.1111/j.1365-3156.2008.02095.x; Jeffery JAL, 2005, AUST J ENTOMOL, V44, P226, DOI 10.1111/j.1440-6055.2005.00479.x; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Maes J, 2005, J APPL ICHTHYOL, V21, P86, DOI 10.1111/j.1439-0426.2004.00628.x; MCCOWN RL, 1981, AGR SYST, V7, P163, DOI 10.1016/0308-521X(81)90044-5; McCune B, 1999, MULTIVARIATE ANAL EC; McDonald N.S., 1991, MONSOONAL AUSTR, P19; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Monteiro LCC, 2007, NEOTROP ENTOMOL, V36, P966, DOI 10.1590/S1519-566X2007000600021; Morisette JT, 2009, FRONT ECOL ENVIRON, V7, P253, DOI 10.1890/070217; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Ruane AC, 2007, EARTH INTERACT, V11, DOI 10.1175/EI225.1; RUSSELL RC, 1986, AUST J ECOL, V11, P99, DOI 10.1111/j.1442-9993.1986.tb01381.x; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Tsou TS, 2002, ESTUARIES, V25, P1372, DOI 10.1007/BF02692231; White G.C., 1990, ANAL WILDLIFE RADIO; Winemiller Kirk O., 1996, P99, DOI 10.1016/B978-012178075-3/50006-4; Yang GJ, 2008, POPUL ECOL, V50, P293, DOI 10.1007/s10144-008-0082-8; Zhang SP, 2008, INT J CLIMATOL, V28, P1563, DOI 10.1002/joc.1659	33	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8296	10.1371/journal.pone.0008296	http://dx.doi.org/10.1371/journal.pone.0008296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011531	Green Published, gold			2022-12-25	WOS:000272830300044
J	Lin, YH; Chang, CC; Wong, CW; Teng, SC				Lin, Yi-Hsuan; Chang, Chia-Ching; Wong, Chui-Wei; Teng, Shu-Chun			Recruitment of Rad51 and Rad52 to Short Telomeres Triggers a Mec1-Mediated Hypersensitivity to Double-Stranded DNA Breaks in Senescent Budding Yeast	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; MAINTENANCE; PATHWAY; DYSFUNCTION; EFFICIENT; INVOLVEMENT; RESCUES; ARREST; REPAIR	Telomere maintenance is required for chromosome stability, and telomeres are typically replicated by the action of telomerase. In both mammalian tumor and yeast cells that lack telomerase, telomeres are maintained by an alternative recombination mechanism. Here we demonstrated that the budding yeast Saccharomyces cerevisiae type I survivors derived from telomerase-deficient cells were hypersensitive to DNA damaging agents. Assays to track telomere lengths and drug sensitivity of telomerase-deficient cells from spore colonies to survivors suggested a correlation between telomere shortening and bleomycin sensitivity. Our genetic studies demonstrated that this sensitivity depends on Mec1, which signals checkpoint activation, leading to prolonged cell-cycle arrest in senescent budding yeasts. Moreover, we also observed that when cells equipped with short telomeres, recruitments of homologous recombination proteins, Rad51 and Rad52, were reduced at an HO-endonuclease-catalyzed double-strand break (DSB), while their associations were increased at chromosome ends. These results suggested that the sensitive phenotype may be attributed to the sequestration of repair proteins to compromised telomeres, thus limiting the repair capacity at bona fide DSB sites.	[Lin, Yi-Hsuan; Chang, Chia-Ching; Wong, Chui-Wei; Teng, Shu-Chun] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan	National Taiwan University	Lin, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	shuchunteng@ntu.edu.tw		TENG, SHU-CHUN/0000-0002-6492-2560	National Science Council [NRPGM-98-3112-B-002-039]; National Health Research Institute of Taiwan [NHRI-EX98-9727BI]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the National Science Council (NRPGM-98-3112-B-002-039) and National Health Research Institute of Taiwan (NHRI-EX98-9727BI) to SCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; HAYFLICK L, 1974, J AM GERIATR SOC, V22, P1; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Huang CF, 2002, J CELL SCI, V115, P275; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; JPMA I, 2003, MOL BIOL CELL, V14, P987, DOI DOI 10.1091/MBC.02-04-0057; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lin CY, 2005, EUKARYOT CELL, V4, P327, DOI 10.1128/EC.4.2.327-336.2005; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Meyer DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003318; NAUK DA, 1971, SSSR, V201, P1496; Nautiyal S, 2002, P NATL ACAD SCI USA, V99, P9316, DOI 10.1073/pnas.142162499; Olovnikov A, 2005, ANN NY ACAD SCI, V1057, P112, DOI 10.1196/annals.1356.006; OLOVNIKOV AM, 1971, SOKL AN SSSR, V201, P1496; Pike BL, 2007, MOL CELL BIOL, V27, P6532, DOI 10.1128/MCB.00471-07; Rose MD., 1990, METHODS YEAST GENETI; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teng SC, 2002, BIOCHEM BIOPH RES CO, V291, P714, DOI 10.1006/bbrc.2002.6509; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(05)00094-8; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tsai HJ, 2006, J BIOL CHEM, V281, P13717, DOI 10.1074/jbc.M600649200; Tsai YL, 2002, MOL CELL BIOL, V22, P5679, DOI 10.1128/MCB.22.16.5679-5687.2002; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8224	10.1371/journal.pone.0008224	http://dx.doi.org/10.1371/journal.pone.0008224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011546	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300010
J	Sobrino, A; Mata, M; Laguna-Fernandez, A; Novella, S; Oviedo, PJ; Garcia-Perez, MA; Tarin, JJ; Cano, A; Hermenegildo, C				Sobrino, Agua; Mata, Manuel; Laguna-Fernandez, Andres; Novella, Susana; Oviedo, Pilar J.; Angel Garcia-Perez, Miguel; Tarin, Juan J.; Cano, Antonio; Hermenegildo, Carlos			Estradiol Stimulates Vasodilatory and Metabolic Pathways in Cultured Human Endothelial Cells	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; BREAST-CANCER CELLS; GENE-EXPRESSION; ASYMMETRIC DIMETHYLARGININE; HEART-DISEASE; REPLACEMENT; CYCLOOXYGENASES; INHIBITION; MECHANISMS; PREVENTION	Vascular effects of estradiol are being investigated because there are controversies among clinical and experimental studies. DNA microarrays were used to investigate global gene expression patterns in cultured human umbilical vein endothelial cells (HUVEC) exposed to 1 nmol/L estradiol for 24 hours. When compared to control, 187 genes were identified as differentially expressed with 1.9-fold change threshold. Supervised principal component analysis and hierarchical cluster analysis revealed the differences between control and estradiol-treated samples. Physiological concentrations of estradiol are sufficient to elicit significant changes in HUVEC gene expression. Notch signaling, actin cytoskeleton signaling, pentose phosphate pathway, axonal guidance signaling and integrin signaling were the top-five canonical pathways significantly regulated by estrogen. A total of 26 regulatory networks were identified as estrogen responsive. Microarray data were confirmed by quantitative RT-PCR in cardiovascular meaning genes; cyclooxigenase (COX) 1, dimethylarginine dimethylaminohydrolase (DDAH) 2, phospholipase A2 group IV (PLA2G4) B, and 7-dehydrocholesterol reductase were up-regulated by estradiol in a dose-dependent and estrogen receptor-dependent way, whereas COX2, DDAH1 and PLA2G4A remained unaltered. Moreover, estradiol-induced COX1 gene expression resulted in increased COX1 protein content and enhanced prostacyclin production. DDAH2 protein content was also increased, which in turn decreased asymmetric dimethylarginine concentration and increased NO release. All stimulated effects of estradiol on gene and protein expression were estrogen receptor-dependent, since were abolished in the presence of the estrogen receptor antagonist ICI 182780. This study identifies new vascular mechanisms of action by which estradiol may contribute to a wide range of biological processes.	[Sobrino, Agua; Laguna-Fernandez, Andres; Novella, Susana; Oviedo, Pilar J.; Angel Garcia-Perez, Miguel; Hermenegildo, Carlos] Univ Valencia, Res Fdn, Hosp Clin Univ, Valencia, Spain; [Mata, Manuel] Univ Valencia, Res Fdn, Hosp Gen Univ, Valencia, Spain; [Novella, Susana; Hermenegildo, Carlos] Univ Valencia, Dept Physiol, Valencia, Spain; [Tarin, Juan J.] Univ Valencia, Dept Funct Biol & Phys Anthropol, Valencia, Spain; [Cano, Antonio] Univ Valencia, Dept Pediat Obstet & Gynecol, Valencia, Spain	Hospital Clinic Universitari de Valencia; University of Valencia; Hospital Clinic Universitari de Valencia; University of Valencia; University of Valencia; University of Valencia; University of Valencia	Sobrino, A (corresponding author), Univ Valencia, Res Fdn, Hosp Clin Univ, Valencia, Spain.	carlos.hermenegildo@uv.es	Garcia Perez, Miguel Angel/S-8090-2018; Novella, Susana/A-7406-2017; Morcillo, Esteban/I-1552-2015; Fernandez, Andres Laguna/G-1262-2015; Roig, Manuel Mata/G-4338-2015; Hermenegildo, Carlos/C-5995-2008	Garcia Perez, Miguel Angel/0000-0002-0626-7502; Novella, Susana/0000-0001-8303-7252; Morcillo, Esteban/0000-0003-4373-9457; Fernandez, Andres Laguna/0000-0002-0066-7222; Roig, Manuel Mata/0000-0002-1506-7983; Tarin, Juan/0000-0002-4436-5162; Hermenegildo, Carlos/0000-0002-4015-2645	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Madrid, Spain [06/0589, RD06/0009/0005]; Conselleri-a de Educacion, Generalitat Valenciana, Spain [BFPI 06/145]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleri-a de Educacion, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants FIS 06/0589 and Red HERACLES RD06/0009/0005 from the Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Madrid, Spain. Pilar J Oviedo holds a post-doc position and Agua Sobrino is a fellowship recipient from the FPI program (BFPI 06/145), both from Conselleri-a de Educacion, Generalitat Valenciana, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archacki Stephen R., 2006, V129, P1; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Cid M C, 1999, Angiogenesis, V3, P271, DOI 10.1023/A:1009023329294; Djurovic S, 2000, J INTERN MED, V247, P279, DOI 10.1046/j.1365-2796.2000.00648.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farina MG, 2007, REPRODUCTION, V134, P355, DOI 10.1530/REP-07-0078; Forbes NS, 2006, METAB ENG, V8, P639, DOI 10.1016/j.ymben.2006.06.005; Gourdy P, 2007, ARTERIOSCL THROM VAS, V27, P2214, DOI 10.1161/ATVBAHA.107.150300; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Graham D, 2007, HYPERTENSION, V50, P1134, DOI 10.1161/HYPERTENSIONAHA.107.095349; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hermenegildo C, 2006, CURR PHARM DESIGN, V12, P205, DOI 10.2174/138161206775193136; Hermenegildo C, 2005, J PHARMACOL EXP THER, V315, P722, DOI 10.1124/jpet.105.090456; Hermenegildo C, 2002, AM J PHYSIOL-HEART C, V283, pH2644, DOI 10.1152/ajpheart.00369.2002; Hiltunen MO, 2002, ATHEROSCLEROSIS, V165, P23, DOI 10.1016/S0021-9150(02)00187-9; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jun SS, 1998, J CLIN INVEST, V102, P176, DOI 10.1172/JCI2034; KolfClauw M, 1996, TERATOLOGY, V54, P115, DOI 10.1002/(SICI)1096-9926(199609)54:3<115::AID-TERA1>3.0.CO;2-2; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E; Mendelsohn ME, 2000, J STEROID BIOCHEM, V74, P337, DOI 10.1016/S0960-0760(00)00110-2; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Monsalve E, 2007, CARDIOVASC RES, V73, P66, DOI 10.1016/j.cardiores.2006.09.020; Oviedo PJ, 2007, FERTIL STERIL, V88, P326, DOI 10.1016/j.fertnstert.2006.11.185; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rupnow HL, 2002, BIOL REPROD, V66, P468, DOI 10.1095/biolreprod66.2.468; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Soares Raquel, 2003, Angiogenesis, V6, P271, DOI 10.1023/B:AGEN.0000029413.32882.dd; Stevenson JC, 2007, MATURITAS, V57, P31, DOI 10.1016/j.maturitas.2007.02.007; THOMAS M, 1990, CANCER RES, V50, P1195; Toth B, 2009, ACTA HISTOCHEM, V111, P508, DOI 10.1016/j.acthis.2008.05.006; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wagner AH, 2001, FASEB J, V15, P2121, DOI 10.1096/fj.01-0123com; Witsch-Baumgartner M, 2001, HUM MUTAT, V17, P172, DOI 10.1002/humu.2	45	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8242	10.1371/journal.pone.0008242	http://dx.doi.org/10.1371/journal.pone.0008242			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011585	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300016
J	Crameri, G; Todd, S; Grimley, S; McEachern, JA; Marsh, GA; Smith, C; Tachedjian, M; De Jong, C; Virtue, ER; Yu, M; Bulach, D; Liu, JP; Michalski, WP; Middleton, D; Field, HE; Wang, LF				Crameri, Gary; Todd, Shawn; Grimley, Samantha; McEachern, Jennifer A.; Marsh, Glenn A.; Smith, Craig; Tachedjian, Mary; De Jong, Carol; Virtue, Elena R.; Yu, Meng; Bulach, Dieter; Liu, Jun-Ping; Michalski, Wojtek P.; Middleton, Deborah; Field, Hume E.; Wang, Lin-Fa			Establishment, Immortalisation and Characterisation of Pteropid Bat Cell Lines	PLOS ONE			English	Article							HUMAN TELOMERASE; HUMAN-FIBROBLASTS; GENE-TRANSFER; NIPAH VIRUS; FRUIT BATS; T-ANTIGENS; SIMIAN-VIRUS-40; TRANSFORMATION; MORBILLIVIRUS; TRANSMISSION	Background: Bats are the suspected natural reservoir hosts for a number of new and emerging zoonotic viruses including Nipah virus, Hendra virus, severe acute respiratory syndrome coronavirus and Ebola virus. Since the discovery of SARS-like coronaviruses in Chinese horseshoe bats, attempts to isolate a SL-CoV from bats have failed and attempts to isolate other bat-borne viruses in various mammalian cell lines have been similarly unsuccessful. New stable bat cell lines are needed to help with these investigations and as tools to assist in the study of bat immunology and virus-host interactions. Methodology/Findings: Black flying foxes (Pteropus alecto) were captured from the wild and transported live to the laboratory for primary cell culture preparation using a variety of different methods and culture media. Primary cells were successfully cultured from 20 different organs. Cell immortalisation can occur spontaneously, however we used a retroviral system to immortalise cells via the transfer and stable production of the Simian virus 40 Large T antigen and the human telomerase reverse transcriptase protein. Initial infection experiments with both cloned and uncloned cell lines using Hendra and Nipah viruses demonstrated varying degrees of infection efficiency between the different cell lines, although it was possible to infect cells in all tissue types. Conclusions/Significance: The approaches developed and optimised in this study should be applicable to bats of other species. We are in the process of generating further cell lines from a number of different bat species using the methodology established in this study.	[Crameri, Gary; Todd, Shawn; Grimley, Samantha; McEachern, Jennifer A.; Marsh, Glenn A.; Tachedjian, Mary; Yu, Meng; Bulach, Dieter; Michalski, Wojtek P.; Middleton, Deborah; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Crameri, Gary; McEachern, Jennifer A.; Smith, Craig; Tachedjian, Mary; De Jong, Carol; Virtue, Elena R.; Yu, Meng; Bulach, Dieter; Field, Hume E.; Wang, Lin-Fa] Australian Biosecur Cooperat Res Ctr Emerging Inf, Brisbane, Qld, Australia; [Grimley, Samantha; Michalski, Wojtek P.] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3004, Australia; [Smith, Craig; De Jong, Carol; Field, Hume E.] Queensland Primary Ind & Fisheries, Brisbane, Qld, Australia; [Virtue, Elena R.; Wang, Lin-Fa] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Liu, Jun-Ping] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; University of Melbourne; Monash University	Crameri, G (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	linfa.wang@csiro.au	Crameri, Gary/H-8441-2013; Marsh, Glenn A/A-5418-2013; Barr, Jennifer A/H-9254-2013; Bulach, Dieter M/D-5793-2011; Michalski, Wojtek/H-3544-2013; wang, lin/GSE-3040-2022; Tachedjian, Mary/H-4572-2013	Marsh, Glenn A/0000-0002-3469-1837; Bulach, Dieter M/0000-0001-9823-6078; Barr, Jennifer/0000-0001-5266-9142; Wang, Lin-Fa/0000-0003-2752-0535; Liu, Jun-Ping/0000-0001-7442-2116; Tachedjian, Mary/0000-0002-8936-6564	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases; Commonwealth Science and Industry Research Organisation (CSIRO) Chief Executive Officer (CEO) Science Leader Award	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Commonwealth Science and Industry Research Organisation (CSIRO) Chief Executive Officer (CEO) Science Leader Award(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The work conducted in this study is funded in part by grants from the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases (to H. F. and L.-F.W.) and the Commonwealth Science and Industry Research Organisation (CSIRO) Chief Executive Officer (CEO) Science Leader Award (to L.-F.W.). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bossart KN, 2008, VIROLOGY, V372, P357, DOI 10.1016/j.virol.2007.11.011; Buser R, 2006, J CELL BIOCHEM, V98, P267, DOI 10.1002/jcb.20715; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; FRESHNEY IR, 2005, TRANSFORMATION IMMOR, P291; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; He YL, 2009, THERIOGENOLOGY, V71, P1417, DOI 10.1016/j.theriogenology.2009.01.012; Julius MA, 2000, BIOTECHNIQUES, V28, P702, DOI 10.2144/00284st06; KASAHARA S, 1983, ANN GENET-PARIS, V26, P197; Kwak S, 2006, ANIM BIOTECHNOL, V17, P51, DOI 10.1080/10495390500461070; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; LECHARDEUR D, 1995, EXP CELL RES, V220, P161, DOI 10.1006/excr.1995.1302; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Meyerson M, 1998, TOXICOL LETT, V103, P41, DOI 10.1016/S0378-4274(98)00278-1; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Namba M, 1996, CRIT REV ONCOGENESIS, V7, P19, DOI 10.1615/CritRevOncog.v7.i1-2.20; SCOTT DM, 1986, EXP CELL RES, V166, P391, DOI 10.1016/0014-4827(86)90485-4; Soloff MS, 2004, MOL HUM REPROD, V10, P685, DOI 10.1093/molehr/gah086; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Stacey G, 2001, CELL BIOL TOXICOL, V17, P231, DOI 10.1023/A:1012525014791; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Takeuchi O, 2004, J ENDOTOXIN RES, V10, P252, DOI 10.1179/096805104225005896; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x	32	110	119	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8266	10.1371/journal.pone.0008266	http://dx.doi.org/10.1371/journal.pone.0008266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011515	gold, Green Published, Green Accepted			2022-12-25	WOS:000272830200010
J	Nasby-Lucas, N; Dewar, H; Lam, CH; Goldman, KJ; Domeier, ML				Nasby-Lucas, Nicole; Dewar, Heidi; Lam, Chi H.; Goldman, Kenneth J.; Domeier, Michael L.			White Shark Offshore Habitat: A Behavioral and Environmental Characterization of the Eastern Pacific Shared Offshore Foraging Area	PLOS ONE			English	Article							SOUTH-FARALLON-ISLANDS; TUNA THUNNUS-OBESUS; CARCHARODON-CARCHARIAS; BLUEFIN TUNA; VERTICAL MOVEMENTS; SWIMMING BEHAVIOR; TEMPERATURE; PERFORMANCE; MIGRATION; TRACKING	Background: Although much is known about the behavior of white sharks in coastal regions, very little is known about their vertical movements offshore in the eastern Pacific where they spend up to five months. We provide the first detailed description of the offshore habitat use of white sharks in the eastern North Pacific. Methodology/Principal Findings: This study uses 2-min data from four recovered pop-up satellite archival tags deployed at Guadalupe Island (2002 and 2005). Deployments ranged from 5.4 to 8.2 months. Two predominant vertical patterns were described. The first was a bimodal vertical pattern with time spent at the surface and at depth, which was observed while traveling. The second was a repetitive oscillatory diving mode displayed by sharks in the Shared Offshore Foraging Area (SOFA). For all four datasets the average maximum daily dive depths ranged from 442.5 to 492.8 m and were typically associated with dissolved oxygen concentrations of above 1.7 ml L-1. Although infrequent, occasional dives to near 1000 m with a minimum temperature of 3.9 degrees C and a minimum O-2 level of 0.3 ml L-1 were observed. Conclusions/Significance: Recovered pop-up satellite tags from Guadalupe Island white sharks advance our understanding of the vertical habitat use of white sharks while offshore. The bimodal vertical pattern during traveling is most likely related to geolocation. The oscillatory dive pattern is likely associated with foraging. While feeding is not documented, foraging is likely occurring in association with the deep scattering layer. Diving depths were not limited by temperature but were constrained by O-2 levels below approximately 1.5 ml L-1. While oxygen may limit the extent of sharks' vertical movements, it will also impact prey distribution. Consequently, the shallow oxygen minimum zone in the SOFA may act to concentrate prey, thus enhancing foraging opportunities in these oligotrophic waters.	[Nasby-Lucas, Nicole; Domeier, Michael L.] Marine Conservat Sci Inst, Fallbrook, CA USA; [Dewar, Heidi] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA; [Lam, Chi H.] Univ So Calif, Los Angeles, CA USA; [Goldman, Kenneth J.] Alaska Dept Fish & Game, Homer, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Southern California; Alaska Department of Fish & Game	Nasby-Lucas, N (corresponding author), Marine Conservat Sci Inst, Fallbrook, CA USA.	nicole@marinecsi.org			George T. Pfleger foundation; Offield family Foundation	George T. Pfleger foundation; Offield family Foundation	This work was funded by the George T. Pfleger foundation and the Offield family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P109; Anderson SD, 2003, CALIF FISH GAME, V89, P96; [Anonymous], 2004, MARINE FISHERIES REV; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bernal D, 2003, J EXP BIOL, V206, P2831, DOI 10.1242/jeb.00481; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; BLOCK BA, 1985, J COMP PHYSIOL B, V156, P229, DOI 10.1007/BF00695777; Block BA, 1997, MAR BIOL, V130, P119, DOI 10.1007/s002270050231; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; BRILL RW, 2001, TUNA PHYSL ECOLOGY E, P00079; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Carey F.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P92; CAREY FG, 1981, FISH B-NOAA, V79, P277; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; CAREY FG, 1982, COPEIA, P254; Compagno LJV., 1984, FAO FISH SYNOP, P20; Deutschlander ME, 1999, J EXP BIOL, V202, P891; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Dickson KA, 1996, COMP BIOCHEM PHYS A, V113, P39, DOI 10.1016/0300-9629(95)02056-X; DICKSON RR, 1972, J CONSEIL, V34, P416; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Domeier ML, 2005, FISH B-NOAA, V103, P292; Emery S.H., 1985, Memoirs of the Southern California Academy of Sciences, V9, P73; EMERY SH, 1986, COPEIA, P700, DOI 10.2307/1444952; Ferreira CA, 1996, GREAT WHITE SHARKS, P381, DOI 10.1016/B978-012415031-7/50036-7; Garcia-Castellano JM, 2005, EJC SUPPL, V3, P63; Gilly WF, 2006, MAR ECOL PROG SER, V324, P1, DOI 10.3354/meps324001; Goldman KJ, 2004, ENVIRON BIOL FISH, V71, P403, DOI 10.1007/s10641-004-6588-9; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Graham J.B., 1983, P248; Hanamoto E., 1987, B JPN SOC FISH OCEAN, V51, P203; HOLLAND KN, 1990, FISH B-NOAA, V88, P493; HOLLAND KN, 1992, NATURE, V358, P410, DOI 10.1038/358410a0; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Linkowski TB, 1996, MAR BIOL, V124, P495, DOI 10.1007/BF00351031; Lowe TE, 2000, MAR BIOL, V136, P1087, DOI 10.1007/s002270000255; Matciak M., 1997, OCEANOLOGICAL STUDIE, V26, P3540; MCCOSKER JE, 1987, COPEIA, P195; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; MUSYL MK, 2004, PFRP NEWSLETTER  OCT, P1; NEILL W H, 1976, Environmental Biology of Fishes, V1, P61, DOI 10.1007/BF00761729; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Okamoto Hiroaki, 2003, Inter-American Tropical Tuna Commission Bulletin, V22, P221; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Strong WR, 1996, GREAT WHITE SHARKS, P229, DOI 10.1016/B978-012415031-7/50022-7; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; TONT SA, 1976, REP CALIF COOP OCEAN, V18, P112; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; WEIHS D, 1973, J MAR RES, V31, P194; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003	68	61	62	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8163	10.1371/journal.pone.0008163	http://dx.doi.org/10.1371/journal.pone.0008163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011032	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829800002
J	Weber, AL; Zhao, Q; McMullen, MD; Doebley, JF				Weber, Allison L.; Zhao, Qiong; McMullen, Michael D.; Doebley, John F.			Using Association Mapping in Teosinte to Investigate the Function of Maize Selection-Candidate Genes	PLOS ONE			English	Article							MAYS SSP PARVIGLUMIS; ARTIFICIAL SELECTION; CROP IMPROVEMENT; DOMESTICATION; ARCHITECTURE; ARABIDOPSIS; EXPRESSION; EVOLUTION; PLANT; INHIBITION	Background: Large-scale screens of the maize genome identified 48 genes that show the putative signature of artificial selection during maize domestication or improvement. These selection-candidate genes may act as quantitative trait loci (QTL) that control the phenotypic differences between maize and its progenitor, teosinte. The selection-candidate genes appear to be located closer in the genome to domestication QTL than expected by chance. Methods and Findings: As a step toward defining the traits controlled by these genes, we performed phenotype-genotype association mapping in teosinte for 32 of the 48 plus three other selection-candidate genes. Our analyses assayed 32 phenotypic traits, many of which were altered during maize domestication or improvement. We observed several significant associations between SNPs in the selection-candidate genes and trait variation in teosinte. These included two associations that surpassed the Bonferroni correction and five instances where a gene significantly associated with the same trait in both of our association mapping panels. Despite these significant associations, when compared as a group the selection-candidate genes performed no better than randomly chosen genes. Conclusions: Our results suggest association analyses can be helpful for identifying traits under the control of selection-candidate genes. Indeed, we present evidence for new functions for several selection-candidate genes. However, with the current set of selection-candidate genes and our association mapping strategy, we found very few significant associations overall and no more than we would have found with randomly chosen genes. We discuss possible reasons that a large number of significant genotype-phenotype associations were not discovered.	[Weber, Allison L.; Zhao, Qiong; Doebley, John F.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [McMullen, Michael D.] Univ Missouri, Plant Genet Res Unit, ARS, USDA, Columbia, MO USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Weber, AL (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	alweber@ncsu.edu			National Science Foundation [DBI-0321467]; National Institutes of Health [GM-58816]; US Department of Agriculture [WIS04772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058816] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation (www.nsf.gov) grant DBI-0321467, National Institutes of Health (www.nih.gov) grant GM-58816, and US Department of Agriculture (www.usda.gov) Hatch grant WIS04772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; HUDSON RR, 1987, GENETICS, V116, P153; Hufford KM, 2007, PLANT PHYSIOL, V144, P1642, DOI 10.1104/pp.107.098988; KING RW, 1973, PLANT PHYSIOL, V51, P727, DOI 10.1104/pp.51.4.727; LANG A, 1977, P NATL ACAD SCI USA, V74, P2412, DOI 10.1073/pnas.74.6.2412; LEDGER SE, 1994, PLANT MOL BIOL, V25, P877, DOI 10.1007/BF00028882; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; RISCH N, 1996, SCIENCE, V273, P1517; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; TAJIMA F, 1983, GENETICS, V105, P437; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Weber AL, 2008, GENETICS, V180, P1221, DOI 10.1534/genetics.108.090134; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wirdnam C, 2004, PLANT MOL BIOL, V56, P717, DOI 10.1007/s11103-004-4679-9; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; YAMASAKI M, 2008, PLANT GENOME, V1; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHANG H, 1992, PLANT CELL, V4, P1575, DOI 10.1105/tpc.4.12.1575; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	32	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8227	10.1371/journal.pone.0008227	http://dx.doi.org/10.1371/journal.pone.0008227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011044	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829800015
J	Perron, JC; Dodd, J				Perron, Jeanette C.; Dodd, Jane			ActRIIA and BMPRII Type II BMP Receptor Subunits Selectively Required for Smad4-Independent BMP7-Evoked Chemotaxis	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; GROWTH-FACTOR-BETA; ACTIN CYTOSKELETON REORGANIZATION; MESSENGER-RNA EXPRESSION; GUIDANCE MOLECULE RGMA; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; DORSAL SPINAL-CORD; TGF-BETA; SIGNALING PATHWAYS	Bone morphogenetic protein (BMP)-evoked reorientation and chemotaxis of cells occurs with rapid onset and involves events local to the cell membrane. The signaling pathways underlying these rapid processes likely diverge from those mediating classical transcriptional responses to BMPs but it remains unclear how BMP receptors are utilized to generate distinct intracellular mechanisms. We show that BMP7-evoked chemotaxis of monocytic cells depends on the activity of canonical type II BMP receptors. Although the three canonical type II BMP receptors are expressed in monocytic cells, inhibition of receptor subunit expression by RNAi reveals that ActRIIA and BMPRII, but not ActRIIB, are each essential for BMP7-evoked chemotaxis but not required individually for BMP-mediated induction. Furthermore, the chemotactic response to BMP7 does not involve canonical Smad4-dependent signaling but acts through PI3K-dependent signaling, illustrating selective activation of distinct intracellular events through differential engagement of receptors. We suggest a model of a BMP receptor complex in which the coordinated activity of ActRIIA and BMPRII receptor subunits selectively mediates the chemotactic response to BMP7.	[Perron, Jeanette C.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA; Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University	Perron, JC (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.	jd18@columbia.edu		Perron, Jeanette C./0000-0002-6942-6320	National Institutes of Health (NIH) [NS 27113]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027113] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by National Institutes of Health (NIH) NS 27113 to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740; DAVID L, 2006, BLOOD; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dupont J, 2003, BIOL REPROD, V68, P1877, DOI 10.1095/biolreprod.102.012005; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Lee DH, 2006, TISSUE ENG, V12, P1577, DOI 10.1089/ten.2006.12.1577; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Liu J, 2003, DEV BIOL, V256, P34, DOI 10.1016/S0012-1606(02)00115-X; Machida H, 2000, EUR J ENDOCRINOL, V143, P705, DOI 10.1530/eje.0.1430705; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Newfeld SJ, 1999, GENETICS, V152, P783; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POSTLETHWAITE AE, 1994, J CELL PHYSIOL, V161, P562, DOI 10.1002/jcp.1041610320; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sanchez-Camacho C, 2005, BRAIN RES REV, V49, P242, DOI 10.1016/j.brainresrev.2004.10.004; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shah PK, 2001, PROTEINS, V45, P408, DOI 10.1002/prot.10010; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shoba LNN, 2003, J CELL BIOCHEM, V88, P1247, DOI 10.1002/jcb.10474; Steuerwald N, 1999, MOL HUM REPROD, V5, P1034, DOI 10.1093/molehr/5.11.1034; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	59	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8198	10.1371/journal.pone.0008198	http://dx.doi.org/10.1371/journal.pone.0008198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	20011660	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829700003
J	Marucci, L; Barton, DAW; Cantone, I; Ricci, MA; Cosma, MP; Santini, S; di Bernardo, D; di Bernardo, M				Marucci, Lucia; Barton, David A. W.; Cantone, Irene; Ricci, Maria Aurelia; Cosma, Maria Pia; Santini, Stefania; di Bernardo, Diego; di Bernardo, Mario			How to Turn a Genetic Circuit into a Synthetic Tunable Oscillator, or a Bistable Switch	PLOS ONE			English	Article							TOGGLE SWITCH; CONSTRUCTION; NETWORKS; BIOLOGY; DESIGN	Systems and Synthetic Biology use computational models of biological pathways in order to study in silico the behaviour of biological pathways. Mathematical models allow to verify biological hypotheses and to predict new possible dynamical behaviours. Here we use the tools of non-linear analysis to understand how to change the dynamics of the genes composing a novel synthetic network recently constructed in the yeast Saccharomyces cerevisiae for In-vivo Reverse-engineering and Modelling Assessment (IRMA). Guided by previous theoretical results that make the dynamics of a biological network depend on its topological properties, through the use of simulation and continuation techniques, we found that the network can be easily turned into a robust and tunable synthetic oscillator or a bistable switch. Our results provide guidelines to properly re-engineering in vivo the network in order to tune its dynamics.	[Marucci, Lucia; Ricci, Maria Aurelia; Cosma, Maria Pia; di Bernardo, Diego] TIGEM, Naples, Italy; [Marucci, Lucia; Santini, Stefania; di Bernardo, Diego; di Bernardo, Mario] Univ Naples Federico II, Dept Comp & Syst Engn, Naples, Italy; [Barton, David A. W.; di Bernardo, Mario] Univ Bristol, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England; [Cantone, Irene] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Bristol; Imperial College London	Marucci, L (corresponding author), TIGEM, Naples, Italy.	dibernardo@tigem.it; mario.dibernardo@unina.it	di Bernardo, Mario/I-2805-2012; Barton, David/R-9896-2019; Barton, David AW/A-2438-2009; Cantone, Irene/AAB-1071-2020; di Bernardo, Diego/I-9440-2012; di Bernardo, Mario/AAL-9311-2021; di Bernardo, Diego/AAF-5881-2021; Marucci, Lucia/P-1582-2016; Cosma, Maria Pia/E-8731-2015	Barton, David/0000-0002-0595-4239; Barton, David AW/0000-0002-0595-4239; Cantone, Irene/0000-0002-8156-7126; di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Mario/0000-0002-2171-4745; di Bernardo, Diego/0000-0002-1911-7407; Marucci, Lucia/0000-0002-7553-6358; Cosma, Maria Pia/0000-0003-4207-5097	EU; SEMM (European School of Molecular Medicine); United Kingdom Engineering and Physical Sciences Research Council (EPSRC); Fondazione Telethon Funding Source: Custom	EU(European Commission); SEMM (European School of Molecular Medicine); United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Fondazione Telethon(Fondazione Telethon)	This work was supported by EU-STREP FP6 grant (COBIOS) to L. M., M. P. C., D. d. B. and M. d. B.; I. C. PhD fellowship was provided by SEMM (European School of Molecular Medicine). L. M. acknowledges support from the United Kingdom Engineering and Physical Sciences Research Council (EPSRC) platform grant "Making it Real" during her visit to the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; BOGACKI P, 1989, APPL MATH LETT, V2, P1; Calzone L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100171; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chandrasekaran S, 2006, MOL CELL, V24, P689, DOI 10.1016/j.molcel.2006.10.028; Cuccato G, 2009, HEREDITY, V102, P527, DOI 10.1038/hdy.2009.18; DELVECCHIO D, 2007, AM CONTR C 2007 ACC; EISWIRTH M, 1991, J PHYS CHEM-US, V95, P1294, DOI 10.1021/j100156a048; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endler L, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0035.focus; Engelborghs K, 2000, SIAM J SCI COMPUT, V22, P1593, DOI 10.1137/S1064827599363381; ENGELBORGHS K, 2001, VD330 TW KU LEUV DEP; Fall CP., 2002, COMPUTATIONAL CELL B; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guantes R, 2006, PLOS COMPUT BIOL, V2, P188, DOI 10.1371/journal.pcbi.0020030; Horsthemke W., 1984, NOISE INDUCED TRANSI; KOVACECH B, 2003, NUCLEIC ACIDS RES, V31, P5831; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kuras L, 1997, EMBO J, V16, P2441, DOI 10.1093/emboj/16.9.2441; LUBISCHER JL, 2007, CELL CYCLE; Luzyanina T, 1996, J COMPUT APPL MATH, V72, P379, DOI 10.1016/0377-0427(96)00008-8; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; MURRAY JD, 2008, MATH BIOL, V1; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; PENGCHENG F, 2009, SYSTEMS BIOL SYNTHET; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; SERTIL O, 1996, MOL CELL BIO, V16, P3264; Seydel R., 2009, PRACTICAL BIFURCATIO, V5; Shampine LF, 2001, APPL NUMER MATH, V37, P441, DOI 10.1016/S0168-9274(00)00055-6; STRICKER J, 2008, NATURE; THOMAS R, 1981, SPRINGER SERIES SYNE; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Widder S, 2007, J THEOR BIOL, V246, P395, DOI 10.1016/j.jtbi.2007.01.004	39	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8083	10.1371/journal.pone.0008083	http://dx.doi.org/10.1371/journal.pone.0008083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997611	gold, Green Published, Green Submitted			2022-12-25	WOS:000272829500005
J	Sarantseva, S; Timoshenko, S; Bolshakova, O; Karaseva, E; Rodin, D; Schwarzman, AL; Vitek, MP				Sarantseva, Svetlana; Timoshenko, Svetlana; Bolshakova, Olga; Karaseva, Eugenia; Rodin, Dmitry; Schwarzman, Alexander L.; Vitek, Michael P.			Apolipoprotein E-Mimetics Inhibit Neurodegeneration and Restore Cognitive Functions in a Transgenic Drosophila Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BLOOD-BRAIN-BARRIER; SYNAPTIC PLASTICITY; AXONAL-TRANSPORT; MOLECULAR-BASIS; A-BETA; PEPTIDE; AGGREGATION; HYPOTHESIS; EXPRESSION	Background: Mutations of the amyloid precursor protein gene (APP) are found in familial forms of Alzheimer's disease (AD) and some lead to the elevated production of amyloid-beta-protein (A beta). While A beta has been implicated in the causation of AD, the exact role played by A beta and its APP precursor are still unclear. Principal Findings: In our study, Drosophila melanogaster transgenics were established as a model to analyze AD-like pathology caused by APP overexpression. We demonstrated that age related changes in the levels and pattern of synaptic proteins accompanied progressive neurodegeneration and impairment of cognitive functions in APP transgenic flies, but that these changes may be independent from the generation of A beta. Using novel peptide mimetics of Apolipoprotein-E, COG112 or COG133 proved to be neuroprotective and significantly improved the learning and memory of APP transgenic flies. Conclusions: The development of neurodegeneration and cognitive deficits was corrected by injections of COG112 or COG133, novel mimetics of apolipoprotein-E (apoE) with neuroprotective activities.	[Sarantseva, Svetlana; Timoshenko, Svetlana; Bolshakova, Olga; Karaseva, Eugenia; Rodin, Dmitry; Schwarzman, Alexander L.] Russian Acad Sci, Petersburg Inst Nucl Phys, Gatchina, Russia; [Schwarzman, Alexander L.] Russian Acad Med Sci, Inst Expt Med, St Petersburg, Russia; [Vitek, Michael P.] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC USA	Russian Academy of Sciences; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Duke University	Sarantseva, S (corresponding author), Russian Acad Sci, Petersburg Inst Nucl Phys, Gatchina, Russia.	Michael.Vitek@Duke.edu	Bolshakova, Olga/S-8262-2018; Latypova, Evgeniya/O-7363-2014	Bolshakova, Olga/0000-0003-3761-3014; Vitek, Michael/0000-0001-8140-8048	Russian Foundation for Basic Research [07-04-00128, 09-04-00647]; Russian Academy of Sciences; Alzheimer's Association [IIRG-07-59655]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Alzheimer's Association(Alzheimer's Association)	This study is supported by the Russian Foundation for Basic Research (grants: 07-04-00128 to A. L. S. and 09-04-00647 to S. S.) and by the Program of the Presidium of the Russian Academy of Sciences "Fundamental Sciences for Medicine" (to A. L. S.) and an Alzheimer's Association grant IIRG-07-59655 to M. P. V. These funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Ashe KH, 2000, ANN NY ACAD SCI, V924, P39; Bolton SJ, 2000, EUR J NEUROSCI, V12, P2847, DOI 10.1046/j.1460-9568.2000.00171.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; Chiang HC, 2009, FASEB J, V23, P1969, DOI 10.1096/fj.08-121152; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Isacson O, 2004, NEURON, V43, P165, DOI 10.1016/j.neuron.2004.07.007; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Peng T, 2004, ACTA BIOCH BIOPH SIN, V36, P629, DOI 10.1093/abbs/36.9.629; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; Samuels SC, 1998, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P267; Sarantseva S V, 2009, Genetika, V45, P119; Sarantseva SV, 2009, BIOCHEM MOSC-SUPPL S, V3, P149, DOI 10.1134/S199075080902005X; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHWARZMAN AL, 2005, AMYLOID, V12, P1; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Senechal Y, 2006, NEURODEGENER DIS, V3, P134, DOI 10.1159/000094772; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; TAN L, 2008, PLOS ONE, V3, P1; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Torroja L, 1999, J NEUROSCI, V19, P7793; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4	56	51	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8191	10.1371/journal.pone.0008191	http://dx.doi.org/10.1371/journal.pone.0008191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997607	gold, Green Published, Green Submitted			2022-12-25	WOS:000272829500015
J	Jawara, M; Smallegange, RC; Jeffries, D; Nwakanma, DC; Awolola, TS; Knols, BGJ; Takken, W; Conway, DJ				Jawara, Musa; Smallegange, Renate C.; Jeffries, David; Nwakanma, Davis C.; Awolola, Taiwo Samson; Knols, Bart G. J.; Takken, Willem; Conway, David J.			Optimizing Odor-Baited Trap Methods for Collecting Mosquitoes during the Malaria Season in The Gambia	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; VECTOR ANOPHELES-GAMBIAE; MM-X TRAPS; CARBON-DIOXIDE; HUMAN SKIN; SEMIFIELD CONDITIONS; MOLECULAR-FORMS; COMPLEX; DIPTERA; ATTRACTIVENESS	Background: Baited traps are potential tools for removal or surveillance of disease vectors. To optimize the use of counter-flow traps baited with human odor ( nylon socks that had been worn for a single day) to capture wild mosquitoes in the Gambia, investigations were conducted at a field experimental site. Methodology/Principal Findings: Experiments employing Latin square design were conducted with a set of six huts to investigate the effects of the following on overnight mosquito trap catches: (1) placement of traps indoors or immediately outdoors, CO2 supply, and presence of a human subject in the hut; (2) trap height for collecting mosquitoes immediately outdoors; (3) height and distance from hut; (4) interaction between multiple traps around a single hut and entry of mosquitoes into huts. A total of 106,600 adult mosquitoes (9.1% Anopheles gambiae s.l., 4.0% other Anopheles species) were collected over 42 nights. The high numbers of An. gambiae s.l. and other mosquitoes collected by odor-baited traps required CO2 but were largely independent of the presence of a person sleeping in the hut or of trap placement indoors or outdoors. For outdoor collection that is considered less intrusive, traps opening 15 cm above the floor of the hut veranda were more highly effective than traps at other heights or further from the hut. There was no significant evidence of saturation or competition by the traps, with multiple traps around a hut each collecting almost as many mosquitoes as single traps and no effect on the numbers of mosquitoes entering the huts. Conclusions/Significance: The outdoor trapping protocol is convenient to compare attractiveness of different odors or synthetic chemicals to malaria vectors and other wild mosquitoes. The finding that such traps are reliably attractive in the presence or absence of a human volunteer encourages their potential development as standardised surveillance tools.	[Jawara, Musa; Jeffries, David; Nwakanma, Davis C.; Awolola, Taiwo Samson; Conway, David J.] MRC Labs, Banjul, Gambia; [Smallegange, Renate C.; Knols, Bart G. J.; Takken, Willem] Wageningen Univ, Entomol Lab, Wageningen, Netherlands	MRC Laboratory Molecular Biology; Wageningen University & Research	Jawara, M (corresponding author), MRC Labs, Banjul, Gambia.	dconway@mrc.gm	Smallegange, Renate C./L-1566-2019	Smallegange, Renate C./0000-0002-6946-9777; Conway, David/0000-0002-8711-3037; Nwakanma, Davis/0000-0002-6706-6069	Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative [121]; Medical Research Council of the United Kingdom	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative(Bill & Melinda Gates Foundation); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded as part of a grant from the Foundation for the National Institutes of Health and the Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative ( GCGH# 121 grant co-ordinated by Dr. Larry Zwiebel), and by the Medical Research Council of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cooper RD, 2004, J AM MOSQUITO CONTR, V20, P239; Cork A, 1996, CIBA F SYMP, V200, P71; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GILLIES MT, 1969, B ENTOMOL RES, V59, P441, DOI 10.1017/S0007485300003412; Healy TP, 2000, MED VET ENTOMOL, V14, P195, DOI 10.1046/j.1365-2915.2000.00238.x; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Omolo MO, 2004, PHYTOCHEMISTRY, V65, P2797, DOI 10.1016/j.phytochem.2004.08.035; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Seyoum A, 2002, AM J TROP MED HYG, V67, P191, DOI 10.4269/ajtmh.2002.67.191; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tan CH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-52	26	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8167	10.1371/journal.pone.0008167	http://dx.doi.org/10.1371/journal.pone.0008167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997640	Green Published, gold, Green Accepted			2022-12-25	WOS:000272829200007
J	Jones, JH; Salathe, M				Jones, James Holland; Salathe, Marcel			Early Assessment of Anxiety and Behavioral Response to Novel Swine-Origin Influenza A(H1N1)	PLOS ONE			English	Article							SOCIAL NETWORKS; RISK; PERCEPTIONS; IMPACT; MEDIA	Background: Since late April, 2009, a novel influenza virus A (H1N1), generally referred to as the "swine flu,'' has spread around the globe and infected hundreds of thousands of people. During the first few days after the initial outbreak in Mexico, extensive media coverage together with a high degree of uncertainty about the transmissibility and mortality rate associated with the virus caused widespread concern in the population. The spread of an infectious disease can be strongly influenced by behavioral changes (e.g., social distancing) during the early phase of an epidemic, but data on risk perception and behavioral response to a novel virus is usually collected with a substantial delay or after an epidemic has run its course. Methodology/Principal Findings: Here, we report the results from an online survey that gathered data (n = 6,249) about risk perception of the Influenza A( H1N1) outbreak during the first few days of widespread media coverage (April 28 - May 5, 2009). We find that after an initially high level of concern, levels of anxiety waned along with the perception of the virus as an immediate threat. Overall, our data provide evidence that emotional status mediates behavioral response. Intriguingly, principal component analysis revealed strong clustering of anxiety about swine flu, bird flu and terrorism. All three of these threats receive a great deal of media attention and their fundamental uncertainty is likely to generate an inordinate amount of fear vis-a-vis their actual threat. Conclusions/Significance: Our results suggest that respondents' behavior varies in predictable ways. Of particular interest, we find that affective variables, such as self-reported anxiety over the epidemic, mediate the likelihood that respondents will engage in protective behavior. Understanding how protective behavior such as social distancing varies and the specific factors that mediate it may help with the design of epidemic control strategies.	[Jones, James Holland] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Salathe, Marcel] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Jones, James Holland] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Jones, JH (corresponding author), Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA.	jhj1@stanford.edu		Jones, James/0000-0003-1680-6757; Salathe, Marcel/0000-0002-5079-7797	NICH [1K01HD051494]; Branco Weiss Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD051494] Funding Source: NIH RePORTER	NICH; Branco Weiss Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by award 1K01HD051494 from NICH (JHJ) and the Branco Weiss Foundation (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKMAN LF, 1984, ANNU REV PUBL HEALTH, V5, P413, DOI 10.1146/annurev.pu.05.050184.002213; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bernard HR, 2005, RES METHODS ANTHR QU, V4th; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Burnham KP, 2002, MULTIMODEL INFERENCE; *CDCP, 2009, SOC MED CDC NOV H1N1; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; de Zwart O, 2007, EMERG INFECT DIS, V13, P290, DOI 10.3201/eid1302.060303; FRASER C, 2009, PANDEMIC POTENTIAL S; Frost K, 1997, AM J PUBLIC HEALTH, V87, P842, DOI 10.2105/AJPH.87.5.842; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Gray GM, 2002, HEALTH AFFAIR, V21, P106, DOI 10.1377/hlthaff.21.6.106; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; *OBJ PLAN, 2009, OP SURV SOFTW; Rubin G., 2009, BMJ-BRIT MED J, V339, P2651, DOI DOI 10.1136/BMJ.B2651; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; *WHO, 2009, INFL A H1N1 PAND AL; World Health Organization, 2009, PAND H1N1 2009 UPD 6; World Health Organization Director-General, 2009, INFL A H1N1; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	30	281	287	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8032	10.1371/journal.pone.0008032	http://dx.doi.org/10.1371/journal.pone.0008032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MW	19997505	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829000001
J	Cheron, G; Sausbier, M; Sausbier, U; Neuhuber, W; Ruth, P; Dan, B; Servais, L				Cheron, Guy; Sausbier, Matthias; Sausbier, Ulrike; Neuhuber, Winfried; Ruth, Peter; Dan, Bernard; Servais, Laurent			BK Channels Control Cerebellar Purkinje and Golgi Cell Rhythmicity In Vivo	PLOS ONE			English	Article							FIELD POTENTIAL OSCILLATIONS; SYNAPTIC INTEGRATION; K+ CHANNELS; CONDUCTANCE; MODULATION; CORTEX; EXCITABILITY; DYSFUNCTION; PLASTICITY; PATTERNS	Calcium signaling plays a central role in normal CNS functioning and dysfunction. As cerebellar Purkinje cells express the major regulatory elements of calcium control and represent the sole integrative output of the cerebellar cortex, changes in neural activity-and calcium-mediated membrane properties of these cells are expected to provide important insights into both intrinsic and network physiology of the cerebellum. We studied the electrophysiological behavior of Purkinje cells in genetically engineered alert mice that do not express BK calcium-activated potassium channels and in wild-type mice with pharmacological BK inactivation. We confirmed BK expression in Purkinje cells and also demonstrated it in Golgi cells. We demonstrated that either genetic or pharmacological BK inactivation leads to ataxia and to the emergence of a beta oscillatory field potential in the cerebellar cortex. This oscillation is correlated with enhanced rhythmicity and synchronicity of both Purkinje and Golgi cells. We hypothesize that the temporal coding modification of the spike firing of both Purkinje and Golgi cells leads to the pharmacologically or genetically induced ataxia.	[Cheron, Guy; Servais, Laurent] Univ Mons, Lab Electrophysiol, Mons, Belgium; [Cheron, Guy; Dan, Bernard] Univ Libre Bruxelles, Lab Neurophysiol & Movement Biomech, Brussels, Belgium; [Sausbier, Matthias; Sausbier, Ulrike; Ruth, Peter] Univ Tubingen, Inst Pharm, Dept Pharmacol & Toxicol, Tubingen, Germany; [Neuhuber, Winfried] Univ Erlangen Nurnberg, Inst Anat, Erlangen, Germany; [Dan, Bernard] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Neurol, Brussels, Belgium; [Servais, Laurent] Hop Robert Debre, Dept Child Neurol, F-75019 Paris, France	University of Mons; Universite Libre de Bruxelles; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Erlangen Nuremberg; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Cheron, G (corresponding author), Univ Mons, Lab Electrophysiol, Mons, Belgium.	l.servais@institut-myologie.org	Servais, Laurent/AAL-7384-2020	Servais, Laurent/0000-0001-9270-4061; Dan, Bernard/0000-0002-2051-9876	Fond National de la Recherche Scientifique (FNRS); Belgian Federal Science Policy Office, the European Space Agency [AO-2004, 118]; Belgian National Fund for Scientific Research (FNRS); Research funds of the Universite Libre de Bruxelles (ULB); Universite de Mons-Hainaut (Belgium)	Fond National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Federal Science Policy Office, the European Space Agency(Belgian Federal Science Policy Office); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Research funds of the Universite Libre de Bruxelles (ULB); Universite de Mons-Hainaut (Belgium)	L. S. was a research assistant of the Fond National de la Recherche Scientifique (FNRS) at the time of the study. This work was funded by the Belgian Federal Science Policy Office, the European Space Agency, (AO-2004, 118), the Belgian National Fund for Scientific Research (FNRS), and research funds of the Universite Libre de Bruxelles (ULB) and the Universite de Mons-Hainaut (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bearzatto B, 2006, FASEB J, V20, P380, DOI 10.1096/fj.05-3785fje; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; BOWER JM, 1990, J COMP NEUROL, V302, P768, DOI 10.1002/cne.903020409; Cheron G, 2008, NEUROSCIENCE, V153, P1, DOI 10.1016/j.neuroscience.2008.01.074; Cheron G, 2005, NEUROSCIENCE, V130, P631, DOI 10.1016/j.neuroscience.2004.09.013; Cheron G, 2004, J NEUROSCI, V24, P434, DOI 10.1523/JNEUROSCI.3197-03.2004; Courtemanche R, 2005, J NEUROPHYSIOL, V93, P2039, DOI 10.1152/jn.00080.2004; Courtemanche R, 2002, J NEUROPHYSIOL, V88, P771, DOI 10.1152/jn.2002.88.2.771; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; De Zeeuw CI, 2008, NEURON, V58, P655, DOI 10.1016/j.neuron.2008.05.019; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Haghdoost-Yazdi H, 2008, BRAIN RES, V1212, P1, DOI 10.1016/j.brainres.2008.03.030; Hartmann MJ, 1998, J NEUROPHYSIOL, V80, P1598, DOI 10.1152/jn.1998.80.3.1598; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V409, P157, DOI 10.1113/jphysiol.1989.sp017490; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LeDoux MS, 2002, EXP BRAIN RES, V145, P457, DOI 10.1007/s00221-002-1127-4; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; Mathie A, 2003, CEREBELLUM, V2, P11, DOI 10.1080/14734220310015593; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; MCDEVITT CJ, 1982, BRAIN RES, V237, P484, DOI 10.1016/0006-8993(82)90460-7; McKay BE, 2004, EUR J NEUROSCI, V20, P729, DOI 10.1111/j.1460-9568.2004.03539.x; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; Nakanishi S, 2005, TRENDS NEUROSCI, V28, P93, DOI 10.1016/j.tins.2004.12.004; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schwarz C, 2001, J NEUROPHYSIOL, V86, P2489, DOI 10.1152/jn.2001.86.5.2489; Servais L, 2005, BRAIN RES, V1055, P171, DOI 10.1016/j.brainres.2005.07.026; Servais L, 2005, NEUROSCIENCE, V134, P1247, DOI 10.1016/j.neuroscience.2005.06.001; Servais L, 2005, EUR J NEUROSCI, V22, P861, DOI 10.1111/j.1460-9568.2005.04275.x; Servais L, 2007, P NATL ACAD SCI USA, V104, P9858, DOI 10.1073/pnas.0607037104; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Simpson JI, 2005, PROG BRAIN RES, V148, P329, DOI 10.1016/S0079-6123(04)48026-1; SUGIHARA I, 1995, EUR J NEUROSCI, V7, P521, DOI 10.1111/j.1460-9568.1995.tb00657.x; Swensen AM, 2003, J NEUROSCI, V23, P9650; VINCENT SR, 1985, J COMP NEUROL, V238, P169, DOI 10.1002/cne.902380205; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004	50	33	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7991	10.1371/journal.pone.0007991	http://dx.doi.org/10.1371/journal.pone.0007991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956720	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827500021
J	Abe, Y; Urakami, H; Ostanin, D; Zibari, G; Hayashida, T; Kitagawa, Y; Grisham, MB				Abe, Yuta; Urakami, Hidejiro; Ostanin, Dmitry; Zibari, Gazi; Hayashida, Tetsu; Kitagawa, Yuko; Grisham, Matthew B.			Induction of Foxp3-Expressing Regulatory T-Cells by Donor Blood Transfusion Is Required for Tolerance to Rat Liver Allografts	PLOS ONE			English	Article							HISTOCOMPATIBILITY COMPLEX ANTIGENS; HEPATIC ALLOGRAFTS; CLASS-I; HEART-TRANSPLANTATION; PROLONGED SURVIVAL; RECIPIENTS; INFILTRATION; CYCLOSPORINE; ANTIBODY; GRAFT	Background: Donor-specific blood transfusion (DST) prior to solid organ transplantation has been shown to induce long-term allograft survival in the absence of immunosuppressive therapy. Although the mechanisms underlying DST-induced allograft tolerance are not well defined, there is evidence to suggest DST induces one or more populations of antigen-specific regulatory cells that suppress allograft rejection. However, neither the identity nor the regulatory properties of these tolerogenic lymphocytes have been reported. Therefore, the objective of this study was to define the kinetics, phenotype and suppressive function of the regulatory cells induced by DST alone or in combination with liver allograft transplantation (LTx). Methodology/Principal Findings: Tolerance to Dark Agouti (DA; RT1(a)) rat liver allografts was induced by injection (iv) of 1 ml of heparinized DA blood to naive Lewis (LEW; RT1(I)) rats once per week for 4 weeks prior to LTx. We found that preoperative DST alone generates CD4(+) T-cells that when transferred into naive LEW recipients are capable of suppressing DA liver allograft rejection and promoting long-term survival of the graft and recipient. However, these DST-generated T-cells did not express the regulatory T-cell (Treg) transcription factor Foxp3 nor did they suppress alloantigen (DA)-induced activation of LEW T-cells in vitro suggesting that these lymphocytes are not fully functional regulatory Tregs. We did observe that DST+LTx (but not DST alone) induced the time-dependent formation of CD4(+)Foxp3(+) Tregs that potently suppressed alloantigen-induced activation of naive LEW T-cells in vitro and liver allograft rejection in vivo. Finally, we present data demonstrating that virtually all of the Foxp3-expressing Tregs reside within the CD4(+)CD45RC(-) population whereas in which approximately 50% of these Tregs express CD25. Conclusions/Significance: We conclude that preoperative DST, in the absence of liver allograft transplantation, induces the formation of CD4(+) T-cells that are not themselves Tregs but give rise directly or indirectly to fully functional CD4(+)CD45RC(-)Foxp3(+) Tregs when transferred into MHC mismatched recipients prior to LTx. These Tregs possess potent suppressive activity and are capable of suppressing acute liver allograft rejection. Understanding the mechanisms by which preoperative DST induces the generation of tolerogenic Tregs in the presence of alloantigens may lead to the development of novel antigen-specific immunological therapies for the treatment of solid organ rejection.	[Abe, Yuta; Urakami, Hidejiro; Ostanin, Dmitry; Grisham, Matthew B.] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Zibari, Gazi] Louisiana State Univ, Hlth Sci Ctr, Dept Surg, Shreveport, LA 71105 USA; [Hayashida, Tetsu; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Keio University	Abe, Y (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA.	mgrish@lsuhsc.edu		Zibari, Gazi B./0000-0001-7689-4299; Ostanin, Dmitry/0000-0002-8015-7432				ALEXANDER JW, 1992, TRANSPLANTATION, V53, P423, DOI 10.1097/00007890-199202010-00030; ARMSTRONG HE, 1987, J EXP MED, V165, P891, DOI 10.1084/jem.165.3.891; BAQUERIZO A, 1989, TRANSPLANT P, V21, P1179; BUGEON L, 1992, TRANSPLANTATION, V54, P219, DOI 10.1097/00007890-199208000-00006; DALLMAN MJ, 1987, J EXP MED, V165, P566, DOI 10.1084/jem.165.2.566; Degauque N, 2007, EUR J IMMUNOL, V37, P147, DOI 10.1002/eji.200635879; Douillard P, 1999, EUR J IMMUNOL, V29, P1919, DOI 10.1002/(SICI)1521-4141(199906)29:06<1919::AID-IMMU1919>3.0.CO;2-8; Flye MW, 1995, TRANSPLANTATION, V60, P1395; *HLTH RES SERV ADM, 2007, 2007 ANN REP US ORG; Jain A, 2002, ANN SURG, V236, P429, DOI 10.1097/00000658-200210000-00005; Josien R, 1998, J CLIN INVEST, V102, P1920, DOI 10.1172/JCI4221; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Kataoka M, 2003, J IMMUNOL, V171, P204, DOI 10.4049/jimmunol.171.1.204; KATZ MR, 1987, TRANSPLANTATION, V43, P499, DOI 10.1097/00007890-198704000-00008; Kitade H, 2005, J IMMUNOL, V175, P4963, DOI 10.4049/jimmunol.175.8.4963; Miyanari N, 1997, HEPATOLOGY, V25, P1008, DOI 10.1002/hep.510250436; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Opelz G, 1997, TRANSPLANTATION, V63, P964, DOI 10.1097/00007890-199704150-00010; Patel R, 1997, CLIN MICROBIOL REV, V10, P86, DOI 10.1128/CMR.10.1.86; POTTER DE, 1991, PEDIATR NEPHROL, V5, P168, DOI 10.1007/BF00852877; QUIGLEY RL, 1989, J IMMUNOL, V142, P463; Shimizu Y, 2001, TRANSPLANT P, V33, P150, DOI 10.1016/S0041-1345(00)01949-7; Urakami H, 2006, TRANSPLANT P, V38, P3244, DOI 10.1016/j.transproceed.2006.10.042; VANTWUYVER E, 1991, NEW ENGL J MED, V325, P1210, DOI 10.1056/NEJM199110243251704; Yamaguchi Y, 1996, J SURG RES, V61, P23, DOI 10.1006/jsre.1996.0075; YAMAGUCHI Y, 1989, TRANSPLANTATION, V47, P171, DOI 10.1097/00007890-198901000-00036	26	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7840	10.1371/journal.pone.0007840	http://dx.doi.org/10.1371/journal.pone.0007840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956764	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827300002
J	Ocampo, A; Zambrano, A; Barrientos, A				Ocampo, Alejandro; Zambrano, Andrea; Barrientos, Antoni			Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis	FASEB JOURNAL			English	Article						mitochondrial metabolism; HAP4; yeast model	MUTANT HUNTINGTIN FRAGMENT; COMPLEX-II; IN-VITRO; PROTEIN-SYNTHESIS; MOUSE MODEL; YEAST; AGGREGATION; EXPRESSION; OVEREXPRESSION; TOXICITY	Alterations in mitochondrial metabolism have been associated with age-related neurodegenerative disorders. This is seen in diseases caused by misfolding of proteins with expanded polyglutamine (polyQ) tracts, such as Huntington's disease. Although evidence of mitochondrial impairment has been extensively documented in patients and disease models, the mechanisms involved and their relevance to the initiation of polyQ cytotoxicity and development of clinical manifestations remain controversial. We report that in yeast models of polyQ cytotoxicity, wild-type and mutant polyQ domains might associate early with the outer mitochondrial membrane. The association of mutant domains with mitochondrial membranes could contribute to induce significant changes in mitochondrial physiology, ultimately compromising the cell's ability to respire. The respiratory defect can be fully prevented by enhancing mitochondrial biogenesis by overexpression of Hap4p, the catalytic subunit of the transcriptional activator Hap2/3/4/5p complex, the master regulator of the expression of many nuclear genes encoding mitochondrial proteins in yeast. Protecting cellular respiratory capacity in this way ameliorates the effect of expanded polyQ on cellular fitness. We conclude that mitochondrial dysfunction is an important contributor to polyQ cytotoxicity. Our results suggest that therapeutic approaches enhancing mitochondrial biogenesis could reduce polyQ toxicity and delay the development of clinical symptoms in patients.-Ocampo, A., Zambrano, A., Barrientos, A. Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis. FASEB J. 24, 1431-1441 (2010). www.fasebj.org	[Zambrano, Andrea; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Ocampo, Alejandro; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami; University of Miami	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.miami.edu		Ocampo, Alejandro/0000-0002-3731-3647	Stanley Glaser Foundation	Stanley Glaser Foundation	The authors thank Prof. Susan Lindquist (Whitehead Institute for Biomedical Research, Cambridge, MA, USA) and Prof. Miriam L. Greenberg (Department of Biological Sciences, Wayne State University, Detroit, MI, USA) for providing reagents. The authors thank Dr. Flavia Fontanesi, Dr. Brant Watson, and Darryl Horn for critical reading of the manuscript. This research was supported by a Stanley Glaser Foundation grant (to A. B.).	Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Bauer PO, 2009, AUTOPHAGY, V5, P747, DOI 10.4161/auto.5.5.8704; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HUNTER FE, 1967, METHOD ENZYMOL, V10, P689; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lascaris R, 2003, GENOME BIOL, V4; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; MCKEE EE, 1984, J BIOL CHEM, V259, P9320; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Panov AV, 2003, ARCH BIOCHEM BIOPHYS, V410, P1, DOI 10.1016/S0003-9861(02)00585-4; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Sokolov S, 2006, BBA-BIOENERGETICS, V1757, P660, DOI 10.1016/j.bbabio.2006.05.004; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wellington CL, 2002, J NEUROSCI, V22, P7862; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389	50	39	39	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1431	1441		10.1096/fj.09-148601	http://dx.doi.org/10.1096/fj.09-148601			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20008543				2022-12-25	WOS:000277158900016
J	Trang, P; Medina, PP; Wiggins, JF; Ruffino, L; Kelnar, K; Omotola, M; Homer, R; Brown, D; Bader, AG; Weidhaas, JB; Slack, FJ				Trang, P.; Medina, P. P.; Wiggins, J. F.; Ruffino, L.; Kelnar, K.; Omotola, M.; Homer, R.; Brown, D.; Bader, A. G.; Weidhaas, J. B.; Slack, F. J.			Regression of murine lung tumors by the let-7 microRNA	ONCOGENE			English	Article						let-7; microRNAs; lung cancer; K-ras	MOUSE MODELS; K-RAS; CANCER; EXPRESSION; INHIBITION; FAMILY; GROWTH; CELLS; SIRNA; HMGA2	MicroRNAs (miRNAs) have recently emerged as an important new class of cellular regulators that control various cellular processes and are implicated in human diseases, including cancer. Here, we show that loss of let-7 function enhances lung tumor formation in vivo, strongly supporting the hypothesis that let-7 is a tumor suppressor. Moreover, we report that exogenous delivery of let-7 to established tumors in mouse models of non-small-cell lung cancer (NSCLC) significantly reduces the tumor burden. These results demonstrate the therapeutic potential of let-7 in NSCLC and point to miRNA replacement therapy as a promising approach in cancer treatment. Oncogene (2010) 29, 1580-1587; doi:10.1038/onc.2009.445; published online 7 December 2009	[Wiggins, J. F.; Ruffino, L.; Kelnar, K.; Omotola, M.; Brown, D.; Bader, A. G.] Mirna Therapeut Inc, Austin, TX USA; [Trang, P.; Medina, P. P.; Slack, F. J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Trang, P.; Weidhaas, J. B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Homer, R.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Homer, R.] VA Connecticut Healthcare Syst, Dept Pathol & Lab Med Serv, West Haven, CT USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Bader, AG (corresponding author), Mirna Therapeut Inc, 2150 Woodward St, Austin, TX USA.	abader@mirnarx.com; joanne.weidhaas@yale.edu; frank.slack@yale.edu	homer, robert/P-3884-2019; Vico, Pedro Pablo Medina/D-1688-2013	homer, robert/0000-0002-2055-5885; Vico, Pedro Pablo Medina/0000-0002-7834-7093; Weidhaas, Joanne/0000-0002-5096-3281; Slack, Frank/0000-0001-8263-0409	NIH NRSA [F32CA130376]; Ministry of Education and Science of Spain (MEC); Hope Funds for Cancer Research; ASTRO; NIH [CA131301-01A1]; Connecticut Department of Public Health [2006-0913]; NATIONAL CANCER INSTITUTE [F32CA130376, K08CA124484, R01CA131301] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education and Science of Spain (MEC)(Spanish Government); Hope Funds for Cancer Research; ASTRO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Department of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Xianping Liang for help with animal husbandry and genotyping, and Paul Lebourgeois for histopathological analyses. PT was supported by an NIH NRSA postdoctoral fellowship (F32CA130376). PM was supported by a postdoctoral fellowship from the Ministry of Education and Science of Spain (MEC) and from the Hope Funds for Cancer Research. JBW was supported by the ASTRO Junior Faculty Career Research Training Award. FJS and JBW were supported by grants from the NIH (CA131301-01A1) and from the Connecticut Department of Public Health (RFP no. 2006-0913).	Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko Vira, 2008, V442, P75, DOI 10.1007/978-1-59745-191-8_6; Brown M, 2003, CANCER BIOL THER, V2, P477, DOI 10.4161/cbt.2.5.450; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Hohla F, 2007, P NATL ACAD SCI USA, V104, P18671, DOI 10.1073/pnas.0709455104; Isobe T, 2005, SEMIN ONCOL, V32, P315, DOI 10.1053/j.seminoncol.2005.02.016; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Levenkova N, 2004, BIOINFORMATICS, V20, P430, DOI 10.1093/bioinformatics/btg437; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Siegfried JM, 1999, PULM PHARMACOL THER, V12, P291, DOI 10.1006/pupt.1999.0210; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; TAKESHITA F, 2009, MOL THER; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	32	379	402	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2010	29	11					1580	1587		10.1038/onc.2009.445	http://dx.doi.org/10.1038/onc.2009.445			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	19966857	Green Accepted, Green Submitted			2022-12-25	WOS:000275694700003
J	Dahlman, JM; Bakkar, N; He, W; Guttridge, DC				Dahlman, Jason M.; Bakkar, Nadine; He, Wei; Guttridge, Denis C.			NF-kappa B Functions in Stromal Fibroblasts to Regulate Early Postnatal Muscle Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; MYOBLAST FUSION; TRANSCRIPTION FACTORS; EMBRYONIC LETHALITY; SKELETAL MYOGENESIS; SIGNALING PATHWAY; CELL ACTIVATION; MEMBRANE-FUSION; IKK-ALPHA	Classical NF-kappa B activity functions as an inhibitor of the skeletal muscle myogenic program. Recent findings reveal that even in newborn RelA/p65(-/-) mice, myofiber numbers are increased over that of wild type mice, suggesting that NF-kappa B may be a contributing factor in early postnatal skeletal muscle development. Here we show that in addition to p65 deficiency, repression of NF-kappa B with the I kappa B alpha-SR transdominant inhibitor or with muscle-specific deletion of IKK beta resulted in similar increases in total fiber numbers as well as an up-regulation of myogenic gene products. Upon further characterization of early postnatal muscle, we observed that NF-kappa B activity progressively declines within the first few weeks of development. At birth, the majority of this activity is compartmentalized to muscle fibers, but by neonatal day 8 NF-kappa B activity from the myofibers diminishes, and instead, stromal fibroblasts become the main cellular compartment within the muscle that contains active NF-kappa B. We find that NF-kappa B functions in these fibroblasts to regulate inducible nitric-oxide synthase expression, which we show is important for myoblast fusion during the growth and maturation process of skeletal muscle. Together, these data broaden our understanding of NF-kappa B during development by showing that in addition to its role as a negative regulator of myogenesis, NF-kappa B also regulates nitric-oxide synthase expression within stromal fibroblasts to stimulate myoblast fusion and muscle hypertrophy.	[Guttridge, Denis C.] Ohio State Univ, Coll Med, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Dahlman, Jason M.; Guttridge, Denis C.] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [He, Wei; Guttridge, Denis C.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Guttridge, Denis C.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Guttridge, DC (corresponding author), Ohio State Univ, Coll Med, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, 460 W 12th Ave,Biomed Res Tower 910, Columbus, OH 43210 USA.	denis.guttridge@osumc.edu	Core, Vector/CAF-4832-2022; He, Wei/J-6275-2016	Guttridge, Denis/0000-0002-7276-6609	National Institutes of Health [R01AR052787]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR052787 (to D. C. G.).	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bilic-Curcic I, 2005, GENESIS, V43, P87, DOI 10.1002/gene.20156; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Delfini MC, 2000, DEVELOPMENT, V127, P5213; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Faigle W, 2000, MOL BIOL CELL, V11, P3485, DOI 10.1091/mbc.11.10.3485; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; JOHNSON SE, 1990, EXP CELL RES, V187, P250, DOI 10.1016/0014-4827(90)90088-R; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Lee KH, 1997, BIOCHEM J, V324, P237, DOI 10.1042/bj3240237; LEE KH, 1994, J BIOL CHEM, V269, P14371; Lehtinen SK, 1996, BIOCHEM BIOPH RES CO, V229, P36, DOI 10.1006/bbrc.1996.1754; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Long JHD, 2006, J MUSCLE RES CELL M, V27, P577, DOI 10.1007/s10974-006-9078-1; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; SOULET L, 1994, MOL REPROD DEV, V39, P49, DOI 10.1002/mrd.1080390109; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wozniak AC, 2007, DEV DYNAM, V236, P240, DOI 10.1002/dvdy.21012; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630	54	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5479	5487		10.1074/jbc.M109.075606	http://dx.doi.org/10.1074/jbc.M109.075606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018862	hybrid, Green Published			2022-12-25	WOS:000275327200041
J	Falk, S; Ravaud, S; Koch, J; Sinning, I				Falk, Sebastian; Ravaud, Stephanie; Koch, Joachim; Sinning, Irmgard			The C Terminus of the Alb3 Membrane Insertase Recruits cpSRP43 to the Thylakoid Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; YIDC/OXA/ALB3 FAMILY; CYTOCHROME-OXIDASE; PERIPLASMIC DOMAIN; PROTEIN INSERTION; CRYSTAL-STRUCTURE; SRP-RECEPTOR; BINDING; YIDC; BIOGENESIS	The YidC/Oxa1/Alb3 family of membrane proteins controls the insertion and assembly of membrane proteins in bacteria, mitochondria, and chloroplasts. Here we describe the molecular mechanisms underlying the interaction of Alb3 with the chloroplast signal recognition particle (cpSRP). The Alb3 C-terminal domain (A3CT) is intrinsically disordered and recruits cpSRP to the thylakoid membrane by a coupled binding and folding mechanism. Two conserved, positively charged motifs reminiscent of chromodomain interaction motifs in histone tails are identified in A3CT that are essential for the Alb3-cpSRP43 interaction. They are absent in the C-terminal domain of Alb4, which therefore does not interact with cpSRP43. Chromodomain 2 in cpSRP43 appears as a central binding platform that can interact simultaneously with A3CT and cpSRP54. The observed negative cooperativity of the two binding events provides the first insights into cargo release at the thylakoid membrane. Taken together, our data show how Alb3 participates in cpSRP-dependent membrane targeting, and our data provide a molecular explanation why Alb4 cannot compensate for the loss of Alb3. Oxa1 and YidC utilize their positively charged, C-terminal domains for ribosome interaction in co-translational targeting. Alb3 is adapted for the chloroplast-specific Alb3-cpSRP43 interaction in post-translational targeting by extending the spectrum of chromodomain interactions.	Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany; [Koch, Joachim] Georg Speyer Haus, Inst Biomed Res, D-60596 Frankfurt, Germany	Ruprecht Karls University Heidelberg; Octapharma		irmi.sinning@bzh.uni-heidelberg.de	Falk, Sebastian/AAG-9706-2019; Ravaud, Stephanie/I-4059-2015; Falk, Sebastian/T-4796-2017	Falk, Sebastian/0000-0001-7848-4621; Ravaud, Stephanie/0000-0001-5867-0785; Falk, Sebastian/0000-0001-7848-4621	Collaborative Research [SFB 638, FOR 967]; Deutsche Forschungsgemeinschaft [GRK1188]; German-Israeli-Foundation	Collaborative Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli-Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Collaborative Research Grants SFB 638 and FOR 967) and Grant GRK1188 from the Deutsche Forschungsgemeinschaft and by the German-Israeli-Foundation (to I. S.).	Amin P, 1999, PLANT PHYSIOL, V121, P61, DOI 10.1104/pp.121.1.61; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong Y, 2008, J BACTERIOL, V190, P2458, DOI 10.1128/JB.01366-07; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eissenberg JC, 2001, GENE, V275, P19, DOI 10.1016/S0378-1119(01)00628-X; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.e03-11-0789; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; GROVES MR, 2002, SPRING LAB MAN, P83; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kathir KM, 2008, J MOL BIOL, V381, P49, DOI 10.1016/j.jmb.2008.05.065; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Klostermann E, 2002, BIOCHEM J, V368, P777, DOI 10.1042/BJ20021291; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Magidovich E, 2007, P NATL ACAD SCI USA, V104, P13022, DOI 10.1073/pnas.0704059104; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2007, BIOL CHEM, V388, P907, DOI 10.1515/BC.2007.111; Schunemann D, 2004, CURR GENET, V44, P295, DOI 10.1007/s00294-003-0450-z; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2005, MOL MEMBR BIOL, V22, P101, DOI 10.1080/09687860500041718; Zeev-Ben-Mordehai T, 2003, BIOPOLYMERS, V68, P395, DOI 10.1002/bip.10287; Zhang YJ, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-290, 10.1186/1471-2148-9-137]	59	74	77	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5954	5962		10.1074/jbc.M109.084996	http://dx.doi.org/10.1074/jbc.M109.084996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018841	Green Published, hybrid			2022-12-25	WOS:000275327200085
J	Obermair, GJ; Schlick, B; Di Biase, V; Subramanyam, P; Gebhart, M; Baumgartner, S; Flucher, BE				Obermair, Gerald J.; Schlick, Bettina; Di Biase, Valentina; Subramanyam, Prakash; Gebhart, Mathias; Baumgartner, Sabine; Flucher, Bernhard E.			Reciprocal Interactions Regulate Targeting of Calcium Channel beta Subunits and Membrane Expression of alpha(1) Subunits in Cultured Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CA2+ CHANNELS; I-II-LINKER; SKELETAL-MUSCLE; FUNCTIONAL EXPRESSION; DENDRITIC SPINES; BRAIN; IDENTIFICATION; CA(V)1.2; CLONING; COMPLEX	Auxiliary beta subunits modulate current properties and mediate the functional membrane expression of voltage-gated Ca2+ channels in heterologous cells. In brain, all four beta isoforms are widely expressed, yet little is known about their specific roles in neuronal functions. Here, we investigated the expression and targeting properties of beta subunits and their role in membrane expression of Ca(V)1.2 alpha(1) subunits in cultured hippocampal neurons. Quantitative reverse transcription-PCR showed equal expression, and immunofluorescence showed a similar distribution of all endogenous beta subunits throughout dendrites and axons. High resolution microscopy of hippocampal neurons transfected with six different V5 epitope-tagged beta subunits demonstrated that all beta subunits were able to accumulate in synaptic terminals and to colocalize with postsynaptic Ca(V)1.2, thus indicating a great promiscuity in alpha(1)-beta interactions. In contrast, restricted axonal targeting of beta(1) and weak colocalization of beta(4b) with Ca(V)1.2 indicated isoform-specific differences in local channel complex formation. Membrane expression of external hemagglutinin epitope-tagged Ca(V)1.2 was strongly enhanced by all beta subunits in an isoform-specific manner. Conversely, mutating the alpha-interaction domain of Ca(V)1.2 (W440A) abolished membrane expression and targeting into dendritic spines. This demonstrates that in neurons the interaction of a beta subunit with the alpha-interaction domain is absolutely essential for membrane expression of alpha(1) subunits, as well as for the subcellular localization of beta subunits, which by themselves possess little or no targeting properties.	[Obermair, Gerald J.; Schlick, Bettina; Di Biase, Valentina; Subramanyam, Prakash; Baumgartner, Sabine; Flucher, Bernhard E.] Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Gebhart, Mathias] Univ Innsbruck, Dept Pharmacol & Toxicol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; University of Innsbruck	Obermair, GJ (corresponding author), Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria.	Gerald.Obermair@i-med.ac.at; bernhard.e.flucher@i-med.ac.at	Di Biase, Valentina/AFE-2569-2022; , Gerald/AAD-3183-2020; Di Biase, Valentina/T-3714-2017; Di Biase, Valentina/AFT-6986-2022; Di Biase, Valentina/AAE-9529-2022	Di Biase, Valentina/0000-0002-3292-6516; Di Biase, Valentina/0000-0002-3292-6516; Di Biase, Valentina/0000-0002-3292-6516; Flucher, Bernhard/0000-0002-5255-4705	Austrian National Bank [P17806-B05, P17807-B05, P20059-B05, P20670, W1101-B12]; Tyrolean Science Fund	Austrian National Bank; Tyrolean Science Fund	This work was supported by grants from the Austrian Science Fund and the Austrian National Bank Grants P17806-B05, P17807-B05, P20059-B05, P20670, and W1101-B12, and the Tyrolean Science Fund (to G. J. O.).	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Butcher AJ, 2006, J PHYSIOL-LONDON, V574, P387, DOI 10.1113/jphysiol.2006.109744; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1998, J BIOENERG BIOMEMBR, V30, P377, DOI 10.1023/A:1021941706726; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Di Biase V, 2009, J NEUROSCI METH, V176, P78, DOI 10.1016/j.jneumeth.2008.08.025; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; Gerster U, 1999, J PHYSIOL-LONDON, V517, P353, DOI 10.1111/j.1469-7793.1999.0353t.x; Goslin K., 1998, CULTURING NERVE CELL, P339; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Koschak A, 2007, J NEUROSCI, V27, P3855, DOI 10.1523/JNEUROSCI.4028-06.2007; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Ludwig A, 1997, J NEUROSCI, V17, P1339; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neuhuber B, 1998, P NATL ACAD SCI USA, V95, P5015, DOI 10.1073/pnas.95.9.5015; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Subramanyam P, 2009, CHANNELS, V3, P343, DOI 10.4161/chan.3.5.9696; Szabo Z, 2006, EUR J NEUROSCI, V24, P709, DOI 10.1111/j.1460-9568.2006.04947.x; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TANAKA O, 1995, BRAIN RES MOL BRAIN, V30, P1, DOI DOI 10.1016/0169-328X(94)00265-G; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Watschinger K, 2008, CHANNELS, V2, P461, DOI 10.4161/chan.2.6.6793; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, NEUROPHARMACOLOGY, V32, P1127, DOI 10.1016/0028-3908(93)90007-P; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Xie M, 2007, J CELL BIOL, V178, P489, DOI 10.1083/jcb.200702072	70	45	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5776	5791		10.1074/jbc.M109.044271	http://dx.doi.org/10.1074/jbc.M109.044271			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996312	Green Published, hybrid			2022-12-25	WOS:000275327200069
J	Tatsumi, K; Sou, YS; Tada, N; Nakamura, E; Iemura, S; Natsume, T; Kang, SH; Chung, CH; Kasahara, M; Kominami, E; Yamamoto, M; Tanaka, K; Komatsu, M				Tatsumi, Kanako; Sou, Yu-shin; Tada, Norihiro; Nakamura, Eri; Iemura, Shun-ichiro; Natsume, Tohru; Kang, Sung Hwan; Chung, Chin Ha; Kasahara, Masanori; Kominami, Eiki; Yamamoto, Masayuki; Tanaka, Keiji; Komatsu, Masaaki			A Novel Type of E3 Ligase for the Ufm1 Conjugation System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; GENE-ACTIVATION; UBIQUITIN; UBIQUITIN-FOLD-MODIFIER-1; TRANSLATION; INHIBITION; REGULATORS; PATHWAYS; FAMILY; MOUSE	The ubiquitin fold modifier 1 (Ufm1) is the most recently discovered ubiquitin-like modifier whose conjugation (ufmylation) system is conserved in multicellular organisms. Ufm1 is known to covalently attach with cellular protein(s) via a specific E1-activating enzyme (Uba5) and an E2-conjugating enzyme (Ufc1), but its E3-ligating enzyme(s) as well as the target protein(s) remain unknown. Herein, we report both a novel E3 ligase for Ufm1, designated Ufl1, and an Ufm1-specific substrate ligated by Ufl1, C20orf116. Ufm1 was covalently conjugated with C20orf116. Although Ufl1 has no obvious sequence homology to any other known E3s for ubiquitin and ubiquitin-like modifiers, the C20orf116.Ufm1 formation was greatly accelerated by Ufl1. The C20orf116.Ufm1 conjugate was cleaved by Ufm1-specific proteases, implying the reversibility of ufmylation. The conjugation was abundant in the liver and lungs of Ufm1-transgenic mice, fractionated into membrane fraction, and impaired in Uba5 knock-out cells. Intriguingly, immunological analysis revealed localizations of Ufl1 and C20orf116 mainly to the endoplasmic reticulum. Our results provide novel insights into the Ufm1 system involved in cellular regulation of multicellular organisms.	[Tatsumi, Kanako; Sou, Yu-shin; Tanaka, Keiji; Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan; [Tatsumi, Kanako; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Tada, Norihiro; Nakamura, Eri] Juntendo Univ, Sch Med, Res Inst Dis, Div Genome Res,Old Age Grad Sch Med,Bunkyo Ku, Tokyo 1138421, Japan; [Sou, Yu-shin; Kominami, Eiki; Komatsu, Masaaki] Juntendo Univ, Sch Med, Res Inst Dis, Old Age Grad Sch Med,Dept Biochem,Bunkyo Ku, Tokyo 1138421, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Kohtoh Ku, Tokyo 1350064, Japan; [Kang, Sung Hwan; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Aoba Ku, Dept Med Biochem, Sendai, Miyagi 9808575, Japan; [Komatsu, Masaaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Juntendo University; Juntendo University; National Institute of Advanced Industrial Science & Technology (AIST); Seoul National University (SNU); Hokkaido University; Tohoku University; Japan Science & Technology Agency (JST)	Komatsu, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan.	komatsu-ms@igakuken.or.jp	Yamamoto, Masayuki/A-4873-2010; Natsume, Tohru/M-7627-2018; Kasahara, Masanori/G-7651-2011; Komatsu, Masaaki/B-8321-2011	Yamamoto, Masayuki/0000-0002-9073-9436; Natsume, Tohru/0000-0002-1510-2582; Komatsu, Masaaki/0000-0001-7672-7722; Sou, Yu-shin/0000-0002-7219-9106	Japan Science and Technology Agency; Ministry of Education, Science and Culture of Japan; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from the Japan Science and Technology Agency (to M. K.); the Ministry of Education, Science and Culture of Japan (to M. K. and K. T.); and New Energy and Industrial Technology Development Organization (to T.N.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; LEE GH, 1995, AM J PATHOL, V147, P1811; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Mizushima T, 2007, BIOCHEM BIOPH RES CO, V362, P1079, DOI 10.1016/j.bbrc.2007.08.129; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449	32	130	139	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5417	5427		10.1074/jbc.M109.036814	http://dx.doi.org/10.1074/jbc.M109.036814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018847	Green Published, hybrid			2022-12-25	WOS:000275327200035
J	Dudnakova, T; Spraggon, L; Slight, J; Hastie, N				Dudnakova, T.; Spraggon, L.; Slight, J.; Hastie, N.			Actin: a novel interaction partner of WT1 influencing its cell dynamic properties	ONCOGENE			English	Article						WT1; actin; nucleo-cytoplasmic shuttling	WILMS-TUMOR GENE; PROTEIN; TRANSCRIPTS; EXPRESSION; NUCLEUS; MYOSIN	The Wilms' tumour suppressor, WT1, is a zinc finger protein with key roles in normal development of the genitourinary system and tumourigenesis. Mutations or deletion of WT1 result in a spectrum of developmental disorders and susceptibility to Wilms' tumour in children. Ectopic expression of Wt1 associated with oncogenic functions has been observed in a large number of malignancies, including haematological and solid cancers. Although Wt1 is predominantly a nuclear protein in normal tissues, it is mostly cytoplasmic in the majority of Wt1-expressing tumours. Actin was identified in this study as a new WT1 interaction partner both in the nucleus and in the cytoplasm. We confirmed this interaction both in vitro and in vivo and started to explore its functional significance. Perturbation of the actin cytoskeleton moved Wt1 off the polysome fraction in the cytoplasm, cancelled its nucleo-cytoplasmic shuttling and altered Wt1 DNA- and RNA-binding abilities. These data have implications for Wt1 functions in relation to RNA metabolism and response to cytoskeletal alterations in cancer cells. Thus, our findings could shed more light on the functions of both these proteins and possibly pave way for the development of new cancer therapies. Oncogene (2010) 29, 1085-1092; doi:10.1038/onc.2009.444; published online 7 December 2009	[Dudnakova, T.; Spraggon, L.; Slight, J.; Hastie, N.] Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Spraggon, L.] Univ Newcastle, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England	University of Edinburgh; Newcastle University - UK	Hastie, N (corresponding author), Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	nick.hastie@hgu.mrc.ac.uk	Spraggon, Lee/E-5900-2012	Dudnakova, Tatyana/0000-0002-8388-8871	MRC; EU; MRC [MC_U127527180] Funding Source: UKRI; Medical Research Council [MC_U127527180] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Drs J Caceres and S Guil for their useful advice and GFP-hnRNP A1 and GFP-SF2 expressing constructs and anti-hnRNP A1 antibody. We also thank Mr Nick Tomczyk from the Chemistry Department at the University of Edinburgh for carrying out MALDI-TOF analysis. This study was funded by a core grant from the MRC and an EU Marie Curie Fellowship to TD.	Bing ZY, 2008, APPL IMMUNOHISTO M M, V16, P316, DOI 10.1097/PAI.0b013e31815c2e02; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; de Lanerolle P, 2005, NAT STRUCT MOL BIOL, V12, P742, DOI 10.1038/nsmb983; Discenza MT, 1997, NUCLEIC ACIDS RES, V25, P4314, DOI 10.1093/nar/25.21.4314; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gimona M, 2008, SEMIN CANCER BIOL, V18, P23, DOI 10.1016/j.semcancer.2007.08.005; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; Jomgeow T, 2006, CANCER SCI, V97, P259, DOI 10.1111/j.1349-7006.2006.00169.x; Ladomery M, 2003, J CELL SCI, V116, P1539, DOI 10.1242/jcs.00324; Ladomery MR, 1999, J BIOL CHEM, V274, P36520, DOI 10.1074/jbc.274.51.36520; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Louvet E, 2009, INT REV CEL MOL BIO, V272, P107, DOI 10.1016/S1937-6448(08)01603-1; Nakatsuka S, 2006, MODERN PATHOL, V19, P804, DOI 10.1038/modpathol.3800588; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Rao JY, 2004, CURR CANCER DRUG TAR, V4, P345, DOI 10.2174/1568009043332998; Sheikh S, 1997, BIOCHEM BIOPH RES CO, V238, P910, DOI 10.1006/bbrc.1997.7407; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; TELLMANN G, 2006, BIOCHEMICA MANNHEIM, V4, P16; Vajjhala PR, 2003, FEBS LETT, V554, P143, DOI 10.1016/S0014-5793(03)01144-X; Viney RL, 2007, PROTEOMICS, V7, P804, DOI 10.1002/pmic.200600666	22	23	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					1085	1092		10.1038/onc.2009.444	http://dx.doi.org/10.1038/onc.2009.444			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19966868				2022-12-25	WOS:000274604400014
J	Khattar, E; Kumar, V				Khattar, Ekta; Kumar, Vijay			Mitogenic Regulation of p27(Kip1) Gene Is Mediated by AP-1 Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; CELL-CYCLE; C-FOS; HEPATOCELLULAR-CARCINOMA; ACTIVATOR PROTEIN-1; INHIBITOR P27(KIP1); CDK INHIBITOR; EXPRESSION; PROMOTER; PROLIFERATION	The abundance of cyclin-dependent kinase inhibitor p27(Kip1) during the cell cycle determines whether cells will proliferate or become quiescent. Although the post-translational regulation of p27(Kip1) is well established, its transcriptional regulation is poorly understood. Here, we report that mitogenic stimulation of quiescent HEK293 and Huh7 cells showed a rapid decline in the levels of p27(Kip1) transcript by 2.4 +/- 0.1-fold. Inhibition of the p27(Kip1) gene in response to mitogens involved transcriptional down-regulation and required newly synthesized protein( s). Mutation of the AP-1 element at position -469 in the human p27(Kip1) promoter abrogated the effect of mitogens. The recruitment of the AP-1 complex to the p27(Kip1) promoter was confirmed by in vitro DNA binding and chromatin immunoprecipitation studies. Reporter gene analysis combined with enforced expression of Jun/Fos proteins suggested the involvement of Jun/Fos heterodimer in the transrepression process. Both MAPK and phosphatidylinositol 3-kinase signaling pathways appeared to mediate p27(Kip1) transcription. Furthermore, hepatitis B virus X protein-mediated down-regulation of p27(Kip1) in a transgenic environment correlated with an increase in c-Fos levels, reiterating the physiological relevance of AP-1 in the transcriptional regulation of p27(Kip1). Collectively, our studies present the first evidence demonstrating the role of the AP-1 complex in transcriptional down-regulation of the p27(Kip1) gene following mitogenic stimulation.	[Khattar, Ekta; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, POB 10504,Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in	Khattar, Ekta/AAE-7597-2020		International Centre for Genetic Engineering and Biotechnology, New Delhi, India	International Centre for Genetic Engineering and Biotechnology, New Delhi, India	This work was supported in part by a core grant of the International Centre for Genetic Engineering and Biotechnology, New Delhi, India.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bagui TK, 2009, CELL CYCLE, V8, P115, DOI 10.4161/cc.8.1.7527; Chassot AA, 2007, ONCOGENE, V26, P5772, DOI 10.1038/sj.onc.1210386; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Coleman J, 2001, BMC Mol Biol, V2, P12, DOI 10.1186/1471-2199-2-12; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Guller M, 2008, WORLD J GASTROENTERO, V14, P6339, DOI 10.3748/wjg.14.6339; GURNEY AL, 1992, J BIOL CHEM, V267, P18133; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; HATTORI M, 1993, AM J PHYSIOL, V264, pG95, DOI 10.1152/ajpgi.1993.264.1.G95; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Karla N, 2004, J BIOL CHEM, V279, P25313, DOI 10.1074/jbc.M400932200; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Liu YC, 1998, FEBS LETT, V441, P200, DOI 10.1016/S0014-5793(98)01549-X; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Minami S, 1997, FEBS LETT, V411, P1, DOI 10.1016/S0014-5793(97)00660-1; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ponzielli R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn735; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Williamson EA, 2002, ONCOGENE, V21, P3199, DOI 10.1038/sj.onc.1205461; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yuen MF, 2001, CANCER, V91, P106, DOI 10.1002/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2	41	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4554	4561		10.1074/jbc.M109.029280	http://dx.doi.org/10.1074/jbc.M109.029280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959471	Green Published, hybrid			2022-12-25	WOS:000275274800032
J	Luo, Y; Pollard, JW; Casadevall, A				Luo, Yong; Pollard, Jeffrey W.; Casadevall, Arturo			Fc gamma Receptor Cross-linking Stimulates Cell Proliferation of Macrophages via the ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PERITONEAL EXUDATE CELLS; CATALYTIC SUBUNIT P34(PSK-J3)/CDK4; INDUCED GRANULOMA-FORMATION; MEDIATED PHAGOCYTOSIS; MURINE MACROPHAGES; BLOOD MONOCYTES; IN-VITRO; TYROSINE PHOSPHORYLATION; CRYPTOCOCCUS-NEOFORMANS	Macrophage proliferation can be stimulated by phagocytosis and by cross-linking of Fc gamma receptors (Fc gamma R). In this study, we investigated the role of Fc gamma R and the signaling cascades that link Fc gamma R activation to cell cycle progression. This effect was mediated by the activating Fc gamma R, including Fc gamma RI and III, via their Fc gamma subunit. Further investigation revealed that the cell cycle machinery was activated by Fc gamma R cross-linking through downstream signaling events. Specifically, we identified the extracellular signal-regulated kinase (ERK) signaling pathway as a mediator of signals from Fc gamma R activation to cyclin D1 expression, because cyclin D1 expression associated with Fc gamma R cross-linking was attenuated by specific inhibitors of the ERK1/2 signaling pathway, PD98059 and U0126 and the spleen tyrosine kinase (Syk) inhibitor, Piceatannol. Our findings establish a link between the ERK activation and cell cycle signaling pathways, thus providing a causal mechanism by which Fc gamma R activation produces a mitogenic effect that stimulates macrophage proliferation. Macrophage mitosis following Fc gamma R activation could potentially affect the outcome of macrophage interactions with intracellular pathogens. In addition, our results suggest the possibility of new treatment options for certain infectious diseases, chronic inflammatory diseases, and leukemias based on interference with Fc gamma R-stimulated macrophage cell proliferation.	[Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave,Forch 411, Bronx, NY 10461 USA.	arturo.casadevall@einstein.yu.edu			National Institutes of Health [AI033142, AI033774, AI052733, HL059842]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030280] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA089617, R01CA131270, T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R01AI033774, R37AI033142, U54AI057158, R01AI052733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI033142, AI033774, AI052733, and HL059842.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; Blom AB, 1999, CYTOKINE, V11, P1046, DOI 10.1006/cyto.1999.0503; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CANNON GJ, 1992, J CELL SCI, V101, P907; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Chen B, 2003, MOL ENDOCRINOL, V17, P1368, DOI 10.1210/me.2003-0036; Chen YC, 2006, WORLD J GASTROENTERO, V12, P5972, DOI 10.3748/wjg.v12.i37.5972; Cote-Velez MJA, 1999, IMMUNOL LETT, V67, P251, DOI 10.1016/S0165-2478(99)00021-8; DAEMS WT, 1982, IMMUNOBIOLOGY, V161, P204, DOI 10.1016/S0171-2985(82)80075-2; DEBAKKER JM, 1985, J SUBMICR CYTOL PATH, V17, P133; DEFRANCO AL, 1982, J EXP MED, V155, P1523, DOI 10.1084/jem.155.5.1523; DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DURDEN DL, 1995, J IMMUNOL, V154, P4039; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FORBES IJ, 1966, J IMMUNOL, V96, P734; GANDOUR DM, 1983, J IMMUNOL, V130, P1108; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P107; GOLD MR, 1995, INT REV CYTOL, V157, P181, DOI 10.1016/S0074-7696(08)62159-2; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Karimi K, 1998, INFLAMMATION, V22, P67, DOI 10.1023/A:1022347808042; Kortylewski M, 2001, BIOCHEM J, V357, P297, DOI 10.1042/0264-6021:3570297; Krasinskas AM, 1998, AM J CLIN PATHOL, V110, P797; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; LIN HS, 1974, J CELL PHYSIOL, V83, P369, DOI 10.1002/jcp.1040830307; LIN HS, 1973, NATURE-NEW BIOL, V243, P176, DOI 10.1038/newbio243176a0; Luo Y, 2005, J IMMUNOL, V174, P7226, DOI 10.4049/jimmunol.174.11.7226; Luo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003219; Marsh CB, 1999, J IMMUNOL, V162, P6217; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MIMS CA, 1964, BRIT J EXP PATHOL, V45, P37; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; MURCH AR, 1981, J PATHOL, V133, P177, DOI 10.1002/path.1711330302; NAITO M, 1991, LAB INVEST, V64, P664; Naito M, 1997, MOL REPROD DEV, V46, P85; Nelson MB, 2001, NEOPLASIA, V3, P115, DOI 10.1038/sj.neo.7900140; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Reid S, 1996, MOL IMMUNOL, V33, P1139, DOI 10.1016/S0161-5890(96)00065-X; REIKVAM A, 1976, ACTA PATH MICRO IM C, V84, P161; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; RIDLEY MJ, 1982, J PATHOL, V136, P59, DOI 10.1002/path.1711360106; Rose DM, 1997, BIOCHEM BIOPH RES CO, V238, P256, DOI 10.1006/bbrc.1997.7271; Rose DM, 1997, J IMMUNOL, V158, P3433; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; SAWYER RT, 1982, LAB INVEST, V46, P165; SCOTT CS, 1983, J CLIN PATHOL, V36, P555, DOI 10.1136/jcp.36.5.555; Song XY, 2004, J LEUKOCYTE BIOL, V75, P1147, DOI 10.1189/jlb.0403128; STEWART CC, 1975, J EXP MED, V141, P1114, DOI 10.1084/jem.141.5.1114; TAKEMURA R, 1986, J CELL BIOL, V102, P55, DOI 10.1083/jcb.102.1.55; Tanguay DA, 1996, J IMMUNOL, V156, P539; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; TSITSIKOV EN, 1995, INT IMMUNOL, V7, P1665, DOI 10.1093/intimm/7.10.1665; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vadiveloo PK, 1999, J LEUKOCYTE BIOL, V66, P579, DOI 10.1002/jlb.66.4.579; VANDERZEIJST BAM, 1978, J EXP MED, V147, P1253, DOI 10.1084/jem.147.4.1253; VIDRIALES MB, 1995, BRIT J HAEMATOL, V89, P342, DOI 10.1111/j.1365-2141.1995.tb03310.x; Voigt H, 1999, CELL MICROBIOL, V1, P195, DOI 10.1046/j.1462-5822.1999.00021.x; WALKER WS, 1988, CELL IMMUNOL, V111, P492, DOI 10.1016/0008-8749(88)90112-8; WESTERMANN J, 1989, J LEUKOCYTE BIOL, V46, P263, DOI 10.1002/jlb.46.3.263; YAMADA M, 1990, J LEUKOCYTE BIOL, V47, P195, DOI 10.1002/jlb.47.3.195; YUAN RR, 1995, J IMMUNOL, V154, P1810	72	29	29	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4232	4242		10.1074/jbc.M109.037168	http://dx.doi.org/10.1074/jbc.M109.037168			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996316	hybrid, Green Published			2022-12-25	WOS:000275254000075
J	Okada, T; Tomita, T; Wulandari, AP; Kuzuyama, T; Nishiyama, M				Okada, Takuya; Tomita, Takeo; Wulandari, Asri P.; Kuzuyama, Tomohisa; Nishiyama, Makoto			Mechanism of Substrate Recognition and Insight into Feedback Inhibition of Homocitrate Synthase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ISOPROPYLMALATE SYNTHASE; LYSINE BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; SACCHAROMYCES-CEREVISIAE; LEPTOSPIRA-INTERROGANS; CITRAMALATE SYNTHASE; REGULATORY MECHANISM; AMINOADIPATE PATHWAY; CRYSTAL-STRUCTURE; MOLECULAR-BASIS	Homocitrate synthase (HCS) catalyzes aldol-type condensation of acetyl coenzyme A (acetyl-CoA) and alpha-ketoglutarate (alpha-KG) to synthesize homocitrate (HC), which is the first and committed step in the lysine biosynthetic pathway through alpha-aminoadipate. As known in most enzymes catalyzing the first reactions in amino acid biosynthetic pathways, HCS is regulated via feedback inhibition by the end product, lysine. Here, we determined the crystal structures of HCS from Thermus thermophilus complexed with alpha-KG, HC, or lysine. In the HC complex, the C1-carboxyl group of HC, which is derived from acetyl-CoA, is hydrogen-bonded with His-292* from another subunit (indicated by the asterisk), indicating direct involvement of this residue in the catalytic mechanism of HCS. The crystal structure of HCS complexed with lysine showed that lysine is bound to the active site with rearrangement of amino acid residues in the substrate-binding site, which accounts for the competitive inhibition by lysine with alpha-KG. Comparison between the structures suggests that His-72, which is conserved in lysine-sensitive HCSs and binds the C5-carboxyl group of alpha-KG, serves as a switch for the conformational change. Replacement of His-72 by leucine made HCS resistant to lysine inhibition, demonstrating the regulatory role of this conserved residue.	[Okada, Takuya; Tomita, Takeo; Wulandari, Asri P.; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Nishiyama, Makoto] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan	University of Tokyo; RIKEN	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Kuzuyama, Tomohisa/0000-0002-7221-5858; Nishiyama, Makoto/0000-0001-8143-8052	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nagase Science and Technology Foundation; Asahi Glass Foundation; Charitable Trust Araki Medical and Biochemistry Memorial Research Promotion Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagase Science and Technology Foundation; Asahi Glass Foundation; Charitable Trust Araki Medical and Biochemistry Memorial Research Promotion Fund	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from the Nagase Science and Technology Foundation, from the Asahi Glass Foundation, and from the Charitable Trust Araki Medical and Biochemistry Memorial Research Promotion Fund. This work was performed with approval from the Photon Factory Program Advisory Committee (Proposals 2007G530 and 2009G540).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2005, J BIOL CHEM, V280, P31633, DOI 10.1074/jbc.M502847200; BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; Broquist HP., 1971, METHODS ENZYMOL, V17B, P112; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; Cavalieri D, 1999, MOL GEN GENET, V261, P152, DOI 10.1007/s004380050952; CHATTERJEE SP, 1994, PLANT MOL BIOL, V26, P285, DOI 10.1007/BF00039539; *COMP COLL PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, P760; Cox RJ, 1996, NAT PROD REP, V13, P29, DOI 10.1039/np9961300029; de Carvalho LPS, 2005, J AM CHEM SOC, V127, P10004, DOI 10.1021/ja052513h; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; de Carvalho LPS, 2009, BIOCHEMISTRY-US, V48, P1996, DOI 10.1021/bi801707t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; HADLER HI, 1963, BIOCHEMISTRY-US, V2, P954, DOI 10.1021/bi00905a010; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LUENGO JM, 1980, J BACTERIOL, V144, P869, DOI 10.1128/JB.144.3.869-876.1980; Ma J, 2008, BIOCHEM J, V415, P45, DOI 10.1042/BJ20080242; MCLEAN PA, 1981, NATURE, V292, P655, DOI 10.1038/292655a0; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki J, 2002, FEBS LETT, V512, P269, DOI 10.1016/S0014-5793(02)02290-1; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian JH, 2008, BIOCHEMISTRY-US, V47, P6851, DOI 10.1021/bi800087k; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Tsubouchi T, 2005, J BIOL CHEM, V280, P18511, DOI 10.1074/jbc.M414456200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Zhang P, 2009, BIOCHEM J, V421, P133, DOI 10.1042/BJ20090336	42	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4195	4205		10.1074/jbc.M109.086330	http://dx.doi.org/10.1074/jbc.M109.086330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996101	hybrid, Green Published			2022-12-25	WOS:000275254000071
J	Saxena, G; Chen, JQ; Shalev, A				Saxena, Geetu; Chen, Junqin; Shalev, Anath			Intracellular Shuttling and Mitochondrial Function of Thioredoxin-interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATING KINASE-1; BETA-CELL APOPTOSIS; OXIDATIVE STRESS; GENE-EXPRESSION; MAMMALIAN THIOREDOXIN; CARDIAC-HYPERTROPHY; GLUCOSE TOXICITY; BINDING-PROTEINS; REDOX REGULATION; IMPORTIN-ALPHA	The thioredoxin-interacting protein TXNIP is a ubiquitously expressed redox protein that promotes apoptosis. Recently, we found that TXNIP deficiency protects against type 1 and 2 diabetes by inhibiting beta cell apoptosis and maintaining pancreatic beta cell mass, indicating that TXNIP plays a key role in beta cell biology. However, very little is known about the intracellular localization and function of TXNIP, and although TXNIP has been thought to be a cytoplasmic protein, our immunohistochemistry studies in beta cells surprisingly revealed a nuclear TXNIP localization, suggesting that TXNIP may shuttle within the cell. Using immunohistochemistry/confocal imaging and cell fractionation/co-immunoprecipitation, we found that, under physiological conditions, TXNIP is localized primarily in the nucleus of pancreatic beta cells, whereas oxidative stress leads to TXNIP shuttling into the mitochondria. In mitochondria, TXNIP binds to and oxidizes Trx2, thereby reducing Trx2 binding to ASK1 and allowing for ASK1 phosphorylation/activation, resulting in induction of the mitochondrial pathway of apoptosis with cytochrome c release and caspase-3 cleavage. TXNIP overexpression and Trx2 (but not cytosolic Trx1) silencing mimic these effects. Thus, we discovered that TXNIP shuttles between subcellular compartments in response to oxidative stress and identified a novel redox-sensitive mitochondrial TXNIP-Trx2-ASK1 signaling cascade.	[Shalev, Anath] Univ Wisconsin, Dept Med, Clin Sci Ctr H4 526, Madison, WI 53792 USA; William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Shalev, A (corresponding author), Univ Wisconsin, Dept Med, Clin Sci Ctr H4 526, 600 Highland Ave, Madison, WI 53792 USA.	as7@medicine.wisc.edu			National Institutes of Health [R01DK-078752]; NIDDK [R21HL-089205]; NHLBI; American Diabetes Association [7-07-CD-22]; Juvenile Diabetes Research Foundation [1-2007-790]; William S. Middleton Memorial Veterans Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); William S. Middleton Memorial Veterans Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK-078752 from NIDDK and R21HL-089205 from NHLBI (to A. S.). This work was also supported by American Diabetes Association Grant 7-07-CD-22 and Juvenile Diabetes Research Foundation Grant 1-2007-790) (to A. S.) and is the result of work supported by resources and use of facilities at the William S. Middleton Memorial Veterans Hospital (Madison, WI).	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Cheng Davis W., 2006, Archives of Physiology and Biochemistry, V112, P189, DOI 10.1080/13813450601093518; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Dutta KK, 2005, LAB INVEST, V85, P798, DOI 10.1038/labinvest.3700280; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim KY, 2004, BIOCHEM BIOPH RES CO, V315, P369, DOI 10.1016/j.bbrc.2004.01.047; Liang MY, 2007, ARTERIOSCL THROM VAS, V27, P77, DOI 10.1161/01.ATV.0000251006.54632.bb; Lim PLK, 2008, TOXICOL SCI, V101, P341, DOI 10.1093/toxsci/kfm273; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yodoi J, 2002, BIOL CHEM, V383, P585, DOI 10.1515/BC.2002.060; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7	43	198	204	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3997	4005		10.1074/jbc.M109.034421	http://dx.doi.org/10.1074/jbc.M109.034421			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959470	Green Published, hybrid			2022-12-25	WOS:000275254000053
J	Tada, H; Okano, HJ; Takagi, H; Shibata, S; Yao, I; Matsumoto, M; Saiga, T; Nakayama, KI; Kashima, H; Takahashi, T; Setou, M; Okano, H				Tada, Hirobumi; Okano, Hirotaka James; Takagi, Hiroshi; Shibata, Shinsuke; Yao, Ikuko; Matsumoto, Masaki; Saiga, Toru; Nakayama, Keiichi I.; Kashima, Haruo; Takahashi, Takuya; Setou, Mitsutoshi; Okano, Hideyuki			Fbxo45, a Novel Ubiquitin Ligase, Regulates Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; F-BOX PROTEIN; CELL-CYCLE; SYNAPTOPHYSIN DEGRADATION; NEUROTRANSMITTER RELEASE; NEURONAL DEVELOPMENT; MESSENGER-RNA; MAMMALIAN CNS; C-ELEGANS; SYSTEM	Neurons communicate with each other through synapses. To establish the precise yet flexible connections that make up neural networks in the brain, continuous synaptic modulation is required. The ubiquitin-proteasome system of protein degradation is one of the critical mechanisms that underlie this process, playing crucial roles in the regulation of synaptic structure and function. We identified a novel ubiquitin ligase, Fbxo45, that functions at synapses. Fbxo45 is evolutionarily conserved and selectively expressed in the nervous system. We demonstrated that the knockdown of Fbxo45 in primary cultured hippocampal neurons resulted in a greater frequency of miniature excitatory postsynaptic currents. We also found that Fbxo45 induces the degradation of a synaptic vesicle-priming factor, Munc13-1. We propose that Fbxo45 plays an important role in the regulation of neurotransmission by modulating Munc13-1 at the synapse.	[Okano, Hirotaka James] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608502, Japan; [Tada, Hirobumi; Okano, Hideyuki] Keio Univ, Sch Med, Bridgestone Lab Dev & Regenerat Neurobiol, Tokyo 1608502, Japan; [Kashima, Haruo] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608502, Japan; [Tada, Hirobumi; Takahashi, Takuya] Yokohama City Univ, Sch Med, Dept Physiol, Kanagawa 2360004, Japan; [Okano, Hirotaka James; Okano, Hideyuki] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan; [Matsumoto, Masaki; Saiga, Toru; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Takagi, Hiroshi; Yao, Ikuko; Setou, Mitsutoshi] Mitsubishi Kagaku Inst, Life Sci Setou Grp, Lab Mol Gerontol, Tokyo 1948511, Japan; [Matsumoto, Masaki; Saiga, Toru; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Hamamatsu, Shizuoka 4313192, Japan	Keio University; Keio University; Keio University; Yokohama City University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyushu University; Hamamatsu University School of Medicine	Okano, HJ (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608502, Japan.	hjokano@sc.itc.keio.ac.jp; setou@hama-med.ac.jp; hidokano@sc.itc.keio.ac.jp	Okano, Hideyuki/I-7584-2019; Tada, Hirobumi/ABB-7665-2020; Shibata, Shinsuke/AAM-6620-2020	Okano, Hirotaka James/0000-0003-4611-7098; Matsumoto, Masaki/0000-0002-6987-0288	Solution-oriented Research for Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science; Keio University; grant-in-aid for Scientific Research on Priority Areas; WAKATE S and SENTAN	Solution-oriented Research for Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University; grant-in-aid for Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); WAKATE S and SENTAN	This work was supported by grants from Solution-oriented Research for Science and Technology, the Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to Hideyuki Okano) and by grants from Japan Society for the Promotion of Science, the Keio University grant-in-aid for Encouragement of Young Medical Scientists (to H. Tada), a grant-in-aid for Scientific Research on Priority Areas (to H. J. Okano), WAKATE S and SENTAN (to M. S.), and a grant-in-aid for the Global COE program (to Keio University) from the MEXT, Japan.	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Deak F, 2009, J NEUROSCI, V29, P8639, DOI 10.1523/JNEUROSCI.0898-09.2009; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fukaya M, 2008, EUR J NEUROSCI, V28, P1744, DOI 10.1111/j.1460-9568.2008.06495.x; Haas KF, 2008, BBA-GENE REGUL MECH, V1779, P495, DOI 10.1016/j.bbagrm.2007.12.010; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Hennou S, 2003, EUR J NEUROSCI, V18, P811, DOI 10.1046/j.1460-9568.2003.02812.x; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; PICKART CM, 2001, ANNU REV BIOCHEM, V503, P533; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Yao I, 1999, J BIOL CHEM, V274, P11889, DOI 10.1074/jbc.274.17.11889; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Yoshida K, 2005, ONCOL REP, V14, P531; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	55	61	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3840	3849		10.1074/jbc.M109.046284	http://dx.doi.org/10.1074/jbc.M109.046284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996097	Green Published, hybrid			2022-12-25	WOS:000275254000037
J	Hamm, CA; Xie, HH; Costa, FF; Vanin, EF; Seftor, EA; Sredni, ST; Bischof, J; Wang, DL; Bonaldo, MF; Hendrix, MJC; Soares, MB				Hamm, Christopher A.; Xie, Hehuang; Costa, Fabricio F.; Vanin, Elio F.; Seftor, Elisabeth A.; Sredni, Simone T.; Bischof, Jared; Wang, Deli; Bonaldo, Maria F.; Hendrix, Mary J. C.; Soares, Marcelo B.			Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2 '-Deoxycytidine Results in Increased Tumorigenicity	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; DNA METHYLATION; GENE-EXPRESSION; BREAST-CANCER; SILENCED GENES; MESSENGER-RNA; HUMAN GENOME; STEM-CELLS; MIDKINE; METHYLTRANSFERASE	Abnormal patterns of DNA methylation are observed in several types of human cancer. While localized DNA methylation of CpG islands has been associated with gene silencing, the effect that genome-wide loss of methylation has on tumorigenesis is not completely known. To examine its effect on tumorigenesis, we induced DNA demethylation in a rat model of human chondrosarcoma using 5-aza-2-deoxycytidine. Rat specific pyrosequencing assays were utilized to assess the methylation levels in both LINEs and satellite DNA sequences following 5-aza-2-deoxycytidine treatment. Loss of DNA methylation was accompanied by an increase in invasiveness of the rat chondrosarcoma cells, in vitro, as well as by an increase in tumor growth in vivo. Subsequent microarray analysis provided insight into the gene expression changes that result from 5-aza-2-deoxycytidine induced DNA demethylation. In particular, two genes that may function in tumorigenesis, sox-2 and midkine, were expressed at low levels in control cells but upon 5-aza-2-deoxycytidine treatment these genes became overexpressed. Promoter region DNA analysis revealed that these genes were methylated in control cells but became demethylated following 5-aza-2-deoxycytidine treatment. Following withdrawal of 5-aza-2-deoxycytidine, the rat chondrosarcoma cells reestablished global DNA methylation levels that were comparable to that of control cells. Concurrently, invasiveness of the rat chondrosarcoma cells, in vitro, decreased to a level indistinguishable to that of control cells. Taken together these experiments demonstrate that global DNA hypomethylation induced by 5-aza-2-deoxycytidine may promote specific aspects of tumorigenesis in rat chondrosarcoma cells.	[Hamm, Christopher A.] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA; [Hamm, Christopher A.; Xie, Hehuang; Costa, Fabricio F.; Vanin, Elio F.; Seftor, Elisabeth A.; Sredni, Simone T.; Bischof, Jared; Bonaldo, Maria F.; Hendrix, Mary J. C.; Soares, Marcelo B.] Childrens Mem Res Ctr, Falk Brain Tumor Ctr, Canc Biol & Epigenom Program, Chicago, IL USA; [Xie, Hehuang; Bonaldo, Maria F.; Hendrix, Mary J. C.; Soares, Marcelo B.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Deli] Northwestern Univ, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	University of Iowa; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	Hamm, CA (corresponding author), Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA.	mbsoares@childrensmemorial.org	Costa, Fabricio/M-5309-2017	Sredni, Simone/0000-0002-1715-3885	The Everett/O'Connor Charitable Trust; Dr. Ralph and Marian C. Falk Medical Research Trust; Gus Foundation; The Maeve McNicholas Memorial Foundation; Medical Research Institute Council	The Everett/O'Connor Charitable Trust; Dr. Ralph and Marian C. Falk Medical Research Trust; Gus Foundation; The Maeve McNicholas Memorial Foundation; Medical Research Institute Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Everett/O'Connor Charitable Trust; Dr. Ralph and Marian C. Falk Medical Research Trust; Gus Foundation; The Maeve McNicholas Memorial Foundation; Medical Research Institute Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2002, VIRCHOWS ARCH, V441, P219, DOI 10.1007/s00428-002-0641-X; Asp J, 2001, J ORTHOPAED RES, V19, P149, DOI 10.1016/S0736-0266(00)00022-X; Asp J, 2000, INT J CANCER, V85, P782, DOI 10.1002/(SICI)1097-0215(20000315)85:6<782::AID-IJC7>3.0.CO;2-O; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Cayre A, 2003, BREAST CANCER RES, V5, pR223, DOI 10.1186/bcr652; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHOI HU, 1971, P NATL ACAD SCI USA, V68, P877, DOI 10.1073/pnas.68.5.877; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Costa FF, 2006, CANCER GENET CYTOGEN, V165, P135, DOI 10.1016/j.cancergencyto.2005.07.023; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Ijichi N, 2004, J BIOCHEM, V135, P413, DOI 10.1093/jb/mvh049; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Ivanov O, 2008, BREAST CANCER RES TR, V111, P411, DOI 10.1007/s10549-007-9796-0; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Kato M, 2000, MODERN PATHOL, V13, P1060, DOI 10.1038/modpathol.3880195; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King KB, 2003, J CELL BIOCHEM, V89, P992, DOI 10.1002/jcb.10571; Lee FY, 1999, J BONE JOINT SURG AM, V81A, P326, DOI 10.2106/00004623-199903000-00004; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; MAIBENCO HC, 1967, CANCER RES, V27, P362; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Morcuende Jose A, 2002, Iowa Orthop J, V22, P28; Mund C, 2005, CANCER RES, V65, P7086, DOI 10.1158/0008-5472.CAN-05-0695; Mund C, 2006, EPIGENETICS-US, V1, P7; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Ropke M, 2003, PATHOL RES PRACT, V199, P437, DOI 10.1078/0344-0338-00443; ROSE JK, 1981, J VIROL, V39, P519, DOI 10.1128/JVI.39.2.519-528.1981; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Sanada Y, 2006, ONCOL REP, V15, P1157; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Soderstrom M, 2001, MATRIX BIOL, V19, P717, DOI 10.1016/S0945-053X(00)00124-4; Soderstrom M, 2001, APMIS, V109, P305, DOI 10.1034/j.1600-0463.2001.d01-125.x; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Stevens Jeff W, 2005, Iowa Orthop J, V25, P135; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Stuart JJ, 2000, BIOCHEM BIOPH RES CO, V274, P641, DOI 10.1006/bbrc.2000.3189; Takai Daiya, 2003, In Silico Biology, V3, P235; Tanabe K, 2008, CANCER SCI, V99, P1125, DOI 10.1111/j.1349-7006.2008.00796.x; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028; Zou P, 2006, J NEUROCHEM, V99, P1470, DOI 10.1111/j.1471-4159.2006.04138.x	55	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8340	10.1371/journal.pone.0008340	http://dx.doi.org/10.1371/journal.pone.0008340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019818	gold, Green Published, Green Submitted			2022-12-25	WOS:000272834200007
J	Salas, A; Fachal, L; Marcos-Alonso, S; Vega, A; Martinon-Torres, F				Salas, Antonio; Fachal, Laura; Marcos-Alonso, Sonia; Vega, Ana; Martinon-Torres, Federico		Grp Invest ESIGEM	Investigating the Role of Mitochondrial Haplogroups in Genetic Predisposition to Meningococcal Disease	PLOS ONE			English	Article							SPORADIC BREAST-CANCER; NEISSERIA-MENINGITIDIS; POPULATION-STRUCTURE; HUMAN MTDNA; DNA; PHYLOGENY; ANCESTRY; EVOLUTIONARY; MUTATIONS; SURVIVAL	Background and Aims: Meningococcal disease remains one of the most important infectious causes of death in industrialized countries. The highly diverse clinical presentation and prognosis of Neisseria meningitidis infections are the result of complex host genetics and environmental interactions. We investigated whether mitochondrial genetic background contributes to meningococcal disease (MD) susceptibility. Methodology/Principal Findings: Prospective controlled study was performed through a national research network on MD that includes 41 Spanish hospitals. Cases were 307 paediatric patients with confirmed MD, representing the largest series of MD patients analysed to date. Two independent sets of ethnicity-matched control samples (CG1 [N = 917]), and CG2 [N = 616]) were used for comparison. Cases and controls underwent mtDNA haplotyping of a selected set of 25 mtDNA SNPs (mtSNPs), some of them defining major European branches of the mtDNA phylogeny. In addition, 34 ancestry informative markers (AIMs) were genotyped in cases and CG2 in order to monitor potential hidden population stratification. Samples of known African, Native American and European ancestry (N = 711) were used as classification sets for the determination of ancestral membership of our MD patients. A total of 39 individuals were eliminated from the main statistical analyses (including fourteen gypsies) on the basis of either non-Spanish self-reported ancestry or the results of AIMs indicating a European membership lower than 95%. Association analysis of the remaining 268 cases against CG1 suggested an overrepresentation of the synonym mtSNP G11719A variant (Pearson's chi-square test; adjusted P-value = 0.0188; OR [95% CI] = 1.63 [1.22-2.18]). When cases were compared with CG2, the positive association could not be replicated. No positive association has been observed between haplogroup (hg) status of cases and CG1/CG2 and hg status of cases and several clinical variants. Conclusions: We did not find evidence of association between mtSNPs and mtDNA hgs with MD after carefully monitoring the confounding effect of population sub-structure. MtDNA variability is particularly stratified in human populations owing to its low effective population size in comparison with autosomal markers and therefore, special care should be taken in the interpretation of seeming signals of positive associations in mtDNA case-control association studies.	[Salas, Antonio; Fachal, Laura] Univ Santiago de Compostela, Unidad Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain; [Salas, Antonio; Fachal, Laura] Univ Santiago de Compostela, Inst Med Legal, Santiago De Compostela, Galicia, Spain; [Fachal, Laura; Vega, Ana] Hosp Clin Univ Santiago, Fdn Publ Galega Med Xenom, Santiago De Compostela, Galicia, Spain; [Marcos-Alonso, Sonia] Hosp Univ A Coruna, Serv Pediat, La Coruna, Galicia, Spain; [Martinon-Torres, Federico] Hosp Clin Univ Santiago, Serv Crit Intermedios & Urgencias Pediat, Santiago De Compostela, Galicia, Spain; [Martinon-Torres, Federico] Inst Invest Sanitaria Santiago, Grp Gallego Genet Vacunas & Invest Pediat, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complejo Hospitalario Universitario A Coruna; Complexo Hospitalario Universitario de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Unidad Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain.	antonio.salas@usc.es	Fachal, Laura/N-5560-2014; Vega, Ana/R-4758-2019; Salas, Antonio/E-3977-2012; Miguel, Ana Mosquera/ABG-9735-2020; Martinon-Torres, Federico/E-4982-2016; Salas, Antonio/U-2029-2019	Fachal, Laura/0000-0002-7256-9752; Salas, Antonio/0000-0002-2336-702X; Miguel, Ana Mosquera/0000-0003-3939-8338; Martinon-Torres, Federico/0000-0002-9023-581X; Salas, Antonio/0000-0002-2336-702X; Esteban, Elisabeth/0000-0003-0159-0375; Concha-Torre, Andres/0000-0002-0698-1570; Munoz-Bonet, Juan Ignacio/0000-0003-4392-6834	Xunta de Galicia [PGIDIT06PXIB208079PR, Grupos Emerxentes: 2008/037]; Fundacion de Investigacion Medica Mutua Madrilena [2008/CL444]; Ministerio de Ciencia e Innovacion [SAF2008-02971]; Instituto Carlos III (Intensificacion de la actividad investigadora); Conselleria de Sanidade [RHI07/2-intensificacion actividad investigadora]; Instituto Carlos III; Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion IDICHUS); Fondo de Investigacion Sanitaria [PI070069]; 'fondos FEDER'	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); Conselleria de Sanidade; Instituto Carlos III(Instituto de Salud Carlos III); Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion IDICHUS); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); 'fondos FEDER'(European Commission)	The present project and the ESIGEM research group were supported by grants from Xunta de Galicia (PGIDIT06PXIB208079PR and Grupos Emerxentes: 2008/037), Fundacion de Investigacion Medica Mutua Madrilena (2008/CL444) and Ministerio de Ciencia e Innovacion (SAF2008-02971) given to AS; Instituto Carlos III (Intensificacion de la actividad investigadora) given to AVG; Conselleria de Sanidade (Xunta de Galicia, RHI07/2-intensificacion actividad investigadora), Instituto Carlos III (Intensificacion de la actividad investigadora), and Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion IDICHUS), Fondo de Investigacion Sanitaria (FIS; PI070069) del plan nacional de I+D+I and 'fondos FEDER' given to FMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Amigo J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S3-S5; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chinnery PF, 1999, LANCET, V354, pSI17; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Hodgetts TJ, 1998, J ACCID EMERG MED, V15, P72; Houshmand M, 2007, RESPIROLOGY, V12, P823, DOI 10.1111/j.1440-1843.2007.01163.x; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Ioannidis JPA, 2007, PLOS MED, V4, P1132, DOI 10.1371/journal.pmed.0040215; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2007, REV CLIN ESP, V207, P563, DOI 10.1157/13111575; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vega A, 2009, GYNECOL ONCOL, V112, P210, DOI 10.1016/j.ygyno.2008.09.012; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343	55	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8347	10.1371/journal.pone.0008347	http://dx.doi.org/10.1371/journal.pone.0008347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019817	gold, Green Published, Green Submitted			2022-12-25	WOS:000272834200013
J	Feng, WG; Leach, SM; Tipney, H; Phang, T; Geraci, M; Spritz, RA; Hunter, LE; Williams, T				Feng, Weiguo; Leach, Sonia M.; Tipney, Hannah; Phang, Tzulip; Geraci, Mark; Spritz, Richard A.; Hunter, Lawrence E.; Williams, Trevor			Spatial and Temporal Analysis of Gene Expression during Growth and Fusion of the Mouse Facial Prominences	PLOS ONE			English	Article							CRANIOFACIAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; TRANSCRIPTIONAL CONTROL; MICROARRAY ANALYSIS; CLEFT LIP/PALATE; BRANCHIAL ARCH; NEURAL CREST; CELLS; DIFFERENTIATION; MICE	Orofacial malformations resulting from genetic and/or environmental causes are frequent human birth defects yet their etiology is often unclear because of insufficient information concerning the molecular, cellular and morphogenetic processes responsible for normal facial development. We have, therefore, derived a comprehensive expression dataset for mouse orofacial development, interrogating three distinct regions - the mandibular, maxillary and frontonasal prominences. To capture the dynamic changes in the transcriptome during face formation, we sampled five time points between E10.5-E12.5, spanning the developmental period from establishment of the prominences to their fusion to form the mature facial platform. Seven independent biological replicates were used for each sample ensuring robustness and quality of the dataset. Here, we provide a general overview of the dataset, characterizing aspects of gene expression changes at both the spatial and temporal level. Considerable coordinate regulation occurs across the three prominences during this period of facial growth and morphogenesis, with a switch from expression of genes involved in cell proliferation to those associated with differentiation. An accompanying shift in the expression of polycomb and trithorax genes presumably maintains appropriate patterns of gene expression in precursor or differentiated cells, respectively. Superimposed on the many coordinated changes are prominence-specific differences in the expression of genes encoding transcription factors, extracellular matrix components, and signaling molecules. Thus, the elaboration of each prominence will be driven by particular combinations of transcription factors coupled with specific cell: cell and cell: matrix interactions. The dataset also reveals several prominence-specific genes not previously associated with orofacial development, a subset of which we externally validate. Several of these latter genes are components of bidirectional transcription units that likely share cis-acting sequences with well-characterized genes. Overall, our studies provide a valuable resource for probing orofacial development and a robust dataset for bioinformatic analysis of spatial and temporal gene expression changes during embryogenesis.	[Feng, Weiguo; Williams, Trevor] Univ Colorado Denver, Dept Craniofacial Biol, Aurora, CO USA; [Williams, Trevor] Univ Colorado Denver, Dept Cell & Dev Biol, Aurora, CO USA; [Leach, Sonia M.; Tipney, Hannah; Phang, Tzulip; Hunter, Lawrence E.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Geraci, Mark] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Spritz, Richard A.] Univ Colorado Denver, Human Med Genet Program, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Feng, WG (corresponding author), Univ Colorado Denver, Dept Craniofacial Biol, Aurora, CO USA.	trevor.williams@ucdenver.edu	wang, edwin/G-5372-2010	Hunter, Lawrence/0000-0003-1455-3370	National Institutes of Health [DE15191 (R.A.S.), LM008111 (L.E.H.), GM083649 (L.E.H.), DE12728 (T.W.)]; An institutional training [T15LM009451]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083649] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008111, T15LM009451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); An institutional training; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by National Institutes of Health Grants DE15191 (R.A.S.), LM008111 (L.E.H.), GM083649 (L.E.H.) and DE12728 (T.W.). An institutional training grant T15LM009451 supported S.M.L. and an AstraZeneca-Fulbright Scholarship supported H.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avila JR, 2006, AM J MED GENET A, V140A, P2562, DOI 10.1002/ajmg.a.31367; Awakura Y, 2008, INT J ONCOL, V33, P893, DOI 10.3892/ijo_00000078; Benayahu D, 2007, CRIT REV EUKAR GENE, V17, P103, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.20; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X; Creuzet S, 2002, DEVELOPMENT, V129, P4301; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Handrigan GR, 2007, CLIN GENET, V71, P109, DOI 10.1111/j.1399-0004.2007.00761.x; Harder JL, 2008, CELL, V133, DOI 10.1016/j.cell.2008.06.002; Herwig R, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e117; Hunter L, 2001, Bioinformatics, V17 Suppl 1, pS115; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Iwase S, 2004, BIOCHEM BIOPH RES CO, V322, P601, DOI 10.1016/j.bbrc.2004.07.163; Jeong J, 2008, DEVELOPMENT, V135, P2905, DOI 10.1242/dev.019778; Jheon AH, 2009, J DENT RES, V88, P12, DOI 10.1177/0022034508327757; JIANG R, 2006, DEV DYNAM, P235; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kaufmann U, 1999, CELL TISSUE RES, V296, P191, DOI 10.1007/s004410051280; Kholodnyuk ID, 2006, INT J CANCER, V119, P99, DOI 10.1002/ijc.21794; Kielty C. M., 2003, CONNECTIVE TISSUE IT, P159; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792; Koval M, 2006, CELL COMMUN ADHES, V13, P127, DOI 10.1080/15419060600726209; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Leach SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000215; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Meunier D, 2003, ANAT EMBRYOL, V207, P109, DOI 10.1007/s00429-003-0330-9; Miyake T, 1996, J CRAN GENET DEV BIO, V16, P1; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagai Y, 2005, GENESIS, V43, P12, DOI 10.1002/gene.20146; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Northcutt RG, 2005, J EXP ZOOL PART B, V304B, P274, DOI 10.1002/jez.b.21063; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Phang T L, 2003, Pac Symp Biocomput, P351; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; ROSNER B, 2006, FUNDAMENTALS BIOSTAT, pR19; ROSSANT J, 2002, MOUSE DEV PATTERNING, pR18; Salbaum JM, 1998, MECH DEVELOP, V71, P201, DOI 10.1016/S0925-4773(98)00005-7; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Suri M, 2005, SEMIN FETAL NEONAT M, V10, P243, DOI 10.1016/j.siny.2004.12.002; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tipney HJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S12; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Yang W, 2001, MOL CELL BIOL, V21, P6031, DOI 10.1128/MCB.21.17.6031-6043.2001; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	76	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8066	10.1371/journal.pone.0008066	http://dx.doi.org/10.1371/journal.pone.0008066			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016822	Green Submitted, Green Published, gold			2022-12-25	WOS:000272834000001
J	Schloss, PD				Schloss, Patrick D.			A High-Throughput DNA Sequence Aligner for Microbial Ecology Studies	PLOS ONE			English	Article							ESTIMATING SPECIES RICHNESS; GUT MICROBIOTA; DIVERSITY; ALIGNMENT; PROGRAMS; DATABASE; ARB; BIOSPHERE; SEARCH	As the scope of microbial surveys expands with the parallel growth in sequencing capacity, a significant bottleneck in data analysis is the ability to generate a biologically meaningful multiple sequence alignment. The most commonly used aligners have varying alignment quality and speed, tend to depend on a specific reference alignment, or lack a complete description of the underlying algorithm. The purpose of this study was to create and validate an aligner with the goal of quickly generating a high quality alignment and having the flexibility to use any reference alignment. Using the simple nearest alignment space termination algorithm, the resulting aligner operates in linear time, requires a small memory footprint, and generates a high quality alignment. In addition, the alignments generated for variable regions were of as high a quality as the alignment of full-length sequences. As implemented, the method was able to align 18 full-length 16S rRNA gene sequences and 58 V2 region sequences per second to the 50,000-column SILVA reference alignment. Most importantly, the resulting alignments were of a quality equal to SILVA-generated alignments. The aligner described in this study will enable scientists to rapidly generate robust multiple sequences alignments that are implicitly based upon the predicted secondary structure of the 16S rRNA molecule. Furthermore, because the implementation is not connected to a specific database it is easy to generalize the method to reference alignments for any DNA sequence.	[Schloss, Patrick D.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Schloss, Patrick D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Michigan System; University of Michigan	Schloss, PD (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	pschloss@umich.edu		Schloss, Patrick/0000-0002-6935-4275	College of Natural Resources and the Environment at the University of Massachusetts; School of Medicine at the University of Michigan; Sloan Foundation; National Science Foundation [0743432]	College of Natural Resources and the Environment at the University of Massachusetts; School of Medicine at the University of Michigan; Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF))	This project was funded by the College of Natural Resources and the Environment at the University of Massachusetts, the School of Medicine at the University of Michigan, a grant from the Sloan Foundation, and a grant from the National Science Foundation ( award #0743432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; GUSFIELD D, 1997, ALGORITHMS STRINGS T, P228; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; TICHY WF, 1984, ACM T COMPUT SYST, V2, P309, DOI 10.1145/357401.357404; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540	35	224	229	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8230	10.1371/journal.pone.0008230	http://dx.doi.org/10.1371/journal.pone.0008230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011594	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300012
J	Shafer, OT; Taghert, PH				Shafer, Orie T.; Taghert, Paul H.			RNA-Interference Knockdown of Drosophila Pigment Dispersing Factor in Neuronal Subsets: The Anatomical Basis of a Neuropeptide's Circadian Functions	PLOS ONE			English	Article							HORMONE-IMMUNOREACTIVE NEURONS; PERIOD CLOCK GENE; PACEMAKER NEURONS; LATERAL NEURONS; NERVOUS-SYSTEM; PDF CELLS; MELANOGASTER; EXPRESSION; RECEPTOR; RHYTHMS	Background: In animals, neuropeptide signaling is an important component of circadian timekeeping. The neuropeptide pigment dispersing factor (PDF) is required for several aspects of circadian activity rhythms in Drosophila. Methodology/Principal Findings: Here we investigate the anatomical basis for PDF's various circadian functions by targeted PDF RNA-interference in specific classes of Drosophila neuron. We demonstrate that PDF is required in the ventrolateral neurons (vLNs) of the central brain and not in the abdominal ganglion for normal activity rhythms. Differential knockdown of PDF in the large or small vLNs indicates that PDF from the small vLNs is likely responsible for the maintenance of free-running activity rhythms and that PDF is not required in the large vLNs for normal behavior. PDF's role in setting the period of free-running activity rhythms and the proper timing of evening activity under light: dark cycles emanates from both subtypes of vLN, since PDF in either class of vLN was sufficient for these aspects of behavior. Conclusions/Significance: These results reveal the neuroanatomical basis PDF's various circadian functions and refine our understanding of the clock neuron circuitry of Drosophila.	[Shafer, Orie T.; Taghert, Paul H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shafer, OT (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	oshafer@umich.edu			NINDS [1K99NS062953-01]; NIMH [MH067122]; NIH [NS057105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS062953, P30NS057105] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the NINDS (1K99NS062953-01) to OTS, by a grant from the NIMH (#MH067122) to PHT, and by an NIH Neuroscience Blueprint Core Grant (#NS057105) to Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EWER J, 1992, J NEUROSCI, V12, P3321; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hamblen MJ, 1998, GENETICS, V149, P165; Harmar AJ, 2003, J NEUROENDOCRINOL, V15, P335, DOI 10.1046/j.1365-2826.2003.01005.x; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2007, COLD SPRING HARB SYM, V72, P517, DOI 10.1101/sqb.2007.72.063; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Hewes RS, 2000, GENETICS, V155, P1711; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kimbrell DA, 2002, GENESIS, V34, P23, DOI 10.1002/gene.10134; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shafer OT, 2002, J NEUROSCI, V22, P5946; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STENGL M, 1994, J COMP PHYSIOL A, V175, P203, DOI 10.1007/BF00215116; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009	50	76	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8298	10.1371/journal.pone.0008298	http://dx.doi.org/10.1371/journal.pone.0008298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011537	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300046
J	Sherman, CDH; Wapstra, E; Olsson, M				Sherman, Craig D. H.; Wapstra, Erik; Olsson, Mats			Consistent Paternity Skew through Ontogeny in Peron's Tree Frog (Litoria peronii)	PLOS ONE			English	Article							FITNESS CONSEQUENCES; POLYANDROUS FEMALES; SPERM COMPETITION; CRINIA-GEORGIANA; FERTILIZATION; BENEFITS; SELECTION; SUCCESS; MICE; MHC	Background: A large number of studies in postcopulatory sexual selection use paternity success as a proxy for fertilization success. However, selective mortality during embryonic development can lead to skews in paternity in situations of polyandry and sperm competition. Thus, when assessment of paternity fails to incorporate mortality skews during early ontogeny, this may interfere with correct interpretation of results and subsequent evolutionary inference. In a previous series of in vitro sperm competition experiments with amphibians (Litoria peronii), we showed skewed paternity patterns towards males more genetically similar to the female. Methodology/Principal Findings: Here we use in vitro fertilizations and sperm competition trials to test if this pattern of paternity of fully developed tadpoles reflects patterns of paternity at fertilization and if paternity skews changes during embryonic development. We show that there is no selective mortality through ontogeny and that patterns of paternity of hatched tadpoles reflects success of competing males in sperm competition at fertilization. Conclusions/Significance: While this study shows that previous inferences of fertilization success from paternity data are valid for this species, rigorous testing of these assumptions is required to ensure that differential embryonic mortality does not confound estimations of true fertilization success.	[Sherman, Craig D. H.] Deakin Univ, Sch Life & Environm Sci, Waurn Ponds, Vic, Australia; [Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Olsson, Mats] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	Deakin University; University of Tasmania; University of Wollongong	Sherman, CDH (corresponding author), Deakin Univ, Sch Life & Environm Sci, Waurn Ponds, Vic, Australia.	csherman@deakin.edu.au	Sherman, Craig/A-2484-2010; Wapstra, Erik/J-7482-2014; Olsson, Mats/AAK-5565-2021	Sherman, Craig/0000-0003-2099-0462; Wapstra, Erik/0000-0002-2050-8026; Olsson, Mats/0000-0002-4130-1323	Australian Research Council [DP0559867]	Australian Research Council(Australian Research Council)	This study was funded by the Australian Research Council ( Discovery grant DP0559867) to MO and EW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne RK, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-34; Dziminski MA, 2006, J EVOLUTION BIOL, V19, P144, DOI 10.1111/j.1420-9101.2005.00978.x; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Firman RC, 2008, EVOLUTION, V62, P603, DOI 10.1111/j.1558-5646.2007.00307.x; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Garcia-Gonzalez F, 2008, EVOLUTION, V62, P1653, DOI 10.1111/j.1558-5646.2008.00362.x; Garcia-Gonzalez F, 2007, CURR BIOL, V17, P32, DOI 10.1016/j.cub.2006.10.054; Gosner K. L., 1960, Herpetologica, V16, P183; Griffiths K, 2006, FROGS REPTILES SYDNE; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P735, DOI 10.1111/j.1420-9101.2004.00873.x; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Rulicke T, 1998, P ROY SOC B-BIOL SCI, V265, P711, DOI 10.1098/rspb.1998.0351; Sherman CDH, 2008, P R SOC B, V275, P971, DOI 10.1098/rspb.2007.1626; SHERMAN CDH, 2009, HEREDITY IN PRESS; Sherman CDH, 2007, CONSERV GENET, V8, P999, DOI 10.1007/s10592-006-9218-6; Sherman CDH, 2009, BIOL LETTERS, V5, P232, DOI 10.1098/rsbl.2008.0796; Stockley P, 1997, P ROY SOC B-BIOL SCI, V264, P1497, DOI 10.1098/rspb.1997.0207; Wedekind C, 1996, HEREDITY, V77, P400, DOI 10.1038/hdy.1996.160; YAMAZAKI K, 1983, SCIENCE, V221, P186, DOI 10.1126/science.6857281	22	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8252	10.1371/journal.pone.0008252	http://dx.doi.org/10.1371/journal.pone.0008252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011595	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830300020
J	Liu, QZ; Sung, AH; Chen, ZX; Liu, JZ; Huang, XD; Deng, YP				Liu, Qingzhong; Sung, Andrew H.; Chen, Zhongxue; Liu, Jianzhong; Huang, Xudong; Deng, Youping			Feature Selection and Classification of MAQC-II Breast Cancer and Multiple Myeloma Microarray Gene Expression Data	PLOS ONE			English	Article							STATISTICAL-INFERENCE; ALGORITHMS; REGRESSION	Microarray data has a high dimension of variables but available datasets usually have only a small number of samples, thereby making the study of such datasets interesting and challenging. In the task of analyzing microarray data for the purpose of, e. g., predicting gene-disease association, feature selection is very important because it provides a way to handle the high dimensionality by exploiting information redundancy induced by associations among genetic markers. Judicious feature selection in microarray data analysis can result in significant reduction of cost while maintaining or improving the classification or prediction accuracy of learning machines that are employed to sort out the datasets. In this paper, we propose a gene selection method called Recursive Feature Addition (RFA), which combines supervised learning and statistical similarity measures. We compare our method with the following gene selection methods: Support Vector Machine Recursive Feature Elimination (SVMRFE) Leave-One-Out Calculation Sequential Forward Selection (LOOCSFS) Gradient based Leave-one-out Gene Selection (GLGS) To evaluate the performance of these gene selection methods, we employ several popular learning classifiers on the MicroArray Quality Control phase II on predictive modeling (MAQC-II) breast cancer dataset and the MAQC-II multiple myeloma dataset. Experimental results show that gene selection is strictly paired with learning classifier. Overall, our approach outperforms other compared methods. The biological functional analysis based on the MAQC-II breast cancer dataset convinced us to apply our method for phenotype prediction. Additionally, learning classifiers also play important roles in the classification of microarray data and our experimental results indicate that the Nearest Mean Scale Classifier (NMSC) is a good choice due to its prediction reliability and its stability across the three performance measurements: Testing accuracy, MCC values, and AUC errors.	[Liu, Qingzhong; Sung, Andrew H.] New Mexico Inst Min & Technol, Dept Comp Sci, Socorro, NM 87801 USA; [Liu, Qingzhong; Sung, Andrew H.] New Mexico Inst Min & Technol, Inst Complex Addit Syst Anal, Socorro, NM USA; [Chen, Zhongxue] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol & Biostat, Miami, FL 33199 USA; [Liu, Jianzhong] QuantumBio Inc, State Coll, PA USA; [Huang, Xudong] Brigham & Womens Hosp, Div Nucl Med & Mol Imaging, Boston, MA 02115 USA; [Huang, Xudong] Brigham & Womens Hosp, Dept Radiol, Ctr Adv Med Imaging, Boston, MA 02115 USA; [Huang, Xudong] Harvard Univ, Sch Med, Boston, MA USA; [Deng, Youping] SpecPro, Vicksburg, MS USA; [Deng, Youping] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	New Mexico Institute of Mining Technology; New Mexico Institute of Mining Technology; State University System of Florida; Florida International University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Southern Mississippi	Liu, QZ (corresponding author), New Mexico Inst Min & Technol, Dept Comp Sci, Socorro, NM 87801 USA.	sung@cs.nmt.edu; youping.deng@usm.edu	Chen, Zhongxue/K-1372-2013; Huang, Xudong/D-9711-2018	Chen, Zhongxue/0000-0003-2537-7843; Huang, Xudong/0000-0002-4811-1901; Liu, Qingzhong/0000-0002-2006-5413	NIH/NCMHD/RIMI [P20MD002725]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD002725] Funding Source: NIH RePORTER	NIH/NCMHD/RIMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The first two authors gratefully appreciate the support for this study from the Institute for Complex Additive Systems Analysis, a research division of New Mexico Tech. The last author highly appreciate the support under the grant of NIH/NCMHD/RIMI, P20MD002725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bo TH, 2002, GENOME BIOL, V3; Brazma A, 2006, NAT REV GENET, V7, P593, DOI 10.1038/nrg1922; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hand DJ, 2005, J BIOMED BIOTECHNOL, P215, DOI 10.1155/JBB.2005.215; HEIJDEN FVD, 2004, CLASSIFICATION PARAM; Inza I, 2002, J INTELL FUZZY SYST, V12, P25; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Liang Yulan, 2005, Int J Bioinform Res Appl, V1, P399, DOI 10.1504/IJBRA.2005.008443; Liu QZ, 2008, PATTERN RECOGN, V41, P56, DOI 10.1016/j.patcog.2007.06.005; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Monari G, 2000, NEUROCOMPUTING, V35, P195, DOI 10.1016/S0925-2312(00)00325-8; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Qin ZS, 2006, BIOINFORMATICS, V22, P1988, DOI 10.1093/bioinformatics/btl284; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Rivals I., 2003, Journal of Machine Learning Research, V3, P1383, DOI 10.1162/153244303322753724; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; SHI L, NATURE BIOT IN PRESS; Tan P, 2005, INTRO DATA MINING, P76; Tang EK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-95; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torrente A, 2005, BIOINFORMATICS, V21, P3993, DOI 10.1093/bioinformatics/bti644; Yu JS, 2005, BIOINFORMATICS, V21, pI487, DOI 10.1093/bioinformatics/bti1030; Zhou X, 2005, BIOINFORMATICS, V21, P1559, DOI 10.1093/bioinformatics/bti216	30	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8250	10.1371/journal.pone.0008250	http://dx.doi.org/10.1371/journal.pone.0008250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011240	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830200005
J	Loutfy, MR; Hart, TA; Mohammed, SS; Su, DS; Ralph, ED; Walmsley, SL; Soje, LC; Muchenje, M; Rachlis, AR; Smaill, FM; Angel, JB; Raboud, JM; Silverman, MS; Tharao, WE; Gough, K; Yudin, MH				Loutfy, Mona R.; Hart, Trevor A.; Mohammed, Saira S.; Su, DeSheng; Ralph, Edward D.; Walmsley, Sharon L.; Soje, Lena C.; Muchenje, Marvelous; Rachlis, Anita R.; Smaill, Fiona M.; Angel, Jonathan B.; Raboud, Janet M.; Silverman, Michael S.; Tharao, Wangari E.; Gough, Kevin; Yudin, Mark H.		Ontario HIV Fertility Res Team	Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study	PLOS ONE			English	Article							SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; INFECTED WOMEN; RISK BEHAVIOR; PREGNANCY; MEN; CHILDREN; HIV/AIDS; PEOPLE; HEALTH	Background: Improvements in life expectancy and quality of life for HIV-positive women coupled with reduced vertical transmission will likely lead numerous HIV-positive women to consider becoming pregnant. In order to clarify the demand, and aid with appropriate health services planning for this population, our study aims to assess the fertility desires and intentions of HIV-positive women of reproductive age living in Ontario, Canada. Methodology/Principal Findings: A cross-sectional study with recruitment stratified to match the geographic distribution of HIV-positive women of reproductive age (18-52) living in Ontario was carried out. Women were recruited from 38 sites between October 2007 and April 2009 and invited to complete a 189-item self-administered survey entitled "The HIV Pregnancy Planning Questionnaire" designed to assess fertility desires, intentions and actions. Logistic regression models were fit to calculate unadjusted and adjusted odds ratios of significant predictors of fertility intentions. The median age of the 490 participating HIV-positive women was 38 (IQR, 32-43) and 61%, 52%, 47% and 74% were born outside of Canada, living in Toronto, of African ethnicity and currently on antiretroviral therapy, respectively. Of total respondents, 69% (95% CI, 64%-73%) desired to give birth and 57% (95% CI, 53%-62%) intended to give birth in the future. In the multivariable model, the significant predictors of fertility intentions were: younger age (age < 40) (p < 0.0001), African ethnicity (p < 0.0001), living in Toronto (p = 0.002), and a lower number of lifetime births (p = 0.02). Conclusions/Significance: The proportions of HIV-positive women of reproductive age living in Ontario desiring and intending pregnancy were higher than reported in earlier North American studies. Proportions were more similar to those reported from African populations. Healthcare providers and policy makers need to consider increasing services and support for pregnancy planning for HIV-positive women. This may be particularly significant in jurisdictions with high levels of African immigration.	[Loutfy, Mona R.; Mohammed, Saira S.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Loutfy, Mona R.; Walmsley, Sharon L.; Rachlis, Anita R.; Gough, Kevin] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hart, Trevor A.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Hart, Trevor A.; Raboud, Janet M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Su, DeSheng; Walmsley, Sharon L.; Raboud, Janet M.] Univ Hlth Network, Toronto, ON, Canada; [Ralph, Edward D.] St Josephs Hlth Care, Infect Dis Care Program, London, ON, Canada; [Soje, Lena C.] Black Coalit AIDS Prevent, Toronto, ON, Canada; [Muchenje, Marvelous; Tharao, Wangari E.] Womens Hlth Womens Hands, Toronto, ON, Canada; [Rachlis, Anita R.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Smaill, Fiona M.] McMaster Univ, Med Ctr, Hamilton Hlth Sci, Hamilton, ON, Canada; [Angel, Jonathan B.] Ottawa Hosp, Ottawa, ON, Canada; [Angel, Jonathan B.] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Silverman, Michael S.] Lakeridge Hlth Ctr, Oshawa, ON, Canada; [Gough, Kevin] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Yudin, Mark H.] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Toronto Metropolitan University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Loutfy, MR (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada.	mona.loutfy@wchospital.ca	Silverman, Michael/J-3776-2014	Silverman, Michael/0000-0002-0389-7656; Hart, Trevor/0000-0001-5107-7452; Angel, Jonathan B/0000-0003-3102-4462; Walmsley, Sharon/0000-0002-3959-5692	CANFAR; Canadian Foundation for AIDS Research; Ontario Ministry of Health and Long-term Care; AIDS Bureau; Ontario HIV Treatment Network	CANFAR; Canadian Foundation for AIDS Research; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); AIDS Bureau; Ontario HIV Treatment Network	This work was supported by a grant from CANFAR, the Canadian Foundation for AIDS Research, and the Ontario Ministry of Health and Long-term Care, AIDS Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, a number of investigators are the recipients of salary support from the Canadian Institutes of Health Research (MRL, TAH) and the Ontario HIV Treatment Network (SLW, JBA, JR).	Aka-Dago-Akribi H, 1999, REPROD HEALTH MATTER, V7, P20, DOI DOI 10.1016/S0968-8080(99)90108-8; Baek C, 2005, ADDRESSING FAMILY PL; Bedimo-Rung Ariane Lisann, 2005, J Natl Med Assoc, V97, P1403; Caffrey P, 2009, GLOB PUBLIC HEALTH, V4, P271, DOI 10.1080/17441690902769651; Chama C, 2007, J OBSTET GYNAECOL, V27, P812, DOI 10.1080/01443610701711706; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Craft SM, 2007, AIDS BEHAV, V11, P927, DOI 10.1007/s10461-007-9219-6; Doyal L, 2005, SOC SCI MED, V60, P1729, DOI 10.1016/j.socscimed.2004.08.041; Dyer SJ, 2004, HUM REPROD, V19, P960, DOI 10.1093/humrep/deh195; Dyer SJ, 2002, HUM REPROD, V17, P1663, DOI 10.1093/humrep/17.6.1663; Feldman R, 2003, REPROD HEALTH MATTER, V11, P162, DOI 10.1016/S0968-8080(03)02284-5; Fowler F.J., 2014, SURV RES METHODS-GER; Germain A, 2009, INT J GYNECOL OBSTET, V106, P185, DOI 10.1016/j.ijgo.2009.03.038; *HLTH CAN, 2007, NOV 2007 HIV AIDS EP; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; KLINE A, 1995, SOC SCI MED, V40, P1539, DOI 10.1016/0277-9536(94)00280-7; Kulczycki A, 2007, STUD FAMILY PLANN, V38, P333, DOI 10.1111/j.1728-4465.2007.00145.x; Gogna ML, 2009, SOC SCI MED, V69, P813, DOI 10.1016/j.socscimed.2009.06.002; London L, 2008, DEV WORLD BIOETH, V8, P11, DOI 10.1111/j.1471-8847.2007.00223.x; LOUTFY M, 2009, 18 CAN C HIV AIDS RE; Mellors Shaun, 2008, HIV AIDS Policy Law Rev, V13, P89; Miller WB, 2004, POP STUD-J DEMOG, V58, P193, DOI 10.1080/0032472042000213712; MOHAMMED S, 2008, ONT HIV TREATM NETW; Morin P, 2003, PAEDIATR PERINAT EP, V17, P97, DOI 10.1046/j.1365-3016.2003.00461.x; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Nobrega AA, 2007, AIDS PATIENT CARE ST, V21, P261, DOI 10.1089/apc.2006.0116; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; Oosterhoff P, 2008, CULT HEALTH SEX, V10, P403, DOI 10.1080/13691050801915192; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Peltzer K, 2009, AIDS BEHAV, V13, P973, DOI 10.1007/s10461-008-9365-5; *PER HIV GUID WORK, 2009, PUBL HLTH SERV TASK; Remis, 2007, RACE ETHNICITY PERSO; Remis RS, 2010, REPORT HIV AIDS ONTA; Richardson D, 1992, Health Visit, V65, P159; Richter DL, 2002, WOMEN HEALTH, V36, P81, DOI 10.1300/J013v36n01_06; Santos N., 1998, Reproductive Health Matters, V6, P31, DOI 10.1016/S0968-8080(98)90005-2; Siegel K, 2001, PSYCHOL WOMEN QUART, V25, P112, DOI 10.1111/1471-6402.00013; Smith DJ, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000298101.56614.af; Sowell RL, 2002, AIDS CARE, V14, P181, DOI 10.1080/09540120220104695; Sowell RL., 1999, J FAMILY NURS, V5, P316, DOI DOI 10.1177/107484079900500305; Stanwood NL, 2007, CONTRACEPTION, V75, P294, DOI 10.1016/j.contraception.2006.12.012; STREIMER DL, 2003, HLTH MEASUREMENT SCA; Titus MJ, 2009, INT J GYNECOL OBSTET, V106, P137, DOI 10.1016/j.ijgo.2009.03.026; *UNAIDS WHO, 2008, 07 AIDS EP UPD DEC 2; Voyer, 1994, CAN J AGING, V13, P392; WELSEY Y, 2000, HEALTH CARE WOMEN IN, V21, P291; Wesley Y, 2003, J NURS SCHOLARSHIP, V35, P37, DOI 10.1111/j.1547-5069.2003.00037.x; YUDIN MH, 2008, FERTIL STERIL S1, V90, pS380; 2009, HIV AIDS POLICY LAW, V14, P49	56	106	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e7925	10.1371/journal.pone.0007925	http://dx.doi.org/10.1371/journal.pone.0007925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533NB	19997556	gold, Green Submitted, Green Published			2022-12-25	WOS:000272829500001
J	Hag, AMF; Kristoffersen, US; Pedersen, SF; Gutte, H; Lebech, AM; Kjaer, A				Hag, Anne Mette Fisker; Kristoffersen, Ulrik Sloth; Pedersen, Sune Folke; Gutte, Henrik; Lebech, Anne-Mette; Kjaer, Andreas			Regional Gene Expression of LOX-1, VCAM-1, and ICAM-1 in Aorta of HIV-1 Transgenic Rats	PLOS ONE			English	Article							ADHESION MOLECULES; DISTURBED FLOW; ATHEROSCLEROSIS; MODEL; ENDOTHELIUM; MECHANISMS; PROFILES; THERAPY; DISEASE	Background: Increased prevalence of atherosclerotic cardiovascular disease in HIV-infected patients has been observed. The cause of this accelerated atherosclerosis is a matter of controversy. As clinical studies are complicated by a multiplicity of risk-factors and a low incidence of hard endpoints, studies in animal models could be attractive alternatives. Methodology/Principal Findings: We evaluated gene expression of lectin-like oxidized-low-density-lipoprotein receptor-1 (LOX-1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 ( ICAM- 1) in HIV-1 transgenic (HIV-1Tg) rats; these genes are all thought to play important roles in early atherogenesis. Furthermore, the plasma level of sICAM-1 was measured. We found that gene expressions of LOX-1 and VCAM- 1 were higher in the aortic arch of HIV-1Tg rats compared to controls. Also, the level of sICAM-1 was elevated in the HIV-1Tg rats compared to controls, but the ICAM- 1 gene expression profile did not show any differences between the groups. Conclusions/Significance: HIV-1Tg rats have gene expression patterns indicating endothelial dysfunction and accelerated atherosclerosis in aorta, suggesting that HIV-infection per se may cause atherosclerosis. This transgenic rat model may be a very promising model for further studies of the pathophysiology behind HIV-associated cardiovascular disease.	[Hag, Anne Mette Fisker; Kristoffersen, Ulrik Sloth; Pedersen, Sune Folke; Gutte, Henrik; Kjaer, Andreas] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Hag, Anne Mette Fisker; Kristoffersen, Ulrik Sloth; Pedersen, Sune Folke; Gutte, Henrik; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Lebech, Anne-Mette] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Hag, AMF (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark.	annemette@mfi.ku.dk	Kjaer, Andreas/E-8932-2015	Kjaer, Andreas/0000-0002-2706-5547; Gutte, Henrik/0000-0001-5494-5323; Lebech, Anne-Mette/0000-0002-0943-3289; Hag, Anne Mette F/0000-0001-9492-3663	Novo Nordisk Foundation; Lundbeck Foundation; A. P. Moller Foundation; The Danish Heart Foundation [09-04-R72-A2356-22560]; Danish Medical Research Council [959592772]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); A. P. Moller Foundation; The Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The financial support from Novo Nordisk Foundation (www.novonordiskfonden.dk), Lundbeck Foundation (www.lundbeckfonden.dk), A. P. Moller Foundation (www.apmollerfonde.dk), The Danish Heart Foundation ( grant no. 09-04-R72-A2356-22560; www.hjerteforeningen.dk), and Danish Medical Research Council ( grant no. 959592772; www.fi.dk) is gratefully acknowledged. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brooks AR, 2004, ENDOTHELIUM-J ENDOTH, V11, P45, DOI 10.1080/10623320490432470; Brooks AR, 2002, PHYSIOL GENOMICS, V9, P27, DOI 10.1152/physiolgenomics.00075.2001; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; DE JW, 2003, CLIN DIAGN LAB IMMUN, V10, P133; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Hag AMF, 2008, BIOCHEM BIOPH RES CO, V377, P689, DOI 10.1016/j.bbrc.2008.10.037; Kline ER, 2008, J INVEST MED, V56, P752, DOI 10.1097/JIM.0b013e3181788d15; Kotler DP, 2008, JAIDS-J ACQ IMM DEF, V49, pS79, DOI 10.1097/QAI.0b013e318186519c; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastroianni CM, 2000, CLIN IMMUNOL, V95, P212, DOI 10.1006/clim.2000.4865; Mazzucchelli R, 2004, MOL IMMUNOL, V41, P979, DOI 10.1016/j.molimm.2004.06.023; Moghadasian MH, 2002, LIFE SCI, V70, P855, DOI 10.1016/S0024-3205(01)01479-5; Mu H, 2007, WORLD J SURG, V31, P632, DOI 10.1007/s00268-006-0730-0; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; OGURA S, 2009, CIRC J; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Ray PE, 2003, KIDNEY INT, V63, P2242, DOI 10.1046/j.1523-1755.2003.00028.x; Reid W, 2004, VIROLOGY, V321, P111, DOI 10.1016/j.virol.2003.12.010; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8170	10.1371/journal.pone.0008170	http://dx.doi.org/10.1371/journal.pone.0008170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997643	gold, Green Published, Green Submitted			2022-12-25	WOS:000272829200009
J	Mukai, M; Replogle, K; Drnevich, J; Wang, G; Wacker, D; Band, M; Clayton, DF; Wingfield, JC				Mukai, Motoko; Replogle, Kirstin; Drnevich, Jenny; Wang, Gang; Wacker, Douglas; Band, Mark; Clayton, David F.; Wingfield, John C.			Seasonal Differences of Gene Expression Profiles in Song Sparrow (Melospiza melodia) Hypothalamus in Relation to Territorial Aggression	PLOS ONE			English	Article							HYPOPHYSEAL PARS TUBERALIS; WHITE-CROWNED SPARROW; CHALLENGE HYPOTHESIS; THYROID-HORMONE; PLASMA-LEVELS; ENDOTHELIAL INTERACTIONS; MEDIAN-EMINENCE; NERVE-TERMINALS; MICROARRAY DATA; JAPANESE-QUAIL	Background: Male song sparrows (Melospiza melodia) are territorial year-round; however, neuroendocrine responses to simulated territorial intrusion (STI) differ between breeding ( spring) and non-breeding seasons ( autumn). In spring, exposure to STI leads to increases in luteinizing hormone and testosterone, but not in autumn. These observations suggest that there are fundamental differences in the mechanisms driving neuroendocrine responses to STI between seasons. Microarrays, spotted with EST cDNA clones of zebra finch, were used to explore gene expression profiles in the hypothalamus after territorial aggression in two different seasons. Methodology/Principal Findings: Free-living territorial male song sparrows were exposed to either conspecific or heterospecific ( control) males in an STI in spring and autumn. Behavioral data were recorded, whole hypothalami were collected, and microarray hybridizations were performed. Quantitative PCR was performed for validation. Our results show 262 cDNAs were differentially expressed between spring and autumn in the control birds. There were 173 cDNAs significantly affected by STI in autumn; however, only 67 were significantly affected by STI in spring. There were 88 cDNAs that showed significant interactions in both season and STI. Conclusions/Significance: Results suggest that STI drives differential genomic responses in the hypothalamus in the spring vs. autumn. The number of cDNAs differentially expressed in relation to season was greater than in relation to social interactions, suggesting major underlying seasonal effects in the hypothalamus which may determine the differential response upon social interaction. Functional pathway analyses implicated genes that regulate thyroid hormone action and neuroplasticity as targets of this neuroendocrine regulation.	[Mukai, Motoko; Wingfield, John C.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mukai, Motoko] Univ Illinois, Dept Vet Biosci, Champaign, IL 61820 USA; [Replogle, Kirstin; Clayton, David F.] Univ Illinois, Dept Cell & Dev Biol, Champaign, IL 61820 USA; [Replogle, Kirstin; Clayton, David F.] Univ Illinois, Inst Genom Biol, Champaign, IL 61820 USA; [Clayton, David F.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Drnevich, Jenny; Band, Mark] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL 61801 USA; [Wang, Gang; Wacker, Douglas; Wingfield, John C.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle	Mukai, M (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	momukai@ucdavis.edu	Mukai, Motoko/L-9910-2014; Clayton, David/B-2190-2008	Mukai, Motoko/0000-0002-5695-3826; Clayton, David/0000-0002-6395-3488	National Science Foundation [IBN-0317141, IOS-0712882, IOS-0750540]; Endowment in Physiology, University of California, Davis; SoNG Initiative [NS045264]; Eli Lilly postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Endowment in Physiology, University of California, Davis(University of California System); SoNG Initiative; Eli Lilly postdoctoral fellowship(Eli Lilly); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Science Foundation grants # IBN-0317141, IOS-0712882, IOS-0750540 and Endowment in Physiology, University of California, Davis ( to JCW), SoNG Initiative # NS045264 (to DFC), and MM was supported by Eli Lilly postdoctoral fellowship ( Eli Lilly Co., Indianapolis, Indiana) during part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2002, DEV DYNAM, V223, P526, DOI 10.1002/dvdy.10075; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Benvenga S, 1998, ENDOCRINOLOGY, V139, P4311, DOI 10.1210/en.139.10.4311; Bockmann J, 1996, ENDOCRINOLOGY, V137, P1804, DOI 10.1210/en.137.5.1804; Bockmann J, 1997, ACTA ANAT, V160, P189; Brouillette J, 2008, NEUROBIOL AGING, V29, P1721, DOI 10.1016/j.neurobiolaging.2007.04.007; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; CALDWELL GS, 1984, P NATL ACAD SCI-BIOL, V81, P5255, DOI 10.1073/pnas.81.16.5255; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Cavigelli SA, 2000, HORM BEHAV, V37, P246, DOI 10.1006/hbeh.2000.1585; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Demas GE, 1999, PHYSIOL BEHAV, V66, P59, DOI 10.1016/S0031-9384(98)00268-6; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Draghici S, 2002, DRUG DISCOV TODAY, V7, pS55, DOI 10.1016/S1359-6446(02)02292-4; ESTIENNE MJ, 1990, BIOL REPROD, V42, P126, DOI 10.1095/biolreprod42.1.126; FOLLETT BK, 1985, J ENDOCRINOL, V107, P211, DOI 10.1677/joe.0.1070211; Gibbons IR, 1996, CELL STRUCT FUNCT, V21, P331, DOI 10.1247/csf.21.331; GROSS DS, 1984, GEN COMP ENDOCR, V56, P283, DOI 10.1016/0016-6480(84)90043-1; Hirschenhauser K, 2003, HORM BEHAV, V43, P508, DOI 10.1016/S0018-506X(03)00027-8; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Jones S, 2008, BRAIN RES BULL, V76, P536, DOI 10.1016/j.brainresbull.2008.03.008; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kameda Y, 2000, CELL TISSUE RES, V299, P71, DOI 10.1007/s004419900131; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Klukowski M, 1998, HORM BEHAV, V33, P197, DOI 10.1006/hbeh.1998.1449; Kouchi Z, 1999, BIOCHEM BIOPH RES CO, V254, P804, DOI 10.1006/bbrc.1998.9977; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; London SE, 2009, DEV NEUROBIOL, V69, P437, DOI 10.1002/dneu.20719; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; MIKAMI S, 1975, CELL TISSUE RES, V162, P419; Nakao N, 2008, REPRODUCTION, V136, P1, DOI 10.1530/REP-08-0041; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; PANKHURST NW, 1993, GEN COMP ENDOCR, V90, P168, DOI 10.1006/gcen.1993.1071; PARKINSON TJ, 1995, P ROY SOC B-BIOL SCI, V259, P1, DOI 10.1098/rspb.1995.0001; PELLETIER J, 1992, CELL TISSUE RES, V267, P301, DOI 10.1007/BF00302968; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; Prevot V, 1999, NEUROSCIENCE, V94, P809, DOI 10.1016/S0306-4522(99)00383-8; Prevot V, 2007, PSYCHONEUROENDOCRINO, V32, pS46, DOI 10.1016/j.psyneuen.2007.03.018; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rubenstein DR, 2005, HORM BEHAV, V48, P329, DOI 10.1016/j.yhbeh.2005.04.006; Schwarzman AL, 1996, CIBA F SYMP, V199, P146; Smith LC, 2005, HORM BEHAV, V47, P76, DOI 10.1016/j.yhbeh.2004.08.012; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soma KK, 2002, HORM BEHAV, V41, P203, DOI 10.1006/hbeh.2001.1750; Soma KK, 2003, J NEUROBIOL, V56, P209, DOI 10.1002/neu.10225; Suzuki H, 2007, NEUROSCI LETT, V421, P152, DOI 10.1016/j.neulet.2007.03.077; Suzuki S, 2007, MOL ENDOCRINOL, V21, P885, DOI 10.1210/me.2006-0403; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; Tsuzuki K, 2000, NEUROSCI LETT, V281, P171, DOI 10.1016/S0304-3940(00)00834-X; URBANSKI HF, 1990, ENDOCRINOLOGY, V127, P2223, DOI 10.1210/endo-127-5-2223; Vie MP, 1997, MOL ENDOCRINOL, V11, P1728, DOI 10.1210/me.11.11.1728; WILSON RC, 1982, BRAIN RES, V248, P177, DOI 10.1016/0006-8993(82)91160-X; WINGFIELD JC, 1985, HORM BEHAV, V19, P174, DOI 10.1016/0018-506X(85)90017-0; WINGFIELD JC, 1994, HORM BEHAV, V28, P1, DOI 10.1006/hbeh.1994.1001; WINGFIELD JC, 1994, ANIM BEHAV, V47, P77, DOI 10.1006/anbe.1994.1009; Wingfield JC, 2005, HORM BEHAV, V48, P253, DOI 10.1016/j.yhbeh.2005.05.009; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1989, J COMP PHYSIOL A, V166, P189; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; YAMAMOTO Y, 1993, J PHYS IV, V3, P39, DOI 10.1051/jp4:1993507; Yamamura T, 2006, CELL TISSUE RES, V324, P175, DOI 10.1007/s00441-005-0126-8; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233	78	70	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8182	10.1371/journal.pone.0008182	http://dx.doi.org/10.1371/journal.pone.0008182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997634	Green Submitted, gold, Green Published			2022-12-25	WOS:000272829200015
J	Arijs, I; De Hertogh, G; Lemaire, K; Quintens, R; Van Lommel, L; Van Steen, K; Leemans, P; Cleynen, I; Van Assche, G; Vermeire, S; Geboes, K; Schuit, F; Rutgeerts, P				Arijs, Ingrid; De Hertogh, Gert; Lemaire, Katleen; Quintens, Roel; Van Lommel, Leentje; Van Steen, Kristel; Leemans, Peter; Cleynen, Isabelle; Van Assche, Gert; Vermeire, Severine; Geboes, Karel; Schuit, Frans; Rutgeerts, Paul			Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment	PLOS ONE			English	Article							ALPHA-DEFENSIN EXPRESSION; ILEAL CROHNS-DISEASE; ULCERATIVE-COLITIS; COLON; MICE; INDUCTION; SYSTEM; ILEUM	Background: Antimicrobial peptides (AMPs) protect the host intestinal mucosa against microorganisms. Abnormal expression of defensins was shown in inflammatory bowel disease (IBD), but it is not clear whether this is a primary defect. We investigated the impact of anti-inflammatory therapy with infliximab on the mucosal gene expression of AMPs in IBD. Methodology/Principal Findings: Mucosal gene expression of 81 AMPs was assessed in 61 IBD patients before and 4-6 weeks after their first infliximab infusion and in 12 control patients, using Affymetrix arrays. Quantitative real-time reverse-transcription PCR and immunohistochemistry were used to confirm microarray data. The dysregulation of many AMPs in colonic IBD in comparison with control colons was widely restored by infliximab therapy, and only DEFB1 expression remained significantly decreased after therapy in the colonic mucosa of IBD responders to infliximab. In ileal Crohn's disease (CD), expression of two neuropeptides with antimicrobial activity, PYY and CHGB, was significantly decreased before therapy compared to control ileums, and ileal PYY expression remained significantly decreased after therapy in CD responders. Expression of the downregulated AMPs before and after treatment (DEFB1 and PYY) correlated with villin 1 expression, a gut epithelial cell marker, indicating that the decrease is a consequence of epithelial damage. Conclusions/Significance: Our study shows that the dysregulation of AMPs in IBD mucosa is the consequence of inflammation, but may be responsible for perpetuation of inflammation due to ineffective clearance of microorganisms.	[Arijs, Ingrid; Cleynen, Isabelle; Van Assche, Gert; Vermeire, Severine; Rutgeerts, Paul] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium; [Arijs, Ingrid; Lemaire, Katleen; Quintens, Roel; Van Lommel, Leentje; Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Leuven, Belgium; [De Hertogh, Gert; Geboes, Karel] Univ Hosp Gasthuisberg, Dept Morphol & Mol Pathol, B-3000 Leuven, Belgium; [Van Steen, Kristel; Leemans, Peter] Univ Liege, Inst Montefiore, Dept Elect Engn & Comp Sci, B-4000 Liege, Belgium; [Rutgeerts, Paul] Univ Hosp Gasthuisberg, Leuven Food Sci & Nutr Res Ctr LFoRCe, B-3000 Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; University of Liege; KU Leuven; University Hospital Leuven	Arijs, I (corresponding author), Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium.	Frans.Schuit@med.kuleuven.be; paul.rutgeerts@uz.kuleuven.be	Arijs, Ingrid/AAJ-3163-2020; Quintens, Roel/G-5339-2017	Quintens, Roel/0000-0002-4359-3403; Arijs, Ingrid/0000-0002-9415-083X; Van Steen, Kristel/0000-0001-9868-5033; Vermeire, Severine/0000-0001-9942-3019	Fund for Scientific Research - Flanders (FWO) Belgium [G.0440.06]	Fund for Scientific Research - Flanders (FWO) Belgium(FWO)	This work was supported by a grant from the Fund for Scientific Research - Flanders (FWO) Belgium (FWO project nr.G.0440.06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006285; Arijs I, 2009, GUT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Dianda L, 1997, AM J PATHOL, V150, P91; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Krause A, 2003, PROTEIN SCI, V12, P143, DOI 10.1110/ps.0213603; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Schmid M, 2007, J LEUKOCYTE BIOL, V81, P907, DOI 10.1189/jlb.0906581; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	35	153	158	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7984	10.1371/journal.pone.0007984	http://dx.doi.org/10.1371/journal.pone.0007984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956723	Green Submitted, gold, Green Published			2022-12-25	WOS:000272827500014
J	Liao, D; Luo, YP; Markowitz, D; Xiang, R; Reisfeld, RA				Liao, Debbie; Luo, Yunping; Markowitz, Dorothy; Xiang, Rong; Reisfeld, Ralph A.			Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model	PLOS ONE			English	Article							DENDRITIC CELLS; SUPPRESSOR-CELLS; APOPTOTIC CELLS; MYELOID CELLS; INFLAMMATION; RECRUITMENT; PROTEASE; IMMUNOGENICITY; IMMUNOTHERAPY; CALRETICULIN	Background: Local inflammation associated with solid tumors commonly results from factors released by tumor cells and the tumor stroma, and promotes tumor progression. Cancer associated fibroblasts comprise a majority of the cells found in tumor stroma and are appealing targets for cancer therapy. Here, our aim was to determine the efficacy of targeting cancer associated fibroblasts for the treatment of metastatic breast cancer. Methodology/Principal Findings: We demonstrate that cancer associated fibroblasts are key modulators of immune polarization in the tumor microenvironment of a 4T1 murine model of metastatic breast cancer. Elimination of cancer associated fibroblasts in vivo by a DNA vaccine targeted to fibroblast activation protein results in a shift of the immune microenvironment from a Th2 to Th1 polarization. This shift is characterized by increased protein expression of IL-2 and IL-7, suppressed recruitment of tumor-associated macrophages, myeloid derived suppressor cells, T regulatory cells, and decreased tumor angiogenesis and lymphangiogenesis. Additionally, the vaccine improved anti-metastatic effects of doxorubicin chemotherapy and enhanced suppression of IL-6 and IL-4 protein expression while increasing recruitment of dendritic cells and CD8(+) T cells. Treatment with the combination therapy also reduced tumor-associated Vegf, Pdgfc, and GM-CSF mRNA and protein expression. Conclusions/Significance: Our findings demonstrate that cancer associated fibroblasts promote tumor growth and metastasis through their role as key modulators of immune polarization in the tumor microenvironment and are valid targets for therapy of metastatic breast cancer.	[Liao, Debbie; Luo, Yunping; Markowitz, Dorothy; Xiang, Rong; Reisfeld, Ralph A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Xiang, Rong] Nankai Univ, Sch Med, Dept Immunol, Tianjin, Peoples R China	Scripps Research Institute; Nankai University	Liao, D (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	reisfeld@scripps.edu			National Institutes of Health (NIH) [T32 HL007195-31]; DOD BCRP [BC050141]; National Science Foundation of China (NSFC) [30672389]; NSFC 973 [2007CB914804]; NSFC 863 [2007AA021010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP(United States Department of Defense); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC 973(National Basic Research Program of China); NSFC 863(National Natural Science Foundation of China (NSFC)National High Technology Research and Development Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) grant T32 HL007195-31 (to L. K. Curtiss, The Scripps Research Institute), DOD BCRP grant BC050141 (to R. A. R.), National Science Foundation of China (NSFC) grant 30672389 (to R. X.), NSFC 973 program grant 2007CB914804 (to R. X.), and NSFC 863 program grant 2007AA021010 (to R. X.). This is TSRI manuscript number 20046-IMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Bocchia M, 2000, HAEMATOLOGICA, V85, P1172; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; ERLER JT, 2008, CLIN EXP METASTASIS; GATELY MK, 1992, CELL IMMUNOL, V143, P127, DOI 10.1016/0008-8749(92)90011-D; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawakami K, 2001, CRIT REV IMMUNOL, V21, P299; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kosmaczewska A, 2008, ARCH IMMUNOL THER EX, V56, P181, DOI 10.1007/s00005-008-0018-1; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ochsenbein AF, 2005, SPRINGER SEMIN IMMUN, V27, P19, DOI 10.1007/s00281-004-0192-0; Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tejada ML, 2006, CLIN CANCER RES, V12, P2676, DOI 10.1158/1078-0432.CCR-05-1770; Waterhouse NJ, 2007, APOPTOSIS, V12, P631, DOI 10.1007/s10495-007-0057-9; Wolf BB, 2008, MINI-REV MED CHEM, V8, P719, DOI 10.2174/138955708784567449; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	44	314	337	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7965	10.1371/journal.pone.0007965	http://dx.doi.org/10.1371/journal.pone.0007965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956757	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827300020
J	Yen, MY; Wu, TSJ; Chiu, AWH; Wong, WW; Wang, PE; Chan, TC; King, CC				Yen, Muh-Yong; Wu, Tsung-Shu Joseph; Chiu, Allen Wen-Hsiang; Wong, Wing-Wai; Wang, Po-En; Chan, Ta-Chien; King, Chwan-Chuen			Taipei's Use of a Multi-Channel Mass Risk Communication Program to Rapidly Reverse an Epidemic of Highly Communicable Disease	PLOS ONE			English	Article							ACUTE HEMORRHAGIC CONJUNCTIVITIS; COXSACKIEVIRUS A24 VARIANT; INFLUENZA-LIKE ILLNESS; OUTBREAK; HUMANS; KOREA; GHANA	Background: In September 2007, an outbreak of acute hemorrhagic conjunctivitis (AHC) occurred in Keelung City and spread to Taipei City. In response to the epidemic, a new crisis management program was implemented and tested in Taipei. Methodology and Principal Findings: Having noticed that transmission surged on weekends during the Keelung epidemic, Taipei City launched a multi-channel mass risk communications program that included short message service (SMS) messages sent directly to approximately 2.2 million Taipei residents on Friday, October 12th, 2007. The public was told to keep symptomatic students from schools and was provided guidelines for preventing the spread of the disease at home. Epidemiological characteristics of Taipei's outbreak were analyzed from 461 sampled AHC cases. Median time from exposure to onset of the disease was 1 day. This was significantly shorter for cases occurring in family clusters than in class clusters (mean+/-SD: 2.6+/-3.2 vs. 4.39+/-4.82 days, p = 0.03), as well as for cases occurring in larger family clusters as opposed to smaller ones (1.261.7 days vs. 3.9+/-4.0 days, p<0.01). Taipei's program had a significant impact on patient compliance. Home confinement of symptomatic children increased from 10% to 60% (p<0.05) and helped curb the spread of AHC. Taipei experienced a rapid decrease in AHC cases between the Friday of the SMS announcement and the following Monday, October 15, (0.70% vs. 0.36%). By October 26, AHC cases reduced to 0.01%. The success of this risk communication program in Taipei (as compared to Keelung) is further reflected through rapid improvements in three epidemic indicators: (1) significantly lower crude attack rates (1.95% vs. 14.92%, p<0.001), (2) a short epidemic period of AHC (13 vs. 34 days), and (3) a quick drop in risk level (1,2 weeks) in Taipei districts that border Keelung (the original domestic epicenter). Conclusions and Significance: The timely launch of this systematic, communication-based intervention proved effective at preventing a dangerous spike in AHC and was able to bring this high-risk disease under control. We recommend that public health officials incorporate similar methods into existing guidelines for preventing pandemic influenza and other emerging infectious diseases.	[Yen, Muh-Yong; Chiu, Allen Wen-Hsiang; Wong, Wing-Wai] Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan; [Yen, Muh-Yong] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Wu, Tsung-Shu Joseph; Chan, Ta-Chien; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan; [Wu, Tsung-Shu Joseph] Luke Int Norway, Notteroy, Norway; [Chiu, Allen Wen-Hsiang] Natl Yang Ming Univ, Dept Urol, Taipei 112, Taiwan; [Wang, Po-En] Dept Hlth, Chilung, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Yang Ming Chiao Tung University	Yen, MY (corresponding author), Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan.	myyen1121@gmail.com; chwanchuen@gmail.com	Wu, Tsung Shu Joseph/K-6138-2018	Wu, Tsung Shu Joseph/0000-0001-6155-9340; King, Chwan-Chuen/0000-0002-6078-2601	Taipei City Government [96001-62-032]	Taipei City Government	This study was financially supported by Taipei City Government Grant 96001-62-032. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, CONTROL COMMUNICABLE; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Berry TR, 2007, HEALTH COMMUN, V21, P35, DOI 10.1080/10410230701283322; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; BRANDFUL JAM, 1990, E AFR MED J, V67, P878; CARRAT F, 1992, AM J EPIDEMIOL, V135, P1293, DOI 10.1093/oxfordjournals.aje.a116236; CHATTERJEE S, 1970, BRIT J OPHTHALMOL, V54, P628, DOI 10.1136/bjo.54.9.628; CHOU MY, 1988, AM J EPIDEMIOL, V127, P795, DOI 10.1093/oxfordjournals.aje.a114861; CHRISTOPHER S, 1982, J INFECT DIS, V146, P16, DOI 10.1093/infdis/146.1.16; Du Ry van Beest Holle M, 2005, EUROSURVEILLANCE, V10, P264; Ghazali O., 2003, SMJ Singapore Medical Journal, V44, P511; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; KUO PC, 2009, EYE; Leveque N, 2007, EUR J CLIN MICROBIOL, V26, P199, DOI 10.1007/s10096-007-0265-9; LIN TL, 2008, TAIWAN EPIDEMIOLOGY, V23, P303; Madhavan H N, 2000, Indian J Ophthalmol, V48, P159; MIRKOVIC RR, 1973, B WORLD HEALTH ORGAN, V49, P341; NGUYENVANTAM JS, 2006, EUROSURVEILL; Oh MD, 2003, EMERG INFECT DIS, V9, P1010; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Park K, 2006, J MED VIROL, V78, P91, DOI 10.1002/jmv.20508; PATRIARCA PA, 1983, JAMA-J AM MED ASSOC, V249, P1283, DOI 10.1001/jama.249.10.1283; Pitrelli Nico, 2007, Ann Ist Super Sanita, V43, P336; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Sandrock C, 2007, CRIT CARE, V11, DOI 10.1186/cc5675; Thomas James C, 2009, J Public Health Manag Pract, V15, pE16, DOI 10.1097/01.PHH.0000346021.06803.76; Yasuda H, 2008, J URBAN HEALTH, V85, P619, DOI 10.1007/s11524-008-9264-0; YEN MY, 2007, TAIWAN EPIDEMIOLOGY, V23, P16; YINMURPHY M, 1993, AM J OPHTHALMOL, V116, P212; Zhao H, 2007, Euro Surveill, V12, pE3; 2004, MMWR MORB MORTAL WKL, V53, P632	31	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7962	10.1371/journal.pone.0007962	http://dx.doi.org/10.1371/journal.pone.0007962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956722	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827300018
J	Barash, U; Cohen-Kaplan, V; Arvatz, G; Gingis-Velitski, S; Levy-Adam, F; Nativ, O; Shemesh, R; Ayalon-Sofer, M; Ilan, N; Vlodavsky, I				Barash, Uri; Cohen-Kaplan, Victoria; Arvatz, Gil; Gingis-Velitski, Svetlana; Levy-Adam, Flonia; Nativ, Ofer; Shemesh, Ronen; Ayalon-Sofer, Michal; Ilan, Neta; Vlodavsky, Israel			A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics	FASEB JOURNAL			English	Article						cell proliferation; colony formation; xenograft; Src; phosphorylation	EXTRACELLULAR-MATRIX; MAMMALIAN HEPARANASE; CANCER METASTASIS; FACTOR EXPRESSION; INHIBITOR PI-88; CELL-ADHESION; ANGIOGENESIS; PROTEIN; GROWTH; PHOSPHORYLATION	Heparanase is a mammalian endo-beta-D-glucuronidase that can cleave heparan sulfate side chains, an activity strongly implicated in tumor cell dissemination. The current study aimed to identify and characterize heparanase splice variants. LEADS, Compugen's alternative splicing modeling platform (Compugen, Tel Aviv, Israel), was used to search for splice variants in silico; tumor-derived cell lines (i.e., CAG myeloma) and tumor biopsies were utilized to validate T5 expression in vivo; signaling (i.e., Src phosphorylation) was evaluated following T5 gene silencing or overexpression and correlated with cell proliferation, colony formation, and tumor xenograft development. A novel spliced form of human heparanase, termed T5, was identified. In this splice variant, 144 bp of intron 5 are joined with exon 4, which results in a truncated, enzymatically inactive protein. T5 overexpression resulted in increased cell proliferation and larger colonies in soft agar, mediated by Src activation. Furthermore, T5 overexpression markedly enhanced tumor xenograft development. T5 expression is up-regulated in 75% of human renal cell carcinoma biopsies examined, which suggests that this splice variant is clinically relevant. Controls included cells overexpressing wild-type heparanase or an empty plasmid and normal-looking tissue adjacent the carcinoma lesion. T5 is a novel functional splice variant of human heparanase endowed with protumorigenic characteristics.-Barash, U., Cohen-Kaplan, V., Arvatz, G., Gingis-Velitski, S., Levy-Adam, F., Nativ, O., Shemesh, R., Ayalon-Sofer, M., Ilan, N., Vlodavsky, I. A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics. FASEB J. 24, 1239-1248 (2010). www.fasebj.org	[Barash, Uri; Cohen-Kaplan, Victoria; Arvatz, Gil; Gingis-Velitski, Svetlana; Levy-Adam, Flonia; Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Nativ, Ofer] Bnai Zion Med Ctr, Dept Urol, Haifa, Israel; [Shemesh, Ronen; Ayalon-Sofer, Michal] Compugen Ltd, Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center	Vlodavsky, I (corresponding author), Technion Israel Inst Technol, Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel.	vlodavsk@cc.huji.ac.il		Barash, Uri/0000-0003-1049-270X	Israel Science Foundation [549/06]; National Cancer Institute, U.S. National Institutes of Health [RO1-CA106456]; DKFZ-MOST; Technion; Israel Cancer Research Fund (ICRF); NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DKFZ-MOST; Technion; Israel Cancer Research Fund (ICRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (549/06); the National Cancer Institute, U.S. National Institutes of Health (RO1-CA106456); the DKFZ-MOST cooperation program in cancer research; the Technion Fine Postdoctoral Fellowship; and the Israel Cancer Research Fund (ICRF) Postdoctoral Fellowship. I. V. is a Research Professor of the ICRF.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Basche M, 2006, CLIN CANCER RES, V12, P5471, DOI 10.1158/1078-0432.CCR-05-2423; Ben-Zaken O, 2008, INT J BIOCHEM CELL B, V40, P530, DOI 10.1016/j.biocel.2007.09.003; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Birzele F, 2008, NUCLEIC ACIDS RES, V36, P550, DOI 10.1093/nar/gkm1054; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doviner V, 2006, MODERN PATHOL, V19, P878, DOI 10.1038/modpathol.3800603; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Fairweather JK, 2008, BIOORGAN MED CHEM, V16, P699, DOI 10.1016/j.bmc.2007.10.044; Ferro V, 2004, MINI-REV MED CHEM, V4, P693, DOI 10.2174/1389557043403729; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Goldshmidt O, 2002, EXP CELL RES, V281, P50, DOI 10.1006/excr.2002.5651; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Kelly T, 2003, CANCER RES, V63, P8749; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Lewis KD, 2008, INVEST NEW DRUG, V26, P89, DOI 10.1007/s10637-007-9080-5; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nadav L, 2006, CANCER RES, V66, P8608, DOI 10.1158/0008-5472.CAN-06-1301; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; Nasser NJ, 2007, BIOCHEM BIOPH RES CO, V354, P33, DOI 10.1016/j.bbrc.2006.12.189; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Simizu S, 2004, J BIOL CHEM, V279, P2697, DOI 10.1074/jbc.M300541200; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Sorek R, 2003, NUCLEIC ACIDS RES, V31, P1067, DOI 10.1093/nar/gkg170; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Sotnikov I, 2004, J IMMUNOL, V172, P5185, DOI 10.4049/jimmunol.172.9.5185; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; van Alphen RJ, 2009, BRIT J CANCER, V100, P228, DOI 10.1038/sj.bjc.6604801; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1983, CANCER RES, V43, P2704; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Xie HQ, 2002, GENOMICS, V80, P326, DOI 10.1006/geno.2002.6841; Zcharia E, 2005, FASEB J, V19, P211, DOI 10.1096/fj.04-1970com; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zetser A, 2003, CANCER RES, V63, P7733	56	36	40	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1239	1248		10.1096/fj.09-147074	http://dx.doi.org/10.1096/fj.09-147074			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	20007507	Green Published			2022-12-25	WOS:000276462300030
J	Rangaraju, S; Khoo, KK; Feng, ZP; Crossley, G; Nugent, D; Khaytin, I; Chi, V; Pham, C; Calabresi, P; Pennington, MW; Norton, RS; Chandy, KG				Rangaraju, Srikant; Khoo, Keith K.; Feng, Zhi-Ping; Crossley, George; Nugent, Daniel; Khaytin, Ilya; Chi, Victor; Pham, Cory; Calabresi, Peter; Pennington, Michael W.; Norton, Raymond S.; Chandy, K. George			Potassium Channel Modulation by a Toxin Domain in Matrix Metalloprotease 23	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH SECRETORY PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; GENE-EXPRESSION PROFILE; CRYSTAL-STRUCTURE; SNAKE-VENOM; SEA-ANEMONE; NMR-SPECTROSCOPY; ION CHANNELS; K+ CHANNEL; SHK TOXIN	Peptide toxins found in a wide array of venoms block K+ channels, causing profound physiological and pathological effects. Here we describe the first functional K+ channel-blocking toxin domain in a mammalian protein. MMP23 (matrix metalloprotease 23) contains a domain (MMP23(TxD)) that is evolutionarily related to peptide toxins from sea anemones. MMP23(TxD) shows close structural similarity to the sea anemone toxins BgK and ShK. Moreover, this domain blocks K+ channels in the nanomolar to low micromolar range (Kv1.6 > Kv1.3 > Kv1.1 = Kv3.2 > Kv1.4, in decreasing order of potency) while sparing other K+ channels (Kv1.2, Kv1.5, Kv1.7, and KCa3.1). Full-length MMP23 suppresses K+ channels by co-localizing with and trapping MMP23(TxD)-sensitive channels in the ER. Our results provide clues to the structure and function of the vast family of proteins that contain domains related to sea anemone toxins. Evolutionary pressure to maintain a channel-modulatory function may contribute to the conservation of this domain throughout the plant and animal kingdoms.	[Chandy, K. George] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Rangaraju, Srikant; Chi, Victor; Pham, Cory; Chandy, K. George] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; [Khoo, Keith K.; Feng, Zhi-Ping; Norton, Raymond S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Khoo, Keith K.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Crossley, George; Nugent, Daniel; Khaytin, Ilya; Pennington, Michael W.] Bachem Biosci Inc, King Of Prussia, PA 19406 USA; [Calabresi, Peter] Johns Hopkins Univ, Sch Med, Dept Neurol Neurosurg, Baltimore, MD 21287 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Walter & Eliza Hall Institute; University of Melbourne; Johns Hopkins University	Chandy, KG (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 291 JISH, Irvine, CA 92697 USA.	gchandy@uci.edu	Calabresi, Peter A./AAF-2288-2019; Khoo, Keith/G-5010-2016; RANGARAJU, SRIKANT/Q-1924-2018	Khoo, Keith/0000-0002-3334-6564; pennington, michael/0000-0001-5446-3447; Norton, Raymond/0000-0001-8893-0584; RANGARAJU, SRIKANT/0000-0003-2765-1500	National Institutes of Health [NS-048252, NS041435]; National Health and Medical Research Council Independent Research Institutes Infrastructure [361646]; Victorian State Government Operational Infrastructure Support grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS099474, R37NS041435, R01NS041435, R01NS048252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Independent Research Institutes Infrastructure; Victorian State Government Operational Infrastructure Support grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-048252 (to K. G. C. and M. W. P.) and NS041435 (to P. C. and K. G. C.). This work was also supported by National Health and Medical Research Council Independent Research Institutes Infrastructure Support Schemes Grant 361646 (to R.S.N.) and a Victorian State Government Operational Infrastructure Support grant (to R.S.N.).	AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; Alessandri-Haber N, 1999, J BIOL CHEM, V274, P35653, DOI 10.1074/jbc.274.50.35653; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Clancy BM, 2003, BONE, V33, P46, DOI 10.1016/S8756-3282(03)00116-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cotton J, 1997, EUR J BIOCHEM, V244, P192, DOI 10.1111/j.1432-1033.1997.00192.x; Cousin X, 1998, J BIOL CHEM, V273, P9812, DOI 10.1074/jbc.273.16.9812; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; FARACO J, 1995, GENOMICS, V25, P630, DOI 10.1016/0888-7543(95)80004-6; Fortunato SJ, 2002, J ASSIST REPROD GEN, V19, P483, DOI 10.1023/A:1020362519981; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; Gilquin B, 2002, J BIOL CHEM, V277, P37406, DOI 10.1074/jbc.M206205200; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; INOUE S, 1991, FEBS LETT, V279, P38, DOI 10.1016/0014-5793(91)80244-W; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; KLAUS W, 1993, J MOL BIOL, V232, P897, DOI 10.1006/jmbi.1993.1438; KOCHVA E, 1993, TOXICON, V31, P541, DOI 10.1016/0041-0101(93)90111-U; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Ohnishi J, 2001, MOL ENDOCRINOL, V15, P747, DOI 10.1210/me.15.5.747; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pan TL, 1998, DEV GENES EVOL, V208, P259, DOI 10.1007/s004270050180; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Pei DQ, 1999, FEBS LETT, V457, P262, DOI 10.1016/S0014-5793(99)01046-7; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; Suzuki N, 2005, ACTA CRYSTALLOGR F, V61, P750, DOI 10.1107/S1744309105020439; Tsang SW, 2007, DEV BIOL, V312, P353, DOI 10.1016/j.ydbio.2007.09.037; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Vacher H, 2007, FASEB J, V21, P906, DOI 10.1096/fj.06-7229com; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; Wang F, 2006, BIOCHEM BIOPH RES CO, V351, P443, DOI 10.1016/j.bbrc.2006.10.067; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Yan L, 2000, DEVELOPMENT, V127, P129; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724; Zhu J, 2001, J BIOL CHEM, V276, P39419, DOI 10.1074/jbc.M107399200	66	59	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9124	9136		10.1074/jbc.M109.071266	http://dx.doi.org/10.1074/jbc.M109.071266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	19965868	hybrid, Green Published			2022-12-25	WOS:000275553700062
J	Qiu, W; Leibowitz, B; Zhang, L; Yu, J				Qiu, W.; Leibowitz, B.; Zhang, L.; Yu, J.			Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis	ONCOGENE			English	Article						PUMA; growth factors; p53; apoptosis; intestinal stem cells; PI3K	GASTROINTESTINAL-TRACT; IONIZING-RADIATION; BH3-ONLY PROTEINS; IN-VIVO; P53; SURVIVAL; GENE; INDUCTION; IDENTIFICATION; EXPRESSION	Gastrointestinal toxicity is the primary limiting factor in abdominal and pelvic radiotherapy, but has no effective treatment currently. We recently showed a critical role of the BH3-only protein p53 upregulated modulator of apoptosis (PUMA) in acute radiation-induced GI damage and GI syndrome in mice. Growth factors such as insulin-like growth factor 1 (IGF-1) and basic fibroblast growth factor (bFGF) have been shown to protect against radiation-induced intestinal injury, although the underlying mechanisms remain to be identified. We report here the suppression of PUMA through the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/p53 axis in the intestinal stem cells as a novel molecular mechanism of growth factor-mediated intestinal radioprotection. IGF-1 or bFGF impaired radiation-induced apoptosis and the expression of PUMA and p53 in the crypt cells and intestinal stem cells. Using colonic epithelial cells that undergo PUMA-dependent and radiation-induced apoptosis, we found that a PI3K inhibitor, dominant-negative PI3K or Mdm2 antagonist restored the induction of PUMA, p53 and apoptosis in the presence of growth factors. In contrast, overexpression of AKT suppressed the induction of PUMA and p53 by radiation. Furthermore, inhibiting PI3K or activating p53 abrogated growth factor-mediated suppression of apoptosis and PUMA expression in the intestinal crypts and stem cells after radiation. Oncogene (2010) 29, 1622-1632; doi:10.1038/onc.2009.451; published online 7 December 2009	[Yu, J.] Univ Pittsburgh, Hillman Canc Ctr Res Pavil, Dept Pathol, Sch Med, Pittsburgh, PA 15213 USA; [Qiu, W.; Leibowitz, B.; Zhang, L.; Yu, J.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Zhang, L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, J (corresponding author), Univ Pittsburgh, Hillman Canc Ctr Res Pavil, Dept Pathol, Sch Med, Suite 2-26H,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yuj2@upmc.edu	Yu, Jian/A-8301-2009; Zhang, Lin/A-7389-2009	Yu, Jian/0000-0002-4021-1000; Zhang, Lin/0000-0003-0018-3903	NIH [CA106348, CA121105, CA129829, UO1-DK085570, U19-A1068021]; American Cancer Society [RSG-07-156-01-CNE]; ACGT; FAMRI; NATIONAL CANCER INSTITUTE [R01CA129829, R01CA121105, R01CA106348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); ACGT; FAMRI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank other members of our labs for helpful discussion and advice and Ms Hong Tao Liu for breeding mice. This work is supported in part by NIH grants CA106348, CA121105, and American Cancer Society grant RSG-07-156-01-CNE (L Zhang), and NIH grants CA129829, UO1-DK085570, U19-A1068021 (pilot project), and those from ACGT and FAMRI (J Yu).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Booth D, 2001, J Natl Cancer Inst Monogr, P16; Bouleau S, 2007, APOPTOSIS, V12, P1377, DOI 10.1007/s10495-007-0072-x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Butt AJ, 1999, IMMUNOL CELL BIOL, V77, P256, DOI 10.1046/j.1440-1711.1999.00822.x; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Clarke AR, 2007, ONCOGENE, V26, P6349, DOI 10.1038/sj.onc.1210457; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; George RJ, 2009, AM J PHYSIOL-GASTR L, V296, pG245, DOI 10.1152/ajpgi.00021.2008; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gu QY, 2004, RADIAT RES, V161, P692, DOI 10.1667/RR3158; Gulati AS, 2008, AM J PHYSIOL-GASTR L, V294, pG286, DOI 10.1152/ajpgi.00416.2007; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Ishizuka S, 2003, NUCLEIC ACIDS RES, V31, P6198, DOI 10.1093/nar/gkg840; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Katoh M, 2006, INT J ONCOL, V29, P163; Kohli M, 2004, P NATL ACAD SCI USA, V101, P16897, DOI 10.1073/pnas.0403405101; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; MERRITT AJ, 1994, CANCER RES, V54, P614; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shaulian E, 1997, ONCOGENE, V15, P2717, DOI 10.1038/sj.onc.1201453; Sun Q, 2009, ONCOGENE, V28, P2348, DOI 10.1038/onc.2009.108; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wilkins HR, 2002, AM J PHYSIOL-GASTR L, V283, pG457, DOI 10.1152/ajpgi.00019.2002; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Yang JY, 2006, INT J ONCOL, V29, P643; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	51	101	116	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2010	29	11					1622	1632		10.1038/onc.2009.451	http://dx.doi.org/10.1038/onc.2009.451			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	19966853	Green Accepted			2022-12-25	WOS:000275694700007
J	Choi, YB; Son, M; Park, M; Shin, J; Yun, Y				Choi, Young Bong; Son, Myoungsun; Park, Mijin; Shin, Jaekyoon; Yun, Yungdae			SOCS-6 Negatively Regulates T Cell Activation through Targeting p56(lck) to Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SRC-FAMILY KINASES; SH2 DOMAIN; IMMUNOLOGICAL SYNAPSE; TYROSINE PHOSPHORYLATION; UBIQUITIN LIGASES; INSULIN-RECEPTOR; ADAPTER PROTEIN; LCK ACTIVITY; BOX MOTIF	The T cell-specific tyrosine kinase, p56(lck), plays crucial roles in T cell receptor (TCR)-mediated T cell activation. Here, we report that SOCS-6 (suppressor of cytokine signaling-6) is a negative regulator of p56(lck). SOCS-6 was identified as a protein binding to the kinase domain of p56(lck) through yeast two-hybrid screening. SOCS-6 bound specifically to p56(lck) (F505), which mimics the active form of p56(lck), but not to wild type p56(lck). In Jurkat T cells, SOCS-6 binding to p56(lck) was detected 1-2 h after TCR stimulation. Confocal microscopy showed that upon APC-T cell conjugation, SOCS-6 was recruited to the immunological synapse and colocalized with the active form of p56(lck). SOCS-6 promoted p56(lck) ubiquitination and its subsequent targeting to the proteasome. Moreover, SOCS-6 overexpression led to repression of TCR-dependent interleukin-2 promoter activity. These results establish that SOCS-6 acts as a negative regulator of T cell activation by promoting ubiquitin-dependent proteolysis.	[Yun, Yungdae] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Choi, Young Bong; Shin, Jaekyoon] Sungkyunkwan Univ, Mol Cell Biol Lab, Sch Med, Suwon 440746, Kyonggi Do, South Korea; [Choi, Young Bong; Shin, Jaekyoon] Samsung Biomed Res Inst, Suwon 440746, Kyonggi Do, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU)	Yun, Y (corresponding author), Ewha Womans Univ, Dept Life Sci, 11-1 Daehyundong, Seoul 120750, South Korea.	YUNYUNG@ewha.ac.kr	Choi, Young Bong/J-4317-2019	Choi, Young Bong/0000-0002-2523-1441	National Research Foundation [KRF-2006-C00308, 2006-2002689, 2009-0060399]; Ministry of Education, Science, and Technology, Korea [2006-08367]; Brain Korea 21 Project	National Research Foundation; Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported in part by National Research Foundation Grants KRF-2006-C00308, 2006-2002689, and 2009-0060399 and KBRDG Initiative Research Program Grant 2006-08367 from the Ministry of Education, Science, and Technology, Korea.; Supported by the Brain Korea 21 Project.	Ahn E, 2006, BLOOD, V107, P1521, DOI 10.1182/blood-2005-05-1859; Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Banerjee A, 2002, J IMMUNOL, V168, P4277, DOI 10.4049/jimmunol.168.9.4277; Bayle J, 2006, FEBS LETT, V580, P2609, DOI 10.1016/j.febslet.2006.03.093; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Choi YB, 1999, J IMMUNOL, V163, P5242; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GERVAIS FG, 1993, MOL CELL BIOL, V13, P7112, DOI 10.1128/MCB.13.11.7112; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hur EM, 2003, J EXP MED, V198, P1463, DOI 10.1084/jem.20030232; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Jury EC, 2003, ARTHRITIS RHEUM-US, V48, P1343, DOI 10.1002/art.10978; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Li L, 2004, J BIOL CHEM, V279, P34107, DOI 10.1074/jbc.M312672200; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nervi S, 2000, J IMMUNOL, V165, P5874, DOI 10.4049/jimmunol.165.10.5874; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park D, 2001, MOL CELLS, V12, P244; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; RUDD CE, 1989, IMMUNOL REV, V111, P225, DOI 10.1111/j.1600-065X.1989.tb00548.x; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wiedemann A, 2005, IMMUNOL LETT, V98, P57, DOI 10.1016/j.imlet.2004.10.014; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yorgin PD, 2000, J IMMUNOL, V164, P2915, DOI 10.4049/jimmunol.164.6.2915; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	48	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7271	7280		10.1074/jbc.M109.073726	http://dx.doi.org/10.1074/jbc.M109.073726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20007709	hybrid, Green Published			2022-12-25	WOS:000275415600039
J	Bailly-Maitre, B; Belgardt, BF; Jordan, SD; Coornaert, B; von Freyend, MJ; Kleinridders, A; Mauer, J; Cuddy, M; Kress, CL; Willmes, D; Essig, M; Hampel, B; Protzer, U; Reed, JC; Bruning, JC				Bailly-Maitre, Beatrice; Belgardt, Bengt F.; Jordan, Sabine D.; Coornaert, Beatrice; von Freyend, Miriam John; Kleinridders, Andre; Mauer, Jan; Cuddy, Michael; Kress, Christina L.; Willmes, Diana; Essig, Manuela; Hampel, Brigitte; Protzer, Ulrike; Reed, John C.; Bruening, Jens C.			Hepatic Bax Inhibitor-1 Inhibits IRE1 alpha and Protects from Obesity-associated Insulin Resistance and Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE; KINASE-B; APOPTOSIS; MICE; IRE1; BI-1	The unfolded protein response (UPR) or endoplasmic reticulum (ER) stress response is a physiological process enabling cells to cope with altered protein synthesis demands. However, under conditions of obesity, prolonged activation of the UPR has been shown to have deteriorating effects on different metabolic pathways. Here we identify Bax inhibitor-1 (BI-1), an evolutionary conserved ER-membrane protein, as a novel modulator of the obesity-associated alteration of the UPR. BI-1 partially inhibits the UPR by interacting with IRE1 alpha and inhibiting IRE1 alpha endonuclease activity as seen on the splicing of the transcription factor Xbp-1. Because we observed a down-regulation of BI-1 expression in liver and muscle of genetically obese ob/ob and db/db mice as well as in mice with diet-induced obesity in vivo, we investigated the effect of restoring BI-1 expression on metabolic processes in these mice. Importantly, BI-1 overexpression by adenoviral gene transfer dramatically improved glucose metabolism in both standard diet-fed mice as well as in mice with diet-induced obesity and, critically, reversed hyperglycemia in db/db mice. This improvement in whole body glucose metabolism and insulin sensitivity was due to dramatically reduced gluconeogenesis as shown by reduction of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase expression. Taken together, these results identify BI-1 as a critical regulator of ER stress responses in the development of obesity associated insulin resistance and provide proof of concept evidence that gene transfer-mediated elevations in hepatic BI-1 may represent a promising approach for the treatment of type 2 diabetes.	[Bailly-Maitre, Beatrice; Belgardt, Bengt F.; Jordan, Sabine D.; Coornaert, Beatrice; Kleinridders, Andre; Mauer, Jan; Willmes, Diana; Essig, Manuela; Hampel, Brigitte; Bruening, Jens C.] Univ Cologne, Dept Internal Med 2, Dept Mouse Genet & Metab, Inst Genet,Ctr Mol Med Cologne,Univ Hosp Cologne, D-50674 Cologne, Germany; [Bailly-Maitre, Beatrice; Belgardt, Bengt F.; Jordan, Sabine D.; Coornaert, Beatrice; Kleinridders, Andre; Mauer, Jan; Willmes, Diana; Essig, Manuela; Hampel, Brigitte; Bruening, Jens C.] Max Planck Inst Biol Ageing, D-50674 Cologne, Germany; [Bailly-Maitre, Beatrice; Cuddy, Michael; Kress, Christina L.; Reed, John C.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [von Freyend, Miriam John; Protzer, Ulrike] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Mol Infectiol Ctr Mol Med Cologne, D-50935 Cologne, Germany; [von Freyend, Miriam John] Univ Hosp Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [von Freyend, Miriam John] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Protzer, Ulrike] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, D-81675 Munich, Germany	University of Cologne; Max Planck Society; Sanford Burnham Prebys Medical Discovery Institute; University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Bruning, JC (corresponding author), Univ Cologne, Dept Internal Med 2, Dept Mouse Genet & Metab, Inst Genet,Ctr Mol Med Cologne,Univ Hosp Cologne, D-50674 Cologne, Germany.	jens.bruening@uni-koeln.de	Longo, Kenneth A/A-5631-2010; Protzer, Ulrike/D-5915-2015	Protzer, Ulrike/0000-0002-9421-1911; Belgardt, Bengt-Frederik/0000-0003-4537-9002; Kleinridders, Andre/0000-0002-4248-6366; Bailly-Maitre, Beatrice/0000-0002-8389-8498; Mauer, Jan/0000-0002-0189-5876	National Institutes of Health [AG15393]; Cologne Cluster of Excellence on Cellular Stress Responses in Agingassociated Diseases; Center of Molecular Medicine Cologne [TV A1]; European Community 7th Framework Programme [FP7/2007-2013, 201608]; German Research Foundation (Deutsche Forschungsgemeinschaft) [1492/7-1, SFB 612 (TP B16), SFB 670 (TP 17)]; Californian Breast Cancer Research Program; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cologne Cluster of Excellence on Cellular Stress Responses in Agingassociated Diseases; Center of Molecular Medicine Cologne; European Community 7th Framework Programme(European Commission); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Californian Breast Cancer Research Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15393 (to J.C.R.). This work was also supported by funding from the Cologne Cluster of Excellence on Cellular Stress Responses in Agingassociated Diseases and grants from the Center of Molecular Medicine Cologne (TV A1; to J.C.B.), European Community 7th Framework Programme (FP7/2007-2013) Grant 201608, acronym " TOBI" (to J.C.B.), German Research Foundation (Deutsche Forschungsgemeinschaft) Grants 1492/7-1, SFB 612 (TP B16), and SFB 670 (TP 17), and the Californian Breast Cancer Research Program.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshiuchi K, 2008, BIOCHEM BIOPH RES CO, V366, P545, DOI 10.1016/j.bbrc.2007.11.182	37	81	87	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6198	6207		10.1074/jbc.M109.056648	http://dx.doi.org/10.1074/jbc.M109.056648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	19996103	Green Published, hybrid			2022-12-25	WOS:000275367500024
J	Bleicken, S; Classen, M; Padmavathi, PVL; Ishikawa, T; Zeth, K; Steinhoff, HJ; Bordignon, E				Bleicken, Stephanie; Classen, Mirjam; Padmavathi, Pulagam V. L.; Ishikawa, Takashi; Zeth, Kornelius; Steinhoff, Heinz-Juergen; Bordignon, Enrica			Molecular Details of Bax Activation, Oligomerization, and Membrane Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; OUTER MITOCHONDRIAL-MEMBRANE; CELL-DEATH; CONFORMATIONAL-CHANGES; PEPTIDE COMPLEX; PORE FORMATION; BCL-2 FAMILY; BH3 DOMAINS; APOPTOSIS; PROTEIN	Bax and Bid are pro-apoptotic members of the Bcl-2 protein family. Upon cleavage by caspase-8, Bid activates Bax. Activated Bax inserts into the mitochondrial outer membrane forming oligomers which lead to membrane poration, release of cytochrome c, and apoptosis. The detailed mechanism of Bax activation and the topology and composition of the oligomers are still under debate. Here molecular details of Bax activation and oligomerization were obtained by application of several biophysical techniques, including atomic force microscopy, cryoelectron microscopy, and particularly electron paramagnetic resonance (EPR) spectroscopy performed on spin-labeled Bax. Incubation with detergents, reconstitution, and Bid-triggered insertion into liposomes were found to be effective in inducing Bax oligomerization. Bid was shown to activate Bax independently of the stoichiometric ratio, suggesting that Bid has a catalytic function and that the interaction with Bax is transient. The formation of a stable dimerization interface involving two Bcl-2 homology 3 (BH3) domains was found to be the nucleation event for Bax homo-oligomerization. Based on intermolecular distance determined by EPR, a model of six adjacent Bax molecules in the oligomer is presented where the hydrophobic hairpins ( helices alpha 5 and alpha 6) are equally spaced in the membrane and the two BH3 domains are in close vicinity in the dimer interface, separated by > 5 nm from the next BH3 pairs.	[Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Ishikawa, Takashi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Padmavathi, Pulagam V. L.; Steinhoff, Heinz-Juergen] Univ Osnabruck, Dept Phys, D-49069 Osnabruck, Germany; [Bleicken, Stephanie] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Classen, Mirjam] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University Osnabruck; Max Planck Society; Max Planck Society	Bordignon, E (corresponding author), ETH, Phys Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch	Ishikawa, Takashi/E-5023-2017; Pulagam, Lakshmi/E-8166-2012; Steinhoff, Heinz-Juergen/H-3791-2014	Ishikawa, Takashi/0000-0002-1976-7477; Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Pamulapati, Padmavathi/0000-0001-5294-137X; Bleicken, Stephanie/0000-0002-4789-0974; Bordignon, Enrica/0000-0003-2450-5161	Deutsche Forschungsgemeinschaft [ZE522-4/1]; Volkswagenstiftung [I-80842]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft via Research Grant ZE522-4/1 (to S. B. and K. Z.) and by Volkswagenstiftung I-80842 ( to H.-J. S.).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Beier C, 2006, BIOPHYS J, V91, P2647, DOI 10.1529/biophysj.105.080051; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; Bordignon E, 2007, BIOL MAGN RESON, V27, P129; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Cartron PF, 2004, FEBS LETT, V578, P41, DOI 10.1016/j.febslet.2004.10.080; Cartron PF, 2004, J BIOL CHEM, V279, P11503, DOI 10.1074/jbc.M311922200; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gao G, 2000, J CELL BIOCHEM, V80, P53; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liang HJ, 2007, P NATL ACAD SCI USA, V104, P8212, DOI 10.1073/pnas.0702336104; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Sanders CR, 2006, MAGN RESON CHEM, V44, pS24, DOI 10.1002/mrc.1816; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	59	140	141	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6636	6647		10.1074/jbc.M109.081539	http://dx.doi.org/10.1074/jbc.M109.081539			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20008353	hybrid, Green Published			2022-12-25	WOS:000275367500068
J	Pandya, RK; Partridge, JR; Love, KR; Schwartz, TU; Ploegh, HL				Pandya, Renuka K.; Partridge, James R.; Love, Kerry Routenberg; Schwartz, Thomas U.; Ploegh, Hidde L.			A Structural Element within the HUWE1 HECT Domain Modulates Self-ubiquitination and Substrate Ubiquitination Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE; E3; PROTEINS; DYNAMICS; PROLIFERATION; ARF-BP1/MULE; ACTIVATION; MECHANISMS; STABILITY; APOPTOSIS	E3 ubiquitin ligases catalyze the final step of ubiquitin conjugation and regulate numerous cellular processes. The HECT class of E3 ubiquitin (Ub) ligases directly transfers Ub from bound E2 enzyme to a myriad of substrates. The catalytic domain of HECT Ub ligases has a bilobal architecture that separates the E2 binding region and catalytic site. An important question regarding HECT domain function is the control of ligase activity and specificity. Here we present a functional analysis of the HECT domain of the E3 ligase HUWE1 based on crystal structures and show that a single N-terminal helix significantly stabilizes the HECT domain. We observe that this element modulates HECT domain activity, as measured by self-ubiquitination induced in the absence of this helix, as distinct from its effects on Ub conjugation of substrate Mcl-1. Such subtle changes to the protein may be at the heart of the vast spectrum of substrate specificities displayed by HECT domain E3 ligases.	[Partridge, James R.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pandya, Renuka K.; Love, Kerry Routenberg; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu; ploegh@wi.mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Pandya, Renuka/0000-0002-7667-607X	National Institutes of Health [F32 AI63854]; United States Department of Defense [W8IXWH-06-1-0789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI063854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant Postdoctoral Fellowship F32 AI63854 (to K. R. L.).; Supported by United States Department of Defense Breast Cancer Research Program Award W8IXWH-06-1-0789.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	33	42	47	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5664	5673		10.1074/jbc.M109.051805	http://dx.doi.org/10.1074/jbc.M109.051805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007713	hybrid, Green Published			2022-12-25	WOS:000275327200059
J	Wu, XL; Ge, HF; Lemon, B; Vonderfecht, S; Weiszmann, J; Hecht, R; Gupte, J; Hager, T; Wang, ZL; Lindberg, R; Li, Y				Wu, Xinle; Ge, Hongfei; Lemon, Bryan; Vonderfecht, Steven; Weiszmann, Jennifer; Hecht, Randy; Gupte, Jamila; Hager, Todd; Wang, Zhulun; Lindberg, Richard; Li, Yang			FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC-ACTIVITY; TRANSGENIC MICE; BETA-KLOTHO; FGF19; FIBROBLAST-GROWTH-FACTOR-19; DETERMINES; EXPRESSION; REGULATOR	FGF19 and FGF21, unique members of the fibroblast growth factor (FGF) family, are hormones that regulate glucose, lipid, and energy homeostasis. Increased hepatocyte proliferation and liver tumor formation have also been observed in FGF19 transgenic mice. Here, we report that, in contrast to FGF19, FGF21 does not induce hepatocyte proliferation in vivo. To identify the mechanism for FGF19-induced hepatocyte proliferation, we explored similarities and differences in receptor specificity between FGF19 and FGF21. We find that although both are able to activate FGF receptors (FGFRs) 1c, 2c, and 3c, only FGF19 activates FGFR4, the predominant receptor in the liver. Using a C-terminal truncation mutant of FGF19 and a series of FGF19/FGF21 chimeric molecules, we determined that amino acids residues 38-42 of FGF19 are sufficient to confer both FGFR4 activation and increased hepatocyte proliferation in vivo to FGF21. These data suggest that activation of FGFR4 is the mechanism whereby FGF19 can increase hepatocyte proliferation and induce hepatocellular carcinoma formation.	[Wu, Xinle; Ge, Hongfei; Lemon, Bryan; Weiszmann, Jennifer; Gupte, Jamila; Wang, Zhulun; Lindberg, Richard; Li, Yang] Amgen Inc, San Francisco, CA 94080 USA; [Vonderfecht, Steven; Hecht, Randy; Hager, Todd] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Li, Y (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	yangl@amgen.com						Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Fukumoto S, 2007, BONE, V40, P1190, DOI 10.1016/j.bone.2006.12.062; Huang XQ, 2009, MOL CARCINOGEN, V48, P553, DOI 10.1002/mc.20494; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	18	132	181	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5165	5170		10.1074/jbc.M109.068783	http://dx.doi.org/10.1074/jbc.M109.068783			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018895	Green Published, hybrid			2022-12-25	WOS:000275327200008
J	Iwata, J; Hosokawa, R; Sanchez-Lara, PA; Urata, M; Slavkin, H; Chai, Y				Iwata, Jun-ichi; Hosokawa, Ryoichi; Sanchez-Lara, Pedro A.; Urata, Mark; Slavkin, Harold; Chai, Yang			Transforming Growth Factor-beta Regulates Basal Transcriptional Regulatory Machinery to Control Cell Proliferation and Differentiation in Cranial Neural Crest-derived Osteoprogenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL DEVELOPMENT; RUNX2; TAFS; MICE; CHONDROGENESIS; INACTIVATION; AUTOPHAGY; PROMOTER; SYSTEM; CYCLE	Transforming growth factor-beta(Tgf-beta) signaling is crucial for regulating craniofacial development. Loss of Tgf-beta signaling results in defects in cranial neural crest cells (CNCC), but the mechanism by which Tgf-beta signaling regulates bone formation in CNCC-derived osteogenic cells remains largely unknown. In this study, we discovered that Tgf-beta regulates the basal transcriptional regulatory machinery to control intramembranous bone development. Specifically, basal transcription factor Taf4b is down-regulated in the CNCC-derived intramembranous bone in Tgfbr2(fl/fl); Wnt1-Cre mice. Tgf-beta specifically induces Taf4b expression. Moreover, small interfering RNA knockdown of Taf4b results in decreased cell proliferation and altered osteogenic differentiation in primary mouse embryonic maxillary mesenchymal cells, as seen in Tgfbr2 mutant cells. In addition, we show that Taf1 is decreased at the osteogenic initiation stage in the maxilla of Tgfbr2 mutant mice. Furthermore, small interfering RNA knockdown of Taf4b and Taf1 together in primary mouse embryonic maxillary mesenchymal cells results in up-regulated osteogenic initiator Runx2 expression, with decreased cell proliferation and altered osteogenic differentiation. Our results indicate a critical function of Tgf-beta-mediated basal transcriptional factors in regulating osteogenic cell proliferation and differentiation in CNCC-derived osteoprogenitor cells during intramembranous bone formation.	[Iwata, Jun-ichi; Hosokawa, Ryoichi; Urata, Mark; Slavkin, Harold; Chai, Yang] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Sanchez-Lara, Pedro A.; Urata, Mark] Childrens Hosp Los Angeles, Div Plast Surg, Los Angeles, CA 90027 USA	University of Southern California; Children's Hospital Los Angeles	Chai, Y (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	ychai@usc.edu	Sanchez-Lara, Pedro A./AAP-5644-2021; Sanchez-Lara, Pedro/F-6352-2012; Sanchez, Pedro/HHM-5713-2022; Sanchez, Pedro/P-1377-2018	Sanchez-Lara, Pedro A./0000-0003-1181-7828; Sanchez-Lara, Pedro/0000-0002-8027-177X; Sanchez, Pedro/0000-0003-1181-7828; 	NIDCR [DE012711, DE014078, U01 DE020065]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE020065, R01DE014078, R37DE012711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE012711, DE014078, and U01 DE020065 from NIDCR (to Y. C.).	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Davidson I, 2005, CELL CYCLE, V4, P1486, DOI 10.4161/cc.4.11.2120; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hilton TL, 2005, MOL CELL BIOL, V25, P4321, DOI 10.1128/MCB.25.10.4321-4332.2005; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Metcalf CE, 2007, DEV DYNAM, V236, P2836, DOI 10.1002/dvdy.21294; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Seo HS, 2009, DEV BIOL, V334, P481, DOI 10.1016/j.ydbio.2009.08.015; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Veenstra GJC, 2001, TRENDS BIOCHEM SCI, V26, P665, DOI 10.1016/S0968-0004(01)01970-3; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015	36	58	59	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4975	4982		10.1074/jbc.M109.035105	http://dx.doi.org/10.1074/jbc.M109.035105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959467	Green Published, hybrid			2022-12-25	WOS:000275274800074
J	Kimura, T; Tomura, H; Sato, K; Ito, M; Matsuoka, I; Im, DS; Kuwabara, A; Mogi, C; Itoh, H; Kurose, H; Murakami, M; Okajima, F				Kimura, Takao; Tomura, Hideaki; Sato, Koichi; Ito, Masaaki; Matsuoka, Isao; Im, Doon-Soon; Kuwabara, Atsushi; Mogi, Chihiro; Itoh, Hiroshi; Kurose, Hitoshi; Murakami, Masami; Okajima, Fumikazu			Mechanism and Role of High Density Lipoprotein-induced Activation of AMP-activated Protein Kinase in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; SPHINGOSINE 1-PHOSPHATE RECEPTORS; OXIDE SYNTHASE PHOSPHORYLATION; INHIBITION; ANGIOGENESIS; MIGRATION; LKB1; ADHESION; MUSCLE; PROLIFERATION	The upstream signaling pathway leading to the activation of AMP-activated protein kinase (AMPK) by high density lipoprotein (HDL) and the role of AMPK in HDL-induced antiatherogenic actions were investigated. Experiments using genetic and pharmacological tools showed that HDL-induced activation of AMPK is dependent on both sphingosine 1-phosphate receptors and scavenger receptor class B type I through calcium/calmodulin dependent protein kinase kinase and, for scavenger receptor class B type I system, additionally serine-threonine kinase LKB1 in human umbilical vein endothelial cells. HDL-induced activation of Akt and endothelial NO synthase, stimulation of migration, and inhibition of monocyte adhesion and adhesion molecule expression were dependent on AMPK activation. The inhibitory role of AMPK in the adhesion molecule expression and monocyte adhesion on endothelium of mouse aorta was confirmed in vivo and ex vivo. On the other hand, stimulation of ERK and proliferation were hardly affected by AMPK knockdown but completely inhibited by an N17Ras, whereas the dominant-negative Ras was ineffective for AMPK activation. In conclusion, dual HDL receptor systems differentially regulate AMPK activity through calcium/calmodulin-dependent protein kinase kinase and/or LKB1. Several HDL-induced antiatherogenic actions are regulated by AMPK, but proliferation-related actions are regulated by Ras rather than AMPK.	[Kimura, Takao; Tomura, Hideaki; Sato, Koichi; Kuwabara, Atsushi; Mogi, Chihiro; Okajima, Fumikazu] Gunma Univ, Lab Signal Transduct, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan; [Kimura, Takao; Kuwabara, Atsushi; Murakami, Masami] Gunma Univ, Grad Sch Med, Dept Clin Lab Med, Maebashi, Gunma 3718511, Japan; [Ito, Masaaki; Matsuoka, Isao] Takasaki Univ Hlth & Welf, Fac Pharm, Pharmacol Lab, Gunma 3700033, Japan; [Im, Doon-Soon] Pusan Natl Univ, Coll Pharm, Pharmacol Lab, Pusan 609735, South Korea; [Itoh, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Nara 6300101, Japan; [Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan	Gunma University; Gunma University; Pusan National University; Nara Institute of Science & Technology; Kyushu University	Okajima, F (corresponding author), Gunma Univ, Lab Signal Transduct, Inst Mol & Cellular Regulat, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan.	fokajima@showa.gunma-u.ac.jp		Matsuoka, Isao/0000-0002-7170-3630; IM, DONG-SOON/0000-0001-8054-8946; Sato, Koichi/0000-0001-7694-4014	Japan Society for the Promotion of Science [20591077, 21390016, 20054003, 20015008, 21591157, 21026004, 21591158, 20790636]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; ONO Medical Research Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ONO Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research 20591077 (to T. K.), 21390016, 20054003, and 20015008 (to F. O.), 21591157 and 21026004 (to H. T.), 21591158 (to K. S.), and 20790636 (to C. M.) from the Japan Society for the Promotion of Science and grants from Global Center of Excellence Program (to K. S. and C. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, ONO Medical Research Foundation (to F. O.), and Takeda Science Foundation (to T. K. and C. M.).	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; CaulinGlaser T, 1997, CIRC RES, V81, P885; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Gaskin FS, 2007, AM J PHYSIOL-HEART C, V292, pH326, DOI 10.1152/ajpheart.00744.2006; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hu ZL, 2008, J BIOL CHEM, V283, P25256, DOI 10.1074/jbc.M802455200; Hutchinson DS, 2008, PHARMACOL THERAPEUT, V119, P291, DOI 10.1016/j.pharmthera.2008.05.008; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Kimura T, 2006, CELL SIGNAL, V18, P841, DOI 10.1016/j.cellsig.2005.07.011; Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kimura T, 2008, J IMMUNOL, V181, P7332, DOI 10.4049/jimmunol.181.10.7332; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Londesborough A, 2008, DEVELOPMENT, V135, P2331, DOI 10.1242/dev.017038; Mineo C, 2006, CARDIOVASC RES, V70, P31, DOI 10.1016/j.cardiores.2006.01.025; Miura S, 2003, ARTERIOSCL THROM VAS, V23, P802, DOI 10.1161/01.ATV.0000066134.79956.58; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nofer Jerzy-Roch, 2005, Expert Rev Cardiovasc Ther, V3, P1071, DOI 10.1586/14779072.3.6.1071; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Okajima F, 2009, ENDOCR J, V56, P317, DOI 10.1507/endocrj.K08E-228; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pace MC, 1999, AM J PHYSIOL-LUNG C, V277, pL106, DOI 10.1152/ajplung.1999.277.1.L106; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rikitake Y, 2000, ARTERIOSCL THROM VAS, V20, P1006, DOI 10.1161/01.ATV.20.4.1006; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	50	63	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4387	4397		10.1074/jbc.M109.043869	http://dx.doi.org/10.1074/jbc.M109.043869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018878	Green Published, hybrid			2022-12-25	WOS:000275274800015
J	Kotani, T; Iemura, S; Natsume, T; Kawakami, K; Yamashita, M				Kotani, Tomoya; Iemura, Shun-ichiro; Natsume, Tohru; Kawakami, Koichi; Yamashita, Masakane			Mys Protein Regulates Protein Kinase A Activity by Interacting with Regulatory Type I alpha Subunit during Vertebrate Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; SIGNALING PATHWAY; NEURAL-TUBE; NEGATIVE REGULATOR; SPINDLE FORMATION; ZEBRAFISH; CAMP; DROSOPHILA; GENE; INDUCTION	During embryonic development, protein kinase A (PKA) plays a key role in cell fate specification by antagonizing the Hedgehog (Hh) signaling pathway. However, the mechanism by which PKA activity is regulated remains unknown. Here we show that the Misty somites (Mys) protein regulates the level of PKA activity during embryonic development in zebrafish. We isolate PKA regulatory type I alpha subunit (Prkar1a) as a protein interacting with Mys by pulldown assay in HEK293 cells followed by mass spectrometry analysis. We show an interaction between endogenous Mys and Prkar1a in the zebrafish embryo. Mys binds to Prkar1a in its C terminus region, termed PRB domain, and activates PKA in vitro. Conversely, knockdown of Mys in zebrafish embryos results in reduction in PKA activity. We also show that knockdown of Mys induces ectopic activation of Hh target genes in the eyes, neural tube, and somites downstream of Smoothened, a protein essential for transduction of Hh signaling activity. The altered patterning of gene expression is rescued by activation of PKA. Together, our results reveal a molecular mechanism of regulation of PKA activity that is dependent on a protein-protein interaction and demonstrate that PKA activity regulated by Mys is indispensable for negative regulation of the Hh signaling pathway in Hh-responsive cells.	[Kotani, Tomoya; Yamashita, Masakane] Hokkaido Univ, Fac Adv Life Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tsukuba, Ibaraki 1350064, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan; [Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan	Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Kotani, T (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan.	tkotani@sci.hokudai.ac.jp	Yamashita, Masakane/A-4556-2012; Natsume, Tohru/M-7627-2018; Kawakami, Koichi/AAF-1380-2019	Yamashita, Masakane/0000-0002-3696-451X; Natsume, Tohru/0000-0002-1510-2582; Kotani, Tomoya/0000-0003-1930-6635	Inamori and Akiyama Foundations; New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology of Japan; Bio-oriented Technology Research Advancement Institution (BRAIN)	Inamori and Akiyama Foundations; New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution (BRAIN)	This work was supported by grants from Inamori and Akiyama Foundations (to T. K.) and the New Energy and Industrial Technology Development Organization (NEDO) (to T. N.), a grant-in-aid for scientific research on Priority Areas "Systems Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. I. and K. K.), and the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) from Bio-oriented Technology Research Advancement Institution (BRAIN) (to M.Y.).	Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen WB, 2001, DEVELOPMENT, V128, P2385; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Ingham PW, 2008, CURR BIOL, V18, pR238, DOI 10.1016/j.cub.2008.01.050; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kamakari S, 2005, LEUKEMIA RES, V29, P17, DOI 10.1016/j.leukres.2004.04.019; Kotani T, 2005, ZYGOTE, V13, P219, DOI 10.1017/S0967199405003321; Kotani T, 2002, DEV BIOL, V252, P271, DOI 10.1006/dbio.2002.0853; Kotani T, 2001, MOL REPROD DEV, V59, P199, DOI 10.1002/mrd.1023; Kotani T, 2008, DEV BIOL, V316, P383, DOI 10.1016/j.ydbio.2008.01.043; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Ma YF, 2005, J BIOL CHEM, V280, P26011, DOI 10.1074/jbc.M409081200; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Philipp M, 2009, CURR BIOL, V19, pR125, DOI 10.1016/j.cub.2008.12.010; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; SARASWAT LD, 1988, J BIOL CHEM, V263, P18241; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; STRUTT DI, 1995, NATURE, V373, P705, DOI 10.1038/373705a0; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; Varga ZM, 2001, DEVELOPMENT, V128, P3497; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	51	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5106	5116		10.1074/jbc.M109.070995	http://dx.doi.org/10.1074/jbc.M109.070995			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018846	Green Published, hybrid			2022-12-25	WOS:000275274800086
J	Lisa, MN; Hemmingsen, L; Vila, AJ				Lisa, Maria-Natalia; Hemmingsen, Lars; Vila, Alejandro J.			Catalytic Role of the Metal Ion in the Metallo-beta-lactamase GOB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CEREUS; STENOTROPHOMONAS-MALTOPHILIA; BACTEROIDES-FRAGILIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; CHRYSEOBACTERIUM-MENINGOSEPTICUM; SPECTROSCOPIC CHARACTERIZATION; ANGSTROM RESOLUTION; REACTION-MECHANISM; SUBSTRATE-BINDING	Metallo-beta-lactamases (M beta Ls) stand as one of the main mechanisms of bacterial resistance toward carbapenems. The rational design of an inhibitor for M beta Ls has been limited by an incomplete knowledge of their catalytic mechanism and by the structural diversity of their active sites. Here we show that the M beta L GOB from Elizabethkingia meningoseptica is active as a monometallic enzyme by using different divalent transition metal ions as surrogates of the native Zn(II) ion. Of the metal derivatives in which Zn(II) is replaced, Co(II) and Cd(II) give rise to the most active enzymes and are shown to occupy the same binding site as the native ion. However, Zn(II) is the only metal ion capable of stabilizing an anionic intermediate that accumulates during nitrocefin hydrolysis, in which the C-N bond has already been cleaved. This finding demonstrates that the catalytic role of the metal ion in GOB is to stabilize the formation of this intermediate prior to nitrogen protonation. This role may be general to all M beta Ls, whereas nucleophile activation by a Zn(II) ion is not a conserved mechanistic feature.	[Vila, Alejandro J.] Univ Nacl Rosario, Dept Quim Biol, Inst Biol Mol & Celular Rosario, Fac Ciencias Bioquim & Farmaceut,IBR,CONICET UNR, RA-2000 Rosario, Santa Fe, Argentina; [Hemmingsen, Lars] Univ Copenhagen, Dept Basic Sci & Environm, DK-1871 Frederiksberg C, Denmark	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Copenhagen	Vila, AJ (corresponding author), Univ Nacl Rosario, Dept Quim Biol, Inst Biol Mol & Celular Rosario, Fac Ciencias Bioquim & Farmaceut,IBR,CONICET UNR, Suipacha 531,S2002LRK, RA-2000 Rosario, Santa Fe, Argentina.	vila@ibr.gov.ar	Hemmingsen, Lars/A-6780-2015; Hemmingsen, Lars/AAD-1318-2020	Hemmingsen, Lars/0000-0002-1823-3035; Hemmingsen, Lars/0000-0002-1823-3035; Vila, Alejandro/0000-0002-7978-3233; Lisa, Maria-Natalia/0000-0001-9630-8090	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bellais S, 2000, ANTIMICROB AGENTS CH, V44, P1878, DOI 10.1128/AAC.44.7.1878-1886.2000; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; Bertini I, 1984, Adv Inorg Biochem, V6, P71; BERTINI I, 1992, J CHEM SOC DALTON, P1443, DOI 10.1039/dt9920001443; Bounaga S, 1998, BIOCHEM J, V331, P703, DOI 10.1042/bj3310703; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Castanheira M, 2004, ANTIMICROB AGENTS CH, V48, P4654, DOI 10.1128/AAC.48.12.4654-4661.2004; COLEMAN JE, 1993, METHOD ENZYMOL, V227, P16; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Crawford PA, 2005, BIOCHEMISTRY-US, V44, P5168, DOI 10.1021/bi047463s; Cricco JA, 1999, COORDIN CHEM REV, V190, P519, DOI 10.1016/S0010-8545(99)00113-7; Cricco JA, 1999, CURR PHARM DESIGN, V5, P915; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Dal Peraro M, 2004, J AM CHEM SOC, V126, P12661, DOI 10.1021/ja048071b; Dal Peraro M, 2004, PROTEINS, V54, P412, DOI 10.1002/prot.10554; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; Damblon C, 2003, J BIOL CHEM, V278, P29240, DOI 10.1074/jbc.M301562200; Diaz N, 2001, J AM CHEM SOC, V123, P9867, DOI 10.1021/ja0113246; Docquier JD, 2004, ANTIMICROB AGENTS CH, V48, P4778, DOI 10.1128/AAC.48.12.4778-4783.2004; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Docquier JD, 2002, ANTIMICROB AGENTS CH, V46, P1823, DOI 10.1128/AAC.46.6.1823-1830.2002; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frere JM, 2005, J ANTIMICROB CHEMOTH, V55, P1051, DOI 10.1093/jac/dki155; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garcia-Saez I, 2003, J BIOL CHEM, V278, P23868, DOI 10.1074/jbc.M301062200; Garcia-Saez I, 2003, J MOL BIOL, V325, P651, DOI 10.1016/S0022-2836(02)01271-8; Garrity JD, 2004, J BIOL CHEM, V279, P920, DOI 10.1074/jbc.M309852200; GETTINS P, 1986, J BIOL CHEM, V261, P5513; Gonzalez JM, 2007, J MOL BIOL, V373, P1141, DOI 10.1016/j.jmb.2007.08.031; Hall BG, 2003, J MOL EVOL, V57, P249, DOI 10.1007/s00239-003-2471-0; HEMMINGSEN L, 1995, BIOCHEMISTRY-US, V34, P7145, DOI 10.1021/bi00021a028; Hemmingsen L, 2004, CHEM REV, V104, P4027, DOI 10.1021/cr030030v; Hemmingsen L, 2004, J BIOL INORG CHEM, V9, P591, DOI 10.1007/s00775-004-0553-0; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Hu ZX, 2008, J AM CHEM SOC, V130, P14207, DOI 10.1021/ja8035916; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; INUBUSHI T, 1983, J MAGN RESON, V51, P128, DOI 10.1016/0022-2364(83)90109-9; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Materon IC, 2004, J MOL BIOL, V344, P653, DOI 10.1016/j.jmb.2004.09.074; McManus-Munoz S, 1999, BIOCHEMISTRY-US, V38, P1547, DOI 10.1021/bi9826512; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; Murphy TA, 2006, J MOL BIOL, V357, P890, DOI 10.1016/j.jmb.2006.01.003; Nauton L, 2008, J MOL BIOL, V375, P257, DOI 10.1016/j.jmb.2007.10.036; Olsen L, 2004, J PHYS CHEM B, V108, P17639, DOI 10.1021/jp0482215; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Rasia RM, 2004, J BIOL CHEM, V279, P26046, DOI 10.1074/jbc.M311373200; ROSENBERG RC, 1975, J AM CHEM SOC, V97, P21, DOI 10.1021/ja00834a006; Saavedra MJ, 2003, ANTIMICROB AGENTS CH, V47, P2330, DOI 10.1128/AAC.47.7.2330-2333.2003; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Spencer J, 2005, J AM CHEM SOC, V127, P14439, DOI 10.1021/ja0536062; Spencer J, 2001, J BIOL CHEM, V276, P33638, DOI 10.1074/jbc.M105550200; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Toney JH, 2001, J BIOL CHEM, V276, P31913, DOI 10.1074/jbc.M104742200; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yanchak MP, 2000, BIOCHEMISTRY-US, V39, P11330, DOI 10.1021/bi0010524	68	27	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4570	4577		10.1074/jbc.M109.063743	http://dx.doi.org/10.1074/jbc.M109.063743			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007696	Green Published, hybrid			2022-12-25	WOS:000275274800034
J	Tang, T; Zhang, J; Yin, J; Staszkiewicz, J; Gawronska-Kozak, B; Jung, DY; Ko, HJ; Ong, H; Kim, JK; Mynatt, R; Martin, RJ; Keenan, M; Gao, ZG; Ye, JP				Tang, Tianyi; Zhang, Jin; Yin, Jun; Staszkiewicz, Jaroslaw; Gawronska-Kozak, Barbara; Jung, Dae Young; Ko, Hwi Jin; Ong, Helena; Kim, Jason K.; Mynatt, Randy; Martin, Roy J.; Keenan, Michael; Gao, Zhanguo; Ye, Jianping			Uncoupling of Inflammation and Insulin Resistance by NF-kappa B in Transgenic Mice through Elevated Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; PPAR-GAMMA; TNF-ALPHA; TARGETED DISRUPTION; GENE-EXPRESSION; P50 SUBUNIT; FOOD-INTAKE; IKK-BETA; OBESITY	To study the metabolic activity of NF-kappa B, we investigated phenotypes of two different mouse models with elevated NF-kappa B activities. The transcriptional activity of NF-kappa B is enhanced either by overexpression of NF-kappa B p65 (RelA) in aP2-p65 mice or inactivation of NF-kappa Bp50 (NF-kappa B1) through gene knock-out. In these models, energy expenditure was elevated in day and night time without a change in locomotion. The mice were resistant to adulthood obesity and diet-induced obesity without reduction in food intake. The adipose tissue growth and adipogenesis were inhibited by the elevated NF-kappa B activity. Peroxisome proliferator-activator receptor gamma expression was reduced by NF-kappa B at the transcriptional level. The two models exhibited elevated inflammatory cytokines (tumor necrosis factor-alpha and interleukin-6) in adipose tissue and serum. However, insulin sensitivity was not reduced by the inflammation in the mice on a chow diet. On a high fat diet, the mice were protected from insulin resistance. The glucose infusion rate was increased more than 30% in the hyperinsulinemic-euglycemic clamp test. Our data suggest that the transcription factor NF-kappa B promotes energy expenditure and inhibits adipose tissue growth. The two effects lead to prevention of adulthood obesity and dietary obesity. The energy expenditure may lead to disassociation of inflammation with insulin resistance. The study indicates that inflammation may prevent insulin resistance by eliminating lipid accumulation.	[Tang, Tianyi; Zhang, Jin; Yin, Jun; Staszkiewicz, Jaroslaw; Gawronska-Kozak, Barbara; Mynatt, Randy; Martin, Roy J.; Gao, Zhanguo; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Martin, Roy J.; Keenan, Michael] Louisiana State Univ Syst, Louisiana State Univ Ag Ctr, Baton Rouge, LA 70808 USA; [Jung, Dae Young; Ko, Hwi Jin; Ong, Helena; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Gawronska-Kozak, Barbara/A-2980-2017; Mynatt, Randall L/N-1980-2017; Ye, Jianping/N-1998-2017	Gawronska-Kozak, Barbara/0000-0002-2006-8534; Mynatt, Randall L/0000-0003-4399-0019; Ye, Jianping/0000-0003-3875-365X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, R01DK080756, R56DK068036, P30DK072476] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56DK068036-06, 1P30 DK072476, P30 DK072476, R56 DK068036, DK80756, R01 DK080756, DK068036, R01 DK068036] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anforth HR, 1998, EUR CYTOKINE NETW, V9, P279; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Gadjeva M, 2004, J IMMUNOL, V173, P5786, DOI 10.4049/jimmunol.173.9.5786; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Gao ZG, 2009, J BIOL CHEM, V284, P18368, DOI 10.1074/jbc.M109.007260; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; KLIR JJ, 1993, AM J PHYSIOL, V265, pR512, DOI 10.1152/ajpregu.1993.265.3.R512; Luheshi GN, 1998, ANN NY ACAD SCI, V856, P83, DOI 10.1111/j.1749-6632.1998.tb08316.x; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Pamir N, 2009, ENDOCRINOLOGY, V150, P4124, DOI 10.1210/en.2009-0137; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Staszkiewicz J, 2008, STEM CELLS, V26, P2666, DOI 10.1634/stemcells.2008-0270; Strasser Florian, 2007, Curr Opin Support Palliat Care, V1, P312, DOI 10.1097/SPC.0b013e3282f3474c; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; von Haehling S, 2002, INT J CARDIOL, V85, P173, DOI 10.1016/S0167-5273(02)00245-0; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Ye JP, 1996, MOL CELL BIOL, V16, P4744; YE JP, 1994, J BIOL CHEM, V269, P25728; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	49	122	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4637	4644		10.1074/jbc.M109.068007	http://dx.doi.org/10.1074/jbc.M109.068007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018865	Green Published, hybrid			2022-12-25	WOS:000275274800042
J	Wang, YJ; Kumar, N; Solt, LA; Richardson, TI; Helvering, LM; Crumbley, C; Garcia-Ordonez, RD; Stayrook, KR; Zhang, X; Novick, S; Chalmers, MJ; Griffin, PR; Burris, TP				Wang, Yongjun; Kumar, Naresh; Solt, Laura A.; Richardson, Timothy I.; Helvering, Leah M.; Crumbley, Christine; Garcia-Ordonez, Ruben D.; Stayrook, Keith R.; Zhang, Xi; Novick, Scott; Chalmers, Michael J.; Griffin, Patrick R.; Burris, Thomas P.			Modulation of Retinoic Acid Receptor-related Orphan Receptor alpha and gamma Activity by 7-Oxygenated Sterol Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; NUCLEAR RECEPTOR; ROR-ALPHA; GENE-EXPRESSION; CIRCADIAN TRANSCRIPTION; BINDING DOMAIN; PPAR-GAMMA; CHOLESTEROL; IDENTIFICATION; METABOLISM	The retinoic acid receptor-related orphan receptors alpha and gamma (ROR alpha(NR1F1) and ROR gamma(NR1F3)) are orphan nuclear receptors and perform critical roles in regulation of development, metabolism, and immune function. Cholesterol and cholesterol sulfate have been suggested to be ROR alpha ligands, but the physiological significance is unclear. To date, no endogenous ROR alpha ligands have been described. Here, we demonstrate that 7-oxygenated sterols function as high affinity ligands for both ROR alpha and ROR gamma by directly binding to their ligand-binding domains (K-i similar to 20 nM), modulating coactivator binding, and suppressing the transcriptional activity of the receptors. One of the 7-oxygenated sterols, 7 alpha-hydroxycholesterol (7 alpha-OHC), serves as a key intermediate in bile acid metabolism, and we show that 7 alpha-OHC modulates the expression of ROR target genes, including Glc-6-Pase and phosphoenolpyruvate carboxykinase, in an ROR-dependent manner. Furthermore, glucose output from hepatocytes is suppressed by 7 alpha-OHC functioning as an ROR alpha/gamma ligand. Thus, ROR alpha and ROR gamma are ligand-regulated members of the NR superfamily and may serve as sensors for 7-oxygenated sterols.	[Wang, Yongjun; Kumar, Naresh; Solt, Laura A.; Crumbley, Christine; Garcia-Ordonez, Ruben D.; Zhang, Xi; Novick, Scott; Chalmers, Michael J.; Griffin, Patrick R.; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA; [Richardson, Timothy I.; Helvering, Leah M.; Stayrook, Keith R.] Eli Lilly & Co, Indianapolis, IN 46258 USA	Scripps Research Institute; Eli Lilly	Burris, TP (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [DK080201, NS066417, NS067589, GM084041]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769, U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067589, R21NS066417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080201, NS066417, and NS067589 ( to T. P. B.) and GM084041 ( to P. R. G.).	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Arca M, 2007, FREE RADICAL BIO MED, V42, P698, DOI 10.1016/j.freeradbiomed.2006.12.013; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Besnard S, 2002, FEBS LETT, V511, P36, DOI 10.1016/S0014-5793(01)03275-6; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; BOSTROM H, 1983, J BIOL CHEM, V258, P5091; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1997, J LIPID RES, V38, P1730; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; HAHN C, 1995, J LIPID RES, V36, P2059; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jessup W, 2005, REJUV RES, V8, P9, DOI 10.1089/rej.2005.8.9; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; KUMAR N, 2009, MOL PHARM, V8, P156; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Maeda Y, 2002, STEROIDS, V67, P703, DOI 10.1016/S0039-128X(02)00027-2; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; Pascal BD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-156; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schoner BE, 2005, MOL GENET METAB, V85, P318, DOI 10.1016/j.ymgme.2005.04.012; SCHWARTZ MA, 1983, J LIPID RES, V24, P28; Staels B, 2007, DRUGS, V67, P1383, DOI 10.2165/00003495-200767100-00001; Stehlin-Gaon C, 2003, NAT STRUCT BIOL, V10, P820, DOI 10.1038/nsb979; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; TENG JI, 1981, J STEROID BIOCHEM, V14, P569, DOI 10.1016/0022-4731(81)90032-7; UCHIDA K, 1975, LIPIDS, V10, P473, DOI 10.1007/BF02532431; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wamil M, 2008, ENDOCRINOLOGY, V149, P5909, DOI 10.1210/en.2008-0420; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	61	142	180	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5013	5025		10.1074/jbc.M109.080614	http://dx.doi.org/10.1074/jbc.M109.080614			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19965867	Green Published, hybrid			2022-12-25	WOS:000275274800078
J	Andreani, G; Celentano, AM; Solana, ME; Cazorla, SI; Malchiodi, EL; Peralta, LAM; Dolcini, GL				Andreani, Guadalupe; Celentano, Ana M.; Solana, Maria E.; Cazorla, Silvia I.; Malchiodi, Emilio L.; Martinez Peralta, Liliana A.; Dolcini, Guillermina L.			Inhibition of HIV-1 Replication in Human Monocyte-Derived Macrophages by Parasite Trypanosoma cruzi	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TROPICAL INFECTIOUS-DISEASES; CHRONIC CHAGAS-DISEASE; MONONUCLEAR PHAGOCYTES; TRANS-SIALIDASE; LYMPHOID-TISSUE; MEASLES-VIRUS; EX-VIVO; EXPRESSION; PATHOGENESIS	Background: Cells of monocyte/macrophage lineage are one of the major targets of HIV-1 infection and serve as reservoirs for viral persistence in vivo. These cells are also the target of the protozoa Trypanosoma cruzi, the causative agent of Chagas disease, being one of the most important endemic protozoonoses in Latin America. It has been demonstrated in vitro that co-infection with other pathogens can modulate HIV replication. However, no studies at cellular level have suggested an interaction between T. cruzi and HIV-1 to date. Methodology/Principal Findings: By using a fully replicative wild-type virus, our study showed that T. cruzi inhibits HIV-1 antigen production by nearly 100% (p<0.001) in monocyte-derived macrophages (MDM). In different infection schemes with luciferase-reporter VSV-G or BaL pseudotyped HIV-1 and trypomastigotes, T. cruzi induced a significant reduction of luciferase level for both pseudotypes in all the infection schemes (p<0.001), T. cruzi-HIV (>99%) being stronger than HIV-T. cruzi (similar to 90% for BaL and similar to 85% for VSV-G) infection. In MDM with established HIV-1 infection, T. cruzi significantly inhibited luciferate activity (p<0.01). By quantifying R-U5 and U5-gag transcripts by real time PCR, our study showed the expression of both transcripts significantly diminished in the presence of trypomastigotes (p<0.05). Thus, T. cruzi inhibits viral post-integration steps, early post-entry steps and entry into MDM. Trypomastigotes also caused a similar to 60-70% decrease of surface CCR5 expression on MDM. Multiplication of T. cruzi inside the MDM does not seem to be required for inhibiting HIV-1 replication since soluble factors secreted by trypomastigotes have shown similar effects. Moreover, the major parasite antigen cruzipain, which is secreted by the trypomastigote form, was able to inhibit viral production in MDM over 90% (p<0.01). Conclusions/Significance: Our study showed that T. cruzi inhibits HIV-1 replication at several replication stages in macrophages, a major cell target for both pathogens.	[Andreani, Guadalupe; Martinez Peralta, Liliana A.; Dolcini, Guillermina L.] Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina; [Celentano, Ana M.; Solana, Maria E.; Cazorla, Silvia I.; Malchiodi, Emilio L.] Univ Buenos Aires, Sch Med, Dept Microbiol, Parasitol Lab, Buenos Aires, DF, Argentina; [Cazorla, Silvia I.; Malchiodi, Emilio L.] Univ Buenos Aires, Sch Pharm & Biochem, CONICET, IDEHU Inst Studies Humoral Immun, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Andreani, G (corresponding author), Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina.	gdolcini@fmed.uba.ar	Cazorla, Silvia/AAA-7958-2022; Dolcini, Guillermina Laura/AAC-2546-2022	Dolcini, Guillermina Laura/0000-0002-1496-0083; Malchiodi, Emilio/0000-0001-7501-3330; Cazorla, Silvia/0000-0002-6811-2207	Argentina's National Agency for Promotion of Science and Technology [PICT 05-33947, PICT 05-34123, PICT 06-608]; National Council for Technology and Scientific Research [PIP 6119]	Argentina's National Agency for Promotion of Science and Technology(ANPCyT); National Council for Technology and Scientific Research	This work was partly supported by grants from Argentina's National Agency for Promotion of Science and Technology (www.agencia.gov.ar) (PICT 05-33947 to LMP, PICT 05-34123 to GLD and PICT 06-608 to ELM) and the National Council for Technology and Scientific Research (www.conicet.gov.ar)( PIP 6119 to GLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Alfano M, 2005, CURR PHARM DESIGN, V11, P2909, DOI 10.2174/1381612054546725; Aquaro S, 1997, J BIOL REG HOMEOS AG, V11, P69; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brodskyn C, 2002, INFECT IMMUN, V70, P3736, DOI 10.1128/IAI.70.7.3736-3743.2002; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Cazorla SI, 2008, VACCINE, V26, P1999, DOI 10.1016/j.vaccine.2008.02.011; Cazorla SI, 2008, INFECT IMMUN, V76, P324, DOI 10.1128/IAI.01163-07; CELENTANO AM, 1992, PARASITE IMMUNOL, V14, P155, DOI 10.1111/j.1365-3024.1992.tb00458.x; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; David A, 2006, J IMMUNOL, V177, P6291, DOI 10.4049/jimmunol.177.9.6291; de Diego J, 1997, J IMMUNOL, V159, P4983; Denkers EY, 2005, TRENDS PARASITOL, V21, P35, DOI 10.1016/j.pt.2004.10.004; Dolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021; Dolcini GL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-53; Ferreira MS, 2002, MEM I OSWALDO CRUZ, V97, P443, DOI 10.1590/S0074-02762002000400001; Frank FM, 2003, VACCINE, V22, P77, DOI 10.1016/S0264-410X(03)00541-3; Garcia M, 2008, J GEN VIROL, V89, P984, DOI 10.1099/vir.0.83601-0; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; Golding H, 2005, J BIOL CHEM, V280, P29570, DOI 10.1074/jbc.M500236200; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Gruppi A, 1997, ACTA TROP, V63, P141, DOI 10.1016/S0001-706X(96)00616-X; Guarner J, 2001, AM J TROP MED HYG, V65, P152, DOI 10.4269/ajtmh.2001.65.152; Gurer C, 2005, J VIROL, V79, P5557, DOI 10.1128/JVI.79.9.5557-5567.2005; Harms G, 2002, TROP MED INT HEALTH, V7, P479, DOI 10.1046/j.1365-3156.2002.00893.x; Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180; Karp CL, 2007, CLIN INFECT DIS, V45, P1208, DOI 10.1086/522181; Kedzierska K, 2003, REV MED VIROL, V13, P39, DOI 10.1002/rmv.369; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.iy.08.040190.001125; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Morel CM, 2003, NAT REV MICROBIOL, V1, P14, DOI 10.1038/nrmicro735; *PAHO, 2003, EP B PAHO; Perez-Ramirez L, 1999, AM J TROP MED HYG, V61, P198; Risso MG, 2004, J INFECT DIS, V189, P2250, DOI 10.1086/420831; Rosestolato CTF, 2002, CELL STRUCT FUNCT, V27, P91, DOI 10.1247/csf.27.91; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Sartori AMC, 1998, CLIN INFECT DIS, V26, P177, DOI 10.1086/516257; Sartori AMC, 2002, AM J TROP MED HYG, V67, P521, DOI 10.4269/ajtmh.2002.67.521; SARTORI AMC, 1995, CLIN INFECT DIS, V21, P1297, DOI 10.1093/clinids/21.5.1297; SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Sorice M, 2001, FEBS LETT, V506, P55, DOI 10.1016/S0014-5793(01)02830-7; SOUTOPADRON T, 1990, J CELL SCI, V96, P485; STEVENSON M, 1994, J LEUKOCYTE BIOL, V56, P278, DOI 10.1002/jlb.56.3.278; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Vaidian Anil K, 2004, Kinetoplastid Biol Dis, V3, P2, DOI 10.1186/1475-9292-3-2; Warrilow D, 2007, CURR HIV RES, V5, P293, DOI 10.2174/157016207780636579; Woolsey AM, 2004, CELL MICROBIOL, V6, P829, DOI 10.1111/j.1462-5822.2004.00405.x; Xiang JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002580; Xiang WS, 2006, PESTIC BIOCHEM PHYS, V85, P1, DOI 10.1016/j.pestbp.2005.09.001; Zhao CQ, 2004, J IMMUNOL, V172, P3086, DOI 10.4049/jimmunol.172.5.3086; Zhao CQ, 2004, CLIN IMMUNOL, V113, P81, DOI 10.1016/j.clim.2004.06.003	63	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8246	10.1371/journal.pone.0008246	http://dx.doi.org/10.1371/journal.pone.0008246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011521	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830300018
J	Facente, SN; Dowling, T; Vittinghoff, E; Sykes, DL; Colfax, GN				Facente, Shelley N.; Dowling, Teri; Vittinghoff, Eric; Sykes, Deanna L.; Colfax, Grant N.			False Positive Rate of Rapid Oral Fluid HIV Tests Increases as Kits Near Expiration Date	PLOS ONE			English	Article								Background: Because a recent cluster of false positive results on the OraQuick ADVANCE(R) Rapid HIV-1/2 Antibody Test occurred in San Francisco on test kits close to their expiration date, we decided to assess the relationship between time to expiration and rate of false positive results from tests used with oral fluid. Methodology/Principal Findings: We analyzed results of 20,904 tests with either an initial HIV-negative result (n = 20,828) or a preliminary positive result that was then negative on confirmatory tests (n = 76). We computed specificity for kits with time to expiration from <= 1 to >= 6 months, with exact binomial confidence intervals, then used logistic regression to estimate the independent association of time to expiration with false positive results, adjusting for site and technician effects. For 1,108 kits used in the last month before expiration, specificity was 98.83% (95% exact binomial confidence interval (CI) 98.00%-99.37%); the upper bound is below the claimed specificity of 99.60%. After adjustment using regression standardization for the effects of site, test lot, and technician factors, adjusted specificity in the last month before expiration was 99.18% (95% bootstrap confidence interval 98.60-99.57%). Conclusions/Significance: We found that specificity of the OraQuick ADVANCE(R) with oral fluid declined significantly with <= 1 month remaining to expiration, leaving little margin for error from other sources.	[Facente, Shelley N.; Dowling, Teri; Colfax, Grant N.] San Francisco Dept Publ Hlth, HIV Prevent Sect, San Francisco, CA USA; [Vittinghoff, Eric] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Sykes, Deanna L.] Calif Dept Publ Hlth, Ctr Infect Dis, Off AIDS, Sacramento, CA USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; California Department of Public Health	Facente, SN (corresponding author), Facente Consulting, Richmond, CA USA.	shelley@facenteconsulting.com	Facente, Shelley/M-1147-2019	Facente, Shelley N./0000-0002-7266-352X				[Anonymous], 2006, BUSINESS WIRE; *CDC, 2003, QUAL ASS GUID US ORA; *CDC, 2008, QUEST ANSW FALS POS; CDC, 2004, MMWR-MORBID MORTAL W, V53, P221; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P1287; *CLIA, 2008, BP010047 CLIA FOOD D; *COUNS TEST LINK U, 2006, CTL DAT QA GUID; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; MacKellar D. A., 2006, Morbidity and Mortality Weekly Report, V55, P673; *OFF AIDS, 2003, ORAQUICK RAP HIV TES; *ORASURE TECHN INC, 2009, US FDA APPR ORAQUICK; OraSure Technologies Inc, 2004, ORAQUICK ADVANCE RAP; *SAN FRANC DEP PUB, 2007, HIV COUNS TEST LINK; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; 2004, BUSINESS WIRE	18	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8217	10.1371/journal.pone.0008217	http://dx.doi.org/10.1371/journal.pone.0008217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011584	Green Published, gold			2022-12-25	WOS:000272830300008
J	Bate, C; Tayebi, M; Diomede, L; Salmona, M; Williams, A				Bate, Clive; Tayebi, Mourad; Diomede, Luisa; Salmona, Mario; Williams, Alun			Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE; INFECTED NEUROBLASTOMA-CELLS; DISEASE AMYLOID PROTEIN; RAT ADIPOCYTES; PROSTAGLANDIN E-2; INSULIN-RECEPTOR; DIABETES-MELLITUS; CULTURED-CELLS; A(2) ACTIVITY; SCRAPIE	Background: A hallmark of the prion diseases is the conversion of the host-encoded cellular prion protein (PrPC) into a disease related, alternatively folded isoform (PrPSc). The accumulation of PrPSc within the brain is associated with synapse loss and ultimately neuronal death. Novel therapeutics are desperately required to treat neurodegenerative diseases including the prion diseases. Principal Findings: Treatment with glimepiride, a sulphonylurea approved for the treatment of diabetes mellitus, induced the release of PrPC from the surface of prion-infected neuronal cells. The cell surface is a site where PrPC molecules may be converted to PrPSc and glimepiride treatment reduced PrPSc formation in three prion infected neuronal cell lines (ScN2a, SMB and ScGT1 cells). Glimepiride also protected cortical and hippocampal neurones against the toxic effects of the prion-derived peptide PrP82-146. Glimepiride treatment significantly reduce both the amount of PrP82-146 that bound to neurones and PrP82-146 induced activation of cytoplasmic phospholipase A(2) (cPLA(2)) and the production of prostaglandin E-2 that is associated with neuronal injury in prion diseases. Our results are consistent with reports that glimepiride activates an endogenous glycosylphosphatidylinositol (GPI)-phospholipase C which reduced PrPC expression at the surface of neuronal cells. The effects of glimepiride were reproduced by treatment of cells with phosphatidylinositol-phospholipase C (PI-PLC) and were reversed by co-incubation with p-chloromercuriphenylsulphonate, an inhibitor of endogenous GPI-PLC. Conclusions: Collectively, these results indicate that glimepiride may be a novel treatment to reduce PrPSc formation and neuronal damage in prion diseases.	[Bate, Clive; Tayebi, Mourad; Williams, Alun] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms, England; [Diomede, Luisa; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy	University of London; University of London Royal Veterinary College; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bate, C (corresponding author), Univ London Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms, England.	cbate@rvc.ac.uk	Diomede, Luisa/P-3417-2014; TAYEBI, MOURAD/F-7404-2010; salmona, mario/ABI-4066-2020; salmona, mario/AAA-7116-2020	Diomede, Luisa/0000-0002-2258-0531; salmona, mario/0000-0002-9098-9873; TAYEBI, MOURAD/0000-0001-8664-6918	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission FP6 NeuroPrion Network of Excellence (http://www.neuroprion.org/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bate C, 2004, NEUROREPORT, V15, P509, DOI 10.1097/00001756-200403010-00025; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2007, NEUROPHARMACOLOGY, V53, P222, DOI 10.1016/j.neuropharm.2007.05.003; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Becker ML, 2008, CLIN PHARMACOL THER, V83, P288, DOI 10.1038/sj.clpt.6100273; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fioriti L, 2007, J NEUROSCI, V27, P1576, DOI 10.1523/JNEUROSCI.5145-06.2007; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Godsave SF, 2008, J NEUROSCI, V28, P12489, DOI 10.1523/JNEUROSCI.4474-08.2008; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Minghetti L, 2002, NEUROLOGY, V58, P127, DOI 10.1212/WNL.58.1.127; Minghetti L, 2000, J NEUROPATH EXP NEUR, V59, P866, DOI 10.1093/jnen/59.10.866; Movahedi S, 1997, BIOCHEM J, V326, P531, DOI 10.1042/bj3260531; Mueller G, 2008, MOL PHARMACOL, V73, P1513, DOI 10.1124/mol.107.043935; Muller G, 2008, BIOCHEMISTRY-US, V47, P1259, DOI 10.1021/bi701413t; Muller G, 2009, CELL SIGNAL, V21, P324, DOI 10.1016/j.cellsig.2008.10.021; MULLER G, 1993, BIOCHEM J, V289, P509; Muller G, 2005, BIOCHEM PHARMACOL, V69, P761, DOI 10.1016/j.bcp.2004.11.014; MULLER G, 1994, J CELL BIOL, V126, P1267, DOI 10.1083/jcb.126.5.1267; Muller G, 2002, MOL MED, V8, P120, DOI 10.1007/BF03402005; Nielsen D, 2004, BIOCHEM J, V380, P571, DOI 10.1042/BJ20040010; Ostlund P, 2001, J BIOL CHEM, V276, P36110, DOI 10.1074/jbc.M105710200; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PARKIN ET, 2004, DUAL MECH SHEDDING C; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Prado MAM, 2004, J NEUROCHEM, V88, P769, DOI 10.1046/j.1471-4159.2003.02199.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Salmona M, 2003, J BIOL CHEM, V278, P48146, DOI 10.1074/jbc.M307295200; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schatzl HM, 1997, J VIROL, V71, P8821; SRINIVASAPPA J, 1989, MICROB PATHOGENESIS, V7, P189, DOI 10.1016/0882-4010(89)90054-5; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stanton JD, 2002, BIOCHEM J, V366, P281, DOI 10.1042/bj20020367; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Williams A, 1997, BRAIN RES, V754, P171, DOI 10.1016/S0006-8993(97)00067-X; WILLIAMS AE, 1994, BRAIN RES, V654, P200, DOI 10.1016/0006-8993(94)90480-4	70	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8221	10.1371/journal.pone.0008221	http://dx.doi.org/10.1371/journal.pone.0008221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011040	gold, Green Published			2022-12-25	WOS:000272829800010
J	Moyer, BD; Hevezi, P; Gao, N; Lu, M; Kalabat, D; Soto, H; Echeverri, F; Laita, B; Yeh, SA; Zoller, M; Zlotnik, A				Moyer, Bryan D.; Hevezi, Peter; Gao, Na; Lu, Min; Kalabat, Dalia; Soto, Hortensia; Echeverri, Fernando; Laita, Bianca; Yeh, Shaoyang Anthony; Zoller, Mark; Zlotnik, Albert			Expression of Genes Encoding Multi-Transmembrane Proteins in Specific Primate Taste Cell Populations	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; BOTULINUM NEUROTOXIN-A; RECEPTOR-CELLS; MAMMALIAN TASTE; TRANSIENT RECEPTOR; MEMBRANE-PROTEIN; PROSTATE-CANCER; FAMILY-MEMBERS; BUDS; CALCIUM	Background: Using fungiform (FG) and circumvallate (CV) taste buds isolated by laser capture microdissection and analyzed using gene arrays, we previously constructed a comprehensive database of gene expression in primates, which revealed over 2,300 taste bud-associated genes. Bioinformatics analyses identified hundreds of genes predicted to encode multi-transmembrane domain proteins with no previous association with taste function. A first step in elucidating the roles these gene products play in gustation is to identify the specific taste cell types in which they are expressed. Methodology/Principal Findings: Using double label in situ hybridization analyses, we identified seven new genes expressed in specific taste cell types, including sweet, bitter, and umami cells (TRPM5-positive), sour cells (PKD2L1-positive), as well as other taste cell populations. Transmembrane protein 44 (TMEM44), a protein with seven predicted transmembrane domains with no homology to GPCRs, is expressed in a TRPM5-negative and PKD2L1-negative population that is enriched in the bottom portion of taste buds and may represent developmentally immature taste cells. Calcium homeostasis modulator 1 (CALHM1), a component of a novel calcium channel, along with family members CALHM2 and CALHM3; multiple C2 domains; transmembrane 1 (MCTP1), a calcium-binding transmembrane protein; and anoctamin 7 (ANO7), a member of the recently identified calcium-gated chloride channel family, are all expressed in TRPM5 cells. These proteins may modulate and effect calcium signalling stemming from sweet, bitter, and umami receptor activation. Synaptic vesicle glycoprotein 2B (SV2B), a regulator of synaptic vesicle exocytosis, is expressed in PKD2L1 cells, suggesting that this taste cell population transmits tastant information to gustatory afferent nerve fibers via exocytic neurotransmitter release. Conclusions/Significance: Identification of genes encoding multi-transmembrane domain proteins expressed in primate taste buds provides new insights into the processes of taste cell development, signal transduction, and information coding. Discrete taste cell populations exhibit highly specific gene expression patterns, supporting a model whereby each mature taste receptor cell is responsible for sensing, transmitting, and coding a specific taste quality.	[Moyer, Bryan D.; Hevezi, Peter; Gao, Na; Lu, Min; Kalabat, Dalia; Soto, Hortensia; Echeverri, Fernando; Laita, Bianca; Yeh, Shaoyang Anthony; Zoller, Mark; Zlotnik, Albert] Senomyx Inc, San Diego, CA USA		Moyer, BD (corresponding author), Senomyx Inc, San Diego, CA USA.	bryan.moyer@senomyx.com			Senomyx, Inc.	Senomyx, Inc.	This study was supported by Senomyx, Inc. (http://www.senomyx.com) and did not use any public funds. Senomyx supported the research (purchased equipment, reagents, and supplies) and approved publication of the manuscript. Senomyx employees were involved in study design, data collection and analysis, and preparation of the manuscript. The authors were all employed by Senomyx, Inc. during the described experiments. P. Hevezi and A. Zlotnik are now in the Department of Physiology and Biophysics as The University of California, Irvine, California, USA. H. Soto is currently at BioLegend, 11080 Roselle Street, San Diego, CA 92121, USA. All authors are aware of and will adhere to the PLoS ONE policies on sharing data and materials, as detailed on the PLoS ONE website.	Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bera TK, 2004, P NATL ACAD SCI USA, V101, P3059, DOI 10.1073/pnas.0308746101; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Braissant O, 1998, BIOCHEMICA, V1, P10; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Das S, 2007, CANCER RES, V67, P1594, DOI 10.1158/0008-5472.CAN-06-2673; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gao N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-20; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Herness MS, 1999, J NEUROPHYSIOL, V82, P260, DOI 10.1152/jn.1999.82.1.260; Hever A, 2007, P NATL ACAD SCI USA, V104, P12451, DOI 10.1073/pnas.0703451104; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Ishimaru Y, 2009, J DENT RES, V88, P212, DOI 10.1177/0022034508330212; Ishimaru Y, 2005, MECH DEVELOP, V122, P1310, DOI 10.1016/j.mod.2005.07.005; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kiessling A, 2005, PROSTATE, V64, P387, DOI 10.1002/pros.20250; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Medler KF, 2003, J NEUROSCI, V23, P2608; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Nakayama A, 2008, J COMP NEUROL, V509, P211, DOI 10.1002/cne.21738; PARAN N, 1975, CELL TISSUE RES, V161, P1; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Romanov RA, 2008, J GEN PHYSIOL, V132, P731, DOI 10.1085/jgp.200810108; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; TAYLOR R, 1994, J NEUROPHYSIOL, V72, P475, DOI 10.1152/jn.1994.72.1.475; WONG L, 1994, CHEM SENSES, V19, P251, DOI 10.1093/chemse/19.3.251; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yoshida R, 2006, ARCH HISTOL CYTOL, V69, P233, DOI 10.1679/aohc.69.233; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007	60	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e7682	10.1371/journal.pone.0007682	http://dx.doi.org/10.1371/journal.pone.0007682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997627	Green Published, gold			2022-12-25	WOS:000272829200001
J	Carr, AJ; Vugler, AA; Hikita, ST; Lawrence, JM; Gias, C; Chen, LL; Buchholz, DE; Ahmado, A; Semo, M; Smart, MJK; Hasan, S; da Cruz, L; Johnson, LV; Clegg, DO; Coffey, PJ				Carr, Amanda-Jayne; Vugler, Anthony A.; Hikita, Sherry T.; Lawrence, Jean M.; Gias, Carlos; Chen, Li Li; Buchholz, David E.; Ahmado, Ahmad; Semo, Ma'ayan; Smart, Matthew J. K.; Hasan, Shazeen; da Cruz, Lyndon; Johnson, Lincoln V.; Clegg, Dennis O.; Coffey, Pete J.			Protective Effects of Human iPS-Derived Retinal Pigment Epithelium Cell Transplantation in the Retinal Dystrophic Rat	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RCS RAT; SUBRETINAL TRANSPLANTATION; AUTOLOGOUS TRANSPLANTATION; PHOTORECEPTOR DEGENERATION; MACULAR TRANSLOCATION; HUMAN FIBROBLASTS; PROGENITOR CELLS; VISUAL FUNCTION; RPE	Transformation of somatic cells with a set of embryonic transcription factors produces cells with the pluripotent properties of embryonic stem cells (ESCs). These induced pluripotent stem (iPS) cells have the potential to differentiate into any cell type, making them a potential source from which to produce cells as a therapeutic platform for the treatment of a wide range of diseases. In many forms of human retinal disease, including age-related macular degeneration (AMD), the underlying pathogenesis resides within the support cells of the retina, the retinal pigment epithelium (RPE). As a monolayer of cells critical to photoreceptor function and survival, the RPE is an ideally accessible target for cellular therapy. Here we report the differentiation of human iPS cells into RPE. We found that differentiated iPS-RPE cells were morphologically similar to, and expressed numerous markers of developing and mature RPE cells. iPS-RPE are capable of phagocytosing photoreceptor material, in vitro and in vivo following transplantation into the Royal College of Surgeons (RCS) dystrophic rat. Our results demonstrate that iPS cells can be differentiated into functional iPS-RPE and that transplantation of these cells can facilitate the short-term maintenance of photoreceptors through phagocytosis of photoreceptor outer segments. Longterm visual function is maintained in this model of retinal disease even though the xenografted cells are eventually lost, suggesting a secondary protective host cellular response. These findings have identified an alternative source of replacement tissue for use in human retinal cellular therapies, and provide a new in vitro cellular model system in which to study RPE diseases affecting human patients.	[Carr, Amanda-Jayne; Vugler, Anthony A.; Lawrence, Jean M.; Gias, Carlos; Chen, Li Li; Ahmado, Ahmad; Semo, Ma'ayan; Smart, Matthew J. K.; Hasan, Shazeen; Coffey, Pete J.] UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England; [Hikita, Sherry T.; Buchholz, David E.; Johnson, Lincoln V.; Clegg, Dennis O.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Johnson, Lincoln V.; Clegg, Dennis O.] Univ Calif Santa Barbara, Ctr Study Macular Degenerat, Santa Barbara, CA 93106 USA; [da Cruz, Lyndon] Moorfields Eye Hosp, Dept Vitreoretinal Surg, London, England	University of London; University College London; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Carr, AJ (corresponding author), UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.	a.carr@ucl.ac.uk	Ahmado, Ahmad/R-5537-2019; Carr, Amanda/ABG-6282-2020	Carr, Amanda/0000-0002-5469-0030; Semo, Ma'ayan/0000-0002-3890-721X; Coffey, Peter/0000-0002-5427-2939	London Project to Cure Blindness; The California Institute for Regenerative Medicine	London Project to Cure Blindness; The California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by funding from the London Project to Cure Blindness and The California Institute for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aisenbrey S, 2002, ARCH OPHTHALMOL-CHIC, V120, P451; BALASUBRAMANIAN S, 2009, STEM CELLS; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Carr AJ, 2009, MOL VIS, V15, P283; Carwile ME, 1998, EXP EYE RES, V66, P791, DOI 10.1006/exer.1998.0488; Chen FK, 2008, INVEST OPHTH VIS SCI, V49, P3143, DOI 10.1167/iovs.07-1648; Chen FK, 2009, INVEST OPHTH VIS SCI, V50, P1848, DOI 10.1167/iovs.08-2845; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Del Priore LV, 2003, INVEST OPHTH VIS SCI, V44, P4044, DOI 10.1167/iovs.02-1175; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Falk T, 2009, NEUROSCI LETT, V458, P49, DOI 10.1016/j.neulet.2009.04.018; Francis PJ, 2009, INVEST OPHTH VIS SCI, V50, P3425, DOI 10.1167/iovs.08-2908; Gabrielian K, 1999, GRAEF ARCH CLIN EXP, V237, P326, DOI 10.1007/s004170050240; Gias C, 2007, EUR J NEUROSCI, V25, P1940, DOI 10.1111/j.1460-9568.2007.05459.x; Grisanti S, 2002, JPN J OPHTHALMOL, V46, P36, DOI 10.1016/S0021-5155(01)00464-6; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Grozdanic SD, 2006, EXP EYE RES, V82, P597, DOI 10.1016/j.exer.2005.08.020; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ho TC, 1997, EXP EYE RES, V64, P133, DOI 10.1006/exer.1996.0199; Huerta JJ, 1997, NEUROSCI LETT, V232, P143, DOI 10.1016/S0304-3940(97)00595-8; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; Jablonski MM, 2000, J NEUROSCI, V20, P7149; Joussen AM, 2006, AM J OPHTHALMOL, V142, P17, DOI 10.1016/j.ajo.2006.01.090; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; Lawrence JM, 2000, INVEST OPHTH VIS SCI, V41, P518; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; LI W, 2009, STEM CELLS; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Luhmann U. F., 2009, INVEST OPHTHALMOL VI; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Ma ZZ, 2009, INVEST OPHTH VIS SCI, V50, P2975, DOI 10.1167/iovs.08-2573; MACHEMER R, 1993, GRAEF ARCH CLIN EXP, V231, P635, DOI 10.1007/BF00921957; MacLaren RE, 2007, OPHTHALMOLOGY, V114, P561, DOI 10.1016/j.ophtha.2006.06.049; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Ming M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-53; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; SCHWEIGERER L, 1987, BIOCHEM BIOPH RES CO, V143, P934, DOI 10.1016/0006-291X(87)90340-8; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; SILVERMAN MS, 1990, CURR EYE RES, V9, P183, DOI 10.3109/02713689008995205; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tezel TH, 2007, AM J OPHTHALMOL, V143, P584, DOI 10.1016/j.ajo.2006.12.007; Thumann G, 2009, GRAEF ARCH CLIN EXP, V247, P363, DOI 10.1007/s00417-008-0998-x; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Villegas-Perez MP, 1998, J COMP NEUROL, V392, P58, DOI 10.1002/(SICI)1096-9861(19980302)392:1<58::AID-CNE5>3.0.CO;2-O; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; West EL, 2009, PROG BRAIN RES, V175, P3, DOI 10.1016/S0079-6123(09)17501-5; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang D, 2009, CELL RES, V52, P615; Zhang Hou-Liang, 2007, Neurosci Bull, V23, P137, DOI 10.1007/s12264-007-0020-3; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	78	332	354	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8152	10.1371/journal.pone.0008152	http://dx.doi.org/10.1371/journal.pone.0008152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997644	gold, Green Published			2022-12-25	WOS:000272829000010
J	Salemi, M; Lamers, SL; Huysentruyt, LC; Galligan, D; Gray, RR; Morris, A; McGrath, MS				Salemi, Marco; Lamers, Susanna L.; Huysentruyt, Leanne C.; Galligan, Derek; Gray, Rebecca R.; Morris, Alanna; McGrath, Michael S.			Distinct Patterns of HIV-1 Evolution within Metastatic Tissues in Patients with Non-Hodgkins Lymphoma	PLOS ONE			English	Article							FOLLICULAR LYMPHOMA; MAXIMUM-LIKELIHOOD; AIDS; MACROPHAGES; INFERENCE; COMMON; CELLS; IDENTIFICATION; RECOMBINATION; PHYLOGENIES	Despite highly active antiretroviral therapy (HAART), AIDS related lymphoma (ARL) occurs at a significantly higher rate in patients infected with the Human Immunodeficiency Virus (HIV) than in the general population. HIV-infected macrophages are a known viral reservoir and have been shown to have lymphomagenic potential in SCID mice; therefore, there is an interest in determining if a viral component to lymphomagenesis also exists. We sequenced HIV-1 envelope gp120 clones obtained post mortem from several tumor and non-tumor tissues of two patients who died with AIDS-related Non-Hodgkin's lymphoma (ARL-NH). Similar results were found in both patients: 1) high-resolution phylogenetic analysis showed a significant degree of compartmentalization between lymphoma and non-lymphoma viral sub-populations while viral sub-populations from lymph nodes appeared to be intermixed within sequences from tumor and non-tumor tissues, 2) a 100-fold increase in the effective HIV population size in tumor versus non-tumor tissues was associated with the emergence of lymphadenopathy and aggressive metastatic ARL, and 3) HIV gene flow among lymph nodes, normal and metastatic tissues was non-random. The different population dynamics between the viruses found in tumors versus the non-tumor associated viruses suggest that there is a significant relationship between HIV evolution and lymphoma pathogenesis. Moreover, the study indicates that HIV could be used as an effective marker to study the origin and dissemination of lymphomas in vivo.	[Salemi, Marco; Gray, Rebecca R.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Lamers, Susanna L.] BioInfoExperts, Thibodaux, LA USA; [Huysentruyt, Leanne C.; Galligan, Derek; Morris, Alanna; McGrath, Michael S.] Univ Calif San Francisco, Dept Med Hematol & Oncol, San Francisco, CA 94143 USA	State University System of Florida; University of Florida; University of California System; University of California San Francisco	Salemi, M (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	salemi@pathology.ufl.edu; mmcgrath@php.ucsf.edu			Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research; NIH [U01 CA096230-06, U01 CA066529-14];  [NS063897];  [AI065265];  [CA09126]; NATIONAL CANCER INSTITUTE [U01CA096230, U01CA066529, T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063897] Funding Source: NIH RePORTER	Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M. S. research is supported in part by PHS R01 awards NS063897 and AI065265, the Laura McClamma Fellowship, the Center for Research in Pediatric Immune Deficiency and Stephany W. Holloway University Chair for AIDS Research. R.R.G. is supported by a T32 award CA09126. S.L.L., L.C.H, D.G, A.M. and M. S. M are supported from NIH grants U01 CA096230-06 and U01 CA066529-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay LR, 2007, CLIN LYMPHOMA MYELOM, V7, P272, DOI 10.3816/CLM.2007.n.002; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Gibson J. D., 1997, NUCL ACIDS RES, V25, P4876; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grogg KL, 2007, J CLIN PATHOL, V60, P1365, DOI 10.1136/jcp.2007.051953; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HERNDIER BG, 1994, AIDS, V8, P1025, DOI 10.1097/00002030-199408000-00003; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kelley T, 2007, LEUKEMIA LYMPHOMA, V48, P2403, DOI 10.1080/10428190701665954; Lamers S, 2004, BIOINFORMATICS, V20, P436, DOI 10.1093/bioinformatics/btg445; Lamers SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005065; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mack KD, 2003, JAIDS-J ACQ IMM DEF, V33, P308, DOI 10.1097/00126334-200307010-00004; Maddison W. P., 2003, MACCLADE VERSION 4 A; MCGRATH MS, 1995, J ACQ IMMUN DEF SYND, V8, P379; Navarro WH, 2006, BLOOD, V107, P13, DOI 10.1182/blood-2004-11-4278; Ng VL, 1998, IMMUNOL REV, V162, P293, DOI 10.1111/j.1600-065X.1998.tb01449.x; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Pybus OG, 2000, GENETICS, V155, P1429; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; SHIRAMIZU B, 1994, CANCER RES, V54, P2069; SHIRAMIZU B, 1997, J ACQUIR IMMUNE DEFI, V14; SLATKIN M, 1989, GENETICS, V123, P603; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford DL, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P267; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zenger E, 2002, CANCER RES, V62, P5536	42	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8153	10.1371/journal.pone.0008153	http://dx.doi.org/10.1371/journal.pone.0008153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997510	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829000011
J	Agarwal, R; Mori, Y; Cheng, YL; Jin, Z; Olaru, AV; Hamilton, JP; David, S; Selaru, FM; Yang, J; Abraham, JM; Montgomery, E; Morin, PJ; Meltzer, SJ				Agarwal, Rachana; Mori, Yuriko; Cheng, Yulan; Jin, Zhe; Olaru, Alexandru V.; Hamilton, James P.; David, Stefan; Selaru, Florin M.; Yang, Jian; Abraham, John M.; Montgomery, Elizabeth; Morin, Patrice J.; Meltzer, Stephen J.			Silencing of Claudin-11 Is Associated with Increased Invasiveness of Gastric Cancer Cells	PLOS ONE			English	Article							TIGHT JUNCTION; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; DOWN-REGULATION; HMLH1 PROMOTER; GENE PROMOTER; EXPRESSION; CARCINOMA; PROTEIN; HYPERMETHYLATION	Background: Claudins are membrane proteins that play critical roles in tight junction (TJ) formation and function. Members of the claudin gene family have been demonstrated to be aberrantly regulated, and to participate in the pathogenesis of various human cancers. In the present study, we report that claudin-11 (CLDN11) is silenced in gastric cancer via hypermethylation of its promoter region. Methodology/Principal Findings: Levels of CLDN11 methylation and mRNA expression were measured in primary gastric cancer tissues, noncancerous gastric mucosae, and cell lines of gastric origin using quantitative methylation-specific PCR (qMSP) and quantitative reverse transcriptase-PCR (qRT-PCR), respectively. Analyses of paired gastric cancers and adjacent normal gastric tissues revealed hypermethylation of the CLDN11 promoter region in gastric cancers, and this hypermethylation was significantly correlated with downregulation of CLDN11 expression vs. normal tissues. The CLDN11 promoter region was also hypermethylated in all gastric cancer cell lines tested relative to immortalized normal gastric epithelial cells. Moreover, CLDN11 mRNA expression was inversely correlated with its methylation level. Treatment of CLDN11-nonexpressing gastric cancer cells with 5-aza-29-deoxycytidine restored CLDN11 expression. Moreover, siRNA-mediated knockdown of CLDN11 expression in normal gastric epithelial cells increased their motility and invasiveness. Conclusions/Significance: These data suggest that hypermethylation of CLDN11, leading to downregulated expression, contributes to gastric carcinogenesis by increasing cellular motility and invasiveness. A further understanding of the mechanisms underlying the role of claudin proteins in gastric carcinogenesis will likely help in the identification of novel approaches for diagnosis and therapy of gastric cancer.	[Agarwal, Rachana; Mori, Yuriko; Cheng, Yulan; Jin, Zhe; Olaru, Alexandru V.; Hamilton, James P.; David, Stefan; Selaru, Florin M.; Yang, Jian; Abraham, John M.; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Montgomery, Elizabeth] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Morin, Patrice J.] NIA, Cellular & Mol Biol Lab, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Agarwal, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	ragarwa9@jhmi.edu		Selaru, Florin/0000-0001-7990-8238	United States National Institutes of Health [CA085069, CA138677, CA146799]; NATIONAL CANCER INSTITUTE [R01CA146799, U01CA085069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000395] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the United States National Institutes of Health grants CA085069, CA138677 and CA146799 to SJ Meltzer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Bronstein JM, 1996, NEUROLOGY, V47, P772, DOI 10.1212/WNL.47.3.772; Cunningham SC, 2006, CANCER EPIDEM BIOMAR, V15, P281, DOI 10.1158/1055-9965.EPI-05-0539; David S, 2009, BIOCHEM BIOPH RES CO, V378, P605, DOI 10.1016/j.bbrc.2008.11.078; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; FINK C, 2009, HISTOCHEM CELL BIOL; Fleisher AS, 1999, CANCER RES, V59, P1090; Fukudome Y, 2000, INT J CANCER, V88, P579, DOI 10.1002/1097-0215(20001115)88:4<579::AID-IJC10>3.0.CO;2-U; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Honda H, 2007, CANCER BIOL THER, V6, P1733, DOI 10.4161/cbt.6.11.4832; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang GH, 1999, LAB INVEST, V79, P903; Katoh M, 2003, INT J MOL MED, V11, P683; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Lee YY, 1997, CANCER, V80, P1889, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1889::AID-CNCR3>3.0.CO;2-J; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Leung SY, 1999, CANCER RES, V59, P159; Lui WY, 2007, J CELL PHYSIOL, V211, P638, DOI 10.1002/jcp.20970; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Michl P, 2003, CANCER RES, V63, P6265; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Mullin JM, 1997, J EXP ZOOL, V279, P484, DOI 10.1002/(SICI)1097-010X(19971201)279:5<484::AID-JEZ11>3.0.CO;2-8; Nakayama F, 2008, PATHOBIOLOGY, V75, P177, DOI 10.1159/000124978; Osanai M, 2007, CANCER SCI, V98, P1557, DOI 10.1111/j.1349-7006.2007.00569.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; RHYU MG, 1994, ONCOGENE, V9, P29; Sanada Y, 2006, J PATHOL, V208, P633, DOI 10.1002/path.1922; Schmutte C, 1997, CANCER RES, V57, P3010; Suzuki H, 1999, INT J CANCER, V83, P309, DOI 10.1002/(SICI)1097-0215(19991029)83:3<309::AID-IJC4>3.0.CO;2-Z; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; TAMURA G, 1995, CANCER RES, V55, P1933; Toyota M, 1999, CANCER RES, V59, P5438; Weinstein R S, 1976, Adv Cancer Res, V23, P23, DOI 10.1016/S0065-230X(08)60543-6; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	40	75	81	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8002	10.1371/journal.pone.0008002	http://dx.doi.org/10.1371/journal.pone.0008002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956721	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827500027
J	Launay, JM; Del Pino, M; Chironi, G; Callebert, J; Peoc'h, K; Megnien, JL; Mallet, J; Simon, A; Rendu, F				Launay, Jean-Marie; Del Pino, Muriel; Chironi, Gilles; Callebert, Jacques; Peoc'h, Katell; Megnien, Jean-Louis; Mallet, Jacques; Simon, Alain; Rendu, Francine			Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LUNG-CANCER; CARDIOVASCULAR-DISEASE; PROMOTER METHYLATION; SUSCEPTIBILITY LOCUS; HABITUAL SMOKERS; DNA METHYLATION; HEAVY SMOKERS; B ACTIVITY; TOBACCO	Background: Postulating that serotonin (5-HT), released from smoking-activated platelets could be involved in smoking-induced vascular modifications, we studied its catabolism in a series of 115 men distributed as current smokers (S), never smokers (NS) and former smokers (FS) who had stopped smoking for a mean of 13 years. Methodology/Principal Findings: 5-HT, monoamine oxidase (MAO-B) activities and amounts were measured in platelets, and 5-hydroxyindolacetic acid (5-HIAA)-the 5-HT/MAO catabolite-in plasma samples. Both platelet 5-HT and plasma 5-HIAA levels were correlated with the 10-year cardiovascular Framingham relative risk (P<0.01), but these correlations became non-significant after adjustment for smoking status, underlining that the determining risk factor among those taken into account in the Framingham risk calculation was smoking. Surprisingly, the platelet 5-HT content was similar in S and NS but lower in FS with a parallel higher plasma level of 5-HIAA in FS. This was unforeseen since MAO-B activity was inhibited during smoking (P<0.00001). It was, however, consistent with a higher enzyme protein concentration found in S and FS than in NS (P<0.001). It thus appears that MAO inhibition during smoking was compensated by a higher synthesis. To investigate the persistent increase in MAO-B protein concentration, a study of the methylation of its gene promoter was undertaken in a small supplementary cohort of similar subjects. We found that the methylation frequency of the MAOB gene promoter was markedly lower (P<0.0001) for S and FS vs. NS due to cigarette smoke-induced increase of nucleic acid demethylase activity. Conclusions/Significance: This is one of the first reports that smoking induces an epigenetic modification. A better understanding of the epigenome may help to further elucidate the physiopathology and the development of new therapeutic approaches to tobacco addiction. The results could have a larger impact than cardiovascular damage, considering that MAO-dependent 5-HT catabolism is also involved in addiction, predisposition to cancer, behaviour and mental health.	[Launay, Jean-Marie; Callebert, Jacques; Peoc'h, Katell] Univ Paris 05, Hop Lariboisiere, AP HP,Fac Pharm, Serv Biochim & Biol Mol Equipe Associee EA 3621, Paris, France; [Del Pino, Muriel; Chironi, Gilles; Megnien, Jean-Louis; Simon, Alain; Rendu, Francine] Univ Paris 06, CNRS, UMR 7131, Hop Broussais, Paris, France; [Chironi, Gilles; Megnien, Jean-Louis; Simon, Alain] Hop Europeen Georges Pompidou Broussais, AP HP, Ctr Med Prevent Cardiovasc, Paris, France; [Mallet, Jacques] UPMC, CNRS, Hop La Pitie Salpetriere,UMR 7091, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, Paris, France; [Rendu, Francine] INSERM, Fac Med Pitie Salpetriere, UMRS Inserm 956, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Launay, JM (corresponding author), Univ Paris 05, Hop Lariboisiere, AP HP,Fac Pharm, Serv Biochim & Biol Mol Equipe Associee EA 3621, Paris, France.	francine.rendu@upmc.fr	callebert, jacques/L-4569-2017; Peoc'h, Katell/V-1604-2017	Peoc'h, Katell/0000-0002-8203-1243	CNRS; ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	This work was supported by grants from the CNRS and the ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baryshnikova E, 2008, CLIN CANCER RES, V14, P1913, DOI 10.1158/1078-0432.CCR-07-1741; Berggren U, 2007, ALCOHOL ALCOHOLISM, V42, P267, DOI 10.1093/alcalc/agm031; BERLIN I, 1995, BIOL PSYCHIAT, V38, P756, DOI 10.1016/0006-3223(95)00084-4; Cao RH, 2007, CURR MED CHEM, V14, P479, DOI 10.2174/092986707779940998; Carney RM, 2007, AM J PSYCHIAT, V164, P1307, DOI 10.1176/appi.ajp.2007.07071053; CESURA AM, 1987, J NEUROCHEM, V48, P170, DOI 10.1111/j.1471-4159.1987.tb13143.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Fowler JS, 2000, AM J PSYCHIAT, V157, P1864, DOI 10.1176/appi.ajp.157.11.1864; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Fowler JS, 2003, P NATL ACAD SCI USA, V100, P11600, DOI 10.1073/pnas.1833106100; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fusegawa Y, 1999, THROMB RES, V93, P271, DOI 10.1016/S0049-3848(98)00184-4; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Gilbert DG, 2003, NICOTINE TOB RES, V5, P813, DOI 10.1080/14622200310001614575; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; KEMA IP, 1993, CLIN CHIM ACTA, V221, P143, DOI 10.1016/0009-8981(93)90029-4; LAN NC, 1989, GENOMICS, V4, P552, DOI 10.1016/0888-7543(89)90279-6; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; Lewis A, 2007, NEUROTOXICOLOGY, V28, P182, DOI 10.1016/j.neuro.2006.05.019; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; Nair S, 2001, PLATELETS, V12, P20, DOI 10.1080/09537100120046020; ORELAND L, 1981, LIFE SCI, V29, P2511, DOI 10.1016/0024-3205(81)90706-2; Page IH., 1968, Serotonin; Pernerstorfer T, 1998, BRIT J HAEMATOL, V102, P1229; Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778; Rommelspacher H, 2002, EUR J PHARMACOL, V441, P115, DOI 10.1016/S0014-2999(02)01452-8; Rybaczyk LA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-134; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Schwartz K, 2005, EUR NEUROPSYCHOPHARM, V15, P235, DOI 10.1016/j.euroneuro.2004.11.001; Serebruany VL, 2001, AM J CARDIOL, V87, P1398, DOI 10.1016/S0002-9149(01)01562-4; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; SIMON A, 1995, CIRCULATION, V92, P1114; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Takajo Y, 2001, J AM COLL CARDIOL, V38, P1320, DOI 10.1016/S0735-1097(01)01583-2; Talhout R, 2007, EUR NEUROPSYCHOPHARM, V17, P627, DOI 10.1016/j.euroneuro.2007.02.013; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Van Tiel ED, 2002, ANN EPIDEMIOL, V12, P378, DOI 10.1016/S1047-2797(01)00282-4; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Witschi H, 2002, TOXICOL SCI, V68, P322, DOI 10.1093/toxsci/68.2.322; Wong WK, 2003, J BIOL CHEM, V278, P36227, DOI 10.1074/jbc.M305549200; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717	53	104	108	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7959	10.1371/journal.pone.0007959	http://dx.doi.org/10.1371/journal.pone.0007959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956754	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827300016
J	Cheung, M; Pei, J; Pei, Y; Jhanwar, SC; Pass, HI; Testa, JR				Cheung, M.; Pei, J.; Pei, Y.; Jhanwar, S. C.; Pass, H. I.; Testa, J. R.			The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival	ONCOGENE			English	Article						mesothelioma; PLZF; genomic imbalances; tumor suppressors; transcription factor	METHYLTHIOADENOSINE PHOSPHORYLASE; GROWTH SUPPRESSION; TUMOR-SUPPRESSOR; PROTEIN PLZF; EXPRESSION; DELETION; TRANSLOCATION; REPRESSION; MECHANISM; APOPTOSIS	DNA copy number analysis was performed, using single-nucleotide polymorphism mapping arrays, to. ne map genomic imbalances in human malignant mesothelioma (MM) cell lines derived from primary tumors. Chromosomal losses accounted for the majority of genomic imbalances. All 22 cell lines examined showed homozygous deletions of 9p21.3, centering at the CDKN2A/ARF and CDKN2B loci. Other commonly underrepresented segments included 1p36, 1p22, 3p21-22, 4q13, 4q34, 11q23, 13q12-13, 14q32, 15q15, 18q12, and 22q12, each observed in 55-90% of cell lines. Focal deletions of 11q23 encompassed the transcriptional repressor gene promyelocytic leukemia zinc finger (PLZF), which was validated by analysis of genomic DNA using real-time polymerase chain reaction (PCR). Semi-quantitative RT PCR and immunoblot analysis revealed that PLZF is greatly downregulated in MM cell lines compared with non-malignant mesothelial cells. Ectopic expression of PLZF in PLZF-deficient MM cells resulted in decreased cell viability, reduced colony formation, as well as increased apoptosis, the latter based on results of various cell death assays and the observation of increased cleavage of caspase 3, PARP, and Mcl-1. These data indicate that deletions of PLZF are a common occurrence in MM and that downregulation of PLZF may contribute to MM pathogenesis by promoting cell survival. Oncogene (2010) 29, 1633-1640; doi:10.1038/onc.2009.455; published online 14 December 2009	[Cheung, M.; Pei, J.; Pei, Y.; Testa, J. R.] Fox Chase Canc Ctr, Canc Genet & Signaling Program, Philadelphia, PA 19111 USA; [Jhanwar, S. C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Pass, H. I.] NYU, Sch Med, Dept Cardiothorac Surg, New York, NY USA	Fox Chase Cancer Center; Memorial Sloan Kettering Cancer Center; New York University	Testa, JR (corresponding author), Fox Chase Canc Ctr, Canc Genet & Signaling Program, 333 Cottman Ave,P3032, Philadelphia, PA 19111 USA.	Joseph.Testa@fccc.edu		Pass, Harvey/0000-0003-3222-3471	National Cancer Institute [CA-114047, CA-06927]; Commonwealth of Pennsylvania; International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE [P30CA006927, P01CA114047] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth of Pennsylvania; International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Craig Menges for helpful suggestions about some of the experiments and Jin Fang for technical assistance on some of the array hybridizations. This work was supported by National Cancer Institute Grants CA-114047 and CA-06927, by an appropriation from the Commonwealth of Pennsylvania, and by a gift from the Local #14 Mesothelioma Fund of the International Association of Heat and Frost Insulators & Allied Workers in memory of Hank Vaughan and Alice Haas. The following Fox Chase Cancer Center shared facilities were used in the course of this work: Cell Culture, Genomics, Flow Cytometry, and DNA Synthesis Facilities.	Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Balsara BR, 1999, CANCER RES, V59, P450; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bernardo MV, 2007, BIOCHEM BIOPH RES CO, V359, P317, DOI 10.1016/j.bbrc.2007.05.085; CHEN SJ, 1993, J CLIN INVEST, V91, P2260, DOI 10.1172/JCI116453; CHEN Z, 1994, P NATL ACAD SCI USA, V91, P1178, DOI 10.1073/pnas.91.3.1178; Cheng JQ, 1999, GENE CHROMOSOME CANC, V24, P238, DOI 10.1002/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M; CHENG JQ, 1994, CANCER RES, V54, P5547; Christopher SA, 2002, CANCER RES, V62, P6639; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; CRAIGHEAD JE, 1982, NEW ENGL J MED, V306, P1446, DOI 10.1056/NEJM198206173062403; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Felicetti F, 2004, ONCOGENE, V23, P4567, DOI 10.1038/sj.onc.1207597; Frizelle SP, 1998, ONCOGENE, V16, P3087, DOI 10.1038/sj.onc.1201870; Greshock J, 2007, CANCER RES, V67, P10173, DOI 10.1158/0008-5472.CAN-07-2102; Illei PB, 2003, CLIN CANCER RES, V9, P2108; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Murthy SS, 1999, J CELL PHYSIOL, V180, P150, DOI 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H; Musti M, 2006, CANCER GENET CYTOGEN, V170, P9, DOI 10.1016/j.cancergencyto.2006.04.011; Pei JM, 2006, CANCER GENET CYTOGEN, V170, P65, DOI 10.1016/j.cancergencyto.2006.05.002; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; Shiraishi K, 2007, ONCOGENE, V26, P339, DOI 10.1038/sj.onc.1209800; Snowden RT, 2003, LEUKEMIA, V17, P1981, DOI 10.1038/sj.leu.2403088; TAGUCHI T, 1993, CANCER RES, V53, P4349; WAGNER J C, 1960, Br J Ind Med, V17, P260; Yang CT, 2000, J NATL CANCER I, V92, P636, DOI 10.1093/jnci/92.8.636; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375	29	43	45	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1633	1640		10.1038/onc.2009.455	http://dx.doi.org/10.1038/onc.2009.455			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	20010871	Green Accepted			2022-12-25	WOS:000275694700008
J	Parke, CL; Wojcik, EJ; Kim, S; Worthylake, DK				Parke, Courtney L.; Wojcik, Edward J.; Kim, Sunyoung; Worthylake, David K.			ATP Hydrolysis in Eg5 Kinesin Involves a Catalytic Two-water Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN MOTOR DOMAIN; PHOSPHATE MONOESTER HYDROLYSIS; X-RAY STRUCTURES; SALT-BRIDGE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SWITCH-II; PROTEINS; RESOLUTION; CRYSTALLOGRAPHY	Motor proteins couple steps in ATP binding and hydrolysis to conformational switching both in and remote from the active site. In our kinesin.AMPPPNP crystal structure, closure of the active site results in structural transformations appropriate for microtubule binding and organizes an orthosteric two-water cluster. We conclude that a proton is shared between the lytic water, positioned for gamma-phosphate attack, and a second water that serves as a general base. To our knowledge, this is the first experimental detection of the catalytic base for any ATPase. Deprotonation of the second water by switch residues likely triggers subsequent large scale structural rearrangements. Therefore, the catalytic base is responsible for initiating nucleophilic attack of ATP and for relaying the positive charge over long distances to initiate mechanotransduction. Coordination of switch movements via sequential proton transfer along paired water clusters may be universal for nucleotide triphosphatases with conserved active sites, such as myosins and G-proteins.	[Parke, Courtney L.; Wojcik, Edward J.; Kim, Sunyoung; Worthylake, David K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kim, S (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [GM066328]; Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066328, R01GM097350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066328 (to E. W.). This work was also supported by funding from Louisiana Board of Regents grants (to D. W. and to S. K.).	Ahmad Z, 2004, J BIOL CHEM, V279, P46057, DOI 10.1074/jbc.M407608200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aqvist J, 1999, CHEM BIOL, V6, pR71, DOI 10.1016/S1074-5521(99)89003-6; Asthagiri D, 2005, P NATL ACAD SCI USA, V102, P6704, DOI 10.1073/pnas.0408071102; Asthagiri D, 2004, P NATL ACAD SCI USA, V101, P7229, DOI 10.1073/pnas.0401696101; Bergmann EM, 1997, J VIROL, V71, P2436, DOI 10.1128/JVI.71.3.2436-2448.1997; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dittrich M, 2005, J BIOENERG BIOMEMBR, V37, P441, DOI 10.1007/s10863-005-9487-7; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; GRANOT J, 1980, BIOCHEMISTRY-US, V19, P3537, DOI 10.1021/bi00556a019; Grigorenko BL, 2007, P NATL ACAD SCI USA, V104, P7057, DOI 10.1073/pnas.0701727104; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hodis E, 2007, TRENDS BIOCHEM SCI, V32, P199, DOI 10.1016/j.tibs.2007.03.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamerlin SCL, 2008, CHEMPHYSCHEM, V9, P1767, DOI 10.1002/cphc.200800356; Kikkawa M, 2008, TRENDS CELL BIOL, V18, P128, DOI 10.1016/j.tcb.2008.01.002; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kull FJ, 2002, J CELL SCI, V115, P15; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; Li GH, 2004, J PHYS CHEM B, V108, P3342, DOI 10.1021/jp0371783; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Onishi H, 1998, P NATL ACAD SCI USA, V95, P6653, DOI 10.1073/pnas.95.12.6653; Onishi H, 2002, P NATL ACAD SCI USA, V99, P15339, DOI 10.1073/pnas.242604099; Onishi H, 2004, BIOCHEMISTRY-US, V43, P3757, DOI 10.1021/bi040002m; Sagnella DE, 1996, BIOPHYS J, V70, P2043, DOI 10.1016/S0006-3495(96)79773-4; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14232, DOI 10.1021/bi961119g; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Wittinghofer A, 2006, TRENDS BIOCHEM SCI, V31, P20, DOI 10.1016/j.tibs.2005.11.012; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yang Y, 2009, J PHYS CHEM A, V113, P12439, DOI 10.1021/jp902949f	47	109	114	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5859	5867		10.1074/jbc.M109.071233	http://dx.doi.org/10.1074/jbc.M109.071233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018897	Green Published, hybrid			2022-12-25	WOS:000275327200076
J	Weaver, MS; Workman, G; Cardo-Vila, M; Arap, W; Pasqualini, R; Sage, EH				Weaver, Matt S.; Workman, Gail; Cardo-Vila, Marina; Arap, Wadih; Pasqualini, Renata; Sage, E. Helene			Processing of the Matricellular Protein Hevin in Mouse Brain Is Dependent on ADAMTS4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; INTEGRIN-LINKED KINASE; PROTEOLYTIC CLEAVAGE; SPARC; ANGIOGENESIS; EXPRESSION; SC1; CELL; AGGRECANASE-1; PLASTICITY	The matricellular SPARC family member hevin (SPARC-like 1/SPARCL-1/SC1/Mast9) contributes to neural development and alters tumor progression in a range of mammalian models. The distribution of hevin in mouse tissues was reexamined with a novel monoclonal antibody that discriminates between hevin and its ortholog SPARC. We now report proteolysis of hevin in many tissues, with the most extensive processing in the brain. We demonstrate a cleavage site within the hevin sequence for the neural tissue proteinase ADAMTS4. Digestion of hevin by ADAMTS4 in vitro produced fragments similar to those present in brain lysates. Monoclonal antibodies revealed a SPARC-like fragment generated from hevin that was co-localized with ADAMTS4 in vivo. We show that proteolysis of hevin by ADAMTS4 in the mouse cerebellum is important for the normal development of this tissue. In conclusion, we have identified the fragmentation of hevin by ADAMTS4 in the mouse brain and propose that this specific proteolysis is integral to cell morphology and extracellular matrix deposition in the developing brain.	Virginia Mason, Benaroya Res Inst, Hope Heart Program, Seattle, WA 98101 USA; [Cardo-Vila, Marina; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Sage, E. Helene] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle	Sage, EH (corresponding author), 1201 9th Ave, Seattle, WA USA.	hsage@benaroyaresearch.org			National Institutes of Health [GM40711, CA109559]; NATIONAL CANCER INSTITUTE [R01CA109559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM40711 and CA109559.	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brekken RA, 2004, J HISTOCHEM CYTOCHEM, V52, P735, DOI 10.1369/jhc.3A6245.2004; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Cheron G, 2008, NEUROSCIENCE, V153, P1, DOI 10.1016/j.neuroscience.2008.01.074; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Ehlen HWA, 2009, J BIOL CHEM, V284, P21545, DOI 10.1074/jbc.M109.016568; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Hu B, 2008, J BIOL CHEM, V283, P24848, DOI 10.1074/jbc.M801433200; IRUELAARISPE ML, 1995, MOL BIOL CELL, V6, P327, DOI 10.1091/mbc.6.3.327; Kang TC, 2002, NEUROCHEM INT, V40, P115, DOI 10.1016/S0197-0186(01)00085-7; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Lively S, 2008, NEUROCHEM RES, V33, P1692, DOI 10.1007/s11064-008-9606-z; Lively S, 2007, NEUROCHEM RES, V32, P65, DOI 10.1007/s11064-006-9226-4; Lively S, 2008, J NEUROCHEM, V107, P1335, DOI 10.1111/j.1471-4159.2008.05696.x; McKinnon PJ, 1996, BRAIN RES, V709, P27, DOI 10.1016/0006-8993(95)01224-9; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nguon K, 2005, CEREBELLUM, V4, P112, DOI 10.1080/14734220510007860; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Soderling JA, 1997, J HISTOCHEM CYTOCHEM, V45, P823, DOI 10.1177/002215549704500607; Sonnewald U, 2003, NMR BIOMED, V16, P424, DOI 10.1002/nbm.837; Sullivan MM, 2008, WOUND REPAIR REGEN, V16, P310, DOI 10.1111/j.1524-475X.2008.00370.x; Sullivan MM, 2006, J BIOL CHEM, V281, P27621, DOI 10.1074/jbc.M510507200; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058	41	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5868	5877		10.1074/jbc.M109.070318	http://dx.doi.org/10.1074/jbc.M109.070318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018883	hybrid, Green Published			2022-12-25	WOS:000275327200077
J	Samarin, J; Wessel, J; Cicha, I; Kroening, S; Warnecke, C; Goppelt-Struebe, M				Samarin, Jana; Wessel, Julia; Cicha, Iwona; Kroening, Sven; Warnecke, Christina; Goppelt-Struebe, Margarete			FoxO Proteins Mediate Hypoxic Induction of Connective Tissue Growth Factor in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL REGULATION; COMBRETASTATIN A-4; STRESS; AGENT; PROLIFERATION; SPECIFICITY; PHOSPHATASE; HOMEOSTASIS	Hypoxia, a driving force in neovascularization, promotes alterations in gene expression mediated by hypoxia-inducible factor (HIF)-1 alpha. Connective tissue growth factor (CTGF, CCN2) is a modulator of endothelial cell growth and migration, but its regulation by hypoxia is poorly understood. Therefore, we analyzed signaling pathways involved in the regulation of CTGF by hypoxia in endothelial cells. Exposure to low oxygen tension or treatment with the hypoxia-mimetic dimethyloxalyl glycine (DMOG) stabilized HIF-1 alpha and up-regulated CTGF in human umbilical vein endothelial cells and in a murine microvascular endothelial cell line. Induction of CTGF correlated with a HIF-dependent increase in protein and mRNA levels, and nuclear accumulation of the transcription factor FoxO3a. By contrast, gene expression and cellular localization of FoxO1 were not significantly altered by hypoxia. Expression of CTGF was strongly reduced by siRNA silencing of FoxO1 or FoxO3a. Furthermore, nuclear exclusion of FoxO1/3a transcription factors by inhibition of serine/threonine protein phosphatases by okadaic acid inhibited CTGF expression, providing evidence for both FoxO proteins as regulators of CTGF expression. The DMOG-stimulated induction of CTGF was further increased when endothelial cells were co-incubated with transforming growth factor-beta, an activator of Smad signaling. Activation of RhoA-Rho kinase signaling by the microtubule-disrupting drug combretastatin A4 also enhanced the DMOG-induced CTGF expression, thus placing CTGF induction by hypoxia in a network of interacting signaling pathways. Our findings provide evidence that FoxO1, hypoxia-stimulated expression of FoxO3a and its nuclear accumulation are required for the induction of CTGF by hypoxia in endothelial cells.	[Samarin, Jana; Wessel, Julia; Kroening, Sven; Warnecke, Christina; Goppelt-Struebe, Margarete] Univ Hosp Erlangen, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Cicha, Iwona] Univ Hosp Erlangen, Dept Cardiol & Angiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Goppelt-Struebe, M (corresponding author), Univ Hosp Erlangen, Dept Hypertens & Nephrol, Loschgestr 8, D-91054 Erlangen, Germany.	margarete.goppelt-struebe@uk-erlangen.de		Cicha, Iwona/0000-0002-7399-5307; Samarin, Jana/0000-0002-5490-0747	Interdisciplinary Center for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	Interdisciplinary Center for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	This work was supported by Project D5 from the Interdisciplinary Center for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg.	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dark GG, 1997, CANCER RES, V57, P1829; Dawson John F., 1999, Frontiers in Bioscience, V4, pd646, DOI 10.2741/Dawson; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Komorowsky C, 2009, J CELL MOL MED, V13, P2353, DOI 10.1111/j.1582-4934.2009.00674.x; Kondo S, 2006, ONCOGENE, V25, P1099, DOI 10.1038/sj.onc.1209129; Kondo S, 2002, CARCINOGENESIS, V23, P769, DOI 10.1093/carcin/23.5.769; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li ZD, 2005, BIOCHEM BIOPH RES CO, V334, P1049, DOI 10.1016/j.bbrc.2005.07.005; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Paik JH, 2006, BIOCHEM SOC T, V34, P731, DOI 10.1042/BST0340731; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papanicolaou KN, 2008, CIRC RES, V102, P16, DOI 10.1161/CIRCRESAHA.107.164186; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Samarin J, 2009, J CELL COMMUN SIGNAL, V3, P79, DOI 10.1007/s12079-009-0055-5; Samarin J, 2009, MOL CANCER RES, V7, P180, DOI 10.1158/1541-7786.MCR-08-0292; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shimo T, 2001, CANCER LETT, V174, P57, DOI 10.1016/S0304-3835(01)00683-8; Truttmann AC, 2004, NEUROSCIENCE, V127, P355, DOI 10.1016/j.neuroscience.2004.05.033; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Woods A, 2009, OSTEOARTHR CARTILAGE, V17, P406, DOI 10.1016/j.joca.2008.07.002; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200	43	30	35	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4328	4336		10.1074/jbc.M109.049650	http://dx.doi.org/10.1074/jbc.M109.049650			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018872	hybrid, Green Published			2022-12-25	WOS:000275274800009
J	Chadli, A; Felts, SJ; Wang, Q; Sullivan, WP; Botuyan, MV; Fauq, A; Ramirez-Alvarado, M; Mer, G				Chadli, Ahmed; Felts, Sara J.; Wang, Qin; Sullivan, William P.; Botuyan, Maria Victoria; Fauq, Abdul; Ramirez-Alvarado, Marina; Mer, Georges			Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; HEAT-SHOCK; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; TRITERPENE CELASTROL; AMYLOID FIBRILS; NUDE-MICE; PROTEIN; COMPLEX; CANCER	Hsp90 is an ATP-dependent molecular chaperone. The best characterized inhibitors of Hsp90 target its ATP binding pocket, causing nonselective degradation of Hsp90 client proteins. Here, we show that the small molecule celastrol inhibits the Hsp90 chaperoning machinery by inactivating the co-chaperone p23, resulting in a more selective destabilization of steroid receptors compared with kinase clients. Our in vitro and in vivo results demonstrate that celastrol disrupts p23 function by altering its three-dimensional structure, leading to rapid formation of amyloid-like fibrils. This study reveals a unique inhibition mechanism of p23 by a small molecule that could be exploited in the dissection of protein fibrillization processes as well as in the therapeutics of steroid receptor-dependent diseases.	[Chadli, Ahmed] Med Coll Georgia, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA 30912 USA; [Felts, Sara J.; Sullivan, William P.; Botuyan, Maria Victoria; Ramirez-Alvarado, Marina; Mer, Georges] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Fauq, Abdul] Mayo Clin, Coll Med, Organ Chem Lab, Jacksonville, FL 32224 USA	University System of Georgia; Augusta University; Mayo Clinic; Mayo Clinic	Chadli, A (corresponding author), Med Coll Georgia, Ctr Mol Chaperone Radiobiol & Canc Virol, 1410 Laney Walker Blvd,CN 3151, Augusta, GA 30912 USA.	achadli@mcg.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; Ramirez-Alvarado, Marina/0000-0003-2325-6773	National Institutes of Health [GM071514, CA109449]; Mayo Foundation; American Heart Association [06-30077N]; NATIONAL CANCER INSTITUTE [R01CA109449, R01CA132878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071514 (to M. R.- A.) and CA109449 (to G. M.). This work was also supported by the Mayo Foundation (to M. R.- A.) and the American Heart Association Grant 06-30077N (to M. R.- A.).	Abbas S, 2007, CLIN CANCER RES, V13, P6769, DOI 10.1158/1078-0432.CCR-07-1536; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Felts SJ, 2007, CELL STRESS CHAPERON, V12, P353, DOI 10.1379/CSC-299.1; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Johnson J, 1996, J STEROID BIOCHEM, V56, P31, DOI 10.1016/0960-0760(95)00221-9; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484	46	71	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4224	4231		10.1074/jbc.M109.081018	http://dx.doi.org/10.1074/jbc.M109.081018			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996313	Green Published, hybrid			2022-12-25	WOS:000275254000074
J	Witwer, KW; Gama, L; Li, M; Bartizal, CM; Queen, SE; Varrone, JJ; Brice, AK; Graham, DR; Tarwater, PM; Mankowski, JL; Zink, MC; Clements, JE				Witwer, Kenneth W.; Gama, Lucio; Li, Ming; Bartizal, Christopher M.; Queen, Suzanne E.; Varrone, John J.; Brice, Angela K.; Graham, David R.; Tarwater, Patrick M.; Mankowski, Joseph L.; Zink, M. Christine; Clements, Janice E.			Coordinated Regulation of SIV Replication and Immune Responses in the CNS	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; BINDING-PROTEIN-BETA; TRANSCRIPTIONAL ACTIVATOR PROTEIN; TUMOR-NECROSIS-FACTOR; LONG TERMINAL REPEAT; BLOOD-BRAIN-BARRIER; CD4(+) T-CELLS; CEREBROSPINAL-FLUID; HIV-1 REPLICATION	Central nervous system (CNS) invasion during acute-stage HIV-infection has been demonstrated in a small number of individuals, but there is no evidence of neurological impairment at this stage and virus infection in brain appears to be controlled until late-stage disease. Using our reproducible SIV macaque model to examine the earliest stages of infection in the CNS, we identified immune responses that differentially regulate inflammation and virus replication in the brain compared to the peripheral blood and lymphoid tissues. SIV replication in brain macrophages and in brain of SIV-infected macaques was detected at 4 days post-inoculation (p.i.). This was accompanied by upregulation of innate immune responses, including IFN beta, IFN beta-induced gene MxA mRNA, and TNF alpha. Additionally, IL-10, the chemokine CCL2, and activation markers in macrophages, endothelial cells, and astrocytes were all increased in the brain at four days p.i. We observed synchronous control of virus replication, cytokine mRNA levels and inflammatory markers (MHC Class II, CD68 and GFAP) by 14 days p.i.; however, control failure was followed by development of CNS lesions in the brain. SIV infection was accompanied by induction of the dominant-negative isoform of C/EBP beta, which regulates SIV, CCL2, and IL6 transcription, as well as inflammatory responses in macrophages and astrocytes. This synchronous response in the CNS is in part due to the effect of the C/EBP beta on virus replication and cytokine expression in macrophage-lineage cells in contrast to CD4+ lymphocytes in peripheral blood and lymphoid tissues. Thus, we have identified a crucial period in the brain when virus replication and inflammation are controlled. As in HIV-infected individuals, though, this control is not sustained in the brain. Our results suggest that intervention with antiretroviral drugs or anti-inflammatory therapeutics with CNS penetration would sustain early control. These studies further suggest that interventions should target HIV-infected individuals with increased CCL2 levels or HIV RNA in the CNS.	[Witwer, Kenneth W.; Gama, Lucio; Li, Ming; Bartizal, Christopher M.; Queen, Suzanne E.; Varrone, John J.; Brice, Angela K.; Graham, David R.; Mankowski, Joseph L.; Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Mankowski, Joseph L.; Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Mankowski, Joseph L.; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Graham, David R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Tarwater, Patrick M.] Texas Tech Univ, Dept Biomed Sci, Hlth Sci Ctr, El Paso, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Texas Tech University System; Texas Tech University	Witwer, KW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	jclements@jhmi.edu	Witwer, Kenneth W./G-1626-2013	Witwer, Kenneth W./0000-0003-1664-4233; Gama, Lucio/0000-0001-9511-012X	National Institutes of Health [MH070306, NS47984, NS050028, NS055648, MH68116, MH061189, NS055651]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061189, P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055651, R01NS050028, R01NS047984, R01NS055648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health Grants MH070306, NS47984, NS050028, NS055648 (to J. E. C.); MH68116, MH061189 (to M. C. Z.); and NS055651 (to J. L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Ances BM, 2008, CURR NEUROL NEUROSCI, V8, P455, DOI 10.1007/s11910-008-0073-3; Babas T, 2003, J VIROL, V77, P208, DOI 10.1128/JVI.77.1.208-216.2003; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; Bartee E, 2008, CURR OPIN MICROBIOL, V11, P378, DOI 10.1016/j.mib.2008.05.015; Bartee E, 2009, J VIROL, V83, P498, DOI 10.1128/JVI.01376-08; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Byrnes AA, 2008, J LEUKOCYTE BIOL, V84, P1447, DOI 10.1189/jlb.0708438; Carruth LM, 2005, J MED PRIMATOL, V34, P109, DOI 10.1111/j.1600-0684.2005.00103.x; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Clements JE, 2005, J NEUROVIROL, V11, P180, DOI 10.1080/13550280590922829; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Czub S, 1996, ACTA NEUROPATHOL, V92, P487, DOI 10.1007/s004010050551; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; de Almeida SN, 2005, J NEUROIMMUNOL, V169, P144, DOI 10.1016/j.jneuroim.2005.07.012; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Fischer-Smith T, 2004, AM J PATHOL, V164, P2089, DOI 10.1016/S0002-9440(10)63767-4; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Gupta S, 2008, IMMUNOLOGY, V124, P553, DOI 10.1111/j.1365-2567.2008.02809.x; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Henderson AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Marcondes MCG, 2008, J INFECT DIS, V197, P1567, DOI 10.1086/588002; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Orandle MS, 2002, J VIROL, V76, P5797, DOI 10.1128/JVI.76.11.5797-5802.2002; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Pope R, 2000, CYTOKINE, V12, P1171, DOI 10.1006/cyto.2000.0691; Raber J, 1998, BRAIN RES REV, V26, P320, DOI 10.1016/S0165-0173(97)00041-6; Roberts ES, 2004, J NEUROIMMUNOL, V157, P81, DOI 10.1016/j.jneuroim.2004.08.030; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; SINCLAIR E, 1992, J NEUROL, V239, P469, DOI 10.1007/BF00856814; Spooner CJ, 2007, MOL IMMUNOL, V44, P1384, DOI 10.1016/j.molimm.2006.05.004; Tanaka N, 2005, J ORTHOP SCI, V10, P3, DOI 10.1007/s00776-004-0859-3; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Wright EK, 2006, J NEUROVIROL, V12, P411, DOI 10.1080/13550280601009538; Zink MC, 2006, CURR HIV RES, V4, P293; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	72	86	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8129	10.1371/journal.pone.0008129	http://dx.doi.org/10.1371/journal.pone.0008129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019816	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834200001
J	Deyts, C; Galan-Rodriguez, B; Martin, E; Bouveyron, N; Roze, E; Charvin, D; Caboche, J; Betuing, S				Deyts, Carole; Galan-Rodriguez, Beatriz; Martin, Elodie; Bouveyron, Nicolas; Roze, Emmanuel; Charvin, Delphine; Caboche, Jocelyne; Betuing, Sandrine			Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation	PLOS ONE			English	Article							BINDING PROTEIN-PHOSPHORYLATION; RHO-ASSOCIATED KINASE; PROJECTION NEURONS; POLYGLUTAMINE AGGREGATION; INTRANUCLEAR INCLUSIONS; LYSOPHOSPHATIDIC ACID; NEURITE RETRACTION; SIGNALING PATHWAY; MUTANT HUNTINGTIN; PREFERENTIAL LOSS	Background: Huntington's disease (HD) is a polyglutamine-expanded related neurodegenerative disease. Despite the ubiquitous expression of expanded, polyQ-Huntingtin (ExpHtt) in the brain, striatal neurons present a higher susceptibility to the mutation. A commonly admitted hypothesis is that Dopaminergic inputs participate to this vulnerability. We previously showed that D2 receptor stimulation increased aggregate formation and neuronal death induced by ExpHtt in primary striatal neurons in culture, and chronic D2 antagonist treatment protects striatal dysfunctions induced by ExpHtt in a lentiviral-induced model system in vivo. The present work was designed to elucidate the signalling pathways involved, downstream D2 receptor (D2R) stimulation, in striatal vulnerability to ExpHtt. Methodology/Principal Findings: Using primary striatal neurons in culture, transfected with a tagged-GFP version of human exon 1 ExpHtt, and siRNAs against D2R or D1R, we confirm that DA potentiates neuronal dysfunctions via D2R but not D1R stimulation. We demonstrate that D2 agonist treatment induces neuritic retraction and growth cone collapse in Htt-and ExpHtt expressing neurons. We then tested a possible involvement of the Rho/ROCK signalling pathway, which plays a key role in the dynamic of the cytoskeleton, in these processes. The pharmacological inhibitors of ROCK (Y27632 and Hydroxyfasudil), as well as siRNAs against ROCK-II, reversed D2-related effects on neuritic retraction and growth cone collapse. We show a coupling between D2 receptor stimulation and Rho activation, as well as hyperphosphorylation of Cofilin, a downstream effector of ROCK-II pathway. Importantly, D2 agonist-mediated potentiation of aggregate formation and neuronal death induced by ExpHtt, was totally reversed by Y27632 and Hydroxyfasudil and ROCK-II siRNAs. Conclusions/Significance: Our data provide the first demonstration that D2R-induced vulnerability in HD is critically linked to the activation of the Rho/ROCK signalling pathway. The inclusion of Rho/ROCK inhibitors could be an interesting therapeutic option aimed at forestalling the onset of the disease.	[Deyts, Carole; Galan-Rodriguez, Beatriz; Martin, Elodie; Bouveyron, Nicolas; Roze, Emmanuel; Charvin, Delphine; Caboche, Jocelyne; Betuing, Sandrine] Univ Paris 06, CNRS, UMR 7102, Paris, France; [Deyts, Carole; Galan-Rodriguez, Beatriz; Martin, Elodie; Bouveyron, Nicolas; Roze, Emmanuel; Charvin, Delphine; Caboche, Jocelyne; Betuing, Sandrine] Univ Paris 06, CNRS, INSERM, UMRS 952,UMR 7224, Paris, France; [Deyts, Carole] Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA; [Roze, Emmanuel] Hop La Pitie Salpetriere, AP HP, Serv Neurol, Paris, France; [Betuing, Sandrine] Univ Evry Val dEssonne, Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Chicago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Betuing, S (corresponding author), Univ Paris 06, CNRS, UMR 7102, Paris, France.	sandrine.betuing@snv.jussieu.fr	Betuing, Sandrine/X-2179-2018; Betuing, Sandrine/F-2967-2013; Betuing, Sandrine/X-1957-2019; IBIS, SINAPTICA/C-2547-2016	Martin, Elodie/0000-0001-5668-7516; Charvin, Delphine/0000-0002-4801-7800	Centre National de la Recherche Scientifique (CNRS); Universite Pierre et Marie Curie-Paris 6; High Q Foundation for Jocelyne Caboche and Sandrine Betuing	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie-Paris 6; High Q Foundation for Jocelyne Caboche and Sandrine Betuing	This work was supported by Centre National de la Recherche Scientifique (CNRS), Universite Pierre et Marie Curie-Paris 6 and High Q Foundation for Jocelyne Caboche and Sandrine Betuing. Carole Deyts and Beatriz Galan-Rodriguez were grant recipients from the High Q foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam OR, 2008, NEUROTHERAPEUTICS, V5, P181, DOI 10.1016/j.nurt.2008.01.008; ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; BAUER PO, 2009, J BIOL CHEM; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bowyer JF, 1996, BRAIN RES, V712, P221, DOI 10.1016/0006-8993(95)01417-9; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Cass WA, 1997, J PHARMACOL EXP THER, V280, P105; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Charvin D, 2008, NEUROBIOL DIS, V29, P22, DOI 10.1016/j.nbd.2007.07.028; Correll CU, 2007, CNS SPECTRUMS, V12, P10, DOI 10.1017/S1092852900015959; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; Cyr M, 2006, FASEB J, V20, P2541, DOI 10.1096/fj.06-6533fje; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Paoletti P, 2008, J NEUROSCI, V28, P10090, DOI 10.1523/JNEUROSCI.3237-08.2008; Parish CL, 2002, EUR J NEUROSCI, V16, P787, DOI 10.1046/j.1460-9568.2002.02132.x; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; RICAURTE GA, 1982, BRAIN RES, V235, P93, DOI 10.1016/0006-8993(82)90198-6; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Robinson P, 2008, NEUROSCIENCE, V153, P762, DOI 10.1016/j.neuroscience.2008.02.052; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; SAPP E, 1995, NEUROSCIENCE, V64, P397, DOI 10.1016/0306-4522(94)00427-7; Senogles SE, 2000, MOL PHARMACOL, V58, P455, DOI 10.1124/mol.58.2.455; SHAO J, 2008, MOL CELL BIOL; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Tallaksen-Greene SJ, 2005, NEUROSCIENCE, V131, P843, DOI 10.1016/j.neuroscience.2004.10.037; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yohrling GJ, 2003, MOL BRAIN RES, V119, P28, DOI 10.1016/j.molbrainres.2003.08.009; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	56	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8287	10.1371/journal.pone.0008287	http://dx.doi.org/10.1371/journal.pone.0008287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016831	gold, Green Published, Green Submitted			2022-12-25	WOS:000272833800004
J	Diaz-Sylvester, PL; Copello, JA				Diaz-Sylvester, Paula L.; Copello, Julio A.			Voltage-Dependent Modulation of Cardiac Ryanodine Receptors (RyR2) by Protamine	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA2+ RELEASE; DIHYDROPYRIDINE RECEPTOR; K+ CHANNELS; SURFACE-CHARGE; MECHANISMS; POLYAMINES; BLOCK	It has been reported that protamine (> 10 mg/ml) blocks single skeletal RyR1 channels and inhibits RyR1-mediated Ca(2+) release from sarcoplasmic reticulum microsomes. We extended these studies to cardiac RyR2 reconstituted into planar lipid bilayers. We found that protamine (0.02-20 mg/ml) added to the cytosolic surface of fully activated RyR2 affected channel activity in a voltage-dependent manner. At membrane voltage (V(m); SR lumen - cytosol) = 0 mV, protamine induced conductance transitions to several intermediate states (substates) as well as full block of RyR2. At V(m) > 10 mV, the substate with the highest level of conductance was predominant. Increasing V(m) from 0 to +80 mV, decreased the number of transitions and residence of the channel in this substate. The drop in current amplitude (full opening to substate) had the same magnitude at 0 and +80 mV despite the similar to 3-fold increase in amplitude of the full opening. This is more similar to rectification of channel conductance induced by other polycations than to the action of selective conductance modifiers (ryanoids, imperatoxin). A distinctive effect of protamine (which might be shared with polylysines and histones but not with non-peptidic polycations) is the activation of RyR2 in the presence of nanomolar cytosolic Ca(2+) and millimolar Mg(2+) levels. Our results suggest that RyRs would be subject to dual modulation (activation and block) by polycationic domains of neighboring proteins via electrostatic interactions. Understanding these interactions could be important as such anomalies may be associated with the increased RyR2-mediated Ca(2+) leak observed in cardiac diseases.	[Diaz-Sylvester, Paula L.; Copello, Julio A.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Diaz-Sylvester, PL (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	jcopello@siumed.edu		Diaz-Sylvester, Paula/0000-0002-1531-1958	National Institutes of Health [R01 GM078665]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 GM078665 to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1969, INT J PROT RES, V1, P221; Balke CW, 2003, J GEN PHYSIOL, V121, P349, DOI 10.1085/jgp.200308841; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; BRUNDER DG, 1992, J PHYSIOL-LONDON, V445, P759, DOI 10.1113/jphysiol.1992.sp018949; Byun Y, 1999, THROMB RES, V94, P53, DOI 10.1016/S0049-3848(98)00201-1; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; COPELLO JA, 2003, BIOPHYS J, V84; Copello JA, 2006, CIRCULATION, V114, P57; Copello JA, 2007, AM J PHYSIOL-CELL PH, V292, pC2129, DOI 10.1152/ajpcell.00437.2006; David JS, 2001, ANESTH ANALG, V92, P817; DESLONGCHAMPS P, 1990, CAN J CHEM, V68, P115, DOI 10.1139/v90-021; DEUTSCH N, 1994, J GEN PHYSIOL, V104, P773, DOI 10.1085/jgp.104.4.773; Diaz-Sylvester PL, 2009, BIOPHYS J, V96, p113A, DOI 10.1016/j.bpj.2008.12.493; DIAZSYLVESTER P, 2006, BIOPHYS J, V89; EBERT G, 1990, PROG COLL POL SCI S, V83, P181; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gillespie D, 2005, J PHYS CHEM B, V109, P15598, DOI 10.1021/jp052471j; Gonzalez A, 2000, P NATL ACAD SCI USA, V97, P4380, DOI 10.1073/pnas.070056497; Green D, 2003, BIOCHEM J, V370, P517, DOI 10.1042/BJ20021488; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOBBHAHN J, 1991, J APPL PHYSIOL, V71, P1415, DOI 10.1152/jappl.1991.71.4.1415; Kobayashi S, 2004, BIOCHEM J, V380, P561, DOI 10.1042/BJ20040112; Koulen P, 2000, MOL BIOL CELL, V11, P2213, DOI 10.1091/mbc.11.7.2213; Li LH, 2005, J GEN PHYSIOL, V126, P285, DOI 10.1085/jgp.200509289; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU XY, 1994, J BIOL CHEM, V269, P6511; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Mead F, 2002, BIOPHYS J, V82, P1953, DOI 10.1016/S0006-3495(02)75544-6; Mead FC, 2004, BIOPHYS J, V87, P3814, DOI 10.1529/biophysj.104.049338; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; OHKUSA T, 1991, J BIOCHEM-TOKYO, V109, P609, DOI 10.1093/oxfordjournals.jbchem.a123428; PALADE P, 1987, J BIOL CHEM, V262, P6149; PARK WK, 1994, CARDIOVASC RES, V28, P505, DOI 10.1093/cvr/28.4.505; Porta M, 2004, BIOPHYS J, V86, p241A; Porta M, 2004, BIOPHYS J, V86, p62A; Porta M, 2008, BBA-BIOMEMBRANES, V1778, P2469, DOI 10.1016/j.bbamem.2008.07.024; Pugsley MK, 2002, LIFE SCI, V72, P293, DOI 10.1016/S0024-3205(02)02245-2; Ranatunga KM, 2007, MOL MEMBR BIOL, V24, P185, DOI 10.1080/09687860601076522; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; Samso M, 1999, J CELL BIOL, V146, P493, DOI 10.1083/jcb.146.2.493; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Sitsapesan R, 1998, STRUCTURE FUNCTION R; Stern MD, 2004, CELL CALCIUM, V35, P591, DOI 10.1016/j.ceca.2004.01.013; Stern MD, 1999, J GEN PHYSIOL, V113, P469, DOI 10.1085/jgp.113.3.469; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Tanna B, 2000, J GEN PHYSIOL, V116, P1, DOI 10.1085/jgp.116.1.1; Terentyev D, 2002, CIRC RES, V91, P414, DOI 10.1161/01.RES.0000032490.04207.BD; Tinker A, 1996, BIOPHYS J, V70, P2110, DOI 10.1016/S0006-3495(96)79777-1; Tripathy A, 1998, J GEN PHYSIOL, V111, P679, DOI 10.1085/jgp.111.5.679; TU Q, 1994, J GEN PHYSIOL, V103, P853, DOI 10.1085/jgp.103.5.853; Uehara A, 1996, BIOPHYS J, V71, P769, DOI 10.1016/S0006-3495(96)79276-7; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; XU L, 1993, J GEN PHYSIOL, V101, P207, DOI 10.1085/jgp.101.2.207; Yamamoto T, 1999, CARDIOVASC RES, V44, P146, DOI 10.1016/S0008-6363(99)00200-X; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V291, P1102, DOI 10.1006/bbrc.2002.6569; Yano M, 1998, J CARDIOVASC PHARM, V32, P96, DOI 10.1097/00005344-199807000-00015	66	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8315	10.1371/journal.pone.0008315	http://dx.doi.org/10.1371/journal.pone.0008315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016815	gold, Green Submitted, Green Published			2022-12-25	WOS:000272833800011
J	Horzinski, L; Huyghe, A; Cardoso, MC; Gonthier, C; Ouchchane, L; Schiffmann, R; Blanc, P; Boespflug-Tanguy, O; Fogli, A				Horzinski, Laetitia; Huyghe, Aurelia; Cardoso, Marie-Celeste; Gonthier, Celine; Ouchchane, Lemlih; Schiffmann, Raphael; Blanc, Pierre; Boespflug-Tanguy, Odile; Fogli, Anne			Eukaryotic Initiation Factor 2B (eIF2B) GEF Activity as a Diagnostic Tool for EIF2B-Related Disorders	PLOS ONE			English	Article							VANISHING WHITE-MATTER; NATURAL-HISTORY; LEUKOENCEPHALOPATHY; ASIALOTRANSFERRIN; MUTATIONS; SUBUNITS; DISEASE; ATAXIA	Background: In recent years, the phenotypes of leukodystrophies linked to mutations in the eukaryotic initiation factor 2B genes have been extended, classically called CACH/VWM (Childhood ataxia with cntral hypomyelination/vanishing white matter disorder). The large clinical spectrum observed from the more severe antenatal forms responsible for fetal death to milder adult forms with an onset after 16 years old and restricted to slow cognitive impairment have lead to the concept of eIF2B-related disorders. The typical MRI pattern with a diffuse CSF-like aspect of the cerebral white matter can lack particularly in the adult forms whereas an increasing number of patients with clinical and MRI criteria for CACH/VWM disease but without eIF2B mutations are found. Then we propose the use of biochemical markers to help in this difficult diagnosis. The biochemical diagnosis of eIF2B-related disorder is difficult as no marker, except the recently described asialotransferrin/transferrin ratio measured in cerebrospinal fluid, has been proposed and validated until now. Decreased eIF2B GEF activity has been previously reported in lymphoblastoid cell lines from 30 eIF2B-mutated patients. Our objective was to evaluate further the utility of this marker and to validate eIF2B GEF activity in a larger cohort as a specific diagnostic test for eIF2B-related disorders. Methodology/Principal Findings: We performed eIF2B GEF activity assays in cells from 63 patients presenting with different clinical forms and eIF2B mutations in comparison to controls but also to patients with defined leukodystrophies or CACH/VWM-like diseases without eIF2B mutations. We found a significant decrease of GEF activity in cells from eIF2B-mutated patients with 100% specificity and 89% sensitivity when the activity threshold was set at <= 77.5%. Conclusion: These results validate the measurement of eIF2B GEF activity in patients' transformed-lymphocytes as an important tool for the diagnosis of eIF2B-related disorders.	[Horzinski, Laetitia; Huyghe, Aurelia; Cardoso, Marie-Celeste; Gonthier, Celine; Blanc, Pierre; Boespflug-Tanguy, Odile; Fogli, Anne] Univ Clermont, INSERM, U931, GReD,CNRS 6247, Clermont Ferrand, France; [Horzinski, Laetitia; Huyghe, Aurelia; Cardoso, Marie-Celeste; Boespflug-Tanguy, Odile; Fogli, Anne] Univ Clermont 1, UFR Med, Clermont Ferrand, France; [Cardoso, Marie-Celeste; Blanc, Pierre; Fogli, Anne] CHU Clermont Ferrand, Serv Biochim Med & Biol Mol, Clermont Ferrand, France; [Ouchchane, Lemlih] Univ Clermont, UFR Med, EA3295, Equipe Rech Signal & Imagerie Med, Clermont Ferrand, France; [Ouchchane, Lemlih] Hop Gabriel Montpied, CHU Clermont Ferrand, Lab Biostat Telemat & Traitement Images, Clermont Ferrand, France; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Boespflug-Tanguy, Odile] Hop Hotel Dieu, CHU Clermont Ferrand, Serv Genet Med, Ctr Reference Leucodystrophies, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand; Baylor Scott & White Health; Baylor University Medical Center; CHU Clermont Ferrand	Horzinski, L (corresponding author), Univ Clermont, INSERM, U931, GReD,CNRS 6247, Clermont Ferrand, France.	anne.fogli@inserm.u-clermont1.fr	Fogli, Anne/AAL-6640-2020; Huyghe, Aurélia/AAA-5203-2020	Fogli, Anne/0000-0002-2651-7441; GONTHIER-GUERET, Celine/0000-0002-4449-559X; BLANC, Pierre/0000-0003-3802-0923	ELA Foundation	ELA Foundation	This work was supported by grants from the ELA Foundation (2006-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; van der Heide M, 2003, TOP CURR GENET, V2, P207; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Vanderver A, 2008, NEUROLOGY, V70, P2226, DOI 10.1212/01.wnl.0000313857.54398.0e; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053	15	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8318	10.1371/journal.pone.0008318	http://dx.doi.org/10.1371/journal.pone.0008318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016818	Green Published, Green Submitted, gold			2022-12-25	WOS:000272833800014
J	Wang, PG; Kudelko, M; Lo, J; Siu, LYL; Kwok, KTH; Sachse, M; Nicholls, JM; Bruzzone, R; Altmeyer, RM; Nal, B				Wang, Pei-Gang; Kudelko, Mateusz; Lo, Joanne; Siu, Lewis Yu Lam; Kwok, Kevin Tsz Hin; Sachse, Martin; Nicholls, John M.; Bruzzone, Roberto; Altmeyer, Ralf M.; Nal, Beatrice			Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; VIRUS-LIKE PARTICLES; YELLOW-FEVER VIRUS; ENVELOPE GLYCOPROTEIN; ENDOPLASMIC-RETICULUM; MODEL SYSTEM; FLAVIVIRUS; MATURATION; TYPE-2; INFECTION	Background: Flavivirus infected cells produce infectious virions and subviral particles, both of which are formed by the assembly of prM and E envelope proteins and are believed to undergo the same maturation process. Dengue recombinant subviral particles have been produced in cell cultures with either modified or chimeric proteins but not using the native forms of prM and E. Methodology/Principal Findings: We have used a codon optimization strategy to obtain an efficient expression of native viral proteins and production of recombinant subviral particles (RSPs) for all four dengue virus (DV) serotypes. A stable HeLa cell line expressing DV1 prME was established (HeLa-prME) and RSPs were analyzed by immunofluorescence and transmission electron microscopy. We found that E protein is mainly present in the endoplasmic reticulum (ER) where assembly of RSPs could be observed. Biochemical characterization of DV1 RSPs secretion revealed both prM protein cleavage and homodimerization of E proteins before their release into the supernatant, indicating that RSPs undergo a similar maturation process as dengue virus. Pulse chase experiment showed that 8 hours are required for the secretion of DV1 RSPs. We have used HeLa-prME to develop a semi-quantitative assay and screened a human siRNA library targeting genes involved in membrane trafficking. Knockdown of 23 genes resulted in a significant reduction in DV RSP secretion, whereas for 22 others we observed an increase of RSP levels in cell supernatant. Conclusions/Significance: Our data describe the efficient production of RSPs containing native prM and E envelope proteins for all dengue serotypes. Dengue RSPs and corresponding producing cell lines are safe and novel tools that can be used in the study of viral egress as well as in the development of vaccine and drugs against dengue virus.	[Wang, Pei-Gang; Kudelko, Mateusz; Siu, Lewis Yu Lam; Kwok, Kevin Tsz Hin; Bruzzone, Roberto; Altmeyer, Ralf M.; Nal, Beatrice] Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Lo, Joanne; Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Nal, Beatrice] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Lo, Joanne; Sachse, Martin] Inst Pasteur, Paris, France	University of Hong Kong; University of Hong Kong; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wang, PG (corresponding author), Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China.	pgwang@hkucc.hku.hk	Bruzzone, Roberto/G-9355-2017; NAL, Beatrice/GYU-8888-2022; Sachse, Martin/W-7403-2019; Bruzzone, Roberto/C-4719-2009; Nicholls, John Malcolm/C-4375-2009	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Nicholls, John Malcolm/0000-0001-7217-7444; Wang, Peigang/0000-0001-6045-2007; Nal, Beatrice/0000-0003-3452-7524; Sachse, Martin/0000-0001-5981-9166	6th European Framework programme DENFRAME; Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID) [08070952]; University of Hong Kong; Consulate General of France in Hong Kong	6th European Framework programme DENFRAME(European Commission); Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID); University of Hong Kong(University of Hong Kong); Consulate General of France in Hong Kong	This work was supported by the 6th European Framework programme DENFRAME and by the Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID#08070952). MK is a PhD student supported by the University of Hong Kong. JL is an MPhil student supported by the University of Hong Kong, and by the "Alexandre Yersin Excellence Scholarship" awarded by the Consulate General of France in Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003; ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995; Barreto DF, 2007, MEM I OSWALDO CRUZ, V102, P175, DOI 10.1590/S0074-02762007005000007; Barth O. M., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P407; Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; DEUBEL V, 1981, AM J TROP MED HYG, V30, P1071, DOI 10.4269/ajtmh.1981.30.1071; dos Santos CND, 2000, VIROLOGY, V274, P292, DOI 10.1006/viro.2000.0457; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041; Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9; JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200; Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060; PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pryor MJ, 2004, J GEN VIROL, V85, P3627, DOI 10.1099/vir.0.80283-0; Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; YU IM, 2009, J VIROL; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t	46	56	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8325	10.1371/journal.pone.0008325	http://dx.doi.org/10.1371/journal.pone.0008325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016834	Green Published, gold			2022-12-25	WOS:000272833800018
J	Ballif, M; Ledergerber, B; Battegay, M; Cavassini, M; Bernasconi, E; Schmid, P; Hirschel, B; Furrer, H; Rickenbach, M; Opravil, M; Weber, R				Ballif, Marie; Ledergerber, Bruno; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Schmid, Patrick; Hirschel, Bernard; Furrer, Hansjakob; Rickenbach, Martin; Opravil, Milos; Weber, Rainer		Swiss HIV Cohort Study	Impact of Previous Virological Treatment Failures and Adherence on the Outcome of Antiretroviral Therapy in 2007	PLOS ONE			English	Article							SWISS HIV COHORT; SELF-REPORTED NONADHERENCE; INFECTED PATIENTS; COMBINATION; PROGRESSION; PREDICTORS; RISK; TIME	Background: Combination antiretroviral treatment (cART) has been very successful, especially among selected patients in clinical trials. The aim of this study was to describe outcomes of cART on the population level in a large national cohort. Methods: Characteristics of participants of the Swiss HIV Cohort Study on stable cART at two semiannual visits in 2007 were analyzed with respect to era of treatment initiation, number of previous virologically failed regimens and self reported adherence. Starting ART in the mono/dual era before HIV-1 RNA assays became available was counted as one failed regimen. Logistic regression was used to identify risk factors for virological failure between the two consecutive visits. Results: Of 4541 patients 31.2% and 68.8% had initiated therapy in the mono/dual and cART era, respectively, and been on treatment for a median of 11.7 vs. 5.7 years. At visit 1 in 2007, the mean number of previous failed regimens was 3.2 vs. 0.5 and the viral load was undetectable (<50 copies/ml) in 84.6% vs. 89.1% of the participants, respectively. Adjusted odds ratios of a detectable viral load at visit 2 for participants from the mono/dual era with a history of 2 and 3, 4, >4 previous failures compared to 1 were 0.9 (95% CI 0.4-1.7), 0.8 (0.4-1.6), 1.6 (0.8-3.2), 3.3 (1.7-6.6) respectively, and 2.3 (1.1-4.8) for >2 missed cART doses during the last month, compared to perfect adherence. From the cART era, odds ratios with a history of 1, 2 and >2 previous failures compared to none were 1.8 (95% CI 1.3-2.5), 2.8 (1.7-4.5) and 7.8 (4.5-13.5), respectively, and 2.8 (1.6-4.8) for >2 missed cART doses during the last month, compared to perfect adherence. Conclusions: A higher number of previous virologically failed regimens, and imperfect adherence to therapy were independent predictors of imminent virological failure.	[Ballif, Marie; Ledergerber, Bruno; Opravil, Milos; Weber, Rainer] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Battegay, Manuel] Univ Basel, Univ Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Cavassini, Matthias] Univ Hosp, Div Infect Dis & Hosp Epidemiol, Lausanne, Switzerland; [Bernasconi, Enos] Cantonal Hosp, Div Infect Dis & Hosp Epidemiol, Lugano, Switzerland; [Schmid, Patrick] Cantonal Hosp, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Hirschel, Bernard] Univ Hosp, Div Infect Dis & Hosp Epidemiol, Geneva, Switzerland; [Furrer, Hansjakob] Univ Hosp Bern, Div Infect Dis, Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Rickenbach, Martin] CHU Vaudois, Swiss HIV Cohort Study, Lausanne, Switzerland	University of Zurich; University Zurich Hospital; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital St. Gallen; University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ballif, M (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	infled@usz.uzh.ch	Ledergerber, Bruno/B-5656-2009; Pantaleo, Giuseppe/K-6163-2016; VALLET, Yannick/F-9979-2011; Weber, Rainer/D-5175-2012; SHCS, social sciences/G-4093-2011; Furrer, Hansjakob/G-6768-2013; cavassini, matthias/F-8987-2017	Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; cavassini, matthias/0000-0003-0933-7833	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JA, 2007, HIV CLIN TRIALS, V8, P221, DOI 10.1310/hct0804-221; Benzie AA, 2007, AIDS, V21, P1423, DOI 10.1097/QAD.0b013e3281532ca7; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; COOPER D, 2008, 15 C RETR OPP INF FE; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Dray-Spira R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000255079.39352.9b; Eron J, 2006, LANCET, V368, P1238, DOI 10.1016/S0140-6736(06)69155-1; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Glass TR, 2008, ANTIVIR THER, V13, P77; Hatano H, 2006, CLIN INFECT DIS, V43, P1329, DOI 10.1086/508655; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; Opravil M, 2002, J INFECT DIS, V185, P1251, DOI 10.1086/340312; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Sabin CA, 2008, AIDS, V22, P1463; Staehelin C, 2003, AIDS, V17, P2237, DOI 10.1097/00002030-200310170-00012; Temesgen Z, 2006, LANCET INFECT DIS, V6, P496, DOI 10.1016/S1473-3099(06)70550-3; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141	22	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8275	10.1371/journal.pone.0008275	http://dx.doi.org/10.1371/journal.pone.0008275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011544	Green Published, gold			2022-12-25	WOS:000272830300029
J	Figueroa, KP; Farooqi, S; Harrup, K; Frank, J; O'Rahilly, S; Pulst, SM				Figueroa, Karla P.; Farooqi, Sadaf; Harrup, Kristopher; Frank, Johnathan; O'Rahilly, Stephen; Pulst, Stefan M.			Genetic Variance in the Spinocerebellar Ataxia Type 2 (ATXN2) Gene in Children with Severe Early Onset Obesity	PLOS ONE			English	Article							GENOME-WIDE SCAN; LOCALIZATION; EXPRESSION; EXPANSION; INTERACTS; RECEPTOR; PROTEIN; REPEAT; REGION; MOUSE	Background: Expansion of a CAG repeat in the coding region of exon 1 in the ATXN2 gene located in human chromosome 12q24.1 causes the neurodegenerative disease spinocerebellar ataxia type 2 (SCA2). In contrast to other polyglutamine (polyQ) disorders, the SCA2 repeat is not highly polymorphic in central European (CEU) controls with Q22 representing 90% of alleles, and Q23 contributing between 5-7% of alleles. Recently, the ATXN2 CAG repeat has been identified as a target of adaptive selection in the CEU population. Mouse lines deficient for atxn2 develop marked hyperphagia and obesity raising the possibility that loss-of-function mutations in the ATXN2 gene may be related to energy balance in humans. Some linkage studies of obesity related phenotypes such as antipsychotic induced weight gain have reported significant lod scores on chromosome 12q24. We tested the hypothesis that rare loss-of-function ATXN2 variants cause obesity analogous to rare mutations in the leptin, leptin receptor and MC4R genes. Methodology/Principal Findings: We sequenced the coding region of ATXN2 including intron-exon boundaries in 92 severely obese children with a body mass index (BMI).3.2 standard deviations above age-and gender-adjusted means. We confirmed five previously identified single nucleotide polymorphisms (SNPs) and three new SNPs resulting in two synonymous substitutions and one intronic polymorphism. Alleles encoding. Q22 were overrepresented in our sample of obese children and contributed 15% of alleles in children identified by their parents as white. SNP rs695872 closely flanking the CAG repeat showed a greatly increased frequency of C/C homozygotes and G/C heterozygotes compared with reported frequencies in the CEU population. Conclusions/Significance: Although we did not identify variants leading to novel amino acid substitutions, nonsense or frameshift mutations, this study warrants further examination of variation in the ATXN2 gene in obesity and related phenotypes in a larger case-control study with emphasis on rs695872 and CAG repeat structure.	[Figueroa, Karla P.; Harrup, Kristopher; Pulst, Stefan M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Farooqi, Sadaf; O'Rahilly, Stephen] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Frank, Johnathan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pulst, Stefan M.] Univ Utah, Program Neurosci, Salt Lake City, UT USA; [Pulst, Stefan M.] Univ Utah, Inst Brain, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Figueroa, KP (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	stefan.pulst@hsc.utah.edu	O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504	The National Institute of Health [R01 NS33123]; Wellcome Trust; Medical Research Council; NIHR Cambridge Biomedical Research Centre; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033123] Funding Source: NIH RePORTER; Medical Research Council [G0900554] Funding Source: researchfish; MRC [G0900554] Funding Source: UKRI	The National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The National Institute of Health R01 NS33123. ISF and SOR are supported by the Wellcome Trust, Medical Research Council and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chagnon YC, 2004, MOL PSYCHIATR, V9, P1067, DOI 10.1038/sj.mp.4001537; Dai F, 2007, INT J OBESITY, V31, P1832, DOI 10.1038/sj.ijo.0803675; Dong CH, 2005, AM J HUM GENET, V76, P427, DOI 10.1086/428438; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Huynh DP, 2003, HUM MOL GENET, V12, P1485, DOI 10.1093/hmg/ddg175; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Kiehl TR, 2006, BIOCHEM BIOPH RES CO, V339, P17, DOI 10.1016/j.bbrc.2005.10.186; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Li WD, 2004, DIABETES, V53, P812, DOI 10.2337/diabetes.53.3.812; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Nechiporuk T, 1997, GENOMICS, V44, P321, DOI 10.1006/geno.1997.4886; Nechiporuk T, 1998, HUM MOL GENET, V7, P1301, DOI 10.1093/hmg/7.8.1301; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Perusse L, 2001, DIABETES, V50, P614, DOI 10.2337/diabetes.50.3.614; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Sahba S, 1998, GENOMICS, V47, P359, DOI 10.1006/geno.1997.5131; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041	23	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8280	10.1371/journal.pone.0008280	http://dx.doi.org/10.1371/journal.pone.0008280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20016785	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300032
J	Hay, E; Nouraud, A; Marie, PJ				Hay, Eric; Nouraud, Alexandra; Marie, Pierre J.			N-Cadherin Negatively Regulates Osteoblast Proliferation and Survival by Antagonizing Wnt, ERK and PI3K/Akt Signalling	PLOS ONE			English	Article							BETA-CATENIN; BONE MASS; PATHWAY; LRP5; EXPRESSION; APOPTOSIS; CELLS; GENE; DIFFERENTIATION; ADHESION	Background: Osteoblasts are bone forming cells that play an essential role in osteogenesis. The elucidation of the mechanisms that control osteoblast number is of major interest for the treatment of skeletal disorders characterized by abnormal bone formation. Canonical Wnt signalling plays an important role in the control of osteoblast proliferation, differentiation and survival. Recent studies indicate that the cell-cell adhesion molecule N-cadherin interacts with the Wnt co-receptors LRP5/6 to regulate osteoblast differentiation and bone accrual. The role of N-cadherin in the control of osteoblast proliferation and survival remains unknown. Methods and Principal Findings: Using murine MC3T3-E1 osteoblastic cells and N-cadherin transgenic mice, we demonstrate that N-cadherin overexpression inhibits cell proliferation in vitro and in vivo. The negative effect of N-cadherin on cell proliferation results from decreased Wnt, ERK and PI3K/Akt signalling and is restored by N-cadherin neutralizing antibody that antagonizes N-cadherin-LRP5 interaction. Inhibition of Wnt signalling using DKK1 or Sfrp1 abolishes the ability of N-cadherin blockade to restore ERK and PI3K signalling and cell proliferation, indicating that the altered cell growth in Ncadherin overexpressing cells is in part secondary to alterations in Wnt signalling. Consistently, we found that N-cadherin overexpression inhibits the expression of Wnt3a ligand and its downstream targets c-myc and cyclin D1, an effect that is partially reversed by N-cadherin blockade. We also show that N-cadherin overexpression decreases osteoblast survival in vitro and in vivo. This negative effect on cell survival results from inhibition of PI3K/Akt signalling and increased Bax/Bcl-2, a mechanism that is rescued by Wnt3a. Conclusion: The data show that N-cadherin negatively controls osteoblast proliferation and survival via inhibition of autocrine/paracrine Wnt3a ligand expression and attenuation of Wnt, ERK and PI3K/Akt signalling, which provides novel mechanisms by which N-cadherin regulates osteoblast number.	[Hay, Eric] INSERM, UMR 606, Lab Osteoblast Biol & Pathol, Paris, France; Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hay, E (corresponding author), INSERM, UMR 606, Lab Osteoblast Biol & Pathol, Paris, France.	pierre.marie@inserm.fr		Hay, Eric/0000-0002-0131-9983	Inserm; EC [LSHM-CT-2003-503020, HEALTH-F2-2008-201099]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from Inserm, the 6th Framework programme Anabonos (EC Contract No: LSHM-CT-2003-503020) and the 7th Framework programme Talos (EC Contract No: HEALTH-F2-2008-201099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; BRADBURY JM, 1994, ONCOGENE, V9, P2597; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Erez N, 2005, EUR J CELL BIOL, V84, P235, DOI 10.1016/j.ejcb.2004.12.007; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Johnson ML, 2005, CRIT REV EUKAR GENE, V15, P229, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.50; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lai CF, 2006, J BONE MINER RES, V21, P1897, DOI 10.1359/JBMR.060906; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; Mbalaviele G, 2006, J BONE MINER RES, V21, P1821, DOI 10.1359/JBMR.060811; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WARDEN SJ, 2009, BONE; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	53	49	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8284	10.1371/journal.pone.0008284	http://dx.doi.org/10.1371/journal.pone.0008284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011526	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300036
J	Nesterovitch, AB; Hogarth, KD; Adarichev, VA; Vinokour, EI; Schwartz, DE; Solway, J; Danilov, SM				Nesterovitch, Andrew B.; Hogarth, Kyle D.; Adarichev, Vyacheslav A.; Vinokour, Elena I.; Schwartz, David E.; Solway, Julian; Danilov, Sergei M.			Angiotensin I-Converting Enzyme Mutation (Trp1197Stop) Causes a Dramatic Increase in Blood ACE	PLOS ONE			English	Article							RENAL TUBULAR DYSGENESIS; ACUTE SEVERE ASTHMA; MONOCLONAL-ANTIBODIES; N-DOMAIN; MOLECULAR-CLONING; POINT MUTATION; HUMAN AIRWAY; HUMAN TESTIS; SERUM; SARCOIDOSIS	Background: Angiotensin-converting enzyme (ACE) metabolizes many peptides and plays a key role in blood pressure regulation and vascular remodeling. Elevated ACE levels may be associated with an increased risk for different cardiovascular or respiratory diseases, including asthma. Previously, a molecular mechanism underlying a 5-fold familial increase of blood ACE was discovered: Pro1199Leu substitution enhanced the cleavage-secretion process. Carriers of this mutation were Caucasians from Europe (mostly Dutch) or had European roots. Methodology/Principal Findings: We have found a family of African-American descent whose affected members' blood ACE level was increased 13-fold over normal. In affected family members, codon TGG coding for Trp1197 was substituted in one allele by TGA (stop codon). As a result, half of ACE expressed in these individuals had a length of 1196 amino acids and lacked a transmembrane anchor. This ACE mutant is not trafficked to the cell membrane and is directly secreted out of cells; this mechanism apparently accounts for the high serum ACE level seen in affected individuals. A haplotype of the mutant ACE allele was determined based on 12 polymorphisms, which may help to identify other carriers of this mutation. Some but not all carriers of this mutation demonstrated airflow obstruction, and some but not all have hypertension. Conclusions/Significance: We have identified a novel Trp1197Stop mutation that results in dramatic elevation of serum ACE. Since blood ACE elevation is often taken as a marker of disease activity (sarcoidosis and Gaucher diseases), it is important for clinicians and medical scientists to be aware of alternative genetic causes of elevated blood ACE that are not apparently linked to disease.	[Nesterovitch, Andrew B.; Vinokour, Elena I.; Schwartz, David E.; Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA; [Hogarth, Kyle D.; Solway, Julian] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Adarichev, Vyacheslav A.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Danilov, Sergei M.] Natl Cardiol Res Ctr, Moscow, Russia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; National Medical Research Center of Cardiology	Nesterovitch, AB (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA.	danilov@uic.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	Departmental funds	Departmental funds	The work was supported from Departmental funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE GM, 1985, Q J MED, V55, P253; Alfalah M, 2001, J BIOL CHEM, V276, P21105, DOI 10.1074/jbc.M100339200; ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, J PROTEOME RES, V4, P258, DOI 10.1021/pr049859w; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; BARNES PJ, 1997, ASTHMA, P577; BARR M, 1991, TERATOLOGY, V44, P485, DOI 10.1002/tera.1420440503; BELDENT V, 1995, J BIOL CHEM, V270, P28962, DOI 10.1074/jbc.270.48.28962; BENETEAUBURNAT B, 1991, CRIT REV CL LAB SCI, V28, P337, DOI 10.3109/10408369109106868; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; Bouzekri N, 2004, EUR J HUM GENET, V12, P460, DOI 10.1038/sj.ejhg.5201166; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; Cole J, 2002, CIRC RES, V90, P87, DOI 10.1161/hh0102.102360; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Farrall M, 1999, NAT GENET, V23, P270, DOI 10.1038/15449; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; GRIFFIN SA, 1991, HYPERTENSION, V17, P626, DOI 10.1161/01.HYP.17.5.626; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Kishimoto, 1997, LEUCOCYTE TYPING, P746; Kramers C, 2003, Ned Tijdschr Geneeskd, V147, P473; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Lacoste M, 2006, J AM SOC NEPHROL, V17, P2253, DOI 10.1681/ASN.2005121303; LATTION AL, 1989, FEBS LETT, V252, P99, DOI 10.1016/0014-5793(89)80897-X; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LIEBERMAN J, 1989, CLIN LAB MED, V9, P745, DOI 10.1016/S0272-2712(18)30602-4; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; Lue KH, 2006, PEDIAT ALLERG IMM-UK, V17, P508, DOI 10.1111/j.1399-3038.2006.00452.x; McKay S, 1998, AM J RESP CELL MOL, V18, P823, DOI 10.1165/ajrcmb.18.6.2924; MILLAR E, 1995, EUR RESPIR J, V8, P1838, DOI 10.1183/09031936.95.08111838; MILLAR EA, 1994, THORAX, V49, P492, DOI 10.1136/thx.49.5.492; NAFTILAN AJ, 1992, J CARDIOVASC PHARM, V20, pS37, DOI 10.1097/00005344-199206201-00008; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Pauls K, 2003, ANDROLOGIA, V35, P32, DOI 10.1046/j.1439-0272.2003.00535.x; Pierre C, 2008, CLIN EXP PHARMACOL P, V35, P431, DOI 10.1111/j.1440-1681.2008.04891.x; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; Ramsay SG, 1997, EUR RESPIR J, V10, P2766, DOI 10.1183/09031936.97.10122766; Ricciardolo FLM, 2003, THORAX, V58, P840, DOI 10.1136/thorax.58.10.840; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; Shen XZ, 2008, INT IMMUNOPHARMACOL, V8, P171, DOI 10.1016/j.intimp.2007.08.010; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SILVERSTEIN E, 1976, ANN NY ACAD SCI, V278, P498, DOI 10.1111/j.1749-6632.1976.tb47062.x; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Soubrier F, 2002, EUR J HUM GENET, V10, P553, DOI 10.1038/sj.ejhg.5200847; STUDDY P, 1978, LANCET, V2, P1331; Veerappan A, 2008, P NATL ACAD SCI USA, V105, P1315, DOI 10.1073/pnas.0709739105; Villard E, 1996, AM J HUM GENET, V58, P1268; WEI L, 1991, J BIOL CHEM, V266, P5540; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711	74	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8282	10.1371/journal.pone.0008282	http://dx.doi.org/10.1371/journal.pone.0008282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011602	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300034
J	Garbin, U; Fratta Pasini, A; Stranieri, C; Cominacini, M; Pasini, A; Manfro, S; Lugoboni, F; Mozzini, C; Guidi, G; Faccini, G; Cominacini, L				Garbin, Ulisse; Fratta Pasini, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Manfro, Stefania; Lugoboni, Fabio; Mozzini, Chiara; Guidi, GianCesare; Faccini, Giovanni; Cominacini, Luciano			Cigarette Smoking Blocks the Protective Expression of Nrf2/ARE Pathway in Peripheral Mononuclear Cells of Young Heavy Smokers Favouring Inflammation	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OBSTRUCTIVE PULMONARY-DISEASE; ELECTRON-SPIN-RESONANCE; NF-E2-RELATED FACTOR-2; OXIDIZED PHOSPHOLIPIDS; ENDOTHELIAL-CELLS; UNSTABLE ANGINA; FREE-RADICALS; IN-VIVO; KAPPA-B	Cigarette smoking is an important risk factor for atherosclerosis, a chronic inflammatory disease. However the underlying factors of this effect are unclear. It has been hypothesized that water-soluble components of cigarette smoke can directly promote oxidative stress in vasculature and blood cells. Aim of this study was to study the relationship between oxidative stress and inflammation in a group of young smokers. To do this we evaluated: 1) the oxidation products of phospholipids (oxPAPC) in peripheral blood mononuclear cells (PBMC); 2) their role in causing PBMC reactive oxygen species (ROS) generation and changes in GSH; 3) the expression of the transcription factor NF-E2-related factor 2 (Nrf2) and of related antioxidant genes ( ARE); 4) the activation of NF-kB and C-reactive protein (CRP) values. We studied 90 healthy volunteers: 32 non-smokers, 32 moderate smokers (5-10 cigarettes/day) and 26 heavy smokers (25-40 cigarettes/day). OxPAPC and p47phox expression, that reasonably reflects NADPH oxidase activity, were higher in moderate smokers and heavy smokers than in non-smokers (p<0.01), the highest values being in heavy smokers (p<0.01). In in vitro studies oxPAPC increased ROS generation via NADPH oxidase activation. GSH in PBMC and plasma was lower in moderate smokers and heavy smokers than in non-smokers (p<0.01), the lowest values being in heavy smokers (p<0.01). Nrf2 expression in PBMC was higher in moderate smokers than in non-smokers (p<0.01), but not in heavy smokers, who had the highest levels of NF-kB and CRP (p<0.01). In in vitro studies oxPAPC dose-dependently increased NF-kB activation, whereas at the highest concentrations Nrf2 expression was repressed. The small interference (si) RNA-mediated knockdown of NF-kappa B/p65 increased about three times the expression of Nrf2 stimulated with oxPAPC. Cigarette smoke promotes oxPAPC formation and oxidative stress in PBMC. This may cause the activation of NF-kB that in turn may participate in the negative regulation of Nrf2/ARE pathway favouring inflammation.	[Garbin, Ulisse; Fratta Pasini, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Manfro, Stefania; Mozzini, Chiara; Cominacini, Luciano] Univ Verona, Sect Internal Med, Dept Biomed & Surg Sci, I-37100 Verona, Italy; [Lugoboni, Fabio] Univ Hosp GB Rossi, Med Serv Addict Disorders, Verona, Italy; [Guidi, GianCesare; Faccini, Giovanni] Univ Verona, Dept Morphol & Biomed Sci, Sect Chem & Clin Microscopy, I-37100 Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Garbin, U (corresponding author), Univ Verona, Sect Internal Med, Dept Biomed & Surg Sci, I-37100 Verona, Italy.	luciano.cominacini@univr.it	mozzini, chiara/AAW-3028-2021; cominacini, luciano/B-2775-2011; Stranieri, Chiara/GWV-1749-2022	Guidi, Gian Cesare/0000-0002-4682-7834	Fondazione Cariverona, Verona, Italy; Ministry of University and Scientific Research of Italy	Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); Ministry of University and Scientific Research of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione Cariverona, Verona, Italy and by grants from the Ministry of University and Scientific Research of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Cominacini L, 2005, J AM COLL CARDIOL, V46, P799, DOI 10.1016/j.jacc.2005.05.063; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Fratta Pasini A, 2007, ARTERIOSCL THROM VAS, V27, P1991, DOI 10.1161/ATVBAHA.107.142695; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Garbin U, 2007, PHARMACOL RES, V56, P515, DOI 10.1016/j.phrs.2007.09.015; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V316, P969, DOI 10.1016/j.bbrc.2004.02.162; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; PRYOR WA, 1983, ENVIRON HEALTH PERSP, V47, P345, DOI 10.1289/ehp.8347345; Pryor WA, 1998, CHEM RES TOXICOL, V11, P441, DOI 10.1021/tx970159y; Rahman I, 1996, FREE RADICAL BIO MED, V21, P669, DOI 10.1016/0891-5849(96)00155-4; Rattazzi M, 2003, J HYPERTENS, V21, P1787, DOI 10.1097/00004872-200310000-00002; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Rouhanizadeh M, 2005, FREE RADICAL BIO MED, V39, P1512, DOI 10.1016/j.freeradbiomed.2005.07.013; Stadler N, 2007, ARTERIOSCL THROM VAS, V27, P120, DOI 10.1161/01.ATV.0000250614.97896.4c; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; ZANG LY, 1995, FREE RADICAL BIO MED, V19, P161, DOI 10.1016/0891-5849(94)00236-D	36	71	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8225	10.1371/journal.pone.0008225	http://dx.doi.org/10.1371/journal.pone.0008225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011043	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829800013
J	Glazer, CA; Smith, IM; Ochs, MF; Begum, S; Westra, W; Chang, SS; Sun, WY; Bhan, S; Khan, Z; Ahrendt, S; Califano, JA				Glazer, Chad A.; Smith, Ian M.; Ochs, Michael F.; Begum, Shahnaz; Westra, William; Chang, Steven S.; Sun, Wenyue; Bhan, Sheetal; Khan, Zubair; Ahrendt, Steven; Califano, Joseph A.			Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC	PLOS ONE			English	Article							DNA METHYLATION; CANCER/TESTIS ANTIGENS; EXPRESSION; GENES; CTCF; BORIS; 5-AZA-2'-DEOXYCYTIDINE; HYPOMETHYLATION; DEMETHYLATION; TRANSCRIPTION	Background: Cancer/testis antigens (CTAs) were first discovered as immunogenic targets normally expressed in germline cells, but differentially expressed in a variety of human cancers. In this study, we used an integrative epigenetic screening approach to identify coordinately expressed genes in human non-small cell lung cancer ( NSCLC) whose transcription is driven by promoter demethylation. Methodology/Principal Findings: Our screening approach found 290 significant genes from the over 47,000 transcripts incorporated in the Affymetrix Human Genome U133 Plus 2.0 expression array. Of the top 55 candidates, 10 showed both differential overexpression and promoter region hypomethylation in NSCLC. Surprisingly, 6 of the 10 genes discovered by this approach were CTAs. Using a separate cohort of primary tumor and normal tissue, we validated NSCLC promoter hypomethylation and increased expression by quantitative RT-PCR for all 10 genes. We noted significant, coordinated coexpression of multiple target genes, as well as coordinated promoter demethylation, in a large set of individual tumors that was associated with the SCC subtype of NSCLC. In addition, we identified 2 novel target genes that exhibited growth-promoting effects in multiple cell lines. Conclusions/Significance: Coordinated promoter demethylation in NSCLC is associated with aberrant expression of CTAs and potential, novel candidate protooncogenes that can be identified using integrative discovery techniques. These findings have significant implications for discovery of novel CTAs and CT antigen directed immunotherapy.	[Glazer, Chad A.; Smith, Ian M.; Chang, Steven S.; Sun, Wenyue; Bhan, Sheetal; Khan, Zubair; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Begum, Shahnaz; Westra, William] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ahrendt, Steven] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Greater Baltimore Medical Center	Glazer, CA (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu		Sun, Wenyue/0000-0003-1673-0895; Ahrendt, Steven/0000-0002-3029-2126	Flight Attendant Medical Research Institute; National Cancer Institute SPORE [5P50CA096784-05]; EDRN [U01CA084986]; NIH [T32]; NATIONAL CANCER INSTITUTE [U01CA084986, P50CA096784] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EDRN; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Califano is supported by a Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the National Cancer Institute SPORE (5P50CA096784-05) and EDRN U01CA084986. Dr. Glazer is funded in part by an NIH T32 Research Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin AJ, 2002, ANTI-CANCER DRUG, V13, P869, DOI 10.1097/00001813-200209000-00013; Bolli M, 2005, INT J CANCER, V115, P960, DOI 10.1002/ijc.20953; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Esteller M, 2002, SCIENCE, V297, P1807; Grunwald C, 2006, INT J CANCER, V118, P2522, DOI 10.1002/ijc.21669; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hirschowitz EA, 2006, J THORAC ONCOL, V1, P93, DOI 10.1097/01243894-200601000-00019; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hu LH, 2007, ANTI-CANCER DRUG, V18, P427, DOI 10.1097/CAD.0b013e328013d99e; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jungbluth AA, 2000, INT J CANCER, V85, P460, DOI 10.1002/(SICI)1097-0215(20000215)85:4<460::AID-IJC3>3.0.CO;2-N; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kang Y, 2007, ONCOGENE, V26, P4394, DOI 10.1038/sj.onc.1210218; Karanikas V, 2008, CANCER BIOL THER, V7, P345, DOI 10.4161/cbt.7.3.5424; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; Raez Luis E, 2006, Expert Opin Emerg Drugs, V11, P445, DOI 10.1517/14728214.11.3.445; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Sugita M, 2002, CANCER RES, V62, P3971; Tajima K, 2003, LUNG CANCER-J IASLC, V42, P23, DOI 10.1016/S0169-5002(03)00244-7; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsai JR, 2007, LUNG CANCER, V56, P185, DOI 10.1016/j.lungcan.2006.12.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; WEBER J, 1994, CANCER RES, V54, P1766; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5	43	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8189	10.1371/journal.pone.0008189	http://dx.doi.org/10.1371/journal.pone.0008189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997593	Green Published, Green Accepted, gold			2022-12-25	WOS:000272829200018
J	Bayley, JP; van Minderhout, I; Hogendoorn, PCW; Cornelisse, CJ; van der Wal, A; Prins, FA; Teppema, L; Dahan, A; Devilee, P; Taschner, PEM				Bayley, Jean-Pierre; van Minderhout, Ivonne; Hogendoorn, Pancras C. W.; Cornelisse, Cees J.; van der Wal, Annemieke; Prins, Frans A.; Teppema, Luc; Dahan, Albert; Devilee, Peter; Taschner, Peter E. M.			Sdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma	PLOS ONE			English	Article							SUCCINATE-DEHYDROGENASE; GENE; MUTATIONS; SYSTEM; H19	Background: Mitochondrial succinate dehydrogenase (SDH) is a component of both the tricarboxylic acid cycle and the electron transport chain. Mutations of SDHD, the first protein of intermediary metabolism shown to be involved in tumorigenesis, lead to the human tumors paraganglioma (PGL) and pheochromocytoma (PC). SDHD is remarkable in showing an 'imprinted' tumor suppressor phenotype. Mutations of SDHD show a very high penetrance in man and we postulated that knockout of Sdhd would lead to the development of PGL/PC, probably in aged mice. Methodology/Principal Findings: We generated a conventional knockout of Sdhd in the mouse, removing the entire third exon. We also crossed this mouse with a knockout of H19, a postulated imprinted modifier gene of Sdhd tumorigenesis, to evaluate if loss of these genes together would lead to the initiation or enhancement of tumor development. Homozygous knockout of Sdhd results in embryonic lethality. No paraganglioma or other tumor development was seen in Sdhd KO mice followed for their entire lifespan, in sharp contrast to the highly penetrant phenotype in humans. Heterozygous Sdhd KO mice did not show hyperplasia of paraganglioma-related tissues such as the carotid body or of the adrenal medulla, or any genotype-related pathology, with similar body and organ weights to wildtype mice. A cohort of Sdhd/H19 KO mice developed several cases of profound cardiac hypertrophy, but showed no evidence of PGL/PC. Conclusions: Knockout of Sdhd in the mouse does not result in a disease phenotype. H19 may not be an initiator of PGL/PC tumorigenesis.	[Bayley, Jean-Pierre; van Minderhout, Ivonne; Devilee, Peter; Taschner, Peter E. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Teppema, Luc; Dahan, Albert] Leiden Univ, Med Ctr, Dept Anaesthesiol, Leiden, Netherlands; [Hogendoorn, Pancras C. W.; Cornelisse, Cees J.; van der Wal, Annemieke; Prins, Frans A.; Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bayley, JP (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	j.p.l.bayley@lumc.nl	Dahan, Albert/B-8845-2008; Devilee, Peter/GXV-8005-2022; Hogendoorn, Pancras C.W./H-5859-2015; Hogendoorn, Pancras/O-6494-2019; DEVILEE, PETER/ABR-2140-2022; Taschner, Peter/J-8853-2014	Dahan, Albert/0000-0003-3161-3945; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Hogendoorn, Pancras/0000-0002-1513-8104; Taschner, Peter/0000-0001-9621-465X	Dutch Cancer Society [RUL2002-2723]; European Union [518200]	Dutch Cancer Society(KWF Kankerbestrijding); European Union(European Commission)	This work was supported by grants from the Dutch Cancer Society (Koningin Wilhelmina Fonds, RUL2002-2723) and the European Union 6th Framework Program (Project No: 518200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1999, CELL MOL BIOL, V45, P737; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benn DE, 2006, J CLIN ENDOCR METAB, V91, P827, DOI 10.1210/jc.2005-1862; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hensen EF, 2004, ONCOGENE, V23, P4076, DOI 10.1038/sj.onc.1207591; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Margetts CDE, 2005, ENDOCR-RELAT CANCER, V12, P161, DOI 10.1677/erc.1.00865; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Riemann K, 2004, CANCER GENET CYTOGEN, V150, P128, DOI 10.1016/j.cancergencyto.2003.10.013; VANDERMEY AGL, 1989, LANCET, V2, P1291; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105	16	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7987	10.1371/journal.pone.0007987	http://dx.doi.org/10.1371/journal.pone.0007987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956719	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500017
J	de Late, PL; Pepin, A; Assaf-Vandecasteele, H; Espinasse, C; Nicolas, V; Asselin-Labat, ML; Bertoglio, J; Pallardy, M; Biola-Vidamment, A				de Late, Perle Latre; Pepin, Aurelie; Assaf-Vandecasteele, Hind; Espinasse, Christophe; Nicolas, Valerie; Asselin-Labat, Marie-Liesse; Bertoglio, Jacques; Pallardy, Marc; Biola-Vidamment, Armelle			Glucocorticoid-induced Leucine Zipper (GILZ) Promotes the Nuclear Exclusion of FOXO3 in a Crm1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROTECTS T-LYMPHOCYTES; FAS-LIGAND EXPRESSION; INDUCED CELL-DEATH; FACTOR-KAPPA-B; FOXO3A-DEPENDENT REGULATION; OXIDATIVE-STRESS; GENE-EXPRESSION; ACTIVATION; BIM	GILZ (glucocorticoid-induced leucine zipper) is an ubiquitous protein whose expression is induced by glucocorticoids in lymphoid cells. We previously showed that GILZ expression is rapidly induced upon interleukin 2 deprivation in T-cells, protecting cells from apoptosis induced by forkhead box subgroup O3 (FOXO3). The aim of this work is to elucidate the molecular mechanism of FOXO factor inhibition by GILZ. We show in the myeloid cell line HL-60 and the lymphoid CTLL-2 T-cell line that GILZ down-regulates the expression of p27(KIP1) and Bim, two FOXO targets involved in cell cycle regulation and apoptosis, respectively. GILZ inhibits FOXO1, FOXO3, and FOXO4 transcriptional activities measured with natural or synthetic FOXO-responsive promoters in HL-60 cells. This inhibitory effect is independent of protein kinase B and I kappa B kinase phosphorylation sites. GILZ does not hinder FOXO3 DNA-binding activity and does not physically interact with FOXO3. However, using fluorescence microscopy, we observe that GILZ expression provokes a Crm-1-dependent nuclear exclusion of FOXO3 leading to its relocalization to the cytoplasm. Moreover, GILZ exclusive cytoplasmic localization is a prerequisite for FOXO3 inhibition and relocalization. We propose that GILZ is a general inhibitor of FOXO factors acting through an original mechanism by preventing them from reaching target genes within the nucleus.	[de Late, Perle Latre; Pepin, Aurelie; Assaf-Vandecasteele, Hind; Espinasse, Christophe; Asselin-Labat, Marie-Liesse; Bertoglio, Jacques; Pallardy, Marc; Biola-Vidamment, Armelle] Univ Paris 11, Fac Pharm, INSERM, UMR S 749, F-92296 Chatenay Malabry, France; [Nicolas, Valerie] Univ Paris 11, IFR141, ITFM, F-92296 Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Biola-Vidamment, A (corresponding author), Univ Paris 11, Fac Pharm, INSERM, UMR S 749, 5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.	armelle.biola-vidamment@u-psud.fr	Biola-Vidamment, Armelle/B-3735-2014; DE LATE, Perle LATRE/ABA-9692-2020	Biola-Vidamment, Armelle/0000-0003-1113-5851; LATRE DE LATE, Perle/0000-0003-3871-6277				Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Baumann S, 2003, ONCOGENE, V22, P1333, DOI 10.1038/sj.onc.1206126; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Biola A, 2001, MOL ENDOCRINOL, V15, P1062, DOI 10.1210/me.15.7.1062; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chow WA, 2000, J IMMUNOL, V164, P3512, DOI 10.4049/jimmunol.164.7.3512; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Redjimi N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-83; Savickiene J, 2004, ANN NY ACAD SCI, V1030, P569, DOI 10.1196/annals.1329.066; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Xiao S, 2001, EUR J IMMUNOL, V31, P3339, DOI 10.1002/1521-4141(200111)31:11<3339::AID-IMMU3339>3.0.CO;2-U; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353	40	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5594	5605		10.1074/jbc.M109.068346	http://dx.doi.org/10.1074/jbc.M109.068346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018851	Green Published, hybrid			2022-12-25	WOS:000275327200051
J	Ito, K; Katsuma, S; Yamamoto, K; Kadono-Okuda, K; Mita, K; Shimada, T				Ito, Katsuhiko; Katsuma, Susumu; Yamamoto, Kimiko; Kadono-Okuda, Keiko; Mita, Kazuei; Shimada, Toru			Yellow-e Determines the Color Pattern of Larval Head and Tail Spots of the Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILES; ROYAL JELLY PROTEINS; DROSOPHILA-YELLOW; FAMILY; CHROMOSOME; HONEYBEE; EBONY	Yellow proteins form a large family in insects. In Drosophila melanogaster, there are 14 yellow genes in the genome. Previous studies have shown that the yellow gene is necessary for normal pigmentation; however, the roles of other yellow genes in body coloration are not known. Here, we provide the first evidence that yellow-e is required for normal body color pattern in insect larvae. In two mutant strains, bts and its allele bts2, of the silkworm Bombyx mori, the larval head cuticle and anal plates are reddish brown instead of the white color found in the wild type. Positional cloning revealed that deletions in the Bombyx homolog of the Drosophila yellow-e gene (Bmyellow-e) were responsible for the bts/bts2 phenotype. Bmyellow-e mRNA was strongly expressed in the trachea, testis, and integument, and expression markedly increased at the molting stages. This profile is quite similar to that of Bmyellow, a regulator of neonatal body color and body markings in Bombyx. Quantitative reverse transcription-PCR analysis showed that Bmyellow-e mRNA was heavily expressed in the integument of the head and tail in which the bts phenotype is observed. The present results suggest that Yellow-e plays a crucial role in the pigmentation process of lepidopteran larvae.	[Ito, Katsuhiko; Katsuma, Susumu; Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Yamamoto, Kimiko; Kadono-Okuda, Keiko; Mita, Kazuei] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Shimada, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	shimada@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/A-2033-2011; Ito, Katsuhiko/B-8861-2015; Shimada, Toru/AAZ-2703-2021	Shimada, Toru/0000-0002-5791-0000; Ito, Katsuhiko/0000-0003-4464-1734; Shimada, Toru/0000-0002-5791-0000	Ministry of Education, Culture, Sports, Science and Technology [17018007]; MAFF-NIAS; National BioResource Project; Japan Science and Technology Agency, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MAFF-NIAS; National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (17018007), MAFF-NIAS (Agrigenome Research Program), National BioResource Project, and Japan Science and Technology Agency (Professional Program for Agricultural Bioinformatics), Japan.	Abe H, 2005, INSECT MOL BIOL, V14, P339, DOI 10.1111/j.1365-2583.2005.00565.x; Banno Y., 2005, GUIDE SILKWORM MUTAN, P1; CHIKUSHI H, 1960, J SERIC SCI JPN, V29, P278; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Daimon T, 2005, INSECT BIOCHEM MOLEC, V35, P1112, DOI 10.1016/j.ibmb.2005.05.005; Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196; Drapeau MD, 2001, BIOCHEM BIOPH RES CO, V281, P611, DOI 10.1006/bbrc.2001.4391; Eguchi R., 2007, Sanshi Konchuu Biotec (Journal of Insect Biotechnology and Sericology), V76, P159; FUJII H, 1998, GENETICAL STOCKS MUT, P1; Fujii T, 2009, GENES GENET SYST, V84, P147, DOI 10.1266/ggs.84.147; Fujii T, 2008, INSECT BIOCHEM MOLEC, V38, P1072, DOI 10.1016/j.ibmb.2008.03.004; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Han D, 2002, BIOCHEM J, V368, P333; Ito K, 2008, P NATL ACAD SCI USA, V105, P7523, DOI 10.1073/pnas.0711841105; Ito K, 2009, INSECT BIOCHEM MOLEC, V39, P287, DOI 10.1016/j.ibmb.2009.01.005; Maleszka R, 2000, BIOCHEM BIOPH RES CO, V270, P773, DOI 10.1006/bbrc.2000.2506; Meng Y, 2009, GENES CELLS, V14, P129, DOI 10.1111/j.1365-2443.2008.01257.x; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Ote M, 2004, INSECT BIOCHEM MOLEC, V34, P775, DOI 10.1016/j.ibmb.2004.04.002; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21	30	35	40	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5624	5629		10.1074/jbc.M109.035741	http://dx.doi.org/10.1074/jbc.M109.035741			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996320	Green Published, hybrid			2022-12-25	WOS:000275327200054
J	Lowe, JM; Cha, H; Yang, Q; Fornace, AJ				Lowe, Julie M.; Cha, Hyukjin; Yang, Qian; Fornace, Albert J., Jr.			Nuclear Factor-kappa B (NF-kappa B) Is a Novel Positive Transcriptional Regulator of the Oncogenic Wip1 Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZING-RADIATION; INDUCED APOPTOSIS; P38 MAPK; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; CELLS; CANCER; P53; TUMORIGENESIS; INHIBITION	The nuclear factor-kappa B (NF-kappa B) family of transcription factors plays a key role in inflammation and augments the initiation, promotion, and progression of cancer. NF-kappa B activation generally leads to transcriptional enhancement of genes important in cell survival and cell growth, which is exploited in cancer cells. In this study, we identify an additional oncogene, PPM1D, which encodes for Wip1, as a transcriptional target of NF-kappa B in breast cancer cells. Inhibition of NF-kappa B or activation of NF-kappa B resulted in decreased or increased Wip1 expression, respectively, at both the mRNA and protein levels. PPM1D promoter activity was positively regulated by NF-kappa B, and this regulation was dependent on the presence of the conserved kappa B site in the PPM1D promoter region. Chromatin immunoprecipitation analysis showed basal binding of the p65 NF-kappa B subunit to the PPM1D promoter region encompassing the kappa B site, which is enhanced after NF-kappa B activation by tumor necrosis factor-kappa. Finally, we show that Wip1 expression is induced in lipopolysaccharide- stimulated mouse splenic B-cells and is required for maximum proliferation. Taken together, these data suggest an additional mechanism by which NF-kappa B may promote tumorigenesis, support the selective use of NF-kappa B inhibitors as chemotherapeutic agents for the treatment of human cancers, and further define a function for Wip1 in inflammation.	[Lowe, Julie M.; Yang, Qian; Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Fornace, Albert J., Jr.] Dankook Univ, Cheonan Chungnam 330714, South Korea; [Cha, Hyukjin] Pochon CHA Univ, Coll Med, Cha Stem Cell Inst, Seoul 135081, South Korea	Georgetown University; Dankook University; Pochon Cha University	Fornace, AJ (corresponding author), New Res Bldg,E504,3970 Reservoir Rd NW, Washington, DC 20057 USA.	af294@georgetown.edu	Cha, Hyuk-Jin/AAB-8508-2020; Fornace, Albert/A-7407-2008	Cha, Hyuk-Jin/0000-0001-9277-2662; Fornace, Albert/0000-0001-9695-085X	Ministry of Education, Science and Technology [R31-10069]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was partially supported by Grant R31-10069 (WCU program) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Aravindan N, 2008, CANCER BIOL THER, V7, P569, DOI 10.4161/cbt.7.4.5534; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chen XF, 2002, CANCER RES, V62, P1213; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Doman RK, 1999, J INTERF CYTOK RES, V19, P261, DOI 10.1089/107999099314199; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujioka S, 2004, J BIOL CHEM, V279, P27549, DOI 10.1074/jbc.M313435200; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kong WH, 2009, CANCER BIOL THER, V8, P555, DOI 10.4161/cbt.8.6.7742; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Munshi A, 2004, MOL CANCER THER, V3, P985; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parssinen J, 2008, CANCER GENET CYTOGEN, V182, P33, DOI 10.1016/j.cancergencyto.2007.12.013; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; Tanaka A, 2005, BLOOD, V105, P2324, DOI 10.1182/blood-2004-08-3247; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tsuboi Y, 2009, J NEUROSURG, V110, P594, DOI 10.3171/2008.8.JNS17648; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Yu E, 2007, BREAST CANCER RES TR, V101, P269, DOI 10.1007/s10549-006-9304-y	50	48	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5249	5257		10.1074/jbc.M109.034579	http://dx.doi.org/10.1074/jbc.M109.034579			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007970	Green Published, hybrid			2022-12-25	WOS:000275327200018
J	Mazhab-Jafari, MT; Marshall, CB; Smith, M; Gasmi-Seabrook, GMC; Stambolic, V; Rottapel, R; Neel, BG; Ikura, M				Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Smith, Matthew; Gasmi-Seabrook, Genevieve M. C.; Stambolic, Vuk; Rottapel, Robert; Neel, Benjamin G.; Ikura, Mitsuhiko			Real-time NMR Study of Three Small GTPases Reveals That Fluorescent 2 '(3 ')-O-(N-Methylanthraniloyl)-tagged Nucleotides Alter Hydrolysis and Exchange Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS ACTIVATOR SON; GTP HYDROLYSIS; CRYSTAL-STRUCTURE; BINDING PROTEINS; STRUCTURAL BASIS; RHOA; MECHANISM; SEVENLESS; NEUROFIBROMIN; PRODUCT	The Ras family of small GTPases control diverse signaling pathways through a conserved "switch" mechanism, which is turned on by binding of GTP and turned off by GTP hydrolysis to GDP. Full understanding of GTPase switch functions requires reliable, quantitative assays for nucleotide binding and hydrolysis. Fluorescently labeled guanine nucleotides, such as 2'(3')-O-(N-methylanthraniloyl) (mant)-substituted GTP and GDP analogs, have been widely used to investigate the molecular properties of small GTPases, including Ras and Rho. Using a recently developed NMR method, we show that the kinetics of nucleotide hydrolysis and exchange by three small GTPases, alone and in the presence of their cognate GTPase-activating proteins ( GAPs) and guanine nucleotide exchange factors, are affected by the presence of the fluorescent mant moiety. Intrinsic hydrolysis of mantGTP by Ras homolog enriched in brain (Rheb) is similar to 10 times faster than that of GTP, whereas it is 3.4 times slower with RhoA. On the other hand, the mant tag inhibits TSC2GAP-catalyzed GTP hydrolysis by Rheb but promotes p120 RasGAP-catalyzed GTP hydrolysis by H-Ras. Guanine nucleotide exchange factor-catalyzed nucleotide exchange for both H-Ras and RhoA was inhibited by mant-substituted nucleotides, and the degree of inhibition depends highly on the GTPase and whether the assay measures association of mantGTP with, or dissociation of mantGDP from the GTPase. These results indicate that the mant moiety has significant and unpredictable effects on GTPase reaction kinetics and underscore the importance of validating its use in each assay.	[Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Smith, Matthew; Gasmi-Seabrook, Genevieve M. C.; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Hlth Network, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Rottapel, Robert; Neel, Benjamin G.] Univ Hlth Network, Ontario Canc Inst, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Smith, Matthew; Gasmi-Seabrook, Genevieve M. C.; Stambolic, Vuk; Rottapel, Robert; Neel, Benjamin G.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), Univ Hlth Network, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca	Smith, Matthew J/AAI-8060-2020; Marshall, Christopher/K-8943-2019	Smith, Matthew J/0000-0003-2896-9350; Marshall, Christopher/0000-0002-7571-5700; Smith, Matthew/0000-0002-9436-2592; Ikura, Mitsuhiko/0000-0002-9524-1303; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877; Rottapel, Robert/0000-0002-6024-5558; Stambolic, Vuk/0000-0001-8853-3239	Cancer Research Society (Canada); United States Department of Defense Tuberous Sclerosis Complex Research	Cancer Research Society (Canada); United States Department of Defense Tuberous Sclerosis Complex Research	This work was supported by grants from the Cancer Research Society (Canada) and a United States Department of Defense Tuberous Sclerosis Complex Research Program Award ( to V. S.).	Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Albert S, 2000, BIOL CHEM, V381, P453, DOI 10.1515/BC.2000.059; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Eberth A, 2005, BIOL CHEM, V386, P1105, DOI 10.1515/BC.2005.127; Ford B, 2006, STRUCTURE, V14, P427, DOI 10.1016/j.str.2005.12.010; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Goddard T. D., SPARKY3; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; NEAL SE, 1990, P NATL ACAD SCI USA, V87, P3562, DOI 10.1073/pnas.87.9.3562; Oleksy A, 2004, ACTA CRYSTALLOGR D, V60, P740, DOI 10.1107/S0907444904002318; Phillips RA, 2003, BIOCHEMISTRY-US, V42, P3956, DOI 10.1021/bi027316z; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Sacco E, 2006, FEBS LETT, V580, P6322, DOI 10.1016/j.febslet.2006.10.040; SCHEIDIG AJ, 1995, J MOL BIOL, V253, P132, DOI 10.1006/jmbi.1995.0541; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spessard GO, 1998, J CHEM INF COMP SCI, V38, P1250, DOI 10.1021/ci980264t; Tan YC, 2002, ANAL BIOCHEM, V310, P156, DOI 10.1016/S0003-2697(02)00382-2; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang BL, 1998, BIOCHEMISTRY-US, V37, P5249, DOI 10.1021/bi9718447	31	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5132	5136		10.1074/jbc.C109.064766	http://dx.doi.org/10.1074/jbc.C109.064766			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018863	Green Published, hybrid			2022-12-25	WOS:000275327200004
J	Dai, SP; Sodhi, C; Cetin, S; Richardson, W; Branca, M; Neal, MD; Prindle, T; Ma, C; Shapiro, RA; Li, B; Wang, JHC; Hackam, DJ				Dai, Shipan; Sodhi, Chhinder; Cetin, Selma; Richardson, Ward; Branca, Maria; Neal, Matthew D.; Prindle, Thomas; Ma, Congrong; Shapiro, Richard A.; Li, Bin; Wang, James H. -C.; Hackam, David J.			Extracellular High Mobility Group Box-1 (HMGB1) Inhibits Enterocyte Migration via Activation of Toll-like Receptor-4 and Increased Cell-Matrix Adhesiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROTIZING ENTEROCOLITIS; EPITHELIAL RESTITUTION; TRACTION FORCE; PROTEIN; TLR4; PATHOGENESIS; EXPRESSION; MEDIATOR; MICE; HMG-1	Toll-like receptor-4 (TLR4) is the receptor for bacterial lipopolysaccharide, yet it may also respond to a variety of endogenous molecules. Necrotizing enterocolitis (NEC) is the leading cause of death from gastrointestinal disease in newborn infants and is characterized by intestinal mucosal destruction and impaired enterocyte migration due to increased TLR4 signaling on enterocytes. The endogenous ligands for TLR4 that lead to impaired enterocyte migration remain unknown. High mobility group box-1 (HMGB1) is a DNA-binding protein that is released from injured cells during inflammation. We thus hypothesize that extracellular HMGB1 inhibits enterocyte migration via activation of TLR4 and sought to define the pathways involved. We now demonstrate that murine and human NEC are associated with increased intestinal HMGB1 expression, that serum HMGB1 is increased in murine NEC, and that HMGB1 inhibits enterocyte migration in vitro and in vivo in a TLR4-dependent manner. This finding was unique to enterocytes as HMGB1 enhanced migration of inflammatory cells in vitro and in vivo. In seeking to understand the mechanisms involved, TLR4-dependent HMGB1 signaling increased RhoA activation in enterocytes, increased phosphorylation of focal adhesion kinase, and increased phosphorylation of cofilin, resulting in increased stress fibers and focal adhesions. Using single cell force traction microscopy, the net effect of HMGB1 signaling was a TLR4-dependent increase in cell force adhesion, accounting for the impaired enterocyte migration. These findings demonstrate a novel pathway by which TLR4 activation by HMGB1 delays mucosal repair and suggest a novel potential therapeutic target in the amelioration of intestinal inflammatory diseases like NEC.	[Dai, Shipan; Sodhi, Chhinder; Cetin, Selma; Richardson, Ward; Branca, Maria; Neal, Matthew D.; Prindle, Thomas; Ma, Congrong; Hackam, David J.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Surg, Pittsburgh, PA 15207 USA; [Dai, Shipan; Sodhi, Chhinder; Richardson, Ward; Neal, Matthew D.; Shapiro, Richard A.; Hackam, David J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15207 USA; [Li, Bin; Wang, James H. -C.] Univ Pittsburgh, Sch Med, Dept Orthoped Surg, Pittsburgh, PA 15207 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hackam, DJ (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Surg, 45th St & Penn Ave, Pittsburgh, PA 15207 USA.	david.hackam@chp.edu	Neal, Matthew/GMW-5601-2022; Li, Bin/B-7802-2012	Neal, Matthew/0000-0001-8931-6236; Hackam, David/0000-0001-5195-8807	National Institutes of Health [R01-GM078238, RO1-DK083752]; Hartwell Foundation, Memphis, TN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation, Memphis, TN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM078238 and RO1-DK083752 ( to D.J.H.) and The Hartwell Foundation, Memphis, TN.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Bailly M, 2003, CURR BIOL, V13, pR128, DOI 10.1016/S0960-9822(03)00072-1; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Leaphart CL, 2007, GASTROENTEROLOGY, V132, P2395, DOI 10.1053/j.gastro.2007.03.029; Ngamkitidechakul C, 2002, BIOTECHNIQUES, V33, P1296, DOI 10.2144/02336pt02; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi FG, 2005, GASTROENTEROLOGY, V128, P1012, DOI 10.1053/j.gastro.2005.01.052; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Zamora R, 2005, AM J PHYSIOL-GASTR L, V289, pG643, DOI 10.1152/ajpgi.00067.2005	23	55	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4995	5002		10.1074/jbc.M109.067454	http://dx.doi.org/10.1074/jbc.M109.067454			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007974	Green Published, hybrid			2022-12-25	WOS:000275274800076
J	Price, CE; Driessen, AJM				Price, Claire E.; Driessen, Arnold J. M.			Conserved Negative Charges in the Transmembrane Segments of Subunit K of the NADH:Ubiquinone Oxidoreductase Determine Its Dependence on YidC for Membrane Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; INNER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; PROTEIN INSERTION; F1FO-ATP SYNTHASE; ATP SYNTHASE; NUCLEAR GENE; COMPLEX-I; BIOGENESIS	All members of the Oxa1/Alb3/YidC family have been implicated in the biogenesis of respiratory and energy transducing proteins. In Escherichia coli, YidC functions together with and independently of the Sec system. Although the range of proteins shown to be dependent on YidC continues to increase, the exact role of YidC in insertion remains enigmatic. Here we show that YidC is essential for the insertion of subunit K of the NADH: ubiquinone oxidoreductase and that the dependence is due to the presence of two conserved glutamate residues in the transmembrane segments of subunit K. The results suggest a model in which YidC serves as a membrane chaperone for the insertion of the less hydrophobic, negatively charged transmembrane segments of NuoK.	Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands; Univ Groningen, Kluyver Ctr Genom Ind Fermentat, NL-9751 NN Haren, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Proteomics Centre	Netherlands Proteomics Centre	This work was supported by a grant from the Netherlands Proteomics Centre.	Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; CAO GQ, 1994, EMBO J, V13, P4662, DOI 10.1002/j.1460-2075.1994.tb06789.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Celebi N, 2008, J MOL BIOL, V375, P1282, DOI 10.1016/j.jmb.2007.11.054; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; JANS DA, 1983, BIOCHEM J, V211, P717, DOI 10.1042/bj2110717; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Kol S, 2006, J BIOL CHEM, V281, P29762, DOI 10.1074/jbc.M605317200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Meyer W, 1997, CURR GENET, V31, P401, DOI 10.1007/s002940050222; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Pohlschroder M, 2005, ANNU REV MICROBIOL, V59, P91, DOI 10.1146/annurev.micro.59.030804.121353; Price CE, 2008, J BIOL CHEM, V283, P26921, DOI 10.1074/jbc.M804490200; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; Saint-Georges Y, 2001, P NATL ACAD SCI USA, V98, P13814, DOI 10.1073/pnas.251503098; Saller MJ, 2009, J BACTERIOL, V191, P6749, DOI 10.1128/JB.00853-09; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Schneider D, 2008, BBA-BIOENERGETICS, V1777, P735, DOI 10.1016/j.bbabio.2008.03.003; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Sellem CH, 2005, GENETICS, V169, P1379, DOI 10.1534/genetics.104.033837; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WACHTER E, 1980, FEBS LETT, V113, P265, DOI 10.1016/0014-5793(80)80606-5; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yu Z, 2008, J BIOL CHEM, V283, P34635, DOI 10.1074/jbc.M804344200	50	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3575	3581		10.1074/jbc.M109.051128	http://dx.doi.org/10.1074/jbc.M109.051128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959836	Green Published, hybrid			2022-12-25	WOS:000275254000008
J	Cooksey, AM; Momen, N; Stocker, R; Burgess, SC				Cooksey, Amanda M.; Momen, Nausheen; Stocker, Russell; Burgess, Shane C.			Identifying Blood Biomarkers and Physiological Processes That Distinguish Humans with Superior Performance under Psychological Stress	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; TRANSGENIC MICE; SERUM RETINOL-BINDING-PROTEIN-4; PLASMA; PROTEOMICS; PROTEIN; HYPERLIPIDEMIA; ASSOCIATION; COAGULATION; INHIBITION	Background: Attrition of students from aviation training is a serious financial and operational concern for the U. S. Navy. Each late stage navy aviator training failure costs the taxpayer over $1,000,000 and ultimately results in decreased operational readiness of the fleet. Currently, potential aviators are selected based on the Aviation Selection Test Battery (ASTB), which is a series of multiple-choice tests that evaluate basic and aviation-related knowledge and ability. However, the ASTB does not evaluate a person's response to stress. This is important because operating sophisticated aircraft demands exceptional performance and causes high psychological stress. Some people are more resistant to this type of stress, and consequently better able to cope with the demands of naval aviation, than others. Methodology/Principal Findings: Although many psychological studies have examined psychological stress resistance none have taken advantage of the human genome sequence. Here we use high-throughput -omic biology methods and a novel statistical data normalization method to identify plasma proteins associated with human performance under psychological stress. We identified proteins involved in four basic physiological processes: innate immunity, cardiac function, coagulation and plasma lipid physiology. Conclusions/Significance: The proteins identified here further elucidate the physiological response to psychological stress and suggest a hypothesis that stress-susceptible pilots may be more prone to shock. This work also provides potential biomarkers for screening humans for capability of superior performance under stress.	[Cooksey, Amanda M.; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Cooksey, Amanda M.; Burgess, Shane C.] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Cooksey, Amanda M.; Burgess, Shane C.] Mississippi State Univ, Inst Digital Biol, Mississippi State, MS 39762 USA; [Momen, Nausheen] Naval Aerosp Med Res Lab, Pensacola, FL USA; [Momen, Nausheen] Navy Recruiting Dist, Boston, MA USA; [Stocker, Russell] Mississippi State Univ, Dept Math & Stat, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Cooksey, AM (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	acooksey@mafes.msstate.edu			USDA [2003-34506-13768]	USDA(United States Department of Agriculture (USDA))	This work was supported by USDA grant number 2003-34506-13768 (http://www.csrees.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLIGAND JL, 1993, P NATL ACAD SCI USA, V90, P347, DOI 10.1073/pnas.90.1.347; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Bierhaus A, 2006, ANESTHESIOL CLIN N A, V24, P325, DOI 10.1016/j.atc.2006.01.001; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; ENDRESEN IM, 1991, BEHAV MED, V17, P167, DOI 10.1080/08964289.1991.9935168; Erikstrup C, 2006, NEW ENGL J MED, V355, P1393; FRANK LH, 1993, P 35 ANN C MIL TEST, V35, P14; Fujita Y, 2004, J HUM GENET, V49, P24, DOI 10.1007/s10038-003-0101-8; HORACKOVA M, 1995, AM J PHYSIOL-CELL PH, V269, pC504, DOI 10.1152/ajpcell.1995.269.2.C504; Hortin GL, 2006, CLIN CHEM, V52, P1218, DOI 10.1373/clinchem.2006.067280; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Jong MC, 1999, BIOCHEM J, V338, P281, DOI 10.1042/0264-6021:3380281; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; KUSHWAHA RS, 1993, J LIPID RES, V34, P1285; Lee DC, 2007, METABOLISM, V56, P327, DOI 10.1016/j.metabol.2006.10.011; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; McCarthy FM, 2007, NUCLEIC ACIDS RES, V35, pD599, DOI 10.1093/nar/gkl936; Hermsdorff HHM, 2009, NUTRITION, V25, P392, DOI 10.1016/j.nut.2008.09.015; Nanduri B, 2008, PROTEOMICS, V8, P2104, DOI 10.1002/pmic.200701048; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SCHEDLOWSKI M, 1992, LIFE SCI, V50, P1201, DOI 10.1016/0024-3205(92)90319-K; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Soutar A K, 1978, Scand J Clin Lab Invest Suppl, V150, P53; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stoney CM, 1999, HEALTH PSYCHOL, V18, P251, DOI 10.1037/0278-6133.18.3.251; Swarnakar S, 2001, J BIOL CHEM, V276, P21121, DOI 10.1074/jbc.M101691200; TAKAHASHI H, 1990, AM J HEMATOL, V33, P90, DOI 10.1002/ajh.2830330204; Takashima N, 2006, NEW ENGL J MED, V355, P1392; von Kanel R, 2001, PSYCHOSOM MED, V63, P531, DOI 10.1097/00006842-200107000-00003; Wirtz PH, 2006, PSYCHOSOM MED, V68, P851, DOI 10.1097/01.psy.0000245866.03456.aa; Yoshida A, 2006, J ATHEROSCLER THROMB, V13, P209, DOI 10.5551/jat.13.209	35	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8371	10.1371/journal.pone.0008371	http://dx.doi.org/10.1371/journal.pone.0008371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020041	Green Submitted, Green Published, gold			2022-12-25	WOS:000272870600011
J	Singh, RK; Lau, D; Noviello, CM; Ghosh, P; Guatelli, JC				Singh, Rajendra Kumar; Lau, David; Noviello, Colleen M.; Ghosh, Partho; Guatelli, John C.			An MHC-I Cytoplasmic Domain/HIV-1 Nef Fusion Protein Binds Directly to the mu Subunit of the AP-1 Endosomal Coat Complex	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; CELL-SURFACE CD4; HIV-1 NEF; DOWN-REGULATION; STRUCTURAL EXPLANATION; RECOGNITION; MOTIF	Background: The down-regulation of the major histocompatibility complex class I (MHC-I) from the surface of infected cells by the Nef proteins of primate immunodeficiency viruses likely contributes to pathogenesis by providing evasion of cell-mediated immunity. HIV-1 Nef-induced down-regulation involves endosomal trafficking and a cooperative interaction between the cytoplasmic domain (CD) of MHC-I, Nef, and the clathrin adaptor protein complex-1 (AP-1). The CD of MHC-I contains a key tyrosine within the sequence YSQA that is required for down-regulation by Nef, but this sequence does not conform to the canonical AP-binding tyrosine-based motif Yxx phi, which mediates binding to the medium (mu) subunits of AP complexes. We previously proposed that Nef allows the MHC-I CD to bind the mu subunit of AP-1 (mu 1) as if it contained a Yxx phi motif. Methods and Findings: Here, we show that a direct interaction between the MHC-I CD/Nef and mu 1 plays a primary role in the down-regulation of MHC-I: GST pulldown assays using recombinant proteins indicated that most of the MHC-I CD and Nef residues that are required for the down-regulation in human cells contribute to direct interactions with a truncated version of mu 1. Specifically, the tyrosine residue of the YSQA sequence in the MHC-I CD as well as Nef residues E62-65 and P78 each contributed to the interaction between MHC-I CD/Nef and mu 1 in vitro, whereas Nef M20 had little to no role. Conversely, residues F172/D174 and V392/L395 of the binding pocket on mu 1 for Yxx phi motifs were required for a robust interaction. Conclusions: These data indicate that the MHC-I cytoplasmic domain, Nef, and the C-terminal two thirds of the mu subunit of AP-1 are sufficient to constitute a biologically relevant interaction. The data also reveal an unexpected role for a hydrophobic pocket in mu 1 for interaction with MHC-I CD/Nef.	[Singh, Rajendra Kumar; Lau, David; Noviello, Colleen M.; Guatelli, John C.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Guatelli, John C.] San Diego Vet Affair Healthcare Syst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Singh, RK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	rajendra84@hotmail.com			National Institutes of Health [AI 076040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health AI 076040 to JCG and a post doctoral research fellowship award from the California HIV/AIDS Research Program (http://www.californiaaidsresearch.org) to RKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; KAMINCHIK J, 1991, J VIROL, V65, P583, DOI 10.1128/JVI.65.2.583-588.1991; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Riggs NL, 1999, VIROLOGY, V258, P203, DOI 10.1006/viro.1999.9736; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200	22	29	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8364	10.1371/journal.pone.0008364	http://dx.doi.org/10.1371/journal.pone.0008364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020046	Green Published, Green Submitted, gold			2022-12-25	WOS:000272870600007
J	Dang, TMH; Nguyen, TNL; Wolbers, M; Tran, ND; Nguyen, DQ; Tran, TVT; Le, THN; Nguyen, TNA; Tran, VQ; Nguyen, TBT; Vo, TH; Day, J; Hoang, TTH; Vo, SK; Nguyen, TN; Dai, VH; Nguyen, HD; Nguyen, HL; Farrar, J; Caws, M				Dang Thi Minh Ha; Nguyen Thi Ngoc Lan; Wolbers, Marcel; Tran Ngoc Duong; Nguyen Dang Quang; Tran Thi Van Thinh; Le Thi Hong Ngoc; Nguyen Thi Ngoc Anh; Tran Van Quyet; Nguyen Thi Bich Tuyen; Vo Thi Ha; Day, Jeremy; Hoang Thi Thanh Hang; Vo Sy Kiet; Nguyen Thi Nho; Dai Viet Hoa; Nguyen Huy Dung; Nguyen Huu Lan; Farrar, Jeremy; Caws, Maxine			Microscopic Observation Drug Susceptibility Assay (MODS) for Early Diagnosis of Tuberculosis in Children	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS	MODS is a novel liquid culture based technique that has been shown to be effective and rapid for early diagnosis of tuberculosis (TB). We evaluated the MODS assay for diagnosis of TB in children in Viet Nam. 217 consecutive samples including sputum (n = 132), gastric fluid (n = 50), CSF (n = 32) and pleural fluid (n = 3) collected from 96 children with suspected TB, were tested by smear, MODS and MGIT. When test results were aggregated by patient, the sensitivity and specificity of smear, MGIT and MODS against "clinical diagnosis'' (confirmed and probable groups) as the gold standard were 28.2% and 100%, 42.3% and 100%, 39.7% and 94.4%, respectively. The sensitivity of MGIT and MODS was not significantly different in this analysis (P = 0.5), but MGIT was more sensitive than MODS when analysed on the sample level using a marginal model (P = 0.03). The median time to detection of MODS and MGIT were 8 days and 13 days, respectively, and the time to detection was significantly shorter for MODS in samples where both tests were positive (P<0.001). An analysis of time-dependent sensitivity showed that the detection rates were significantly higher for MODS than for MGIT by day 7 or day 14 (P<0.001 and P = 0.04), respectively. MODS is a rapid and sensitive alternative method for the isolation of M. tuberculosis from children.	[Dang Thi Minh Ha; Nguyen Thi Ngoc Lan; Tran Ngoc Duong; Nguyen Dang Quang; Tran Thi Van Thinh; Le Thi Hong Ngoc; Nguyen Thi Ngoc Anh; Tran Van Quyet; Nguyen Thi Bich Tuyen; Vo Thi Ha; Nguyen Thi Nho; Dai Viet Hoa; Nguyen Huy Dung; Nguyen Huu Lan] Pham Ngoc Thach Hosp, TB Dept, Ho Chi Minh City, Vietnam; [Dang Thi Minh Ha; Wolbers, Marcel; Day, Jeremy; Hoang Thi Thanh Hang; Vo Sy Kiet; Farrar, Jeremy; Caws, Maxine] Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Dang Thi Minh Ha; Wolbers, Marcel; Day, Jeremy; Hoang Thi Thanh Hang; Vo Sy Kiet; Farrar, Jeremy; Caws, Maxine] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford	Dang, TMH (corresponding author), Pham Ngoc Thach Hosp, TB Dept, Ho Chi Minh City, Vietnam.	hadtm@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Caws, Maxine/0000-0002-9109-350X; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust of Great Britain	Wellcome Trust of Great Britain(Wellcome Trust)	This study was supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinza Nicoleta, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P65; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Caws M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001173; Gray JW, 2004, CLIN BIOCHEM, V37, P450, DOI 10.1016/j.clinbiochem.2004.03.003; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4750-4752.2002; PEPE, 2004, STAT EVALUATION MED; Raqib R, 2009, CLIN VACCINE IMMUNOL, V16, P521, DOI 10.1128/CVI.00391-08; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; STOP TB, 2006, WHOHTMTB2006371; Stop TB Partnership Childhood TB Subgroup World Health Organization, 2006, Int J Tuberc Lung Dis, V10, P1091; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2005, J INFECT DIS, V192, P79, DOI 10.1086/430616; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; *WHO, 2009, GLOB TUB CONTR EP ST, P161; *WHO GLOB TUB PROG, WHOTB98258 GLOB TUB	18	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8341	10.1371/journal.pone.0008341	http://dx.doi.org/10.1371/journal.pone.0008341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020056	gold, Green Published, Green Submitted			2022-12-25	WOS:000272834200008
J	Demina, GR; Makarov, VA; Nikitushkin, VD; Ryabova, OB; Vostroknutova, GN; Salina, EG; Shleeva, MO; Goncharenko, AV; Kaprelyants, AS				Demina, Galina R.; Makarov, Vadim A.; Nikitushkin, Vadim D.; Ryabova, Olga B.; Vostroknutova, Galina N.; Salina, Elena G.; Shleeva, Margarita O.; Goncharenko, Anna V.; Kaprelyants, Arseny S.			Finding of the Low Molecular Weight Inhibitors of Resuscitation Promoting Factor Enzymatic and Resuscitation Activity	PLOS ONE			English	Article							NON-CULTURABLE CELLS; MYCOBACTERIUM-TUBERCULOSIS; STATIONARY-PHASE; IN-VITRO; GROWTH; RPF; FAMILY; DOMAIN; REACTIVATION; PROTEINS	Background: Resuscitation promoting factors (RPF) are secreted proteins involved in reactivation of dormant actinobacteria, including Mycobacterium tuberculosis. They have been considered as prospective targets for the development of new antituberculosis drugs preventing reactivation of dormant tubercle bacilli, generally associated with latent tuberculosis. However, no inhibitors of Rpf activity have been reported so far. The goal of this study was to find low molecular weight compounds inhibiting the enzymatic and biological activities of Rpfs. Methodology/Principal Findings: Here we describe a novel class of 2-nitrophenylthiocyanates (NPT) compounds that inhibit muralytic activity of Rpfs with IC(50) 1-7 mu g/ml. Fluorescence studies revealed interaction of active NPTs with the internal regions of the Rpf molecule. Candidate inhibitors of Rpf enzymatic activity showed a bacteriostatic effect on growth of Micrococcus luteus (in which Rpf is essential for growth protein) at concentrations close to IC50. The candidate compounds suppressed resuscitation of dormant ("non-culturable'') cells of M. smegmatis at 1 mu g/ml or delayed resuscitation of dormant M. tuberculosis obtained in laboratory conditions at 10 mg/ml. However, they did not inhibit growth of active mycobacteria under these concentrations. Conclusions/Significance: NPT are the first example of low molecular weight compounds that inhibit the enzymatic and biological activities of Rpf proteins.	[Demina, Galina R.; Makarov, Vadim A.; Nikitushkin, Vadim D.; Ryabova, Olga B.; Vostroknutova, Galina N.; Salina, Elena G.; Shleeva, Margarita O.; Goncharenko, Anna V.; Kaprelyants, Arseny S.] RAS, AN Bach Inst Biochem, Moscow 117901, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Demina, GR (corresponding author), RAS, AN Bach Inst Biochem, Moscow 117901, Russia.	arseny@inbi.ras.ru	Makarov, Vadim/HGB-7756-2022; Makarov, Vadim/AAE-5483-2021; Nikitushkin, Vadim D./N-6426-2016; Shleeva, Margarita/ADL-9159-2022; Riabova, Olga/K-6030-2015	Makarov, Vadim/0000-0001-8746-2694; Makarov, Vadim/0000-0001-8746-2694; Riabova, Olga/0000-0002-3794-6495	Molecular and Cellular Biology; Russian Academy of Sciences; EU	Molecular and Cellular Biology; Russian Academy of Sciences(Russian Academy of Sciences); EU(European Commission)	This study has received funding from the Programme Molecular and Cellular Biology, Russian Academy of Sciences and "New Medicine for TB'' EU project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atrih A, 1999, ANTON LEEUW INT J G, V75, P299, DOI 10.1023/A:1001800507443; Biketov S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-146; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905; Cohen-Gonsaud M, 2004, TRENDS BIOCHEM SCI, V29, P7, DOI 10.1016/j.tibs.2003.10.009; Connell ND, 1995, METHOD CELL BIOL, V45, P107, DOI DOI 10.1016/S0091-679X(08)61848-8; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Finan C.L., 2003, THESIS U WALES ABERY; HURST DT, 1995, J HETEROCYCLIC CHEM, V32, P697, DOI 10.1002/jhet.5570320254; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4]; Makarov V, 2006, J ANTIMICROB CHEMOTH, V57, P1134, DOI 10.1093/jac/dkl095; Man J. C. de, 1975, European Journal of Applied Microbiology, V1, P67; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Mukamolova G, 2008, INFECT DIS-SER, P83, DOI 10.1007/978-1-59745-569-5_10; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Mukamolova GV, 2002, MOL MICROBIOL, V46, P611, DOI 10.1046/j.1365-2958.2002.03183.x; QAZI SS, 2008, ARCH MICROBIOL, V189, P6; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; Ruggiero A, 2007, ACTA CRYSTALLOGR F, V63, P870, DOI 10.1107/S1744309107043217; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Russell-Goldman E, 2008, INFECT IMMUN, V76, P4269, DOI 10.1128/IAI.01735-07; Salina E G, 2006, Mikrobiologiia, V75, P502; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; SUMMERS LA, 1965, AUST J CHEM, V18, P1695, DOI 10.1071/CH9651695; Telkov MV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P414, DOI 10.1134/S0006297906040092; TEMPLIN MF, 1992, J BIOL CHEM, V267, P20039; WALLIS RS, 1994, J LEUKOCYTE BIOL, V55, P676, DOI 10.1002/jlb.55.5.676; Zhu WM, 2003, TUBERCULOSIS, V83, P261, DOI 10.1016/S1472-9792(03)00052-0	33	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8174	10.1371/journal.pone.0008174	http://dx.doi.org/10.1371/journal.pone.0008174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016836	gold, Green Published, Green Submitted			2022-12-25	WOS:000272834000003
J	Jawaid, S; Seidle, H; Zhou, WD; Abdirahman, H; Abadeer, M; Hix, JH; van Hoek, ML; Couch, RD				Jawaid, Safdar; Seidle, Heather; Zhou, Weidong; Abdirahman, Hafsa; Abadeer, Maher; Hix, Joseph H.; van Hoek, Monique L.; Couch, Robin D.			Kinetic Characterization and Phosphoregulation of the Francisella tularensis 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (MEP Synthase)	PLOS ONE			English	Article							2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE PATHWAY; MEVALONATE-INDEPENDENT PATHWAY; HIGHER-PLANT CHLOROPLASTS; SYNECHOCYSTIS SP PCC6803; ISOPRENOID BIOSYNTHESIS; ESCHERICHIA-COLI; NONMEVALONATE PATHWAY; TERPENOID BIOSYNTHESIS; 4-(CYTIDINE 5'-DIPHOSPHO)-2-C-METHYL-D-ERYTHRITOL; MYCOBACTERIUM-TUBERCULOSIS	Deliberate and natural outbreaks of infectious disease underscore the necessity of effective vaccines and antimicrobial/antiviral therapeutics. The prevalence of antibiotic resistant strains and the ease by which antibiotic resistant bacteria can be intentionally engineered further highlights the need for continued development of novel antibiotics against new bacterial targets. Isoprenes are a class of molecules fundamentally involved in a variety of crucial biological functions. Mammalian cells utilize the mevalonic acid pathway for isoprene biosynthesis, whereas many bacteria utilize the methylerythritol phosphate (MEP) pathway, making the latter an attractive target for antibiotic development. In this report we describe the cloning and characterization of Francisella tularensis MEP synthase, a MEP pathway enzyme and potential target for antibiotic development. In vitro growth-inhibition assays using fosmidomycin, an inhibitor of MEP synthase, illustrates the effectiveness of MEP pathway inhibition with F. tularensis. To facilitate drug development, F. tularensis MEP synthase was cloned, expressed, purified, and characterized. Enzyme assays produced apparent kinetic constants (K(M)(DXP) = 104 mu M, K(M)(NADPH) = 13 mu M, k(cat)(DXP) = 2 s(-1), k(cat)(NADPH) = 1.3 s(-1)), an IC(50) for fosmidomycin of 247 nM, and a K(i) for fosmidomycin of 99 nM. The enzyme exhibits a preference for Mg(+2) as a divalent cation. Titanium dioxide chromatography-tandem mass spectrometry identified Ser177 as a site of phosphorylation. S177D and S177E site-directed mutants are inactive, suggesting a mechanism for post-translational control of metabolic flux through the F. tularensis MEP pathway. Overall, our study suggests that MEP synthase is an excellent target for the development of novel antibiotics against F. tularensis.	[Jawaid, Safdar; Seidle, Heather; Abdirahman, Hafsa; Abadeer, Maher; Couch, Robin D.] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA; [Zhou, Weidong; Hix, Joseph H.; van Hoek, Monique L.] George Mason Univ, Dept Mol & Microbiol, Manassas, VA USA; [Jawaid, Safdar; Seidle, Heather; Abdirahman, Hafsa; Abadeer, Maher; Hix, Joseph H.; van Hoek, Monique L.; Couch, Robin D.] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA; [Zhou, Weidong] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA	George Mason University; George Mason University; George Mason University; George Mason University	Jawaid, S (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA USA.	rcouch@gmu.edu	JAWAID, SAFDAR/C-1444-2013; van Hoek, Monique/E-1629-2011	van Hoek, Monique/0000-0003-1679-4899; Abadeer, Maher/0000-0001-5479-8255	George Mason University	George Mason University	This work was supported by startup funds provided by George Mason University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; AGRANOFF BW, 1959, J AM CHEM SOC, V81, P1254, DOI 10.1021/ja01514a059; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; Altincicek B, 2001, FEBS LETT, V499, P37, DOI 10.1016/S0014-5793(01)02516-9; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; AMDUR BH, 1957, J AM CHEM SOC, V79, P2647; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Campisi S, 2001, POPTRONICS, V2, P4; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hecht S, 2001, P NATL ACAD SCI USA, V98, P14837, DOI 10.1073/pnas.201399298; Henriksson LM, 2006, ACTA CRYSTALLOGR D, V62, P807, DOI 10.1107/S0907444906019196; Herzberg G, 2000, Tech Hand Up Extrem Surg, V4, P2, DOI 10.1097/00130911-200003000-00002; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; HILL RE, 1989, J AM CHEM SOC, V117, P1661; JORDAN PM, 1983, BIOCHEM J, V213, P153, DOI 10.1042/bj2130153; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; JULLIARD JH, 1992, CR ACAD SCI III-VIE, V314, P285; Kollas AK, 2002, FEBS LETT, V532, P432, DOI 10.1016/S0014-5793(02)03725-0; Koppisch AT, 2002, BIOCHEMISTRY-US, V41, P236, DOI 10.1021/bi0118207; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P2925, DOI 10.1016/S0040-4039(00)00295-1; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P703, DOI 10.1016/S0040-4039(99)02143-7; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; McAteer S, 2001, J BACTERIOL, V183, P7403, DOI 10.1128/JB.183.24.7403-7407.2001; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; Ortmann R, 2007, ARCH PHARM, V340, P483, DOI 10.1002/ardp.200700149; Putra SR, 1998, TETRAHEDRON LETT, V39, P23, DOI 10.1016/S0040-4039(97)10458-0; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 2008, LIPIDS, V43, P1095, DOI 10.1007/s11745-008-3261-7; Singh P, 2007, INT J GREENH GAS CON, V1, P5, DOI 10.1016/S1750-5836(07)00015-1; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Walker JR, 2005, J ORG CHEM, V70, P9955, DOI 10.1021/jo0516786; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Woo YH, 2006, BIOORGAN MED CHEM, V14, P2375, DOI 10.1016/j.bmc.2005.11.012; Yajima S, 2004, J AM CHEM SOC, V126, P10824, DOI 10.1021/ja040126m; Yin XH, 2003, BBA-PROTEINS PROTEOM, V1652, P75, DOI 10.1016/j.bbapap.2003.08.005; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	24	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8288	10.1371/journal.pone.0008288	http://dx.doi.org/10.1371/journal.pone.0008288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011597	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300039
J	Jung, B; Gomez, J; Chau, E; Cabral, J; Lee, JK; Anselm, A; Slowik, P; Ream-Robinson, D; Messer, K; Sporn, J; Shin, SK; Boland, CR; Goel, A; Carethers, JM				Jung, Barbara; Gomez, Jessica; Chau, Eddy; Cabral, Jennifer; Lee, Jeffrey K.; Anselm, Aimee; Slowik, Przemyslaw; Ream-Robinson, Deena; Messer, Karen; Sporn, Judith; Shin, Sung K.; Boland, C. Richard; Goel, Ajay; Carethers, John M.			Activin Signaling in Microsatellite Stable Colon Cancers Is Disrupted by a Combination of Genetic and Epigenetic Mechanisms	PLOS ONE			English	Article							FACTOR-BETA RECEPTOR; DPC4 GENE; GROWTH; PROTEIN; INACTIVATION; MUTATION; CELLS; TRANSFORMATION; RESTORATION; METHYLATION	Background: Activin receptor 2 (ACVR2) is commonly mutated in microsatellite unstable (MSI) colon cancers, leading to protein loss, signaling disruption, and larger tumors. Here, we examined activin signaling disruption in microsatellite stable (MSS) colon cancers. Methods: Fifty-one population-based MSS colon cancers were assessed for ACVR1, ACVR2 and pSMAD2 protein. Consensus mutation-prone portions of ACVR2 were sequenced in primary cancers and all exons in colon cancer cell lines. Loss of heterozygosity (LOH) was evaluated for ACVR2 and ACVR1, and ACVR2 promoter methylation by methylation-specific PCR and bisulfite sequencing and chromosomal instability (CIN) phenotype via fluorescent LOH analysis of 3 duplicate markers. ACVR2 promoter methylation and ACVR2 expression were assessed in colon cancer cell lines via qPCR and IP-Western blots. Re-expression of ACVR2 after demethylation with 5-aza-29-deoxycytidine (5-Aza) was determined. An additional 26 MSS colon cancers were assessed for ACVR2 loss and its mechanism, and ACVR2 loss in all tested cancers correlated with clinicopathological criteria. Results: Of 51 MSS colon tumors, 7(14%) lost ACVR2, 2 (4%) ACVR1, and 5(10%) pSMAD2 expression. No somatic ACVR2 mutations were detected. Loss of ACVR2 expression was associated with LOH at ACVR2 (p<0.001) and ACVR2 promoter hypermethylation (p<0.05). ACVR2 LOH, but not promoter hypermethylation, correlated with CIN status. In colon cancer cell lines with fully methylated ACVR2 promoter, loss of ACVR2 mRNA and protein expression was restored with 5-Aza treatment. Loss of ACVR2 was associated with an increase in primary colon cancer volume (p<0.05). Conclusions: Only a small percentage of MSS colon cancers lose expression of activin signaling members. ACVR2 loss occurs through LOH and ACVR2 promoter hypermethylation, revealing distinct mechanisms for ACVR2 inactivation in both MSI and MSS subtypes of colon cancer.	[Jung, Barbara; Chau, Eddy; Cabral, Jennifer; Lee, Jeffrey K.; Anselm, Aimee; Slowik, Przemyslaw; Ream-Robinson, Deena; Sporn, Judith; Carethers, John M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jung, Barbara; Gomez, Jessica; Messer, Karen; Carethers, John M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Jung, Barbara; Carethers, John M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Shin, Sung K.; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Dept Med, Dallas, TX USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Baylor University; Baylor University Medical Center	Jung, B (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	bjung@ucsd.edu		Goel, Ajay/0000-0003-1396-6341; Shin, Sung Kwan/0000-0001-5466-1400	UCSD Academic Senate; U.S. Public Health Service [DK074019, DK067287]; VA Research Service; American Cancer Society Institutional Research [70-002]; UCSD Digestive Diseases Research Development Center [DK080506]; NCI Cancer Center [2 P30 CA023100-23]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA072851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287, R24DK080506, K08DK074019] Funding Source: NIH RePORTER	UCSD Academic Senate; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); VA Research Service(US Department of Veterans Affairs); American Cancer Society Institutional Research(American Cancer Society); UCSD Digestive Diseases Research Development Center; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the UCSD Academic Senate to B. J., the U.S. Public Health Service DK074019 to B. J.; DK067287, the VA Research Service, and the American Cancer Society Institutional Research Grant # 70-002 to J. M. C., and the UCSD Digestive Diseases Research Development Center (DK080506). DNA sequencing was performed by the DNA Sequencing Shared Resource, UCSD Cancer Center, which is funded in part by NCI Cancer Center Support Grant # 2 P30 CA023100-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Carethers JM, 1998, GASTROENTEROLOGY, V114, P1188, DOI 10.1016/S0016-5085(98)70424-X; CARETHERS JM, 2003, GASTROINTESTINAL CAN, P407; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Deacu E, 2004, CANCER RES, V64, P7690, DOI 10.1158/0008-5472.CAN-04-2082; Deng GR, 1999, CANCER RES, V59, P2029; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Gong JG, 2003, CANCER RES, V63, P3340; Grady WM, 1998, CANCER RES, V58, P3101; Grady WM, 1999, CANCER RES, V59, P320; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hempen PM, 2003, CANCER RES, V63, P994; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; Lee YJ, 2006, GENESIS, V44, P487, DOI 10.1002/dvg.20238; Mori Y, 2001, CANCER RES, V61, P6046; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Olaru A, 2003, LAB INVEST, V83, P1867, DOI 10.1097/01.LAB.0000106723.75567.72; Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P429, DOI 10.1158/1055-9965.EPI-04-0486; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Schutte M, 1996, CANCER RES, V56, P2527; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Takagi Y, 1996, GASTROENTEROLOGY, V111, P1369, DOI 10.1053/gast.1996.v111.pm8898652	25	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8308	10.1371/journal.pone.0008308	http://dx.doi.org/10.1371/journal.pone.0008308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011542	Green Submitted, Green Published, gold			2022-12-25	WOS:000272830300053
J	Ould-yahoui, A; Tremblay, E; Sbai, O; Ferhat, L; Bernard, A; Charrat, E; Gueye, Y; Lim, NH; Brew, K; Risso, JJ; Dive, V; Khrestchatisky, M; Rivera, S				Ould-yahoui, Adlane; Tremblay, Evelyne; Sbai, Oualid; Ferhat, Lotfi; Bernard, Anne; Charrat, Eliane; Gueye, Yatma; Lim, Ngee Han; Brew, Keith; Risso, Jean-Jacques; Dive, Vincent; Khrestchatisky, Michel; Rivera, Santiago			A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; HIPPOCAMPAL-NEURONS; ACTIN CYTOSKELETON; TERMINAL DOMAIN; DEFICIENT MICE; AXONAL GROWTH; MESSENGER-RNA; GELATINASE-B	Background: Tissue inhibitor of metalloproteinases-1 (TIMP-1) displays pleiotropic activities, both dependent and independent of its inhibitory activity on matrix metalloproteinases (MMPs). In the central nervous system (CNS), TIMP-1 is strongly upregulated in reactive astrocytes and cortical neurons following excitotoxic/inflammatory stimuli, but no information exists on its effects on growth and morphology of cortical neurons. Principal Findings: We found that 24 h incubation with recombinant TIMP-1 induced a 35% reduction in neurite length and significantly increased growth cones size and the number of F-actin rich microprocesses. TIMP-1 mediated reduction in neurite length affected both dendrites and axons after 48 h treatment. The effects on neurite length and morphology were not elicited by a mutated form of TIMP-1 inactive against MMP-1, -2 and -3, and still inhibitory for MMP-9, but were mimicked by a broad spectrum MMP inhibitor. MMP-9 was poorly expressed in developing cortical neurons, unlike MMP-2 which was present in growth cones and whose selective inhibition caused neurite length reductions similar to those induced by TIMP-1. Moreover, TIMP-1 mediated changes in cytoskeleton reorganisation were not accompanied by modifications in the expression levels of actin, beta III-tubulin, or microtubule assembly regulatory protein MAP2c. Transfection-mediated overexpression of TIMP-1 dramatically reduced neuritic arbour extension in the absence of detectable levels of released extracellular TIMP-1. Conclusions: Altogether, TIMP-1 emerges as a modulator of neuronal outgrowth and morphology in a paracrine and autrocrine manner through the inhibition, at least in part, of MMP-2 and not MMP-9. These findings may help us understand the role of the MMP/TIMP system in post-lesion pre-scarring conditions.	[Ould-yahoui, Adlane; Tremblay, Evelyne; Sbai, Oualid; Ferhat, Lotfi; Bernard, Anne; Charrat, Eliane; Gueye, Yatma; Khrestchatisky, Michel; Rivera, Santiago] Univ Mediterranee, CNRS, UMR 6184, NICN, Marseille, France; [Lim, Ngee Han] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London, England; [Brew, Keith] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL USA; [Risso, Jean-Jacques] Univ Mediterranee, IMNSSA, UMR PPCOE MD2, Dept Rech Marine & Subaquat, Toulon Armees, France; [Dive, Vincent] CEA, DIEP, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London; University of Oxford; State University System of Florida; Florida Atlantic University; UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Ould-yahoui, A (corresponding author), Univ Mediterranee, CNRS, UMR 6184, NICN, Marseille, France.	santiago.rivera@univmed.fr	Ferhat, Lotfi/D-8207-2017; Lim, Ngee Han/B-4226-2011; Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019; ferhat, lotfi/S-3017-2019	Brew, Keith/0000-0003-1306-1032; ferhat, lotfi/0000-0003-2763-9472; Lim, Ngee Han/0000-0002-8520-7857	CNRS; Universite de la Mediterranee; Letten Foundation; Institut de Recherche sur la Moelle Epiniere (IRME); Association Francaise contre les Myopathies (AFM); Direction Generale de l'Armement (DGA); French Ministry of Research; Association Bir el Bey (Tunisia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; Letten Foundation; Institut de Recherche sur la Moelle Epiniere (IRME); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Direction Generale de l'Armement (DGA)(General Electric); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Bir el Bey (Tunisia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding to the UMR 6184 laboratory from the CNRS and the Universite de la Mediterranee, and by grants to MK and SR from the Letten Foundation, from the Institut de Recherche sur la Moelle Epiniere (IRME), from the Association Francaise contre les Myopathies (AFM) and from the Direction Generale de l'Armement (DGA). AO-Y is recipient of a doctoral fellowship from the French Ministry of Research and the AFM. OS is recipient of a doctoral fellowship from the Association Bir el Bey (Tunisia) and from the AFM. YG is recipient of a fellowship from the Letten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P64, DOI 10.1016/j.mcn.2004.08.013; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bouquet C, 2007, ADV EXP MED BIOL, V621, P1, DOI 10.1007/978-0-387-76715-4_1; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Bugno M, 1999, FEBS LETT, V448, P9, DOI 10.1016/S0014-5793(99)00323-3; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chaillan FA, 2006, BEHAV BRAIN RES, V173, P191, DOI 10.1016/j.bbr.2006.06.020; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Cursio R, 2001, FASEB J, V15, P93, DOI 10.1096/fj.01-0279fje; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Dive V, 2005, INT J CANCER, V113, P775, DOI 10.1002/ijc.20459; Gonthier B, 2007, CEREB CORTEX, V17, P1712, DOI 10.1093/cercor/bhl082; Gonthier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005099; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Jourquin J, 2005, EUR J NEUROSCI, V22, P2569, DOI 10.1111/j.1460-9568.2005.04426.x; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kaczmarek L, 2002, EMBO J, V21, P6643, DOI 10.1093/emboj/cdf676; Khuth ST, 2001, J VIROL, V75, P8268, DOI 10.1128/JVI.75.17.8268-8282.2001; Lorenzl S, 2003, J NEUROL SCI, V207, P71, DOI 10.1016/S0022-510X(02)00398-2; McFarlane S, 2003, NEURON, V37, P559, DOI 10.1016/S0896-6273(03)00089-8; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Ogier C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-68; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Oliver GW, 1997, ANAL BIOCHEM, V244, P161, DOI 10.1006/abio.1996.9895; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; RIVERA OC, 2002, EUR J NEUROSCI; Rivera S, 1997, J NEUROSCI, V17, P4223; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; RIVERA S, 1999, ADV SYNAPTIC PLASTIC, P53; SBAI O, IN PRESS; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Vaillant C, 1999, J NEUROSCI, V19, P4994; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	48	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8289	10.1371/journal.pone.0008289	http://dx.doi.org/10.1371/journal.pone.0008289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011518	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830300040
J	Khanim, FL; Hayden, RE; Birtwistle, J; Lodi, A; Tiziani, S; Davies, NJ; Ride, JP; Viant, MR; Gunther, UL; Mountford, JC; Schrewe, H; Green, RM; Murray, JA; Drayson, MT; Bunce, CM				Khanim, Farhat L.; Hayden, Rachel E.; Birtwistle, Jane; Lodi, Alessia; Tiziani, Stefano; Davies, Nicholas J.; Ride, Jon P.; Viant, Mark R.; Gunther, Ulrich L.; Mountford, Joanne C.; Schrewe, Heinrich; Green, Richard M.; Murray, Jim A.; Drayson, Mark T.; Bunce, Chris M.			Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INHIBITS CELL-GROWTH; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDIN; OLDER PATIENTS; MYELODYSPLASTIC-SYNDROME; PROMYELOCYTIC LEUKEMIA; OXIDATIVE STRESS; INDUCE APOPTOSIS; DOWN-REGULATION	Background: The majority of acute myeloid leukaemia (AML) patients are over sixty years of age. With current treatment regimens, survival rates amongst these, and also those younger patients who relapse, remain dismal and novel therapies are urgently required. In particular, therapies that have anti-leukaemic activity but that, unlike conventional chemotherapy, do not impair normal haemopoiesis. Principal Findings: Here we demonstrate the potent anti-leukaemic activity of the combination of the lipid-regulating drug bezafibrate (BEZ) and the sex hormone medroxyprogesterone acetate (MPA) against AML cell lines and primary AML cells. The combined activity of BEZ and MPA (B/M) converged upon the increased synthesis and reduced metabolism of prostaglandin D-2 (PGD(2)) resulting in elevated levels of the downstream highly bioactive, anti-neoplastic prostaglandin 15-deoxy Delta(12,14) PGJ(2) (15d-PGJ(2)). BEZ increased PGD(2) synthesis via the generation of reactive oxygen species (ROS) and activation of the lipid peroxidation pathway. MPA directed prostaglandin synthesis towards 15d-PGJ(2) by inhibiting the PGD(2) 11 beta-ketoreductase activity of the aldo-keto reductase AKR1C3, which metabolises PGD(2) to 9 alpha 11 beta-PGF(2 alpha). B/M treatment resulted in growth arrest, apoptosis and cell differentiation in both AML cell lines and primary AML cells and these actions were recapitulated by treatment with 15d-PGJ(2). Importantly, the actions of B/M had little effect on the survival of normal adult myeloid progenitors. Significance: Collectively our data demonstrate that B/M treatment of AML cells elevated ROS and delivered the antineoplastic actions of 15d-PGJ(2). These observations provide the mechanistic rationale for the redeployment of B/M in elderly and relapsed AML.	[Khanim, Farhat L.; Hayden, Rachel E.; Birtwistle, Jane; Davies, Nicholas J.; Ride, Jon P.; Viant, Mark R.; Green, Richard M.; Bunce, Chris M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Lodi, Alessia; Tiziani, Stefano; Gunther, Ulrich L.] Univ Birmingham, Henry Wellcome Bldg Biomol NMR Spect, CRUK Inst Canc Studies, Birmingham, W Midlands, England; [Mountford, Joanne C.] Univ Glasgow, Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland; [Schrewe, Heinrich] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Schrewe, Heinrich] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Murray, Jim A.] Queen Elizabeth Hosp, Ctr Clin Haematol, Birmingham B15 2TH, W Midlands, England; [Drayson, Mark T.] Univ Birmingham, Div Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Glasgow; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Birmingham; University of Birmingham	Khanim, FL (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	C.M.Bunce@bham.ac.uk	Viant, Mark R/B-6339-2009; mountford, joanne c/H-1010-2012	Viant, Mark R/0000-0001-5898-4119; mountford, joanne c/0000-0003-2142-6572; Bunce, Chris/0000-0003-4084-8973; Drayson, Mark/0000-0002-1528-7564	Leukaemia Research UK; Marie Curie Transfer of Knowledge (ToK) (MOTET)	Leukaemia Research UK; Marie Curie Transfer of Knowledge (ToK) (MOTET)(European Commission)	Funding was recieved from Leukaemia Research UK and Marie Curie Transfer of Knowledge (ToK) (MOTET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldini G, 2007, BIOCHEMISTRY-US, V46, P2707, DOI 10.1021/bi0618565; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Birtwistle L, 2009, MUTAT RES-FUND MOL M, V662, P67, DOI 10.1016/j.mrfmmm.2008.12.010; Breitkreutz I, 2008, EXPERT OPIN DRUG MET, V4, P973, DOI [10.1517/17425255.4.7.973, 10.1517/17425255.4.7.973 ]; Brunoldi EA, 2007, CHEM RES TOXICOL, V20, P1528, DOI 10.1021/tx700231a; Bunce CM, 1996, BBA-MOL CELL RES, V1311, P189, DOI 10.1016/0167-4889(96)00005-5; Burnett AK, 2006, SEMIN HEMATOL, V43, P96, DOI 10.1053/j.seminhematol.2006.01.003; Burnett AK, 2009, BRIT J HAEMATOL, V145, P318, DOI 10.1111/j.1365-2141.2009.07604.x; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cox B, 2002, BBA-MOL CELL BIOL L, V1584, P37, DOI 10.1016/S1388-1981(02)00267-6; Craig CM, 2008, BLOOD REV, V22, P221, DOI 10.1016/j.blre.2008.03.002; Date M, 2003, LIVER INT, V23, P460, DOI 10.1111/j.1478-3231.2003.00877.x; Deschler B, 2006, HAEMATOLOGICA, V91, P1513; Desmond JC, 2003, CANCER RES, V63, P505; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Estey E, 2007, J CLIN ONCOL, V25, P1908, DOI 10.1200/JCO.2006.10.2731; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; Fenton SL, 1999, BRIT J HAEMATOL, V105, P448, DOI 10.1111/j.1365-2141.1999.01355.x; Fenton SL, 2003, LEUKEMIA, V17, P568, DOI 10.1038/sj.leu.2402843; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; GILES H, 1988, PROSTAGLANDINS, V35, P277, DOI 10.1016/0090-6980(88)90093-7; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Grant S, 2008, BEST PRACT RES CL HA, V21, P629, DOI 10.1016/j.beha.2008.08.003; Hasegawa H, 2007, BLOOD, V110, P1664, DOI 10.1182/blood-2007-01-068981; Hayashi N, 2004, INT J ONCOL, V24, P89; Hayden RE, 2009, LEUKEMIA, V23, P292, DOI 10.1038/leu.2008.283; Hodges NJ, 2007, MUTAGENESIS, V22, P189, DOI 10.1093/mutage/gem001; KALANTARI P, 2009, FASEB J; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1933, DOI 10.1002/cncr.23655; Kim HS, 1996, PROSTAGLANDINS, V51, P413, DOI 10.1016/0090-6980(96)00047-0; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kohrt Holbrook E, 2008, J Natl Compr Canc Netw, V6, P1003; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kuendgen A, 2007, CANCER-AM CANCER SOC, V110, P943, DOI 10.1002/cncr.22891; Landar A, 2006, BIOCHEM J, V394, P185, DOI 10.1042/BJ20051259; Lin MS, 2007, J DIGEST DIS, V8, P82, DOI 10.1111/j.1443-9573.2007.00290.x; Lin SX, 2006, MOL CELL ENDOCRINOL, V248, P38, DOI 10.1016/j.mce.2005.11.035; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mills KI, 1998, FEBS LETT, V440, P158, DOI 10.1016/S0014-5793(98)01435-5; Milne GL, 2005, ANTIOXID REDOX SIGN, V7, P210, DOI 10.1089/ars.2005.7.210; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; Moriai M, 2009, INT J ONCOL, V34, P1363, DOI 10.3892/ijo_00000263; Morosetti R, 2004, INT J ONCOL, V25, P493; Nagase T, 1995, DNA Res, V2, P37, DOI 10.1093/dnares/2.1.37; Nikitakis NG, 2002, BRIT J CANCER, V87, P1396, DOI 10.1038/sj.bjc.6600618; NILSSON A, 1995, EUR J CELL BIOL, V67, P379; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Paumi CM, 2003, BIOCHEMISTRY-US, V42, P5429, DOI 10.1021/bi027347u; PENNING TM, 1985, J BIOL CHEM, V260, P5266; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sanchez-Gomez FJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P150, DOI 10.1016/j.abb.2006.10.032; Scatena R, 2004, BIOCHEM BIOPH RES CO, V319, P967, DOI 10.1016/j.bbrc.2004.05.072; Scatena R, 2003, CHEM RES TOXICOL, V16, P1440, DOI 10.1021/tx0341052; Scatena R, 1999, CELL DEATH DIFFER, V6, P781, DOI 10.1038/sj.cdd.4400551; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Tallman MS, 2008, SEMIN HEMATOL, V45, pS25, DOI 10.1053/j.seminhematol.2008.07.008; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tallman MS, 2004, SEMIN HEMATOL, V41, P27, DOI 10.1053/j.seminhematol.2004.02.004; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251	69	53	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8147	10.1371/journal.pone.0008147	http://dx.doi.org/10.1371/journal.pone.0008147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997560	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000272829500009
J	Heinrich, C; Keller, C; Boulay, A; Vecchi, M; Bianchi, M; Sack, R; Lienhard, S; Duss, S; Hofsteenge, J; Hynes, NE				Heinrich, C.; Keller, C.; Boulay, A.; Vecchi, M.; Bianchi, M.; Sack, R.; Lienhard, S.; Duss, S.; Hofsteenge, J.; Hynes, N. E.			Copine-III interacts with ErbB2 and promotes tumor cell migration	ONCOGENE			English	Article						quantitative mass spectrometry; ErbB2; HRG; Copine-III; FRET acceptor photobleaching; cell migration	BREAST-CANCER; C2 DOMAIN; AUTOPHOSPHORYLATION SITES; PROTEIN; RECEPTOR; IDENTIFICATION; KINASE; RACK1; ADHESION; FAMILY	ErbB2 amplification and overexpression in breast cancer correlates with aggressive disease and poor prognosis. To find novel ErbB2-interacting proteins, we used stable isotope labeling of amino acids in cell culture followed by peptide affinity pull-downs and identified specific binders using relative quanti. cation by mass spectrometry. Copine-III, a member of a Ca2+-dependent phospholipid-binding protein family, was identified as binding to phosphorylated Tyr1248 of ErbB2. In breast cancer cells, Copine-III requires Ca2+ for binding to the plasma membrane, where it interacts with ErbB2 upon receptor stimulation, an interaction that is dependent on receptor activity. Copine-III also binds receptor of activated C kinase 1 and colocalizes with phosphorylated focal adhesion kinase at the leading edge of migrating cells. Importantly, knockdown of Copine-III in T47D breast cancer cells causes a decrease in Src kinase activation and ErbB2-dependent wound healing. Our data suggest that Copine-III is a novel player in the regulation of ErbB2-dependent cancer cell motility. In primary breast tumors, high CPNE3 RNA levels significantly correlate with ERBB2 amplification. Moreover, in an in situ tissue microarray analysis, we detected differential protein expression of Copine-III in normal versus breast, prostate and ovarian tumors, suggesting a more general role for Copine-III in carcinogenesis. Oncogene (2010) 29, 1598-1610; doi:10.1038/onc.2009.456; published online 14 December 2009	[Heinrich, C.; Keller, C.; Boulay, A.; Sack, R.; Lienhard, S.; Duss, S.; Hofsteenge, J.; Hynes, N. E.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Vecchi, M.; Bianchi, M.] IFOM, FIRC Inst Mol Oncol Fdn, Milan, Italy	Friedrich Miescher Institute for Biomedical Research; IFOM - FIRC Institute of Molecular Oncology	Hynes, NE (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66,WRO 1066-206, CH-4058 Basel, Switzerland.	nancy.hynes@fmi.ch	Vecchi, Manuela/L-3502-2017	Vecchi, Manuela/0000-0002-2750-9160; Sack, Ragna/0000-0003-0963-8089; Keller Valsecchi, Claudia Isabelle/0000-0003-4135-5927; Duss, Stephan/0000-0002-0521-162X	TRANSFOG FP6 IP [LSHC-CT-2004-503438]; Novartis Research Foundation	TRANSFOG FP6 IP; Novartis Research Foundation	We thank Elizabeth A Grimm for the polyclonal Copine-III antibody, Martin Spiess for the transferrin receptor antibody, Susanne Schenk for help in generating the Copine-III monoclonal antibody, Laurent Gelman for help with FRET, Michael Rebhan for some bioinformatic analyses and Gwen MacDonald and Julien Dey for helpful discussions. We also thank Daniel Hess and Florence Dalvai for help with establishing the 'MRM buddy'. The work of CH, MV and MB was partially supported by TRANSFOG FP6 IP funding (LSHC-CT-2004-503438). The laboratories of NEH and JH are supported by the Novartis Research Foundation.	AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Church DL, 2003, GENETICS, V165, P563; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Gharbi S, 2002, MOL CELL PROTEOMICS, V1, P91, DOI 10.1074/mcp.T100007-MCP200; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; HAZAN R, 1990, CELL GROWTH DIFFER, V1, P3; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hua J, 2001, GENE DEV, V15, P2263, DOI 10.1101/gad.918101; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Nagy P, 1998, CYTOMETRY, V32, P120, DOI 10.1002/(SICI)1097-0320(19980601)32:2<120::AID-CYTO7>3.0.CO;2-P; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tomsig JL, 2004, BIOCHEM J, V378, P1089, DOI 10.1042/BJ20031654; Tomsig JL, 2003, J BIOL CHEM, V278, P10048, DOI 10.1074/jbc.M212632200; Tomsig JL, 2002, CELL MOL LIFE SCI, V59, P1467, DOI 10.1007/s00018-002-8522-7; Traxler P, 2004, CANCER RES, V64, P4931, DOI 10.1158/0008-5472.CAN-03-3681; White SL, 2004, BRIT J CANCER, V90, P173, DOI 10.1038/sj.bjc.6601458; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	49	42	50	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2010	29	11					1598	1610		10.1038/onc.2009.456	http://dx.doi.org/10.1038/onc.2009.456			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	20010870	Green Submitted			2022-12-25	WOS:000275694700005
J	Roux, J; Carles, M; Koh, H; Goolaerts, A; Ganter, MT; Chesebro, BB; Howard, M; Houseman, BT; Finkbeiner, W; Shokat, KM; Paquet, AC; Matthay, MA; Pittet, JF				Roux, Jeremie; Carles, Michel; Koh, Hidefumi; Goolaerts, Arnaud; Ganter, Michael T.; Chesebro, Brian B.; Howard, Marybeth; Houseman, Benjamin T.; Finkbeiner, Walter; Shokat, Kevan M.; Paquet, Agnes C.; Matthay, Michael A.; Pittet, Jean-Francois			Transforming Growth Factor beta 1 Inhibits Cystic Fibrosis Transmembrane Conductance Regulator-dependent cAMP-stimulated Alveolar Epithelial Fluid Transport via a Phosphatidylinositol 3-Kinase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG LIQUID CLEARANCE; TGF-BETA; PHOSPHOINOSITIDE 3-KINASE; DECREASES EXPRESSION; HEMORRHAGIC-SHOCK; CFTR EXPRESSION; DOWN-REGULATION; ION-TRANSPORT; CELLS; ACTIVATION	Exogenous or endogenous beta 2-adrenergic receptor agonists enhance alveolar epithelial fluid transport via a cAMP-dependent mechanism that protects the lungs from alveolar flooding in acute lung injury. However, impaired alveolar fluid clearance is present in most of the patients with acute lung injury and is associated with increased mortality, although the mechanisms responsible for this inhibition of the alveolar epithelial fluid transport are not completely understood. Here, we found that transforming growth factor beta 1 (TGF-beta 1), a critical mediator of acute lung injury, inhibits beta(2)-adrenergic receptor agonist-stimulated vectorial fluid and Cl- transport across primary rat and human alveolar epithelial type II cell monolayers. This inhibition is due to a reduction in the cystic fibrosis transmembrane conductance regulator activity and biosynthesis mediated by a phosphatidylinositol 3-kinase (PI3K)-dependent heterologous desensitization and down-regulation of the beta(2)-adrenergic receptors. Consistent with these in vitro results, inhibition of the PI3K pathway or pretreatment with soluble chimeric TGF-beta type II receptor restored beta(2)-adrenergic receptor agonist-stimulated alveolar epithelial fluid transport in an in vivo model of acute lung injury induced by hemorrhagic shock in rats. The results demonstrate a novel role for TGF-beta 1 in impairing the beta-adrenergic agonist-stimulated alveolar fluid clearance in acute lung injury, an effect that could be corrected by using PI3K inhibitors that are safe to use in humans.	[Roux, Jeremie; Carles, Michel; Koh, Hidefumi; Goolaerts, Arnaud; Ganter, Michael T.; Chesebro, Brian B.; Howard, Marybeth; Matthay, Michael A.; Pittet, Jean-Francois] Univ Calif San Francisco, Surg Res Lab, Dept Anesthesia, San Francisco, CA 94110 USA; [Roux, Jeremie; Carles, Michel; Koh, Hidefumi; Goolaerts, Arnaud; Ganter, Michael T.; Chesebro, Brian B.; Howard, Marybeth; Matthay, Michael A.; Pittet, Jean-Francois] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA; [Matthay, Michael A.; Pittet, Jean-Francois] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94110 USA; [Paquet, Agnes C.; Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Finkbeiner, Walter] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94110 USA; [Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94110 USA; [Carles, Michel] Fac Med, INSERM, U895, Cell Death & Survival Team,Equipe AVENIR 3, F-06103 Nice, France; [Carles, Michel] Univ Nice Sophia Antipolis, F-06103 Nice, France; [Carles, Michel] Ctr Hosp Univ, Dept Anesthesie Reanimat, F-06103 Nice, France	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Roux, J (corresponding author), San Francisco Gen Hosp, Dept Anesthesia, Rm 3C-38,1001 Potrero Ave, San Francisco, CA 94110 USA.	Jeremie.Roux@gmail.com	Carles, Michel/CAH-0065-2022; Roux, Jeremie/A-9746-2013	Roux, Jeremie/0000-0001-5712-8660; CARLES, MICHEL/0000-0001-5485-1511	National Institutes of Health [P50HL074005, HL-51854, HL-51856, T32 GM008440]; American Lung Association Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051856, R01HL051856, R01HL051854, P50HL074005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50HL074005, Project 4 (to J.-F. P.), HL-51854 and HL-51856 (to M. A. M.), and T32 GM008440 (to J.R.). This work was also supported by a American Lung Association Senior Research Training Fellowship (to J. R.).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Banday AA, 2007, AM J PHYSIOL-RENAL, V293, pF877, DOI 10.1152/ajprenal.00184.2007; BERTHIAUME Y, 1991, J APPL PHYSIOL, V70, P2490, DOI 10.1152/jappl.1991.70.6.2490; BERTHIAUME Y, 1987, J CLIN INVEST, V79, P335, DOI 10.1172/JCI112817; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; El-Haroun H, 2004, CIRC RES, V94, P353, DOI 10.1161/01.RES.0000111801.48626.F4; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Frank J, 2003, J BIOL CHEM, V278, P43939, DOI 10.1074/jbc.M304882200; Fukuda N, 2000, J APPL PHYSIOL, V89, P672, DOI 10.1152/jappl.2000.89.2.672; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hamacher J, 2002, AM J RESP CRIT CARE, V166, P651, DOI 10.1164/rccm.2109004; Howe K, 2002, AM J PHYSIOL-CELL PH, V283, pC1667, DOI 10.1152/ajpcell.00414.2001; Howe KL, 2004, EXP CELL RES, V298, P473, DOI 10.1016/j.yexcr.2004.04.026; Hurst V, 1999, AM J PHYSIOL-LUNG C, V276, pL582, DOI 10.1152/ajplung.1999.276.4.L582; Icard P, 1999, AM J PHYSIOL-LUNG C, V277, pL1232, DOI 10.1152/ajplung.1999.277.6.L1232; Jiang X, 2001, J MEMBRANE BIOL, V181, P195, DOI 10.1007/s00232-001-0022-4; Jiang XP, 1998, AM J PHYSIOL-CELL PH, V275, pC1610, DOI 10.1152/ajpcell.1998.275.6.C1610; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lee I, 2005, FASEB J, V19, pA1027; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mak JCW, 2000, N-S ARCH PHARMACOL, V362, P520, DOI 10.1007/s002100000321; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; McAuley DF, 2004, CRIT CARE MED, V32, P1470, DOI 10.1097/01.CCM.0000129489.34416.0E; MCDONALD RA, 1995, P NATL ACAD SCI USA, V92, P7560, DOI 10.1073/pnas.92.16.7560; Modelska K, 1999, AM J PHYSIOL-LUNG C, V276, pL844, DOI 10.1152/ajplung.1999.276.5.L844; Modelska K, 1997, AM J PHYSIOL-LUNG C, V273, pL305, DOI 10.1152/ajplung.1997.273.2.L305; Mutlu G, 2005, CIRC RES, V96, P999, DOI 10.1161/01.RES.0000164554.21993.AC; Mutlu GM, 2008, AM J RESP CELL MOL, V38, P127, DOI 10.1165/rcmb.2007-0198TR; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; NOGAMI M, 1994, AM J PHYSIOL, V266, pL187, DOI 10.1152/ajplung.1994.266.2.L187; Norlin A, 1998, AM J PHYSIOL-LUNG C, V274, pL235, DOI 10.1152/ajplung.1998.274.2.L235; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pittet JF, 2001, J IMMUNOL, V166, P6301, DOI 10.4049/jimmunol.166.10.6301; PITTET JF, 1994, J CLIN INVEST, V94, P663, DOI 10.1172/JCI117383; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Pruliere-Escabasse V, 2005, AM J PHYSIOL-LUNG C, V288, pL77, DOI 10.1152/ajplung.00048.2004; Roux J, 2005, J BIOL CHEM, V280, P18579, DOI 10.1074/jbc.M410561200; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sakuma T, 1997, AM J RESP CRIT CARE, V155, P506, DOI 10.1164/ajrccm.155.2.9032186; Sakuma T, 2001, J APPL PHYSIOL, V90, P10, DOI 10.1152/jappl.2001.90.1.10; Su X, 2006, AM J PHYSIOL-LUNG C, V290, pL769, DOI 10.1152/ajplung.00334.2005; TIBALLI RN, 1995, J CLIN MICROBIOL, V33, P915, DOI 10.1128/JCM.33.4.915-917.1995; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2002, LANCET, V360, P619, DOI 10.1016/S0140-6736(02)09774-X; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035	54	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4278	4290		10.1074/jbc.M109.036731	http://dx.doi.org/10.1074/jbc.M109.036731			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996317	Green Published, hybrid			2022-12-25	WOS:000275274800004
J	Song, JY; Park, YH; Nemeria, NS; Kale, S; Kakalis, L; Jordan, F				Song, Jaeyoung; Park, Yun-Hee; Nemeria, Natalia S.; Kale, Sachin; Kakalis, Lazaros; Jordan, Frank			Nuclear Magnetic Resonance Evidence for the Role of the Flexible Regions of the E1 Component of the Pyruvate Dehydrogenase Complex from Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; ESCHERICHIA-COLI; THIAMIN DIPHOSPHATE; MULTIENZYME COMPLEX; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; REDUCTIVE ACETYLATION; 1',4'-IMINOPYRIMIDINE TAUTOMER; SUBSTRATE; BINDING; RESIDUES	Most bacterial pyruvate dehydrogenase complexes from either Gram-positive or Gram-negative bacteria have E1 components with an alpha(2) homodimeric quaternary structure. In a sequel to our previous publications, we present the first NMR study on the flexible regions of the E1 component from Escherichia coli and its biological relevance. We report sequence-specific NMR assignments for 6 residues in the N-terminal 1-55 region and for a glycine in each of the two mobile active center loops of the E1 component, a 200-kDa homodimer. This was accomplished by using site-specific substitutions and appropriate labeling patterns along with a peptide with the sequence corresponding to the N-terminal 1-35 amino acids of the E1 component. To study the functions of these mobile regions, we also examined the spectra in the presence of (a) a reaction intermediate analog known to affect the mobility of the active center loops, (b) an E2 component construct consisting of a lipoyl domain and peripheral subunit binding domain, and (c) a peptide corresponding to the amino acid sequence of the E2 peripheral subunit binding domain. Deductions from the NMR studies are in excellent agreement with our functional finding, providing a clear indication that the N-terminal region of the E1 interacts with the E2 peripheral subunit binding domain and that this interaction precedes reductive acetylation. The results provide the first structural support to the notion that the N-terminal region of the E1 component of this entire class of bacterial pyruvate dehydrogenase complexes is responsible for binding the E2 component.	[Song, Jaeyoung; Park, Yun-Hee; Nemeria, Natalia S.; Kale, Sachin; Kakalis, Lazaros; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	frjordan@rutgers.edu			NIGMS NIH HHS [R01 GM050380] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050380] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2004, BIOCHEMISTRY-US, V43, P2405, DOI 10.1021/bi030200y; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; BRAUN D, 1994, J AM CHEM SOC, V116, P8466, DOI 10.1021/ja00098a005; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHENG H, 1995, ARCH BIOCHEM BIOPHYS, V316, P619, DOI 10.1006/abbi.1995.1082; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; Hengeveld AF, 2002, FEBS LETT, V522, P173, DOI 10.1016/S0014-5793(02)02931-9; Hengeveld AF, 2002, BIOCHEMISTRY-US, V41, P7490, DOI 10.1021/bi012172u; Hong J, 1998, BBA-PROTEIN STRUCT M, V1385, P187, DOI 10.1016/S0167-4838(98)00068-5; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DD, 2008, BIOCHEM J, V409, P357, DOI 10.1042/BJ20071119; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; KALE S, 2007, THESIS RUTGERS U NEW; Kale S, 2008, P NATL ACAD SCI USA, V105, P1158, DOI 10.1073/pnas.0709328105; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; Kale S, 2009, J BIOL CHEM, V284, P33122, DOI 10.1074/jbc.M109.065508; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 2002, BIOCHEMISTRY-US, V41, P15459, DOI 10.1021/bi0205909; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Rodriguez JC, 2006, BIOCHEMISTRY-US, V45, P4578, DOI 10.1021/bi0600188; RUSSELL GC, 1992, BIOCHEM J, V287, P611, DOI 10.1042/bj2870611; Sambrook J., 1989, MOL CLONING LAB MANU, V2; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P155, DOI 10.1111/j.1432-1033.1983.tb07441.x; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; Wallis NG, 1996, J MOL BIOL, V263, P463, DOI 10.1006/jmbi.1996.0589; Wei W, 2003, PROTEIN EXPRES PURIF, V28, P140, DOI 10.1016/S1046-5928(02)00674-5; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192	43	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4680	4694		10.1074/jbc.M109.082842	http://dx.doi.org/10.1074/jbc.M109.082842			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996100	hybrid, Green Published			2022-12-25	WOS:000275274800046
J	de Graaf, TA; Jacobs, C; Roebroeck, A; Sack, AT				de Graaf, Tom A.; Jacobs, Christianne; Roebroeck, Alard; Sack, Alexander T.			FMRI Effective Connectivity and TMS Chronometry: Complementary Accounts of Causality in the Visuospatial Judgment Network	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR THRESHOLD; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; VISUAL-CORTEX; BRAIN; PARIETAL; DISTANCE; AREAS; IMAGERY	Background: While traditionally quite distinct, functional neuroimaging (e.g. functional magnetic resonance imaging: fMRI) and functional interference techniques (e.g. transcranial magnetic stimulation: TMS) increasingly address similar questions of functional brain organization, including connectivity, interactions, and causality in the brain. Time-resolved TMS over multiple brain network nodes can elucidate the relative timings of functional relevance for behavior ("TMS chronometry''), while fMRI functional or effective connectivity (fMRI EC) can map task-specific interactions between brain regions based on the interrelation of measured signals. The current study empirically assessed the relation between these different methods. Methodology/Principal Findings: One group of 15 participants took part in two experiments: one fMRI EC study, and one TMS chronometry study, both of which used an established cognitive paradigm involving one visuospatial judgment task and one color judgment control task. Granger causality mapping (GCM), a data-driven variant of fMRI EC analysis, revealed a frontal-to-parietal flow of information, from inferior/middle frontal gyrus (MFG) to posterior parietal cortex (PPC). FMRI EC-guided Neuronavigated TMS had behavioral effects when applied to both PPC and to MFG, but the temporal pattern of these effects was similar for both stimulation sites. At first glance, this would seem in contradiction to the fMRI EC results. However, we discuss how TMS chronometry and fMRI EC are conceptually different and show how they can be complementary and mutually constraining, rather than contradictory, on the basis of our data. Conclusions/Significance: The findings that fMRI EC could successfully localize functionally relevant TMS target regions on the single subject level, and conversely, that TMS confirmed an fMRI EC identified functional network to be behaviorally relevant, have important methodological and theoretical implications. Our results, in combination with data from earlier studies by our group (Sack et al., 2007, Cerebral Cortex), lead to informed speculations on complex brain mechanisms, and TMS disruption thereof, underlying visuospatial judgment. This first in-depth empirical and conceptual comparison of fMRI EC and TMS chronometry thereby shows the complementary insights offered by the two methods.	[de Graaf, Tom A.; Jacobs, Christianne; Roebroeck, Alard; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [de Graaf, Tom A.; Jacobs, Christianne; Roebroeck, Alard; Sack, Alexander T.] Maastricht Brain Imaging Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University	de Graaf, TA (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	tom.degraaf@maastrichtuniversity.nl		Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (NWO) [021-002-087, 452-06-003, 400-07-048]; Deutsche Forschungsgemeinschaft; Netherlands Organization for Scientific Research [DN 55-19]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	T. A. G. was supported by a Grant from the Netherlands Organization for Scientific Research (NWO; Grant number 021-002-087), A. T. S. was also supported by NWO (Grant number 452-06-003), as was C. J. (Grant number 400-07-048). Furthermore, this work was supported by a cooperation Grant from the Deutsche Forschungsgemeinschaft and the Netherlands Organization for Scientific Research (DN 55-19). Website NWO: www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; Bestmann S, 2005, NEUROIMAGE, V28, P22, DOI 10.1016/j.neuroimage.2005.05.027; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Edelman G.M., 2000, UNIVERSE CONSCIOUSNE, V1st Edn; Edin Fredrik, 2007, Journal of Integrative Neuroscience, V6, P567, DOI 10.1142/S0219635207001702; Ellison A, 2007, NEUROPSYCHOLOGIA, V45, P3335, DOI 10.1016/j.neuropsychologia.2007.06.014; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; Mottaghy FM, 2003, NEUROIMAGE, V18, P565, DOI 10.1016/S1053-8119(03)00010-7; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Penny WD, 2004, NEUROIMAGE, V23, pS264, DOI 10.1016/j.neuroimage.2004.07.041; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Sack AT, 2008, J NEUROSCI, V28, P8417, DOI 10.1523/JNEUROSCI.2656-08.2008; Sack AT, 2007, CEREB CORTEX, V17, P2841, DOI 10.1093/cercor/bhm013; Sack AT, 2006, CURR OPIN NEUROBIOL, V16, P593, DOI 10.1016/j.conb.2006.06.016; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Sack AT, 2006, NEUROIMAGE, V29, P1326, DOI 10.1016/j.neuroimage.2005.08.027; Sack AT, 2002, COGNITIVE BRAIN RES, V13, P85, DOI 10.1016/S0926-6410(01)00087-8; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Talairach J., 1988, COPLANAR STEREOTAXIC; Wassermann E., 2008, OXFORD HDB TRANSCRAN; [No title captured]; [No title captured]; [No title captured]	40	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8307	10.1371/journal.pone.0008307	http://dx.doi.org/10.1371/journal.pone.0008307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011541	Green Submitted, gold, Green Published			2022-12-25	WOS:000272830300052
J	Hodel, EM; Kabanywanyi, AM; Malila, A; Zanolari, B; Mercier, T; Beck, HP; Buclin, T; Olliaro, P; Decosterd, LA; Genton, B				Hodel, Eva Maria; Kabanywanyi, Abdunoor Mulokozi; Malila, Aggrey; Zanolari, Boris; Mercier, Thomas; Beck, Hans-Peter; Buclin, Thierry; Olliaro, Piero; Decosterd, Laurent Arthur; Genton, Blaise			Residual Antimalarials in Malaria Patients from Tanzania - Implications on Drug Efficacy Assessment and Spread of Parasite Resistance	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; POPULATION PHARMACOKINETICS; SULFADOXINE-PYRIMETHAMINE; CONGENITAL TOXOPLASMOSIS; ARTEMETHER-LUMEFANTRINE; SELF-MEDICATION; CHLOROQUINE; CHILDREN; BLOOD; DETERMINANTS	Background: Repeated antimalarial treatment for febrile episodes and self-treatment are common in malaria-endemic areas. The intake of antimalarials prior to participating in an in vivo study may alter treatment outcome and affect the interpretation of both efficacy and safety outcomes. We report the findings from baseline plasma sampling of malaria patients prior to inclusion into an in vivo study in Tanzania and discuss the implications of residual concentrations of antimalarials in this setting. Methods and Findings: In an in vivo study conducted in a rural area of Tanzania in 2008, baseline plasma samples from patients reporting no antimalarial intake within the last 28 days were screened for the presence of 14 antimalarials (parent drugs or metabolites) using liquid chromatography-tandem mass spectrometry. Among the 148 patients enrolled, 110 (74.3%) had at least one antimalarial in their plasma: 80 (54.1%) had lumefantrine above the lower limit of calibration (LLC = 4 ng/mL), 7 (4.7%) desbutyl-lumefantrine (4 ng/mL), 77 (52.0%) sulfadoxine (0.5 ng/mL), 15 (10.1%) pyrimethamine (0.5 ng/mL), 16 (10.8%) quinine (2.5 ng/mL) and none chloroquine (2.5 ng/mL). Conclusions: The proportion of patients with detectable antimalarial drug levels prior to enrollment into the study is worrying. Indeed artemether-lumefantrine was supposed to be available only at government health facilities. Although sulfadoxine-pyrimethamine is only recommended for intermittent preventive treatment in pregnancy (IPTp), it was still widely used in public and private health facilities and sold in drug shops. Self-reporting of previous drug intake is unreliable and thus screening for the presence of antimalarial drug levels should be considered in future in vivo studies to allow for accurate assessment of treatment outcome. Furthermore, persisting sub-therapeutic drug levels of antimalarials in a population could promote the spread of drug resistance. The knowledge on drug pressure in a given population is important to monitor standard treatment policy implementation.	[Hodel, Eva Maria; Beck, Hans-Peter; Genton, Blaise] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Kabanywanyi, Abdunoor Mulokozi; Malila, Aggrey] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Kabanywanyi, Abdunoor Mulokozi; Malila, Aggrey] Ifakara Hlth Inst, Ifakara, Tanzania; [Zanolari, Boris; Mercier, Thomas; Buclin, Thierry; Decosterd, Laurent Arthur] Univ Lausanne Hosp, Dept Med, Div Clin Pharmacol, Lausanne, Switzerland; [Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Olliaro, Piero] UNICEF, UNDP, World Bank, WHO Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; Ifakara Health Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; The World Bank; World Health Organization	Hodel, EM (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	blaise.genton@unibas.ch	Hodel, Eva Maria/E-1258-2014; Decosterd, Laurent/E-8494-2019; Buclin, Thierry/P-1640-2014	Hodel, Eva Maria/0000-0001-5821-1685; Decosterd, Laurent/0000-0002-9840-1325; Buclin, Thierry/0000-0003-0639-5536; Beck, Hans-Peter/0000-0001-8326-4834; Mercier, Thomas/0000-0003-1921-4837	Swiss National Science Foundation [320000-112479, 326000-121314/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Support for this work was provided by grant No. 320000-112479 from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx). LAD received a REQUIP Grant N 326000-121314/1 from the Swiss National Science Foundation for the acquisition of a new LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ASS MON ANT DRUG EFF; Babalola CP, 1998, PHARM WORLD SCI, V20, P118, DOI 10.1023/A:1008699022244; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Ben Quashie N, 2005, J TROP PEDIATRICS, V51, P149, DOI 10.1093/tropej/fmh104; Corvaisier S, 2004, ANTIMICROB AGENTS CH, V48, P3794, DOI 10.1128/AAC.48.10.3794-3800.2004; EDSTEIN MD, 1987, CHEMOTHERAPY, V33, P229, DOI 10.1159/000238499; EHRHARDT S, T R SOC TROP MED HYG, V97, P697; Evans JA, 2005, QJM-INT J MED, V98, P789, DOI 10.1093/qjmed/hci121; Green MD, 2007, J INFECT DIS, V196, P1403, DOI 10.1086/522632; HELLGREN U, 1994, TROP MED PARASITOL, V45, P293; Hetzel MW, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-83; Hetzel MW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-7; Hodel EM, 2009, J CHROMATOGR B, V877, P867, DOI 10.1016/j.jchromb.2009.02.006; JACKSON PR, 1991, BRIT J CLIN PHARMACO, V31, P55, DOI 10.1111/j.1365-2125.1991.tb03857.x; Mahomva A. I., 1996, Central African Journal of Medicine, V42, P345; MANSOR SM, 1989, BRIT J CLIN PHARMACO, V27, P381, DOI 10.1111/j.1365-2125.1989.tb05381.x; Mockenhaupt FP, 2000, ANTIMICROB AGENTS CH, V44, P835, DOI 10.1128/AAC.44.4.835-839.2000; Newton PN, 2002, ANTIMICROB AGENTS CH, V46, P1125, DOI 10.1128/AAC.46.4.1125-1127.2002; Nsimba SED, 2005, J CLIN PHARM THER, V30, P515, DOI 10.1111/j.1365-2710.2005.00645.x; NWANYANWU O, T R SOC TROP MED HYG, V90, P66; Obua C, 2006, Afr Health Sci, V6, P86; Obua C, 2008, BRIT J CLIN PHARMACO, V65, P493, DOI 10.1111/j.1365-2125.2007.03050.x; OFORIADJEI D, 1984, LANCET, V1, P1246; Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Rahman MM, 2008, T ROY SOC TROP MED H, V102, P861, DOI 10.1016/j.trstmh.2008.05.022; ROMBO L, 1986, TROP MED PARASITOL, V37, P237; Schwick P, 1998, TROP MED INT HEALTH, V3, P828, DOI 10.1046/j.1365-3156.1998.00307.x; Stepniewska K, 2008, ANTIMICROB AGENTS CH, V52, P1589, DOI 10.1128/AAC.00903-07; TALISUNA A, T R SOC TROP MED HYG, V96, P310; Tippawangkosol Pongsri, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P220; Trenque T, 2004, BRIT J CLIN PHARMACO, V57, P735, DOI 10.1111/j.1365-2125.2004.02077.x; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Verhoef H, 1999, AM J TROP MED HYG, V61, P770, DOI 10.4269/ajtmh.1999.61.770; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; WHITE NJ, 1982, AM J MED, V73, P564, DOI 10.1016/0002-9343(82)90337-0; Wichmann O, 2007, T ROY SOC TROP MED H, V101, P637, DOI 10.1016/j.trstmh.2007.03.004	39	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8184	10.1371/journal.pone.0008184	http://dx.doi.org/10.1371/journal.pone.0008184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011529	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300002
J	Sebastiani, P; Montano, M; Puca, A; Solovieff, N; Kojima, T; Wang, MC; Melista, E; Meltzer, M; Fischer, SEJ; Andersen, S; Hartley, SH; Sedgewick, A; Arai, Y; Bergman, A; Barzilai, N; Terry, DF; Riva, A; Anselmi, CV; Malovini, A; Kitamoto, A; Sawabe, M; Arai, T; Gondo, Y; Steinberg, MH; Hirose, N; Atzmon, G; Ruvkun, G; Baldwin, CT; Perls, TT				Sebastiani, Paola; Montano, Monty; Puca, Annibale; Solovieff, Nadia; Kojima, Toshio; Wang, Meng C.; Melista, Efthymia; Meltzer, Micah; Fischer, Sylvia E. J.; Andersen, Stacy; Hartley, Stephen H.; Sedgewick, Amanda; Arai, Yasumichi; Bergman, Aviv; Barzilai, Nir; Terry, Dellara F.; Riva, Alberto; Anselmi, Chiara Viviani; Malovini, Alberto; Kitamoto, Aya; Sawabe, Motoji; Arai, Tomio; Gondo, Yasuyuki; Steinberg, Martin H.; Hirose, Nobuyoshi; Atzmon, Gil; Ruvkun, Gary; Baldwin, Clinton T.; Perls, Thomas T.			RNA Editing Genes Associated with Extreme Old Age in Humans and with Lifespan in C-elegans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN LONGEVITY; EXCEPTIONAL LONGEVITY; MESSENGER-RNA; INSULIN; CENTENARIANS; POPULATION; MORTALITY; GENOTYPE; GENETICS	Background: The strong familiality of living to extreme ages suggests that human longevity is genetically regulated. The majority of genes found thus far to be associated with longevity primarily function in lipoprotein metabolism and insulin/IGF-1 signaling. There are likely many more genetic modifiers of human longevity that remain to be discovered. Methodology/Principal Findings: Here, we first show that 18 single nucleotide polymorphisms (SNPs) in the RNA editing genes ADARB1 and ADARB2 are associated with extreme old age in a U. S. based study of centenarians, the New England Centenarian Study. We describe replications of these findings in three independently conducted centenarian studies with different genetic backgrounds (Italian, Ashkenazi Jewish and Japanese) that collectively support an association of ADARB1 and ADARB2 with longevity. Some SNPs in ADARB2 replicate consistently in the four populations and suggest a strong effect that is independent of the different genetic backgrounds and environments. To evaluate the functional association of these genes with lifespan, we demonstrate that inactivation of their orthologues adr-1 and adr-2 in C. elegans reduces median survival by 50%. We further demonstrate that inactivation of the argonaute gene, rde-1, a critical regulator of RNA interference, completely restores lifespan to normal levels in the context of adr-1 and adr-2 loss of function. Conclusions/Significance: Our results suggest that RNA editors may be an important regulator of aging in humans and that, when evaluated in C. elegans, this pathway may interact with the RNA interference machinery to regulate lifespan.	[Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen H.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Montano, Monty; Meltzer, Micah] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Puca, Annibale; Anselmi, Chiara Viviani; Malovini, Alberto] IRCCS Multimed, Dept Genet, Milan, Italy; [Kojima, Toshio; Kitamoto, Aya] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Kanagawa, Japan; [Wang, Meng C.; Fischer, Sylvia E. J.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Genet, Boston, MA 02114 USA; [Wang, Meng C.; Fischer, Sylvia E. J.; Ruvkun, Gary] Harvard Univ, Sch Med, Boston, MA USA; [Melista, Efthymia; Steinberg, Martin H.; Baldwin, Clinton T.] Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; [Andersen, Stacy; Terry, Dellara F.; Perls, Thomas T.] Boston Univ, Sch Med, Dept Med, Geriatr Sect, Boston, MA 02118 USA; [Sedgewick, Amanda] Boston Univ, Sch Engn, Dept Bioengn, Boston, MA 02215 USA; [Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Sch Med, Dept Internal Med, Div Geriatr Med, Tokyo, Japan; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, Diabet Res Ctr, Bronx, NY 10467 USA; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Riva, Alberto] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sawabe, Motoji; Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Gondo, Yasuyuki] Osaka Univ, Grad Sch Human Sci, Osaka, Japan	Boston University; Boston University; IRCCS Multimedica; RIKEN; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University; Keio University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; University of Florida; Tokyo Metropolitan Institute of Gerontology; Osaka University	Sebastiani, P (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	sebas@bu.edu; mmontano@bu.edu	Malovini, Alberto/I-8727-2018; Sedgewick, Amanda/AAU-5217-2020; Wang, Meng/F-2951-2019; Puca, Annibale Alessandro/K-2099-2018	Malovini, Alberto/0000-0003-2857-5773; Wang, Meng/0000-0002-5898-6007; Riva, Alberto/0000-0001-9150-8333; sebastiani, paola/0000-0001-6419-1545; Baldwin, Clinton/0000-0002-3275-9463; Kitamoto, Aya/0000-0002-0223-3874; Steinberg, Martin/0000-0001-8800-8020; Perls, Thomas/0000-0002-2492-4334; Andersen, Stacy/0000-0002-2442-6386; Montano, Monty/0000-0002-1473-887X; Terry, Dellara/0000-0002-1538-0216	National Institutes of Health [R01 HL087681, K24 AG025727, R01 AR055115, RO1 AG027216]; Italian Ministry of Research and University; Glenn Foundation [AG-027734, AG-18728, RR-12248, DK-20541, M01-RR12248]; Life Sciences Research Foundation; MGH ECOR Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR012248] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027216, K24AG025727, R01AG018728, P01AG027734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR)); Glenn Foundation; Life Sciences Research Foundation; MGH ECOR Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: R01 HL087681 (to M. H. S), K24 AG025727 (to T. T. P), R01 AR055115 (to M. M.), RO1 AG027216 (to C. B.), the Italian Ministry of Research and University (to A. P. and A. M), and the following grants to G. A, A. B. and N. B.: AG-027734, AG-18728, RR-12248, DK-20541, and M01-RR12248 and a grant from the Glenn Foundation. M. C. W. is supported by a Life Sciences Research Foundation fellowship. S. E. J. F. is supported by the MGH ECOR Fund for Medical Discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2004, J AM GERIATR SOC, V52, P274, DOI 10.1111/j.1532-5415.2004.52068.x; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Maas Stefan, 2006, RNA Biol, V3, P1; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2002, CURR OPIN GENET DEV, V12, P362, DOI 10.1016/S0959-437X(02)00310-6; Perls T, 2001, J GERONTOL A-BIOL, V56, pM67, DOI 10.1093/gerona/56.2.M67; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Salvioli S, 2006, FREE RADICAL RES, V40, P1303, DOI 10.1080/10715760600917136; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenhofen EA, 2006, J AM GERIATR SOC, V54, P1237, DOI 10.1111/j.1532-5415.2006.00826.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Sebastiani P, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-6; Sorkin J, 2005, MECH AGEING DEV, V126, P347, DOI 10.1016/j.mad.2004.08.027; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; WANG D, 2004, COLD SPRING HARB SYM, V69, P429; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yang JH, 2003, IMMUNOLOGY, V109, P15, DOI 10.1046/j.1365-2567.2003.01598.x; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	51	60	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8210	10.1371/journal.pone.0008210	http://dx.doi.org/10.1371/journal.pone.0008210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011587	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300005
J	Giraud, G; Ramqvist, T; Pastrana, DV; Pavot, V; Lindau, C; Kogner, P; Orrego, A; Buck, CB; Allander, T; Holm, S; Gustavsson, B; Dalianis, T				Giraud, Geraldine; Ramqvist, Torbjorn; Pastrana, Diana V.; Pavot, Vincent; Lindau, Cecilia; Kogner, Per; Orrego, Abiel; Buck, Christopher B.; Allander, Tobias; Holm, Stefan; Gustavsson, Bengt; Dalianis, Tina			DNA from KI, WU and Merkel Cell Polyomaviruses Is Not Detected in Childhood Central Nervous System Tumours or Neuroblastomas	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; JC VIRUS; BK VIRUS; HUMAN BRAIN; EXPRESSION; INFECTION; CARCINOMA; CHILDREN; ANTIGEN; IDENTIFICATION	Background: BK and JC polyomaviruses (BKV and JCV) are potentially oncogenic and have in the past inconclusively been associated with tumours of the central nervous system (CNS), while BKV has been hinted, but not confirmed to be associated with neuroblastomas. Recently three new polyomaviruses (KIPyV, WUPyV and MCPyV) were identified in humans. So far KIPyV and WUPyV have not been associated to human diseases, while MCPyV was discovered in Merkel Cell carcinomas and may have neuroepithelial cell tropism. However, all three viruses can be potentially oncogenic and this compelled us to investigate for their presence in childhood CNS and neuroblastomas. Methodology: The presence of KI, WU and MCPyV DNA was analysed, by a joint WU and KI specific PCR (covering part of VP1) and by a MCPyV specific regular and real time quantitative PCR (covering part of Large T) in 25 CNS tumour biopsies and 31 neuroblastoma biopsies from the Karolinska University Hospital, Sweden. None of the three new human polyomaviruses were found to be associated with any of the tumours, despite the presence of PCR amplifiable DNA assayed by a S14 housekeeping gene PCR. Conclusion: In this pilot study, the presence of MCPyV, KI and WU was not observed in childhood CNS tumours and neuroblastomas. Nonetheless, we suggest that additional data are warranted in tumours of the central and peripheral nervous systems and we do not exclude that other still not yet detected polyomaviruses could be present in these tumours.	[Giraud, Geraldine; Ramqvist, Torbjorn; Pavot, Vincent; Orrego, Abiel; Dalianis, Tina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Pastrana, Diana V.; Buck, Christopher B.] NCI, Cellular Oncol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Lindau, Cecilia; Allander, Tobias] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kogner, Per; Holm, Stefan] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Gustavsson, Bengt] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Dalianis, Tina] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control	Giraud, G (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	geraldine.giraud@ki.se	Buck, Christopher/G-8358-2017; Pastrana, Diana/ABD-6830-2020	Buck, Christopher/0000-0003-3165-8094; Pavot, Vincent/0000-0002-7362-643X; Kogner, Per/0000-0002-2202-9694; Dalianis, Tina/0000-0001-7022-2424; Pastrana, Diana V./0000-0002-8084-5665	Swedish Children's Cancer Foundation [PROJ07/004]; Swedish Cancer Foundation [08 0278]; Swedish Research Council [K2008-57X-15282-04-3]; Stockholm City Council [75034]; Karolinska Institutet; Stockholm Cancer Society [081041]; King Gustav V's Jubilee Foundation [084052]; NATIONAL CANCER INSTITUTE [ZIABC011090] Funding Source: NIH RePORTER	Swedish Children's Cancer Foundation; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm City Council; Karolinska Institutet(Karolinska Institutet); Stockholm Cancer Society; King Gustav V's Jubilee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported financially by: the Swedish Children's Cancer Foundation (project number PROJ07/004) http://www.barncancerfonden.se/, the Swedish Cancer Foundation (project number 08 0278) http://www.cancerfonden.se/, the Swedish Research Council (VR) (project number K2008-57X-15282-04-3) http://www.vr.se/, The Stockholm City Council (project number 75034) http://international.stockholm.se/Politics-and-organisation/Organisation/The-City-Council/, Karolinska Institutet http://ki.se/, the Stockholm Cancer Society (project number 081041) http://www.radiumhemmetsforskningsfonder.com/, and the King Gustav V's Jubilee Foundation (project number 084052) http://www.radiumhemmetsforskningsfonder.com/. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abed Y, 2007, EMERG INFECT DIS, V13, P1939, DOI 10.3201/eid1312.070909; Abend JR, 2009, SEMIN CANCER BIOL, V19, P252, DOI 10.1016/j.semcancer.2009.02.004; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; ALLISON AC, 1980, VIRAL ONCOLOGY, P481; Andres C, 2009, J DTSCH DERMATOL GES, V7, P843; Barbanti-Brodano G, 2006, ADV EXP MED BIOL, V577, P319; BARZON L, 2009, J INFECT DIS    1027; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; Bluemn EG, 2009, J CLIN VIROL, V44, P164, DOI 10.1016/j.jcv.2008.11.008; BOGDANOVIC G, 1995, CLIN DIAGN VIROL, V4, P223, DOI 10.1016/0928-0197(95)00013-X; Busam KJ, 2009, AM J SURG PATHOL, V33, P1378, DOI 10.1097/PAS.0b013e3181aa30a5; CHUA KL, 1995, ANAL QUANT CYTOL, V17, P221; Dalianis T, 1990, Adv Cancer Res, V55, P57, DOI 10.1016/S0065-230X(08)60468-6; Dalianis T, 2009, SEMIN CANCER BIOL, V19, P270, DOI 10.1016/j.semcancer.2009.04.001; Del Valle L., 2002, HUMAN POLYOMAVIRUSES, P409; DWORKIN A, 2009, J INVEST DERMATOL; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Flaegstad T, 1999, CANCER RES, V59, P1160; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Giraud G, 2008, J CLIN MICROBIOL, V46, P3595, DOI 10.1128/JCM.01635-08; Goh S, 2009, EMERG INFECT DIS, V15, P489, DOI 10.3201/eid1503.081206; Han TH, 2007, EMERG INFECT DIS, V13, P1766, DOI 10.3201/eid1311.070872; Heck JE, 2009, PAEDIATR PERINAT EP, V23, P125, DOI 10.1111/j.1365-3016.2008.00983.x; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Kantola K, 2009, J CLIN VIROL, V45, P292, DOI 10.1016/j.jcv.2009.04.008; Kassem A, 2009, INT J CANCER, V125, P356, DOI 10.1002/ijc.24323; Khalili K, 2006, ADV EXP MED BIOL, V577, P274; Krona C, 2008, INT J ONCOL, V32, P575; Krynska B, 1999, P NATL ACAD SCI USA, V96, P11519, DOI 10.1073/pnas.96.20.11519; LANNERING B, 2009, ACTA PAEDIAT; Lee W, 2006, ADV EXP MED BIOL, V577, P310; LOYO M, 2009, INT J CANC; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; Norja P, 2007, J CLIN VIROL, V40, P307, DOI 10.1016/j.jcv.2007.09.008; PADGETT BL, 1971, LANCET, V1, P1257; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Rencic A, 1996, P NATL ACAD SCI USA, V93, P7352, DOI 10.1073/pnas.93.14.7352; RHOADS DD, 1986, MOL CELL BIOL, V6, P2774, DOI 10.1128/MCB.6.8.2774; Ridd K, 2009, J INVEST DERMATOL, V129, P250, DOI 10.1038/jid.2008.215; Rollison DEM, 2005, INT J CANCER, V113, P769, DOI 10.1002/ijc.20641; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Scotting PJ, 2005, NAT REV CANCER, V5, P481, DOI 10.1038/nrc1633; Sharp CP, 2009, J INFECT DIS, V199, P398, DOI 10.1086/596062; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Stolt A, 2005, INT J CANCER, V113, P393, DOI 10.1002/ijc.20573; White MK, 2005, BRAIN RES REV, V50, P69, DOI 10.1016/j.brainresrev.2005.04.007; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575	50	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8239	10.1371/journal.pone.0008239	http://dx.doi.org/10.1371/journal.pone.0008239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011509	Green Submitted, Green Published, gold			2022-12-25	WOS:000272830200001
J	Jubault, T; Brambati, SM; Degroot, C; Kullmann, B; Strafella, AP; Lafontaine, AL; Chouinard, S; Monchi, O				Jubault, Thomas; Brambati, Simona M.; Degroot, Clotilde; Kullmann, Benoit; Strafella, Antonio P.; Lafontaine, Anne-Louise; Chouinard, Sylvain; Monchi, Oury			Regional Brain Stem Atrophy in Idiopathic Parkinson's Disease Detected by Anatomical MRI	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CORE ASSESSMENT PROGRAM; COGNITIVE IMPAIRMENT; CEREBRAL ATROPHY; DIAGNOSIS; PATHOLOGY; DEMENTIA; ACCURACY	Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder characterized by the dysfunction of dopaminergic dependent cortico-basal ganglia loops and diagnosed on the basis of motor symptoms (tremors and/or rigidity and bradykinesia). Post-mortem studies tend to show that the destruction of dopaminergic neurons in the substantia nigra constitutes an intermediate step in a broader neurodegenerative process rather than a unique feature of Parkinson's disease, as a consistent pattern of progression would exist, originating from the medulla oblongata/pontine tegmentum. To date, neuroimaging techniques have been unable to characterize the pre-symptomatic stages of PD. However, if such a regular neurodegenerative pattern were to exist, consistent damages would be found in the brain stem, even at early stages of the disease. We recruited 23 PD patients at Hoenn and Yahr stages I to II of the disease and 18 healthy controls (HC) matched for age. T1-weighted anatomical scans were acquired (MPRAGE, 1 mm3 resolution) and analyzed using an optimized VBM protocol to detect white and grey matter volume reduction without spatial a priori. When the HC group was compared to the PD group, a single cluster exhibited statistical difference (p < 0.05 corrected for false detection rate, 4287 mm3) in the brain stem, between the pons and the medulla oblongata. The present study provides in-vivo evidence that brain stem damage may be the first identifiable stage of PD neuropathology, and that the identification of this consistent damage along with other factors could help with earlier diagnosis in the future. This damage could also explain some non-motor symptoms in PD that often precede diagnosis, such as autonomic dysfunction and sleep disorders.	[Jubault, Thomas; Brambati, Simona M.; Degroot, Clotilde; Kullmann, Benoit; Monchi, Oury] Inst Univ Geriatrie Montreal, Unite Neuroimagerie Fonctionelle, Montreal, PQ, Canada; [Jubault, Thomas; Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada; [Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; [Strafella, Antonio P.] Univ Toronto, CAMH PET Imaging Ctr, Toronto, ON, Canada; [Lafontaine, Anne-Louise] McGill Univ, Ctr Hlth, Movement Disorders Unit, Montreal, PQ, Canada; [Chouinard, Sylvain] Ctr Hosp Univ Montreal, Unite Desordres Mouvement, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; McGill University; Universite de Montreal	Jubault, T (corresponding author), Inst Univ Geriatrie Montreal, Unite Neuroimagerie Fonctionelle, Montreal, PQ, Canada.	thomas.jubault@umontreal.ca	Brambati, Simona Maria/GRO-4583-2022; Monchi, Oury/N-8417-2019	Brambati, Simona Maria/0000-0002-9227-1443; 	Canadian Institutes for Health Research [MOP-81114]; Fond de la Recherche du Quebec; Parkinson Society of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fond de la Recherche du Quebec; Parkinson Society of Canada	This work was supported by an operating grant from the Canadian Institutes for Health Research to OM (MOP-81114). OM receives a faculty salary award from the Fond de la Recherche du Quebec and TJ a postdoctoral fellowship from the Parkinson Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Chaudhuri KR, 2001, CURR OPIN NEUROL, V14, P505, DOI 10.1097/00019052-200108000-00012; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; DUYCKAERTS C, 2003, REV NEUROL PARIS, V159; ESCOUROLLE R, 1970, REV PRATICIEN, V20, P5175; FRISTON KJ, 1995, HUM BRAIN MAPP; Gagnon JF, 2002, NEUROLOGY, V59, P585, DOI 10.1212/WNL.59.4.585; Ghorayeb I, 2005, REV NEUROL-FRANCE, V161, P907, DOI 10.1016/S0035-3787(05)85154-9; GOOD CD, 2001, VOXEL BASED MORPHOME; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242; Meara J, 1999, AGE AGEING, V28, P99, DOI 10.1093/ageing/28.2.99; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Price S, 2004, NEUROIMAGE, V23, P663, DOI 10.1016/j.neuroimage.2004.06.013; Ramirez-Ruiz B, 2005, J NEUROL, V252, P1345, DOI 10.1007/s00415-005-0864-2; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Seppi K, 2005, CURR OPIN NEUROL, V18, P370, DOI 10.1097/01.wco.0000173141.74137.63; Sohn YH, 1998, YONSEI MED J, V39, P50, DOI 10.3349/ymj.1998.39.1.50; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; WARD CD, 1983, NEUROLOGY, V33, P943, DOI 10.1212/WNL.33.7.943	31	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2009	4	12							e8247	10.1371/journal.pone.0008247	http://dx.doi.org/10.1371/journal.pone.0008247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NG	20011063	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830000001
J	Abadie, V; Bonduelle, O; Duffy, D; Parizot, C; Verrier, B; Combadiere, B				Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Verrier, Bernard; Combadiere, Behazine			Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice	PLOS ONE			English	Article							MODIFIED VACCINIA VIRUS; CD8-ALPHA(+) DENDRITIC CELLS; CD8(+) T-CELLS; SMALLPOX VACCINE; LYMPH-NODE; IN-VIVO; ATTENUATED MVA; LANGERHANS CELLS; ANKARA MVA; MEMORY	Background: Obtaining a certain multi-functionality of cellular immunity for the control of infectious diseases is a burning question in immunology and in vaccine design. Early events, including antigen shuttling to secondary lymphoid organs and recruitment of innate immune cells for adaptive immune response, determine host responsiveness to antigens. However, the sequence of these events and their impact on the quality of the immune response remain to be elucidated. Here, we chose to study Modified Vaccinia virus Ankara (MVA) which is now replacing live Smallpox vaccines and is proposed as an attenuated vector for vaccination strategies against infectious diseases. Methodology/Principal findings: We analyzed in vivo mechanisms triggered following intradermal (i.d.) and intramuscular (i.m.) Modified Vaccinia virus Ankara (MVA) administration. We demonstrated significant differences in the antigen shuttling to lymphoid organs by macrophages (M Phi s), myeloid dendritic cells (DCs), and neutrophils (PMNs). MVA i.d. administration resulted in better antigen distribution and more sustained antigen-presenting cells (APCs) recruitment into draining lymph nodes than with i.m. administration. These APCs, which comprise both DCs and M Phi s, were differentially involved in T cell priming and shaped remarkably the quality of cytokine-producing virus-specific T cells according to the entry route of MVA. Conclusions/Significance: This study improves our understanding of the mechanisms of antigen delivery and their consequences on the quality of immune responses and provides new insights for vaccine development.	[Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Combadiere, Behazine] INSERM, U945, Paris, France; [Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Combadiere, Behazine] Univ Paris 06, Paris, France; [Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Combadiere, Behazine] AP HP, Paris, France; [Verrier, Bernard] CNRS UCBL, Inst Biol & Chim Prot, UMR 5086, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Abadie, V (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	behazine.combadiere@upmc.fr	Combadiere, Behazine/S-8054-2019; Combadiere, Behazine/G-3881-2013; verrier, bernard/J-4094-2017	Combadiere, Behazine/0000-0002-2353-4406; verrier, bernard/0000-0002-8478-7095; PARIZOT, Christophe/0000-0001-5723-4471	Fondation pour la Recherche Medicale (FRM); MuNanoVac (EU-FP6); Agence Nationale de Recherche; ANRS	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); MuNanoVac (EU-FP6)(European Commission); Agence Nationale de Recherche(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by a grant from Fondation pour la Recherche Medicale (FRM), MuNanoVac (EU-FP6), and Young Investigator Awards of the Agence Nationale de Recherche. B. Combadiere is a recipient of INSERM-Interface program. D. Duffy is a recipient of ANRS fellowship. V. Abadie is a recipient of the FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Amara RR, 2004, J VIROL, V78, P3811, DOI 10.1128/JVI.78.8.3811-3816.2004; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Bontkes HJ, 2005, CELL ONCOL, V27, P175; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Cosma A, 2004, CLIN DIAGN LAB IMMUN, V11, P406, DOI 10.1128/CDLI.11.2.406-410.2004; Drexler I, 2003, P NATL ACAD SCI USA, V100, P217, DOI 10.1073/pnas.262668999; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iga M, 2007, VACCINE, V25, P4554, DOI 10.1016/j.vaccine.2007.04.028; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Phelps AL, 2007, VACCINE, V25, P34, DOI 10.1016/j.vaccine.2006.07.022; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Puissant B, 2006, CELL MOL LIFE SCI, V63, P2249, DOI 10.1007/s00018-006-6313-2; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Usherwood EJ, 1999, J IMMUNOL, V162, P3350; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	48	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8159	10.1371/journal.pone.0008159	http://dx.doi.org/10.1371/journal.pone.0008159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997562	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829500012
J	Hellquist, A; Zucchelli, M; Lindgren, CM; Saarialho-Kere, U; Jarvinen, TM; Koskenmies, S; Julkunen, H; Onkamo, P; Skoog, T; Panelius, J; Raisanen-Sokolowski, A; Hasan, T; Widen, E; Gunnarson, I; Svenungsson, E; Padyukov, L; Assadi, G; Berglind, L; Makela, VV; Kivinen, K; Wong, A; Graham, DSC; Vyse, TJ; D'Amato, M; Kere, J				Hellquist, Anna; Zucchelli, Marco; Lindgren, Cecilia M.; Saarialho-Kere, Ulpu; Jarvinen, Tiina M.; Koskenmies, Sari; Julkunen, Heikki; Onkamo, Paivi; Skoog, Tiina; Panelius, Jaana; Raisanen-Sokolowski, Anne; Hasan, Taina; Widen, Elisabeth; Gunnarson, Iva; Svenungsson, Elisabet; Padyukov, Leonid; Assadi, Ghazaleh; Berglind, Linda; Makela, Ville-Veikko; Kivinen, Katja; Wong, Andrew; Graham, Deborah S. Cunningham; Vyse, Timothy J.; D'Amato, Mauro; Kere, Juha			Identification of MAMDC1 as a Candidate Susceptibility Gene for Systemic Lupus Erythematosus (SLE)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULES; TUMOR-NECROSIS-FACTOR; AUTOIMMUNE-DISEASE; IMMUNOGLOBULIN SUPERFAMILY; LINKAGE DISEQUILIBRIUM; UP-REGULATION; TNF-ALPHA; NEUROTICISM; EXPRESSION	Background: Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with multiple susceptibility genes. We have previously reported suggestive linkage to the chromosomal region 14q21-q23 in Finnish SLE families. Principal Findings: Genetic fine mapping of this region in the same family material, together with a large collection of parent affected trios from UK and two independent case-control cohorts from Finland and Sweden, indicated that a novel uncharacterized gene, MAMDC1 (MAM domain containing glycosylphosphatidylinositol anchor 2, also known as MDGA2, MIM 611128), represents a putative susceptibility gene for SLE. In a combined analysis of the whole dataset, significant evidence of association was detected for the MAMDC1 intronic single nucleotide polymorphisms (SNP) rs961616 (P - value = 0.001, Odds Ratio (OR) = 1.292, 95% CI 1.103-1.513) and rs2297926 (P - value = 0.003, OR = 1.349, 95% CI 1.109-1.640). By Northern blot, real-time PCR (qRT-PCR) and immunohistochemical (IHC) analyses, we show that MAMDC1 is expressed in several tissues and cell types, and that the corresponding mRNA is up-regulated by the pro-inflammatory cytokines tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) in THP-1 monocytes. Based on its homology to known proteins with similar structure, MAMDC1 appears to be a novel member of the adhesion molecules of the immunoglobulin superfamily (IgCAM), which is involved in cell adhesion, migration, and recruitment to inflammatory sites. Remarkably, some IgCAMs have been shown to interact with ITGAM, the product of another SLE susceptibility gene recently discovered in two independent genome wide association (GWA) scans. Significance: Further studies focused on MAMDC1 and other molecules involved in these pathways might thus provide new insight into the pathogenesis of SLE.	[Hellquist, Anna; Zucchelli, Marco; Skoog, Tiina; Assadi, Ghazaleh; D'Amato, Mauro; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Med, Oxford, England; [Saarialho-Kere, Ulpu; Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana] Univ Helsinki, Cent Hosp, Dept Dermatol, FIN-00170 Helsinki, Finland; [Saarialho-Kere, Ulpu; Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana] Skin & Allergy Hosp, Helsinki, Finland; [Saarialho-Kere, Ulpu; Skoog, Tiina] Stockholm Soder Hosp, Karolinska Inst, Dermatol Sect, Stockholm, Sweden; [Saarialho-Kere, Ulpu; Skoog, Tiina] Stockholm Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Jarvinen, Tiina M.; Koskenmies, Sari; Widen, Elisabeth; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Widen, Elisabeth; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Julkunen, Heikki] Peijas Hosp, Vantaa, Finland; [Julkunen, Heikki] Helsinki Univ Hosp, Dept Med, Vantaa, Finland; [Onkamo, Paivi] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Raisanen-Sokolowski, Anne] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Raisanen-Sokolowski, Anne] Univ Helsinki, Cent Hosp, Transplantat Lab, Helsinki, Finland; [Hasan, Taina] Univ Tampere, FIN-33101 Tampere, Finland; [Hasan, Taina] Tampere Univ Hosp, Dept Dermatol, Tampere, Finland; [Gunnarson, Iva; Svenungsson, Elisabet; Padyukov, Leonid] Karolinska Univ Hosp, Karolinska Inst, Rheumatol Unit, Dept Med, Stockholm, Sweden; [Berglind, Linda; Makela, Ville-Veikko; Kere, Juha] Karolinska Univ Hosp, Clin Res Ctr, Huddinge, Sweden; [Kivinen, Katja] Wellcome Trust Sanger Inst, Cambridge, England; [Wong, Andrew; Graham, Deborah S. Cunningham] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Rheumatol Sect, London, England; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Mol Genet & Rheumatol Sect, London, England	Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Wellcome Trust Sanger Institute; Imperial College London; Imperial College London	Hellquist, A (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	juha.kere@ki.se	Wong, Andrew/M-8899-2016; D'Amato, Mauro/F-2450-2010; Räisänen-Sokolowski, Anne/AAD-7005-2021; D'Amato, Mauro/B-5050-2019; Kere, Juha/AAX-9117-2021; Wong, Andrew/AAE-6995-2019; Kere, Juha/A-9179-2008; Skoog, Tiina/B-8598-2014; Skoog, Tiina/N-3525-2019; Padyukov, Leonid/A-4890-2009	Wong, Andrew/0000-0003-2079-4779; D'Amato, Mauro/0000-0003-2743-5197; Räisänen-Sokolowski, Anne/0000-0002-2154-7377; D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; Wong, Andrew/0000-0003-2079-4779; Kere, Juha/0000-0003-1974-0271; Skoog, Tiina/0000-0002-0148-0654; Padyukov, Leonid/0000-0003-2950-5670; Kivinen, Katja/0000-0002-1135-7625; Svenungsson, Elisabet/0000-0003-3396-3244; Lindgren, Cecilia/0000-0002-4903-9374; Assadi, Ghazaleh/0000-0002-3723-9141	Academy of Finland; Sigrid Juselius Foundation; Finska Lakarsallskapet, Finland; Swedish Research Council; Helsinki University Central Hospital Research Fund [TYH5241]; Welander-Finsen Foundation, Sweden; Helsinki Biomedical Graduate School; University of Helsinki Research Foundation; Biomedicum Helsinki Foundation; Swedish Heart-Lung Foundation; Royal Physiographic Society in Lund; The King Gustaf V 80th Birthday Fund; Ake Wiberg Foundation; Stockholm County Council	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakarsallskapet, Finland; Swedish Research Council(Swedish Research CouncilEuropean Commission); Helsinki University Central Hospital Research Fund; Welander-Finsen Foundation, Sweden; Helsinki Biomedical Graduate School; University of Helsinki Research Foundation; Biomedicum Helsinki Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Royal Physiographic Society in Lund; The King Gustaf V 80th Birthday Fund; Ake Wiberg Foundation; Stockholm County Council(Stockholm County Council)	This study was supported by the Academy of Finland, Sigrid Juselius Foundation and Finska Lakarsallskapet, Finland and Swedish Research Council (to JK and US-K), the Helsinki University Central Hospital Research Fund (TYH5241), the Welander-Finsen Foundation, Sweden (to TS), the Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine (to TMJ), and by personal grants from the University of Helsinki Research Foundation and the Biomedicum Helsinki Foundation (TMJ). Further support came from the Swedish Heart-Lung Foundation, The Royal Physiographic Society in Lund, The King Gustaf V 80th Birthday Fund, The Ake Wiberg Foundation and ALF funding from Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aringer M, 2003, ARTHRITIS RES THER, V5, P172, DOI 10.1186/ar770; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELMONT HM, 1994, ARTHRITIS RHEUM, V37, P376, DOI 10.1002/art.1780370311; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Criswell LA, 2008, BULL HOSP JT DIS, V66, P176; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; De Juan C, 2002, ONCOGENE, V21, P3089, DOI 10.1038/sj.onc.1205383; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Diaz-Lopez A, 2005, EXP CELL RES, V307, P91, DOI 10.1016/j.yexcr.2005.02.016; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Fairhurst AM, 2006, ADV IMMUNOL, V92, P1, DOI 10.1016/S0065-2776(06)92001-X; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Harley JB, 2006, SPRINGER SEMIN IMMUN, V28, P119, DOI 10.1007/s00281-006-0040-5; Hettema JM, 2009, PSYCHIAT GENET, V19, P213, DOI 10.1097/YPG.0b013e32832cec22; HOCHBERG MC, 1987, J RHEUMATOL, V14, P867; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Koskenmies S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009977; Koskenmies S, 2008, LUPUS, V17, P337, DOI 10.1177/0961203307087403; Koskenmies S, 2004, EUR J HUM GENET, V12, P489, DOI 10.1038/sj.ejhg.5201125; Koskenmies S, 2001, J RHEUMATOL, V28, P758; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lee YH, 2005, HUM GENET, V118, P434, DOI 10.1007/s00439-005-0073-1; Litwack ED, 2004, MOL CELL NEUROSCI, V25, P263, DOI 10.1016/j.mcn.2003.10.016; McHale JF, 1999, J IMMUNOL, V163, P3993; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Molina V, 2005, AUTOIMMUNITY, V38, P235, DOI 10.1080/08916930500050277; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; Norman MU, 2005, TISSUE ANTIGENS, V66, P163, DOI 10.1111/j.1399-0039.2005.00434.x; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; PALLIS M, 1993, ANN RHEUM DIS, V52, P667, DOI 10.1136/ard.52.9.667; Rhodes B, 2008, RHEUMATOLOGY, V47, P1603, DOI 10.1093/rheumatology/ken247; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Sfikakis PP, 1999, CLIN RHEUMATOL, V18, P317, DOI 10.1007/s100670050109; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Svenungsson E, 2008, SCAND J RHEUMATOL, V37, P352, DOI 10.1080/03009740802007514; Svenungsson E, 2003, ARTHRITIS RHEUM-US, V48, P2533, DOI 10.1002/art.11264; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Tsao BP, 2004, CURR OPIN RHEUMATOL, V16, P513, DOI 10.1097/01.bor.0000132648.62680.81; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; WIDIGER TA, 1992, J PERS, V60, P363, DOI 10.1111/j.1467-6494.1992.tb00977.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou XD, 2003, ARTHRITIS RHEUM-US, V48, P2585, DOI 10.1002/art.11220	60	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8037	10.1371/journal.pone.0008037	http://dx.doi.org/10.1371/journal.pone.0008037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997561	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829500003
J	Salzler, HR; Davidson, JM; Montgomery, ND; Duronio, RJ				Salzler, Harmony R.; Davidson, Jean M.; Montgomery, Nathan D.; Duronio, Robert J.			Loss of the Histone Pre-mRNA Processing Factor Stem-Loop Binding Protein in Drosophila Causes Genomic Instability and Impaired Cellular Proliferation	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; DNA-SYNTHESIS; S-PHASE; 3' END; CYCLE PROGRESSION; IN-VIVO; REPLICATION; MELANOGASTER; CHROMATIN; CELLS	Background: Metazoan replication-dependent histone mRNAs terminate in a conserved stem-loop structure rather than a polyA tail. Formation of this unique mRNA 3' end requires Stem-loop Binding Protein ( SLBP), which directly binds histone pre-mRNA and stimulates 3' end processing. The 3' end stem-loop is necessary for all aspects of histone mRNA metabolism, including replication coupling, but its importance to organism fitness and genome maintenance in vivo have not been characterized. Methodology/Principal Findings: In Drosophila, disruption of the Slbp gene prevents normal histone pre-mRNA processing and causes histone pre-mRNAs to utilize the canonical 3' end processing pathway, resulting in polyadenylated histone mRNAs that are no longer properly regulated. Here we show that Slbp mutants display genomic instability, including loss of heterozygosity (LOH), increased presence of chromosome breaks, tetraploidy, and changes in position effect variegation (PEV). During imaginal disc growth, Slbp mutant cells show defects in S phase and proliferate more slowly than control cells. Conclusions/Significance: These data are consistent with a model in which changing the 3' end of histone mRNA disrupts normal replication-coupled histone mRNA biosynthesis and alters chromatin assembly, resulting in genomic instability, inhibition of cell proliferation, and impaired development.	[Salzler, Harmony R.; Montgomery, Nathan D.; Duronio, Robert J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Davidson, Jean M.; Duronio, Robert J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Duronio, Robert J.] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; [Duronio, Robert J.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Salzler, HR (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	duronio@med.unc.edu	Davidson, Jean/G-7558-2012	Davidson, Jean/0000-0001-5951-5955; Salzler, Harmony/0000-0002-1544-8700; Duronio, Robert/0000-0001-6469-6965; Montgomery, Nathan/0000-0003-1765-6623	National Science Foundation [MCB-9984068]; National Institutes of Health [GM57859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057859] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation (MCB-9984068) and the National Institutes of Health ( GM57859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADESNIK M, 1972, J MOL BIOL, V67, P397, DOI 10.1016/0022-2836(72)90458-5; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BIRNSTIEL ML, 1998, STRUCTURE FUNCTION M, P155; Cakmakci NG, 2008, MOL CELL BIOL, V28, P1182, DOI 10.1128/MCB.01500-07; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; de la Cruz Aida Flor A., 2008, V420, P373, DOI 10.1007/978-1-59745-583-1_24; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2005, RNA, V11, P1835, DOI 10.1261/rna.2179305; Dominski Z, 1995, RNA, V1, P915; Dominski Z, 2003, P NATL ACAD SCI USA, V100, P9422, DOI 10.1073/pnas.1533509100; DOMINSKI Z, 2007, GENE; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Ephrussi B, 1944, GENETICS, V29, P148; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GATTI M, 1974, GENETICS, V77, P701; Godfrey AC, 2006, RNA, V12, P396, DOI 10.1261/rna.2270406; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hanlon SE, 2003, GENETICS, V164, P1333; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Konev AY, 2003, GENETICS, V165, P2039; Lanzotti DJ, 2002, MOL CELL BIOL, V22, P2267, DOI 10.1128/MCB.22.7.2267-2282.2002; LEVINE BJ, 1987, P NATL ACAD SCI USA, V84, P6189, DOI 10.1073/pnas.84.17.6189; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Loupart ML, 2000, CURR BIOL, V10, P1547, DOI 10.1016/S0960-9822(00)00844-7; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; MOORE GD, 1979, NATURE, V282, P312, DOI 10.1038/282312a0; MOORE GD, 1983, GENETICS, V105, P327; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PARKER DR, 1965, MUTAT RES, V2, P523, DOI 10.1016/0027-5107(65)90017-5; Paro R, 2000, DROSOPHILA PROTOCOLS; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sanchez R, 2002, MOL CELL BIOL, V22, P7093, DOI 10.1128/MCB.22.20.7093-7104.2002; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Tsui KC, 1997, GENETICS, V145, P647; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Wagner EJ, 2006, MOL CELL BIOL, V26, P6702, DOI 10.1128/MCB.00391-06; XU T, 1993, DEVELOPMENT, V117, P1223; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Ye XF, 2003, CELL CYCLE, V2, P185, DOI 10.4161/cc.2.3.389; ZHANG P, 1994, P NATL ACAD SCI USA, V91, P3539, DOI 10.1073/pnas.91.9.3539; Zhao XJ, 2004, J CELL SCI, V117, P6043, DOI 10.1242/jcs.01523	66	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8168	10.1371/journal.pone.0008168	http://dx.doi.org/10.1371/journal.pone.0008168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997601	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829200008
J	Guo, JH; Cagatay, T; Zhou, GJ; Chan, CC; Blythe, S; Suyama, K; Zheng, L; Pan, KF; Qian, CP; Hamelin, R; Thibodeau, SN; Klein, PS; Wharton, KA; Liu, WG				Guo, Jianhui; Cagatay, Tolga; Zhou, Guangjin; Chan, Chih-Chiang; Blythe, Shelby; Suyama, Kaye; Zheng, Li; Pan, Kaifeng; Qian, Chiping; Hamelin, Richard; Thibodeau, Stephen N.; Klein, Peter S.; Wharton, Keith A., Jr.; Liu, Wanguo			Mutations in the Human naked cuticle Homolog NKD1 Found in Colorectal Cancer Alter Wnt/Dvl/beta-Catenin Signaling	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; WNT PATHWAY; MISMATCH REPAIR; BETA-CATENIN; MICROSATELLITE INSTABILITY; NEGATIVE REGULATION; GENETIC ALTERATIONS; DROSOPHILA; ANTAGONIST; ACTIVATION	Background: Mutation of Wnt signal antagonists Apc or Axin activates beta-catenin signaling in many cancers including the majority of human colorectal adenocarcinomas. The phenotype of apc or axin mutation in the fruit fly Drosophila melanogaster is strikingly similar to that caused by mutation in the segment-polarity gene, naked cuticle (nkd). Nkd inhibits Wnt signaling by binding to the Dishevelled (Dsh/Dvl) family of scaffold proteins that link Wnt receptor activation to beta-catenin accumulation and TCF-dependent transcription, but human NKD genes have yet to be directly implicated in cancer. Methodology/Principal Findings: We identify for the first time mutations in NKD1 - one of two human nkd homologs - in a subset of DNA mismatch repair-deficient colorectal tumors that are not known to harbor mutations in other Wnt-pathway genes. The mutant Nkd1 proteins are defective at inhibiting Wnt signaling; in addition, the mutant Nkd1 proteins stabilize beta-catenin and promote cell proliferation, in part due to a reduced ability of each mutant Nkd1 protein to bind and destabilize Dvl proteins. Conclusions/Significance: Our data raise the hypothesis that specific NKD1 mutations promote Wnt-dependent tumorigenesis in a subset of DNA mismatch-repair-deficient colorectal adenocarcinomas and possibly other Wnt-signal driven human cancers.	[Guo, Jianhui; Qian, Chiping; Liu, Wanguo] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, Stanley S Scott Canc Ctr, New Orleans, LA USA; [Cagatay, Tolga; Chan, Chih-Chiang; Wharton, Keith A., Jr.] UT SW Med Ctr, Simmons Comprehens Canc Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX USA; [Cagatay, Tolga; Chan, Chih-Chiang; Wharton, Keith A., Jr.] UT SW Med Ctr, Simmons Comprehens Canc Ctr, Dept Mol Biol, Dallas, TX USA; [Zhou, Guangjin; Zheng, Li; Pan, Kaifeng; Qian, Chiping; Thibodeau, Stephen N.; Liu, Wanguo] Mayo Clin, Dept Lab Med & Pathol, Mayo Clin Coll Med, Rochester, MN USA; [Blythe, Shelby; Klein, Peter S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Suyama, Kaye] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Hamelin, Richard] INSERM, Equipe Microsatellites & Canc U938, Paris, France; [Suyama, Kaye] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Blythe, Shelby; Wharton, Keith A., Jr.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; University of Pennsylvania; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); Howard Hughes Medical Institute; Stanford University; University of Pennsylvania	Guo, JH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, Stanley S Scott Canc Ctr, New Orleans, LA USA.	kwhartonjr@gmail.com; wliu2@lsuhsc.edu	Chan, Chih-Chiang/G-4923-2011; Guo, Jianhui/AAJ-6220-2020; zhou, guangjin/F-9031-2011; CHAN, CHIH-CHIANG/AGM-3463-2022	CHAN, CHIH-CHIANG/0000-0003-2626-3805; Blythe, Shelby/0000-0003-4986-2579	American Cancer Society Institutional Research Grant; National Institutes of Health [R01-GM65404, R01-CA60117]; Mayo Clinic/Foundation; NATIONAL CANCER INSTITUTE [R01CA060117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065404, R01GM076621] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic/Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an American Cancer Society Institutional Research Grant ( to K. W.); the National Institutes of Health (R01-GM65404 to K. W.; R01-CA60117 to S. N. T.); and the Mayo Clinic/Foundation ( to W. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Boland CR, 1998, CANCER RES, V58, P5248; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; Chan CC, 2007, DEV BIOL, V311, P538, DOI 10.1016/j.ydbio.2007.09.002; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Duval A, 1999, CANCER RES, V59, P4213; Duval A, 2002, CANCER RES, V62, P2447; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Guo JH, 2004, BIOCHEM BIOPH RES CO, V324, P922, DOI 10.1016/j.bbrc.2004.09.133; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hlubek F, 2007, FRONT BIOSCI, V12, P458, DOI 10.2741/2075; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; Katoh M, 2001, INT J ONCOL, V19, P963; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Li Q, 2005, J BIOL CHEM, V280, P2831, DOI 10.1074/jbc.M405680200; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rousset R, 2002, J BIOL CHEM, V277, P49019, DOI 10.1074/jbc.M203246200; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; SOKOL SY, 1995, DEVELOPMENT, V121, P3487; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Toft NJ, 1998, J PATHOL, V185, P123; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Waldrop S, 2006, GENETICS, V174, P331, DOI 10.1534/genetics.106.061853; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang S, 2007, MOL CELL BIOL, V27, P4454, DOI 10.1128/MCB.00133-07	48	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7982	10.1371/journal.pone.0007982	http://dx.doi.org/10.1371/journal.pone.0007982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956716	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827500012
J	McCarty, JP; Jorgensen, JG; Wolfenbarger, LL				McCarty, John P.; Jorgensen, Joel G.; Wolfenbarger, L. LaReesa			Behavior of Buff-Breasted Sandpipers (Tryngites subruficollis) during Migratory Stopover in Agricultural Fields	PLOS ONE			English	Article							SOUTHERN HIGH-PLAINS; MIGRANT SHOREBIRDS; HABITAT USE; BIRDS; ABUNDANCE; CONSERVATION; GRASSLANDS; PESTICIDES; MORTALITY	Background: Understanding the behavior of birds in agricultural habitats can be the first step in evaluating the conservation implications of birds' use of landscapes shaped by modern agriculture. The existence and magnitude of risk from agricultural practices and the quality of resources agricultural lands provide will be determined largely by how birds use these habitats. Buff-breasted Sandpipers (Tryngites subruficollis) are a species of conservation concern. During spring migration large numbers of Buff-breasted Sandpipers stopover in row crop fields in the Rainwater Basin region of Nebraska. We used behavioral observations as a first step in evaluating how Buff-breasted Sandpipers use crop fields during migratory stopover. Methodology/Principal Findings: We measured behavior during migratory stopover using scan and focal individual sampling to determine how birds were using crop fields. Foraging was the most frequent behavior observed, but the intensity of foraging changed over the course of the day with a distinct mid-day low point. Relative to other migrating shorebirds, Buff-breasted Sandpipers spent a significant proportion of their time in social interactions including courtship displays. Conclusions/Significance: Our results show that the primary use of upland agricultural fields by migrating Buff-breasted Sandpipers is foraging while wetlands are used for maintenance and resting. The importance of foraging in row crop fields suggests that both the quality of food resources available in fields and the possible risks from dietary exposure to agricultural chemicals will be important to consider when developing conservation plans for Buff-breasted Sandpipers migrating through the Great Plains.	[McCarty, John P.; Wolfenbarger, L. LaReesa] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Jorgensen, Joel G.] Nebraska Game & Pk Commiss, Nongame Bird Program, Lincoln, NE USA	University of Nebraska System	McCarty, JP (corresponding author), Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.	jmccarty@unomaha.edu	McCarty, John P/E-9797-2011	McCarty, John P/0000-0002-6278-5451	Nebraska State Wildlife Grant Program [T-43-R]; Department of Biology at the University of Nebraska at Omaha; Nebraska Game and Parks Commission	Nebraska State Wildlife Grant Program; Department of Biology at the University of Nebraska at Omaha; Nebraska Game and Parks Commission	Funding was provided by a grant from the Nebraska State Wildlife Grant Program (T-43-R - http://www.ngpc.state.ne.us/wildlife/programs/grants/).Additional support was provided by the Department of Biology at the University of Nebraska at Omaha and the Nebraska Game and Parks Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, after being awarded this grant one author (Jorgensen) was hired by the agency that awarded the grant.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andrei AE, 2007, WATERBIRDS, V30, P326, DOI 10.1675/1524-4695(2007)030[0326:BOMSIS]2.0.CO;2; BEST LB, 1995, AM MIDL NAT, V134, P1, DOI 10.2307/2426479; BRENNAN EK, 2006, THESIS TEXAS TU LUBB; Brown S, 2001, US SHOREBIRD CONSERV; Burton NHK, 2005, BIRD STUDY, V52, P120, DOI 10.1080/00063650509461381; Corson MS, 1998, ECOL MODEL, V105, P299, DOI 10.1016/S0304-3800(97)00174-9; Davis CA, 1998, CONDOR, V100, P266, DOI 10.2307/1370267; De Leon MT, 1999, CONDOR, V101, P645, DOI 10.2307/1370194; DIETRICH DR, 1995, ARCH ENVIRON CON TOX, V29, P140, DOI 10.1007/BF00213099; Fox AD, 2005, GLOBAL CHANGE BIOL, V11, P881, DOI 10.1111/j.1365-2486.2005.00941.x; Gillings S, 2005, AUK, V122, P1249, DOI 10.1642/0004-8038(2005)122[1249:DSDNPN]2.0.CO;2; Grue CE, 1997, AM ZOOL, V37, P369; Isacch JP, 2003, WATERBIRDS, V26, P494, DOI 10.1675/1524-4695(2003)026[0494:HUBNSI]2.0.CO;2; Isacch JP, 2003, J FIELD ORNITHOL, V74, P233, DOI 10.1648/0273-8570-74.3.233; Jorgensen J. G., 2007, THESIS U NEBRASKA OM; JORGENSEN JG, 2007, INT WADER STUDY GROU, V112, P45; Jorgensen JG, 2008, CONDOR, V110, P63, DOI 10.1525/cond.2008.110.1.63; Kostecke RM, 2003, WATERBIRDS, V26, P192, DOI 10.1675/1524-4695(2003)026[0192:NBOAAI]2.0.CO;2; Krapu GL, 2004, WILDLIFE SOC B, V32, P127, DOI 10.2193/0091-7648(2004)32[127:LWCMLI]2.0.CO;2; Kuwae T, 2007, MAR BIOL, V151, P663, DOI 10.1007/s00227-006-0506-y; Lanctot RB, 2002, WILSON BULL, V114, P44, DOI 10.1676/0043-5643(2002)114[0044:CSOTBB]2.0.CO;2; LANCTOT RB, 1994, BIRDS N AM, V91; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; MINEAU P, 2005, PSWGTR191 USDA; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; ORING LEWIS W., 1964, AUK, V81, P83; Rottenborn SC, 1996, WILSON BULL, V108, P783; Shepherd PCF, 2004, J WILDLIFE MANAGE, V68, P61, DOI 10.2193/0022-541X(2004)068[0061:MAAHPO]2.0.CO;2; Skagen SK, 2006, AUK, V123, P313, DOI 10.1642/0004-8038(2006)123[313:MSATCO]2.0.CO;2; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; U.S. Shorebird Conservation Plan, 2004, HIGH PRIOR SHOR 2004; *US EPA, 2008, FEB 5 8 2008 FIFRA S; Vyas NB, 1999, TOXICOL IND HEALTH, V15, P186, DOI 10.1191/074823399678846628; Walker CH, 2003, ECOTOXICOLOGY, V12, P307, DOI 10.1023/A:1022523331343; WINDINGSTAD RM, 1989, J WILDLIFE DIS, V25, P38, DOI 10.7589/0090-3558-25.1.38; Young Jessica R., 2005, P616	37	3	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8000	10.1371/journal.pone.0008000	http://dx.doi.org/10.1371/journal.pone.0008000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956768	Green Published, gold			2022-12-25	WOS:000272827500026
J	Smith, SG; Joosten, SA; Verscheure, V; Pathan, AA; McShane, H; Ottenhoff, THM; Dockrell, HM; Mascart, F				Smith, Steven G.; Joosten, Simone A.; Verscheure, Virginie; Pathan, Ansar A.; McShane, Helen; Ottenhoff, Tom H. M.; Dockrell, Hazel M.; Mascart, Francoise			Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; INTERFERON-GAMMA; FLOW-CYTOMETRY; T-CELLS; IMMUNITY; INFECTION; VACCINE; ASSAYS; IMMUNOGENICITY; ENUMERATION	A number of different interferon-gamma ELISpot protocols are in use in laboratories studying antigen-specific immune responses. It is therefore unclear how results from different assays compare, and what factors most significantly influence assay outcome. One such difference is that some laboratories use a short in vitro stimulation period of cells before they are transferred to the ELISpot plate; this is commonly done in the case of frozen cells, in order to enhance assay sensitivity. Other differences that may be significant include antibody coating of plates, the use of media with or without serum, the serum source and the number of cells added to the wells. The aim of this paper was to identify which components of the different ELISpot protocols influenced assay sensitivity and inter-laboratory variation. Four laboratories provided protocols for quantifying numbers of interferon-gamma spot forming cells in human peripheral blood mononuclear cells stimulated with Mycobacterium tuberculosis derived antigens. The differences in the protocols were compared directly. We found that several sources of variation in assay protocols can be eliminated, for example by avoiding serum supplementation and using AIM-V serum free medium. In addition, the number of cells added to ELISpot wells should also be standardised. Importantly, delays in peripheral blood mononuclear cell processing before stimulation had a marked effect on the number of detectable spot forming cells; processing delay thus should be minimised as well as standardised. Finally, a pre-stimulation culture period improved the sensitivity of the assay, however this effect may be both antigen and donor dependent. In conclusion, small differences in ELISpot protocols in routine use can affect the results obtained and care should be given to conditions selected for use in a given study. A pre-stimulation step may improve the sensitivity of the assay, particularly when cells have been previously frozen.	[Smith, Steven G.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Joosten, Simone A.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Verscheure, Virginie; Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Pathan, Ansar A.; McShane, Helen] Jenner Inst, Oxford, England; [Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Immunobiol Clin, Brussels, Belgium	University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite Libre de Bruxelles; University of Oxford; Jenner Institute; Universite Libre de Bruxelles	Smith, SG (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	steven.smith@lshtm.ac.uk	Joosten, Simone/E-4731-2011; Joosten, Simone A/F-1357-2011	Joosten, Simone A/0000-0002-9878-0863; McShane, Helen/0000-0002-2126-5142; Dockrell, Hazel/0000-0003-1869-9107; Smith, Steven/0000-0001-5623-7806	European Commission [LSHP-CT-2003-503367]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was initiated in and supported by the Correlates of Immunity work package (WP4) of TBVAC, supported by the European Commission, within the 6th Framework Program; contract LSHP-CT-2003-503367. Funder URL: http://cordis.europa.eu/fp6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Doherty TM, 2005, J IMMUNOL METHODS, V298, P129, DOI 10.1016/j.jim.2005.01.013; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Jacobsen M, 2008, BIOL CHEM, V389, P487, DOI 10.1515/BC.2008.053; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; OTTENHOFF TH, 2009, EUR J IMMUNOL; Ottenhoff THM, 2003, ADV EXP MED BIOL, V531, P279; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Tassignon J, 2005, J IMMUNOL METHODS, V305, P188, DOI 10.1016/j.jim.2005.07.014; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934	20	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7972	10.1371/journal.pone.0007972	http://dx.doi.org/10.1371/journal.pone.0007972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956718	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000272827500007
J	Agassandian, M; Chen, BB; Schuster, CC; Houtman, JCD; Mallampalli, RK				Agassandian, Marianna; Chen, Bill B.; Schuster, Christopher C.; Houtman, Jon C. D.; Mallampalli, Rama K.			14-3-3 zeta escorts CCT alpha for calcium-activated nuclear import in lung epithelia	FASEB JOURNAL			English	Article						membrane; homeostasis; lipid	CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; GLYCOPROTEIN IB-ALPHA; SURFACTANT-PROTEIN-D; PHOSPHATIDYLCHOLINE SYNTHESIS; PSEUDOMONAS-AERUGINOSA; REGULATORY ENZYME; STRUCTURAL BASIS; BINDING-SITE; LOCALIZATION; PHOSPHORYLATION	Integrity of animal biomembranes is critical to preserve normal cellular functions and viability. Phosphatidylcholine, an indispensible membrane component, requires the enzyme CCT alpha for its biosynthesis. Nuclear expression of CCT alpha is needed for expansion of the nuclear membrane network, but mechanisms for CCT alpha nuclear import are unknown. Herein, we show that in epithelia, extracellular Ca2+ triggers CCT alpha cytoplasmic-nuclear translocation. CCT alpha nuclear import was associated with binding to 14-3-3 zeta, a key regulator of protein trafficking. 14-3-3 zeta was both sufficient and required for CCT alpha nuclear import. Helix G within the 14-3-3 zeta binding groove interacts with a putative molecular signature within the CCT alpha carboxyl-terminal phosphoserine motif (residues 328-343). 14-3-3 zeta was critically involved in preserving phosphatidylcholine synthesis and cell viability in a model of Pseudomonas aeruginosa infection where Ca2+ concentrations increase within epithelia. Thus, 14-3-3 zeta controls CCT alpha nuclear import in response to calcium signals, thereby regulating mammalian phospholipid synthesis. Agassandian, M., Chen, B. B., Schuster, C. C., Houtman, J. C. D., Mallampalli, R. K. 14-3-3 zeta escorts CCT alpha for calcium-activated nuclear import in lung epithelia. FASEB J. 24, 1271-1283 (2010). www.fasebj.org	[Agassandian, Marianna; Chen, Bill B.; Schuster, Christopher C.; Mallampalli, Rama K.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Univ Iowa, Dept Vet Affairs Med Ctr, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Mallampalli, RK (corresponding author), Univ Pittsburgh, Pulm Allergy & Crit Care Div, Dept Internal Med, NW628 Montefiore,3459 5th Ave, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu		Houtman, Jon/0000-0002-5307-9854	U.S. Department of Veteran's Affairs; U.S National Institutes of Health [R01 HL097376, R01 HL081784, R01 HL068135]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, R01HL081784, R01HL068135, R01HL097376] Funding Source: NIH RePORTER	U.S. Department of Veteran's Affairs(US Department of Veterans Affairs); U.S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Merit Review Award from the U.S. Department of Veteran's Affairs, and U.S National Institutes of Health R01 grants HL097376, HL081784, and HL068135 (to R. K. M).	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Agassandian M, 2007, BIOCHEM J, V403, P409, DOI 10.1042/BJ20061364; Athwal GS, 1998, PLANT CELL PHYSIOL, V39, P1065, DOI 10.1093/oxfordjournals.pcp.a029303; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chan HC, 2000, BIOCHEM BIOPH RES CO, V270, P581, DOI 10.1006/bbrc.2000.2454; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Cooley J, 2008, J LEUKOCYTE BIOL, V83, P946, DOI 10.1189/jlb.1007684; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DeLong CJ, 2000, J BIOL CHEM, V275, P32325, DOI 10.1074/jbc.M004644200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Frick M, 2004, AM J PHYSIOL-LUNG C, V286, pL210, DOI 10.1152/ajplung.00332.2003; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Gu MY, 1998, J BIOL CHEM, V273, P33465, DOI 10.1074/jbc.273.50.33465; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; Li PP, 2007, J VIROL, V81, P6099, DOI 10.1128/JVI.02195-06; Mangin P, 2004, BLOOD, V104, P420, DOI 10.1182/blood-2003-08-2881; McCoy DM, 2006, AM J RESP CELL MOL, V35, P394, DOI 10.1165/rcmb.2005-0401OC; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Neuweiler H, 2004, CURR PHARM BIOTECHNO, V5, P285, DOI 10.2174/1389201043376896; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Srinivasan M, 2007, J IMMUNOL, V179, P3734, DOI 10.4049/jimmunol.179.6.3734; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; WANG YL, 1993, J BIOL CHEM, V268, P5899; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746; Zhou JM, 2003, J BIOL CHEM, V278, P37032, DOI 10.1074/jbc.M304316200	44	17	17	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1271	1283		10.1096/fj.09-136044	http://dx.doi.org/10.1096/fj.09-136044			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	20007511	Green Published			2022-12-25	WOS:000276462300033
J	Lebska, M; Ciesielski, A; Szymona, L; Godecka, L; Lewandowska-Gnatowska, E; Szczegielniak, J; Muszynska, G				Lebska, Maja; Ciesielski, Arkadiusz; Szymona, Lidia; Godecka, Luiza; Lewandowska-Gnatowska, Elzbieta; Szczegielniak, Jadwiga; Muszynska, Grazyna			Phosphorylation of Maize Eukaryotic Translation Initiation Factor 5A (eIF5A) by Casein Kinase 2 IDENTIFICATION OF PHOSPHORYLATED RESIDUE AND INFLUENCE ON INTRACELLULAR LOCALIZATION OF eIF5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; PROTEIN-KINASES; SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION; CK2 PHOSPHORYLATION; EIF2-BETA SUBUNIT; TERMINAL DOMAIN; PLANT-GROWTH; EXPRESSION; ARABIDOPSIS	Maize eukaryotic translation initiation factor 5A (ZmeIF5A) co-purifies with the catalytic alpha subunit of protein kinase CK2 and is phosphorylated by this enzyme. Phosphorylated ZmeIF5A was also identified after separation of maize leaf proteins by two-dimensional electrophoresis. Multiple sequence alignment of eIF5A proteins showed that in monocots, in contrast to other eukaryotes, there are two serine/threonine residues that could potentially be phosphorylated by CK2. To identify the phosphorylation site(s) of ZmeIF5A, the serine residues potentially phosphorylated by CK2 were mutated. ZmeIF5A and its mutated variants S2A and S4A were expressed in Escherichia coli and purified. Of these recombinant proteins, only ZmeIF5A-S2A was not phosphorylated by maize CK2. Also, Arabidopsis thaliana and Saccharomyces cerevisiae eIF5A-S2A mutants were not phosphorylated despite effective phosphorylation of wild-type variants. A newly developed method exploiting the specificity of thrombin cleavage was used to confirm that Ser(2) in ZmeIF5A is indeed phosphorylated. To find a role of the Ser(2) phosphorylation, ZmeIF5A and its variants mutated at Ser(2) (S2A and S2D) were transiently expressed in maize protoplasts. The expressed fluorescence labeled proteins were visualized by confocal microscopy. Although wild-type ZmeIF5A and its S2A variant were distributed evenly between the nucleus and cytoplasm, the variant with Ser(2) replaced by aspartic acid, which mimics a phosphorylated serine, was sequestered in the nucleus. These results suggests that phosphorylation of Ser(2) plays a role in regulation of nucleocytoplasmic shuttling of eIF5A in plant cells.	[Lebska, Maja; Ciesielski, Arkadiusz; Szymona, Lidia; Godecka, Luiza; Lewandowska-Gnatowska, Elzbieta; Szczegielniak, Jadwiga; Muszynska, Grazyna] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Muszynska, G (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland.	muszynsk@ibb.waw.pl		Borkiewicz, Lidia/0000-0002-2834-0969	Ministry of Science and Higher Education [PBZ-MIN-014/P05/2004]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Ministry of Science and Higher Education Grant PBZ-MIN-014/P05/2004.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; BODENBACH L, 1994, EUR J BIOCHEM, V220, P263, DOI 10.1111/j.1432-1033.1994.tb18622.x; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chou WC, 2004, PHYSIOL PLANTARUM, V121, P50, DOI 10.1111/j.0031-9317.2004.00292.x; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Ciceri P, 1997, PLANT CELL, V9, P97, DOI 10.1105/tpc.9.1.97; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; DOBROWOLSKA G, 1992, EUR J BIOCHEM, V204, P299, DOI 10.1111/j.1432-1033.1992.tb16637.x; DOBROWOLSKA G, 1987, BIOCHIM BIOPHYS ACTA, V931, P188, DOI 10.1016/0167-4889(87)90206-0; DOBROWOLSKA G, 1991, BIOCHIM BIOPHYS ACTA, V1129, P139, DOI 10.1016/0167-4781(91)90230-J; Dresselhaus T, 1999, PLANT MOL BIOL, V39, P1063, DOI 10.1023/A:1006176819213; Espunya MC, 2005, J EXP BOT, V56, P3183, DOI 10.1093/jxb/eri315; Espunya MC, 1999, PLANT J, V19, P655, DOI 10.1046/j.1365-313x.1999.00563.x; Feng HZ, 2007, PLANT PHYSIOL, V144, P1531, DOI 10.1104/pp.107.098079; French AC, 2007, J BIOL CHEM, V282, P29667, DOI 10.1074/jbc.M706457200; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hopkins MT, 2008, PLANT PHYSIOL, V148, P479, DOI 10.1104/pp.108.118869; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Jao DLE, 2002, J CELL BIOCHEM, V86, P590, DOI 10.1002/jcb.10235; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; KANG HA, 1993, J BIOL CHEM, V268, P14750; KLIMCZAK LJ, 1995, PLANT CELL, V7, P105, DOI 10.1105/tpc.7.1.105; KLIMCZAK LJ, 1994, PLANT PHYSIOL, V105, P911, DOI 10.1104/pp.105.3.911; Lebska M, 2009, PHYSIOL PLANTARUM, V136, P251, DOI 10.1111/j.1399-3054.2009.01238.x; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu Z, 2008, J EXP BOT, V59, P939, DOI 10.1093/jxb/ern017; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Llorens F, 2005, MOL CELL BIOCHEM, V274, P53, DOI 10.1007/s11010-005-3081-5; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Martel V, 2002, ANN NY ACAD SCI, V973, P272, DOI 10.1111/j.1749-6632.2002.tb04648.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Pagano MA, 2005, MOL CELL BIOCHEM, V274, P23, DOI 10.1007/s11010-005-3116-y; Park MH, 1997, BIOL SIGNAL, V6, P115; Parreiras-E-Silva LT, 2007, BIOCHEM BIOPH RES CO, V362, P393, DOI 10.1016/j.bbrc.2007.07.185; Peracchia G, 1999, PLANT MOL BIOL, V40, P199, DOI 10.1023/A:1006196530079; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Riera M, 2001, PLANT J, V25, P365, DOI 10.1046/j.1365-313x.2001.00973.x; Sarno S, 2005, BBA-PROTEINS PROTEOM, V1754, P263, DOI 10.1016/j.bbapap.2005.07.043; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shugar D, 2005, BBA-PROTEINS PROTEOM, V1754, P1, DOI 10.1016/j.bbapap.2005.10.008; Stemmer C, 2002, J BIOL CHEM, V277, P1092, DOI 10.1074/jbc.M109503200; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Thompson JE, 2004, TRENDS PLANT SCI, V9, P174, DOI 10.1016/j.tplants.2004.02.008; Wang HM, 2003, J CELL BIOCHEM, V88, P812, DOI 10.1002/jcb.10438; Wang TW, 2001, J BIOL CHEM, V276, P17541, DOI 10.1074/jbc.M008544200	56	28	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6217	6226		10.1074/jbc.M109.018770	http://dx.doi.org/10.1074/jbc.M109.018770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018887	hybrid, Green Published			2022-12-25	WOS:000275367500026
J	Bhunia, A; Domadia, PN; Torres, J; Hallock, KJ; Ramamoorthy, A; Bhattacharjya, S				Bhunia, Anirban; Domadia, Prerna N.; Torres, Jaume; Hallock, Kevin J.; Ramamoorthy, Ayyalusamy; Bhattacharjya, Surajit			NMR Structure of Pardaxin, a Pore-forming Antimicrobial Peptide, in Lipopolysaccharide Micelles MECHANISM OF OUTER MEMBRANE PERMEABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; HOST-DEFENSE PEPTIDES; RELAXATION DISPERSION; SECONDARY STRUCTURE; BURKHOLDERIA-CENOCEPACIA; THERMODYNAMIC ANALYSIS; CORE-OLIGOSACCHARIDE; HEMOLYTIC ACTIVITIES; CHANNEL FORMATION; DESIGNED PEPTIDE	Lipopolysaccharide (LPS), the major constituent of the outer membrane of Gram-negative bacteria, is an important element against permeability of bactericidal agents, including antimicrobial peptides. However, structural determinants of antimicrobial peptides for LPS recognition are not clearly understood. Pardaxins (Pa1, Pa2, Pa3, and Pa4) are a group of pore-forming bactericidal peptides found in the mucous glands of sole fishes. Despite having a low net positive charge, pardaxins contain a broad spectrum of antibacterial activities. To elucidate the structural basis of LPS interactions of pardaxins, herein, we report the first three-dimensional structure of Pa4 bound to LPS micelles. The binding kinetics of Pa4 with LPS is estimated using [N-15-Leu-19] relaxation dispersion NMR experiments. LPS/Pa4 interactions are further characterized by a number of biophysical methods, including isothermal titration calorimetry, P-31 NMR, saturation transfer difference NMR, dynamic light scattering, and IR spectroscopy. In the LPS-Pa4 complex, Pa4 adopts a unique helix-turn-helix conformation resembling a "horseshoe." Interestingly, the LPS-bound structure of Pa4 shows striking differences with the structures determined in lipid micelles or organic solvents. Saturation transfer difference NMR identifies residues of Pa4 that are intimately associated with LPS micelles. Collectively, our results provide mechanistic insights into the outer membrane permeabilization by pardaxin.	[Hallock, Kevin J.; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Bhunia, Anirban; Domadia, Prerna N.; Torres, Jaume; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore	University of Michigan System; University of Michigan; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu; surajit@ntu.edu.sg	Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020; Bhattacharjya, SURAJIT/A-2183-2011	Torres, Jaume/0000-0002-1282-9727; Bhunia, Anirban/0000-0002-8752-2842; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900	National Institutes of Health [AI 054515]; A*Star Biomedical Research Council Singapore [06/1/22/19/446]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*Star Biomedical Research Council Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 054515 (to A. R.). This work was also supported by Grant 06/1/22/19/446 from A*Star Biomedical Research Council Singapore (to S. B.).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bhattacharjya S, 1997, BIOPOLYMERS, V41, P251, DOI 10.1002/(SICI)1097-0282(199703)41:3<251::AID-BIP2>3.0.CO;2-R; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Bhunia A, 2008, BIOCHEM BIOPH RES CO, V369, P853, DOI 10.1016/j.bbrc.2008.02.105; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gunn JS, 2001, J ENDOTOXIN RES, V7, P57, DOI 10.1177/09680519010070011001; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; Hallock KJ, 2002, BIOPHYS J, V82, P2499, DOI 10.1016/S0006-3495(02)75592-6; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haselhorst T, 2001, J AM CHEM SOC, V123, P10705, DOI 10.1021/ja011156h; HOLLOWAY PW, 1989, BIOCHEMISTRY-US, V28, P931, DOI 10.1021/bi00429a002; Howe J, 2007, BIOPHYS J, V92, P2796, DOI 10.1529/biophysj.106.095711; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Lazarovici P, 1992, J NAT TOXINS, V1, P1; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Marsh D, 1999, BIOPHYS J, V77, P2630, DOI 10.1016/S0006-3495(99)77096-7; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramamoorthy A, 2004, ANNU REP NMR SPECTRO, V52, P1, DOI 10.1016/S0066-4103(04)52001-X; RAMAMOORTHY A, 2009, BIOCH BIOPH IN PRESS; Ramamoorthy A, 2006, BIOCHEMISTRY-US, V45, P6529, DOI 10.1021/bi052629q; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; SABERWAL G, 1993, J BIOL CHEM, V268, P14081; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; SHAI Y, 1990, J BIOL CHEM, V265, P20202; SHAI Y, 1991, J BIOL CHEM, V266, P22346; Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305; SHAI Y, 1994, TOXICOLOGY, V87, P109, DOI 10.1016/0300-483X(94)90157-0; SHAI Y, 1988, FEBS LETT, V242, P161, DOI 10.1016/0014-5793(88)81007-X; STRAIN SM, 1983, J BIOL CHEM, V258, P3466; Thennarasu S, 1996, PROTEIN ENG, V9, P1219, DOI 10.1093/protein/9.12.1219; Thomas CJ, 2001, J BIOL CHEM, V276, P35701, DOI 10.1074/jbc.M011319200; THOMPSON SA, 1986, SCIENCE, V233, P341, DOI 10.1126/science.233.4761.341; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Tolkatchev D, 2003, J AM CHEM SOC, V125, P12432, DOI 10.1021/ja021238l; Tossi A, 2000, BIOPOLYMERS, V55, P4; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; ZAGORSKI MG, 1991, BIOCHEMISTRY-US, V30, P8009, DOI 10.1021/bi00246a019; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zintsmaster JS, 2008, J AM CHEM SOC, V130, P14060, DOI 10.1021/ja805839y	75	117	119	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3883	3895		10.1074/jbc.M109.065672	http://dx.doi.org/10.1074/jbc.M109.065672			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959835	Green Published, hybrid			2022-12-25	WOS:000275254000042
J	Higgins, WJ; Fox, DM; Kowalski, PS; Nielsen, JE; Worrall, DM				Higgins, Wayne J.; Fox, Denise M.; Kowalski, Piotr S.; Nielsen, Jens E.; Worrall, D. Margaret			Heparin Enhances Serpin Inhibition of the Cysteine Protease Cathepsin L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER PROGRESSION; INDUCED APOPTOSIS; CERVICAL-CANCER; BINDING SITE; ANTIGEN; ANTITHROMBIN; EXPRESSION; IDENTIFICATION; ANGIOGENESIS	The glycosaminoglycan heparin is known to possess anti-metastatic activity in experimental models and preclinical studies, but there is still uncertainty over its mechanism of action in this respect. As an anticoagulant, heparin enhances inhibition of thrombin by the serpin antithrombin III, but a similar cofactor role has not been previously investigated for proteases linked to metastasis. The squamous cell carcinoma antigens (serpins B3 and B4) are tumor-associated proteins that can inhibit papain-like cysteine proteases, including cathepsins L, K, and S. In this study, we show that SCCA-1 (B3) and SCCA-2 (B4) can bind heparin as demonstrated by affinity chromatography, native PAGE gel shifts, and intrinsic fluorescence quenching. Binding was specific for heparin and heparan sulfate but not other glycosaminoglycans. The presence of heparin accelerated inhibition of cathepsin L by both serpins, and in the case of SCCA-1, heparin increased the second order inhibition rate constant from 5.4 x 10(5) to> 10(8), indicating a rate enhancement of at least 180-fold. A templating mechanism was shown, consistent with ternary complex formation. Furthermore, SCCA-1 inhibition of cathepsin L-like proteolytic activity secreted from breast and melanoma cancer cell lines was significantly enhanced by heparin. This is the first example of glycosaminoglycan enhancement of B-clade serpin activity and the first report of heparin acting as a cofactor in serpin cross-class inhibition of cysteine proteases. Most importantly, this finding raises the possibility that the anticancer properties of heparin may be due, at least partly, to enhanced inhibition of prometastatic proteases.	[Higgins, Wayne J.; Fox, Denise M.; Kowalski, Piotr S.; Nielsen, Jens E.; Worrall, D. Margaret] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin	Worrall, DM (corresponding author), Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland.	mworrall@ucd.ie	Kowalski, Piotr/AAF-7450-2021	Kowalski, Piotr/0000-0001-8607-0189; Nielsen, Jens Erik/0000-0002-2831-7718	Irish Cancer Society Research [CR105WOR]; Science Foundation Ireland UREKA; University College Dublin	Irish Cancer Society Research; Science Foundation Ireland UREKA(Science Foundation Ireland); University College Dublin	This work was supported by Irish Cancer Society Research Grant CR105WOR, a Science Foundation Ireland UREKA studentship (to P. S. K.), and a University College Dublin research demonstratorship (to D. M. F.).	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; BARNES RC, 1995, FEBS LETT, V373, P61, DOI 10.1016/0014-5793(95)01015-7; Barnes RC, 2000, GYNECOL ONCOL, V78, P62, DOI 10.1006/gyno.2000.5818; BODY JJ, 1990, CANCER, V65, P1552, DOI 10.1002/1097-0142(19900401)65:7<1552::AID-CNCR2820650717>3.0.CO;2-D; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Burden RE, 2008, MOL CANCER THER, V7, P538, DOI 10.1158/1535-7163.MCT-07-0528; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Gupta VK, 2008, BIOCHIMIE, V90, P749, DOI 10.1016/j.biochi.2008.01.004; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Iwasaki M, 2004, EXP CELL RES, V299, P525, DOI 10.1016/j.yexcr.2004.06.020; Jayson GC, 1997, BRIT J CANCER, V75, P9, DOI 10.1038/bjc.1997.3; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kanaji S, 2007, FEBS LETT, V581, P4260, DOI 10.1016/j.febslet.2007.07.072; Katagiri C, 2006, J CELL BIOL, V172, P983, DOI 10.1083/jcb.200508064; KATO H, 1982, CANCER, V50, P1294, DOI 10.1002/1097-0142(19821001)50:7<1294::AID-CNCR2820500712>3.0.CO;2-K; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; McGettrick AF, 2001, EUR J BIOCHEM, V268, P5868, DOI 10.1046/j.0014-2956.2001.02535.x; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; MOLINA R, 1990, CLIN CHEM, V36, P251; Nakashima T, 2006, HEAD NECK-J SCI SPEC, V28, P24, DOI 10.1002/hed.20293; Niers TMH, 2007, CRIT REV ONCOL HEMAT, V61, P195, DOI 10.1016/j.critrevonc.2006.07.007; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Ornstein DL, 1999, HAEMOSTASIS, V29, P48; PRATT CW, 1992, J BIOL CHEM, V267, P8795; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Richard B, 2006, THROMB HAEMOSTASIS, V95, P229, DOI 10.1160/TH05-08-0546; Rose Mark J., 2004, Current Drug Targets - Inflammation and Allergy, V3, P221, DOI 10.2174/1568010043343589; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Sakata Y, 2004, J BIOL CHEM, V279, P5081, DOI 10.1074/jbc.M311585200; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Stabuc B, 2006, NEOPLASMA, V53, P259; Suminami Y, 2000, BRIT J CANCER, V82, P981, DOI 10.1054/bjoc.1999.1028; TAKEDA A, 1995, FEBS LETT, V359, P78, DOI 10.1016/0014-5793(94)01456-B; Troy AM, 2004, EUR J CANCER, V40, P1610, DOI 10.1016/j.ejca.2004.03.011; Uemura Y, 2000, INT J CANCER, V89, P368, DOI 10.1002/1097-0215(20000720)89:4<368::AID-IJC9>3.0.CO;2-6; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; Yang Z, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-8; Zhang WQ, 2005, BLOOD, V106, P1621, DOI 10.1182/blood-2005-02-0547; Zheng B, 2009, BIOCHEM BIOPH RES CO, V380, P143, DOI 10.1016/j.bbrc.2009.01.057	46	44	44	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3722	3729		10.1074/jbc.M109.037358	http://dx.doi.org/10.1074/jbc.M109.037358			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959474	hybrid, Green Published			2022-12-25	WOS:000275254000024
J	Tee, AEL; Marshall, GM; Liu, PY; Xu, N; Haber, M; Norris, MD; Iismaa, SE; Liu, T				Tee, Andrew E. L.; Marshall, Glenn M.; Liu, Pei Y.; Xu, Ning; Haber, Michelle; Norris, Murray D.; Iismaa, Siiri E.; Liu, Tao			Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; SH-SY5Y CELLS; BINDING SITE; ACID; MYC; GTP; ACTIVATION; EXPRESSION; TRYPTOPHAN	We have demonstrated previously that the Myc oncoprotein blocks cancer cell differentiation by forming a novel transcriptional repressor complex with histone deacetylase and inhibiting gene transcription of tissue transglutaminase (TG2). Moreover, induction of TG2 gene transcription and transamidase activity is essential for the differentiating effects of retinoids in cancer cells. Here, we show that two structurally distinct TG2 protein isoforms, the full-length (TG2-L) and the short form (TG2-S), exert opposing effects on cell differentiation. Repression of TG2-L with small interfering RNA, which did not affect TG2-S expression, induced dramatic neuritic differentiation in neuroblastoma cells. In contrast, overexpression of TG2-S or a GTP-binding-deficient mutant of TG2-L (R580A), both of which lack the GTP-binding Arg-580 residue, induced neuroblastoma cell differentiation, which was blocked by an inhibitor of transamidase activity. Whereas N-Myc repressed and retinoid activated both TG2 isoforms, repression of TG2-L, but not simultaneous repression of TG2-L and TG2-S, enhanced neuroblastoma cell differentiation due to N-Myc small interfering RNA or retinoid. Moreover, suppression of vasoactive intestinal peptide (VIP) expression alone induced neuroblastoma cell differentiation, and VIP was up-regulated by TG2-L, but not TG2-S. Taken together, our data indicate that TG2-L and TG2-S exert opposite effects on cell differentiation due to differences in GTP binding and modulation of VIP gene transcription. Our findings highlight the potential importance of repressing the GTP binding activity of TG2-L or activating the transamidase activity of TG2-L or TG2-S for the treatment of neuroblastoma, and possibly also other Myc-induced malignancies, and for enhancing retinoid anticancer effects.	[Tee, Andrew E. L.; Marshall, Glenn M.; Liu, Pei Y.; Xu, Ning; Haber, Michelle; Norris, Murray D.; Iismaa, Siiri E.; Liu, Tao] Sydney Childrens Hosp, Childrens Canc Inst Australia, Sydney, NSW 2031, Australia; [Marshall, Glenn M.] Sydney Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Sydney, NSW 2031, Australia; [Iismaa, Siiri E.] Univ New S Wales, Victor Chang Cardiac Res Inst, Sydney, NSW 2050, Australia	Children's Cancer Institute; University of Sydney; University of Sydney; University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Liu, T (corresponding author), Sydney Childrens Hosp, Childrens Canc Inst Australia, High St, Sydney, NSW 2031, Australia.	tliu@ccia.unsw.edu.au	Iismaa, Siiri/C-9300-2013; Liu, Tao/A-3922-2015	Iismaa, Siiri/0000-0003-2409-7356; Liu, Tao/0000-0001-6244-7316; Norris, Murray/0000-0002-0632-4589; Haber, Michelle/0000-0003-2036-8817	National Health and Medical Research Council of Australia [568753, 459406]; Cancer Institute of New South Wales	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales	This work was supported in part by National Health and Medical Research Council of Australia Grants 568753 and 459406. The authors were also supported by the Cancer Institute of New South Wales and National Health and Medical Research Council program grants and a Cancer Institute New South Wales Career Development Fellowship. The Children's Cancer Institute Australia for Medical Research is affiliated with University of New South Wales and Sydney Children's Hospital.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Balajthy Z, 2006, BLOOD, V108, P2045, DOI 10.1182/blood-2004-02-007948; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Citron BA, 2002, NEUROCHEM INT, V40, P69, DOI 10.1016/S0197-0186(01)00062-6; FRAIJ BM, 1992, J BIOL CHEM, V267, P22616; Iismaa SE, 2003, P NATL ACAD SCI USA, V100, P12636, DOI 10.1073/pnas.1635052100; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Lee JS, 2006, FRONT BIOSCI-LANDMRK, V11, P2774, DOI 10.2741/2007; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Ruan QM, 2008, INT J CLIN EXP MED, V1, P248; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6	25	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3561	3567		10.1074/jbc.M109.053041	http://dx.doi.org/10.1074/jbc.M109.053041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007697	Green Published, hybrid			2022-12-25	WOS:000275254000006
J	Zhang, YY; Dong, YL; Wu, X; Lu, Y; Xu, ZP; Knapp, A; Yue, Y; Xu, TJ; Xie, ZC				Zhang, Yiying; Dong, Yuanlin; Wu, Xu; Lu, Yan; Xu, Zhipeng; Knapp, Andrew; Yue, Yun; Xu, Tiejun; Xie, Zhongcong			The Mitochondrial Pathway of Anesthetic Isoflurane-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PROTEIN-LEVELS; ALZHEIMERS-DISEASE; CASPASE-3 ACTIVATION; CALCIUM HOMEOSTASIS; CELL-DEATH; SEVOFLURANE; DEMENTIA; EXPOSURE; LINK; BAX	The common inhalation anesthetic isoflurane has been shown to induce apoptosis, which then leads to accumulation of beta-amyloid protein, the hallmark feature of Alzheimer disease neuropathogenesis. The underlying molecular mechanism of the isoflurane-induced apoptosisis largely unknown. We, therefore, set out to assess whether isoflurane can induce apoptosis by regulating Bcl-2 family proteins, enhancing reactive oxygen species (ROS) accumulation, and activating the mitochondrial pathway of apoptosis. We performed these studies in cultured cells, primary neurons, and mice. Here we show for the first time that treatment with 2% isoflurane for 6 h can increase pro-apoptotic factor Bax levels, decrease antiapoptotic factor Bcl-2 levels, increase ROS accumulation, facilitate cytochrome c release from the mitochondria to the cytosol, induce activation of caspase-9 and caspase-3, and finally cause apoptosis as compared with the control condition. We have further found that isoflurane can increase the mRNA levels of Bax and reduce the mRNA levels of Bcl-2. The isoflurane-induced ROS accumulation can be attenuated by the intracellular calcium chelator BAPTA. Finally, the anesthetic desflurane does not induce activation of mitochondrial pathway of apoptosis. These results suggest that isoflurane may induce apoptosis through Bcl-2 family proteins- and ROS-associated mitochondrial pathway of apoptosis. These findings, which have identified at least partially the molecular mechanism by which isoflurane induces apoptosis, will promote more studies aimed at studying the potential neurotoxic effects of anesthetics.	[Xie, Zhongcong] Harvard Univ, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Dept Anesthesia Crit Care & Pain Med,Sch Med,Dept, Geriatr Anesthesia Res Unit,Genet & Aging Res Uni, Charlestown, MA 02129 USA; [Wu, Xu] China Med Univ, Fac Forens Med, Dept Forens Pathol, Shenyang 110001, Peoples R China; [Lu, Yan] China Med Univ, Affiliated Shengjing Hosp, Hlth Minist Congenital Malformat, Key Lab, Shenyang 110004, Liaoning, Peoples R China; Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesia, Beijing 100020, Peoples R China; [Zhang, Yiying; Xu, Tiejun] Xuzhou Med Coll, Dept Anat & Neurobiol, Xuzhou 221002, Peoples R China	Harvard University; Massachusetts General Hospital; China Medical University; China Medical University; Capital Medical University; Xuzhou Medical University	Xie, ZC (corresponding author), Harvard Univ, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Dept Anesthesia Crit Care & Pain Med,Sch Med,Dept, Geriatr Anesthesia Res Unit,Genet & Aging Res Uni, 114 16th St 3750, Charlestown, MA 02129 USA.	zxie@partners.org		Dong, Yuanlin/0000-0002-4760-0519	National Institutes of Health [K08 NS048140, R21 AG029856, R01 GM088801]; Alzheimer Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 NS048140, R21 AG029856, and R01 GM088801. This work was also supported by an American Geriatrics Society Jahnigen Award and an Investigator- initiated Research Grant from the Alzheimer Association (to Z. X.).	BOHNEN N, 1994, INT J NEUROSCI, V77, P181, DOI 10.3109/00207459408986029; Bufill E, 2009, NEUROLOGIA, V24, P108; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Gasparini M, 2002, NEUROL SCI, V23, P11, DOI 10.1007/s100720200017; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Knopman DS, 2005, NEUROLOGY, V65, P986, DOI 10.1212/01.WNL.0000171954.92119.c7; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Rutter GA, 2006, BIOCHEM SOC T, V34, P351, DOI 10.1042/BST0340351; Szeto HH, 2008, ANN NY ACAD SCI, V1147, P112, DOI 10.1196/annals.1427.013; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wei HF, 2009, CURR ALZHEIMER RES, V6, P30, DOI 10.2174/156720509787313934; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2005, J MOL NEUROSCI, V25, P67, DOI 10.1385/JMN:25:1:067; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Zhang GH, 2008, J NEUROSCI, V28, P4551, DOI 10.1523/JNEUROSCI.5694-07.2008; Zhen Y, 2009, ANESTHESIOLOGY, V111, P741, DOI 10.1097/ALN.0b013e3181b27fd4	31	163	172	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4025	4037		10.1074/jbc.M109.065664	http://dx.doi.org/10.1074/jbc.M109.065664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007710	Green Published, hybrid			2022-12-25	WOS:000275254000056
J	Le Gouar, PJ; Vallet, D; David, L; Bermejo, M; Gatti, S; Levrero, F; Petit, EJ; Menard, N				Le Gouar, Pascaline J.; Vallet, Dominique; David, Laetitia; Bermejo, Magdalena; Gatti, Sylvain; Levrero, Florence; Petit, Eric J.; Menard, Nelly			How Ebola Impacts Genetics of Western Lowland Gorilla Populations	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; EMERGING INFECTIOUS-DISEASES; NATURAL-POPULATION; GENOTYPING ERRORS; COMPUTER-PROGRAM; BARBARY MACAQUES; BOTTLENECK; VIRUS; SIZE; CONSERVATION	Background: Emerging infectious diseases in wildlife are major threats for both human health and biodiversity conservation. Infectious diseases can have serious consequences for the genetic diversity of populations, which could enhance the species' extinction probability. The Ebola epizootic in western and central Africa induced more than 90% mortality in Western lowland gorilla population. Although mortality rates are very high, the impacts of Ebola on genetic diversity of Western lowland gorilla have never been assessed. Methodology/Principal Findings: We carried out long term studies of three populations of Western lowland gorilla in the Republic of the Congo (Odzala-Kokoua National Park, Lossi gorilla sanctuary both affected by Ebola and Lossi's periphery not affected). Using 17 microsatellite loci, we compared genetic diversity and structure of the populations and estimate their effective size before and after Ebola outbreaks. Despite the effective size decline in both populations, we did not detect loss in genetic diversity after the epizootic. We revealed temporal changes in allele frequencies in the smallest population. Conclusions/Significance: Immigration and short time elapsed since outbreaks could explain the conservation of genetic diversity after the demographic crash. Temporal changes in allele frequencies could not be explained by genetic drift or random sampling. Immigration from genetically differentiated populations and a non random mortality induced by Ebola, i.e., selective pressure and cost of sociality, are alternative hypotheses. Understanding the influence of Ebola on gorilla genetic dynamics is of paramount importance for human health, primate evolution and conservation biology.	[Le Gouar, Pascaline J.; Vallet, Dominique; David, Laetitia; Gatti, Sylvain; Levrero, Florence; Petit, Eric J.; Menard, Nelly] Univ Rennes 1, UMR Ecobio 6553, CNRS, Paimpont, France; [Bermejo, Magdalena] Univ Barcelona, Dept Biol Anim, ECOFAC, Barcelona, Spain; [Levrero, Florence] Univ St Etienne, Lab Ecol & Neuroethol Sensorielles, EA 3988, St Etienne, France; [Petit, Eric J.] Univ Rennes 1, UMR BiO3P 1099, INRA, Le Rheu, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; University of Barcelona; Universite Jean Monnet; INRAE; Universite de Rennes	Le Gouar, PJ (corresponding author), Univ Rennes 1, UMR Ecobio 6553, CNRS, Paimpont, France.	pascalinelegouar@free.fr	Petit, Eric J/C-1091-2011; Le Gouar, Pascaline/A-6209-2010; VALLET, Dominique/L-2309-2018; MENARD, Nelly/L-2214-2018	Petit, Eric J/0000-0001-5058-5826; VALLET, Dominique/0000-0002-8551-6019; Levrero, Florence/0000-0002-6904-1375; MENARD, Nelly/0000-0003-4122-9330; Le Gouar, Pascaline/0000-0001-5309-3667	Ministere de l'Ecologie et du Developpement Durable, France; DG Environnement, UE	Ministere de l'Ecologie et du Developpement Durable, France; DG Environnement, UE	This research is funded by the ECOFOR program (Ministere de l'Ecologie et du Developpement Durable, France) and the Especes-Phares program (DG Environnement, UE, carried out by RAPAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; BAKER CS, 1994, J HERED, V85, P52; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bayes M. K., 2000, Conservation Genetics, V1, P173, DOI 10.1023/A:1026595324974; BELKHIR K, 1996, GENETIX LOGICIEL WIN; Bermejo M, 2004, AM J PRIMATOL, V64, P223, DOI 10.1002/ajp.20073; Bermejo M, 1999, ORYX, V33, P323, DOI 10.1017/S0030605300030726; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bradley BJ, 2004, CURR BIOL, V14, P510, DOI 10.1016/j.cub.2004.02.062; Bradley Brenda J., 2000, Conservation Genetics, V1, P289, DOI 10.1023/A:1011514007741; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Clifford SL, 1999, MOL ECOL, V8, P1556, DOI 10.1046/j.1365-294X.1999.07184.x; Clifford SL, 2003, CAM S BIO EVOL ANTHR, V35, P269; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2006, P ROY SOC B-BIOL SCI, V273, P341, DOI 10.1098/rspb.2005.3329; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Frankham R., 2002, INTRO CONSERVATION G; Garrigan D, 2003, EVOLUTION, V57, P1707; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Gerber LR, 2005, ECOL APPL, V15, P1402, DOI 10.1890/04-0880; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GROSS L, 2005, PLOS BIOL, V3, pE403; Gulland F. M. D., 1995, P20, DOI 10.1017/CBO9780511629396.002; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Harcourt A H, 1980, J Reprod Fertil Suppl, VSuppl 28, P59; Harcourt AH, 1996, BIOL CONSERV, V75, P165, DOI 10.1016/0006-3207(95)00059-3; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARTL GB, 1994, BIODIVERS CONSERV, V3, P546, DOI 10.1007/BF00115160; Hawley DM, 2006, MOL ECOL, V15, P263, DOI 10.1111/j.1365-294X.2005.02767.x; Hedrick PW, 1998, GENETICA, V104, P207, DOI 10.1023/A:1026494212540; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Hopkin M, 2007, NATURE, V449, P127, DOI 10.1038/449127a; Huijbregts B, 2003, ORYX, V37, P437, DOI 10.1017/S0030605303000802; HUO CH, 2003, MOL ECOL NOTES, V3, P669; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lathuilliere M, 2001, AM J PRIMATOL, V55, P151, DOI 10.1002/ajp.1048; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Levrero F, 2006, AM J PRIMATOL, V68, P275, DOI 10.1002/ajp.20223; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Lukas D, 2004, MOL ECOL, V13, P3389, DOI 10.1111/j.1365-294X.2004.02353.x; Magliocca F, 1999, AM J PRIMATOL, V48, P1, DOI 10.1002/(SICI)1098-2345(1999)48:1<1::AID-AJP1>3.0.CO;2-2; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Morvan JM, 1999, MICROBES INFECT, V1, P1193, DOI 10.1016/S1286-4579(99)00242-7; Murphy M.F., 1982, International Zoo Yearbook, V22, P180, DOI 10.1111/j.1748-1090.1982.tb02031.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nunn CL, 2008, EVOL ECOL, V22, P519, DOI 10.1007/s10682-007-9180-x; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; Queney G, 2000, MOL ECOL, V9, P1253, DOI 10.1046/j.1365-294x.2000.01003.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rizkalla C, 2007, ECOHEALTH, V4, P151, DOI 10.1007/s10393-007-0096-2; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; SLATKIN M, 1995, MOL BIOL EVOL, V12, P473; Smith DG, 2000, AM J PRIMATOL, V50, P1; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Sullivan N, 2003, J VIROL, V77, P9733, DOI 10.1128/JVI.77.18.9733-9737.2003; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Valsecchi E, 2004, ANIM CONSERV, V7, P139, DOI 10.1017/S1367943004001325; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vogel G, 2007, SCIENCE, V317, P1484, DOI 10.1126/science.317.5844.1484; Vogel TU, 1999, IMMUNOL REV, V167, P327, DOI 10.1111/j.1600-065X.1999.tb01402.x; Waldick RC, 2002, MOL ECOL, V11, P2241, DOI 10.1046/j.1365-294X.2002.01605.x; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; WATTERSON GA, 1978, GENETICS, V88, P171; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilberg MJ, 2004, MOL ECOL NOTES, V4, P783, DOI 10.1111/j.1471-8286.2004.00797.x; Wisely SM, 2008, J WILDLIFE DIS, V44, P53, DOI 10.7589/0090-3558-44.1.53	108	25	25	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8375	10.1371/journal.pone.0008375	http://dx.doi.org/10.1371/journal.pone.0008375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020045	Green Published, gold, Green Submitted			2022-12-25	WOS:000272870600014
J	Ganzhorn, JU; Arrigo-Nelson, S; Boinski, S; Bollen, A; Carrai, V; Derby, A; Donati, G; Koenig, A; Kowalewski, M; Lahann, P; Norscia, I; Polowinsky, SY; Schwitzer, C; Stevenson, PR; Talebi, MG; Tan, C; Vogel, ER; Wright, PC				Ganzhorn, Joerg U.; Arrigo-Nelson, Summer; Boinski, Sue; Bollen, An; Carrai, Valentina; Derby, Abigail; Donati, Giuseppe; Koenig, Andreas; Kowalewski, Martin; Lahann, Petra; Norscia, Ivan; Polowinsky, Sandra Y.; Schwitzer, Christoph; Stevenson, Pablo R.; Talebi, Mauricio G.; Tan, Chia; Vogel, Erin R.; Wright, Patricia C.			Possible Fruit Protein Effects on Primate Communities in Madagascar and the Neotropics	PLOS ONE			English	Article							NUTRITIONAL QUALITY; SEASONAL-VARIATION; DIETARY-RESPONSE; FOLIVOROUS LEMUR; SEED DISPERSAL; LEAF CHEMISTRY; HOWLER MONKEYS; NATIONAL-PARK; RAIN-FOREST; FOOD	Background: The ecological factors contributing to the evolution of tropical vertebrate communities are still poorly understood. Primate communities of the tropical Americas have fewer folivorous but more frugivorous genera than tropical regions of the Old World and especially many more frugivorous genera than Madagascar. Reasons for this phenomenon are largely unexplored. We developed the hypothesis that Neotropical fruits have higher protein concentrations than fruits from Madagascar and that the higher representation of frugivorous genera in the Neotropics is linked to high protein concentrations in fruits. Low fruit protein concentrations in Madagascar would restrict the evolution of frugivores in Malagasy communities. Methodology/Principal Findings: We reviewed the literature for nitrogen concentrations in fruits from the Neotropics and from Madagascar, and analyzed fruits from an additional six sites in the Neotropics and six sites in Madagascar. Fruits from the Neotropical sites contain significantly more nitrogen than fruits from the Madagascar sites. Nitrogen concentrations in New World fruits are above the concentrations to satisfy nitrogen requirements of primates, while they are at the lower end or below the concentrations to cover primate protein needs in Madagascar. Conclusions/Significance: Fruits at most sites in the Neotropics contain enough protein to satisfy the protein needs of primates. Thus, selection pressure to develop new adaptations for foods that are difficult to digest (such as leaves) may have been lower in the Neotropics than in Madagascar. The low nitrogen concentrations in fruits from Madagascar may contribute to the almost complete absence of frugivorous primate species on this island.	[Ganzhorn, Joerg U.; Lahann, Petra] Univ Hamburg, Biozentrum Grindel, Hamburg, Germany; [Arrigo-Nelson, Summer; Derby, Abigail; Kowalewski, Martin; Stevenson, Pablo R.; Tan, Chia; Vogel, Erin R.] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci Ecol & E, Stony Brook, NY 11794 USA; [Boinski, Sue] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Bollen, An] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Bollen, An] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Carrai, Valentina; Donati, Giuseppe; Norscia, Ivan] Univ Pisa, Dept Biol, Pisa, Italy; [Koenig, Andreas; Wright, Patricia C.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Lahann, Petra] Forschungsinstitut Biol Landwirtschaftlicher Nutz, Dummerstorf, Germany; [Polowinsky, Sandra Y.; Schwitzer, Christoph] Bristol Conservat & Sci Fdn, Bristol, Avon, England; [Talebi, Mauricio G.] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England	University of Hamburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida; University of Antwerp; University of Pisa; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Forschungsinstitut fur Nutztierbiologie (FBN); University of Cambridge	Ganzhorn, JU (corresponding author), Univ Hamburg, Biozentrum Grindel, Hamburg, Germany.	ganzhorn@zoologie.uni-hamburg.de	Koenig, Andreas/G-6705-2013; Ganzhorn, Joerg/AAO-6955-2020; Koenig, Andreas/AAE-6492-2020; Norscia, Ivan/J-3321-2015; Talebi, Mauricio/J-9376-2014	Koenig, Andreas/0000-0003-1494-9156; Ganzhorn, Joerg/0000-0003-1395-9758; Koenig, Andreas/0000-0003-1494-9156; Norscia, Ivan/0000-0002-1618-7717; Donati, Giuseppe/0000-0002-4803-0642; Talebi, Mauricio/0000-0001-6783-2715	Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Belgian Fund for Scientific Research; Flanders; Conservation International's Primate Action Fund; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; Earthwatch Institute; German Primate Center; Italian Ministry for Scientific Research (MURST); J. William Fulbright Foundation; Margot Marsh Biodiversity Foundation; National Science Foundation; National Geographic; St. Louis Zoo	Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Flanders; Conservation International's Primate Action Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Earthwatch Institute; German Primate Center; Italian Ministry for Scientific Research (MURST)(Ministry of Education, Universities and Research (MIUR)); J. William Fulbright Foundation; Margot Marsh Biodiversity Foundation; National Science Foundation(National Science Foundation (NSF)); National Geographic(National Geographic Society); St. Louis Zoo	Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL), the Belgian Fund for Scientific Research, Flanders, Conservation International's Primate Action Fund, the Deutsche Forschungsgemeinschaft, the Deutscher Akademischer Austauschdienst, Earthwatch Institute, the German Primate Center, the Italian Ministry for Scientific Research (MURST), the J. William Fulbright Foundation, the Margot Marsh Biodiversity Foundation, the National Science Foundation, National Geographic, and St. Louis Zoo. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsalis S, 1999, INT J PRIMATOL, V20, P193, DOI 10.1023/A:1020518419038; ATSALIS S, 2007, NATURAL HIST BROWN M; Bollen A, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P93, DOI 10.1007/1-4020-3833-X_6; Bollen A, 2004, OECOLOGIA, V139, P604, DOI 10.1007/s00442-004-1544-0; Bollen An, 2007, P127; Brockman D.K., 2005, PRIMATE SEASONALITY; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; Conklin-Brittain NL, 1999, J CHEM ECOL, V25, P2601, DOI 10.1023/A:1020835120701; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; Curtis DJ, 2004, AM J PHYS ANTHROPOL, V124, P234, DOI 10.1002/ajpa.10268; DAUSMANN K, LEAPING AHE IN PRESS; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Donati G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1237, DOI 10.1007/s00265-007-0354-x; Emmons Louise H., 1999, P171, DOI 10.1017/CBO9780511542381.011; ESTRADA A, 1984, AM J PRIMATOL, V6, P77, DOI 10.1002/ajp.1350060202; Estrada A, 1986, FRUGIVORY SEED DISPE, P93; *FAO, 1991, GUID LAND EV EXT GRA; Faulkner AL, 2006, FOLIA PRIMATOL, V77, P218, DOI 10.1159/000091231; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039; Fleagle John G., 1999, P92, DOI 10.1017/CBO9780511542381.007; FLEMING TH, 1987, ANNU REV ECOL SYST, V18, P91, DOI 10.1146/annurev.ecolsys.18.1.91; Foster R. B., 1982, ECOLOGY TROPICAL FOR, P201; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Ganzhorn Jorg U., 1999, P75, DOI 10.1017/CBO9780511542381.005; Ganzhorn JU, 2004, J ZOOL, V263, P393, DOI 10.1017/S0952836904005394; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Ganzhorn JU, 2002, OECOLOGIA, V131, P427, DOI 10.1007/s00442-002-0891-y; GAUTIERHION A, 1989, ECOLOGY, V70, P1826, DOI 10.2307/1938115; GENIN FGS, EVOLUTION E IN PRESS; Godfrey LR, 2004, J HUM EVOL, V47, P145, DOI 10.1016/j.jhevol.2004.06.003; Goodman SM, 1997, REV ECOL-TERRE VIE, V52, P321; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Heiduck S, 1997, INT J PRIMATOL, V18, P487, DOI 10.1023/A:1026355004744; Heymann EW, 2001, AM J PRIMATOL, V55, P171, DOI 10.1002/ajp.1050; HLADIK CM, 1971, FOLIA PRIMATOL, V16, P85, DOI 10.1159/000155393; JANSON C, 2005, TROPICAL FRUITS FRUG, P307; JANSON CH, 1986, FRUGIVORES SEED DISP, P00083, DOI DOI 10.1007/978-94-009-4812-9_9; Kappeler PM, 1996, BIOL J LINN SOC, V59, P297; Kay R.F., 1984, P21; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Lahann P, 2007, J ZOOL, V271, P88, DOI 10.1111/j.1469-7998.2006.00222.x; Lambert J.E., 2007, PRIMATES PERSPECTIVE, P482, DOI DOI 10.1146/ANNUREV-ANTHRO-102313-025928; Langrand O., 1990, GUIDE BIRDS MADAGASC; Levey DJ, 2000, J CHEM ECOL, V26, P1749, DOI 10.1023/A:1005503316406; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; MILTON K, 1981, BIOTROPICA, V13, P177, DOI 10.2307/2388122; MILTON K, 1990, J TROP ECOL, V6, P493, DOI 10.1017/S0266467400004909; Mutschler T, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P221; Norconk MA, 2004, INT J PRIMATOL, V25, P1, DOI 10.1023/B:IJOP.0000014642.68751.ed; O'Brien TG, 1998, NATURE, V392, P668, DOI 10.1038/33580; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; OFTEDAL OT, 1991, PHILOS T R SOC B, V334, P161, DOI 10.1098/rstb.1991.0105; Powzyk JA, 2003, INT J PRIMATOL, V24, P1143, DOI 10.1023/B:IJOP.0000005984.36518.94; RASAMIMANANA B, 2004, DOMINANCE FEMELLES M; Richard AF, 2000, J HUM EVOL, V39, P381, DOI 10.1006/jhev.2000.0427; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Silver SC, 2000, ZOO BIOL, V19, P95, DOI 10.1002/1098-2361(2000)19:2<95::AID-ZOO1>3.0.CO;2-D; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Simmen B, 2007, INT J PRIMATOL, V28, P1253, DOI 10.1007/s10764-007-9217-6; SPSS, 1999, SPSS BAS 9 0 US GUID; Stevenson P, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P37, DOI 10.1007/1-4020-3833-X_3; Stevenson PR, 2004, INT J PRIMATOL, V25, P367, DOI 10.1023/B:IJOP.0000019157.35464.a0; Strier K.B., 2007, PRIMATE BEHAV ECOLOG, V3rd ed.; Terborgh J., 1987, P205; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Terborgh J., 1986, CONSERVATION BIOL SC, P330; van Schaik CP, 2005, CAM S BIO EVOL ANTHR, V44, P445, DOI 10.1017/CBO9780511542343.016; White T. C. R., 1993, INADEQUATE ENV NITRO; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Wright Patricia C., 1997, P127; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Wright PC, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P121, DOI 10.1007/1-4020-3833-X_7; ZUNINO GE, 1989, B PRIMATOLOGICO LATI, V1, P75	80	66	67	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8253	10.1371/journal.pone.0008253	http://dx.doi.org/10.1371/journal.pone.0008253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016841	Green Published, Green Submitted, gold			2022-12-25	WOS:000272834000006
J	Mancini, N; Diotti, RA; Perotti, M; Sautto, G; Clementi, N; Nitti, G; Patel, AH; Ball, JK; Clementi, M; Burioni, R				Mancini, Nicasio; Diotti, Roberta A.; Perotti, Mario; Sautto, Giuseppe; Clementi, Nicola; Nitti, Giovanni; Patel, Arvind H.; Ball, Jonathan K.; Clementi, Massimo; Burioni, Roberto			Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; E2 ENVELOPE GLYCOPROTEIN; HYPERVARIABLE REGION 1; SYNERGISTIC NEUTRALIZATION; CONFORMATIONAL EPITOPES; REPERTOIRE CLONING; CD4-BINDING SITE; MAJOR GENOTYPES; CELL-CULTURE; V3 LOOP	Anti-hepatitis C virus (HCV) cross-neutralizing human monoclonal antibodies, directed against conserved epitopes on surface E2 glycoprotein, are central tools for understanding virus-host interplay, and for planning strategies for prevention and treatment of this infection. Recently, we developed a research aimed at identifying these antibody specificities. The characteristics of one of these antibodies (Fab e20) were addressed in this study. Firstly, using immunofluorescence and FACS analysis of cells expressing envelope HCV glycoproteins, Fab e20 was able to recognize all HCV genotypes. Secondly, competition assays with a panel of mouse and rat monoclonals, and alanine scanning mutagenesis analyses located the e20 epitope within the CD81 binding site, documenting that three highly conserved HCV/E2 residues (W529, G530 and D535) are critical for e20 binding. Finally, a strong neutralizing activity against HCV pseudoparticles (HCVpp) incorporating envelope glycoproteins of genotypes 1a, 1b, 2a, 2b and 4, and against the cell culture-grown (HCVcc) JFH1 strain, was observed. The data highlight that neutralizing antibodies against HCV epitopes present in all HCV genotypes are elicited during natural infection. Their availability may open new avenues to the understanding of HCV persistence and to the development of strategies for the immune control of this infection.	[Mancini, Nicasio; Diotti, Roberta A.; Perotti, Mario; Sautto, Giuseppe; Clementi, Nicola; Nitti, Giovanni; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy; [Patel, Arvind H.] Univ Glasgow, Inst Virol, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Ball, Jonathan K.] Univ Nottingham, Inst Infect Immun & Inflammat, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2RD, England	Vita-Salute San Raffaele University; University of Glasgow; University of Nottingham	Mancini, N (corresponding author), Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy.	mancini.nicasio@hsr.it	Burioni, Roberto/F-2396-2012; Clementi, Massimo/F-6646-2013; Clementi, Nicola/G-8545-2014; Ball, Jonathan/HGU-3130-2022; Mancini, Nicasio/AAN-6203-2020; Sautto, Giuseppe Andrea/A-8588-2015	Clementi, Nicola/0000-0002-1822-9861; Sautto, Giuseppe Andrea/0000-0002-0273-2235; Clementi, Massimo/0000-0002-7461-5898; MANCINI, Nicasio/0000-0003-0637-0910; ball, jonathan/0000-0001-5773-8733	Medical Research Council [G0801169, MC_U130184144] Funding Source: Medline; MRC [MC_U130184144, G0801169] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allander T, 2000, J GEN VIROL, V81, P2451, DOI 10.1099/0022-1317-81-10-2451; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bowen DG, 2005, J HEPATOL, V42, P408, DOI 10.1016/j.jhep.2004.12.013; BUCHBINDER A, 1992, AIDS RES HUM RETROV, V8, P425, DOI 10.1089/aid.1992.8.425; BUGLI F, 2001, J VIROL, V83; Burioni R, 1998, HEPATOLOGY, V28, P810, DOI 10.1002/hep.510280331; Burioni R, 2004, VIROLOGY, V327, P242, DOI 10.1016/j.virol.2004.06.042; Burioni R, 2002, J VIROL, V76, P11775, DOI 10.1128/JVI.76.22.11775-11779.2002; Burioni R, 2001, VIROLOGY, V288, P29, DOI 10.1006/viro.2001.1014; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Esumi M, 2002, VACCINE, V20, P3095, DOI 10.1016/S0264-410X(02)00271-2; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; FARCI P, 1994, P NATL ACAD SCI USA, V91, P7792, DOI 10.1073/pnas.91.16.7792; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Iacob RE, 2008, BBA-PROTEINS PROTEOM, V1784, P530, DOI 10.1016/j.bbapap.2007.12.015; Ishii K, 1998, HEPATOLOGY, V28, P1117, DOI 10.1002/hep.510280429; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; LAAL S, 1994, J VIROL, V68, P4001, DOI 10.1128/JVI.68.6.4001-4008.1994; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Manzin A, 2000, J VIROL, V74, P4327, DOI 10.1128/JVI.74.9.4327-4334.2000; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Piazza M, 1997, ARCH INTERN MED, V157, P1537, DOI 10.1001/archinte.157.14.1537; Plaisant P, 1997, RES VIROLOGY, V148, P165, DOI 10.1016/S0923-2516(97)89904-9; Prabhu R, 2004, AM J PATHOL, V165, P1163, DOI 10.1016/S0002-9440(10)63377-9; Puntoriero G, 1998, EMBO J, V17, P3521, DOI 10.1093/emboj/17.13.3521; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; TILLEY SA, 1992, AIDS RES HUM RETROV, V8, P461, DOI 10.1089/aid.1992.8.461; Timm J, 2007, WORLD J GASTROENTERO, V13, P4808, DOI 10.3748/wjg.v13.i36.4808; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Webster DP, 2009, LANCET INFECT DIS, V9, P108, DOI 10.1016/S1473-3099(09)70020-9; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; ZHANG P, 2009, P NATL ACAD SCI US	51	54	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8254	10.1371/journal.pone.0008254	http://dx.doi.org/10.1371/journal.pone.0008254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011511	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000272830200007
J	Souza-e-Silva, H; Savino, W; Feijoo, RA; Vasconcelos, ATR				Souza-e-Silva, Hallan; Savino, Wilson; Feijoo, Raul A.; Ribeiro Vasconcelos, Ana Tereza			A Cellular Automata-Based Mathematical Model for Thymocyte Development	PLOS ONE			English	Article							BONE-MARROW-CELLS; MEDULLA MIGRATION; DIFFERENTIATION; THYMUS; DURATION; MICROENVIRONMENTS; POPULATION; CHEMOKINES; DYNAMICS; GROWTH	Intrathymic T cell development is an important process necessary for the normal formation of cell-mediated immune responses. Importantly, such a process depends on interactions of developing thymocytes with cellular and extracellular elements of the thymic microenvironment. Additionally, it includes a series of oriented and tunely regulated migration events, ultimately allowing mature cells to cross endothelial barriers and leave the organ. Herein we built a cellular automata-based mathematical model for thymocyte migration and development. The rules comprised in this model take into account the main stages of thymocyte development, two-dimensional sections of the normal thymic microenvironmental network, as well as the chemokines involved in intrathymic cell migration. Parameters of our computer simulations with further adjusted to results derived from previous experimental data using sub-lethally irradiated mice, in which thymus recovery can be evaluated. The model fitted with the increasing numbers of each CD4/CD8-defined thymocyte subset. It was further validated since it fitted with the times of permanence experimentally ascertained in each CD4/CD8-defined differentiation stage. Importantly, correlations using the whole mean volume of young normal adult mice revealed that the numbers of cells generated in silico with the mathematical model fall within the range of total thymocyte numbers seen in these animals. Furthermore, simulations made with a human thymic epithelial network using the same mathematical model generated similar profiles for temporal evolution of thymocyte developmental stages. Lastly, we provided in silico evidence that the thymus architecture is important in the thymocyte development, since changes in the epithelial network result in different theoretical profiles for T cell development/migration. This model likely can be used to predict thymocyte evolution following therapeutic strategies designed for recovery of the thymus in diseases coursing with thymus involution, such as some primary immunodeficiencies, acute infections, and malnutrition.	[Souza-e-Silva, Hallan; Ribeiro Vasconcelos, Ana Tereza] LNCC MCT, Bioinformat Lab, Petropolis, Brazil; [Savino, Wilson] Inst Oswaldo Cruz, Lab Thymus Res, BR-20001 Rio De Janeiro, Brazil; [Feijoo, Raul A.] INCT MACC, Natl Inst Sci & Technol Med Assisted Sci Comp, Petropolis, Brazil; [Feijoo, Raul A.] LNCC MCT, Comp Sci Coordinat, Petropolis, Brazil	Laboratorio Nacional de Computacao Cientifica (LNCC); Fundacao Oswaldo Cruz; Laboratorio Nacional de Computacao Cientifica (LNCC)	Souza-e-Silva, H (corresponding author), Univ Fed Vicosa, Dept Phys, Vicosa, MG, Brazil.	savino@fiocruz.br	Vasconcelos, Ana Tereza R/I-1011-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; 	Brazilian Ministries of Science (PCI-LNCC - www.lncc.br, and CNPq-www.cnpq.br), Education (CAPES-www.capes.gov.br), and Health (Fiocruz - www.fiocruz.br)	Brazilian Ministries of Science (PCI-LNCC - www.lncc.br, and CNPq-www.cnpq.br), Education (CAPES-www.capes.gov.br), and Health (Fiocruz - www.fiocruz.br)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been funded with grants from the Brazilian Ministries of Science (PCI-LNCC - www.lncc.br, and CNPq-www.cnpq.br), Education (CAPES-www.capes.gov.br), and Health (Fiocruz - www.fiocruz.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990; Efroni S, 2005, COMPUTER, V38, P38, DOI 10.1109/MC.2005.31; Efroni S, 2003, GENOME RES, V13, P2485, DOI 10.1101/gr.1215303; Efroni S, 2007, PLOS COMPUT BIOL, V3, P127, DOI 10.1371/journal.pcbi.0030013; EREN R, 1988, CELL IMMUNOL, V112, P449, DOI 10.1016/0008-8749(88)90315-2; Geankoplis Christie J, 1993, TRANSPORT PROCESS UN, V3rd; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Lewin R, 1993, COMPLEXITY LIFE EDGE; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; MEHR R, 1993, MECH AGEING DEV, V67, P159, DOI 10.1016/0047-6374(93)90120-G; Mehr R, 1996, J THEOR BIOL, V181, P157, DOI 10.1006/jtbi.1996.0122; MEHR R, 1995, J THEOR BIOL, V175, P103, DOI 10.1006/jtbi.1995.0124; MENDESDACRUZ DA, 2008, J IMMUNOL, V180, P8; MENDESDACRUZ DA, 2008, J IMMUNOL, V180, P11; Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; SALINAS FA, 1972, J CELL PHYSIOL, V80, P339, DOI 10.1002/jcp.1040800304; Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Savino W, 2007, EXP PHYSIOL, V92, P813, DOI 10.1113/expphysiol.2007.038422; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Shi HJ, 2006, MATH BIOSCI ENG, V3, P237; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Suzuki G, 1999, J IMMUNOL, V162, P5981; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; WOLFRAM S, 1986, THEORY APLLICATIONS; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zhou R, 2004, J MOL ENDOCRINOL, V32, P349, DOI 10.1677/jme.0.0320349	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8233	10.1371/journal.pone.0008233	http://dx.doi.org/10.1371/journal.pone.0008233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011042	gold, Green Published, Green Submitted			2022-12-25	WOS:000272829800017
J	Tan, CE; Li, HJ; Zhang, XG; Zhang, H; Han, PY; An, Q; Ding, WJ; Wang, MQ				Tan, Cong E.; Li, Hong Jun; Zhang, Xian Geng; Zhang, Hui; Han, Pei Yu; An, Qu; Ding, Wei Jun; Wang, Mi Qu			The Impact of the Wenchuan Earthquake on Birth Outcomes	PLOS ONE			English	Article							SEX-RATIO; STRESS; TWIN; PREGNANCY; PROVINCE; DECLINE; AREA	Background: Earthquakes and other catastrophic events frequently occurring worldwide can be considered as outliers and cause a growing and urgent need to improve our understanding of the negative effects imposed by such disasters. Earthquakes can intensively impact the birth outcomes upon psychological and morphological development of the unborn children, albeit detailed characteristics remain obscure. Methods and Findings: We utilized the birth records at Du Jiang Yan and Peng Zhou counties to investigate the birth outcomes as a consequence of a major earthquake occurred in Wenchuan, China on May 12, 2008. Totally 13,003 of neonates were recorded, with 6638 and 6365 for pre- and post-earthquake, respectively. Significant low birthweight, high ratio of low birthweight, and low Apgar scores of post-earthquake group were observed. In contrast, the sex ratio at birth, birth length and length of gestation did not show statistical differences. The overall ratio of birth-defect in the post-earthquake (1.18%) is statistically high than that of pre- earthquake (0.99%), especially for those in the first trimester on earthquake day (1.47%). The birth-defect spectrum was dramatically altered after earthquake, with the markedly increased occurrences of ear malformations. The ratio of preterm birth post-earthquake (7.41%) is significant increased than that of pre- earthquake (5.63%). For the birth outcomes of twins, significant differences of the ratio of twins, birth weight, ratio of low birthweight and birth-defect rate were observed after earthquake. Conclusion: A hospital-based study of birth outcomes impacted by the Wenchuan earthquake shows that the earthquake was associated with significant effects on birth outcomes, indicating it is a major monitor for long-term pregnant outcomes.	[Tan, Cong E.; Li, Hong Jun; Zhang, Xian Geng; Zhang, Hui; Han, Pei Yu; An, Qu; Ding, Wei Jun; Wang, Mi Qu] Chengdu Univ Tradit Chinese Med, Inst Basic Med, Chengdu, Peoples R China; [Tan, Cong E.] Shaanxi Univ Chinese Med, Xian, Peoples R China	Chengdu University of Traditional Chinese Medicine; Shaanxi University of Chinese Medicine	Tan, CE (corresponding author), Chengdu Univ Tradit Chinese Med, Inst Basic Med, Chengdu, Peoples R China.	Ding2004wj@yahoo.com.cn; wangmiqu@yahoo.com.cn		Ding, Wei-Jun/0000-0002-0419-0900	National Science Funds of China [30873316, 90709053]	National Science Funds of China	This work is supported by National Science Funds of China (NO. 30873316, and NO. 90709053)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein E, 2009, Minerva Ginecol, V61, P113; CASTILLA EE, 1986, INT J EPIDEMIOL, V15, P364, DOI 10.1093/ije/15.3.364; Catalano R, 2006, HUM REPROD, V21, P3127, DOI 10.1093/humrep/del283; Chang HL, 2002, PSYCHIAT CLIN NEUROS, V56, P139, DOI 10.1046/j.1440-1819.2002.00948.x; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Hibino Y, 2009, PSYCHIAT CLIN NEUROS, V63, P107, DOI 10.1111/j.1440-1819.2008.01911.x; King S, 2000, Sante Ment Que, V25, P163; Li S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004964; Liu Shi-an, 2009, Zhonghua Yufang Yixue Zazhi, V43, P380, DOI 10.3760/cma.j.issn.0253-9624.2009.05.010; MONTENEGRO MA, 1995, ARCH ORAL BIOL, V40, P33; Parsons T, 2008, NATURE, V454, P509, DOI 10.1038/nature07177; Saadat M, 2008, J BIOSOC SCI, V40, P935, DOI 10.1017/S0021932008002745; Siribaddana SH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-49; Sornette D, 2002, P NATL ACAD SCI USA, V99, P2522, DOI 10.1073/pnas.022581999; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Stone R, 2009, SCIENCE, V324, P713, DOI 10.1126/science.324_713; Wadhawan R, 2009, PEDIATRICS, V123, pE220, DOI 10.1542/peds.2008-1126; Young NM, 2007, ANAT REC, V290, P123, DOI 10.1002/ar.20415; Zhu J, 2000, Zhonghua Er Bi Yan Hou Ke Za Zhi, V35, P62	20	66	66	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8200	10.1371/journal.pone.0008200	http://dx.doi.org/10.1371/journal.pone.0008200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997649	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829500018
J	Doeschl-Wilson, A; Sawalha, R; Gubbins, S; Villanueva, B				Doeschl-Wilson, Andrea; Sawalha, Rami; Gubbins, Simon; Villanueva, Beatriz			Implications of Conflicting Associations of the Prion Protein (PrP) Gene with Scrapie Susceptibility and Fitness on the Persistence of Scrapie	PLOS ONE			English	Article							SHEEP FLOCK; BRITISH SHEEP; GREAT-BRITAIN; POPULATION-DYNAMICS; BREEDING PROGRAMS; NATURAL SCRAPIE; TSE RESISTANCE; GENOTYPE; TRAITS; POLYMORPHISMS	Background: Existing mathematical models for scrapie dynamics in sheep populations assume that the PrP gene is only associated with scrapie susceptibility and with no other fitness related traits. This assumption contrasts recent findings of PrP gene associations with post-natal lamb survival in scrapie free Scottish Blackface populations. Lambs with scrapie resistant genotypes were found to have significantly lower survival rates than those with susceptible genotypes. The present study aimed to investigate how these conflicting PrP gene associations may affect the dynamic patterns of PrP haplotype frequencies and disease prevalence. Methodology/Principal Findings: A deterministic mathematical model was developed to explore how the associations between PrP genotype and both scrapie susceptibility and postnatal lamb mortality affect the prevalence of scrapie and the associated change in PrP gene frequencies in a closed flock of sheep. The model incorporates empirical evidence on epidemiological and biological characteristics of scrapie and on mortality rates induced by causes other than scrapie. The model results indicate that unfavorable associations of the scrapie resistant PrP haplotypes with post-natal lamb mortality, if sufficiently strong, can increase scrapie prevalence during an epidemic, and result in scrapie persisting in the population. The range of model parameters, for which such effects were observed, is realistic but relatively narrow. Conclusions/Significance: The results of the present model suggest that for most parameter combinations an unfavourable association between PrP genotype and post-natal lamb mortality does not greatly alter the dynamics of scrapie and, hence, would not have an adverse impact on a breeding programme. There were, however, a range of scenarios, narrow, but realistic, in which such an unfavourable association resulted in an increased prevalence and in the persistence of infection. Consequently, associations between PrP genotypes and fitness traits should be taken into account when designing future models and breeding programmes.	[Doeschl-Wilson, Andrea; Sawalha, Rami; Villanueva, Beatriz] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Gubbins, Simon] Pirbright Labs, Inst Anim Hlth, Surrey, England; [Villanueva, Beatriz] Minist Ciencia Innovac, Dept Mejora Genet Anim, Inst Nacl Invest & Tecnol Agr & Alimentaria SGIT, Madrid, Spain	Scottish Agricultural College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Doeschl-Wilson, A (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	andrea.wilson@sac.ac.uk		Gubbins, Simon/0000-0003-0538-4173; Wilson, Andrea/0000-0002-2658-6973	Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC) [IAH1320]; BBSRC [BBS/E/I/00001320] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001320] Funding Source: researchfish	Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Scottish Government. SG also acknowledges funding from the Biotechnology and Biological Sciences Research Council (BBSRC) [grant code IAH1320]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; Falconer D. S, 1996, INTRO QUANTITATIVE G; FOSTER JD, 1989, VET REC, V125, P415, DOI 10.1136/vr.125.16.415; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gubbins S, 2006, PREV VET MED, V73, P17, DOI 10.1016/j.prevetmed.2005.08.001; Gubbins S, 2005, PREV VET MED, V69, P175, DOI 10.1016/j.prevetmed.2004.12.009; Gubbins S, 2005, PREV VET MED, V67, P143, DOI 10.1016/j.prevetmed.2004.08.007; Gubbins S, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-3; Hagenaars TJ, 2000, MATH BIOSCI, V168, P117, DOI 10.1016/S0025-5564(00)00048-1; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Hunter N, 1997, VET REC, V141, P137, DOI 10.1136/vr.141.6.137; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; Lewis RM, 2000, LIVEST PROD SCI, V67, P129, DOI 10.1016/S0301-6226(00)00182-2; Luhken G, 2007, VET RES, V38, P65, DOI 10.1051/vetres:2006046; Matthews L, 2001, ARCH VIROL, V146, P1173, DOI 10.1007/s007050170113; Moore RC, 2009, ANIMAL, V3, P336, DOI 10.1017/S1751731108003637; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Pritchard TC, 2008, ANIMAL, V2, P1421, DOI 10.1017/S1751731108002747; Roden JA, 2006, PREV VET MED, V73, P1, DOI 10.1016/j.prevetmed.2005.08.002; Sawalha RM, 2007, J ANIM SCI, V85, P632, DOI 10.2527/jas.2006-372; Sawalha RM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001236; SLATE J, 2005, P R SOC B, V272, P2337; Stringer SM, 1998, MATH BIOSCI, V153, P79, DOI 10.1016/S0025-5564(98)10036-6; Sweeney T, 2008, VET RES, V39, DOI 10.1051/vetres:2008004; Woolhouse MEJ, 1999, PHILOS T R SOC B, V354, P751, DOI 10.1098/rstb.1999.0427; Woolhouse MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1205, DOI 10.1098/rspb.1998.0421; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0	28	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7970	10.1371/journal.pone.0007970	http://dx.doi.org/10.1371/journal.pone.0007970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956715	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500005
J	Han, L; Wierenga, ATJ; Rozenveld-Geugien, M; van de Lande, K; Vellenga, E; Schuringa, JJ				Han, Lina; Wierenga, Albertus T. J.; Rozenveld-Geugien, Marjan; van de Lande, Kim; Vellenga, Edo; Schuringa, Jan Jacob			Single-Cell STAT5 Signal Transduction Profiling in Normal and Leukemic Stem and Progenitor Cell Populations Reveals Highly Distinct Cytokine Responses	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM/PROGENITOR CELLS; LONG-TERM MAINTENANCE; SELF-RENEWAL; CONSTITUTIVE ACTIVATION; STAT5A(-/-)5B(-/-) MICE; BONE-MARROW; FLT3; DIFFERENTIATION; ENGRAFTMENT	Background: Signal Transducer and Activator of Transcription 5 (STAT5) plays critical roles in normal and leukemic hematopoiesis. However, the manner in which STAT5 responds to early-acting and lineage-restricted cytokines, particularly in leukemic stem/progenitor cells, is largely unknown. Methodology/Principal Findings: We optimized a multiparametric flow cytometry protocol to analyze STAT5 phosphorylation upon cytokine stimulation in stem and progenitor cell compartments at a single-cell level. In normal cord blood (CB) cells, STAT5 phosphorylation was efficiently induced by TPO, IL-3 and GM-CSF within CD34(+)CD38(-) hematopoietic stem cells (HSCs). EPO- and SCF-induced STAT5 phosphorylation was largely restricted to the megakaryocyte-erythroid progenitor (MEP) compartment, while G-CSF as well IL-3 and GM-CSF were most efficient in inducing STAT5 phosphorylation in the myeloid progenitor compartments. Strikingly, mobilized adult peripheral blood (PB) CD34(+) cells responded much less efficiently to cytokine-induced STAT5 activation, with the exception of TPO. In leukemic stem and progenitor cells, highly distinct cytokine responses were observed, differing significantly from their normal counterparts. These responses could not be predicted by the expression level of cytokine receptors. Also, heterogeneity existed in cytokine requirements for long-term expansion of AML CD34(+) cells on stroma. Conclusions/Significance: In conclusion, our optimized multiparametric flow cytometry protocols allow the analysis of signal transduction at the single cell level in normal and leukemic stem and progenitor cells. Our study demonstrates highly distinctive cytokine responses in STAT5 phosphorylation in both normal and leukemic stem/progenitor cells.	[Han, Lina; Wierenga, Albertus T. J.; Rozenveld-Geugien, Marjan; van de Lande, Kim; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Han, Lina] Harbin Med Univ, Clin Coll 1, Dept Hematol, Harbin, Peoples R China	University of Groningen; Harbin Medical University	Han, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands.	j.schuringa@int.umcg.nl	Han, Lina/J-5119-2015	Han, Lina/0000-0003-1538-1734	NWO-VENI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2004); NWO-VIDI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2008); KWF [RUG 2009-4275]	NWO-VENI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2004)(Netherlands Organization for Scientific Research (NWO)); NWO-VIDI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2008)(Netherlands Organization for Scientific Research (NWO)); KWF	This work was supported by grants from the NWO-VENI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2004), NWO-VIDI (Nederlandse organisatie voor Wetenschappelijk Onderzoek, 2008), and KWF (Koningin Wilhelmina Fonds, RUG 2009-4275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlini P, 2008, BLOOD, V111, P1767, DOI 10.1182/blood-2007-07-097543; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Birkenkamp KU, 2001, LEUKEMIA, V15, P1923, DOI 10.1038/sj.leu.2402317; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Bradley HL, 2004, BLOOD, V103, P2965, DOI 10.1182/blood-2003-08-2963; Bradley HL, 2002, BLOOD, V100, P3983, DOI 10.1182/blood-2002-05-1602; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; Drayer AL, 2005, STEM CELLS, V23, P240, DOI 10.1634/stemcells.2004-0153; Fatrai S, 2008, EXP HEMATOL, V36, P1254, DOI 10.1016/j.exphem.2008.04.015; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Grebien F, 2008, BLOOD, V111, P4511, DOI 10.1182/blood-2007-07-102848; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Herrera C, 2001, BRIT J HAEMATOL, V114, P920, DOI 10.1046/j.1365-2141.2001.02974.x; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kieslinger M, 2000, GENE DEV, V14, P232; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Liu G, 2007, EXP HEMATOL, V35, P1684, DOI 10.1016/j.exphem.2007.08.026; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Moshaver B, 2008, STEM CELLS, V26, P3059, DOI 10.1634/stemcells.2007-0861; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Olthof SG, 2008, STEM CELLS, V26, P1732, DOI 10.1634/stemcells.2007-0899; Pallis M, 2003, LEUKEMIA RES, V27, P803, DOI 10.1016/S0145-2126(03)00012-2; Recher C, 2005, CELL CYCLE, V4, P1540; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Schuringa Jan Jacob, 2009, V538, P287, DOI 10.1007/978-1-59745-418-6_14; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Ustun C, 2009, LEUKEMIA RES, V33, P735, DOI 10.1016/j.leukres.2008.09.027; Van Etten RA, 2007, ONCOGENE, V26, P6738, DOI 10.1038/sj.onc.1210758; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wierenga ATJ, 2006, BLOOD, V107, P4326, DOI 10.1182/blood-2005-11-4608; Xiao WB, 2008, J CLIN INVEST, V118, P924, DOI 10.1172/JCI34013	48	24	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7989	10.1371/journal.pone.0007989	http://dx.doi.org/10.1371/journal.pone.0007989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956772	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500019
J	Peschiaroli, A; Skaar, JR; Pagano, M; Melino, G				Peschiaroli, A.; Skaar, J. R.; Pagano, M.; Melino, G.			The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival	ONCOGENE			English	Article						ubiquitin; F-box proteins; beta-Trcp; degradation	F-BOX PROTEINS; KAPPA-B-ALPHA; REPEAT-CONTAINING PROTEIN; MEDIATED DEGRADATION; LIGASE; INHIBITION; BETA-TRCP1; PATHWAY; PLAYERS; CDC25A	Ubiquitin-specific proteases (USPs) are a subclass of cysteine proteases that catalyze the removal of ubiquitin (either monomeric or chains) from substrates, thus counteracting the activity of E3 ubiquitin ligases. Although the importance of USPs in a multitude of processes, from hereditary cancer to neurodegeneration, is well established, our knowledge on their mode of regulation, substrate specificity and biological function is quite limited. In this study we identify USP47 as a novel interactor of the E3 ubiquitin ligase, Skp1/Cul1/F-box protein beta-transducin repeat-containing protein (SCF beta-Trcp). We found that both beta-Trcp1 and beta-Trcp2 bind specifically to USP47, and point mutations in the beta-Trcp WD-repeat region completely abolished USP47 binding, indicating an E3-substrate-type interaction. However, unlike canonical beta-Trcp substrates, USP47 protein levels were neither affected by silencing of beta-Trcp nor modulated in a variety of processes, such as cell-cycle progression, DNA damage checkpoint responses or tumor necrosis factor (TNF) pathway activation. Notably, genetic or siRNA-mediated depletion of USP47 induced accumulation of Cdc25A, decreased cell survival and augmented the cytotoxic effects of anticancer drugs. In conclusion, we showed that USP47, a novel beta-Trcp interactor, regulates cell growth and survival, potentially providing a novel target for anticancer therapies. Oncogene (2010) 29, 1384-1393; doi:10.1038/onc.2009.430; published online 7 December 2009	[Peschiaroli, A.; Melino, G.] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, IDI IRCCS Biochem Lab, I-00173 Rome, Italy; [Skaar, J. R.; Pagano, M.] NYU, Sch Med, Dept Pathol, NYU Canc Inst, New York, NY USA; [Pagano, M.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA; [Melino, G.] Univ Leicester, Toxicol Unit, MRC, Leicester, Leics, England	University of Rome Tor Vergata; New York University; Howard Hughes Medical Institute; New York University; University of Leicester	Melino, G (corresponding author), Univ Rome, Dept Expt Med & Biochem Sci, IDI IRCCS Biochem Lab, Via Montpellier, I-00133 Rome, RM, Italy.	gerry.melino@uniroma2.it		PESCHIAROLI, ANGELO/0000-0001-6311-2382; pagano, michele/0000-0003-3210-2442	EU [LSHB-CT-019067]; Alleanza contro il Cancro [ACC12/6]; MIUR/PRIN [RBIP06LCA9_0023]; AIRC [2008-2010_33-08]; ISS 'Program Italia-USA' [N526D5]; Italian Human ProteomeNet [RBRN07BMCT_007]; Telethon; National Institutes of Health [R01-GM57587, R37-CA76584, R21-CA125173]; Multiple Myeloma Research Foundation; Philip Morris USA Inc.; Philip Morris International; American Cancer Society; MRC [MC_U132670600] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R21CA125173, R37CA076584, R21CA161108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; Medical Research Council [MC_U132670600] Funding Source: researchfish	EU(European Commission); Alleanza contro il Cancro; MIUR/PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC(Fondazione AIRC per la ricerca sul cancro); ISS 'Program Italia-USA'; Italian Human ProteomeNet; Telethon(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; Philip Morris USA Inc.; Philip Morris International; American Cancer Society(American Cancer Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported by grants from EU EPISTEM (LSHB-CT-019067), 'Alleanza contro il Cancro' (ACC12/6), MIUR/PRIN (RBIP06LCA9_0023), AIRC (2008-2010_33-08), ISS 'Program Italia-USA' N526D5, Italian Human ProteomeNet RBRN07BMCT_007 and Telethon to GM; and grants from the National Institutes of Health (R01-GM57587, R37-CA76584 and R21-CA125173) and Multiple Myeloma Research Foundation to MP. Research described in this article was also supported in part by Philip Morris USA Inc. and Philip Morris International to GM. JRS was supported by the American Cancer Society-Mr and Mrs William G Campbell Postdoctoral Fellowship in Memory of Carolyn Cabott. MP is an Investigator with the Howard Hughes Medical Institute.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cai ZZ, 1997, J BIOL CHEM, V272, P96; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Melino G, 2005, CELL DEATH DIFFER, V12, P1155, DOI 10.1038/sj.cdd.4401740; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soldatenkov VA, 1999, CANCER RES, V59, P5085; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Syljuasen RG, 2004, CANCER RES, V64, P9035, DOI 10.1158/0008-5472.CAN-04-2434; Tang WG, 2005, CANCER RES, V65, P1904, DOI 10.1158/0008-5472.CAN-04-2597; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	39	58	62	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1384	1393		10.1038/onc.2009.430	http://dx.doi.org/10.1038/onc.2009.430			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19966869	Green Accepted			2022-12-25	WOS:000275170600013
J	Gasmi-Seabrook, GMC; Marshall, CB; Cheung, M; Kim, B; Wang, F; Jang, YJ; Mak, TW; Stambolic, V; Ikura, M				Gasmi-Seabrook, Genevieve M. C.; Marshall, Christopher B.; Cheung, Melissa; Kim, Bryan; Wang, Feng; Jang, Ying Ju; Mak, Tak W.; Stambolic, Vuk; Ikura, Mitsuhiko			Real-time NMR Study of Guanine Nucleotide Exchange and Activation of RhoA by PDZ-RhoGEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PH DOMAIN; GTPASES; COMPLEX; ASSIGNMENT; PROTEINS; BINDING; LARGER; VIEW; RAS	Small guanosine triphosphatases (GTPases) become activated when GDP is replaced by GTP at the highly conserved nucleotide binding site. This process is intrinsically very slow in most GTPases but is significantly accelerated by guanine nucleotide exchange factors (GEFs). Nucleotide exchange in small GTPases has been widely studied using spectroscopy with fluorescently tagged nucleotides. However, this method suffers from effects of the bulky fluorescent moiety covalently attached to the nucleotide. Here, we have used a newly developed real-time NMR-based assay to monitor small GTPase RhoA nucleotide exchange by probing the RhoA conformation. We compared RhoA nucleotide exchange from GDP to GTP and GTP analogues in the absence and presence of the catalytic DH-PH domain of PDZ-RhoGEF (DH-PHPRG). Using the non-hydrolyzable analogue guanosine-5'-O-(3-thiotriphosphate), which we found to be a reliable mimic of GTP, we obtained an intrinsic nucleotide exchange rate of 5.5 x 10(-4) min(-1). This reaction is markedly accelerated to 1179 x 10(-4) min(-1) in the presence of DH-PHPRG at a ratio of 1: 8,000 relative to RhoA. Mutagenesis studies confirmed the importance of Arg-868 near a conserved region (CR3) of the Dbl homology (DH) domain and revealed that Glu-741 in CR1 is critical for full activity of DH-PHPRG, together suggesting that the catalytic mechanism of PDZ-RhoGEF is similar to Tiam1. Mutation of the single RhoA (E97A) residue that contacts the pleckstrin homology (PH) domain rendered the mutant 10-fold less sensitive to the activity of DH-PHPRG. Interestingly, this mutation does not affect RhoA activation by leukemia-associated RhoGEF (LARG), indicating that the PH domains of these two homologous GEFs may play different roles.	[Gasmi-Seabrook, Genevieve M. C.; Marshall, Christopher B.; Cheung, Melissa; Kim, Bryan; Wang, Feng; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Hlth Network, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Jang, Ying Ju; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada; [Gasmi-Seabrook, Genevieve M. C.; Marshall, Christopher B.; Cheung, Melissa; Kim, Bryan; Wang, Feng; Jang, Ying Ju; Mak, Tak W.; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), MaRS Toronto Med Discovery Tower,Rm 4-804,101 Col, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca	Marshall, Christopher/K-8943-2019; Cheung, Melissa/L-6029-2016	Marshall, Christopher/0000-0002-7571-5700; Ikura, Mitsuhiko/0000-0002-9524-1303; Cheung, Melissa/0000-0002-8076-0725; Wang, Feng/0000-0002-4322-2127; Stambolic, Vuk/0000-0001-8853-3239	Cancer Research Society (Canada); Canada Foundation for Innovation	Cancer Research Society (Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by a grant from the Cancer Research Society (Canada).; A grant from the Canada Foundation for Innovation funded the Bruker 800- and 600-MHz NMR spectrometers.	Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fu M, 2007, DIABETES, V56, P1363, DOI 10.2337/db06-1421; Gu J, 2006, CANCER-AM CANCER SOC, V106, P2716, DOI 10.1002/cncr.21944; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kintscher C, 2009, J MOL BIOL, V387, P270, DOI 10.1016/j.jmb.2009.01.056; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; Oleksy A, 2004, ACTA CRYSTALLOGR D, V60, P740, DOI 10.1107/S0907444904002318; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; SCHEIDIG AJ, 1995, J MOL BIOL, V253, P132, DOI 10.1006/jmbi.1995.0541; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014	30	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5137	5145		10.1074/jbc.M109.064691	http://dx.doi.org/10.1074/jbc.M109.064691			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018869	Green Published, hybrid			2022-12-25	WOS:000275327200005
J	Li, JP; Fu, YN; Chen, YR; Tan, TH				Li, Ju-Pi; Fu, Yu-Ning; Chen, Yi-Rong; Tan, Tse-Hua			JNK Pathway-associated Phosphatase Dephosphorylates Focal Adhesion Kinase and Suppresses Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; PROTEIN-TYROSINE PHOSPHATASES; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PHOSPHORYLATION; VHR; AUTOPHOSPHORYLATION; FIBROBLASTS; ACTIVATION; LMW-DSP2	JNK pathway-associated phosphatase (JKAP, also named DUSP22) is expressed in various tissues, indicating that JKAP may have an important biological function. We showed that JKAP localized in the actin filament-enriched region. Expression of JKAP reduced cell migration, whereas a JKAP mutant lacking catalytic activity promoted cell motility. JKAP efficiently removed tyrosine phosphorylation of several proteins. We have identified focal adhesion kinase (FAK) as a substrate of JKAP. Overexpression of JKAP, but not JKAP mutant lacking catalytic activity, decreased FAK phosphorylation at tyrosines 397, 576, and 577 in H1299 cells. Consistent with these results, decreasing JKAP expression by RNA interference promoted cell migration and Src-induced FAK phosphorylation. Taken together, this study identified a new role for JKAP in the modulation of FAK phosphorylation and cell motility.	[Li, Ju-Pi; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Miaoli County, Taiwan; [Fu, Yu-Ning; Chen, Yi-Rong] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan 35053, Miaoli County, Taiwan; [Tan, Tse-Hua] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Baylor College of Medicine	Chen, YR (corresponding author), 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	yrchen@nhri.org.tw; ttan@nhri.org.tw	Tan, Tse-Hua/E-3983-2010; Chen, Yi-Rong/CAF-2186-2022; Li, Ju-Pi/AAS-8866-2021; Tan, Tse-Hua/ABD-7080-2021; Chen, Yi-Rong/CAH-7991-2022; Chen, Yi-Rong/E-3991-2010	Tan, Tse-Hua/0000-0003-4969-3170; Chen, Yi-Rong/0000-0002-4307-3002; Li, Ju-Pi/0000-0003-3406-4865; Tan, Tse-Hua/0000-0003-4969-3170; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002	National Institutes of Health [1R01-AI066895]; National Health Research Institutes, Taiwan [MG-097-PP-03, 98A1-IMPP01-014]; Department of Health, Taiwan [DOH97-TD-G-111-0037]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Department of Health, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-AI066895 (to T.-H. T.). This work was also supported by National Health Research Institutes, Taiwan, Grants MG-097-PP-03 (to Y.-R.C.) and 98A1-IMPP01-014 (to T.-H. T.) and Department of Health, Taiwan, Grant DOH97-TD-G-111-0037 (to Y.-R.C.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2002, J BIOL CHEM, V277, P5524, DOI 10.1074/jbc.M107653200; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Aoyama K, 2001, J BIOL CHEM, V276, P27575, DOI 10.1074/jbc.M100408200; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Hood KL, 2002, BIOCHEM BIOPH RES CO, V298, P545, DOI 10.1016/S0006-291X(02)02488-9; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Maa MC, 1998, BIOCHEM BIOPH RES CO, V251, P344, DOI 10.1006/bbrc.1998.9464; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Wang JY, 2008, J NEUROCHEM, V107, P1544, DOI 10.1111/j.1471-4159.2008.05714.x; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yokota T, 2007, PROTEINS, V66, P272, DOI 10.1002/prot.21152; Yoon TS, 2005, PROTEINS, V61, P694, DOI 10.1002/prot.20642; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	33	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5472	5478		10.1074/jbc.M109.060186	http://dx.doi.org/10.1074/jbc.M109.060186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018849	Green Published, hybrid			2022-12-25	WOS:000275327200040
J	Bonadies, N; Neururer, C; Steege, A; Vallabhapurapu, S; Pabst, T; Mueller, BU				Bonadies, N.; Neururer, Ch; Steege, A.; Vallabhapurapu, S.; Pabst, T.; Mueller, B. U.			PU.1 is regulated by NF-kappa B through a novel binding site in a 17 kb upstream enhancer element	ONCOGENE			English	Article						NF-kappa B; PU.1; Spi-1; enhancer	TRANSCRIPTION FACTOR PU.1; ACUTE MYELOID-LEUKEMIA; C/EBP-ALPHA BINDS; DNA-BINDING; GENE; EXPRESSION; NEUTROPHILS; DISRUPTION; MECHANISMS; PROMOTER	The majority of patients with acute myeloid leukemia (AML) still die of their disease, and novel therapeutic concepts are needed. Timely expression of the hematopoietic master regulator PU.1 is crucial for normal development of myeloid and lymphoid cells. Targeted disruption of an upstream regulatory element (URE) located several kb upstream in the PU.1 promoter decreases PU.1 expression thereby inducing AML in mice. In addition, suppression of PU.1 has been observed in specific subtypes of human AML. Here, we identified nuclear factor-kappa B (NF-kappa B) to activate PU.1 expression through a novel site within the URE. We found sequence variations of this particular NF-kappa B site in 4 of 120 AML patients. These variant NF-kappa B sequences failed to mediate activation of PU.1. Moreover, the synergistic activation of PU.1 together with CEBPB through these variant sequences was also lost. Finally, AML patients with such variant sequences had suppressed PU.1 mRNA expression. This study suggests that changes of a single base pair in a distal element critically affect the regulation of the tumor suppressor gene PU.1 thereby contributing to the development of AML. Oncogene (2010) 29, 1062-1072; doi:10.1038/onc.2009.371; published online 7 December 2009	[Bonadies, N.; Neururer, Ch; Steege, A.; Vallabhapurapu, S.; Mueller, B. U.] Univ Bern, Univ Hosp Bern, Dept Internal Med & Clin Res, CH-3010 Bern, Switzerland; [Pabst, T.] Univ Bern, Univ Hosp Bern, Dept Med Oncol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Mueller, BU (corresponding author), Univ Bern, Univ Hosp Bern, Dept Internal Med & Clin Res, CH-3010 Bern, Switzerland.	beatrice.mueller@insel.ch	Bonadies, Nicolas/F-2388-2017; Steege, Andreas/F-3885-2010	Bonadies, Nicolas/0000-0001-8761-2066; 	Swiss National Science Foundation [SF 310000-113761]; Swiss Cancer League [OCS 01731082005]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League	This work was supported by a grant from the Swiss National Science Foundation SF 310000-113761 (to BUM), and a grant from the Swiss Cancer League, OCS 01731082005 (to BUM).	Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hoogenkamp M, 2007, MOL CELL BIOL, V27, P7425, DOI 10.1128/MCB.00905-07; HROMAS R, 1993, BLOOD, V82, P2998; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Kummalue T, 2003, J LEUKOCYTE BIOL, V74, P464, DOI 10.1189/jlb.1202622; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mueller BU, 2006, BLOOD, V107, P3330, DOI 10.1182/blood-2005-07-3068; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nijnik A, 2003, NUCLEIC ACIDS RES, V31, P1497, DOI 10.1093/nar/gkg231; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Suraweera N, 2005, ONCOGENE, V24, P3678, DOI 10.1038/sj.onc.1208422; Tisne C, 1999, BIOCHEMISTRY-US, V38, P3883, DOI 10.1021/bi982402d; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; VOSO MT, 1994, P NATL ACAD SCI USA, V91, P7932, DOI 10.1073/pnas.91.17.7932; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291	39	30	31	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					1062	1072		10.1038/onc.2009.371	http://dx.doi.org/10.1038/onc.2009.371			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19966852				2022-12-25	WOS:000274604400012
J	Escamilla-Powers, JR; Daniel, CJ; Farrell, A; Taylor, K; Zhang, XL; Byers, S; Sears, R				Escamilla-Powers, Julienne R.; Daniel, Colin J.; Farrell, Amy; Taylor, Karyn; Zhang, Xiaoli; Byers, Sarah; Sears, Rosalie			The Tumor Suppressor Protein HBP1 Is a Novel c-Myc-binding Protein That Negatively Regulates c-Myc Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE BREAST-CANCER; RETINOBLASTOMA PROTEIN; ESSENTIAL COFACTOR; GENE-EXPRESSION; REPRESSOR HBP1; TARGET; TRRAP; CELL; MAX; BOX	c-Myc is an important transcription factor that regulates cellular proliferation, cell growth, and differentiation. A number of transcriptional co-factors for c-Myc have been described that have binding sites within highly conserved regions of the c-Myc transactivational domain (TAD). Given the importance of the c-Myc TAD, we set out to identify new proteins that interact with this region using a yeast two-hybrid assay. HBP1 was identified in our screen as a protein that interacts with full-length c-Myc but not a c-Myc mutant lacking the TAD. HBP1 is a transcriptional repressor and has been shown to negatively regulate the cell cycle. A correlation between HBP1 under-expression and breast cancer relapse has been described, suggesting that HBP1 may be an important tumor suppressor protein. We have found that HBP1 binds c-Myc in cells, and expression of HBP1 inhibits c-Myc transactivational activity at least partly by preventing c-Myc binding to target gene promoters. c-Myc binds to the C terminus of HBP1, a region lost in some breast tumors, and some HBP1 mutants found in breast cancer weakly interact with and/or no longer negatively regulate c-Myc. This work adds to our understanding of c-Myc regulation and mechanisms of tumor suppression by HBP1.	[Escamilla-Powers, Julienne R.; Daniel, Colin J.; Farrell, Amy; Taylor, Karyn; Zhang, Xiaoli; Byers, Sarah; Sears, Rosalie] Oregon Hlth & Sci Univ, Dept Med & Mol Genet, Portland, OR 97239 USA	Oregon Health & Science University	Sears, R (corresponding author), 3181 SW Sam Jackson Pk Rd,L103A, Portland, OR 97239 USA.	searsr@ohsu.edu			National Institutes of Health [R01 CA100855, R01 CA100855-05S1, T32-CA106195]; NATIONAL CANCER INSTITUTE [T32CA106195, R01CA100855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA100855 (to R. S.), R01 CA100855-05S1 (a minority supplement to J. R. E.-P.), and T32-CA106195 (to A. F.).	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bolognese F, 2006, GENE, V366, P109, DOI 10.1016/j.gene.2005.07.046; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Driouch K, 1998, CANCER RES, V58, P2081; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Jones RM, 1996, MOL CELL BIOL, V16, P4754; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Lavender P, 1997, ONCOGENE, V14, P2721, DOI 10.1038/sj.onc.1201243; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; LESAGE F, 1994, NUCLEIC ACIDS RES, V22, P3685, DOI 10.1093/nar/22.18.3685; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Mitchell KO, 2000, CANCER RES, V60, P6318; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; Park J, 2001, GENE DEV, V15, P1619, DOI 10.1101/gad.900101; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Shih HH, 1998, MOL CELL BIOL, V18, P4732, DOI 10.1128/MCB.18.8.4732; Shih HH, 2001, MOL CELL BIOL, V21, P5723, DOI 10.1128/MCB.21.17.5723-5732.2001; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; ZENKLUSEN JC, 1995, ONCOGENE, V11, P359; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06	56	31	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4847	4858		10.1074/jbc.M109.074856	http://dx.doi.org/10.1074/jbc.M109.074856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20008325	Green Published, hybrid			2022-12-25	WOS:000275274800063
J	Kim, JY; Lee, YC; Kim, C				Kim, Ji Young; Lee, Young Chul; Kim, Changsoo			Direct Inhibition of Pumilo Activity by Bam and Bgcn in Drosophila Germ Line Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNCHBACK MESSENGER-RNA; OF-MARBLES; SELF-RENEWAL; PROTEIN; NANOS; OVARY; GENE; TRANSCRIPTION; MAINTENANCE; BINDING	The fate of stem cells is intricately regulated by numerous extrinsic and intrinsic factors that promote maintenance or differentiation. The RNA-binding translational repressor Pumilio (Pum) in conjunction with Nanos (Nos) is required for self-renewal, whereas Bam (bag-of-marbles) and Bgcn (benign gonial cell neoplasm) promote differentiation of germ line stem cells in the Drosophila ovary. Genetic analysis suggests that Bam and Bgcn antagonize Pum/Nos function to promote differentiation; however, the molecular basis of this epistatic relationship is currently unknown. Here, we show that Bam and Bgcn inhibit Pum function through direct binding. We identified a ternary complex involving Bam, Bgcn, and Pum in which Bam, but not Bgcn, directly interacts with Pum, and this interaction is greatly increased by the presence of Bgcn. In a heterologous reporter assay to monitor Pum activity, Bam, but not Bgcn, inhibits Pum activity. Notably, the N-terminal region of Pum, which lacks the C-terminal RNA-binding Puf domain, mediates both the ternary protein interaction and the Bam inhibition of Pum function. These studies suggest that, in cystoblasts, Bam and Bgcn may directly inhibit Pum/Nos activity to promote differentiation of germ line stem cells.	[Kim, Ji Young; Lee, Young Chul; Kim, Changsoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Kim, C (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	changgk@chonnam.ac.kr			Korea Science and Engineering Foundation; Chonnam National University; BK21 Program; National Research Foundation [2009-0088438]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Chonnam National University; BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation	This work was supported by research grants from the Basic Research Program and National Research Laboratory of the Korea Science and Engineering Foundation, a research fund of Chonnam National University in 2004, and the BK21 Program (to C. K.) and Basic Science Research Program Grant 2009-0088438 from the National Research Foundation (to Y. C. L.).	Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Forbes A, 1998, DEVELOPMENT, V125, P679; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Gilboa L, 2003, DEVELOPMENT, V130, P6625, DOI 10.1242/dev.00853; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Lavoie CA, 1999, DEV BIOL, V212, P405, DOI 10.1006/dbio.1999.9346; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Lin HF, 1997, DEVELOPMENT, V124, P2463; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; NGUYEN VT, 1988, ANAL BIOCHEM, V171, P404, DOI 10.1016/0003-2697(88)90505-2; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Ohlstein B, 2000, GENETICS, V155, P1809; Parisi M, 1999, GENETICS, V153, P235; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; SIKORSKI RS, 1989, GENETICS, V122, P19; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Spradling AC, 1997, COLD SPRING HARB SYM, V62, P25; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Todeschini AR, 2008, P NATL ACAD SCI USA, V105, P1925, DOI 10.1073/pnas.0709619104; Verrotti AC, 2000, DEVELOPMENT, V127, P5225; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zamore PD, 1997, RNA, V3, P1421	37	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4741	4746		10.1074/jbc.M109.002014	http://dx.doi.org/10.1074/jbc.M109.002014			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018853	hybrid, Green Published			2022-12-25	WOS:000275274800052
J	Li, S; Zheng, H; Mao, AP; Zhong, B; Li, Y; Liu, Y; Gao, Y; Ran, Y; Tien, P; Shu, HB				Li, Shu; Zheng, Hao; Mao, Ai-Ping; Zhong, Bo; Li, Ying; Liu, Yu; Gao, Yan; Ran, Yong; Tien, Po; Shu, Hong-Bing			Regulation of Virus-triggered Signaling by OTUB1-and OTUB2-mediated Deubiquitination of TRAF3 and TRAF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; E3 UBIQUITIN LIGASE; INNATE IMMUNE-RESPONSES; TUMOR-SUPPRESSOR CYLD; DOUBLE-STRANDED-RNA; IFN-BETA PROMOTER; INDUCIBLE GENE-I; RIG-I; ANTIVIRAL RESPONSES; NEGATIVE REGULATION	Ubiquitination and deubiquitination have emerged as critical post-translational regulatory mechanisms for activation or attenuation of the virus-triggered type I interferon (IFN)(2) induction pathways. In this study, we identified two deubiquitinating enzymes, OTUB1 and OTUB2, as negative regulators of virus-triggered type I IFN induction. Overexpression of OTUB1 and OTUB2 inhibited virus-induced activation of IRF3 and NF-kappa B, transcription of the IFNB1 gene as well as cellular antiviral response, whereas knockdown of OTUB1 and OTUB2 had opposite effects. Coimmunoprecipitations indicated OTUB1 and -2 interacted with TRAF3 and TRAF6, two E3 ubiquitin ligases required for virus-triggered IRF3 and NF-kappa B activation, respectively. Furthermore, we found that OTUB1 and OTUB2 mediated virus-triggered deubiquitination of TRAF3 and -6. These findings suggest that OTUB1 and OTUB2 negatively regulate virus-triggered type IIFN induction and cellular antiviral response by deubiquitinating TRAF3 and -6.	[Li, Shu; Zheng, Hao; Mao, Ai-Ping; Zhong, Bo; Li, Ying; Liu, Yu; Gao, Yan; Ran, Yong; Tien, Po; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Modern Virol Ctr, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Ctr, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn		, Yong/0000-0002-7005-435X	Chinese 973 Program [2006CB504301, 2010CB911802]; National Natural Science Foundation of China [30630019, 30921001]; Chinese 111 Project [B06018]; Chinese National Science and Technology [2008ZX10002-014]	Chinese 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project); Chinese National Science and Technology(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese 973 Program (2006CB504301 and 2010CB911802), the National Natural Science Foundation of China (30630019 and 30921001), the Chinese 111 Project (B06018), and the Chinese National Science and Technology Major Project (2008ZX10002-014).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	38	129	137	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4291	4297		10.1074/jbc.M109.074971	http://dx.doi.org/10.1074/jbc.M109.074971			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996094	Green Published, hybrid			2022-12-25	WOS:000275274800005
J	Masuda, T; Goto, F; Yoshihara, T; Mikami, B				Masuda, Taro; Goto, Fumiyuki; Yoshihara, Toshihiro; Mikami, Bunzo			Crystal Structure of Plant Ferritin Reveals a Novel Metal Binding Site That Functions as a Transit Site for Metal Transfer in Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSE SPLEEN APOFERRITIN; PISUM-SATIVUM FERRITIN; PEA-SEED-FERRITIN; H-CHAIN FERRITINS; ESCHERICHIA-COLI; DIFFERENTIAL EXPRESSION; IRON INCORPORATION; HIGH-RESOLUTION; CORE-FORMATION; IN-VITRO	Ferritins are important iron storage and detoxification proteins that are widely distributed in living kingdoms. Because plant ferritin possesses both a ferroxidase site and a ferrihydrite nucleation site, it is a suitable model for studying the mechanism of iron storage in ferritin. This article presents for the first time the crystal structure of a plant ferritin from soybean at 1.8-angstrom resolution. The soybean ferritin 4 (SFER4) had a high structural similarity to vertebrate ferritin, except for the N-terminal extension region, the C-terminal short helix E, and the end of the BC-loop. Similar to the crystal structures of other ferritins, metal binding sites were observed in the iron entry channel, ferroxidase center, and nucleation site of SFER4. In addition to these conventional sites, a novel metal binding site was discovered intermediate between the iron entry channel and the ferroxidase site. This site was coordinated by the acidic side chain of Glu(173) and carbonyl oxygen of Thr(168), which correspond, respectively, to Glu(140) and Thr(135) of human H chain ferritin according to their sequences. A comparison of the ferroxidase activities of the native and the E173A mutant of SFER4 clearly showed a delay in the iron oxidation rate of the mutant. This indicated that the glutamate residue functions as a transit site of iron from the 3-fold entry channel to the ferroxidase site, which may be universal among ferritins.	[Masuda, Taro] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Lab Food Qual Design & Dev, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan; [Goto, Fumiyuki; Yoshihara, Toshihiro] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Biotechnol Sector, Chiba 2701194, Japan	Kyoto University; Kyoto University; Central Research Institute of Electric Power Industry - Japan	Masuda, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Lab Food Qual Design & Dev, Kyoto 6110011, Japan.	masutaro@kais.kyoto-u.ac.jp	Masuda, Taro/G-4276-2011	Masuda, Taro/0000-0002-5549-375X	Shorai Foundation for Science and Technology	Shorai Foundation for Science and Technology	This work was supported a grant from the Shorai Foundation for Science and Technology	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AROSIO P, 1978, J BIOL CHEM, V253, P4451; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bou-Abdallah F, 2004, BIOCHEMISTRY-US, V43, P4332, DOI 10.1021/bi0498813; Briat J. F., 1995, Iron nutrition in soils and plants. Proceedings of the Seventh International Symposium on Iron Nutrition and Interactions in Plants, Zaragoza, Spain, 27 June-2 July 1993., P265; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; CHASTEEN ND, 1982, J BIOL CHEM, V257, P7672; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Dong XB, 2007, FEBS LETT, V581, P5796, DOI 10.1016/j.febslet.2007.11.049; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOBISLOISY I, 1995, EUR J BIOCHEM, V231, P609, DOI 10.1111/j.1432-1033.1995.0609d.x; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Gaymard F, 1996, BIOCHEM J, V318, P67, DOI 10.1042/bj3180067; Granier T, 1998, PROTEINS, V31, P477, DOI 10.1002/(SICI)1097-0134(19980601)31:4<477::AID-PROT13>3.3.CO;2-T; Granier T, 2003, J BIOL INORG CHEM, V8, P105, DOI 10.1007/s00775-002-0389-4; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Jiang TB, 2005, J INTEGR PLANT BIOL, V47, P477, DOI 10.1111/j.1744-7909.2005.00044.x; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; LAULHERE JP, 1993, BIOCHEM J, V290, P693, DOI 10.1042/bj2900693; LAULHERE JP, 1989, J BIOL CHEM, V264, P3629; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; LEIBOLD EA, 1984, J BIOL CHEM, V259, P4327; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Li CR, 2009, J BIOL CHEM, V284, P16743, DOI 10.1074/jbc.M109.011528; Li CR, 2009, BIOCHIMIE, V91, P230, DOI 10.1016/j.biochi.2008.09.008; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; LOBREAUX S, 1992, PLANT MOL BIOL, V19, P563, DOI 10.1007/BF00026783; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; Masuda T, 2003, BBA-PROTEINS PROTEOM, V1645, P113, DOI 10.1016/S1570-9639(02)00523-X; Masuda T, 2001, J BIOL CHEM, V276, P19575, DOI 10.1074/jbc.M011399200; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PAQUES EP, 1980, EUR J BIOCHEM, V107, P447; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Petit JM, 2001, BIOCHEM J, V359, P575, DOI 10.1042/0264-6021:3590575; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; RAGLAND M, 1990, J BIOL CHEM, V265, P18339; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Savino G, 1997, J BIOL CHEM, V272, P33319, DOI 10.1074/jbc.272.52.33319; STEFANINI S, 1989, BIOCHEMISTRY-US, V28, P378, DOI 10.1021/bi00427a052; Stillman TJ, 2003, J BIOL CHEM, V278, P26275, DOI 10.1074/jbc.M207354200; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Strozycki PM, 2003, PHYSIOL PLANTARUM, V118, P380, DOI 10.1034/j.1399-3054.2003.00081.x; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; Toussaint L, 2007, J MOL BIOL, V365, P440, DOI 10.1016/j.jmb.2006.10.010; TREFFRY A, 1989, FEBS LETT, V247, P268, DOI 10.1016/0014-5793(89)81350-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P959, DOI 10.1042/bj3050959; Wardrop AJ, 1999, BIOCHEM J, V337, P523, DOI 10.1042/0264-6021:3370523; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; WICKS RE, 1993, BIOCHEM BIOPH RES CO, V192, P813, DOI 10.1006/bbrc.1993.1487; YABLONSKI MJ, 1992, BIOCHEMISTRY-US, V31, P9680, DOI 10.1021/bi00155a022; YANG CY, 1987, BIOCHEMISTRY-US, V26, P497, DOI 10.1021/bi00376a023; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v	69	93	103	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4049	4059		10.1074/jbc.M109.059790	http://dx.doi.org/10.1074/jbc.M109.059790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007325	Green Published, hybrid			2022-12-25	WOS:000275254000058
J	Melzer, N; Villmann, C; Becker, K; Harvey, K; Harvey, RJ; Vogel, N; Kluck, CJ; Kneussel, M; Becker, CM				Melzer, Nima; Villmann, Carmen; Becker, Kristina; Harvey, Kirsten; Harvey, Robert J.; Vogel, Nico; Kluck, Christoph J.; Kneussel, Matthias; Becker, Cord-Michael			Multifunctional Basic Motif in the Glycine Receptor Intracellular Domain Induces Subunit-specific Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; SPLICE VARIANT; PROTEIN; GEPHYRIN; DETERMINES; MODULATION; SYNAPSES; TOPOLOGY; IMPORT; NOTCH	The strychnine-sensitive glycine receptor (GlyR) is a ligand-gated ion channel that mediates fast synaptic inhibition in the vertebrate central nervous system. As a member of the family of Cys-loop receptors, it assembles from five homologous subunits (GlyR alpha 1-4 and -beta). Each subunit contains an extracellular ligand binding domain, four transmembrane domains (TM), and an intracellular domain, formed by the loop connecting TM3 and TM4(TM3-4 loop). The TM3-4 loops of the subunits GlyR alpha 1 and -alpha 3 harbor a conserved basic motif, which is part of a potential nuclear localization signal. When tested for functionality by live cell imaging of green fluorescent protein and beta-galactosidase-tagged domain constructs, the TM3-4 loops of GlyR alpha 1 and -alpha 3, but not of GlyR alpha 2 and -beta, exhibited nuclear sorting activity. Subunit specificity may be attributed to slight amino acid alterations in the basic motif. In yeast two-hybrid screening and GST pulldown assays, karyopherin alpha 3 and alpha 4 were found to interact with the TM3-4 loop, providing a molecular mechanism for the observed intracellular trafficking. These results indicate that the multifunctional basic motif of the TM3-4 loop is capable of mediating a karyopherin-dependent intracellular sorting of full-length GlyRs.	[Melzer, Nima; Villmann, Carmen; Becker, Kristina; Vogel, Nico; Kluck, Christoph J.; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Harvey, Kirsten; Harvey, Robert J.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Kneussel, Matthias] Univ Hamburg, ZMNH, D-20251 Hamburg, Germany	University of Erlangen Nuremberg; University of London; University College London; University of London School of Pharmacy; University of Hamburg	Becker, CM (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	cmb@biochem.uni-erlangen.de	Harvey, Robert/D-3994-2016	Harvey, Robert/0000-0001-5956-6664; Kneussel, Matthias/0000-0003-4900-366X	Deutsche Forschungsgemeinschaft [BE1138/5-3]; Elitenetzwerk Bayern [K-BM-200385]; Medical Research Council [G0500833, G0501258, G0601585]; European Framework Program 7 [HEALTH-F4-2008-202088]; MRC [G0501258, G0500833, G0601585] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Framework Program 7; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Deutsche Forschungsgemeinschaft (BE1138/5-3), Elitenetzwerk Bayern (Lead Structures of Cell Function, K-BM-200385), the Medical Research Council (G0500833, G0501258, and G0601585 to K. H. and R. J. H.), and European Framework Program 7 (Neuro Cypress, HEALTH-F4-2008-202088).	Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Bluem R, 2007, J BIOL CHEM, V282, P37783, DOI 10.1074/jbc.M708301200; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Croci C, 2003, J BIOL CHEM, V278, P6128, DOI 10.1074/jbc.M205162200; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Holmes KD, 2002, J NEUROCHEM, V81, P1152, DOI 10.1046/j.1471-4159.2002.00865.x; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lischka P, 2003, J VIROL, V77, P3734, DOI 10.1128/JVI.77.6.3734-3748.2003; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oertel J, 2007, J BIOL CHEM, V282, P2798, DOI 10.1074/jbc.M608941200; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3730	3739		10.1074/jbc.M109.030460	http://dx.doi.org/10.1074/jbc.M109.030460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959465	hybrid, Green Published			2022-12-25	WOS:000275254000025
J	Shi, WW; Cui, NR; Wu, ZY; Yang, Y; Zhang, S; Gai, HY; Zhu, DL; Jiang, C				Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Yang, Yang; Zhang, Shuang; Gai, Hongyu; Zhu, Daling; Jiang, Chun			Lipopolysaccharides Up-regulate Kir6.1/SUR2B Channel Expression and Enhance Vascular K-ATP Channel Activity via NF-kappa B-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE; POTASSIUM CHANNELS; GENE-EXPRESSION; ACTIVATION; SEPSIS; ENDOTOXEMIA; SUBUNIT; ARTERY; PHOSPHORYLATION	Sepsis is a severe medical condition causing a large number of deaths worldwide. Recent studies indicate that the septic susceptibility is attributable to the vascular ATP-sensitive K+ (K-ATP) channel. However, the mechanisms underlying the channel modulation in sepsis are still unclear. Here we show evidence for the modulation of vascular K-ATP channel by septic pathogen lipopolysaccharides (LPS). In isolated mesenteric arterial rings, phenylephrine (PE) produced concentration-dependent vasoconstriction that was relaxed by pinacidil, a selective K-ATP channel opener. The PE response was disrupted with a LPS treatment. In acutely dissociated aortic smooth myocytes the LPS treatment augmented K-ATP channel activity, and hyperpolarized the cells. Quantitative PCR analysis showed that LPS raised Kir6.1 and SUR2B transcripts in a concentration-dependent manner, which was suppressed by transcriptional inhibition. Consistently, the same LPS treatment did not affect Kir6.1/SUR2B channels in a heterologous expression system. The LPS effect on Kir6.1 and SUR2B expression was abolished in the presence of NF-kappa B inhibitors. Several other Toll-like receptor ligands also stimulated Kir6.1 and SUR2B expression to a similar degree as LPS. Thus, the effect of LPS on vasodilation involves up-regulation of K-ATP channel expression, in which the NF-kappa B-dependent signaling plays an important role.	[Zhang, Shuang; Zhu, Daling] Harbin Med Coll, Sch Pharm, Harbin 150081, Heilongjiang, Peoples R China; [Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Yang, Yang; Gai, Hongyu; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Harbin Medical University; University System of Georgia; Georgia State University	Zhu, DL (corresponding author), Harbin Med Coll, Sch Pharm, Harbin 150081, Heilongjiang, Peoples R China.	dalingz@yahoo.com; cjiang@gsu.edu	Yang, Yang/B-3440-2008; SHI, WEIWEI/B-3477-2008	Yang, Yang/0000-0003-4275-0515; SHI, WEIWEI/0000-0001-6216-712X; Yang, Yang/0000-0001-6417-3654	National Institutes of Health [HD060959]; National Natural Science Foundation of China [30470752]; American Heart Association [09GRNT2010037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Grant HD060959 (to C. J.). This work was also supported by the National Natural Science Foundation of China (Grant number 30470752, to D. L. Z.) and by the American Heart Association (Grant 09GRNT2010037, to C. J.).	Bonev AD, 1996, J GEN PHYSIOL, V108, P315, DOI 10.1085/jgp.108.4.315; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Croker B, 2007, NAT GENET, V39, P1453, DOI 10.1038/ng.2007.25; Czaika G, 2000, MUSCLE NERVE, V23, P967; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Gardiner SM, 1999, BRIT J PHARMACOL, V128, P1772, DOI 10.1038/sj.bjp.0702985; Gesser B, 2007, J INVEST DERMATOL, V127, P2129, DOI 10.1038/sj.jid.5700859; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jin XC, 2004, AM J PHYSIOL-GASTR L, V287, pG274, DOI 10.1152/ajpgi.00472.2003; KAMOUCHI M, 1994, AM J PHYSIOL, V266, pH1687, DOI 10.1152/ajpheart.1994.266.5.H1687; Kane GC, 2006, FASEB J, V20, P2271, DOI 10.1096/fj.06-6349com; LANDRY DW, 1992, J CLIN INVEST, V89, P2071, DOI 10.1172/JCI115820; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Malm TM, 2007, J NEUROSCI, V27, P3712, DOI 10.1523/JNEUROSCI.0059-07.2007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; NELSON MT, 1990, NATURE, V344, P770, DOI 10.1038/344770a0; O'Brien AJ, 2005, BRIT J PHARMACOL, V144, P367, DOI 10.1038/sj.bjp.0706065; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; SCHEIFELE DW, 1985, AM J CLIN PATHOL, V83, P227, DOI 10.1093/ajcp/83.2.227; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; SOLOMON MA, 1994, AM J PHYSIOL, V266, pH757, DOI 10.1152/ajpheart.1994.266.2.H757; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Wang XR, 2003, CIRC RES, V92, P1225, DOI 10.1161/01.RES.0000075601.95738.6D; Watanabe E, 2009, CRIT CARE MED, V37, P357, DOI 10.1097/CCM.0b013e31819311c0; Wu CC, 2004, BRIT J PHARMACOL, V142, P479, DOI 10.1038/sj.bjp.0705794; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Ye D, 2005, AM J PHYSIOL-HEART C, V288, pH358, DOI 10.1152/ajpheart.00423.2004; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	36	36	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3021	10.1074/jbc.M109.058313	http://dx.doi.org/10.1074/jbc.M109.058313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19959479	Green Published, hybrid			2022-12-25	WOS:000273829000017
J	Cakir, I; Perello, M; Lansari, O; Messier, NJ; Vaslet, CA; Nillni, EA				Cakir, Isin; Perello, Mario; Lansari, Omar; Messier, Norma J.; Vaslet, Charles A.; Nillni, Eduardo A.			Hypothalamic Sirt1 Regulates Food Intake in a Rodent Model System	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROTHYROTROPIN-RELEASING HORMONE; HIGH-FAT DIET; CALORIE RESTRICTION; GENE-EXPRESSION; ENERGY HOMEOSTASIS; SIRNA DELIVERY; CELL-SURVIVAL; IN-VIVO; TRANSCRIPTION	Sirt1 is an evolutionarily conserved NAD+ dependent deacetylase involved in a wide range of processes including cellular differentiation, apoptosis, as well as metabolism, and aging. In this study, we investigated the role of hypothalamic Sirt1 in energy balance. Pharmacological inhibition or siRNA mediated knock down of hypothalamic Sirt1 showed to decrease food intake and body weight gain. Central administration of a specific melanocortin antagonist, SHU9119, reversed the anorectic effect of hypothalamic Sirt1 inhibition, suggesting that Sirt1 regulates food intake through the central melanocortin signaling. We also showed that fasting increases hypothalamic Sirt1 expression and decreases FoxO1 (Forkhead transcription factor) acetylation suggesting that Sirt1 regulates the central melanocortin system in a FoxO1 dependent manner. In addition, hypothalamic Sirt1 showed to regulate S6K signaling such that inhibition of the fasting induced Sirt1 activity results in up-regulation of the S6K pathway. Thus, this is the first study providing a novel role for the hypothalamic Sirt1 in the regulation of food intake and body weight. Given the role of Sirt1 in several peripheral tissues and hypothalamus, potential therapies centered on Sirt1 regulation might provide promising therapies in the treatment of metabolic diseases including obesity.	[Cakir, Isin; Perello, Mario; Lansari, Omar; Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Div Endocrinol, Dept Med,Warren Alpert Med Sch, Providence, RI 02903 USA; [Cakir, Isin; Lansari, Omar; Nillni, Eduardo A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Messier, Norma J.; Vaslet, Charles A.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Cakir, I (corresponding author), Brown Univ, Rhode Isl Hosp, Div Endocrinol, Dept Med,Warren Alpert Med Sch, Providence, RI 02903 USA.	Eduardo_Nillni@brown.edu		Perello, Mario/0000-0003-2114-6765; cakir, isin/0000-0003-4293-7267	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIH) [R01 DK58148]; National Institute of Neurological Disorders and Stroke/NIH [R01 NS045231]; Center for Cancer Signaling Networks COBRE [5PR20RR015578-09]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045231] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Cancer Signaling Networks COBRE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIH) Grant R01 DK58148 and National Institute of Neurological Disorders and Stroke/NIH Grant R01 NS045231 to E.A.N. Gene expression studies were supported by the Center for Cancer Signaling Networks COBRE Grant 5PR20RR015578-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Guissouma H, 2006, NEUROSCI LETT, V406, P240, DOI 10.1016/j.neulet.2006.07.041; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hassani Z, 2005, J GENE MED, V7, P198, DOI 10.1002/jgm.659; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Niedemhofer LJ, 2008, INT J BIOCHEM CELL B, V40, P176, DOI 10.1016/j.biocel.2007.10.008; Nillni EA, 2000, J BIOL CHEM, V275, P36124, DOI 10.1074/jbc.M003549200; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; Nillni EA, 1996, ENDOCRINOLOGY, V137, P5651, DOI 10.1210/en.137.12.5651; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Perello M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1348, DOI 10.1152/ajpendo.00466.2006; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; RAMADORI G, 2009, ENDOCRINOLOGY; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	50	155	159	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8322	10.1371/journal.pone.0008322	http://dx.doi.org/10.1371/journal.pone.0008322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20020036	Green Published, gold, Green Submitted			2022-12-25	WOS:000272833800016
J	Robbins, ML; Wang, PH; Sekhon, RS; Chopra, S				Robbins, Michael L.; Wang, PoHao; Sekhon, Rajandeep S.; Chopra, Surinder			Gene Structure Induced Epigenetic Modifications of pericarp color1 Alleles of Maize Result in Tissue-Specific Mosaicism	PLOS ONE			English	Article							CHROMATIN; METHYLATION; PARAMUTATION; INHERITANCE; SEQUENCES; RECOMBINATION; ARABIDOPSIS; EXPRESSION; DIVERSITY; INSERTION	Background: The pericarp color1 (p1) gene encodes for a myb-homologous protein that regulates the biosynthesis of brick-red flavonoid pigments called phlobahpenes. The pattern of pigmentation on the pericarp and cob glumes depends upon the allelic constitution at the p1 locus. p1 alleles have unique gene structure and copy number which have been proposed to influence the epigenetic regulation of tissue-specific gene expression. For example, the presence of tandem-repeats has been correlated with the suppression of pericarp pigmentation though a mechanism associated with increased DNA methylation. Methodology/Principal Findings: Herein, we extensively characterize a p1 allele called P1-mosaic (P1-mm) that has mosaic pericarp and light pink or colorless cob glumes pigmentation. Relative to the P1-wr (white pericarp and red cob glumes), we show that the tandem repeats of P1-mm have a modified gene structure containing a reduced number of repeats. The P1-mm has reduced DNA methylation at a distal enhancer and elevated DNA methylation downstream of the transcription start site. Conclusions/Significance: Mosaic gene expression occurs in many eukaryotes. Herein we use maize p1 gene as model system to provide further insight about the mechanisms that govern expression mosaicism. We suggest that the gene structure of P1-mm is modified in some of its tandem gene repeats. It is known that repeated genes are susceptible to chromatin-mediated regulation of gene expression. We discuss how the modification to the tandem repeats of P1-mm may have disrupted the epigenetic mechanisms that stably confer tissue-specific expression.	[Robbins, Michael L.; Wang, PoHao; Sekhon, Rajandeep S.; Chopra, Surinder] Penn State Univ, Dept Crop & Soil Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Robbins, ML (corresponding author), Penn State Univ, Dept Crop & Soil Sci, University Pk, PA 16802 USA.	sic3@psu.edu			NSF [MCB-0619330]; Hatch [4154]; Department of Crop and Soil Sciences; Plant Biology Graduate Program	NSF(National Science Foundation (NSF)); Hatch(United States Department of Agriculture (USDA)); Department of Crop and Soil Sciences; Plant Biology Graduate Program	This work was supported by an NSF award MCB-0619330, a Hatch 4154 award to SC, and dissertation award from the College of Agricultural Sciences and Research Assistantships from the Department of Crop and Soil Sciences and Plant Biology Graduate Program to MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EG, 1924, GENETICS, V9, P442; ANDERSON EG, 1929, MICH ACAD SCI ARTS, V9, P5; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; ATHMA P, 1992, GENETICS, V131, P199; ATHMA P, 1991, GENETICS, V128, P163; BARCLAY PC, 1954, P NATL ACAD SCI USA, V40, P1118, DOI 10.1073/pnas.40.12.1118; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bender J, 1998, TRENDS BIOCHEM SCI, V23, P252, DOI 10.1016/S0968-0004(98)01225-0; BRAWN RI, 1966, MAIZE GENETICS COOPE, V40, P92; BRINK RA, 1966, MAIZE GENET COOP NEW, V40, P149; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Chandler VL, 2004, COLD SPRING HARB SYM, V69, P355, DOI 10.1101/sqb.2004.69.355; Chopra S, 1998, MOL GEN GENET, V260, P372, DOI 10.1007/s004380050906; Chopra S, 2003, GENETICS, V163, P1135; Cocciolone SM, 2001, PLANT J, V27, P467, DOI 10.1046/j.1365-313X.2001.01124.x; Coe EH, 2001, NAT REV GENET, V2, P898, DOI 10.1038/35098524; Correns C. J., 1900, BERICHTE DTSCH BOT G, V18, P158, DOI DOI 10.1111/J.1438-8677.1900.TB04893.X; Emerson RA, 1939, GENETICS, V24, P368; Emerson RA, 1914, AM NAT, V48, P87, DOI 10.1086/279393; Emerson RA, 1917, GENETICS, V2, P1; EMERSON RA, 1911, ANN REPT NEBRASKA AG, V24, P59; Eyster WH, 1925, GENETICS, V10, P179; Fedoroff N, 1998, GENETICS, V150, P957; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Goettel W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000516; Grant-Downton RT, 2004, TRENDS GENET, V20, P188, DOI 10.1016/j.tig.2004.02.005; GROTEWOLD E, 1991, MOL GEN GENET, V230, P329, DOI 10.1007/BF00290684; Hayes HK, 1917, GENETICS, V2, P261; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; LECHELT C, 1989, MOL GEN GENET, V219, P225, DOI 10.1007/BF00261181; Li GF, 2002, BIOESSAYS, V24, P234, DOI 10.1002/bies.10055; Lisch D, 2002, P NATL ACAD SCI USA, V99, P6130, DOI 10.1073/pnas.052152199; Matzke M, 2001, GENETICS, V158, P451; NELSON OE, 1991, MAIZE GENETICS COOPE, V65, P85; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Robbins ML, 2008, GENETICS, V178, P1859, DOI 10.1534/genetics.107.082503; ROBBINS ML, 2008, MAIZE GENET COOP NEW, V82, P28; Sabl JF, 1996, GENETICS, V142, P447; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; SCHWARTZ D, 1982, P NATL ACAD SCI-BIOL, V79, P5991, DOI 10.1073/pnas.79.19.5991; Sekhon RS, 2007, GENETICS, V175, P1059, DOI 10.1534/genetics.106.066134; Sekhon RS, 2009, GENETICS, V181, P81, DOI 10.1534/genetics.108.097170; Sidorenko LV, 2000, PLANT J, V22, P471, DOI 10.1046/j.1365-313x.2000.00750.x; Sidorenko LV, 2001, PLANT CELL, V13, P319, DOI 10.1105/tpc.13.2.319; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Slotkin RK, 2003, GENETICS, V165, P781; SUTO T, 1952, J FAS HOKKAIDO U, V6, P68; Watanabe K, 2005, PLANT J, V44, P531, DOI 10.1111/j.1365-313X.2005.02546.x; Ye F, 1996, P NATL ACAD SCI USA, V93, P10881, DOI 10.1073/pnas.93.20.10881; Zhang F, 2005, PLANT CELL, V17, P903, DOI 10.1105/tpc.104.029660; Zhang F, 2006, GENETICS, V174, P753, DOI 10.1534/genetics.105.053942; Zhang PF, 2000, PLANT CELL, V12, P2311, DOI 10.1105/tpc.12.12.2311	54	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8231	10.1371/journal.pone.0008231	http://dx.doi.org/10.1371/journal.pone.0008231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011605	Green Submitted, gold, Green Published			2022-12-25	WOS:000272830300013
J	Tinahones, F; Salas, J; Mayas, MD; Ruiz-Villalba, A; Macias-Gonzalez, M; Garrido-Sanchez, L; DeMora, M; Moreno-Santos, I; Bernal, R; Cardona, F; El Bekay, R				Tinahones, Francisco; Salas, Julian; Dolores Mayas, Maria; Ruiz-Villalba, Adrian; Macias-Gonzalez, Manuel; Garrido-Sanchez, Lourdes; DeMora, Manuel; Moreno-Santos, Inmaculada; Bernal, Rosa; Cardona, Fernando; El Bekay, Rajaa			VEGF Gene Expression in Adult Human Thymus Fat: A Correlative Study with Hypoxic Induced Factor and Cyclooxigenase-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ARTERY GRAFT; PPAR-GAMMA; IN-VITRO; ANGIOGENESIS; CANCER; CYCLOOXYGENASE-2; DIFFERENTIATION; ADIPOCYTES; INDUCTION	It is well known that the adult human thymus degenerates into fat tissue; however, it has never been considered as a potential source of angiogenic factors. Recently, we have described that this fat (TAT) produces angiogenic factors and induces human endothelial cell proliferation and migration, indicating its potential angiogenic properties. Design: Adult thymus fat and subcutaneous adipose tissue specimens were obtained from 28 patients undergoing cardiac surgery, making this tissue readily available as a prime source of adipose tissue. We focused our investigation on determining VEGF gene expression and characterizing the different genes, mediators of inflammation and adipogenesis, and which are known to play a relevant role in angiogenesis regulation. Results: We found that VEGF-A was the isoform most expressed in TAT. This expression was accompanied by an upregulation of HIF-1 alpha, COX-2 and HO-1 proteins, and by increased HIF-1 DNA binding activity, compared to SAT. Furthermore, we observed that TAT contains a high percentage of mature adipocytes, 0.25% of macrophage cells, 15% of endothelial cells and a very low percentage of thymocyte cells, suggesting the cellular variability of TAT, which could explain the differences in gene expression observed in TAT. Subsequently, we showed that the expression of genes known as adipogenic mediators, including PPAR gamma 1/gamma 2, FABP-4 and adiponectin was similar in both TAT and SAT. Moreover the expression of these latter genes presented a significantly positive correlation with VEGF, suggesting the potential association between VEGF and the generation of adipose tissue in adult thymus. Conclusion: Here we suggest that this fat has a potential angiogenic function related to ongoing adipogenesis, which substitutes immune functions within the adult thymus. The expression of VEGF seems to be associated with COX-2, HO-1 and adipogenesis related genes, suggesting the importance that this new fat has acquired in research in relation to adipogenesis and angiogenesis.	[Tinahones, Francisco; Dolores Mayas, Maria; Macias-Gonzalez, Manuel; Garrido-Sanchez, Lourdes; Moreno-Santos, Inmaculada; Bernal, Rosa; Cardona, Fernando; El Bekay, Rajaa] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Tinahones, Francisco] Hosp Virgen de la Victoria, Serv Endocrinol, Malaga, Spain; [Salas, Julian] Hosp Carlos Haya, Dept Cirugia Cardiovasc, Malaga, Spain; [Ruiz-Villalba, Adrian; El Bekay, Rajaa] Hosp Virgen de la Victoria, Lab Invest Biomed, Fdn Inst Mediterraneo Avance Biotecnol & Invest S, Malaga, Spain; [DeMora, Manuel] Hosp Carlos Haya, Dept Enfermedades Cardiovasc, Malaga, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Hospital Virgen de la Victoria; Hospital Carlos Haya; Hospital Virgen de la Victoria; Hospital Carlos Haya	Tinahones, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.	elbekay@gmail.com	Bekay, Rajaa El/AAZ-3959-2020; Bernal-Lopez, Rosa/F-3548-2011; Cardona, Fernando/AAG-7835-2019; Tinahones, Francisco José/AAB-2882-2020; Cardona, Fernando/H-6022-2015; El Bekay, RAJAA/AGN-6069-2022; Ruiz-Villalba, Adrián/AAP-6130-2020; MACIAS-GONZALEZ, MANUEL/E-7584-2016	Cardona, Fernando/0000-0003-4460-6824; Cardona, Fernando/0000-0003-4460-6824; El Bekay, RAJAA/0000-0003-3332-3431; , Adrian/0000-0001-8063-0317; MACIAS-GONZALEZ, MANUEL/0000-0002-6475-4704; Tinahones, Francisco J/0000-0001-6871-4403	Andalusian Health Service [SAS PI-0251]; Spanish Ministry of Health [CP07/00288, CP04/00039, CP07/0095, PI070953]	Andalusian Health Service; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by grants from Andalusian Health Service [SAS PI-0251]; R. El Bekay, M. Macias and F. Cardona are recipients of a post doctoral grant 'Miguel Servet' (FIS-2007) [CP07/00288, CP04/00039, CP07/0095] from the Spanish Ministry of Health; and part of this project was supported by grant from Spanish Ministry of Health (FIS) [PI070953]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano A, 2001, MOL CELL ENDOCRINOL, V174, P71, DOI 10.1016/S0303-7207(00)00450-0; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Chinen J, 2006, J ALLERGY CLIN IMMUN, V118, P489, DOI 10.1016/j.jaci.2006.05.021; Csiki I, 2006, CANCER RES, V66, P143, DOI 10.1158/0008-5472.CAN-05-1357; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Fernandez M, 2003, BRIT J PHARMACOL, V139, P634, DOI 10.1038/sj.bjp.0705272; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Fukuda R, 2003, CANCER RES, V63, P2330; Hale Laura P, 2004, Ann Diagn Pathol, V8, P50, DOI 10.1016/j.anndiagpath.2003.11.006; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Mukherjee D, 1999, AM J CARDIOL, V84, P598, DOI 10.1016/S0002-9149(99)00387-2; PACIFICO AD, 1986, ANN THORAC SURG, V42, P708, DOI 10.1016/S0003-4975(10)64618-8; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rathore KS, 2009, TEX HEART I J, V36, P131; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Saiki A, 2006, INT J OBESITY, V30, P1676, DOI 10.1038/sj.ijo.0803316; SALAS J, 2009, CELL TISSUE RES; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Solban N, 2006, CANCER RES, V66, P5633, DOI 10.1158/0008-5472.CAN-06-0604; Sosman JA, 2003, NAT MED, V9, P649, DOI 10.1038/nm0603-649; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TRAYHURN P, 2008, BR J NUTR, V100, P236; Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8213	10.1371/journal.pone.0008213	http://dx.doi.org/10.1371/journal.pone.0008213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011601	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830300006
J	Veitia, RA; Bottani, S				Veitia, Reiner A.; Bottani, Samuel			Whole Genome Duplications and a 'Function' for Junk DNA? Facts and Hypotheses	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; EUKARYOTIC GENOME; NUCLEAR-DNA; GENES; EVOLUTION; RETROTRANSPOSITION; TETRAPLOIDY; COEVOLUTION; DYNAMICS; SIZE	Background: The lack of correlation between genome size and organismal complexity is understood in terms of the massive presence of repetitive and non-coding DNA. This non-coding subgenome has long been called "junk'' DNA. However, it might have important functions. Generation of junk DNA depends on proliferation of selfish DNA elements and on local or global DNA duplication followed by genic non-fonctionalization. Methodology/Principal Findings: Evidence from genomic analyses and experimental data indicates that Whole Genome Duplications (WGD) are often followed by a return to the diploid state, through DNA deletions and intra/interchromosomal rearrangements. We use simple theoretical models and simulations to explore how a WGD accompanied by sequence deletions might affect the dosage balance often required among several gene products involved in regulatory processes. We find that potential genomic deletions leading to changes in nuclear and cell volume might potentially perturb gene dosage balance. Conclusions/Significance: The potentially negative impact of DNA deletions can be buffered if deleted genic DNA is, at least temporarily, replaced by repetitive DNA so that the nuclear/cell volume remains compatible with normal living. Thus, we speculate that retention of non-functionalized non-coding DNA, and replacement of deleted DNA through proliferation of selfish elements, might help avoid dosage imbalances in cycles of polyploidization and diploidization, which are particularly frequent in plants.	[Veitia, Reiner A.] CNRS, Inst Jacques Monod, UMR 7592, Paris, France; [Bottani, Samuel] CNRS, Lab Mat & Syst Complexes MSC, UMR 7057, Paris, France; [Veitia, Reiner A.; Bottani, Samuel] Univ Paris 07, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Veitia, RA (corresponding author), CNRS, Inst Jacques Monod, UMR 7592, Paris, France.	reiner.veitia@inserm.fr			Universite Paris Diderot/Paris 7; Institut Universitaire de France	Universite Paris Diderot/Paris 7; Institut Universitaire de France	The research was funded by the Universite Paris Diderot/Paris 7. RAV is also funded by the Institut Universitaire de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; BENNETT M D, 1971, Proceedings of the Royal Society of London Series B Biological Sciences, V178, P277; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Cavalier-Smith T, 1999, GENETICA, V106, P3, DOI 10.1023/A:1003701925110; CAVALIERSMITH T, 1982, ANNU REV BIOPHYS BIO, V11, P273, DOI 10.1146/annurev.bb.11.060182.001421; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; MIRSKY AE, 1951, J GEN PHYSIOL, V34, P451, DOI 10.1085/jgp.34.4.451; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Patrushev LI, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1519, DOI 10.1134/S0006297908130117; Patrushev LI, 1997, BIOCHEM MOL BIOL INT, V41, P851; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Sharma A, 2008, P NATL ACAD SCI USA, V105, P15470, DOI 10.1073/pnas.0805694105; SWIFT H, 1950, P NATL ACAD SCI USA, V36, P643, DOI 10.1073/pnas.36.11.643; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Veitia RA, 2004, GENETICS, V168, P569, DOI 10.1534/genetics.104.029785; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Vinogradov AE, 1998, J THEOR BIOL, V193, P197, DOI 10.1006/jtbi.1997.0629; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; VONSTERNBERG RM, 1992, GENETICA, V86, P215, DOI 10.1007/BF00133722; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100	36	9	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8201	10.1371/journal.pone.0008201	http://dx.doi.org/10.1371/journal.pone.0008201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011530	Green Submitted, Green Published, gold			2022-12-25	WOS:000272830300004
J	Poll, G; Braun, T; Jakovljevic, J; Neueder, A; Jakob, S; Woolford, JL; Tschochner, H; Milkereit, P				Poell, Gisela; Braun, Tobias; Jakovljevic, Jelena; Neueder, Andreas; Jakob, Steffen; Woolford, John L., Jr.; Tschochner, Herbert; Milkereit, Philipp			rRNA Maturation in Yeast Cells Depleted of Large Ribosomal Subunit Proteins	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE VIABILITY; FUNCTIONAL-ANALYSIS; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; NUCLEAR EXPORT; 80S RIBOSOME; FINAL STEP; GENES; BIOGENESIS; 5.8S	The structural constituents of the large eukaryotic ribosomal subunit are 3 ribosomal RNAs, namely the 25S, 5.8S and 5S rRNA and about 46 ribosomal proteins (r-proteins). They assemble and mature in a highly dynamic process that involves more than 150 proteins and 70 small RNAs. Ribosome biogenesis starts in the nucleolus, continues in the nucleoplasm and is completed after nucleo-cytoplasmic translocation of the subunits in the cytoplasm. In this work we created 26 yeast strains, each of which conditionally expresses one of the large ribosomal subunit (LSU) proteins. In vivo depletion of the analysed LSU r-proteins was lethal and led to destabilisation and degradation of the LSU and/or its precursors. Detailed steady state and metabolic pulse labelling analyses of rRNA precursors in these mutant strains showed that LSU r-proteins can be grouped according to their requirement for efficient progression of different steps of large ribosomal subunit maturation. Comparative analyses of the observed phenotypes and the nature of r-protein - rRNA interactions as predicted by current atomic LSU structure models led us to discuss working hypotheses on i) how individual r-proteins control the productive processing of the major 59 end of 5.8S rRNA precursors by exonucleases Rat1p and Xrn1p, and ii) the nature of structural characteristics of nascent LSUs that are required for cytoplasmic accumulation of nascent subunits but are nonessential for most of the nuclear LSU pre-rRNA processing events.	[Poell, Gisela; Braun, Tobias; Neueder, Andreas; Jakob, Steffen; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Inst Biochem 3, Regensburg, Germany; [Jakovljevic, Jelena; Woolford, John L., Jr.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	University of Regensburg; Carnegie Mellon University	Poll, G (corresponding author), Univ Regensburg, Inst Biochem 3, Regensburg, Germany.	jw17@andrew.cmu.edu; herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de	Neueder, Andreas/K-4319-2015	Neueder, Andreas/0000-0002-2389-5236; Woolford, John/0000-0002-7553-7043	Deutsche Forschungsgemeinschaft [FOR-1068]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, in the research unit FOR-1068 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; BaudinBaillieu A, 1997, MOL CELL BIOL, V17, P5023, DOI 10.1128/MCB.17.9.5023; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Briones E, 1998, J BIOL CHEM, V273, P31956, DOI 10.1074/jbc.273.48.31956; Burke D., 2000, METHODS YEAST GENETI; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; DeLabre ML, 2002, BBA-GENE STRUCT EXPR, V1574, P255, DOI 10.1016/S0167-4781(01)00372-4; DESHMUKH M, 1993, MOL CELL BIOL, V13, P2835, DOI 10.1128/MCB.13.5.2835; DONOVAN DM, 1990, MOL CELL BIOL, V10, P6097, DOI 10.1128/MCB.10.11.6097; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Faber AW, 2006, BIOCHEM BIOPH RES CO, V345, P796, DOI 10.1016/j.bbrc.2006.04.166; Faber AW, 2002, RNA, V8, P1095, DOI 10.1017/S1355838202021027; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FRIED HM, 1985, MOL CELL BIOL, V5, P99, DOI 10.1128/MCB.5.1.99; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Geerlings TH, 2000, RNA, V6, P1698, DOI 10.1017/S1355838200001540; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; Hofer A, 2007, J BIOL CHEM, V282, P32630, DOI 10.1074/jbc.M705057200; Iouk TL, 2001, MOL CELL BIOL, V21, P1260, DOI 10.1128/MCB.21.4.1260-1271.2001; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Koller HT, 1996, YEAST, V12, P53, DOI 10.1002/(SICI)1097-0061(199601)12:1<53::AID-YEA886>3.0.CO;2-M; Kufel J, 1999, RNA, V5, P909, DOI 10.1017/S135583829999026X; LIANG X, 2009, RNA; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; LINDAHL L, 1992, NUCLEIC ACIDS RES, V20, P295, DOI 10.1093/nar/20.2.295; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUCIOLI A, 1988, MOL CELL BIOL, V8, P4792, DOI 10.1128/MCB.8.11.4792; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; MOORE JBT, 2009, HAEMATOLOGICA; Moore Peter B, 2009, J Biol, V8, P8, DOI 10.1186/jbiol103; OHTAKE Y, 1995, GENETICS, V140, P129; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Rivlin AA, 1999, J MOL BIOL, V294, P909, DOI 10.1006/jmbi.1999.3309; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; ROHL R, 1982, P NATL ACAD SCI-BIOL, V79, P729, DOI 10.1073/pnas.79.3.729; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; RUTGERS CA, 1990, BIOCHIM BIOPHYS ACTA, V1050, P74, DOI 10.1016/0167-4781(90)90144-Q; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; Sambrook J., 2002, MOL CLONING LAB MANU; SANTOS C, 1994, J BIOL CHEM, V269, P15689; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; SHUAI K, 1991, NUCLEIC ACIDS RES, V19, P5059, DOI 10.1093/nar/19.18.5059; SMITT WWS, 1972, EXP CELL RES, V71, P33, DOI 10.1016/0014-4827(72)90259-5; Song JR, 1996, CURR GENET, V30, P273, DOI 10.1007/s002940050132; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Timsit Y, 2009, INT J MOL SCI, V10, P817, DOI 10.3390/ijms10030817; TRAPMAN J, 1976, BIOCHIM BIOPHYS ACTA, V442, P275, DOI 10.1016/0005-2787(76)90302-6; TRAPMAN J, 1976, BIOCHIM BIOPHYS ACTA, V442, P265, DOI 10.1016/0005-2787(76)90301-4; van Beekvelt CA, 2001, NUCLEIC ACIDS RES, V29, P5001, DOI 10.1093/nar/29.24.5001; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Venema J, 1998, METH MOL B, V77, P257; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S; YON J, 1991, MOL GEN GENET, V227, P72, DOI 10.1007/BF00260709; Yu X, 2001, J BIOL CHEM, V276, P33821, DOI 10.1074/jbc.M103772200; Zengel JM, 2003, RNA, V9, P1188, DOI 10.1261/rna.5400703; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	72	77	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8249	10.1371/journal.pone.0008249	http://dx.doi.org/10.1371/journal.pone.0008249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011513	Green Submitted, Green Published, gold			2022-12-25	WOS:000272830200004
J	McKernan, DP; Nolan, A; Brint, EK; O'Mahony, SM; Hyland, NP; Cryan, JF; Dinan, TG				McKernan, Declan P.; Nolan, Aoife; Brint, Elizabeth K.; O'Mahony, Siobhain M.; Hyland, Niall P.; Cryan, John F.; Dinan, Timothy G.			Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome	PLOS ONE			English	Article							WISTAR-KYOTO RATS; FUNCTIONAL GASTROINTESTINAL DISORDERS; IMPAIRED GASTRIC ACCOMMODATION; VISCERAL HYPERSENSITIVITY; NEGATIVE REGULATION; IMMUNE DYSFUNCTION; EPITHELIAL-CELLS; NERVE INJURY; MAP KINASE; GUT AXIS	Background: Irritable bowel syndrome (IBS) is largely viewed as a stress-related disorder caused by aberrant brain-gut-immune communication and altered gastrointestinal (GI) homeostasis. Accumulating evidence demonstrates that stress modulates innate immune responses; however, very little is known on the immunological effects of stress on the GI tract. Toll-like receptors (TLRs) are critical pattern recognition molecules of the innate immune system. Activation of TLRs by bacterial and viral molecules leads to activation of NF-kB and an increase in inflammatory cytokine expression. It was our hypothesis that innate immune receptor expression may be changed in the gastrointestinal tract of animals with stress-induced IBS-like symptoms. Methodology/Principal Findings: In this study, our objective was to evaluate the TLR expression profile in the colonic mucosa of two rat strains that display colonic visceral hypersensivity; the stress-sensitive Wistar-Kyoto (WKY) rat and the maternally separated (MS) rat. Quantitative PCR of TLR2-10 mRNA in both the proximal and distal colonic mucosae was carried out in adulthood. Significant increases are seen in the mRNA levels of TLR3, 4 & 5 in both the distal and proximal colonic mucosa of MS rats compared with controls. No significant differences were noted for TLR 2, 7, 9 & 10 while TLR 6 could not be detected in any samples in both rat strains. The WKY strain have increased levels of mRNA expression of TLR3, 4, 5, 7, 8, 9 & 10 in both the distal and proximal colonic mucosa compared to the control Sprague-Dawley strain. No significant differences in expression were found for TLR2 while as before TLR6 could not be detected in all samples in both strains. Conclusions: These data suggest that both early life stress (MS) and a genetic predisposition (WKY) to stress affect the expression of key sentinels of the innate immune system which may have direct relevance for the molecular pathophysiology of IBS.	[McKernan, Declan P.; Nolan, Aoife; Brint, Elizabeth K.; O'Mahony, Siobhain M.; Hyland, Niall P.; Cryan, John F.; Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Lab Neurogastroenterol, Cork, Ireland; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Hyland, Niall P.; Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [O'Mahony, Siobhain M.] Natl Univ Ireland Univ Coll Cork, Dept Anat, Cork, Ireland; [Brint, Elizabeth K.] Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	McKernan, DP (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Lab Neurogastroenterol, Cork, Ireland.	j.cryan@ucc.ie; t.dinan@ucc.ie	O'Mahony, Siobhain M./AAE-9167-2021; Dinan, Timothy/ABA-8284-2020; McKernan, Declan P/AEK-0857-2022; Cryan, John F./A-6950-2013	O'Mahony, Siobhain M./0000-0002-9597-9391; McKernan, Declan P/0000-0002-9691-1671; Cryan, John F./0000-0001-5887-2723; Dinan, Timothy/0000-0002-2316-7220; Hyland, Niall/0000-0003-0060-7390; Brint, Elizabeth/0000-0001-9214-149X	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan; SFI; GlaxoSmithKline	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland); SFI(Science Foundation Ireland); GlaxoSmithKline(GlaxoSmithKline)	The Alimentary Pharmabiotic Centre is a Centre for Science and Technology (CSET) funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan. The authors and their work were supported by SFI and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Arebi N, 2008, ALIMENT PHARM THER, V28, P830, DOI 10.1111/j.1365-2036.2008.03801.x; Bailey MT, 2007, AM J PHYSIOL-REG I, V293, pR1180, DOI 10.1152/ajpregu.00307.2007; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Brades S, 2009, GASTROENTEROLOGY, V136, P1339, DOI 10.1053/j.gastro.2008.12.044; CERVERO F, 1992, TRENDS NEUROSCI, V15, P374, DOI 10.1016/0166-2236(92)90182-8; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Clarke G, 2009, TRENDS MOL MED, V15, P478, DOI 10.1016/j.molmed.2009.08.001; De La Garza R, 2004, BRAIN RES, V1021, P209, DOI 10.1016/j.brainres.2004.06.052; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Dinan TG, 2008, AM J GASTROENTEROL, V103, P2570, DOI 10.1111/j.1572-0241.2008.01871.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gopal R, 2008, PARASITE IMMUNOL, V30, P563, DOI 10.1111/j.1365-3024.2008.01055.x; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; Gunter WD, 2000, PHYSIOL BEHAV, V69, P379, DOI 10.1016/S0031-9384(99)00254-1; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hutchinson MR, 2009, BRAIN BEHAV IMMUN; Hyland NP, 2009, GUT, V58, P1029, DOI 10.1136/gut.2008.167882; Hyland NP, 2008, GASTROENTEROLOGY, V134, pA552; John CD, 2003, CURR OPIN PHARMACOL, V3, P78, DOI 10.1016/S1471-4892(02)00009-7; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P389, DOI 10.1111/j.1365-2982.2008.01220.x; Lahmame A, 1997, EUR J PHARMACOL, V337, P115, DOI 10.1016/S0014-2999(97)01276-4; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macsharry J, 2008, SCAND J GASTROENTERO, V43, P1467, DOI 10.1080/00365520802276127; Malkesman O, 2006, BIOL PSYCHIAT, V59, P17, DOI 10.1016/j.biopsych.2005.05.039; MALKESMAN O, 2009, PROGR NEURO IN PRESS; Martinez V, 2007, N-S ARCH PHARMACOL, V376, P205, DOI 10.1007/s00210-007-0195-1; Mayer EA, 2008, GUT, V57, DOI 10.1136/gut.2006.101675; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Nielsen MA, 2006, SCAND J GASTROENTERO, V41, P773, DOI 10.1080/00365520500483215; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; O'Malley D, 2010, NEUROGASTROENT MOTIL, V22, P301, DOI 10.1111/j.1365-2982.2009.01412.x; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; OBATA K, 2008, J NEUROCHEM; OHMAN L, 2009, NEUROGASTROENTEROL M; Ohman L, 2009, AM J GASTROENTEROL, V104, P1205, DOI 10.1038/ajg.2009.116; OMALLEY D, 2009, STRESS IN PRESS; PARE WP, 1993, J PHYSIOL-PARIS, V87, P229, DOI 10.1016/0928-4257(93)90010-Q; Park JH, 2005, DIGEST DIS SCI, V50, P1454, DOI 10.1007/s10620-005-2860-x; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Quigley EMM, 2003, SCAND J GASTROENTERO, V38, P1, DOI 10.1080/00855910310001403; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Thomas R. R., 1999, FLUOROPOLYMERS, P47; Zhang Y, 2008, J NEUROIMMUNOL, V194, P115, DOI 10.1016/j.jneuroim.2007.12.002; Zhang Y, 2008, J NEUROIMMUNOL, V204, P13, DOI 10.1016/j.jneuroim.2008.08.011	67	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8226	10.1371/journal.pone.0008226	http://dx.doi.org/10.1371/journal.pone.0008226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011045	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829800014
J	Chevaliez, S; Bouvier-Alias, M; Brillet, R; Pawlotsky, JM				Chevaliez, Stephane; Bouvier-Alias, Magali; Brillet, Rozenn; Pawlotsky, Jean-Michel			Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice	PLOS ONE			English	Article							POLYMERASE INHIBITOR; PLUS RIBAVIRIN; PEGINTERFERON; TELAPREVIR; PROTEASE; ASSAY; CLASSIFICATION; SYSTEM	Background: With the development of new specific inhibitors of hepatitis C virus (HCV) enzymes and functions that may yield different antiviral responses and resistance profiles according to the HCV subtype, correct HCV genotype 1 subtype identification is mandatory in clinical trials for stratification and interpretation purposes and will likely become necessary in future clinical practice. The goal of this study was to identify the appropriate molecular tool(s) for accurate HCV genotype 1 subtype determination. Methodology/Principal Findings: A large cohort of 500 treatment-naive patients eligible for HCV drug trials and infected with either subtype 1a or 1b was studied. Methods based on the sole analysis of the 5' non-coding region (5'NCR) by sequence analysis or reverse hybridization failed to correctly identify HCV subtype 1a in 22.8%-29.5% of cases, and HCV subtype 1b in 9.5%-8.7% of cases. Natural polymorphisms at positions 107, 204 and/or 243 were responsible for mis-subtyping with these methods. A real-time PCR method using genotype- and subtype-specific primers and probes located in both the 5'NCR and the NS5B-coding region failed to correctly identify HCV genotype 1 subtype in approximately 10% of cases. The second-generation line probe assay, a reverse hybridization assay that uses probes targeting both the 5'NCR and core-coding region, correctly identified HCV subtypes 1a and 1b in more than 99% of cases. Conclusions/Significance: In the context of new HCV drug development, HCV genotyping methods based on the exclusive analysis of the 5'NCR should be avoided. The second-generation line probe assay is currently the best commercial assay for determination of HCV genotype 1 subtypes 1a and 1b in clinical trials and practice.	[Chevaliez, Stephane; Bouvier-Alias, Magali; Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, French Natl Reference Ctr Viral Hepatitis B C & D, Dept Virol, F-94010 Creteil, France; [Chevaliez, Stephane; Bouvier-Alias, Magali; Brillet, Rozenn; Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chevaliez, S (corresponding author), Univ Paris 12, Hop Henri Mondor, French Natl Reference Ctr Viral Hepatitis B C & D, Dept Virol, F-94010 Creteil, France.	jean-michel.pawlotsky@hmn.aphp.fr	Pawlotsky, Jean-Michel/R-8159-2018; Bouvier-Alias, Magali/S-5631-2018	Bouvier-Alias, Magali/0000-0003-1590-5980; Pawlotsky, Jean-Michel/0000-0003-0745-7559	VIRGIL European Network of Excellence on Antiviral Drug Resistance [LSHM-CT-2004-503359]; Priority 1 "Life Sciences, Genomics and Biotechnology for Health''; 6th Framework Program of the European Union	VIRGIL European Network of Excellence on Antiviral Drug Resistance; Priority 1 "Life Sciences, Genomics and Biotechnology for Health''; 6th Framework Program of the European Union(European Commission)	The Trugene HCV 5'NC Genotyping kits and the INNO-LiPA HCV kits were kindly provided by Siemens Medical Solutions Diagnostics. The Abbott RealTime HCV Genotype II kits were kindly provided by Abbott Molecular. This work is part of the activity of the VIRGIL European Network of Excellence on Antiviral Drug Resistance supported by a grant (LSHM-CT-2004-503359) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health'' program in the 6th Framework Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Bouchardeau F, 2007, J CLIN MICROBIOL, V45, P1140, DOI 10.1128/JCM.01982-06; Bronowicki JP, 2006, GASTROENTEROLOGY, V131, P1040, DOI 10.1053/j.gastro.2006.07.022; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; Chevaliez S, 2008, BEST PRACT RES CL GA, V22, P1031, DOI 10.1016/j.bpg.2008.11.004; Erhardt A, 2009, ANTIVIR THER, V14, P23; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang LJ, 2009, J HEPATOL, V50, pS6, DOI 10.1016/S0168-8278(09)60010-6; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kwo P, 2009, J HEPATOL, V50, pS4, DOI 10.1016/S0168-8278(09)60006-4; Liang YQ, 2008, GASTROENTEROLOGY, V135, P1710, DOI 10.1053/j.gastro.2008.07.023; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martro E, 2008, J CLIN MICROBIOL, V46, P192, DOI 10.1128/JCM.01623-07; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Meffre C, 2007, HEPATOLOGY, V46, p625A; Morice Y, 2001, J GEN VIROL, V82, P1001, DOI 10.1099/0022-1317-82-5-1001; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Nettles R, 2008, HEPATOLOGY, V48, p1025A; Nolte FS, 2003, J CLIN MICROBIOL, V41, P1558, DOI 10.1128/JCM.41.4.1558-1564.2003; Nolte FS, 2001, MOL DIAGN, V6, P265, DOI 10.1054/modi.2001.29157; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pawlotsky Jean-Michel, 2009, Therap Adv Gastroenterol, V2, P205, DOI 10.1177/1756283X09336045; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Qiu P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-62; Ross RS, 2007, J VIROL METHODS, V143, P153, DOI 10.1016/j.jviromet.2007.03.006; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson P, 2009, J HEPATOL, V50, pS37, DOI 10.1016/S0168-8278(09)60092-1; Verbeeck J, 2008, J CLIN MICROBIOL, V46, P1901, DOI 10.1128/JCM.02390-07; Villano S, 2006, HEPATOLOGY, V44, p607A; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506	39	105	115	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8209	10.1371/journal.pone.0008209	http://dx.doi.org/10.1371/journal.pone.0008209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997618	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829700007
J	Kooij, G; Backer, R; Koning, JJ; Reijerkerk, A; van Horssen, J; van der Pol, SMA; Drexhage, J; Schinkel, A; Dijkstra, CD; den Haan, JMM; Geijtenbeek, TBH; de Vries, HE				Kooij, Gijs; Backer, Ronald; Koning, Jasper J.; Reijerkerk, Arie; van Horssen, Jack; van der Pol, Susanne M. A.; Drexhage, Joost; Schinkel, Alfred; Dijkstra, Christine D.; den Haan, Joke M. M.; Geijtenbeek, Teunis B. H.; de Vries, Helga E.			P-Glycoprotein Acts as an Immunomodulator during Neuroinflammation	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; BLOOD-BRAIN-BARRIER; T-CELL-ACTIVATION; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; GLATIRAMER ACETATE; PATHOGENESIS; TRANSPORT; DRUG; MICE	Background: Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system in which autoreactive myelin-specific T cells cause extensive tissue damage, resulting in neurological deficits. In the disease process, T cells are primed in the periphery by antigen presenting dendritic cells (DCs). DCs are considered to be crucial regulators of specific immune responses and molecules or proteins that regulate DC function are therefore under extensive investigation. We here investigated the potential immunomodulatory capacity of the ATP binding cassette transporter P-glycoprotein (Pgp). P-gp generally drives cellular efflux of a variety of compounds and is thought to be involved in excretion of inflammatory agents from immune cells, like DCs. So far, the immunomodulatory role of these ABC transporters is unknown. Methods and Findings: Here we demonstrate that P-gp acts as a key modulator of adaptive immunity during an in vivo model for neuroinflammation. The function of the DC is severely impaired in P-gp knockout mice (Mdr1a/1b-/-), since both DC maturation and T cell stimulatory capacity is significantly decreased. Consequently, Mdr1a/1b-/- mice develop decreased clinical signs of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. Reduced clinical signs coincided with impaired T cell responses and T cell-specific brain inflammation. We here describe the underlying molecular mechanism and demonstrate that P-gp is crucial for the secretion of pro-inflammatory cytokines such as TNF-alpha and IFN-gamma. Importantly, the defect in DC function can be restored by exogenous addition of these cytokines. Conclusions: Our data demonstrate that P-gp downmodulates DC function through the regulation of pro-inflammatory cytokine secretion, resulting in an impaired immune response. Taken together, our work highlights a new physiological role for P-gp as an immunomodulatory molecule and reveals a possible new target for immunotherapy.	[Kooij, Gijs; Backer, Ronald; Koning, Jasper J.; Reijerkerk, Arie; van Horssen, Jack; van der Pol, Susanne M. A.; Drexhage, Joost; Dijkstra, Christine D.; den Haan, Joke M. M.; de Vries, Helga E.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Schinkel, Alfred] Netherlands Canc Inst NKI, Dept Mol Biol, Amsterdam, Netherlands; [Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Kooij, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	He.devries@vumc.nl	den Haan, Joke MM/A-4281-2010; Kooij, Gijs/AAA-4268-2020; Backer, Ronald/F-5437-2013	den Haan, Joke MM/0000-0002-4421-6917; Backer, Ronald/0000-0003-1464-3755; de Vries, Helga/0000-0001-7904-7124; Kooij, Gijs/0000-0002-9488-2918; van Horssen, Jack/0000-0003-4078-7402	Netherlands Organization of Scientific Research [016.046.314, 917.46.311]; VICI [918.56.612]; Dutch foundation of MS Research; Netherlands [MS 05-567]; J. van Horssen and J. Drexhage [MS 05-358c]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); VICI(Netherlands Organization for Scientific Research (NWO)); Dutch foundation of MS Research; Netherlands(Netherlands Government); J. van Horssen and J. Drexhage	This work was supported by grants from the Netherlands Organization of Scientific Research (grant 016.046.314, G. Kooij, A. Reijerkerk; grant 917.46.311, J. den Haan, R. Backer), a VICI grant (918.56.612, J. Koning) and grants from the Dutch foundation of MS Research, The Netherlands ( grant MS 05-567, J. van Horssen and J. Drexhage; grant MS 05-358c, J. van Horssen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Backer R, 2008, EUR J IMMUNOL, V38, P370, DOI 10.1002/eji.200737647; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnes KM, 1996, BIOCHEMISTRY-US, V35, P4820, DOI 10.1021/bi952380k; Bauer B, 2005, EXP BIOL MED, V230, P118; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Drach J, 1996, BLOOD, V88, P1747, DOI 10.1182/blood.V88.5.1747.bloodjournal8851747; Eisenbraun MD, 1999, J IMMUNOL, V163, P2621; Ernest S, 1999, J AM SOC NEPHROL, V10, P2306; Ewing C, 1998, IMMUNOL CELL BIOL, V76, P47, DOI 10.1046/j.1440-1711.1998.00718.x; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Frank MH, 2001, J IMMUNOL, V166, P2451, DOI 10.4049/jimmunol.166.4.2451; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fukao T, 2001, J IMMUNOL, V166, P4446, DOI 10.4049/jimmunol.166.7.4446; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Huang YH, 1999, CLIN EXP IMMUNOL, V116, P326; Hussien Y, 2001, J NEUROIMMUNOL, V121, P102, DOI 10.1016/S0165-5728(01)00432-5; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Koubeissi A, 2006, BIOORG MED CHEM LETT, V16, P5700, DOI 10.1016/j.bmcl.2006.07.059; Lagas JS, 2008, ANTIMICROB AGENTS CH, V52, P1034, DOI 10.1128/AAC.01041-07; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lucchinetti C, 2001, CURR OPIN NEUROL, V14, P259, DOI 10.1097/00019052-200106000-00002; Meijer OC, 1998, ENDOCRINOLOGY, V139, P1789, DOI 10.1210/en.139.4.1789; Pendse SS, 2006, AM J TRANSPLANT, V6, P2884, DOI 10.1111/j.1600-6143.2006.01561.x; Quah BJC, 2005, J CELL MOL MED, V9, P643, DOI 10.1111/j.1582-4934.2005.tb00494.x; Raggers RJ, 2001, BIOCHEM J, V357, P859, DOI 10.1042/0264-6021:3570859; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Schroeijers AB, 2002, J IMMUNOL, V168, P1572, DOI 10.4049/jimmunol.168.4.1572; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; THIEBAUT F, 1989, J HISTOCHEM CYTOCHEM, V37, P159, DOI 10.1177/37.2.2463300; Vieira PL, 2003, J IMMUNOL, V170, P4483, DOI 10.4049/jimmunol.170.9.4483; Weiss HA, 2007, J NEUROIMMUNOL, V191, P79, DOI 10.1016/j.jneuroim.2007.09.011	39	55	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8212	10.1371/journal.pone.0008212	http://dx.doi.org/10.1371/journal.pone.0008212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997559	Green Published, gold			2022-12-25	WOS:000272829700009
J	Liu, JX; Song, JX				Liu, Jingxian; Song, Jianxing			Insights into Protein Aggregation by NMR Characterization of Insoluble SH3 Mutants Solubilized in Salt-Free Water	PLOS ONE			English	Article							FOLDING TRANSITION-STATE; LACTALBUMIN MOLTEN GLOBULE; BETA-LACTOGLOBULIN; BACKBONE DYNAMICS; PURE WATER; MOLECULAR-DYNAMICS; CIRCULAR-DICHROISM; SPECTRAL DENSITIES; DENATURED STATE; CHEMICAL-SHIFTS	Protein aggregation in vivo has been extensively associated with a large spectrum of human diseases. On the other hand, mechanistic insights into protein aggregation in vitro were incomplete due to the inability in solubilizing insoluble proteins for high-resolution biophysical investigations. However, a new avenue may be opened up by our recent discovery that previously-thought insoluble proteins can in fact be solubilized in salt-free water. Here we use this approach to study the NMR structural and dynamic properties of an insoluble SH3 mutant with a naturally-occurring insertion of Val22 at the tip of the diverging turn. The obtained results reveal: 1) regardless of whether the residue is Val, Ala, Asp or Arg, the insertion will render the first hNck2 SH3 domain to be insoluble in buffers. Nevertheless, all four mutants could be solubilized in salt-free water and appear to be largely unfolded as evident from their CD and NMR HSQC spectra. 2) Comparison of the chemical shift deviations reveals that while in V22-SH3 the second helical region is similarly populated as in the wild-type SH3 at pH 2.0, the first helical region is largely unformed. 3) In V22-SH3, many non-native medium-range NOEs manifest to define non-native helical conformations. In the meanwhile a small group of native-like long-range NOEs still persists, indicating the existence of a rudimentary native-like tertiary topology. 4) Although overall, V22-SH3 has significantly increased backbone motions on the ps-ns time scale, some regions still own restricted backbone motions as revealed by analyzing N-15 relaxation data. Our study not only leads to the establishment of the first high-resolution structural and dynamic picture for an insoluble protein, but also shed more light on the molecular events for the nonhierarchical folding mechanism. Furthermore, a general mechanism is also proposed for in vivo protein aggregation triggered by the genetic mutation and posttranslational modification.	[Liu, Jingxian; Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Liu, JX (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchsj@nus.edu.sg	Song, Jianxing/H-8026-2012; Song, Jianxing/J-3617-2013	Song, Jianxing/0000-0003-0224-6322	Ministry of Education (MOE) of Singapore [R-154-000-388-112]	Ministry of Education (MOE) of Singapore(Ministry of Education, Singapore)	This study is supported by the Ministry of Education (MOE) of Singapore Tier 2 Grant R-154-000-388-112 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos FF, 2009, BIOCHEMISTRY-US, V48, P1332, DOI 10.1021/bi802148r; Arai M, 1998, J MOL BIOL, V275, P149, DOI 10.1006/jmbi.1997.1456; Avbelj F, 2004, P NATL ACAD SCI USA, V101, P17394, DOI 10.1073/pnas.0407969101; Bai P, 2001, PROTEIN SCI, V10, P55, DOI 10.1110/ps.34101; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Blanco FJ, 1999, J MOL BIOL, V285, P741, DOI 10.1006/jmbi.1998.2333; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Chikenji G, 2000, P NATL ACAD SCI USA, V97, P14273, DOI 10.1073/pnas.97.26.14273; Crowhurst KA, 2003, BIOCHEMISTRY-US, V42, P8687, DOI 10.1021/bi034601p; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; DAVIDSON AR, 1994, P NATL ACAD SCI USA, V91, P2146, DOI 10.1073/pnas.91.6.2146; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELAK K, 2009, POLYELECTROLYTE DOMA, V48, P3669; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Ding F, 2005, STRUCTURE, V13, P1047, DOI 10.1016/j.str.2005.04.009; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; ENGLANDER SW, 2002, BIOPHYS CHEM, V10, P101; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fujiwara K, 1999, BIOCHEMISTRY-US, V38, P4455, DOI 10.1021/bi982683p; Gnanakaran S, 2003, BIOPHYS J, V84, P1548, DOI 10.1016/S0006-3495(03)74966-2; Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Gruebele M, 1998, NAT STRUCT BIOL, V5, P662, DOI 10.1038/1354; Gsponer J, 2002, P NATL ACAD SCI USA, V99, P6719, DOI 10.1073/pnas.092686399; Hamada D, 1996, NAT STRUCT BIOL, V3, P868, DOI 10.1038/nsb1096-868; Hamada D, 1997, J MOL BIOL, V269, P479, DOI 10.1006/jmbi.1997.1055; Hubner IA, 2005, J MOL BIOL, V349, P424, DOI 10.1016/j.jmb.2005.03.050; ISHIMA R, 1995, J BIOMOL NMR, V6, P217, DOI 10.1007/BF00211786; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Kristjansdottir S, 2005, J MOL BIOL, V347, P1053, DOI 10.1016/j.jmb.2005.01.009; Kuwajima K, 1996, J MOL BIOL, V264, P806, DOI 10.1006/jmbi.1996.0678; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Kuwata K, 2001, NAT STRUCT BIOL, V8, P151, DOI 10.1038/84145; Li MF, 2007, BIOCHEM BIOPH RES CO, V360, P128, DOI 10.1016/j.bbrc.2007.06.031; Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187; Li MF, 2006, PROTEIN SCI, V15, P1835, DOI 10.1110/ps.062306906; Li W, 2000, HISTOL HISTOPATHOL, V15, P947, DOI 10.14670/HH-15.947; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Liu JX, 2008, BIOPHYS J, V95, P4803, DOI 10.1529/biophysj.107.125641; Liu JX, 2008, BIOCHEM BIOPH RES CO, V366, P585, DOI 10.1016/j.bbrc.2007.12.022; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Luheshi LM, 2009, FEBS LETT, V583, P2581, DOI 10.1016/j.febslet.2009.06.030; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418; Mayer BJ, 2001, J CELL SCI, V114, P1253; Park S, 2006, J BIOMOL NMR, V34, P203, DOI 10.1007/s10858-006-0019-5; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG ZY, 1995, PHILOS T ROY SOC B, V348, P43, DOI 10.1098/rstb.1995.0044; Ran XY, 2008, PROTEINS, V72, P1019, DOI 10.1002/prot.21999; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHWARZINGER S, J BIOMOL NMR, V18, P43; Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022; Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815; Song JX, 1998, J MOL BIOL, V280, P167, DOI 10.1006/jmbi.1998.1826; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Viguera AR, 2001, J MOL BIOL, V311, P357, DOI 10.1006/jmbi.2001.4738; Wei Z, 2005, J MOL BIOL, V348, P205, DOI 10.1016/j.jmb.2005.02.028; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816	71	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7805	10.1371/journal.pone.0007805	http://dx.doi.org/10.1371/journal.pone.0007805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956763	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827300001
J	Saito, Y; Owaki, T; Matsunaga, T; Saze, M; Miura, S; Maeda, M; Eguchi, M; Tanaka, R; Taira, J; Kodama, H; Goto, S; Niitsu, Y; Terada, H; Fukai, F				Saito, Yohei; Owaki, Toshiyuki; Matsunaga, Takuya; Saze, Mizue; Miura, Shogo; Maeda, Mao; Eguchi, Mayu; Tanaka, Rika; Taira, Junichi; Kodama, Hiroaki; Goto, Sumio; Niitsu, Yoshiroh; Terada, Hiroshi; Fukai, Fumio			Apoptotic Death of Hematopoietic Tumor Cells through Potentiated and Sustained Adhesion to Fibronectin via VLA-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DRUG-RESISTANCE; BONE-MARROW MICROENVIRONMENT; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; TENASCIN-C; CAM-DR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; ACTIVATION; EXPRESSION	It has been postulated that inactivated beta 1-integrins are involved in the disordered growth of hematopoietic tumor cells. We recently found that TNIIIA2, a peptide derived from tenascin-C, strongly activates beta 1-integrins through binding with syndecan-4. We show here that Ramos Burkitt's lymphoma cells can survive and grow in suspension but undergo apoptosis when kept adhering to fibronectin by stimulation with TNIIIA2. Other integrin activators, Mg2+ and TS2/16 (an integrin-activating antibody), were also capable of inducing apoptosis. The inactivation of ERK1/2 and Akt and the subsequent activation of Bad were involved in the apoptosis. The results using other hematopoietic tumor cell lines expressing different levels of fibronectin receptors (VLA-4 and VLA-5) showed that potentiated and sustained adhesion to fibronectin via VLA-4 causally induces apoptosis also in various types of hematopoietic tumor cells in addition to Ramos cells. Because TNIIIA2 requires syndecan-4 as a membrane receptor for activation of beta 1-integrins, it induced apoptosis preferentially in hematopoietic tumor cells, which expressed both VLA-4 and syndecan-4 as membrane receptors mediating the effects of fibronectin and TNIIIA2, respectively. Therefore, normal peripheral blood cells, such as neutrophils, monocytes, and lymphocytes, which poorly expressed syndecan-4, were almost insusceptible to TNIIIA2-induced apoptosis. The TNIIIA2-related matricryptic site of TN-C could contribute, once exposed, to preventing prolonged survival of hematopoietic malignant progenitors through potentiated and sustained activation of VLA-4.	[Tanaka, Rika; Fukai, Fumio] Tokyo Univ Sci, Dept Mol Pathophysiol, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Saito, Yohei; Owaki, Toshiyuki; Terada, Hiroshi; Fukai, Fumio] Tokyo Univ Sci, Ctr Drug Delivery Res, Noda, Chiba 2788510, Japan; [Matsunaga, Takuya; Niitsu, Yoshiroh] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Chuo Ku, Sapporo, Hokkaido 060854, Japan; [Taira, Junichi; Kodama, Hiroaki] Saga Univ, Fac Sci & Engn, Saga 8490922, Japan; [Goto, Sumio] Azabu Univ, Sch Life & Environm Sci, Kanagawa 2298501, Japan	Tokyo University of Science; Tokyo University of Science; Sapporo Medical University; Saga University; Azabu University	Fukai, F (corresponding author), Tokyo Univ Sci, Dept Mol Pathophysiol, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp		Taira, Junichi/0000-0002-8438-865X	Ministry for Education, Culture, Sports, Science and Technology of Japan; Vehicle Racing Commemorative Foundation	Ministry for Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation	This work was supported in part by the High-Tech Research Center Project for Private Universities with a matching fund subsidy from Ministry for Education, Culture, Sports, Science and Technology of Japan (2004-2008) and by the Vehicle Racing Commemorative Foundation.	Atula T, 2003, ANTICANCER RES, V23, P3051; BRADSTOCK KF, 1995, LEUKEMIA LYMPHOMA, V18, P1, DOI 10.3109/10428199509064917; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; CHILOSI M, 1993, AM J PATHOL, V143, P1348; CLARK BR, 1992, BAILLIERE CLIN HAEM, V5, P619, DOI 10.1016/S0950-3536(11)80010-7; COULOMBEL L, 1988, BLOOD, V71, P329; Damiano JS, 2001, LEUKEMIA, V15, P1232, DOI 10.1038/sj.leu.2402179; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DREXLER HG, 1986, CANCER RES, V46, P6078; Fukai F, 2000, CELL MOL BIOL, V46, P145; FUKAI F, 1991, J BIOL CHEM, V266, P8807; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; JOSHI P, 1993, J CELL SCI, V106, P389; Kamiya SL, 2002, BIOCHEMISTRY-US, V41, P3270, DOI 10.1021/bi015660a; Kaneider NC, 2001, BIOCHEM BIOPH RES CO, V287, P42, DOI 10.1006/bbrc.2001.5534; Kapur R, 2001, BLOOD, V97, P1975, DOI 10.1182/blood.V97.7.1975; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Leins A, 2003, CANCER-AM CANCER SOC, V98, P2430, DOI 10.1002/cncr.11796; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; LIGHTNER VA, 1990, ANN NY ACAD SCI, V580, P260, DOI 10.1111/j.1749-6632.1990.tb17935.x; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Molla A, 2000, CELL GROWTH DIFFER, V11, P83; Murti KG, 1996, EXP CELL RES, V226, P47, DOI 10.1006/excr.1996.0201; OCKLIND G, 1993, J HISTOCHEM CYTOCHEM, V41, P1163, DOI 10.1177/41.8.7687262; RAZ A, 1983, SCIENCE, V221, P1307, DOI 10.1126/science.6612347; SACHS L, 1995, ADV CANCER RES, V66, P1, DOI 10.1016/S0065-230X(08)60250-X; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; SANCHEZAPARICIO P, 1994, J CELL BIOL, V126, P271, DOI 10.1083/jcb.126.1.271; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Shain KH, 2000, CURR OPIN ONCOL, V12, P557, DOI 10.1097/00001622-200011000-00008; SUGAHARA H, 1994, J EXP MED, V179, P1757, DOI 10.1084/jem.179.6.1757; Takagi J, 1997, J BIOCHEM, V121, P914; Terui Y, 1996, J IMMUNOL, V156, P1981; Tsunoda T, 2003, AM J PATHOL, V162, P1857, DOI 10.1016/S0002-9440(10)64320-9; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; Wang MWJ, 1998, CELL GROWTH DIFFER, V9, P105; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Yamashita Y, 1999, J IMMUNOL, V162, P5940	43	11	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7006	7015		10.1074/jbc.M109.027581	http://dx.doi.org/10.1074/jbc.M109.027581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20007695	Green Published, hybrid			2022-12-25	WOS:000275415600014
J	Berlin, S; Keren-Raifman, T; Castel, R; Rubinstein, M; Dessauer, CW; Ivanina, T; Dascal, N				Berlin, Shai; Keren-Raifman, Tal; Castel, Ruth; Rubinstein, Moran; Dessauer, Carmen W.; Ivanina, Tatiana; Dascal, Nathan			G alpha(i) and G beta gamma Jointly Regulate the Conformations of a G beta gamma Effector, the Neuronal G Protein-activated K+ Channel (GIRK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT STOICHIOMETRY; SIGNALING COMPLEXES; POTASSIUM CHANNEL; XENOPUS-OOCYTES; LIVING CELLS; BINDING; MODULATION; GPCR; G(BETA-GAMMA); RECTIFICATION	Stable complexes among G proteins and effectors are an emerging concept in cell signaling. The prototypical G beta gamma effector G protein-activated K+ channel (GIRK; Kir3) physically interacts with G beta gamma but also with G alpha(i/o). Whether and how G alpha(i/o) subunits regulate GIRK in vivo is unclear. We studied triple interactions among GIRK subunits 1 and 2, G alpha(i3) and G beta gamma. We used in vitro protein interaction assays and in vivo intramolecular Forster resonance energy transfer (i-FRET) between fluorophores attached to N and C termini of either GIRK1 or GIRK2 subunit. We demonstrate, for the first time, that G beta gamma and G alpha i3 distinctly and interdependently alter the conformational states of the heterotetrameric GIRK1/2 channel. Biochemical experiments show that G beta gamma greatly enhances the binding of GIRK1 subunit to G i3 GDP and, unexpectedly, to G alpha(GTP)(i3), i-FRET showed that both G alpha(i3) and G beta gamma induced distinct conformational changes in GIRK1 and GIRK2. Moreover, GIRK1 and GIRK2 subunits assumed unique, distinct conformations when coexpressed with a "constitutively active" G alpha(i3) mutant and G beta gamma together. These conformations differ from those assumed by GIRK1 or GIRK2 after separate coexpression of either G alpha(i3) or G beta gamma. Both biochemical and i-FRET data suggest that GIRK acts as the nucleator of the GIRK-G alpha-G beta gamma signaling complex and mediates allosteric interactions between G alpha(GTP)(i3) and G beta gamma. Our findings imply that G alpha(i/o) and the G alpha(i)beta gamma heterotrimer can regulate a G beta gamma effector both before and after activation by neurotransmitters.	[Berlin, Shai; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Berlin, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	shaiberlin@gmail.com; dascaln@post.tau.ac.il	Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Berlin, shai/0000-0002-5153-4876; Dessauer, Carmen/0000-0003-1210-4280; Rubinstein, Moran/0000-0003-2617-2276	National Institutes of Health [GM68493, GM60419]; United States Israel Binational Science Foundation [01-122]; Israel Science Foundation [49/08, 1396/05]; Segol Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068493, R01GM060419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Segol Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM68493 (to N.D.) and GM60419 (to C.W.D.). This work was also supported by the United States Israel Binational Science Foundation Grant 01-122 (to N.D. and C.W.D.), Israel Science Foundation Grants 49/08 and 1396/05 (to N.D.), and a Segol Fellowship (to M.R.).	Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Rishal I, 2003, J BIOL CHEM, V278, P3840, DOI 10.1074/jbc.C200605200; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2; Silverman SK, 1996, J BIOL CHEM, V271, P30524, DOI 10.1074/jbc.271.48.30524; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Tucker SJ, 1996, AM J PHYSIOL-HEART C, V271, pH379, DOI 10.1152/ajpheart.1996.271.1.H379; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Vorobiov D, 1998, PFLUG ARCH EUR J PHY, V436, P56, DOI 10.1007/s004240050604; Wang JT, 2009, J BIOL CHEM, V284, P16906, DOI 10.1074/jbc.M109.006585; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yamada M, 1998, PHARMACOL REV, V50, P723; YAMADA M, 1993, J BIOL CHEM, V268, P24551; Zheng J, 2003, J NEUROSCI, V23, P8167	36	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6179	6185		10.1074/jbc.M109.085944	http://dx.doi.org/10.1074/jbc.M109.085944			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018875	Green Published, hybrid			2022-12-25	WOS:000275367500022
J	Ghosh, J; Anderson, PJ; Chandrasekaran, S; Caparon, MG				Ghosh, Joydeep; Anderson, Patricia J.; Chandrasekaran, Sukantha; Caparon, Michael G.			Characterization of Streptococcus pyogenes beta-NAD(+) Glycohydrolase RE-EVALUATION OF ENZYMATIC PROPERTIES ASSOCIATED WITH PATHOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; CYCLIC ADP-RIBOSE; CYTOLYSIN-MEDIATED TRANSLOCATION; NAD-GLYCOHYDROLASE; RIBOSYLTRANSFERASE ACTIVITY; RIBOSYLATING TOXINS; BACILLUS-SUBTILIS; HUMAN CD38; PURIFICATION; INTERMEDIATE	The Gram-positive pathogen Streptococcus pyogenes injects a beta-NAD(+) glycohydrolase (SPN) into the cytosol of an infected host cell using the cytolysin-mediated translocation pathway. In this compartment, SPN accelerates the death of the host cell by an unknown mechanism that may involve its beta-NAD(+)-dependent enzyme activities. SPN has been reported to possess the unique characteristic of not only catalyzing hydrolysis of beta-NAD(+), but also carrying out ADP-ribosyl cyclase and ADP-ribosyltransferase activities, making SPN the only beta-NAD(+) glycohydrolase that can catalyze all of these reactions. With the long term goal of understanding how these activities may contribute to pathogenesis, we have further characterized the enzymatic activity of SPN using highly purified recombinant protein. Kinetic studies of the multiple activities of SPN revealed that SPN possessed only beta-NAD(+) hydrolytic activity and lacked detectable ADP-ribosyl cyclase and ADP-ribosyltransferase activities. Similarly, SPN was unable to catalyze cyclic ADPR hydrolysis, and could not catalyze methanolysis or transglycosidation. Kinetic analysis of product inhibition by recombinant SPN demonstrated an ordered uni-bi mechanism, with ADPribose being released as a second product. SPN was unaffected by product inhibition using nicotinamide, suggesting that this moiety contributes little to the binding energy of the substrate. Upon transformation, SPN was toxic to Saccharomyces cerevisiae, whereas a glycohydrolase-inactive SPN allowed for viability. Taken together, these data suggest that SPN functions exclusively as a strict beta-NAD(+) glycohydrolase during pathogenesis.	[Ghosh, Joydeep; Chandrasekaran, Sukantha; Caparon, Michael G.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Anderson, Patricia J.] Washington Univ, Div Hematol, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Caparon, MG (corresponding author), Washington Univ, Dept Mol Microbiol, Sch Med, 660 S Euclid Ave,Box 8230, St Louis, MO 63110 USA.	caparon@borcim.wustl.edu			National Institutes of Health [AI064721]; United States Public Health Service; American Heart Association National Scientist Development Award [0530110N];  [09GRNT2220282]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association National Scientist Development Award(American Heart Association); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064721 (to M. G. C.) from the United States Public Health Service. This work was also supported by an American Heart Association National Scientist Development Award (0530110N) and subsequently a Grant-in-aid (09GRNT2220282 to P. J. A.).	Ajdic D, 2000, FEMS MICROBIOL LETT, V191, P235, DOI 10.1111/j.1574-6968.2000.tb09345.x; Armstrong S, 2004, BIOCHEMISTRY-US, V43, P183, DOI 10.1021/bi034772u; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; Bricker AL, 2005, INFECT IMMUN, V73, P6562, DOI 10.1128/IAI.73.10.6562-6566.2005; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAVIS WB, 1980, ANTIMICROB AGENTS CH, V17, P663, DOI 10.1128/AAC.17.4.663; DOMENIGHINI M, 1994, MOL MICROBIOL, V14, P41, DOI 10.1111/j.1365-2958.1994.tb01265.x; EVERSE J, 1975, ARCH BIOCHEM BIOPHYS, V169, P714, DOI 10.1016/0003-9861(75)90216-7; EVERSE J, 1975, ARCH BIOCHEM BIOPHYS, V169, P702, DOI 10.1016/0003-9861(75)90215-5; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gerlach D, 1996, FEMS MICROBIOL LETT, V136, P71; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GRUSHOFF PS, 1975, J BACTERIOL, V122, P599, DOI 10.1128/JB.122.2.599-605.1975; Han S, 2002, INT J MED MICROBIOL, V291, P523; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; KANDEL J, 1974, J BIOL CHEM, V249, P2088; KAPLAN NO, 1955, METHOD ENZYMOL, V2, P551; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; Kimoto H, 2006, J BIOL CHEM, V281, P9181, DOI 10.1074/jbc.M506879200; KUSHNER S, 1978, GENETIC ENG, P173; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HC, 1999, MOL CELL BIOCHEM, V193, P89; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Love ML, 2004, STRUCTURE, V12, P477, DOI 10.1016/j.str.2004.02.006; Lund FE, 2005, ANAL BIOCHEM, V346, P336, DOI 10.1016/j.ab.2005.08.016; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; MATHER IH, 1972, BIOCHEM J, V129, P141, DOI 10.1042/bj1290141; Meehl MA, 2005, PLOS PATHOG, V1, P362, DOI 10.1371/journal.ppat.0010035; Michos A, 2006, J BIOL CHEM, V281, P8216, DOI 10.1074/jbc.M511674200; MULLERSTEFFNER H, 1994, BIOCHEM BIOPH RES CO, V204, P1279, DOI 10.1006/bbrc.1994.2601; Oppenheimer N. J., 1992, ENZYMES, P453; OPPENHEIMER NJ, 1994, MOL CELL BIOCHEM, V138, P245, DOI 10.1007/BF00928468; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; SCHUBER F, 1976, EUR J BIOCHEM, V65, P247, DOI 10.1111/j.1432-1033.1976.tb10411.x; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; SEGEL IH, 1975, ENZYME KINETICS, P544; Stevens DL, 2000, J INFECT DIS, V182, P1117, DOI 10.1086/315850; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; TARNUS C, 1988, BIOORG CHEM, V16, P38, DOI 10.1016/0045-2068(88)90036-3; Tatsuno I, 2007, MICROBIOL-SGM, V153, P4253, DOI 10.1099/mic.0.2007/009555-0; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	46	36	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5683	5694		10.1074/jbc.M109.070300	http://dx.doi.org/10.1074/jbc.M109.070300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018886	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000275327200061
J	Jeyaraj, SC; Singh, M; Ayupova, DA; Govindaraju, S; Lee, BS				Jeyaraj, Selvi C.; Singh, Mamata; Ayupova, Dina A.; Govindaraju, Suman; Lee, Beth S.			Transcriptional Control of Human Antigen R by Bone Morphogenetic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-RENAL-FAILURE; RNA-BINDING PROTEINS; POSTTRANSCRIPTIONAL GENE-REGULATION; MESSENGER-RNA; ALTERNATIVE PROMOTERS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; HUR; EXPRESSION; BMP-7	Human antigen R (HuR) is an RNA-binding protein with protective activities against cellular stress. This study considers the mechanisms by which HuR transcriptional regulation occurs in renal proximal tubule cells. Under basal conditions, HuRmRNA is expressed in two forms: one that contains a similar to 20-base 5'-untranslated region (UTR) sequence and one that contains a similar to 150-base, G + C-rich 5'-UTR that is inhibitory to translation. Recovery from cellular stresses such as thapsigargin and ATP depletion induced increased expression of the shorter, more translatable transcript and decreased expression of the longer form. Analysis of HuR upstream regions revealed sequences necessary for regulation of the shorter mRNA. Within the long, G + C-rich 5'-UTR exist multiple copies of the alternate Smad 1/5/8-binding motif GCCGnCGC. Recovery from ATP depletion induced increases in Smad1/5/8 levels; further, gel shift and chromatin immunoprecipitation analyses demonstrated the ability of these Smads to bind to the relevant motif in the HuR 5'-UTR. Transfection of exogenous Smad 1 increased HuR mRNA expression. Finally, HuR mRNA expression driven by the Smad-binding sites was responsive to BMP-7, a protein with known protective effects against ischemic injury in kidney. These data suggest that transcriptional induction of a readily translatable HuR mRNA may be driven by a mechanism known to protect the kidney from injury and provides a novel pathway through which administration of BMP-7 may attenuate renal damage.	[Jeyaraj, Selvi C.; Singh, Mamata; Ayupova, Dina A.; Govindaraju, Suman; Lee, Beth S.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Lee, BS (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	National Institutes of Health [RO1 DK052131, RO1 AR051515]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK052131 and RO1 AR051515 (to B. S. L.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Ashworth SL, 2003, AM J PHYSIOL-RENAL, V284, pF852, DOI 10.1152/ajprenal.00210.2002; Ayupova DA, 2009, AM J PHYSIOL-RENAL, V297, pF95, DOI 10.1152/ajprenal.90632.2008; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Cochrane J, 1999, RENAL FAILURE, V21, P135, DOI 10.3109/08860229909066978; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130, DOI 10.1152/ajprenal.2000.279.1.F130; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Jeyaraj SC, 2006, AM J PHYSIOL-RENAL, V291, pF1255, DOI 10.1152/ajprenal.00440.2005; Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Martinez G, 2001, EXP NEPHROL, V9, P372; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mazan-Mamczarz K, 2008, CANCER RES, V68, P7730, DOI 10.1158/0008-5472.CAN-08-2393; Meldrum KK, 2001, AM J PHYSIOL-REG I, V281, pR359, DOI 10.1152/ajpregu.2001.281.1.R359; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Nabors LB, 2001, CANCER RES, V61, P2154; NGUYEN VT, 1994, EUR J BIOCHEM, V220, P239; Okano HJ, 1997, J NEUROSCI, V17, P3024; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; Palmer BF, 1997, J INVEST MED, V45, P346; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Rasband WS, 1997, IMAGE J; Rothhammer T, 2005, CANCER RES, V65, P448; Rudnicki M, 2007, KIDNEY INT, V71, P325, DOI 10.1038/sj.ki.5002043; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Simon N, 1999, AM J PHYSIOL-RENAL, V276, pF382, DOI 10.1152/ajprenal.1999.276.3.F382; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Tsuritani K, 2007, GENOME RES, V17, P1005, DOI 10.1101/gr.6030107; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Vrljicak P, 2004, AM J PHYSIOL-RENAL, V286, pF625, DOI 10.1152/ajprenal.00152.2003; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; Vukicevic S, 1996, P NATL ACAD SCI USA, V93, P9021, DOI 10.1073/pnas.93.17.9021; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Wang SN, 2001, J AM SOC NEPHROL, V12, P2392, DOI 10.1681/ASN.V12112392; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeng Q, 2000, J CELL SCI, V113, P471	57	21	21	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4432	4440		10.1074/jbc.M109.062216	http://dx.doi.org/10.1074/jbc.M109.062216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018854	Green Published, hybrid			2022-12-25	WOS:000275274800020
J	Yuan, HF; Wang, ZQ; Gao, CG; Chen, WG; Huang, Q; Yee, JK; Bhatia, R; Chen, WY				Yuan, Hongfeng; Wang, Zhiqiang; Gao, Chunggang; Chen, Wengang; Huang, Qin; Yee, Jiing-Kuan; Bhatia, Ravi; Chen, WenYong			BCR-ABL Gene Expression Is Required for Its Mutations in a Novel KCL-22 Cell Culture Model for Acquired Resistance of Chronic Myelogenous Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE DOMAIN MUTATIONS; IMATINIB RESISTANCE; POINT MUTATIONS; OLIGOMERIZATION DOMAIN; CLINICAL RESISTANCE; NILOTINIB AMN107; RNA INTERFERENCE; INHIBITOR; BCR/ABL	Acquired resistance through genetic mutations is a common phenomenon in several cancer therapies using molecularly targeted drugs, best exemplified by the BCR-ABL inhibitor imatinib in treating chronic myelogenous leukemia (CML). Overcoming acquired resistance is a daunting therapeutic challenge, and little is known about how these mutations evolve. To facilitate understanding the resistance mechanisms, we developed a novel culture model for CML acquired resistance in which the CML cell line KCL-22, following initial response to imatinib, develops resistant T315I BCR-ABL mutation. We demonstrate that the emergence of BCR-ABL mutations do not require preexisting BCR-ABL mutations derived from the original patient as the subclones of KCL-22 cells can form various BCR-ABL mutations upon imatinib treatment. BCR-ABL mutation rates vary from cell clone to clone and passages, in contrast to the relatively stable mutation rate of the hypoxanthine-guanine phosphoribosyltransferase gene. Strikingly, development of BCR-ABL mutations depends on its gene expression because BCR-ABL knockdown completely blocks KCL-22 cell relapse on imatinib and acquisition of mutations. We further show that the endogenous BCR-ABL locus has significantly higher mutagenesis potential than the transduced randomly integrated BCR-ABL cDNA. Our study suggests important roles of BCR-ABL gene expression and its native chromosomal locus for acquisition of BCR-ABL mutations and provides a new tool for further studying resistance mechanisms.	[Chen, WenYong] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Chen, Wengang; Huang, Qin] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA; [Yee, Jiing-Kuan] City Hope Natl Med Ctr, Dept Virol, Duarte, CA 91010 USA; [Bhatia, Ravi] City Hope Natl Med Ctr, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope	Chen, WY (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	wechen@coh.org	Chen, WenYong/D-6748-2012; yuan, hongfeng/A-3633-2012; wang, zhiqiang/D-6011-2012	Chen, WenYong/0000-0001-6913-5729	City of Hope; United States Department of Defense; STOPCANCER Foundation; V-Foundation	City of Hope; United States Department of Defense(United States Department of Defense); STOPCANCER Foundation; V-Foundation	This work was supported by start-up funds from the City of Hope, grants from the United States Department of Defense, the STOPCANCER Foundation ( to W.Y.C.), and a translational research grant from the V-Foundation ( to W.Y.C. and R. B.).	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Huntly BJP, 2003, BLOOD, V102, P1160, DOI 10.1182/blood-2003-01-0123; Jiang XY, 2007, J NATL CANCER I, V99, P680, DOI 10.1093/jnci/djk150; Karpinets TV, 2006, CURR GENOMICS, V7, P481, DOI 10.2174/138920206779315764; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kowolik CM, 2003, MOL THER, V8, P324, DOI 10.1016/S1525-0016(03)00166-7; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; La Rosee P, 2002, CANCER RES, V62, P7149; Li MJ, 2003, OLIGONUCLEOTIDES, V13, P401, DOI 10.1089/154545703322617087; Lucas CM, 2009, HAEMATOL-HEMATOL J, V94, P1362, DOI 10.3324/haematol.2009.009134; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; OSTERHOLM AM, 1995, CARCINOGENESIS, V16, P1909, DOI 10.1093/carcin/16.8.1909; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Ramaraj P, 2004, CANCER RES, V64, P5322, DOI 10.1158/0008-5472.CAN-03-3656; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Ricci C, 2002, CANCER RES, V62, P5995; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Rosenhahn J, 2007, INT J ONCOL, V31, P121; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shi JX, 2007, HUM MUTAT, V28, P131, DOI 10.1002/humu.20423; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Tipping AJ, 2003, EXP HEMATOL, V31, P1073, DOI 10.1016/j.exphem.2003.08.006; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wertheim JA, 2002, BLOOD, V99, P4122, DOI 10.1182/blood.V99.11.4122; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Zhao X, 2002, NAT STRUCT BIOL, V9, P117; Zhelev Z, 2004, FEBS LETT, V570, P195, DOI 10.1016/j.febslet.2004.06.048	43	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5085	5096		10.1074/jbc.M109.039206	http://dx.doi.org/10.1074/jbc.M109.039206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007699	hybrid, Green Published			2022-12-25	WOS:000275274800084
J	Park, OJ; Kim, HJ; Woo, KM; Baek, JH; Ryoo, HM				Park, Ok-Jin; Kim, Hyun-Jung; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo			FGF2-activated ERK Mitogen-activated Protein Kinase Enhances Runx2 Acetylation and Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FACTOR BETA-1; DNA-BINDING; CELL-LINE; PHOSPHORYLATION	Runx2 is a key transcription factor regulating osteoblast differentiation and skeletal morphogenesis, and FGF2 is one of the most important regulators of skeletal development. The importance of the ERK mitogen-activated protein (MAP) kinase pathway in cranial suture development was demonstrated by the findings that the inhibition of FGF/FGF receptor (FGFR) signaling by a MEK blocker prevents the premature suture closure caused by an Fgfr2 mutation in mice. We previously demonstrated that ERK activation does not affect Runx2 gene expression but that it stimulates Runx2 transcriptional activity. However, the molecular mechanism underlying Runx2 activation by FGF/FGFR or ERK was still unclear. In this study, we found that FGF2 treatment increased the protein level of exogenously over-expressed Runx2 and that this increase is reversed by ERK inhibitors. In contrast, overexpression of constitutively active MEK strongly increased the Runx2 protein level, which paralleled an increase in Runx2 acetylation. As Runx2 protein phosphorylation mediated by ERK directly correlates with Runx2 protein stabilization, acetylation, and ubiquitination, we undertook to identify the ERK-dependent phosphorylation sites in Runx2. Analysis of two C-terminal Runx2 deletion constructs showed that the middle third of the protein is responsible for ERK-induced stabilization and activation. An in silico analysis of highly conserved ERK targets indicated that there are three relevant serine residues in this domain. Site-directed mutagenesis implicated Ser-301 in for ERK-mediated Runx2 stabilization and acetylation. In conclusion, the FGF2-induced ERK MAP kinase strongly increased the Runx2 protein level through an increase in acetylation and a decrease in ubiquitination, and these processes require the phosphorylation of Runx2 Ser-301 residue.	[Park, Ok-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Park, Ok-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dent Res Inst, Program BK21, Seoul 110749, South Korea; [Kim, Hyun-Jung] Bone Res Inst BioRunx Co Ltd, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Ryoo, HM (corresponding author), Seoul Natl Univ, Sch Dent, Dept Mol Genet, 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Baek, Jeong-Hwa/A-8628-2012; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009	Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189	Korea Health 21 R&D Project, Ministry of Health and Welfare [A010252, A085021]; Korean Government (MOEHRD, Basic Research Promotion Fund) [KRF-2008-532-C00018]	Korea Health 21 R&D Project, Ministry of Health and Welfare; Korean Government (MOEHRD, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (A010252 and A085021), and by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund, KRF-2008-532-C00018).	Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frank RN, 2003, INVEST OPHTH VIS SCI, V44, P1; Fukuoka H, 2007, J ANAT, V211, P8, DOI 10.1111/j.1469-7580.2007.00739.x; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; Kaunisto A, 2009, CELL DEATH DIFFER, V16, P1215, DOI 10.1038/cdd.2009.35; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim HJ, 2006, J CELL PHYSIOL, V207, P114, DOI 10.1002/jcp.20552; Kim HJ, 2004, J CELL BIOCHEM, V91, P1239, DOI 10.1002/jcb.20038; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Li TF, 2004, EXP CELL RES, V299, P128, DOI 10.1016/j.yexcr.2004.05.025; Liang K, 1999, ENDOCRINOLOGY, V140, P5780; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Naganawa T, 2008, J CELL BIOCHEM, V103, P1975, DOI 10.1002/jcb.21589; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	56	84	85	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3568	3574		10.1074/jbc.M109.055053	http://dx.doi.org/10.1074/jbc.M109.055053			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007706	Green Published, hybrid			2022-12-25	WOS:000275254000007
J	Goh, JO; Tan, JC; Park, DC				Goh, Joshua O.; Tan, Jiat Chow; Park, Denise C.			Culture Modulates Eye-Movements to Visual Novelty	PLOS ONE			English	Article							OBJECT; ATTENTION; DISTRACTORS; CAPTURE; BINDING; CONTEXT; TASKS; AGE	Background: When viewing complex scenes, East Asians attend more to contexts whereas Westerners attend more to objects, reflecting cultural differences in holistic and analytic visual processing styles respectively. This eye-tracking study investigated more specific mechanisms and the robustness of these cultural biases in visual processing when salient changes in the objects and backgrounds occur in complex pictures. Methodology/Principal Findings: Chinese Singaporean (East Asian) and Caucasian US (Western) participants passively viewed pictures containing selectively changing objects and background scenes that strongly captured participants' attention in a data-driven manner. We found that although participants from both groups responded to object changes in the pictures, there was still evidence for cultural divergence in eye-movements. The number of object fixations in the US participants was more affected by object change than in the Singapore participants. Additionally, despite the picture manipulations, US participants consistently maintained longer durations for both object and background fixations, with eye-movements that generally remained within the focal objects. In contrast, Singapore participants had shorter fixation durations with eye-movements that alternated more between objects and backgrounds. Conclusions/Significance: The results demonstrate a robust cultural bias in visual processing even when external stimuli draw attention in an opposite manner to the cultural bias. These findings also extend previous studies by revealing more specific, but consistent, effects of culture on the different aspects of visual attention as measured by fixation duration, number of fixations, and saccades between objects and backgrounds.	[Goh, Joshua O.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Tan, Jiat Chow] Duke NUS Grad Med Sch, Cognit Neurosci Lab, Singapore, Singapore; [Park, Denise C.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA	University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore; University of Texas System; University of Texas Dallas	Goh, JO (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	jogoh2@uiuc.edu	GOH, JOSHUA/C-8063-2016	GOH, JOSHUA/0000-0001-7808-5452	NIH [R-37-AG006265-26, R-01-AG015047-09]; NATIONAL INSTITUTE ON AGING [R37AG006265, R01AG015047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant numbers R-37-AG006265-26 and R-01-AG015047-09 awarded to Denise Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2005, J EXP PSYCHOL GEN, V134, P207, DOI 10.1037/0096-3445.134.2.207; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Chee MWL, 2006, J COGNITIVE NEUROSCI, V18, P495, DOI 10.1162/jocn.2006.18.4.495; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Duchowski A.T., 2003, EYE TRACKING METHODO; Forster S, 2008, J EXP PSYCHOL-APPL, V14, P73, DOI 10.1037/1076-898X.14.1.73; Godijn R, 2008, VIS COGN, V16, P279, DOI 10.1080/13506280701437295; GOH JO, 2009, CULTURE SCULPTS PERC; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Gronau N, 2006, PSYCHON B REV, V13, P570, DOI 10.3758/BF03193964; Gutchess AH, 2006, COGN AFFECT BEHAV NE, V6, P102, DOI 10.3758/CABN.6.2.102; Hedden T, 2008, PSYCHOL SCI, V19, P12, DOI 10.1111/j.1467-9280.2008.02038.x; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; JENKINS LJ, 2009, SOC COGN AF IN PRESS; Ji LJ, 2004, J PERS SOC PSYCHOL, V87, P57, DOI 10.1037/0022-3514.87.1.57; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; MULLER HJ, 1991, J EXP PSYCHOL HUMAN, V17, P107, DOI 10.1037/0096-1523.17.1.107; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Neo G, 2006, PERCEPT PSYCHOPHYS, V68, P1286, DOI 10.3758/BF03193728; Nisbett R.E, 2003, GEOGRAPHY THOUGHT AS; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Potter MC, 2009, J EXP PSYCHOL HUMAN, V35, P28, DOI 10.1037/a0013624; Prinzmetal W, 2005, J EXP PSYCHOL GEN, V134, P73, DOI 10.1037/0096-3445.134.1.73; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Salvucci D.D., 2000, P EYE TRACKING RES A, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Schwarz W, 2008, J EXP PSYCHOL HUMAN, V34, P1337, DOI 10.1037/a0011060; Shomstein S, 2004, PSYCHON B REV, V11, P247, DOI 10.3758/BF03196566; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Yi DJ, 2006, BRAIN RES, V1080, P53, DOI 10.1016/j.brainres.2006.01.090	40	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8238	10.1371/journal.pone.0008238	http://dx.doi.org/10.1371/journal.pone.0008238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533OP	20016829	gold, Green Published, Green Submitted			2022-12-25	WOS:000272834000005
J	Sinclair, BJ; Gibbs, AG; Lee, WK; Rajamohan, A; Roberts, SP; Socha, JJ				Sinclair, Brent J.; Gibbs, Allen G.; Lee, Wah-Keat; Rajamohan, Arun; Roberts, Stephen P.; Socha, John J.			Synchrotron X-Ray Visualisation of Ice Formation in Insects during Lethal and Non-Lethal Freezing	PLOS ONE			English	Article							COLD ADAPTATION; TOLERANCE; LARVAE; DESICCATION; PHYSIOLOGY; SURVIVAL; DIPTERA; FLY	Although the biochemical correlates of freeze tolerance in insects are becoming well-known, the process of ice formation in vivo is subject to speculation. We used synchrotron x-rays to directly visualise real-time ice formation at 3.3 Hz in intact insects. We observed freezing in diapausing 3(rd) instar larvae of Chymomyza amoena (Diptera: Drosophilidae), which survive freezing if it occurs above -14 degrees C, and non-diapausing 3(rd) instar larvae of C. amoena and Drosophila melanogaster (Diptera: Drosophilidae), neither of which survive freezing. Freezing was readily observed in all larvae, and on one occasion the gut was seen to freeze separately from the haemocoel. There were no apparent qualitative differences in ice formation between freeze tolerant and non-freeze tolerant larvae. The time to complete freezing was positively related to temperature of nucleation (supercooling point, SCP), and SCP declined with decreasing body size, although this relationship was less strong in diapausing C. amoena. Nucleation generally occurred at a contact point with the thermocouple or chamber wall in non-diapausing larvae, but at random in diapausing larvae, suggesting that the latter have some control over ice nucleation. There were no apparent differences between freeze tolerant and non-freeze tolerant larvae in tracheal displacement or distension of the body during freezing, although there was markedly more distension in D. melanogaster than in C. amoena regardless of diapause state. We conclude that although control of ice nucleation appears to be important in freeze tolerant individuals, the physical ice formation process itself does not differ among larvae that can and cannot survive freezing. This suggests that a focus on cellular and biochemical mechanisms is appropriate and may reveal the primary adaptations allowing freeze tolerance in insects.	[Sinclair, Brent J.; Rajamohan, Arun] Univ Western Ontario, Dept Biol, London, ON, Canada; [Gibbs, Allen G.; Roberts, Stephen P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Lee, Wah-Keat] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Socha, John J.] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA	Western University (University of Western Ontario); Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; United States Department of Energy (DOE); Argonne National Laboratory; Virginia Polytechnic Institute & State University	Sinclair, BJ (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	bsincla7@uwo.ca	Gibbs, Allen/D-6968-2011; Lee, Wah-Keat/GRR-9734-2022; Gibbs, Allen G/G-6939-2014	Gibbs, Allen G/0000-0001-5233-2056; Rajamohan, Arun/0000-0003-1587-2891; Sinclair, Brent/0000-0002-8191-9910	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Center for Research Resources (NCRR) [RR022885]; NSERC; Canada Foundation for Innovation; Ontario Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR022885] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. This work was supported by grant number RR022885 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); an NSERC Discovery Grant and grants from the Canada Foundation for Innovation and the Ontario Research Fund to BJS. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the funding bodies or Argonne National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Atici O, 2003, PHYTOCHEMISTRY, V64, P1187, DOI 10.1016/S0031-9422(03)00420-5; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; BAND HT, 1982, EXPERIENTIA, V38, P1448, DOI 10.1007/BF01955762; BLOCK W, 1994, ACTA OECOL, V15, P13; Bundy JG, 2003, CRYOLETTERS, V24, P347; Colinet H, 2007, J THERM BIOL, V32, P374, DOI 10.1016/j.jtherbio.2007.03.005; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Izumi Y, 2006, J INSECT PHYSIOL, V52, P215, DOI 10.1016/j.jinsphys.2005.11.001; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Lee Wah-Keat, 2009, BMC Physiology, V9, P2, DOI 10.1186/1472-6793-9-2; Markow T.A., 2005, DROSOPHILA GUIDE SPE; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mietchen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003826; Palmer CM, 2004, BIOTECHNIQUES, V37, P212, DOI 10.2144/04372BI01; Philip BN, 2008, J EXP BIOL, V211, P1114, DOI 10.1242/jeb.016758; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; RING RA, 1982, COMP BIOCHEM PHYS A, V73, P605, DOI 10.1016/0300-9629(82)90267-5; ROJAS RR, 1992, CRYO-LETT, V13, P355; SALT R. W., 1963, CANADIAN ENTOMOL, V95, P1190; SALT RW, 1962, NATURE, V193, P1207, DOI 10.1038/1931207a0; SHIMADA K, 1988, CRYO-LETT, V9, P5; Sinclair BJ, 1997, J INSECT PHYSIOL, V43, P621, DOI 10.1016/S0022-1910(97)00018-8; Sinclair BJ, 2004, J EXP BIOL, V207, P1287, DOI 10.1242/jeb.00880; Sinclair BJ, 2003, BIOL REV, V78, P181, DOI 10.1017/S1464793102006024; Socha JJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-6; Somme L, 2000, CRYOLETTERS, V21, P289; Storey K.B., 2008, HYPOMETABOLISM ANIMA, P101; Storey KB, 1997, COMP BIOCHEM PHYS A, V117, P319, DOI 10.1016/S0300-9629(96)00270-8; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; STRACHAN LA, 2009, THESIS U W ONTARIO L; Takahashi H, 2008, CRYOBIOLOGY, V57, P75, DOI 10.1016/j.cryobiol.2008.04.004; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Worland MR, 2004, J INSECT PHYSIOL, V50, P225, DOI 10.1016/j.jinsphys.2003.12.001; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	37	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8259	10.1371/journal.pone.0008259	http://dx.doi.org/10.1371/journal.pone.0008259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011523	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300023
J	Kolaczkowski, B; Thornton, JW				Kolaczkowski, Bryan; Thornton, Joseph W.			Long-Branch Attraction Bias and Inconsistency in Bayesian Phylogenetics	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SUBSTITUTION RATES VARY; POSTERIOR PROBABILITIES; PARSIMONY; BOOTSTRAP; INFERENCE; MODEL; EVOLUTION; SUPPORT; TREES	Bayesian inference (BI) of phylogenetic relationships uses the same probabilistic models of evolution as its precursor maximum likelihood (ML), so BI has generally been assumed to share ML's desirable statistical properties, such as largely unbiased inference of topology given an accurate model and increasingly reliable inferences as the amount of data increases. Here we show that BI, unlike ML, is biased in favor of topologies that group long branches together, even when the true model and prior distributions of evolutionary parameters over a group of phylogenies are known. Using experimental simulation studies and numerical and mathematical analyses, we show that this bias becomes more severe as more data are analyzed, causing BI to infer an incorrect tree as the maximum a posteriori phylogeny with asymptotically high support as sequence length approaches infinity. BI's long branch attraction bias is relatively weak when the true model is simple but becomes pronounced when sequence sites evolve heterogeneously, even when this complexity is incorporated in the model. This bias-which is apparent under both controlled simulation conditions and in analyses of empirical sequence data-also makes BI less efficient and less robust to the use of an incorrect evolutionary model than ML. Surprisingly, BI's bias is caused by one of the method's stated advantages-that it incorporates uncertainty about branch lengths by integrating over a distribution of possible values instead of estimating them from the data, as ML does. Our findings suggest that trees inferred using BI should be interpreted with caution and that ML may be a more reliable framework for modern phylogenetic analysis.	[Kolaczkowski, Bryan; Thornton, Joseph W.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; Howard Hughes Medical Institute; University of Oregon	Kolaczkowski, B (corresponding author), Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022		Howard Hughes Medical Institute; National Science Foundation [DEB-0516530, IGERT DGE-9972830]; National Institutes of Health [NIH R01-GM62351]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062351] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Howard Hughes Medical Institute, National Science Foundation (DEB-0516530, IGERT DGE-9972830), National Institutes of Health (NIH R01-GM62351), and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2004, SUBJECTIVE PROBABILI; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Bruno WJ, 1999, MOL BIOL EVOL, V16, P564, DOI 10.1093/oxfordjournals.molbev.a026137; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Chang JT, 1996, MATH BIOSCI, V134, P189, DOI 10.1016/0025-5564(95)00172-7; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Edwards AWF, 1992, LIKELIHOOD; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; HILLIS DM, 1994, NATURE, V369, P363, DOI 10.1038/369363a0; Hillis DM, 1997, SCIENCE, V276, P218, DOI 10.1126/science.276.5310.218; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; HUELSENBECK JP, 1995, SYST BIOL, V17, P48; Inagaki Y, 2004, MOL BIOL EVOL, V21, P1340, DOI 10.1093/molbev/msh130; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Kolaczkowski B, 2008, MOL BIOL EVOL, V25, P1054, DOI 10.1093/molbev/msn042; Kolaczkowski B, 2007, MOL BIOL EVOL, V24, P2108, DOI 10.1093/molbev/msm141; Kolaczkowski B, 2006, MOL BIOL EVOL, V23, P1819, DOI 10.1093/molbev/msl059; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Lewis PO, 2001, TRENDS ECOL EVOL, V16, P30, DOI 10.1016/S0169-5347(00)02025-5; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Misawa K, 2003, J MOL EVOL, V57, pS290, DOI 10.1007/s00239-003-0039-7; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; PENNY D, 1992, TRENDS ECOL EVOL, V7, P73, DOI 10.1016/0169-5347(92)90244-6; Rogers JS, 1997, SYST BIOL, V46, P354, DOI 10.2307/2413629; Rogers JS, 2001, SYST BIOL, V50, P713, DOI 10.1080/106351501753328839; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmons MP, 2004, MOL BIOL EVOL, V21, P188, DOI 10.1093/molbev/msh014; Spencer M, 2005, MOL BIOL EVOL, V22, P1161, DOI 10.1093/molbev/msi123; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Susko E, 2008, SYST BIOL, V57, P602, DOI 10.1080/10635150802302468; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Taylor DJ, 2004, MOL BIOL EVOL, V21, P1534, DOI 10.1093/molbev/msh156; Yang Z, 2005, SYST BIOL, V54, P455, DOI 10.1080/10635150590945313; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yang ZZ, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P63	58	65	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e7891	10.1371/journal.pone.0007891	http://dx.doi.org/10.1371/journal.pone.0007891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011052	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829800001
J	Szafran, AT; Hartig, S; Sun, HY; Uray, IP; Szwarc, M; Shen, YQ; Mediwala, SN; Bell, J; McPhaul, MJ; Mancini, MA; Marcelli, M				Szafran, Adam T.; Hartig, Sean; Sun, Huiying; Uray, Ivan P.; Szwarc, Maria; Shen, Yuqing; Mediwala, Sanjay N.; Bell, Jennifer; McPhaul, Michael J.; Mancini, Michael A.; Marcelli, Marco			Androgen Receptor Mutations Associated with Androgen Insensitivity Syndrome: A High Content Analysis Approach Leading to Personalized Medicine	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; QUALITATIVE ABNORMALITY; ESTROGEN-RECEPTOR; SKIN FIBROBLASTS; GENE-EXPRESSION; RESISTANCE; COACTIVATOR; TRANSCRIPTION; SPECIFICITY; STABILITY	Androgen insensitivity syndrome (AIS) is a rare disease associated with inactivating mutations of AR that disrupt male sexual differentiation, and cause a spectrum of phenotypic abnormalities having as a common denominator loss of reproductive viability. No established treatment exists for these conditions, however there are sporadic reports of patients (or recapitulated mutations in cell lines) that respond to administration of supraphysiologic doses (or pulses) of testosterone or synthetic ligands. Here, we utilize a novel high content analysis (HCA) approach to study AR function at the single cell level in genital skin fibroblasts (GSF). We discuss in detail findings in GSF from three historical patients with AIS, which include identification of novel mechanisms of AR malfunction, and the potential ability to utilize HCA for personalized treatment of patients affected by this condition.	[Szafran, Adam T.; Hartig, Sean; Uray, Ivan P.; Szwarc, Maria; Mancini, Michael A.; Marcelli, Marco] Baylor Coll Med, Dept Mol & Cellular Biol & Med, Houston, TX 77030 USA; [Sun, Huiying; Shen, Yuqing; Mediwala, Sanjay N.; Marcelli, Marco] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Sun, Huiying; Shen, Yuqing; Mediwala, Sanjay N.; Marcelli, Marco] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bell, Jennifer] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [McPhaul, Michael J.] Univ Texas Southwestern Med Sch, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Szafran, AT (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol & Med, Houston, TX 77030 USA.	mancini@bcm.edu; marcelli@bcm.edu	McPhaul, Michael/AAC-7124-2020; marcelli, marco/AGR-6853-2022		Gilson-Logenbaugh Foundation; VA; Solvay Clinical Research; Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics;  [R01 DK-55622];  [U54 HD-07495];  [P30 CA125123];  [P30 DK56338]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK055622] Funding Source: NIH RePORTER	Gilson-Logenbaugh Foundation; VA(US Department of Veterans Affairs); Solvay Clinical Research(Solvay SA); Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Gilson-Logenbaugh Foundation (MAM and MM), VA Merit Award (MM), R01 DK-55622 (MAM), and the Solvay Clinical Research Award (SNM). Imaging resources were supported by U54 HD-07495 (O'Malley), P30 CA125123 (Osborne), P30 DK56338 (Estes), the Dan L. Duncan Cancer Center and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2000, J CLIN ENDOCR METAB, V85, P658, DOI 10.1210/jc.85.2.658; Amazit L, 2007, MOL CELL BIOL, V27, P6913, DOI 10.1128/MCB.01695-06; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; BEITEL LK, 1994, J CLIN INVEST, V94, P546, DOI 10.1172/JCI117368; Berno V, 2006, METHOD ENZYMOL, V414, P188, DOI 10.1016/s0076-6879(06)14011-2; Berno V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002286; Bevan CL, 1996, HUM MOL GENET, V5, P265, DOI 10.1093/hmg/5.2.265; Bouvattier C, 2002, J CLIN ENDOCR METAB, V87, P29, DOI 10.1210/jc.87.1.29; BROWN TR, 1982, J CLIN ENDOCR METAB, V55, P61, DOI 10.1210/jcem-55-1-61; DEBELLIS A, 1994, J CLIN ENDOCR METAB, V78, P513, DOI 10.1210/jc.78.3.513; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Georget V, 1998, J CLIN ENDOCR METAB, V83, P3597, DOI 10.1210/jc.83.10.3597; GRIFFIN JE, 1979, J CLIN INVEST, V64, P1624, DOI 10.1172/JCI109624; GRINO PB, 1989, J CLIN ENDOCR METAB, V68, P578, DOI 10.1210/jcem-68-3-578; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Holterhus PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r37; KEENAN BS, 1974, J CLIN ENDOCR METAB, V38, P1143, DOI 10.1210/jcem-38-6-1143; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Ledig S, 2005, HORM RES, V63, P263, DOI 10.1159/000086018; MARCELLI M, 1994, J CLIN INVEST, V94, P1642, DOI 10.1172/JCI117507; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Mazur T, 2005, ARCH SEX BEHAV, V34, P411, DOI 10.1007/s10508-005-4341-x; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; MCPHAUL MJ, 1992, J CLIN INVEST, V90, P2097, DOI 10.1172/JCI116093; Nazareth LV, 1999, MOL ENDOCRINOL, V13, P2065, DOI 10.1210/me.13.12.2065; PINSKY L, 1989, AM J MED GENET, V32, P100, DOI 10.1002/ajmg.1320320121; PINSKY L, 1992, CLIN INVEST MED, V15, P456; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Radmayr C, 1998, EUR UROL, V33, P222, DOI 10.1159/000019540; RISSTALPERS C, 1994, PEDIATR RES, V36, P227, DOI 10.1203/00006450-199408000-00015; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Szafran AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003605; SZAFRAN AT, 2008, P INT S BIOMED IMAGI, P320; VILLEGAS J, 2005, CURR PROTOC MOL BIOL, pCH28, DOI DOI 10.1002/0471142727.MB2803S71; Wang MH, 2005, BIOCHEM BIOPH RES CO, V335, P335, DOI 10.1016/j.bbrc.2005.07.077; Weidemann W, 1998, J CLIN ENDOCR METAB, V83, P1173, DOI 10.1210/jc.83.4.1173; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; [No title captured]	41	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8179	10.1371/journal.pone.0008179	http://dx.doi.org/10.1371/journal.pone.0008179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011049	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829800003
J	Teves, ME; Guidobaldi, HA; Unates, DR; Sanchez, R; Miska, W; Publicover, SJ; Garcia, AAM; Giojalas, LC				Teves, Maria E.; Guidobaldi, Hector A.; Unates, Diego R.; Sanchez, Raul; Miska, Werner; Publicover, Stephen J.; Garcia, Aduen A. Morales; Giojalas, Laura C.			Molecular Mechanism for Human Sperm Chemotaxis Mediated by Progesterone	PLOS ONE			English	Article							ADENYLYL-CYCLASE; HUMAN SPERMATOZOA; SIGNALING PATHWAY; PLASMA-MEMBRANE; CA2+ ENTRY; CHANNELS; CALCIUM; PHOSPHORYLATION; EXPRESSION; KINASE	Sperm chemotaxis is a chemical guiding mechanism that may orient spermatozoa to the egg surface. A picomolar concentration gradient of Progesterone ( P), the main steroidal component secreted by the cumulus cells that surround the egg, attracts human spermatozoa. In order to elucidate the molecular mechanism of sperm chemotaxis mediated by P, we combine the application of different strategies: pharmacological inhibition of signaling molecules, measurements of the concentrations of second messengers and activation of the chemotactic signaling. Our data implicate a number of classic signal transduction pathways in the response and provide a model for the sequence of events, where the tmAC-cAMP-PKA pathway is activated first, followed by protein tyrosine phosphorylation ( equatorial band and flagellum) and calcium mobilization (through IP3R and SOC channels), whereas the sGC-cGMP-PKG cascade, is activated later. These events lead to sperm orientation towards the source of the chemoattractant. The finding proposes a molecular mechanism which contributes to the understanding of the signal transduction pathway that takes place in a physiological process as chemotaxis.	[Teves, Maria E.; Guidobaldi, Hector A.; Unates, Diego R.; Giojalas, Laura C.] Univ Nacl Cordoba, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina; [Sanchez, Raul] Univ La Frontera, Dept Ciencias Preclin, Ctr Biotecnol Reprod, Temuco, Chile; [Miska, Werner] Univ Giessen, Ctr Dermatol & Androl, Giessen, Germany; [Publicover, Stephen J.; Garcia, Aduen A. Morales] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	National University of Cordoba; Universidad de La Frontera; Justus Liebig University Giessen; University of Birmingham	Teves, ME (corresponding author), Univ Nacl Cordoba, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina.	lcgiojalas@com.uncor.edu	Guidobaldi, Héctor Alejandro/K-6724-2017; Teves, Maria/AAJ-9523-2020; Sanchez, Raul/ABH-3868-2020; Publicover, Steve J/E-7970-2018; Sanchez, Raul/L-1224-2016	Guidobaldi, Héctor Alejandro/0000-0002-5033-2981; Teves, Maria/0000-0001-7035-2202; Sanchez, Raul/0000-0003-4853-4282; Giojalas, Laura/0000-0002-1036-1251	SECYT-UNC; CONICET; FONCYT (Argentina); MINCYT (Argentina); BMBF (Germany); Royal Society (UK)	SECYT-UNC(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT (Argentina)(FONCyT); MINCYT (Argentina); BMBF (Germany)(Federal Ministry of Education & Research (BMBF)); Royal Society (UK)(Royal Society of London)	This work was supported by the following science promotion agencies: SECYT-UNC, CONICET and FONCYT (Argentina); MINCYT (Argentina); BMBF (Germany) and Royal Society (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Guidobaldi HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003040; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Baxendale RW, 2003, MOL REPROD DEV, V66, P181, DOI 10.1002/mrd.10344; Bedu-Addo K, 2005, MOL HUM REPROD, V11, P683, DOI 10.1093/molehr/gah226; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; Beltran C, 2007, BIOCHEM BIOPH RES CO, V358, P1128, DOI 10.1016/j.bbrc.2007.05.061; BRANHAM MT, 2009, J BIOL CHEM; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buffone MG, 2004, HUM REPROD, V19, P139, DOI 10.1093/humrep/deh040; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Felix R, 2005, REPRODUCTION, V129, P251, DOI 10.1530/rep.1.00478; Fellner SK, 2008, AM J PHYSIOL-RENAL, V294, pF212, DOI 10.1152/ajprenal.00244.2007; Fodor AA, 1997, J GEN PHYSIOL, V110, P591, DOI 10.1085/jgp.110.5.591; Furlong LI, 2000, BIOL REPROD, V62, P606, DOI 10.1095/biolreprod62.3.606; FURUYA S, 1992, J ASSIST REPROD GEN, V9, P391, DOI 10.1007/BF01203965; GO KJ, 1985, BIOL REPROD, V32, P145, DOI 10.1095/biolreprod32.1.145; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Harrison RAP, 2003, REPROD DOMEST ANIM, V38, P102, DOI 10.1046/j.1439-0531.2003.00400.x; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Khorasani AM, 2000, J ANDROL, V21, P586; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; Kirkman-Brown JC, 2003, DEV BIOL, V259, P71, DOI 10.1016/S0012-1606(03)00137-4; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Machado-Oliveira G, 2008, DEVELOPMENT, V135, P3677, DOI 10.1242/dev.024521; Miraglia E, 2007, FERTIL STERIL, V87, P1059, DOI 10.1016/j.fertnstert.2006.07.1540; Munck S, 2004, EUR J NEUROSCI, V19, P791, DOI 10.1111/j.0953-816X.2004.03118.x; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parinaud J, 1996, J CLIN ENDOCR METAB, V81, P1357, DOI 10.1210/jc.81.4.1357; PETERSON RN, 1980, J CELL SCI, V43, P93; Petrunkina AM, 2003, J ANDROL, V24, P423; Poutrain P, 2009, J EXP BOT, V60, P1387, DOI 10.1093/jxb/erp017; Revelli A, 2002, ENDOCR REV, V23, P484, DOI 10.1210/er.2001-0020; Revelli A, 2001, BIOL REPROD, V64, P1708, DOI 10.1095/biolreprod64.6.1708; Sakkas D, 2003, BIOL REPROD, V68, P1463, DOI 10.1095/biolreprod.102.011023; Shiba K, 2008, P NATL ACAD SCI USA, V105, P19312, DOI 10.1073/pnas.0808580105; Shimizu H, 2008, P NATL ACAD SCI USA, V105, P11998, DOI 10.1073/pnas.0802175105; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Tubbs C, 2008, STEROIDS, V73, P935, DOI 10.1016/j.steroids.2007.12.022; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHO, 1999, WHO LAB MAN EX HUM S, P1; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Yoshida M, 2003, P NATL ACAD SCI USA, V100, P149, DOI 10.1073/pnas.0135565100	61	113	118	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8211	10.1371/journal.pone.0008211	http://dx.doi.org/10.1371/journal.pone.0008211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997608	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829700008
J	Chen, SH; Su, SY; Lo, CZ; Chen, KH; Huang, TJ; Kuo, BH; Lin, CY				Chen, Shu-Hwa; Su, Sheng-Yao; Lo, Chen-Zen; Chen, Kuei-Hsien; Huang, Teng-Jay; Kuo, Bo-Han; Lin, Chung-Yen			PALM: A Paralleled and Integrated Framework for Phylogenetic Inference with Automatic Likelihood Model Selectors	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; PROTEIN EVOLUTION; RECONSTRUCTION; PROGRAM; DIALIGN; SPACE; DNA	Background: Selecting an appropriate substitution model and deriving a tree topology for a given sequence set are essential in phylogenetic analysis. However, such time consuming, computationally intensive tasks rely on knowledge of substitution model theories and related expertise to run through all possible combinations of several separate programs. To ensure a thorough and efficient analysis and avert tedious manipulations of various programs, this work presents an intuitive framework, the phylogenetic reconstruction with automatic likelihood model selectors (PALM), with convincing, updated algorithms and a best-fit model selection mechanism for seamless phylogenetic analysis. Methodology: As an integrated framework of ClustalW, PhyML, MODELTEST, ProtTest, and several in-house programs, PALM evaluates the fitness of 56 substitution models for nucleotide sequences and 112 substitution models for protein sequences with scores in various criteria. The input for PALM can be either sequences in FASTA format or a sequence alignment file in PHYLIP format. To accelerate the computing of maximum likelihood and bootstrapping, this work integrates MPICH2/PhyML, PalmMonitor and Palm job controller across several machines with multiple processors and adopts the task parallelism approach. Moreover, an intuitive and interactive web component, PalmTree, is developed for displaying and operating the output tree with options of tree rooting, branches swapping, viewing the branch length values, and viewing bootstrapping score, as well as removing nodes to restart analysis iteratively. Significance: The workflow of PALM is straightforward and coherent. Via a succinct, user-friendly interface, researchers unfamiliar with phylogenetic analysis can easily use this server to submit sequences, retrieve the output, and re-submit a job based on a previous result if some sequences are to be deleted or added for phylogenetic reconstruction. PALM results in an inference of phylogenetic relationship not only by vanquishing the computation difficulty of ML methods but also providing statistic methods for model selection and bootstrapping. The proposed approach can reduce calculation time, which is particularly relevant when querying a large data set. PALM can be accessed online at http://palm.iis.sinica.edu.tw.	[Chen, Shu-Hwa; Su, Sheng-Yao; Lo, Chen-Zen; Chen, Kuei-Hsien; Huang, Teng-Jay; Kuo, Bo-Han; Lin, Chung-Yen] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Lin, Chung-Yen] Natl Hlth Res Inst, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan; [Lin, Chung-Yen] Natl Taiwan Univ, Coll Life Sci, Inst Fishery Sci, Taipei 10764, Taiwan; [Lin, Chung-Yen] Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chen, SH (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	cylin@iis.sinica.edu.tw	Lin, Chung-Yen/AAQ-3833-2021	Lin, Chung-Yen/0000-0002-4733-9488	National Science Council (NSC)/National Research Program of Genomic Medicine (NRPGM), Taiwan [NSC 98-3112-B-400-010, NSC 98-2221-E-001-018, NSC 98-2811-001-014]	National Science Council (NSC)/National Research Program of Genomic Medicine (NRPGM), Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported by National Science Council (NSC)/National Research Program of Genomic Medicine (NRPGM), Taiwan, for financially supporting this research under Contract No. NSC 98-3112-B-400-010, NSC 98-2221-E-001-018 and NSC 98-2811-001-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Brauer MJ, 2002, MOL BIOL EVOL, V19, P1717, DOI 10.1093/oxfordjournals.molbev.a003994; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Essoussi N, 2008, BIOINFORMATION, V2, P452; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Felsenstein J, 2001, SYST BIOL, V50, P465, DOI 10.1080/106351501750435022; GILBERTD R, READSEQ; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keane TM, 2007, NUCLEIC ACIDS RES, V35, pW33, DOI 10.1093/nar/gkm359; Keane TM, 2005, BIOINFORMATICS, V21, P969, DOI 10.1093/bioinformatics/bti100; Lin CY, 2005, NUCLEIC ACIDS RES, V33, pW553, DOI 10.1093/nar/gki494; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; MOUNT DW, 2008, CHOOSING METHOD PHYL; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Robinson DM, 2003, MOL BIOL EVOL, V20, P1692, DOI 10.1093/molbev/msg184; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Tao N, 2005, FINDMODEL TOOL SELEC; Tarraga J, 2007, NUCLEIC ACIDS RES, V35, pW38, DOI 10.1093/nar/gkm224; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; Thorne JL, 2007, CURR OPIN STRUC BIOL, V17, P337, DOI 10.1016/j.sbi.2007.05.006; Vinh LS, 2004, MOL BIOL EVOL, V21, P1565, DOI 10.1093/molbev/msh176; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	37	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8116	10.1371/journal.pone.0008116	http://dx.doi.org/10.1371/journal.pone.0008116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997614	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829500007
J	Worthley, DL; Whitehall, VLJ; Buttenshaw, RL; Irahara, N; Greco, SA; Ramsnes, I; Mallitt, KA; Le Leu, RK; Winter, J; Hu, Y; Ogino, S; Young, GP; Leggett, BA				Worthley, D. L.; Whitehall, V. L. J.; Buttenshaw, R. L.; Irahara, N.; Greco, S. A.; Ramsnes, I.; Mallitt, K-A; Le Leu, R. K.; Winter, J.; Hu, Y.; Ogino, S.; Young, G. P.; Leggett, B. A.			DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer	ONCOGENE			English	Article						DNA methylation; epigenetics; colorectal cancer; carcinogenesis	NORMAL COLONIC-MUCOSA; MICROSATELLITE INSTABILITY; ULCERATIVE-COLITIS; BRAF MUTATION; CHROMOSOMAL INSTABILITY; PROMOTER METHYLATION; SERRATED ADENOMAS; MOLECULAR-ORIGINS; PHENOTYPE; POLYPS	There are two major molecular pathways to sporadic colorectal cancer, the chromosomal instability (CIN) and the CpG island methylator phenotype (CIMP) pathways. This study recruited 166 patients undergoing colonoscopy. Biopsy samples were collected from the cecum, transverse colon, sigmoid colon and rectum. DNA methylation was quantified at 'type A' (ESR1, GATA5, HIC1, HPP1, SFRP1) and 'type C' markers (MGMT, MLH1, CDKN2A, MINT2, MINT31, IGF2, CACNA1G, NEU-ROG1, SOCS1, RUNX3), and LINE-1. 'Type A' genes are frequently methylated in normal and neoplastic tissues, proportional to tissue age. 'Type C' methylation is more specific for neoplasia. The last five 'type C' markers comprise a CIMP panel. The mean 'type A' and CIMP-panel methylation Z-scores were calculated. In all, 88 patients had adenomatous lesions, 32 had proximal serrated polyps (PSPs) and 50 were normal. Most 'type A' genes showed direct correlations between methylation and age (ESR1, rho = 0.66, P < 0.0001), with higher methylation distally (ESR1, P < 0.0001). On multivariate analysis, 'type A' methylation was inversely associated with colorectal adenomas (odds ratio 0.23, P < 0.001), the precursor to CIN cancers. CIMP-panel methylation was significantly associated with advanced PSPs (odds ratio = 5.1, P = 0.009), the precursor to CIMP cancers. DNA methylation in normal mucosa varied with age and region and was associated with pathway-specific pathology. In the future, the colorectal field could yield important information and potentially inform clinical practice. Oncogene (2010) 29, 1653-1662; doi:10.1038/onc.2009.449; published online 7 December 2009	[Worthley, D. L.; Whitehall, V. L. J.; Buttenshaw, R. L.; Greco, S. A.; Ramsnes, I.; Leggett, B. A.] Queensland Inst Med Res, Bancroft Ctr, Conjoint Gastroenterol Lab, Herston, Qld 4029, Australia; [Worthley, D. L.; Whitehall, V. L. J.; Buttenshaw, R. L.; Greco, S. A.; Ramsnes, I.; Leggett, B. A.] Royal Brisbane & Womens Hosp, Res Fdn Clin Res Ctr, Brisbane, Qld, Australia; [Irahara, N.; Ogino, S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Mallitt, K-A] Queensland Inst Med Res, Stat Unit, Herston, Qld 4029, Australia; [Le Leu, R. K.; Winter, J.; Hu, Y.; Young, G. P.] Flinders Univ S Australia, Flinders Ctr Canc Prevent & Control, Adelaide, SA, Australia; [Ogino, S.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, S.] Harvard Univ, Sch Med, Boston, MA USA	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; QIMR Berghofer Medical Research Institute; Flinders University South Australia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Worthley, DL (corresponding author), Queensland Inst Med Res, Bancroft Ctr, Conjoint Gastroenterol Lab, Rm H07,PO RBH, Herston, Qld 4029, Australia.	daniel.worthley@uqconnect.edu.au	Mallitt, Kylie-Ann/E-2240-2011; Whitehall, Vicki L/B-6262-2013; Leggett, Barbara A/D-3579-2011; Mallitt, Kylie-Ann/GPF-9322-2022; Le Leu, Richard K/H-4555-2013; Whitehall, Vicki/E-5414-2019	Mallitt, Kylie-Ann/0000-0002-5722-7287; Whitehall, Vicki L/0000-0002-8285-2391; Mallitt, Kylie-Ann/0000-0002-5722-7287; Le Leu, Richard K/0000-0003-4704-4943; Winter, Jean/0000-0002-2041-8602; Leggett, Barbara/0000-0003-2062-7380; Young, Graeme/0000-0001-9458-8383	National Health and Medical Research Council [442965]; Gastroenterological Society of Australia; Royal Australasian College of Physicians Cottrell Fellowship; Royal Brisbane and Women's Hospital Foundation; Queensland Smart State PhD award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Gastroenterological Society of Australia; Royal Australasian College of Physicians Cottrell Fellowship; Royal Brisbane and Women's Hospital Foundation; Queensland Smart State PhD award	We thank the gastroenterologists and gastroenterology nurses who helped to collect samples. This study was funded by a National Health and Medical Research Council project grant (442965), a Gastroenterological Society of Australia post-graduate medical scholarship (DLW), the Royal Australasian College of Physicians Cottrell Fellowship (DLW), a Royal Brisbane and Women's Hospital Foundation Research Grant (VLW, DLW, BAL) and a Queensland Smart State PhD award (DLW).	Ahuja N, 1998, CANCER RES, V58, P5489; Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Al-Ghnaniem R, 2007, AM J CLIN NUTR, V86, P1064, DOI 10.1093/ajcn/86.4.1064; Ally MS, 2009, CANCER EPIDEM BIOMAR, V18, P922, DOI 10.1158/1055-9965.EPI-08-0703; Australian Cancer Network Colorectal Cancer Guidelines Revision Committee, 2005, GUID PREV EARL DET M; Belshaw NJ, 2008, BRIT J CANCER, V99, P136, DOI 10.1038/sj.bjc.6604432; Botteri E, 2008, GASTROENTEROLOGY, V134, P388, DOI 10.1053/j.gastro.2007.11.007; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; East JE, 2008, GASTROENTEROL CLIN N, V37, P25, DOI 10.1016/j.gtc.2007.12.014; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Giovannucci E, 2005, JNCI-J NATL CANCER I, V97, P1317, DOI 10.1093/jnci/dji305; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Horii J, 2008, CLIN BIOCHEM, V41, P1440, DOI 10.1016/j.clinbiochem.2008.08.089; Hornsby PJ, 2007, J CLIN ONCOL, V25, P1852, DOI 10.1200/JCO.2006.10.3101; IRAHARA N, 2009, J MOL DIAGN IN PRESS; Ishikawa F, 2003, CANCER SCI, V94, P944, DOI 10.1111/j.1349-7006.2003.tb01382.x; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JPJ, 2001, CANCER RES, V61, P3573; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kim JY, 2005, P NATL ACAD SCI USA, V102, P17739, DOI 10.1073/pnas.0503976102; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Nakagawa H, 2001, CANCER RES, V61, P6991; Nuovo GJ, 2006, DIAGN MOL PATHOL, V15, P17, DOI 10.1097/00019606-200603000-00003; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Preston SL, 2003, CANCER RES, V63, P3819; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Sandborn WJ, 1997, ANN INTERN MED, V126, P364, DOI 10.7326/0003-4819-126-5-199703010-00004; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shen L, 2007, CLIN CANCER RES, V13, P6093, DOI 10.1158/1078-0432.CCR-07-1011; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tycko B, 2003, ANN NY ACAD SCI, V983, P43, DOI 10.1111/j.1749-6632.2003.tb05961.x; VANMUNSTER IP, 1994, DIGEST DIS SCI, V39, P834, DOI 10.1007/BF02087431; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Ye CZ, 2006, ONCOL REP, V16, P429; Young J, 2001, P NATL ACAD SCI USA, V98, P265, DOI 10.1073/pnas.011415298	57	85	92	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1653	1662		10.1038/onc.2009.449	http://dx.doi.org/10.1038/onc.2009.449			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	19966864				2022-12-25	WOS:000275694700010
J	Chinen, M; Morita, M; Fukumura, K; Tani, T				Chinen, Madoka; Morita, Misato; Fukumura, Kazuhiro; Tani, Tokio			Involvement of the Spliceosomal U4 Small Nuclear RNA in Heterochromatic Gene Silencing at Fission Yeast Centromeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; SPLICING MUTANTS; SACCHAROMYCES-CEREVISIAE; LYSINE-9 METHYLATION; HISTONE H3; CELL-CYCLE; TRI-SNRNP; DOMAINS; PROTEIN	prp13-1 is one of the mutants isolated in a screen for defective pre-mRNA splicing at a nonpermissive temperature in fission yeast Schizosaccharomyces pombe. We cloned the prp13(+) gene and found that it encodes U4 small nuclear RNA (snRNA) involved in the assembly of the spliceosome. The prp13-1 mutant produced elongated cells, a phenotype similar to cell division cycle mutants, and displays a high incidence of lagging chromosomes on anaphase spindles. The mutant is hypersensitive to the microtubule-destabilizing drug thiabendazole, supporting that prp13-1 has a defect in chromosomal segregation. We found that the prp13-1 mutation resulted in expression of the ura4(+) gene inserted in the pericentromeric heterochromatin region and reduced recruitment of the heterochromatin protein Swi6p to that region, indicating defects in the formation of pericentromeric heterochromatin, which is essential for the segregation of chromosomes, in prp13-1. The formation of centromeric heterochromatin is induced by the RNA interference (RNAi) system in S. pombe. Inprp13-1, the processing of centromeric noncoding RNAs to siRNAs, which direct the heterochromatin formation, was impaired and unprocessed noncoding RNAs were accumulated. These results suggest that U4 snRNA is required for the RNAi-directed heterochromatic gene silencing at the centromeres. In relation to the linkage between the spliceosomal U4 snRNA and the RNAi-directed formation of heterochromatin, we identified a mRNA-type intron in the centromeric noncoding RNAs. We propose a model in which the assembly of the spliceosome or a sub-spliceosome complex on the intron-containing centromeric noncoding RNAs facilitates the RNAi-directed formation of heterochromatin at centromeres, through interaction with the RNA-directed RNA polymerase complex.	[Chinen, Madoka; Morita, Misato; Fukumura, Kazuhiro; Tani, Tokio] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan	Kumamoto University	Tani, T (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan.	ttani@sci.kumamoto-u.ac.jp		Fukumura, Kazuhiro/0000-0002-3491-4500	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science Research Fellowships for Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. T.) and the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to M. C.).	Alfa C., 1993, EXPT FISSION YEAST; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Beales M, 2000, YEAST, V16, P1001, DOI 10.1002/1097-0061(200008)16:11<1001::AID-YEA605>3.0.CO;2-6; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Burge CB, 1999, RNA WORLD, P525; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; HU J, 1995, MOL CELL BIOL, V15, P1274; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; LOCKHART SR, 1994, MOL CELL BIOL, V14, P3623, DOI 10.1128/MCB.14.6.3623; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Romfo CM, 1999, RNA, V5, P49, DOI 10.1017/S1355838299981323; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Weidenhammer EM, 1997, MOL CELL BIOL, V17, P3580, DOI 10.1128/MCB.17.7.3580; WERSIG C, 1990, NUCLEIC ACIDS RES, V18, P6223, DOI 10.1093/nar/18.21.6223; White SA, 2008, CURR TOP MICROBIOL, V320, P157	39	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5630	5638		10.1074/jbc.M109.074393	http://dx.doi.org/10.1074/jbc.M109.074393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018856	Green Published, hybrid			2022-12-25	WOS:000275327200055
J	Matsuda, M; Hoshino, T; Yamashita, Y; Tanaka, K; Maji, D; Sato, K; Adachi, H; Sobue, G; Ihn, H; Funasaka, Y; Mizushima, T				Matsuda, Minoru; Hoshino, Tatsuya; Yamashita, Yasuhiro; Tanaka, Ken-ichiro; Maji, Daisuke; Sato, Keizo; Adachi, Hiroaki; Sobue, Gen; Ihn, Hironobu; Funasaka, Yoko; Mizushima, Tohru			Prevention of UVB Radiation-induced Epidermal Damage by Expression of Heat Shock Protein 70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INDUCED GASTRIC-LESIONS; BASE EXCISION-REPAIR; ULTRAVIOLET-B LIGHT; HUMAN SKIN; IN-VIVO; RECEPTOR ACTIVATION; LOCAL HYPERTHERMIA; INDUCED APOPTOSIS; GENETIC-EVIDENCE	Irradiation with UV light, especially UVB, causes epidermal damage via the induction of apoptosis, inflammatory responses, and DNA damage. Various stressors, including UV light, induce heat shock proteins (HSPs) and the induction, particularly that of HSP70, provides cellular resistance to such stressors. The anti-inflammatory activity of HSP70, such as its inhibition of nuclear factor kappa B (NF-kappa B), was recently revealed. These in vitro results suggest that HSP70 protects against UVB-induced epidermal damage. Here we tested this idea by using transgenic mice expressing HSP70 and cultured keratinocytes. Irradiation of wild-type mice with UVB caused epidermal damage such as induction of apoptosis, which was suppressed in transgenic mice expressing HSP70. UVB-induced apoptosis in cultured keratinocytes was suppressed by overexpression of HSP70. Irradiation of wild-type mice with UVB decreased the cutaneous level of I kappa B-alpha (an inhibitor of NF-kappa B) and increased the infiltration of leukocytes and levels of pro-inflammatory cytokines and chemokines in the epidermis. These inflammatory responses were suppressed in transgenic mice expressing HSP70. In vitro, the overexpression of HSP70 suppressed the expression of pro-inflammatory cytokines and chemokines and increased the level of I kappa B-alpha in keratinocytes irradiated with UVB. UVB induced an increase in cutaneous levels of cyclobutane pyrimidine dimers and 8-hydroxy-2'-deoxyguanosine, both of which were suppressed in transgenic mice expressing HSP70. This study provides genetic evidence that HSP70 protects the epidermis from UVB-induced radiation damage. The findings here also suggest that the protective action of HSP70 is mediated by anti-apoptotic, anti-inflammatory, and anti-DNA damage effects.	[Matsuda, Minoru; Hoshino, Tatsuya; Yamashita, Yasuhiro; Tanaka, Ken-ichiro; Sato, Keizo; Ihn, Hironobu; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Maji, Daisuke] Saishunkan Pharmaceut Co Ltd, Kumamoto 8612201, Japan; [Funasaka, Yoko] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Adachi, Hiroaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Kumamoto University; Kobe University; Nagoya University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Hon Machi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Tanaka, Ken-ichiro/J-8557-2013; Adachi, Hiroaki/AAM-7812-2020	Adachi, Hiroaki/0000-0002-9302-4663	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Health, Labour, and Welfare of Japan, as well as the Japan Science and Technology Agency, grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Bases R, 2006, CELL STRESS CHAPERON, V11, P240, DOI 10.1379/CSC-185R.1; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNET S, 1989, MUTAT RES, V219, P217, DOI 10.1016/0921-8734(89)90003-9; Budiyanto A, 2000, CARCINOGENESIS, V21, P2085, DOI 10.1093/carcin/21.11.2085; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; Guo SH, 2007, CELL STRESS CHAPERON, V12, P245, DOI 10.1379/CSC-265.1; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Ishihara T, 2009, J PHARMACOL EXP THER, V328, P152, DOI 10.1124/jpet.108.144451; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jantschitsch C, 2003, PHOTOCH PHOTOBIO SCI, V2, P899, DOI 10.1039/b301253k; Jonak C., 2006, International Journal of Cosmetic Science, V28, P233, DOI 10.1111/j.1467-2494.2006.00327.x; KANE KS, 1995, J INVEST DERMATOL, V104, P62, DOI 10.1111/1523-1747.ep12613497; Kenny MK, 2001, J BIOL CHEM, V276, P9532, DOI 10.1074/jbc.M009297200; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; MAYTIN EV, 1994, J INVEST DERMATOL, V103, P547, DOI 10.1111/1523-1747.ep12396274; Mendez F, 2003, CELL STRESS CHAPERON, V8, P153, DOI 10.1379/1466-1268(2003)008<0153:HSPSOT>2.0.CO;2; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morris SD, 2002, CLIN EXP DERMATOL, V27, P220, DOI 10.1046/j.1365-2230.2002.01012.x; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Ohkawara T, 2005, SCAND J GASTROENTERO, V40, P1049, DOI 10.1080/00365520510023161; Ohkawara T, 2006, INT J MOL MED, V17, P229; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Sato K, 2002, FASEB J, V16, P1713, DOI 10.1096/fj.02-0331com; SATO K, 1992, J BIOL CHEM, V267, P25371; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Takashima A, 1996, PHOTOCHEM PHOTOBIOL, V63, P397, DOI 10.1111/j.1751-1097.1996.tb03054.x; Tanaka K, 2005, J PHARMACOL EXP THER, V315, P624, DOI 10.1124/jpet.105.088674; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; TRAUTINGER F, 1993, J INVEST DERMATOL, V101, P334, DOI 10.1111/1523-1747.ep12365491; Trautinger F, 1996, J INVEST DERMATOL, V107, P442, DOI 10.1111/1523-1747.ep12365498; TRAUTINGER F, 1995, J INVEST DERMATOL, V105, P160, DOI 10.1111/1523-1747.ep12317003; Trautinger F, 1999, EXP DERMATOL, V8, P187, DOI 10.1111/j.1600-0625.1999.tb00369.x; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Wilson N, 2000, J CUTAN PATHOL, V27, P176, DOI 10.1034/j.1600-0560.2000.027004176.x; Zhou XW, 1998, J INVEST DERMATOL, V111, P194, DOI 10.1046/j.1523-1747.1998.00266.x; Zou Y, 1998, J BIOL CHEM, V273, P12887, DOI 10.1074/jbc.273.21.12887; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	57	55	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5848	5858		10.1074/jbc.M109.063453	http://dx.doi.org/10.1074/jbc.M109.063453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018843	Green Published, hybrid			2022-12-25	WOS:000275327200075
J	Rodionov, RN; Murry, DJ; Vaulman, SF; Stevens, JW; Lentz, SR				Rodionov, Roman N.; Murry, Daryl J.; Vaulman, Sarah F.; Stevens, Jeff W.; Lentz, Steven R.			Human Alanine-Glyoxylate Aminotransferase 2 Lowers Asymmetric Dimethylarginine and Protects from Inhibition of Nitric Oxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY HYPEROXALURIA TYPE-1; RAT-KIDNEY; DIMETHYLAMINOHYDROLASE DDAH; SYNTHASE PATHWAY; HEPATIC ALANINE; MITOCHONDRIA; NG,NG-DIMETHYLARGININE; PURIFICATION; HYPERTENSION; METABOLISM	Elevated blood concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric-oxide (NO) synthase, are found in association with diabetes, hypertension, congestive heart failure, and atherosclerosis. ADMA levels are controlled by dimethylarginine dimethylaminohydrolases (DDAHs), cytosolic enzymes that hydrolyze ADMA to citrulline and dimethylamine. ADMA also has been proposed to be regulated through an alternative pathway by alanine-glyoxylate aminotransferase 2 (AGXT2), a mitochondrial aminotransferase expressed primarily in the kidney. The goal of this study was to define the subcellular localization of human AGXT2 and test the hypothesis that overexpression of human AGXT2 protects from ADMA-induced inhibition in nitric oxide (NO) production. AGXT2 was cloned from human kidney cDNA and overexpressed in COS-7 cells and human umbilical vein endothelial cells with a C-terminal FLAG epitope tag. Mitochondrial localization of human AGXT2 was demonstrated by confocal microscopy and a 41-amino acid N-terminal mitochondrial cleavage sequence was delineated by N-terminal sequencing of the mature protein. Overexpression of human AGXT2 in the liver of C57BL/6 mice using an adenoviral expression vector produced significant decreases in ADMA levels in plasma and liver. Overexpression of human AGXT2 also protected endothelial cells from ADMA-mediated inhibition of NO production. We conclude that mitochondrially localized human AGXT2 is able to effectively metabolize ADMA in vivo resulting in decreased ADMA levels and improved endothelial NO production.	[Rodionov, Roman N.; Vaulman, Sarah F.; Stevens, Jeff W.; Lentz, Steven R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Murry, Daryl J.] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Rodionov, Roman N.] Tech Univ Dresden, Univ Ctr Vasc Med, Univ Hosp Carl Gustav Carus, Div Angiol,Dept Med 3, D-01307 Dresden, Germany	University of Iowa; University of Iowa; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Lentz, SR (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	steven-lentz@uiowa.edu	Rodionov, Roman/E-1476-2012	Lentz, Steven/0000-0002-8885-4718	National Institutes of Health [HL63943, NS24621]; Office of Research and Development, United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63943 and NS24621. This work was also supported by the Office of Research and Development, United States Department of Veterans Affairs.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Boger RH, 2005, VASC MED, V10, pS1, DOI 10.1191/1358863xvm594ed; Cooper AJL, 2003, BIOCHEM J, V376, P169, DOI 10.1042/BJ20030988; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DANPURE CJ, 1989, J CELL BIOL, V108, P1345, DOI 10.1083/jcb.108.4.1345; Dayal S, 2008, AM J PHYSIOL-HEART C, V295, pH816, DOI 10.1152/ajpheart.01348.2007; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; Hartzoulakis B, 2007, BIOORG MED CHEM LETT, V17, P3953, DOI 10.1016/j.bmcl.2007.04.095; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; Jacobi J, 2008, AM J PHYSIOL-HEART C, V294, pH1058, DOI 10.1152/ajpheart.01103.2007; Kaschnitz R M, 1979, Methods Enzymol, V55, P79; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; KIMOTO M, 1995, J BIOCHEM-TOKYO, V117, P237, DOI 10.1093/jb/117.2.237; KONTANI Y, 1993, BIOCHIM BIOPHYS ACTA, V1156, P161, DOI 10.1016/0304-4165(93)90131-Q; LEE ISM, 1995, J BIOCHEM, V117, P856, DOI 10.1093/oxfordjournals.jbchem.a124787; Lee ISM, 1999, NEPHRON, V83, P184, DOI 10.1159/000045507; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Matsuguma K, 2006, J AM SOC NEPHROL, V17, P2176, DOI 10.1681/ASN.2005121379; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NOGUCHI T, 1978, BIOCHEM J, V169, P113, DOI 10.1042/bj1690113; OGAWA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P526, DOI 10.1016/0003-9861(87)90060-9; OGAWA T, 1990, J BIOL CHEM, V265, P20938; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Rodionov RN, 2008, ARTERIOSCL THROM VAS, V28, P1031, DOI 10.1161/ATVBAHA.108.164830; ROWSELL EV, 1972, BIOCHEM J, V127, P155, DOI 10.1042/bj1270155; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; TAKADA Y, 1982, COMP BIOCHEM PHYS B, V72, P597, DOI 10.1016/0305-0491(82)90512-0; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vasquez EC, 1998, EXP NEUROL, V154, P353, DOI 10.1006/exnr.1998.6917; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	38	90	96	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5385	5391		10.1074/jbc.M109.091280	http://dx.doi.org/10.1074/jbc.M109.091280			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018850	Green Published, hybrid			2022-12-25	WOS:000275327200032
J	Chan, HL; Chou, HC; Duran, M; Gruenewald, J; Waterfield, MD; Ridley, A; Timms, JF				Chan, Hong-Lin; Chou, Hsiu-Chuan; Duran, MaCarmen; Gruenewald, Jana; Waterfield, Michael D.; Ridley, Anne; Timms, John F.			Major Role of Epidermal Growth Factor Receptor and Src Kinases in Promoting Oxidative Stress-dependent Loss of Adhesion and Apoptosis in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; TYROSINE PHOSPHORYLATION; C-SRC; REDOX REGULATION; PHOSPHATIDYLINOSITOL 3-KINASE; REVERSIBLE INACTIVATION; ERBB-2 OVEREXPRESSION; GEL-ELECTROPHORESIS	A growing body of evidence suggests that reactive oxygen species are critical components of cell signaling pathways, in particular regulating protein phosphorylation events. Here, we show that oxidative stress in response to hydrogen peroxide treatment of human epithelial cells induces robust tyrosine phosphorylation on multiple proteins. Using an anti-phosphotyrosine purification and liquid chromatography-tandem mass spectrometry approach, we have identified many of these H2O2-induced tyrosine-phosphorylated proteins. Importantly, we show that epidermal growth factor receptor (EGFR) and Src are the primary upstream kinases mediating these events through their redox activation. The finding that many of the identified proteins have functions in cell adhesion, cell-cell junctions, and the actin cytoskeleton prompted us to examine stress-induced changes in adhesion. Immunofluorescence analysis showed that H2O2 alters cell adhesion structures and the actin cytoskeleton causing loss of adhesion and apoptosis. Remarkably, these cellular changes could be attenuated by inhibition of EGFR and Src, identifying these kinases as targets to block oxidative damage. In summary, our data demonstrate that EGFR and Src together play a central role in oxidative stress-induced phosphorylation, which in turn results in loss of adhesion, morphological changes, and cell damage in epithelial cells. These data also provide a general model for redox signaling in other cell systems.	[Timms, John F.] UCL, Canc Prote Lab, EGA Inst Womens Hlth, London WC1E 6BT, England; [Chan, Hong-Lin] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Chan, Hong-Lin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Chou, Hsiu-Chuan; Gruenewald, Jana; Ridley, Anne] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Waterfield, Michael D.] Ludwig Inst Canc Res, London W1W 7BS, England; [Chou, Hsiu-Chuan] Ind Technol Res Inst, Hsinchu 31040, Taiwan	University of London; University College London; National Tsing Hua University; National Tsing Hua University; University of London; King's College London; Ludwig Institute for Cancer Research; Industrial Technology Research Institute - Taiwan	Timms, JF (corresponding author), UCL, Canc Prote Lab, EGA Inst Womens Hlth, Cruciform Bldg,1-1-09,Gower St, London WC1E 6BT, England.	jtimms@wibr.ucl.ac.uk	Duran, MCarmen/K-8898-2012; DURAN-RUIZ, MCarmen/N-1426-2015; Duran, Carmen M/P-4175-2017; Timms, John/A-1556-2010	DURAN-RUIZ, MCarmen/0000-0003-3954-3734; Duran, Carmen M/0000-0003-3954-3734; Timms, John/0000-0002-4507-835X; Ridley, Anne/0000-0001-8186-5708	EMF Biological Research Trust [BRT 06/28]; Association for International Cancer Research [05-426]; European Union [FP6 LSHC-CT-2003-502935]; National Science Council of Taiwan [97-2311-B-007-005]; Eve Appeal; Department of Health National Institute for Health Research Biomedical Research Centres	EMF Biological Research Trust(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Association for International Cancer Research; European Union(European Commission); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Eve Appeal; Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	This work was supported by grants from the EMF Biological Research Trust Grant BRT 06/28, the Association for International Cancer Research Grant 05-426, European Union Grants FP6 LSHC-CT-2003-502935, National Science Council of Taiwan Grant 97-2311-B-007-005, and from the Eve Appeal. This work was undertaken at University College London Hospital/University College London that received a portion of funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boardman KC, 2004, J CELL PHYSIOL, V199, P57, DOI 10.1002/jcp.10451; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chan HL, 2005, PROTEOMICS, V5, P2908, DOI 10.1002/pmic.200401300; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gharbi S, 2002, MOL CELL PROTEOMICS, V1, P91, DOI 10.1074/mcp.T100007-MCP200; Gomez S, 1999, BBA-MOL CELL RES, V1452, P121, DOI 10.1016/S0167-4889(99)00124-X; Gozin A, 1998, FREE RADICAL BIO MED, V25, P1021, DOI 10.1016/S0891-5849(98)00134-8; Guo J, 2003, NEUROSCI LETT, V345, P101, DOI 10.1016/S0304-3940(03)00483-X; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Irby RB, 2002, CANCER RES, V62, P2669; Khadaroo RG, 2003, SURGERY, V134, P242, DOI 10.1067/msy.2003.228; KREBS EG, 1994, TRENDS BIOCHEM SCI, V19, P439, DOI 10.1016/0968-0004(94)90125-2; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leslie NR, 2004, BIOCHEM SOC T, V32, P1018, DOI 10.1042/BST0321018; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pu MY, 1996, ONCOGENE, V13, P2615; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; RHEE SG, 2000, SCI STKE, pE1; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; STAMPS AC, 1994, INT J CANCER, V57, P865, DOI 10.1002/ijc.2910570616; SULLIVAN SG, 1994, FREE RADICAL BIO MED, V16, P399, DOI 10.1016/0891-5849(94)90042-6; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Timms JF, 2002, ONCOGENE, V21, P6573, DOI 10.1038/sj.onc.1205847; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; van Wetering S, 2002, J CELL SCI, V115, P1837; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; White SL, 2004, BRIT J CANCER, V90, P173, DOI 10.1038/sj.bjc.6601458; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	50	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4307	4318		10.1074/jbc.M109.047027	http://dx.doi.org/10.1074/jbc.M109.047027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996095	Green Published, hybrid			2022-12-25	WOS:000275274800007
J	Kesavan, K; Ratliff, J; Johnson, EW; Dahlberg, W; Asara, JM; Misra, P; Frangioni, JV; Jacoby, DB				Kesavan, Kamala; Ratliff, Judson; Johnson, Eric W.; Dahlberg, William; Asara, John M.; Misra, Preeti; Frangioni, John V.; Jacoby, Douglas B.			Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; HIGH-GRADE GLIOMA; PDGF-C; CANCER-CELLS; MATRIX METALLOPROTEINASE-2; HEPATOCELLULAR-CARCINOMA; ALPHA-RECEPTOR; VEGF TREATMENT; BRAIN-TUMORS; IN-VITRO	TM601 is a synthetic form of chlorotoxin, a 36-amino acid peptide derived from the venom of the Israeli scorpion, Leirius quinquestriatus, initially found to specifically bind and inhibit the migration of glioma cells in culture. Subsequent studies demonstrated specific in vitro binding to additional tumor cell lines. Recently, we demonstrated that proliferating human vascular endothelial cells are the only normal cell line tested that exhibits specific binding to TM601. Here, we identify annexin A2 as a novel binding partner for TM601 in multiple human tumor cell lines and human umbilical vein endothelial cell (HUVEC). We demonstrate that the surface binding of TM601 to the pancreatic tumor cell line Panc-1 is dependent on the expression of annexin A2. Identification of annexin A2 as a binding partner for TM601 is also consistent with the anti-angiogenic effects of TM601. Annexin A2 functions in angiogenesis by binding to tissue plasminogen activator and regulating plasminogen activation on vascular endothelial cells. We demonstrate that in HUVECs, TM601 inhibits both vascular endothelial growth factor-and basic fibroblast growth factor-induced tissue plasminogen activator activation, which is required for activation of plasminogen to plasmin. Consistent with inhibition of cell surface protease activity, TM601 also inhibits platelet-derived growth factor-C induced trans-well migration of both HUVEC and U373-MG glioma cells.	[Kesavan, Kamala; Ratliff, Judson; Johnson, Eric W.; Dahlberg, William; Jacoby, Douglas B.] TransMol Inc, Cambridge, MA 02139 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Jacoby, DB (corresponding author), TransMol Inc, Cambridge, MA 02139 USA.	jacoby@transmolecular.com						Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Diaz VM, 2004, GUT, V53, P993, DOI 10.1136/gut.2003.026831; Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO;2-J; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; GIBBIN TE, 2009, J CLIN ONCOL, V27; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; Inokuchi J, 2009, INT J CANCER, V124, P68, DOI 10.1002/ijc.23928; Iwadate Y, 2004, CANCER RES, V64, P2496, DOI 10.1158/0008-5472.CAN-03-1254; JACOBY DB, 2010, ANTICANCER IN PRESS, V30; Le DM, 2003, J NEUROSCI, V23, P4034; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lokker NA, 2002, CANCER RES, V62, P3729; Lyons SA, 2002, GLIA, V39, P162, DOI 10.1002/glia.10083; Mamelak AN, 2007, EXPERT OPIN DRUG DEL, V4, P175, DOI 10.1517/17425247.4.2.175; Mamelak AN, 2006, J CLIN ONCOL, V24, P3644, DOI 10.1200/JCO.2005.05.4569; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Misra P, 2007, J NUCL MED, V48, P1379, DOI 10.2967/jnumed.107.040303; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Nygaard SJT, 1998, J NEURO-ONCOL, V38, P11, DOI 10.1023/A:1005953000523; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; REEVES SA, 1992, CANCER RES, V52, P6871; ROSEMAN BJ, 1994, ONCOL RES, V6, P561; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Ullrich N, 1995, NEUROREPORT, V7, P343, DOI 10.1097/00001756-199512290-00082; Veiseh M, 2007, CANCER RES, V67, P6882, DOI 10.1158/0008-5472.CAN-06-3948; Yu GR, 2007, EXP MOL MED, V39, P641, DOI 10.1038/emm.2007.70; Zhong LP, 2009, ARCH ORAL BIOL, V54, P17, DOI 10.1016/j.archoralbio.2008.08.006; Zimmermann U, 2004, VIRCHOWS ARCH, V445, P368, DOI 10.1007/s00428-004-1103-4	39	105	114	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4366	4374		10.1074/jbc.M109.066092	http://dx.doi.org/10.1074/jbc.M109.066092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018898	Green Published, hybrid			2022-12-25	WOS:000275274800013
J	Graziani, A; Poteser, M; Heupel, WM; Schleifer, H; Krenn, M; Drenckhahn, D; Romanin, C; Baumgartner, W; Groschner, K				Graziani, Annarita; Poteser, Michael; Heupel, Wolfgang-Moritz; Schleifer, Hannes; Krenn, Martin; Drenckhahn, Detlev; Romanin, Christoph; Baumgartner, Werner; Groschner, Klaus			Cell-Cell Contact Formation Governs Ca2+ Signaling by TRPC4 in the Vascular Endothelium EVIDENCE FOR A REGULATORY TRPC4-beta-CATENIN INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; OPERATED CALCIUM-ENTRY; SURFACE EXPRESSION; ALPHA-CATENIN; VE-CADHERIN; CHANNELS; PROLIFERATION; PERMEABILITY; ADHESION; COMPLEX	TRPC4 is well recognized as a prominent cation channel in the vascular endothelium, but its contribution to agonist-induced endothelial Ca2+ entry is still a matter of controversy. Here we report that the cellular targeting and Ca2+ signaling function of TRPC4 is determined by the state of cell-cell adhesions during endothelial phenotype transitions. TRPC4 surface expression in human microvascular endothelial cells (HMEC-1) increased with the formation of cell-cell contacts. Epidermal growth factor recruited TRPC4 into the plasma membrane of proliferating cells but initiated retrieval of TRPC4 from the plasma membrane in quiescent, barrier-forming cells. Epidermal growth factor-induced Ca2+ entry was strongly promoted by the formation of cell-cell contacts, and both siRNA and dominant negative knockdown experiments revealed that TRPC4 mediates stimulated Ca2+ entry exclusively in proliferating clusters that form immature cell-cell contacts. TRPC4 co-precipitated with the junctional proteins beta-catenin and VE-cadherin. Analysis of cellular localization of fluorescent fusion proteins provided further evidence for recruitment of TRPC4 into junctional complexes. Analysis of TRPC4 function in the HEK293 expression system identified beta-catenin as a signaling molecule that enables cell-cell contact-dependent promotion of TRPC4 function. Our results place TRPC4 as a Ca2+ entry channel that is regulated by cell-cell contact formation and interaction with beta-catenin. TRPC4 is suggested to serve stimulated Ca2+ entry in a specific endothelial state during the transition from a proliferating to a quiescent phenotype. Thus, TRPC4 may adopt divergent, as yet unappreciated functions in endothelial Ca2+ homeostasis and emerges as a potential key player in endothelial phenotype switching and tuning of cellular growth factor signaling.	[Graziani, Annarita; Poteser, Michael; Schleifer, Hannes; Krenn, Martin; Groschner, Klaus] Graz Univ, Inst Pharmaceut Sci Pharmacol & Toxicol, A-8010 Graz, Austria; [Heupel, Wolfgang-Moritz; Drenckhahn, Detlev] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany; [Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Baumgartner, Werner] Rhein Westfal TH Aachen, Inst Biol 2, Dept Cellular Neurobion, D-52056 Aachen, Germany	University of Graz; University of Wurzburg; Johannes Kepler University Linz; RWTH Aachen University	Groschner, K (corresponding author), Graz Univ, Inst Pharmaceut Sci Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	klaus.groschner@uni-graz.at	Groschner, Klaus/A-2550-2010; Romanin, Christoph/D-5399-2009; Baumgartner, Werner/C-5013-2012	Groschner, Klaus/0000-0002-8659-377X; Romanin, Christoph/0000-0003-3756-4136; Baumgartner, Werner/0000-0002-3160-2050; Poteser, Michael/0000-0002-9962-1098	FWF [P19820, P18475, P18169]	FWF(Austrian Science Fund (FWF))	This work was supported by FWF (Austrian Science Fund) Projects P19820 (to K. G.), P18475 (to M. P.), and P18169 (to C. R.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Flockerzi V, 2005, PFLUG ARCH EUR J PHY, V451, P81, DOI 10.1007/s00424-005-1443-1; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Giannini AL, 2000, EXP CELL RES, V255, P207, DOI 10.1006/excr.1999.4785; Giannini AL, 2000, J BIOL CHEM, V275, P21883, DOI 10.1074/jbc.M001929200; Heupel WM, 2009, J CELL SCI, V122, P1616, DOI 10.1242/jcs.040212; Kamei J, 2003, BIOCHEM BIOPH RES CO, V312, P380, DOI 10.1016/j.bbrc.2003.10.129; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kuang HB, 2009, FRONT BIOSCI-LANDMRK, V14, P2212, DOI 10.2741/3373; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Mery L, 2002, J CELL SCI, V115, P3497; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Vestweber D, 2000, J PATHOL, V190, P281; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wakabayashi I, 2006, J VASC RES, V43, P238, DOI 10.1159/000091235; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	32	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4213	4223		10.1074/jbc.M109.060301	http://dx.doi.org/10.1074/jbc.M109.060301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996314	hybrid, Green Published			2022-12-25	WOS:000275254000073
J	Hirano, M; Takeuchi, Y; Aoki, T; Yanagida, T; Ide, T				Hirano, Minako; Takeuchi, Yuko; Aoki, Takaaki; Yanagida, Toshio; Ide, Toru			Rearrangements in the KcsA Cytoplasmic Domain Underlie Its Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-ION CHANNELS; FULL-LENGTH KCSA; POTASSIUM-CHANNEL; SELECTIVITY FILTER; FLUORESCENCE; CONFORMATION; CONDUCTION; PROTEINS; DYNAMICS	A change of cytosolic pH 7 to 4 opens the bacterial potassium channel KcsA. However, the overall gating mechanism leading to channel opening, especially the contribution of the cytoplasmic domain, remains unsolved. Here we report that deletion of the cytoplasmic domain resulted in changes in channel conductance and gating behavior at pH 4 without channel opening at pH 7. To probe for rearrangements in the cytoplasmic domain during channel opening, amino acid residues were substituted with cysteines and labeled with a fluorophore (tetramethylrhodamine maleimide) that exhibits increased fluorescence intensity upon transfer from a hydrophilic to hydrophobic environment. In all cases channel open probability (P-o) was similar to 1 at pH 4 and similar to 0 at pH 7. Major increases in fluorescence intensity were observed for tetramethylrhodamine maleimide-labeled residues in the cytoplasmic domain as pH changed from 7 to 4, which suggests the fluorophores shifted from a hydrophilic to hydrophobic environment. Dipicrylamide, a lipid soluble quencher, reduced the fluorescence intensities of labeled residues in the cytosolic domain at pH 4. These results reveal that a decrease in pH introduces major conformational rearrangements associated with channel opening in the KcsA cytoplasmic domain.	[Hirano, Minako; Takeuchi, Yuko; Aoki, Takaaki; Yanagida, Toshio; Ide, Toru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Ide, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	ide@phys1.med.osaka-u.ac.jp	Ide, Toru/L-7110-2015	Hirano, Minako/0000-0002-7246-0087	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Molecular and System Life Science and Innovative Nanoscience of Supermolecular Motor Proteins Working in Biomembranes) and the Hayashi Memorial Foundation for Female Natural Scientists.	Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chakrapani S, 2007, NAT STRUCT MOL BIOL, V14, P180, DOI 10.1038/nsmb0307-180; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Corvini PFX, 2000, MICROBIOL-SGM, V146, P2671, DOI 10.1099/00221287-146-10-2671; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ide T, 1999, BIOCHEM BIOPH RES CO, V265, P595, DOI 10.1006/bbrc.1999.1720; Ide T, 2002, SINGLE MOL, V3, P33, DOI 10.1002/1438-5171(200204)3:1<33::AID-SIMO33>3.0.CO;2-U; Iwamoto M, 2006, J BIOL CHEM, V281, P28379, DOI 10.1074/jbc.M602018200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106	23	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3777	3783		10.1074/jbc.M109.084368	http://dx.doi.org/10.1074/jbc.M109.084368			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959477	Green Published, hybrid			2022-12-25	WOS:000275254000030
J	Marchenko, S; Chernyavsky, AI; Arredondo, J; Gindi, V; Grando, SA				Marchenko, Steve; Chernyavsky, Alexander I.; Arredondo, Juan; Gindi, Vivian; Grando, Sergei A.			Antimitochondrial Autoantibodies in Pemphigus Vulgaris A MISSING LINK IN DISEASE PATHOPHYSIOLOGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BASAL-CELL SHRINKAGE; SIGNALING PATHWAYS; APOPTOTIC MECHANISM; DNA ANTIBODIES; MESSENGER-RNA; NITRIC-OXIDE; FAS-LIGAND; ACANTHOLYSIS; ACTIVATION	A loss of epidermal cohesion in pemphigus vulgaris (PV) results from autoantibody action on keratinocytes (KCs) activating the signaling kinases and executioner caspases that damage KCs, causing their shrinkage, detachment from neighboring cells, and rounding up (apoptolysis). In this study, we found that PV antibody binding leads to activation of epidermal growth factor receptor kinase, Src, p38 MAPK, and JNK in KCs with time pattern variations from patient to patient. Both extrinsic and intrinsic apoptotic pathways were also activated. Although Fas ligand neutralizing antibody could inhibit the former pathway, the mechanism of activation of the latter remained unknown. PV antibodies increased cytochrome c release, suggesting damage to mitochondria. The immunoblotting experiments revealed penetration of PVIgG into the subcellular mitochondrial fraction. The antimitochondrial antibodies from different PV patients recognized distinct combinations of antigens with apparent molecular sizes of 25, 30, 35, 57, 60, and 100 kDa. Antimitochondrial antibodies were pathogenic because their absorption abolished the ability of PVIgG to cause keratinocyte detachment both in vitro and in vivo. The downstream signaling of antimitochondrial antibodies involved JNK and late p38 MAPK activation, whereas the signaling of anti-desmoglein 3 (Dsg3) antibody involved JNK and biphasic p38 MAPK activation. Using KCs grown from Dsg3(-/-) mice, we determined that Dsg3 did not serve as a surrogate antigen allowing antimitochondrial antibodies to enter KCs. The PVIgG-induced activation of epidermal growth factor receptor and Src was affected neither in Dsg3(-/-) KCs nor due to absorption of antimitochondrial antibodies. These results demonstrated that apoptolysis in PV is a complex process initiated by at least three classes of autoantibodies directed against desmosomal, mitochondrial, and other keratinocyte self-antigens. These autoantibodies synergize with the proapoptotic serum and tissue factors to trigger both extrinsic and intrinsic pathways of cell death and break the epidermal cohesion, leading to blisters. Further elucidation of the primary signaling events downstream of PV autoantigens will be crucial for the development of a more successful therapy for PV patients.	[Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, 134 Sprague Hall, Irvine, CA 92697 USA.	sgrando@uci.edu			National Institutes of Health [GM62136]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62136 (to S. A. G.). A preliminary account was presented at the 69th Annual Meeting of the Society for Investigative Dermatology, Montreal, Canada, May 6-9, 2009, and published in the form of an abstract (Chernyavsky, A. I., Arredondo, J., and Grando, S. A. (2009) J. Invest. Dermatol. 129, Suppl. S11 (Abstr. 64)).	Alascon-Segovia D, 1998, J Autoimmun, V11, P509, DOI 10.1006/jaut.1998.0238; Alecu M, 1999, Roum Arch Microbiol Immunol, V58, P121; Ameglio F, 1999, J BIOL REG HOMEOS AG, V13, P220; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Baroni A, 2002, DERMATOLOGY, V205, P116, DOI 10.1159/000063895; Barwise JL, 1996, J CELL SCI, V109, P247; Bastian Boris C., 1994, Journal of Dermatological Science, V8, P194, DOI 10.1016/0923-1811(94)90054-X; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Bhol KC, 2001, CLIN IMMUNOL, V100, P172, DOI 10.1006/clim.2001.5061; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; Bystryn JC, 2006, J AM ACAD DERMATOL, V54, P513, DOI 10.1016/j.jaad.2005.12.003; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chernyavsky AI, 2004, J CELL BIOL, V166, P261, DOI 10.1083/jcb.200401034; Chernyavsky AI, 2008, J BIOL CHEM, V283, P3401, DOI 10.1074/jbc.M704956200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Cirillo N, 2008, J CELL BIOCHEM, V103, P598, DOI 10.1002/jcb.21431; Cirillo N, 2007, J CELL PHYSIOL, V212, P563, DOI 10.1002/jcp.21111; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Fearnley Ian M, 2007, Methods Mol Biol, V357, P103; Feliciani C, 2003, EXP DERMATOL, V12, P466, DOI 10.1034/j.1600-0625.2002.120415.x; Feliciani C, 2000, J INVEST DERMATOL, V114, P71, DOI 10.1046/j.1523-1747.2000.00835.x; Frusic-Zlotkin M, 2005, ANN NY ACAD SCI, V1050, P371, DOI 10.1196/annals.1313.040; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; GEOGHEGAN W, 1992, J INVEST DERMATOL, V98, P589; Gheorghe Emma, 2005, Rom J Morphol Embryol, V46, P73; Golan TD, 1997, LUPUS, V6, P18, DOI 10.1177/096120339700600103; Golan TD, 1997, LEUKEMIA, V11, P6, DOI 10.1038/sj.leu.2400519; GOLAN TD, 1993, J INVEST DERMATOL, V100, P316, DOI 10.1111/1523-1747.ep12469994; GRANDO SA, 1989, AUTOIMMUNITY, V3, P247, DOI 10.3109/08916938908997095; GRANDO SA, 1991, CLIN EXP DERMATOL, V16, P359, DOI 10.1111/j.1365-2230.1991.tb00401.x; GRANDO SA, 1989, ARCH DERMATOL, V125, P925, DOI 10.1001/archderm.125.7.925; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando Sergei A., 1992, Journal of Dermatological Science, V4, P95, DOI 10.1016/0923-1811(92)90065-J; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Ishibashi H, 2005, SEMIN LIVER DIS, V25, P337, DOI 10.1055/s-2005-916325; Lanza A, 2007, BRIT J DERMATOL, V156, P400, DOI 10.1111/j.1365-2133.2006.07654.x; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Lim PL, 2006, IMMUNOL LETT, V103, P17, DOI 10.1016/j.imlet.2005.10.023; LOTTI RES, 2009, J INVEST DERMATO S14, V129; Marquina M, 2008, BRIT J DERMATOL, V159, P68, DOI 10.1111/j.1365-2133.2008.08582.x; Mohiti J, 1995, MOL MEMBR BIOL, V12, P321, DOI 10.3109/09687689509072434; Musante L, 2005, CLIN EXP IMMUNOL, V141, P491, DOI 10.1111/j.1365-2249.2005.02862.x; Narbutt J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/875394; Nguyen VT, 2000, J BIOL CHEM, V275, P29466, DOI 10.1074/jbc.M003174200; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; Nguyen VT, 2004, EXP CELL RES, V294, P534, DOI 10.1016/j.yexcr.2003.12.010; Nguyen VT, 2004, J BIOL CHEM, V279, P2135, DOI 10.1074/jbc.M309000200; Orlov MD, 2006, AUTOIMMUNITY, V39, P557, DOI 10.1080/08916930600971729; Pacheco-Tovar MG, 2009, J EUR ACAD DERMATOL, V23, P697, DOI 10.1111/j.1468-3083.2009.03162.x; Podszywalow-Bartnicka P, 2007, ACTA BIOCHIM POL, V54, P261, DOI 10.18388/abp.2007_3246; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; RAINTEAU D, 1995, FEBS LETT, V360, P80, DOI 10.1016/0014-5793(95)00087-P; Rivadeneyra-Espinoza L, 2006, J AUTOIMMUN, V26, P52, DOI 10.1016/j.jaut.2005.10.008; Ruiz-Argueelles A, 2007, J AUTOIMMUN, V29, P281, DOI 10.1016/j.jaut.2007.07.012; Sanchez-Carpintero I, 2004, BRIT J DERMATOL, V151, P565, DOI 10.1111/j.1365-2133.2004.06147.x; SAYAMA K, 1994, J INVEST DERMATOL, V103, P330, DOI 10.1111/1523-1747.ep12394858; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SCHULZE K, 1989, CIRC RES, V64, P179, DOI 10.1161/01.RES.64.2.179; Seddiki N, 2001, J IMMUNOL, V166, P6423, DOI 10.4049/jimmunol.166.10.6423; Siebra MX, 2006, BRAZ J MED BIOL RES, V39, P671, DOI 10.1590/S0100-879X2006000500014; Stulik J, 2003, PROTEOMICS, V3, P951, DOI 10.1002/pmic.200300370; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; TIGALONOWA M, 1990, ACTA DERM-VENEREOL, V70, P385; TSERAIDIS G S, 1972, Arkhiv Patologii, V34, P72; TSERAIDIS G S, 1971, Vestnik Dermatologii i Venerologii, V45, P8; Wang X, 2004, FEBS LETT, V567, P281, DOI 10.1016/j.febslet.2004.04.083; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Yanase K, 1997, J CLIN INVEST, V100, P25, DOI 10.1172/JCI119517	75	62	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3695	3704		10.1074/jbc.M109.081570	http://dx.doi.org/10.1074/jbc.M109.081570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007702	Green Published, hybrid			2022-12-25	WOS:000275254000021
J	Sharma, MR; Donhofer, A; Barat, C; Marquez, V; Datta, PP; Fucini, P; Wilson, DN; Agrawal, RK				Sharma, Manjuli R.; Doenhoefer, Alexandra; Barat, Chandana; Marquez, Viter; Datta, Partha P.; Fucini, Paola; Wilson, Daniel N.; Agrawal, Rajendra K.			PSRP1 Is Not a Ribosomal Protein, but a Ribosome-binding Factor That Is Recycled by the Ribosome-recycling Factor (RRF) and Elongation Factor G (EF-G)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI 70S RIBOSOME; 30 S SUBUNIT; CHLOROPLAST RIBOSOME; BACTERIAL RIBOSOME; STATIONARY-PHASE; STRUCTURAL BASIS; IDENTIFICATION; TRANSLATION; INITIATION; DOMAIN	Plastid-specific ribosomal proteins (PSRPs) have been proposed to play roles in the light-dependent regulation of chloroplast translation. Here we demonstrate that PSRP1 is not a bona fide ribosomal protein, but rather a functional homologue of the Escherichia coli cold-shock protein pY. Three-dimensional Cryo-electron microscopic (Cryo-EM) reconstructions reveal that, like pY, PSRP1 binds within the intersubunit space of the 70S ribosome, at a site overlapping the positions of mRNA and A-and P-site tRNAs. PSRP1 induces conformational changes within ribosomal components that comprise several intersubunit bridges, including bridge B2a, thereby stabilizes the ribosome against dissociation. We find that the presence of PSRP1/pY lowers the binding of tRNA to the ribosome. Furthermore, similarly to tRNAs, PSRP1/pY is recycled from the ribosome by the concerted action of the ribosome-recycling factor (RRF) and elongation factor G (EF-G). These results suggest a novel function for EF-G and RRF in the post-stress return of PSRP1/pY-inactivated ribosomes to the actively translating pool.	[Sharma, Manjuli R.; Barat, Chandana; Datta, Partha P.; Agrawal, Rajendra K.] New York State Dept Hlth, Wadsworth Ctr, Div Translat Med, Albany, NY 12201 USA; [Doenhoefer, Alexandra; Marquez, Viter; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Doenhoefer, Alexandra; Marquez, Viter; Wilson, Daniel N.] Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; [Doenhoefer, Alexandra; Marquez, Viter; Wilson, Daniel N.] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany; [Fucini, Paola] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Agrawal, Rajendra K.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; University of Munich; University of Munich; University of Munich; Goethe University Frankfurt; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wilson, DN (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	wilson@lmb.uni-muenchen.de; agrawal@wadsworth.org	Fucini, Paola/M-1118-2014; Wilson, Daniel/AAE-8504-2019	Fucini, Paola/0000-0003-1724-8507; Wilson, Daniel/0000-0003-3816-3828	National Institutes of Health [R01 GM61576]; Human Frontiers of Science Program; Deutsche Forschungsgemeinschaft [WI3285/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers of Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM61576 (to R. K. A.). This work was also supported by the Human Frontiers of Science Program (to D. N. W.) and the Deutsche Forschungsgemeinschaft Grant WI3285/1-1 (to D. N. W.).	Agafonov DE, 2001, EMBO REP, V2, P399; Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Allen JF, 2003, PHILOS T ROY SOC B, V358, P144; Barat C, 2007, MOL CELL, V27, P250, DOI 10.1016/j.molcel.2007.06.005; Barkan A, 2000, BIOCHIMIE, V82, P559, DOI 10.1016/S0300-9084(00)00602-7; Barnes D, 2003, ANTIOXID REDOX SIGN, V5, P89, DOI 10.1089/152308603321223577; Brock S, 1998, MOL MICROBIOL, V29, P409, DOI 10.1046/j.1365-2958.1998.00893.x; Bruick RK, 1999, TRENDS PLANT SCI, V4, P190, DOI 10.1016/S1360-1385(99)01402-8; BUBUNENKO MG, 1994, J BIOL CHEM, V269, P18223; CARSON M, 1991, APPL CRYSTALLOGR, V24, P103; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; Daniell H, 2003, NAT BIOTECHNOL, V21, P374, DOI 10.1038/nbt0403-374; Firpo MA, 1996, J BIOL CHEM, V271, P4693; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GNIRKE A, 1989, J BIOL CHEM, V264, P7291; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Hirokawa G, 2006, TRENDS BIOCHEM SCI, V31, P143, DOI 10.1016/j.tibs.2006.01.007; Hirokawa G, 2005, RNA, V11, P1317, DOI 10.1261/rna.2520405; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; JOHNSON CH, 1990, J BIOL CHEM, V265, P12790; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; Maki Y, 2000, GENES CELLS, V5, P965, DOI 10.1046/j.1365-2443.2000.00389.x; Manuell A, 2004, BIOCHEM SOC T, V32, P601, DOI 10.1042/BST0320601; Parsons L, 2001, BIOCHEMISTRY-US, V40, P10979, DOI 10.1021/bi011077i; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Rak A, 2002, BIOCHEM BIOPH RES CO, V299, P710, DOI 10.1016/S0006-291X(02)02721-3; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma MR, 2007, P NATL ACAD SCI USA, V104, P19315, DOI 10.1073/pnas.0709856104; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Somanchi A, 1999, CURR OPIN PLANT BIOL, V2, P404, DOI 10.1016/S1369-5266(99)00013-8; TAN XL, 1994, J BIOL CHEM, V269, P20905; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Ueta M, 2005, GENES CELLS, V10, P1103, DOI 10.1111/j.1365-2443.2005.00903.x; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Yamaguchi K, 2000, J BIOL CHEM, V275, P28455, DOI 10.1074/jbc.M004350200; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Yamaguchi K, 2002, PLANT CELL, V14, P2957, DOI 10.1105/tpc.004341; Ye KQ, 2002, EUR J BIOCHEM, V269, P5182, DOI 10.1046/j.1432-1033.2002.03222.x; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zerges W, 2000, BIOCHIMIE, V82, P583, DOI 10.1016/S0300-9084(00)00603-9	49	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4006	4014		10.1074/jbc.M109.062299	http://dx.doi.org/10.1074/jbc.M109.062299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965869	Green Published, hybrid			2022-12-25	WOS:000275254000054
J	Steichen, JM; Iyer, GH; Li, S; Saldanha, SA; Deal, MS; Woods, VL; Taylor, SS				Steichen, Jon M.; Iyer, Ganesh H.; Li, Sheng; Saldanha, S. Adrian; Deal, Michael S.; Woods, Virgil L., Jr.; Taylor, Susan S.			Global Consequences of Activation Loop Phosphorylation on Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-DEPENDENT KINASE; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; STRUCTURAL BASIS; MECHANISM; EXCHANGE; AUTOPHOSPHORYLATION; DOMAIN; CONFORMATION; THREONINE	Phosphorylation of the activation loop is one of the most common mechanisms for regulating protein kinase activity. The catalytic subunit of cAMP-dependent protein kinase autophosphorylates Thr(197) in the activation loop when expressed in Escherichia coli. Although mutation of Arg(194) to Ala prevents autophosphorylation, phosphorylation of Thr(197) can still be achieved by a heterologous protein kinase, phosphoinositide-dependent protein kinase (PDK1), in vitro. In this study, we examined the structural and functional consequences of adding a single phosphate to the activation loop of cAMP-dependent protein kinase by comparing the wild type C-subunit to the R194A mutant either in the presence or the absence of activation loopphosphorylation. Phosphorylation of Thr(197) decreased the K-m by similar to 15- and 7-fold for kemptide and ATP, respectively, increased the stability of the enzyme as measured by fluorescence and circular dichroism, and enhanced the binding between the C-subunit and IP20, a protein kinase inhibitor peptide. Additionally, deuterium exchange coupled to mass spectrometry was used to compare the structural dynamics of these proteins. All of the regions of the C-subunit analyzed underwent amide hydrogen exchange at a higher or equal rate in the unphosphorylated enzyme compared with the phosphorylated enzyme. The largest changes occurred at the C terminus of the activation segment in the p + 1 loop/APE regions and the alpha H-alpha I loop motifs and leads to the prediction of a coordinated phosphorylation-induced salt bridge between two conserved residues, Glu(208) and Arg(280).	[Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health [GM19301, CA099835, CA118595, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170, GM007752]; University of California IUCRP [UC10591]; NATIONAL CANCER INSTITUTE [R21CA099835, R33CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, R01AI081982, R21AI076961, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684, R01GM020501, R01GM019301, F32GM020501, R01GM066170, R37GM019301, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California IUCRP(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM19301 (to S.S.T.) and CA099835, CA118595, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V.L.W.). This work was also supported by National Institutes of Health Pharmacological Sciences Training Grant GM007752 (to J.M.S.) and by Discovery Grant UC10591 from the University of California IUCRP	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Cauthron RD, 1998, MOL CELL BIOL, V18, P1416, DOI 10.1128/MCB.18.3.1416; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Lee T, 2005, J MOL BIOL, V353, P600, DOI 10.1016/j.jmb.2005.08.029; LEVIN LR, 1990, MOL CELL BIOL, V10, P1066, DOI 10.1128/MCB.10.3.1066; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; ORR JW, 1994, J BIOL CHEM, V269, P27715; Pace C N, 1986, Methods Enzymol, V131, P266; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030	34	62	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3825	3832		10.1074/jbc.M109.061820	http://dx.doi.org/10.1074/jbc.M109.061820			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965870	Green Published, hybrid			2022-12-25	WOS:000275254000035
J	Sun, HQ; Li, D; Chen, S; Liu, YY; Liao, XL; Deng, WQ; Li, N; Zeng, M; Tao, DC; Ma, YX				Sun, Huaqin; Li, Dan; Chen, Shu; Liu, Yanyan; Liao, Xiaolin; Deng, Wenqian; Li, Na; Zeng, Mei; Tao, Dachang; Ma, Yongxin			Zili Inhibits Transforming Growth Factor-beta Signaling by Interacting with Smad4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIWI; ZEBRAFISH; PROTEIN; ORGANIZER; GENES	Piwi proteins are required for germ cell proliferation, differentiation, and germ line stem cell maintenance. In normal tissues, human and mouse Piwil2 are primarily expressed in testis but widely expressed in tumors. However, the underlying mechanism remains largely unknown. In vertebrates, transforming growth factor (TGF)-beta signaling plays an important role in patterning embryo and control of cell growth and differentiation. A previous study has shown a role for Zili, a Piwil2 gene in zebrafish, in germ cells in zebrafish. Here we report that zili functions in patterning the early embryo and inhibits TGF-beta signaling. Whole mount expression analysis shows that zili expresses not only in PGCs but also in axis. Ectopic expression of zili causes fusion of the eyes and reduction of mesodermal marker genes expression, suggesting that zili functions to inhibit Nodal signaling and mesoderm formation. Genetic interaction shows that zili inhibits Nodal and bone morphogenetic protein signaling. The results of protein interaction assays identify that Zili binds to Smad4 via its N-terminal domain and prevents the formation of Smad2/3/4 and Smad1/5/9/4 complexes to antagonize TGF-beta signaling. This work shows that zili plays a role in early embryogenesis beyond germ line as a novel negative regulator of TGF-beta signaling, extending the function of Piwi proteins in vertebrates.	Sichuan Univ, Dept Med Genet, W China Hosp, Chengdu 610041, Peoples R China; Sichuan Univ, Div Morbid Genom, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Ma, YX (corresponding author), 1st Keyuan 4 Lu,Gaopeng Dadao, Chengdu 610041, Peoples R China.	mayongxin@gmail.com	Deng, Wenqian/AGY-3727-2022; liu, yan/HCI-5542-2022	Li, Na/0000-0001-6163-1648	National Natural Science Foundation of China [30770812, 90919006]; National High-Tech Research and Development Program of China [2008AA02Z102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30770812 and 90919006 and National High-Tech Research and Development Program of China Grant 2008AA02Z102.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kondo M, 2007, FEBS J, V274, P2960, DOI 10.1111/j.1742-4658.2007.05838.x; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mullins MC, 1996, DEVELOPMENT, V123, P81; Ober EA, 1999, DEV BIOL, V215, P167, DOI 10.1006/dbio.1999.9455; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Tan Cheong-Huat, 2002, Gene Expression Patterns, V2, P257, DOI 10.1016/S1567-133X(02)00052-2; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Westerfield M, 1993, ZEBRAFISH BOOK; Whitman M, 2005, DEVELOPMENT, V132, P4205, DOI 10.1242/dev.02023; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5	34	24	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4243	4250		10.1074/jbc.M109.079533	http://dx.doi.org/10.1074/jbc.M109.079533			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007318	hybrid, Green Published			2022-12-25	WOS:000275254000076
J	Siddiqui, MR; Velidi, NR; Pati, S; Rath, N; Kanungo, AK; Bhanjadeo, AK; Rao, BB; Ojha, BM; Moorthy, KK; Soutar, D; Porter, JDH; Rao, PVR				Siddiqui, M. Ruby; Velidi, Nageswara Rao; Pati, Surendra; Rath, Nilambar; Kanungo, Akshay K.; Bhanjadeo, Amiya K.; Rao, Bandaru Bhaskar; Ojha, Bijaya M.; Moorthy, Kodyur Krishna; Soutar, Douglas; Porter, John D. H.; Rao, Pemmaraju V. Ranganadha			Integration of Leprosy Elimination into Primary Health Care in Orissa, India	PLOS ONE			English	Article								Background: Leprosy was eliminated as a public health problem (, 1 case per 10,000) in India by December 2005. With this target in sight the need for a separate vertical programme was diminished. The second phase of the National Leprosy Eradication Programme was therefore initiated: decentralisation of the vertical programme, integration of leprosy services into the primary health care (PHC) system and development of a surveillance system to monitor programme performance. Methodology/Principal Findings: To study the process of integration a qualitative analysis of issues and perceptions of patients and providers, and a review of leprosy records and registers to evaluate programme performance was carried out in the state of Orissa, India. Program performance indicators such as a low mean defaulter rate of 3.83% and a low-misdiagnosis rate of 4.45% demonstrated no detrimental effect of integration on program success. PHC staff were generally found to be highly knowledgeable of diagnosis and management of leprosy cases due to frequent training and a support network of leprosy experts. However in urban hospitals district-level leprosy experts had assumed leprosy activities. The aim was to aid busy PHC staff but it also compromised their leprosy knowledge and management capacity. Inadequate monitoring of a policy of 'new case validation,' in which MDT was not initiated until primary diagnosis had been verified by a leprosy expert, may have led to approximately 26% of suspect cases awaiting confirmation of diagnosis 1-8 months after their initial PHC visit. Conclusions/Significance: This study highlights the need for effective monitoring and evaluation of the integration process. Inadequate monitoring could lead to a reduction in early diagnosis, a delay in initiation of MDT and an increase in disability rates. This in turn could reverse some of the programme's achievements. These findings may help Andhra Pradesh and other states in India to improve their integration process and may also have implications for other disease elimination programmes such as polio and guinea worm (dracunculiasis) as they move closer to their elimination goals.	[Siddiqui, M. Ruby; Porter, John D. H.] London Sch Hyg & Trop Med, London WC1, England; [Velidi, Nageswara Rao; Rath, Nilambar; Kanungo, Akshay K.; Bhanjadeo, Amiya K.; Rao, Bandaru Bhaskar; Ojha, Bijaya M.] LEPRA Hlth Act, Bargarh, Orissa, India; [Pati, Surendra] LEPRA Hlth Act, Bhubaneswar, Orissa, India; [Moorthy, Kodyur Krishna] LEPRA Hlth Act, Hyderabad, Andhra Pradesh, India; [Soutar, Douglas] LEPRA Hlth Act, Colchester, Essex, England; [Rao, Pemmaraju V. Ranganadha] LEPRA Hlth Act, W Marredpally, Secunderabad, India	University of London; London School of Hygiene & Tropical Medicine	Siddiqui, MR (corresponding author), Med Sans Frontieres, London, England.	ruby.siddiqui@london.msf.org		Siddiqui, Ruby/0000-0002-9638-594X	LEPRA UK (Leprosy Relief Association)	LEPRA UK (Leprosy Relief Association)	This study was funded by LEPRA UK (Leprosy Relief Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1970, RES ACT SOCIOLOGY TH; *CENTR LEPR DIV, 2003, NAT LEPR ER PROGR GU; *DIR GEN HLTH SERV, 2006, NAT ACT PLAN YEAR 20; Glaser B, 1978, DISCOV GROUNDED THEO; *GOV IND, 2005, NLEP NEW CAS DET CON; *GOV IND ILEP DIR, 2005, LEARN MAT LEPR CAP B; Green J., 2004, QUALITATIVE METHODS, V2nd; *MIN HLTH FAM WELF, 2004, VAL LEPR DIAGN IND	8	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8351	10.1371/journal.pone.0008351	http://dx.doi.org/10.1371/journal.pone.0008351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020051	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000272870600005
J	Farioli-Vecchioli, S; Saraulli, D; Costanzi, M; Leonardi, L; Cina, I; Micheli, L; Nutini, M; Longone, P; Oh, SP; Cestari, V; Tirone, F				Farioli-Vecchioli, Stefano; Saraulli, Daniele; Costanzi, Marco; Leonardi, Luca; Cina, Irene; Micheli, Laura; Nutini, Michele; Longone, Patrizia; Oh, S. Paul; Cestari, Vincenzo; Tirone, Felice			Impaired Terminal Differentiation of Hippocampal Granule Neurons and Defective Contextual Memory in PC3/Tis21 Knockout Mice	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; NERVE GROWTH-FACTOR; CELL-CYCLE; ADULT NEUROGENESIS; SYNAPTIC PLASTICITY; PROGENITOR CELLS; MESSENGER-RNA; PC3; INHIBITION; EXPRESSION	Neurogenesis in the dentate gyrus of the adult hippocampus has been implicated in neural plasticity and memory, but the molecular mechanisms controlling the proliferation and differentiation of newborn neurons and their integration into the synaptic circuitry are still largely unknown. To investigate this issue, we have analyzed the adult hippocampal neurogenesis in a PC3/Tis21-null mouse model. PC3/Tis21 is a transcriptional co-factor endowed with antiproliferative and prodifferentiative properties; indeed, its upregulation in neural progenitors has been shown to induce exit from cell cycle and differentiation. We demonstrate here that the deletion of PC3/Tis21 causes an increased proliferation of progenitor cells in the adult dentate gyrus and an arrest of their terminal differentiation. In fact, in the PC3/Tis21-null hippocampus postmitotic undifferentiated neurons accumulated, while the number of terminally differentiated neurons decreased of 40%. As a result, PC3/Tis21-null mice displayed a deficit of contextual memory. Notably, we observed that PC3/Tis21 can associate to the promoter of Id3, an inhibitor of proneural gene activity, and negatively regulates its expression, indicating that PC3/Tis21 acts upstream of Id3. Our results identify PC3/Tis21 as a gene required in the control of proliferation and terminal differentiation of newborn neurons during adult hippocampal neurogenesis and suggest its involvement in the formation of contextual memories.	[Farioli-Vecchioli, Stefano; Leonardi, Luca; Cina, Irene; Micheli, Laura; Tirone, Felice] Fondaz S Lucia, Inst Neurobiol & Mol Med, CNR, Rome, Italy; [Saraulli, Daniele; Costanzi, Marco; Cestari, Vincenzo] CNR, Inst Neurosci, Rome, Italy; [Saraulli, Daniele; Costanzi, Marco; Cestari, Vincenzo] LUMSA Univ, Fac Educ Sci, Rome, Italy; [Nutini, Michele; Longone, Patrizia] Fondaz S Lucia, Mol Neurobiol Unit, Rome, Italy; [Oh, S. Paul] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Universita LUMSA; State University System of Florida; University of Florida	Farioli-Vecchioli, S (corresponding author), Fondaz S Lucia, Inst Neurobiol & Mol Med, CNR, Rome, Italy.	vincenzo.cestari@ipsifar.rm.cnr.it; tirone@inmm.cnr.it	Longone, Patrizia/G-8428-2016; vecchioli, stefano farioli/ABE-2288-2020; Micheli, Laura/AAY-1641-2020; Tirone, Felice/P-6745-2014	Longone, Patrizia/0000-0001-8964-1637; MICHELI, LAURA/0000-0001-8647-7261; farioli vecchioli, stefano/0000-0001-7059-7779; Tirone, Felice/0000-0002-0980-4377; Cestari, Vincenzo/0000-0002-9623-157X	FIRB (Fondo Investimenti Ricerca di Base) [RBIN04P4ET]; Italian Ministry of Research; PRIN (Progettidi Ricerca di Interesse Nazionale) [20074Z3H3N_003]; FILAS	FIRB (Fondo Investimenti Ricerca di Base); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); PRIN (Progettidi Ricerca di Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FILAS	This research was supported by FIRB (Fondo Investimenti Ricerca di Base) project RBIN04P4ET (to F. T.; by the Italian Ministry of Research; http://www.miur.it/DefaultDesktop.aspx) and by PRIN (Progettidi Ricerca di Interesse Nazionale) project 20074Z3H3N_003 (to F. T.; by Italian Ministry of Research; http://www.miur.it/DefaultDesktop.aspx). LM and MC were supported by FILAS (Finanziaria Laziale di Sviluppo; Regione Lazio; http://www. filas. it/Page. aspx? IDPage = 156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Arguello AA, 2008, NEUROSCIENCE, V157, P70, DOI 10.1016/j.neuroscience.2008.08.064; ATTARDO A, 2009, CEREB CORTEX    0529; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Canzoniere D, 2004, J NEUROSCI, V24, P3355, DOI 10.1523/JNEUROSCI.3860-03.2004; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Corrente G, 2002, NEUROREPORT, V13, P417, DOI 10.1097/00001756-200203250-00011; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; DISALVO CV, 1995, CELL PROLIFERAT, V28, P511, DOI 10.1111/j.1365-2184.1995.tb00089.x; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fukuda S, 2003, J NEUROSCI, V23, P9357; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; IACOPETTI P, 1994, MECH DEVELOP, V47, P127, DOI 10.1016/0925-4773(94)90085-X; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kitajima K, 2006, BRAIN RES, V1073, P93, DOI 10.1016/j.brainres.2005.12.048; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Malin EL, 2006, P NATL ACAD SCI USA, V103, P1959, DOI 10.1073/pnas.0510890103; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; MCGAUGH JL, 1970, PHYSIOL BEHAV, V5, P1109, DOI 10.1016/0031-9384(70)90197-6; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2000, J CELL SCI, V113, P1101; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; ONEILL LP, 1995, EMBO J, V14, P3946, DOI 10.1002/j.1460-2075.1995.tb00066.x; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Passeri D, 2006, MOL CELL BIOL, V26, P5023, DOI 10.1128/MCB.01360-05; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WILSON RC, 1976, BEHAV BIOL, V17, P495, DOI 10.1016/S0091-6773(76)90901-9; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	82	66	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8339	10.1371/journal.pone.0008339	http://dx.doi.org/10.1371/journal.pone.0008339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020054	gold, Green Published			2022-12-25	WOS:000272834200006
J	Alexandrov, LB; Alexandrova, S; Usheva, A				Alexandrov, Ludmil B.; Alexandrova, Stoyana; Usheva, Anny			Computer Modeling Describes Gravity-Related Adaptation in Cell Cultures	PLOS ONE			English	Article							ESCHERICHIA-COLI; SURVIVAL; STARVATION; EVOLUTION; STRESS; RPOS	Questions about the changes of biological systems in response to hostile environmental factors are important but not easy to answer. Often, the traditional description with differential equations is difficult due to the overwhelming complexity of the living systems. Another way to describe complex systems is by simulating them with phenomenological models such as the well-known evolutionary agent-based model (EABM). Here we developed an EABM to simulate cell colonies as a multi-agent system that adapts to hyper-gravity in starvation conditions. In the model, the cell's heritable characteristics are generated and transferred randomly to offspring cells. After a qualitative validation of the model at normal gravity, we simulate cellular growth in hyper-gravity conditions. The obtained data are consistent with previously confirmed theoretical and experimental findings for bacterial behavior in environmental changes, including the experimental data from the microgravity Atlantis and the Hypergravity 3000 experiments. Our results demonstrate that it is possible to utilize an EABM with realistic qualitative description to examine the effects of hypergravity and starvation on complex cellular entities.	[Alexandrov, Ludmil B.; Alexandrova, Stoyana; Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Alexandrov, Ludmil B.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Alexandrova, Stoyana] Bryn Mawr Coll, Dept Phys, Bryn Mawr, PA 19010 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Cambridge; Bryn Mawr College	Alexandrov, LB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu	Alexandrov, Ludmil/B-6582-2014; Alexandrov, Ludmil/AAS-1454-2021	Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Ludmil/0000-0003-3596-4515	National Institutes of Health (NIH) [R01 GM073911]; Howard Hughes Medical Institute's Science Horizons Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute's Science Horizons Research(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health (NIH) grant R01 GM073911. SA was financed by Howard Hughes Medical Institute's Science Horizons Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; COOPER T, 2003, ESCHERICHIA COLI, P1072; Figge MT, 2006, PLOS COMPUT BIOL, V2, P1377, DOI 10.1371/journal.pcbi.0020171; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; GAC M, 2008, ESCHERICHIA COLI, V178, P1049; Ingber D, 1999, FASEB J, V13, pS3; JOHNSON BC, 2006, GRAVITATIONAL SPACE, V19; Kim PS, 2008, B MATH BIOL, V70, P728, DOI 10.1007/s11538-007-9276-z; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; Mitchell S. D., 2003, BIOL COMPLEXITY INTE; ONEAL CR, 1994, J BACTERIOL, V176, P4610, DOI 10.1128/JB.176.15.4610-4616.1994; Prescott L., 1996, MICROBIOLOGY, V3rd ed; Saint-Ruf C, 2004, GENETICS, V168, P541, DOI 10.1534/genetics.104.028704; Schaechter M, 2001, MICROBIOL MOL BIOL R, V65, P119, DOI 10.1128/MMBR.65.1.119-130.2001; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; SIEGELE DA, 1992, J BACTERIOL, V174, P345, DOI 10.1128/jb.174.2.345-348.1992; Spector MP, 1998, ADV MICROB PHYSIOL, V40, P233, DOI 10.1016/S0065-2911(08)60133-2; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Sun T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002129; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Zinser ER, 2000, J BACTERIOL, V182, P4361, DOI 10.1128/JB.182.15.4361-4365.2000	25	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8332	10.1371/journal.pone.0008332	http://dx.doi.org/10.1371/journal.pone.0008332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016778	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834000018
J	Perlin, MW; Sinelnikov, A				Perlin, Mark W.; Sinelnikov, Alexander			An Information Gap in DNA Evidence Interpretation	PLOS ONE			English	Article							MICROSATELLITE MARKERS; TANDEM REPEATS; STR MIXTURES; PEAK AREAS; PROFILES; IDENTIFICATION; DECONVOLUTION; SIMULATION; GENETICS; MODEL	Forensic DNA evidence often contains mixtures of multiple contributors, or is present in low template amounts. The resulting data signals may appear to be relatively uninformative when interpreted using qualitative inclusion-based methods. However, these same data can yield greater identification information when interpreted by computer using quantitative data-modeling methods. This study applies both qualitative and quantitative interpretation methods to a well-characterized DNA mixture and dilution data set, and compares the inferred match information. The results show that qualitative interpretation loses identification power at low culprit DNA quantities (below 100 pg), but that quantitative methods produce useful information down into the 10 pg range. Thus there is a ten-fold information gap that separates the qualitative and quantitative DNA mixture interpretation approaches. With low quantities of culprit DNA (10 pg to 100 pg), computer-based quantitative interpretation provides greater match sensitivity.	[Perlin, Mark W.] Cybergenetics, Pittsburgh, PA USA; [Sinelnikov, Alexander] Genetica, Cincinnati, OH USA		Perlin, MW (corresponding author), Cybergenetics, Pittsburgh, PA USA.	perlin@cybgen.com			Office of Justice Programs [2001-IJ-CX-K003]; National Institute of Justice; Department of Justice	Office of Justice Programs; National Institute of Justice(US National Institute of Justice); Department of Justice	This research was supported in part under Award number 2001-IJ-CX-K003 from the Office of Justice Programs, National Institute of Justice, Department of Justice (www.ojp.usdoj.gov/nij/). Cybergenetics (www.cybgen.com) provided salary support for Drs. Perlin and Sinelnikov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken C., 2004, STAT EVALUATION EVID; [Anonymous], 1950, PROBABILITY WEIGHING; BALDING DJ, 2009, INTERPRETING LOW TEM; Bill M, 2005, FORENSIC SCI INT, V148, P181, DOI 10.1016/j.forsciint.2004.06.037; BLUMSTEIN A, 1988, J QUANTITATIVE CRIMI, V0004; Buckleton J.S., 2004, FORENSIC DNA EVIDENC; Budowle B, 2009, J FORENSIC SCI, V54, P810, DOI 10.1111/j.1556-4029.2009.01046.x; Budowle B, 2009, CROAT MED J, V50, P207, DOI 10.3325/cmj.2009.50.207; Butler J., 2005, PROM 16 INT S HUM ID; Butler JM, 2005, FORENSIC DNA TYPING; Clayton TM, 1998, FORENSIC SCI INT, V91, P55, DOI 10.1016/S0379-0738(97)00175-8; Cook R, 1998, SCI JUSTICE, V38, P151, DOI 10.1016/S1355-0306(98)72099-4; Cowell RG, 2007, BAYESIAN ANAL, V2, P333, DOI 10.1214/07-BA214; Cowell RG, 2007, FORENSIC SCI INT, V166, P28, DOI 10.1016/j.forsciint.2006.03.021; Cowell RG, 2008, FORENS SCI INT-GEN S, V1, P640, DOI 10.1016/j.fsigss.2007.10.087; Cupples CM, 2009, J FORENSIC SCI, V54, P103, DOI 10.1111/j.1556-4029.2008.00914.x; Curran JM, 2008, SCI JUSTICE, V48, P168, DOI 10.1016/j.scijus.2007.09.014; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Evett IW, 1998, J FORENSIC SCI, V43, P62; Feller W., 1968, INTRO PROBABILITY TH, VI; FREGEAU CJ, 1993, BIOTECHNIQUES, V15, P100; Gelman A., 1995, BAYESIAN DATA ANAL; Gilder JR, 2007, J FORENSIC SCI, V52, P97, DOI 10.1111/j.1556-4029.2006.00318.x; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Gill P, 1998, FORENSIC SCI INT, V91, P41, DOI 10.1016/S0379-0738(97)00174-6; Gill P, 2000, FORENSIC SCI INT, V112, P17, DOI 10.1016/S0379-0738(00)00158-4; Gill P, 2006, FORENSIC SCI INT, V160, P90, DOI 10.1016/j.forsciint.2006.04.009; Gill P, 2005, NUCLEIC ACIDS RES, V33, P632, DOI 10.1093/nar/gki205; GILL P, 2009, GENETICS, V3, P104; *ILL STAT POL, 2008, PCR INT PROT 6 02 DN; KING G, 1989, AM J POLIT SCI, V33, P762, DOI 10.2307/2111071; Koehler JJ, 2001, LAW HUMAN BEHAV, V25, P493, DOI 10.1023/A:1012892815916; Kullback S., 1968, INFORM THEORY STAT; Ladd C, 2001, CROAT MED J, V42, P244; Lancia G, 1998, DISCRETE APPL MATH, V88, P291, DOI 10.1016/S0166-218X(98)80006-1; Lindley D.V., 2006, UNDERSTANDING UNCERT; Michaelis R C, 2008, LITIGATORS GUIDE DNA; Mortera J, 2003, THEOR POPUL BIOL, V63, P191, DOI 10.1016/S0040-5809(03)00006-6; *NAT RES COUNC, 1996, EV FOR DNA EV UPD EV; National Academy of Sciences, 2009, STRENGTHENING FORENS; NIEZGODA SJ, 1995, 6 INT S HUM ID SCOTT; O'Hagan A., 2004, BAYESIAN INFERENCE; Perlin MW, 2001, J FORENSIC SCI, V46, P1372; PERLIN MW, 1995, AM J HUM GENET, V57, P1199; PERLIN MW, 2009, MATCH LIKEL IN PRESS; PERLIN MW, 2006, PROM 17 INT S HUM ID; Perlin MW, 2003, PROM 14 INT S HUM ID; Savage L.J., 1954, FDN STAT; Scientific Working Group on DNA Analysis Methods (SWGDAM), 2000, FORENSIC SCI COMMUN, V2; Sisson SA, 2007, AM STAT, V61, P112, DOI 10.1198/000313007X169965; Stenman J, 2001, NAT BIOTECHNOL, V19, P1011, DOI 10.1038/nbt1101-1011b; Stolovitzky G, 1996, P NATL ACAD SCI USA, V93, P12947, DOI 10.1073/pnas.93.23.12947; THOMAS DC, 1995, MARKOV CHAIN MONTE C, P419; TOBIN WA, 2006, CHAMPION, V30, P12; Wang TW, 2006, J FORENSIC SCI, V51, P1284, DOI 10.1111/j.1556-4029.2006.00268.x; WICKENHEISER R, 2004, J BIOLAW BUS, V7; Zedlewski Edwin, 2006, NIJ J, V253, P2	57	44	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8327	10.1371/journal.pone.0008327	http://dx.doi.org/10.1371/journal.pone.0008327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20020039	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834000014
J	Kozera, L; White, E; Calaghan, S				Kozera, Lukasz; White, Ed; Calaghan, Sarah			Caveolae Act as Membrane Reserves Which Limit Mechanosensitive I-Cl,I-swell Channel Activation during Swelling in the Rat Ventricular Myocyte	PLOS ONE			English	Article							CARDIAC MYOCYTES; TYROSINE KINASES; CHLORIDE CHANNEL; APICAL MEMBRANE; VOLUME; SRC; INCREASES; VESICLES; PROTEIN; STRETCH	Background: Many ion channels are preferentially located in caveolae where compartmentalisation/scaffolding with signal transduction components regulates their activity. Channels that are mechanosensitive may be additionally dependent on caveolar control of the mechanical state of the membrane. Here we test which mechanism underlies caveolar-regulation of the mechanosensitive I-Cl,I-swell channel in the adult cardiac myocyte. Methodology/Principal Findings: Rat ventricular myocytes were exposed to solution of 0.02 tonicity (T; until lysis), 0.64T for 10-15 min (swelling), and/or methyl-beta-cyclodextrin (MBCD; to disrupt caveolae). MBCD and 0.64T swelling reduced the number of caveolae visualised by electron microscopy by 75 and 50% respectively. MBCD stimulated translocation of caveolin 3 from caveolae-enriched buoyant membrane fractions, but both caveolin 1 and 3 remained in buoyant fractions after swelling. I-Cl,I-swell inhibition in control cells decreased time to half-maximal volume (t(0.5,vol); 0.64T), consistent with a role for I-Cl,I-swell in volume regulation. MBCD-treated cells showed reduced time to lysis (0.02T) and t(0.5,vol) (0.64T) compared with controls. The negative inotropic response to swelling (an index of I-Cl,I-swell activation) was enhanced by MBCD. Conclusions/Significance: These data show that disrupting caveolae removes essential membrane reserves, which speeds swelling in hyposmotic conditions, and thereby promotes activation of I-Cl,I-swell. They illustrate a general principle whereby caveolae as a membrane reserve limit increases in membrane tension during stretch/swelling thereby restricting mechanosensitive channel activation.	[Kozera, Lukasz; White, Ed; Calaghan, Sarah] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England	University of Leeds	Kozera, L (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England.	s.c.calaghan@leeds.ac.uk		Calaghan, Sarah/0000-0002-9145-2576	Cardiovascular Institute at Leeds (CRISTAL); British Heart Foundation [PG/06/047]	Cardiovascular Institute at Leeds (CRISTAL); British Heart Foundation(British Heart Foundation)	This work was supported by a Cardiovascular Institute at Leeds (CRISTAL) Ph. D. studentship to L. K. and the British Heart Foundation (grant number PG/06/047 to S. C, E. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; BOYETT MR, 1991, EXP PHYSIOL, V76, P259, DOI 10.1113/expphysiol.1991.sp003492; Brette F, 2000, AM J PHYSIOL-HEART C, V279, pH1963, DOI 10.1152/ajpheart.2000.279.4.H1963; Browe DM, 2003, J GEN PHYSIOL, V122, P689, DOI 10.1085/jgp.200308899; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Calaghan SC, 1998, PFLUG ARCH EUR J PHY, V436, P948, DOI 10.1007/s004240050728; Dick GM, 1999, BRIT J PHARMACOL, V127, P1819, DOI 10.1038/sj.bjp.0702730; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; GABELLA G, 1978, J ULTRA MOL STRUCT R, V65, P135, DOI 10.1016/S0022-5320(78)90051-5; Groulx N, 2006, J MEMBRANE BIOL, V214, P43, DOI 10.1007/s00232-006-0080-8; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Kawabe J, 2004, AM J PHYSIOL-HEART C, V286, pH1845, DOI 10.1152/ajpheart.00593.2003; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kohl P, 2003, PROG BIOPHYS MOL BIO, V82, P221, DOI 10.1016/S0079-6107(03)00024-5; KORDYLEWSKI L, 1993, CIRC RES, V73, P135, DOI 10.1161/01.RES.73.1.135; LEWIS SA, 1984, J MEMBRANE BIOL, V82, P123, DOI 10.1007/BF01868937; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; Li GR, 2002, AM J PHYSIOL-HEART C, V282, pH1270, DOI 10.1152/ajpheart.00946.2001; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; MARTINEZPALOMO A, 1973, J CELL BIOL, V58, P1, DOI 10.1083/jcb.58.1.1; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Okada Yasunobu, 1999, Journal of Physiology (Cambridge), V520, P2, DOI 10.1111/j.1469-7793.1999.00002.x; PAGE E, 1978, AM J PHYSIOL, V235, pC147, DOI 10.1152/ajpcell.1978.235.5.C147; Patel HH, 2007, FASEB J, V21, P1565, DOI 10.1096/fj.06-7719com; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Ren ZJ, 2005, AM J PHYSIOL-HEART C, V288, pH2628, DOI 10.1152/ajpheart.00992.2004; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Sens P, 2007, LIPID RAFTS CAVEOLAE, P25; SEVERS NJ, 1988, J CELL SCI, V90, P341; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Trouet D, 1999, J PHYSIOL-LONDON, V520, P113, DOI 10.1111/j.1469-7793.1999.t01-1-00113.x; TSENG GN, 1992, AM J PHYSIOL, V262, pC1056, DOI 10.1152/ajpcell.1992.262.4.C1056; VANDENBERG JI, 1994, J GEN PHYSIOL, V104, P997, DOI 10.1085/jgp.104.6.997; Vandenberg JI, 1997, AM J PHYSIOL-CELL PH, V273, pC541, DOI 10.1152/ajpcell.1997.273.2.C541; Walsh KB, 2005, AM J PHYSIOL-HEART C, V289, pH2566, DOI 10.1152/ajpheart.00292.2005	39	83	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8312	10.1371/journal.pone.0008312	http://dx.doi.org/10.1371/journal.pone.0008312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011535	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300055
J	Imai, N; Samejima, H; Langner, A; Ong, RC; Kita, S; Titin, J; Chung, AYC; Lagan, P; Lee, YF; Kitayama, K				Imai, Nobuo; Samejima, Hiromitsu; Langner, Andreas; Ong, Robert C.; Kita, Satoshi; Titin, Jupiri; Chung, Arthur Y. C.; Lagan, Peter; Lee, Ying Fah; Kitayama, Kanehiro			Co-Benefits of Sustainable Forest Management in Biodiversity Conservation and Carbon Sequestration	PLOS ONE			English	Article							REDUCED-IMPACT; TROPICAL FORESTS; MALAYSIA; SABAH; INDONESIA	Background: Sustainable forest management (SFM), which has been recently introduced to tropical natural production forests, is beneficial in maintaining timber resources, but information about the co-benefits for biodiversity conservation and carbon sequestration is currently lacking. Methodology/Principal Findings: We estimated the diversity of medium to large-bodied forest-dwelling vertebrates using a heat-sensor camera trapping system and the amount of above-ground, fine-roots, and soil organic carbon by a combination of ground surveys and aerial-imagery interpretations. This research was undertaken both in SFM applied as well as conventionally logged production forests in Sabah, Malaysian Borneo. Our carbon estimation revealed that the application of SFM resulted in a net gain of 54 Mg C ha(-1) on a landscape scale. Overall vertebrate diversity was greater in the SFM applied forest than in the conventionally logged forest. Specifically, several vertebrate species (6 out of recorded 36 species) showed higher frequency in the SFM applied forest than in the conventionally logged forest. Conclusions/Significance: The application of SFM to degraded natural production forests could result in greater diversity and abundance of vertebrate species as well as increasing carbon storage in the tropical rain forest ecosystems.	[Imai, Nobuo; Samejima, Hiromitsu; Langner, Andreas; Kita, Satoshi; Kitayama, Kanehiro] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Ong, Robert C.; Titin, Jupiri; Chung, Arthur Y. C.; Lee, Ying Fah] Forest Res Ctr, Sabah Forestry Dept, Sandakan, Sabah, Malaysia; [Lagan, Peter] Deramakot Forest Off, Sabah Forestry Dept, Sandakan, Sabah, Malaysia	Kyoto University; Pusat Penyelidikan Hutan; Pusat Penyelidikan Hutan	Imai, N (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan.	inobuo@kais.kyoto-u.ac.jp	Langner, Andreas/J-9746-2019; Imai, Nobuo/AAR-7008-2020	Langner, Andreas/0000-0002-8083-3779; Imai, Nobuo/0000-0002-8435-7693	Ministry of the Environment, Japan [F-071]; JSPS	Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Global Environment Research Fund (F-071) of the Ministry of the Environment, Japan, to KK and in part by the JSPS AA Science Platform Program to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Bertault JG, 1997, FOREST ECOL MANAG, V94, P209, DOI 10.1016/S0378-1127(96)03974-6; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brown S, 1997, 134 FAO; Gitelson AA, 2004, J PLANT PHYSIOL, V161, P165, DOI 10.1078/0176-1617-01176; *INT TROP TIMB ORG, 2006, STAT TROP FOR MAN 20; IUCN, 2014, IUCN RED LIST THREAT; KLEINE M, 1993, FOREST ECOL MANAG, V61, P277, DOI 10.1016/0378-1127(93)90207-4; Kollert W, 2007, FOREST POLICY ECON, V9, P862, DOI 10.1016/j.forpol.2006.03.005; Lagan P, 2007, ECOL RES, V22, P414, DOI 10.1007/s11284-007-0362-3; LEE YF, 2006, P 2 WORKSH SYN CARB; ONG RC, 1996, DIPTEROCARP FOREST E, P274; ONG RC, 1995, 2 FRC SAB FOR DEP; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Putz FE, 2008, PLOS BIOL, V6, P1368, DOI 10.1371/journal.pbio.0060166; *SAB FOR DEP, 2005, FOR MAN PLANT, V2; Sist P, 1998, FOREST ECOL MANAG, V108, P251, DOI 10.1016/S0378-1127(98)00228-X; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; World Resources Institute, 2005, MILL EC ASS EC HUM W	20	51	53	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8267	10.1371/journal.pone.0008267	http://dx.doi.org/10.1371/journal.pone.0008267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011516	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830200011
J	Guenther, FH; Brumberg, JS; Wright, EJ; Nieto-Castanon, A; Tourville, JA; Panko, M; Law, R; Siebert, SA; Bartels, JL; Andreasen, DS; Ehirim, P; Mao, H; Kennedy, PR				Guenther, Frank H.; Brumberg, Jonathan S.; Wright, E. Joseph; Nieto-Castanon, Alfonso; Tourville, Jason A.; Panko, Mikhail; Law, Robert; Siebert, Steven A.; Bartels, Jess L.; Andreasen, Dinal S.; Ehirim, Princewill; Mao, Hui; Kennedy, Philip R.			A Wireless Brain-Machine Interface for Real-Time Speech Synthesis	PLOS ONE			English	Article							THOUGHT-TRANSLATION DEVICE; COMPUTER INTERFACE; CORTICAL CONTROL; CONE ELECTRODE; ARM MOVEMENTS; MOTOR CORTEX; BCI; COMMUNICATION; PERCEPTION; TTD	Background: Brain-machine interfaces (BMIs) involving electrodes implanted into the human cerebral cortex have recently been developed in an attempt to restore function to profoundly paralyzed individuals. Current BMIs for restoring communication can provide important capabilities via a typing process, but unfortunately they are only capable of slow communication rates. In the current study we use a novel approach to speech restoration in which we decode continuous auditory parameters for a real-time speech synthesizer from neuronal activity in motor cortex during attempted speech. Methodology/Principal Findings: Neural signals recorded by a Neurotrophic Electrode implanted in a speech-related region of the left precentral gyrus of a human volunteer suffering from locked-in syndrome, characterized by near-total paralysis with spared cognition, were transmitted wirelessly across the scalp and used to drive a speech synthesizer. A Kalman filter-based decoder translated the neural signals generated during attempted speech into continuous parameters for controlling a synthesizer that provided immediate (within 50 ms) auditory feedback of the decoded sound. Accuracy of the volunteer's vowel productions with the synthesizer improved quickly with practice, with a 25% improvement in average hit rate (from 45% to 70%) and 46% decrease in average endpoint error from the first to the last block of a three-vowel task. Conclusions/Significance: Our results support the feasibility of neural prostheses that may have the potential to provide near-conversational synthetic speech output for individuals with severely impaired speech motor control. They also provide an initial glimpse into the functional properties of neurons in speech motor cortical areas.	[Guenther, Frank H.; Brumberg, Jonathan S.; Tourville, Jason A.; Panko, Mikhail; Law, Robert] Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; [Guenther, Frank H.; Brumberg, Jonathan S.; Tourville, Jason A.; Panko, Mikhail; Law, Robert] Boston Univ, Sargent Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; [Guenther, Frank H.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Brumberg, Jonathan S.; Wright, E. Joseph; Siebert, Steven A.; Bartels, Jess L.; Andreasen, Dinal S.; Kennedy, Philip R.] Neural Signals Inc, Duluth, GA USA; [Nieto-Castanon, Alfonso] StatsANC LLC, Buenos Aires, DF, Argentina; [Andreasen, Dinal S.] Georgia Tech Res Inst, Marietta, GA USA; [Ehirim, Princewill] Gwinnett Med Ctr, Lawrenceville, GA USA; [Mao, Hui] Emory Univ Hosp, Emory Ctr Syst Imaging, Atlanta, GA 30322 USA	Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology; Emory University	Guenther, FH (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.	guenther@cns.bu.edu		Tourville, Jason/0000-0002-7197-2427; Brumberg, Jonathan/0000-0001-5739-968X; Panko, Mikhail/0000-0003-3927-1265; Nieto-Castanon, Alfonso/0000-0002-3451-3475	National Institute on Deafness and other Communication Disorders [R44-DC007050, R01-DC007683, R01-DC002852]; CELEST; NSF [SBE-0354378]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R44DC007050, R01DC002852, R01DC007683] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CELEST(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research supported by National Institute on Deafness and other Communication Disorders grants R44-DC007050, R01-DC007683, and R01-DC002852 and by CELEST, an NSF Science of Learning Center (SBE-0354378). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Employees EJW, SAS, JLB, DSA, and PRK of Neural Signals, Inc (the recipient of Grant R44-DC007050; http://www.neuralsignals.com) played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Bartels J, 2008, J NEUROSCI METH, V174, P168, DOI 10.1016/j.jneumeth.2008.06.030; Birbaumer N, 2003, IEEE T NEUR SYS REH, V11, P120, DOI 10.1109/TNSRE.2003.814439; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2000, IEEE T REHABIL ENG, V8, P190, DOI 10.1109/86.847812; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Cox D. R., 1962, RENEWAL THEORY; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; FANT G, 1959, ERICSSON TECHNICS, V1, P106; FLANAGAN JL, 1963, 15 ANN M AUD ENG SOC; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Hinterberger T, 2003, CLIN NEUROPHYSIOL, V114, P416, DOI 10.1016/S1388-2457(02)00411-X; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; KENNEDY PR, 1989, J NEUROSCI METH, V29, P181, DOI 10.1016/0165-0270(89)90142-8; KENNEDY PR, 1992, NEUROSCI LETT, V142, P89, DOI 10.1016/0304-3940(92)90627-J; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Kim S-P, 2007, 3 INT IEEE EMBS C NE; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 1999, EXP BRAIN RES, V124, P223, DOI 10.1007/s002210050617; Lawrence W., 1953, COMMUN THEOR, P460; MAEDA S, 1990, NATO ADV SCI I D-BEH, V55, P131; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Rabiner L. R., 1993, FUNDAMENTALS SPEECH; RABINER LR, 1968, J ACOUST SOC AM, V43, P822, DOI 10.1121/1.1910901; REMEZ RE, 1981, SCIENCE, V212, P947, DOI 10.1126/science.7233191; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P222, DOI 10.1109/86.847823; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Zemlin W., 1998, SPEECH HEARING SCI A	48	164	171	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8218	10.1371/journal.pone.0008218	http://dx.doi.org/10.1371/journal.pone.0008218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011034	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829800009
J	Pradelli, LA; Beneteau, M; Chauvin, C; Jacquin, MA; Marchetti, S; Munoz-Pinedo, C; Auberger, P; Pende, M; Ricci, JE				Pradelli, L. A.; Beneteau, M.; Chauvin, C.; Jacquin, M. A.; Marchetti, S.; Munoz-Pinedo, C.; Auberger, P.; Pende, M.; Ricci, J-E			Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation	ONCOGENE			English	Article						apoptosis; protein translation; glycolysis; AMPK; mTOR; Mcl-1	POSITRON-EMISSION-TOMOGRAPHY; CANCER-THERAPY; GLUCOSE-METABOLISM; EXPRESSION; SURVIVAL; TRAIL; NECROSIS; MTOR; AKT; MODULATION	Most cancer cells exhibit increased glycolysis for generation of their energy supply. This specificity could be used to preferentially kill these cells. In this study, we identified the signaling pathway initiated by glycolysis inhibition that results in sensitization to death receptor (DR)-induced apoptosis. We showed, in several human cancer cell lines (such as Jurkat, HeLa, U937), that glucose removal or the use of nonmetabolizable form of glucose (2-deoxyglucose) dramatically enhances apoptosis induced by Fas or by tumor necrosis factor-related apoptosis-inducing ligand. This sensitization is controlled through the adenosine monophosphate (AMP)-activated protein kinase (AMPK), which is the central energy-sensing system of the cell. We established the fact that AMPK is activated upon glycolysis block resulting in mammalian target of rapamycin (mTOR) inhibition leading to Mcl-1 decrease, but no other Bcl-2 anti-apoptotic members. Interestingly, we determined that, upon glycolysis inhibition, the AMPK-mTOR pathway controlled Mcl-1 levels neither through transcriptional nor through posttranslational mechanism but rather by controlling its translation. Therefore, our results show a novel mechanism for the sensitization to DR-induced apoptosis linking glucose metabolism to Mcl-1 down-expression. In addition, this study provides a rationale for the combined use of DR ligands with AMPK activators or mTOR inhibitors in the treatment of human cancers. Oncogene (2010) 29, 1641-1652; doi:10.1038/onc.2009.448; published online 7 December 2009	[Pradelli, L. A.; Beneteau, M.; Jacquin, M. A.; Ricci, J-E] Fac Med Nice, INSERM, Equipe AVENIR 3, U895,C3M, F-06107 Nice 2, France; [Pradelli, L. A.; Beneteau, M.; Jacquin, M. A.; Marchetti, S.; Auberger, P.; Ricci, J-E] Univ Nice Sophia Antipolis, Nice, France; [Chauvin, C.; Pende, M.] INSERM, U845, Paris, France; [Chauvin, C.; Pende, M.] Univ Paris 05, Fac Med, UMRS 845, Paris, France; [Munoz-Pinedo, C.] Inst Invest Biomed Bellvitge IDIBELL, Ctr Mol Oncol, Barcelona, Spain; [Marchetti, S.; Auberger, P.] Fac Med Nice, INSERM, Equipe 2, U895,C3M, F-06034 Nice, France; [Ricci, J-E] Ctr Hosp Univ Nice, Dept Anesthesie Reanimat, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Ricci, JE (corresponding author), Fac Med Nice, INSERM, Equipe AVENIR 3, U895,C3M, 28 Ave Valombrose, F-06107 Nice 2, France.	ricci@unice.fr	AUBERGER, Patrick/G-1491-2013; Pende, Mario/AFR-1348-2022; Munoz-Pinedo, Cristina/B-6118-2008; Ricci, Jean Ehrland/I-7117-2016; Marchetti, Sandrine/P-6479-2016; RICCI, Jean Ehrland/AAS-4379-2020	AUBERGER, Patrick/0000-0002-2481-8275; Pende, Mario/0000-0002-7864-8937; Munoz-Pinedo, Cristina/0000-0002-9120-664X; Ricci, Jean Ehrland/0000-0003-1585-8117; Marchetti, Sandrine/0000-0001-8326-5730; RICCI, Jean Ehrland/0000-0003-1585-8117	Association pour la Recherche sur le Cancer; l'Agence Nationale de la Recherche [ANR-09-JCJC-0003-01]; Conseil regional Provence-Alpes-Cote-d'Azur; La Fondation de France; Fondo de Investigaciones Sanitarias of Spain; INSERM-CHU de Nice	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); l'Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil regional Provence-Alpes-Cote-d'Azur(Region Provence-Alpes-Cote d'AzurRegion Auvergne-Rhone-Alpes); La Fondation de France(Fondation de France); Fondo de Investigaciones Sanitarias of Spain(Instituto de Salud Carlos III); INSERM-CHU de Nice(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank Magali Herrant for her input, Audrey Paul and Celine Gracia for their technical assistance, Issam Ben Sahra, Vanessa Lavallard and Drs Anne-Odile Hueber, Frederic Bost, Stephane Rocchi and Marcel Deckert for providing tools and advises, Dr Ulrich Maurer for providing GSK3 inhibitor and Dr DR Green for Bcl-2 overexpressing Jurkat cells. This study was supported by the Association pour la Recherche sur le Cancer and by l'Agence Nationale de la Recherche (ref ANR-09-JCJC-0003-01). LAP and MAJ received a fellowship from the Conseil regional Provence-Alpes-Cote-d'Azur. MB is supported by a fellowship from La Fondation de France, CM-P is supported by the Fondo de Investigaciones Sanitarias of Spain and J-ER is a recipient of a contrat d'interface INSERM-CHU de Nice.	Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Chi MMY, 2000, J BIOL CHEM, V275, P40252, DOI 10.1074/jbc.M005508200; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Detterbeck FC, 2004, CHEST, V126, P1656, DOI 10.1378/chest.126.5.1656; Eguchi Y, 1997, CANCER RES, V57, P1835; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Ferrari D, 1998, J EXP MED, V188, P979, DOI 10.1084/jem.188.5.979; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HALICKA HD, 1995, CANCER RES, V55, P444; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Kruyt FAE, 2008, CANCER LETT, V263, P14, DOI 10.1016/j.canlet.2008.02.003; Lavallard VJ, 2009, CANCER RES, V69, P3013, DOI 10.1158/0008-5472.CAN-08-2731; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Luciano F, 2002, LEUKEMIA, V16, P700, DOI 10.1038/sj.leu.2402401; Marchetti S, 2009, EMBO J, V28, P2449, DOI 10.1038/emboj.2009.183; MAURER F, 1906, HDB VERGLEICHENDEN 1, V3, P1; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Nam SY, 2002, ONCOGENE, V21, P337, DOI 10.1038/sj.onc.1205068; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; VOLLAND S, 1992, INT J CANCER, V52, P384, DOI 10.1002/ijc.2910520310; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	38	105	113	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1641	1652		10.1038/onc.2009.448	http://dx.doi.org/10.1038/onc.2009.448			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	19966861				2022-12-25	WOS:000275694700009
J	Hirota, N; Yasuda, D; Hashidate, T; Yamamoto, T; Yamaguchi, S; Nagamune, T; Nagase, T; Shimizu, T; Nakamura, M				Hirota, Nobuaki; Yasuda, Daisuke; Hashidate, Tomomi; Yamamoto, Teruyasu; Yamaguchi, Satoshi; Nagamune, Teruyuki; Nagase, Takahide; Shimizu, Takao; Nakamura, Motonao			Amino Acid Residues Critical for Endoplasmic Reticulum Export and Trafficking of Platelet-activating Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; V2 VASOPRESSIN; PHARMACOLOGICAL CHAPERONES; LIGAND-BINDING; TRANSMEMBRANE DOMAINS; IDENTIFICATION; MUTATIONS; RESCUE; INHIBITION; EXPRESSION	Several residues are conserved in the transmembrane domains (TMs) of G-protein coupled receptors. Here we demonstrate that a conserved proline, Pro(247), in TM6 of platelet-activating factor receptor (PAFR) is required for endoplasmic reticulum (ER) export and trafficking after agonist-induced internalization. Alanine-substituted mutants of the conserved residues of PAFRs, including P247A, were retained in the ER. Because a PAFR antagonist, Y-24180, acted as a pharmacological chaperone to rescue ER retention, this retention is due to misfolding of PAFR. Methylcarbamyl (mc)-PAF, a PAFR agonist, did not increase the cell surface expression of P247A, even though another ER-retained mutant, D63A, was effectively trafficked. Signaling and accumulation of the receptors in the early endosomes were observed in the mc-PAF-treated P247A-expressing cells, suggesting that P247A was trafficked to the cell surface by mc-PAF, and thereafter disappeared from the surface due to aberrant trafficking, e.g. enhanced internalization, deficiency in recycling, and/or accelerated degradation. The aberrant trafficking was confirmed with a sortase-A-mediated method for labeling cell surface proteins. These results demonstrate that the conserved proline in TM6 is crucial for intracellular trafficking of PAFR.	[Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Hirota, Nobuaki; Nagase, Takahide] Univ Tokyo, Dept Resp Med, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Yamamoto, Teruyasu; Yamaguchi, Satoshi; Nagamune, Teruyuki] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1130033, Japan; [Yamaguchi, Satoshi; Nagamune, Teruyuki; Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Nakamura, M (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moto-nakamura@umin.net	Shimizu, Takao/AAV-7052-2021; Nagamune, Teruyuki/R-7708-2017; Yamaguchi, Satoshi/V-3211-2017	Nagamune, Teruyuki/0000-0002-2435-0270; Yamaguchi, Satoshi/0000-0003-4822-7469; Yasuda, Daisuke/0000-0001-5513-0695	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Center for NanoBio Integration, the University of Tokyo	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration, the University of Tokyo	This work was supported in part by a grant-in-aid for Challenging Exploratory Research (to M. N.) and a grant-in-aid for Specially Promoted Research (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants from the Japan Society for the Promotion of Science (Global COE program) and the Center for NanoBio Integration, the University of Tokyo.	Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANDA PK, 1993, MOL PHARMACOL, V43, P516; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Conner AC, 2005, MOL PHARMACOL, V67, P20, DOI 10.1124/mol.67.1.20; Eilers M, 2005, BIOCHEMISTRY-US, V44, P8959, DOI 10.1021/bi047316u; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Ishii I, 1997, J BIOL CHEM, V272, P7846, DOI 10.1074/jbc.272.12.7846; Ishii I, 1998, J BIOL CHEM, V273, P9878, DOI 10.1074/jbc.273.16.9878; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OFLAHERTY JT, 1987, BIOCHEM BIOPH RES CO, V147, P18, DOI 10.1016/S0006-291X(87)80081-5; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAN Y, 1994, J BIOL CHEM, V269, P31933; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; Parent JL, 1996, BIOCHEM BIOPH RES CO, V219, P968, DOI 10.1006/bbrc.1996.0341; Parent JL, 1996, J BIOL CHEM, V271, P23298, DOI 10.1074/jbc.271.38.23298; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; ROSE PM, 1995, FEBS LETT, V361, P243, DOI 10.1016/0014-5793(95)00164-5; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; SOUIED E, 1994, HUM MOL GENET, V3, P1433, DOI 10.1093/hmg/3.8.1433; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Tan CM, 2003, J BIOL CHEM, V278, P35678, DOI 10.1074/jbc.M301888200; TERASAWA M, 1990, PROSTAGLANDINS, V40, P553, DOI 10.1016/0090-6980(90)90001-C; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Xia S, 2004, P NATL ACAD SCI USA, V101, P15207, DOI 10.1073/pnas.0406571101; Xu W, 2001, BIOCHEMISTRY-US, V40, P8018, DOI 10.1021/bi002490d; Yamamoto T, 2009, CHEM COMMUN, P1022, DOI 10.1039/b818792d; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Zhang HFM, 2003, J BIOL CHEM, V278, P33011, DOI 10.1074/jbc.M305352200	47	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5931	5940		10.1074/jbc.M109.066282	http://dx.doi.org/10.1074/jbc.M109.066282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007715	hybrid, Green Published			2022-12-25	WOS:000275327200083
J	Regazzetti, C; Bost, F; Le Marchand-Brustel, Y; Tanti, JF; Giorgetti-Peraldi, S				Regazzetti, Claire; Bost, Frederic; Le Marchand-Brustel, Yannick; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie			Insulin Induces REDD1 Expression through Hypoxia-inducible Factor 1 Activation in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT/ENHANCER-BINDING PROTEIN; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; FACTOR-I; STRESS; TARGET; TUMOR; MTOR; GENE; RAPAMYCIN	REDD1 (regulated in development and DNA damage responses) is essential for the inhibition of mTORC1 (mammalian target of rapamycin complex) signaling pathway in response to hypoxia. REDD1 expression is regulated by many stresses such as hypoxia, oxidative stress, and energy depletion. However, the regulation of REDD1 expression in response to insulin remains unknown. In the present study, we demonstrate that in murine and in human adipocytes, insulin stimulates REDD1 expression. Insulin-induced REDD1 expression occurs through phosphoinositide 3-kinase/mTOR-dependent pathways. Moreover, using echinomycin, a hypoxia-inducible factor 1 (HIF-1) inhibitor, and HIF-1 alpha small interfering RNA, we demonstrate that insulin stimulates REDD1 expression only through the transcription factor HIF-1. In conclusion, our study shows that insulin stimulates REDD1 expression in adipocytes.	Mediterranean Res Ctr Mol Med, Team Cellular & Mol Physiopathol Obes & Diabet, INSERM, U895, F-06204 Nice, France; Univ Nice Sophia Antipolis, Inst Federatif Rech 50, F-06204 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Giorgetti-Peraldi, S (corresponding author), Ctr Mediterraneen Med Mol, INSERM, U895, Batiment Archimed,151 Route St Antoine Ginestiere, F-06204 Nice 3, France.	peraldis@unice.fr	BOST, Frederic/AAN-4691-2020	BOST, Frederic/0000-0003-4509-4701; Tanti, Jean-Francois/0000-0003-1782-1318; Regazzetti, Claire/0000-0002-8094-5885; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618	INSERM, France; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); Association for Research on Diabetes (Paris, France); Association pour la Recherche contre le Cancer [1018]; University of Nice-Sophia Antipolis, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes; European Commission [LSHM-CT-2005-018734]	INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); Association for Research on Diabetes (Paris, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); University of Nice-Sophia Antipolis, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by INSERM, France, the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM), ALFEDIAM-Roche Diagnostics, the Association for Research on Diabetes (Paris, France), the Association pour la Recherche contre le Cancer Grant 1018, the University of Nice-Sophia Antipolis, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes. This work is part of the project "Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome" (HEPADIP), which is supported by the European Commission as an integrated Project under the 6th Framework Program, Contract LSHM-CT-2005-018734.	Aouadi M, 2007, FEBS LETT, V581, P5591, DOI 10.1016/j.febslet.2007.10.064; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Datta K, 2004, CANCER RES, V64, P456, DOI 10.1158/0008-5472.CAN-03-2706; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Eriksson JW, 2007, FEBS LETT, V581, P3734, DOI 10.1016/j.febslet.2007.06.044; Frost RA, 2009, J CELL BIOCHEM, V108, P1192, DOI 10.1002/jcb.22349; Glassford AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1590, DOI 10.1152/ajpendo.00490.2007; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Jin HO, 2009, FEBS LETT, V583, P123, DOI 10.1016/j.febslet.2008.11.035; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Lee JW, 2007, CANCER SCI, V98, P1476, DOI 10.1111/j.1349-7006.2007.00535.x; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079	30	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5157	5164		10.1074/jbc.M109.047688	http://dx.doi.org/10.1074/jbc.M109.047688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996311	hybrid, Green Published			2022-12-25	WOS:000275327200007
J	Wu, LLY; Fan, YJ; Li, SH; Li, XJ; Zhou, XF				Wu, Linda Lin-yan; Fan, Yongjun; Li, Shihua; Li, Xiao-Jiang; Zhou, Xin-Fu			Huntingtin-associated Protein-1 Interacts with Pro-brain-derived Neurotrophic Factor and Mediates Its Transport and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT SECRETION; BDNF MESSENGER-RNA; PRIMARY SENSORY NEURONS; VAL66MET POLYMORPHISM; INTRACELLULAR TRAFFICKING; HIPPOCAMPAL-NEURONS; SYNAPTIC MODULATION; ANTEROGRADE TRANSPORT; AXONAL-TRANSPORT; NERVOUS-SYSTEM	Brain-derived neurotrophic factor (BDNF) plays a pivotal role in brain development and synaptic plasticity. It is synthesized as a precursor (pro-BDNF), sorted into the secretory pathway, transported along dendrites and axons, and released in an activity-dependent manner. Mutant Huntingtin with expanded polyglutamine (polyQ) and the V66M polymorphism of BDNF reduce the dendritic distribution and axonal transport of BDNF. However, the mechanism underlying this defective transport remains unclear. Here, we report that Huntingtin-associated protein-1 (HAP1) interacts with the prodomain of BDNF and that the interaction was reduced in the presence of polyQ-expanded Huntingtin and BDNF V66M. Consistently, there was reduced coimmunoprecipitation of pro-BDNF with HAP1 in the brain homogenate of Huntington disease. Pro-BDNF distribution in the neuronal processes and its accumulation in the proximal and distal segments of crushed sciatic nerve and the activity-dependent release of pro-BDNF were abolished in HAP1(-/-) mice. These results suggest that HAP1 may participate in axonal transport and activity-dependent release of pro-BDNF by interacting with the BDNF prodomain. Accordingly, the decreased interaction between HAP1 and pro-BDNF in Huntington disease may reduce the release and transport of BDNF.	[Wu, Linda Lin-yan; Fan, Yongjun; Zhou, Xin-Fu] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Wu, Linda Lin-yan; Fan, Yongjun; Zhou, Xin-Fu] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Flinders University South Australia; Flinders University South Australia; Emory University	Zhou, XF (corresponding author), Flinders Univ S Australia, Dept Human Physiol, GPO Box 2100, Adelaide, SA 5001, Australia.	Xin-fu.zhou@flinders.edu.au	Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/F-4119-2013; zhou, xin-fu/G-6643-2011	Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175; 	National Health and Medical Research Council [375110, 480423]; Flinders University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Flinders University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Health and Medical Research Council Grants 375110 and 480423.; Supported by an International postgraduate research scholarship and Flinders University postgraduate scholarships.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Butowt R, 2001, J NEUROSCI, V21, P8915, DOI 10.1523/JNEUROSCI.21-22-08915.2001; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Conner JM, 1998, REV NEUROSCIENCE, V9, P91; del Toro D, 2006, J NEUROSCI, V26, P12748, DOI 10.1523/JNEUROSCI.3873-06.2006; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Ferrer I, 1999, REV NEUROLOGIA, V29, P515, DOI 10.33588/rn.2906.99173; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; GRAY EG, 1962, J ANAT, V96, P79; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hashimoto K, 2007, BIOESSAYS, V29, P116, DOI 10.1002/bies.20534; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; Hibbert AP, 2003, J BIOL CHEM, V278, P48129, DOI 10.1074/jbc.M300961200; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Humbert Sandrine, 2005, Journal de la Societe de Biologie, V199, P247, DOI 10.1051/jbio:2005026; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Martin EJ, 1999, J COMP NEUROL, V403, P421; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Momose Y, 2002, ANN NEUROL, V51, P133, DOI 10.1002/ana.10079; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tonra JR, 1999, MICROSC RES TECHNIQ, V45, P225, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<225::AID-JEMT6>3.0.CO;2-1; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; von Bartheld CS, 2001, MOL NEUROBIOL, V24, P1, DOI 10.1385/MN:24:1-3:001; Wang H, 2002, NEUROSCIENCE, V112, P967, DOI 10.1016/S0306-4522(02)00085-4; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	72	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5614	5623		10.1074/jbc.M109.073197	http://dx.doi.org/10.1074/jbc.M109.073197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996106	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000275327200053
J	Liang, Y; Zhong, ZD; Huang, YJ; Deng, W; Cao, JX; Tsao, G; Liu, QT; Pei, DQ; Kang, TB; Zeng, YX				Liang, Yi; Zhong, Zhendong; Huang, Yijun; Deng, Wen; Cao, Junxia; Tsao, George; Liu, Quentin; Pei, Duanqing; Kang, Tiebang; Zeng, Yi-Xin			Stem-like Cancer Cells Are Inducible by Increasing Genomic Instability in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE POPULATION; PROSPECTIVE IDENTIFICATION; EVOLUTION; LEUKEMIA; EFFLUX	The existence of cancer stem cells (CSCs) or stem-like cancer cells (SLCCs) is regarded as the cause of tumor formation and recurrence. However, the origin of such cells remains controversial with two competing hypotheses: CSCs are either transformed from tissue adult stem cells or dedifferentiated from transformed progenitor cells. Compelling evidence has determined the chromosomal aneuploidy to be one of the hallmarks of cancer cells, indicating genome instability plays an important role in tumorigenesis, for which CSCs are believed to be the initiator. To gain direct evidence that genomic instability is involved in the induction of SLCCs, we utilized multiple approaches to enhance genomic instability and monitored the percentage of SLCC in cultured cancer cells. Using side population (SP) cells as a marker for SLCC in human nasopharyngeal carcinoma (NPC) and CD133 for human neuroblastoma cells, we found that DNA damage inducers, UV and mitomycin C were capable of increasing SP cells in NPC CNE-2 and neuroblastoma SKN-SH cells. Likewise, either overexpression of a key regulator of cell cycle, Mad2, or knock down of Aurora B, an important kinase in mitosis, or Cdh1, a key E3 ligase in cell cycle, resulted in a significant increase of SP cells in CNE-2. More interestingly, enrichment of SP cells was observed in recurrent tumor tissues as compared with the primary tumor in the same NPC patients. Our study thus suggested that, beside transformation of tissue stem cells leading to CSC generation, genomic instability could be another potential mechanism resulting in SLCC formation, especially at tumor recurrence stage.	[Liang, Yi; Zhong, Zhendong; Cao, Junxia; Liu, Quentin; Kang, Tiebang; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510060, Guangdong, Peoples R China; [Liang, Yi; Zhong, Zhendong; Cao, Junxia; Liu, Quentin; Kang, Tiebang; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Huang, Yijun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510060, Guangdong, Peoples R China; [Deng, Wen; Tsao, George] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Pei, Duanqing] Guangzhou Inst Biomed, Guangzhou 510663, Guangdong, Peoples R China; [Pei, Duanqing] Guangzhou Inst Hlth, Guangzhou 510663, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Kang, TB (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, 651 DongFeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	kangtb@mail.sysu.edu.cn; zengyix@mail.sysu.edu.cn	Deng, Wen/M-5208-2019; Deng, Wen/C-4154-2009; Zhong, Zhendong/K-5223-2013	Kang, Tiebang/0000-0001-8805-4174	Chinese National 973 Program [2006CB910104, 2010CB912201]; Chinese National 863 Program [2006AA02A404]; Guangdong Province-National Natural Science Foundation of China [u0732005]	Chinese National 973 Program(National Basic Research Program of China); Chinese National 863 Program; Guangdong Province-National Natural Science Foundation of China	The work was supported by the Chinese National 973 Program (Grants 2006CB910104 and 2010CB912201), the Chinese National 863 Program (Grant 2006AA02A404), and the Guangdong Province-National Natural Science Foundation of China Cooperation Program (Grant u0732005).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bapat SA, 2007, SEMIN CANCER BIOL, V17, P204, DOI 10.1016/j.semcancer.2006.05.001; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Deng W, 2003, CYTOM PART A, V51A, P46, DOI 10.1002/cyto.a.10004; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Houghton J, 2007, SEMIN CANCER BIOL, V17, P191, DOI 10.1016/j.semcancer.2006.04.003; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lagasse E, 2008, GENE THER, V15, P136, DOI 10.1038/sj.gt.3303068; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li LD, 2009, CELL CYCLE, V8, P1000, DOI 10.4161/cc.8.7.8041; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2003, CANCER RES, V63, P5821; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509	37	91	108	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4931	4940		10.1074/jbc.M109.048397	http://dx.doi.org/10.1074/jbc.M109.048397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007324	Green Published, hybrid			2022-12-25	WOS:000275274800070
J	Rossi, A; Pisani, F; Nicchia, GP; Svelto, M; Frigeri, A				Rossi, Andrea; Pisani, Francesco; Nicchia, Grazia Paola; Svelto, Maria; Frigeri, Antonio			Evidences for a Leaky Scanning Mechanism for the Synthesis of the Shorter M23 Protein Isoform of Aquaporin-4 IMPLICATION IN ORTHOGONAL ARRAY FORMATION AND NEUROMYELITIS OPTICA ANTIBODY INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSENSITIVE WATER CHANNEL; MUSCLE PLASMA-MEMBRANE; MULTIPLE-SCLEROSIS; MESSENGER-RNA; SQUARE ARRAYS; MOUSE-BRAIN; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; FREEZE-FRACTURE; KNOCKOUT MICE	Aquaporin-4 (AQP4) exists as two major isoforms that differ in the length of the N terminus, the shorter AQP4-M23 and the longer AQP4-M1. Both isoforms form tetramers, which can further aggregate in the plasma membrane to form typical orthogonal arrays of particles (OAPs) whose dimension depends on the ratio of the M1 and M23. In this study, we tested the hypothesis that the M23 isoform can be produced directly by the M1 mRNA. In cells transiently transfected with AQP4-M1 coding sequence we observed besides AQP4-M1 the additional presence of the AQP4-M23 isoform associated with the formation of typical OAPs observable by two-dimensional blue native/SDS-PAGE and total internal reflection microscopy. The mutation of the second in-frame methionine M23 in AQP4-M1 (AQP4-M1(M23I)) prevented the expression of the M23 isoform and the formation of OAPs. We propose "leaky scanning" as a translational mechanism for the expression of AQP4-M23 protein isoform and that the formation of OAPs may occur even in the absence of AQP4-M23 mRNA. This mechanism can have important pathophysiological implications for the cell regulation of the M1/M23 ratio and thus OAP size. In this study we also provide evidence that AQP4-M1 is mobile in the plasma membrane, that it is inserted and not excluded into immobile OAPs, and that it is an important determinant of OAP structure and size.	[Frigeri, Antonio] Univ Bari, Dept Gen & Environm Physiol, I-70125 Bari, Italy; Univ Bari, Ctr Excellence Comparat Genom, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Frigeri, A (corresponding author), Univ Bari, Dept Gen & Environm Physiol, I-70125 Bari, Italy.	a.frigeri@biologia.uniba.it	PISANI, Francesco/AAC-1749-2019; frigeri, Antonio/AAC-6336-2022; Svelto, Maria/P-6186-2014	PISANI, Francesco/0000-0001-8511-117X; Frigeri, Antonio/0000-0002-5284-2934; Svelto, Maria/0000-0002-5584-9541; Rossi, Andrea/0000-0001-5863-6448	Progetto strategico regionale Neurobiotech [124]; Rete Nazionale di Proteomica, Fondo per gli Investimenti della Ricerca di Base 2008 [RBRN07BMCT]	Progetto strategico regionale Neurobiotech; Rete Nazionale di Proteomica, Fondo per gli Investimenti della Ricerca di Base 2008	This work was supported by Progetto strategico regionale Neurobiotech, Project Number 124 Regione Puglia and Rete Nazionale di Proteomica, Fondo per gli Investimenti della Ricerca di Base 2008, RBRN07BMCT.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545; FRIGERI A, 1995, J CELL SCI, V108, P2993; Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nicchia GP, 2008, J NEUROCHEM, V105, P2156, DOI 10.1111/j.1471-4159.2008.05302.x; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Nicchia GP, 2008, GLIA, V56, P869, DOI 10.1002/glia.20661; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2003, J CLIN PATHOL, V56, P972, DOI 10.1136/jcp.56.12.972; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; SCHOTLAND DL, 1981, ACTA NEUROPATHOL, V54, P189, DOI 10.1007/BF00687741; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Umenishi F, 1996, DNA CELL BIOL, V15, P475, DOI 10.1089/dna.1996.15.475; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; Van Hoek AN, 2000, AM J PHYSIOL-RENAL, V278, pF310, DOI 10.1152/ajprenal.2000.278.2.F310; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; WAKAYAMA Y, 1984, NEUROLOGY, V34, P1313, DOI 10.1212/WNL.34.10.1313; WAKAYAMA Y, 1986, ACTA NEUROPATHOL, V72, P130, DOI 10.1007/BF00685974; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yang BX, 1996, J BIOL CHEM, V271, P4577; Zelenin S, 2000, PEDIATR RES, V48, P335, DOI 10.1203/00006450-200009000-00012	55	46	49	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4562	4569		10.1074/jbc.M109.069245	http://dx.doi.org/10.1074/jbc.M109.069245			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007705	Green Published, hybrid			2022-12-25	WOS:000275274800033
J	Asaoka, Y; Kanai, F; Ichimura, T; Tateishi, K; Tanaka, Y; Ohta, M; Seto, M; Tada, M; Ijichi, H; Ikenoue, T; Kawabe, T; Isobe, T; Yaffe, MB; Omata, M				Asaoka, Yoshinari; Kanai, Fumihiko; Ichimura, Tohru; Tateishi, Keisuke; Tanaka, Yasuo; Ohta, Miki; Seto, Motoko; Tada, Motohisa; Ijichi, Hideaki; Ikenoue, Tsuneo; Kawabe, Takao; Isobe, Toshiaki; Yaffe, Michael B.; Omata, Masao			Identification of a Suppressive Mechanism for Hedgehog Signaling through a Novel Interaction of Gli with 14-3-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CUBITUS-INTERRUPTUS; BINDING; CANCER; PATHWAYS; 14-3-3-PROTEINS; DEGRADATION; ACTIVATION; EXPRESSION; FAMILY	Gli transcription factors are central effectors of Hedgehog signaling in development and tumorigenesis. Using a tandem affinity purification (TAP) strategy and mass spectrometry, we have found that Gli1 interacts with 14-3-3 epsilon, and that Gli2 and Gli3 also bind to 14-3-3 epsilon through homologous sites. This interaction depends on their phosphorylation, and cAMP-dependent protein kinase (PKA), a known negative regulator of Hedgehog signaling serves as a responsible kinase. A Gli2 mutant engineered to eliminate this interaction exhibited increased transcriptional activity (2 similar to 3 x). Transcriptional repression by 14-3-3 binding was also observed with Gli3, when its N-terminal repressor domain was deleted. The phosphorylation sites responsible for the binding to 14-3-3 are distinct from those required for proteolysis, the known mechanism for PKA-induced repression of Hh signaling. Our data propose a novel mechanism in which PKA down-regulates Hedgehog signaling by promoting the interaction between Gli and 14-3-3 as well as proteolysis. Given the certain neuronal or malignant disorders in human caused by the abnormality of 17p13 encompassing 14-3-3 epsilon overlap with increased Hh signaling, the Gli-14-3-3 interaction may have pathological significance for those human diseases.	[Seto, Motoko; Ijichi, Hideaki; Ikenoue, Tsuneo; Kawabe, Takao] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Kawabe, Takao] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo 1138655, Japan; [Kanai, Fumihiko; Tada, Motohisa] Chiba Univ, Grad Sch Med, Dept Med, Chiba 2608677, Japan; [Kanai, Fumihiko; Tada, Motohisa] Chiba Univ, Grad Sch Med, Dept Clin Oncol, Chiba 2608677, Japan; [Ichimura, Tohru] Natl Def Acad, Dept Appl Chem, Kanagawa 2398686, Japan; [Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Tokyo 1920397, Japan; MIT, Canc Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Tokyo; University of Tokyo; Chiba University; Chiba University; National Defence Academy - Japan; Tokyo Metropolitan University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Asaoka, Y (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	yasa-tky@umin.ac.jp	Ijichi, Hideaki/AAE-6692-2022; Isobe, Toshiaki/Q-9279-2017; Asaoka, Yoshinari/ABC-5412-2021; IJICHI, Hideaki/AGZ-2874-2022; Ijichi, Hideaki/V-2720-2019	Ijichi, Hideaki/0000-0002-2379-7986; Asaoka, Yoshinari/0000-0002-2805-8226; IJICHI, Hideaki/0000-0002-2379-7986; Tanaka, Yasuo/0000-0002-2917-3365	National Institutes of Health [GM60594]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60594 (to M.B.Y.).	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Ferretti E, 2005, TRENDS MOL MED, V11, P537, DOI 10.1016/j.molmed.2005.10.005; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lau JMC, 2006, DEV DYNAM, V235, P1761, DOI 10.1002/dvdy.20816; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Tada M, 2008, CLIN CANCER RES, V14, P3768, DOI 10.1158/1078-0432.CCR-07-1181; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tanaka Y, 2006, ONCOGENE, V25, P633, DOI 10.1038/sj.onc.1209093; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	34	31	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4185	4194		10.1074/jbc.M109.038232	http://dx.doi.org/10.1074/jbc.M109.038232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996099	Green Published, hybrid			2022-12-25	WOS:000275254000070
J	Girvetz, EH; Zganjar, C; Raber, GT; Maurer, EP; Kareiva, P; Lawler, JJ				Girvetz, Evan H.; Zganjar, Chris; Raber, George T.; Maurer, Edwin P.; Kareiva, Peter; Lawler, Joshua J.			Applied Climate-Change Analysis: The Climate Wizard Tool	PLOS ONE			English	Article							FOOD SECURITY; WINTER CHILL; PRECIPITATION; TEMPERATURE; IMPACTS; MODEL; VARIABILITY; SNOWPACK; FRUIT	Background: Although the message of "global climate change'' is catalyzing international action, it is local and regional changes that directly affect people and ecosystems and are of immediate concern to scientists, managers, and policy makers. A major barrier preventing informed climate-change adaptation planning is the difficulty accessing, analyzing, and interpreting climate-change information. To address this problem, we developed a powerful, yet easy to use, web-based tool called Climate Wizard (http://ClimateWizard.org) that provides non-climate specialists with simple analyses and innovative graphical depictions for conveying how climate has and is projected to change within specific geographic areas throughout the world. Methodology/Principal Findings: To demonstrate the Climate Wizard, we explored historic trends and future departures (anomalies) in temperature and precipitation globally, and within specific latitudinal zones and countries. We found the greatest temperature increases during 1951-2002 occurred in northern hemisphere countries (especially during January-April), but the latitude of greatest temperature change varied throughout the year, sinusoidally ranging from approximately 50 degrees N during February-March to 10 degrees N during August-September. Precipitation decreases occurred most commonly in countries between 0-20 degrees N, and increases mostly occurred outside of this latitudinal region. Similarly, a quantile ensemble analysis based on projections from 16 General Circulation Models (GCMs) for 2070-2099 identified the median projected change within countries, which showed both latitudinal and regional patterns in projected temperature and precipitation change. Conclusions/Significance: The results of these analyses are consistent with those reported by the Intergovernmental Panel on Climate Change, but at the same time, they provide examples of how Climate Wizard can be used to explore regionally- and temporally-specific analyses of climate change. Moreover, Climate Wizard is not a static product, but rather a data analysis framework designed to be used for climate change impact and adaption planning, which can be expanded to include other information, such as downscaled future projections of hydrology, soil moisture, wildfire, vegetation, marine conditions, disease, and agricultural productivity.	[Girvetz, Evan H.; Lawler, Joshua J.] Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA; [Girvetz, Evan H.; Zganjar, Chris] Nature Conservancy, Global Climate Change Program, Arlington, VA USA; [Raber, George T.] Univ So Mississippi, Dept Geog & Geol, Hattiesburg, MS 39406 USA; [Maurer, Edwin P.] Santa Clara Univ, Dept Civil Engn, Santa Clara, CA 95053 USA; [Kareiva, Peter] Nature Conservancy, Worldwide Off, Seattle, WA USA	University of Washington; University of Washington Seattle; Nature Conservancy; University of Southern Mississippi; Santa Clara University; Nature Conservancy	Girvetz, EH (corresponding author), Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA.	girvetz@u.washington.edu	Maurer, Edwin P/C-7190-2009; Girvetz, Evan/B-3533-2010	Maurer, Edwin P/0000-0001-7134-487X; 	Nature Conservancy Climate Change Program	Nature Conservancy Climate Change Program	E. Girvetz was supported by a generous donation to The Nature Conservancy. G. Raber and C. Zganjar were supported by The Nature Conservancy Climate Change Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002499; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bachelet D, 2001, ECOSYSTEMS, V4, P164, DOI 10.1007/s10021-001-0002-7; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Bissonette JA, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P3; Brekke LD, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006941; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Climate Change Science Program CCSP, 2008, PREL REV AD OPT CLIM; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Daly C, 2000, ECOL APPL, V10, P449, DOI 10.1890/1051-0761(2000)010[0449:DSOTGI]2.0.CO;2; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; Forster P., 2007, CLIMATE CHANGE 2007; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Fried JS, 2008, CLIMATIC CHANGE, V87, pS251, DOI 10.1007/s10584-007-9360-2; Giorgi F, 2005, CLIMATIC CHANGE, V73, P239, DOI 10.1007/a10584-005-6857-4; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; Hamlet AF, 2005, J HYDROMETEOROL, V6, P330, DOI 10.1175/JHM420.1; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Luedeling E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006166; Manabe S, 2004, HYDROLOG SCI J, V49, P625, DOI 10.1623/hysj.49.4.625.54429; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; Maurer EP, 2009, HYDROL EARTH SYST SC, V13, P183, DOI 10.5194/hess-13-183-2009; Maurer E. P., 2007, EOS T AM GEOPHYS UN, V88, P504, DOI DOI 10.1029/2007EO470006; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MITCHELL TD, 2004, COMPR SET HIGH RES G; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Parry ML, 2007, CLIMATE CHANGE 2007; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; PIERCE D, 2006, NCDF INTERFACE UNIDA; Pierce DW, 2009, P NATL ACAD SCI USA, V106, P8441, DOI 10.1073/pnas.0900094106; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Poulter B, 2008, INT J GEOGR INF SCI, V22, P167, DOI 10.1080/13658810701371858; R Core Team, 2021, R LANG ENV STAT COMP; Reading CJ, 1998, OECOLOGIA, V117, P469, DOI 10.1007/s004420050682; REICHLER T, 2008, J GEOPHYS RES ATMOSP, V113; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tebaldi C, 2005, J CLIMATE, V18, P1524, DOI 10.1175/JCLI3363.1; WHITE D, 2009, MAPTREE MAPPING PRUN; WIGLEY TML, 2006, REPORT CLIMATE CHANG; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e	54	114	119	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8320	10.1371/journal.pone.0008320	http://dx.doi.org/10.1371/journal.pone.0008320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016827	Green Published, gold			2022-12-25	WOS:000272833800015
J	Hawn, TR; Scholes, D; Wang, HW; Li, SS; Stapleton, AE; Janer, M; Aderem, A; Stamm, WE; Zhao, LP; Hooton, TM				Hawn, Thomas R.; Scholes, Delia; Wang, Hongwei; Li, Sue S.; Stapleton, Ann E.; Janer, Marta; Aderem, Alan; Stamm, Walter E.; Zhao, Lue Ping; Hooton, Thomas M.			Genetic Variation of the Human Urinary Tract Innate Immune Response and Asymptomatic Bacteriuria in Women	PLOS ONE			English	Article							P-BLOOD-GROUP; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; RISK-FACTORS; ARG753GLN POLYMORPHISM; RECEPTOR POLYMORPHISMS; LEGIONNAIRES-DISEASE; SEXUAL-ACTIVITY; CUTTING EDGE; YOUNG-WOMEN	Background: Although several studies suggest that genetic factors are associated with human UTI susceptibility, the role of DNA variation in regulating early in vivo urine inflammatory responses has not been fully examined. We examined whether candidate gene polymorphisms were associated with altered urine inflammatory profiles in asymptomatic women with or without bacteriuria. Methodology: We conducted a cross-sectional analysis of asymptomatic bacteriuria (ASB) in 1,261 asymptomatic women ages 18-49 years originally enrolled as participants in a population-based case-control study of recurrent UTI and pyelonephritis. We genotyped polymorphisms in CXCR1, CXCR2, TLR1, TLR2, TLR4, TLR5, and TIRAP in women with and without ASB. We collected urine samples and measured levels of uropathogenic bacteria, neutrophils, and chemokines. Principal Findings: Polymorphism TLR2_G2258A, a variant associated with decreased lipopeptide-induced signaling, was associated with increased ASB risk (odds ratio 3.44, 95% CI; 1.65-7.17). Three CXCR1 polymorphisms were associated with ASB caused by gram-positive organisms. ASB was associated with urinary CXCL-8 levels, but not CXCL-5, CXCL-6, or sICAM-1 (P <= 0.0001). Urinary levels of CXCL-8 and CXCL-6, but not ICAM-1, were associated with higher neutrophil levels (P <= 0.0001). In addition, polymorphism CXCR1_G827C was associated with increased CXCL-8 levels in women with ASB (P=0.004). Conclusions: TLR2 and CXCR1 polymorphisms were associated with ASB and a CXCR1 variant was associated with urine CXCL-8 levels. These results suggest that genetic factors are associated with early in vivo human bladder immune responses prior to the development of symptomatic UTIs.	[Hawn, Thomas R.; Stapleton, Ann E.; Stamm, Walter E.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Scholes, Delia] Univ Washington, Grp Hlth Ctr Hlth Studies, Seattle, WA 98195 USA; [Scholes, Delia] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wang, Hongwei; Li, Sue S.; Zhao, Lue Ping] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Janer, Marta; Aderem, Alan] Inst Syst Biol, Seattle, WA USA; [Hooton, Thomas M.] Univ Miami, Dept Med, Miami, FL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Institute for Systems Biology (ISB); University of Miami	Hawn, TR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	thawn@u.washington.edu	Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [2 PO1 DK53369-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053369, R01DK062863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases ( NIDDK) grant #2 PO1 DK53369-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Bengtsson C, 1998, SCAND J UROL NEPHROL, V32, P284; Benson M, 1996, J INFECT DIS, V174, P1080, DOI 10.1093/infdis/174.5.1080; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Czaja CA, 2009, J INFECT DIS, V200, P528, DOI 10.1086/600385; Davidoff R, 1997, J UROLOGY, V157, P1980, DOI 10.1016/S0022-5347(01)64914-0; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; GAYMANS R, 1976, LANCET, V2, P674; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; HEDGES S, 1992, J INFECT DIS, V166, P653, DOI 10.1093/infdis/166.3.653; HOOTEN TM, 1994, CLIN INFECT DIS, V19, P274, DOI 10.1093/clinids/19.2.274; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; Hopkins WJ, 1999, AM J MED GENET, V83, P422, DOI 10.1002/(SICI)1096-8628(19990423)83:5<422::AID-AJMG16>3.0.CO;2-1; Ishitoya S, 2002, BJU INT, V89, P851, DOI 10.1046/j.1464-410X.2002.02782.x; JACOBSON SH, 1994, NEPHRON, V67, P172, DOI 10.1159/000187923; Jantausch BA, 2000, PEDIATR NEPHROL, V15, P236, DOI 10.1007/s004670000456; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; Kassir K, 2001, CLIN DIAGN LAB IMMUN, V8, P1060, DOI 10.1128/CDLI.8.6.1060-1063.2001; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; KINANE DF, 1982, BRIT MED J, V285, P7, DOI 10.1136/bmj.285.6334.7; KO YC, 1993, INFECT IMMUN, V61, P1307, DOI 10.1128/IAI.61.4.1307-1314.1993; KUNIN CM, 1970, NEW ENGL J MED, V282, P1443, DOI 10.1056/NEJM197006252822601; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Marple CD, 1941, ANN INTERN MED, V14, P2220, DOI 10.7326/0003-4819-14-12-2220; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Nicolle LE, 1997, INFECT DIS CLIN N AM, V11, P647, DOI 10.1016/S0891-5520(05)70378-0; NORDEN CW, 1968, ANNU REV MED, V19, P431, DOI 10.1146/annurev.me.19.020168.002243; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Olszyna DP, 2001, J INFECT DIS, V184, P301, DOI 10.1086/322030; Olszyna DP, 2000, J INFECT DIS, V182, P1731, DOI 10.1086/317603; Otto G, 2005, KIDNEY INT, V68, P62, DOI 10.1111/j.1523-1755.2005.00381.x; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Storm Niels, 2003, Methods Mol Biol, V212, P241; STROM BL, 1987, ANN INTERN MED, V107, P816, DOI 10.7326/0003-4819-107-6-816; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Tabel Y, 2007, INT J IMMUNOGENET, V34, P399, DOI 10.1111/j.1744-313X.2007.00709.x; TOMISAWA S, 1989, SCAND J INFECT DIS, V21, P403, DOI 10.3109/00365548909167444; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	69	42	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8300	10.1371/journal.pone.0008300	http://dx.doi.org/10.1371/journal.pone.0008300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016852	gold, Green Submitted, Green Published			2022-12-25	WOS:000272833800005
J	Hedges, D; Burges, D; Powell, E; Almonte, C; Huang, J; Young, S; Boese, B; Schmidt, M; Pericak-Vance, MA; Martin, E; Zhang, X; Harkins, TT; Zuchner, S				Hedges, Dale; Burges, Dan; Powell, Eric; Almonte, Cherylyn; Huang, Jia; Young, Stuart; Boese, Benjamin; Schmidt, Mike; Pericak-Vance, Margaret A.; Martin, Eden; Zhang, Xinmin; Harkins, Timothy T.; Zuechner, Stephan			Exome Sequencing of a Multigenerational Human Pedigree	PLOS ONE			English	Article							GENOMIC SELECTION; HYBRID SELECTION; CAPTURE; EXONS; GENE	Over the next few years, the efficient use of next-generation sequencing (NGS) in human genetics research will depend heavily upon the effective mechanisms for the selective enrichment of genomic regions of interest. Recently, comprehensive exome capture arrays have become available for targeting approximately 33 Mb or similar to 180,000 coding exons across the human genome. Selective genomic enrichment of the human exome offers an attractive option for new experimental designs aiming to quickly identify potential disease-associated genetic variants, especially in family-based studies. We have evaluated a 2.1 M feature human exome capture array on eight individuals from a three-generation family pedigree. We were able to cover up to 98% of the targeted bases at a long-read sequence read depth of >= 3, 86% at a read depth of >= 10, and over 50% of all targets were covered with >= 20 reads. We identified up to 14,284 SNPs and small indels per individual exome, with up to 1,679 of these representing putative novel polymorphisms. Applying the conservative genotype calling approach HCDiff, the average rate of detection of a variant allele based on Illumina 1 M BeadChips genotypes was 95.2% at >= 10x sequence. Further, we propose an advantageous genotype calling strategy for low covered targets that empirically determines cut-off thresholds at a given coverage depth based on existing genotype data. Application of this method was able to detect >99% of SNPs covered >= 8x. Our results offer guidance for "real-world'' applications in human genetics and provide further evidence that microarray-based exome capture is an efficient and reliable method to enrich for chromosomal regions of interest in next-generation sequencing experiments.	[Hedges, Dale; Powell, Eric; Almonte, Cherylyn; Huang, Jia; Schmidt, Mike; Pericak-Vance, Margaret A.; Martin, Eden; Zuechner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Burges, Dan; Boese, Benjamin; Zhang, Xinmin; Harkins, Timothy T.] Roche Diagnost Corp Inc, Indianapolis, IN USA; [Young, Stuart] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA	University of Miami; Roche Holding; University of Miami	Hedges, D (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	szuchner@med.miami.edu			National Institute for Neurology and Stroke [NS065712, NS026630]; National Human Genome Research Institute [RC2HG005605]; Roche Inc; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, U54NS065712] Funding Source: NIH RePORTER	National Institute for Neurology and Stroke; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Roche Inc(Roche Holding); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the National Institute for Neurology and Stroke ( NS065712 to S. Z. and NS026630 to M. A. P-V), the National Human Genome Research Institute ( RC2HG005605 to E. M), and Roche Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Buxbaum Joseph D, 2009, Dialogues Clin Neurosci, V11, P35; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hegde MR, 2008, HUM MUTAT, V29, P1091, DOI 10.1002/humu.20831; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Nachman MW, 2000, GENETICS, V156, P297; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Okou DT, 2009, ANN HUM GENET, V73, P502, DOI 10.1111/j.1469-1809.2009.00530.x; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SEXTON DP, 2007, 57 ANN M AM SOC HUM, pA2168; Taly V, 2007, CHEMBIOCHEM, V8, P263, DOI 10.1002/cbic.200600425; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zuchner S, 2009, MOL PSYCHIATR, V14, P6, DOI 10.1038/mp.2008.83	29	58	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8232	10.1371/journal.pone.0008232	http://dx.doi.org/10.1371/journal.pone.0008232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011588	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300014
J	Alexa, K; Choe, SK; Hirsch, N; Etheridge, L; Laver, E; Sagerstrom, CG				Alexa, Kristen; Choe, Seong-Kyu; Hirsch, Nicolas; Etheridge, Letitiah; Laver, Elizabeth; Sagerstroem, Charles G.			Maternal and Zygotic aldh1a2 Activity Is Required for Pancreas Development in Zebrafish	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; CENTRAL-NERVOUS-SYSTEM; VITAMIN-A-DEFICIENCY; ALDEHYDE DEHYDROGENASE; EMBRYONIC-DEVELOPMENT; MESODERMAL SIGNALS; ENDODERM FORMATION; ORGAN DEVELOPMENT; CAUDAL HINDBRAIN; XENOPUS EMBRYOS	We have isolated and characterized a novel zebrafish pancreas mutant. Mutant embryos lack expression of isl1 and sst in the endocrine pancreas, but retain isl1 expression in the CNS. Non-endocrine endodermal gene expression is less affected in the mutant, with varying degrees of residual expression observed for pdx1, carbA, hhex, prox1, sid4, transferrin and ifabp. In addition, mutant embryos display a swollen pericardium and lack fin buds. Genetic mapping revealed a mutation resulting in a glycine to arginine change in the catalytic domain of the aldh1a2 gene, which is required for the production of retinoic acid from vitamin A. Comparison of our mutant (aldh1a2(um22)) to neckless (aldh1a2(i26)), a previously identified aldh1a2 mutant, revealed similarities in residual endodermal gene expression. In contrast, treatment with DEAB (diethylamino-benzaldehyde), a competitive reversible inhibitor of Aldh enzymes, produces a more severe phenotype with complete loss of endodermal gene expression, indicating that a source of Aldh activity persists in both mutants. We find that mRNA from the aldh1a2(um22) mutant allele is inactive, indicating that it represents a null allele. Instead, the residual Aldh activity is likely due to maternal aldh1a2, since we find that translation-blocking, but not splice-blocking, aldh1a2 morpholinos produce a phenotype similar to DEAB treatment. We conclude that Aldh1a2 is the primary Aldh acting during pancreas development and that maternal Aldh1a2 activity persists in aldh1a2(um22) and aldh1a2(i26) mutant embryos.	[Alexa, Kristen; Choe, Seong-Kyu; Hirsch, Nicolas; Etheridge, Letitiah; Laver, Elizabeth; Sagerstroem, Charles G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Alexa, K (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	charles.sagerstrom@umassmed.edu			JDRF [1-2007-753]; NIDDK [5 P30 DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by JDRF grant 1-2007-753 (http://www.jdrf.org), as well as by DERC grant 5 P30 DK32520 from the NIDDK (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HL, 1996, J BIOL CHEM, V271, P9526, DOI 10.1074/jbc.271.16.9526; Ang HL, 1999, EUR J BIOCHEM, V260, P227, DOI 10.1046/j.1432-1327.1999.00139.x; Aoki TO, 2002, DEVELOPMENT, V129, P275; Begemann G, 2001, DEVELOPMENT, V128, P3081; Begemann G, 2004, DEV BIOL, V271, P119, DOI 10.1016/j.ydbio.2004.03.033; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Blumberg B, 1997, DEVELOPMENT, V124, P373; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Chen YL, 2001, MECH DEVELOP, V101, P91, DOI 10.1016/S0925-4773(00)00558-X; Costaridis P, 1996, DEV DYNAM, V205, P41; David NB, 2001, DEVELOPMENT, V128, P3937; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dickman ED, 1997, DEVELOPMENT, V124, P3111; diIorio PJ, 2005, DEV BIOL, V282, P55, DOI 10.1016/j.ydbio.2005.02.036; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dupe V, 1999, DEVELOPMENT, V126, P5051; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Gale E, 1999, MECH DEVELOP, V89, P43, DOI 10.1016/S0925-4773(99)00202-6; Grandel H, 2002, DEVELOPMENT, V129, P2851; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinkel MD, 2009, P NATL ACAD SCI USA, V106, P7864, DOI 10.1073/pnas.0813108106; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; Kopinke D, 2006, DEV DYNAM, V235, P2695, DOI 10.1002/dvdy.20905; KRAFT JC, 1994, BIOCHEM J, V301, P111, DOI 10.1042/bj3010111; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Malpel S, 2000, DEVELOPMENT, V127, P3057; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mic FA, 2002, DEVELOPMENT, V129, P2271; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; MorrissKay GM, 1996, FASEB J, V10, P961, DOI 10.1096/fasebj.10.9.8801178; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Pittlik S, 2008, GENE EXPR PATTERNS, V8, P141, DOI 10.1016/j.gep.2007.11.003; PLATEROTI M, 1993, EXP CELL RES, V208, P137, DOI 10.1006/excr.1993.1231; Reiter JF, 2001, DEVELOPMENT, V128, P125; Roman BL, 2002, DEVELOPMENT, V129, P3009; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sagerstrom CG, 1996, DEVELOPMENT, V122, P1873; Sagerstrom GC, 2001, DEV DYNAM, V220, P402, DOI 10.1002/dvdy.1119; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Song JB, 2007, DEV BIOL, V303, P561, DOI 10.1016/j.ydbio.2006.11.040; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; van der Wees J, 1998, DEVELOPMENT, V125, P545; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Wells JM, 2000, DEVELOPMENT, V127, P1563; White JC, 1998, P NATL ACAD SCI USA, V95, P13459, DOI 10.1073/pnas.95.23.13459; White JC, 2000, DEV BIOL, V220, P263, DOI 10.1006/dbio.2000.9635; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	68	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8261	10.1371/journal.pone.0008261	http://dx.doi.org/10.1371/journal.pone.0008261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011517	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830200008
J	Zhang, JY; Vankova, R; Malbeck, J; Dobrev, PI; Xu, YY; Chong, K; Neff, MM				Zhang, Jingyu; Vankova, Radomira; Malbeck, Jiri; Dobrev, Petre I.; Xu, Yunyuan; Chong, Kang; Neff, Michael M.			AtSOFL1 and AtSOFL2 Act Redundantly as Positive Modulators of the Endogenous Content of Specific Cytokinins in Arabidopsis	PLOS ONE			English	Article							TRANSGENIC TOBACCO PLANTS; OXIDASE/DEHYDROGENASE GENES; ISOPENTENYL TRANSFERASE; MERISTEM ACTIVITY; BIOSYNTHESIS; EXPRESSION; THALIANA; OXIDASE; MAIZE; IDENTIFICATION	Background: Although cytokinins have been known for decades to play important roles in the regulation of plant growth and development, our knowledge of the regulatory mechanism of endogenous content of specific cytokinins remains limited. Methodology/Principal Findings: Here, we characterized two SOB five-like (SOFL) genes, AtSOFL1 and AtSOFL2, in Arabidopsis (Arabidopsis thaliana) and showed that they acted redundantly in regulating specific cytokinin levels. Analysis of the translational fusion AtSOFL1: AtSOFL1-GUS and AtSOFL2: AtSOFL2-GUS indicated that AtSOFL1 and AtSOFL2 exhibited similar expression patterns. Both proteins were predominantly expressed in the vascular tissues of developing leaves, flowers and siliques, but barely detectable in roots and stems. Overexpression of either AtSOFL1 or AtSOFL2 led to increased cytokinin content and obvious corresponding mutant phenotypes for both transgenic seedlings and adult plants. In addition, overexpression and site-directed mutagenesis experiments demonstrated that the SOFL domains are necessary for AtSOFL2's overexpression phenotypes. Silencing or disrupting either AtSOFL1 or AtSOFL2 caused no obvious developmental defects. Endogenous cytokinin analysis, however, revealed that compared to the wild type control, the SOFL1-RNAi62 sofl2-1 double mutant accumulated lower levels of trans-zeatin riboside monophosphate (tZRMP) and N-6-(Delta(2)-isopentenyl) adenosine monophosphate (iPRMP), which are biosynthetic intermediates of bioactive cytokinins. The double mutant also displayed decreased response to exogenous cytokinin in both callus-formation and inhibition-of-hypocotyl-elongation assays. Conclusions/Significance: Taken together, our data suggest that in plants AtSOFL1 and AtSOFL2 work redundantly as positive modulators in the fine-tuning of specific cytokinin levels as well as responsiveness.	[Zhang, Jingyu; Xu, Yunyuan; Chong, Kang] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China; [Vankova, Radomira; Malbeck, Jiri; Dobrev, Petre I.] Inst Expt Bot, Lab Hormonal Regulat Plants, Prague, Czech Republic; [Neff, Michael M.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Washington State University	Zhang, JY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China.	mmneff@wsu.edu	Zhang, Jingyu/AAL-4934-2021; Dobrev, Petre I./H-2391-2014; Vanková, Radomíra/G-6808-2014; Malbeck, Jiří/F-7358-2014	Malbeck, Jiří/0000-0001-6796-2608	Monsanto Corporation - Washington University Biology Research Agreement [46011J]; United States National Science Foundation [0758411]; United States Department of Energy [DE-FG02-08ER15927]; Grant Agency of the Czech Republic [206/06/1306]	Monsanto Corporation - Washington University Biology Research Agreement; United States National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was initially supported by the Monsanto Corporation - Washington University Biology Research Agreement (grant number 46011J to Michael M. Neff). Work was also supported by the United States National Science Foundation (Division of Integrative Organismal Systems, Grant Number 0758411 to Michael M. Neff), the United States Department of Energy (Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, Grant Number DE-FG02-08ER15927 to Michael M. Neff) and the Grant Agency of the Czech Republic (grant number 206/06/1306 to Radomira Vankova). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYOSHI DE, 1984, P NATL ACAD SCI-BIOL, V81, P5994, DOI 10.1073/pnas.81.19.5994; Armstrong DJ, 1994, CYTOKININS CHEM ACTI, P139; Astot C, 2000, P NATL ACAD SCI USA, V97, P14778, DOI 10.1073/pnas.260504097; BARRY GF, 1984, P NATL ACAD SCI-BIOL, V81, P4776, DOI 10.1073/pnas.81.15.4776; Bilyeu KD, 2001, PLANT PHYSIOL, V125, P378, DOI 10.1104/pp.125.1.378; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; HEWELT A, 1994, PLANT J, V6, P879, DOI 10.1046/j.1365-313X.1994.6060879.x; Houba-Herin N, 1999, PLANT J, V17, P615, DOI 10.1046/j.1365-313X.1999.00408.x; Howell SH, 2003, TRENDS PLANT SCI, V8, P453, DOI 10.1016/S1360-1385(03)00191-2; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Jung B, 2009, PLANT CELL, V21, P876, DOI 10.1105/tpc.108.062612; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; LI Y, 1992, DEV BIOL, V153, P386, DOI 10.1016/0012-1606(92)90123-X; *MC M, 1994, CYTOK CHEM ACT FUNCT, P155; McGaw Brian A., 1995, P98; MEDFORD JI, 1989, PLANT CELL, V1, P403, DOI 10.1105/tpc.1.4.403; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Morris RO, 1999, BIOCHEM BIOPH RES CO, V255, P328, DOI 10.1006/bbrc.1999.0199; MOYTKA V, 2003, PHYSIOL PLANTARUM, V117, P11; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Spichal L, 2004, PLANT CELL PHYSIOL, V45, P1299, DOI 10.1093/pcp/pch132; Sun JQ, 2003, PLANT PHYSIOL, V131, P167, DOI 10.1104/pp.011494; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; Turk EM, 2003, PLANT PHYSIOL, V133, P1643, DOI 10.1104/pp.103.030882; VONSCHWARTZENBE.K, 2007, PLANT PHYSIOL, P786; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Yang SH, 2003, PLANT MOL BIOL, V51, P237, DOI 10.1023/A:1021115816540; Yonekura-Sakakibara K, 2004, PLANT PHYSIOL, V134, P1654, DOI 10.1104/pp.103.037176; Zhang J, 2006, PLANT J, V46, P834, DOI 10.1111/j.1365-313X.2006.02745.x; Zubko E, 2002, PLANT J, V29, P797, DOI 10.1046/j.1365-313X.2002.01256.x	47	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8236	10.1371/journal.pone.0008236	http://dx.doi.org/10.1371/journal.pone.0008236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011053	Green Submitted, gold, Green Published			2022-12-25	WOS:000272829800020
J	McGovern, G; Mabbott, N; Jeffrey, M				McGovern, Gillian; Mabbott, Neil; Jeffrey, Martin			Scrapie Affects the Maturation Cycle and Immune Complex Trapping by Follicular Dendritic Cells in Mice	PLOS ONE			English	Article							PRION PROTEIN ACCUMULATION; GERMINAL CENTER REACTION; SHEEP; PRP; SPLEEN; INFECTION; BRAIN; MOUSE; PATHOGENESIS; EXPRESSION	Transmissible spongiform encephalopathies (TSEs) or prion diseases are infectious neurological disorders of man and animals, characterised by abnormal disease-associated prion protein (PrP(d)) accumulations in the brain and lymphoreticular system (LRS). Prior to neuroinvasion, TSE agents often accumulate to high levels within the LRS, apparently without affecting immune function. However, our analysis of scrapie-affected sheep shows that PrP(d) accumulations within the LRS are associated with morphological changes to follicular dendritic cells (FDCs) and tingible body macrophages (TBMs). Here we examined FDCs and TBMs in the mesenteric lymph nodes (MLNs) of scrapie-affected mice by light and electron microscopy. In MLNs from uninfected mice, FDCs could be morphologically categorised into immature, mature and regressing forms. However, in scrapie-affected MLNs this maturation cycle was adversely affected. FDCs characteristically trap and retain immune complexes on their surfaces, which they display to B-lymphocytes. In scrapie-affected MLNs, some FDCs were found where areas of normal and abnormal immune complex retention occurred side by side. The latter colocalised with PrP(d) plasmalemmal accumulations. Our data suggest this previously unrecognised morphology represents the initial stage of an abnormal FDC maturation cycle. Alterations to the FDCs included PrP(d) accumulation, abnormal cell membrane ubiquitin and excess immunoglobulin accumulation. Regressing FDCs, in contrast, appeared to lose their membrane-attached PrP(d). Together, these data suggest that TSE infection adversely affects the maturation and regression cycle of FDCs, and that PrP(d) accumulation is causally linked to the abnormal pathology observed. We therefore support the hypothesis that TSEs cause an abnormality in immune function.	[McGovern, Gillian; Jeffrey, Martin] Vet Labs Agcy Lasswade, Penicuik, Midlothian, Scotland; [Mabbott, Neil] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Mabbott, Neil] Univ Edinburgh, Royal Dick Sch Vet Sci, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	McGovern, G (corresponding author), Vet Labs Agcy Lasswade, Penicuik, Midlothian, Scotland.	g.mcgovern@vla.defra.gsi.gov.uk	McGOVERN, GILLIAN/C-3441-2011; Jeffrey, Martin/D-2251-2009; Mabbott, Neil/AAF-8777-2020	McGOVERN, GILLIAN/0000-0001-5344-5909; Mabbott, Neil/0000-0001-7395-1796	Veterinary laboratory Agency Seedcorn; UK Biotechnology and Biological Sciences Research Council; BBSRC [BB/D00831X/2, BBS/E/A/00001659, BB/D00831X/1, BB/D00831X/3, BBS/E/A/00001660] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00831X/3, BB/D00831X/1, BBS/E/A/00001660, BBS/E/A/00001659, BBS/E/I/00000989, BB/D00831X/2] Funding Source: researchfish	Veterinary laboratory Agency Seedcorn; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Veterinary laboratory Agency Seedcorn inward investment fund and UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce ME, 2000, IMMUNOL TODAY, V21, P442, DOI 10.1016/S0167-5699(00)01696-0; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Denzer K, 2000, J CELL SCI, V113, P3365; DICKINSON AG, 1969, J COMP PATHOL, V79, P15, DOI 10.1016/0021-9975(69)90021-8; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; Eaton SL, 2007, J GEN VIROL, V88, P1384, DOI 10.1099/vir.0.82197-0; Eaton SL, 2009, VET IMMUNOL IMMUNOP, V131, P105, DOI 10.1016/j.vetimm.2009.02.012; FARQUHAR CF, 1993, TRANSMISSIBLE SPONGI, P301; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; HEINEN E, 1995, FOLLICULAR DENDRITIC, P5; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Jeffrey M, 2000, J PATHOL, V191, P323, DOI 10.1002/1096-9896(200007)191:3&lt;323::AID-PATH629&gt;3.0.CO;2-Z; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2000, ARCH VIROL, P23; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; LANGEVELD JPM, 1993, TRANSMISSIBLE SPONGI, P315; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Manson J., 1992, Neurodegeneration, V1, P45; McGovern G, 2004, J COMP PATHOL, V130, P181, DOI 10.1016/j.jcpa.2003.11.001; McGovern G, 2009, VET PATHOL, V46, P233, DOI 10.1354/vp.46-2-233; McGovern G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001304; MILLER GW, 1975, P NATL ACAD SCI USA, V72, P418, DOI 10.1073/pnas.72.2.418; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; NOSSAL GJV, 1994, IMMUNOL REV, V137, P173, DOI 10.1111/j.1600-065X.1994.tb00664.x; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; RADEMAKERS LHPM, 1992, CELL TISSUE RES, V269, P359, DOI 10.1007/BF00319629; RADOUX D, 1985, ADV EXP MED BIOL, V186, P185; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Smith J P, 1998, Dev Immunol, V6, P285, DOI 10.1155/1998/38923; Sukumar S, 2008, CELL TISSUE RES, V332, P89, DOI 10.1007/s00441-007-0566-4; Taylor PR, 2002, EUR J IMMUNOL, V32, P1888; TEW JG, 1982, J RETICULOENDOTH SOC, V31, P371; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; VEERMAN AJP, 1975, CELL TISSUE RES, V156, P417, DOI 10.1007/BF00225103; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586	44	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8186	10.1371/journal.pone.0008186	http://dx.doi.org/10.1371/journal.pone.0008186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997557	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829700002
J	Edeling, MA; Sanker, S; Shima, T; Umasankar, PK; Honing, S; Kim, HY; Davidson, LA; Watkins, SC; Tsang, M; Owen, DJ; Traub, LM				Edeling, Melissa A.; Sanker, Subramaniam; Shima, Takaki; Umasankar, P. K.; Hoening, Stefan; Kim, Hye Y.; Davidson, Lance A.; Watkins, Simon C.; Tsang, Michael; Owen, David J.; Traub, Linton M.			Structural Requirements for PACSIN/Syndapin Operation during Zebrafish Embryonic Notochord Development	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; CONVERGENT EXTENSION; TRANSGENIC ZEBRAFISH; CATION CHANNEL; CELL-ADHESION; SYNDAPIN-I; BODY AXIS; PROTEIN; DOMAIN; MORPHOGENESIS	PACSIN/Syndapin proteins are membrane-active scaffolds that participate in endocytosis. The structure of the Drosophila Syndapin N-terminal EFC domain reveals a crescent shaped antiparallel dimer with a high affinity for phosphoinositides and a unique membrane-inserting prong upon the concave surface. Combined structural, biochemical and reverse genetic approaches in zebrafish define an important role for Syndapin orthologue, Pacsin3, in the early formation of the notochord during embryonic development. In pacsin3-morphant embryos, midline convergence of notochord precursors is defective as axial mesodermal cells fail to polarize, migrate and differentiate properly. The pacsin3 morphant phenotype of a stunted body axis and contorted trunk is rescued by ectopic expression of Drosophila Syndapin, and depends critically on both the prong that protrudes from the surface of the bowed Syndapin EFC domain and the ability of the antiparallel dimer to bind tightly to phosphoinositides. Our data confirm linkage between directional migration, endocytosis and cell specification during embryonic morphogenesis and highlight a key role for Pacsin3 in this coupling in the notochord.	[Edeling, Melissa A.; Owen, David J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Sanker, Subramaniam; Umasankar, P. K.; Watkins, Simon C.; Traub, Linton M.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Shima, Takaki; Tsang, Michael] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Hoening, Stefan] Univ Cologne, Inst Biochem 1, Cologne, Germany; [Hoening, Stefan] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Kim, Hye Y.; Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cologne; University of Cologne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Edeling, MA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.	traub@pitt.edu	Watkins, Simon/ABG-2590-2021; Tsang, Michael/AAG-9338-2020; Tsang, Michael/ABV-0504-2022; TSANG, Michael/E-2758-2013; Tsang, Michael W/I-9305-2014	Watkins, Simon/0000-0003-4092-1552; Tsang, Michael/0000-0001-7123-0063; TSANG, Michael/0000-0001-6384-2422; Tsang, Michael W/0000-0001-7123-0063; Umasankar, Perunthottathu/0000-0001-5548-1022; KIM, HYE YOUNG/0000-0002-3600-4180; Traub, Linton/0000-0002-1303-0298	NIH [R01 DK53249, P30 DK79307, R01 HD044750, R01 HL088016]; Wellcome Trust Senior Fellowship; German Science Foundation [SFB 635, SFB670]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053249, P30DK079307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Fellowship(Wellcome Trust); German Science Foundation(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants R01 DK53249 and pilot project on P30 DK79307 to LMT, R01 HD044750 to LAD and R01 HL088016 to MT, a Wellcome Trust Senior Fellowship to DJO, and German Science Foundation grants (SFB 635 and SFB670) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2007, MOL BIOSYST, V3, P51, DOI 10.1039/b613673g; Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Chen WB, 2001, DEVELOPMENT, V128, P2385; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Gansner JM, 2007, DEV BIOL, V307, P202, DOI 10.1016/j.ydbio.2007.04.029; Gansner JM, 2008, DEV DYNAM, V237, P3715, DOI 10.1002/dvdy.21779; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Granato M, 1996, DEVELOPMENT, V123, P399; Haendel MA, 2004, TOXICOL SCI, V81, P390, DOI 10.1093/toxsci/kfh202; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Harvey SA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000101; Hawkins TA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-42; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hotta K, 2007, DEV GROWTH DIFFER, V49, P373, DOI 10.1111/j.1440-169x.2007.00935.x; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kandachar V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-50; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Kumar V, 2009, MOL CELL NEUROSCI, V40, P234, DOI 10.1016/j.mcn.2008.10.011; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mangos S, 2007, GENE EXPR PATTERNS, V7, P480, DOI 10.1016/j.modgep.2006.10.011; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Modregger J, 2000, J CELL SCI, V113, P4511; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Odenthal J, 1996, DEVELOPMENT, V123, P103; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pagnon-Minot A, 2008, DEV BIOL, V316, P21, DOI 10.1016/j.ydbio.2007.12.033; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stemple DL, 1996, DEVELOPMENT, V123, P117; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Sumoy L, 2001, GENE, V262, P199, DOI 10.1016/S0378-1119(00)00531-X; Teraoka H, 2006, TOXICOL APPL PHARM, V212, P24, DOI 10.1016/j.taap.2005.06.016; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tilton F, 2006, TOXICOL APPL PHARM, V216, P55, DOI 10.1016/j.taap.2006.04.014; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	92	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8150	10.1371/journal.pone.0008150	http://dx.doi.org/10.1371/journal.pone.0008150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997509	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000272829000008
J	Lee, E; Jeong, J; Kim, SE; Song, EJ; Kang, SW; Lee, KJ				Lee, Eunsun; Jeong, Jaeho; Kim, Sung Eun; Song, Eun Joo; Kang, Sang Won; Lee, Kong-Joo			Multiple Functions of Nm23-H1 Are Regulated by Oxido-Reduction System	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; NERVE GROWTH-FACTOR; NF-KAPPA-B; METASTASIS SUPPRESSOR; TUMOR-METASTASIS; DNA-BINDING; OXIDATIVE STRESS; POSTTRANSLATIONAL MODIFICATIONS; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR	Nucleoside diphosphate kinase (NDPK, Nm23), a housekeeping enzyme, is known to be a multifunctional protein, acting as a metastasis suppressor, transactivation activity on c-myc, and regulating endocytosis. The cellular mechanisms regulating Nm23 functions are poorly understood. In this study, we identified the modifications and interacting proteins of Nm23-H1 in response to oxidative stress. We found that Cys109 in Nm23-H1 is oxidized to various oxidation states including intra-and inter-disulfide crosslinks, glutathionylation, and sulfonic acid formation in response to H2O2 treatment both in vivo and in vitro. The cross-linking sites and modifications of oxidized Nm23-H1 were identified by peptide sequencing using UPLC ESIq-TOF tandem MS. Glutathionylation and oxidation of Cys109 inhibited the NDPK enzymatic activity of Nm23-H1. We also found that thioredoxin reductase 1 (TrxR1) is an interacting protein of Nm23-H1, and it binds specifically to oxidized Nm23-H1. Oxidized Nm23 is a substrate of NADPH-TrxR1-thioredoxin shuttle system, and the disulfide crosslinking is reversibly reduced and the enzymatic activity is recovered by this system. Oxidation of Cys109 in Nm23-H1 inhibited its metastatic suppressor activity as well as the enzymatic activities. The mutant, Nm23-H1 C109A, retained both the enzymatic and metastasis suppressor activities under oxidative stress. This suggests that key enzymatic and metastasis suppressor functions of Nm23-H1 are regulated by oxido-reduction of its Cys109.	[Lee, Eunsun] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Div Life & Pharmaceut Sci, Coll Pharm, Seoul, South Korea; Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, E (corresponding author), Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Div Life & Pharmaceut Sci, Coll Pharm, Seoul, South Korea.	kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Song, Eun Joo/0000-0002-2420-6666				Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DELAROSA A, 1995, BIOESSAYS, V17, P53, DOI 10.1002/bies.950170111; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; Freije JMP, 1996, CURR TOP MICROBIOL, V213, P215; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gervasi F, 1996, CELL GROWTH DIFFER, V7, P1689; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Heo YJ, 1997, J CHROMATOGR A, V781, P251; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Ishijima Y, 1999, FEBS LETT, V445, P155, DOI 10.1016/S0014-5793(99)00116-7; JI L, 1995, J BIOL CHEM, V270, P13392, DOI 10.1074/jbc.270.22.13392; Kim S, 2006, NUCLEIC ACIDS RES, V34, pW258, DOI 10.1093/nar/gkl245; Kim SY, 1997, MOL CELLS, V7, P630; Kim SY, 2001, J BIOCHEM MOL BIOL, V34, P355; Kim SY, 2000, CELL GROWTH DIFFER, V11, P485; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; Kraeft SK, 1996, EXP CELL RES, V227, P63, DOI 10.1006/excr.1996.0250; LEONE A, 1993, ONCOGENE, V8, P2325; LUNDSTROMLJUNG J, 1995, FEBS LETT, V357, P305, DOI 10.1016/0014-5793(94)01386-F; Murakami M, 2008, INT J CANCER, V123, P500, DOI 10.1002/ijc.23568; Na S, 2008, MOL CELL PROTEOMICS, V7, P2452, DOI 10.1074/mcp.M800101-MCP200; NAKAYAMA T, 1992, J NATL CANCER I, V84, P1349, DOI 10.1093/jnci/84.17.1349; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Ouatas T, 2003, J BIOENERG BIOMEMBR, V35, P73, DOI 10.1023/A:1023497924277; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Pinon VPB, 1999, EXP CELL RES, V246, P355, DOI 10.1006/excr.1998.4318; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; POSTEL EH, 1994, J BIOL CHEM, V269, P8627; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200	49	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7949	10.1371/journal.pone.0007949	http://dx.doi.org/10.1371/journal.pone.0007949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956735	Green Submitted, gold, Green Published			2022-12-25	WOS:000272827300008
J	Fainaru, O; Almog, N; Yung, CW; Nakai, K; Montoya-Zavala, M; Abdollahi, A; D'Amato, R; Ingber, DE				Fainaru, Ofer; Almog, Nava; Yung, Chong Wing; Nakai, Kei; Montoya-Zavala, Martin; Abdollahi, Amir; D'Amato, Robert; Ingber, Donald E.			Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells	FASEB JOURNAL			English	Article						immune cells; vasculogenesis	DIFFERENTIATION; PRECURSORS; DEPLETION	Dendritic cells (DCs)-immunomodulatory cells that initiate adaptive immune responses-have recently been shown to exert proangiogenic effects when infiltrating the tumor microenvironment. As tumors that escape immune surveillance inhibit DC maturation, we explored whether maturation status determines their ability to promote angiogenesis and whether angiogenesis depends on the presence of DCs. Using mouse xenograft models of human tumors, we show that fast-growing "angiogenic" tumors are infiltrated by a more immature DC population than respective dormant avascular tumors. Accordingly, supplementation of immature DCs, but not mature DCs, enhanced tumor growth. When DCs were mixed with Matrigel and injected subcutaneously into mice, only immature DCs promoted the ingrowth of patent blood vessels. Notably, depletion of DCs in a transgenic mouse model that allows for their conditional ablation completely abrogated basic fibroblast growth factor-induced angiogenesis in Matrigel plugs, and significantly inhibited tumor growth in these mice. Because immature DCs actively promote angiogenesis and tumor growth, whereas DC maturation or ablation suppresses this response, we conclude that angiogenesis is dependent on the presence of immature DCs. Thus, cancer immunotherapies that promote DC maturation may act by both augmenting the host immune response to the tumor and by suppressing tumor angiogenesis.-Fainaru, O., Almog, N., Yung, C. W., Nakai, K., Montoya-Zavala, M., Abollahi, A., D'Amato, R., Ingber, D. E. Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells. FASEB J. 24, 1411-1418 (2010). www.fasebj.org	[Ingber, Donald E.] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA 02115 USA; [Fainaru, Ofer; Yung, Chong Wing; Montoya-Zavala, Martin; D'Amato, Robert; Ingber, Donald E.] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Fainaru, Ofer; Yung, Chong Wing; Montoya-Zavala, Martin] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Nakai, Kei; D'Amato, Robert] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Montoya-Zavala, Martin; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Harvard Sch Engn & Appl Sci, Boston, MA 02115 USA; [Almog, Nava; Abdollahi, Amir] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Abdollahi, Amir] Heidelberg Univ, Dept Radiat Oncol, Sch Med, Heidelberg, Germany; [Abdollahi, Amir] German Canc Res Ctr, D-6900 Heidelberg, Germany	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; St. Elizabeth's Medical Center; Tufts University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Ingber, DE (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, 300 Longwood Ave, Boston, MA 02115 USA.	donald.ingber@childrens.harvard.edu	Ingber, Donald E/AAC-5894-2019		Fulbright and Rothschild Foundations; European Molecular Biology Organization (EMBO); German Research Council [DFG-SPP1190]; National Aeronautics and Space Administration Specialized Center of Research (NSCOR) [NNJ04HJ12G]; U.S. Department of Defense [W81XWH-04-1-0316]; U.S. National Institutes of Health [P01 CA045548]; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER	Fulbright and Rothschild Foundations; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); German Research Council(German Research Foundation (DFG)); National Aeronautics and Space Administration Specialized Center of Research (NSCOR); U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to Dr. Judah Folkman, who helped launch and guide this effort. The authors also thank Lauren Bazinet for her expert technical assistance, and Kristin Johnson and Clare Lamont for photography and graphic art. This research was supported by the Fulbright and Rothschild Foundations and the European Molecular Biology Organization (EMBO) Fellowship (O.F.); German Research Council Priority Research Program Tumor-Vessel Interface (DFG-SPP1190) and National Aeronautics and Space Administration Specialized Center of Research (NSCOR) NNJ04HJ12G (A. A.); and U.S. Department of Defense Breast Cancer Innovator award W81XWH-04-1-0316 and U.S. National Institutes of Health award P01 CA045548 (D. I.).	Adini A, 2009, J IMMUNOL METHODS, V342, P78, DOI 10.1016/j.jim.2008.11.016; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Coukos G, 2005, BRIT J CANCER, V92, P1182, DOI 10.1038/sj.bjc.6602476; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2006, BBA-REV CANCER, V1766, P159, DOI 10.1016/j.bbcan.2006.06.003; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Fainaru O, 2008, FASEB J, V22, P522, DOI 10.1096/fj.07-9034com; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Huarte E, 2008, CANCER RES, V68, P7684, DOI 10.1158/0008-5472.CAN-08-1167; Jinushi M, 2007, CLIN CANCER RES, V13, P3762, DOI 10.1158/1078-0432.CCR-07-0880; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nakai K, 2008, INVEST OPHTH VIS SCI, V49, P3666, DOI 10.1167/iovs.07-1640; NAUMOV GN, J NATL CANC I, V98, P316; PASSANITI A, 1992, LAB INVEST, V67, P519; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040	29	77	81	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1411	1418		10.1096/fj.09-147025	http://dx.doi.org/10.1096/fj.09-147025			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20008545	Green Published			2022-12-25	WOS:000277158900014
J	Anastasiadou, E; Boccellato, F; Vincenti, S; Rosato, P; Bozzoni, I; Frati, L; Faggioni, A; Presutti, C; Trivedi, P				Anastasiadou, E.; Boccellato, F.; Vincenti, S.; Rosato, P.; Bozzoni, I.; Frati, L.; Faggioni, A.; Presutti, C.; Trivedi, P.			Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b	ONCOGENE			English	Article						EBV; microRNA; TCL1; LMP1; mir-29b	LATENT MEMBRANE PROTEIN-1; B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ENDEMIC BURKITTS-LYMPHOMA; GENE-EXPRESSION; KAPPA-B; DNA METHYLTRANSFERASES; GROWTH TRANSFORMATION; MICRORNA MIR-146A; T-CELLS	Epstein-Barr virus (EBV) encoded latent membrane protein 1 (LMP1) is noted for its transforming potential. Yet, it also acts as a cytostatic and growth-relenting factor in Burkitt's lymphoma (BL) cells. The underlying molecular mechanisms of the growth inhibitory property of LMP1 have remained largely unknown. In this study, we show that LMP1 negatively regulates a major oncogene, TCL1, in diffuse large B-cell lymphoma (DLBCL) and BL cells. MicroRNA (miR) profiling of LMP1 transfectants showed that among others, miR-29b, is upregulated. LMP1 diminished TCL1 by inducing miR-29b through C-terminus activation region 1 (CTAR1) and CTAR2. miR-29b locked nucleic acid (LNA) antisense oligonucleotide transfection into LMP1-expressing cells reduced miR-29b expression and consequently reconstituted TCL1, suggesting that LMP1 negatively regulates TCL1 through miR-29b upregulation. The miR-29b increase by LMP1 was due to an increase in the cluster pri-miR-29b1-a transcription, derived from human chromosome 7. Using pharmacological inhibitors, we found that p38 mitogen-activated protein kinase-activating function of LMP1 is important for this effect. The ability of LMP1 to negatively regulate TCL1 through miR-29b might underlie its B-cell lymphoma growth antagonistic property. As LMP1 is also important for B-cell transformation, we suggest that the functional dichotomy of this viral protein may depend on a combination of levels of its expression, lineage and differentiation of the target cells and regulation of miRs, which then directs the outcome of the cellular response. Oncogene (2010) 29, 1316-1328; doi:10.1038/onc.2009.439; published online 7 December 2009	[Anastasiadou, E.; Boccellato, F.; Rosato, P.; Frati, L.; Faggioni, A.; Trivedi, P.] Univ Roma La Sapienza, Dept Expt Med & Pathol, Ist Pasteur Fdn Cenci Bolognetti, I-00161 Rome, Italy; [Vincenti, S.; Bozzoni, I.; Presutti, C.] Univ Roma La Sapienza, Dept Genet & Mol Biol, I-00161 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome	Trivedi, P (corresponding author), Univ Roma La Sapienza, Dept Expt Med & Pathol, Ist Pasteur Fdn Cenci Bolognetti, Viale Regina Elena 324, I-00161 Rome, Italy.	Pankaj.Trivedi@uniroma1.it	Anastasiadou, Eleni/AAI-1845-2020; Frati, Luigi/ABI-7437-2020; ANASTASIADOU, ELENI/AAU-6080-2021; Vincenti, Sara/N-6007-2018	ANASTASIADOU, ELENI/0000-0003-0212-6734; PRESUTTI, Carlo/0000-0003-3837-2275; bozzoni, irene/0000-0002-3485-8537; Vincenti, Sara/0000-0003-3692-1947; Boccellato, Francesco/0000-0001-6013-7154	MIUR; Associazione Italiana per la ricerca sul Cancro (AIRC); Ministero della Salute; Pasteur Cenci-Bolognetti Foundation; Fondazione Italiana per la sclerosi multipla (FISM); European Union [LSHB-CT-2004 005276]; SIROCCO [037900]	MIUR(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Pasteur Cenci-Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Fondazione Italiana per la sclerosi multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); European Union(European Commission); SIROCCO	We thank V Licursi, V Del Vescovo and Dr R Negri's group members for help with microarray scanning facility and statistical analysis. We thank Dr Martin Rowe (Birmingham University, UK) for providing mutant LMP1 plasmids and comments. Dr Michael Teitell (UCLA, Los Angeles) and Dr Stefanie Gofflot (University of Liege, Belgium) are acknowledged for supplying TCL1 promoter reporter constructs and SUDH4 DLBCL cell line, respectively. This work was supported by grants from MIUR and Associazione Italiana per la ricerca sul Cancro (AIRC), progetto strategico ISS 9ACF/1 of Ministero della Salute, Pasteur Cenci-Bolognetti Foundation, Fondazione Italiana per la sclerosi multipla (FISM), Sixth Research Framework Programme of the European Union, Project RIGHT (LSHB-CT-2004 005276) and SIROCCO (037900).	ALEXANDER WS, 1989, MOL CELL BIOL, V9, P67, DOI 10.1128/MCB.9.1.67; Amini RM, 2002, LEUKEMIA LYMPHOMA, V43, P2179, DOI 10.1080/1042819021000032917; BAICHWAL VR, 1988, ONCOGENE, V2, P461; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bell AI, 2006, J GEN VIROL, V87, P2885, DOI 10.1099/vir.0.81906-0; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Boccellato F, 2007, J VIROL, V81, P2274, DOI 10.1128/JVI.01822-06; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Cardinaud B, 2009, LEUKEMIA, V23, P2174, DOI 10.1038/leu.2009.125; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; CUOMO L, 1992, INT J CANCER, V51, P949, DOI 10.1002/ijc.2910510619; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Dirmeier U, 2003, CANCER RES, V63, P2982; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Floettmann JE, 1997, ONCOGENE, V15, P1851, DOI 10.1038/sj.onc.1201359; Floettmann JE, 1996, VIROLOGY, V223, P29, DOI 10.1006/viro.1996.0452; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Horenstein MG, 1997, BLOOD, V90, P1186, DOI 10.1182/blood.V90.3.1186; Hoyer KK, 2002, P NATL ACAD SCI USA, V99, P14392, DOI 10.1073/pnas.212410199; HUDSON GS, 1985, J VIROL, V53, P528, DOI 10.1128/JVI.53.2.528-535.1985; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Kawanishi M, 1997, VIROLOGY, V228, P244, DOI 10.1006/viro.1996.8370; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kiss C, 2003, P NATL ACAD SCI USA, V100, P4813, DOI 10.1073/pnas.0730710100; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Lam N, 2004, J VIROL, V78, P1657, DOI 10.1128/JVI.78.4.1657-1664.2004; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lay JD, 2003, J BIOMED SCI, V10, P146, DOI 10.1159/000068077; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OHNO S, 1984, J EXP MED, V159, P1762, DOI 10.1084/jem.159.6.1762; Pajic A, 2001, INT J CANCER, V93, P810, DOI 10.1002/ijc.1404; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Rahadiani N, 2008, BIOCHEM BIOPH RES CO, V377, P579, DOI 10.1016/j.bbrc.2008.10.007; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Said JW, 2001, LAB INVEST, V81, P555, DOI 10.1038/labinvest.3780264; Sandberg ML, 2000, J VIROL, V74, P9755, DOI 10.1128/JVI.74.20.9755-9761.2000; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Tao Q, 1998, BLOOD, V91, P1373, DOI 10.1182/blood.V91.4.1373; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; VIRGILIO L, 1993, P NATL ACAD SCI USA, V90, P9275, DOI 10.1073/pnas.90.20.9275; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; Wang S, 1996, CANCER RES, V56, P4610; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	59	48	49	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1316	1328		10.1038/onc.2009.439	http://dx.doi.org/10.1038/onc.2009.439			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19966860				2022-12-25	WOS:000275170600007
J	Cheung, AF; Carter, AM; Kostova, KK; Woodruff, JF; Crowley, D; Bronson, RT; Haigis, KM; Jacks, T				Cheung, A. F.; Carter, A. M.; Kostova, K. K.; Woodruff, J. F.; Crowley, D.; Bronson, R. T.; Haigis, K. M.; Jacks, T.			Complete deletion of Apc results in severe polyposis in mice	ONCOGENE			English	Article						Apc truncation; Apc null; colon cancer; mouse model	FAMILIAL ADENOMATOUS POLYPOSIS; BETA-CATENIN; MOUSE MODEL; MUTATION; ACTIVATION; REGULATOR; PHENOTYPE; PROTEIN; SITE; RAS	The adenomatous polyposis coli (APC) gene product is mutated in the vast majority of human colorectal cancers. APC negatively regulates the WNT pathway by aiding in the degradation of beta-catenin, which is the transcription factor activated downstream of WNT signaling. APC mutations result in beta-catenin stabilization and constitutive WNT pathway activation, leading to aberrant cellular proliferation. APC mutations associated with colorectal cancer commonly fall in a region of the gene termed the mutation cluster region and result in expression of an N-terminal fragment of the APC protein. Biochemical and molecular studies have revealed localization of APC/Apc to different sub-cellular compartments and various proteins outside of the WNT pathway that associate with truncated APC/Apc. These observations and genotype-phenotype correlations have led to the suggestion that truncated APC bears neomorphic and/or dominant-negative function that support tumor development. To analyze this possibility, we have generated a novel allele of Apc in the mouse that yields complete loss of Apc protein. Our studies reveal that whole-gene deletion of Apc results in more rapid tumor development than the APC multiple intestinal neoplasia (Apc(Min)) truncation. Furthermore, we found that adenomas bearing truncated Apc had increased beta-catenin activity when compared with tumors lacking Apc protein, which could lead to context-dependent inhibition of tumorigenesis. Oncogene (2010) 29, 1857-1864; doi:10.1038/onc.2009.457; published online 14 December 2009	[Cheung, A. F.; Carter, A. M.; Kostova, K. K.; Woodruff, J. F.; Crowley, D.; Jacks, T.] MIT, Robert Koch Inst, Cambridge, MA 02139 USA; [Cheung, A. F.; Carter, A. M.; Kostova, K. K.; Woodruff, J. F.; Crowley, D.; Jacks, T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Crowley, D.; Jacks, T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Bronson, R. T.] Tufts Univ, Sch Med & Vet Med, Dept Pathol, Boston, MA 02111 USA; [Haigis, K. M.] Harvard Univ, Sch Med, Dept Pathol, Masschusetts Gen Hosp,Canc Ctr, Charlestown, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Tufts University; Harvard University	Jacks, T (corresponding author), MIT, Robert Koch Inst, 77 Massachusetts Ave,E17-517, Cambridge, MA 02139 USA.	tjacks@mit.edu	Kostova, Kamena/AAK-9431-2020	Kostova, Kamena/0000-0001-9973-401X	Howard Hughes Medical Institute; National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Jacks labs, Keara Lane in particular, for experimental advice and assistance. This work was supported by the Howard Hughes Medical Institute and partially by the Cancer Center Support (core) Grant P30-CA14051 from the National Cancer Institute. TJ is a Howard Hughes Investigator and a Daniel K Ludwig Scholar.	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Haigis KM, 2004, P NATL ACAD SCI USA, V101, P9769, DOI 10.1073/pnas.0403338101; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HERRERA L, 1986, AM J MED GENET, V25, P473, DOI 10.1002/ajmg.1320250309; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nathke I, 2004, J CELL SCI, V117, P4873, DOI 10.1242/jcs.01313; Nieuwenhuis MH, 2007, CRIT REV ONCOL HEMAT, V61, P153, DOI 10.1016/j.critrevonc.2006.07.004; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P2954, DOI 10.1073/pnas.042699199; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Soravia C, 1998, AM J HUM GENET, V62, P1290, DOI 10.1086/301883; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2	32	54	61	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1857	1864		10.1038/onc.2009.457	http://dx.doi.org/10.1038/onc.2009.457			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20010873	Green Accepted, Green Submitted			2022-12-25	WOS:000276022800014
J	Doronkin, S; Djagaeva, I; Nagle, ME; Reiter, LT; Seagroves, TN				Doronkin, S.; Djagaeva, I.; Nagle, M. E.; Reiter, L. T.; Seagroves, T. N.			Dose-dependent modulation of HIF-1 alpha/sima controls the rate of cell migration and invasion in Drosophila ovary border cells	ONCOGENE			English	Article						hypoxia; metastasis; invasion; HIF-1 alpha; VHL; PHD	GENE DISRUPTION PROJECT; E-CADHERIN; DE-CADHERIN; TRANSCRIPTIONAL ACTIVITY; PROLYL HYDROXYLASE; HYPOXIC RESPONSE; HIF-ALPHA; EXPRESSION; PROTEIN; MECHANISMS	The role of the hypoxic response during metastasis was analysed in migrating border cells of the Drosophila ovary. Acute exposure to 1% O-2 delayed or blocked border cell migration (BCM), whereas prolonged exposure resulted in the first documented accelerated BCM phenotype. Similarly, manipulating the expression levels of sima, the Drosophila hypoxia-inducible factor (HIF)-1 alpha ortholog, revealed that Sima can either block or restore BCM in a dose-dependent manner. In contrast, overexpression of Vhl (Drosophila von Hippel-Lindau) generated a range of phenotypes, including blocked, delayed and accelerated BCM, whereas over-expression of hph (Drosophila HIF prolyl hydroxylase) only accelerated BCM. Mosaic clone analysis of sima or tango (HIF-1 beta ortholog) mutants revealed that cells lacking Hif-1 transcriptional activity were preferentially detected in the leading cell position of the cluster, resulting in either a delay or acceleration of BCM. Moreover, in sima mutant cell clones, there was reduced expression of nuclear slow border cells (Slbo) and basolateral DE-cadherin, proteins essential for proper BCM. These results show that Sima levels de. ne the rate of BCM in part through regulation of Slbo and DE-cadherin, and suggest that dynamic regulation of Hif-1 activity is necessary to maintain invasive potential of migrating epithelial cells. Oncogene (2010) 29, 1123-1134; doi: 10.1038/onc.2009.407; published online 7 December 2009	[Doronkin, S.; Djagaeva, I.; Reiter, L. T.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Nagle, M. E.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN 38163 USA; [Reiter, L. T.] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN 38163 USA; [Seagroves, T. N.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Doronkin, S (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, 855 Monroe Ave,Suite 515, Memphis, TN 38163 USA.	sdoronki@utmem.edu	Seagroves, Tiffany/AAE-3278-2019; Reiter, Lawrence/H-4161-2019	Seagroves, Tiffany/0000-0002-6937-943X; Reiter, Lawrence/0000-0002-4100-2630	Medical Student Research Fellowship (MSRF, NIH); Dorothy K Gerwin and the Maston Callison Bowld Cancer Research; UTHSC Molecular Resource Center; UTHSC Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [R01CA138488] Funding Source: NIH RePORTER	Medical Student Research Fellowship (MSRF, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothy K Gerwin and the Maston Callison Bowld Cancer Research; UTHSC Molecular Resource Center; UTHSC Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Eric Spana of the Duke Model Systems Genomics core facility for generating UAS-Vhl/VHL transgenic fly stocks. Drs Bruce Edgar, Denise Montell and Pernille Rorth generously shared reagents. Several stocks were obtained from the Bloomington Drosophila Stock Center. DE-cadherin antibodies were obtained from the Developmental Studies Hybridoma Bank. MN was supported by a Medical Student Research Fellowship (MSRF, NIH). All work was supported by the Dorothy K Gerwin and the Maston Callison Bowld Cancer Research funds at UTHSC (to TNS), the UTHSC Molecular Resource Center (to LTR) and the UTHSC Clinical and Translational Science Institute.	Adryan B, 2000, ONCOGENE, V19, P2803, DOI 10.1038/sj.onc.1203611; Arquier N, 2006, BIOCHEM J, V393, P471, DOI 10.1042/BJ20050675; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; Cameron CM, 2008, EXP BIOL MED, V233, P1044, DOI 10.3181/0709-RM-263; Carthew RW, 2005, CURR OPIN GENET DEV, V15, P358, DOI 10.1016/j.gde.2005.06.002; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Frei C, 2004, DEV CELL, V6, P241, DOI 10.1016/S1534-5807(03)00409-X; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gorr TA, 2004, J BIOL CHEM, V279, P36048, DOI 10.1074/jbc.M405077200; Janardhan HP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143jc2; Jang ACC, 2007, J MAMMARY GLAND BIOL, V12, P103, DOI 10.1007/s10911-007-9042-8; Jiang Y, 2005, LEUKEMIA, V19, P1239, DOI 10.1038/sj.leu.2403734; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Mathieu J, 2007, GENETICS, V176, P1579, DOI 10.1534/genetics.107.071282; Montell DJ, 2006, CURR OPIN GENET DEV, V16, P374, DOI 10.1016/j.gde.2006.06.010; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Mortimer NT, 2009, DEV BIOL, V329, P294, DOI 10.1016/j.ydbio.2009.03.001; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Oda H, 1997, GENES CELLS, V2, P29, DOI 10.1046/j.1365-2443.1997.d01-284.x; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Rorth P, 2000, MOL CELL, V6, P23; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5; Russell RC, 2007, CELL CYCLE, V6, P56, DOI 10.4161/cc.6.1.3668; Schober M, 2005, DEVELOPMENT, V132, P3493, DOI 10.1242/dev.01911; Seifeddine R, 2008, CANCER RES, V68, P2158, DOI 10.1158/0008-5472.CAN-07-1190; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Spradling AC, 1999, GENETICS, V153, P135; Starz-Gaiano M, 2004, CURR OPIN GENET DEV, V14, P86, DOI 10.1016/j.gde.2003.12.001; Starz-Gaiano M, 2008, DEV CELL, V14, P726, DOI 10.1016/j.devcel.2008.03.005; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262; Zhong H, 1999, CANCER RES, V59, P5830	59	12	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1123	1134		10.1038/onc.2009.407	http://dx.doi.org/10.1038/onc.2009.407			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19966858				2022-12-25	WOS:000274912100004
J	Bublik, DR; Scolz, M; Triolo, G; Monte, M; Schneider, C				Bublik, Debora Rosa; Scolz, Massimiliano; Triolo, Gianluca; Monte, Martin; Schneider, Claudio			Human GTSE-1 Regulates p21(CIP1/WAF1) Stability Conferring Resistance to Paclitaxel Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC LOCALIZATION; MEDIATED DEGRADATION; INDUCED APOPTOSIS; UP-REGULATION; P21; PROTEIN; CELLS; GENE; P53; PHOSPHORYLATION	p21(CIP1/WAF1) belongs to the CIP/KIP family of Cdk inhibitors, and its expression is tightly controlled during the cell cycle, mainly by transcriptional and post-translational mechanisms. Fine regulation of p21(CIP1/WAF1) levels is critical for cell cycle control and for cellular response to stress. In the present work, we describe a novel mechanism to modulate p21(CIP1/WAF1) levels mediated by the human GTSE-1 (G(2) and S phase-expressed-1) protein. Our results provide evidence that hGTSE-1 protects p21(CIP1/WAF1) from proteasome-dependent degradation as part of a functional complex containing the Hsp90-binding TPR protein WISp39. We further show that the hGTSE-1 N-terminal portion is sufficient for p21(CIP1/WAF1) binding and stabilization. Finally, we demonstrate that hGTSE-1 mediated-p21(CIP1/WAF1) stabilization is clearly involved in the ability of cells to counteract cytotoxicity induced by the microtubule poison paclitaxel.	[Monte, Martin; Schneider, Claudio] Int Ctr Genet Engn & Biotechnol, Lab Nazl Consorzio Interuniv Biotecnol, I-34149 Trieste, Italy; [Triolo, Gianluca] Int Ctr Genet Engn & Biotechnol, Genome Stabil Lab, I-34149 Trieste, Italy; [Schneider, Claudio] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Schneider, C (corresponding author), Int Ctr Genet Engn & Biotechnol, Lab Nazl Consorzio Interuniv Biotecnol, Area Sci Pk,Padriciano 99, I-34149 Trieste, Italy.	schneide@lncib.it	Triolo, Gianluca/AAH-9610-2020	Monte, Martin/0000-0002-5068-563X	Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Istruzione; dell'Universitae della Ricerca (MIUR); Fondo per gli Investimenti della Ricerca di Base [RBIN04N4-003]; TRANSlational and Functional Onco-Genomics (TRANSFOG) [FP6 503438, PICT0700283]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universitae della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); TRANSlational and Functional Onco-Genomics (TRANSFOG)	This work was supported by Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Istruzione, dell'Universitae della Ricerca (MIUR) Fondo per gli Investimenti della Ricerca di Base RBIN04N4-003, TRANSlational and Functional Onco-Genomics (TRANSFOG) FP6 503438 (to C.S.), and PICT0700283 (to M.M.).	ABBAS T, 2009, NAT REV CANC; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Cayrol C, 1998, ONCOGENE, V17, P2437, DOI 10.1038/sj.onc.1202189; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Collavin L, 2000, FEBS LETT, V481, P57, DOI 10.1016/S0014-5793(00)01969-4; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Debernardis D, 1997, CANCER RES, V57, P870; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kagawa S, 1999, CELL DEATH DIFFER, V6, P765, DOI 10.1038/sj.cdd.4400549; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li WW, 1999, MOL PHARMACOL, V55, P1088, DOI 10.1124/mol.55.6.1088; LI Y, 1994, ONCOGENE, V9, P2261; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Monte M, 2000, GENE, V254, P229, DOI 10.1016/S0378-1119(00)00260-2; Monte M, 2004, J BIOL CHEM, V279, P11744, DOI 10.1074/jbc.M311123200; Monte M, 2003, J BIOL CHEM, V278, P30356, DOI 10.1074/jbc.M302902200; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Pfleger CM, 2000, GENE DEV, V14, P655; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Utrera R, 1998, EMBO J, V17, P5015, DOI 10.1093/emboj/17.17.5015; Westbrook TF, 2002, MOL CELL BIOL, V22, P7041, DOI 10.1128/MCB.22.20.7041-7052.2002; Yang WT, 2003, CANCER, V98, P1123, DOI 10.1002/cncr.11625; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	34	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5274	5281		10.1074/jbc.M109.045948	http://dx.doi.org/10.1074/jbc.M109.045948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018861	Green Published, hybrid			2022-12-25	WOS:000275327200021
J	Khurana, S; Jaiswal, AK; Mukhopadhyay, A				Khurana, Satish; Jaiswal, Amit K.; Mukhopadhyay, Asok			Hepatocyte Nuclear Factor-4 alpha Induces Transdifferentiation of Hematopoietic Cells into Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; STEM-CELLS; ONCOSTATIN-M; PROGENITOR CELLS; MOLECULAR-BASIS; GROWTH-FACTOR; LIVER; EXPRESSION; DIFFERENTIATION; REPAIR	Hematopoietic stem cells can directly transdifferentiate into hepatocytes because of cellular plasticity, but the molecular basis of transdifferentiation is not known. Here, we show the molecular basis using lineage-depleted oncostatin M receptor beta-expressing (Lin(-)OSMR beta(+)) mouse bone marrow cells in a hepatic differentiation culture system. Differentiation of the cells was marked by the expression of albumin. Hepatocyte nuclear factor (HNF)-4 alpha was expressed and translocated into the nuclei of the differentiating cells. Suppression of its activation in OSM-neutralized culture medium inhibited cellular differentiation. Ectopic expression of full-length HNF4 alpha in 32D myeloid cells resulted in decreased myeloid colony-forming potential and increased expression of hepatocyte-specific genes and proteins. Nevertheless, the neohepatocytes produced in culture expressed active P450 enzyme. The obligatory role of HNF4 alpha in hepatic differentiation was confirmed by transfecting Lin(-)OSMR beta(+) cells with dominant negative HNF4 alpha in the differentiation culture because its expression inhibited the transcription of the albumin and tyrosine aminotransferase genes. The loss and gain of functional activities strongly suggested that HNF4 alpha plays a central role in the transdifferentiation process. For the first time, this report demonstrates the mechanism of transdifferentiation of hematopoietic cells into hepatocytes, in which HNF4 alpha serves as a molecular switch.	[Khurana, Satish; Jaiswal, Amit K.; Mukhopadhyay, Asok] Natl Inst Immunol, Stem Cell Biol Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Stem Cell Biol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	ashok@nii.res.in	Jaiswal, Amit/GRS-1053-2022; Khurana, Satish/H-9090-2016	Khurana, Satish/0000-0001-5176-1510				Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Fiegel HC, 2003, STEM CELLS, V21, P98, DOI 10.1634/stemcells.21-1-98; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Khurana S, 2007, STEM CELLS, V25, P1439, DOI 10.1634/stemcells.2006-0656; Khurana S, 2008, J HEPATOL, V49, P998, DOI 10.1016/j.jhep.2008.05.019; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Li JX, 2000, GENE DEV, V14, P464; Li WC, 2005, J CELL MOL MED, V9, P569, DOI 10.1111/j.1582-4934.2005.tb00489.x; Lian GW, 2006, EXP HEMATOL, V34, P348, DOI 10.1016/j.exphem.2005.12.004; Madhusudhan T, 2003, J HEMATOTH STEM CELL, V12, P243, DOI 10.1089/152581603321628386; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Taylor DG, 1996, NUCLEIC ACIDS RES, V24, P2930, DOI 10.1093/nar/24.15.2930; Thowfeequ S, 2007, DEV DYNAM, V236, P3208, DOI 10.1002/dvdy.21336; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434	42	22	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4725	4731		10.1074/jbc.M109.058198	http://dx.doi.org/10.1074/jbc.M109.058198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018873	Green Published, hybrid			2022-12-25	WOS:000275274800050
J	Wyatt, AR; Wilson, MR				Wyatt, Amy R.; Wilson, Mark R.			Identification of Human Plasma Proteins as Major Clients for the Extracellular Chaperone Clusterin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FORMATION; MACULAR DEGENERATION; APOLIPOPROTEIN-J; FIBRINOGEN DEPOSITION; BASEMENT-MEMBRANE; QUALITY-CONTROL; SHEAR-STRESS; VESSEL WALL; COMPLEMENT; DRUSEN	Clusterin (CLU) is an extracellular chaperone that is likely to play an important role in protein folding quality control. This study identified three deposition disease-associated proteins as major plasma clients for clusterin by studying CLU-client complexes formed in response to physiologically relevant stress (shear stress, similar to 36 dynes/cm(2) at 37 degrees C). Analysis of plasma samples by size exclusion chromatography indicated that (i) relative to control plasma, stressed plasma contained proportionally more soluble protein species of high molecular weight, and (ii) high molecular weight species were far more abundant when proteins purified by anti-CLU immunoaffinity chromatography from stressed plasma were compared with those purified from control plasma. SDS-PAGE and Western blot analyses indicated that a variety of proteins co-purified with CLU from both stressed and control plasma; however, several proteins were uniquely present or much more abundant when plasma was stressed. These proteins were identified by mass spectrometry as ceruloplasmin, fibrinogen, and albumin. Immunodot blot analysis of size exclusion chromatography fractionated plasma suggested that CLU-client complexes generated in situ are very large and may reach >= 4 x 10(7) Da. Lastly, sandwich enzyme-linked immunosorbent assay detected complexes containing CLU and ceruloplasmin, fibrinogen, or albumin in stressed but not control plasma. We have previously proposed that CLU-client complexes serve as vehicles to dispose of damaged misfolded extracellular proteins in vivo via receptor-mediated endocytosis. A better understanding of these mechanisms is likely to ultimately lead to the identification of new therapies for extracellular protein deposition disorders.	[Wyatt, Amy R.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Wollongong	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mrw@uow.edu	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Wyatt, Amy/0000-0002-3650-2438	Australian Research Council [DP0773555]; Australian Postgraduate Award; Australian Institute for Nuclear Science and Engineering Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); Australian Institute for Nuclear Science and Engineering Postgraduate Award	This work was supported by Australian Research Council Grant DP0773555. Recipient of an Australian Postgraduate Award and an Australian Institute for Nuclear Science and Engineering Postgraduate Award.	Atmeh RF, 1997, ELECTROPHORESIS, V18, P2055, DOI 10.1002/elps.1150181130; Badimon JJ, 1999, CIRCULATION, V99, P1780, DOI 10.1161/01.CIR.99.14.1780; Barbucci R, 2003, BIOMACROMOLECULES, V4, P1506, DOI 10.1021/bm0340366; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; CHAVERS B, 1984, DIABETOLOGIA, V26, P415; COHN RA, 1978, LAB INVEST, V39, P13; CONNAGHAN DG, 1985, BLOOD, V65, P589; COSTANTINI V, 1991, CANCER RES, V51, P354; COSTANTINI V, 1992, J LAB CLIN MED, V119, P124; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dardik A, 2005, J VASC SURG, V41, P869, DOI 10.1016/j.jvs.2005.01.020; DUJOVNE I, 1972, KIDNEY INT, V2, P33, DOI 10.1038/ki.1972.67; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; Freixes M, 2004, ACTA NEUROPATHOL, V108, P295, DOI 10.1007/s00401-004-0891-6; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; FRENCH LE, 1992, CLIN EXP IMMUNOL, V88, P389; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Gorinstein S, 2003, J AGR FOOD CHEM, V51, P822, DOI 10.1021/jf0206926; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; JENNE DE, 1991, J BIOL CHEM, V266, P11030; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Ker Y. C., 1998, Lebensmittel-Wissenschaft and Technologie, V31, P107, DOI 10.1006/fstl.1997.0306; Kim SH, 2007, LANGMUIR, V23, P5657, DOI 10.1021/la0634701; KINGSTON IB, 1977, P NATL ACAD SCI USA, V74, P5377, DOI 10.1073/pnas.74.12.5377; Klose R, 2000, J BIOL CHEM, V275, P38206, DOI 10.1074/jbc.M003640200; KOFFLER D, 1966, AM J PATHOL, V49, P383; KOFFLER D, 1965, J CLIN INVEST, V44, P1665, DOI 10.1172/JCI105273; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Lakins JN, 2002, BIOCHEMISTRY-US, V41, P282, DOI 10.1021/bi0157666; MAILHAC A, 1994, CIRCULATION, V90, P988, DOI 10.1161/01.CIR.90.2.988; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; MILLER K, 1976, DIABETES, V25, P701, DOI 10.2337/diabetes.25.8.701; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; NEWSOME DA, 1986, INVEST OPHTH VIS SCI, V27, P1675; Park DC, 2008, NEOPLASIA, V10, P964, DOI 10.1593/neo.08604; Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; RAIJ L, 1981, LANCET, V1, P671; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Sakaguchi H, 2002, EXP EYE RES, V74, P547, DOI 10.1006/exer.2002.1186; Schinke T, 1997, FEBS LETT, V412, P559, DOI 10.1016/S0014-5793(97)00827-2; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; Shiose S, 2004, GRAEF ARCH CLIN EXP, V242, P777, DOI 10.1007/s00417-004-0910-2; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; UEMICHI T, 1994, J CLIN INVEST, V93, P731, DOI 10.1172/JCI117027; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; WALKER FJ, 1990, J BIOL CHEM, V265, P1834; WESTBERG NG, 1972, DIABETES, V21, P163, DOI 10.2337/diab.21.3.163; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; WILSON MR, 1992, BIOCHIM BIOPHYS ACTA, V1159, P319, DOI 10.1016/0167-4838(92)90062-I; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; WILSON MR, 2008, HEAT SHOCK PROTEINS; WITTE DP, 1993, AM J PATHOL, V143, P763; WOJTUKIEWICZ MZ, 1989, THROMB RES, V55, P279, DOI 10.1016/0049-3848(89)90445-3; WOJTUKIEWICZ MZ, 1989, THROMB HAEMOSTASIS, V62, P1062; Wyatt AR, 2009, CURR MED CHEM, V16, P2855, DOI 10.2174/092986709788803187; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zakharova ET, 2000, ARCH BIOCHEM BIOPHYS, V374, P222, DOI 10.1006/abbi.1999.1559; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	80	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3532	3539		10.1074/jbc.M109.079566	http://dx.doi.org/10.1074/jbc.M109.079566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996109	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000275254000002
J	del Corral, H; Paris, SC; Marin, ND; Marin, DM; Lopez, L; Henao, HM; Martinez, T; Villa, L; Barrera, LF; Ortiz, BL; Ramirez, ME; Montes, CJ; Oquendo, MC; Arango, LM; Riano, F; Aguirre, C; Bustamante, A; Belisle, JT; Dobos, K; Mejia, GI; Giraldo, MR; Brennan, PJ; Robledo, J; Arbelaez, MP; Rojas, CA; Garcia, LF				del Corral, Helena; Paris, Sara C.; Marin, Nancy D.; Marin, Diana M.; Lopez, Lucelly; Henao, Hanna M.; Martinez, Teresita; Villa, Liliana; Barrera, Luis F.; Ortiz, Blanca L.; Ramirez, Maria E.; Montes, Carlos J.; Oquendo, Maria C.; Arango, Lisandra M.; Riano, Felipe; Aguirre, Carlos; Bustamante, Alberto; Belisle, John T.; Dobos, Karen; Mejia, Gloria I.; Giraldo, Margarita R.; Brennan, Patrick J.; Robledo, Jaime; Arbelaez, Maria P.; Rojas, Carlos A.; Garcia, Luis F.			IFN gamma Response to Mycobacterium tuberculosis, Risk of Infection and Disease in Household Contacts of Tuberculosis Patients in Colombia	PLOS ONE			English	Article							T-CELL RESPONSES; LATENT TUBERCULOSIS; IMMUNE-RESPONSES; PREDICTIVE-VALUE; SKIN-TEST; ASSAYS; DIAGNOSIS; CHILDREN; ANTIGENS; ELISPOT	Objectives: Household contacts (HHCs) of pulmonary tuberculosis patients are at high risk of Mycobacterium tuberculosis infection and early disease development. Identification of individuals at risk of tuberculosis disease is a desirable goal for tuberculosis control. Interferon-gamma release assays (IGRAs) using specific M. tuberculosis antigens provide an alternative to tuberculin skin testing (TST) for infection detection. Additionally, the levels of IFN gamma produced in response to these antigens may have prognostic value. We estimated the prevalence of M. tuberculosis infection by IGRA and TST in HHCs and their source population (SP), and assessed whether IFN gamma levels in HHCs correlate with tuberculosis development. Methods: A cohort of 2060 HHCs was followed for 2-3 years after exposure to a tuberculosis case. Besides TST, IFN gamma responses to mycobacterial antigens: CFP, CFP-10, HspX and Ag85A were assessed in 7-days whole blood cultures and compared to 766 individuals from the SP in Medellin, Colombia. Isoniazid prophylaxis was not offered to child contacts because Colombian tuberculosis regulations consider it only in children under 5 years, TST positive without BCG vaccination. Results: Using TST 65.9% of HHCs and 42.7% subjects from the SP were positive (OR 2.60, p, 0.0001). IFN gamma response to CFP-10, a biomarker of M. tuberculosis infection, tested positive in 66.3% HHCs and 24.3% from the SP (OR = 6.07, p, 0.0001). Tuberculosis incidence rate was 7.0/1000 person years. Children <5 years accounted for 21.6% of incident cases. No significant difference was found between positive and negative IFN gamma responders to CFP-10 (HR 1.82 95% CI 0.79-4.20 p = 0.16). However, a significant trend for tuberculosis development amongst high HHC IFN gamma producers was observed (trend Log rank p = 0.007). Discussion: CFP-10-induced IFN gamma production is useful to establish tuberculosis infection prevalence amongst HHC and identify those at highest risk of disease. The high tuberculosis incidence amongst children supports administration of chemoprohylaxis to child contacts regardless of BCG vaccination.	[del Corral, Helena; Marin, Diana M.; Lopez, Lucelly; Martinez, Teresita; Villa, Liliana; Arbelaez, Maria P.; Rojas, Carlos A.] Univ Antioquia, Epidemiol Grp, Medellin, Colombia; [del Corral, Helena] Univ Antioquia, Escuela Microbiol, Medellin, Colombia; [Paris, Sara C.; Marin, Nancy D.; Henao, Hanna M.; Villa, Liliana; Barrera, Luis F.; Ortiz, Blanca L.; Ramirez, Maria E.; Montes, Carlos J.; Oquendo, Maria C.; Arango, Lisandra M.; Riano, Felipe; Garcia, Luis F.] Univ Antioquia, Grp Inmunol Celular & Immunogenet, Medellin, Colombia; [Aguirre, Carlos; Bustamante, Alberto] Univ Antioquia, Dept Pediat, Medellin, Colombia; [del Corral, Helena; Paris, Sara C.; Marin, Diana M.; Lopez, Lucelly; Henao, Hanna M.; Martinez, Teresita; Barrera, Luis F.; Ortiz, Blanca L.; Oquendo, Maria C.; Arango, Lisandra M.; Mejia, Gloria I.; Robledo, Jaime; Arbelaez, Maria P.; Rojas, Carlos A.; Garcia, Luis F.] Ctr Colombiano Invest TB, Medellin, Colombia; [Mejia, Gloria I.; Robledo, Jaime] Corp Invest Biol, Medellin, Colombia; [Belisle, John T.; Dobos, Karen; Brennan, Patrick J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Giraldo, Margarita R.] Direcc Secc Salud Antioquia, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Colorado State University	del Corral, H (corresponding author), Univ Antioquia, Epidemiol Grp, Medellin, Colombia.	lfgarcia@udea.edu.co	Belisle, John T/B-8944-2017; Rojas Cruz, Carlos Alberto/GZM-2307-2022; Dobos, Karen/D-1170-2017	Belisle, John T/0000-0002-2539-2798; Rojas Cruz, Carlos Alberto/0000-0003-0915-6653; Dobos, Karen/0000-0001-7115-8524; Marin Agudelo, Nancy Dora/0000-0002-2626-3349; Arbelaez Montoya, Maria Patricia/0000-0003-2435-4658; Marin Pineda, Diana/0000-0002-4715-8388; Barrera, Luis/0000-0002-6108-6747; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318	Colciencias, Bogota, Colombia [11150416335, 34261817270, 111540820482]; Direccion Seccional de Salud de Antioquia, Medellin' Colombia [2007SS162363]; NIAID [HHSN26266400091C, N01-AI-40091]	Colciencias, Bogota, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Direccion Seccional de Salud de Antioquia, Medellin' Colombia; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by Colciencias, Bogota, Colombia Grants: 11150416335, 34261817270, 111540820482; Direccion Seccional de Salud de Antioquia, Medellin' Colombia, Grant 2007SS162363; NIAID Contract No. HHSN26266400091C NIH, NIAID N01-AI-40091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, INT J TUBERC LUNG D, V11, P350; *AM THOR SOC, 1999, AM J RESP CRIT CARE, pS221; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Arend SM, 2000, INFECT IMMUN, V68, P3314, DOI 10.1128/IAI.68.6.3314-3321.2000; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; BASS JB, 1990, AM REV RESPIR DIS, V142, P725; Black GF, 2003, CLIN DIAGN LAB IMMUN, V10, P602, DOI 10.1128/CDLI.10.4.602-611.2003; CARDOSOLEAO S, 2004, PRACTICAL HDB PHENOT; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Connell TG, 2006, EXPERT REV MOL DIAGN, V6, P663, DOI 10.1586/14737159.6.5.663; *DANE, 2006, CENS GEN 2005 REP CO; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Dillon DC, 2000, J CLIN MICROBIOL, V38, P3285, DOI 10.1128/JCM.38.9.3285-3290.2000; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 2007, B WORLD HEALTH ORGAN, V85, P364, DOI 10.2471/BLT.06.037580; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gray A., 2001, DEFINITIONS CROWDING; Higuchi K, 2008, TUBERCULOSIS, V88, P244, DOI 10.1016/j.tube.2007.11.009; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001; JOHNSON NL, 1994, CONTINUOS UNIVARIATE; KLEINBAUM D, 2005, LOGISTIC REGRESSION, P327; Lalvani A, 2005, LANCET INFECT DIS, V5, P322, DOI 10.1016/S1473-3099(05)70118-3; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; Lewinsohn DA, 2008, PEDIATR RES, V63, P115, DOI 10.1203/PDR.0b013e3181652085; Lewinsohn DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003407; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Maher D, 2007, B WORLD HEALTH ORGAN, V85, P341, DOI 10.2471/BLT.06.037820; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; *MIN SAL COL, 2000, GUIA AT TUB PULM EXT; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mostowy S, 2004, TUBERCULOSIS, V84, P197, DOI 10.1016/j.tube.2004.02.002; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Richeldi L, 2007, PEDIATRICS, V119, pE1, DOI 10.1542/peds.2006-1057; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Soysal A, 2008, JPN J INFECT DIS, V61, P192; STOP TB, 2006, GUIDANCE NATL TUBERC; Styblo K, 1980, Adv Tuberc Res, V20, P1; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; WHO, 2008, IMPL WHO STOP TB STR; World Health Organization, 2008, GLOB TUB CONTR SURV; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	53	76	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8257	10.1371/journal.pone.0008257	http://dx.doi.org/10.1371/journal.pone.0008257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011589	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300022
J	Fant, X; Srsen, V; Espigat-Georger, A; Merdes, A				Fant, Xavier; Srsen, Vlastimil; Espigat-Georger, Aude; Merdes, Andreas			Nuclei of Non-Muscle Cells Bind Centrosome Proteins upon Fusion with Differentiating Myoblasts	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; MICROTUBULE NUCLEATION; GAMMA-TUBULIN; ORGANIZATION; ELONGATION; CENTRIOLES; FILAMENTS; MYOSIN	Background: In differentiating myoblasts, the microtubule network is reorganized from a centrosome-bound, radial array into parallel fibres, aligned along the long axis of the cell. Concomitantly, proteins of the centrosome relocalize from the pericentriolar material to the outer surface of the nucleus. The mechanisms that govern this relocalization are largely unknown. Methodology: In this study, we perform experiments in vitro and in cell culture indicating that microtubule nucleation at the centrosome is reduced during myoblast differentiation, while nucleation at the nuclear surface increases. We show in heterologous cell fusion experiments, between cultures of differentiating mouse myoblasts and human cells of nonmuscular origin, that nuclei from non-muscle cells recruit centrosome proteins once fused with the differentiating myoblasts. This recruitment still occurs in the presence of cycloheximide and thus appears to be independent of new protein biosynthesis. Conclusions: Altogether, our data suggest that nuclei of undifferentiated cells have the dormant potential to bind centrosome proteins, and that this potential becomes activated during myoblast differentiation.	[Fant, Xavier; Srsen, Vlastimil] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Espigat-Georger, Aude; Merdes, Andreas] Ctr Natl Rech Sci Pierre Fabre, UMR 2587, Toulouse, France	University of Edinburgh	Fant, X (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	andreas.merdes@istmt.cnrs.fr			Wellcome Trust; Association Francaise contre les Myopathies [12471]	Wellcome Trust(Wellcome TrustEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The work was supported in part by a Wellcome Trust Senior Research Fellowship to A. M., by a Wellcome Trust Prize Fellowship to X. F. (http://www.wellcome.ac.uk), and by grant 12471 from the "Association Francaise contre les Myopathies'', awarded to A. M. (http://www.afm-france.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; ANTIN PB, 1981, J CELL BIOL, V90, P300, DOI 10.1083/jcb.90.2.300; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; CONNOLLY JA, 1986, EUR J CELL BIOL, V39, P341; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; HOLTZER H, 1975, P NATL ACAD SCI USA, V72, P513, DOI 10.1073/pnas.72.2.513; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Moudjou M, 1996, J CELL SCI, V109, P875; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Paoletti A, 1996, J CELL SCI, V109, P3089; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; PRZYBYLSKI RJ, 1971, J CELL BIOL, V48, P214; SAITOH O, 1988, CELL TISSUE RES, V252, P263; Schmit AC, 2002, INT REV CYTOL, V220, P257; Srsen V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-28; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; WARREN RH, 1974, J CELL BIOL, V63, P550, DOI 10.1083/jcb.63.2.550; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255	22	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8303	10.1371/journal.pone.0008303	http://dx.doi.org/10.1371/journal.pone.0008303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011525	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300050
J	Zot, HG; Hasbun, JE; Van Minh, N				Zot, Henry G.; Hasbun, Javier E.; Van Minh, Nguyen			Striated Muscle Regulation of Isometric Tension by Multiple Equilibria	PLOS ONE			English	Article							THIN FILAMENT; MYOSIN SUBFRAGMENT-1; COOPERATIVE BINDING; ACTIN; TROPOMYOSIN; TROPONIN; MODEL; CONTRACTION; ACTIVATION; DIFFRACTION	Cooperative activation of striated muscle by calcium is based on the movement of tropomyosin described by the steric blocking theory of muscle contraction. Presently, the Hill model stands alone in reproducing both myosin binding data and a sigmoidal-shaped curve characteristic of calcium activation (Hill TL (1983) Two elementary models for the regulation of skeletal muscle contraction by calcium. Biophys J 44: 383-396.). However, the free myosin is assumed to be fixed by the muscle lattice and the cooperative mechanism is based on calcium-dependent interactions between nearest neighbor tropomyosin subunits, which has yet to be validated. As a result, no comprehensive model has been shown capable of fitting actual tension data from striated muscle. We show how variable free myosin is a selective advantage for activating the muscle and describe a mechanism by which a conformational change in tropomyosin propagates free myosin given constant total myosin. This mechanism requires actin, tropomyosin, and filamentous myosin but is independent of troponin. Hence, it will work equally well with striated, smooth and non-muscle contractile systems. Results of simulations with and without data are consistent with a strand of tropomyosin composed of similar to 20 subunits being moved by the concerted action of 3-5 myosin heads, which compares favorably with the predicted length of tropomyosin in the overlap region of thick and thin filaments. We demonstrate that our model fits both equilibrium myosin binding data and steady-state calcium-dependent tension data and show how both the steepness of the response and the sensitivity to calcium can be regulated by the actin-troponin interaction. The model simulates non-cooperative calcium binding both in the presence and absence of strong binding myosin as has been observed. Thus, a comprehensive model based on three well-described interactions with actin, namely, actin-troponin, actin-tropomyosin, and actin-myosin can explain the cooperative calcium activation of striated muscle.	[Zot, Henry G.] Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA; [Hasbun, Javier E.] Univ W Georgia, Dept Phys, Carrollton, GA USA; [Van Minh, Nguyen] Univ W Georgia, Dept Math, Carrollton, GA USA	University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia	Zot, HG (corresponding author), Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA.	hzot@westga.edu			National Science Foundation [MCB-0508203]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation to HGZ (MCB-0508203). The NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNIESZKA GR, 2008, J MOL BIOL, V379, P929; AKIHIRO N, 2001, J MOL BIOL, V308, P241; Bekyarova TI, 2008, P NATL ACAD SCI USA, V105, P10372, DOI 10.1073/pnas.0709877105; CORNELIUS F, 1980, J GEN PHYSIOL, V75, P709, DOI 10.1085/jgp.75.6.709; EISENBERG E, 1980, BIOPHYS J, V29, P195, DOI 10.1016/S0006-3495(80)85126-5; GEEVES MA, 1987, BIOPHYS J, V52, P215, DOI 10.1016/S0006-3495(87)83208-3; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Getz EB, 1998, BIOPHYS J, V75, P2971, DOI 10.1016/S0006-3495(98)77738-0; GOLDMAN YE, 1986, J PHYSIOL-LONDON, V378, P175, DOI 10.1113/jphysiol.1986.sp016213; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREASER ML, 1971, J BIOL CHEM, V246, P4226; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; HILL LE, 1992, J BIOL CHEM, V267, P16106; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1983, BIOPHYS J, V44, P383, DOI 10.1016/S0006-3495(83)84312-4; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; KAWAI M, 1987, PFLUG ARCH EUR J PHY, V408, P1, DOI 10.1007/BF00581833; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; REGNIER MA, 2002, J PHYSL, V15, P485; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; ROSENFELD SS, 1987, J BIOL CHEM, V262, P9984; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; Tregear RT, 2004, BIOPHYS J, V86, P3009, DOI 10.1016/S0006-3495(04)74350-7; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8052	10.1371/journal.pone.0008052	http://dx.doi.org/10.1371/journal.pone.0008052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997610	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829700001
J	Kitchen, SG; Bennett, M; Galic, Z; Kim, J; Xu, Q; Young, A; Lieberman, A; Joseph, A; Goldstein, H; Ng, H; Yang, O; Zack, JA				Kitchen, Scott G.; Bennett, Michael; Galic, Zoran; Kim, Joanne; Xu, Qing; Young, Alan; Lieberman, Alexis; Joseph, Aviva; Goldstein, Harris; Ng, Hwee; Yang, Otto; Zack, Jerome A.			Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice	PLOS ONE			English	Article							SCID-HU MOUSE; BLOOD MONONUCLEAR-CELLS; VIRUS TYPE-1 INFECTION; HUMAN THYMIC IMPLANTS; IN-VIVO; EFFECTOR FUNCTIONS; VIRAL-INFECTIONS; FINE SPECIFICITY; GENE-EXPRESSION; RECEPTOR GENES	There is a desperate need for effective therapies to fight chronic viral infections. The immune response is normally fastidious at controlling the majority of viral infections and a therapeutic strategy aimed at reestablishing immune control represents a potentially powerful approach towards treating persistent viral infections. We examined the potential of genetically programming human hematopoietic stem cells to generate mature CD8+ cytotoxic T lymphocytes that express a molecularly cloned, "transgenic" human anti-HIV T cell receptor (TCR). Anti-HIV TCR transduction of human hematopoietic stem cells directed the maturation of a large population of polyfunctional, HIV-specific CD8+ cells capable of recognizing and killing viral antigen-presenting cells. Thus, through this proof-of-concept we propose that genetic engineering of human hematopoietic stem cells will allow the tailoring of effector T cell responses to fight HIV infection or other diseases that are characterized by the loss of immune control.	[Kitchen, Scott G.; Galic, Zoran; Kim, Joanne; Xu, Qing; Young, Alan; Lieberman, Alexis; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Yang, Otto] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA; [Bennett, Michael; Ng, Hwee; Yang, Otto; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bennett, Michael; Ng, Hwee; Yang, Otto; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Joseph, Aviva; Goldstein, Harris] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Joseph, Aviva; Goldstein, Harris] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kitchen, SG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.	skitchen@ucla.edu			California Institute for Regenerative Medicine (CIRM) [RC1-00149-1]; UCLA Center for AIDS esearch (CFAR)	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); UCLA Center for AIDS esearch (CFAR)	This work was funded by the California Institute for Regenerative Medicine (CIRM) Grant # RC1-00149-1 (http://www.cirm.ca.gov) and the UCLA Center for AIDS esearch (CFAR) (http://www.aidsinstitute.med.ucla.edu/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AKKINA RK, 1994, BLOOD, V84, P1393; Amado RG, 1999, J VIROL, V73, P6361, DOI 10.1128/JVI.73.8.6361-6369.1999; Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101; Benito JM, 2004, AIDS REV, V6, P79; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Bollard CM, 2007, BLOOD, V110, P2838, DOI 10.1182/blood-2007-05-091280; Bollard CM, 2004, BIOL BLOOD MARROW TR, V10, P143, DOI 10.1016/j.bbmt.2003.09.017; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bristol GC, 1997, METHODS, V12, P343, DOI 10.1006/meth.1997.0488; Brodie SJ, 2000, J CLIN INVEST, V105, P1407, DOI 10.1172/JCI8707; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Clay TM, 1999, J IMMUNOL, V163, P507; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; DiGiusto DL, 1996, BLOOD, V87, P1261, DOI 10.1182/blood.V87.4.1261.bloodjournal8741261; Flamand L, 1998, P NATL ACAD SCI USA, V95, P3111, DOI 10.1073/pnas.95.6.3111; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; Galic Z, 2009, STEM CELLS, V27, P100, DOI 10.1634/stemcells.2008-0813; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Huynen MA, 1996, SCIENCE, V272, P1962, DOI 10.1126/science.272.5270.1962; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; Joseph A, 2008, J VIROL, V82, P3078, DOI 10.1128/JVI.01812-07; Kitchen SG, 2005, P NATL ACAD SCI USA, V102, P3794, DOI 10.1073/pnas.0406603102; Kitchen SG, 2000, J VIROL, V74, P2943, DOI 10.1128/JVI.74.6.2943-2948.2000; Kitchen SG, 1998, J VIROL, V72, P9054, DOI 10.1128/JVI.72.11.9054-9060.1998; Lieberman J, 1997, BLOOD, V90, P2196, DOI 10.1182/blood.V90.6.2196.2196_2196_2206; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miles JJ, 2006, CURR MED CHEM, V13, P2725, DOI 10.2174/092986706778521959; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; Sullivan YB, 2001, IMMUNOLOGY, V103, P270, DOI 10.1046/j.1365-2567.2001.01243.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; TERSTAPPEN LWMM, 1992, BLOOD, V79, P666; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; WALKER BD, 1989, P NATL ACAD SCI USA, V86, P9514, DOI 10.1073/pnas.86.23.9514; WithersWard ES, 1997, NAT MED, V3, P1102, DOI 10.1038/nm1097-1102; Yang L, 2005, P NATL ACAD SCI USA, V102, P4518, DOI 10.1073/pnas.0500600102; Yang L, 2002, P NATL ACAD SCI USA, V99, P6204, DOI 10.1073/pnas.092154599; Yang LP, 1998, J EXP MED, V187, P1139, DOI 10.1084/jem.187.7.1139; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zhao YB, 2007, CANCER RES, V67, P2425, DOI 10.1158/0008-5472.CAN-06-3977	52	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8208	10.1371/journal.pone.0008208	http://dx.doi.org/10.1371/journal.pone.0008208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997617	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829500021
J	Wust, S; Tischner, D; John, M; Tuckermann, JP; Menzfeld, C; Hanisch, UK; van den Brandt, J; Luhder, F; Reichardt, HM				Wuest, Simone; Tischner, Denise; John, Michael; Tuckermann, Jan P.; Menzfeld, Christiane; Hanisch, Uwe-Karsten; van den Brandt, Jens; Luehder, Fred; Reichardt, Holger M.			Therapeutic and Adverse Effects of a Non-Steroidal Glucocorticoid Receptor Ligand in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; DNA-BINDING; IN-VIVO; T-CELLS; INFLAMMATION; REPRESSION; APOPTOSIS; METHYLPREDNISOLONE; TRANSACTIVATION	Background: Dissociating glucocorticoid receptor (GR) ligands hold great promise for treating inflammatory disorders since it is assumed that they exert beneficial activities mediated by transrepression but avoid adverse effects of GR action requiring transactivation. Here we challenged this paradigm by investigating 2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride (CpdA), a dissociating non-steroidal GR ligand, in the context of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Methodology/Principal Findings: CpdA inhibited pro-inflammatory mediators in myelin-specific T cells and fibroblasts in a GR-dependent manner while gene activation was abolished. However, it also induced massive apoptosis in various cell types even in the absence of the GR by engaging a Bcl-2- and caspase-dependent pathway. (1)H NMR spectroscopy corroborated these findings by revealing that CpdA dissolved in buffered solutions rapidly decomposes into aziridine intermediates known to act as alkylating pro-apoptotic agents. Importantly, the dichotomy of CpdA action also became evident in vivo. Administration of high-dose CpdA to mice was lethal while treatment of EAE with low to intermediate amounts of CpdA dissolved in water significantly ameliorated the disease. The beneficial effect of CpdA required expression of the GR in T cells and was achieved by down regulating LFA-1 and CD44 on peripheral Th cells and by repressing IL-17 production. Conclusions/Significance: CpdA has significant therapeutic potential although adverse effects severely compromise its application in vivo. Hence, non-steroidal GR ligands require careful analysis prior to their translation into new therapeutic concepts.	[Wuest, Simone; Luehder, Fred] Univ Gottingen & Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Gottingen, Germany; [Tischner, Denise; van den Brandt, Jens; Reichardt, Holger M.] Univ Gottingen, Sch Med, Dept Cellular & Mol Immunol, Gottingen, Germany; [John, Michael] Univ Gottingen, Inst Inorgan Chem, Gottingen, Germany; [Tuckermann, Jan P.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Menzfeld, Christiane; Hanisch, Uwe-Karsten] Univ Gottingen, Dept Neuropathol, Sch Med, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Gottingen	Wust, S (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	fred.luehder@med.uni-goettingen.de; hreichardt@med.uni-goettingen.de	John, Michael/I-5673-2019; Reichardt, Holger/AAF-3048-2020	John, Michael/0000-0002-5786-9028; Reichardt, Holger/0000-0003-4647-057X	Gemeinnutzige Hertie-Stiftung [1.01.1/06/010]; Deutsche Forschungsgemeinschaft [Re1631/1-3, Tu220/3-1]	Gemeinnutzige Hertie-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Gemeinnutzige Hertie-Stiftung (1.01.1/06/010) and the Deutsche Forschungsgemeinschaft (Re1631/1-3, Tu220/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2001, J CLIN INVEST, V107, P265, DOI 10.1172/JCI12157; BROIS SJ, 1970, TETRAHEDRON, V26, P296; CHAPMAN NB, 1963, J CHEM SOC, P1385, DOI 10.1039/jr9630001385; Coghlan MJ, 2003, MOL ENDOCRINOL, V17, P860, DOI 10.1210/me.2002-0355; CRIST DR, 1980, ORG MAGN RESONANCE, V13, P45, DOI 10.1002/mrc.1270130110; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOLD R, 1995, P NATL ACAD SCI USA, V92, P5850, DOI 10.1073/pnas.92.13.5850; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; HENCH PS, 1950, ARCH INTERN MED, V85, P545, DOI 10.1001/archinte.1950.00230100002001; Herold MJ, 2006, J BIOL CHEM, V281, P13663, DOI 10.1074/jbc.M600266200; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kirwan J, 2007, CURR OPIN RHEUMATOL, V19, P233, DOI 10.1097/BOR.0b013e3280d6471a; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Louw A, 1999, ENDOCRINOLOGY, V140, P2044, DOI 10.1210/en.140.5.2044; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; Luhder F, 2009, CRIT REV IMMUNOL, V29, P255, DOI 10.1615/CritRevImmunol.v29.i3.50; MILLIGAN NM, 1987, J NEUROL NEUROSUR PS, V50, P511, DOI 10.1136/jnnp.50.5.511; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Oliveri RL, 1998, NEUROLOGY, V50, P1833, DOI 10.1212/WNL.50.6.1833; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Tanner TM, 2003, MOL CELL ENDOCRINOL, V201, P155, DOI 10.1016/S0303-7207(02)00411-2; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Tuckermann JP, 2005, CRIT REV CL LAB SCI, V42, P71, DOI 10.1080/10408360590888983; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Tudor G, 2000, CELL DEATH DIFFER, V7, P574, DOI 10.1038/sj.cdd.4400688; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434	37	59	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8202	10.1371/journal.pone.0008202	http://dx.doi.org/10.1371/journal.pone.0008202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997594	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829500019
J	Chen, F; Hu, YL; Li, DQ; Chen, HD; Zhang, XL				Chen, Fang; Hu, Yilan; Li, Dongqing; Chen, Haidan; Zhang, Xiao-Lian			CS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2	PLOS ONE			English	Article							RNA APTAMERS; CD81; IDENTIFICATION; INTERFERON; TIME; GENOTYPE-6; RECEPTORS; RIBAVIRIN; SELECTION; BINDING	Currently, the development of effective diagnostic reagents as well as treatments against Hepatitis C virus (HCV) remains a high priority. In this study, we have described the development of an alive cell surface -Systematic Evolution of Ligands by Exponential Enrichment (CS-SELEX) technique and screened the functional ssDNA aptamers that specifically bound to HCV envelope surface glycoprotein E2. Through 13 rounds of selection, the CS-SELEX generated high-affinity ssDNA aptamers, and the selected ssDNA aptamer ZE2 demonstrated the highest specificity and affinity to E2-positive cells. HCV particles could be specifically captured and diagnosed using the aptamer ZE2. A good correlation was observed in HCV patients between HCV E2 antigen-aptamer assay and assays for HCV RNA quantities or HCV antibody detection. Moreover, the selected aptamers, especially ZE2, could competitively inhibit E2 protein binding to CD81, an important HCV receptor, and significantly block HCV cell culture (HCVcc) infection of human hepatocytes (Huh7.5.1) in vitro. Our data demonstrate that the newly selected ssDNA aptamers, especially aptamer ZE2, hold great promise for developing new molecular probes, as an early diagnostic reagent for HCV surface antigen, or a therapeutic drug specifically for HCV.	[Chen, Fang; Hu, Yilan; Li, Dongqing; Chen, Haidan; Zhang, Xiao-Lian] Wuhan Univ, Sch Med, Hubei Prov Key Lab Allergy & Immunol, State Key Lab Virol,Dept Immunol, Wuhan, Hubei, Peoples R China	Wuhan University	Chen, F (corresponding author), Wuhan Univ, Sch Med, Hubei Prov Key Lab Allergy & Immunol, State Key Lab Virol,Dept Immunol, Wuhan, Hubei, Peoples R China.	zhangxl65@whu.edu.cn		Chen, Haidan/0000-0002-6086-7402	National Natural Science Foundation of China [20532020, 30670098, 30870122]; 973 Program of China [2006CB504300, 2009CB522507]; Hubei Province Natural Science Foundation [2006ABD007]; National Grand Program on Key Infectious Disease [2008ZX10003-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province); National Grand Program on Key Infectious Disease	This work was supported by grants from the National Natural Science Foundation of China (20532020, 30670098, and 30870122), the 973 Program of China (2006CB504300, 2009CB522507), the Hubei Province Natural Science Foundation (2006ABD007), and National Grand Program on Key Infectious Disease (2008ZX10003-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bellecave Pantxika, 2008, Hepatology, V48, P1330, DOI 10.1002/hep.22571; Biroccio A, 2002, J VIROL, V76, P3688, DOI 10.1128/JVI.76.8.3688-3696.2002; Boyer N, 2000, J HEPATOL, V32, P98, DOI 10.1016/S0168-8278(00)80419-5; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cao J, 2003, CELL RES, V13, P473, DOI 10.1038/sj.cr.7290190; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; De LC, 2005, EUR J CLIN MICROBIOL, V24, P566, DOI 10.1007/s10096-005-1369-8; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2000, REV MED VIROL, V10, P101, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;101::AID-RMV268&gt;3.0.CO;2-W; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Hsu CS, 2008, LIVER INT, V28, P271, DOI 10.1111/j.1478-3231.2007.01626.x; Hwang B, 2004, RNA, V10, P1277, DOI 10.1261/rna.7100904; Kikuchi K, 2003, J BIOCHEM, V133, P263, DOI 10.1093/jb/mvg036; Li PF, 2007, VACCINE, V25, P1544, DOI 10.1016/j.vaccine.2006.09.091; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Memon MI, 2002, J VIRAL HEPATITIS, V9, P84, DOI 10.1046/j.1365-2893.2002.00329.x; Menegazzi P, 2008, NEW MICROBIOL, V31, P181; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Oh HB, 2008, J MED VIROL, V80, P1712, DOI 10.1002/jmv.21162; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pan Q, 2005, ANTIMICROB AGENTS CH, V49, P4052, DOI 10.1128/AAC.49.10.4052-4060.2005; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rosenberg S, 2001, J MOL BIOL, V313, P451, DOI 10.1006/jmbi.2001.5055; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smallwood GA, 2008, TRANSPLANTATION, V86, P1795, DOI 10.1097/TP.0b013e3181914188; Takahashi M, 2005, J CLIN MICROBIOL, V43, P186, DOI 10.1128/JCM.43.1.186-191.2005; Yang JH, 2002, J VIROL METHODS, V102, P119, DOI 10.1016/S0166-0934(02)00007-1	39	66	72	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8142	10.1371/journal.pone.0008142	http://dx.doi.org/10.1371/journal.pone.0008142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997645	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829000004
J	Williams, CA; Bell, SV; Jenkins, A				Williams, Carrie A.; Bell, Shannon V.; Jenkins, Andrew			A Residue in Loop 9 of the beta 2-Subunit Stabilizes the Closed State of the GABA(A) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZODIAZEPINE BINDING-SITE; LIGAND-INDUCED CHANGES; AGONIST BINDING; A RECEPTOR; AMINO-ACID; CHANNEL; MODULATION; PROPOFOL; PROTEIN; ETOMIDATE	In gamma-aminobutyric acid type A (GABA(A)) receptors, the structural elements that couple ligand binding to channel opening remain poorly defined. Here, site-directed mutagenesis was used to determine if Loop 9 on the non-GABA binding site interface of the beta 2-subunit may be involved in GABA(A) receptor activation. Specifically, residues Gly(170)-Gln(185) of the beta 2-subunit were mutated to alanine, co-expressed with wild-type alpha 1- and gamma 2S-subunits in human embryonic kidney (HEK) 293 cells and assayed for their activation by GABA, the intravenous anesthetic propofol and the endogenous neurosteroid pregnanolone using whole cell macroscopic recordings. Three mutants, G170A, V175A, and G177A, produced 2.5-, 6.7-, and 5.6-fold increases in GABA EC50 whereas one mutant, Q185A, produced a 5.2-fold decrease in GABA EC50. None of the mutations affected the ability of propofol or pregnanolone to potentiate a submaximal GABA response, but the Q185A mutant exhibited 8.3- and 3.5-fold increases in the percent direct activation by propofol and pregnanolone, respectively. Mutant Q185A receptors also had an increased leak current that was sensitive to picrotoxin, indicating an increased gating efficiency. Further Q185E, Q185L, and Q185W substitutions revealed a strong correlation between the hydropathy of the amino acid at this position and the GABA EC50. Taken together, these results indicate that beta 2 Loop 9 is involved in receptor activation by GABA, propofol, and pregnanolone and that beta 2(Q185) participates in hydrophilic interactions that are important for stabilizing the closed state of the GABA(A) receptor.	[Jenkins, Andrew] Emory Univ, Sch Med, Dept Anesthesiol, Rollins Res Ctr 5013, Atlanta, GA 30322 USA; [Jenkins, Andrew] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University	Jenkins, A (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, Rollins Res Ctr 5013, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	ajenki2@emory.edu	Jenkins, Andrew/E-1180-2011		NIGMS, National Institutes of Health [073959, F32 084621]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grants 073959 (to A. J.) and F32 084621 (to C. A. W.).	Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Eddins D, 2002, AM J PHYSIOL-CELL PH, V283, pC1454, DOI 10.1152/ajpcell.00204.2002; Findlay GS, 2001, NEUROSCI LETT, V305, P76, DOI 10.1016/S0304-3940(01)01879-1; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Padgett CL, 2008, J BIOL CHEM, V283, P2702, DOI 10.1074/jbc.M705699200; Paulo JA, 2009, PROTEIN EXPRES PURIF, V67, P76, DOI 10.1016/j.pep.2009.05.001; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Scheller M, 2002, J NEUROSCI, V22, P8411; Sedelnikova A, 2005, J BIOL CHEM, V280, P1535, DOI 10.1074/jbc.M409908200; Sharkey LM, 2008, MOL PHARMACOL, V74, P203, DOI 10.1124/mol.108.044891; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Wafford KA, 1996, MOL PHARMACOL, V50, P670; Williams DB, 2002, J NEUROSCI, V22, P7417; ZAMYATNIN AA, 1984, ANNU REV BIOPHYS BIO, V13, P145, DOI 10.1146/annurev.bb.13.060184.001045; Zouridakis M, 2009, IUBMB LIFE, V61, P407, DOI 10.1002/iub.170	45	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7281	7287		10.1074/jbc.M109.050294	http://dx.doi.org/10.1074/jbc.M109.050294			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20007704	Green Published, hybrid			2022-12-25	WOS:000275415600040
J	Arragain, S; Garcia-Serres, R; Blondin, G; Douki, T; Clemancey, M; Latour, JM; Forouhar, F; Neely, H; Montelione, GT; Hunt, JF; Mulliez, E; Fontecave, M; Atta, M				Arragain, Simon; Garcia-Serres, Ricardo; Blondin, Genevieve; Douki, Thierry; Clemancey, Martin; Latour, Jean-Marc; Forouhar, Farhad; Neely, Helen; Montelione, Gaetano T.; Hunt, John F.; Mulliez, Etienne; Fontecave, Marc; Atta, Mohamed			Post-translational Modification of Ribosomal Proteins STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF RimO FROM THERMOTOGA MARITIMA, A RADICAL S-ADENOSYLMETHIONINE METHYLTHIOTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRANSFER-RNA; ESCHERICHIA-COLI; CATALYTIC MECHANISM; ENZYME; METHYLATION; INSIGHTS; CLUSTER; BINDING; SULFUR	Post-translational modifications of ribosomal proteins are important for the accuracy of the decoding machinery. A recent in vivo study has shown that the rimO gene is involved in generation of the 3-methylthio derivative of residue Asp-89 in ribosomal protein S12 (Anton, B. P., Saleh, L., Benner, J. S., Raleigh, E. A., Kasif, S., and Roberts, R. J. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 1826-1831). This reaction is formally identical to that catalyzed by MiaB on the C2 of adenosine 37 near the anticodon of several tRNAs. Wepresent spectroscopic evidence that Thermotoga maritima RimO, like MiaB, contains two [4Fe-4S] centers, one presumably bound to three invariant cysteines in the central radical S-adenosylmethionine (AdoMet) domain and the other to three invariant cysteines in the N-terminal UPF0004 domain. We demonstrate that holo-RimO can specifically methylthiolate the aspartate residue of a 20-mer peptide derived from S12, yielding a mixture of mono-and bismethyl-thio derivatives. Finally, we present the 2.0 angstrom crystal structure of the central radical AdoMet and the C-terminal TRAM (tRNA methyltransferase 2 and MiaB) domains in apo-RimO. Although the core of the open triose-phosphate isomerase (TIM) barrel of the radical AdoMet domain was conserved, RimO showed differences in domain organization compared with other radical AdoMet enzymes. The unusually acidic TRAM domain, likely to bind the basic S12 protein, is located at the distal edge of the radical AdoMet domain. The basic S12 protein substrate is likely to bind RimO through interactions with both the TRAM domain and the concave surface of the incomplete TIM barrel. These biophysical results provide a foundation for understanding the mechanism of methylthioation by radical AdoMet enzymes in the MiaB/RimO family.	[Forouhar, Farhad; Neely, Helen; Montelione, Gaetano T.; Hunt, John F.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Arragain, Simon; Garcia-Serres, Ricardo; Blondin, Genevieve; Clemancey, Martin; Latour, Jean-Marc; Mulliez, Etienne; Fontecave, Marc; Atta, Mohamed] CEA CNRS UJF, Commissariat Energie Atom Grenoble, iRTSV LCBM, UMR 5249, F-38054 Grenoble 09, France; [Douki, Thierry] CEA UJF, Lab Les Acides Nucl, Commissariat Energie Atom Grenoble, DSM INaC SCIB,UMR E3, F-38054 Grenoble 09, France; [Forouhar, Farhad; Neely, Helen; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Dept Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Fontecave, Marc] Coll France, F-75005 Paris, France	Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; UDICE-French Research Universities; PSL Research University Paris; College de France	Hunt, JF (corresponding author), Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA.	jfhunt@biology.columbia.edu; mohamed.atta@cea.fr	Arragain, Simon/AAA-6356-2019; Thierry, Douki/H-2108-2018; García-Serres, Ricardo/E-4344-2012	Arragain, Simon/0000-0002-6500-0066; Thierry, Douki/0000-0002-5022-071X; García-Serres, Ricardo/0000-0001-5203-0568; Montelione, Gaetano/0000-0002-9440-3059	Northeast Structural Genomics Consortium [GM074958, GM062413]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, P50GM062413] Funding Source: NIH RePORTER	Northeast Structural Genomics Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sylvie Kieffer-Jaquinod (CEA-iRTSV-EDyP-Grenoble) for MS2 analysis, Bernard Dublet for matrix-assisted laser desorption ionization time-of-flight experiments, and Fabien Pierrel for cloning the rimO gene from T. maritima. The crystallographic work was supported by National Institutes of Health Protein Structure Initiative Grants GM074958 and GM062413 to the Northeast Structural Genomics Consortium.	Anantharaman V, 2001, FEMS MICROBIOL LETT, V197, P215, DOI 10.1111/j.1574-6968.2001.tb10606.x; Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Bai Y, 2007, ACTA CRYSTALLOGR F, V63, P135, DOI 10.1107/S1744309107002904; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chandor-Proust A, 2008, J BIOL CHEM, V283, P36361, DOI 10.1074/jbc.M806503200; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; DONG HJ, 1995, J MOL BIOL, V248, P551, DOI 10.1006/jmbi.1995.0242; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontecave M, 2008, CHEM BIOL, V15, P209, DOI 10.1016/j.chembiol.2008.02.011; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Forouhar F, 2006, J BIOL CHEM, V281, P7533, DOI 10.1074/jbc.M507996200; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Kowalak JA, 1996, PROTEIN SCI, V5, P1625, DOI 10.1002/pro.5560050816; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lee TT, 2004, STRUCTURE, V12, P397, DOI 10.1016/j.str.2004.02.009; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller R, 2007, J APPL CRYSTALLOGR, V40, P938, DOI 10.1107/S0021889807034565; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Seemann M, 2009, J AM CHEM SOC, V131, P13184, DOI 10.1021/ja9012408; Selmer M, 1999, SCIENCE, V286, P2349, DOI 10.1126/science.286.5448.2349; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Walters EM, 2005, J AM CHEM SOC, V127, P9612, DOI 10.1021/ja051909q; Yang J, 2009, BIOCHEMISTRY-US, V48, P9234, DOI 10.1021/bi9010286; Zarembinski TI, 2003, PROTEINS, V50, P177, DOI 10.1002/prot.10311	41	53	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5792	5801		10.1074/jbc.M109.065516	http://dx.doi.org/10.1074/jbc.M109.065516			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007320	Green Published, hybrid			2022-12-25	WOS:000275327200070
J	Ogihara, T; Chuang, JC; Vestermark, GL; Garmey, JC; Ketchum, RJ; Huang, XL; Brayman, KL; Thorner, MO; Repa, JJ; Mirmira, RG; Evans-Molina, C				Ogihara, Takeshi; Chuang, Jen-Chieh; Vestermark, George L.; Garmey, James C.; Ketchum, Robert J.; Huang, Xiaolun; Brayman, Kenneth L.; Thorner, Michael O.; Repa, Joyce J.; Mirmira, Raghavendra G.; Evans-Molina, Carmella			Liver X Receptor Agonists Augment Human Islet Function through Activation of Anaplerotic Pathways and Glycerolipid/Free Fatty Acid Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRANSCRIPTION FACTOR; INSULIN GENE-TRANSCRIPTION; GLUCOSE-HOMEOSTASIS; BETA-CELLS; LIPID-METABOLISM; SECRETION; EXPRESSION; RAT; BIOSYNTHESIS; SUPPRESSION	Recent studies in rodent models suggest that liver X receptors (LXRs) may play an important role in the maintenance of glucose homeostasis and islet function. To date, however, no studies have comprehensively examined the role of LXRs in human islet biology. Human islets were isolated from non-diabetic donors and incubated in the presence or absence of two synthetic LXR agonists, TO-901317 and GW3965, under conditions of low and high glucose. LXR agonist treatment enhanced both basal and stimulated insulin secretion, which corresponded to an increase in the expression of genes involved in anaplerosis and reverse cholesterol transport. Furthermore, enzyme activity of pyruvate carboxylase, a key regulator of pyruvate cycling and anaplerotic flux, was also increased. Whereas LXR agonist treatment up-regulated known downstream targets involved in lipogenesis, we observed no increase in the accumulation of intra-islet triglyceride at the dose of agonist used in our study. Moreover, LXR activation increased expression of the genes encoding hormone-sensitive lipase and adipose triglyceride lipase, two enzymes involved in lipolysis and glycerolipid/free fatty acid cycling. Chronically, insulin gene expression was increased after treatment with TO-901317, and this was accompanied by increased Pdx-1 nuclear protein levels and enhanced Pdx-1 binding to the insulin promoter. In conclusion, our data suggest that LXR agonists have a direct effect on the islet to augment insulin secretion and expression, actions that should be considered either as therapeutic or unintended side effects, as these agents are developed for clinical use.	[Vestermark, George L.; Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Ogihara, Takeshi; Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Ogihara, Takeshi; Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Chuang, Jen-Chieh; Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Garmey, James C.; Thorner, Michael O.] Univ Virginia, Dept Med, Charlottesville, VA 22904 USA; [Huang, Xiaolun; Brayman, Kenneth L.] Univ Virginia, Dept Surg, Charlottesville, VA 22904 USA; [Ketchum, Robert J.] Rocky Vista Univ, Dept Struct Med, Parker, CO 80134 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of Virginia	Evans-Molina, C (corresponding author), Indiana Univ, Sch Med, Dept Med, 635 Barnhill Dr,MS 2031A, Indianapolis, IN 46202 USA.	cevansmo@iupui.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Repa, Joyce/0000-0001-5740-1954	National Institutes of Health [R01DK60581, K08 DK080225]; Manpei Suzuki Diabetes Foundation; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK060581, K08DK080225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK60581 (to R. G. M.) and K08 DK080225 (to C. E.-M.). This work was also supported by a Manpei Suzuki Diabetes Foundation Grant (to T.O.), an American Diabetes Association mentor-based post-doctoral fellowship (to R. G. M.), and an American Diabetes Association Research Award (to J.J.R.).	Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Choe SS, 2007, DIABETES, V56, P1534, DOI 10.2337/db06-1059; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200; Gravena C, 2002, J ENDOCRINOL, V173, P73, DOI 10.1677/joe.0.1730073; Green CD, 2009, ENDOCRINOLOGY, V150, P2637, DOI 10.1210/en.2008-1039; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Leibiger B, 2000, J BIOL CHEM, V275, P30153, DOI 10.1074/jbc.M005216200; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Liu YQ, 1999, DIABETES, V48, P1747, DOI 10.2337/diabetes.48.9.1747; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Mallini N, 2008, CHEM BIOL DRUG DES, V71, P140, DOI 10.1111/j.1747-0285.2007.00620.x; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Ogihara T, 2003, J BIOL CHEM, V278, P21693, DOI 10.1074/jbc.M302684200; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz H, 2009, DIABETOLOGIA, V52, P1352, DOI 10.1007/s00125-009-1366-z; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Wente W, 2007, ENDOCRINOLOGY, V148, P1843, DOI 10.1210/en.2006-1247; Yeom SY, 2006, MOL CELL BIOL, V26, P4553, DOI 10.1128/MCB.01412-05; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584; Zitzer H, 2006, ENDOCRINOLOGY, V147, P3898, DOI 10.1210/en.2005-1483	57	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5392	5404		10.1074/jbc.M109.064659	http://dx.doi.org/10.1074/jbc.M109.064659			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007976	Green Published, hybrid			2022-12-25	WOS:000275327200033
J	Ahmed, KM; Tsai, CY; Lee, WH				Ahmed, Kazi Mokim; Tsai, Connie Y.; Lee, Wen-Hwa			Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE CULTURES; BREAST-CANCER; EPITHELIAL ACINI; CDNA INTEGRATION; BRCA1; CELLS; EXPRESSION; PROTEINS; LET-7; MORPHOGENESIS	The high mobility group AT-hook 2 (HMGA2), a DNA architectural protein, is highly regulated during development and plays an important role in tumorigenesis. Indeed, HMGA2 was overexpressed in many different kinds of tumors. However, the mechanisms regulating HMGA2 expression remain elusive. Using microarray analysis, we found that HMGA2, along with a dozen of other genes, was co-repressed by ZBRK1, BRCA1, and CtIP. BRCA1 exerts its transcriptional repression activity through interaction with the transcriptional repressor ZBRK1 in the central domain, and with CtIP in the C-terminal BRCT domain. Here, we show that ZBRK1, BRCA1, and CtIP form a repression complex that coordinately regulates HMGA2 expression via a ZBRK1 recognition site in the HMGA2 promoter. Depletion of any of the proteins in this complex via adenoviral RNA interference in MCF10A mammary epithelial cells activates HMGA2 expression, resulting in increased colony formation in soft agar. Similarly, depletion of ZBRK1, or ectopic overexpression of HMGA2, in MCF10A cells induces abnormal acinar size with increased cell number and inhibits normal acinar formation. Consistently, many BRCA1-deficient mouse breast tumors express higher levels of HMGA2 than BRCA1-proficient tumors. These results suggest that activation of HMGA2 gene expression through derepression of the ZBRK1/BRCA1/CtIP complex is a significant step in accelerating breast tumorigenesis.	[Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014		National Institutes of Health [CA94170]; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94170 ( to W. H. L.).	Ashar HR, 1996, GENOMICS, V31, P207, DOI 10.1006/geno.1996.0033; Buckley NE, 2007, MOL CANCER RES, V5, P261, DOI 10.1158/1541-7786.MCR-06-0250; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Droge P, 2008, CELL STEM CELL, V2, P8, DOI 10.1016/j.stem.2007.12.003; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Furuta S, 2006, CANCER CELL, V10, P13, DOI 10.1016/j.ccr.2006.05.022; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Langelotz C, 2003, BRIT J CANCER, V88, P1406, DOI 10.1038/sj.bjc.6600935; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li AYJ, 2009, CANCER RES, V69, P5699, DOI 10.1158/0008-5472.CAN-08-4833; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu F, 2006, MOL CELL BIOL, V26, P3124, DOI 10.1128/MCB.26.8.3124-3134.2006; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagpal S, 1999, J BIOL CHEM, V274, P22563, DOI 10.1074/jbc.274.32.22563; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Zhang HT, 2000, DNA CELL BIOL, V19, P253, DOI 10.1089/10445490050021168; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zheng L, 2000, ONCOGENE, V19, P6159, DOI 10.1038/sj.onc.1203968; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	42	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4464	4471		10.1074/jbc.M109.062265	http://dx.doi.org/10.1074/jbc.M109.062265			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007691	hybrid, Green Published			2022-12-25	WOS:000275274800024
J	Feliciangeli, S; Tardy, MP; Sandoz, G; Chatelain, FC; Warth, R; Barhanin, J; Bendahhou, S; Lesage, F				Feliciangeli, Sylvain; Tardy, Magalie P.; Sandoz, Guillaume; Chatelain, Franck C.; Warth, Richard; Barhanin, Jacques; Bendahhou, Said; Lesage, Florian			Potassium Channel Silencing by Constitutive Endocytosis and Intracellular Sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; MEMBRANE; ENDOSOMES; TREK-1; LOCALIZATION; PHARMACOLOGY; CONDUCTANCE; MODULATION; RECEPTORS; PROTEINS	Tandem of P domains in a weak inwardly rectifying K+ channel 1 (TWIK1) is a K+ channel that produces unusually low levels of current. Replacement of lysine 274 by a glutamic acid (K274E) is associated with stronger currents. This mutation would prevent conjugation of a small ubiquitin modifier peptide to Lys-274, a mechanism proposed to be responsible for channel silencing. However, we found no biochemical evidence of TWIK1 sumoylation, and we showed that the conservative change K274R did not increase current, suggesting that K274E modifies TWIK1 gating through a charge effect. Now we rule out an eventual effect of K274E on TWIK1 trafficking, and we provide convincing evidence that TWIK1 silencing results from its rapid retrieval from the cell surface. TWIK1 is internalized via a dynamin-dependent mechanism and addressed to the recycling endosomal compartment. Mutation of a diisoleucine repeat located in its cytoplasmic C terminus (I293A, I294A) stabilizes TWIK1 at the plasma membrane, resulting in robust currents. The effects of I293A, I294A on channel trafficking and of K274E on channel activity are cumulative, promoting even more currents. Activation of serotoninergic receptor 5-HT1R or adrenoreceptor alpha 2A-AR stimulates TWIK1 but has no effect on TWIK1I293A, I294A, suggesting that G(i) protein activation is a physiological signal for increasing the number of active channels at the plasma membrane.	[Feliciangeli, Sylvain; Tardy, Magalie P.; Sandoz, Guillaume; Chatelain, Franck C.; Lesage, Florian] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Feliciangeli, Sylvain; Tardy, Magalie P.; Sandoz, Guillaume; Chatelain, Franck C.; Lesage, Florian] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Warth, Richard] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Barhanin, Jacques; Bendahhou, Said] TIANP, CNRS, F-06103 Nice 2, France; [Barhanin, Jacques; Bendahhou, Said] Univ Nice Sophia Antipolis, F-06103 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Regensburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lesage, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Lesage, Florian/P-9780-2019; Warth, Richard/N-7119-2014; Lesage, Florian/D-5097-2011; Feliciangeli, Sylvain/Q-1292-2016; sandoz, guillaume/AAI-9236-2020	Lesage, Florian/0000-0002-4406-7106; Warth, Richard/0000-0001-6084-0659; Lesage, Florian/0000-0002-4406-7106; Feliciangeli, Sylvain/0000-0003-3358-3719; sandoz, guillaume/0000-0003-1251-0852; CHATELAIN, Franck C./0000-0002-8426-8893	Fondation pour la Recherche Me dicale	Fondation pour la Recherche Me dicale(Fondation pour la Recherche Medicale)	This work was supported by the Fondation pour la Recherche Me dicale (Equipe labellise e to F. L.).	Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Cain SM, 2008, MOL CELL NEUROSCI, V37, P32, DOI 10.1016/j.mcn.2007.08.009; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Gounon P, 2002, METHOD MICROBIOL, V31, P531, DOI 10.1016/S0580-9517(02)31029-8; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LIPKOWITZ MS, 1992, AM J PHYSIOL, V263, pF144, DOI 10.1152/ajprenal.1992.263.1.F144; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; NEWMAN GR, 2001, RESIN MICROSCOPY ONE; OKUSA MD, 1994, AM J PHYSIOL, V267, pF347, DOI 10.1152/ajprenal.1994.267.3.F347; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel AJ, 2000, J BIOL CHEM, V275, P28722, DOI 10.1074/jbc.M003755200; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; WILSON VG, 2005, SCI STKE, pPE32, DOI DOI 10.1126/STKE.2902005PE32	47	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4798	4805		10.1074/jbc.M109.078535	http://dx.doi.org/10.1074/jbc.M109.078535			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959478	Green Published, hybrid			2022-12-25	WOS:000275274800058
J	Maita, N; Nyirenda, J; Igura, M; Kamishikiryo, J; Kohda, D				Maita, Nobuo; Nyirenda, James; Igura, Mayumi; Kamishikiryo, Jun; Kohda, Daisuke			Comparative Structural Biology of Eubacterial and Archaeal Oligosaccharyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; X-RAY-DIFFRACTION; PROTEIN GLYCOSYLATION; STT3 SUBUNIT; COMPLEX; TRANSFERASE; IDENTIFICATION; GLYCOPROTEIN; GLYCAN; OST3P	Oligosaccharyltransferase (OST) catalyzes the transfer of an oligosaccharide from a lipid donor to an asparagine residue in nascent polypeptide chains. In the bacterium Campylobacter jejuni, a single-subunit membrane protein, PglB, catalyzes N-glycosylation. We report the 2.8 angstrom resolution crystal structure of the C-terminal globular domain of PglB and its comparison with the previously determined structure from the archaeon Pyrococcus AglB. The two distantly related oligosaccharyltransferases share unexpected structural similarity beyond that expected from the sequence comparison. The common architecture of the putative catalytic sites revealed a new catalytic motif in PglB. Site-directed mutagenesis analyses confirmed the contribution of this motif to the catalytic function. Bacterial PglB and archaeal AglB constitute a protein family of the catalytic subunit of OST along with STT3 from eukaryotes. A structure-aided multiple sequence alignment of the STT3/PglB/AglB protein family revealed three types of OST catalytic centers. This novel classification will provide a useful framework for understanding the enzymatic properties of the OST enzymes from Eukarya, Archaea, and Bacteria.	[Maita, Nobuo; Nyirenda, James; Igura, Mayumi; Kamishikiryo, Jun; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Kohda, D (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	kohda@bioreg.kyushu-u.ac.jp	Maita, Nobuo/J-1443-2012; Kohda, Daisuke/I-4990-2019; Nyirenda, James/AAP-4432-2020	Maita, Nobuo/0000-0003-2260-5783; Kohda, Daisuke/0000-0001-8234-3776; Nyirenda, James/0000-0001-7122-3189; Kamishikiryo, Jun/0000-0002-7505-7429	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by a Japanese government scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.; Supported by Grants-in-Aid for Scientific Research on Priority Areas and the Targeted Proteins Research Program from MEXT of Japan.	Abu-Qarn Mehtap, 2007, Archaea, V2, P73; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Eichler J, 2003, MICROBIOL-SGM, V149, P3347, DOI 10.1099/mic.0.26591-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2007, ACTA CRYSTALLOGR F, V63, P798, DOI 10.1107/S1744309107040134; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Standley DM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-221; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200	44	73	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4941	4950		10.1074/jbc.M109.081752	http://dx.doi.org/10.1074/jbc.M109.081752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007322	hybrid, Green Published			2022-12-25	WOS:000275274800071
J	Su, B; Bu, YH; Engelberg, D; Gelman, IH				Su, Bing; Bu, Yahao; Engelberg, David; Gelman, Irwin H.			SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C-Raf/MEK/ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CYTOSKELETAL ARCHITECTURE; MATRIX METALLOPROTEINASES; TYROSINE PHOSPHORYLATION; BINDING PROTEIN; HUMAN BREAST; SUBSTRATE; SSECKS; SRC; ACTIVATION	SSeCKS/Gravin/AKAP12 ("SSeCKS") encodes a cytoskeletal protein that regulatesG(1)-> S progression by scaffolding cyclins, protein kinase C (PKC) and PKA. SSeCKS is down-regulated in many tumor types including prostate, and when re-expressed in MAT-LyLu (MLL) prostate cancer cells, SSeCKS selectively inhibits metastasis by suppressing neovascularization at distal sites, correlating with its ability to down-regulate proangiogenic genes including Vegfa. However, the forced re-expression of VEGF only rescues partial lung metastasis formation. Here, we show that SSeCKS potently inhibits chemotaxis and Matrigel invasion, motility parameters contributing to metastasis formation. SSeCKS suppressed serum-induced activation of the Raf/MEK/ERK pathway, resulting in down-regulation of matrix metalloproteinase-2 expression. In contrast, SSeCKS had no effect on serum-induced phosphorylation of the Src substrate, Shc, in agreement with our previous data that SSeCKS does not inhibit Src kinase activity in cells. Invasiveness and chemotaxis could be restored by the forced expression of constitutively active MEK1, MEK2, ERK1, or PKC alpha. SSeCKS suppressed phorbol ester-induced ERK1/2 activity only if it encoded its PKC binding domain (amino acids 553-900), suggesting that SSeCKS attenuates ERK activation through a direct scaffolding of conventional and/or novel PKC isozymes. Finally, control of MLL invasiveness by SSeCKS is influenced by the actin cytoskeleton: the ability of SSeCKS to inhibit podosome formation is unaffected by cytochalasin D or jasplakinolide, whereas its ability to inhibit MEK1/2 and ERK1/2 activation is nullified by jasplakinolide. Our findings suggest that SSeCKS suppresses metastatic motility by disengaging activated Src and then inhibiting the PKC-Raf/MEK/ERK pathways controlling matrix metalloproteinase-2 expression and podosome formation.	[Su, Bing; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Bu, Yahao] Kinex Pharmaceut LLC, Buffalo, NY 14203 USA; [Engelberg, David] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Roswell Park Cancer Institute; Hebrew University of Jerusalem	Gelman, IH (corresponding author), Elm & Carlton Sts, Buffalo, NY 14263 USA.	irwin.gelman@roswellpark.org			NCI NIH HHS [2P30 CA016056, R01 CA094108, CA94108, P30 CA016056, R55 CA094108] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA094108, R55CA094108] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Boissier S, 2000, CANCER RES, V60, P2949; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Chapline C, 1996, J BIOL CHEM, V271, P6417, DOI 10.1074/jbc.271.11.6417; Chapline C, 1998, J BIOL CHEM, V273, P19482, DOI 10.1074/jbc.273.31.19482; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gelman IH, 2006, MOL CANCER RES, V4, P151, DOI 10.1158/1541-7786.MCR-05-0252; Gelman IH, 1998, CELL MOTIL CYTOSKEL, V41, P1; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Guvakova MA, 2002, J CELL SCI, V115, P4149, DOI 10.1242/jcs.00104; Heuertz RM, 1997, AM J RESP CELL MOL, V17, P456, DOI 10.1165/ajrcmb.17.4.2702; HYATT SL, 1994, CELL GROWTH DIFFER, V5, P495; Itoh T, 1998, CANCER RES, V58, P1048; Kim BS, 1998, J NEUROCHEM, V71, P1333; KLEINMAN HK, 2007, CURRENT PROTOCOLS CE; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Lin XY, 1997, CANCER RES, V57, P2304; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; LIN XY, 1995, MOL CELL BIOL, V15, P2754; Lokeshwar BL, 1999, ANN NY ACAD SCI, V878, P271, DOI 10.1111/j.1749-6632.1999.tb07690.x; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Nelson PJ, 1999, J CELL SCI, V112, P361; Nelson PJ, 1997, MOL CELL BIOCHEM, V175, P233, DOI 10.1023/A:1006836003758; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinkas J, 2002, CANCER RES, V62, P4781; Piontek J, 2003, J BIOL CHEM, V278, P38970, DOI 10.1074/jbc.M306749200; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Suthiphongchai T, 2003, ONCOL RES, V13, P253, DOI 10.3727/096504003108748302; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tao JC, 2007, J BIOL CHEM, V282, P6597, DOI 10.1074/jbc.M608927200; van der Voort CR, 2000, J NEUROIMMUNOL, V108, P82, DOI 10.1016/S0165-5728(00)00253-8; Vayalil PK, 2004, CARCINOGENESIS, V25, P987, DOI 10.1093/carcin/bgh095; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Xia W, 2001, CANCER RES, V61, P5644; Xia W, 2002, EXP CELL RES, V277, P139, DOI 10.1006/excr.2002.5560; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	47	64	65	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4578	4586		10.1074/jbc.M109.073494	http://dx.doi.org/10.1074/jbc.M109.073494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018890	hybrid, Green Published			2022-12-25	WOS:000275274800035
J	Zhu, H; Shuman, S				Zhu, Hui; Shuman, Stewart			Gap Filling Activities of Pseudomonas DNA Ligase D (LigD) Polymerase and Functional Interactions of LigD with the DNA End-binding Ku Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; JOINING FUNCTION; REPAIR; COMPONENT; PRIMASE; LAMBDA; COMPLEX; MYCOBACTERIA; MECHANISM; BACTERIA	Many bacterial pathogens, including Pseudomonas aeruginosa, have a nonhomologous end joining (NHEJ) system of DNA double strand break (DSB) repair driven by Ku and DNA ligase D(LigD). LigD is a multifunctional enzyme composed of a ligase domain fused to an autonomous polymerase module (POL) that adds ribonucleotides or deoxyribonucleotides to DSB ends and primer-templates. LigD POL and the eukaryal NHEJ polymerase lambda are thought to bridge broken DNA ends via contacts with a duplex DNA segment downstream of the primer terminus, a scenario analogous to gap repair. Here, we characterized the gap repair activity of Pseudomonas LigD POL, which is more efficient than simple templated primer extension and relies on a 5'-phosphate group on the distal gap strand end to confer apparent processivity in filling gaps of 3 or 4 nucleotides. Mutations of the His-553, Arg-556, and Lys-566 side chains implicated in DNA 5'-phosphate binding eliminate the preferential filling of 5'-phosphate gaps. Mutating Phe-603, which is imputed to stack on the nucleobase of the template strand that includes the 1st bp of the downstream gap duplex segment, selectively affects incorporation of the final gap-closing nucleotide. We find that Pseudomonas Ku stimulates POL-catalyzed ribonucleotide addition to a plasmid DSB end and promotes plasmid end joining by full-length Pseudomonas LigD. A series of incremental truncations from the C terminus of the 293-amino acid Ku polypeptide identifies Ku-(1-229) as sufficient for homodimerization and LigD stimulation. The slightly longer Ku-(1-253) homodimer forms stable complexes at both ends of linear plasmid DNA that protect the DSBs from digestion by 5'- and 3'-exonucleases.	[Zhu, Hui; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611.	Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; Brissett NC, 2007, SCIENCE, V318, P456, DOI 10.1126/science.1145112; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Garcia-Diaz M, 2006, CELL, V124, P331, DOI [10.1016/j.cell.2005.10.039, 10.1016/j.cel.2005.10.039]; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Ito N, 2003, GENES CELLS, V8, P913, DOI 10.1111/j.1365-2443.2003.00693.x; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Lipps G, 2004, NAT STRUCT MOL BIOL, V11, P157, DOI 10.1038/nsmb723; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Yakovleva L, 2006, J BIOL CHEM, V281, P25026, DOI 10.1074/jbc.M603302200; Zhu H, 2006, P NATL ACAD SCI USA, V103, P1711, DOI 10.1073/pnas.0509083103; Zhu H, 2005, J BIOL CHEM, V280, P33707, DOI 10.1074/jbc.M506838200; Zhu H, 2005, J BIOL CHEM, V280, P25973, DOI 10.1074/jbc.M504002200; Zhu H, 2005, J BIOL CHEM, V280, P418, DOI 10.1074/jbc.M410110200; Zhu H, 2008, J BIOL CHEM, V283, P8331, DOI 10.1074/jbc.M705476200; Zhu H, 2007, NUCLEIC ACIDS RES, V35, P3631, DOI 10.1093/nar/gkm145; Zhu H, 2006, J BIOL CHEM, V281, P13873, DOI 10.1074/jbc.M600055200	30	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4815	4825		10.1074/jbc.M109.073874	http://dx.doi.org/10.1074/jbc.M109.073874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018881	Green Published, hybrid			2022-12-25	WOS:000275274800060
J	Bellemare, J; Rouleau, M; Harvey, M; Guillemette, C				Bellemare, Judith; Rouleau, Melanie; Harvey, Mario; Guillemette, Chantal			Modulation of the Human Glucuronosyltransferase UGT1A Pathway by Splice Isoform Polypeptides Is Mediated through Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCURONOSYLTRANSFERASE; ENDOPLASMIC-RETICULUM; SIGNAL SEQUENCE; HUMAN BILIRUBIN; COMPLEX LOCUS; METABOLISM; HOMODIMERIZATION; EXPRESSION; REGULATORS; VARIANTS	This study investigated the molecular mechanisms underlying the regulatory effect of the newly discovered 45-kDa enzymatically inactive UGT1A spliced polypeptides, named isoform i2, upon UGT1A-mediated glucuronidation. Initially, using an inducible system that mimics the relative abundance of isoforms 1 and 2 of UGT1A1 in human tissues, the rates of formation of glucuronides were significantly reduced. We then used a heterologous system constitutively expressing both isoforms i1 and i2 for an in- depth investigation of the presence of spliced i2 on glucuronidation kinetics. UGT1A1, UGT1A7, and UGT1A8 were selected as candidates for these studies. In all cases, co-expression of i1 and i2 in HEK293 cells leads to a significant reduction of the velocity of the glucuronidation reaction without affecting the affinity (K-m (app)) for all substrates tested and the K-m for the co-substrate, UDP-glucuronic acid. The data are consistent with a dominant-negative model of inhibition but do not sustain with an UGT1A_i2-mediated inhibition by competitive binding for substrate or the co-substrate. In contrast, the data from the co-immunoprecipitation experiments are indicative of the existence of a mixture homo-oligomeric (i1-i1 or i2-i2) and hetero-oligomeric (i1-i2) complexes in which the i2-i2 and i1-i2 subunits would be inactive. Thus, protein-protein interactions are likely responsible for the inhibition of active UGT1A_i1 by i2 spliced polypeptides. This new regulatory mechanism may alternatively modulate cellular response to endo/xeno stimulus.	[Guillemette, Chantal] Univ Laval, CHU Laval, Res Ctr, Pharmacogenom Lab, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Pharm, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Guillemette, C (corresponding author), Univ Laval, CHU Laval, Res Ctr, Pharmacogenom Lab, 2705 Boul Laurier,T3-48, Quebec City, PQ G1V 4G2, Canada.	Chantal.Guillemette@crchul.ulaval.ca	Guillemette, Chantal/AAT-6246-2020; Guillemette, Chantal/J-6463-2012	Guillemette, Chantal/0000-0002-1113-1212; Rouleau, Melanie/0000-0003-4154-3127; Rouleau, Michele/0000-0002-2357-1848	Canadian Institutes of Health Research; Canada Research Chair Program; Fonds de la Recherche en Sante du Quebec; National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funds from the Canadian Institutes of Health Research and the Canada Research Chair Program ( to C. G.).; Recipient of a Canadian Institutes of Health Research Frederick Banting and Charles Best studentship award.; Recipient of a graduate studentship award from the Fonds de la Recherche en Sante du Quebec and National Sciences and Engineering Research Council of Canada.	BELLEMARE J, 2009, PHARMACOGEN IN PRESS; Bernard O, 2004, DRUG METAB DISPOS, V32, P775, DOI 10.1124/dmd.32.8.775; Ciotti M, 1998, BIOCHEMISTRY-US, V37, P11018, DOI 10.1021/bi980747q; Finel M, 2008, CURR DRUG METAB, V9, P70, DOI 10.2174/138920008783331158; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P1781, DOI 10.1124/dmd.107.016402; Fujiwara R, 2010, J PHARM SCI-US, V99, P442, DOI 10.1002/jps.21830; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Ghosh SS, 2001, J BIOL CHEM, V276, P42108, DOI 10.1074/jbc.M106742200; Girard H, 2007, PHARMACOGENET GENOM, V17, P1077, DOI 10.1097/FPC.0b013e3282f1f118; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Kern A, 2008, ENDOCRINOLOGY, V149, P1277, DOI 10.1210/en.2007-1348; Kurkela M, 2007, PHARMACOGENET GENOM, V17, P115, DOI 10.1097/FPC.0b013e328011b598; Lepine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331; Levesque E, 2007, HEPATOLOGY, V45, P128, DOI 10.1002/hep.21464; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; Operana TN, 2007, J BIOL CHEM, V282, P4821, DOI 10.1074/jbc.M609417200; Ouzzine M, 1999, FEBS LETT, V454, P187, DOI 10.1016/S0014-5793(99)00797-8; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; PETERS WHM, 1984, J BIOL CHEM, V259, P1701; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stasiv Y, 2001, J BIOL CHEM, V276, P42241, DOI 10.1074/jbc.M105066200; Venkatakrishnan K, 2001, J CLIN PHARMACOL, V41, P1149, DOI 10.1177/00912700122012724; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	25	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3600	3607		10.1074/jbc.M109.083139	http://dx.doi.org/10.1074/jbc.M109.083139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996319	Green Published, hybrid			2022-12-25	WOS:000275254000011
J	Wu, Y; Song, SW; Sun, JY; Bruner, JM; Fuller, GN; Zhang, W				Wu, Ying; Song, Sonya W.; Sun, Jiyuan; Bruner, Janet M.; Fuller, Gregory N.; Zhang, Wei			IIp45 Inhibits Cell Migration through Inhibition of HDAC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASES; MOLECULAR CHAPERONE; BINDING-PROTEIN; ACETYLATION; HSP90; CORTACTIN; INVASION; CANCER; CYTOSKELETON; ACTIVATION	IIp45 (aka MIIP) is a newly discovered gene whose protein product inhibits cell migration. HDAC6 is a class IIb deacetylase that specifically deacetylates alpha-tubulin, modulates microtubule dynamics, and promotes cell migration. A yeast two-hybrid assay using IIp45 as bait identified HDAC6 protein as a binding partner of IIp45. This physical interaction of the two functionally antagonistic proteins was confirmed by glutathione S-transferase pulldown assay and co-immunoprecipitation assay in human cells. Serial deletion constructs of HDAC6 were used to characterize the interaction of HDAC6 and IIp45, and this analysis found that the two catalytic domains of HDAC6 protein are required for IIp45 binding. We examined the protein expression patterns of IIp45 and HDAC6 in glioma tissues. Elevated protein levels of HDAC6 were found in high grade glioma samples, in contrast to the decreased protein expression of IIp45. The potential negative regulation of HDAC6 expression by IIp45 was confirmed in cell lines with altered IIp45 expression by constitutive overexpression or small interfering RNA knockdown. Protein turnover study revealed that overexpression of IIp45 significantly reduces the intracellular protein stability of endogenous HDAC6, indicating a possible mechanism for the negative regulation of HDAC6 by IIp45. Results from the HDAC activity assay demonstrated that overexpressed IIp45 effectively decreases HDAC6 activity, increases acetylated alpha-tubulin, and reduces cell migration. The increased cell migration resulting from siIIp45 knockdown was significantly reversed by co-transfection of siHDAC6. Thus, we report here for the first time a novel mechanism by which IIp45 inhibits cell motility through inhibition of HDAC6.	[Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, Houston, TX 77030 USA; [Song, Sonya W.] Capital Med Univ, Beijing Shijitan Hosp, Beijing 100069, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Capital Medical University	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, 1515 Holcombe Blvd, Houston, TX 77030 USA.	wzhang@mdanderson.org	sun, jiyuan/B-3828-2010	Fuller, Gregory/0000-0001-9447-2647	James S. McDonnell Foundation	James S. McDonnell Foundation	This work was supported by a grant from the James S. McDonnell Foundation.	Aoyagi S, 2005, TRENDS CELL BIOL, V15, P565, DOI 10.1016/j.tcb.2005.09.003; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Moser C, 2009, ANTICANCER RES, V29, P2031; Ohoka Y, 1998, GENES CELLS, V3, P603, DOI 10.1046/j.1365-2443.1998.00216.x; Rao R, 2008, BLOOD, V112, P1886, DOI 10.1182/blood-2008-03-143644; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Song SW, 2005, CANCER RES, V65, P3562, DOI 10.1158/0008-5472.CAN-04-3392; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Witt O, 2009, CURR PHARM DESIGN, V15, P436, DOI 10.2174/138161209787315774; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200	31	41	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3554	3560		10.1074/jbc.M109.063354	http://dx.doi.org/10.1074/jbc.M109.063354			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20008322	hybrid, Green Published			2022-12-25	WOS:000275254000005
J	Annan, RB; Lee, AY; Reid, ID; Sayad, A; Whiteway, M; Hallett, M; Thomas, DY				Annan, Robert B.; Lee, Anna Y.; Reid, Ian D.; Sayad, Azin; Whiteway, Malcolm; Hallett, Michael; Thomas, David Y.			A Biochemical Genomics Screen for Substrates of Ste20p Kinase Enables the In Silico Prediction of Novel Substrates	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; PROTEIN-PROTEIN INTERACTIONS; HIDDEN MARKOV-MODELS; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; ACTIN CYTOSKELETON; BUDDING YEAST; PHEROMONE RESPONSE; GLOBAL ANALYSIS; CELL POLARITY	The Ste20/PAK family is involved in many cellular processes, including the regulation of actin-based cytoskeletal dynamics and the activation of MAPK signaling pathways. Despite its numerous roles, few of its substrates have been identified. To better characterize the roles of the yeast Ste20p kinase, we developed an in vitro biochemical genomics screen to identify its substrates. When applied to 539 purified yeast proteins, the screen reported 14 targets of Ste20p phosphorylation. We used the data resulting from our screen to build an in silico predictor to identify Ste20p substrates on a proteome-wide basis. Since kinase-substrate specificity is often mediated by additional binding events at sites distal to the phosphorylation site, the predictor uses the presence/absence of multiple sequence motifs to evaluate potential substrates. Statistical validation estimates a threefold improvement in substrate recovery over random predictions, despite the lack of a single dominant motif that can characterize Ste20p phosphorylation. The set of predicted substrates significantly overrepresents elements of the genetic and physical interaction networks surrounding Ste20p, suggesting that some of the predicted substrates are in vivo targets. We validated this combined experimental and computational approach for identifying kinase substrates by confirming the in vitro phosphorylation of polarisome components Bni1p and Bud6p, thus suggesting a mechanism by which Ste20p effects polarized growth.	[Annan, Robert B.; Thomas, David Y.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Lee, Anna Y.; Reid, Ian D.; Sayad, Azin; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Whiteway, Malcolm] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ, Canada; [Lee, Anna Y.; Hallett, Michael] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Hallett, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	McGill University; McGill University; National Research Council Canada; McGill University; McGill University	Annan, RB (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	robert.annan@mail.mcgill.ca	Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X; Hallett, Michael/0000-0001-6738-6786; Reid, Ian/0000-0002-1079-3724	National Science and Engineering Research Council of Canada; National Research Council Canada; National Cancer Institute of Canada; Canadian Institutes of Health Research	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	R.B.A. and A.Y.L. were the recipients of National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) graduate student fellowships. This work was supported by the National Research Council Canada (NRC; http://www.nrc-cnrc.gc.ca) and grants to M.W. and D.Y.T. from the National Cancer Institute of Canada (http://cancer.ca/research/) and the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; [Anonymous], SGD SACCHAROMYCES GE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chang EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000656; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chiroli E, 2003, J CELL BIOL, V160, P857, DOI 10.1083/jcb.200209097; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Eby JJ, 1998, CURR BIOL, V8, P967, DOI 10.1016/S0960-9822(98)00398-4; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; Goehring AS, 2003, MOL BIOL CELL, V14, P1501, DOI 10.1091/mbc.E02-06-0348; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Holly SP, 1999, J CELL BIOL, V147, P845, DOI 10.1083/jcb.147.4.845; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Jin H, 2000, MOL BIOL CELL, V11, P647, DOI 10.1091/mbc.11.2.647; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Loyet KM, 2005, MOL CELL PROTEOMICS, V4, P235, DOI 10.1074/mcp.R400011-MCP200; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Moses AM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r23; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Payne WE, 1997, NUCLEIC ACIDS RES, V25, P57, DOI 10.1093/nar/25.1.57; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pruyne D, 2000, J CELL SCI, V113, P571; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; R Development Core Team, 2007, R LANG ENV STAT COMP; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; RAMER SW, 1993, P NATL ACAD SCI USA, V90, P452, DOI 10.1073/pnas.90.2.452; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; ROSE MD, 1990, METHODS YEAST GENETI, V5; Saunders NFW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-245; Senawongse P, 2005, J CHEM INF MODEL, V45, P1147, DOI 10.1021/ci050047+; Shah Kavita, 2003, Methods Mol Biol, V233, P253; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu C, 1997, J BIOL CHEM, V272, P30623, DOI 10.1074/jbc.272.49.30623; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu GZ, 2005, CELL CYCLE, V4, P52, DOI 10.4161/cc.4.1.1353; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	66	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8279	10.1371/journal.pone.0008279	http://dx.doi.org/10.1371/journal.pone.0008279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20020052	Green Published, gold			2022-12-25	WOS:000272834000010
J	Frank, RT; Edmiston, M; Kendall, SE; Najbauer, J; Cheung, CW; Kassa, T; Metz, MZ; Kim, SU; Glackin, CA; Wu, AM; Yazaki, PJ; Aboody, KS				Frank, Richard T.; Edmiston, Marissa; Kendall, Stephen E.; Najbauer, Joseph; Cheung, Chia-Wei; Kassa, Thewodros; Metz, Marianne Z.; Kim, Seung U.; Glackin, Carlotta A.; Wu, Anna M.; Yazaki, Paul J.; Aboody, Karen S.			Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies	PLOS ONE			English	Article							BREAST-CANCER CELLS; BRAIN METASTASES; RESISTANCE; HERCEPTIN; TROPISM; TARGET; GROWTH	Background: Recombinant monoclonal antibodies have emerged as important tools for cancer therapy. Despite the promise shown by antibody-based therapies, the large molecular size of antibodies limits their ability to efficiently penetrate solid tumors and precludes efficient crossing of the blood-brain-barrier into the central nervous system (CNS). Consequently, poorly vascularized solid tumors and CNS metastases cannot be effectively treated by intravenously-injected antibodies. The inherent tumor-tropic properties of human neural stem cells (NSCs) can potentially be harnessed to overcome these obstacles and significantly improve cancer immunotherapy. Intravenously-delivered NSCs preferentially migrate to primary and metastatic tumor sites within and outside the CNS. Therefore, we hypothesized that NSCs could serve as an ideal cellular delivery platform for targeting antibodies to malignant tumors. Methods and Findings: As proof-of-concept, we selected Herceptin(TM) (trastuzumab), a monoclonal antibody widely used to treat HER2-overexpressing breast cancer. HER2 overexpression in breast cancer is highly correlated with CNS metastases, which are inaccessible to trastuzumab therapy. Therefore, NSC-mediated delivery of trastuzumab may improve its therapeutic efficacy. Here we report, for the first time, that human NSCs can be genetically modified to secrete anti-HER2 immunoglobulin molecules. These NSC-secreted antibodies assemble properly, possess tumor cell-binding affinity and specificity, and can effectively inhibit the proliferation of HER2-overexpressing breast cancer cells in vitro. We also demonstrate that immunoglobulin-secreting NSCs exhibit preferential tropism to tumor cells in vivo, and can deliver antibodies to human breast cancer xenografts in mice. Conclusions: Taken together, these results suggest that NSCs modified to secrete HER2-targeting antibodies constitute a promising novel platform for targeted cancer immunotherapy. Specifically, this NSC-mediated antibody delivery system has the potential to significantly improve clinical outcome for patients with HER2-overexpressing breast cancer.	[Frank, Richard T.; Edmiston, Marissa; Najbauer, Joseph; Metz, Marianne Z.; Aboody, Karen S.] City Hope Natl Med Ctr, Div Hematol, Duarte, CA 91010 USA; [Frank, Richard T.; Edmiston, Marissa; Najbauer, Joseph; Metz, Marianne Z.; Aboody, Karen S.] City Hope Natl Med Ctr, Div Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Frank, Richard T.; Edmiston, Marissa; Kendall, Stephen E.; Najbauer, Joseph; Cheung, Chia-Wei; Kassa, Thewodros; Metz, Marianne Z.; Glackin, Carlotta A.; Yazaki, Paul J.; Aboody, Karen S.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Kendall, Stephen E.; Glackin, Carlotta A.] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Cheung, Chia-Wei; Kassa, Thewodros; Yazaki, Paul J.] City Hope Natl Med Ctr, Dept Canc Immunotherapy & Tumor Immunol, Duarte, CA 91010 USA; [Aboody, Karen S.] City Hope Natl Med Ctr, Dept Neurosci, Duarte, CA 91010 USA; [Wu, Anna M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Gachon Univ, Gil Hosp, Inst Regenerat Med, Inchon, South Korea	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia; Gachon University	Frank, RT (corresponding author), City Hope Natl Med Ctr, Div Hematol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	rikfrank@gmail.com; kaboody@coh.org		Wu, Anna/0000-0001-8487-823X	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; Jewish Federation's Jeanne Schnitzer Reynolds Fund for Women's Health; Ziman Family Foundation; Helen and Morgan Chu Graduate Student Fellowship; Irell and Manella Graduate School of Biological Sciences; Beckman Research Institute at City of Hope	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; Jewish Federation's Jeanne Schnitzer Reynolds Fund for Women's Health; Ziman Family Foundation; Helen and Morgan Chu Graduate Student Fellowship; Irell and Manella Graduate School of Biological Sciences; Beckman Research Institute at City of Hope	This work was supported by the Rosalinde and Arthur Gilbert Foundation, STOP CANCER, The Jewish Federation's Jeanne Schnitzer Reynolds Fund for Women's Health, Ziman Family Foundation, the Helen and Morgan Chu Graduate Student Fellowship, the Irell and Manella Graduate School of Biological Sciences and the Beckman Research Institute at City of Hope. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Aboody KS, 2006, NEURO-ONCOLOGY, V8, P119, DOI 10.1215/15228517-2005-012; Adams GP, 2001, CANCER RES, V61, P4750; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Danks MK, 2007, CANCER RES, V67, P22, DOI 10.1158/0008-5472.CAN-06-3607; Dimopoulou I, 2006, ANN ONCOL, V17, P372, DOI 10.1093/annonc/mdj057; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; Joo KM, 2009, MOL THER, V17, P570, DOI 10.1038/mt.2008.290; Kim Seung U, 2002, Methods Mol Biol, V198, P55; Kute T, 2004, CYTOM PART A, V57A, P86, DOI 10.1002/cyto.a.10095; Melisko ME, 2009, NAT CLIN PRACT ONCOL, V6, P25, DOI 10.1038/ncponc1243; Molina MA, 2001, CANCER RES, V61, P4744; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Nielsen DL, 2009, CANCER TREAT REV, V35, P121, DOI 10.1016/j.ctrv.2008.09.003; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; SPECTOR NL, 2009, J CLIN ONCOL; Yazaki PJ, 2004, PROTEIN ENG DES SEL, V17, P481, DOI 10.1093/protein/gzh056; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146	22	59	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8314	10.1371/journal.pone.0008314	http://dx.doi.org/10.1371/journal.pone.0008314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016813	Green Published, gold, Green Submitted			2022-12-25	WOS:000272833800010
J	Elrefaei, M; Burke, CM; Baker, CAR; Jones, NG; Bousheri, S; Bangsberg, DR; Cao, HY				Elrefaei, Mohamed; Burke, Candace M.; Baker, Chris A. R.; Jones, Norman G.; Bousheri, Stephanie; Bangsberg, David R.; Cao, Huyen			TGF-beta and IL-10 Production by HIV-Specific CD8+T Cells Is Regulated by CTLA-4 Signaling on CD4+T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CD8(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; CYTOKINE PRODUCTION; UP-REGULATION; CUTTING EDGE; EXPRESSION; PROLIFERATION; INFECTION; INTERLEUKIN-10	Immune dysregulation in HIV-1 infection is associated with increased expression of inhibitory molecules such as CTLA-4, TGF-beta, and IL-10. In this study we examined one potential mechanism for regulating TGF-beta and IL-10 expression by HIV-specific suppressor CD8+ T cells. No overlap between TGF-beta, IL-10, and IFN-gamma cytokine production by HIV-specific CD8+ T cells was observed. TGF-beta positive and IL-10 positive cells were FOXP3 negative, CD25 negative, and displayed a heterogeneous surface expression of CD127. TGF-beta and IL-10 positive CD8+ T cells did not express CTLA-4. Nevertheless, CTLA-4 blockade resulted in a significant decrease in HIV-specific TGF-beta positive and IL-10 positive CD8+ T cell responses, and a concomitant increase in HIV-specific IFN-gamma positive CD8+ T cell responses. Depletion of CD4+ T cells abrogated the impact of CTLA-4 on HIV-specific TGF-beta positive and IL-10 positive CD8+ T cells. Our study suggests that CTLA-4 Signaling on CD4+ T cells regulates the inhibitory functions of the HIV-specific suppressor CD8+ T cells.	[Elrefaei, Mohamed; Burke, Candace M.; Baker, Chris A. R.; Jones, Norman G.; Bousheri, Stephanie; Cao, Huyen] Calif Dept Publ Hlth, Richmond, CA USA; [Bangsberg, David R.] Massachusetts Gen Hosp, Harvard Initiat Global Hlth, Cambridge, MA USA	California Department of Public Health; Harvard University; Massachusetts General Hospital	Elrefaei, M (corresponding author), Calif Dept Publ Hlth, Richmond, CA USA.	hcao@dhs.ca.gov		Baker, Chris/0000-0002-6248-654X	NIH [AI43885, MH54907, AI71772]; California Research Center for the Biology of HIV in Minorities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071772, R01AI043885, R21AI043885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Research Center for the Biology of HIV in Minorities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by NIH grants AI43885, MH54907, AI71772, and California Research Center for the Biology of HIV in Minorities grant, UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Asseman C., 2002, Autoimmunity Reviews, V1, P190, DOI 10.1016/S1568-9972(02)00054-X; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; BALASHOV KE, 1995, J CLIN INVEST, V95, P2711, DOI 10.1172/JCI117973; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Elrefaei M, 2006, J IMMUNOL, V176, P1274, DOI 10.4049/jimmunol.176.2.1274; Elrefaei M, 2008, J IMMUNOL, V180, P7757, DOI 10.4049/jimmunol.180.11.7757; Elrefaei M, 2007, J IMMUNOL, V178, P3265, DOI 10.4049/jimmunol.178.5.3265; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Filaci G, 2004, CLIN EXP MED, V4, P86, DOI 10.1007/s10238-004-0042-3; Filaci G, 2004, HUM IMMUNOL, V65, P142, DOI 10.1016/j.humimm.2003.12.001; Filaci G, 2001, J IMMUNOL, V166, P6452, DOI 10.4049/jimmunol.166.10.6452; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Kumar V, 2004, J CLIN INVEST, V114, P1222, DOI 10.1172/JCI200423166; Leng QB, 2002, AIDS, V16, P519, DOI 10.1097/00002030-200203080-00002; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Levings MK, 2002, J EXP MED, V196, P1335, DOI 10.1084/jem.20021139; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; McEvers K, 2005, VACCINE, V23, P4128, DOI 10.1016/j.vaccine.2005.03.022; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Reinhold D, 1999, IMMUNOL TODAY, V20, P384, DOI 10.1016/S0167-5699(99)01497-8; Riley JL, 2000, J EXP MED, V191, P1987, DOI 10.1084/jem.191.11.1987; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Scotto L, 2004, HUM IMMUNOL, V65, P1297, DOI 10.1016/j.humimm.2004.09.004; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; SHARMA V, 1995, BIOCHEM BIOPH RES CO, V208, P704, DOI 10.1006/bbrc.1995.1395; Sousa AE, 1999, J IMMUNOL, V162, P3718; Steiner K, 1999, CLIN EXP IMMUNOL, V115, P451; Sung JL, 2003, INT IMMUNOPHARMACOL, V3, P233, DOI 10.1016/S1567-5769(02)00276-X; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Valdez H, 1997, AIDS Clin Rev, P187; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	50	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8194	10.1371/journal.pone.0008194	http://dx.doi.org/10.1371/journal.pone.0008194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20016783	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300003
J	Lacroix-Lamande, S; Rochereau, N; Mancassola, R; Barrier, M; Clauzon, A; Laurent, F				Lacroix-Lamande, Sonia; Rochereau, Nicolas; Mancassola, Roselyne; Barrier, Mathieu; Clauzon, Amandine; Laurent, Fabrice			Neonate Intestinal Immune Response to CpG Oligodeoxynucleotide Stimulation	PLOS ONE			English	Article							CRYPTOSPORIDIUM-PARVUM INFECTION; EPITHELIAL-CELLS; VACCINE DEVELOPMENT; MUCOSAL; MICE; HOMEOSTASIS; RECEPTORS; TOLERANCE; TLR9; LIFE	Background: The development of mucosal vaccines is crucial to efficiently control infectious agents for which mucosae are the primary site of entry. Major drawbacks of these protective strategies are the lack of effective mucosal adjuvant. Synthetic oligodeoxynucleotides that contain several unmethylated cytosine-guanine dinucleotide (CpG-ODN) motifs are now recognized as promising adjuvants displaying mucosal adjuvant activity through direct activation of TLR9-expressing cells. However, little is known about the efficacy of these molecules in stimulating the intestinal immune system in neonates. Methodology/Principal Findings: First, newborn mice received CpG-ODN orally, and the intestinal cytokine and chemokine response was measured. We observed that oral administration of CpG-ODN induces CXC and CC chemokine responses and a cellular infiltration in the intestine of neonates as detected by immunohistochemistry. We next compared the efficiency of the oral route to intraperitoneal administration in stimulating the intestinal immune responses of both adults and neonates. Neonates were more responsive to TLR9-stimulation than adults whatever the CpG-ODN administration route. Their intestinal epithelial cells (IECs) indirectly responded to TLR9 stimulation and contributed to the CXC chemokine response, whereas other TLR9-bearing cells of the lamina-propria produced CC chemokines and Th1-type cytokines. Moreover, we showed that the intestine of adult exhibited a significantly higher level of IL10 at homeostasis than neonates, which might be responsible for the unresponsiveness to TLR9-stimulation, as confirmed by our findings in IL10-deficient mice. Conclusions/Significance: This is the first report that deciphers the role played by CpG-ODN in the intestine of neonates. This work clearly demonstrates that an intraperitoneal administration of CpG-ODN is more efficient in neonates than in adults to stimulate an intestinal chemokine response due to their lower IL-10 intestinal level. In addition we report the efficiency of the oral route at inducing intestinal chemokine responses in neonate that might be taken into consideration for further vaccine development against neonatal diseases.	[Lacroix-Lamande, Sonia; Rochereau, Nicolas; Mancassola, Roselyne; Barrier, Mathieu; Clauzon, Amandine; Laurent, Fabrice] INRA Tours, Lab Controle & Immunol Malad Enter Nouveau Ne, Infectiol Anim & Sante Publ UR1282, Nouzilly, France	INRAE	Lacroix-Lamande, S (corresponding author), INRA Tours, Lab Controle & Immunol Malad Enter Nouveau Ne, Infectiol Anim & Sante Publ UR1282, Nouzilly, France.	slacroix@tours.inra.fr	Laurent, fabrice/AAC-2266-2019	Laurent, fabrice/0000-0002-9687-7952; , rochereau/0000-0002-6522-895X; LAMANDE, Sonia/0000-0002-7865-4587	INRA	INRA	This research program was supported by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Auray G, 2007, MICROBES INFECT, V9, P574, DOI 10.1016/j.micinf.2007.01.026; Ballas ZK, 2007, IMMUNOL RES, V39, P15, DOI 10.1007/s12026-007-0066-3; Barrier M, 2006, J INFECT DIS, V193, P1400, DOI 10.1086/503748; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Booth JS, 2009, MUCOSAL IMMUNOL, V2, P265, DOI 10.1038/mi.2009.6; Czerkinsky C, 1999, IMMUNOL REV, V170, P197, DOI 10.1111/j.1600-065X.1999.tb01339.x; Fadel SA, 2002, J IMMUNOL, V169, P3293, DOI 10.4049/jimmunol.169.6.3293; Gupta K, 2008, DRUGS R&D, V9, P137, DOI 10.2165/00126839-200809030-00001; Ito S, 2005, J IMMUNOL, V174, P777, DOI 10.4049/jimmunol.174.2.777; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Lacroix-Lamande S, 2002, INFECT IMMUN, V70, P2090, DOI 10.1128/IAI.70.4.2090-2099.2002; LECCE JG, 1979, ENVIRON HEALTH PERSP, V33, P57, DOI 10.2307/3429072; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Raghavan S, 2003, INFECT IMMUN, V71, P7014, DOI 10.1128/IAI.71.12.7014-7022.2003; Ramirez K, 2009, J IMMUNOL, V182, P1211, DOI 10.4049/jimmunol.182.2.1211; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; Wang DQ, 2005, VACCINE, V23, P2614, DOI 10.1016/j.vaccine.2004.11.028; Wilson C B, 1991, Adv Exp Med Biol, V310, P17	28	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8291	10.1371/journal.pone.0008291	http://dx.doi.org/10.1371/journal.pone.0008291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011519	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300041
J	Srinivasan, R; Zabuawala, T; Huang, H; Zhang, JY; Gulati, P; Fernandez, S; Karlo, JC; Landreth, GE; Leone, G; Ostrowski, MC				Srinivasan, Ruchika; Zabuawala, Tahera; Huang, Hong; Zhang, Jianying; Gulati, Parul; Fernandez, Soledad; Karlo, J. Colleen; Landreth, Gary E.; Leone, Gustavo; Ostrowski, Michael C.			Erk1 and Erk2 Regulate Endothelial Cell Proliferation and Migration during Mouse Embryonic Angiogenesis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MICE LACKING; MAP KINASE; IN-VIVO; FAK; SRC; MOTILITY	Angiogenesis is a complex process orchestrated by both growth factors and cell adhesion and is initiated by focal degradation of the vascular basement membrane with subsequent migration and proliferation of endothelial cells. The Ras/Raf/MEK/ERK pathway is required for EC function during angiogenesis. Although in vitro studies implicate ERK1 and ERK2 in endothelial cell survival, their precise role in angiogenesis in vivo remains poorly defined. Cre/loxP technology was used to inactivate Erk1 and Erk2 in endothelial cells during murine development, resulting in embryonic lethality due to severely reduced angiogenesis. Deletion of Erk1 and Erk2 in primary endothelial cells resulted in decreased cell proliferation and migration, but not in increased apoptosis. Expression of key cell cycle regulators was diminished in the double knockout cells, and decreased DNA synthesis could be observed in endothelial cells during embryogenesis. Interestingly, both Paxillin and Focal Adhesion Kinase were expressed at lower levels in endothelial cells lacking Erk1 and Erk2 both in vivo and in vitro, leading to defects in the organization of the cytoskeleton and in cell motility. The regulation of Paxillin and Focal Adhesion Kinase expression occurred post-transcriptionally. These results demonstrate that ERK1 and ERK2 coordinate endothelial cell proliferation and migration during angiogenesis.	[Srinivasan, Ruchika; Zabuawala, Tahera; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Srinivasan, Ruchika; Zabuawala, Tahera; Leone, Gustavo; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Tumor Microenvironm Program, Columbus, OH 43210 USA; [Huang, Hong] Nationwide Childrens Hosp, Ctr Cardiovasc Med, Columbus, OH USA; [Zhang, Jianying; Gulati, Parul; Fernandez, Soledad] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Karlo, J. Colleen; Landreth, Gary E.] Case Western Reserve Univ, Dept Cellular & Mol Neurosci, Cleveland, OH 44106 USA; [Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Case Western Reserve University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Srinivasan, R (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu	Gulati, Parul/K-7375-2013; Ostrowski, Michael/H-3108-2011	Gulati, Parul/0000-0001-9341-9844; Ostrowski, Michael/0000-0003-2948-6297	NCI [R01-CA53271, P01-CA097189]; Evelyn Simmers Foundation; Department of Defense Breast Cancer Program; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA053271] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Evelyn Simmers Foundation; Department of Defense Breast Cancer Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NCI grants R01-CA53271, P01-CA097189 and the Evelyn Simmers Foundation (MCO). TZ was funded by a predoctoral fellowship from the Department of Defense Breast Cancer Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Houle F, 2007, J CELL SCI, V120, P3666, DOI 10.1242/jcs.003251; Huang H, 2003, IN VITRO CELL DEV-AN, V39, P43; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Liu WL, 2001, ENDOCRINOLOGY, V142, P1710, DOI 10.1210/en.142.5.1710; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Pages Gilles, 2004, Methods Mol Biol, V250, P155; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rose JL, 2007, J PHARMACOL EXP THER, V321, P318, DOI 10.1124/jpet.106.113498; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Serban D, 2008, CIRC RES, V102, P1350, DOI 10.1161/CIRCRESAHA.107.169664; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Shen TL, 2001, FEBS LETT, V499, P176, DOI 10.1016/S0014-5793(01)02545-5; Son SH, 2009, CANCER LETT, V280, P86, DOI 10.1016/j.canlet.2009.02.012; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WEI G, 2009, BLOOD; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J	51	114	118	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8283	10.1371/journal.pone.0008283	http://dx.doi.org/10.1371/journal.pone.0008283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011539	Green Published, gold			2022-12-25	WOS:000272830300035
J	Attout, T; Hoerauf, A; Denece, G; Debrah, AY; Marfo-Debrekyei, Y; Boussinesq, M; Wanji, S; Martinez, V; Mand, S; Adjei, O; Bain, O; Specht, S; Martin, C				Attout, Tarik; Hoerauf, Achim; Denece, Gaelle; Debrah, Alexander Yaw; Marfo-Debrekyei, Yeboah; Boussinesq, Michel; Wanji, Samuel; Martinez, Valerie; Mand, Sabine; Adjei, Ohene; Bain, Odile; Specht, Sabine; Martin, Coralie			Lymphatic Vascularisation and Involvement of Lyve-1(+) Macrophages in the Human Onchocerca Nodule	PLOS ONE			English	Article							SKIN-LESIONS; WOLBACHIA ENDOBACTERIA; CD11B(+) MACROPHAGES; ANGIOGENIC ACTIVITY; FILARIAL NEMATODES; LYMPHANGIOGENESIS; VOLVULUS; IVERMECTIN; CANCER; GROWTH	Onchocerciasis, caused by the filarial nematode Onchocerca volvulus, is a parasitic disease leading to debilitating skin disease and blindness, with major economic and social consequences. The pathology of onchocerciasis is principally considered to be a consequence of long-standing host inflammatory responses. In onchocerciasis a subcutaneous nodule is formed around the female worms, the core of which is a dense infiltrate of inflammatory cells in which microfilariae are released. It has been established that the formation of nodules is associated with angiogenesis. In this study, we show using specific markers of endothelium (CD31) and lymphatic endothelial cells (Lyve-1, Podoplanin) that not only angiogenesis but also lymphangiogenesis occurs within the nodule. 7% of the microfilariae could be found within the lymphatics, but none within blood vessels in these nodules, suggesting a possible route of migration for the larvae. The neovascularisation was associated with a particular pattern of angio/lymphangiogenic factors in nodules of onchocerciasis patients, characterized by the expression of CXCL12, CXCR4, VEGF-C, Angiopoietin-1 and Angiopoietin-2. Interestingly, a proportion of macrophages were found to be positive for Lyve-1 and some were integrated into the endothelium of the lymphatic vessels, revealing their plasticity in the nodular micro-environment. These results indicate that lymphatic as well as blood vascularization is induced around O. volvulus worms, either by the parasite itself, e. g. by the release of angiogenic and lymphangiogenic factors, or by consecutive host immune responses.	[Attout, Tarik; Denece, Gaelle; Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, USM Parasitol Comparee & Modeles Expt 307, F-75231 Paris, France; [Hoerauf, Achim; Mand, Sabine; Specht, Sabine] Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Debrah, Alexander Yaw; Marfo-Debrekyei, Yeboah; Adjei, Ohene] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana; [Boussinesq, Michel] IRD, UMR 1045, Montpellier, France; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon; [Wanji, Samuel] Univ Buea, Dept Biochem & Microbiol, Buea, Cameroon; [Martinez, Valerie] Hop Antoine Beclere, Serv Med Interne & Immunol Clin, Clamart, France	Museum National d'Histoire Naturelle (MNHN); University of Bonn; Kumasi Center for Collaborative Research; Institut de Recherche pour le Developpement (IRD); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Attout, T (corresponding author), Museum Natl Hist Nat, USM Parasitol Comparee & Modeles Expt 307, F-75231 Paris, France.	cmartin@mnhn.fr	martin, coralie/O-3983-2019; Boussinesq, Michel/J-7256-2016; Martin, Coralie/N-6293-2018	martin, coralie/0000-0003-3801-2595; Boussinesq, Michel/0000-0001-6312-0681; Debrah, Alexander Yaw/0000-0001-5721-0891	European Community [INCO-CT-2006-032321]; Region Ile de France	European Community(European Commission); Region Ile de France(Region Ile-de-France)	This work was supported by European Community grant INCO-CT-2006-032321. T. Attout was supported by a postdoctoral fellowship from Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; BAIN O, 1985, CR ACAD SCI III-VIE, V301, P513; BAIN O, 1994, PARASITE, V1, P241, DOI 10.1051/parasite/1994013241; BAIN O, 1976, Annales de Parasitologie Humaine et Comparee, V51, P461; BAIN O, 2003, FILARIA J, V2, P16, DOI DOI 10.1186/1475-2883-2-16; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bernardini G, 2003, J IMMUNOL METHODS, V273, P83, DOI 10.1016/S0022-1759(02)00420-9; BEVERIDGE I, 1980, TROPENMED PARASITOL, V31, P75; BONUCCI E, 1979, TROPENMED PARASITOL, V30, P489; Brattig NW, 2004, MICROBES INFECT, V6, P113, DOI 10.1016/j.micinf.2003.11.003; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; BRUMPT E, 1904, REV MED HYG TROP, V1, P43; BURCHARD GD, 1979, TROPENMED PARASITOL, V30, P103; BUTTNER DW, 1982, TROPENMED PARASITOL, V33, P201; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; COLLINS RC, 1982, AM J TROP MED HYG, V31, P267, DOI 10.4269/ajtmh.1982.31.267; Connor D H, 1970, Hum Pathol, V1, P553, DOI 10.1016/S0046-8177(70)80057-0; CONNOR DH, 1969, ARCH PATHOL, V87, P193; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; DUKE BOL, 1970, T ROY SOC TROP MED H, V64, P791, DOI 10.1016/0035-9203(70)90030-1; EDGEWORTH JD, 1993, CLIN EXP IMMUNOL, V92, P84, DOI 10.1111/j.1365-2249.1993.tb05952.x; GEORGE GH, 1985, AM J TROP MED HYG, V34, P1144, DOI 10.4269/ajtmh.1985.34.1144; Hartmann S, 2002, PARASITE IMMUNOL, V24, P253, DOI 10.1046/j.1365-3024.2002.00459.x; Higazi TB, 2003, MOL BIOCHEM PARASIT, V129, P61, DOI 10.1016/S0166-6851(03)00094-X; Hoerauf A, 2005, PARASITE IMMUNOL, V27, P417, DOI 10.1111/j.1365-3024.2005.00792.x; Hoerauf A, 2002, TRENDS PARASITOL, V18, P25, DOI 10.1016/S1471-4922(01)02173-0; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Jeon BH, 2008, CANCER RES, V68, P1100, DOI 10.1158/0008-5472.CAN-07-2572; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; KERSHAW WE, 1954, BRIT MED J, V2, P724, DOI 10.1136/bmj.2.4890.724; Knab J, 1997, TROP MED INT HEALTH, V2, P1156, DOI 10.1046/j.1365-3156.1997.d01-217.x; LABADIELAGRAVE D, 1899, ARCH PARASITOL, V2, P451; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PARKHOUSE RME, 1985, CLIN EXP IMMUNOL, V62, P13; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; REBER E W, 1964, Z Tropenmed Parasitol, V15, P153; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Ruegg C, 2006, J LEUKOCYTE BIOL, V80, P682, DOI 10.1189/jlb.0606394; Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; SCHULZKEY H, 1976, TROPENMED PARASITOL, V27, P229; Smith R J, 1988, Trop Med Parasitol, V39 Suppl 4, P418; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Tawe W, 2000, MOL BIOCHEM PARASIT, V109, P91, DOI 10.1016/S0166-6851(00)00231-0; Vuong P N, 1994, Rev Elev Med Vet Pays Trop, V47, P47; VUONG PN, 1988, TROP MED PARASITOL, V39, P105; VUONG PN, 1993, ANN PARASIT HUM COMP, V68, P176, DOI 10.1051/parasite/1993684176; VUONG PN, 1992, ANN PARASIT HUM COMP, V67, P194, DOI 10.1051/parasite/1992676194; VUONGNGOC P, 1986, ANN PARASIT HUM COMP, V61, P311, DOI 10.1051/parasite/1986613311; Wildenburg G, 1997, PARASITOL RES, V83, P109, DOI 10.1007/s004360050220; WILDENBURG G, 1994, TROP MED PARASITOL, V45, P87; Wildenburg G, 1998, PARASITOLOGY, V116, P257, DOI 10.1017/S0031182097002278; Wildenburg G, 1998, TROP MED INT HEALTH, V3, P918	59	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8234	10.1371/journal.pone.0008234	http://dx.doi.org/10.1371/journal.pone.0008234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011036	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829800018
J	Ronan, EO; Lee, LN; Beverley, PCL; Tchilian, EZ				Ronan, Edward O.; Lee, Lian Ni; Beverley, Peter C. L.; Tchilian, Elma Z.			Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection	PLOS ONE			English	Article							T-CELL RESPONSES; PULMONARY TUBERCULOSIS; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; BOVIS BCG; ANTIGEN 85B; IN-VIVO; MUCOSAL; CD4; LYMPHOCYTES	Background: In pulmonary Mycobacterium tuberculosis (Mtb) infection, immune responses are delayed compared to other respiratory infections, so that antigen-specific cells are not detected in the lungs earlier than day 14. Even after parenteral immunization with Bacille Calmette Guerin (BCG) or a subunit vaccine, the immune response after Mtb challenge is only slightly accelerated and the kinetics of pulmonary Mtb growth do not differ between naive and immunized animals up to day 14. Methods and Findings: Mice were immunized intranasally with a recombinant adenovirus expressing mycobacterial antigen 85A (Ad85A), challenged by aerosol with Mtb and the kinetics of Mtb growth in the lungs measured. Intranasal immunization with Ad85A inhibits Mtb growth in the early phase of infection, up to day 8. Protection is sustained for at least 7 months and correlates with the presence of antigen-specific activated effector CD8 T cells in the lungs. Antigen 85A-specific T cells respond to antigen presenting cells from the lungs of mice immunized with Ad85A 23 weeks previously, demonstrating the persistence of antigen in the lungs. Conclusions/Significance: Intranasal immunization with Ad85A can inhibit early growth of Mtb because it establishes a lung antigen depot and maintains an activated lung-resident lymphocyte population. We propose that an optimal immunization strategy for tuberculosis should aim to induce both lung and systemic immunity, targeting the early and late phases of Mtb growth.	[Ronan, Edward O.; Lee, Lian Ni; Beverley, Peter C. L.; Tchilian, Elma Z.] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford	Ronan, EO (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	elma.tchilian@ndm.ox.ac.uk	Tchilian, Elma Z/Q-5976-2017	Tchilian, Elma Z/0000-0002-4869-5118; Lee, Lian Ni/0000-0003-3915-3015; Beverley, Peter/0000-0003-0481-2180	UK Medical Research Council [G0701235]; Medical Research Council [G0701235] Funding Source: researchfish; MRC [G0701235] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a UK Medical Research Council (www.mrc.ac.uk) Grant No: G0701235. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Beverley PCL, 2008, EXPERT REV VACCINES, V7, P1165, DOI 10.1586/14760584.7.8.1165; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mollenkopf HJ, 2004, J INFECT DIS, V190, P588, DOI 10.1086/422394; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Serbina NV, 2001, INFECT IMMUN, V69, P4320, DOI 10.1128/IAI.69.7.4320-4328.2001; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; TATSIS N, 2007, VIROLOGY, V22, P22; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Xing Z, 2009, EXPERT REV VACCINES, V8, P1465, DOI 10.1586/ERV.09.110; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856; Yu H, 2008, LAB ANIM-UK, V42, P294, DOI 10.1258/la.2007.007055	37	43	44	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8235	10.1371/journal.pone.0008235	http://dx.doi.org/10.1371/journal.pone.0008235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011050	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829800019
J	Yoshimura, T; Sonoda, KH; Sugahara, M; Mochizuki, Y; Enaida, H; Oshima, Y; Ueno, A; Hata, Y; Yoshida, H; Ishibashi, T				Yoshimura, Takeru; Sonoda, Koh-Hei; Sugahara, Mika; Mochizuki, Yasutaka; Enaida, Hiroshi; Oshima, Yuji; Ueno, Akifumi; Hata, Yasuaki; Yoshida, Hiroki; Ishibashi, Tatsuro			Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; PROLIFERATIVE DIABETIC-RETINOPATHY; RETINAL VEIN OCCLUSION; MONOCYTE CHEMOTACTIC PROTEIN-1; MULTIPLEX BEAD ANALYSIS; C-C CHEMOKINES; VITREOUS FLUID; MACULAR EDEMA; INTRAVITREAL TRIAMCINOLONE	Inflammation affects the formation and the progression of various vitreoretinal diseases. We performed a comprehensive analysis of inflammatory immune mediators in the vitreous fluids from total of 345 patients with diabetic macular edema (DME, n = 92), proliferative diabetic retinopathy (PDR, n = 147), branch retinal vein occlusion (BRVO, n = 30), central retinal vein occlusion (CRVO, n = 13) and rhegmatogenous retinal detachment (RRD, n = 63). As a control, we selected a total of 83 patients with either idiopathic macular hole (MH) or idiopathic epiretinal membrane (ERM) that were free of major pathogenic intraocular changes, such as ischemic retina and proliferative membranes. The concentrations of 20 soluble factors (nine cytokines, six chemokines, and five growth factors) were measured simultaneously by multiplex bead analysis system. Out of 20 soluble factors, three factors: interleukin-6 (IL-6), interleukin-8 (IL-8), and monocyte chemoattractant protein-1 (MCP-1) were significantly elevated in all groups of vitreoretinal diseases ( DME, PDR, BRVO, CRVO, and RRD) compared with control group. According to the correlation analysis in the individual patient's level, these three factors that were simultaneously increased, did not show any independent upregulation in all the examined diseases. Vascular endothelial growth factor ( VEGF) was significantly elevated in patients with PDR and CRVO. In PDR patients, the elevation of VEGF was significantly correlated with the three factors: IL-6, IL-8, and MCP-1, while no significant correlation was observed in CRVO patients. In conclusion, multiplex bead system enabled a comprehensive soluble factor analysis in vitreous fluid derived from variety of patients. Major three factors: IL-6, IL-8, and MCP-1 were strongly correlated with each other indicating a common pathway involved in inflammation process in vitreoretinal diseases.	[Yoshimura, Takeru; Sonoda, Koh-Hei; Sugahara, Mika; Mochizuki, Yasutaka; Enaida, Hiroshi; Oshima, Yuji; Ueno, Akifumi; Hata, Yasuaki; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan; [Yoshida, Hiroki] Saga Univ, Fac Med, Dept Biomol Sci, Saga 840, Japan	Kyushu University; Saga University	Yoshimura, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan.	sonodak@med.kyushu-u.ac.jp		Yoshimura, Takeru/0000-0002-5983-7193	Ministry of Education, Science, Sports and Culture, Japan [14770962, 13470369]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture, Japan (B2 No. 14770962: K-H. Sonoda, B2 No. 13470369: T. Ishibashi) (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuElAsrar AM, 1997, AM J OPHTHALMOL, V123, P599, DOI 10.1016/S0002-9394(14)71072-4; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Arimura N, 2009, OPHTHALMOLOGY, V116, P921, DOI 10.1016/j.ophtha.2008.12.024; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Canton A, 2004, ARCH OPHTHALMOL-CHIC, V122, P743, DOI 10.1001/archopht.122.5.743; Capeans C, 1998, RETINA-J RET VIT DIS, V18, P546; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chan Chi-Chao, 2002, Curr Opin Ophthalmol, V13, P411, DOI 10.1097/00055735-200212000-00012; CHARTERIS DG, 1992, OPHTHALMOLOGY, V99, P1364; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Chong DY, 2008, INVEST OPHTH VIS SCI, V49, P3193, DOI 10.1167/iovs.07-1641; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; DEBOER JH, 1993, INVEST OPHTH VIS SCI, V34, P3376; ELASRAR AM, 1992, AM J OPHTHALMOL, V114, P731, DOI 10.1016/S0002-9394(14)74052-8; ELNER SG, 1995, CURR EYE RES, V14, P1045, DOI 10.3109/02713689508998529; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kastelan S, 2007, MED HYPOTHESES, V68, P1016, DOI 10.1016/j.mehy.2006.05.073; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; Lewandowska-Furmanik Maria, 2002, Med Sci Monit, V8, pCR526; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lutty GA, 1996, ARCH OPHTHALMOL-CHIC, V114, P971, DOI 10.1001/archopht.1996.01100140179011; Maier R, 2008, MOL VIS, V14, P637; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Mitamura Y, 2002, JPN J OPHTHALMOL, V46, P218, DOI 10.1016/S0021-5155(01)00497-X; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Nguyen QD, 2006, AM J OPHTHALMOL, V142, P961, DOI 10.1016/j.ajo.2006.06.068; Oppenheim JJ, 2001, INT J HEMATOL, V74, P3, DOI 10.1007/BF02982543; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Park SP, 2008, CLIN EXP OPHTHALMOL, V36, P831, DOI 10.1111/j.1442-9071.2009.01909.x; Pe'er J, 1998, OPHTHALMOLOGY, V105, P412, DOI 10.1016/S0161-6420(98)93020-2; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Siawaya JFD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002535; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Struyf S, 2003, ADV IMMUNOL, V81, P1, DOI 10.1016/S0065-2776(03)81001-5; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vilcek J, 2004, TRENDS PHARMACOL SCI, V25, P201, DOI 10.1016/j.tips.2004.02.011; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Yilmaz T, 2009, OPHTHALMOLOGY, V116, P902, DOI 10.1016/j.ophtha.2009.02.002; Yoshida A, 1998, INVEST OPHTH VIS SCI, V39, P1097; Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489; Yuuki T, 2001, J DIABETES COMPLICAT, V15, P257, DOI 10.1016/S1056-8727(01)00155-6	51	253	267	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8158	10.1371/journal.pone.0008158	http://dx.doi.org/10.1371/journal.pone.0008158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997642	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829200005
J	Dutta, S; Sullivan, JS; Grady, KK; Haynes, JD; Komisar, J; Batchelor, AH; Soisson, L; Diggs, CL; Heppner, DG; Lanar, DE; Collins, WE; Barnwell, JW				Dutta, Sheetij; Sullivan, JoAnn S.; Grady, Katharine K.; Haynes, J. David; Komisar, Jack; Batchelor, Adrian H.; Soisson, Lorraine; Diggs, Carter L.; Heppner, D. Gray; Lanar, David E.; Collins, William E.; Barnwell, John W.			High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model	PLOS ONE			English	Article							INSTITUTE-OF-RESEARCH; BLOOD-STAGE MALARIA; PLASMODIUM-FALCIPARUM; VACCINE CANDIDATE; MONKEYS; IMMUNOGENICITY; INVASION; SAFETY; AMA-1; CHILDREN	A Plasmodium falciparum 3D7 strain Apical Membrane Antigen-1 (AMA1) vaccine, formulated with AS02A adjuvant, slowed parasite growth in a recent Phase 1/2a trial, however sterile protection was not observed. We tested this AS02A, and a Montanide ISA720 (ISA) formulation of 3D7 AMA1 in Aotus monkeys. The 3D7 parasite does not invade Aotus erythrocytes, hence two heterologous strains, FCH/4 and FVO, were used for challenge, FCH/4 AMA1 being more homologous to 3D7 than FVO AMA1. Following three vaccinations, the monkeys were challenged with 50,000 FCH/4 or 10,000 FVO parasites. Three of the six animals in the AMA+ISA group were protected against FCH/4 challenge. One monkey did not become parasitemic, another showed only a short period of low level parasitemia that self-cured, and a third animal showed a delay before exhibiting its parasitemic phase. This is the first protection shown in primates with a recombinant P. falciparum AMA1 without formulation in Freund's complete adjuvant. No animals in the AMA+AS02(A) group were protected, but this group exhibited a trend towards reduced growth rate. A second group of monkeys vaccinated with AMA+ISA vaccine was not protected against FVO challenge, suggesting strain-specificity of AMA1-based protection. Protection against FCH/4 strain correlated with the quantity of induced antibodies, as the protected animals were the only ones to have in vitro parasite growth inhibitory activity of > 70% at 1:10 serum dilution; immuno-fluorescence titers.8,000; ELISA titers against full-length AMA1 > 300,000 and ELISA titer against AMA1 domains1+2 > 100,000. A negative correlation between log ELISA titer and day 11 cumulative parasitemia (Spearman rank r = 20.780, p value = 0.0001), further confirmed the relationship between antibody titer and protection. High titers of cross-strain inhibitory antibodies against AMA1 are therefore critical to confer solid protection, and the Aotus model can be used to down-select future AMA1 formulations, prior to advanced human trials.	[Dutta, Sheetij; Batchelor, Adrian H.] Walter Reed Army Inst Res, Dept Epitope Mapping, Silver Spring, MD USA; [Sullivan, JoAnn S.; Grady, Katharine K.; Collins, William E.; Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Atlanta, GA USA; [Soisson, Lorraine; Diggs, Carter L.] US Agcy Int Dev, Malaria Vaccine Dev Program, Washington, DC 20523 USA; [Haynes, J. David; Komisar, Jack; Heppner, D. Gray; Lanar, David E.] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Dutta, S (corresponding author), Walter Reed Army Inst Res, Dept Epitope Mapping, Silver Spring, MD USA.	sheetij.dutta@us.army.mil; wzb3@cdc.gov	Lanar, David E/B-3560-2011		U.S. Agency for International Development (USAID)	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding for this work was provided by U.S. Agency for International Development (USAID) Malaria Vaccine Development Program. Two of the authors on the paper, CLD and LS, are USAID representatives and were involved in the planning phase of this study.	Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; COLLINS WE, 1994, AM J TROP MED HYG, V51, P224, DOI 10.4269/ajtmh.1994.51.224; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Fandeur T, 1998, AM J TROP MED HYG, V58, P225, DOI 10.4269/ajtmh.1998.58.225; Hall Molly J., 2002, PTSD RES Q, V13, P1; Haynes J David, 2002, Methods Mol Med, V72, P535, DOI 10.1385/1-59259-271-6:535; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Izumiyama S, 2009, EXP PARASITOL, V121, P144, DOI 10.1016/j.exppara.2008.10.008; Kaneko O, 1999, EXP PARASITOL, V93, P116, DOI 10.1006/expr.1999.4441; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1999, INFECT IMMUN, V67, P43, DOI 10.1128/IAI.67.1.43-49.1999; Lehtoranta L, 2009, J VIROL METHODS, V159, P271, DOI 10.1016/j.jviromet.2009.04.015; Lynch MM, 2009, CLIN VACCINE IMMUNOL, V16, P293, DOI 10.1128/CVI.00230-08; Miura K, 2008, J IMMUNOL, V181, P8776, DOI 10.4049/jimmunol.181.12.8776; NAGATAKE T, 1992, AM J TROP MED HYG, V47, P614, DOI 10.4269/ajtmh.1992.47.614; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x	37	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8138	10.1371/journal.pone.0008138	http://dx.doi.org/10.1371/journal.pone.0008138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997632	gold, Green Submitted, Green Published			2022-12-25	WOS:000272829000002
J	Ronen, D; Rosenberg, MM; Shalev, DE; Rosenberg, M; Rotem, S; Friedler, A; Ravid, S				Ronen, Daniel; Rosenberg, Masha M.; Shalev, Deborah E.; Rosenberg, Michael; Rotem, Shahar; Friedler, Assaf; Ravid, Shoshana			The Positively Charged Region of the Myosin IIC Non-helical Tailpiece Promotes Filament Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ISOFORMS; CASEIN KINASE-II; NONMUSCLE MYOSIN; SMOOTH-MUSCLE; CELLULAR-LOCALIZATION; COILED-COIL; NMR-SPECTROSCOPY; PHOSPHORYLATION; ROD; CYTOKINESIS	The motor protein, non-muscle myosin II (NMII), must undergo dynamic oligomerization into filaments to participate in cellular processes such as cell migration and cytokinesis. A small non-helical region at the tail of the long coiled-coil region (tailpiece) is a common feature of all dynamically assembling myosin II proteins. In this study, we investigated the role of the tailpiece in NMII-C self-assembly. We show that the tailpiece is natively unfolded, as seen by circular dichroism and NMR experiments, and is divided into two regions of opposite charge. The positively charged region (Tailpiece(1946-1967)) starts at residue 1946 and is extended by seven amino acids at its N terminus from the traditional coiled-coil ending proline (Tailpiece(1953-1967)). Pull-down and sedimentation assays showed that the positive Tailpiece(1946-1967) binds to assembly incompetent NMII-C fragments inducing filament assembly. The negative region, residues 1968-2000, is responsible for NMII paracrystal morphology as determined by chimeras in which the negative region was swapped between the NMII isoforms. Mixing the positive and negative peptides had no effect on the ability of the positive peptide to bind and induce filament assembly. This study provides molecular insight into the role of the structurally disordered tailpiece of NMII-C in shifting the oligomeric equilibrium of NMII-C toward filament assembly and determining its morphology.	[Rosenberg, Masha M.; Rotem, Shahar; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Ravid, Shoshana] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Friedler, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Safra Campus, IL-91904 Jerusalem, Israel.	assaf@chem.ch.huji.ac.il; shoshr@ekmd.huji.ac.il	Shalev, Deborah E/AAY-2873-2021		Israel Ministry of Health [3114]; European Research Council	Israel Ministry of Health; European Research Council(European Research Council (ERC)European Commission)	This work was supported in part by Israel Ministry of Health Grant 3114 (to S. R.) and a starting grant from the European Research Council (to A. F.).	ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; ATKINSON SJ, 1991, J CELL SCI, V99, P823; Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KELLEY CA, 1990, J BIOL CHEM, V265, P17876; KENDRICKJONES J, 1971, J MOL BIOL, V59, P527, DOI 10.1016/0022-2836(71)90316-0; Kolega J, 1999, CELL MOTIL CYTOSKEL, V43, P255, DOI 10.1002/(SICI)1097-0169(1999)43:3<255::AID-CM8>3.0.CO;2-T; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Rovner AS, 2002, J CELL BIOL, V156, P113, DOI 10.1083/jcb.200107131; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sellers J. R., 1999, MYOSINS; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; SINARD JH, 1990, J CELL BIOL, V111, P2417, DOI 10.1083/jcb.111.6.2417; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; Straussman R, 2001, J CELL SCI, V114, P3047; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Turbedsky K, 2005, J MOL BIOL, V345, P351, DOI 10.1016/j.jmb.2004.10.049; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744	51	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7079	7086		10.1074/jbc.M109.049221	http://dx.doi.org/10.1074/jbc.M109.049221			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19959848	Green Published, hybrid			2022-12-25	WOS:000275415600021
J	Hamasaki-Katagiri, N; Ames, JB				Hamasaki-Katagiri, Nobuko; Ames, James B.			Neuronal Calcium Sensor-1 (Ncs1p) Is Up-regulated by Calcineurin to Promote Ca2+ Tolerance in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-HAND PROTEINS; P-TYPE ATPASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 4-KINASE; CA2+-BINDING PROTEINS; CRYSTAL-STRUCTURE; GUANYLYL CYCLASE; TRANSCRIPTIONAL REPRESSOR; 3-DIMENSIONAL STRUCTURE	Neuronal calcium sensor (NCS) proteins regulate signal transduction and are highly conserved from yeast to humans. NCS homolog in fission yeast (Ncs1p) is essential for cell growth under extreme Ca2+ conditions. Ncs1p expression increases similar to 100-fold when fission yeast grows in high extracellular Ca2+ (>0.1 M). Here, we show that Ca2+-induced expression of Ncs1p is controlled at the level of transcription. Transcriptional reporter assays show that ncs1 promoter activity increased 30-fold when extracellular Ca2+ was raised to 0.1 M and was highly Ca2+-specific. Ca2+-dependent transcription of ncs1 is abolished by the calcineurin inhibitor (FK506) and by knocking out the calcineurin target, prz1. Thus, Ca2+-induced expression of Ncs1p is linked to the calcineurin/prz1 stress response. The Ca2+-responsive ncs1 promoter region consists of 130 nucleotides directly upstream from the start codon and contains tandem repeats of the sequence, 5'-caact-3', that binds to Prz1p. The Ca2+-sensitive ncs1 Delta phenotype is rescued by a yam8 null mutation, suggesting a possible interaction between Ncs1p and the Ca2+ channel, Yam8p. Ca2+ uptake and Ncs1p binding to yeast membranes are both decreased in yam8 Delta, suggesting Ca2+-induced binding of Ncs1p to Yam8p results in channel closure. We propose that Ncs1p promotes Ca2+ tolerance in fission yeast, in part by cytosolic Ca2+ buffering and perhaps by negatively regulating the Yam8p Ca2+ channel.	[Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Hamasaki-Katagiri, Nobuko] Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA	University of California System; University of California Davis; University System of Maryland; University of Maryland Baltimore	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu			National Institutes of Health [EY012347, NS059969]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS059969 (to J. B. A.).	Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Carnero E, 2000, MOL GEN GENET, V264, P173, DOI 10.1007/s004380000318; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Catty P, 1996, BIOSCIENCE REP, V16, P75, DOI 10.1007/BF01206198; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; DAVIS TN, 1995, ADV SEC MESS PHOSPH, V30, P339; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; EILAM Y, 1987, J GEN MICROBIOL, V133, P1641; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; ESCHER A, 1989, P NATL ACAD SCI USA, V86, P6528, DOI 10.1073/pnas.86.17.6528; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Furune T, 2008, GENES GENET SYST, V83, P373, DOI 10.1266/ggs.83.373; GHISLAIN M, 1990, J BIOL CHEM, V265, P18400; HALACHMI D, 1992, EUR J BIOCHEM, V207, P1003, DOI 10.1111/j.1432-1033.1992.tb17136.x; Hamasaki-Katagiri N, 2004, J BIOL CHEM, V279, P12744, DOI 10.1074/jbc.M311895200; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; HIDAKA H, 1993, NEUROSCI RES, V16, P73, DOI 10.1016/0168-0102(93)90074-Z; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; IIDA H, 1990, J BIOL CHEM, V265, P13391; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; Maeda T, 2004, GENES CELLS, V9, P71, DOI 10.1111/j.1356-9597.2004.00699.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser MJ, 1997, J CELL SCI, V110, P1805; Moser NJ, 1996, MOL CELL BIOL, V16, P4824; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Okorokov LA, 2001, FEBS LETT, V505, P321, DOI 10.1016/S0014-5793(01)02852-6; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Tasaka Y, 2000, BIOCHEM BIOPH RES CO, V269, P265, DOI 10.1006/bbrc.2000.2278; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	76	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4405	4414		10.1074/jbc.M109.058594	http://dx.doi.org/10.1074/jbc.M109.058594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018864	Green Published, hybrid			2022-12-25	WOS:000275274800017
J	Ooshio, T; Kobayashi, R; Ikeda, W; Miyata, M; Fukumoto, Y; Matsuzawa, N; Ogita, H; Takai, Y				Ooshio, Takako; Kobayashi, Reiko; Ikeda, Wataru; Miyata, Muneaki; Fukumoto, Yuri; Matsuzawa, Naomi; Ogita, Hisakazu; Takai, Yoshimi			Involvement of the Interaction of Afadin with ZO-1 in the Formation of Tight Junctions in Madin-Darby Canine Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; EPITHELIAL-CELLS; ADHESION MOLECULE; E-CADHERIN; DIRECT BINDING; ALPHA-CATENIN; MDCK CELLS; NECTIN; ORGANIZATION; PROTEIN	Tight junctions (TJs) and adherens junctions (AJs) are major junctional apparatuses in epithelial cells. Claudins and junctional adhesion molecules (JAMs) are major cell adhesion molecules (CAMs) at TJs, whereas cadherins and nectins are major CAMs at AJs. Claudins and JAMs are associated with ZO proteins, whereas cadherins are associated with beta-and alpha-catenins, and nectins are associated with afadin. We previously showed that nectins first form cell-cell adhesions where the cadherin-catenin complex is recruited to form AJs, followed by the recruitment of the JAM-ZO and claudin-ZO complexes to the apical side of AJs to form TJs. It is not fully understood how TJ components are recruited to the apical side of AJs. We studied the roles of afadin and ZO-1 in the formation of TJs in Madin-Darby canine kidney (MDCK) cells. Before the formation of TJs, ZO-1 interacted with afadin through the two proline-rich regions of afadin and the SH3 domain of ZO-1. During and after the formation of TJs, ZO-1 dissociated from afadin and associated with JAM-A. Knockdown of afadin impaired the formation of both AJs and TJs in MDCK cells, whereas knockdown of ZO-1 impaired the formation of TJs, but not AJs. Re-expression of full-length afadin restored the formation of both AJs and TJs in afadin-knockdown MDCK cells, whereas re-expression of afadin-Delta PR1-2, which is incapable of binding to ZO-1, restored the formation of AJs, but not TJs. These results indicate that the transient interaction of afadin with ZO-1 is necessary for the formation of TJs in MDCK cells.	[Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ooshio, Takako] Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	Kobe University; Osaka University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020; Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058; Ooshio, Takako/0000-0001-6508-8152; Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Hyogo Science and Technology Association	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association	This work was supported by a grant-in-aid for scientific research and for Cancer Research and by Targeted Proteins Research Program ( TPRP) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2007-2009), and by Hyogo Science and Technology Association.	Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Okamoto R, 2005, GENES CELLS, V10, P435, DOI 10.1111/j.1365-2443.2005.00846.x; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Yagi T, 2000, GENE DEV, V14, P1169; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yamada A, 2005, J BIOL CHEM, V280, P6016, DOI 10.1074/jbc.M408215200; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; YONEMURA S, 1995, J CELL SCI, V108, P127	44	86	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5003	5012		10.1074/jbc.M109.043760	http://dx.doi.org/10.1074/jbc.M109.043760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20008323	Green Published, hybrid			2022-12-25	WOS:000275274800077
J	Abulrob, A; Lu, ZF; Baumann, E; Vobornik, D; Taylor, R; Stanimirovic, D; Johnston, LJ				Abulrob, Abedelnasser; Lu, Zhengfang; Baumann, Ewa; Vobornik, Dusan; Taylor, Rod; Stanimirovic, Danica; Johnston, Linda J.			Nanoscale Imaging of Epidermal Growth Factor Receptor Clustering EFFECTS OF INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCANNING OPTICAL MICROSCOPY; EGF RECEPTOR; CELL-SURFACE; FLUORESCENCE MICROSCOPY; LIPID RAFTS; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; FIELD; ORGANIZATION; ACTIVATION	The development of some solid tumors is associated with overexpression of the epidermal growth factor receptor (EGFR) and often correlates with poor prognosis. Near field scanning optical microscopy, a technique with subdiffraction-limited optical resolution, was used to examine the influence of two inhibitors (the chimeric 225 antibody and tyrosine phosphorylation inhibitor AG1478) on the nanoscale clustering of EGFR in HeLa cells. The EGFR is organized in small clusters, average diameter of 150 nm, on the plasma membrane for both control and EGF-treated cells. The numbers of receptors in individual clusters vary from as few as one or two proteins to greater than 100. Both inhibitors yield an increased cluster density and an increase in the fraction of clusters with smaller diameters and fewer receptors. Exposure to AG1478 also decreases the fraction of EGFR that colocalizes with both rafts and caveolae. EGF stimulation results in a significant loss of the full-length EGFR from the plasma membrane with the concomitant appearance of low molecular mass proteolytic products. By contrast, AG1478 reduces the level of EGFR degradation. Changes in receptor clustering provide one mechanism for regulating EGFR signaling and are relevant to the design of strategies for therapeutic interventions based on modulating EGFR signaling.	[Abulrob, Abedelnasser; Baumann, Ewa; Stanimirovic, Danica] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R5, Canada; [Lu, Zhengfang; Vobornik, Dusan; Taylor, Rod; Johnston, Linda J.] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R5, Canada	National Research Council Canada; National Research Council Canada	Abulrob, A (corresponding author), Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R5, Canada.	Abedelnasser.Abulrob@nrc.gc.ca; Linda.Johnston@nrc-cnrc.gc.ca		Johnston, Linda/0000-0002-9136-4920	Canadian Institute for Photonics Innovation	Canadian Institute for Photonics Innovation	This work was supported in part by a grant from the Canadian Institute for Photonics Innovation (to L.J.J., D.V., and R.T.).	Abulrob A, 2008, J MICROSC-OXFORD, V232, P225, DOI 10.1111/j.1365-2818.2008.02093.x; Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Alexander A., 1998, FRONT BIOSCI-LANDMRK, V3, pD729, DOI [10.1101/cshperspect.a017459, DOI 10.1101/CSHPERSPECT.A017459]; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Chen Y, 2008, J LIPID RES, V49, P2268, DOI 10.1194/jlr.D800031-JLR200; Ciardiello F, 1998, CLIN CANCER RES, V4, P821; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; de Bakker BI, 2007, CHEMPHYSCHEM, V8, P1473, DOI 10.1002/cphc.200700169; de Bakker BI, 2008, J CELL SCI, V121, P627, DOI 10.1242/jcs.019513; Dunn RC, 1999, CHEM REV, V99, P2891, DOI 10.1021/cr980130e; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; El-Rayes BF, 2004, BRIT J CANCER, V91, P418, DOI 10.1038/sj.bjc.6601921; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; GULLICK WJ, 1986, CANCER RES, V46, P285; Gumbleton M, 2000, PHARM RES-DORDR, V17, P1035, DOI 10.1023/A:1026464526074; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Hoppener C, 2005, BIOPHYS J, V88, P3681, DOI 10.1529/biophysj.104.051458; Hoppener C, 2008, NANO LETT, V8, P642, DOI 10.1021/nl073057t; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Ianoul A, 2004, BIOPHYS J, V87, P3525, DOI [10.1529/biophysj.104.046383, 10.1529/biophysj.104.046393]; Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Jia CL, 2007, BIOELECTROMAGNETICS, V28, P197, DOI 10.1002/bem.20293; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lewis A, 2003, NAT BIOTECHNOL, V21, P1377, DOI 10.1038/nbt898; Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; MURAKAMI Y, 1994, BIOCHEM J, V301, P63, DOI 10.1042/bj3010063; Nagy P, 1999, J CELL SCI, V112, P1733; Ness GO, 1996, INT J CANCER, V65, P161, DOI 10.1002/(SICI)1097-0215(19960117)65:2<161::AID-IJC6>3.0.CO;2-X; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Xiao ZY, 2008, BIOCHEM BIOPH RES CO, V369, P730, DOI 10.1016/j.bbrc.2008.02.084; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yu CX, 2009, BIOCHEM BIOPH RES CO, V378, P376, DOI 10.1016/j.bbrc.2008.11.018	52	71	73	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3145	3156		10.1074/jbc.M109.073338	http://dx.doi.org/10.1074/jbc.M109.073338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19959837	Green Published, hybrid			2022-12-25	WOS:000273829000030
J	Weng, JW; Fan, KN; Wang, WN				Weng, Jing-Wei; Fan, Kang-Nian; Wang, Wen-Ning			The Conformational Transition Pathway of ATP Binding Cassette Transporter MsbA Revealed by Atomistic Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; RESTING-STATE CONFORMATION; ESCHERICHIA-COLI MSBA; ABC TRANSPORTER; NUCLEOTIDE-BINDING; MULTIDRUG TRANSPORTER; MALTOSE TRANSPORTER; ALTERNATING ACCESS; STRUCTURAL BASIS; P-GLYCOPROTEIN	ATP binding cassette transporters are integral membrane proteins that use the energy released from ATP hydrolysis at the two nucleotide binding domains (NBDs) to translocate a wide variety of substrates through a channel at the two transmembrane domains (TMDs) across the cell membranes. MsbA from Gram-negative bacteria is a lipid and multidrug resistance ATP binding cassette exporter that can undergo large scale conformational changes between the outward-facing and the inward-facing conformations revealed by crystal structures in different states. Here, we use targeted molecular dynamics simulation methods to explore the atomic details of the conformational transition from the outward-facing to the inward-facing states of MsbA. The molecular dynamics trajectories revealed a clear spatiotemporal order of the conformational movements. The disruption of the nucleotide binding sites at the NBD dimer interface is the very first event that initiates the following conformational changes, verifying the assumption that the conformational conversion is triggered by ATP hydrolysis. The conserved x-loops of the NBDs were identified to participate in the interaction network that stabilizes the cytoplasmic tetrahelix bundle of the TMDs and play an important role in mediating the cross-talk between the NBD and TMD. The movement of the NBD dimer is transmitted through x-loops to break the tetrahelix bundle, inducing the packing rearrangements of the transmembrane helices at the cytoplasmic side and the periplasmic side sequentially. The packing rearrangement within each periplasmic wing of TMD that results in exposure of the substrate binding sites occurred at the end stage of the trajectory, preventing the wrong timing of the binding site accessibility.	[Wang, Wen-Ning] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Key Lab Mol Catalysis & Innovat Mat, Dept Chem, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, WN (corresponding author), 220 Handan Rd, Shanghai 200433, Peoples R China.	wnwang@fudan.edu.cn	Fan, K/GXH-3734-2022		National High Technology Research Program of China [2006AA02A320]; National Major Basic Research Program of China [2009CB918600, 2009ZX09301-011]; National Science Foundation of China [20973040]; Science and Technology Commission of Shanghai Municipality [08DZ2270500]; Shanghai Leading Academic Discipline [B108]	National High Technology Research Program of China(National High Technology Research and Development Program of China); National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	This work was supported by National High Technology Research Program of China Grant 2006AA02A320, National Major Basic Research Program of China Grants 2009CB918600 and 2009ZX09301-011, National Science Foundation of China Grant 20973040, Science and Technology Commission of Shanghai Municipality Grant 08DZ2270500, and Shanghai Leading Academic Discipline Project B108.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Apostolakis J, 1999, J CHEM PHYS, V110, P2099, DOI 10.1063/1.477819; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Buchaklian AH, 2006, BIOCHEMISTRY-US, V45, P12539, DOI 10.1021/bi060830a; Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Choe S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1940048; Compoint M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1869413; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Grottesi A, 2005, BIOCHEMISTRY-US, V44, P14586, DOI 10.1021/bi0510429; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kong YF, 2002, P NATL ACAD SCI USA, V99, P5999, DOI 10.1073/pnas.092051099; Law RJ, 2008, BIOPHYS J, V95, P2739, DOI 10.1529/biophysj.107.128025; Law RJ, 2003, BIOPHYS J, V84, P14, DOI 10.1016/S0006-3495(03)74829-2; LING V, 1992, CANCER-AM CANCER SOC, V69, P2603, DOI 10.1002/1097-0142(19920515)69:10<2603::AID-CNCR2820691034>3.0.CO;2-E; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Moussatova A, 2008, BBA-BIOMEMBRANES, V1778, P1757, DOI 10.1016/j.bbamem.2008.06.009; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Sonne J, 2007, BIOPHYS J, V92, P2727, DOI 10.1529/biophysj.106.097972; Swift RV, 2008, BIOCHEMISTRY-US, V47, P4102, DOI 10.1021/bi8000209; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; van der Vaart A, 2004, BIOPHYS J, V87, P562, DOI 10.1529/biophysj.103.037333; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2008, BIOPHYS J, V95, P5100, DOI 10.1529/biophysj.108.139444; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	64	48	49	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3053	10.1074/jbc.M109.056432	http://dx.doi.org/10.1074/jbc.M109.056432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996093	Green Published, hybrid			2022-12-25	WOS:000273829000021
J	Teschendorff, AE; Menon, U; Gentry-Maharaj, A; Ramus, SJ; Gayther, SA; Apostolidou, S; Jones, A; Lechner, M; Beck, S; Jacobs, IJ; Widschwendter, M				Teschendorff, Andrew E.; Menon, Usha; Gentry-Maharaj, Aleksandra; Ramus, Susan J.; Gayther, Simon A.; Apostolidou, Sophia; Jones, Allison; Lechner, Matthias; Beck, Stephan; Jacobs, Ian J.; Widschwendter, Martin			An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; GENE-EXPRESSION; HUMAN COLON; DNA; METHYLATION; PROFILES; CELLS; HYPERMETHYLATION; NEUTROPHILS; MARKER	Background: Recent studies have shown that DNA methylation (DNAm) markers in peripheral blood may hold promise as diagnostic or early detection/risk markers for epithelial cancers. However, to date no study has evaluated the diagnostic and predictive potential of such markers in a large case control cohort and on a genome-wide basis. Principal Findings: By performing genome-wide DNAm profiling of a large ovarian cancer case control cohort, we here demonstrate that active ovarian cancer has a significant impact on the DNAm pattern in peripheral blood. Specifically, by measuring the methylation levels of over 27,000 CpGs in blood cells from 148 healthy individuals and 113 age-matched pretreatment ovarian cancer cases, we derive a DNAm signature that can predict the presence of active ovarian cancer in blind test sets with an AUC of 0.8 (95% CI (0.74-0.87)). We further validate our findings in another independent set of 122 posttreatment cases (AUC = 0.76 (0.72-0.81)). In addition, we provide evidence for a significant number of candidate risk or early detection markers for ovarian cancer. Furthermore, by comparing the pattern of methylation with gene expression data from major blood cell types, we here demonstrate that age and cancer elicit common changes in the composition of peripheral blood, with a myeloid skewing that increases with age and which is further aggravated in the presence of ovarian cancer. Finally, we show that most cancer and age associated methylation variability is found at CpGs located outside of CpG islands. Significance: Our results underscore the potential of DNAm profiling in peripheral blood as a tool for detection or risk-prediction of epithelial cancers, and warrants further in-depth and higher CpG coverage studies to further elucidate this role.	[Teschendorff, Andrew E.; Beck, Stephan] UCL, Med Genom Grp, Inst Canc, London, England; [Menon, Usha; Gentry-Maharaj, Aleksandra; Ramus, Susan J.; Gayther, Simon A.; Apostolidou, Sophia; Jones, Allison; Lechner, Matthias; Jacobs, Ian J.; Widschwendter, Martin] UCL, Dept Gynecol Oncol, Elizabeth Garrett Anderson Inst Womens Hlth, London, England	University of London; University College London; University of London; University College London	Teschendorff, AE (corresponding author), UCL, Med Genom Grp, Inst Canc, London, England.	a.teschendorff@ucl.ac.uk; m.widschwendter@ucl.ac.uk	Menon, Usha/C-4716-2008; Jacobs, Ian J/F-1743-2013; Ramus, Susan/AAG-8352-2019	Menon, Usha/0000-0003-3708-1732; Jacobs, Ian J/0000-0002-8112-4624; Ramus, Susan/0000-0003-0005-7798; Gentry-Maharaj, Alex/0000-0001-7270-9762; Apostolidou, Sophia/0000-0003-2659-0451; Widschwendter, Martin/0000-0002-7778-8380; Jacobs, Ian/0000-0002-5005-2672	Department of Health, National Institute for Health (NIHR), Biomedical Research Centres; Heller Research Fellowship; Wellcome Trust	Department of Health, National Institute for Health (NIHR), Biomedical Research Centres(National Institute for Health Research (NIHR)); Heller Research Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Eve Appeal and undertaken at University College London Hospital (UCLH)/University College London (UCL) which received a proportion of funding from the Department of Health, National Institute for Health (NIHR), Biomedical Research Centres funding scheme. AET was supported by a Heller Research Fellowship. AET wishes to thank Michael and Morven Heller for the Heller Research Fellowship. SB was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balz V, 2002, CANCER GENET CYTOGEN, V138, P120, DOI 10.1016/S0165-4608(02)00601-5; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Christensen BC, 2009, CANCER RES, V69, P227, DOI 10.1158/0008-5472.CAN-08-2586; Cooney CA, 2007, DIS MARKERS, V23, P121, DOI 10.1155/2007/394034; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2008, P NATL ACAD SCI USA, V105, P18718, DOI 10.1073/pnas.0808709105; Meng HL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-457; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pauler DK, 2001, CANCER EPIDEM BIOMAR, V10, P489; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Quaye L, 2009, BRIT J CANCER, V100, P993, DOI 10.1038/sj.bjc.6604947; R Development Core Team, 2009, R FDN STAT COMP; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; SATOMI A, 1995, ACTA ONCOL, V34, P69, DOI 10.3109/02841869509093641; Stirewalt DL, 2009, LEUKEMIA, V23, P391, DOI 10.1038/leu.2008.176; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TESCHENDORFF AE, AGE DEPENDENT UNPUB; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; WEISENBERGER D, 2008, COMPREHENSIVE DNA ME; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977	43	246	254	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8274	10.1371/journal.pone.0008274	http://dx.doi.org/10.1371/journal.pone.0008274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20019873	Green Submitted, Green Published, gold			2022-12-25	WOS:000272870600004
J	Perne, A; Muellner, MK; Steinrueck, M; Craig-Mueller, N; Mayerhofer, J; Schwarzinger, I; Sloane, M; Uras, IZ; Hoermann, G; Nijman, SMB; Mayerhofer, M				Perne, Andrea; Muellner, Markus K.; Steinrueck, Magdalena; Craig-Mueller, Nils; Mayerhofer, Julia; Schwarzinger, Ilse; Sloane, Mathew; Uras, Iris Z.; Hoermann, Gregor; Nijman, Sebastian M. B.; Mayerhofer, Matthias			Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis	PLOS ONE			English	Article							BREAST-CANCER; DIDEMNIN-B; EXPRESSION; POTASSIUM; DIGITALIS; CARCINOMA; OUABAIN; FIBROBLASTS; MECHANISMS; DIGITOXIN	Background: Cardiac glycosides are Na+/K+-pump inhibitors widely used to treat heart failure. They are also highly cytotoxic, and studies have suggested specific anti-tumor activity leading to current clinical trials in cancer patients. However, a definitive demonstration of this putative anti-cancer activity and the underlying molecular mechanism has remained elusive. Methodology/Principal Findings: Using an unbiased transcriptomics approach, we found that cardiac glycosides inhibit general protein synthesis. Protein synthesis inhibition and cytotoxicity were not specific for cancer cells as they were observed in both primary and cancer cell lines. These effects were dependent on the Na+/K+-pump as they were rescued by expression of a cardiac glycoside-resistant Na+/K+-pump. Unlike human cells, rodent cells are largely resistant to cardiac glycosides in vitro and mice were found to tolerate extremely high levels. Conclusions/Significance: The physiological difference between human and mouse explains the previously observed sensitivity of human cancer cells in mouse xenograft experiments. Thus, published mouse xenograft models used to support anti-tumor activity for these drugs require reevaluation. Our finding that cardiac glycosides inhibit protein synthesis provides a mechanism for the cytotoxicity of CGs and raises concerns about ongoing clinical trials to test CGs as anti-cancer agents in humans.	[Perne, Andrea; Steinrueck, Magdalena; Mayerhofer, Julia; Schwarzinger, Ilse; Hoermann, Gregor; Mayerhofer, Matthias] Med Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria; [Muellner, Markus K.; Craig-Mueller, Nils; Sloane, Mathew; Uras, Iris Z.; Nijman, Sebastian M. B.] Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria	Medical University of Vienna; Austrian Academy of Sciences	Perne, A (corresponding author), Med Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria.	snijman@cemm.oeaw.at; matthias.mayerhofer@meduniwien.ac.at	Uras, Iris/AAH-2221-2021; Hoermann, Gregor/B-8832-2016	Hoermann, Gregor/0000-0002-7374-4380; Uras, Iris/0000-0002-2434-2756	Austrian Society of Laboratory Medicine and Clinical Chemistry	Austrian Society of Laboratory Medicine and Clinical Chemistry	Parts of this study were supported by a grant from the Austrian Society of Laboratory Medicine and Clinical Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2205; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; ANTECOL MH, 1986, CANCER RES, V46, P1867; CAHN F, 1978, J BIOL CHEM, V253, P7798; CAIN JM, 1992, INVEST NEW DRUG, V10, P23, DOI 10.1007/BF01275473; CATIMEL G, 1995, CANCER CHEMOTH PHARM, V35, P246, DOI 10.1007/BF00686555; Dresser MJ, 2000, DRUG METAB DISPOS, V28, P1135; EMANUEL JR, 1988, J BIOL CHEM, V263, P7726; ENNIS HL, 1961, BIOCHIM BIOPHYS ACTA, V50, P399, DOI 10.1016/0006-3002(61)90355-9; Ewertz M, 2001, ACTA ONCOL, V40, P467, DOI 10.1080/028418601750288181; Figlin RA, 2008, J NATL COMPR CANC S5, V6, pS21; Figlin Robert A, 2008, J Natl Compr Canc Netw, V6 Suppl 5, pS1; GOLDIN AG, 1984, LANCET, V1, P1134; Han KQ, 2007, WORLD J GASTROENTERO, V13, P3374, DOI 10.3748/wjg.v13.i24.3374; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; INADA A, 1993, BIOL PHARM BULL, V16, P930, DOI 10.1248/bpb.16.930; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lefranc F, 2008, NEOPLASIA, V10, P198, DOI 10.1593/neo.07928; LEVINE H, 1966, NATURE, V211, P1302, DOI 10.1038/2111302a0; LUBIN M, 1964, BIOCHIM BIOPHYS ACTA, V80, P614, DOI 10.1016/0926-6550(64)90306-8; LYNCH DAF, 1994, J CLIN PATHOL, V47, P122, DOI 10.1136/jcp.47.2.122; MANKOVITZ R, 1974, CELL, V3, P221, DOI 10.1016/0092-8674(74)90135-4; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Mijatovic T, 2008, NEOPLASIA, V10, P573, DOI 10.1593/neo.08290; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prassas I, 2008, CLIN CANCER RES, V14, P5778, DOI 10.1158/1078-0432.CCR-08-0706; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Siewert E, 1999, EUR J BIOCHEM, V265, P251, DOI 10.1046/j.1432-1327.1999.00719.x; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Stenkvist B, 1999, ONCOL REP, V6, P493; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; Svensson A, 2005, ANTICANCER RES, V25, P207; TABOULET P, 1993, J TOXICOL-CLIN TOXIC, V31, P247, DOI 10.3109/15563659309000392; TAYLOR SA, 1992, INVEST NEW DRUG, V10, P55, DOI 10.1007/BF01275484; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; WRIGHT JC, 1955, ARCH INTERN MED, V96, P61, DOI 10.1001/archinte.1955.04430010075008; Zavareh RB, 2008, CANCER RES, V68, P6688, DOI 10.1158/0008-5472.CAN-07-6833; ZHANG H, 2008, P NATL ACAD SCI US	43	63	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8292	10.1371/journal.pone.0008292	http://dx.doi.org/10.1371/journal.pone.0008292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016840	gold, Green Submitted, Green Published			2022-12-25	WOS:000272834000011
J	Wang, SJ; Xin, FX; Liu, XY; Wang, YX; An, ZY; Qi, QS; Wang, PG				Wang, Shengjun; Xin, Fengxue; Liu, Xiaoyue; Wang, Yuxiao; An, Zhenyi; Qi, Qingsheng; Wang, Peng George			N-Terminal Deletion of Peptide: N-Glycanase Results in Enhanced Deglycosylation Activity	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTION; CYTOPLASMIC PEPTIDE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; YEAST PEPTIDE; 2-DIMENSIONAL GEL; QUALITY-CONTROL; GLYCOPROTEINS; COMPLEX; OLIGOSACCHARIDES	Peptide:N-glycanase catalyzes the detachment of N-linked glycan chains from glycopeptides or glycoproteins by hydrolyzing the beta-aspartylglucosaminyl bond. Peptide:N-glycanase in yeast binds to Rad23p through its N-terminus. In this study, the complex formed between Peptide:N-glycanase and Rad23p was found to exhibit enhanced deglycosylation activity, which suggests an important role for this enzyme in the misfolded glycoprotein degradation pathway in vivo. To investigate the role of this enzyme in this pathway, we made stepwise deletions of the N-terminal helices of peptide: N-glycanase. Enzymatic analysis of the deletion mutants showed that deletion of the N-terminal H1 helix (Png1p-Delta H1) enhanced the deglycosylation activity of N-glycanase towards denatured glycoproteins. In addition, this mutant exhibited high deglycosylation activity towards native glycoproteins. Dynamic simulations of the wild type and N-terminal H1 deletion mutant implied that Png1p-Delta H1 is more flexible than wild type Png1p. The efficient deglycosylation of Png1p-Delta H1 towards native and non-native glycoproteins offers a potential biotechnological application.	[Wang, Shengjun; Xin, Fengxue; Liu, Xiaoyue; Wang, Yuxiao; An, Zhenyi; Qi, Qingsheng; Wang, Peng George] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Qi, Qingsheng; Wang, Peng George] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Wang, SJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	qiqingsheng@sdu.edu.cn	WANG, Peng/GSN-5263-2022; Qi, Qingsheng/F-7418-2013		National Natural Science Foundation of China [30870022]; Foundation for Excellent Young Scholars in Shandong Province of China [2006BS02011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scholars in Shandong Province of China	This work was financially supported by a grant from the National Natural Science Foundation of China (30870022) and Foundation for Excellent Young Scholars in Shandong Province of China (2006BS02011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSOMIAN GD, 1990, J BIOL CHEM, V265, P6967; Biswas S, 2004, BIOCHEM BIOPH RES CO, V323, P149, DOI 10.1016/j.bbrc.2004.08.061; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Charlwood J, 2000, ANAL BIOCHEM, V284, P49, DOI 10.1006/abio.2000.4687; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; He ZC, 2006, BIOCHEM BIOPH RES CO, V343, P496, DOI 10.1016/j.bbrc.2006.03.007; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Jett M, 1971, J Biol Chem, V246, P3686; Joshi S, 2005, FEBS LETT, V579, P823, DOI 10.1016/j.febslet.2004.12.060; Kamoda S, 2006, J CHROMATOGR A, V1106, P67, DOI 10.1016/j.chroma.2005.08.052; Katiyar S, 2002, J BIOL CHEM, V277, P12953, DOI 10.1074/jbc.M111383200; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Su Yi-Shan, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P911; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V302, P1, DOI 10.1016/S0006-291X(03)00052-4; Suzuki T, 2001, BIOCHEM BIOPH RES CO, V287, P1083, DOI 10.1006/bbrc.2001.5688; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; Suzuki T, 2006, J BIOL CHEM, V281, P22152, DOI 10.1074/jbc.M603236200; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wang SJ, 2007, ACTA BIOCH BIOPH SIN, V39, P8, DOI 10.1111/j.1745-7270.2007.00244.x; Xin FX, 2008, BIOCHEM BIOPH RES CO, V368, P907, DOI 10.1016/j.bbrc.2008.02.017; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; ZHAO G, 2008, GLYCOBIOLOGY; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	39	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8335	10.1371/journal.pone.0008335	http://dx.doi.org/10.1371/journal.pone.0008335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016784	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834000021
J	Garcia, V; Garcia, JM; Silva, J; Martin, P; Pena, C; Dominguez, G; Diaz, R; Herrera, M; Maximiano, C; Sabin, P; Rueda, A; Cruz, MA; Rodriguez, J; Canales, MA; Bonilla, F; Provencio, M				Garcia, Vanesa; Miguel Garcia, Jose; Silva, Javier; Martin, Paloma; Pena, Cristina; Dominguez, Gemma; Diaz, Raquel; Herrera, Mercedes; Maximiano, Constanza; Sabin, Pilar; Rueda, Antonio; Angel Cruz, Miguel; Rodriguez, Jose; Angel Canales, Miguel; Bonilla, Felix; Provencio, Mariano			Extracellular Tumor-Related mRNA in Plasma of Lymphoma Patients and Survival Implications	PLOS ONE			English	Article							B-CELL LYMPHOMA; BREAST-CANCER PATIENTS; HODGKINS-LYMPHOMA; DNA; BIOMARKERS; DISEASE	Background: We studied anomalous extracellular mRNAs in plasma from patients with diffuse large B-cell lymphoma (DLBCL) and their survival implications. mRNAs studied have been reported in the literature as markers of poor (BCL2, CCND2, MYC) and favorable outcome (LMO2, BCL6, FN1) in tumors. These markers were also analyzed in lymphoma tissues to test possible associations with their presence in plasma. Methodology/Principal Findings: mRNA from 42 plasma samples and 12 tumors from patients with DLBCL was analyzed by real-time PCR. Samples post-treatment were studied. The immunohistochemistry of BCL2 and BCL6 was defined. Presence of circulating tumor cells was determined by analyzing the clonality of the immunoglobulin heavy-chain genes by PCR. In DLBCL, MYC mRNA was associated with short overall survival. mRNA targets with unfavorable outcome in tumors were associated with characteristics indicative of poor prognosis, with partial treatment response and with short progression-free survival in patients with complete response. In patients with low IPI score, unfavorable mRNA targets were related to shorter overall survival, partial response, high LDH levels and death. mRNA disappeared in post-treatment samples of patients with complete response, and persisted in those with partial response or death. No associations were found between circulating tumor cells and plasma mRNA. Absence of BCL6 protein in tumors was associated with presence of unfavorable plasma mRNA. Conclusions/Significance: Through a non-invasive procedure, tumor-derived mRNAs can be obtained in plasma. mRNA detected in plasma did not proceed from circulating tumor cells. In our study, unfavorable targets in plasma were associated with poor prognosis in B-cell lymphomas, mainly MYC mRNA. Moreover, the unfavorable targets in plasma could help us to classify patients with poor outcome within the good prognosis group according to IPI.	[Garcia, Vanesa; Miguel Garcia, Jose; Silva, Javier; Pena, Cristina; Dominguez, Gemma; Diaz, Raquel; Herrera, Mercedes; Maximiano, Constanza; Bonilla, Felix] Puerta de Hierro Univ Hosp, Dept Med Oncol, Madrid, Spain; [Martin, Paloma] Puerta de Hierro Univ Hosp, Dept Mol Pathol, Madrid, Spain; [Sabin, Pilar; Rodriguez, Jose] Gregorio Maranon Hosp, Dept Med Oncol, Madrid, Spain; [Rueda, Antonio] Virgen Victoria Hosp, Dept Med Oncol, Malaga, Spain; [Angel Cruz, Miguel] Virgen Salud Hosp, Dept Med Oncol, Toledo, Spain; [Angel Canales, Miguel] Hosp La Paz, Dept Hematol, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; General University Gregorio Maranon Hospital; Hospital Universitario La Paz	Garcia, V (corresponding author), Puerta de Hierro Univ Hosp, Dept Med Oncol, Madrid, Spain.	fbonilla.hpth@salud.madrid.org; mprovencio.hpth@salud.madrid.org	Acosta, Paloma Martin/AAF-7998-2021; Canales, Miguel Angel/GPC-7039-2022; Canales, Miguel/AAA-3647-2020; Provencio, Mariano/ABE-8586-2020; Alonso, Constanza Maximiano/AAE-9102-2021	Acosta, Paloma Martin/0000-0002-3274-4595; Canales, Miguel Angel/0000-0002-6550-2621; Provencio, Mariano/0000-0001-9053-9197; Alonso, Constanza Maximiano/0000-0002-4051-3965; Provencio Pulla, Mariano/0000-0001-6315-7919; DIAZ MARTINEZ, RAQUEL/0000-0001-9748-3464; Garcia-Barberan, Vanesa/0000-0002-2531-0203	Instituto de Salud Carlos III [(FIS)-PI04/0053, (RETIC) RD06/0020/0020]; MICINN (SAF) [2004-01002, SAF 2007-60214]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MICINN (SAF)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by the following grants: Instituto de Salud Carlos III (FIS)-PI04/0053 and (RETIC) RD06/0020/0020; MICINN (SAF) 2004-01002 and SAF 2007-60214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dasi F, 2001, LAB INVEST, V81, P767, DOI 10.1038/labinvest.3780285; Frickhofen N, 1997, BLOOD, V90, P4953, DOI 10.1182/blood.V90.12.4953.4953_4953_4960; Gandhi MK, 2006, CLIN CANCER RES, V12, P460, DOI 10.1158/1078-0432.CCR-05-2008; Garcia JM, 2006, GENE CHROMOSOME CANC, V45, P692, DOI 10.1002/gcc.20334; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; Garcia V, 2008, CANCER LETT, V263, P312, DOI 10.1016/j.canlet.2008.01.008; Lossos IS, 2006, J CLIN ONCOL, V24, P995, DOI 10.1200/JCO.2005.02.4786; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Seki R, 2009, CANCER SCI, V100, P1842, DOI 10.1111/j.1349-7006.2009.01268.x; SHAPIRO B, 1983, CANCER, V51, P2116, DOI 10.1002/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tibiletti MG, 2009, HUM PATHOL, V40, P645, DOI 10.1016/j.humpath.2008.06.032; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202	17	19	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8173	10.1371/journal.pone.0008173	http://dx.doi.org/10.1371/journal.pone.0008173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016842	Green Submitted, Green Published, gold			2022-12-25	WOS:000272833800002
J	Joppa, LN; Pfaff, A				Joppa, Lucas N.; Pfaff, Alexander			High and Far: Biases in the Location of Protected Areas	PLOS ONE			English	Article							TROPICAL FORESTS; GAP ANALYSIS; BIODIVERSITY; DEFORESTATION; DISTRIBUTIONS; VERTEBRATES; AMAZON; PARKS	Background: About an eighth of the earth's land surface is in protected areas (hereafter "PAs''), most created during the 20(th) century. Natural landscapes are critical for species persistence and PAs can play a major role in conservation and in climate policy. Such contributions may be harder than expected to implement if new PAs are constrained to the same kinds of locations that PAs currently occupy. Methodology/Principal Findings: Quantitatively extending the perception that PAs occupy "rock and ice'', we show that across 147 nations PA networks are biased towards places that are unlikely to face land conversion pressures even in the absence of protection. We test each country's PA network for bias in elevation, slope, distances to roads and cities, and suitability for agriculture. Further, within each country's set of PAs, we also ask if the level of protection is biased in these ways. We find that the significant majority of national PA networks are biased to higher elevations, steeper slopes and greater distances to roads and cities. Also, within a country, PAs with higher protection status are more biased than are the PAs with lower protection statuses. Conclusions/Significance: In sum, PAs are biased towards where they can least prevent land conversion (even if they offer perfect protection). These globally comprehensive results extend findings from nation-level analyses. They imply that siting rules such as the Convention on Biological Diversity's 2010 Target [to protect 10% of all ecoregions] might raise PA impacts if applied at the country level. In light of the potential for global carbon-based payments for avoided deforestation or REDD, these results suggest that attention to threat could improve outcomes from the creation and management of PAs.	[Joppa, Lucas N.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA	Duke University	Joppa, LN (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA.	joppatri@yahoo.com			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This study was funded by a National Science Foundation Graduate Research Fellowship to Lucas Joppa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Ball I., 2000, MARXAN V1 8 2 MARINE; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; CIESIN (Center for International Earth Science Information Network Columbia University); IFPRI (International Food Policy Research Institute); The World Bank and CIAT (Centro Internacional De Agricultura Tropical), 2000, GLOB RUR URB MAPP PR; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Fischer G, 2002, GLOBAL AGROECOLOGICA; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gorenflo LJ, 2006, BIOSCIENCE, V56, P723, DOI 10.1641/0006-3568(2006)56[723:KHDOGI]2.0.CO;2; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; JOPPA L, ECOLOGICAL IN PRESS; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Locke H, 2005, ENVIRON CONSERV, V32, P1, DOI 10.1017/S0376892905001852; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; *NIMA, 2000, VECT MAP LEV 0 DIG C; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Pfaff ASP, 2004, RESOUR ENERGY ECON, V26, P237, DOI 10.1016/j.reseneeco.2003.11.009; Pfaff ASP, 1999, J ENVIRON ECON MANAG, V37, P26, DOI 10.1006/jeem.1998.1056; PRESSEY RL, 1994, AUST J ECOL, V19, P375, DOI 10.1111/j.1442-9993.1994.tb00503.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Scott JM, 2004, NAT RESOUR J, V44, P1041; SCOTT JM, 1999, CONSERVATION BIOL NE, V6, P1; USGS, 2006, SHUTTL RAD TOP MISS; 2009, LANGUAGE ENV STAT CO	40	567	589	5	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8273	10.1371/journal.pone.0008273	http://dx.doi.org/10.1371/journal.pone.0008273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011603	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300028
J	Berkemeyer, S; Schumacher, J; Thiem, U; Pientka, L				Berkemeyer, Shoma; Schumacher, Jochen; Thiem, Ulrich; Pientka, Ludger			Bone T-Scores and Functional Status: A Cross-Sectional Study on German Elderly	PLOS ONE			English	Article							HIP FRACTURE; OLDER MEN; OSTEOPOROSIS; RISK; MOBILITY; TIME	Background: We explore the association between bone T-scores, used in osteoporosis diagnosis, and functional status since we hypothesized that bone health can impact elderly functional status and indirectly independence. Methods: In a cross-sectional study (2005-2006) on community dwelling elderly (>=75 years) from Herne, Germany we measured bone T-scores with Dual-energy X-ray Absorptiometry, and functional status indexed by five geriatric tests: activities of daily living, instrumental activities of daily living, test of dementia, geriatric depression score and the timed-up-and-go test, and two pooled indexes: raw and standardized. Generalized linear regression was used to determine the relationship between T-scores and functional status. Results: From 3243 addresses, only 632 (19%) completed a clinical visit, of which only 440 (male: female, 243: 197) could be included in analysis. T-scores (20.99, 95% confidence interval [CI], 21.1-0.9) predicted activities of daily living (95.3 CI, 94.5-96.2), instrumental activities of daily living (7.3 CI, 94.5-96.2), and timed-up-and-go test (10.7 CI, 10.0-11.3) (P<= 0.05). Pooled data showed that a unit improvement in T-score improved standardized pooled functional status (15 CI, 14.7-15.3) by 0.41 and the raw (99.4 CI, 97.8-101.0) by 2.27 units. These results were limited due to pooling of different scoring directions, selection bias, and a need to follow-up with evidence testing. Conclusions: T-scores associated with lower functional status in community-dwelling elderly. Regular screening of osteoporosis as a preventive strategy might help maintain life quality with aging.	[Berkemeyer, Shoma; Thiem, Ulrich; Pientka, Ludger] Ruhr Univ Bochum, Dept Geriatr, Marienhosp Herne, D-4690 Herne, Germany; [Schumacher, Jochen] Univ Duisburg Essen, Alfried Krupp Krankenhaus Steele, Dept Internal Med, Essen, Germany	Ruhr University Bochum; University of Duisburg Essen	Berkemeyer, S (corresponding author), Ruhr Univ Bochum, Dept Geriatr, Marienhosp Herne, D-4690 Herne, Germany.	shoma.berkemeyer@ruhr-uni-bochum.de			Elsbeth-Bonhof-Stiftung, Berlin; Robert Bosch Foundation, Stuttgart	Elsbeth-Bonhof-Stiftung, Berlin; Robert Bosch Foundation, Stuttgart	This study was supported by the Elsbeth-Bonhof-Stiftung, Berlin. Drs Schumacher and Thiem were both financed by research grants from the Robert Bosch Foundation, Stuttgart. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH M, 1995, SCHRIFTENREIHE GERIA; Body J J, 2008, Rev Med Brux, V29, P289; Breuil V, 2008, JOINT BONE SPINE, V75, P585, DOI 10.1016/j.jbspin.2008.01.024; Burke-Doe Annie, 2008, J Geriatr Phys Ther, V31, P11; Carpenter CR, 2009, ACAD EMERG MED, V16, P211, DOI 10.1111/j.1553-2712.2009.00351.x; del Rio L, 2008, CLIN EXP RHEUMATOL, V26, P283; Frassetto Lynda, 2009, P503; Gunter KB, 2000, J GERONTOL A-BIOL, V55, pM672, DOI 10.1093/gerona/55.11.M672; Haussler B, 2007, OSTEOPOROSIS INT, V18, P77, DOI 10.1007/s00198-006-0206-y; Joel M E, 1998, Curr Opin Rheumatol, V10, P362, DOI 10.1097/00002281-199807000-00015; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; Karagas MR, 1996, AM J EPIDEMIOL, V143, P677; Knoke JD, 2003, AM J EPIDEMIOL, V158, P1132, DOI 10.1093/aje/kwg265; Lau AN, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-151; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; MAHONEY F I, 1965, Md State Med J, V14, P61; Morris R, 2001, AGE AGEING, V30, P371, DOI 10.1093/ageing/30.5.371; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; *NIH, 2005, OST DIAGN; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raisz LG, 2000, MAYO CLIN PROC, V75, P885, DOI 10.4065/75.9.885; Russell MA, 2006, J GERONTOL A-BIOL, V61, P1090, DOI 10.1093/gerona/61.10.1090; Spangler L, 2008, J GEN INTERN MED, V23, P567, DOI 10.1007/s11606-008-0525-0; Stubbs B, 2009, INT PSYCHOGERIATR, V21, P180, DOI 10.1017/S1041610208007849; Thrane Gyrd, 2007, BMC Geriatr, V7, P1, DOI 10.1186/1471-2318-7-1; TUMULTY K, 2009, HLTH CARE UNLIKELY C, V173, P28; Waldman A, 2003, DRUGS, V63, P139, DOI 10.2165/00003495-200363020-00002; Whitson HE, 2008, AGING CLIN EXP RES, V20, P585; *WHO, 2004, ASS FRACT RISK ITS A; Wildner M, 1999, OSTEOPOROSIS INT, V9, P144, DOI 10.1007/s001980050128; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517; Zystra RG, 2008, J AM MED DIR ASSOC, V9, P109, DOI 10.1016/j.jamda.2007.09.008; 2002, HAMBURGER EINSTUFUNG	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8216	10.1371/journal.pone.0008216	http://dx.doi.org/10.1371/journal.pone.0008216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011039	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829800008
J	Abrajano, JJ; Qureshi, IA; Gokhan, S; Zheng, DY; Bergman, A; Mehler, MF				Abrajano, Joseph J.; Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Bergman, Aviv; Mehler, Mark F.			REST and CoREST Modulate Neuronal Subtype Specification, Maturation and Maintenance	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; FOREBRAIN CHOLINERGIC NEURONS; EMBRYONIC STEM-CELLS; RADIAL GLIAL-CELLS; LIM-HOMEOBOX GENE; IN-VIVO; TARGET GENES; DEVELOPMENTAL-CHANGES; GROWTH-FACTOR; TRANSCRIPTION FACTOR	Background: The repressor element-1 silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a master regulator of neuronal gene expression. REST functions as a modular scaffold for dynamic recruitment of epigenetic regulatory factors including its primary cofactor, the corepressor for element-1-silencing transcription factor (CoREST), to genomic loci that contain the repressor element-1 (RE1) binding motif. While REST was initially believed to silence RE1 containing neuronal genes in neural stem cells (NSCs) and non-neuronal cells, emerging evidence shows an increasingly complex cell type- and developmental stage-specific repertoire of REST target genes and functions that include regulation of neuronal lineage maturation and plasticity. Methodology/Principal Findings: In this study, we utilized chromatin immunoprecipitation on chip (ChIP-chip) analysis to examine REST and CoREST functions during NSC-mediated specification of cholinergic neurons (CHOLNs), GABAergic neurons (GABANs), glutamatergic neurons (GLUTNs), and medium spiny projection neurons (MSNs). We identified largely distinct but overlapping profiles of REST and CoREST target genes during neuronal subtype specification including a disproportionately high percentage that are exclusive to each neuronal subtype. Conclusions/Significance: Our findings demonstrate that the differential deployment of REST and CoREST is an important regulatory mechanism that mediates neuronal subtype specification by modulating specific gene networks responsible for inducing and maintaining neuronal subtype identity. Our observations also implicate a broad array of factors in the generation of neuronal diversity including but not limited to those that mediate homeostasis, cell cycle dynamics, cell viability, stress responses and epigenetic regulation.	[Abrajano, Joseph J.; Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA; [Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Abrajano, Joseph J.; Zheng, Deyou; Bergman, Aviv; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Zheng, Deyou; Bergman, Aviv] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA; [Abrajano, Joseph J.; Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Mehler, Mark F.] Albert Einstein Coll Med, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Abrajano, JJ (corresponding author), Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA.	mehler@aecom.yu.edu		Zheng, Deyou/0000-0003-4354-5337	National Institutes of Health [AG028872, AG027734, NS38902, MH66290]; Roslyn and Leslie Goldstein Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028872, P01AG027734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roslyn and Leslie Goldstein Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A. B. is supported by grants from the National Institutes of Health (AG028872, AG027734) and M. F. M. is supported by grants from the National Institutes of Health (NS38902, MH66290), as well as by the F. M. Kirby, the Rosanne H. Silbermann, the Alpern Family, the Mildred and Bernard H. Kayden and the Roslyn and Leslie Goldstein Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi Fatima, 2009, Hum Genet, V125, P344; Adegbola A, 2008, AM J MED GENET A, V146A, P505, DOI 10.1002/ajmg.a.32142; Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Alvarez-Rodriguez R, 2009, J CELL SCI, V122, P595, DOI 10.1242/jcs.037556; Ando Y, 2003, NEUROCHEM RES, V28, P839, DOI 10.1023/A:1023258923002; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bonsi P, 2008, NEUROPHARMACOLOGY, V55, P392, DOI 10.1016/j.neuropharm.2008.05.020; Brivanlou AH, 1998, NAT GENET, V20, P109, DOI 10.1038/2402; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; BRUCE AW, 2009, GENOME RES; CEDAR H, 2009, NAT REV GENET; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426; Cohen RI, 1996, J NEUROSCI, V16, P6433; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Ferrari-Toninelli G, 2008, NEUROSCIENCE, V154, P946, DOI 10.1016/j.neuroscience.2008.04.025; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fiumelli H, 2008, CELL MOTIL CYTOSKEL, V65, P495, DOI 10.1002/cm.20278; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; Gokhan S, 2001, ANAT RECORD, V265, P142, DOI 10.1002/ar.1136; Goncalves MBCV, 2009, DEV BIOL, V326, P305, DOI 10.1016/j.ydbio.2008.11.018; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harkany T, 2003, EUR J NEUROSCI, V18, P1979, DOI 10.1046/j.1460-9568.2003.02898.x; Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Huang YF, 2002, J NEUROSCI, V22, P8422; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Jin JZ, 2006, DEV DYNAM, V235, P547, DOI 10.1002/dvdy.20642; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; KAZANTSEVA A, 2009, J NEUROCHEM; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; KOLLER KJ, 1985, J NEUROSCI, V5, P2882; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kortazar D, 2007, EXP CELL RES, V313, P425, DOI 10.1016/j.yexcr.2006.09.002; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lakowski B, 2006, J MOL NEUROSCI, V29, P227, DOI 10.1385/JMN:29:3:227; Lein PJ, 2002, J NEUROSCI, V22, P10377; Li HD, 2007, GLIA, V55, P24, DOI 10.1002/glia.20434; Marmur R, 1998, J NEUROSCI, V18, P9800; Marmur R, 1998, DEV BIOL, V204, P577, DOI 10.1006/dbio.1998.9099; Martorana A, 2006, SYNAPSE, V60, P371, DOI 10.1002/syn.20306; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Ohashi S, 2000, J NEUROCHEM, V75, P1781, DOI 10.1046/j.1471-4159.2000.0751781.x; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pepin D, 2007, TRENDS ENDOCRIN MET, V18, P215, DOI 10.1016/j.tem.2007.05.004; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Reilly JO, 2002, MOL CELL NEUROSCI, V19, P88, DOI 10.1006/mcne.2001.1063; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; SNYDER GL, 1994, J NEUROCHEM, V63, P1766; Staropoli JF, 2005, J MOL NEUROSCI, V27, P175, DOI 10.1385/JMN:27:2:175; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Williams S, 2002, BIOCHEM BIOPH RES CO, V290, P1321, DOI 10.1006/bbrc.2002.6351; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zhang HY, 2008, J NEUROSCI RES, V86, P1217, DOI 10.1002/jnr.21581; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zheng DY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r9; Zhu G, 2000, J NEUROSCI RES, V59, P312, DOI 10.1002/(SICI)1097-4547(20000201)59:3<312::AID-JNR4>3.0.CO;2-A; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I; Zhu H, 2006, INT J DEV BIOL, V50, P71, DOI 10.1387/ijdb.052087hz	111	88	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e7936	10.1371/journal.pone.0007936	http://dx.doi.org/10.1371/journal.pone.0007936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997604	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829500002
J	Blank, HM; Gajjar, S; Belyanin, A; Polymenis, M				Blank, Heidi M.; Gajjar, Shefali; Belyanin, Andrey; Polymenis, Michael			Sulfur Metabolism Actively Promotes Initiation of Cell Division in Yeast	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; MITOCHONDRIAL PROTEIN ABF2P; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; AMINO-ACIDS; CYCLE; DYSFUNCTION; MECHANISM; GENOME; MUTATIONS	Background: Sulfur metabolism is required for initiation of cell division, but whether or not it can actively promote cell division remains unknown. Methodology/Principal Findings: Here we show that yeast cells with more mtDNA have an expanded reductive phase of their metabolic cycle and an increased sulfur metabolic flux. We also show that in wild type cells manipulations of sulfur metabolic flux phenocopy the enhanced growth rate of cells with more mtDNA. Furthermore, introduction of a hyperactive cystathionine-beta-synthase (CBS) allele in wild type cells accelerates initiation of DNA replication. Conclusions/Significance: Our results reveal a novel connection between a key sulfur metabolic enzyme, CBS, and the cell cycle. Since the analogous hyperactive CBS allele in human CBS suppresses other disease-causing CBS mutations, our findings may be relevant for human pathology. Taken together, our results demonstrate the importance of sulfur metabolism in actively promoting initiation of cell division.	[Blank, Heidi M.; Gajjar, Shefali; Belyanin, Andrey; Polymenis, Michael] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Blank, HM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	polymenis@tamu.edu	Polymenis, Michael/AAJ-3389-2021		National Science Foundation [MCB-0818248]; Direct For Biological Sciences [0818248] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (MCB-0818248) to M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Belew MS, 2009, PROTEIN EXPRES PURIF, V64, P139, DOI 10.1016/j.pep.2008.10.012; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Friddle RW, 2004, BIOPHYS J, V86, P1632, DOI 10.1016/S0006-3495(04)74231-9; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kaiser C., 1994, METHODS YEAST GENETI; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kraus JP, 1999, HUM MUTAT, V13, P362; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; PORRO D, 1988, BIOTECHNOL BIOENG, V32, P411, DOI 10.1002/bit.260320402; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stigter D, 2004, BIOPHYS CHEM, V110, P171, DOI 10.1016/j.bpc.2004.01.012; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2009, P NATL ACAD SCI USA, V106, P14293, DOI 10.1073/pnas.0907786106; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763	40	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8018	10.1371/journal.pone.0008018	http://dx.doi.org/10.1371/journal.pone.0008018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956742	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500039
J	Bui-Nguyen, TM; Pakala, SB; Sirigiri, RD; Xia, W; Hung, MC; Sarin, SK; Kumar, V; Slagle, BL; Kumar, R				Bui-Nguyen, T. M.; Pakala, S. B.; Sirigiri, R. D.; Xia, W.; Hung, M-C; Sarin, S. K.; Kumar, V.; Slagle, B. L.; Kumar, R.			NF-kappa B signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx	ONCOGENE			English	Article						MTA1; hepatitis B virus; HBx; signaling; MTA coregulator; liver cancer	X-PROTEIN; HEPATOCELLULAR-CARCINOMA; UP-REGULATION; CELL-LINES; EXPRESSION; TRANSCRIPTION; GENE; CANCER; COREGULATORS; COREPRESSOR	Metastasis-associated protein 1 (MTA1), a master chromatin modi. er, has been shown to regulate cancer progression and is widely upregulated in human cancer, including hepatitis B virus-associated hepatocellular carcinomas (HCCs). Here we provide evidence that hepatitis B virus transactivator protein HBx stimulates the expression of MTA1 but not of MTA2 or MTA3. The underlying mechanism of HBx stimulation of MTA1 involves HBx targeting of transcription factor nuclear factor (NF)-kappa B and the recruitment of HBx/p65 complex to the NF-kappa B consensus motif on the relaxed MTA1 gene chromatin. We also discovered that MTA1 depletion in HBx-expressing cells severely impairs the ability of HBx to stimulate NF-kappa B signaling and the expression of target proinflammatory molecules. Furthermore, the presence of HBx in HBx-infected HCCs correlated well with increased MTA1 and NF-kappa B-p65. Collectively, these findings revealed a previously unrecognized integral role of MTA1 in HBx stimulation of NF-kappa B signaling and consequently, the expression of NF-kappa B targets gene products with functions in inflammation and tumorigenesis. Oncogene (2010) 29, 1179-1189; doi: 10.1038/onc.2009.404; published online 14 December 2009	[Bui-Nguyen, T. M.; Pakala, S. B.; Sirigiri, R. D.; Kumar, R.] George Washington Univ, Dept Biochem & Mol Biol, Inst Coregulator Biol, Washington, DC 20037 USA; [Xia, W.; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, M-C] China Med Univ & Hosp, Grad Inst Canc Biol, Ctr Mol Med, Taichung, Taiwan; [Sarin, S. K.] GB Pant Hosp, Dept Gastroenterol, Inst Liver & Biliary Sci, New Delhi, India; [Sarin, S. K.] Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India; [Kumar, V.] Int Ctr Genet Engn & Biotechnol, Virol Lab, New Delhi, India; [Slagle, B. L.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	George Washington University; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; Govind Ballabh Pant Institute of Postgraduate Medical Education & Research; Institute of Liver & Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Baylor College of Medicine	Kumar, R (corresponding author), George Washington Univ, Dept Biochem & Mol Biol, Inst Coregulator Biol, 2300 1 St, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Hung, Mien-Chie/ABD-5911-2021; Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010	Hung, Mien-Chie/0000-0003-4317-4740; Kumar, Rakesh/0000-0001-7664-0803; Pakala, Suresh Babu/0000-0002-5679-4837	NIH [CA98823, 95388]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Aleem Siddiqui for pCMVXF and pCMV-Core constructs, Ranjit Banerjee for the HVC core plasmid, Amanda J Hodgson for technical assistance and Xuemei Wang for statistical analysis. The work was supported by NIH Grant CA98823 (RK). Work in Dr Betty L Slagle laboratory is supported by the NIH Grant 95388.	Anderson P, 2007, MOL CELL, V25, P796, DOI 10.1016/j.molcel.2007.03.005; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Bergametti F, 1999, ONCOGENE, V18, P2860, DOI 10.1038/sj.onc.1202643; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cheng ASL, 2004, MODERN PATHOL, V17, P1169, DOI 10.1038/modpathol.3800196; Chirillo P, 1996, J VIROL, V70, P641, DOI 10.1128/JVI.70.1.641-646.1996; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dvorchik I, 2007, CURR PHARM DESIGN, V13, P1527, DOI 10.2174/138161207780765846; Giannini R, 2005, ANTICANCER RES, V25, P4287; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hamatsu T, 2003, ONCOL REP, V10, P599; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jang KS, 2006, CANCER SCI, V97, P374, DOI 10.1111/j.1349-7006.2006.00186.x; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; Kidd M, 2006, ANN SURG ONCOL, V13, P253, DOI 10.1245/ASO.2006.12.011; Kim SY, 2008, BMB REP, V41, P158, DOI 10.5483/BMBRep.2008.41.2.158; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Ray RB, 2001, FEMS MICROBIOL LETT, V202, P149, DOI 10.1111/j.1574-6968.2001.tb10796.x; Ryu SH, 2008, HEPATOLOGY, V47, P929, DOI 10.1002/hep.22124; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SLAGLE BL, 1991, CANCER RES, V51, P49; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; TOH Y, 1995, GENE, V159, P97, DOI 10.1016/0378-1119(94)00410-T; Weil R, 1999, MOL CELL BIOL, V19, P6345; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Yun C, 2002, CANCER LETT, V184, P97, DOI 10.1016/S0304-3835(02)00187-8; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003	38	54	59	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1179	1189		10.1038/onc.2009.404	http://dx.doi.org/10.1038/onc.2009.404			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	20010875	Green Accepted			2022-12-25	WOS:000274912100009
J	Gao, DT; Ashraf, MZ; Kar, NS; Lin, D; Sayre, LM; Podrez, EA				Gao, Detao; Ashraf, Mohammad Z.; Kar, Niladri S.; Lin, De; Sayre, Lawrence M.; Podrez, Eugene A.			Structural Basis for the Recognition of Oxidized Phospholipids in Oxidized Low Density Lipoproteins by Class B Scavenger Receptors CD36 and SR-BI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; MEMBRANE; ESTERS; FAMILY; LDL	Specific oxidized phospholipids (oxPC(CD36)) accumulate in vivo at sites of oxidative stress and serve as high affinity ligands for scavenger receptors class B (CD36 and SR-BI). Recognition of oxPC(CD36) by scavenger receptors plays a role in several pathophysiological processes. The structural basis for the recognition of oxPC(CD36) by CD36 and SR-BI is poorly understood. A characteristic feature of oxPC(CD36) is an sn-2 acyl group that incorporates a terminal gamma-hydroxy (or oxo)-alpha,beta-unsaturated carbonyl. In the present study, a series of model oxidized phospholipids were designed, synthesized, and tested for their ability to serve as ligands for CD36 and SR-BI. We demonstrated that intact the sn-1 hydrophobic chain, the sn-3 hydrophilic phosphocholine or phosphatidic acid group, and the polar sn-2 tail are absolutely essential for high affinity binding. We further found that a terminal negatively charged carboxylate at the sn-2 position suffices to generate high binding affinity to class B scavenger receptors. In addition, factors such as polarity, rigidity, optimal chain length of sn-2, and sn-3 positions and negative charge at the sn-3 position of phospholipids further modulate the binding affinity. We conclude that all three positions of oxidized phospholipids are essential for the effective recognition by scavenger receptors class B. Furthermore, the structure of residues in these positions controls the affinity of the binding. The present studies suggest that, in addition to oxPC(CD36), other oxidized phospholipids observed in vivo may represent novel ligands for scavenger receptors class B.	[Ashraf, Mohammad Z.; Kar, Niladri S.; Podrez, Eugene A.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Gao, Detao; Lin, De; Sayre, Lawrence M.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Podrez, EA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,ND50, Cleveland, OH 44195 USA.	podreze@ccf.org	LIN, DE/F-2522-2010		National Institutes of Health [HL053315, HL077213, 2P01HL073311-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL077213, R01HL053315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL053315, HL077213 and 2P01HL073311-06 (to E. A. P.) and HL053315 (to L. M. S.).	Ashraf MZ, 2008, J BIOL CHEM, V283, P10408, DOI 10.1074/jbc.M710474200; GOLDSTEIN JL, 1974, P NATL ACAD SCI USA, V71, P4288, DOI 10.1073/pnas.71.11.4288; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; HOPPE G, 1994, J CLIN INVEST, V94, P1506, DOI 10.1172/JCI117490; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597	15	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4447	4454		10.1074/jbc.M109.082800	http://dx.doi.org/10.1074/jbc.M109.082800			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996318	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000275274800022
J	Taira, N; Yamamoto, H; Yamaguchi, T; Miki, Y; Yoshida, K				Taira, Naoe; Yamamoto, Hiroyuki; Yamaguchi, Tomoko; Miki, Yoshio; Yoshida, Kiyotsugu			ATM Augments Nuclear Stabilization of DYRK2 by Inhibiting MDM2 in the Apoptotic Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; TOPOISOMERASE-II-ALPHA; P53 TUMOR-SUPPRESSOR; LYN TYROSINE KINASE; OXIDATIVE STRESS; P53-DEPENDENT APOPTOSIS; PROTEIN-KINASES; FAMILY KINASES; PHOSPHORYLATION; ABL	The tumor suppressor p53 is a transcription factor that regulates cell cycle, DNA repair, senescence, and apoptosis in response to DNA damage. Phosphorylation of p53 at Ser-46 is indispensable for the commitment to apoptotic cell death. A previous study has shown that upon exposure to genotoxic stress, DYRK2 translocates into the nucleus and phosphorylates p53 at Ser-46, thereby inducing apoptosis. However, less is known about mechanisms responsible for intracellular control of DYRK2. Here we show the functional nuclear localization signal at N-terminal domain of DYRK2. Under normal conditions, nuclear and not cytoplasmic DYRK2 is ubiquitinated by MDM2, resulting in its constitutive degradation. In the presence of proteasome inhibitors, we detected a stable complex of DYRK2 with MDM2 at the nucleus. Upon exposure to genotoxic stress, ATM phosphorylates DYRK2 at Thr-33 and Ser-369, which enables DYRK2 to escape from degradation by dissociation from MDM2 and to induce the kinase activity toward p53 at Ser-46 in the nucleus. These findings indicate that ATM controls stability and pro-apoptotic function of DYRK2 in response to DNA damage.	[Taira, Naoe; Yamamoto, Hiroyuki; Yamaguchi, Tomoko; Miki, Yoshio; Yoshida, Kiyotsugu] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Miki, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.	miki.mgen@mri.tmd.ac.jp; yos.mgen@mri.tmd.ac.jp			Ministry of Education, Science, and Culture of Japan; Uehara Memorial Foundation; Senri Life Science Foundation; Takeda Science Foundation; Kowa Life Science Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Senri Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kowa Life Science Foundation	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (to K. Y. and Y. M.), Uehara Memorial Foundation (to K. Y.), Senri Life Science Foundation (to K. Y.), Takeda Science Foundation (to K. Y.), and Kowa Life Science Foundation (to K. Y.).	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kimura J, 2008, NUCLEIC ACIDS RES, V36, P5250, DOI 10.1093/nar/gkn506; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Nihira K, 2008, ONCOGENE, V27, P7285, DOI 10.1038/onc.2008.334; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Peretz S, 2001, P NATL ACAD SCI USA, V98, P1676, DOI 10.1073/pnas.041416598; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Shinagawa H, 2008, ANTIOXID REDOX SIGN, V10, P939, DOI 10.1089/ars.2007.1851; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200; Yamaguchi T, 2007, CELL SIGNAL, V19, P2088, DOI 10.1016/j.cellsig.2007.06.002; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Yoshida K, 2001, MOL PHARMACOL, V60, P1431, DOI 10.1124/mol.60.6.1431; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021	29	51	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4909	4919		10.1074/jbc.M109.042341	http://dx.doi.org/10.1074/jbc.M109.042341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19965871	Green Published, hybrid			2022-12-25	WOS:000275274800068
J	O'Leary, DA; Sharif, O; Anderson, P; Tu, B; Welch, G; Zhou, YY; Caldwell, JS; Engels, IH; Brinker, A				O'Leary, Debra A.; Sharif, Orzala; Anderson, Paul; Tu, Buu; Welch, Genevieve; Zhou, Yingyao; Caldwell, Jeremy S.; Engels, Ingo H.; Brinker, Achim			Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; RNA SPLICING FACTORS; HISTONE DEACETYLASE INHIBITOR; CELL-CYCLE ARREST; MESSENGER-RNA; NONSENSE MUTATION; FUNCTIONAL-ANALYSIS; DMD-GENE; DROSOPHILA DEVELOPMENT; VARIABLE PHENOTYPES	One therapeutic approach to Duchenne Muscular Dystrophy (DMD) recently entering clinical trials aims to convert DMD phenotypes to that of a milder disease variant, Becker Muscular Dystrophy (BMD), by employing antisense oligonucleotides (AONs) targeting splice sites, to induce exon skipping and restore partial dystrophin function. In order to search for small molecule and genetic modulators of AON-dependent and independent exon skipping, we screened similar to 10,000 known small molecule drugs, >17,000 cDNA clones, and >2,000 kinase-targeted siRNAs against a 5.6 kb luciferase minigene construct, encompassing exon 71 to exon 73 of human dystrophin. As a result, we identified several enhancers of exon skipping, acting on both the reporter construct as well as endogenous dystrophin in mdx cells. Multiple mechanisms of action were identified, including histone deacetylase inhibition, tubulin modulation and pre-mRNA processing. Among others, the nucleolar protein NOL8 and staufen RNA binding protein homolog 2 (Stau2) were found to induce endogenous exon skipping in mdx cells in an AON-dependent fashion. An unexpected but recurrent theme observed in our screening efforts was the apparent link between the inhibition of cell cycle progression and the induction of exon skipping.	[O'Leary, Debra A.; Sharif, Orzala; Anderson, Paul; Tu, Buu; Welch, Genevieve; Zhou, Yingyao; Caldwell, Jeremy S.; Engels, Ingo H.; Brinker, Achim] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis	O'Leary, DA (corresponding author), Dart Neurosci, San Diego, CA USA.	oleary.debra@gmail.com; iengels@gnf.org			Foundation to Eradicate Duchenne (FED); Novartis Research Foundation	Foundation to Eradicate Duchenne (FED); Novartis Research Foundation	This work was supported by the Foundation to Eradicate Duchenne (FED) (http://www.duchennemd.org) and the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; AHMED S, 2009, NAT GENET; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Belanger G, 2003, J NEUROCHEM, V86, P669, DOI 10.1046/j.1471-4159.2003.01883.x; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; BUSHBY KMD, 1991, LANCET, V337, P1022, DOI 10.1016/0140-6736(91)92671-N; Caceres JF, 2007, CELL, V131, P645, DOI 10.1016/j.cell.2007.11.001; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Castellano S, 2000, ARCH PHARM, V333, P373, DOI 10.1002/1521-4184(200011)333:11<373::AID-ARDP373>3.0.CO;2-6; Chang JS, 2005, LIFE SCI, V76, P1883, DOI 10.1016/j.lfs.2004.11.003; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; CHOU TB, 1987, EMBO J, V6, P4095, DOI 10.1002/j.1460-2075.1987.tb02755.x; COLUSSI C, 2009, FASEB J; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Davis RL, 2009, HUM MUTAT, V30, P221, DOI 10.1002/humu.20839; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Disset A, 2006, HUM MOL GENET, V15, P999, DOI 10.1093/hmg/ddl015; DUBEL S, 1988, J CELL SCI, V91, P347; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Ginjaar IB, 2000, EUR J HUM GENET, V8, P793, DOI 10.1038/sj.ejhg.5200535; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Gurpur PB, 2009, AM J PATHOL, V174, P999, DOI 10.2353/ajpath.2009.080537; Hanamura A, 1998, RNA, V4, P430; Havlioglu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001246; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Hodgkinson JE, 2008, INT J PARASITOL, V38, P1149, DOI 10.1016/j.ijpara.2008.02.001; HOLDEN HE, 1980, ENVIRON MUTAGEN, V2, P67, DOI 10.1002/em.2860020110; HORWITZ SB, 1977, LLOYDIA, V40, P82; Hussein MR, 2006, INT J EXP PATHOL, V87, P451, DOI 10.1111/j.1365-2613.2006.00470.x; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong JH, 2007, J NEUROCHEM, V102, P2073, DOI 10.1111/j.1471-4159.2007.04697.x; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Katzenberger RJ, 2009, J BIOL CHEM, V284, P10737, DOI 10.1074/jbc.M809506200; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kimura T, 1993, Gan To Kagaku Ryoho, V20, P816; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Labourier E, 1999, GENE DEV, V13, P740, DOI 10.1101/gad.13.6.740; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; MATSUMOTO K, 1992, CHROMOSOMA, V102, P60, DOI 10.1007/BF00352291; McAlinden A, 2005, J BIOL CHEM, V280, P32700, DOI 10.1074/jbc.M505940200; Melis MA, 1998, HUM MUTAT, pS137; MIKHAILOV M V, 1981, Molekulyarnaya Biologiya (Moscow), V15, P690; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Muntoni F, 2003, CURR OPIN NEUROL, V16, P577, DOI 10.1097/00019052-200310000-00003; Nam YJ, 2008, BIOCHEM BIOPH RES CO, V372, P525, DOI 10.1016/j.bbrc.2008.05.047; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Nishiyama A, 2008, ANN HUM GENET, V72, P717, DOI 10.1111/j.1469-1809.2008.00468.x; Nissim-Rafinia M, 2004, EMBO REP, V5, P1071, DOI 10.1038/sj.embor.7400273; Radojevic V, 2000, CELL TISSUE RES, V300, P447, DOI 10.1007/s004410000213; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; RING HJ, 1994, MOL CELL BIOL, V14, P7499, DOI 10.1128/MCB.14.11.7499; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Sazani P, 2001, NUCLEIC ACIDS RES, V29, P3965, DOI 10.1093/nar/29.19.3965; Scaife RM, 2004, MOL CANCER THER, V3, P1229; Schaider H, 1995, ANTICANCER RES, V15, P2501; Sekiguchi T, 2006, NUCLEIC ACIDS RES, V34, P4593, DOI 10.1093/nar/gkl603; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Song JD, 2008, INT J ONCOL, V33, P1299, DOI 10.3892/ijo_00000121; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Takai N, 2006, INT J MOL MED, V17, P323; Tazi J, 1997, J MOL MED, V75, P786, DOI 10.1007/s001090050168; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vandenburgh H, 2009, FASEB J, V23, P3325, DOI 10.1096/fj.09-134411; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wells DJ, 2008, GENE THER, V15, P1077, DOI 10.1038/gt.2008.97; WELSH MJ, 1979, J CELL BIOL, V81, P624, DOI 10.1083/jcb.81.3.624; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Wilton SD, 1997, MUSCLE NERVE, V20, P728; YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou YY, 2007, J CHEM INF MODEL, V47, P1386, DOI 10.1021/ci700092v; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	107	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8348	10.1371/journal.pone.0008348	http://dx.doi.org/10.1371/journal.pone.0008348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020055	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834200014
J	Zhao, HB; Ru, BH; Teeling, EC; Faulkes, CG; Zhang, SY; Rossiter, SJ				Zhao, Huabin; Ru, Binghua; Teeling, Emma C.; Faulkes, Christopher G.; Zhang, Shuyi; Rossiter, Stephen J.			Rhodopsin Molecular Evolution in Mammals Inhabiting Low Light Environments	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ROD VISUAL PIGMENTS; BOVINE RHODOPSIN; COLOR-VISION; ULTRAVIOLET VISION; ADAPTIVE EVOLUTION; CICHLID FISHES; MARINE MAMMALS; VERTEBRATES; ADAPTATIONS	The ecological radiation of mammals to inhabit a variety of light environments is largely attributed to adaptive changes in their visual systems. Visual capabilities are conferred by anatomical features of the eyes as well as the combination and properties of their constituent light sensitive pigments. To test whether evolutionary switches to different niches characterized by dim-light conditions coincided with molecular adaptation of the rod pigment rhodopsin, we sequenced the rhodopsin gene in twenty-two mammals including several bats and subterranean mole-rats. We compared these to thirty-seven published mammal rhodopsin sequences, from species with divergent visual ecologies, including nocturnal, diurnal and aquatic groups. All taxa possessed an intact functional rhodopsin; however, phylogenetic tree reconstruction recovered a gene tree in which rodents were not monophyletic, and also in which echolocating bats formed a monophyletic group. These conflicts with the species tree appear to stem from accelerated evolution in these groups, both of which inhabit low light environments. Selection tests confirmed divergent selection pressures in the clades of subterranean rodents and bats, as well as in marine mammals that live in turbid conditions. We also found evidence of divergent selection pressures among groups of bats with different sensory modalities based on vision and echolocation. Sliding window analyses suggest most changes occur in transmembrane domains, particularly obvious within the pinnipeds; however, we found no obvious pattern between photopic niche and predicted spectral sensitivity based on known critical amino acids. This study indicates that the independent evolution of rhodopsin vision in ecologically specialised groups of mammals has involved molecular evolution at the sequence level, though such changes might not mediate spectral sensitivity directly.	[Zhao, Huabin; Ru, Binghua; Zhang, Shuyi] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Teeling, Emma C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Teeling, Emma C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Faulkes, Christopher G.; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University College Dublin; University College Dublin; University of London; Queen Mary University London	Zhao, HB (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn; s.j.rossiter@qmul.ac.uk	Zhang, Shuyi/B-5117-2011; Zhao, Huabin/D-6956-2011; Faulkes, Chris/O-8101-2019; Zhao, Huabin/AAS-7513-2020; Rossiter, Stephen J/E-2111-2011	Zhao, Huabin/0000-0002-7848-6392; Teeling, Emma/0000-0002-3309-1346; Faulkes, Christopher/0000-0002-5228-9075; Rossiter, Stephen/0000-0002-3881-4515	National "985" Project; "211" Project; Royal Society Research; Science Foundation Ireland [PIYRA [06/YI3/B932]]	National "985" Project; "211" Project(Anhui UniversityMinistry of Education, China); Royal Society Research(Royal Society of London); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a grant under the Key Construction Program of the National "985" Project and "211" Project to S.Z., a Royal Society Research Fellowship to S.J.R and a Science Foundation Ireland grant PIYRA [06/YI3/B932] to E.C.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Cott H.B., 1940, ADAPTIVE COLORATION; CRESCITELLI F, 1991, VISION RES, V31, P339, DOI 10.1016/0042-6989(91)90086-K; David-Gray ZK, 2002, EUR J NEUROSCI, V16, P1186, DOI 10.1046/j.1460-9568.2002.02161.x; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; Fasick JI, 2000, VISUAL NEUROSCI, V17, P781, DOI 10.1017/S095252380017511X; FERRARI M, 1993, COLORS SURVIVAL MIMI; Griebel U, 2006, MAR MAMMAL SCI, V22, P156, DOI 10.1111/j.1748-7692.2006.00010.x; GRIEBEL U, 1992, VISION RES, V32, P477, DOI 10.1016/0042-6989(92)90239-F; GRIEBEL U, 2002, VIENNA SCH MARINE BI; Griebel Ulrike, 2003, Aquatic Mammals, V29, P18, DOI 10.1578/016754203101024040; Henry EC, 2006, J COMP NEUROL, V495, P434, DOI 10.1002/cne.20883; HINTON HE, 1973, NATURAL DECEPTION; HULSENBECK JP, 2001, BAYESIAN INFERENCE P; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kimchi T, 2002, CURR OPIN NEUROBIOL, V12, P728, DOI 10.1016/S0959-4388(02)00381-1; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; LDOS SC, 2006, CURR BIOL, V16, pR81; Levenson DH, 2006, J COMP PHYSIOL A, V192, P833, DOI 10.1007/s00359-006-0121-x; Levenson DH, 2003, P ROY SOC B-BIOL SCI, V270, P673, DOI 10.1098/rspb.2002.2278; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Maddison, 2019, MESQUITE MODULAR SYS; MADSEN CJ, 1980, CETACEAN BEHAV; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; Moss CF, 2003, CURR OPIN NEUROBIOL, V13, P751, DOI 10.1016/j.conb.2003.10.016; MUNTZ WRA, 1976, VISION RES, V16, P897, DOI 10.1016/0042-6989(76)90218-2; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Nei M., 2000, MOL EVOLUTION PHYLOG; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2001, EUR J NEUROSCI, V13, P1520, DOI 10.1046/j.0953-816x.2001.01533.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pride D.T., 2004, SWAPP 1 0 2 TOOL ANA; Shi YS, 2003, P NATL ACAD SCI USA, V100, P8308, DOI 10.1073/pnas.1532535100; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Southall KD, 2002, MAR MAMMAL SCI, V18, P275, DOI 10.1111/j.1748-7692.2002.tb01033.x; Sugawara T, 2002, MOL BIOL EVOL, V19, P1807, DOI 10.1093/oxfordjournals.molbev.a004004; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trumpp-Kallmeyer S, 1995, Pharm Acta Helv, V70, P255, DOI 10.1016/0031-6865(95)00029-9; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; Wickler W., 1968, MIMICRY PLANTS ANIMA; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; Yokoyama S, 2005, GENETICS, V170, P335, DOI 10.1534/genetics.104.039511; Yokoyama S, 1996, ANNU REV ECOL SYST, V27, P543, DOI 10.1146/annurev.ecolsys.27.1.543; Yokoyama S, 2004, MOL BIOL EVOL, V21, P2071, DOI 10.1093/molbev/msh217; Yokoyama S, 2000, FEBS LETT, V486, P167, DOI 10.1016/S0014-5793(00)02269-9; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	66	39	39	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8326	10.1371/journal.pone.0008326	http://dx.doi.org/10.1371/journal.pone.0008326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016835	gold, Green Published, Green Submitted			2022-12-25	WOS:000272834000013
J	Gidijala, L; Kiel, JAKW; Douma, RD; Seifar, RM; van Gulik, WM; Bovenberg, RAL; Veenhuis, M; van der Klei, IJ				Gidijala, Loknath; Kiel, Jan A. K. W.; Douma, Rutger D.; Seifar, Reza M.; van Gulik, Walter M.; Bovenberg, Roel A. L.; Veenhuis, Marten; van der Klei, Ida J.			An Engineered Yeast Efficiently Secreting Penicillin	PLOS ONE			English	Article							HANSENULA-POLYMORPHA; ISOPENICILLIN-N; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; PEROXISOMAL MEMBRANE; ARXULA-ADENINIVORANS; MASS-SPECTROMETRY; MATRIX PROTEIN; CHRYSOGENUM; GENE	This study aimed at developing an alternative host for the production of penicillin ( PEN). As yet, the industrial production of this beta(-)lactam antibiotic is confined to the filamentous fungus Penicillium chrysogenum. As such, the yeast Hansenula polymorpha, a recognized producer of pharmaceuticals, represents an attractive alternative. Introduction of the P. chrysogenum gene encoding the non-ribosomal peptide synthetase (NRPS) delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase (ACVS) in H. polymorpha, resulted in the production of active ACVS enzyme, when co-expressed with the Bacillus subtilis sfp gene encoding a phosphopantetheinyl transferase that activated ACVS. This represents the first example of the functional expression of a non-ribosomal peptide synthetase in yeast. Co-expression with the P. chrysogenum genes encoding the cytosolic enzyme isopenicillin N synthase as well as the two peroxisomal enzymes isopenicillin N acyl transferase (IAT) and phenylacetyl CoA ligase (PCL) resulted in production of biologically active PEN, which was efficiently secreted. The amount of secreted PEN was similar to that produced by the original P. chrysogenum NRRL1951 strain (approx. 1 mg/L). PEN production was decreased over two-fold in a yeast strain lacking peroxisomes, indicating that the peroxisomal localization of IAT and PCL is important for efficient PEN production. The breakthroughs of this work enable exploration of new yeast-based cell factories for the production of (novel) b-lactam antibiotics as well as other natural and semi-synthetic peptides (e.g. immunosuppressive and cytostatic agents), whose production involves NRPS's.	[Gidijala, Loknath; Kiel, Jan A. K. W.; Bovenberg, Roel A. L.; Veenhuis, Marten; van der Klei, Ida J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands; [Gidijala, Loknath; Kiel, Jan A. K. W.; Douma, Rutger D.; Seifar, Reza M.; van Gulik, Walter M.; Veenhuis, Marten; van der Klei, Ida J.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Douma, Rutger D.; Seifar, Reza M.; van Gulik, Walter M.] Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Delft, Netherlands; [Bovenberg, Roel A. L.] DSM Biotechnol Ctr, Delft, Netherlands	University of Groningen; Delft University of Technology; DSM NV	Gidijala, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands.	i.j.van.der.klei@rug.nl	van der Klei, Ida J/D-1919-2012	Van der Klei, Ida J./0000-0001-7165-9679	Netherlands Ministry of Economic Affairs; B-Basic partner organizations; public-private NWO-ACTS programme; Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations; public-private NWO-ACTS programme; Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	LG, JAKWK and RD are financially supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations (www.b-basic.nl) through B-Basic, a public-private NWO-ACTS programme (ACTS = Advanced Chemical Technologies for Sustainability). This project was carried out within the research programme of the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerends RJS, 1997, YEAST, V13, P1437; Baerends RJS, 1996, J BIOL CHEM, V271, P8887, DOI 10.1074/jbc.271.15.8887; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; DEMAIN A, 1983, BIOSYNTHESIS BETA LA, P180; DITZELMULLER G, 1983, ARCH MICROBIOL, V135, P63, DOI 10.1007/BF00419484; Evers ME, 2004, ADV BIOCHEM ENG BIOT, V88, P111, DOI 10.1007/b99259; Gellissen G, 2005, FEMS YEAST RES, V5, P1079, DOI 10.1016/j.femsyr.2005.06.004; Gidijala L, 2007, FEMS YEAST RES, V7, P1160, DOI 10.1111/j.1567-1364.2007.00228.x; Gidijala L, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-29; GLEESON MA, 1988, YEAST, V4, P293, DOI 10.1002/yea.320040407; Haan GJ, 2002, FEMS YEAST RES, V2, P17, DOI 10.1016/S1567-1356(01)00057-5; HILLENGA DJ, 1994, EUR J BIOCHEM, V224, P581, DOI 10.1111/j.1432-1033.1994.t01-1-00581.x; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kleijn RJ, 2007, METAB ENG, V9, P112, DOI 10.1016/j.ymben.2006.08.004; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Kresse H, 2007, NAT REV DRUG DISCOV, V6, P19, DOI 10.1038/nrd2226; Lutz MV, 2005, FEMS YEAST RES, V5, P1063, DOI 10.1016/j.femsyr.2005.07.002; Mashego MR, 2003, BIOTECHNOL BIOENG, V83, P395, DOI 10.1002/bit.10683; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Nagotu S, 2008, BBA-MOL CELL RES, V1783, P760, DOI 10.1016/j.bbamcr.2007.10.018; RAMOS FR, 1985, ANTIMICROB AGENTS CH, V27, P380, DOI 10.1128/AAC.27.3.380; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Seifar RM, 2008, J CHROMATOGR A, V1187, P103, DOI 10.1016/j.chroma.2008.02.008; Siewers V, 2009, METAB ENG, V11, P391, DOI 10.1016/j.ymben.2009.08.002; Sprote P, 2009, EUKARYOT CELL, V8, P421, DOI 10.1128/EC.00374-08; Stockmann C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-22; van der Lende TR, 2002, FUNGAL GENET BIOL, V37, P49, DOI 10.1016/S1087-1845(02)00036-1; van Dijk R, 2000, ENZYME MICROB TECH, V26, P793, DOI 10.1016/S0141-0229(00)00173-3; VANDERKLEI IJ, 1991, ARCH MICROBIOL, V156, P15, DOI 10.1007/BF00418181; Waksman SA, 1944, P NATL ACAD SCI USA, V30, P99, DOI 10.1073/pnas.30.5.99; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; ZWART KB, 1983, A VAN LEEUW J MICROB, V49, P369	36	58	61	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8317	10.1371/journal.pone.0008317	http://dx.doi.org/10.1371/journal.pone.0008317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016817	Green Published, Green Submitted, gold			2022-12-25	WOS:000272833800013
J	Pettengill, MA; Lam, VW; Ojcius, DM				Pettengill, Matthew A.; Lam, Verissa W.; Ojcius, David M.			The Danger Signal Adenosine Induces Persistence of Chlamydial Infection through Stimulation of A2b Receptors	PLOS ONE			English	Article							EPITHELIAL-CELLS; BACTERIAL PERSISTENCE; IMMUNE-RESPONSE; HOST-CELLS; TRACHOMATIS; GRANULOMA; PARADIGM; SURVIVAL; HYPOXIA; RELEASE	Infections with intracellular bacteria such as chlamydiae affect the majority of the world population. Infected tissue inflammation and granuloma formation help contain the short-term expansion of the invading pathogen, leading also to local tissue damage and hypoxia. However, the effects of key aspects of damaged inflamed tissues and hypoxia on continued infection with intracellular bacteria remain unknown. We find that development of Chlamydia trachomatis is reversibly retarded by prolonged exposure of infected cells to extracellular adenosine, a hallmark of hypoxia and advanced inflammation. In epithelial cells, this effect was mediated by the A2b adenosine receptor, unique in the adenosine receptor family for having a hypoxia-inducible factor (HIF1-alpha) binding site at its promoter region, and was dependent on an increase in the intracellular cAMP levels, but was independent of cAMP-dependent protein kinase (PKA). Further study of adenosine receptor signaling during intracellular bacterial infection could lead to breakthroughs in our understanding of persistent infections with these ubiquitous pathogens.	[Pettengill, Matthew A.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced	Pettengill, MA (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA.	dojcius@ucmerced.edu	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; Pettengill, Matthew/0000-0002-4579-0187	University of California	University of California(University of California System)	University of California funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bavoil PM, 2000, MICROBIOL-UK, V146, P2723, DOI 10.1099/00221287-146-11-2723; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Darville T, 2007, J IMMUNOL, V179, P3707, DOI 10.4049/jimmunol.179.6.3707; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Fang Y, 2007, J PHARMACOL EXP THER, V322, P1189, DOI 10.1124/jpet.107.119933; Hoare A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-5; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Roan NR, 2008, CELL MICROBIOL, V10, P9, DOI 10.1111/j.1462-5822.2007.01069.x; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun Y, 2008, J IMMUNOL, V180, P4173, DOI 10.4049/jimmunol.180.6.4173; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; WARD ME, 1982, J GEN MICROBIOL, V128, P639; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Yang X, 1999, J IMMUNOL, V162, P1010; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026	31	28	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8299	10.1371/journal.pone.0008299	http://dx.doi.org/10.1371/journal.pone.0008299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011598	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300047
J	Bayle, DJ; Henaff, MA; Krolak-Salmon, P				Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre			Unconsciously Perceived Fear in Peripheral Vision Alerts the Limbic System: A MEG Study	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; MEDIAL PREFRONTAL CORTEX; TEMPORAL-LOBE EPILEPSY; TIME-COURSE; FACE PERCEPTION; NEURAL ACTIVITY; HUMAN AMYGDALA; MOTOR CONTROL; RECOGNITION; RESPONSES	Background: In ecological situations, threatening stimuli often come out from the peripheral vision. Such aggressive messages must trigger rapid attention to the periphery to allow a fast and adapted motor reaction. Several clues converge to hypothesize that peripheral danger presentation can trigger off a fast arousal network potentially independent of the consciousness spot. Methodology/Principal Findings: In the present MEG study, spatio-temporal dynamics of the neural processing of danger related stimuli were explored as a function of the stimuli position in the visual field. Fearful and neutral faces were briefly presented in the central or peripheral visual field, and were followed by target faces stimuli. An event-related beamformer source analysis model was applied in three time windows following the first face presentations: 80 to 130 ms, 140 to 190 ms, and 210 to 260 ms. The frontal lobe and the right internal temporal lobe part, including the amygdala, reacted as soon as 80 ms of latency to fear occurring in the peripheral vision. For central presentation, fearful faces evoked the classical neuronal activity along the occipito-temporal visual pathway between 140 and 190 ms. Conclusions: Thus, the high spatio-temporal resolution of MEG allowed disclosing a fast response of a network involving medial temporal and frontal structures in the processing of fear related stimuli occurring unconsciously in the peripheral visual field. Whereas centrally presented stimuli are precisely processed by the ventral occipito-temporal cortex, the related-to-danger stimuli appearing in the peripheral visual field are more efficient to produce a fast automatic alert response possibly conveyed by subcortical structures.	[Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre] INSERM, U821, F-69008 Lyon, France; [Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre] Univ Lyon 1, F-69365 Lyon, France; [Bayle, Dimitri J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Krolak-Salmon, Pierre] Hosp Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); CHU Lyon	Bayle, DJ (corresponding author), INSERM, U821, F-69008 Lyon, France.	dimitri.bayle@inserm.fr	krolak-salmon, pierre/AAV-2152-2020	bayle, dimitri/0000-0003-1867-2721	Institut National de la Sante et de la Recherche Medicale (INSERM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The research was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; BALOTA DA, 1983, J VERB LEARN VERB BE, V22, P88, DOI 10.1016/S0022-5371(83)80008-5; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Baumgartner C, 2000, J CLIN NEUROPHYSIOL, V17, P177, DOI 10.1097/00004691-200003000-00007; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERSON DM, 1988, PROG BRAIN RES, V75, P17; Bish JP, 2004, NEUROSCI LETT, V362, P48, DOI 10.1016/j.neulet.2004.02.032; Bullier J, 1996, J PHYSIOLOGY-PARIS, V90, P217, DOI 10.1016/S0928-4257(97)81426-X; Carlsson K, 2004, EMOTION, V4, P340, DOI 10.1037/1528-3542.4.4.340; Carrasco M, 2003, NAT NEUROSCI, V6, P699, DOI 10.1038/nn1079; Carretie L, 2005, NEUROIMAGE, V24, P615, DOI 10.1016/j.neuroimage.2004.09.009; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Cheyne D, 2007, CLIN NEUROPHYSIOL, V118, P1691, DOI 10.1016/j.clinph.2007.05.064; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Faw B, 2003, CONSCIOUS COGN, V12, P83, DOI 10.1016/S1053-8100(02)00030-2; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Ioannides AA, 2004, NEUROIMAGE, V23, P473, DOI 10.1016/j.neuroimage.2004.06.023; KIHLSTROM JF, 1987, SCIENCE, V237, P1445, DOI 10.1126/science.3629249; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LeDoux J, 1996, PROG BRAIN RES, V107, P437; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; MARCEL PM, 1983, CAN J PSYCHOL, V37, P324; Mermillod M, 2009, CONNECT SCI, V21, P75, DOI 10.1080/09540090802213974; Mikuni N, 1997, NEUROIMAGE, V5, P298, DOI 10.1006/nimg.1997.0272; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Moses SN, 2007, BRAIN RES BULL, V71, P452, DOI 10.1016/j.brainresbull.2006.08.016; MUNK MHJ, 1995, P NATL ACAD SCI USA, V92, P988, DOI 10.1073/pnas.92.4.988; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; NIEDENTHAL PM, 1990, J EXP SOC PSYCHOL, V26, P505, DOI 10.1016/0022-1031(90)90053-O; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; PARK JY, 2008, CORTEX          0629; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; POSNER J, 2008, HUM BRAIN MAPP; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Pourtois G, 2004, EUR J NEUROSCI, V20, P3507, DOI 10.1111/j.1460-9568.2004.03794.x; Rigoulot S, 2008, BRAIN TOPOGR, V20, P216, DOI 10.1007/s10548-008-0050-9; ROBINSON SE, 2004, NEUROL CLIN NEUROPHY, P109; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; SOARES JJF, 1993, PSYCHOPHYSIOLOGY, V30, P460, DOI 10.1111/j.1469-8986.1993.tb02069.x; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Tesche CD, 1997, BRAIN RES, V749, P53, DOI 10.1016/S0006-8993(96)01286-3; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Whalen PJ, 1998, J NEUROSCI, V18, P411; Williams LM, 2004, COGNITIVE BRAIN RES, V21, P114, DOI 10.1016/j.cogbrainres.2004.06.005; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Williams MA, 2004, EXP BRAIN RES, V154, P403, DOI 10.1007/s00221-003-1740-x; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3	84	49	49	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8207	10.1371/journal.pone.0008207	http://dx.doi.org/10.1371/journal.pone.0008207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011048	Green Published, gold			2022-12-25	WOS:000272829800006
J	Link, A; Shin, SK; Nagasaka, T; Balaguer, F; Koi, M; Jung, B; Boland, CR; Goel, A				Link, Alexander; Shin, Sung Kwan; Nagasaka, Takeshi; Balaguer, Francesc; Koi, Minoru; Jung, Barbara; Boland, C. Richard; Goel, Ajay			JC Virus Mediates Invasion and Migration in Colorectal Metastasis	PLOS ONE			English	Article							T-ANTIGEN EXPRESSION; CHROMOSOMAL INSTABILITY; COLON-CANCER; PROTEINS; POLYOMAVIRUS; CELLS; DNA; IDENTIFICATION; TRANSFORMATION; ASSOCIATION	Introduction: JC Virus (JCV), a human polyomavirus, is frequently present in colorectal cancers (CRCs). JCV large T-Ag (T-Ag) expressed in approximately half of all CRC's, however, its functional role in CRC is poorly understood. We hypothesized that JCV T-Ag may mediate metastasis in CRC cells through increased migration and invasion. Material and Methods: CRC cell lines (HCT116 and SW837) were stably transfected with JCV early transcript sequences cloned into pCR3 or empty vectors. Migration and invasion assays were performed using Boyden chambers. Global gene expression analysis was performed to identify genetic targets and pathways altered by T-Ag expression. Microarray results were validated by qRT-PCR, protein expression analyses and immunohistochemistry. Matching primary CRCs and liver metastases from 33 patients were analyzed for T-Ag expression by immunohistochemistry. Results: T-Ag expressing cell lines showed 2 to 3-fold increase in migration and invasion compared to controls. JCV T-Ag expression resulted in differential expression of several genetic targets, including genes that mediate cell migration and invasion. Pathway analysis suggested a significant involvement of these genes with AKT and MAPK signaling. Treatment with selective PI3K/AKT and MAPK pathway inhibitors resulted in reduced migration and invasion. In support of our in-vitro results, immunohistochemical staining of the advanced stage tumors revealed frequent JCV T-Ag expression in metastatic primary tumors (92%) as well as in their matching liver metastasis (73%). Conclusion: These data suggest that JCV T-Ag expression in CRC associates with a metastatic phenotype, which may partly be mediated through the AKT/MAPK signaling pathway. Frequent expression of JCV T-Ag in CRC liver metastasis provides further clues supporting a mechanistic role for JCV as a possible mediator of cellular motility and invasion in CRC.	[Link, Alexander; Shin, Sung Kwan; Balaguer, Francesc; Koi, Minoru; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Div Gastroenterol,Dept Internal Med, Dallas, TX USA; [Link, Alexander; Shin, Sung Kwan; Balaguer, Francesc; Koi, Minoru; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA; [Nagasaka, Takeshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg & Surg Oncol, Okayama 7008530, Japan; [Jung, Barbara] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Link, Alexander] Otto von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Shin, Sung Kwan] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol,Div Gastroenterol, Seoul, South Korea; [Balaguer, Francesc] Univ Barcelona, IDIBAPS, CIBEREHD,Dept Gastroenterol, Inst Malalties Digest & Metab,Hosp Clin, Barcelona, Catalonia, Spain	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Okayama University; University of California System; University of California San Diego; Otto von Guericke University; Yonsei University; Yonsei University Health System; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Link, A (corresponding author), Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Div Gastroenterol,Dept Internal Med, Dallas, TX USA.	rick.boland@baylorhealth.edu; ajay.goel@baylorhealth.edu	Koi, Minoru/C-3489-2012; Balaguer, Francesc/GPX-7801-2022; Koi, Minoru/G-9197-2014; BALAGUER, FRANCESC/G-2389-2016	Shin, Sung Kwan/0000-0001-5466-1400; Balaguer, Francesc/0000-0002-0206-0539; Link, Alexander/0000-0002-9514-4562; Goel, Ajay/0000-0003-1396-6341; Nagasaka, Takeshi/0000-0002-4236-350X	National Cancer Institute [R01 CA72851, CA129286]; National Institutes of Health; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA098572, R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Boland CR, 2005, GUT, V54, P1321, DOI 10.1136/gut.2004.060079; BOLLAG B, 1992, VIRUS RES, V25, P223, DOI 10.1016/0168-1702(92)90136-W; Bollag B, 2000, VIROLOGY, V274, P165, DOI 10.1006/viro.2000.0451; Bollag B, 2006, J NEUROVIROL, V12, P428, DOI 10.1080/13550280601009553; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Del Valle L, 2002, J NEUROVIROL, V8, P138, DOI 10.1080/13550280290101111; Enam S, 2002, CANCER RES, V62, P7093; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FRISQUE RJ, 1980, J VIROL, V35, P265, DOI 10.1128/JVI.35.1.265-269.1980; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Goel A, 2006, GASTROENTEROLOGY, V130, P1950, DOI 10.1053/j.gastro.2006.02.061; Hausen HZ, 2008, P NATL ACAD SCI USA, V105, P16063, DOI 10.1073/pnas.0808973105; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; ISHAQ M, 1994, P NATL ACAD SCI USA, V91, P8283, DOI 10.1073/pnas.91.17.8283; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; [苟新敏 Gou Xinmin], 2003, [癌症, Chinese  Journal  of  Cancer], V22, P481; Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Knecht H, 2001, ONCOLOGY-BASEL, V60, P289, DOI 10.1159/000058523; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; Morris MA, 2008, EUR J CELL BIOL, V87, P677, DOI 10.1016/j.ejcb.2008.03.005; Nosho K, 2009, NEOPLASIA, V11, P87, DOI 10.1593/neo.81188; PADGETT BL, 1976, J INFECT DIS, V133, P686, DOI 10.1093/infdis/133.6.686; PADGETT BL, 1977, CANCER RES, V37, P718; Querbes W, 2004, J VIROL, V78, P250, DOI 10.1128/JVI.78.1.250-256.2004; Ravichandran V, 2007, J VIROL, V81, P6412, DOI 10.1128/JVI.02658-06; Ricciardiello L, 2003, CANCER RES, V63, P7256; Ricciardiello L, 2001, J VIROL, V75, P1996, DOI 10.1128/JVI.75.4.1996-2001.2001; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Saglam O, 2007, CLIN COLORECTAL CANC, V6, P652, DOI 10.3816/CCC.2007.n.034; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Schmitz KJ, 2007, VIRCHOWS ARCH, V450, P151, DOI 10.1007/s00428-006-0342-y; Shaw Leslie M., 2004, V294, P97; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0; TROWBRIDGE PW, 1995, J NEUROVIROL, V1, P195, DOI 10.3109/13550289509113966; VARAKIS J, 1978, CANCER RES, V38, P1718; Verma S, 2006, VIROLOGY, V345, P457, DOI 10.1016/j.virol.2005.10.012; White MK, 2005, EUR J CANCER, V41, P2537, DOI 10.1016/j.ejca.2005.08.019; Zur Hausen H, 2001, ONCOGENE, V20, P7820, DOI 10.1038/sj.onc.1204958	44	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8146	10.1371/journal.pone.0008146	http://dx.doi.org/10.1371/journal.pone.0008146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997600	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829000007
J	Dessing, MC; Hirst, RA; de Vos, AF; van der Poll, T				Dessing, Mark C.; Hirst, Robert A.; de Vos, Alex F.; van der Poll, Tom			Role of Toll-Like Receptors 2 and 4 in Pulmonary Inflammation and Injury Induced by Pneumolysin in Mice	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE PNEUMOLYSIN; INDUCED LUNG INFLAMMATION; LIPOTEICHOIC ACID LTA; CELL-WALL; LIPOPOLYSACCHARIDE; INDUCTION; VIRULENCE; RECOGNITION; PROTEIN; MD-2	Background: Pneumolysin (PLN) is an intracellular toxin of Streptococcus pneumoniae that has been implicated as a major virulence factor in infections caused by this pathogen. Conserved bacterial motifs are recognized by the immune system by pattern recognition receptors among which the family of Toll-like receptors (TLRs) prominently features. The primary objective of the present study was to determine the role of TLR2 and TLR4 in lung inflammation induced by intrapulmonary delivery of PLN. Methodology/Results: First, we confirmed that purified PLN activates cells via TLR4 (not via TLR2) in vitro, using human embryonic kidney cells transfected with either TLR2 or TLR4. Intranasal administration of PLN induced an inflammatory response in the pulmonary compartment of mice in vivo, as reflected by influx of neutrophils, release of proinflammatory cytokines and chemokines, and a rise in total protein concentrations in bronchoalveolar lavage fluid. These PLN-induced responses were dependent in part, not only on TLR4, but also on TLR2, as indicated by studies using TLR deficient mice. Conclusion: These data suggest that although purified PLN is recognized by TLR4 in vitro, PLN elicits lung inflammation in vivo by mechanisms that may involve multiple TLRs.	[Dessing, Mark C.; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [Dessing, Mark C.; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Hirst, Robert A.] Univ Leicester, Dept Infect Inflammat & Immun, Leicester, Leics, England	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Leicester	Dessing, MC (corresponding author), Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands.	m.c.dessing@amc.uva.nl	Hirst, Robert/AAD-1649-2022	Hirst, Robert Anthony/0000-0003-1989-1790	Academic Medical Center, Amsterdam, The Netherlands	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government)	Mark Dessing was supported by an institutional research grant from the Academic Medical Center, Amsterdam, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander JE, 1998, MICROB PATHOGENESIS, V24, P167, DOI 10.1006/mpat.1997.0185; Benton KA, 1997, INFECT IMMUN, V65, P1237, DOI 10.1128/IAI.65.4.1237-1244.1997; Bernatoniene J, 2008, J INFECT DIS, V198, P1823, DOI 10.1086/593177; Bernstein JM, 1999, CHEST, V115, p9S, DOI 10.1378/chest.115.suppl_1.9S; BERRY AM, 1992, MICROB PATHOGENESIS, V12, P87, DOI 10.1016/0882-4010(92)90111-Z; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Campbell GD, 1999, CHEST, V115, p14S, DOI 10.1378/chest.115.suppl_1.14S; Cockeran R, 2002, J INFECT DIS, V186, P562, DOI 10.1086/341563; Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Ellingsen EA, 2002, MED SCI MONITOR, V8, pBR149; FELDMAN C, 1990, MICROB PATHOGENESIS, V9, P275, DOI 10.1016/0882-4010(90)90016-J; FELDMAN C, 1991, AM J RESP CELL MOL, V5, P416, DOI 10.1165/ajrcmb/5.5.416; Ha UH, 2008, J BIOL CHEM, V283, P30624, DOI 10.1074/jbc.M802519200; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Hoshino K, 1999, J IMMUNOL, V162, P3749; HOULDSWORTH S, 1994, INFECT IMMUN, V62, P1501, DOI 10.1128/IAI.62.4.1501-1503.1994; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; JOHNSON MK, 1977, FEMS MICROBIOL LETT, V2, P243; KANCLERSKI K, 1987, J CLIN MICROBIOL, V25, P222, DOI 10.1128/JCM.25.2.222-225.1987; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Maus UA, 2004, J IMMUNOL, V173, P1307, DOI 10.4049/jimmunol.173.2.1307; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; MITCHELL TJ, 1989, BIOCHIM BIOPHYS ACTA, V1007, P67, DOI 10.1016/0167-4781(89)90131-0; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PATON JC, 1983, INFECT IMMUN, V41, P1212, DOI 10.1128/IAI.41.3.1212-1216.1983; Paton JC, 1996, TRENDS MICROBIOL, V4, P103, DOI 10.1016/0966-842X(96)81526-5; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Rijneveld AW, 2002, J INFECT DIS, V185, P123, DOI 10.1086/338008; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9	46	30	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7993	10.1371/journal.pone.0007993	http://dx.doi.org/10.1371/journal.pone.0007993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956717	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500022
J	Stauber, M; Sachidanandan, C; Morgenstern, C; Ish-Horowicz, D				Stauber, Michael; Sachidanandan, Chetana; Morgenstern, Christina; Ish-Horowicz, David			Differential Axial Requirements for Lunatic Fringe and Hes7 Transcription during Mouse Somitogenesis	PLOS ONE			English	Article							SOMITE SEGMENTATION CLOCK; CENTRAL-NERVOUS-SYSTEM; PRESOMITIC MESODERM; DYNAMIC EXPRESSION; NOTCH PATHWAY; ZEBRAFISH SOMITOGENESIS; OSCILLATOR MECHANISM; PARAXIAL MESODERM; DEFICIENT MICE; GENE	Vertebrate segmentation is regulated by the "segmentation clock'', which drives cyclic expression of several genes in the caudal presomitic mesoderm (PSM). One such gene is Lunatic fringe (Lfng), which encodes a modifier of Notch signalling, and which is also expressed in a stripe at the cranial end of the PSM, adjacent to the newly forming somite border. We have investigated the functional requirements for these modes of Lfng expression during somitogenesis by generating mice in which Lfng is expressed in the cranial stripe but strongly reduced in the caudal PSM, and find that requirements for Lfng activity alter during axial growth. Formation of cervical, thoracic and lumbar somites/vertebrae, but not sacral and adjacent tail somites/vertebrae, depends on caudal, cyclic Lfng expression. Indeed, the sacral region segments normally in the complete absence of Lfng and shows a reduced requirement for another oscillating gene, Hes7, indicating that the architecture of the clock alters as segmentation progresses. We present evidence that Lfng controls dorsal-ventral axis specification in the tail, and also suggest that Lfng controls the expression or activity of a long-range signal that regulates axial extension.	[Stauber, Michael; Sachidanandan, Chetana; Morgenstern, Christina; Ish-Horowicz, David] London Res Inst, Canc Res UK, Lab Dev Genet, London, England	Cancer Research UK	Stauber, M (corresponding author), Hannover Med Sch, Inst Mol Biol OE5250, D-30623 Hannover, Germany.	david.horowicz@cancer.org.uk		Morgenstern, Christina/0000-0003-2943-9634; Ish-Horowicz, David/0000-0001-5684-7129	Cancer Research UK; Max Planck Society	Cancer Research UK(Cancer Research UK); Max Planck Society(Max Planck Society)	This research was funded by Cancer Research UK, and an Otto Hahn Medal fellowship of the Max Planck Society (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Blair SS, 2000, CURR BIOL, V10, pR608, DOI 10.1016/S0960-9822(00)00633-3; Blanc V, 2005, MOL CELL BIOL, V25, P7260, DOI 10.1128/MCB.25.16.7260-7269.2005; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen J, 2005, GENESIS, V43, P196, DOI 10.1002/gene.20171; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Elmasri H, 2004, GENE EXPR PATTERNS, V4, P553, DOI 10.1016/j.modgep.2004.02.003; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gossler A., 2002, MOUSE DEV, P127; Gridley T, 2006, DEV DYNAM, V235, P2330, DOI 10.1002/dvdy.20850; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Hahn KL, 2009, REPRODUCTION, V137, P79, DOI 10.1530/REP-08-0207; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Holley SA, 2002, DEVELOPMENT, V129, P1175; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kageyama R, 2007, DEV DYNAM, V236, P1403, DOI 10.1002/dvdy.21114; Kaufman MH, 1994, ATLAS MOUSE DEV; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Leve C, 2001, DEV GENES EVOL, V211, P493, DOI 10.1007/s00427-001-0181-4; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; OKA C, 1995, DEVELOPMENT, V121, P3291; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Prince VE, 2001, MECH DEVELOP, V105, P175, DOI 10.1016/S0925-4773(01)00398-7; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Sato Y, 2002, DEVELOPMENT, V129, P3633; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; TAM PPL, 1994, ANAT EMBRYOL, V189, P275; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; WALLIN J, 1994, DEVELOPMENT, V120, P1109; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Wilson V, 1996, MECH DEVELOP, V55, P79, DOI 10.1016/0925-4773(95)00493-9; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	74	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7996	10.1371/journal.pone.0007996	http://dx.doi.org/10.1371/journal.pone.0007996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956724	Green Submitted, gold, Green Published			2022-12-25	WOS:000272827500023
J	Kingsley, C; Peters, B; Babaahmady, K; Pomeroy, L; Rahman, D; Vaughan, R; Lehner, T				Kingsley, Cherry; Peters, Barry; Babaahmady, Kaboutar; Pomeroy, Laura; Rahman, Durdana; Vaughan, Robert; Lehner, Thomas			Heterosexual and Homosexual Partners Practising Unprotected Sex May Develop Allogeneic Immunity and to a Lesser Extent Tolerance	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; MUCOSAL ALLOIMMUNIZATION; HIV-1; TRANSMISSION; RESPONSES; DISEASE; SURFACE; TYPE-1	Background: Epidemiological studies suggest that allogeneic immunity may inhibit HIV-1 transmission from mother to baby and is less frequent in multiparous than uniparous women. Alloimmune responses may also be elicited during unprotected heterosexual intercourse, which is associated ex vivo with resistance to HIV infection. Methodology/Principal Findings: The investigation was carried out in well-defined heterosexual and homosexual monogamous partners, practising unprotected sex and a heterosexual cohort practising protected sex. Allogeneic CD4(+) and CD8(+) T cell proliferative responses were elicited by stimulating PBMC with the partners' irradiated monocytes and compared with 3(rd) party unrelated monocytes, using the CFSE method. Significant increase in allogeneic proliferative responses was found in the CD4(+) and CD8(+) T cells to the partners' irradiated monocytes, as compared with 3(rd) party unrelated monocytes (p <= 0.001). However, a significant decrease in proliferative responses, especially of CD8(+) T cells to the partners' compared with 3(rd) party monocytes was consistent with tolerization, in both the heterosexual and homosexual partners (p<0.01). Examination of CD4(+)CD25(+)FoxP3(+) regulatory T cells by flow cytometry revealed a significantly greater proportion of these cells in the homosexual than heterosexual partners practising unprotected sex (p<0.05). Ex vivo studies of infectivity of PBMC with HIV-1 showed significantly greater inhibition of infectivity of PBMC from heterosexual subjects practising unprotected compared with those practising protected sex (p = 0.02). Conclusions/Significance: Both heterosexual and homosexual monogamous partners practising unprotected sex develop allogeneic CD4(+) and CD8(+) T cell proliferative responses to the partners' unmatched cells and a minority may be tolerized. However, a greater proportion of homosexual rather than heterosexual partners developed CD4(+)CD25FoxP3(+) regulatory T cells. These results, in addition to finding greater inhibition of HIV-1 infectivity in PBMC ex vivo in heterosexual partners practising unprotected, compared with those practising protected sex, suggest that allogeneic immunity may play a significant role in the immuno-pathogenesis of HIV-1 infection.	[Kingsley, Cherry; Babaahmady, Kaboutar; Rahman, Durdana; Lehner, Thomas] Guys Hosp, Kings Coll London, Mucosal Immunol Unit, London SE1 9RT, England; [Peters, Barry; Pomeroy, Laura] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England; [Vaughan, Robert] Guys Hosp, Kings Coll London, Dept Tissue Typing, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Kingsley, C (corresponding author), Guys Hosp, Kings Coll London, Mucosal Immunol Unit, London SE1 9RT, England.	thomas.lehner@kcl.ac.uk			St. Thomas' Charitable Foundation; European Union Europrise [LSHP-CT-2006-037611]	St. Thomas' Charitable Foundation; European Union Europrise	This project was supported by the Guy's and St. Thomas' Charitable Foundation and the European Union Europrise (LSHP-CT-2006-037611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Bergmeier LA, 2005, J GEN VIROL, V86, P2231, DOI 10.1099/vir.0.80802-0; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Furci L, 1997, J EXP MED, V186, P455, DOI 10.1084/jem.186.3.455; Jarvinen LZ, 2003, TRANSPLANTATION, V76, P1375, DOI 10.1097/01.TP.0000093462.16309.73; Jeffrey PL, 2009, EUR J IMMUNOL, V39, P1956, DOI 10.1002/eji.200939228; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; KIND C, 1995, EUR J PEDIATR, V154, P542, DOI 10.1007/s004310050339; Koelman CA, 2000, J REPROD IMMUNOL, V46, P155, DOI 10.1016/S0165-0378(99)00062-5; Kristiansen TB, 2001, J IMMUNOL METHODS, V252, P147, DOI 10.1016/S0022-1759(01)00349-0; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; Martin-Fontecha A, 2008, J EXP MED, V205, P2561, DOI 10.1084/jem.20081212; Peters B, 2004, LANCET, V363, P518, DOI 10.1016/S0140-6736(04)15538-4; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Steger U, 2006, TRANSPLANTATION, V82, P1202, DOI 10.1097/01.tp.0000235913.58337.b4; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7938	10.1371/journal.pone.0007938	http://dx.doi.org/10.1371/journal.pone.0007938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956755	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827300003
J	de Marco, MDF; Alejo, A; Hudson, P; Damon, IK; Alcami, A				del Mar Fernandez de Marco, Maria; Alejo, Ali; Hudson, Paul; Damon, Inger K.; Alcami, Antonio			The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon	FASEB JOURNAL			English	Article						immune modulation; cytokine; infection; smallpox; vaccine	VACCINIA VIRUS; IMMUNE EVASION; ALPHA/BETA INTERFERON; POXVIRUS INFECTION; ANTIVIRAL ACTIVITY; HUMAN-COMPLEMENT; III INTERFERONS; BINDING-PROTEIN; HOST RESPONSE; RECEPTOR	Variola virus (VARV) caused smallpox, one of the most devastating human diseases and the first to be eradicated, but its deliberate release represents a dangerous threat. Virulent orthopoxviruses infecting humans, such as monkeypox virus (MPXV), could fill the niche left by smallpox eradication and the cessation of vaccination. However, immunomodulatory activities and virulence determinants of VARV and MPXV remain largely unexplored. We report the molecular characterization of the VARV- and MPXV-secreted type I interferon-binding proteins, which interact with the cell surface after secretion and prevent type I interferon responses. The proteins expressed in the baculovirus system have been purified, and their interferon-binding properties characterized by surface plasmon resonance. The ability of these proteins to inhibit a broad range of interferons was investigated to identify potential adaptation to the human immune system. Furthermore, we demonstrate by Western blot and activity assays the expression of the type I interferon inhibitor during VARV and MPXV infections. These findings are relevant for the design of new vaccines and therapeutics to smallpox and emergent virulent orthopoxviruses because the type I interferon-binding protein is a major virulence factor in animal models, vaccination with this protein induces protective immunity, and its neutralization prevents disease progression.-Fernandez de Marco, M. M., Alejo, A., Hudson, P., Damon, I. K., Alcami, A. The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. FASEB J. 24, 1479-1488 (2010). www.fasebj.org	[del Mar Fernandez de Marco, Maria; Alcami, Antonio] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Alejo, Ali] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain; [Hudson, Paul; Damon, Inger K.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Alcami, Antonio] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Centers for Disease Control & Prevention - USA; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Alcami, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera,1 Campus Canto Blanco, E-28049 Madrid, Spain.	aalcami@cbm.uam.es	Alejo, Ali/AAF-1477-2020; Alcami, Antonio/F-8512-2015	Alejo, Ali/0000-0002-1613-6063; Alcami, Antonio/0000-0002-3333-6016	Wellcome Trust; European Union; Spanish Ministry of Science and Innovation; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank R. Martin for excellent technical assistance and Sylvia Gutierrez Erlandsson for help with microscopy. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This work was funded by the Wellcome Trust and the European Union. A. Alejo was supported by a Ramon y Cajal contract (Spanish Ministry of Science and Innovation). This article is dedicated to the memory of Riccardo Wittek.	Alcami A, 1996, COMP IMMUNOL MICROB, V19, P305, DOI 10.1016/0147-9571(96)00013-6; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Bartlett NW, 2005, J GEN VIROL, V86, P1589, DOI 10.1099/vir.0.80904-0; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Brunetti CR, 2003, P NATL ACAD SCI USA, V100, P4831, DOI 10.1073/pnas.0737244100; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; DAVIES MV, 1992, J VIROL, V66, P1943, DOI 10.1128/JVI.66.4.1943-1950.1992; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Dunlop LR, 2003, MICROBES INFECT, V5, P1049, DOI 10.1016/S1286-4579(03)00194-1; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Kim M, 2004, J BIOL CHEM, V279, P25838, DOI 10.1074/jbc.M400343200; Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Rubins KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002628; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511; Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; Stanford MM, 2007, IMMUNOL CELL BIOL, V85, P93, DOI 10.1038/sj.icb.7100033; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; Verardi PH, 2001, J VIROL, V75, P11, DOI 10.1128/JVI.75.1.11-18.2001; Waibler Z, 2009, J VIROL, V83, P1563, DOI 10.1128/JVI.01617-08; Weaver JR, 2008, IMMUNOL REV, V225, P96, DOI 10.1111/j.1600-065X.2008.00691.x; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854; Yadav VN, 2008, J VIROL, V82, P3283, DOI 10.1128/JVI.01935-07; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	45	21	21	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1479	1488		10.1096/fj.09-144733	http://dx.doi.org/10.1096/fj.09-144733			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20019241	Green Published, hybrid			2022-12-25	WOS:000277158900020
J	Jeong, BS; Hu, WW; Belyi, V; Rabadan, R; Levine, AJ				Jeong, Byeong-Seon; Hu, Wenwei; Belyi, Vladimir; Rabadan, Raul; Levine, Arnold J.			Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis	FASEB JOURNAL			English	Article						single nucleotide polymorphism; transcription regulation	SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR-SUPPRESSOR PATHWAY; WILD-TYPE P53; CANCER; MDM2; CELL; SUSCEPTIBILITY; HAPLOTYPES; VARIANTS; GROWTH	Human populations contain a functional coding polymorphism (codon 72) in the p53 gene. To explore whether this polymorphism alters the transcriptional pattern of p53-regulated genes, the human isogenic cell lines harboring p53 with either the proline or arginine at codon 72 were employed to activate p53-mediated transcription. Thirty-four p53-regulated genes were assayed for their increased levels of mRNA using quantitative real-time PCR. The largest difference between p53-arginine and p53-proline was found with the PERP gene involved in cell-cell adhesion and apoptosis. The most common set of genes that are transcribed better by the p53-arginine protein than the p53-proline protein was found in the apoptotic function (DR-4, NOXA, PUMA, and PIG-3). LIF, a cytokine that is required for optimal reproductive function, was produced at 2 x higher levels by the p53-arginine than the p53-proline allele. The genes that induced their mRNAs at the highest levels compared to the baseline tended to be synthesized better by the p53-arginine protein than the p53-proline protein. These molecular studies may help to explain the complicated associations observed between this polymorphism and the incidence of some cancers, the longevity of some populations, and the fecundity of different groups.-Jeong, B.-S., Hu, W., Belyi, V., Rabadan, R., Levine, A. J. Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis. FASEB J. 24, 1347-1353 (2010). www.fasebj.org	[Levine, Arnold J.] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA; [Jeong, Byeong-Seon; Hu, Wenwei; Levine, Arnold J.] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ USA; [Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY USA	Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Columbia University	Levine, AJ (corresponding author), Inst Adv Study, Sch Nat Sci, Einstein Dr, Princeton, NJ 08540 USA.	alevine@ias.edu	Rabadan, Raul/AAZ-7367-2020	Rabadan, Raul/0000-0001-7946-9255				Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Attardi LD, 2000, GENE DEV, V14, P704; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; BIRGANDER R, 1995, CARCINOGENESIS, V16, P2233, DOI 10.1093/carcin/16.9.2233; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Granja F, 2004, CANCER LETT, V210, P151, DOI 10.1016/j.canlet.2004.01.016; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hu WW, 2008, CELL CYCLE, V7, P848, DOI 10.4161/cc.7.7.5658; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Ihrie RA, 2005, CELL CYCLE, V4, P873, DOI 10.4161/cc.4.7.1836; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Karlan BY, 2003, GYNECOL ONCOL, V88, pS11, DOI 10.1006/gyno.2002.6675; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Komarova EA, 1998, ONCOGENE, V17, P1089, DOI 10.1038/sj.onc.1202303; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murphy ME, 2006, CELL DEATH DIFFER, V13, P916, DOI 10.1038/sj.cdd.4401907; Orsted DD, 2007, J EXP MED, V204, P1295, DOI 10.1084/jem.20062476; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Salvioli S, 2005, CELL CYCLE, V4, P1264, DOI 10.4161/cc.4.9.1978; Shi H, 2009, AM J HUM GENET, V84, P534, DOI 10.1016/j.ajhg.2009.03.009; Sjalander A, 1996, CARCINOGENESIS, V17, P1313, DOI 10.1093/carcin/17.6.1313; Strong LC, 2003, GYNECOL ONCOL, V88, pS4, DOI 10.1006/gyno.2002.6673; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; van Heemst D, 2005, EXP GERONTOL, V40, P11, DOI 10.1016/j.exger.2004.10.001; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; WESTON A, 1994, CARCINOGENESIS, V15, P583, DOI 10.1093/carcin/15.4.583; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277	44	49	50	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1347	1353		10.1096/fj.09-146001	http://dx.doi.org/10.1096/fj.09-146001			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20019240				2022-12-25	WOS:000277158900008
J	Pulkkinen, V; Bruce, S; Rintahaka, J; Hodgson, U; Laitinen, T; Alenius, H; Kinnula, VL; Myllarniemi, M; Matikainen, S; Kere, J				Pulkkinen, Ville; Bruce, Sara; Rintahaka, Johanna; Hodgson, Ulla; Laitinen, Tarja; Alenius, Harri; Kinnula, Vuokko L.; Myllarniemi, Marjukka; Matikainen, Sampsa; Kere, Juha			ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses	FASEB JOURNAL			English	Article						immunology; interferon; interstitial lung disease; virus	NF-KAPPA-B; EPITHELIAL-CELLS; EXPRESSION; RECOGNITION; INTERFERON; RNA; PHAGOCYTOSIS; ANTIBODIES; VIRUSES; PATHWAY	Viral infections and abnormal host response are thought to cause epithelial injury in idiopathic pulmonary fibrosis (IPF). To understand IPF pathogenesis, we have used overexpression cell models and expression microarrays to discover genes networked with ELMO domain containing 2 (ELMOD2) gene genetically implicated in IPF. The identified pathways were confirmed in vitro, and ELMOD2 protein expression was characterized in tissue samples. Here 303 genes were significantly altered after ELMOD2 transfection of human alveolar epithelial A549 cell line. The enriched pathways were interferon induction, viral response, antigen processing and presentation, and I-/nuclear factor-kappa B signaling. ELMOD2 showed immunoreactivity in macrophages and type II alveolar epithelial cells in normal human lung. In A549 cells, forced expression of ELMOD2 increased type I and type III interferon mRNA expression, and ELMOD2- specific siRNA molecules inhibited expression of these antiviral cytokines in response to Toll- like receptor three (TLR3) activation. In human macrophages silencing of ELMOD2 inhibited TLR3-dependent expression of type I and type III interferon genes. Influenza A virus infection decreased ELMOD2 mRNA expression in A549 cells and macrophages suggesting negative regulation in viral infections. In summary, our results show that TLR3 pathway is dependent on ELMOD2.-Pulkkinen, V., Bruce, S., Rintahaka, J., Hodgson, U., Laitinen, T., Alenius, H., Kinnula, V. L., Myllarniemi, M., Matikainen, S., Kere, J. ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses. FASEB J. 24, 1167-1177 (2010). www.fasebj.org	[Pulkkinen, Ville; Kere, Juha] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Hodgson, Ulla; Kinnula, Vuokko L.; Myllarniemi, Marjukka] Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland; Univ Helsinki, Div Pulm Med, FIN-00014 Helsinki, Finland; [Pulkkinen, Ville; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Bruce, Sara; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr Novum, Huddinge, Sweden; [Bruce, Sara; Kere, Juha] Karolinska Inst, Clin Res Ctr, Huddinge, Sweden; [Alenius, Harri; Matikainen, Sampsa] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [Hodgson, Ulla; Laitinen, Tarja; Kinnula, Vuokko L.; Myllarniemi, Marjukka] Univ Helsinki, Cent Hosp, Div Pulm Med, Helsinki, Finland; [Laitinen, Tarja] Univ Helsinki, Cent Hosp, Res Unit Pulm Dis, Helsinki, Finland; [Laitinen, Tarja] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Pulkkinen, V (corresponding author), Univ Helsinki, Dept Med Genet, POB 63, FIN-00014 Helsinki, Finland.	ville.pulkkinen@helsinki.fi	Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Matikainen, Sampsa/AAH-8654-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Alenius, Harri/0000-0003-0106-8923; Myllarniemi, L Marjukka/0000-0001-9343-0867	Academy of Finland; Sigrid Juselius Foundation; Jalkanen Foundation; Finnish Anti-Tuberculosis Association Foundation; Swedish Research Council and Heart and Lung Foundation (Sweden); Helsinki University Central Hospital (HUSEVO); Jalmari and Rauha Ahokas Foundation; Finnish Medical Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jalkanen Foundation; Finnish Anti-Tuberculosis Association Foundation; Swedish Research Council and Heart and Lung Foundation (Sweden)(Swedish Research Council); Helsinki University Central Hospital (HUSEVO); Jalmari and Rauha Ahokas Foundation; Finnish Medical Foundation	The authors thank Riitta Kankanen, Tiina Marjomaa, and the personnel at the Karolinska Institutes Bioinformatics and Expression Analysis Core Facility for their skillful laboratory work. Professor Ilkka Julkunen (National Institute for Health and Welfare, Helsinki, Finland) is acknowledged for providing the anti-MxA antibodies and Dr. Kaisa Salmenkivi (University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland) for providing normal lung tissue for immunohistochemical stainings. This study has been supported by the Academy of Finland, Sigrid Juselius Foundation, Sirpa and Markku Jalkanen Foundation, Finnish Anti-Tuberculosis Association Foundation, Swedish Research Council and Heart and Lung Foundation (Sweden), Helsinki University Central Hospital (HUSEVO), Jalmari and Rauha Ahokas Foundation, and Finnish Medical Foundation.	AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hodgson U, 2006, AM J HUM GENET, V79, P149, DOI 10.1086/504639; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; LUNG ML, 1985, LANCET, V1, P889; MANIKA K, 2007, DIFFUSE LUNG DIS, V24, P134; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Meliconi R, 1996, THORAX, V51, P315, DOI 10.1136/thx.51.3.315; Miettinen M, 2001, GENES IMMUN, V2, P349, DOI 10.1038/sj.gene.6363791; Myllarniemi M, 2008, J PATHOL, V214, P456, DOI 10.1002/path.2300; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; RONNI T, 1993, J IMMUNOL, V150, P1715; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; UEDA T, 1992, AM REV RESPIR DIS, V146, P266, DOI 10.1164/ajrccm/146.1.266; Vannella KM, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-2; Vendelin J, 2006, HUM MOL GENET, V15, P2923, DOI 10.1093/hmg/ddl234; Yonemaru M, 1997, EUR RESPIR J, V10, P2040, DOI 10.1183/09031936.97.10092040	38	46	49	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1167	1177		10.1096/fj.09-138545	http://dx.doi.org/10.1096/fj.09-138545			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19966137				2022-12-25	WOS:000276462300024
J	Kohler, EM; Brauburger, K; Behrens, J; Schneikert, J				Kohler, E. M.; Brauburger, K.; Behrens, J.; Schneikert, J.			Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients	ONCOGENE			English	Article						adenomatous polyposis coli; APC; beta-catenin; colon cancer; mutation	ADENOMATOUS POLYPOSIS-COLI; SOMATIC MUTATIONS; DESTRUCTION COMPLEX; SUPPRESSOR PROTEIN; CLUSTER REGION; FUNCTIONAL INTERACTION; CRYSTAL-STRUCTURE; STEM-CELLS; IN-VIVO; GENE	The adenomatous polyposis coli (APC) protein is a negative regulator of the mitogenic transcription factor beta-catenin by stimulating its proteasomal degradation. This involves several APC domains, including the binding sites for axin/conductin, the recently described beta-Catenin Inhibitory Domain (CID) and the third 20 amino acid repeat (20R3) that is a beta-catenin-binding site. The four 15 amino acid repeats (15R) and the 20R1 are also beta-catenin-binding sites, but their role in beta-catenin degradation has remained unclear. We show here that binding of beta-catenin to the 15R of APC is necessary and sufficient to target beta-catenin for degradation whereas binding to the 20R1 is neither necessary nor sufficient. The first 15R displays the highest affinity for beta-catenin in the 15R-20R1 module. Biallelic mutations of the APC gene lead to colon cancer in familial adenomatous polyposis coli (FAP) and result in the synthesis of truncated products lacking domains involved in beta-catenin degradation but still having a minimal length. The analysis of the distribution of truncating mutations along the APC sequence in colorectal tumours from FAP patients revealed that the first 15R is one target of the positive selection of mutations that lead to tumour development. Oncogene (2010) 29, 1663-1671; doi:10.1038/onc.2009.447; published online 7 December 2009	[Kohler, E. M.; Brauburger, K.; Behrens, J.; Schneikert, J.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Bayern, Germany	University of Erlangen Nuremberg	Schneikert, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Gluckstr 6, D-91054 Erlangen, Bayern, Germany.	jschneik@molmed.uni-erlangen.de		Wenzel, Eva Maria/0000-0002-5561-3344	Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Sander Stiftung	Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Sander Stiftung	We thank G Daum for technical, and A Doebler for secretarial assistances. We thank also I Wacker for critical reading of the paper. This work was supported by grants from the Interdisziplinares Zentrum fur Klinische Forschung (IZKF) and the Sander Stiftung to JB.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Clarke AR, 2006, ONCOGENE, V25, P7512, DOI 10.1038/sj.onc.1210065; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; GRODEN J, 1993, AM J HUM GENET, V52, P263; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Groves C, 2002, AM J PATHOL, V160, P2055, DOI 10.1016/S0002-9440(10)61155-8; Gupta PK, 1997, CANCER RES, V57, P1188; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Kawahara K, 2000, J BIOL CHEM, V275, P8369, DOI 10.1074/jbc.275.12.8369; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Kotiligam D, 2008, HISTOL HISTOPATHOL, V23, P117, DOI 10.14670/HH-23.117; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Latchford A, 2007, HUM MOL GENET, V16, P78, DOI 10.1093/hmg/ddl442; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Menendez M, 2008, GASTROENTEROLOGY, V134, P56, DOI 10.1053/j.gastro.2007.10.009; MIYAKI M, 1994, CANCER RES, V54, P3011; Miyaki M, 2008, INT J CANCER, V122, P2491, DOI 10.1002/ijc.23390; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; OLSCHWANG S, 1993, AM J HUM GENET, V52, P273; Peterson-Nedry W, 2008, DEV BIOL, V320, P226, DOI 10.1016/j.ydbio.2008.05.521; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1997, CANCER RES, V57, P4624; Schneikert J, 2006, INT J CANCER, V119, P74, DOI 10.1002/ijc.21826; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Tickenbrock L, 2003, J MOL BIOL, V327, P359, DOI 10.1016/S0022-2836(03)00144-X; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603	58	13	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1663	1671		10.1038/onc.2009.447	http://dx.doi.org/10.1038/onc.2009.447			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	19966865				2022-12-25	WOS:000275694700011
J	Sirvent, A; Benistant, C; Pannequin, J; Veracini, L; Simon, V; Bourgaux, JF; Hollande, F; Cruzalegui, F; Roche, S				Sirvent, A.; Benistant, C.; Pannequin, J.; Veracini, L.; Simon, V.; Bourgaux, J-F; Hollande, F.; Cruzalegui, F.; Roche, S.			Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization	ONCOGENE			English	Article						tyrosine kinase Src; oncogenic signalling; colorectal cancer; invasion; Csk	ADAPTER PROTEIN; DOWN-REGULATION; BREAST-CANCER; ENRICHED MICRODOMAINS; C-SRC; GROWTH; ACTIVATION; PHOSPHORYLATION; PROLIFERATION; ASSOCIATION	The nonreceptor tyrosine kinases of the Src family (SFK) are frequently deregulated in human colorectal cancer (CRC), and they have been implicated in tumour growth and metastasis. How SFK are activated in this cancer has not been clearly established. Here, we show that the SFK-dependent invasion is induced by inactivation of the negative regulator C-terminal Src kinase, Csk. While the level of Csk was inconsistent with SFK activity in colon cancer cells, its membrane translocation, needed for efficient regulation of membrane-localized SFK activity, was impaired. Accordingly, Csk downregulation did not affect SFK oncogenic activity in these cells, whereas expression of a membrane-localized form of this kinase affected their invasive activity. Downregulation of the transmembrane and rafts-localized Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched microdomain (PAG), was instrumental for the cytoplasmic accumulation of Csk. Re-expression of PAG in cells from late-stage CRC inhibited SFK invasive activity in a Csk-dependent manner. Conversely, inactivation of its residual expression in early-stage CRC cells promoted SFK invasive activity. Finally, this mechanism was specific to CRC as Csk coupling to SFK was readily detected in breast cancer cells. Therefore, Csk mis-localization defines a novel mechanism for SFK oncogenic activation in CRC cells. Oncogene (2010) 29, 1303-1315; doi:10.1038/onc.2009.450; published online 14 December 2009	[Sirvent, A.; Benistant, C.; Veracini, L.; Simon, V.; Roche, S.] Univ Montpellier I, CNRS, CRBM, UMR5237,Equipe Labellisee Ligue Natl Canc, F-34293 Montpellier 05, France; [Pannequin, J.; Hollande, F.] Univ Montpellier 2, IGF, Montpellier, France; [Pannequin, J.; Hollande, F.] Univ Montpellier I, INSERM, U661, UMR5203, F-34293 Montpellier 05, France; [Bourgaux, J-F] CHU Caremeau, Serv Hepatogastroenterol, Nimes, France; [Cruzalegui, F.] Inst Rech Servier, Div Canc Res & Drug Discovery, Croissy Sur Seine, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Servier; Institut de Recherches Internationales Servier	Roche, S (corresponding author), Univ Montpellier I, CNRS, CRBM, UMR5237,Equipe Labellisee Ligue Natl Canc, 1919 Route Mende, F-34293 Montpellier 05, France.	serge.roche@crbm.cnrs.fr	Benistant, Christine/M-5771-2018; Hollande, Frederic/E-3133-2013; Hollande, Frederic/GLS-4120-2022	Hollande, Frederic/0000-0002-7046-8392; pannequin, julie/0000-0002-9956-373X; roche, serge/0000-0003-3413-3859	Servier Laboratories; la Ligue Nationale Contre le Cancer; CNRS; University of Montpellier 1 and 2; l'Association pour la Recherche contre le Cancer (ARC); INCa;  [4025]	Servier Laboratories; la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Montpellier 1 and 2; l'Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); INCa(Institut National du Cancer (INCA) France); 	We thank M Okada, S Parsons, P Mangeat and N Morin for various reagents; C Naudin, G Collin and C Leroy for technical assistance; Sylvain De Rossi and Virginie Georget (Montpellier RIO Imaging platform) for confocal microscopy analysis; and J Hickmann for helpful discussion. This work was supported by Servier Laboratories, la Ligue Nationale Contre le Cancer, the CNRS, the University of Montpellier 1 and 2 and l'Association pour la Recherche contre le Cancer (ARC, n<SUP>o</SUP> 4025). AS was supported by Servier Laboratories and by the INCa. SR and CB are INSERM investigators.	Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Benistant C, 2001, CANCER RES, V61, P1415; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boureux A, 2005, J CELL SCI, V118, P3717, DOI 10.1242/jcs.02491; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Cam WR, 2001, CANCER, V92, P61, DOI 10.1002/1097-0142(20010701)92:1<61::AID-CNCR1292>3.0.CO;2-D; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Collin G, 2007, MOL CELL BIOL, V27, P7631, DOI 10.1128/MCB.00543-07; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar RC, 2004, J BIOL CHEM, V279, P23773, DOI 10.1074/jbc.M312368200; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KOEGL M, 1994, BIOCHEM J, V302, P737, DOI 10.1042/bj3020737; Kunte DP, 2005, FEBS LETT, V579, P3497, DOI 10.1016/j.febslet.2005.05.030; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Nusrat A, 2000, J CELL SCI, V113, P1771; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Pannequin J, 2007, GASTROENTEROLOGY, V133, P1554, DOI 10.1053/j.gastro.2007.08.023; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Saito K, 2008, BIOCHEM BIOPH RES CO, V366, P969, DOI 10.1016/j.bbrc.2007.12.055; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Stewart RA, 2003, ONCOGENE, V22, P6436, DOI 10.1038/sj.onc.1206820; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Tauzin S, 2008, BLOOD, V111, P2310, DOI 10.1182/blood-2007-05-090985; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Veracini L, 2008, J CELL BIOL, V182, P603, DOI 10.1083/jcb.200705102; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321; Zhu S, 2008, ONCOGENE, V27, P2027, DOI 10.1038/sj.onc.1210838; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	47	47	47	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1303	1315		10.1038/onc.2009.450	http://dx.doi.org/10.1038/onc.2009.450			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	20010872	Green Submitted			2022-12-25	WOS:000275170600006
J	Massip, L; Garand, C; Labbe, A; Perreault, E; Turaga, RVN; Bohr, VA; Lebel, M				Massip, L.; Garand, C.; Labbe, A.; Perreault, E.; Turaga, R. V. N.; Bohr, V. A.; Lebel, M.			Depletion of WRN protein causes RACK1 to activate several protein kinase C isoforms	ONCOGENE			English	Article						Werner syndrome; mass spectrometry; RACK1; PKC activation	WERNER-SYNDROME PROTEIN; OXIDATIVE STRESS; DNA-DAMAGE; FUNCTIONAL INTERACTION; BETA; PHOSPHORYLATION; DELTA; TRANSLOCATION; EPSILON; BREAKS	Werner's syndrome (WS) is a rare autosomal disease characterized by the premature onset of several age-associated pathologies. The protein defective in patients with WS (WRN) is a helicase/exonuclease involved in DNA repair, replication, transcription and telomere maintenance. In this study, we show that a knock down of the WRN protein in normal human fibroblasts induces phosphorylation and activation of several protein kinase C (PKC) enzymes. Using a tandem affinity purification strategy, we found that WRN physically and functionally interacts with receptor for activated C-kinase 1 (RACK1), a highly conserved anchoring protein involved in various biological processes, such as cell growth and proliferation. RACK1 binds strongly to the RQC domain of WRN and weakly to its acidic repeat region. Purified RACK1 has no impact on the helicase activity of WRN, but selectively inhibits WRN exonuclease activity in vitro. Interestingly, knocking down RACK1 increased the cellular frequency of DNA breaks. Depletion of the WRN protein in return caused a fraction of nuclear RACK1 to translocate out of the nucleus to bind and activate PKC delta and PKC beta II in the membrane fraction of cells. In contrast, different DNA-damaging treatments known to activate PKCs did not induce RACK1/PKCs association in cells. Overall, our results indicate that a depletion of the WRN protein in normal fibroblasts causes the activation of several PKCs through translocation and association of RACK1 with such kinases. Oncogene (2010) 29, 1486-1497; doi:10.1038/onc.2009.443; published online 7 December 2009	[Massip, L.; Garand, C.; Labbe, A.; Perreault, E.; Turaga, R. V. N.; Lebel, M.] Univ Laval, Hop Hotel Dieu, Dept Mol Biol Med Biochem & Pathol, Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada; [Bohr, V. A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Laval University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lebel, M (corresponding author), Univ Laval, Hop Hotel Dieu, Dept Mol Biol Med Biochem & Pathol, Ctr Rech Cancerol, 9 McMahon St, Quebec City, PQ G1R 2J6, Canada.	michel.lebel@crhdq.ulaval.ca	Bohr, Vilhelm/AAP-5931-2020; Perreault, Eric/B-7632-2009	Garand, Chantal/0000-0003-0716-6487	Canadian Institutes of Health Research; National Institute on Aging, NIH; Fonds de la Recherche en Sante du Quebec; NATIONAL INSTITUTE ON AGING [ZIAAG000721] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Mrs N Roberge for the FACS analyses (Centre de Recherche en Cancerologie, Quebec City, Qc). This study was supported by the Canadian Institutes of Health Research to ML and in part by funds from the intramural Program of the National Institute on Aging, NIH to VAB. ML is a senior scholar from the Fonds de la Recherche en Sante du Quebec.	Battaini F, 1997, TRENDS NEUROSCI, V20, P410, DOI 10.1016/S0166-2236(97)01084-9; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Brosh RM, 2001, EMBO J, V20, P5791; Cheng WH, 2008, MOL BIOL CELL, V19, P3923, DOI 10.1091/mbc.E07-07-0698; Cheng WH, 2007, EXP GERONTOL, V42, P871, DOI 10.1016/j.exger.2007.04.011; Cooper MP, 2000, GENE DEV, V14, P907; Corsini E, 2005, J LEUKOCYTE BIOL, V77, P247, DOI 10.1189/jlb.0504268; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Davis T, 2007, ANN NY ACAD SCI, V1100, P455, DOI 10.1196/annals.1395.051; Davis T, 2009, BIOGERONTOLOGY, V10, P253, DOI 10.1007/s10522-008-9179-x; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Egidy G, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-34; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; Indig FE, 2004, J STRUCT BIOL, V146, P251, DOI 10.1016/j.jsb.2003.11.009; Kaneto H, 2005, CURR DIABETES REV, V1, P65, DOI 10.2174/1573399052952613; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Kohda Y, 2005, J PHARMACOL SCI, V98, P49, DOI 10.1254/jphs.FP0040926; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011; MASSIP L, 2009, FASEB J; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Melcher R, 2000, CYTOGENET CELL GENET, V91, P180, DOI 10.1159/000056841; Min W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-8; Nitti M, 2008, MOL ASPECTS MED, V29, P36, DOI 10.1016/j.mam.2007.09.001; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Ottaviani E, 2001, COMP BIOCHEM PHYS C, V129, P295, DOI 10.1016/S1532-0456(01)00211-3; Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pascale A, 1996, J NEUROCHEM, V67, P2471; Pass JM, 2001, AM J PHYSIOL-HEART C, V281, pH2500, DOI 10.1152/ajpheart.2001.281.6.H2500; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Slager RE, 2008, J HISTOCHEM CYTOCHEM, V56, P7, DOI 10.1369/jhc.7A7249.2007; Stawowy P, 2005, CARDIOVASC RES, V67, P50, DOI 10.1016/j.cardiores.2005.03.002; Szekely AM, 2005, MOL CELL BIOL, V25, P10492, DOI 10.1128/MCB.25.23.10492-10506.2005; Turaga RVN, 2007, AGING CELL, V6, P471, DOI 10.1111/j.1474-9726.2007.00301.x; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134	53	12	12	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1486	1497		10.1038/onc.2009.443	http://dx.doi.org/10.1038/onc.2009.443			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19966859	Green Accepted			2022-12-25	WOS:000275392400007
J	Hundsrucker, C; Skroblin, P; Christian, F; Zenn, HM; Popara, V; Joshi, M; Eichhorst, J; Wiesner, B; Herberg, FW; Reif, B; Rosenthal, W; Klussmann, E				Hundsrucker, Christian; Skroblin, Philipp; Christian, Frank; Zenn, Hans-Michael; Popara, Viola; Joshi, Mangesh; Eichhorst, Jenny; Wiesner, Burkhard; Herberg, Friedrich W.; Reif, Bernd; Rosenthal, Walter; Klussmann, Enno			Glycogen Synthase Kinase 3 beta Interaction Protein Functions as an A-kinase Anchoring Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PRINCIPAL CELLS; PKA REGULATORY SUBUNITS; PHASE PEPTIDE-SYNTHESIS; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; SCAFFOLDING PROTEINS; DIFFICULT SEQUENCES; AKAP BINDING; PHOSPHORYLATION; GSK-3-BETA	A-kinase anchoring proteins (AKAPs) include a family of scaffolding proteins that target protein kinase A (PKA) and other signaling proteins to cellular compartments and thereby confine the activities of the associated proteins to distinct regions within cells. AKAPs bind PKA directly. The interaction is mediated by the dimerization and docking domain of regulatory subunits of PKA and the PKA-binding domain of AKAPs. Analysis of the interactions between the dimerization and docking domain and various PKA-binding domains yielded a generalized motif allowing the identification of AKAPs. Our bioinformatics and peptide array screening approaches based on this signature motif identified GSKIP (glycogen synthase kinase 3 beta interaction protein) as an AKAP. GSKIP directly interacts with PKA and GSK3 beta (glycogen synthase kinase 3 beta). It is widely expressed and facilitates phosphorylation and thus inactivation of GSK3 beta by PKA. GSKIP contains the evolutionarily conserved domain of unknown function 727. We show here that this domain of GSKIP and its vertebrate orthologues binds both PKA and GSK3 beta and thereby provides a mechanism for the integration of PKA and GSK3 beta signaling pathways.	[Hundsrucker, Christian; Skroblin, Philipp; Christian, Frank; Popara, Viola; Joshi, Mangesh; Eichhorst, Jenny; Wiesner, Burkhard; Reif, Bernd; Klussmann, Enno] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Zenn, Hans-Michael; Herberg, Friedrich W.] Univ Kassel, Inst Biol, D-34134 Kassel, Germany; [Rosenthal, Walter] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Rosenthal, Walter] Charite, Dept Mol Pharmacol & Cell Biol, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Universitat Kassel; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klussmann, E (corresponding author), Leibniz Inst Mol Pharmacol, Campus Berlin Buch,Robert Rossle Str 10, D-13125 Berlin, Germany.	klussmann@fmp-berlin.de	Herberg, Friedrich W/B-5572-2015	Herberg, Friedrich W/0000-0001-7117-7653; Skroblin, Philipp/0000-0003-0321-3493; Reif, Bernd/0000-0001-7368-7198; Christian, Frank/0000-0001-8208-5930	Deutsche Forschungsgemeinschaft Forschergruppe 806 [KL1415/4-1]; European Union [037189]; German Ministry of Education and Science [FKZ 0315097, 0315516]	Deutsche Forschungsgemeinschaft Forschergruppe 806(German Research Foundation (DFG)); European Union(European Commission); German Ministry of Education and Science	This work was supported by Deutsche Forschungsgemeinschaft Forschergruppe 806, Project KL1415/4-1, the European Union Project Thera cAMP, Proposal 037189, and the GoBio Program of the German Ministry of Education and Science Grants FKZ 0315097 and 0315516.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Billadeau DD, 2007, PANCREATOLOGY, V7, P398, DOI 10.1159/000108955; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Dodge-Kafka K. L., 2008, V186, P3, DOI 10.1007/978-3-540-72843-6_1; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Han JD, 1997, J BIOL CHEM, V272, P26611, DOI 10.1074/jbc.272.42.26611; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; HOUSLAY MD, 2006, SCI STKE, pE32; Hundsrucker C., 2008, V186, P483, DOI 10.1007/978-3-540-72843-6_20; HUNDSRUCKER C, 2007, THESIS FREE U BERLIN; Hundsrucker C, 2006, BIOCHEM J, V396, P297, DOI 10.1042/BJ20051970; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; HYDE C, 1994, INT J PEPT PROT RES, V43, P431; Jensen J, 2007, CELL SIGNAL, V19, P204, DOI 10.1016/j.cellsig.2006.06.006; Kassir Y, 2006, CURR DRUG TARGETS, V7, P1455, DOI 10.2174/1389450110607011455; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McCahill A. C., 2008, V186, P125, DOI 10.1007/978-3-540-72843-6_6; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; Schmidt A, 2009, TRAFFIC, V10, P2, DOI 10.1111/j.1600-0854.2008.00843.x; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; Vijayaraghavan S, 1999, MOL ENDOCRINOL, V13, P705, DOI 10.1210/me.13.5.705; Wang XL, 2000, J NEUROSCI, V20, P8551; Wojtal KA, 2006, MOL BIOL CELL, V17, P3638, DOI 10.1091/mbc.E06-03-0230; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yao HB, 2002, J CHEM NEUROANAT, V23, P291, DOI 10.1016/S0891-0618(02)00014-5; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	55	43	47	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5507	5521		10.1074/jbc.M109.047944	http://dx.doi.org/10.1074/jbc.M109.047944			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007971	hybrid, Green Published			2022-12-25	WOS:000275327200044
J	Andersen, JT; Daba, MB; Berntzen, G; Michaelsen, TE; Sandlie, I				Andersen, Jan Terje; Daba, Muluneh Bekele; Berntzen, Goril; Michaelsen, Terje E.; Sandlie, Inger			Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED RECEPTOR; CHRONIC HEPATITIS-C; FAMILIAL HYPERCATABOLIC HYPOPROTEINEMIA; GLUTATHIONE-S-TRANSFERASE; ALPHA FUSION PROTEIN; PH-DEPENDENT BINDING; SERUM HALF-LIFE; CRYSTAL-STRUCTURE; HUMAN IGG1; THERAPEUTIC ANTIBODIES	The neonatal Fc receptor (FcRn) regulates the serum half-life of both IgG and albumin through a pH-dependent mechanism that involves salvage from intracellular degradation. Therapeutics and diagnostics built on IgG, Fc, and albumin fusions are frequently evaluated in rodents regarding biodistribution and pharmacokinetics. Thus, it is important to address cross-species ligand reactivity with FcRn, because in vivo testing of such molecules is done in the presence of competing murine ligands, both in wild type (WT) and human FcRn (hFcRn) transgenic mice. Here, binding studies were performed in vitro using enzyme-linked immunosorbent assay and surface plasmon resonance with recombinant soluble forms of human (shFcRn(WT)) and mouse (smFcRn(WT)) receptors. No binding of albumin from either species was observed at physiological pH to either receptor. At acidic pH, a 100-fold difference in binding affinity was observed. Specifically, smFcRn(WT) bound human serum albumin with a K-D of similar to 90 mu M, whereas shFcRn(WT) bound mouse serum albumin with a K-D of 0.8 mu M. shFcRn(WT) ignored mouse IgG1, and smFcRn(WT) bound strongly to human IgG1. The latter pair also interacted at physiological pH with calculated affinity in the micromolar range. In all cases, binding of albumin and IgG from either species to both receptors were additive. Cross-species albumin binding differences could partly be explained by non-conserved amino acids found within the alpha 2-domain of the receptor. Such distinct cross-species FcRn binding differences must be taken into consideration when IgG- and albumin-based therapeutics and diagnostics are evaluated in rodents for their pharmacokinetics.	[Andersen, Jan Terje; Daba, Muluneh Bekele; Berntzen, Goril; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, N-0371 Oslo, Norway; [Andersen, Jan Terje; Daba, Muluneh Bekele; Berntzen, Goril; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0371 Oslo, Norway; [Michaelsen, Terje E.] Univ Oslo, Inst Pharm, N-0371 Oslo, Norway; [Michaelsen, Terje E.] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Andersen, JT (corresponding author), Univ Oslo, Dept Mol Biosci, POB 1041, N-0371 Oslo, Norway.	janta@imbv.uio.no; sandlie@imbv.uio.no	Andersen, Jan Terje/AAB-6209-2020	Michaelsen, Terje Einar/0000-0001-8877-8519; Andersen, Jan Terje/0000-0003-1710-1628	Steering Board for Research in Molecular Biology; Biotechnology and Bioinformatics at the University of Oslo; Norwegian Research Council [179573]; Norwegian Cancer Society [B95078]	Steering Board for Research in Molecular Biology; Biotechnology and Bioinformatics at the University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics at the University of Oslo (to J. T. A.), The Norwegian Research Council (Grant 179573), and the Norwegian Cancer Society (Grant B95078).	Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Bain VG, 2006, J HEPATOL, V44, P671, DOI 10.1016/j.jhep.2005.12.011; Balan V, 2006, ANTIVIR THER, V11, P35; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Cox GN, 2004, EXP HEMATOL, V32, P441, DOI 10.1016/j.exphem.2004.01.012; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; ESUMI H, 1979, BIOCHEM BIOPH RES CO, V87, P1191, DOI 10.1016/S0006-291X(79)80033-9; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Kaplan W, 1997, PROTEIN SCI, V6, P399; Kenanova V, 2005, CANCER RES, V65, P622; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; MACKENZIE N, 1984, IMMUNOL TODAY, V5, P364, DOI 10.1016/0167-5699(84)90080-X; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Medesan C, 1997, J IMMUNOL, V158, P2211; MICHAELSEN TE, 1991, EUR J IMMUNOL, V21, P11, DOI 10.1002/eji.1830210103; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Norderhaug L, 1997, J IMMUNOL METHODS, V204, P77, DOI 10.1016/S0022-1759(97)00034-3; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; Tudyka T, 1997, PROTEIN SCI, V6, P2180; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Vaccaro C, 2006, P NATL ACAD SCI USA, V103, P18709, DOI 10.1073/pnas.0606304103; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; WALDMANN TA, 1990, J CLIN INVEST, V86, P2093, DOI 10.1172/JCI114947; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wunder A, 2003, J IMMUNOL, V170, P4793, DOI 10.4049/jimmunol.170.9.4793; Yazaki PJ, 2008, NUCL MED BIOL, V35, P151, DOI 10.1016/j.nucmedbio.2007.10.010; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014; Zhu XP, 2002, BIOCHEM J, V367, P703, DOI 10.1042/BJ20020200	58	134	151	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4826	4836		10.1074/jbc.M109.081828	http://dx.doi.org/10.1074/jbc.M109.081828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018855	hybrid, Green Published			2022-12-25	WOS:000275274800061
J	Maritzen, T; Schmidt, MR; Kukhtina, V; Higman, VA; Strauss, H; Volkmer, R; Oschkinat, H; Dotti, CG; Haucke, V				Maritzen, Tanja; Schmidt, Michael R.; Kukhtina, Viktoria; Higman, Victoria A.; Strauss, Holger; Volkmer, Rudolf; Oschkinat, Hartmut; Dotti, Carlos G.; Haucke, Volker			A Novel Subtype of AP-1-binding Motif within the Palmitoylated trans-Golgi Network/Endosomal Accessory Protein Gadkin/gamma-BAR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EAR-BINDING MOTIF; CLATHRIN; MEMBRANE; AP-1; TRAFFICKING; COMPLEX; CELLS; ENTHOPROTIN; ENDOSOMES; DOMAINS	Membrane traffic between the trans-Golgi network (TGN) and endosomes is mediated in part by the assembly of clathrin-AP-1 adaptor complex-coated vesicles. This process involves multiple accessory proteins that directly bind to the ear domain of AP-1 gamma via degenerate peptide motifs that conform to the consensus sequence empty setG(P/D/E)(empty set/L/M) (with empty set being a large hydrophobic amino acid). Recently, gamma-BAR (hereafter referred to as Gadkin for reasons explained below) has been identified as a novel AP-1 recruitment factor involved in AP-1-dependent endosomal trafficking of lysosomal enzymes. How precisely Gadkin interacts with membranes and with AP-1 gamma has remained unclear. Here we show that Gadkin is an S-palmitoylated peripheral membrane protein that lacks stable tertiary structure. S-Palmitoylation is required for the recruitment of Gadkin to TGN/endosomal membranes but not for binding to AP-1. Furthermore, we identify a novel subtype of AP-1-binding motif within Gadkin that specifically associates with the gamma 1-adaptin ear domain. Mutational inactivation of this novel type of motif, either alone or in combination with three more conventional AP-1 gamma binding peptides, causes Gadkin to mislocalize to the plasma membrane and interferes with its ability to render AP-1 brefeldin A-resistant, indicating its physiological importance. Our studies thus unravel the molecular basis for Gadkin-mediated AP-1 recruitment to TGN/endosomal membranes and identify a novel subtype of the AP-1-binding motif.	[Maritzen, Tanja; Schmidt, Michael R.; Kukhtina, Viktoria; Haucke, Volker] Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, D-14195 Berlin, Germany; [Maritzen, Tanja; Schmidt, Michael R.; Kukhtina, Viktoria; Haucke, Volker] Charite Univ Med Berlin, D-14195 Berlin, Germany; [Higman, Victoria A.; Strauss, Holger; Oschkinat, Hartmut; Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Dotti, Carlos G.] Univ Louvain, Sch Med, Mol & Dev Genet Program, Vlanders Inst Biotechnol, B-3000 Louvain, Belgium; [Dotti, Carlos G.] Univ Louvain, Sch Med, Dept Human Genet, B-3000 Louvain, Belgium; [Volkmer, Rudolf] Charite Univ Med Berlin, Inst Med Immunol, D-10115 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haucke, V (corresponding author), Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany.	volker.haucke@fu-berlin.de	Dotti, Carlos G/I-5533-2015; Higman, Victoria/H-3795-2011; Strauss, Holger Martin/I-8403-2012	Dotti, Carlos G/0000-0003-4052-1719; Higman, Victoria/0000-0002-3204-2665; Haucke, Volker/0000-0003-3119-6993; Volkmer, Rudolf/0000-0003-4710-1143; Oschkinat, Hartmut/0000-0002-4384-9544; Maritzen, Tanja/0000-0003-4993-0340	Deutsche Forschungsgemeinschaft (DFG) [HA2686/1-3, 1-4, SFB 449/TP A11]; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG Grants HA2686/1-3 and 1-4 to V. H. and T. M.), SFB 449/TP A11 (to V. H.) and Z1 (to R. V.), and DFG Exc 257-Neurocure.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Dittie AS, 1996, J CELL BIOL, V132, P523, DOI 10.1083/jcb.132.4.523; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Hirst J, 2005, MOL BIOL CELL, V16, P2554, DOI 10.1091/mbc.E04-12-1077; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Neubrand VE, 2005, EMBO J, V24, P1122, DOI 10.1038/sj.emboj.7600600; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Varoqueaux F, 2005, MOL CELL BIOL, V25, P5973, DOI 10.1128/MCB.25.14.5973-5984.2005; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wasiak S, 2003, FEBS LETT, V555, P437, DOI 10.1016/S0014-5793(03)01299-7; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T	26	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4074	4086		10.1074/jbc.M109.049197	http://dx.doi.org/10.1074/jbc.M109.049197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965873	Green Published, hybrid			2022-12-25	WOS:000275254000060
J	Hashem, AM; Flaman, AS; Farnsworth, A; Brown, EG; Van Domselaar, G; He, RT; Li, XG				Hashem, Anwar M.; Flaman, Anathea S.; Farnsworth, Aaron; Brown, Earl G.; Van Domselaar, Gary; He, Runtao; Li, Xuguang			Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases	PLOS ONE			English	Article							IN-VITRO; VACCINE EFFECTIVENESS; PANDEMIC INFLUENZA; EVANS BLUE; REPLICATION; ACTIVATION; INFECTION; EMERGENCE; TRANSFECTION; SENSITIVITY	Background: Influenza viruses cause serious infections that can be prevented or treated using vaccines or antiviral agents, respectively. While vaccines are effective, they have a number of limitations, and influenza strains resistant to currently available anti-influenza drugs are increasingly isolated. This necessitates the exploration of novel anti-influenza therapies. Methodology/Principal Findings: We investigated the potential of aurintricarboxylic acid (ATA), a potent inhibitor of nucleic acid processing enzymes, to protect Madin-Darby canine kidney cells from influenza infection. We found, by neutral red assay, that ATA was protective, and by RT-PCR and ELISA, respectively, confirmed that ATA reduced viral replication and release. Furthermore, while pre-treating cells with ATA failed to inhibit viral replication, pre-incubation of virus with ATA effectively reduced viral titers, suggesting that ATA may elicit its inhibitory effects by directly interacting with the virus. Electron microscopy revealed that ATA induced viral aggregation at the cell surface, prompting us to determine if ATA could inhibit neuraminidase. ATA was found to compromise the activities of virus-derived and recombinant neuraminidase. Moreover, an oseltamivir-resistant H1N1 strain with H274Y was also found to be sensitive to ATA. Finally, we observed additive protective value when infected cells were simultaneously treated with ATA and amantadine hydrochloride, an anti-influenza drug that inhibits M2-ion channels of influenza A virus. Conclusions/Significance: Collectively, these data suggest that ATA is a potent anti-influenza agent by directly inhibiting the neuraminidase and could be a more effective antiviral compound when used in combination with amantadine hydrochloride.	[Hashem, Anwar M.; Flaman, Anathea S.; Farnsworth, Aaron; Li, Xuguang] Hlth Canada, Ctr Biol Res Biol & Genet Therapies Directorate, HPFB, Ottawa, ON K1A 0L2, Canada; [Van Domselaar, Gary; He, Runtao] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Hashem, Anwar M.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Hashem, Anwar M.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Emerging Pathogens Res Ctr, Ottawa, ON, Canada	Health Canada; Public Health Agency of Canada; University of Ottawa; University of Ottawa	Hashem, AM (corresponding author), Hlth Canada, Ctr Biol Res Biol & Genet Therapies Directorate, HPFB, Ottawa, ON K1A 0L2, Canada.	Sean_Li@hc-sc.gc.ca	Hashem, Anwar M/B-2301-2017; Hashem, Anwar/E-9411-2011	Hashem, Anwar M/0000-0002-8471-7011; 	Canadian Regulatory Strategy for Biotechnology; CIHR team grant for Influenza Pandemic Preparedness [TPA 90188]	Canadian Regulatory Strategy for Biotechnology; CIHR team grant for Influenza Pandemic Preparedness(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Regulatory Strategy for Biotechnology (RH and XL) and the CIHR team grant for Influenza Pandemic Preparedness number: TPA 90188 for EGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Aymard M, 2003, Dev Biol (Basel), V115, P75; BALZARINI J, 1986, BIOCHEM BIOPH RES CO, V136, P64, DOI 10.1016/0006-291X(86)90877-6; Banzhoff A, 2008, INFLUENZA OTHER RESP, V2, P243, DOI 10.1111/j.1750-2659.2008.00059.x; Beery R, 2001, ENDOCRINOLOGY, V142, P3098, DOI 10.1210/en.142.7.3098; Belshe RB, 2009, NEW ENGL J MED, V360, P2667, DOI 10.1056/NEJMe0903995; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; Buxton RC, 2000, ANAL BIOCHEM, V280, P291, DOI 10.1006/abio.2000.4517; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P8; Chen CW, 2002, BRIT J PHARMACOL, V137, P1011, DOI 10.1038/sj.bjp.0704955; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; CUSHMAN M, 1991, J MED CHEM, V34, P329, DOI 10.1021/jm00105a052; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DE J, 2005, NEW ENGL J MED, V353, P2667; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Drape RJ, 2006, VACCINE, V24, P4475, DOI 10.1016/j.vaccine.2005.08.012; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Glasspool-Malone J, 1999, HUM GENE THER, V10, P1703, DOI 10.1089/10430349950017707; Glasspool-Malone J, 2002, METHOD ENZYMOL, V346, P72; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Haimsohn M, 2002, ENDOCRINOLOGY, V143, P837, DOI 10.1210/en.143.3.837; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; He RT, 2004, BIOCHEM BIOPH RES CO, V320, P1199, DOI 10.1016/j.bbrc.2004.06.076; Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006; HUNT DM, 1975, J VIROL, V16, P1146, DOI 10.1128/JVI.16.5.1146-1153.1975; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Matsuno H, 1998, THROMB HAEMOSTASIS, V79, P865; Myskiw C, 2007, J VIROL, V81, P3027, DOI 10.1128/JVI.02531-06; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Sidwell RW, 2005, ANTIVIR RES, V68, P10, DOI 10.1016/j.antiviral.2005.06.003; SIDWELL RW, 1995, CHEMOTHERAPY, V41, P455, DOI 10.1159/000239382; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; STEWARD DL, 1977, ANN NY ACAD SCI, V284, P638, DOI 10.1111/j.1749-6632.1977.tb21998.x; Tsi CJ, 2002, MOL PHARMACOL, V62, P90, DOI 10.1124/mol.62.1.90; Walther W, 2005, J GENE MED, V7, P477, DOI 10.1002/jgm.690; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002	50	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8350	10.1371/journal.pone.0008350	http://dx.doi.org/10.1371/journal.pone.0008350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020057	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834200015
J	Nelissen, K; Joly, O; Durand, JB; Todd, JT; Vanduffel, W; Orban, GA				Nelissen, Koen; Joly, Olivier; Durand, Jean-Baptiste; Todd, James T.; Vanduffel, Wim; Orban, Guy A.			The Extraction of Depth Structure from Shading and Texture in the Macaque Brain	PLOS ONE			English	Article							SURFACE ORIENTATION; 3D SHAPE; 3-DIMENSIONAL SHAPE; CONTRAST AGENT; OBJECT SHAPE; VISUAL SHAPE; PERCEPTION; MONKEY; REPRESENTATION; MOTION	We used contrast-agent enhanced functional magnetic resonance imaging (fMRI) in the alert monkey to map the cortical regions involved in the extraction of 3D shape from the monocular static cues, texture and shading. As in the parallel human imaging study [1], we contrasted the 3D condition to several 2D control conditions. The extraction of 3D shape from texture (3D SfT) involves both ventral and parietal regions, in addition to early visual areas. Strongest activation was observed in CIP, with decreasing strength towards the anterior part of the intraparietal sulcus (IPS). In the ventral stream 3D SfT sensitivity was observed in a ventral portion of TEO. The extraction of 3D shape from shading (3D SfS) involved predominantly ventral regions, such as V4 and a dorsal potion of TEO. These results are similar to those obtained earlier in human subjects and indicate that the extraction of 3D shape from texture is performed in both ventral and dorsal regions for both species, as are the motion and disparity cues, whereas shading is mainly processed in the ventral stream.	[Nelissen, Koen; Joly, Olivier; Durand, Jean-Baptiste; Vanduffel, Wim; Orban, Guy A.] Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, Leuven, Belgium; [Todd, James T.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Nelissen, Koen; Vanduffel, Wim] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02114 USA; [Vanduffel, Wim] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	KU Leuven; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Nelissen, K (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02114 USA.	koen.nelissen@med.kuleuven.be	Durand, Jean-Baptiste/ABE-9090-2020; DURAND, Jean-Baptiste/E-9252-2011	DURAND, Jean-Baptiste/0000-0003-4780-8691; Orban, Guy/0000-0002-8179-9584; Joly, Olivier/0000-0002-5818-6552	EU [GOA 2005/18]	EU(European Commission)	This work was supported by EU project Insight 2+ and Neurobotics and GOA 2005/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; DHOTEL CC, 2002, P IEEE INT S BIOM IM, V7, P21; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Fize D, 2003, J NEUROSCI, V23, P7395; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Fukuda M, 2005, CEREB CORTEX, V15, P823, DOI 10.1093/cercor/bhh183; GATTASS R, 1988, J NEUROSCI, V8, P1831; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Georgieva SS, 2008, CEREB CORTEX, V18, P2416, DOI 10.1093/cercor/bhn002; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Joly O, 2009, NEUROIMAGE, V47, P262, DOI 10.1016/j.neuroimage.2009.04.043; Kaas JH, 2001, PROG BRAIN RES, V134, P285; Kolster H, 2009, J NEUROSCI, V29, P7031, DOI 10.1523/JNEUROSCI.0518-09.2009; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Liu Y, 2004, J NEUROSCI, V24, P3795, DOI 10.1523/JNEUROSCI.0150-04.2004; Mandeville JB, 1999, MAGNET RESON MED, V42, P591, DOI 10.1002/(SICI)1522-2594(199909)42:3<591::AID-MRM23>3.0.CO;2-8; Moore C, 2001, NEURON, V29, P277, DOI 10.1016/S0896-6273(01)00197-0; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; NORMAN JF, 1995, PERCEPT PSYCHOPHYS, V57, P629; ORBAN GA, 2008, SENSES COMPREHENSIVE, V2, P235; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; Todd JT, 2004, PSYCHOL SCI, V15, P40, DOI 10.1111/j.0963-7214.2004.01501007.x; Todd JT, 2004, TRENDS COGN SCI, V8, P115, DOI 10.1016/j.tics.2004.01.006; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; Zhang Y, 2007, VISUAL NEUROSCI, V24, P207, DOI 10.1017/S0952523807070411	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8306	10.1371/journal.pone.0008306	http://dx.doi.org/10.1371/journal.pone.0008306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011540	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300051
J	Sousa, KM; Villaescusa, JC; Cajanek, L; Ondr, JK; Castelo-Branco, G; Hofstra, W; Bryja, V; Palmberg, C; Bergman, T; Wainwright, B; Lang, RA; Arenas, E				Sousa, Kyle M.; Villaescusa, J. Carlos; Cajanek, Lukas; Ondr, Jennifer K.; Castelo-Branco, Goncalo; Hofstra, Wytske; Bryja, Vitezslav; Palmberg, Carina; Bergman, Tomas; Wainwright, Brandon; Lang, Richard A.; Arenas, Ernest			Wnt2 Regulates Progenitor Proliferation in the Developing Ventral Midbrain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; BETA-CATENIN; DOPAMINERGIC CELLS; DISHEVELLED PHOSPHORYLATION; INCREASES DIFFERENTIATION; NEURONAL DIFFERENTIATION; SIGNALING COMPONENTS; TARGETED DISRUPTION; INT-1 PROTOONCOGENE; MURINE INT-1	Wnts are secreted, lipidated proteins that regulate multiple aspects of brain development, including dopaminergic neuron development. In this study, we perform the first purification and signaling analysis of Wnt2 and define the function of Wnt2 in ventral midbrain precursor cultures, as well as in Wnt2-null mice in vivo. We found that purified Wnt2 induces the phosphorylation of both Lrp5/6 and Dvl-2/3, and activates beta-catenin in SN4741 dopaminergic cells. Moreover, purified Wnt2 increases progenitor proliferation, and the number of dopaminergic neurons in ventral midbrain precursor cultures. In agreement with these findings, analysis of the ventral midbrain of developing Wnt2-null mice revealed a decrease in progenitor proliferation and neurogenesis that lead to a decrease in the number of postmitotic precursors and dopaminergic neurons. Collectively, our observations identify Wnt2 as a novel regulator of dopaminergic progenitors and dopaminergic neuron development.	[Hofstra, Wytske; Bryja, Vitezslav; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden; [Ondr, Jennifer K.; Lang, Richard A.] Childrens Hosp Res Fdn, Dev Biol Div, Cincinnati, OH 45229 USA; [Ondr, Jennifer K.; Lang, Richard A.] Childrens Hosp Res Fdn, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno 61107, Czech Republic; [Bryja, Vitezslav] Inst Biophys AS CR, Brno 61107, Czech Republic; [Palmberg, Carina; Bergman, Tomas] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 1, SE-17177 Stockholm, Sweden; [Sousa, Kyle M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wainwright, Brandon] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	Karolinska Institutet; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Karolinska Institutet; University of Michigan System; University of Michigan; University of Queensland	Arenas, E (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Scheeles Vag 1,A1 2, S-17177 Stockholm, Sweden.	ernest.arenas@ki.se	Lang, Richard/E-5578-2011; Castelo-Branco, Gonçalo/B-1635-2009; Bryja, Vítězslav/P-4217-2019; Castelo-Branco, Goncalo/A-8357-2015; Castelo-Branco, Gonçalo/O-9162-2019; Bryja, Vít?zslav/H-1925-2014; Cajanek, Lukas/ABG-6559-2020; Arenas, Ernest/AAO-5231-2020	Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vítězslav/0000-0002-9136-5085; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vít?zslav/0000-0002-9136-5085; Cajanek, Lukas/0000-0003-2914-8589; Arenas, Ernest/0000-0003-0197-6577; Lang, Richard/0000-0002-5212-254X; Wainwright, Brandon/0000-0003-0406-2092; Villaescusa, J. Carlos/0000-0001-9456-9828	Swedish Foundation for Strategic Research; Swedish Research Council [VR2008:2811]; Norwegian Research Council; European Commission; Karolinska Institute; FEBS; Portuguese Fundacao para a Ciencia e Tecnologia; Calouste Gulbenkian Foundation	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Karolinska Institute(Karolinska Institutet); FEBS; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Calouste Gulbenkian Foundation	This work was supported in part by the Swedish Foundation for Strategic Research (INGVAR and CEDB), Swedish Research Council (VR2008:2811 and DBRM), Norwegian Research Council, European Commission (Euro-StemCell), and Karolinska Institute.; Supported by a FEBS Long-Term fellowship.; Supported by the Portuguese Fundacao para a Ciencia e Tecnologia, Karolinksa Institute, and the Calouste Gulbenkian Foundation. Present address: The Wellcome Trust/CRUK, Gurdon Inst., University of Cambridge, Cambridge CB2 1QN, UK.	Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Bellusci S, 1997, DEVELOPMENT, V124, P53; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; WAINWRIGHT BJ, 1988, EMBO J, V7, P1743, DOI 10.1002/j.1460-2075.1988.tb03003.x; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	41	61	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7246	7253		10.1074/jbc.M109.079822	http://dx.doi.org/10.1074/jbc.M109.079822			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20018874	hybrid, Green Published			2022-12-25	WOS:000275415600037
J	Checquolo, S; Palermo, R; Cialfi, S; Ferrara, G; Oliviero, C; Talora, C; Bellavia, D; Giovenco, A; Grazioli, P; Frati, L; Gulino, A; Screpanti, I				Checquolo, S.; Palermo, R.; Cialfi, S.; Ferrara, G.; Oliviero, C.; Talora, C.; Bellavia, D.; Giovenco, A.; Grazioli, P.; Frati, L.; Gulino, A.; Screpanti, I.			Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia	ONCOGENE			English	Article						c-Cbl; E3 ligase; ubiquitinylation; Notch3; pre-TCR; T-cell leukemia	NF-KAPPA-B; PRE-TCR; TYROSINE PHOSPHORYLATION; CONSTITUTIVE ACTIVATION; SIGNALING PROMOTES; UBIQUITIN LIGASES; GAMMA-CHAIN; PKC-THETA; RECEPTOR; LEUKEMOGENESIS	Notch3 and pT alpha signaling events are essential for T-cell leukemogenesis and characterize murine and human T-cell acute lymphoblastic leukemia. Genetic ablation of pT alpha expression in Notch3 transgenic mice abrogates tumor development, indicating that pT alpha signaling is crucial to the Notch3-mediated leukemogenesis. Here we report a novel direct interaction between Notch3 and pT alpha. This interaction leads to the recruitment and persistence of the E3 ligase protein c-Cbl to the lipid rafts in Notch3-IC transgenic thymocytes. Conversely, deletion of pT alpha in Notch3 transgenic mice leads to cytoplasmic retention of c-Cbl that targets Notch3 protein to the proteasomal-degradative pathway. It appears that protein kinase C theta (PKC theta), by regulating tyrosine and serine phosphorylation of Cbl, is able to control its function. We report here that the increased Notch3-IC degradation correlates with higher levels of c-Cbl tyrosine phosphorylation in Notch3-IC/pT alpha(-/-) double-mutant thymocytes, which also display a decreased PKC theta activity. Our data indicate that pT alpha/pre-T-cell receptor is able to regulate the different subcellular localization of c-Cbl and, by regulating PKC theta activity, is also able to influence its ubiquitin ligase activity upon Notch3 protein. Oncogene (2010) 29, 1463-1474; doi:10.1038/onc.2009.446; published online 7 December 2009	[Frati, L.; Gulino, A.] Neuromed Inst, Pozzilli, Italy; [Checquolo, S.; Palermo, R.; Cialfi, S.; Ferrara, G.; Oliviero, C.; Talora, C.; Bellavia, D.; Giovenco, A.; Grazioli, P.; Frati, L.; Gulino, A.; Screpanti, I.] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Screpanti, I.] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	IRCCS Neuromed; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Screpanti, I (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy.	isabella.screpanti@uniroma1.it	Palermo, Rocco/I-5140-2016; Bellavia, Diana/AAO-6348-2021; Talora, Claduio/AIC-4932-2022; Frati, Luigi/ABI-7437-2020	Palermo, Rocco/0000-0003-0134-9370; Talora, Claduio/0000-0002-6973-2184; CHECQUOLO, Saula/0000-0001-5109-8392	Italian Association for Cancer Research (AIRC); Italian Ministry of University and Research (MIUR); PRIN; Italian Ministry of Health; European Union [LHSB-CT-2003-543410]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission)	We thank Dr A Joutel for Notch3 antibodies and Dr R Bei for purification of mouse monoclonal pT alpha antibody, Dr F Grassi for c-Cbl plasmid and Dr M Bouche for PKC theta plasmids. This work was supported by the Italian Association for Cancer Research (AIRC), the Italian Ministry of University and Research (MIUR), PRIN Program, the Italian Ministry of Health and the European Union (Euro-Thymaide FP6 Integrated Project; LHSB-CT-2003-543410).	Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Benson RA, 2005, EUR J IMMUNOL, V35, P859, DOI 10.1002/eji.200425562; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Brizzi MF, 1998, EXP HEMATOL, V26, P1229; Campese AF, 2003, SEMIN CELL DEV BIOL, V14, P151, DOI 10.1016/S1084-9521(02)00184-2; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Felli MP, 2005, ONCOGENE, V24, P992, DOI 10.1038/sj.onc.1208302; Gay DL, 2008, IMMUNOL RES, V42, P51, DOI 10.1007/s12026-008-8034-0; GROETTRUP M, 1992, EMBO J, V11, P2735, DOI 10.1002/j.1460-2075.1992.tb05339.x; Hehner SP, 2000, J IMMUNOL, V164, P3829, DOI 10.4049/jimmunol.164.7.3829; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Liu YH, 1999, J IMMUNOL, V162, P7095; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Panigada M, 2002, J EXP MED, V195, P1585, DOI 10.1084/jem.20020047; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rothenberg EV, 2001, NAT IMMUNOL, V2, P189, DOI 10.1038/85231; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Schweisguth F, 1999, P NATL ACAD SCI USA, V96, P11382, DOI 10.1073/pnas.96.20.11382; SPOLSKI R, 1988, EUR J IMMUNOL, V18, P295; Talora C, 2006, BLOOD, V107, P3313, DOI 10.1182/blood-2005-07-2823; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001	41	26	26	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1463	1474		10.1038/onc.2009.446	http://dx.doi.org/10.1038/onc.2009.446			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19966856				2022-12-25	WOS:000275392400005
J	De Jonge, N; Hohlweg, W; Garcia-Pino, A; Respondek, M; Buts, L; Haesaerts, S; Lah, J; Zangger, K; Loris, R				De Jonge, Natalie; Hohlweg, Walter; Garcia-Pino, Abel; Respondek, Michal; Buts, Lieven; Haesaerts, Sarah; Lah, Jurij; Zangger, Klaus; Loris, Remy			Structural and Thermodynamic Characterization of Vibrio fischeri CcdB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PROTEIN-STRUCTURE; KILLER PROTEIN; DNA CLEAVAGE; GYRASE; ENERGETICS; BINDING; REJUVENATION; RECOGNITION; INDUCTION	CcdB(Vfi) from Vibrio fischeri is a member of the CcdB family of toxins that poison covalent gyrase-DNA complexes. In solution CcdB(Vfi) is a dimer that unfolds to the corresponding monomeric components in a two-state fashion. In the unfolded state, the monomer retains a partial secondary structure. This observation correlates well with the crystal and NMR structures of the protein, which show a dimer with a hydrophobic core crossing the dimer interface. In contrast to its F plasmid homologue, CcdB(Vfi) possesses a rigid dimer interface, and the apparent relative rotations of the two subunits are due to structural plasticity of the monomer. CcdB(Vfi) shows a number of non-conservative substitutions compared with the F plasmid protein in both the CcdA and the gyrase binding sites. Although variation in the CcdA interaction site likely determines toxin-antitoxin specificity, substitutions in the gyrase-interacting region may have more profound functional implications.	[De Jonge, Natalie; Garcia-Pino, Abel; Buts, Lieven; Haesaerts, Sarah; Loris, Remy] Vrije Univ Brussel, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Hohlweg, Walter; Respondek, Michal; Zangger, Klaus] Graz Univ, Inst Chem, A-8010 Graz, Austria; [Lah, Jurij] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia	Vrije Universiteit Brussel; University of Graz; University of Ljubljana	Loris, R (corresponding author), Vrije Univ Brussel, Dept Mol & Cellular Interact, Pl Laan 2, B-1050 Brussels, Belgium.	Remy.Loris@VIB-VUB.be	Loris, Remy/GPG-0894-2022	Haesaerts, Sarah/0000-0003-3913-9125; Zangger, Klaus/0000-0003-1682-1594; Loris, Remy/0000-0002-8862-3338; Garcia-Pino, Abel/0000-0002-0634-0300	Vlaams Interuniversitair Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Ministry of Higher Education, Science and Technology; Agency for Research of Republic of Slovenia [P1-0201, J1-6653]; Instituut voor Wetenschap en Technologie; Belgian Federal Science Policy Office (DWTC); European Space Agency [AO2004]; FWO; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Vlaams Interuniversitair Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Ministry of Higher Education, Science and Technology; Agency for Research of Republic of Slovenia(Slovenian Research Agency - Slovenia); Instituut voor Wetenschap en Technologie; Belgian Federal Science Policy Office (DWTC)(Belgian Federal Science Policy Office); European Space Agency(European Space AgencyEuropean Commission); FWO(FWO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the Vlaams Interuniversitair Instituut voor Biotechnologie, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), and the Onderzoeksraad of the Vrije Universiteit Brussel. The work was also supported by the Ministry of Higher Education, Science and Technology and by the Agency for Research of Republic of Slovenia (Grants P1-0201 and J1-6653).; Recipient of a predoctoral grant from the Instituut voor Wetenschap en Technologie. Present address: arGEN-X BVBA, Technologiepark 30, 9052 Zwijnaarde, Belgium.; Supported by the Belgian Federal Science Policy Office (DWTC) and the European Space Agency in the context of Prodex project AO2004.; Recipient of a postdoctoral fellowship from the FWO.; Supported by the Austrian Science Foundation (Project 19902).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; BAHASSI EM, 1995, MOL MICROBIOL, V15, P1031, DOI 10.1111/j.1365-2958.1995.tb02278.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajaj K, 2004, BIOCHEM J, V380, P409, DOI 10.1042/BJ20031528; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchlow SE, 1997, J MOL BIOL, V273, P826, DOI 10.1006/jmbi.1997.1357; Dao-Thi MH, 2000, J MOL BIOL, V299, P1373, DOI 10.1006/jmbi.2000.3815; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; De Jonge N, 2007, ACTA CRYSTALLOGR F, V63, P356, DOI 10.1107/S1744309107012092; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drobnak I, 2009, J MOL BIOL, V392, P63, DOI 10.1016/j.jmb.2009.05.086; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Ladbury J.E., 1998, BIOCALORIMETRY APPL; Lah J, 2005, J BIOL CHEM, V280, P17397, DOI 10.1074/jbc.M501128200; Lah J, 2003, J BIOL CHEM, V278, P14101, DOI 10.1074/jbc.M209855200; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Maki S, 1996, J MOL BIOL, V256, P473, DOI 10.1006/jmbi.1996.0102; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Oberer M, 1999, BIOL CHEM, V380, P1413, DOI 10.1515/BC.1999.181; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Press W. H., 1992, ART SCI COMPUTING; Respondek M, 2009, BIOMOL NMR ASSIGN, V3, P145, DOI 10.1007/s12104-009-9161-9; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; SantosSierra S, 1997, FEMS MICROBIOL LETT, V152, P51, DOI 10.1016/S0378-1097(97)00177-8; Simic M, 2009, ACTA CHIM SLOV, V56, P139; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wilbaux M, 2007, J BACTERIOL, V189, P2712, DOI 10.1128/JB.01679-06; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305	51	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5606	5613		10.1074/jbc.M109.068429	http://dx.doi.org/10.1074/jbc.M109.068429			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19959472	Green Published, hybrid			2022-12-25	WOS:000275327200052
J	Nabuurs, SM; van Mierlo, CPM				Nabuurs, Sanne M.; van Mierlo, Carlo P. M.			Interrupted Hydrogen/Deuterium Exchange Reveals the Stable Core of the Remarkably Helical Molten Globule of alpha-beta Parallel Protein Flavodoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZOTOBACTER-VINELANDII APOFLAVODOXIN; FOLDING INTERMEDIATE; HYDROGEN-EXCHANGE; UNFOLDED MOLECULES; ENERGY LANDSCAPE; ON-PATHWAY; AGGREGATION; EQUILIBRIUM; LACTALBUMIN; APOMYOGLOBIN	Kinetic intermediates that appear early during protein folding often resemble the relatively stable molten globule intermediates formed by several proteins under mildly denaturing conditions. Molten globules have a substantial amount of secondary structure but lack virtually all tertiary side-chain packing characteristics of natively folded proteins. Due to exposed hydrophobic groups, molten globules are prone to aggregation, which can have detrimental effects on organisms. The molten globule that is observed during folding of alpha-beta parallel flavodoxin from Azotobacter vinelandii is a remarkably non-native species. This folding intermediate is helical and contains no beta-sheet and is kinetically off-pathway to the native state. It can be trapped under native-like conditions by substituting residue Phe(44) for Tyr(44). To characterize this species at the residue level, in this study, use is made of interrupted hydrogen/deuterium exchange detected by NMR spectroscopy. In the molten globule of flavodoxin, the helical region comprising residues Leu(110)-Val(125) is shown to be better protected against exchange than the other ordered parts of the folding intermediate. This helical region is better buried than the other helices, causing its context-dependent stabilization against unfolding. Residues Leu(110)-Val(125) thus form the stable core of the helical molten globule of alpha-beta parallel flavodoxin, which is almost entirely structured. Non-native docking of helices in the molten globule of flavodoxin prevents formation of the parallel beta-sheet of native flavodoxin. Hence, to produce native alpha-beta parallel protein molecules, the off-pathway species needs to unfold.	[Nabuurs, Sanne M.; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands	Wageningen University & Research	van Mierlo, CPM (corresponding author), Wageningen Univ, Biochem Lab, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	vanMierlo, Carlo p/B-4491-2016	vanMierlo, Carlo p/0000-0002-5358-8392				Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; Arai M, 2002, J MOL BIOL, V321, P121, DOI 10.1016/S0022-2836(02)00566-1; Arai M, 1996, FOLD DES, V1, P275, DOI 10.1016/S1359-0278(96)00041-7; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BALDWIN RL, 1994, NATURE, V369, P183, DOI 10.1038/369183a0; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Fernandez-Recio J, 2001, BIOCHEMISTRY-US, V40, P15234, DOI 10.1021/bi010216t; Forge V, 1999, J MOL BIOL, V288, P673, DOI 10.1006/jmbi.1999.2687; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Kato H, 2007, J MOL BIOL, V365, P870, DOI 10.1016/j.jmb.2006.10.047; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Melo EP, 2003, BIOCHEMISTRY-US, V42, P7611, DOI 10.1021/bi034267x; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Nishimura C, 2005, P NATL ACAD SCI USA, V102, P4765, DOI 10.1073/pnas.0409538102; Nishimura C, 2008, J MOL BIOL, V378, P715, DOI 10.1016/j.jmb.2008.03.025; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Otzen DE, 2007, BBA-PROTEINS PROTEOM, V1774, P323, DOI 10.1016/j.bbapap.2006.11.012; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Spence GR, 2004, J MOL BIOL, V341, P215, DOI 10.1016/j.jmb.2004.05.049; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; Yamasaki K, 2003, BIOPOLYMERS, V69, P176, DOI 10.1002/bip.10351	44	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4165	4172		10.1074/jbc.M109.087932	http://dx.doi.org/10.1074/jbc.M109.087932			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959481	Green Published, hybrid			2022-12-25	WOS:000275254000068
J	Luo, YP; Zhou, H; Krueger, J; Kaplan, C; Liao, D; Markowitz, D; Liu, C; Chen, T; Chuang, TH; Xiang, R; Reisfeld, RA				Luo, Y. P.; Zhou, H.; Krueger, J.; Kaplan, C.; Liao, D.; Markowitz, D.; Liu, C.; Chen, T.; Chuang, T-H; Xiang, R.; Reisfeld, R. A.			The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression	ONCOGENE			English	Article						tumor-associated macrophages; tumor microenvironment; Fra-1; IL-6/JAK/Stat3 signaling pathway	TRANSCRIPTION FACTORS; ANTITUMOR IMMUNITY; UP-REGULATION; CANCER CELLS; MACROPHAGES; STAT3; ACTIVATION; METASTASIS; EXPRESSION; TARGETS	A growing body of evidence indicates that interactions between neoplastic cells and tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are crucial in promoting tumor cell invasion and progression. Macrophages have an ambiguous role in these processes as this M1 phenotype correlates with tumoricidal capacity, whereas TAMs of M2 phenotype exert tumor-promoting effects. In this study, we provide evidence that interactions between mouse breast tumor cells and TAMs remodel the TME, leading to the upregulation of Fra-1, a member of the FOS family of transcription factor. In turn, this proto-oncogene initiates activation of the IL-6/JAK/Stat3 signaling pathway. This creates a malignant switch in breast tumor cells, leading to increased release of proangiogenic factors MMP-9, vascular endothelial growth factor and transforming growth factor-beta from tumor cells and intensified invasion and progression of breast cancer. Proof of the concept for the crucial role played by transcription factor Fra-1 in regulating these processes was established by specific knockdown of Fra-1 with small interfering RNA, which resulted in a marked suppression of tumor cell invasion, angiogenesis and metastasis in a mouse breast cancer model. Such a strategy could eventually lead to future efficacious treatments of metastatic breast cancer. Oncogene (2010) 29, 662-673; doi: 10.1038/onc.2009.308; published online 7 December 2009	[Luo, Y. P.; Zhou, H.; Krueger, J.; Kaplan, C.; Liao, D.; Markowitz, D.; Liu, C.; Chen, T.; Chuang, T-H; Xiang, R.; Reisfeld, R. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Luo, Y. P.; Chen, T.] Chongqing Univ Med Sci, Dept Lab Med, Chongqing, Peoples R China; [Xiang, R.] Nankai Univ, Dept Immunol, Tianjin 300071, Peoples R China	Scripps Research Institute; Chongqing Medical University; Nankai University	Luo, YP (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, R218,IMM13,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ypluo@scripps.edu; reisfeld@scripps.edu	Chuang, Tsung-Hsien/F-9679-2010	Chen, Tingmei/0000-0003-4250-674X	National Science Foundation of China (NSFC) [30672389, 2007CB914804, 2007AA021010, 30671983]; NIH [CA 115751]; EMD Lexigen Research Center [SFP 1645]; NATIONAL CANCER INSTITUTE [R01CA127535, R01CA115751] Funding Source: NIH RePORTER	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMD Lexigen Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K Cairns for editorial assistance. This work was supported by grants from the National Science Foundation of China (NSFC): Grant 30672389 (to RX), NSFC 973 program Grant 2007CB914804 (to RX), and NSFC 863 program Grant 2007AA021010 (to RX), Grant No. 30671983 from The National Natural Science Foundation of China (to YL); grant from NIH CA 115751 (to RAR); and Grant SFP 1645 from the EMD Lexigen Research Center (to RAR). This is The Scripps Research Institute's manuscript number 19572-IMM.	Adiseshaiah P, 2005, ONCOGENE, V24, P4193, DOI 10.1038/sj.onc.1208583; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Asschert JGW, 1999, INT J CANCER, V81, P236, DOI 10.1002/(SICI)1097-0215(19990412)81:2<236::AID-IJC12>3.0.CO;2-R; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; FRASER CC, 1995, BLOOD, V86, P183, DOI 10.1182/blood.V86.1.183.bloodjournal861183; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Knudsen E, 2002, EUR J HAEMATOL, V69, P284, DOI 10.1034/j.1600-0609.2002.02657.x; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Lewen S, 2008, CANCER IMMUNOL IMMUN, V57, P507, DOI 10.1007/s00262-007-0389-x; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Philips A, 1998, MOL ENDOCRINOL, V12, P973, DOI 10.1210/me.12.7.973; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; VAN RN, 1989, J IMMUNOL METHODS, V124, P1; VAN RN, 1994, J IMMUNOL METHODS, V174, P83; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zerbini LF, 2003, CANCER RES, V63, P2206	36	68	74	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 4	2010	29	5					662	673		10.1038/onc.2009.308	http://dx.doi.org/10.1038/onc.2009.308			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	551QI	19966854	Green Accepted			2022-12-25	WOS:000274223700004
J	Minakshi, R; Padhan, K; Rani, M; Khan, N; Ahmad, F; Jameel, S				Minakshi, Rinki; Padhan, Kartika; Rani, Manjusha; Khan, Nabab; Ahmad, Faizan; Jameel, Shahid			The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon Receptor	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; HEPATITIS-E VIRUS; P38 MAP KINASE; UNFOLDED PROTEIN; ER STRESS; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; ALPHA RECEPTOR; MESSENGER-RNA; SIGNALING PATHWAY	The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is reported to cause apoptosis of infected cells and several of its proteins including the 3a accessory protein, are pro-apoptotic. Since the 3a protein localizes to the endoplasmic reticulum (ER)-Golgi compartment, its role in causing ER stress was investigated in transiently transfected cells. Cells expressing the 3a proteins showed ER stress based on activation of genes for the ER chaperones GRP78 and GRP94. Since ER stress can cause differential modulation of the unfolded protein response (UPR), which includes the inositol-requiring enzyme 1 (IRE-1), activating transcription factor 6 (ATF6) and PKR-like ER kinase (PERK) pathways, these were individually tested in 3a-expressing cells. Only the PERK pathway was found to be activated in 3a-expressing cells based on (1) increased phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha) and inhibitory effects of a dominant-negative form of eIF2 alpha on GRP78 promoter activity, (2) increased translation of activating transcription factor 4 (ATF4) mRNA, and (3) ATF4-dependent activation of the C/EBP homologous protein (CHOP) gene promoter. Activation of PERK affects innate immunity by suppression of type 1 interferon (IFN) signaling. The 3a protein was found to induce serine phosphorylation within the IFN alpha-receptor subunit 1 (IFNAR1) degradation motif and to increase IFNAR1 ubiquitination. Confocal microscopic analysis showed increased translocation of IFNAR1 into the lysosomal compartment and flow cytometry showed reduced levels of IFNAR1 in 3a-expressing cells. These results provide further mechanistic details of the pro-apoptotic effects of the SARS-CoV 3a protein, and suggest a potential role for it in attenuating interferon responses and innate immunity.	[Minakshi, Rinki; Padhan, Kartika; Rani, Manjusha; Khan, Nabab; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Minakshi, Rinki; Ahmad, Faizan] Ctr Interdisciplinary Res Basic Sci, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jamia Millia Islamia	Minakshi, R (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	shahid@icgeb.res.in	Padhan, Kartika/O-8215-2017; Minakshi, Rinki/AGZ-8783-2022; Ahmad, Faizan/AGH-4493-2022; khan, Nabab/Z-3970-2019	Ahmad, Faizan/0000-0001-7021-7502; khan, Nabab/0000-0002-8563-5341; Rinki, Minakshi/0000-0001-5768-4640; PADHAN, KARTIKA/0000-0001-9561-4256	Department of Biotechnology (DBT), Government of India; Council for Scientific and Industrial Research, India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology (DBT), Government of India (http://dbtindia.nic.in); KP received a Senior Research Fellowship from the Council for Scientific and Industrial Research, India. The ICGEB also receives core support from DBT and the same is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Basu L, 1998, VIROLOGY, V242, P14, DOI 10.1006/viro.1997.9002; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bechill J, 2008, J VIROL, V82, P4492, DOI 10.1128/JVI.00017-08; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Ciccaglione AR, 2007, VIRUS RES, V126, P128, DOI 10.1016/j.virusres.2007.02.006; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dimcheff DE, 2003, J VIROL, V77, P12617, DOI 10.1128/JVI.77.23.12617-12629.2003; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Lai WL, 2005, FREE RADICAL BIO MED, V38, P1585, DOI 10.1016/j.freeradbiomed.2005.02.024; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Law PTW, 2005, J GEN VIROL, V86, P1921, DOI 10.1099/vir.0.80813-0; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; MORI K, 1993, CELL, V74, P743; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Padhan K, 2008, J GEN VIROL, V89, P1960, DOI 10.1099/vir.0.83665-0; Padhan K, 2007, J GEN VIROL, V88, P3067, DOI 10.1099/vir.0.82856-0; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Roy AK, 2004, J BIOL CHEM, V279, P28345, DOI 10.1074/jbc.M400457200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Tan YJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-5; Tan YJ, 2004, J VIROL, V78, P6723, DOI 10.1128/JVI.78.13.6723-6734.2004; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Vilcek J, 2003, NAT IMMUNOL, V4, P8, DOI 10.1038/ni0103-8; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; WATOWICH SS, 1991, J VIROL, V65, P3590, DOI 10.1128/JVI.65.7.3590-3597.1991; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yuan XL, 2007, AM J RESP CELL MOL, V37, P9, DOI 10.1165/rcmb.2005-0345RC; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997	77	156	165	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8342	10.1371/journal.pone.0008342	http://dx.doi.org/10.1371/journal.pone.0008342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020050	Green Published, Green Submitted, gold			2022-12-25	WOS:000272834200009
J	Leopold, PL; O'Mahony, MJ; Lian, XJ; Tilley, AE; Harvey, BG; Crystal, RG				Leopold, Philip L.; O'Mahony, Michael J.; Lian, X. Julie; Tilley, Ann E.; Harvey, Ben-Gary; Crystal, Ronald G.			Smoking Is Associated with Shortened Airway Cilia	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN BRONCHIAL EPITHELIUM; SURFACE LIQUID VOLUME; CIGARETTE-SMOKE; CYSTIC-FIBROSIS; ULTRASTRUCTURAL ABNORMALITIES; RESPIRATORY EPITHELIUM; MUCOCILIARY TRANSPORT; TRACHEAL EPITHELIUM; GENE-EXPRESSION	Background: Whereas cilia damage and reduced cilia beat frequency have been implicated as causative of reduced mucociliary clearance in smokers, theoretically mucociliary clearance could also be affected by cilia length. Based on models of mucociliary clearance predicting that cilia length must exceed the 6-7 mu m airway surface fluid depth to generate force in the mucus layer, we hypothesized that cilia height may be decreased in airway epithelium of normal smokers compared to nonsmokers. Methodology/Principal Findings: Cilia length in normal nonsmokers and smokers was evaluated in aldehyde-fixed, paraffin-embedded endobronchial biopsies, and air-dried and hydrated samples were brushed from human airway epithelium via fiberoptic bronchoscopy. In 28 endobronchial biopsies, healthy smoker cilia length was reduced by 15% compared to nonsmokers (p < 0.05). In 39 air-dried samples of airway epithelial cells, smoker cilia length was reduced by 13% compared to nonsmokers (p < 0.0001). Analysis of the length of individual, detached cilia in 27 samples showed that smoker cilia length was reduced by 9% compared to nonsmokers (p < 0.05). Finally, in 16 fully hydrated, unfixed samples, smoker cilia length was reduced 7% compared to nonsmokers (p < 0.05). Using genome-wide analysis of airway epithelial gene expression we identified 6 cilia-related genes whose expression levels were significantly reduced in healthy smokers compared to healthy nonsmokers. Conclusions/Significance: Models predict that a reduction in cilia length would reduce mucociliary clearance, suggesting that smoking-associated shorter airway epithelial cilia play a significant role in the pathogenesis of smoking-induced lung disease.	[Leopold, Philip L.; O'Mahony, Michael J.; Lian, X. Julie; Tilley, Ann E.; Harvey, Ben-Gary; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Leopold, Philip L.; O'Mahony, Michael J.; Tilley, Ann E.; Harvey, Ben-Gary; Crystal, Ronald G.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY USA	Cornell University; Cornell University	Leopold, PL (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.	geneticmedicine@med.cornell.edu			NCRR NIH HHS [M01RR00047, M01 RR000047] Funding Source: Medline; NHLBI NIH HHS [R01 HL074326, P50 HL084936] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074326, P50HL084936] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AILSBY RL, 1973, J PATHOL, V109, P75, DOI 10.1002/path.1711090108; ALBERT RE, 1969, ARCH ENVIRON HEALTH, V18, P738, DOI 10.1080/00039896.1969.10665482; AUERBACH O, 1979, NEW ENGL J MED, V300, P381, DOI 10.1056/NEJM197902223000801; BALLENGER JJ, 1960, NEW ENGL J MED, V263, P832, DOI 10.1056/NEJM196010272631704; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Calderon-Garciduenas L, 2001, AM J RESP CELL MOL, V24, P132, DOI 10.1165/ajrcmb.24.2.4157; Calderon-Garciduenas L, 1998, TOXICOL SCI, V46, P352, DOI 10.1006/toxs.1998.2549; Calderon-Garciduenas L, 1999, CARCINOGENESIS, V20, P383, DOI 10.1093/carcin/20.3.383; CAMNER P, 1972, ARCH ENVIRON HEALTH, V25, P60, DOI 10.1080/00039896.1972.10666136; CHANG SC, 1957, CANCER-AM CANCER SOC, V10, P1246, DOI 10.1002/1097-0142(195711/12)10:6<1246::AID-CNCR2820100623>3.0.CO;2-Z; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Danel C, 1996, AM J RESP CRIT CARE, V153, P362, DOI 10.1164/ajrccm.153.1.8542144; FOX B, 1983, EUR J RESPIR DIS, V64, P11; FOX B, 1981, CHEST, V80, P796, DOI 10.1378/chest.80.6.796; FULFORD GR, 1986, J THEOR BIOL, V121, P381, DOI 10.1016/S0022-5193(86)80098-4; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; GREENSTONE M, 1985, BRIT J DIS CHEST, V79, P9, DOI 10.1016/0007-0971(85)90003-8; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hylkema MN, 2007, EUR RESPIR J, V29, P438, DOI 10.1183/09031936.00124506; IBRAHIM AL, 1979, J ENVIRON PATHOL TOX, V3, P251; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; LEE RKW, 1997, LUNG SCI FDN, P2295; Look DC, 2001, AM J PATHOL, V159, P2055, DOI 10.1016/S0002-9440(10)63057-X; LOURENCO RV, 1971, J CLIN INVEST, V50, P1411, DOI 10.1172/JCI106624; LUNGARELLA G, 1983, LUNG, V161, P147, DOI 10.1007/BF02713856; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P429; MELLICK PW, 1977, LAB INVEST, V36, P82; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; MISKOVITS G, 1974, ACTA MORPHOL HUNG, V22, P91; Murin S, 2005, CLEV CLIN J MED, V72, P916, DOI 10.3949/ccjm.72.10.916; NAGAI A, 1991, AM REV RESPIR DIS, V144, P901, DOI 10.1164/ajrccm/144.4.901; NIKULA KJ, 1988, AM J PATHOL, V131, P373; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Ortug C, 2003, ANN ANAT, V185, P207, DOI 10.1016/S0940-9602(03)80024-9; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; PEDERSEN M, 1983, EUR J RESPIR DIS, V64, P355; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Rajagopalan V, 2009, MOL BIOL CELL, V20, P708, DOI 10.1091/mbc.E08-07-0746; ROSS KFA, 1953, Q J MICROSC SCI, V94, P125; Salathe M, 1997, LUNG SCI FDN, P2295; SANDERSON MJ, 1981, J CELL SCI, V47, P331; SERAFINI SM, 1977, B EUR PHYSIOPATH RES, V13, P551; SISSON JH, 1994, AM J RESP CRIT CARE, V149, P205, DOI 10.1164/ajrccm.149.1.8111584; SLEIGH MA, 1981, CHEST, V80, P791; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; SMALLMAN LA, 1986, HUM PATHOL, V17, P848, DOI 10.1016/S0046-8177(86)80206-4; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; STANLEY PJ, 1986, THORAX, V41, P519, DOI 10.1136/thx.41.7.519; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; VASTAG E, 1985, EUR J RESPIR DIS, V66, P93; VERDUGO P, 1991, AM REV RESPIR DIS, V144, pS33, DOI 10.1164/ajrccm/144.3_pt_2.S33; VERRA F, 1995, AM J RESP CRIT CARE, V151, P630; WANNER A, 1977, AM REV RESPIR DIS, V116, P73; WANNER A, 1985, EUR J RESPIR DIS, V66, P49; WOLFF RK, 1986, ENVIRON HEALTH PERSP, V66, P223, DOI 10.2307/3430237; YEATES DB, 1997, LUNG SCI FDN, P2295; 2005, J CLIN ONCOL, V23, P3175	66	141	145	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8157	10.1371/journal.pone.0008157	http://dx.doi.org/10.1371/journal.pone.0008157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016779	Green Submitted, Green Published, gold			2022-12-25	WOS:000272834000002
J	Duffy, D; Dawoodji, A; Agger, EM; Andersen, P; Westermann, J; Bell, EB				Duffy, Darragh; Dawoodji, Amina; Agger, Else Marie; Andersen, Peter; Westermann, Juergen; Bell, Eric B.			Immunological Memory Transferred with CD4 T Cells Specific for Tuberculosis Antigens Ag85B-TB10.4: Persisting Antigen Enhances Protection	PLOS ONE			English	Article							IN-VIVO; NAIVE-PHENOTYPE; BCG VACCINATION; B-CELLS; IMMUNITY; EFFICACY; SURVIVAL; ANTIBODY; SUBSETS; TB10.4	Background: High levels of death and morbidity worldwide caused by tuberculosis has stimulated efforts to develop a new vaccine to replace BCG. A number of Mycobacterium tuberculosis (Mtb)-specific antigens have been synthesised as recombinant subunit vaccines for clinical evaluation. Recently a fusion protein of TB antigen Ag85B combined with a second immunodominant TB antigen TB10.4 was emulsified with a novel non-phospholipid-based liposomal adjuvant to produce a new subunit vaccine, investigated here. Currently, there is no consensus as to whether or not long-term T cell memory depends on a source of persisting antigen. To explore this and questions regarding lifespan, phenotype and cytokine patterns of CD4 memory T cells, we developed an animal model in which vaccine-induced CD4 memory T cells could transfer immunity to irradiated recipients. Methodology/Principal Findings: The transfer of protective immunity using Ag85B-TB10.4-specific, CD45RB(low) CD62L(low) CD4 T cells was assessed in sub-lethally irradiated recipients following challenge with live BCG, used here as a surrogate for virulent Mtb. Donor T cells also carried an allotype marker allowing us to monitor numbers of antigen-specific, cytokine-producing CD4 T cells in recipients. The results showed that both Ag85B-TB10.4 and BCG vaccination induced immunity that could be transferred with a single injection of 3 x 10(6) CD4 T cells. Ten times fewer numbers of CD4 T cells (0.3 x 10(6)) from donors immunised with Ag85B-TB10.4 vaccine alone, transferred equivalent protection. CD4 T cells from donors primed by BCG and boosted with the vaccine similarly transferred protective immunity. When BCG challenge was delayed for 1 or 2 months after transfer (a test of memory T cell survival) recipients remained protected. Importantly, recipients that contained persisting antigen, either live BCG or inert vaccine, showed significantly higher levels of protection (p<0.01). Overall the numbers of IFN-gamma-producing CD4 T cells were poorly correlated with levels of protection. Conclusions/Significance: The Ag85B-TB10.4 vaccine, with or without BCG-priming, generated TB-specific CD4 T cells that transferred protective immunity in mice challenged with BCG. The level of protection was enhanced in recipients containing a residual source of specific antigen that could be either viable or inert.	[Duffy, Darragh; Dawoodji, Amina; Bell, Eric B.] Univ Manchester, Immunol Sect, Manchester, Lancs, England; [Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Westermann, Juergen] Med Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany	University of Manchester; Statens Serum Institut; University of Lubeck	Duffy, D (corresponding author), Univ Paris 06, INSERM, U543, Lab Immunol Cellulaire, Paris, France.	eric.bell@manchester.ac.uk		Andersen, Peter/0000-0002-5869-2551	European Commission [LSHP-CT-2003-503367]; Dunhill Medical Trust	European Commission(European CommissionEuropean Commission Joint Research Centre); Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported with funds from the European Commission contract no. LSHP-CT-2003-503367. Additional funding was provided by the Dunhill Medical Trust (www.dunhillmedical.org.uk) to EBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; BELL EB, 1987, J IMMUNOL, V139, P1379; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; Bell EB, 2001, EUR J IMMUNOL, V31, P1685, DOI 10.1002/1521-4141(200106)31:6<1685::AID-IMMU1685>3.0.CO;2-V; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Bunce C, 1997, J EXP MED, V185, P767, DOI 10.1084/jem.185.4.767; Christensen D, 2007, BBA-BIOMEMBRANES, V1768, P2120, DOI 10.1016/j.bbamem.2007.05.009; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Duffy D, 2006, IMMUNOLOGY, V119, P376, DOI 10.1111/j.1365-2567.2006.02446.x; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gray D, 2002, NAT REV IMMUNOL, V2, P60, DOI 10.1038/nri706; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Hayashi N, 2002, P NATL ACAD SCI USA, V99, P6187, DOI 10.1073/pnas.092129899; Hayden KA, 1996, J IMMUNOL, V156, P48; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Leung CC, 2001, INT J TUBERC LUNG D, V5, P717; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mustafa AS, 2000, INFECT IMMUN, V68, P3933, DOI 10.1128/IAI.68.7.3933-3940.2000; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Robertson JM, 2006, IMMUNOL REV, V211, P49, DOI 10.1111/j.0105-2896.2006.00383.x; SARAWAR SR, 1993, EUR J IMMUNOL, V23, P103, DOI 10.1002/eji.1830230117; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; SPARSHOTT SM, 1994, EUR J IMMUNOL, V24, P2573, DOI 10.1002/eji.1830241102; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; TOYOHARA M, 1959, Tubercle, V40, P184, DOI 10.1016/S0041-3879(59)80039-8; Yang CP, 2006, INT IMMUNOL, V18, P515, DOI 10.1093/intimm/dxh392; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	52	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8272	10.1371/journal.pone.0008272	http://dx.doi.org/10.1371/journal.pone.0008272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011592	Green Submitted, gold, Green Published			2022-12-25	WOS:000272830300027
J	Maffucci, T; Raimondi, C; Abu-Hayyeh, S; Dominguez, V; Sala, G; Zachary, I; Falasca, M				Maffucci, Tania; Raimondi, Claudio; Abu-Hayyeh, Shadi; Dominguez, Veronica; Sala, Gianluca; Zachary, Ian; Falasca, Marco			A Phosphoinositide 3-Kinase/Phospholipase Cgamma1 Pathway Regulates Fibroblast Growth Factor-Induced Capillary Tube Formation	PLOS ONE			English	Article							PHOSPHOLIPASE-C-GAMMA; ENDOTHELIAL-CELL PROLIFERATION; FACTOR RECEPTOR 1; SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL 3-KINASE; PLC-GAMMA; ANGIOGENESIS; ACTIVATION; KINASE; PHOSPHORYLATION	Background: The fibroblast growth factors (FGFs) are key regulators of embryonic development, tissue homeostasis and tumour angiogenesis. Binding of FGFs to their receptor(s) results in activation of several intracellular signalling cascades including phosphoinositide 3-kinase (PI3K) and phospholipase C (PLC)gamma 1. Here we investigated the basic FGF (FGF-2)-mediated activation of these enzymes in human umbilical vein endothelial cells (HUVECs) and defined their role in FGF-2-dependent cellular functions. Methodology/Principal Findings: We show that FGF-2 activates PLC gamma 1 in HUVECs measured by analysis of total inositol phosphates production upon metabolic labelling of cells and intracellular calcium increase. We further demonstrate that FGF-2 activates PI3K, assessed by analysing accumulation of its lipid product phosphatidylinositol-3,4,5-P(3) using TLC and confocal microscopy analysis. PI3K activity is required for FGF-2-induced PLC gamma 1 activation and the PI3K/PLC gamma 1 pathway is involved in FGF-2-dependent cell migration, determined using Transwell assay, and in FGF-2-induced capillary tube formation (tubulogenesis assays in vitro). Finally we show that PI3K-dependent PLC gamma 1 activation regulates FGF-2-mediated phosphorylation of Akt at its residue Ser473, determined by Western blotting analysis. This occurs through protein kinase C (PKC)alpha activation since dowregulation of PKC alpha expression using specific siRNA or blockade of its activity using chemical inhibition affects the FGF-2-dependent Ser473 Akt phosphorylation. Furthermore inhibition of PKC alpha blocks FGF-2-dependent cell migration. Conclusion/Significance: These data elucidate the role of PLC gamma 1 in FGF-2 signalling in HUVECs demonstrating its key role in FGF-2-dependent tubulogenesis. Furthermore these data unveil a novel role for PLC gamma 1 as a mediator of PI3K-dependent Akt activation and as a novel key regulator of different Akt-dependent processes.	[Maffucci, Tania; Raimondi, Claudio; Dominguez, Veronica; Sala, Gianluca; Falasca, Marco] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Inositide Signalling Grp,Ctr Diabet, London, England; [Abu-Hayyeh, Shadi; Zachary, Ian] UCL, British Heart Fdn Labs, Ctr Cardiovasc Biol & Med, Dept Med, London, England	University of London; Queen Mary University London; University of London; University College London	Maffucci, T (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Inositide Signalling Grp,Ctr Diabet, London, England.	m.falasca@qmul.ac.uk	Raimondi, Claudio/AAJ-4335-2020; Sala, Gianluca/C-2056-2017; Falasca, Marco/S-4020-2016	Raimondi, Claudio/0000-0002-1419-6855; Sala, Gianluca/0000-0002-4494-915X; Falasca, Marco/0000-0002-9801-7235	British Heart Foundation [PG/04/033/16906, PG/06/022/20348]; Barts and The London Charity [430/647]; Association for International Cancer Research [05-127]; British Heart Foundation [RG/06/003/21131] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Barts and The London Charity; Association for International Cancer Research; British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation (grant PG/04/033/16906 and grant PG/06/022/20348 to MF). SA-H was supported by British Heart Foundation (grant PG/04/033/16906 to MF). VD was supported by Barts and The London Charity (grant 430/647 to TM). GS was supported by Association for International Cancer Research (grant 05-127 to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; BURGESS WH, 1990, MOL CELL BIOL, V10, P4770, DOI 10.1128/MCB.10.9.4770; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Ear T, 2001, J IMMUNOL METHODS, V257, P41, DOI 10.1016/S0022-1759(01)00445-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gliki G, 2002, CELL BIOL INT, V26, P751, DOI 10.1016/S1065-6995(02)90926-1; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Landgren E, 1998, ONCOGENE, V17, P283, DOI 10.1038/sj.onc.1201936; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lee H, 2002, MOL VIS, V8, P17; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Maffucci T, 2007, BIOCHEM SOC T, V35, P229, DOI 10.1042/BST0350229; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Malek AM, 1997, PEDIATR NEUROSURG, V27, P182, DOI 10.1159/000121249; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; McLaughlin AP, 2001, AM J PHYSIOL-CELL PH, V281, pC1448, DOI 10.1152/ajpcell.2001.281.5.C1448; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Mochizuki Y, 2002, ONCOGENE, V21, P7027, DOI 10.1038/sj.onc.1205736; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; NGUYEN M, 1994, J NATL CANCER I, V86, P356, DOI 10.1093/jnci/86.5.356; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Preiss S, 2007, CARDIOVASC RES, V73, P833, DOI 10.1016/j.cardiores.2006.12.019; Price JT, 1999, CANCER RES, V59, P5475; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; SOUTTER AD, 1993, CANCER RES, V53, P5297; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Thomas SM, 2003, CANCER RES, V63, P5629; Turner T, 1997, CLIN CANCER RES, V3, P2275; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096	60	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8285	10.1371/journal.pone.0008285	http://dx.doi.org/10.1371/journal.pone.0008285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011604	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300037
J	Blom, SM; Schmitt, N; Jensen, HS				Blom, Sigrid Marie; Schmitt, Nicole; Jensen, Henrik Sindal			The Acrylamide (S)-2 As a Positive and Negative Modulator of Kv7 Channels Expressed in Xenopus laevis Oocytes	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; ANTICONVULSANT RETIGABINE; MOLECULAR DETERMINANTS; DOMINANT DEAFNESS; OPENER RETIGABINE; MAMMALIAN-CELLS; ACTIVATION; SUBUNITS; FORM; PHARMACOLOGY	Background: Activation of voltage-gated potassium channels of the Kv7 (KCNQ) family reduces cellular excitability. These channels are therefore attractive targets for treatment of diseases characterized by hyperexcitability, such as epilepsy, migraine and neuropathic pain. Retigabine, which opens Kv7.2-5, is now in clinical trial phase III for the treatment of partial onset seizures. One of the main obstacles in developing Kv7 channel active drugs has been to identify compounds that can discriminate between the neuronal subtypes, a feature that could help diminish side effects and increase the potential of drugs for particular indications. Methodology/Principal Findings: In the present study we have made a thorough investigation of the Bristol-Myers Squibb compound (S)-N-[1-(4-Cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide [(S)-2] on human Kv7.1-5 channels expressed in Xenopus laevis oocytes. We found that the compound was a weak inhibitor of Kv7.1. In contrast, (S)-2 efficiently opened Kv7.2-5 by producing hyperpolarizing shifts in the voltage-dependence of activation and enhancing the maximal current amplitude. Further, it reduced inactivation, accelerated activation kinetics and slowed deactivation kinetics. The mechanisms of action varied between the subtypes. The enhancing effects of (S)-2 were critically dependent on a tryptophan residue in S5 also known to be crucial for the effects of retigabine, (S)-1 and BMS-204352. However, while (S)-2 did not at all affect a mutant Kv7.4 with a leucine in this position (Kv7.4-W242L), a Kv7.2 with the same mutation (Kv7.2-W236L) was inhibited by the compound, showing that (S)-2 displays a subtype-selective interaction with in the Kv7 family. Conclusions/Significance: These results offer further insight into pharmacological activation of Kv7 channels, add to the understanding of small molecule interactions with the channels and may contribute to the design of subtype selective modulators.	[Blom, Sigrid Marie; Jensen, Henrik Sindal] H Lundbeck & Co AS, Sect Early Target Pharmacol & Physiol, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Lundbeck Corporation; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Blom, SM (corresponding author), H Lundbeck & Co AS, Sect Early Target Pharmacol & Physiol, Copenhagen, Denmark.	HSIN@Lundbeck.com	; Schmitt, Nicole/B-8725-2012	Blom, Sigrid Marie/0000-0002-2255-3234; Schmitt, Nicole/0000-0001-9482-9749	Danish National Research Foundation Centre for Cardiac Arrhythmia	Danish National Research Foundation Centre for Cardiac Arrhythmia(Danmarks Grundforskningsfond)	Funding was provided by the Danish National Research Foundation Centre for Cardiac Arrhythmia (www.DARC.ku.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bentzen BH, 2006, NEUROPHARMACOLOGY, V51, P1068, DOI 10.1016/j.neuropharm.2006.07.001; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Hansen HH, 2006, J PHARMACOL EXP THER, V318, P1006, DOI 10.1124/jpet.106.106757; Jensen HS, 2007, BIOPHYS J, V92, P2747, DOI 10.1529/biophysj.106.101287; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Mackie AR, 2008, MOL PHARMACOL, V74, P1171, DOI 10.1124/mol.108.049825; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Martin V, 2007, GEOSPATIAL HEALTH, V2, P3, DOI 10.4081/gh.2007.250; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroder RL, 2001, NEUROPHARMACOLOGY, V40, P888, DOI 10.1016/S0028-3908(01)00029-6; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Seebohm G, 2005, CELL PHYSIOL BIOCHEM, V16, P255, DOI 10.1159/000089851; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Tatulian L, 2003, J PHYSIOL-LONDON, V549, P57, DOI 10.1113/jphysiol.2003.039842; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Towart Rob, 2009, Journal of Pharmacological and Toxicological Methods, V60, P1, DOI 10.1016/j.vascn.2009.04.197; Wang HS, 2000, MOL PHARMACOL, V57, P1218; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wu YJ, 2004, BIOORG MED CHEM LETT, V14, P1991, DOI 10.1016/j.bmcl.2004.01.069; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874	33	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8251	10.1371/journal.pone.0008251	http://dx.doi.org/10.1371/journal.pone.0008251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011514	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830200006
J	Duncan, PI; Raymond, F; Fuerholz, A; Sprenger, N				Duncan, Peter I.; Raymond, Frederic; Fuerholz, Andreas; Sprenger, Norbert			Sialic Acid Utilisation and Synthesis in the Neonatal Rat Revisited	PLOS ONE			English	Article							HUMAN-MILK; DEVELOPMENTAL-CHANGES; BRAIN GANGLIOSIDES; GENE-EXPRESSION; OLIGOSACCHARIDES; MOUSE; METABOLISM; EXCRETION; INFANTS; CHROMATOGRAPHY	Background: Milk is the sole source of nutrients for neonatal mammals and is generally considered to have co-evolved with the developmental needs of the suckling newborn. One evolutionary conserved constituent of milk and present on many glycoconjugates is sialic acid. The brain and colon are major sites of sialic acid display and together with the liver also of synthesis. Methodology/Principal Findings: In this study we examined in rats the relationship between the sialic acid content of milk and the uptake, utilization and synthesis of sialic acid in suckling pups. In rat milk sialic acid was found primarily as 3'sialyllactose and at highest levels between 3 and 10 days postpartum and that decreased towards weaning. In the liver of suckling pups sialic acid synthesis paralleled the increase in milk sialic acid reaching and keeping maximum activity from postnatal day 5 onwards. In the colon, gene expression profiles suggested that a switch from sialic acid uptake and catabolism towards sialic acid synthesis and utilization occurred that mirrored the change of sialic acid in milk from high to low expression. In brain sialic acid related gene expression profiles did not change to any great extent during the suckling period. Conclusions/Significance: Our results support the views that (i) when milk sialic acid levels are high, in the colon this sialic acid is catabolized to GlcNAc that in turn may be used as such or used as substrate for sialic acid synthesis and (ii) when milk sialic acid levels are low the endogenous sialic acid synthetic machinery in colon is activated.	[Duncan, Peter I.; Raymond, Frederic; Fuerholz, Andreas; Sprenger, Norbert] Nestle Res Ctr, CH-1000 Lausanne, Switzerland	Nestle SA	Duncan, PI (corresponding author), Nestle Res Ctr, CH-1000 Lausanne, Switzerland.	peter.duncan@rdls.nestle.com; norbert.sprenger@rdls.nestle.com		Raymond, Frederic/0000-0002-6148-6898	Nestec Ltd	Nestec Ltd	This work was funded by Nestec Ltd. The funders had input in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; BRUNETTI P, 1962, J BIOL CHEM, V237, P2447; Chaturvedi P, 2001, ADV EXP MED BIOL, V501, P315; Coppa GV, 2001, ADV EXP MED BIOL, V501, P307; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DICKSON JJ, 1978, BIOCHEM J, V170, P407, DOI 10.1042/bj1700407; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Gal B, 1997, COMP BIOCHEM PHYS B, V118, P13, DOI 10.1016/S0305-0491(97)00016-3; HARA S, 1986, J CHROMATOGR, V377, P111, DOI 10.1016/S0378-4347(00)80766-5; Horstkorte R, 1999, EUR J BIOCHEM, V260, P923, DOI 10.1046/j.1432-1327.1999.00253.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KARIM M, 2006, PERSPECT AGR VET SCI, V1, P18; KUHN NJ, 1972, BIOCHEM J, V130, P177, DOI 10.1042/bj1300177; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Kunz C, 1996, J CHROMATOGR B, V685, P211, DOI 10.1016/S0378-4347(96)00181-8; Laule O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-311; Luchansky SJ, 2003, J BIOL CHEM, V278, P8035, DOI 10.1074/jbc.M212127200; MORGAN BLG, 1980, J NUTR, V110, P416, DOI 10.1093/jn/110.3.416; MUCHMORE EA, 1992, GLYCOBIOLOGY, V2, P337, DOI 10.1093/glycob/2.4.337; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; NOHLE U, 1984, H-S Z PHYSIOL CHEM, V365, P1457, DOI 10.1515/bchm2.1984.365.2.1457; NOHLE U, 1981, H-S Z PHYSIOL CHEM, V362, P1495, DOI 10.1515/bchm2.1981.362.2.1495; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; SABHARWAL H, 1991, J PEDIATR GASTR NUTR, V12, P480, DOI 10.1097/00005176-199105000-00012; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; SVENNERHOLM L, 1989, BIOCHIM BIOPHYS ACTA, V1005, P109, DOI 10.1016/0005-2760(89)90175-6; Urashima T, 2001, GLYCOCONJUGATE J, V18, P357, DOI 10.1023/A:1014881913541; VANRINSUM J, 1983, BIOCHEM J, V210, P21, DOI 10.1042/bj2100021; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Wang B, 1998, COMP BIOCHEM PHYS A, V119, P435, DOI 10.1016/S1095-6433(97)00445-5; Wang B, 2001, AM J CLIN NUTR, V74, P510; Wang B, 2007, ASIA PAC J CLIN NUTR, V16, P110; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; WITT W, 1979, NUTR METAB, V23, P51; Yarovaya N, 2005, NEUROBIOL DIS, V19, P351, DOI 10.1016/j.nbd.2004.12.020	43	33	35	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8241	10.1371/journal.pone.0008241	http://dx.doi.org/10.1371/journal.pone.0008241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011510	gold, Green Submitted, Green Published			2022-12-25	WOS:000272830200002
J	Moyano, AJ; Smania, AM				Moyano, Alejandro J.; Smania, Andrea M.			Simple Sequence Repeats and Mucoid Conversion: Biased mucA Mutagenesis in Mismatch Repair-Deficient Pseudomonas aeruginosa	PLOS ONE			English	Article							DNA-POLYMERASE-IV; GRAM-NEGATIVE BACTERIA; ALLOW RAPID DETECTION; CYSTIC-FIBROSIS; ESCHERICHIA-COLI; GENETIC ADAPTATION; SUICIDE VECTOR; LACZ MUTATIONS; ALGINATE; REPLICATION	In Pseudomonas aeruginosa, conversion to the mucoid phenotype marks the onset of an irreversible state of the infection in Cystic Fibrosis (CF) patients. The main pathway for mucoid conversion is mutagenesis of the mucA gene, frequently due to -1 bp deletions in a simple sequence repeat (SSR) of 5 Gs (G(5)-SSR426). We have recently observed that this mucA mutation is particularly accentuated in Mismatch Repair System (MRS)-deficient cells grown in vitro. Interestingly, previous reports have shown a high prevalence of hypermutable MRS-deficient strains occurring naturally in CF chronic lung infections. Here, we used mucA as a forward mutation model to systematically evaluate the role of G(5)-SSR426 in conversion to mucoidy in a MRS-deficient background, with this being the first analysis combining SSR-dependent localized hypermutability and the acquisition of a particular virulence/persistence trait in P. aeruginosa. In this study, mucA alleles were engineered with different contents of G: C SSRs, and tested for their effect on the mucoid conversion frequency and mucA mutational spectra in a mutS-deficient strain of P. aeruginosa. Importantly, deletion of G(5)-SSR426 severely reduced the emergence frequency of mucoid variants, with no preferential site of mutagenesis within mucA. Moreover, although mutagenesis in mucA was not totally removed, this was no longer the main pathway for mucoid conversion, suggesting that G(5)-SSR426 biased mutations towards mucA. Mutagenesis in mucA was restored by the addition of a new SSR (C-6-SSR431), and even synergistically increased when G(5)-SSR426 and C-6-SSR431 were present simultaneously, with the mucA mutations being restricted to -1 bp deletions within any of both G:C SSRs. These results confirm a critical role for G(5)-SSR426 enhancing the mutagenic process of mucA in MRS-deficient cells, and shed light on another mechanism, the SSR-localized hypermutability, contributing to mucoid conversion in P. aeruginosa.	[Moyano, Alejandro J.; Smania, Andrea M.] Univ Nacl Cordoba, CONICET, Dept Quim Biol,Fac Ciencias Quim, CIQUIBIC, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Moyano, AJ (corresponding author), Univ Nacl Cordoba, CONICET, Dept Quim Biol,Fac Ciencias Quim, CIQUIBIC, RA-5000 Cordoba, Argentina.	asmania@mail.fcq.unc.edu.ar	Moyano, Alejandro/AAB-9092-2019; Smania, Andrea/AAG-1105-2022; Smania, Andrea/AFK-2800-2022	Moyano, Alejandro/0000-0002-4976-7611; Smania, Andrea/0000-0002-6527-7719	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT-2007-00687]; Secretaria de Ciencia y Tecnica (SECYT-UNC) [05/C486]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Secretaria de Ciencia y Tecnica (SECYT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) Grant PICT-2007-00687 (http://www.agencia.gov.ar/), and Secretaria de Ciencia y Tecnica (SECYT-UNC) Grant 05/C486 (http://www.secyt.unc.edu.ar/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony M, 2002, J CLIN MICROBIOL, V40, P2772, DOI 10.1128/JCM.40.8.2772-2778.2002; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; Blazquez J, 2003, CLIN INFECT DIS, V37, P1201, DOI 10.1086/378810; Blazquez J, 2006, MOL MICROBIOL, V62, P84, DOI 10.1111/j.1365-2958.2006.05366.x; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Boucher JC, 2000, MOL MICROBIOL, V36, P341, DOI 10.1046/j.1365-2958.2000.01846.x; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; Cezairliyan BO, 2009, MOL MICROBIOL, V72, P368, DOI 10.1111/j.1365-2958.2009.06654.x; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; CUPPLES CG, 1990, GENETICS, V125, P275; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; FOSTER PL, 1994, SCIENCE, V265, P407, DOI 10.1126/science.8023164; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gawel D, 2002, MUTAT RES-FUND MOL M, V501, P129, DOI 10.1016/S0027-5107(02)00020-9; GOVAN JRW, 1981, J GEN MICROBIOL, V125, P217; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; KRIEG DP, 1986, J CLIN MICROBIOL, V24, P986, DOI 10.1128/JCM.24.6.986-990.1986; Kuban W, 2004, J BACTERIOL, V186, P4802, DOI 10.1128/JB.186.14.4802-4807.2004; Kuban W, 2005, J BACTERIOL, V187, P6862, DOI 10.1128/JB.187.19.6862-6866.2005; Levy DD, 2001, MUTAT RES-FUND MOL M, V474, P1, DOI 10.1016/S0027-5107(00)00169-X; MAI GT, 1993, INFECT IMMUN, V61, P559, DOI 10.1128/IAI.61.2.559-564.1993; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; MARTIN DW, 1993, MOL MICROBIOL, V9, P497, DOI 10.1111/j.1365-2958.1993.tb01711.x; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Petrosino JF, 2002, ANTIMICROB AGENTS CH, V46, P1535, DOI 10.1128/AAC.46.5.1535-1539.2002; PIER GB, 1990, SCIENCE, V249, P537, DOI 10.1126/science.2116663; Qiu DR, 2008, MICROBIOL-SGM, V154, P2119, DOI 10.1099/mic.0.2008/017368-0; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Reiling SA, 2005, MICROBIOL-SGM, V151, P2251, DOI 10.1099/mic.0.27772-0; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Sanders LH, 2006, J BACTERIOL, V188, P8573, DOI 10.1128/JB.01481-06; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; Schnider-Keel U, 2001, APPL ENVIRON MICROB, V67, P5683, DOI 10.1128/AEM.67.12.5683-5693.2001; SIMPSON JA, 1989, FREE RADICAL BIO MED, V6, P347, DOI 10.1016/0891-5849(89)90078-6; Smania AM, 2004, MICROBIOL-SGM, V150, P1327, DOI 10.1099/mic.0.26751-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tegova R, 2004, J BACTERIOL, V186, P2735, DOI 10.1128/JB.186.9.2735-2744.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Yang ZW, 2001, MUTAT RES-FUND MOL M, V484, P95, DOI 10.1016/S0027-5107(01)00257-3; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684	61	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8203	10.1371/journal.pone.0008203	http://dx.doi.org/10.1371/journal.pone.0008203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997602	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829500020
J	Carrega, P; Pezzino, G; Queirolo, P; Bonaccorsi, I; Falco, M; Vita, G; Pende, D; Misefari, A; Moretta, A; Mingari, MC; Moretta, L; Ferlazzo, G				Carrega, Paolo; Pezzino, Gaetana; Queirolo, Paola; Bonaccorsi, Irene; Falco, Michela; Vita, Giuseppe; Pende, Daniela; Misefari, Aldo; Moretta, Alessandro; Mingari, Maria Cristina; Moretta, Lorenzo; Ferlazzo, Guido			Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells	PLOS ONE			English	Article							CLASS-I MOLECULES; MHC CLASS-I; ANTIGEN ABNORMALITIES; INHIBITORY RECEPTORS; MALIGNANT-CELLS; T-CELLS; RECOGNITION; EXPRESSION; IDENTIFICATION; CYTOTOXICITY	Background: Despite Natural Killer (NK) cells were originally defined as effectors of spontaneous cytotoxicity against tumors, extremely limited information is so far available in humans on their capability of killing cancer cells in an autologous setting. Methodology/Principal Findings: We have established a series of primary melanoma cell lines from surgically resected specimens and here showed that human melanoma cells were highly susceptible to lysis by activated autologous NK cells. A variety of NK cell activating receptors were involved in killing: particularly, DNAM-1 and NKp46 were the most frequently involved. Since self HLA class I molecules normally play a protective role from NK cell-mediated attack, we analyzed HLA class I expression on melanomas in comparison to autologous lymphocytes. We found that melanoma cells presented specific allelic losses in 50% of the patients analyzed. In addition, CD107a degranulation assays applied to NK cells expressing a single inhibitory receptor, revealed that, even when expressed, specific HLA class I molecules are present on melanoma cell surface in amount often insufficient to inhibit NK cell cytotoxicity. Remarkably, upon activation, also the so called "unlicensed'' NK cells, i.e. NK cells not expressing inhibitory receptor specific for self HLA class I molecules, acquired the capability of efficiently killing autologous melanoma cells, thus additionally contributing to the lysis by a mechanism independent of HLA class I expression on melanoma cells. Conclusions/Significance: We have investigated in details the mechanisms controlling the recognition and lysis of melanoma cells by autologous NK cells. In these autologous settings, we demonstrated an efficient in vitro killing upon NK cell activation by mechanisms that may be related or not to abnormalities of HLA class I expression on melanoma cells. These findings should be taken into account in the design of novel immunotherapy approaches against melanoma.	[Carrega, Paolo; Falco, Michela; Moretta, Lorenzo] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Pezzino, Gaetana; Bonaccorsi, Irene; Ferlazzo, Guido] Univ Messina, Lab Immunol & Biotherapy, Dept Human Pathol, Messina, Italy; [Queirolo, Paola; Pende, Daniela; Mingari, Maria Cristina] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Vita, Giuseppe; Misefari, Aldo] Univ Messina, Dept Pathol & Expt Microbiol, Unit Cell Typing, Messina, Italy; [Moretta, Alessandro; Mingari, Maria Cristina; Moretta, Lorenzo] Univ Genoa, Dept Expt Med, Genoa, Italy; [Moretta, Alessandro; Moretta, Lorenzo] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Messina; University of Genoa; IRCCS AOU San Martino IST; University of Messina; University of Genoa; University of Genoa	Carrega, P (corresponding author), Ist Giannina Gaslini, I-16148 Genoa, Italy.	guido.ferlazzo@unime.it	Bonaccorsi, Irene/J-7409-2016; Queirolo, Paola/K-6778-2016; Pende, Daniela/J-7429-2016; Carrega, Paolo/G-4883-2018; Mingari, Maria Cristina/AAB-1315-2019; Falco, Michela/K-1574-2016; Moretta, Lorenzo/AAA-7239-2020	Bonaccorsi, Irene/0000-0002-2893-0117; Queirolo, Paola/0000-0002-9917-6633; Pende, Daniela/0000-0003-1565-451X; Carrega, Paolo/0000-0001-8541-9115; Falco, Michela/0000-0002-0317-9830; Moretta, Lorenzo/0000-0003-4658-1747; Ferlazzo, Guido/0000-0002-3874-8554	Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Banco di Sicilia; Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica; Regione Sicilia, Ricerca Sanitaria Regionale 2007	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Banco di Sicilia; Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica; Regione Sicilia, Ricerca Sanitaria Regionale 2007	Research in the authors' laboratories is supported by: Associazione Italiana per la Ricerca sul Cancro (AIRC) (http://www.airc.it); Fondazione Banco di Sicilia (http://www.fondazionebancodisicilia.it/it/); Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica (http://www.ministerosalute.it/); Regione Sicilia, Ricerca Sanitaria Regionale 2007 (http://www.regione.sicilia.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; LopezBotet M, 1997, IMMUNOL REV, V155, P165, DOI 10.1111/j.1600-065X.1997.tb00949.x; Lozupone F, 2004, CANCER RES, V64, P378, DOI 10.1158/0008-5472.CAN-03-1501; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Pende D, 1998, EUR J IMMUNOL, V28, P2384, DOI 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Porgador A, 1997, P NATL ACAD SCI USA, V94, P13140, DOI 10.1073/pnas.94.24.13140; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Seliger B, 2002, SEMIN CANCER BIOL, V12, P3, DOI 10.1006/scbi.2001.0404; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010	27	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8132	10.1371/journal.pone.0008132	http://dx.doi.org/10.1371/journal.pone.0008132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997637	Green Submitted, gold, Green Published			2022-12-25	WOS:000272829200002
J	Klosowska-Wardega, A; Hasumi, Y; Burmakin, M; Ahgren, A; Stuhr, L; Moen, I; Reed, RK; Rubin, K; Hellberg, C; Heldin, CH				Klosowska-Wardega, Agnieszka; Hasumi, Yoko; Burmakin, Mikhail; Ahgren, Aive; Stuhr, Linda; Moen, Ingrid; Reed, Rolf K.; Rubin, Kristofer; Hellberg, Carina; Heldin, Carl-Henrik			Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-BB; INHIBITION; CANCER; CHEMOTHERAPY; TUMORS; TRANSPORT; PERICYTES; EFFICACY; IMATINIB; VESSELS	Elevation of the interstitial fluid pressure (IFP) of carcinoma is an obstacle in treatment of tumors by chemotherapy and correlates with poor drug uptake. Previous studies have shown that treatment with inhibitors of platelet-derived growth factor ( PDGF) or vascular endothelial growth factor ( VEGF) signaling lowers the IFP of tumors and improve chemotherapy. In this study, we investigated whether the combination of PDGFR and VEGFR inhibitors could further reduce the IFP of KAT-4 human carcinoma tumors. The tumor IFP was measured using the wick-in-needle technique. The combination of STI571 and PTK/ZK gave an additive effect on the lowering of the IFP of KAT-4 tumors, but the timing of the treatment was crucial. The lowering of IFP following combination therapy was accompanied by vascular remodeling and decreased vascular leakiness. The effects of the inhibitors on the therapeutic efficiency of Taxol were investigated. Whereas the anti-PDGF and anti-VEGF treatment did not significantly inhibit tumor growth, the inhibitors enhanced the effect of chemotherapy. Despite having an additive effect in decreasing tumor IFP, the combination therapy did not further enhance the effect of chemotherapy. Simultaneous targeting of VEGFR and PDGFR kinase activity may be a useful strategy to decrease tumor IFP, but the timing of the inhibitors should be carefully determined.	[Klosowska-Wardega, Agnieszka; Hasumi, Yoko; Burmakin, Mikhail; Ahgren, Aive; Hellberg, Carina; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Uppsala, Sweden; [Stuhr, Linda; Moen, Ingrid; Reed, Rolf K.] Univ Bergen, Dept Biomed, Bergen, Norway; [Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; University of Bergen; Uppsala University	Klosowska-Wardega, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Uppsala, Sweden.	Agnieszka.Klosowska-Wardega@LICR.uu.se	Reed, Rolf K./B-9422-2017; Rubin, Kristofer/AAC-1810-2020	Reed, Rolf K./0000-0002-2633-6595; Rubin, Kristofer/0000-0003-2789-6276; Burmakin, Mikhail/0000-0002-1370-6251	Swedish Cancer Foundation; Swedish Science Council; Research Council of Norway; Norwegian Cancer Society	Swedish Cancer Foundation; Swedish Science Council; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	KR was funded by the Swedish Cancer Foundation and the Swedish Science Council. RR was funded by the Research Council of Norway, and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; AIN KB, 1994, J CLIN ENDOCR METAB, V78, P1097, DOI 10.1210/jc.78.5.1097; [Anonymous], 1988, LAB ANIM-UK, V22, P195; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hasumi Y, 2007, INT J CANCER, V121, P2606, DOI 10.1002/ijc.22999; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Jain RK, 2008, SCI AM, V298, P56, DOI 10.1038/scientificamerican0108-56; JAIN RK, 1991, INT J RADIAT BIOL, V60, P85, DOI 10.1080/09553009114551621; Lee CG, 2000, CANCER RES, V60, P5565; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pietras K, 2003, CLIN CANCER RES, V9, P3779; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2001, CANCER RES, V61, P2929; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; Rubin K, 2000, INT J CANCER, V86, P636, DOI 10.1002/(SICI)1097-0215(20000601)86:5<636::AID-IJC6>3.0.CO;2-R; Salnikov AV, 2006, INT J CANCER, V119, P2795, DOI 10.1002/ijc.22217; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Wood JM, 2000, CANCER RES, V60, P2178	27	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8149	10.1371/journal.pone.0008149	http://dx.doi.org/10.1371/journal.pone.0008149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997591	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829200003
J	Crostarosa, F; Aravantinou, M; Akpogheneta, OJ; Jasny, E; Shaw, A; Kenney, J; Piatak, M; Lifson, JD; Teitelbaum, A; Hu, LY; Chudolij, A; Zydowsky, TM; Blanchard, J; Gettie, A; Robbiani, M				Crostarosa, Federica; Aravantinou, Meropi; Akpogheneta, Onome J.; Jasny, Edith; Shaw, Andrew; Kenney, Jessica; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Thomas M.; Blanchard, James; Gettie, Agegnehu; Robbiani, Melissa			A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PLASMACYTOID DENDRITIC CELLS; LENTIVIRUS-INDUCED PROTECTION; RHESUS MACAQUES; T-CELLS; CD8(+) LYMPHOCYTES; TYPE-2 HSV-2; DEPO-PROVERA; DOUBLE-BLIND; HIV-1 LEVELS	Background: Herpes simplex virus type-2 (HSV-2) infection enhances the transmission and acquisition of human immunodeficiency virus (HIV). This occurs in symptomatic and asymptomatic stages of HSV-2 infection, suggesting that obvious herpetic lesions are not required to increase HIV spread. An animal model to investigate the underlying causes of the synergistic action of the two viruses and where preventative strategies can be tested under such complex physiological conditions is currently unavailable. Methodology/Principal Findings: We set out to establish a rhesus macaque model in which HSV-2 infection increases the susceptibility to vaginal infection with a model immunodeficiency virus (simian-human immunodeficiency virus, SHIV-RT), and to more stringently test promising microbicides. HSV-2 exposure significantly increased the frequency of vaginal SHIV-RT infection (n = 6). Although cervical lesions were detected in only similar to 10% of the animals, long term HSV-2 DNA shedding was detected (in 50% of animals followed for 2 years). Vaginal HSV-2 exposure elicited local cytokine/chemokine (n = 12) and systemic low-level HSV-2-specific adaptive responses in all animals (n = 8), involving CD4(+) and CD8(+) HSV-specific T cells (n = 5). Local cytokine/chemokine responses were lower in co-infected animals, while simian immunodeficiency virus (SIV)-specific adaptive responses were comparable in naive and HSV-2-infected animals (n = 6). Despite the increased frequency of SHIV-RT infection, a new generation microbicide gel, comprised of Carraguard (R) and a non-nucleoside reverse transcriptase inhibitor MIV-150 (PC-817), blocked vaginal SHIV-RT infection in HSV-2-exposed animals (n = 8), just as in naive animals. Conclusions/Significance: We established a unique HSV-2 macaque model that will likely facilitate research to define how HSV-2 increases HIV transmission, and enable more rigorous evaluation of candidate anti-viral approaches in vivo.	[Crostarosa, Federica; Aravantinou, Meropi; Akpogheneta, Onome J.; Jasny, Edith; Shaw, Andrew; Kenney, Jessica; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Thomas M.; Robbiani, Melissa] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick, MD 21701 USA; [Blanchard, James] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Population Council; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tulane University; Rockefeller University	Crostarosa, F (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org		Akpogheneta, Onome/0000-0002-5213-4903	USAID Cooperative Agreement [GPO-A-00-04-00019-00]; Swedish Ministry of Foreign Affairs; NIH [R37 AI040877, U19 AI065412, RR00164]; National Cancer Institute (NCI) [N01 CO 124000]; F.M. Kirby Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040877, U19AI065412] Funding Source: NIH RePORTER	USAID Cooperative Agreement(United States Agency for International Development (USAID)); Swedish Ministry of Foreign Affairs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); F.M. Kirby Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the USAID Cooperative Agreement GPO-A-00-04-00019-00, the Swedish Ministry of Foreign Affairs, NIH grants R37 AI040877, U19 AI065412, the NIH base grant RR00164, and in part with Federal funds from the National Cancer Institute (NCI), NIH, under contract N01 CO 124000 (JDL and MP are employed at SAIC, but are funded by NCI. SAIC provided no funds for this research. JDL and MP provided reagents and analytical support.). MR is a 2002 Elizabeth Glaser Scientist. FC and OJA were supported by the F. M. Kirby Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600; AURELIAN, 1992, HERPES SIMPLEX VIRUS, P473; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Celum C.L., 2004, HERPES, V11, p36A; Cline AN, 2005, J MED PRIMATOL, V34, P303; *COMM CAR US LAB A, 1985, GUID CAR US LAB AN, P1; Corey L, 2007, J INFECT DIS, V195, P1242, DOI 10.1086/513570; CUNNINGHAM AL, 1989, J CLIN INVEST, V83, P490, DOI 10.1172/JCI113908; Cunningham Anthony L, 2004, J HIV Ther, V9, P9; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gauduin MC, 2006, METHODS, V38, P263, DOI 10.1016/j.ymeth.2005.12.004; Genesca M, 2007, J MED PRIMATOL, V36, P266, DOI 10.1111/j.1600-0684.2007.00244.x; Harandi AM, 2001, AM J REPROD IMMUNOL, V46, P420, DOI 10.1034/j.1600-0897.2001.d01-34.x; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; Huff JL, 2003, EMERG INFECT DIS, V9, P246; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; King NJC, 1998, J IMMUNOL, V160, P1173; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; KOELLE DM, 1994, J INFECT DIS, V169, P956, DOI 10.1093/infdis/169.5.956; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; MERTZ GJ, 1985, SEX TRANSM DIS, V12, P33, DOI 10.1097/00007435-198501000-00007; Mikloska Z, 1998, J INFECT DIS, V177, P827, DOI 10.1086/515236; Mikloska Z, 1996, J INFECT DIS, V173, P7, DOI 10.1093/infdis/173.1.7; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Moriuchi M, 2000, VIROLOGY, V278, P534, DOI 10.1006/viro.2000.0667; PARR MB, 1994, LAB INVEST, V70, P369; Peretti S, 2005, BLOOD, V106, P1305, DOI 10.1182/blood-2004-12-4899; Pollara G, 2003, J INFECT DIS, V187, P165, DOI 10.1086/367675; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Sacks SL, 2004, ANTIVIR RES, V63, pS19, DOI 10.1016/j.antiviral.2004.06.004; Sariol CA, 2005, J MED PRIMATOL, V34, P13, DOI 10.1111/j.1600-0684.2004.00086.x; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Teleshova N, 2004, J IMMUNOL, V173, P1647, DOI 10.4049/jimmunol.173.3.1647; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523; Zuckerman RA, 2009, AIDS, V23, P479, DOI 10.1097/QAD.0b013e328326ca62	57	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8060	10.1371/journal.pone.0008060	http://dx.doi.org/10.1371/journal.pone.0008060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	20011586	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400014
J	Cooper, VS; Carlson, WA; LiPuma, JJ				Cooper, Vaughn S.; Carlson, Wendy A.; LiPuma, John J.			Susceptibility of Caenorhabditis elegans to Burkholderia Infection Depends on Prior Diet and Secreted Bacterial Attractants	PLOS ONE			English	Article							CEPACIA GENOMOVAR-III; CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; INNATE IMMUNITY; COMPLEX; MODEL; EPIDEMIOLOGY; PATHOGENESIS; CENOCEPACIA	The nematode Caenorhabditis elegans may be killed by certain pathogenic bacteria and thus is a model organism for studying interactions between bacteria and animal hosts. However, growing nematodes on prey bacteria may influence their susceptibility to potential pathogens. A method of axenic nematode culture was developed to isolate and quantify interactions between C. elegans and potentially pathogenic strains of the Burkholderia cepacia complex. Studying these dynamics in liquid solution rather than on agar surfaces minimized nematode avoidance behavior and resolved more differences among isolates. Most isolates of B. cenocepacia, B. ambifaria and B. cepacia caused 60-80% mortality of nematodes after 7 days, whereas isolates of B. multivorans caused less mortality (<25%) and supported nematode reproduction. However, some B. cenocepacia isolates recovered from chronic infections were much less virulent (5-28% mortality). As predicted, prior diet altered the outcome of interactions between nematodes and bacteria. When given the choice between Burkholderia and E. coli as prey on agar, axenically raised nematodes initially preferred most lethal Burkholderia isolates to E. coli as a food source, but this was not the case for nematodes fed E. coli, which avoided toxic Burkholderia. This food preference was associated with the cell-free supernatant and thus secreted compounds likely mediated bacterial-nematode interactions. This model, which isolates interactions between bacteria and nematodes from the effects of prior feeding, demonstrates that bacteria can influence nematode behavior and their susceptibility to pathogens.	[Cooper, Vaughn S.; Carlson, Wendy A.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [LiPuma, John J.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA	University System Of New Hampshire; University of New Hampshire; University of Michigan System; University of Michigan	Cooper, VS (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	vaughn.cooper@unh.edu		Cooper, Vaughn/0000-0001-7726-0765	New Hampshire Agricultural Experiment Station [H-496]; University of Michigan; National Science Foundation (NSF) [DBI-0618719]; Cystic Fibrosis Foundation	New Hampshire Agricultural Experiment Station; University of Michigan(University of Michigan System); National Science Foundation (NSF)(National Science Foundation (NSF)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by the New Hampshire Agricultural Experiment Station grant H-496 to V. S. C., by the Mott Golf Classic Scholar Award from the University of Michigan to J.J.L. and V. S. C, and by National Science Foundation (NSF) DBI-0618719 to the University of New Hampshire. J.J.L. is supported by the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Baldwin A, 2008, J CLIN MICROBIOL, V46, P290, DOI 10.1128/JCM.01818-07; Bargmann C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; BIRREN BW, 2005, GENOME SEQUENCE BURK; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Cardona ST, 2005, FEMS MICROBIOL LETT, V250, P97, DOI 10.1016/j.femsle.2005.06.050; Chen JS, 2001, J PEDIATR-US, V139, P643, DOI 10.1067/mpd.2001.118430; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; CLEGG ED, 2002, USE CEHR AXENIC MEDI; Coenye T, 2003, MICROBIOL-SGM, V149, P77, DOI 10.1099/mic.0.25850-0; Coenye T, 2002, J CLIN MICROBIOL, V40, P3300, DOI 10.1128/JCM.40.9.3300-3307.2002; Coenye T, 2003, J CLIN MICROBIOL, V41, P2797, DOI 10.1128/JCM.41.6.2797-2798.2003; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Engledow AS, 2004, J BACTERIOL, V186, P6015, DOI 10.1128/JB.186.18.6015-6024.2004; Forrester S, 2007, FOODBORNE PATHOG DIS, V4, P67, DOI 10.1089/fpd.2006.64; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Henry DA, 1997, J CLIN MICROBIOL, V35, P614, DOI 10.1128/JCM.35.3.614-619.1997; HINRICH S, 2007, MOL MICROBIOL, V66, P563; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Kidd TJ, 2008, RES MICROBIOL, V159, P194, DOI 10.1016/j.resmic.2008.01.001; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Ledson MJ, 2002, THORAX, V57, P142, DOI 10.1136/thorax.57.2.142; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; LiPuma J J, 1998, Curr Opin Pulm Med, V4, P337, DOI 10.1097/00063198-199811000-00005; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; LiPuma JJ, 2003, SEMIN RESP CRIT CARE, V24, P681, DOI 10.1055/s-2004-815664; LiPuma JJ, 2003, J NEMATOL, V35, P212; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; McDowell A, 2004, J MED MICROBIOL, V53, P663, DOI 10.1099/jmm.0.45557-0; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Smith MP, 2002, FEMS MICROBIOL LETT, V210, P181, DOI 10.1111/j.1574-6968.2002.tb11178.x; SPRINGMAN AC, 2009, APPL ENVIRON MICROB; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tomlin KL, 2004, J MICROBIOL METH, V57, P95, DOI 10.1016/j.mimet.2003.12.007; UEHLINGER S, 2009, INFECT IMMUN; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Wopperer J, 2006, APPL ENVIRON MICROB, V72, P1579, DOI 10.1128/AEM.72.2.1579-1587.2006; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	62	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7961	10.1371/journal.pone.0007961	http://dx.doi.org/10.1371/journal.pone.0007961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956737	Green Submitted, gold, Green Published			2022-12-25	WOS:000272827300017
J	Tang-Schomer, MD; Patel, AR; Baas, PW; Smith, DH				Tang-Schomer, Min D.; Patel, Ankur R.; Baas, Peter W.; Smith, Douglas H.			Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration	FASEB JOURNAL			English	Article						traumatic brain injury; traumatic axonal injury; taxol; micropattern	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SODIUM-CHANNELS; BETA-APP; CYTOSKELETAL; ELONGATION; GROWTH; TETRODOTOXIN; ACCUMULATION	Little is known about which components of the axonal cytoskeleton might break during rapid mechanical deformation, such as occurs in traumatic brain injury. Here, we micropatterned neuronal cell cultures on silicone membranes to induce dynamic stretch exclusively of axon fascicles. After stretch, undulating distortions formed along the axons that gradually relaxed back to a straight orientation, demonstrating a delayed elastic response. Subsequently, swellings developed, leading to degeneration of almost all axons by 24 h. Stabilizing the microtubules with taxol maintained the undulating geometry after injury but greatly reduced axon degeneration. Conversely, destabilizing microtubules with nocodazole prevented undulations but greatly increased the rate of axon loss. Ultrastructural analyses of axons postinjury revealed immediate breakage and buckling of microtubules in axon undulations and progressive loss of microtubules. Collectively, these data suggest that dynamic stretch of axons induces direct mechanical failure at specific points along microtubules. This microtubule disorganization impedes normal relaxation of the axons, resulting in undulations. However, this physical damage also triggers progressive disassembly of the microtubules around the breakage points. While the disintegration of microtubules allows delayed recovery of the "normal" straight axon morphology, it comes at a great cost by interrupting axonal transport, leading to axonal swelling and degeneration.-Tang-Schomer, M. D., Patel, A. R,, Baas, P. W., Smith, D. H. Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration. FASEB J. 24, 1401-1410 (2010). www.fasebj.org	[Tang-Schomer, Min D.; Patel, Ankur R.; Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Tang-Schomer, Min D.; Patel, Ankur R.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Baas, Peter W.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Drexel University	Smith, DH (corresponding author), 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	Tang-Schomer, Min/AAD-9501-2020; smith, douglas/A-1321-2007; Tang-Schomer, Min/C-1967-2013	Tang-Schomer, Min/0000-0001-7585-3890; 	NIH [NS-056202, NS-038104, NS-048949]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048949, P01NS056202, R01NS038104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Tracy Yuen, Catherine von Reyn, and Matthew Weingard from the Center for Brain Injury and Repair, University of Pennsylvania, for technical assistance; Ray Meade from the Biomedical Imaging Core, University of Pennsylvania, for electron microscopic assistance; and Dr. David Meaney from the Department of Bioengineering, University of Pennsylvania, for insightful discussions. This work is supported by NIH grants NS-056202, NS-038104, and NS-048949 (to D. H. S.).	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; AHMAD FJ, 1993, J NEUROSCI, V13, P856; BAAS PW, 1993, J NEUROSCI, V13, P2177; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; DYE RB, 1993, J BIOL CHEM, V268, P6847; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; MCINTOSH JR, 1984, NATURE, V312, P196, DOI 10.1038/312196b0; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; Tang MD, 2003, J AM CHEM SOC, V125, P12988, DOI 10.1021/ja037677h; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; ZHENG J, 1991, J NEUROSCI, V11, P1117	43	238	245	2	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1401	1410		10.1096/fj.09-142844	http://dx.doi.org/10.1096/fj.09-142844			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20019243	Green Published			2022-12-25	WOS:000277158900013
J	Gerashchenko, MV; Su, D; Gladyshev, VN				Gerashchenko, Maxim V.; Su, Dan; Gladyshev, Vadim N.			CUG Start Codon Generates Thioredoxin/Glutathione Reductase Isoforms in Mouse Testes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL THIOREDOXIN REDUCTASE; ALTERNATIVE SPLICING VARIANT; TRANSLATION INITIATION; GLUTATHIONE-REDUCTASE; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; SPERM MATURATION; SELENOCYSTEINE; MECHANISM; GENE	Mammalian cytosolic and mitochondrial thioredoxin reductases are essential selenocysteine-containing enzymes that control thioredoxin functions. Thioredoxin/glutathione reductase (TGR) is a third member of this enzyme family. It has an additional glutaredoxin domain and shows highest expression in testes. Herein, we found that human and several other mammalian TGR genes lack any AUG codons that could function in translation initiation. Although mouse and rat TGRs have such codons, we detected protein sequences upstream of them by immunoblot assays and direct proteomic analyses. Further gene engineering and expression analyses demonstrated that a CUG codon, located upstream of the sequences previously thought to initiate translation, is the actual start codon in mouse TGR. The use of this codon relies on the Kozak consensus sequence and ribosome-scanning mechanism. However, CUG serves as an inefficient start codon that allows downstream initiation, thus generating two isoforms of the enzyme in vivo and in vitro. The use of CUG evolved in mammalian TGRs, and in some of these organisms, GUG is used instead. The newly discovered longer TGR form shows cytosolic localization in cultured cells and is expressed in spermatids in mouse testes. This study shows that CUG codon is used as an inefficient start codon to generate protein isoforms in mouse.	[Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gerashchenko, Maxim V.; Su, Dan; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Gerashchenko, Maxim V.; Su, Dan; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Div Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Su, Dan/B-1972-2010; Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Gladyshev, Vadim/0000-0002-0372-7016; Gerashchenko, Maxim/0000-0001-8396-2202	NIGMS NIH HHS [R37 GM065204, GM065204, R01 GM065204] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065204, R37GM065204] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Andersson M, 1996, J BIOL CHEM, V271, P10116, DOI 10.1074/jbc.271.17.10116; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Chang EY, 2005, FREE RADICAL BIO MED, V39, P1666, DOI 10.1016/j.freeradbiomed.2005.08.008; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; FALVEY E, 1995, EMBO J, V14, P4307, DOI 10.1002/j.1460-2075.1995.tb00105.x; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Imataka H, 1997, EMBO J, V16, P817, DOI 10.1093/emboj/16.4.817; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kehr S, 2009, J MOL BIOL, V389, P808, DOI 10.1016/j.jmb.2009.04.024; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Miranda-Vizuete A, 2002, MOL CELLS, V13, P488; Mokrejs M, 2006, NUCLEIC ACIDS RES, V34, pD125, DOI 10.1093/nar/gkj081; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Rundlof AK, 2001, J BIOL CHEM, V276, P30542, DOI 10.1074/jbc.M101452200; Rundlof AK, 2007, DIFFERENTIATION, V75, P123, DOI 10.1111/j.1432-0436.2006.00121.x; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Su D, 2004, BIOCHEMISTRY-US, V43, P12177, DOI 10.1021/bi048478t; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; TAIRA M, 1990, J BIOL CHEM, V265, P16491; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	47	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4595	4602		10.1074/jbc.M109.070532	http://dx.doi.org/10.1074/jbc.M109.070532			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018845	Green Published, hybrid			2022-12-25	WOS:000275274800037
J	Palmer, SJ; Santucci, N; Widagdo, J; Bontempo, SJ; Taylor, KM; Tay, ESE; Hook, J; Lemckert, F; Gunning, PW; Hardeman, EC				Palmer, Stephen J.; Santucci, Nicole; Widagdo, Jocelyn; Bontempo, Sara J.; Taylor, Kylie M.; Tay, Enoch S. E.; Hook, Jeff; Lemckert, Frances; Gunning, Peter W.; Hardeman, Edna C.			Negative Autoregulation of GTF2IRD1 in Williams-Beuren Syndrome via a Novel DNA Binding Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; GENERAL TRANSCRIPTION FACTOR-3; TFII-I GENES; EXPRESSION; DELETION; MICE; ENHANCER; REPEATS; 7Q11.23; PROTEIN	The GTF2IRD1 gene is of principal interest to the study of Williams-Beuren syndrome (WBS). This neurodevelopmental disorder results from the hemizygous deletion of a region of chromosome 7q11.23 containing 28 genes including GTF2IRD1. WBS is thought to be caused by haploinsufficiency of certain dosage-sensitive genes within the deleted region, and the feature of supravalvular aortic stenosis (SVAS) has been attributed to reduced elastin caused by deletion of ELN. Human genetic mapping data have implicated two related genes GTF2IRD1 and GTF2I in the cause of some the key features of WBS, including craniofacial dysmorphology, hypersociability, and visuospatial deficits. Mice with mutations of the Gtf2ird1 allele show evidence of craniofacial abnormalities and behavioral changes. Here we show the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. The affinity for this protein-DNA interaction is critically dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This autoregulatory mechanism leads to dosage compensation of GTF2IRD1 transcription in WBS patients. The GTF2IRD1 promoter represents the first established in vivo gene target of the GTF2IRD1 protein, and we use it to model its DNA interaction capabilities.	[Palmer, Stephen J.] Univ New S Wales, Dept Anat, Sch Med Sci, Sydney, NSW 2052, Australia; [Hook, Jeff; Gunning, Peter W.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia; [Santucci, Nicole; Bontempo, Sara J.; Tay, Enoch S. E.] Childrens Hosp, Muscle Dev Unit, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Lemckert, Frances; Gunning, Peter W.] Childrens Hosp, Oncol Res Unit, Westmead, NSW 2145, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Children's Medical Research Institute - Australia; University of Sydney; University of Sydney	Palmer, SJ (corresponding author), Univ New S Wales, Dept Anat, Sch Med Sci, Rm 502,Wallace Wurth C27, Sydney, NSW 2052, Australia.	s.palmer@unsw.edu.au	Gunning, Peter W/E-9058-2010; Palmer, Stephen/F-2822-2013; Hardeman, Edna C/F-8872-2012; Widagdo, Jocelyn/J-6316-2013	Palmer, Stephen/0000-0002-4907-4719; Widagdo, Jocelyn/0000-0001-9667-9203; Hardeman, Edna/0000-0003-1649-7712; Gunning, Peter/0000-0003-0833-3128	Australian National Health and Medical Research Council (NHMRC) [423401]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Project Grant 423401 from the Australian National Health and Medical Research Council (NHMRC).	ANTONELL A, 2009, J MED GENET; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Collette JC, 2009, J HUM GENET, V54, P193, DOI 10.1038/jhg.2009.5; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Durkin ME, 2001, GENOMICS, V73, P20, DOI 10.1006/geno.2001.6507; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Karmiloff-Smith A, 2003, J MED GENET, V40, P136, DOI 10.1136/jmg.40.2.136; Li HH, 2009, EMBO MOL MED, V1, P50, DOI 10.1002/emmm.200900003; Makeyev AV, 2009, GENE, V433, P16, DOI 10.1016/j.gene.2008.11.027; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Palmer SJ, 2007, GENE EXPR PATTERNS, V7, P396, DOI 10.1016/j.modgep.2006.11.008; Polly P, 2003, J BIOL CHEM, V278, P36603, DOI 10.1074/jbc.M212814200; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Roy AL, 2007, BBA-GENE STRUCT EXPR, V1769, P613, DOI 10.1016/j.bbaexp.2007.10.002; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Stekel DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-6; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tay ESE, 2003, BIOCHEM J, V374, P359, DOI 10.1042/BJ20030189; Thompson PD, 2007, FEBS LETT, V581, P1233, DOI 10.1016/j.febslet.2007.02.040; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; van Hagen JM, 2007, NEUROBIOL DIS, V26, P112, DOI 10.1016/j.nbd.2006.12.009; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; Vullhorst D, 2003, J BIOL CHEM, V278, P8370, DOI 10.1074/jbc.M209361200; Young EJ, 2008, GENES BRAIN BEHAV, V7, P224, DOI 10.1111/j.1601-183X.2007.00343.x	33	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4715	4724		10.1074/jbc.M109.086660	http://dx.doi.org/10.1074/jbc.M109.086660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007321	hybrid, Green Published			2022-12-25	WOS:000275274800049
J	Li, BH; Zhao, L; Wang, C; Guo, HZ; Wu, L; Zhang, XM; Qian, WZ; Wang, H; Guo, YJ				Li, Bohua; Zhao, Lei; Wang, Chong; Guo, Huaizu; Wu, Lan; Zhang, Xunming; Qian, Weizhu; Wang, Hao; Guo, Yajun			The Protein-Protein Interface Evolution Acts in a Similar Way to Antibody Affinity Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC HYPERMUTATION; STRUCTURAL BASIS; RATIONAL DESIGN; RECOGNITION; INTERLEUKIN-2; REPERTOIRE; ANTIGEN	Understanding the evolutionary mechanism that acts at the interfaces of protein-protein complexes is a fundamental issue with high interest for delineating the macromolecular complexes and networks responsible for regulation and complexity in biological systems. To investigate whether the evolution of protein-protein interface acts in a similar way as antibody affinity maturation, we incorporated evolutionary information derived from antibody affinity maturation with common simulation techniques to evaluate prediction success rates of the computational method in affinity improvement in four different systems: antibody-receptor, antibody-peptide, receptor-membrane ligand, and receptor-soluble ligand. It was interesting to find that the same evolutionary information could improve the prediction success rates in all the four protein-protein complexes with an exceptional high accuracy (>57%). One of the most striking findings in our present study is that not only in the antibody-combining site but in other protein-protein interfaces almost all of the affinity-enhancing mutations are located at the germline hotspot sequences (RGYW or WA), indicating that DNA hot spot mechanisms may be widely used in the evolution of protein-protein interfaces. Our data suggest that the evolution of distinct protein-protein interfaces may use the same basic strategy under selection pressure to maintain interactions. Additionally, our data indicate that classical simulation techniques incorporating the evolutionary information derived from in vivo antibody affinity maturation can be utilized as a powerful tool to improve the binding affinity of protein-protein complex with a high accuracy.	[Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Guo, Yajun] Second Mil Med Univ, Gen Hosp 301, Ctr Canc, Shanghai 200433, Peoples R China; [Li, Bohua; Qian, Weizhu; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China; [Li, Bohua; Qian, Weizhu; Wang, Hao; Guo, Yajun] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China; [Wang, Chong; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Med, Shanghai 200025, Peoples R China; [Wang, Chong; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200025, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, New Lib Bldg,10-11th Floor,800 Xiang Yin Rd, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888; Zhao, Lei/0000-0002-5884-2708	National Natural Science Foundation of China; Ministry of Science and Technology of China; National Key Project for Infectious Diseases; National Key Project for New Drug Development and Manufacture; Shanghai Commission of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Project for Infectious Diseases; National Key Project for New Drug Development and Manufacture; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by grants from the National Natural Science Foundation of China, Ministry of Science and Technology of China (973 and 863 program projects), National Key Project for Infectious Diseases, National Key Project for New Drug Development and Manufacture, and Shanghai Commission of Science and Technology.	BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Clark LA, 2006, J IMMUNOL, V177, P333, DOI 10.4049/jimmunol.177.1.333; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Du JM, 2007, J BIOL CHEM, V282, P15073, DOI 10.1074/jbc.M701654200; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Gemma S, 2006, J MED CHEM, V49, P3421, DOI 10.1021/jm060257t; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5; Kabat E. A., 1991, NIH PUBLICATION; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9	37	20	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3865	3871		10.1074/jbc.M109.076547	http://dx.doi.org/10.1074/jbc.M109.076547			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007707	hybrid, Green Published			2022-12-25	WOS:000275254000040
J	Spencer, JL; Raghu, S				Spencer, Joseph L.; Raghu, S.			Refuge or Reservoir? The Potential Impacts of the Biofuel Crop Miscanthus x giganteus on a Major Pest of Maize	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; DIABROTICA-VIRGIFERA-VIRGIFERA; HOST-RANGE; COLEOPTERA; CHRYSOMELIDAE; BIOENERGY; ECOLOGY; LARVAE; SURVIVAL; INVASION	Background: Interest in the cultivation of biomass crops like the C4 grass Miscanthus x giganteus (Miscanthus) is increasing as global demand for biofuel grows. In the US, Miscanthus is promoted as a crop well-suited to the Corn Belt where it could be cultivated on marginal land interposed with maize and soybean. Interactions (direct and indirect) of Miscanthus, maize, and the major Corn Belt pest of maize, the western corn rootworm, (Diabrotica virgifera virgifera LeConte, WCR) are unknown. Adding a perennial grass/biomass crop to this system is concerning since WCR is adapted to the continuous availability of its grass host, maize (Zea mays). Methodology/Principal Findings: In a greenhouse and field study, we investigated WCR development and oviposition on Miscanthus. The suitability of Miscanthus for WCR development varied across different WCR populations. Data trends indicate that WCR populations that express behavioural resistance to crop rotation performed as well on Miscanthus as on maize. Over the entire study, total adult WCR emergence from Miscanthus (212 WCR) was 29.6% of that from maize (717 WCR). Adult dry weight was 75-80% that of WCR from maize; female emergence patterns on Miscanthus were similar to females developing on maize. There was no difference in the mean no. of WCR eggs laid at the base of Miscanthus and maize in the field. Conclusions/Significance: Field oviposition and significant WCR emergence from Miscanthus raises many questions about the nature of likely interactions between Miscanthus, maize and WCR and the potential for Miscanthus to act as a refuge or reservoir for Corn Belt WCR. Responsible consideration of the benefits and risks associated with Corn Belt Miscanthus are critical to protecting an agroecosystem that we depend on for food, feed, and increasingly, fuel. Implications for European agroecosystems in which Miscanthus is being proposed are also discussed in light of the WCR's recent invasion into Europe.	[Spencer, Joseph L.; Raghu, S.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Raghu, S.] Arid Zone Res Inst, Alice Springs, NT, Australia	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Spencer, JL (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	raghu@illinois.edu	Raghu, S./A-1281-2010; Spencer, Joe/B-6876-2012	Raghu, S./0000-0001-5843-5435; Spencer, Joe/0000-0003-4757-563X	Illinois Natural History Survey	Illinois Natural History Survey	These authors have no support or funding to report. Institutional funds from the Illinois Natural History Survey (where the authors were employed at the time of undertaking of this study) were used to defray part of the operational costs of this study. The Illinois Natural History Survey had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyeo W. T., 1964, Journal of the Kansas Entomological Society, V37, P9; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; BRANSON TF, 1970, J ECON ENTOMOL, V63, P800, DOI 10.1093/jee/63.3.800; BRANSON TF, 1967, J ECON ENTOMOL, V60, P201, DOI 10.1093/jee/60.1.201; Breitenbach S., 2005, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V57, P241; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clark TL, 2004, ENVIRON ENTOMOL, V33, P681, DOI 10.1603/0046-225X-33.3.681; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Forbes S.A., 1883, REPORT STATE ENTOMOL, V12, P10; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Heaton E. A., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P433, DOI 10.1023/B:MITI.0000038848.94134.be; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hibbard BE, 2004, J ECON ENTOMOL, V97, P871, DOI 10.1603/0022-0493(2004)097[0871:ROEDOE]2.0.CO;2; Khanna M, 2008, BIOMASS BIOENERG, V32, P482, DOI 10.1016/j.biombioe.2007.11.003; LATTZ DH, 2008, FARM INCOME PRODUCTI; Lefko SA, 2008, J APPL ENTOMOL, V132, P189, DOI 10.1111/j.1439-0418.2008.01279.x; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Levine Eli, 2002, American Entomologist, V48, P94; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 2009, AGR FOREST ENTOMOL, V11, P29, DOI 10.1111/j.1461-9563.2008.00419.x; Moeser J, 2009, AGR FOREST ENTOMOL, V11, P3, DOI 10.1111/j.1461-9563.2008.00404.x; Moeser J, 2004, ENVIRON ENTOMOL, V33, P1169, DOI 10.1603/0046-225X-33.5.1169; *NAT AGR STAT SERV, 2009, US ALL STAT DAT CORN; Onstad DW, 1999, ENVIRON ENTOMOL, V28, P188, DOI 10.1093/ee/28.2.188; Onstad DW, 2001, ENTOMOL EXP APPL, V100, P195, DOI 10.1023/A:1019289030248; Oyediran IO, 2005, J ECON ENTOMOL, V98, P1679, DOI 10.1603/0022-0493-98.5.1679; Oyediran IO, 2004, ENVIRON ENTOMOL, V33, P740, DOI 10.1603/0046-225X-33.3.740; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Rice ME., 2004, PLANT HLTH PROG, DOI [10.1094/PHP-2004-0301-01-RV, DOI 10.1094/PHP-2004-0301-01-RV]; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Schneider JE, 2008, INT J HEALTH CARE FI, V8, P13, DOI 10.1007/s10754-007-9029-4; SHAW JT, 1976, NATURAL HIST SURVEY, V96; Sivcev I, 2009, J APPL ENTOMOL, V133, P430, DOI 10.1111/j.1439-0418.2009.01402.x; Spencer J.L., 2008, INSECT RESISTANCE MA, P153, DOI [10.1016/B978-0-12-373858-5.X5001-1, DOI 10.1016/B978-0-12-373858-5.X5001-1]; Spencer JL, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P121, DOI 10.1079/9780851998176.0121; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; Stewart JR, 2009, GCB BIOENERGY, V1, P126, DOI 10.1111/j.1757-1707.2009.01010.x; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; *UN FAO, 2009, FAOSTAT PROD PRODSTA; *UN ORG EC COOP, 2008, AGR OUTL 2008 2017; *USDA, 2006, AGR CHEM PROD TECHN; *USDA, 2006, EC INFORM B; *USDA, 2008, AD GEN ENG CROPS US; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Wilson TA, 2004, ENVIRON ENTOMOL, V33, P1102, DOI 10.1603/0046-225X-33.4.1102; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303	50	35	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8336	10.1371/journal.pone.0008336	http://dx.doi.org/10.1371/journal.pone.0008336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016814	Green Published, Green Submitted, gold			2022-12-25	WOS:000272834000022
J	Nakamura, T; Hillary, FG; Biswal, BB				Nakamura, Toru; Hillary, Frank G.; Biswal, Bharat B.			Resting Network Plasticity Following Brain Injury	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; NEURONAL AVALANCHES; FMRI; REORGANIZATION; ARCHITECTURE; PERFORMANCE; ACTIVATION; CORTEX	The purpose of this study was to examine neural network properties at separate time-points during recovery from traumatic brain injury (TBI) using graph theory. Whole-brain analyses of the topological properties of the fMRI signal were conducted in 6 participants at 3 months and 6 months following severe TBI. Results revealed alterations of network properties including a change in the degree distribution, reduced overall strength in connectivity, and increased "small-worldness'' from 3 months to 6 months post injury. The findings here indicate that, during recovery from injury, the strength but not the number of network connections diminishes, so that over the course of recovery, the network begins to approximate what is observed in healthy adults. These are the first data examining functional connectivity in a disrupted neural system during recovery.	[Nakamura, Toru; Biswal, Bharat B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA; [Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Nakamura, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, 185 S Orange Ave, Newark, NJ 07103 USA.	fhillary@psu.edu; bbiswal@yahoo.com	Hillary, Frank/AAN-8622-2021; nakamura, Toru/A-4535-2010		US National Institutes of Health [5R01NS049176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The current work is supported by US National Institutes of Health grant 5R01NS049176 to B. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; FITZPATRICK NM, 2008, 36 ANN M INT NEUR SO; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; HILLARY FG, BRAIN IMAGI IN PRESS; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Marchiori M, 2000, PHYSICA A, V285, P539, DOI 10.1016/S0378-4371(00)00311-3; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1093/neucas/8.5.345; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stanley H.E., 1971, INTRO PHASE TRANSITI; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	58	183	187	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8220	10.1371/journal.pone.0008220	http://dx.doi.org/10.1371/journal.pone.0008220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011533	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830300009
J	Tompkins, DH; Besnard, V; Lange, AW; Wert, SE; Keiser, AR; Smith, AN; Lang, R; Whitsett, JA				Tompkins, David H.; Besnard, Valerie; Lange, Alexander W.; Wert, Susan E.; Keiser, Angela R.; Smith, April N.; Lang, Richard; Whitsett, Jeffrey A.			Sox2 Is Required for Maintenance and Differentiation of Bronchiolar Clara, Ciliated, and Goblet Cells	PLOS ONE			English	Article							BASAL-CELLS; EPITHELIAL-CELLS; LUNG DEVELOPMENT; STEM-CELLS; AIRWAY; TRANSCRIPTION; MULTIPOTENT; ALVEOLARIZATION; MECHANISMS; EXPRESSION	The bronchioles of the murine lung are lined by a simple columnar epithelium composed of ciliated, Clara, and goblet cells that together mediate barrier function, mucociliary clearance and innate host defense, vital for pulmonary homeostasis. In the present work, we demonstrate that expression of Sox2 in Clara cells is required for the differentiation of ciliated, Clara, and goblet cells that line the bronchioles of the postnatal lung. The gene was selectively deleted in Clara cells utilizing Scgb1a1-Cre, causing the progressive loss of Sox2 in the bronchioles during perinatal and postnatal development. The rate of bronchiolar cell proliferation was decreased and associated with the formation of an undifferentiated, cuboidal-squamous epithelium lacking the expression of markers of Clara cells (Scgb1a1), ciliated cells (FoxJ1 and alpha-tubulin), and goblet cells (Spdef and Muc5AC). By adulthood, bronchiolar cell numbers were decreased and Sox2 was absent in extensive regions of the bronchiolar epithelium, at which time residual Sox2 expression was primarily restricted to selective niches of CGRP staining neuroepithelial cells. Allergen-induced goblet cell differentiation and mucus production was absent in the respiratory epithelium lacking Sox2. In vitro, Sox2 activated promoter-luciferase reporter constructs for differentiation markers characteristic of Clara, ciliated, and goblet cells, Scgb1a1, FoxJ1, and Agr2, respectively. Sox2 physically interacted with Smad3 and inhibited TGF-beta 1/Smad3-mediated transcriptional activity in vitro, a pathway that negatively regulates proliferation. Sox2 is required for proliferation and differentiation of Clara cells that serve as the progenitor cells from which Clara, ciliated, and goblet cells are derived.	[Tompkins, David H.] Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Perinatal Inst, Cincinnati, OH USA; Cincinnati Childrens Hosp, Med Ctr, Div Pediat Ophthalmol, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Tompkins, DH (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Perinatal Inst, Cincinnati, OH USA.	jeff.whitsett@cchmc.org	Lang, Richard/E-5578-2011	Lang, Richard/0000-0002-5212-254X; Besnard, Valerie/0000-0002-2614-629X	National Institutes of Health [HL090156, HL099580]; University of Cincinnati College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090156, R01HL095580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support from the National Institutes of Health HL090156 and HL099580 (J. A. W. and S. E. W.), and partial fulfillment of the graduate thesis in the Cancer Cell Biology program of the University of Cincinnati College of Medicine (D. H. T.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Besnard V, 2007, AM J PHYSIOL-LUNG C, V293, pL1395, DOI 10.1152/ajplung.00275.2007; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHEN G, 2009, J CLIN INVE IN PRESS; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Evans E.F., 1975, HDB SENSORY PHYSL, P1; EVANS MJ, 1978, LAB INVEST, V38, P648; EVANS MJ, 1974, CHEST, V65, pS62, DOI 10.1378/chest.65.4_Supplement.62S; *GENEPAINT, ATL GEN EXPR PATT MO; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hsia CCW, 2004, J APPL PHYSIOL, V97, P1992, DOI 10.1152/japplphysiol.00530.2004; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lange AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005711; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Park ET, 2008, INT J CANCER, V122, P1253, DOI 10.1002/ijc.23225; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Schoch KG, 2004, AM J PHYSIOL-LUNG C, V286, pL631, DOI 10.1152/ajplung.00112.2003; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P695, DOI 10.1513/pats.200801-011AW; STRIPP BR, 1992, J BIOL CHEM, V267, P14703; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC; Zhang LQ, 1997, BBA-GENE STRUCT EXPR, V1350, P359, DOI 10.1016/S0167-4781(96)00180-7	52	136	138	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8248	10.1371/journal.pone.0008248	http://dx.doi.org/10.1371/journal.pone.0008248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011520	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300019
J	van der Linden, M; Al-Lahham, A; Nicklas, W; Reinert, RR				van der Linden, Mark; Al-Lahham, Adnan; Nicklas, Werner; Reinert, Ralf Rene			Molecular Characterization of Pneumococcal Isolates from Pets and Laboratory Animals	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INVASIVE DISEASE; IDENTIFICATION; CLONES; RATS; MENINGITIS; INFECTIONS; RESISTANCE; OUTBREAK; GERMANY	Background: Between 1986 and 2008 Streptococcus pneumoniae was isolated from 41 pets/zoo animals (guinea pigs (n = 17), cats (n = 12), horses (n = 4), dogs (n = 3), dolphins (n = 2), rat (n = 2), gorilla (n = 1)) treated in medical veterinary laboratories and zoos, and 44 laboratory animals (mastomys (multimammate mice; n = 32), mice (n = 6), rats (n = 4), guinea pigs (n = 2)) during routine health monitoring in an animal facility. S. pneumoniae was isolated from nose, lung and respiratory tract, eye, ear and other sites. Methodology/Principal Findings: Carriage of the same isolate of S. pneumoniae over a period of up to 22 weeks was shown for four mastomys. Forty-one animals showed disease symptoms. Pneumococcal isolates were characterized by optochin sensitivity, bile solubility, DNA hybridization, pneumolysin PCR, serotyping and multilocus sequence typing. Eighteen of the 32 mastomys isolates (56%) were optochin resistant, all other isolates were optochin susceptible. All mastomys isolates were serotype 14, all guinea pig isolates serotype 19F, all horse isolates serotype 3. Rats had serotypes 14 or 19A, mice 33A or 33F. Dolphins had serotype 23F, the gorilla serotype 14. Cats and dogs had many different serotypes. Four isolates were resistant to macrolides, three isolates also to clindamycin and tetracyclin. Mastomys isolates were sequence type (ST) 15 (serotype 14), an ST/serotype combination commonly found in human isolates. Cats, dogs, pet rats, gorilla and dolphins showed various human ST/serotype combinations. Lab rats and lab mice showed single locus variants (SLV) of human STs, in human ST/serotype combinations. All guinea pig isolates showed the same completely new combination of known alleles. The horse isolates showed an unknown allele combination and three new alleles. Conclusions/Significance: The isolates found in mastomys, mice, rats, cats, dogs, gorilla and dolphins are most likely identical to human pneumococcal isolates. Isolates from guinea pigs and horses appear to be specialized clones for these animals. Our data redraw attention to the fact that pneumococci are not strictly human pathogens. Pet animals that live in close contact to humans, especially children, can be infected by human isolates and also carriage of even resistant isolates is a realistic possibility.	[van der Linden, Mark; Reinert, Ralf Rene] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany; [Al-Lahham, Adnan] German Jordanian Univ, Sch Appl Med Sci, Amman, Jordan; [Nicklas, Werner] German Canc Res Ctr, D-6900 Heidelberg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; German-Jordanian University; Helmholtz Association; German Cancer Research Center (DKFZ)	van der Linden, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany.	mlinden@ukaachen.de	van der Linden, Mark/B-9305-2009; Reinert, Ralf Rene/D-6897-2011	van der Linden, Mark/0000-0002-6574-4313; 	Robert Koch Institute [1369-235]; German Ministry of Health	Robert Koch Institute; German Ministry of Health	The work was funded, in part, by grant 1369-235 from the Robert Koch Institute and the German Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2006, MICROB DRUG RESIST, V12, P239, DOI 10.1089/mdr.2006.12.239; AMTSBERG G, 1980, HDB BAKTERIELLEN INF, V2; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Baker D. G., 2003, NATURAL PATHOGENS LA; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; CHANTER N, 1994, EQUINE VET J, V26, P5, DOI 10.1111/j.2042-3306.1994.tb04319.x; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; Chiavolini D, 2008, CLIN MICROBIOL REV, V21, P666, DOI 10.1128/CMR.00012-08; *CLIN LAB STAND I, 2006, PERF STAND ANT SUSC; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Duarte RS, 2005, J CLIN MICROBIOL, V43, P4592, DOI 10.1128/JCM.43.9.4592-4601.2005; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; FALLON MT, 1988, LAB ANIM SCI, V38, P129; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; FORD TM, 1965, LAB ANIM CARE, V15, P448; Gerber J, 2001, ACTA NEUROPATHOL, V101, P499; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Higgins R, 2000, CAN VET J, V41, P105; HOMBURGER F, 1945, SCIENCE, V102, P449, DOI 10.1126/science.102.2653.449; HUBER L, 1988, CAN VET J, V29, P665; Kuusi M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-36; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Michaud S, 1996, Can J Infect Dis, V7, P329; MIRICK GS, 1950, AM J HYG, V52, P48, DOI 10.1093/oxfordjournals.aje.a119408; MITRUKA BM, 1971, YALE J BIOL MED, V44, P253; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Reinert RR, 2005, J CLIN MICROBIOL, V43, P6035, DOI 10.1128/JCM.43.12.6035-6041.2005; Reinert RR, 2004, INT J ANTIMICROB AG, V24, P43, DOI 10.1016/j.ijantimicag.2004.02.020; van der Linden M, 2007, ANTIMICROB AGENTS CH, V51, P1830, DOI 10.1128/AAC.01453-06; Van der Ven LTM, 1999, INFECT IMMUN, V67, P6098, DOI 10.1128/IAI.67.11.6098-6103.1999; WEISBROTH SH, 1969, LAB ANIM CARE, V19, P473; Whatmore AM, 2001, J CLIN MICROBIOL, V39, P4196, DOI 10.1128/JCM.39.1.4196-4199.2001; Whatmore AM, 1999, INFECT IMMUN, V67, P2776, DOI 10.1128/IAI.67.6.2776-2782.1999; Zhang SP, 2006, J VET DIAGN INVEST, V18, P221, DOI 10.1177/104063870601800217	34	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8286	10.1371/journal.pone.0008286	http://dx.doi.org/10.1371/journal.pone.0008286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011527	Green Submitted, gold, Green Published			2022-12-25	WOS:000272830300038
J	Sengupta, U; Ukil, S; Dimitrova, N; Agrawal, S				Sengupta, Urmi; Ukil, Sanchaita; Dimitrova, Nevenka; Agrawal, Shipra			Expression-Based Network Biology Identifies Alteration in Key Regulatory Pathways of Type 2 Diabetes and Associated Risk/Complications	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-INTERACTION NETWORK; JAK/STAT SIGNALING PATHWAY; HUMAN SKELETAL-MUSCLE; FACTOR RECEPTOR; INSULIN-RESISTANCE; HIGH GLUCOSE; TGF-BETA; FATTY-ACIDS; MITOCHONDRIAL FISSION	Type 2 diabetes mellitus (T2D) is a multifactorial and genetically heterogeneous disease which leads to impaired glucose homeostasis and insulin resistance. The advanced form of disease causes acute cardiovascular, renal, neurological and microvascular complications. Thus there is a constant need to discover new and efficient treatment against the disease by seeking to uncover various novel alternate signalling mechanisms that can lead to diabetes and its associated complications. The present study allows detection of molecular targets by unravelling their role in altered biological pathways during diabetes and its associated risk factors and complications. We have used an integrated functional networks concept by merging co-expression network and interaction network to detect the transcriptionally altered pathways and regulations involved in the disease. Our analysis reports four novel significant networks which could lead to the development of diabetes and other associated dysfunctions. (a) The first network illustrates the up regulation of TGFBRII facilitating oxidative stress and causing the expression of early transcription genes via MAPK pathway leading to cardiovascular and kidney related complications. (b) The second network demonstrates novel interactions between GAPDH and inflammatory and proliferation candidate genes i.e., SUMO4 and EGFR indicating a new link between obesity and diabetes. (c) The third network portrays unique interactions PTPN1 with EGFR and CAV1 which could lead to an impaired vascular function in diabetic nephropathy condition. (d) Lastly, from our fourth network we have inferred that the interaction of beta-catenin with CDH5 and TGFBR1 through Smad molecules could contribute to endothelial dysfunction. A probability of emergence of kidney complication might be suggested in T2D condition. An experimental investigation on this aspect may further provide more decisive observation in drug target identification and better understanding of the pathophysiology of T2D and its complications.	[Sengupta, Urmi; Ukil, Sanchaita; Agrawal, Shipra] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India; [Agrawal, Shipra] BioCOS Life Sci Private Ltd, Bangalore, Karnataka, India; [Dimitrova, Nevenka] Briarcliff Manor, Philips Res N Amer, New York, NY USA	Philips; Philips Research	Sengupta, U (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	shipra@ibab.ac.in			Philips Research Asia, Bangalore; India Department of Information Technology, New Delhi, India	Philips Research Asia, Bangalore; India Department of Information Technology, New Delhi, India	This work was partially funded by Philips Research Asia, Bangalore, India Department of Information Technology, New Delhi, India. One of the authors in this paper, Dr. Nevenka Dimitrova who belongs to Philips Research Asia, Bangalore, India has actively participated in planning and executing this study.	Adhikary L, 2004, DIABETOLOGIA, V47, P1210, DOI 10.1007/s00125-004-1437-0; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baudry A, 2002, EMBO REP, V3, P323, DOI 10.1093/embo-reports/kvf078; Begley TJ, 2002, MOL CANCER RES, V1, P103; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Bento JL, 2004, DIABETES, V53, P3007, DOI 10.2337/diabetes.53.11.3007; Bergholdt R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r253; Bhattacharya S, 2007, J INDIAN MED ASSOC, V105, P594; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Bouskela E, 2007, B ACAD NAT MED PARIS, V191, P475, DOI 10.1016/S0001-4079(19)33040-7; Bray GA, 2008, AM J CLIN NUTR, V87, P1212, DOI 10.1093/ajcn/87.5.1212; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Catalan V, 2008, CLIN ENDOCRINOL, V68, P213, DOI 10.1111/j.1365-2265.2007.03021.x; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cheyssac C, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-44; Chu LH, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-56; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Corton M, 2007, J CLIN ENDOCR METAB, V92, P328, DOI 10.1210/jc.2006-1665; Das UN, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-35; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Friedel CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-519; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Gogg S, 2002, J BIOL CHEM, V277, P36045, DOI 10.1074/jbc.M200575200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Hittel DS, 2005, DIABETES, V54, P1283, DOI 10.2337/diabetes.54.5.1283; Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x; Hong SW, 2001, AM J PATHOL, V158, P1653; Hong YR, 1998, BIOCHEM BIOPH RES CO, V249, P697, DOI 10.1006/bbrc.1998.9253; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Janghorbani M, 2006, ACTA NEUROL SCAND, V114, P384, DOI 10.1111/j.1600-0404.2006.00716.x; Jbour AS, 2003, SAUDI MED J, V24, P761; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047; Konishi A, 2003, J BIOL CHEM, V278, P35049, DOI 10.1074/jbc.M304913200; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Li C., 2003, ANAL GENE EXPRESSION, P120; Lin CL, 2008, AM J NEPHROL, V28, P290, DOI 10.1159/000111142; Lin HY, 2007, DIABETES, V56, P1177, DOI 10.2337/db06-1283; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Luo XP, 2004, AM J PHYSIOL-ENDOC M, V287, pE991, DOI 10.1152/ajpendo.00200.2004; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mao CP, 2005, ACTA PHARMACOL SIN, V26, P982, DOI 10.1111/j.1745-7254.2005.00133.x; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marks JB, 1998, MED CLIN N AM, V82, P877, DOI 10.1016/S0025-7125(05)70028-6; Marrero MB, 2006, AM J PHYSIOL-RENAL, V290, pF762, DOI 10.1152/ajprenal.00181.2005; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; McCole DF, 2007, J BIOL CHEM, V282, P13303, DOI 10.1074/jbc.M700424200; McKnight AJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-5; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Ng A, 2006, NUCLEIC ACIDS RES, V34, pD527, DOI 10.1093/nar/gkj044; Ng SK, 2003, BIOINFORMATICS, V19, P923, DOI 10.1093/bioinformatics/btg118; Ng SK, 2003, NUCLEIC ACIDS RES, V31, P251, DOI 10.1093/nar/gkg079; Noso S, 2007, J CLIN ENDOCR METAB, V92, P2358, DOI 10.1210/jc.2007-0031; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Okazaki Yuko, 2007, Clin Exp Nephrol, V11, P77, DOI 10.1007/s10157-006-0456-1; Oksvold MP, 2004, FEBS LETT, V569, P207, DOI 10.1016/j.febslet.2004.05.068; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Ramachandran A, 2002, CURR SCI INDIA, V83, P1471; RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Sasso FC, 2005, J AM COLL CARDIOL, V46, P827, DOI 10.1016/j.jacc.2005.06.007; Sato H, 1998, AM J NEPHROL, V18, P490, DOI 10.1159/000013415; SayedAhmed N, 1996, EXP NEPHROL, V4, P330; SCARDONI G, 2008, CENTISCAPE CYTOSCAPE; Schwartz MM, 1998, NEPHROL DIAL TRANSPL, V13, P2547, DOI 10.1093/ndt/13.10.2547; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; SHANKLAND SJ, 1995, KIDNEY INT, V47, P782, DOI 10.1038/ki.1995.119; Shen W, 2006, J AM SOC NEPHROL, V17, P2414, DOI 10.1681/ASN.2005111157; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Stein A, 2005, NUCLEIC ACIDS RES, V33, pD413, DOI 10.1093/nar/gki037; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tappenden KA, 1998, DIGEST DIS SCI, V43, P1526, DOI 10.1023/A:1018819032620; Tian YC, 2002, AM J PATHOL, V160, P1619, DOI 10.1016/S0002-9440(10)61109-1; Tornow S, 2003, NUCLEIC ACIDS RES, V31, P6283, DOI 10.1093/nar/gkg838; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Wei WZ, 2008, BIOCHEM BIOPH RES CO, V375, P454, DOI 10.1016/j.bbrc.2008.08.028; Weisstein E.W., LEAST SQUARES FITTIN; Whorwood CB, 2002, DIABETES, V51, P1066, DOI 10.2337/diabetes.51.4.1066; Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yang X, 2002, DIABETOLOGIA, V45, P1584, DOI 10.1007/s00125-002-0905-7; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhao JW, 2008, CELL PHYSIOL BIOCHEM, V21, P445, DOI 10.1159/000129637	125	53	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8100	10.1371/journal.pone.0008100	http://dx.doi.org/10.1371/journal.pone.0008100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997558	gold, Green Submitted, Green Published			2022-12-25	WOS:000272829500006
J	Doly, S; Bertran-Gonzalez, J; Callebert, J; Bruneau, A; Banas, SM; Belmer, A; Boutourlinsky, K; Herve, D; Launay, JM; Maroteaux, L				Doly, Stephane; Bertran-Gonzalez, Jesus; Callebert, Jacques; Bruneau, Alexandra; Banas, Sophie Marie; Belmer, Arnauld; Boutourlinsky, Katia; Herve, Denis; Launay, Jean-Marie; Maroteaux, Luc			Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice	PLOS ONE			English	Article							RAT NUCLEUS-ACCUMBENS; RELEASE IN-VIVO; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; GENE-EXPRESSION; DOPAMINE RELEASE; REVERSES HYPERTHERMIA; ECSTASY; COCAINE; SENSITIZATION; D1	The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and serotonin transporters to produce efflux of dopamine and serotonin, respectively, in regions of the brain that have been implicated in reward. However, the role of serotonin/dopamine interactions in the behavioral effects of MDMA remains unclear. We previously showed that MDMA-induced locomotion, serotonin and dopamine release are 5-HT2B receptor-dependent. The aim of the present study was to determine the contribution of serotonin and 5-HT2B receptors to the reinforcing properties of MDMA. We show here that 5-HT2B-/- mice do not exhibit behavioral sensitization or conditioned place preference following MDMA (10 mg/kg) injections. In addition, MDMA-induced reinstatement of conditioned place preference after extinction and locomotor sensitization development are each abolished by a 5-HT2B receptor antagonist (RS127445) in wild type mice. Accordingly, MDMA-induced dopamine D1 receptor-dependent phosphorylation of extracellular regulated kinase in nucleus accumbens is abolished in mice lacking functional 5-HT2B receptors. Nevertheless, high doses (30 mg/kg) of MDMA induce dopamine-dependent but serotonin and 5-HT2B receptor-independent behavioral effects. These results underpin the importance of 5-HT2B receptors in the reinforcing properties of MDMA and illustrate the importance of dose-dependent effects of MDMA on serotonin/dopamine interactions.	[Doly, Stephane; Bertran-Gonzalez, Jesus; Bruneau, Alexandra; Banas, Sophie Marie; Belmer, Arnauld; Boutourlinsky, Katia; Herve, Denis; Maroteaux, Luc] INSERM, U839, Paris, France; [Doly, Stephane; Bertran-Gonzalez, Jesus; Bruneau, Alexandra; Banas, Sophie Marie; Belmer, Arnauld; Boutourlinsky, Katia; Herve, Denis; Maroteaux, Luc] Univ Paris 06, Inst Fer Moulin, UMR S0839, Paris, France; [Callebert, Jacques; Launay, Jean-Marie] Hop Lariboisiere, AP HP, Serv Biochim, F-75475 Paris, France; [Callebert, Jacques; Launay, Jean-Marie] INSERM, U942, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Doly, S (corresponding author), INSERM, U839, Paris, France.	luc.maroteaux@upmc.fr	Belmer, Arnauld/AAE-2554-2019; doly, stephane/Y-2318-2019; callebert, jacques/L-4569-2017; Bertran-Gonzalez, J/L-1410-2017; Maroteaux, Luc/H-4585-2019; HERVE, Denis/E-2929-2017	Belmer, Arnauld/0000-0001-6640-5631; doly, stephane/0000-0002-3517-8605; Bertran-Gonzalez, J/0000-0002-3794-1782; Maroteaux, Luc/0000-0002-9499-8603; HERVE, Denis/0000-0003-1376-1522	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; Fondation pour les Maladies Orphelines; Association pour la Recherche contre le Cancer; French Ministry of Research (Agence Nationale pour la Recherche); European Community	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation pour les Maladies Orphelines; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); French Ministry of Research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); European Community(European Commission)	This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie and grants from the Fondation de France, the Fondation pour la Recherche Medicale, the Fondation pour les Maladies Orphelines, the Association pour la Recherche contre le Cancer, the French Ministry of Research (Agence Nationale pour la Recherche) and the European Community. LM's team is an "Equipe FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquas E, 2007, J NEUROCHEM, V102, P121, DOI 10.1111/j.1471-4159.2007.04451.x; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Ball KT, 2005, PSYCHOPHARMACOLOGY, V181, P676, DOI 10.1007/s00213-005-0038-z; Bankson MG, 2004, J NEUROCHEM, V91, P852, DOI 10.1111/j.1471-4159.2004.02763.x; Bankson MG, 2001, J PHARMACOL EXP THER, V297, P846; Baumann MH, 2000, SYNAPSE, V36, P102, DOI 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; BERGER UV, 1992, EUR J PHARMACOL, V215, P153, DOI 10.1016/0014-2999(92)90023-W; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Blessing WW, 2003, J NEUROSCI, V23, P6385; Bonaventure P, 2002, BRAIN RES, V943, P38, DOI 10.1016/S0006-8993(02)02504-0; Bonhaus DW, 1999, BRIT J PHARMACOL, V127, P1075, DOI 10.1038/sj.bjp.0702632; Cadoni C, 2005, BRAIN RES, V1055, P143, DOI 10.1016/j.brainres.2005.07.002; CALLAWAY CW, 1990, J PHARMACOL EXP THER, V254, P456; Choi DS, 1996, FEBS LETT, V391, P45, DOI 10.1016/0014-5793(96)00695-3; Crespi D, 1997, BRIT J PHARMACOL, V121, P1735, DOI 10.1038/sj.bjp.0701325; Daniela E, 2004, PHARMACOL BIOCHEM BE, V77, P745, DOI 10.1016/j.pbb.2004.01.008; De Deurwaerdere P, 1998, J NEUROSCI, V18, P6528; Doly S, 2008, J NEUROSCI, V28, P2933, DOI 10.1523/JNEUROSCI.5723-07.2008; Duxon MS, 1997, NEUROSCIENCE, V76, P323, DOI 10.1016/S0306-4522(96)00480-0; Federici M, 2007, BIOL PSYCHIAT, V62, P680, DOI 10.1016/j.biopsych.2006.11.019; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; Harrison TS, 2004, DRUGS, V64, P1715; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kehne JH, 1996, NEUROPSYCHOPHARMACOL, V15, P116, DOI 10.1016/0893-133X(95)00160-F; Koch S, 1997, J NEURAL TRANSM, V104, P135, DOI 10.1007/BF01273176; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V22, P513, DOI 10.1016/S0893-133X(99)00148-7; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; NASH JF, 1991, J PHARMACOL EXP THER, V259, P820; Nelson LS, 2007, CLIN TOXICOL, V45, P315, DOI 10.1080/15563650701285289; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Parrott AC, 2004, PSYCHOPHARMACOLOGY, V173, P234, DOI 10.1007/s00213-003-1712-7; Ramos M, 2004, PSYCHOPHARMACOLOGY, V177, P100, DOI 10.1007/s00213-004-1937-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rothman RB, 2007, AAPS J, V9, pE1, DOI 10.1208/aapsj0901001; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Salzmann J, 2003, BRIT J PHARMACOL, V140, P831, DOI 10.1038/sj.bjp.0705506; Scearce-Levie K, 1999, PSYCHOPHARMACOLOGY, V141, P154, DOI 10.1007/s002130050819; Schmuck K, 1996, EUR J NEUROSCI, V8, P959, DOI 10.1111/j.1460-9568.1996.tb01583.x; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Shioda K, 2008, NEUROTOXICOLOGY, V29, P1030, DOI 10.1016/j.neuro.2008.07.005; Slot LAB, 2008, BEHAV PHARMACOL, V19, P145, DOI 10.1097/FBP.0b013e3282f62cb2; STEWART J, 1993, BEHAV PHARMACOL, V4, P289; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Valjent E, 2000, J NEUROSCI, V20, P8701; VALJENT E, 2009, NEUROPSYCHOPHARMACOL; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Wainscott DB, 1996, J PHARMACOL EXP THER, V276, P720; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004	58	63	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7952	10.1371/journal.pone.0007952	http://dx.doi.org/10.1371/journal.pone.0007952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956756	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827300010
J	Raharijaona, M; Le Pennec, S; Poirier, J; Mirebeau-Prunier, D; Rouxel, C; Jacques, C; Fontaine, JF; Malthiery, Y; Houlgatte, R; Savagner, F				Raharijaona, Mahatsangy; Le Pennec, Soazig; Poirier, Julie; Mirebeau-Prunier, Delphine; Rouxel, Clothilde; Jacques, Caroline; Fontaine, Jean-Fred; Malthiery, Yves; Houlgatte, Remi; Savagner, Frederique			PGC-1-Related Coactivator Modulates Mitochondrial-Nuclear Crosstalk through Endogenous Nitric Oxide in a Cellular Model of Oncocytic Thyroid Tumours	PLOS ONE			English	Article							RESPIRATORY GENE-EXPRESSION; CYCLE PROGRESSION; INDUCIBLE COACTIVATOR; SIGNALING PATHWAYS; ENERGY-METABOLISM; MAMMALIAN-CELLS; FACTORS NRF-1; BIOGENESIS; TRANSCRIPTION; PGC-1-ALPHA	Background: The PGC-1 related coactivator (PRC), which shares structural and functional features with PGC-1 alpha, is believed to regulate several metabolic pathways as well as mitochondrial biogenesis. Its involvement in the early programming of cell proliferation suggests the existence of finely regulated crosstalk between mitochondrial functions and the cell cycle status. Methodology/Principal Findings: PRC-regulated pathways were explored in a cell-line model derived from mitochondrial-rich tumours with an essentially oxidative metabolism and specifically high PRC expression. The functional status of mitochondria was compared to the results of microarray analysis under conditions of temporal PRC inhibition. To specify the fine PRC regulation, the expression levels of the genes and proteins involved in the oxidative phosphorylation process were studied by real time quantitative PCR and western blotting. As in earlier studies on PGC-1 alpha, we investigated the role of nitric oxide in PRC-regulated mitochondrial biogenesis and determined its action in the control of the phosphorylation status of the mitogen-activated protein kinase pathway. Conclusion/Significance: We found that nitric oxide rapidly influences PRC expression at the transcriptional level. Focusing on mitochondrial energetic metabolism, we observed that PRC differentially controls respiratory chain complexes and coupling efficiency in a time-dependent manner to maintain mitochondrial homeostasis. Our results highlight the key role of PRC in the rapid modulation of metabolic functions in response to the status of the cell cycle.	[Raharijaona, Mahatsangy; Houlgatte, Remi; Savagner, Frederique] Inst Thorax, UMR 915, INSERM, Nantes, France; [Raharijaona, Mahatsangy; Houlgatte, Remi] Univ Nantes, Nantes, France; [Le Pennec, Soazig; Poirier, Julie; Mirebeau-Prunier, Delphine; Rouxel, Clothilde; Jacques, Caroline; Fontaine, Jean-Fred; Malthiery, Yves; Savagner, Frederique] INSERM, UMR 694, Angers, France; [Le Pennec, Soazig; Poirier, Julie; Mirebeau-Prunier, Delphine; Rouxel, Clothilde; Jacques, Caroline; Fontaine, Jean-Fred; Malthiery, Yves; Savagner, Frederique] Univ Angers, Angers, France; [Mirebeau-Prunier, Delphine; Malthiery, Yves; Savagner, Frederique] CHU Angers, Biochim Lab, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Raharijaona, M (corresponding author), Inst Thorax, UMR 915, INSERM, Nantes, France.	frederique.savagner@univ-angers.fr	LE PENNEC, Soazig/H-3817-2017; Fontaine, Jean-Fred/GNP-2904-2022; Houlgatte, Remi/P-3020-2017; Prunier, Delphine/K-3301-2015	Fontaine, Jean-Fred/0000-0002-1101-4091; Rouxel, Clotilde/0000-0002-9374-3609	French Ministry of Research; Institut National de la Recherche Medicale (INSERM); University Hospital of Angers; Ligue Contre le Cancer	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Hospital of Angers; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the French Ministry of Research, the Institut National de la Recherche Medicale (INSERM), the University Hospital of Angers and the Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Au HC, 1998, EUR J BIOCHEM, V251, P164, DOI 10.1046/j.1432-1327.1998.2510164.x; Baris O, 2005, ONCOGENE, V24, P4155, DOI 10.1038/sj.onc.1208578; Baris O, 2004, J CLIN ENDOCR METAB, V89, P994, DOI 10.1210/jc.2003-031238; Barlow C, 2006, AM J RESP CELL MOL, V34, P7, DOI 10.1165/rcmb.2005-0153OC; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Brookes PS, 2002, METHOD ENZYMOL, V359, P305; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Conour JE, 2004, PHYSIOL GENOMICS, V18, P196, DOI 10.1152/physiolgenomics.00058.2004; Contestabile A, 2008, PROG NEUROBIOL, V84, P317, DOI 10.1016/j.pneurobio.2008.01.002; Crook MF, 2008, FASEB J, V22, P225, DOI 10.1096/fj.07-8573com; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fontaine JF, 2008, ONCOGENE, V27, P2228, DOI 10.1038/sj.onc.1210853; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Patel A, 2002, J ENDOCRINOL INVEST, V25, P675, DOI 10.1007/BF03345100; Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rustin P, 2004, METHOD ENZYMOL, V382, P81; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Savagner F, 2001, THYROID, V11, P327, DOI 10.1089/10507250152039055; Savagner F, 2003, BIOCHEM BIOPH RES CO, V310, P779, DOI 10.1016/j.bbrc.2003.09.076; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Tanaka T, 2005, FREE RADICAL BIO MED, V38, P1231, DOI 10.1016/j.freeradbiomed.2005.01.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	52	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7964	10.1371/journal.pone.0007964	http://dx.doi.org/10.1371/journal.pone.0007964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956726	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827300019
J	Butler, PL; Mallampalli, RK				Butler, Phillip L.; Mallampalli, Rama K.			Cross-talk between Remodeling and de Novo Pathways Maintains Phospholipid Balance through Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; PLATELET-ACTIVATING-FACTOR; ADULT-RAT LUNG; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; II CELLS; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; ACYL-COA; CHOLINEPHOSPHATE CYTIDYLYLTRANSFERASE; MOLECULAR DETERMINANTS	Phosphatidylcholine (PtdCho), the major phospholipid of animal membranes, is generated by its remodeling and de novo synthesis. Overexpression of the remodeling enzyme, LPCAT1 (acyl-CoA: lysophosphatidylcholine acyltransferase) in epithelia decreased de novo PtdCho synthesis without significantly altering cellular PtdCho mass. Overexpression of LPCAT1 increased degradation of CPT1 (cholinephosphotransferase), a resident Golgi enzyme that catalyzes the terminal step for de novo PtdCho synthesis. CPT1 degradation involved its multiubiquitination and processing via the lysosomal pathway. CPT1 mutants harboring arginine substitutions at multiple carboxyl-terminal lysines exhibited proteolytic resistance to effects of LPCAT1 overexpression in cells and restored de novo PtdCho synthesis. Thus, cross-talk between phospholipid remodeling and de novo pathways involves ubiquitin-lysosomal processing of a key molecular target that mechanistically provides homeostatic control of cellular PtdCho content.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Internal Med, Pittsburgh, PA 15213 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mallampalli, RK (corresponding author), UPMC Montefiore, NW628,3459 5th Ave, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu			National Institutes of Health R01 [HL097376, HL096376, HL098174, HL081784, HL068135]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081784, R01HL098174, R01HL096376, R01HL068135, R01HL097376] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL097376, HL096376, HL098174, HL081784, and HL068135 (to R. K. M.). This work was also supported by a Merit Review Award from the Department of Veterans Affairs.	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Agassandian M, 2007, BIOCHEM J, V403, P409, DOI 10.1042/BJ20061364; Bladergroen BA, 1999, EUR J BIOCHEM, V264, P152, DOI 10.1046/j.1432-1327.1999.00589.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; CHEN M, 1990, AM J PHYSIOL, V258, pL195, DOI 10.1152/ajplung.1990.258.4.L195; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cui Z, 1995, BIOCHEM J, V312, P939, DOI 10.1042/bj3120939; DENBREEJEN JN, 1989, BIOCHIM BIOPHYS ACTA, V1002, P277, DOI 10.1016/0005-2760(89)90341-X; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; Dietl P, 2004, BIOL NEONATE, V85, P299, DOI 10.1159/000078176; Fisher AB, 1997, AM J PHYSIOL-LUNG C, V272, pL238, DOI 10.1152/ajplung.1997.272.2.L238; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MALLAMPALLI RK, 1993, PEDIATR RES, V34, P502, DOI 10.1203/00006450-199310000-00024; MALLAMPALLI RK, 1994, AM J RESP CELL MOL, V10, P48, DOI 10.1165/ajrcmb.10.1.8292380; Mallampalli RK, 1996, BIOCHEM J, V318, P333, DOI 10.1042/bj3180333; MALLAMPALLI RK, 1994, AM J PHYSIOL-LUNG C, V267, pL641, DOI 10.1152/ajplung.1994.267.6.L641; MASON RJ, 1984, BIOCHIM BIOPHYS ACTA, V794, P392, DOI 10.1016/0005-2760(84)90005-5; McCoy DM, 2006, AM J RESP CELL MOL, V35, P394, DOI 10.1165/rcmb.2005-0401OC; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; McMaster CR, 1997, BBA-LIPID LIPID MET, V1348, P100, DOI 10.1016/S0005-2760(97)00097-0; MILLER JC, 1981, J BIOL CHEM, V256, P2662; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NICHOLAS TE, 1982, RESP PHYSIOL, V49, P315, DOI 10.1016/0034-5687(82)90119-0; Pelham HRB, 2004, CURR BIOL, V14, pR357, DOI 10.1016/j.cub.2004.04.027; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Salome RG, 2000, J APPL PHYSIOL, V88, P10, DOI 10.1152/jappl.2000.88.1.10; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; TERCE F, 1991, BIOCHIM BIOPHYS ACTA, V1084, P69, DOI 10.1016/0005-2760(91)90057-O; TIJBURG LBM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P167, DOI 10.1016/0005-2760(91)90091-U; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; WRIGHT JR, 1990, AM J PHYSIOL, V259, pL1, DOI 10.1152/ajplung.1990.259.2.L1; Wright MM, 2001, J BIOL CHEM, V276, P25254, DOI 10.1074/jbc.M011552200; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Ye GM, 2005, DNA SEQUENCE, V16, P386, DOI 10.1080/10425170500213712; Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746	55	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6246	6258		10.1074/jbc.M109.017350	http://dx.doi.org/10.1074/jbc.M109.017350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018880	hybrid, Green Published			2022-12-25	WOS:000275367500029
J	Machutta, CA; Bommineni, GR; Luckner, SR; Kapilashrami, K; Ruzsicska, B; Simmerling, C; Kisker, C; Tonge, PJ				Machutta, Carl A.; Bommineni, Gopal R.; Luckner, Sylvia R.; Kapilashrami, Kanishk; Ruzsicska, Bela; Simmerling, Carlos; Kisker, Caroline; Tonge, Peter J.			Slow Onset Inhibition of Bacterial beta-Ketoacyl-acyl Carrier Protein Synthases by Thiolactomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS KASA; ESCHERICHIA-COLI; RESIDENCE TIME; BIOLOGICAL PROPERTIES; CRYSTAL-STRUCTURE; ENOYL REDUCTASE; DRUG-TARGET; CELL-WALL; ENZYMES	Thiolactomycin (TLM), a natural product thiolactone antibiotic produced by species of Nocardia and Streptomyces, is an inhibitor of the beta-ketoacyl-acyl carrier protein synthase (KAS) enzymes in the bacterial fatty acid synthase pathway. Using enzyme kinetics and direct binding studies, TLM has been shown to bind preferentially to the acyl-enzyme intermediates of the KASI and KASII enzymes from Mycobacterium tuberculosis and Escherichia coli. These studies, which utilized acylenzyme mimics in which the active site cysteine was replaced by a glutamine, also revealed that TLM is a slow onset inhibitor of the KASI enzymes KasA and ecFabB but not of the KASII enzymes KasB and ecFabF. The differential affinity of TLM for the acyl-KAS enzymes is proposed to result from structural change involving the movement of helices alpha 5 and alpha 6 that prepare the enzyme to bind malonyl-AcpM or TLM and that is initiated by formation of hydrogen bonds between the acyl-enzyme thioester and the oxyanion hole. The finding that TLM is a slow onset inhibitor of ecFabB supports the proposal that the long residence time of TLM on the ecFabB homologues in Serratia marcescens and Klebsiella pneumonia is an important factor for the in vivo antibacterial activity of TLM against these two organisms despite the fact that the in vitro MIC values are only 100-200 mu g/ml. The mechanistic data on the interaction of TLM with KasA will provide an important foundation for the rational development of high affinity KasA inhibitors based on the thiolactone skeleton.	[Simmerling, Carlos; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Luckner, Sylvia R.; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	peter.tonge@sunysb.edu	Tonge, Peter J/A-7443-2009; Kisker, Caroline/T-1724-2019	Tonge, Peter J/0000-0003-1606-3471; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [R01AI044639]; Deutsche Forschungsgemeinschaft [SFB 630]; Forschungszentrum [FZ82]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI044639 (to P.J.T.). This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB 630 and Forschungszentrum FZ82 (to C.K.).	Argyrou A, 2006, BIOCHEMISTRY-US, V45, P13947, DOI 10.1021/bi061874m; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Brown MS, 2003, J AM CHEM SOC, V125, P10166, DOI 10.1021/ja034540i; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edwards P, 1997, FEBS LETT, V402, P62, DOI 10.1016/S0014-5793(96)01437-8; HAMADA S, 1990, ORAL MICROBIOL IMMUN, V5, P340, DOI 10.1111/j.1399-302X.1990.tb00438.x; HAYASHI T, 1983, BIOCHEM BIOPH RES CO, V115, P1108, DOI 10.1016/S0006-291X(83)80050-3; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Jackowski S, 2002, ANTIMICROB AGENTS CH, V46, P1246, DOI 10.1128/AAC.46.5.1246-1252.2002; Jones AL, 2003, PLANTA, V216, P752, DOI 10.1007/s00425-002-0925-z; Kim P, 2006, J MED CHEM, V49, P159, DOI 10.1021/jm050825p; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Liu XY, 2008, P NATL ACAD SCI USA, V105, P13321, DOI 10.1073/pnas.0806873105; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; McFadden JM, 2005, J MED CHEM, V48, P946, DOI 10.1021/jm049389h; McFadden JM, 2002, ORG LETT, V4, P3859, DOI 10.1021/ol026685k; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; NISHIDA I, 1986, J BIOCHEM-TOKYO, V99, P1447, DOI 10.1093/oxfordjournals.jbchem.a135614; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; OISHI H, 1982, J ANTIBIOT, V35, P391, DOI 10.7164/antibiotics.35.391; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; SATO T, 1989, J ANTIBIOT, V42, P890, DOI 10.7164/antibiotics.42.890; Schaeffer ML, 2004, TUBERCULOSIS, V84, P353, DOI 10.1016/j.tube.2004.03.001; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Schaeffer ML, 2001, BBA-MOL CELL BIOL L, V1532, P67, DOI 10.1016/S1388-1981(01)00116-0; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; Sridharan S, 2007, J MOL BIOL, V366, P469, DOI 10.1016/j.jmb.2006.11.006; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; TSAY JT, 1992, J BACTERIOL, V174, P508, DOI 10.1128/jb.174.2.508-513.1992; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Walsh C., 2003, ANTIBIOTICS ACTIONS, P23, DOI DOI 10.1128/9781555817886; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Zhang YM, 2006, J BIOL CHEM, V281, P17390, DOI 10.1074/jbc.M513199200	51	30	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6161	6169		10.1074/jbc.M109.077909	http://dx.doi.org/10.1074/jbc.M109.077909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018879	hybrid, Green Published			2022-12-25	WOS:000275367500020
J	Fritton, JC; Kawashima, Y; Mejia, W; Courtland, HW; Elis, S; Sun, H; Wu, YG; Rosen, CJ; Clemmons, D; Yakar, S				Fritton, J. Christopher; Kawashima, Yuki; Mejia, Wilson; Courtland, Hayden-Williams; Elis, Sebastien; Sun, Hui; Wu, Yinjgie; Rosen, Clifford J.; Clemmons, David; Yakar, Shoshana			The Insulin-like Growth Factor-1 Binding Protein Acid-labile Subunit Alters Mesenchymal Stromal Cell Fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY-COMPOSITION; ADIPOCYTE DIFFERENTIATION; RECEPTOR DEFICIENCY; BONE-MARROW; PPAR-GAMMA; HORMONE; SERUM; ROSIGLITAZONE; OSTEOPOROSIS; DENSITY	Age-related osteoporosis is accompanied by an increase in marrow adiposity and a reduction in serum insulin-like growth factor-1 (IGF-1) and the binding proteins that stabilize IGF-1. To determine the relationship between these proteins and bone marrow adiposity, we evaluated the adipogenic potential of marrow-derived mesenchymal stromal cells (MSCs) from mice with decreased serum IGF-1 due to knockdown of IGF-1 production by the liver or knock-out of the binding proteins. We employed 10-16-week-old, liver-specific IGF-1-deficient, IGFBP-3 knockout (BP3KO) and acid-labile subunit knock-out (ALSKO) mice. We found that expression of the late adipocyte differentiation marker peroxisome proliferator-activated receptor gamma was increased in marrow isolated from ALSKO mice. When induced with adipogenic media, MSC cultures from ALSKO mice revealed a significantly greater number of differentiated adipocytes compared with controls. MSCs from ALSKO mice also exhibited decreased alkaline-phosphatase positive colony size in cultures that were stimulated with osteoblast differentiation media. These osteoblast-like cells from ALSKO mice failed to induce osteoclastogenesis of control cells in co-culture assays, indicating that impairment of IGF-1 complex formation with ALS in bone marrow alters cell fate, leading to increased adipogenesis.	[Fritton, J. Christopher] Univ Med & Dent New Jersey, Dept Orthopaed, Newark, NJ 07103 USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA; [Clemmons, David] Univ N Carolina, Div Endocrinol, Chapel Hill, NC 27599 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Maine Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Yakar, S (corresponding author), 1 Gustave L Levy Pl,Box 1055, New York, NY 10029 USA.	shoshana.yakar@mssm.edu	Elis, Sebastien/K-6158-2019	Fritton, James/0000-0002-6475-7622	National Institutes of Health [AR054919, AR055141, AR045433, AR053853, AR054604]; Charles H. Revson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054604, R01AR054919, R01AR055141, R01AR053853, R01AR045433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Revson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR054919 and AR055141 (to S. Y.), AG02331 (to D. C.), and AR045433, AR053853, and AR054604 (to C. J. R.). This work was also supported by a Charles H. Revson Foundation Fellowship (to J. C. F.).	Ackert-Bicknell CL, 2009, ENDOCRINOLOGY, V150, P1330, DOI 10.1210/en.2008-0936; Ali AT, 2005, CLIN CHIM ACTA, V354, P101, DOI 10.1016/j.cccn.2004.11.026; Bachrach LK, 1998, J BONE MINER RES, V13, P415, DOI 10.1359/jbmr.1998.13.3.415; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chan SSY, 2009, AM J PHYSIOL-ENDOC M, V296, pE654, DOI 10.1152/ajpendo.90846.2008; Di Iorgi N, 2008, J CLIN ENDOCR METAB, V93, P2281, DOI 10.1210/jc.2007-2691; Domene H M, 2005, J Endocrinol Invest, V28, P43; Domene HM, 2009, HORM RES, V72, P129, DOI 10.1159/000232486; FRITTON JC, 2010, J BONE MINE IN PRESS; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Garnero P, 2000, LANCET, V355, P898, DOI 10.1016/S0140-6736(99)05463-X; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Kasukawa Y, 2004, CURR PHARM DESIGN, V10, P2577, DOI 10.2174/1381612043383764; Labarta JI, 1997, CLIN ENDOCRINOL, V47, P657, DOI 10.1046/j.1365-2265.1997.2581078.x; Laron Z, 2006, CLIN ENDOCRINOL, V65, P114, DOI 10.1111/j.1365-2265.2006.02558.x; Lecka-Czernik B, 2007, ENDOCRINOLOGY, V148, P903, DOI 10.1210/en.2006-1121; Liney GP, 2007, J MAGN RESON IMAGING, V26, P787, DOI 10.1002/jmri.21072; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Misra M, 2008, AM J PHYSIOL-ENDOC M, V295, pE385, DOI 10.1152/ajpendo.00052.2008; Nam S Y, 2000, Obes Rev, V1, P73, DOI 10.1046/j.1467-789x.2000.00015.x; Niu TH, 2005, GENE, V361, P38, DOI 10.1016/j.gene.2005.07.016; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Ogawa S, 1999, BIOCHEM BIOPH RES CO, V260, P122, DOI 10.1006/bbrc.1999.0896; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Shang CA, 2003, MOL ENDOCRINOL, V17, P2494, DOI 10.1210/me.2003-0139; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Sztefko K, 2009, ADV MED SCI-POLAND, V54, P51, DOI 10.2478/v10039-009-0017-4; Ueland T, 2004, GROWTH HORM IGF RES, V14, P404, DOI 10.1016/j.ghir.2004.06.002; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2006, J ENDOCRINOL, V189, P289, DOI 10.1677/joe.1.06657; Yakar S, 2009, FASEB J, V23, P709, DOI 10.1096/fj.08-118976	37	15	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4709	4714		10.1074/jbc.M109.041913	http://dx.doi.org/10.1074/jbc.M109.041913			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007694	Green Published, hybrid			2022-12-25	WOS:000275274800048
J	Govindan, MV				Govindan, Manjapra Variath			Recruitment of cAMP-response Element-binding Protein and Histone Deacetylase Has Opposite Effects on Glucocorticoid Receptor Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; CORTICOTROPIN-RELEASING FACTOR; NUCLEAR FACTOR-I; CYCLIC-AMP; COREPRESSOR COMPLEX; PHOSPHORYLATED CREB; NEGATIVE REGULATION; TRANSGENIC MICE; ATT-20 CELLS; DNA-BINDING	Glucocorticoids control the synthesis of the glucocorticoid receptor (GR) in various tissues through a negative feedback regulation of the mRNA. In this study, we have identified feedback regulatory domains in the human GR gene promoter and examined the roles of GR, the cAMP-response element-binding protein (CREB), and HDAC-6 in association with promoter elements of the human GR gene. Using breast cancer T47D and HeLa-GR cells, we identify specific negative glucocorticoid-response elements in the GR gene. The feedback regulatory domains were also involved in interactions with CREB. GR-bound negative glucocorticoid-response elements recruited HDAC-6, and this was dependent on treatment with dexamethasone. Both CREB and HDAC-6 formed complexes with GR-dexamethasone. The HDAC-6 LXXLL motif between amino acids 313 and 418 made direct contact with the GR AF-1 domain. Interestingly enough, although the level of GR decreased in CREB knockdown cells, it was elevated in HDAC-6 knockdown cells. Our results suggest that CREB-P is dephosphorylated and that HDAC-6 is recruited by the GR, and they play opposite roles in the negative feedback regulation of the GR gene.	[Govindan, Manjapra Variath] Univ Laval, Ctr Rech Cancerol, Ctr Hosp Univ Quebec, Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; [Govindan, Manjapra Variath] Univ Laval, Fac Med, Dept Mol Biol Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Govindan, MV (corresponding author), Univ Laval, Ctr Rech Cancerol, Ctr Hosp Univ Quebec, Hotel Dieu Quebec, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	mgovindanv@gmail.com						AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barnes PJ, 1995, BIOCHEM SOC T, V23, P940, DOI 10.1042/bst0230940; BLACK EJ, 1991, ONCOGENE, V6, P1949; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; Bodwell JE, 1998, J STEROID BIOCHEM, V65, P91, DOI 10.1016/S0960-0760(97)00185-4; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Burke ZD, 1997, NEUROSCIENCE, V78, P1177, DOI 10.1016/S0306-4522(96)00603-3; CAIRNS C, 1993, DNA CELL BIOL, V12, P695, DOI 10.1089/dna.1993.12.695; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CHROUSOS GP, 1982, J CLIN INVEST, V69, P1261, DOI 10.1172/JCI110565; DALLMAN M F, 1972, Endocrinology, V91, P961; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; EBERWINE JH, 1984, J BIOL CHEM, V259, P2166; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Govindan M, 2009, P NATL ACAD SCI USA, V106, P19854, DOI 10.1073/pnas.0910134106; GOVINDAN MV, 1991, J STEROID BIOCHEM, V40, P317, DOI 10.1016/0960-0760(91)90197-D; GOVINDAN MV, 1980, EXP CELL RES, V127, P293, DOI 10.1016/0014-4827(80)90435-8; GuardiolaDiaz HM, 1996, MOL ENDOCRINOL, V10, P317, DOI 10.1210/me.10.3.317; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2003, METHOD ENZYMOL, V364, P246; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; JONES MT, 1976, J ENDOCRINOL, V69, P1, DOI 10.1677/joe.0.0690001; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kovacs KJ, 2000, J NEUROSCI, V20, P3843, DOI 10.1523/JNEUROSCI.20-10-03843.2000; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Kuwahara S, 2003, J NEUROSCI, V23, P10231; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LaRochelle O, 2008, J BIOL CHEM, V283, P8190, DOI 10.1074/jbc.M800640200; Leahy P, 1999, J BIOL CHEM, V274, P8813, DOI 10.1074/jbc.274.13.8813; LECLERC S, 1991, J BIOL CHEM, V266, P17333; LECLERC S, 1991, J BIOL CHEM, V266, P8711; Levine SJ, 1996, AM J RESP CELL MOL, V15, P245, DOI 10.1165/ajrcmb.15.2.8703481; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PEPIN MC, 1992, MOL PHARMACOL, V41, P1016; PERRY M, 1982, J BIOL CHEM, V257, P7336; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; ROCHE PJ, 1988, GENE, V71, P421, DOI 10.1016/0378-1119(88)90059-5; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; ROSEN LB, 1992, ENDOCRINOLOGY, V130, P2237, DOI 10.1210/en.130.4.2237; SASAKI K, 1984, J BIOL CHEM, V259, P15424; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SCHILLING K, 1991, NEUROENDOCRINOLOGY, V53, P528, DOI 10.1159/000125768; SCHLECHTE JA, 1982, J STEROID BIOCHEM, V16, P69, DOI 10.1016/0022-4731(82)90145-5; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; TREMBLAY Y, 1988, P NATL ACAD SCI USA, V85, P8890, DOI 10.1073/pnas.85.23.8890; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VERBEECK MAE, 1990, FEBS LETT, V272, P89, DOI 10.1016/0014-5793(90)80455-R; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Warriar N, 1996, J BIOL CHEM, V271, P18662, DOI 10.1074/jbc.271.31.18662; WARRIAR N, 1994, J BIOL CHEM, V269, P29010; Webster JC, 1997, J BIOL CHEM, V272, P9287; Werner S, 1996, STEROIDS, V61, P216, DOI 10.1016/0039-128X(96)00017-7; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	68	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4489	4510		10.1074/jbc.M109.072728	http://dx.doi.org/10.1074/jbc.M109.072728			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018896	Green Published, hybrid			2022-12-25	WOS:000275274800027
J	Takahashi, E; Nagano, O; Ishimoto, T; Yae, T; Suzuki, Y; Shinoda, T; Nakamura, S; Niwa, S; Ikeda, S; Koga, H; Tanihara, H; Saya, H				Takahashi, Eri; Nagano, Osamu; Ishimoto, Takatsugu; Yae, Toshifumi; Suzuki, Yoshimi; Shinoda, Takeshi; Nakamura, Satoshi; Niwa, Shinichiro; Ikeda, Shun; Koga, Hisashi; Tanihara, Hidenobu; Saya, Hideyuki			Tumor Necrosis Factor-alpha Regulates Transforming Growth Factor-beta-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; ANCHORAGE-INDEPENDENT GROWTH; PROTEIN-KINASE-C; IN-VIVO; FIBROBLAST MIGRATION; ADHESION MOLECULES; HYALURONAN-BINDING; ENDOTHELIAL-CELLS; MICROARRAY DATA; UP-REGULATION	Aberrant epithelial-mesenchymal transition (EMT) is involved in development of fibrotic disorders and cancer invasion. Alterations of cell-extracellular matrix interaction also contribute to those pathological conditions. However, the functional interplay between EMT and cell-extracellular matrix interactions remains poorly understood. We now show that the inflammatory mediator tumor necrosis factor-alpha (TNF-alpha) induces the formation of fibrotic foci by cultured retinal pigment epithelial cells through activation of transforming growth factor-beta (TGF-beta) signaling in a manner dependent on hyaluronan-CD44- moesin interaction. TNF-alpha promoted CD44 expression and moesin phosphorylation by protein kinase C, leading to the pericellular interaction of hyaluronan and CD44. Formation of the hyaluronan-CD44-moesin complex resulted in both cell-cell dissociation and increased cellular motility through actin remodeling. Furthermore, this complex was found to be associated with TGF-beta receptor II and clathrin at actin microdomains, leading to activation of TGF-beta signaling. We established an in vivo model of TNF-alpha-induced fibrosis in the mouse eye, and such ocular fibrosis was attenuated in CD44-null mice. The production of hyaluronan and its interaction with CD44, thus, play an essential role in TNF-alpha-inducedEMTand are potential therapeutic targets in fibrotic disorders.	[Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo 1608582, Japan; [Takahashi, Eri; Tanihara, Hidenobu] Kumamoto Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Kumamoto 8608556, Japan; [Nagano, Osamu; Saya, Hideyuki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Suzuki, Yoshimi; Shinoda, Takeshi; Nakamura, Satoshi; Niwa, Shinichiro] Link Genom Inc, Dept Biomed Res & Dev, Tokyo 1030024, Japan; [Ikeda, Shun; Koga, Hisashi] Kazusa DNA Res Inst, Dept Human Genome Res, Lab Med Genom, Chiba 2920818, Japan	Keio University; Kumamoto University; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	hsaya@a5.keio.jp	Saya, Hideyuki/J-4325-2013; Ishimoto, Takatsugu/AAP-1356-2020; Nagano, Osamu/J-5874-2013	Ishimoto, Takatsugu/0000-0003-1852-1835; Nagano, Osamu/0000-0002-7630-142X; Saya, Hideyuki/0000-0001-6610-1902	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to O.N. and H.S.) and by a grant from the National Institute of Biomedical Innovation, Japan (to H.S.).	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; Anggiansah CL, 2003, J PHYSIOL-LONDON, V550, P631, DOI 10.1113/jphysiol.2003.038943; Armstrong D, 1998, OPHTHALMOLOGICA, V212, P410, DOI 10.1159/000027378; Banh A, 2007, MOL VIS, V13, P2248; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dureau P, 2000, GRAEF ARCH CLIN EXP, V238, P608, DOI 10.1007/s004170000156; Florquin S, 2002, AM J KIDNEY DIS, V39, P407, DOI 10.1053/ajkd.2002.30563; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; HAYNES BF, 1991, ARTHRITIS RHEUM, V34, P1434; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Kaida M, 2000, INVEST OPHTH VIS SCI, V41, P3215; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KAN FWK, 1990, ANAT REC, V228, P370, DOI 10.1002/ar.1092280403; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kosaki R, 1999, CANCER RES, V59, P1141; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; KUPPNER MC, 1993, CURR EYE RES, V12, P923, DOI 10.3109/02713689309020399; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Limb GA, 1996, GRAEF ARCH CLIN EXP, V234, P213, DOI 10.1007/BF00430412; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; McKay BS, 1997, EXP EYE RES, V65, P661, DOI 10.1006/exer.1997.0374; Mitsuda S, 2005, DEV BIOL, V280, P122, DOI 10.1016/j.ydbio.2005.01.009; Mrass P, 2008, IMMUNITY, V29, P971, DOI 10.1016/j.immuni.2008.10.015; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Okamoto I, 1998, J NATL CANCER I, V90, P307, DOI 10.1093/jnci/90.4.307; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WIEDEMANN P, 1992, SURV OPHTHALMOL, V36, P373, DOI 10.1016/0039-6257(92)90115-A; Wyatt TA, 1997, AM J PHYSIOL-LUNG C, V273, pL1007, DOI 10.1152/ajplung.1997.273.5.L1007; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeng CX, 1998, INT J CANCER, V77, P396; ZUK A, 1989, J CELL BIOL, V108, P903, DOI 10.1083/jcb.108.3.903	65	127	133	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4060	4073		10.1074/jbc.M109.056523	http://dx.doi.org/10.1074/jbc.M109.056523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965872	Green Published, hybrid			2022-12-25	WOS:000275254000059
J	Norambuena, A; Palma, F; Poblete, MI; Donoso, MV; Pardo, E; Gonzalez, A; Huidobro-Toro, JP				Norambuena, Andres; Palma, Francisco; Poblete, M. Ines; Donoso, M. Veronica; Pardo, Evelyn; Gonzalez, Alfonso; Huidobro-Toro, J. Pablo			UTP Controls Cell Surface Distribution and Vasomotor Activity of the Human P2Y(2) Receptor through an Epidermal Growth Factor Receptor-transregulated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; PROTEIN-COUPLED RECEPTORS; PROMOTES CARDIOMYOCYTE HYPERTROPHY; ADHESION MOLECULE-1 EXPRESSION; GREEN FLUORESCENT PROTEIN; NUCLEOTIDE RECEPTOR; LIPID RAFTS; TYROSINE KINASE; ACTIN CYTOSKELETON; EGF RECEPTOR	Extracellular nucleotides transmit signals into the cells through the P2 family of cell surface receptors. These receptors are amply expressed in human blood vessels and participate in vascular tone control; however, their signaling mechanisms remain unknown. Here we show that in smooth muscle cells of isolated human chorionic arteries, the activation of the P2Y(2) receptor (P2Y(2)R) induces not only its partition into membrane rafts but also its rapid internalization. Cholesterol depletion with methyl-beta-cyclodextrin reduced the association of the agonist-activated receptor into membrane rafts but did not affect either the UTP-mediated vasoconstrictions or the vasomotor responses elicited by both serotonin and KCl. Ex vivo perfusion of human chorionic artery segments with 1-10 mu M UTP, a selective P2Y(2)R agonist, displaced the P2Y(2)R localization into membrane rafts within 1 min, a process preceded by the activation of both RhoA and Rac1 GTPases. AG1478, a selective and potent inhibitor of the epidermal growth factor receptor tyrosine kinase activity, not only blocked the UTP-induced vasomotor activity but also abrogated both RhoA and Rac1 activation, the P2Y(2)R association with membrane rafts, and its internalization. Altogether, these results show for the first time that the plasma membrane distribution of the P2Y(2)R is transregulated by the epidermal growth factor receptor, revealing an unsuspected functional interplay that controls both the membrane distribution and the vasomotor activity of the P2Y(2)R in intact human blood vessels.	Pontificia Univ Catolica Chile, Inst Milenio Biol Fundamental & Aplicada, Ctr Regulac Celular & Patol JV Luco, Santiago 7780344, Chile; [Norambuena, Andres] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Ciencias Fisiol, Fac Ciencias Biol, Charlottesville, VA 22908 USA; [Pardo, Evelyn; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Escuela Med, Santiago 7780344, Chile	Pontificia Universidad Catolica de Chile; University of Virginia; Pontificia Universidad Catolica de Chile	Norambuena, A (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Ciencias Fisiol, Fac Ciencias Biol, Charlottesville, VA 22908 USA.	an2r@virginia.edu			Fondo Nacional de Areas Prioritarias [13980001]; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia [PFB12/2007]; Ministerio de Planificacion y Cooperacion de Chile; Center for Cell Regulation and Pathology; General Secretariat of the Organization of American States; Center for Cell Regulation and Pathology training; Comision Nacional de Investigacion Cientifica y Tecnologica graduate student	Fondo Nacional de Areas Prioritarias; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Ministerio de Planificacion y Cooperacion de Chile; Center for Cell Regulation and Pathology; General Secretariat of the Organization of American States; Center for Cell Regulation and Pathology training; Comision Nacional de Investigacion Cientifica y Tecnologica graduate student	This work was supported by Fondo Nacional de Areas Prioritarias Grant 13980001, Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia Grant PFB12/2007, and the Millenium Institute for Fundamental and Applied Biology, which is financed in part by the Ministerio de Planificacion y Cooperacion de Chile.; Supported in part by a postdoctoral training fellowship from the Center for Cell Regulation and Pathology and from the General Secretariat of the Organization of American States, Scholarship Program for Academic Studies. To whom correspondence should be addressed: Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908. E-mail: an2r@virginia.edu.; Supported by a Center for Cell Regulation and Pathology training fellowship.; Recipient of a Comision Nacional de Investigacion Cientifica y Tecnologica graduate student fellowship.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; Benard V, 2002, METHOD ENZYMOL, V345, P349; BERK BC, 1985, J CLIN INVEST, V75, P1083, DOI 10.1172/JCI111772; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Buvinic S, 2007, J CELL SCI, V120, P4289, DOI 10.1242/jcs.03490; Buvinic S, 2006, J PHYSIOL-LONDON, V573, P427, DOI 10.1113/jphysiol.2006.105882; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Donoso MV, 2005, AM J PHYSIOL-HEART C, V288, pH2439, DOI 10.1152/ajpheart.00548.2004; Ecke D, 2008, BIOCHEM J, V409, P107, DOI 10.1042/BJ20070671; Elia MG, 2005, CELL SIGNAL, V17, P739, DOI 10.1016/j.cellsig.2004.10.013; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hailstones D, 1998, J LIPID RES, V39, P369; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; HOLLENBERG MD, 1995, MOL CELL BIOCHEM, V149, P77, DOI 10.1007/BF01076566; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lemarie CA, 2006, CIRC RES, V99, P434, DOI 10.1161/01.RES.0000237388.89261.47; Liao ZJ, 2007, J CELL SCI, V120, P1654, DOI 10.1242/jcs.03441; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Loirand G, 1999, J PHYSIOL-LONDON, V516, P825, DOI 10.1111/j.1469-7793.1999.0825u.x; Maguire JJ, 2005, TRENDS PHARMACOL SCI, V26, P448, DOI 10.1016/j.tips.2005.07.007; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Morris JB, 2004, J BIOL CHEM, V279, P8740, DOI 10.1074/jbc.M310012200; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; MURAMATSU I, 1985, Canadian Journal of Physiology and Pharmacology, V63, P994; Murasawa S, 1998, HYPERTENSION, V32, P668, DOI 10.1161/01.HYP.32.4.668; Norambuena A, 2008, MOL PHARMACOL, V74, P1666, DOI 10.1124/mol.108.048496; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Sauzeau V, 2000, AM J PHYSIOL-HEART C, V278, pH1751, DOI 10.1152/ajpheart.2000.278.6.H1751; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tulapurkar ME, 2006, J NEUROCHEM, V96, P624, DOI 10.1111/j.1471-4159.2005.03594.x; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; Ushio-Fukai M, 2005, CIRC RES, V97, P829, DOI 10.1161/01.RES.0000185322.46009.F5; Valdecantos P, 2003, PLACENTA, V24, P17, DOI 10.1053/plac.2002.0862; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; WALTERS WAW, 1991, REPROD FERT DEVELOP, V3, P475, DOI 10.1071/RD9910475; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Westermann M, 2005, HISTOCHEM CELL BIOL, V123, P613, DOI 10.1007/s00418-004-0750-5; YLIKORKALA O, 1985, AM J OBSTET GYNECOL, V152, P318, DOI 10.1016/S0002-9378(85)80221-0; Yu N, 2008, CIRC RES, V102, P581, DOI 10.1161/CIRCRESAHA.107.162271; Zhang H, 2004, CIRC RES, V95, P989, DOI 10.1161/01.RES.0000147962.01036.bb	80	16	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2940	10.1074/jbc.M109.081166	http://dx.doi.org/10.1074/jbc.M109.081166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996104	Green Published, hybrid			2022-12-25	WOS:000273829000008
J	Prpich, AM; Sheng, YB; Wang, W; Biswas, ME; Chen, P				Prpich, Andrew M.; Sheng, Yuebiao; Wang, Wei; Biswas, M. Elias; Chen, P.			Tension at the Surface: Which Phase Is More Important, Liquid or Vapor?	PLOS ONE			English	Article							ADSORPTION-KINETICS; WATER; INTERFACE; EXCHANGE; DYNAMICS; ALCOHOLS	Tension at the surface is a most fundamental physicochemical property of a liquid surface. The concept of surface tension has widespread implications in numerous natural, engineering and biomedical processes. Research to date has been largely focused on the liquid side; little attention has been paid to the vapor-the other side of the surface, despite over 100 years of study. However, the question remains as to whether the vapor plays any role, and to what extent it affects the surface tension of the liquid. Here we show a systematic study of the effect of vapor on the surface tension and in particular, a surprising observation that the vapor, not the liquid, plays a dominant role in determining the surface tension of a range of common volatile organic solutions. This is in stark contrast to results of common surfactants where the concentration in the liquid plays the major role. We further confirmed our results with a modified adsorption isotherm and molecular dynamics simulations, where highly structured, hydrogen bonded networks, and in particular a solute depletion layer just beneath the Gibbs dividing surface, were revealed.	[Prpich, Andrew M.; Sheng, Yuebiao; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Sheng, Yuebiao; Wang, Wei] Nanjing Univ, Natl Lab Solid State Microstruct, Inst Biophys, Nanjing 210008, Peoples R China; [Sheng, Yuebiao; Wang, Wei] Nanjing Univ, Dept Phys, Nanjing 210008, Peoples R China; [Biswas, M. Elias] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	University of Waterloo; Nanjing University; Nanjing University; Johns Hopkins University	Prpich, AM (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC); Ontario Graduate Scholarships (OGS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC)(Canada Research Chairs); Ontario Graduate Scholarships (OGS)(Ontario Graduate Scholarship)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Research Chairs (CRC), and Ontario Graduate Scholarships (OGS). The molecular dynamics simulations were made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET: www.sharcnet.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchette F, 2006, NAT PHYS, V2, P254, DOI 10.1038/nphys268; BLEYS G, 1985, J PHYS CHEM-US, V89, P1027, DOI 10.1021/j100252a028; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burki J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090601; CHANG CH, 1992, COLLOID SURFACE, V69, P189, DOI 10.1016/0166-6622(92)80230-Y; Chang TM, 2005, J PHYS CHEM B, V109, P5759, DOI 10.1021/jp045649v; Dixit S, 2002, NATURE, V416, P829, DOI 10.1038/416829a; Eastoe J, 2000, ADV COLLOID INTERFAC, V85, P103, DOI 10.1016/S0001-8686(99)00017-2; Fainerman VB, 1996, J COLLOID INTERF SCI, V178, P168, DOI 10.1006/jcis.1996.0105; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; Guo JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157401; Hommelen J. R, 1959, J COLLOID SCI, V14, P385, DOI DOI 10.1016/0095-8522(59)90003-0; Lague P, 2004, J PHYS CHEM B, V108, P363, DOI 10.1021/jp030458y; Langmuir I., 1932, NOBEL LECT CHEM 1922; Lin SY, 1997, LANGMUIR, V13, P6211, DOI 10.1021/la970614q; MACLEOD CA, 1994, J COLLOID INTERF SCI, V166, P73, DOI 10.1006/jcis.1994.1273; MATSUMOTO M, 1988, J CHEM PHYS, V88, P3233, DOI 10.1063/1.453919; MILLER R, 1986, COLLOID POLYM SCI, V264, P357, DOI 10.1007/BF01418196; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; Prpich AM, 2008, J PHYS CHEM C, V112, P2522, DOI 10.1021/jp077012s; Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536; Regan BC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1887827; ROTENBERG Y, 1983, J COLLOID INTERF SCI, V93, P169, DOI 10.1016/0021-9797(83)90396-X; Vyawahare S, 2006, NANO LETT, V6, P271, DOI 10.1021/nl0522678; WOLFE J, 1985, J MEMBRANE BIOL, V86, P127, DOI 10.1007/BF01870779	25	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8281	10.1371/journal.pone.0008281	http://dx.doi.org/10.1371/journal.pone.0008281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011532	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830300033
J	Muller, B; Vounatsou, P; Ngandolo, BNR; Diguimbaye-Djaibe, C; Schiller, I; Marg-Haufe, B; Oesch, B; Schelling, E; Zinsstag, J				Mueller, Borna; Vounatsou, Penelope; Ngandolo, Bongo Nare Richard; Diguimbaye-Djaibe, Colette; Schiller, Irene; Marg-Haufe, Beatrice; Oesch, Bruno; Schelling, Esther; Zinsstag, Jakob			Bayesian Receiver Operating Characteristic Estimation of Multiple Tests for Diagnosis of Bovine Tuberculosis in Chadian Cattle	PLOS ONE			English	Article							FLUORESCENCE POLARIZATION ASSAY; MYCOBACTERIUM-BOVIS; CHARACTERISTIC CURVES; INFECTIOUS-DISEASES; IMMUNE-RESPONSES; LESIONS; IDENTIFICATION; ANTIBODIES; INSPECTION; ABATTOIR	Background: Bovine tuberculosis (BTB) today primarily affects developing countries. In Africa, the disease is present essentially on the whole continent; however, little accurate information on its distribution and prevalence is available. Also, attempts to evaluate diagnostic tests for BTB in naturally infected cattle are scarce and mostly complicated by the absence of knowledge of the true disease status of the tested animals. However, diagnostic test evaluation in a given setting is a prerequisite for the implementation of local surveillance schemes and control measures. Methodology/Principal Findings: We subjected a slaughterhouse population of 954 Chadian cattle to single intra-dermal comparative cervical tuberculin (SICCT) testing and two recently developed fluorescence polarization assays (FPA). Using a Bayesian modeling approach we computed the receiver operating characteristic (ROC) curve of each diagnostic test, the true disease prevalence in the sampled population and the disease status of all sampled animals in the absence of knowledge of the true disease status of the sampled animals. In our Chadian setting, SICCT performed better if the cut-off for positive test interpretation was lowered from >4 mm (OIE standard cut-off) to >2 mm. Using this cut-off, SICCT showed a sensitivity and specificity of 66% and 89%, respectively. Both FPA tests showed sensitivities below 50% but specificities above 90%. The true disease prevalence was estimated at 8%. Altogether, 11% of the sampled animals showed gross visible tuberculous lesions. However, modeling of the BTB disease status of the sampled animals indicated that 72% of the suspected tuberculosis lesions detected during standard meat inspections were due to other pathogens than Mycobacterium bovis. Conclusions/Significance: Our results have important implications for BTB diagnosis in a high incidence sub-Saharan African setting and demonstrate the practicability of our Bayesian approach for diagnostic test evaluation.	[Mueller, Borna; Schelling, Esther; Zinsstag, Jakob] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; [Vounatsou, Penelope] Swiss Trop Inst, Dept Biostat & Epidemiol, CH-4002 Basel, Switzerland; [Ngandolo, Bongo Nare Richard; Diguimbaye-Djaibe, Colette] Lab Rech Vet & Zootech Farcha, Ndjamena, Chad; [Schiller, Irene; Marg-Haufe, Beatrice; Oesch, Bruno] Prionics AG, Schlieren, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Muller, B (corresponding author), Univ Stellenbosch, Fac Hlth Sci, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res,Div Mol Biol, Cape Town, South Africa.	bmuller@sun.ac.za	Müller, Borna/AAS-9471-2020; Zinsstag, Jakob/A-8317-2008; Schelling, Esther/K-7990-2015	Zinsstag, Jakob/0000-0002-8899-6097; Schelling, Esther/0000-0001-6444-0898; Vounatsou, Penelope/0000-0002-4904-5352	Swiss National Science Foundation [107559]; Prionics AG, Schlieren-Zurich, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Prionics AG, Schlieren-Zurich, Switzerland	Our work has received financial support from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx; project no. 107559) and from Prionics AG, Schlieren-Zurich, Switzerland (www.prionics.com). The Swiss National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Prionics AG had no role in study design, data collection and analysis and decision to publish but employees of Prionics AG were involved in manuscript writing.	AMENI G, 2008, CLIN VACCINE IMMUNOL; Asseged B, 2004, TROP ANIM HEALTH PRO, V36, P537, DOI 10.1023/B:TROP.0000040934.32330.44; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; CANCELA MMG, 1993, J COMP PATHOL, V109, P361, DOI 10.1016/S0021-9975(08)80299-X; Choi YK, 2006, J AGR BIOL ENVIR ST, V11, P210, DOI 10.1198/108571106X110883; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; CORNER LA, 1990, AUST VET J, V67, P389, DOI 10.1111/j.1751-0813.1990.tb03020.x; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Diguimbaye-Djaibe C, 2006, SCHWEIZ ARCH TIERH, V148, P251, DOI 10.1024/0036-7281.148.5.251; Diguimbaye-Djaibe C, 2006, EMERG INFECT DIS, V12, P769; Estrada-Chavez Ciro, 2004, Veterinaria Mexico, V35, P225; Gardner IA, 2006, VET CLIN PATH, V35, P8, DOI 10.1111/j.1939-165X.2006.tb00082.x; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Herenda D, 1994, CHAP 2 GEN PATHOLOGI; Jolley ME, 2003, COMB CHEM HIGH T SCR, V6, P235, DOI 10.2174/138620703106298419; Jolley ME, 2007, VET MICROBIOL, V120, P113, DOI 10.1016/j.vetmic.2006.10.018; Lachnik J, 2002, J CLIN MICROBIOL, V40, P3364, DOI 10.1128/JCM.40.9.3364-3373.2002; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Lin M, 1996, CLIN DIAGN LAB IMMUN, V3, P438, DOI 10.1128/CDLI.3.4.438-443.1996; MOORE DF, 1995, J CLIN MICROBIOL, V33, P2686, DOI 10.1128/JCM.33.10.2686-2691.1995; Muller B, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-26; Ngandolo BNR, 2009, PREV VET MED, V89, P81, DOI 10.1016/j.prevetmed.2009.02.003; OIE, 2022, NUMB NEW H5 OUTBR; Oloya J, 2006, TROP ANIM HEALTH PRO, V38, P275, DOI 10.1007/s11250-006-4322-7; Oloya J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-95; Pollock JM, 2005, VET IMMUNOL IMMUNOP, V108, P37, DOI 10.1016/j.vetimm.2005.08.012; Quirin R, 2001, ONDERSTEPOORT J VET, V68, P231; RENWICK AR, 2006, EPIDEMIOL INFECT, P1; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Sulieman MS, 2002, J VET MED B, V49, P415, DOI 10.1046/j.1439-0450.2002.00565.x; Surujballi OP, 2002, VET MICROBIOL, V87, P149, DOI 10.1016/S0378-1135(02)00044-5; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Teklu A, 2004, REV SCI TECH OIE, V23, P957, DOI 10.20506/rst.23.3.1534; Thornton P.K., 2002, MAPPING POVERTY LIVE; Varello K, 2008, J VET DIAGN INVEST, V20, P164, DOI 10.1177/104063870802000204; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; Watrelot-Virieux D, 2006, J VET MED B, V53, P321, DOI 10.1111/j.1439-0450.2006.00957.x; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312; WHO, 2006, CONTR NEGL ZOON DIS; ZINSSTAG J, 2006, MYCOBACTERIUM BOVIS; 2001, NUTR HLTH DEV COUNTR	47	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8215	10.1371/journal.pone.0008215	http://dx.doi.org/10.1371/journal.pone.0008215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011046	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829800007
J	Joshi, D; Quadri, M; Gangane, N; Joshi, R; Gangane, N				Joshi, Deepti; Quadri, Munira; Gangane, Neha; Joshi, Rajnish; Gangane, Nitin			Association of Epstein Barr Virus Infection (EBV) with Breast Cancer in Rural Indian Women	PLOS ONE			English	Article							REAL-TIME PCR; MEDULLARY CARCINOMA; LYMPHOID STROMA; EXPRESSION; RISK; DISEASE; ABSENCE; GENOME; CELLS; EPIDEMIOLOGY	Introduction: Breast cancer is the most common malignancy affecting females worldwide but conventional risk factors are able to explain only a small proportion of these cases. A possible viral etiology for breast cancer has been proposed and Epstein-Barr Virus (EBV) is a widely researched candidate virus. The aim of the present study, first one of its kind from India, was to determine if there is a greater association of EBV infection with breast cancer patients as compared to patients with benign breast diseases. Methods: We looked for expression of Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1) in breast cancer tissue specimens by employing immunohistochemistry (IHC). We also measured levels of anti-EBNA-1 Immunoglobulin (IgG) antibodies in stored sera of these patients using commercial Enzyme linked Immunosorbent Assay ( ELISA) kit. Patients with benign breast diseases were used as a comparison group for both immunohistochemical and serological analysis. Results: 58 cases of malignant breast disease and 63 of benign breast disease (controls) were included in the study. Using manufacturer determined cut-off of 3 IU/ml, 50/55 tested ( 90.9%) cases and 27/33 tested (81.8%) controls were seropositive for anti-EBNA-1 IgG. Mean antibody levels were significantly higher for cases (54.22 IU/ml) as compared to controls (18.68 IU/ml). IHC for EBNA-1 was positive in 28/51 cases (54.9%). No IHC positivity was noted in the tested 30 controls. Our results show that EBNA-1 expression is seen in a significant proportion of breast cancer tissue specimens from rural India and as compared to patients with benign breast diseases these patients also have a higher immunological response against EBNA-1.	[Joshi, Deepti; Quadri, Munira; Gangane, Nitin] Mahatma Gandhi Inst Med Sci, Dept Pathol, Sevagram, Maharashtra, India; [Joshi, Rajnish] Mahatma Gandhi Inst Med Sci, Dept Med, Sevagram, Maharashtra, India	Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram	Joshi, D (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Pathol, Sevagram, Maharashtra, India.	nitingangane@rediffmail.com		Joshi, Rajnish/0000-0002-4702-0522	University Grants Commission ( UGC), New Delhi, India; Indian Council of Medical research ( ICMR), New Delhi India	University Grants Commission ( UGC), New Delhi, India(University Grants Commission, India); Indian Council of Medical research ( ICMR), New Delhi India(Indian Council of Medical Research (ICMR))	This study was supported by research grants from University Grants Commission ( UGC), New Delhi, India. Neha Gangane was supported by a short term scholarship from Indian Council of Medical research ( ICMR), New Delhi India for her work in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni A, 2001, J NATL CANCER I, V93, P560, DOI 10.1093/jnci/93.7.560; [Anonymous], 2001, LANCET, V358, P1389; Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Brink AATP, 2000, J NATL CANCER I, V92, P655, DOI 10.1093/jnci/92.8.655; Chu JS, 1998, CANCER LETT, V124, P53, DOI 10.1016/S0304-3835(97)00449-7; Chu PGG, 2001, AM J PATHOL, V159, P571, DOI 10.1016/S0002-9440(10)61728-2; Dadmanesh F, 2001, HISTOPATHOLOGY, V38, P54, DOI 10.1046/j.1365-2559.2001.01055.x; Deshpande CG, 2002, LAB INVEST, V82, P1193, DOI 10.1097/01.LAB.0000029150.90532.24; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; GAFFEY MJ, 1993, MODERN PATHOL, V6, P721; Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688; Glaser SL, 1998, INT J CANCER, V75, P555; Grinstein S, 2002, CANCER RES, V62, P4876; Hennard C, 2006, J PATHOL, V209, P430, DOI 10.1002/path.1996; Herrmann K, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr561; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HORIUCHI K, 1994, J CLIN PATHOL, V47, P538, DOI 10.1136/jcp.47.6.538; Huang J, 2003, J VIROL, V77, P13267, DOI 10.1128/JVI.77.24.13267-13274.2003; Kalkan A, 2005, MED PRIN PRACT, V14, P268, DOI 10.1159/000085748; Kijima Y, 2001, J MED VIROL, V64, P513, DOI 10.1002/jmv.1079; LABRECQUE LG, 1995, CANCER RES, V55, P39; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; LUQMANI YA, 1995, INT J ONCOL, V6, P899; Mant C, 2004, INTERVIROLOGY, V47, P2, DOI 10.1159/000076636; McCall SA, 2001, JNCI-J NATL CANCER I, V93, P148, DOI 10.1093/jnci/93.2.148; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Murray PG, 2003, CANCER RES, V63, P2338; NANDKUMAR A, 2001, NATL CANC REGISTRY P; Perkins RS, 2006, BREAST CANCER RES, V8, DOI 10.1186/BCR1627; Perrigoue JG, 2005, CANCER EPIDEM BIOMAR, V14, P809, DOI 10.1158/1055-9965.EPI-04-0763; Preciado MV, 2005, ARCH PATHOL LAB MED, V129, P377; Ribeiro-Silva A, 2004, BRAZ J MED BIOL RES, V37, P89, DOI 10.1590/S0100-879X2004000100013; Richardson AK, 2004, BRIT J CANCER, V90, P2149, DOI 10.1038/sj.bjc.6601822; SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939; Thorne LB, 2005, DIAGN MOL PATHOL, V14, P29, DOI 10.1097/01.pas.0000144448.23464.ab; Trabelsi A, 2008, ANN BIOL CLIN-PARIS, V66, P59, DOI 10.1684/abc.2008.0191; Tsai JH, 2005, J MED VIROL, V75, P276, DOI 10.1002/jmv.20267; Xue SA, 2003, BRIT J CANCER, V89, P113, DOI 10.1038/sj.bjc.6601027; Yasui Y, 2001, CANCER EPIDEM BIOMAR, V10, P9	44	53	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8180	10.1371/journal.pone.0008180	http://dx.doi.org/10.1371/journal.pone.0008180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997605	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829200014
J	Li, XX; Wong, GLH; To, KF; Wong, VWS; Lai, LH; Chow, DKL; Lau, JYW; Sung, JJY; Ding, CM				Li, Xiao-Xing; Wong, Grace Lai-Hung; To, Ka-Fai; Wong, Vincent Wai-Sun; Lai, Larry Hin; Chow, Dorothy Kai-Lai; Lau, James Yun-Wong; Sung, Joseph Jao-Yiu; Ding, Chunming			Bacterial Microbiota Profiling in Gastritis without Helicobacter pylori Infection or Non-Steroidal Anti-Inflammatory Drug Use	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; MOLECULAR ANALYSIS; SEQUENCE-ANALYSIS; GUT MICROBIOTA; RIBOSOMAL DNA; DIVERSITY; OBESITY; FLORA; IDENTIFICATION; MICROFLORA	Recent 16S ribosomal RNA gene (rRNA) molecular profiling of the stomach mucosa revealed a surprising complexity of microbiota. Helicobacter pylori infection and non-steroidal anti-inflammatory drug (NSAID) use are two main contributors to gastritis and peptic ulcer. However, little is known about the association between other members of the stomach microbiota and gastric diseases. In this study, cloning and sequencing of the 16S rRNA was used to profile the stomach microbiota from normal and gastritis patients. One hundred and thirty three phylotypes from eight bacterial phyla were identified. The stomach microbiota was found to be closely adhered to the mucosa. Eleven Streptococcus phylotypes were successfully cultivated from the biopsies. One to two genera represented a majority of clones within any of the identified phyla. We further developed two real-time quantitative PCR assays to quantify the relative abundance of the Firmicutes phylum and the Streptococcus genus. Significantly higher abundance of the Firmicutes phylum and the Streptococcus genus within the Firmicutes phylum was observed in patients with antral gastritis, compared with normal controls. This study suggests that the genus taxon level can largely represent much higher taxa such as the phylum. The clinical relevance and the mechanism underlying the altered microbiota composition in gastritis require further functional studies.	[Li, Xiao-Xing; Sung, Joseph Jao-Yiu; Ding, Chunming] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Grace Lai-Hung; Wong, Vincent Wai-Sun; Lai, Larry Hin; Chow, Dorothy Kai-Lai; Lau, James Yun-Wong; Sung, Joseph Jao-Yiu] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Ding, Chunming] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Li, XX (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	cmding@gmail.com	Lau, James Y. W./O-2612-2016; Sung, Joseph J. Y./R-3203-2018; Lai, Larry H/D-3513-2011; Li, Xiao-xing/B-9114-2008; Wong, Vincent WS/K-3864-2014; Ding, Chunming/B-2593-2008; Wong, Grace LH/L-8586-2014	Lau, James Y. W./0000-0003-0122-4068; Sung, Joseph J. Y./0000-0003-3125-5199; Li, Xiao-xing/0000-0001-8791-7505; Wong, Vincent WS/0000-0003-2215-9410; Ding, Chunming/0000-0002-2063-5594; Wong, Grace LH/0000-0002-2863-9389	Chinese University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong)	This work is supported by the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LP, 1999, J CLIN MICROBIOL, V37, P1069, DOI 10.1128/JCM.37.4.1069-1076.1999; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; ECKLOFF BW, 1994, INT J SYST BACTERIOL, V44, P320, DOI 10.1099/00207713-44-2-320; EDWARDS U, 1989, NUCLEIC ACIDS RES, V16, P7843; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GUERRE J, 1986, PATHOL BIOL, V34, P57; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hume G, 2002, PATHOLOGY, V34, P561, DOI 10.1080/0031302021000035965; Kimura K, 2000, GASTROENTEROL CLIN N, V29, P609, DOI 10.1016/S0889-8553(05)70133-3; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; MARSHALL BJ, 1984, LANCET, V1, P1311; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Monstein HJ, 2000, J MED MICROBIOL, V49, P817, DOI 10.1099/0022-1317-49-9-817; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Quivey RG, 2001, CRIT REV ORAL BIOL M, V12, P301, DOI 10.1177/10454411010120040201; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tiveljung A, 1998, J MED MICROBIOL, V47, P695, DOI 10.1099/00222615-47-8-695; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100	40	150	170	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7985	10.1371/journal.pone.0007985	http://dx.doi.org/10.1371/journal.pone.0007985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956741	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500015
J	Chuan, YC; Iglesias-Gato, D; Fernandez-Perez, L; Cedazo-Minguez, A; Pang, ST; Norstedt, G; Pousette, A; Flores-Morales, A				Chuan, Y-C; Iglesias-Gato, D.; Fernandez-Perez, L.; Cedazo-Minguez, A.; Pang, S-T; Norstedt, G.; Pousette, A.; Flores-Morales, A.			Ezrin mediates c-Myc actions in prostate cancer cell invasion	ONCOGENE			English	Article						ezrin; c-Myc; metastasis; cell invasion; androgen	ANDROGEN RECEPTOR; GENE-EXPRESSION; AKT ACTIVITY; IN-VIVO; PROGRESSION; ACTIVATION; SUPPRESSOR; PATHWAYS; GROWTH; PTEN	The forced overexpression of c-Myc in mouse prostate and in normal human prostate epithelial cells results in tumor transformation with an invasive phenotype. How c-Myc regulates cell invasion is poorly understood. In this study, we have investigated the interplay of c-Myc and androgens in the regulation of prostate cancer cell invasion. We found that c-Myc induces cell invasion and anchorage-independent growth by regulating ezrin protein expression in the presence of androgens. The activity of the ezrin promoter is controlled by androgens through c-Myc, which binds to a phylogenetically conserved E-Box located in the proximal promoter region. Besides, we also show that ezrin is an important regulator of c-Myc protein levels. These effects are achieved through androgen-induced changes in ezrin phosphorylation, which results in the regulation of downstream signals. These downstream signals involve the modulation of Akt and GSK-3 beta activity resulting in increased c-Myc protein synthesis and inhibition of its degradation. In summary, we have shown a key role for ezrin as a mediator of c-Myc-induced tumorigenesis in prostate cancer cells. Oncogene (2010) 29, 1531-1542; doi:10.1038/onc.2009.442; published online 14 December 2009	[Chuan, Y-C] Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Chuan, Y-C; Iglesias-Gato, D.; Norstedt, G.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Fernandez-Perez, L.] Univ Las Palmas GC, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Fernandez-Perez, L.] Canary Inst Canc Res, Las Palmas Gran Canaria, Spain; [Cedazo-Minguez, A.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Pang, S-T] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Surg,Div Urol, Tao Yuan, Taiwan; [Pousette, A.] Karolinska Inst, Androl Ctr, Stockholm, Sweden	Novo Nordisk Foundation; University of Copenhagen; Karolinska Institutet; Universidad de Las Palmas de Gran Canaria; Karolinska Institutet; Chang Gung Memorial Hospital; Chang Gung University; Karolinska Institutet	Chuan, YC (corresponding author), Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark.	yin.choy.chuan@cpr.ku.dk	Fernandez-Perez, Leandro/H-1493-2015; Cedazo-Minguez, Angel/C-6707-2012; Iglesias-Gato, Diego/R-1794-2016	Fernandez-Perez, Leandro/0000-0001-7802-465X; Cedazo-Minguez, Angel/0000-0003-4626-4864; Iglesias-Gato, Diego/0000-0002-8982-9936; Norstedt, Gunnar/0000-0002-7759-3241	Novo Nordisk Foundation Center for Protein Research; Karolinska Institutet, Cancerfonden [45576-B01-01XAB]; Swedish Research Council [VR- 529-2002-6766]; Robert Lundberg Memorial Foundation [2007Lund0045]	Novo Nordisk Foundation Center for Protein Research; Karolinska Institutet, Cancerfonden(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Robert Lundberg Memorial Foundation	We thank Maria Henriksson for providing the c-Myc expression plasmid. The work carried out in this study was in part supported by the Novo Nordisk Foundation Center for Protein Research, Karolinska Institutet, Cancerfonden (45576-B01-01XAB), Swedish Research Council (VR- 529-2002-6766) and the Robert Lundberg Memorial Foundation (2007Lund0045).	Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bernard D, 2003, J CLIN INVEST, V112, P1724; Bonaccorsi L, 2000, ENDOCRINOLOGY, V141, P3172, DOI 10.1210/en.141.9.3172; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Hellerstedt BA, 2003, UROL ONCOL-SEMIN ORI, V21, P272, DOI 10.1016/S1078-1439(03)00046-2; Jenkins RB, 1997, CANCER RES, V57, P524; JOSHUA AM, 2007, BIOCH BIOPHYS ACTA; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Liao XB, 2004, ENDOCRINOLOGY, V145, P2941, DOI 10.1210/en.2003-1519; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Pang ST, 2004, ONCOL REP, V11, P1187; Pang ST, 2004, UROLOGY, V63, P609, DOI 10.1016/j.urology.2003.09.068; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; SADI MV, 1991, CANCER, V67, P3065, DOI 10.1002/1097-0142(19910615)67:12<3065::AID-CNCR2820671222>3.0.CO;2-U; Sawyer TK, 2004, EXPERT OPIN INV DRUG, V13, P1; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; Valdman A, 2005, EUR UROL, V48, P852, DOI 10.1016/j.eururo.2005.03.013; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Williams K, 2005, PROSTATE, V63, P369, DOI 10.1002/pros.20200; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972	40	49	56	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1531	1542		10.1038/onc.2009.442	http://dx.doi.org/10.1038/onc.2009.442			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	20010876				2022-12-25	WOS:000275392400011
J	Zhang, WC; Peng, YJ; Zhang, GS; He, WQ; Qiao, YN; Dong, YY; Gao, YQ; Chen, C; Zhang, CH; Li, W; Shen, HH; Ning, W; Kamm, KE; Stull, JT; Gao, X; Zhu, MS				Zhang, Wen-Cheng; Peng, Ya-Jing; Zhang, Gen-Sheng; He, Wei-Qi; Qiao, Yan-Ning; Dong, Ying-Ying; Gao, Yun-Qian; Chen, Chen; Zhang, Cheng-Hai; Li, Wen; Shen, Hua-Hao; Ning, Wen; Kamm, Kristine E.; Stull, James T.; Gao, Xiang; Zhu, Min-Sheng			Myosin Light Chain Kinase Is Necessary for Tonic Airway Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CA2+ SENSITIZATION; NONMUSCLE MYOSIN; RHOA/RHO-KINASE; II INHIBITOR; G-PROTEINS; MICE; PHOSPHORYLATION; PHOSPHATASE; ASTHMA	Different interacting signaling modules involving Ca2+/calmodulin-dependent myosin light chain kinase, Ca2+-independent regulatory light chain phosphorylation, myosin phosphatase inhibition, and actin filament-based proteins are proposed as specific cellular mechanisms involved in the regulation of smooth muscle contraction. However, the relative importance of specific modules is not well defined. By using tamoxifen-activated and smooth muscle-specific knock-out of myosin light chain kinase in mice, we analyzed its role in tonic airway smooth muscle contraction. Knock-out of the kinase in both tracheal and bronchial smooth muscle significantly reduced contraction and myosin phosphorylation responses to K+-depolarization and acetylcholine. Kinase-deficient mice lacked bronchial constrictions in normal and asthmatic airways, whereas the asthmatic inflammation response was not affected. These results indicate that myosin light chain kinase acts as a central participant in the contractile signaling module of tonic smooth muscle. Importantly, contractile airway smooth muscles are necessary for physiological and asthmatic airway resistance.	[Zhang, Wen-Cheng; Peng, Ya-Jing; He, Wei-Qi; Qiao, Yan-Ning; Dong, Ying-Ying; Gao, Yun-Qian; Chen, Chen; Zhang, Cheng-Hai; Gao, Xiang; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Zhang, Wen-Cheng; Peng, Ya-Jing; He, Wei-Qi; Qiao, Yan-Ning; Dong, Ying-Ying; Gao, Yun-Qian; Chen, Chen; Zhang, Cheng-Hai; Gao, Xiang; Zhu, Min-Sheng] MOE Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Zhang, Gen-Sheng; Li, Wen; Shen, Hua-Hao] Zhejiang Univ, Sch Med, Hosp 2, Dept Resp Dis, Hangzhou 310009, Zhejiang, Peoples R China; [Ning, Wen] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Nanjing University; Zhejiang University; Nankai University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, MS (corresponding author), 12 Xue Fu Rd, Nanjing 210061, Peoples R China.	zhums@nju.edu.cn	He, Weiqi/I-7935-2013; Zhang, Wencheng/AAO-8445-2020; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Qiao, Yanning/0000-0002-8092-4662; Chen, Chen/0000-0001-7075-8501	National Basic Research Program of China [973 2009CB942602, 2005CB522501, 2007CB947100, 2009CB522101]; National Institutes of Health [HL26043]; National Natural Science Funding of China [30570911]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, R37HL026043] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Basic Research Program of China Grants 973 2009CB942602, 2005CB522501, 2007CB947100, and 2009CB522101, National Institutes of Health Grant HL26043, and National Natural Science Funding of China Grant 30570911.	Ammit AJ, 2000, AM J RESP CRIT CARE, V161, P257, DOI 10.1164/ajrccm.161.1.9901005; BARNES PJ, 1992, AIRWAY SMOOTH MUSCLE, P59; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Diamant Z, 2007, RESP MED, V101, P378, DOI 10.1016/j.rmed.2006.12.004; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; GOLENHOFEN K, 1991, DIGEST DIS, V9, P341, DOI 10.1159/000171321; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Harnett KM, 2005, AM J PHYSIOL-GASTR L, V288, pG407, DOI 10.1152/ajpgi.00398.2004; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; HIMPENS B, 1988, J GEN PHYSIOL, V92, P713, DOI 10.1085/jgp.92.6.713; Hirota S, 2007, EUR RESPIR J, V30, P114, DOI 10.1183/09031936.00147706; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; JIANG H, 1992, AM J RESP CELL MOL, V7, P567, DOI 10.1165/ajrcmb/7.6.567; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kume H, 2008, CURR MED CHEM, V15, P2876, DOI 10.2174/092986708786242831; LINDER ME, 1992, SCI AM, V267, P56; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V291, pL281, DOI 10.1152/ajplung.00320.2005; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Patel CA, 2006, AM J PHYSIOL-GASTR L, V291, pG830, DOI 10.1152/ajpgi.00130.2006; Rattan S, 2008, AM J PHYSIOL-GASTR L, V294, pG687, DOI 10.1152/ajpgi.00501.2007; Sausbier M, 2007, FASEB J, V21, P812, DOI 10.1096/fj.06-7167com; Schaafsma D, 2004, BRIT J PHARMACOL, V143, P477, DOI 10.1038/sj.bjp.0705903; Schelegle ES, 2003, ANAT REC PART A, V270A, P11, DOI 10.1002/ar.a.10004; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; SETO M, 1990, PFLUG ARCH EUR J PHY, V415, P484, DOI 10.1007/BF00373627; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AV, 1968, J PHARMACOL EXP THER, V159, P129; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sward K, 2003, CURR HYPERTENS REP, V5, P66, DOI 10.1007/s11906-003-0013-1; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Wu Y, 2008, AM J PHYSIOL-LUNG C, V295, pL988, DOI 10.1152/ajplung.90202.2008; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009	47	49	50	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5522	5531		10.1074/jbc.M109.062836	http://dx.doi.org/10.1074/jbc.M109.062836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018858	Green Published, hybrid			2022-12-25	WOS:000275327200045
J	Balakrishnan, L; Stewart, J; Polaczek, P; Campbell, JL; Bambara, RA				Balakrishnan, Lata; Stewart, Jason; Polaczek, Piotr; Campbell, Judith L.; Bambara, Robert A.			Acetylation of Dna2 Endonuclease/Helicase and Flap Endonuclease 1 by p300 Promotes DNA Stability by Creating Long Flap Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR P300; OKAZAKI FRAGMENT MATURATION; BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; POLYMERASE-DELTA; REPLICATION FORK; HUMAN FEN1; YEAST; GLYCOSYLASE; CLEAVAGE	Flap endonuclease 1 (FEN1) and Dna2 endonuclease/helicase (Dna2) sequentially coordinate their nuclease activities for efficient resolution of flap structures that are created during the maturation of Okazaki fragments and repair of DNA damage. Acetylation of FEN1 by p300 inhibits its endonuclease activity, impairing flap cleavage, a seemingly undesirable effect. We now show that p300 also acetylates Dna2, stimulating its 5'-3' endonuclease, the 5'-3' helicase, and DNA-dependent ATPase activities. Furthermore, acetylated Dna2 binds its DNA substrates with higher affinity. Differential regulation of the activities of the two endonucleases by p300 indicates a mechanism in which the acetylase promotes formation of longer flaps in the cell at the same time as ensuring correct processing. Intentional formation of longer flaps mediated by p300 in an active chromatin environment would increase the resynthesis patch size, providing increased opportunity for incorrect nucleotide removal during DNA replication and damaged nucleotide removal during DNA repair. For example, altering the ratio between short and long flap Okazaki fragment processing would be a mechanism for better correction of the error-prone synthesis catalyzed by DNA polymerase alpha.	[Balakrishnan, Lata; Stewart, Jason; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Polaczek, Piotr; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM024441 (to R. A. B.) and GM087666 (to J. L. C.).	Alexiadis V, 1997, CHROMOSOMA, V105, P324; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kim MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004864; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; SLIJEPCEVIC P, 1994, MUTAT RES, V323, P113, DOI 10.1016/0165-7992(94)90084-1; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	31	46	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4398	4404		10.1074/jbc.M109.086397	http://dx.doi.org/10.1074/jbc.M109.086397			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20019387	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000275274800016
J	Giraldo, AMV; Medus, ML; Lebrero, MG; Pagano, RS; Labriola, CA; Landolfo, L; Delfino, JM; Parodi, AJ; Caramelo, JJ				Villamil Giraldo, Ana Maria; Lopez Medus, Maximo; Gonzalez Lebrero, Mariano; Pagano, Rodrigo S.; Labriola, Carlos A.; Landolfo, Lucas; Delfino, Jose M.; Parodi, Armando J.; Caramelo, Julio J.			The Structure of Calreticulin C-terminal Domain Is Modulated by Physiological Variations of Calcium Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR CHAPERONE; QUALITY-CONTROL; P-DOMAIN; BINDING; CALNEXIN; PROTEIN; LECTIN; CONFORMATION	Calreticulin is an abundant endoplasmic reticulum resident protein that fulfills at least two basic functions. Firstly, due to its ability to bind monoglucosylated high mannose oligosaccharides, calreticulin is a central component of the folding quality control system of glycoproteins. On the other hand, thanks to its capacity to bind high amounts of calcium, calreticulin is one of the main calcium buffers in the endoplasmic reticulum. This last activity resides on a highly negatively charged domain located at the C terminus. Interestingly, this domain has been proposed to regulate the intracellular localization of calreticulin. Structural information for this domain is currently scarce. Here we address this issue by employing a combination of biophysical techniques and molecular dynamics simulation. We found that calreticulin C-terminal domain at low calcium concentration displays a disordered structure, whereas calcium addition induces a more rigid and compact conformation. Remarkably, this change develops when calcium concentration varies within a range similar to that taking place in the endoplasmic reticulum upon physiological fluctuations. In addition, a much higher calcium concentration is necessary to attain similar responses in a peptide displaying a randomized sequence of calreticulin C-terminal domain, illustrating the sequence specificity of this effect. Molecular dynamics simulation reveals that this ordering effect is a consequence of the ability of calcium to bring into close proximity residues that lie apart in the primary structure. These results place calreticulin in a new setting in which the protein behaves not only as a calcium-binding protein but as a finely tuned calcium sensor.	[Villamil Giraldo, Ana Maria; Lopez Medus, Maximo; Pagano, Rodrigo S.; Landolfo, Lucas; Caramelo, Julio J.] Fdn Inst Leloir, Lab Struct Cell Biol, Buenos Aires, DF, Argentina; [Labriola, Carlos A.; Parodi, Armando J.] Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina; [Labriola, Carlos A.; Parodi, Armando J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Villamil Giraldo, Ana Maria; Gonzalez Lebrero, Mariano; Delfino, Jose M.] Univ Buenos Aires, Dept Biol Chem, Buenos Aires, DF, Argentina; [Villamil Giraldo, Ana Maria; Gonzalez Lebrero, Mariano; Delfino, Jose M.] Univ Buenos Aires, Inst Biochem & Biophys, Sch Pharm & Biochem, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Dept Biol Chem, Sch Sci, RA-1428 Buenos Aires, DF, Argentina	Leloir Institute; Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Caramelo, JJ (corresponding author), Fdn Inst Leloir, Lab Struct Cell Biol, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	jcaramelo@leloir.org.ar		Gonzalez Lebrero, Mariano/0000-0003-4327-1735	National Institutes of Health [GM044500]; Howard Hughes Medical Institute; University of Buenos Aires; National Agency for the Promotion of Science and Technology (Argentina); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Buenos Aires(University of Buenos Aires); National Agency for the Promotion of Science and Technology (Argentina)(ANPCyT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044500. This work was also supported by the Howard Hughes Medical Institute, by the University of Buenos Aires, and by the National Agency for the Promotion of Science and Technology (Argentina).	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bouvier M, 2000, BIOCHEMISTRY-US, V39, P14950, DOI 10.1021/bi0019545; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gunsteren W. F., 1990, ANGEW CHEM INT EDIT, V29, P992; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Labriola C, 1999, MOL BIOL CELL, V10, P1381, DOI 10.1091/mbc.10.5.1381; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Mukhopadhyay K, 1998, BIOPHYS CHEM, V74, P175, DOI 10.1016/S0301-4622(98)00177-X; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; STORRS RW, 1992, BIOPOLYMERS, V32, P1695, DOI 10.1002/bip.360321211; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Toft KN, 2008, BBA-PROTEINS PROTEOM, V1784, P1265, DOI 10.1016/j.bbapap.2008.05.005; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van der Wal FJ, 1998, EUR J BIOCHEM, V256, P51, DOI 10.1046/j.1432-1327.1998.2560051.x; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Yu R, 2000, J BIOL CHEM, V275, P23648, DOI 10.1074/jbc.M002684200	45	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4544	4553		10.1074/jbc.M109.034512	http://dx.doi.org/10.1074/jbc.M109.034512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018892	Green Published, hybrid			2022-12-25	WOS:000275274800031
J	Zhu, HL; Fernandez, C; Fan, JB; Shewmaker, F; Chen, J; Minton, AP; Liang, Y				Zhu, Hai-Li; Fernandez, Cristina; Fan, Jun-Bao; Shewmaker, Frank; Chen, Jie; Minton, Allen P.; Liang, Yi			Quantitative Characterization of Heparin Binding to Tau Protein IMPLICATION FOR INDUCER-MEDIATED TAU FILAMENT FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; FULL-LENGTH TAU; LIGHT-SCATTERING; ALZHEIMER; AGGREGATION; POLYMERIZATION; FLUORESCENCE; PATHOGENESIS; DIMERIZATION; MECHANISM	Neurofibrillary tangles, principally composed of bundles of filaments formed by the microtubule-associated protein Tau, are a hallmark of a group of neurodegenerative diseases such as Alzheimer disease. Polyanionic cofactors such as heparin can induce Tau filament formation in vitro. Here we quantitatively characterize the interaction between recombinant human Tau fragment Tau(244-372) and heparin (average molecular mass = 7 kDa) as well as heparin-induced fibril formation by using static light scattering, isothermal titration calorimetry, turbidity assays, and transmission electron microscopy. Our data clearly show that at physiological pH, heparin 7K, and human Tau(244-372) form a tight 1:1 complex with an equilibrium association constant exceeding 10(6) M-1 under reducing conditions, triggering Tau fibrillization. In the absence of dithiothreitol, heparin shows a moderate binding affinity (10(5) M-1) to Tau(244-372), similarly triggering Tau fibrillization. Further fibrillization kinetics analyses show that the lag time appears to be approximately invariant up to a molar ratio of 2:1 and then increases at larger ratios of heparin/Tau. The maximum slope representing the apparent rate constant for fibril growth increases sharply with substoichiometric ratios of heparin/Tau and then decreases to some extent with ratios of >1:1. The retarding effect of heparin in excess is attributed to the large increase in ionic strength of the medium arising from free heparin. Together, these results suggest that the formation of the 1:1 complex of Tau monomer and heparin plays an important role in the inducer-mediated Tau filament formation, providing clues to understanding the pathogenesis of neurodegenerative diseases.	[Zhu, Hai-Li; Fan, Jun-Bao; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Fernandez, Cristina; Shewmaker, Frank; Minton, Allen P.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Fan, Jun-bao/E-7155-2012; Fernandez, Cristina/G-2269-2015	Liang, Yi/0000-0002-7349-8300; Fernandez, Cristina/0000-0003-3792-4015; Minton, Allen/0000-0001-8459-1247; Fan, Junbao/0000-0002-1709-3659	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30770421, 30970599]; Chinese 111 Project [B06018]; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024956] Funding Source: NIH RePORTER	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301, National Natural Science Foundation of China Grants 30770421 and 30970599, and Chinese 111 Project Grant B06018. This work was also supported in part by National Institutes of Health grants through the Intramural Research Program of the NIDDK.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Attri AK, 2005, ANAL BIOCHEM, V346, P132, DOI 10.1016/j.ab.2005.08.013; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Kameyama K, 2006, BIOPHYS J, V90, P2164, DOI 10.1529/biophysj.105.074310; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Necula M, 2004, ANAL BIOCHEM, V333, P205, DOI 10.1016/j.ab.2004.05.044; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Perez M, 1996, J NEUROCHEM, V67, P1183; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stacey K. A., 1956, LIGHT SCATTERING PHY; THEISEN A, 2000, REFRACTIVE INCREMENT, P55; van Holde K.E., 2006, PRINCIPLES PHYS BIOC, P91; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wilson DM, 1997, AM J PATHOL, V150, P2181; Xu H, 2005, J BIOL INORG CHEM, V10, P529, DOI 10.1007/s00775-005-0007-3	40	76	75	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3592	3599		10.1074/jbc.M109.035691	http://dx.doi.org/10.1074/jbc.M109.035691			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959468	hybrid, Green Published			2022-12-25	WOS:000275254000010
J	Nierkens, S; den Brok, MH; Roelofsen, T; Wagenaars, JAL; Figdor, CG; Ruers, TJ; Adema, GJ				Nierkens, Stefan; den Brok, Martijn H.; Roelofsen, Thijs; Wagenaars, Jori A. L.; Figdor, Carl G.; Ruers, Theo J.; Adema, Gosse J.			Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice	PLOS ONE			English	Article							T-CELL IMMUNITY; DENDRITIC CELLS; ANTITUMOR IMMUNITY; RADIOFREQUENCY ABLATION; CROSS-PRESENTATION; BACTERIAL-DNA; TUMOR; OLIGODEOXYNUCLEOTIDE; ANTIGEN; INDUCTION	Background: The TLR9 agonist CpG is increasingly applied in preclinical and clinical studies as a therapeutic modality to enhance tumor immunity. The clinical application of CpG appears, however, less successful than would be predicted from animal studies. One reason might be the different administration routes applied in most mouse studies and clinical trials. We studied whether the efficacy of CpG as an adjuvant in cancer immunotherapy is dependent on the route of CpG administration, in particular when the tumor is destructed in situ. Methodology/Principal Findings: In situ tumor destruction techniques are minimally invasive therapeutic alternatives for the treatment of (nonresectable) solid tumors. In contrast to surgical resection, tumor destruction leads to the induction of weak but tumor-specific immunity that can be enhanced by coapplication of CpG. As in situ tumor destruction by cryosurgery creates an instant local release of antigens, we applied this model to study the efficacy of CpG to enhance antitumor immunity when administrated via different routes: peritumoral, intravenous, and subcutaneous but distant from the tumor. We show that peritumoral administration is superior in the activation of dendritic cells, induction of tumor-specific CTL, and long-lasting tumor protection. Although the intravenous and subcutaneous (at distant site) exposures are commonly used in clinical trials, they only provided partial protection or even failed to enhance antitumor responses as induced by cryosurgery alone. Conclusions/Significance: CpG administration greatly enhances the efficacy of in situ tumor destruction techniques, provided that CpG is administered in close proximity of the released antigens. Hence, this study helps to provide directions to fully benefit from CpG as immune stimulant in a clinical setting.	[Nierkens, Stefan; den Brok, Martijn H.; Roelofsen, Thijs; Wagenaars, Jori A. L.; Figdor, Carl G.; Adema, Gosse J.] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Ruers, Theo J.] Netherlands Canc Inst, Amsterdam, Netherlands	Radboud University Nijmegen; Netherlands Cancer Institute	Nierkens, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands.	g.adema@ncmls.ru.nl	Brok, Martijn H den/O-1054-2013; Nierkens, Stefan/AAQ-5564-2021; Figdor, Carl G/A-4232-2010; Adema, G.J./H-8007-2014	Nierkens, Stefan/0000-0003-3406-817X; Figdor, Carl G/0000-0002-2366-9212; Roelofsen, Thijs/0000-0003-1470-8846; den Brok, Martijn/0000-0002-2368-0411	Dutch Cancer Society [KWF-2003-2893, KWF-2004-3137, KWF-2005-3325]; Dutch Cancer Society (KWF, Amsterdam, The Netherlands)	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Cancer Society (KWF, Amsterdam, The Netherlands)(KWF KankerbestrijdingNetherlands Government)	This research was made possible by grants of the Dutch Cancer Society (KWF-2003-2893, KWF-2004-3137, KWF-2005-3325). SN is a research fellow of the Dutch Cancer Society (KWF, Amsterdam, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Baines J, 2003, CLIN CANCER RES, V9, P2693; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Davila E, 2003, CANCER RES, V63, P3281; den Brok MHMGM, 2006, BRIT J CANCER, V95, P896, DOI 10.1038/sj.bjc.6603341; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; den Brok MHMGM, 2005, EXPERT REV VACCINES, V4, P699, DOI 10.1586/14760584.4.5.699; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Fallarino F, 2006, EUR J IMMUNOL, V36, P8, DOI 10.1002/eji.200535667; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Heckelsmiller K, 2002, J IMMUNOL, V169, P3892, DOI 10.4049/jimmunol.169.7.3892; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hoene V, 2006, J LEUKOCYTE BIOL, V80, P1328, DOI 10.1189/jlb.0106011; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huang A, 2002, BRIT J SURG, V89, P303, DOI 10.1046/j.0007-1323.2001.02004.x; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Milas L, 2004, CANCER RES, V64, P5074, DOI 10.1158/0008-5472.CAN-04-0926; Mulier S, 2008, ANN SURG ONCOL, V15, P144, DOI 10.1245/s10434-007-9478-5; Murad YM, 2007, EXPERT OPIN BIOL TH, V7, P1257, DOI 10.1517/14712598.7.8.1257; Nierkens S, 2008, CANCER RES, V68, P5390, DOI 10.1158/0008-5472.CAN-07-6023; Ninalga C, 2005, J IMMUNOTHER, V28, P20, DOI 10.1097/00002371-200501000-00003; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Schmidt C, 2007, NAT BIOTECHNOL, V25, P825, DOI 10.1038/nbt0807-825; van Maren WWC, 2008, IMMUNOLOGY, V124, P445, DOI 10.1111/j.1365-2567.2008.02871.x; von Beust BR, 2005, EUR J IMMUNOL, V35, P1869, DOI 10.1002/eji.200526124; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602	39	69	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8368	10.1371/journal.pone.0008368	http://dx.doi.org/10.1371/journal.pone.0008368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020049	Green Submitted, Green Published, gold			2022-12-25	WOS:000272870600009
J	Carrasco, MA; Barnosky, AD; Graham, RW				Carrasco, Marc A.; Barnosky, Anthony D.; Graham, Russell W.			Quantifying the Extent of North American Mammal Extinction Relative to the Pre-Anthropogenic Baseline	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIP; DIVERSITY; FUTURE; DISTRIBUTIONS; RAREFACTION; QUATERNARY; MEGAFAUNA; RICHNESS; ECOLOGY; TRENDS	Earth has experienced five major extinction events in the past 450 million years. Many scientists suggest we are now witnessing a sixth, driven by human impacts. However, it has been difficult to quantify the real extent of the current extinction episode, either for a given taxonomic group at the continental scale or for the worldwide biota, largely because comparisons of pre-anthropogenic and anthropogenic biodiversity baselines have been unavailable. Here, we compute those baselines for mammals of temperate North America, using a sampling-standardized rich fossil record to reconstruct species-area relationships for a series of time slices ranging from 30 million to 500 years ago. We show that shortly after humans first arrived in North America, mammalian diversity dropped to become at least 15%-42% too low compared to the "normal" diversity baseline that had existed for millions of years. While the Holocene reduction in North American mammal diversity has long been recognized qualitatively, our results provide a quantitative measure that clarifies how significant the diversity reduction actually was. If mass extinctions are defined as loss of at least 75% of species on a global scale, our data suggest that North American mammals had already progressed one-fifth to more than halfway (depending on biogeographic province) towards that benchmark, even before industrialized society began to affect them. Data currently are not available to make similar quantitative estimates for other continents, but qualitative declines in Holocene mammal diversity are also widely recognized in South America, Eurasia, and Australia. Extending our methodology to mammals in these areas, as well as to other taxa where possible, would provide a reasonable way to assess the magnitude of global extinction, the biodiversity impact of extinctions of currently threatened species, and the efficacy of conservation efforts into the future.	[Carrasco, Marc A.; Barnosky, Anthony D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Carrasco, Marc A.; Barnosky, Anthony D.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Graham, Russell W.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Graham, Russell W.] Penn State Univ, Earth & Mineral Sci Museum, University Pk, PA 16802 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Carrasco, MA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	carrasco@berkeley.edu			National Science Foundation [EAR-0310221, DEB-0543641, EAR-9005144, EAR-9807499]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation Grants EAR-0310221 and DEB-0543641 (Barnosky) and EAR-9005144 and EAR-9807499 (Graham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 1998, BIODIVERSITY DYNAMICS, P232; ALROY J, 1992, PALEOBIOLOGY, V18, P326, DOI 10.1017/S0094837300010873; Alroy J, 2003, J MAMMAL, V84, P431, DOI 10.1644/1545-1542(2003)084<0431:TIABMD>2.0.CO;2; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Barnosky AD, 2005, PLOS BIOL, V3, P1356, DOI 10.1371/journal.pbio.0030266; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2002, EVOL ECOL RES, V4, P811; Barnosky AD, 2001, CONSERV BIOL, V15, P658, DOI 10.1046/j.1523-1739.2001.015003658.x; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brook BW, 2007, QUATERNARY SCI REV, V26, P560, DOI 10.1016/j.quascirev.2006.10.008; Brown J. H., 1995, MACROECOLOGY; CARRASCO MA, 2005, MIOCENE MAMMAL MAPPI; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; CONDON SM, 2005, GEOLOGICAL SURVEY PR, V1706, P1; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Desmet P, 2004, ECOL SOC, V9; Escarguel G, 2004, PALAEOGEOGR PALAEOCL, V202, P181, DOI 10.1016/S0031-0182(03)00630-8; *FAUNMAP WORK GROU, 1994, ILLINOIS STATE MUSEU, V25, P690; Fortelius M., 2009, NEOGENE OLD WORLD DA; GODRON M, 1971, Oecologia Plantarum, V6, P189; GRAHAM R W, 1976, Paleobiology, V2, P343; Graham RW, 1996, SCIENCE, V272, P1601; GRAHAM RW, 1985, ACTA ZOOL FENN, V170, P181; HAGMEIER EDWIN M., 1966, SYST ZSOL, V15, P279, DOI 10.2307/2411986; HAGMEIER EM, 1964, SYST ZOOL, V13, P125, DOI 10.2307/2411486; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; Janis CM., 1998, EVOLUTION TERTIARY M, V1; Johnson C., 2007, AUSTR MAMMAL EXTINCT; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Leakey R.E., 1995, 6 EXTINCTION PATTERN; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; Lugo AE, 1999, J BIOGEOGR, V26, P1025, DOI 10.1046/j.1365-2699.1999.00329.x; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Myers N., 1979, SINKING ARK; Ostling A, 2003, OIKOS, V103, P218, DOI 10.1034/j.1600-0706.2003.12600.x; Plotkin JB, 2000, P NATL ACAD SCI USA, V97, P10850, DOI 10.1073/pnas.97.20.10850; Prothero DR, 1998, EVOLUTION TERTIARY M, VI, P9; RAUP D M, 1975, Paleobiology, V1, P333; Regan HM, 2001, AM NAT, V157, P1, DOI 10.1086/317005; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 2001, P NATL ACAD SCI USA, V98, P5404, DOI 10.1073/pnas.101092798; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; *SMITHS I, 2009, NAT MUS NAT HIST N A; STORER JE, 1989, PAPERS FOSSIL RODENT, P17; Tedford R.H., 1987, P153; Tedford Richard H., 2004, P169; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Weiher E, 1999, J ECOL, V87, P1005, DOI 10.1046/j.1365-2745.1999.00412.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	64	33	33	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8331	10.1371/journal.pone.0008331	http://dx.doi.org/10.1371/journal.pone.0008331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016820	Green Submitted, Green Published, gold			2022-12-25	WOS:000272834000017
J	Foley, JE; Nieto, NC; Barbet, A; Foley, P				Foley, Janet E.; Nieto, Nathan C.; Barbet, Anthony; Foley, Patrick			Antigen Diversity in the Parasitic Bacterium Anaplasma phagocytophilum Arises from Selectively-Represented, Spatially Clustered Functional Pseudogenes	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; RATS NEOTOMA-FUSCIPES; MULTIGENE FAMILY; SENSU-LATO; INFECTION; MARGINALE; RECOMBINATION; EXPRESSION; MSP2; DNA	Anaplasma phagocytophilum is a tick-transmitted bacterial pathogen of humans and other animals, and is an obligate intracellular parasite. Throughout the course of infection, hosts acquire temporary resistance to granulocytic anaplasmosis as they develop immunity specific for the major antigen, major surface protein 2 (Msp2). However, the bacterium then utilizes a novel recombination mechanism shuffling functional pseudogenes sequentially into an expression cassette with conserved 59 and 39 ends, bypassing host immunity. Approximately 100 pseudogenes are present in the only fully sequenced human-origin HZ genome, representing the possibility for almost unlimited antigenic diversity. In the present study, we identified a select group of 20% of the A. phagocytophilum HZ msp2 pseudogenes that have matched preferentially to human, canine, and equine expression cassettes. Pseudogenes cluster predominantly in one spatial run limited to a single genomic island in less than 50% of the genome but phylogenetically related pseudogenes are neither necessarily located in close proximity on the genome nor share similar percent identity with expression cassettes. Pseudogenes near the expression cassette (and the origin) are more likely to be expressed than those farther away. Taken together, these findings suggest that there may be natural selection pressure to retain pseudogenes in one cluster near the putative origin of replication, even though global recombination shuffles pseudogenes around the genome, separating pseudogenes that share genetic origins as well as those with similar identities.	[Foley, Janet E.; Nieto, Nathan C.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Barbet, Anthony] Univ Florida, Dept Pathobiol, Gainesville, FL USA; [Foley, Patrick] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA	University of California System; University of California Davis; State University System of Florida; University of Florida; California State University System; California State University Sacramento	Foley, JE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	jefoley@ucdavis.edu			National Institutes of General Medical Sciences Evolution of Infectious Disease program [RO1 GM081714]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081714] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences Evolution of Infectious Disease program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of General Medical Sciences Evolution of Infectious Disease program # RO1 GM081714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Barbet AF, 2006, INFECT IMMUN, V74, P6429, DOI 10.1128/IAI.00809-06; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2003, INFECT IMMUN, V71, P6627, DOI 10.1128/IAI.71.11.6627-6632.2003; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Castro MB, 2001, AM J TROP MED HYG, V65, P261, DOI 10.4269/ajtmh.2001.65.261; DONELSON JE, 1995, J BIOL CHEM, V270, P7783, DOI 10.1074/jbc.270.14.7783; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Egenvall A, 2000, VET REC, V146, P186, DOI 10.1136/vr.146.7.186; Foley J, 2008, EXP APPL ACAROL, V45, P155, DOI 10.1007/s10493-008-9173-7; Foley JE, 2002, J WILDLIFE DIS, V38, P194, DOI 10.7589/0090-3558-38.1.194; Friedberg EC, 2006, IMPLICIT GENOME, P39; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Futse JE, 2009, INFECT IMMUN, V77, P3181, DOI 10.1128/IAI.00348-09; Granquist EG, 2008, INFECT IMMUN, V76, P120, DOI 10.1128/IAI.01206-07; Ioannidis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-182; Lin Q, 2006, INFECT IMMUN, V74, P2052, DOI 10.1128/IAI.74.4.2052-2062.2006; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Morissette E, 2009, EMERG INFECT DIS, V15, P928, DOI 10.3201/eid1506.081610; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; Nicholson WL, 1999, J CLIN MICROBIOL, V37, P3323, DOI 10.1128/JCM.37.10.3323-3327.1999; NIETO N, 2009, VECTOR BORNE ZOONOTI; Nieto NC, 2008, J MED ENTOMOL, V45, P763, DOI 10.1603/0022-2585(2008)45[763:EOSRSA]2.0.CO;2; Ohashi N, 1998, INFECT IMMUN, V66, P132, DOI 10.1128/IAI.66.1.132-139.1998; PALMER G, 2009, CELLULAR MICROBIOLOG; Stuen S, 1998, VET REC, V143, P553, DOI 10.1136/vr.143.20.553; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Wang XQ, 2004, INFECT IMMUN, V72, P6852, DOI 10.1128/IAI.72.12.6852-6859.2004; Wuritu G, 2009, JPN J INFECT DIS, V62, P142; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	36	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8265	10.1371/journal.pone.0008265	http://dx.doi.org/10.1371/journal.pone.0008265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016821	Green Submitted, Green Published, gold			2022-12-25	WOS:000272833800003
J	Brusko, TM; Wasserfall, CH; Hulme, MA; Cabrera, R; Schatz, D; Atkinson, MA				Brusko, Todd M.; Wasserfall, Clive H.; Hulme, Maigan A.; Cabrera, Roniel; Schatz, Desmond; Atkinson, Mark A.			Influence of Membrane CD25 Stability on T Lymphocyte Activity: Implications for Immunoregulation	PLOS ONE			English	Article							SOLUBLE INTERLEUKIN-2-RECEPTOR; PROTEOLYTIC CLEAVAGE; BINDS INTERLEUKIN-2; IL-2 RECEPTOR; ALPHA-SUBUNIT; CELLS; EXPRESSION; MECHANISM; DISEASE; CANCER	Background: CD25, a component of the IL-2 receptor, is important in T cell proliferation, activation induced cell death, as well as the actions of both regulatory (Treg) and effector (Teff) T cells. Recent genome wide association studies have implicated the CD25 locus as an important region for genetic susceptibility to a number of autoimmune disorders, with serum levels of soluble CD25 receptor (sCD25) serving as a potential phenotypic marker for this association. However, the functional impact of CD25 cleavage, as well as the influence of sCD25 on immunoregulatory activities, remain largely unknown and form the basis of this effort. Methodology/Principal Findings: The generation of sCD25 by Treg (CD4(+)CD25(+)) and Teff (CD4(+)CD25(-)) cells was examined during in vitro suppression assays, efforts that demonstrated constitutive and stable surface CD25 expression on Treg throughout the period of in vitro assessment. In contrast, Teff cells increased CD25 expression during the process of in vitro suppression, with supernatant sCD25 levels correlating to the amount of cellular proliferation. Interestingly, under serum-free conditions, Tregs partially lost their characteristic anergic and suppressive properties. sCD25 supplementation at physiological concentrations to serum free in vitro suppression assays reduced Teff proliferation without specifically influencing suppression. Indeed, sCD25 production within these cultures correlated with cell death. Conclusions/Significance: These results support the notion that sCD25 functions as both a surrogate marker of T cell activation as well as an indicator of subsequent cellular death. In addition, the role of CD25 in immunomodulation is likely dependent on the local inflammatory milieu, with molecules capable of modulating surface CD25 expression playing a key role in defining immune responsiveness.	[Brusko, Todd M.; Wasserfall, Clive H.; Hulme, Maigan A.; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Brusko, Todd M.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Cabrera, Roniel] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Schatz, Desmond] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of California System; University of California San Francisco; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brusko, TM (corresponding author), Univ Florida, Dept Pathol, Gainesville, FL 32611 USA.	atkinson@ufl.edu	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; Brusko, Todd/0000-0003-2878-9296	The National Institutes of Health [AI42288, AI39250]; American Diabetes Association; Juvenile Diabetes Research Foundation (JDRF); Brehm Coalition for Type 1 Diabetes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039250, P01AI042288] Funding Source: NIH RePORTER	The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Brehm Coalition for Type 1 Diabetes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported, in part, by grants from The National Institutes of Health (AI42288 and AI39250), the American Diabetes Association, the Juvenile Diabetes Research Foundation (JDRF) (Post Doctoral Fellowship to TMB), and the Brehm Coalition for Type 1 Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bank U, 1999, J INTERF CYTOK RES, V19, P1277, DOI 10.1089/107999099312957; Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Brusko Todd M, 2007, Immunol Invest, V36, P607, DOI 10.1080/08820130701790368; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Horiuchi S, 1997, IMMUNOLOGY, V91, P28, DOI 10.1046/j.1365-2567.1997.00236.x; JACQUES Y, 1987, J IMMUNOL, V139, P2308; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kobayashi H, 1999, CYTOKINE, V11, P1065, DOI 10.1006/cyto.1999.0509; LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Makis AC, 2005, J INFECTION, V51, P206, DOI 10.1016/j.jinf.2004.10.013; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nelson JD, 1998, ADV EXP MED BIOL, V438, P1; Oh U, 2006, J INFECT DIS, V193, P1557, DOI 10.1086/503874; RUBIN LA, 1986, J IMMUNOL, V137, P3841; RUBIN LA, 1985, J IMMUNOL, V135, P3172; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Sheu BC, 2001, CANCER RES, V61, P237; Smith KA, 2006, CELL RES, V16, P11, DOI 10.1038/sj.cr.7310003; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; VanParijs L, 1997, J IMMUNOL, V158, P3738; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	35	46	49	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7980	10.1371/journal.pone.0007980	http://dx.doi.org/10.1371/journal.pone.0007980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956753	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500011
J	Lewis, DA; Travers, JB; Somani, AK; Spandau, DF				Lewis, D. A.; Travers, J. B.; Somani, A-K; Spandau, D. F.			The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer	ONCOGENE			English	Article						aging; IGF-1R; skin cancer; keratinocytes; fibroblasts; UVB	GROWTH-FACTOR-I; HUMAN KERATINOCYTES; INSULIN; RECEPTOR; FIBROBLASTS; APOPTOSIS; LINK	The appropriate response of human keratinocytes to ultraviolet-B (UVB) is dependent on the activation status of the insulin-like growth factor 1 (IGF-1) receptor. Keratinocytes grown in conditions in which the IGF-1 receptor is inactive inappropriately replicate in the presence of UVB-induced DNA damage. In human skin, epidermal keratinocytes do not express IGF-1, and hence the IGF-1 receptor on keratinocytes is activated by IGF-1 secreted from dermal fibroblasts. We now show that the IGF-1 produced by human fibroblasts is essential for the appropriate UVB response of keratinocytes. Furthermore, the expression of IGF-1 is silenced in senescent fibroblasts in vitro. Using quantitative reverse transcriptase-PCR and immunohistochemisty, we can show that IGF-1 expression is also silenced in geriatric dermis in vivo. The diminished IGF-1 expression in geriatric skin correlates with an inappropriate UVB response in geriatric volunteers. Finally, the appropriate UVB response is restored in geriatric skin in vivo through pretreatment with exogenous IGF-1. These studies provide further evidence for a role of the IGF-1 receptor (IGF-1R) in suppressing UVB-induced carcinogenesis, suggest that fibroblasts have a critical role in maintaining appropriate activation of the keratinocyte IGF-1R, and imply that reduced expression of IGF-1 in geriatric skin could be an important component in the development of aging-related non-melanoma skin cancer. Oncogene (2010) 29, 1475-1485; doi:10.1038/onc.2009.440; published online 7 December 2009	[Lewis, D. A.; Travers, J. B.; Somani, A-K; Spandau, D. F.] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Travers, J. B.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Travers, J. B.] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Travers, J. B.] Univ Sch Med, Richard L Roudebush VA Med Ctr, Indianapolis, IN USA; [Spandau, D. F.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Spandau, DF (corresponding author), Indiana Univ, Sch Med, Dept Dermatol, 975 W Walnut St,Room 349, Indianapolis, IN 46202 USA.	dspanda@iupui.edu	Somani, ally-khan/AAA-9656-2020	Somani, Ally-Khan/0000-0003-2166-4896; Travers, Jeffrey/0000-0001-7232-1039	National Institutes of Health [R01ES11155, R21CA131901, R01HL062996, U19A1070448]; VA Merit Award; NATIONAL CANCER INSTITUTE [R21CA131901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to Dr Raymond Konger for his valuable suggestions. The recombinant human IGF-1 was generously provided by Tercica, Inc. This work was supported by grants from the National Institutes of Health (R01ES11155 and R21CA131901 to DFS; R01HL062996 and U19A1070448 to JBT) and VA Merit Award (JBT).	Chuang TY, 2005, BRIT J DERMATOL, V153, P552, DOI 10.1111/j.1365-2133.2005.06738.x; Cotton J, 1997, RADIAT RES, V147, P148, DOI 10.2307/3579415; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donovan EA, 2008, CRIT REV ONCOL HEMAT, V66, P91, DOI 10.1016/j.critrevonc.2007.09.003; Dziadziuszko R, 2008, J THORAC ONCOL, V3, P815, DOI 10.1097/JTO.0b013e31818180f5; FERBER A, 1993, J BIOL CHEM, V268, P17883; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; Lann D, 2008, J MAMMARY GLAND BIOL, V13, P371, DOI 10.1007/s10911-008-9100-x; Lewis DA, 2003, EXP CELL RES, V284, P316, DOI 10.1016/S0014-4827(02)00043-5; Lewis DA, 2003, J INVEST DERMATOL, V120, P483, DOI 10.1046/j.1523-1747.2003.12060.x; LEWIS DA, 2007, J INVEST DERMATOL, V128, P1022; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lewis DA, 2009, J INVEST DERMATOL, V129, P787, DOI 10.1038/jid.2008.293; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; TAVAKKOL A, 1992, J INVEST DERMATOL, V99, P343, DOI 10.1111/1523-1747.ep12616668; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928	20	91	94	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1475	1485		10.1038/onc.2009.440	http://dx.doi.org/10.1038/onc.2009.440			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19966862	Green Accepted			2022-12-25	WOS:000275392400006
J	Chung, CW; Zhang, QL; Qiao, LY				Chung, Chul-Won; Zhang, Qing L.; Qiao, Li-Ya			Endogenous Nerve Growth Factor Regulates Collagen Expression and Bladder Hypertrophy through Akt and MAPK Pathways during Cystitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; NEUROTROPHIC FACTOR; URINARY-BLADDER; HEMORRHAGIC CYSTITIS; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; UP-REGULATION; SUBSTANCE-P; C-JUN; ACTIVATION	Type I collagen forms the main constituent of the extracellular matrix in visceral organs. We reported here that cyclophosphamide (CYP)-induced cystitis significantly increased the production of type I collagen in the inflamed bladder leading to increases in the bladder weight and the thickness of the bladder wall. The endogenous nerve growth factor (NGF) in the urinary bladder regulated type I collagen expression because the neutralizing NGF antibody attenuated cystitis-induced type I collagen up-regulation in the inflamed bladder. Neutralizing NGF antibody also subsequently reversed cystitis-induced increases in bladder weight. Further studies on the intermediate signaling pathways mediating NGF-induced type I collagen expression in the inflamed bladder during cystitis revealed that Akt, JNK, and ERK1/2 activities were increased in the inflamed bladder, whereas p38 MAPK remained unchanged. Suppression of endogenous NGF level with neutralizing NGF antibody significantly blocked the increased activity of Akt, JNK, and ERK1/2 in the inflamed bladder during cystitis. These results indicate that endogenous NGF plays an important role in the activation of Akt and MAPK in the urinary bladder and in bladder hypertrophy during cystitis.	[Chung, Chul-Won; Zhang, Qing L.; Qiao, Li-Ya] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Virginia Commonwealth University	Qiao, LY (corresponding author), MMRB 5038,Box 980551, Richmond, VA 23298 USA.	lqiao2@vcu.edu			National Institutes of Health [DK077917]; Interstitial Cystitis Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interstitial Cystitis Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK077917 (to L.-Y.Q.). This work was also supported by a grant from the Interstitial Cystitis Association (to L.-Y.Q.).	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Batler RA, 2002, J UROLOGY, V168, P819, DOI 10.1016/S0022-5347(05)64750-7; Chen MW, 1995, WORLD J UROL, V13, P344; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; DEVRIES CR, 1990, J UROLOGY, V143, P1; DONNERER J, 1992, ANN NY ACAD SCI, V657, P505, DOI 10.1111/j.1749-6632.1992.tb22814.x; DONNERER J, 1992, NEUROSCIENCE, V49, P693, DOI 10.1016/0306-4522(92)90237-V; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; FLEISCHMAJER R, 1990, ANN NY ACAD SCI, V580, P161, DOI 10.1111/j.1749-6632.1990.tb17927.x; GABELLA G, 1990, ANAT EMBRYOL, V182, P409; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; GOMES TNA, 1995, BRAZ J MED BIOL RES, V28, P1103; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Howard PS, 2005, UROLOGY, V66, P1349, DOI 10.1016/j.urology.2005.06.124; Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Klinger MB, 2008, AM J PHYSIOL-RENAL, V295, pF1778, DOI 10.1152/ajprenal.90501.2008; Lee Sang Don, 2006, J Pediatr Urol, V2, P225, DOI 10.1016/j.jpurol.2006.03.011; LEVINE LA, 1989, J UROLOGY, V141, P1063, DOI 10.1016/S0022-5347(17)41173-6; Li FF, 2009, BIOCHEM BIOPH RES CO, V386, P289, DOI 10.1016/j.bbrc.2009.05.084; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; Lutz M, 2004, EUR J BIOCHEM, V271, P920, DOI 10.1111/j.1432-1033.2004.03994.x; Madduri S, 2009, NEUROSCI RES, V65, P88, DOI 10.1016/j.neures.2009.06.003; Majumdar P, 2009, DIABETES-METAB RES, V25, P452, DOI 10.1002/dmrr.964; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Murray E, 2004, J UROLOGY, V172, P2434, DOI 10.1097/01.ju.0000143549.29867.4e; Nazif O, 2007, UROLOGY, V69, P24, DOI 10.1016/j.urology.2006.08.1108; Oddiah D, 1998, NEUROREPORT, V9, P1455, DOI 10.1097/00001756-199805110-00038; Oka M, 2009, J UROLOGY, V182, P382, DOI 10.1016/j.juro.2009.02.104; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Papakrivopoulou J, 2004, CARDIOVASC RES, V61, P736, DOI 10.1016/j.cardiores.2003.12.018; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; Qiao LY, 2007, AM J PHYSIOL-REG I, V292, pR1368, DOI 10.1152/ajpregu.00570.2006; Reunanen N, 2000, J BIOL CHEM, V275, P34634, DOI 10.1074/jbc.C000175200; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Roza C, 2001, PAIN, V93, P213, DOI 10.1016/S0304-3959(01)00318-9; Saini Rajiv, 2008, Curr Urol Rep, V9, P314, DOI 10.1007/s11934-008-0054-8; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Skaper SD, 2001, MOL BRAIN RES, V97, P177, DOI 10.1016/S0169-328X(01)00314-X; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Stanzel RDP, 2008, EXP NEUROL, V211, P203, DOI 10.1016/j.expneurol.2008.01.028; STILLWELL TJ, 1988, CANCER, V61, P451, DOI 10.1002/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Tekgul S, 1996, J UROLOGY, V156, P582, DOI 10.1016/S0022-5347(01)65757-4; Theiss AL, 2004, INFLAMM BOWEL DIS, V10, P871, DOI 10.1097/00054725-200411000-00021; Tonra JR, 1998, J NEUROSCI, V18, P4374; TUTTLE JB, 1994, J AUTONOM NERV SYST, V49, P147, DOI 10.1016/0165-1838(94)90134-1; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; WU BY, 1989, J BIOL CHEM, V264, P9000; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731	57	33	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4206	4212		10.1074/jbc.M109.040444	http://dx.doi.org/10.1074/jbc.M109.040444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996110	Green Published, hybrid			2022-12-25	WOS:000275254000072
J	Xu, H; Dhanasekaran, DN; Lee, CM; Reddy, EP				Xu, Hua; Dhanasekaran, Danny N.; Lee, Clement M.; Reddy, E. Premkumar			Regulation of Neurite Outgrowth by Interactions between the Scaffolding Protein, JNK-associated Leucine Zipper Protein, and Neuronal Growth-associated Protein Superior Cervical Ganglia Clone 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCG10 MESSENGER-RNA; MICROTUBULE DYNAMICS; MAP-KINASE; STATHMIN; FAMILY; DIFFERENTIATION; LOCALIZATION; INDUCTION; MODULES; JLP	JLP (JNK-associated leucine zipper protein) is a novel scaffolding protein involved in JNK signaling. Although it is known that JLP is highly expressed in brain, the biological function of JLP in neuronal systems remains unknown. Here, we report a novel interaction between JLP and SCG10 (superior cervical ganglia clone 10), which is a microtubule-destabilizing factor that is essential for neurite outgrowth. Inhibition of endogenous JLP expression using small interference RNA methodology strongly enhanced nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Our results show that JLP negatively regulates NGF-induced neurite outgrowth by decreasing the level of phosphorylated SCG10. Furthermore, inhibition of JNK phosphorylation by a small molecule inhibitor, SP600125, resulted in inhibition of SCG10 phosphorylation and inhibition of neurite growth. Taken together, our results suggest that JLP negatively regulates NGF-induced neurite outgrowth through a sequestering mechanism that results in an attenuation of NGF-induced SCG10 phosphorylation.	[Xu, Hua; Dhanasekaran, Danny N.; Lee, Clement M.; Reddy, E. Premkumar] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lee, CM (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, 3307 N Broad St, Philadelphia, PA 19140 USA.	clement@temple.edu; reddy@temple.edu	Lee, Clement M./E-7104-2012; Reddy, E. Premkumar/F-6233-2011	Lee, Clement M./0000-0003-3486-8492; 	NATIONAL CANCER INSTITUTE [R01CA123233] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA123233-02, R01 CA123233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; Gantulga D, 2008, J BIOCHEM, V144, P693, DOI 10.1093/jb/mvn123; Gelderblom M, 2004, INT J DEV NEUROSCI, V22, P559, DOI 10.1016/j.ijdevneu.2004.07.014; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Hannan AJ, 1996, NEUROSCIENCE, V72, P889, DOI 10.1016/0306-4522(95)00593-5; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Mori N, 2002, J NEUROSCI RES, V70, P264, DOI 10.1002/jnr.10353; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Ozon S, 1998, J NEUROCHEM, V70, P2386; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828	22	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3548	3553		10.1074/jbc.M109.064113	http://dx.doi.org/10.1074/jbc.M109.064113			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959466	Green Published, hybrid			2022-12-25	WOS:000275254000004
J	Zhang, YQ; Yin, LY; Anderson, J; Ma, HY; Gonzalez, FJ; Willson, TM; Edwards, PA				Zhang, Yanqiao; Yin, Liya; Anderson, Jody; Ma, Huiyan; Gonzalez, Frank J.; Willson, Timothy M.; Edwards, Peter A.			Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE CHOLESTEROL TRANSPORT; HIGH-DENSITY-LIPOPROTEIN; ORPHAN NUCLEAR RECEPTOR; N-TERMINAL KINASE; BILE-ACIDS; SR-BI; IN-VIVO; ESSENTIAL REGULATOR; LIPID HOMEOSTASIS; GENE-EXPRESSION	Farnesoid X receptor (FXR) plays important regulatory roles in bile acid, lipoprotein, and glucose homeostasis. Here, we have utilized Fxr(-/-) mice and mice deficient in scavenger receptor class B type I (SR-BI), together with an FXR-specific agonist and adenovirus expressing hepatocyte nuclear factor 4 alpha or constitutively active FXR, to identify the mechanisms by which activation of FXR results in hypocholesterolemia. We identify a novel pathway linking FXR to changes in hepatic p-JNK, hepatocyte nuclear factor 4 alpha, and finally SR-BI. Importantly, we demonstrate that the FXR-dependent increase in SR-BI results in both hypocholesterolemia and an increase in reverse cholesterol transport, a process involving the transport of cholesterol from peripheral macrophages to the liver for excretion into the feces. In addition, we demonstrate that FXR activation also induces an SR-BI-independent increase in reverse cholesterol transport and reduces intestinal cholesterol absorption. Together, these data indicate that FXR is a promising therapeutic target for treatment of hypercholesterolemia and coronary heart disease.	[Zhang, Yanqiao] Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Anderson, Jody; Edwards, Peter A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Edwards, Peter A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Edwards, Peter A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Willson, Timothy M.] GlaxoSmithKline Inc, Discovery Med Chem, Res Triangle Pk, NC 27709 USA	Northeast Ohio Medical University (NEOMED); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); GlaxoSmithKline	Zhang, YQ (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, 4209 State Route 44, Rootstown, OH 44272 USA.	yzhang@neoucom.edu	feinstein, doug/M-9414-2019		National Institutes of Health [HL30568, HL68445]; American Heart Association Beginning [0565173Y]; Scientist Development [0830255N]; Laubisch Fund; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL068445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Beginning(American Heart Association); Scientist Development; Laubisch Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by National Institutes of Health Grants HL30568 and HL68445 (to P. A. E.). This work was also supported by American Heart Association Beginning Grant-in-aid 0565173Y (to Y. Z.), Scientist Development Grant 0830255N (to Y. Z.), and a grant from the Laubisch Fund (to Y. Z.).	Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calpe-Berdiel L, 2008, J LIPID RES, V49, P1904, DOI 10.1194/jlr.M700470-JLR200; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Drewes T, 1996, MOL CELL BIOL, V16, P925; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hubbert ML, 2007, MOL ENDOCRINOL, V21, P1359, DOI 10.1210/me.2007-0089; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Jiang Shuying, 2003, Nucl Recept, V1, P5, DOI 10.1186/1478-1336-1-5; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee H, 2006, J LIPID RES, V47, P201, DOI 10.1194/jlr.M500417-JLR200; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004; TURLEY SD, 1994, J LIPID RES, V35, P328; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	51	81	84	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3035	10.1074/jbc.M109.083899	http://dx.doi.org/10.1074/jbc.M109.083899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996107	Green Published, hybrid			2022-12-25	WOS:000273829000019
J	Vincent, AL; Lager, KM; Harland, M; Lorusso, A; Zanella, E; Ciacci-Zanella, JR; Kehrli, ME; Klimov, A				Vincent, Amy L.; Lager, Kelly M.; Harland, Michelle; Lorusso, Alessio; Zanella, Eraldo; Ciacci-Zanella, Janice R.; Kehrli, Marcus E., Jr.; Klimov, Alexander			Absence of 2009 Pandemic H1N1 Influenza A Virus in Fresh Pork	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; SWINE; PIGS; PATHOGENICITY; PATHOGENESIS	The emergence of the pandemic 2009 H1N1 influenza A virus in humans and subsequent discovery that it was of swine influenza virus lineages raised concern over the safety of pork. Pigs experimentally infected with pandemic 2009 H1N1 influenza A virus developed respiratory disease; however, there was no evidence for systemic disease to suggest that pork from pigs infected with H1N1 influenza would contain infectious virus. These findings support the WHO recommendation that pork harvested from pandemic influenza A H1N1 infected swine is safe to consume when following standard meat hygiene practices.	[Vincent, Amy L.; Lager, Kelly M.; Harland, Michelle; Lorusso, Alessio; Zanella, Eraldo; Ciacci-Zanella, Janice R.; Kehrli, Marcus E., Jr.] ARS, Virus & Pr Dis Res Unit, Natl Anim Dis Ctr, USDA, Iowa City, IA USA; [Zanella, Eraldo] Univ Passo Fundo, Passo Fundo, RS, Brazil; [Ciacci-Zanella, Janice R.] EMBRAPA Brazilian Agr Res Corp, Labex USA, Brasilia, DF, Brazil; [Klimov, Alexander] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	United States Department of Agriculture (USDA); Universidade de Passo Fundo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Centers for Disease Control & Prevention - USA	Vincent, AL (corresponding author), ARS, Virus & Pr Dis Res Unit, Natl Anim Dis Ctr, USDA, Iowa City, IA USA.	amy.vincent@ars.usda.gov	Lorusso, Alessio/A-7311-2016; zanella, janice/AAV-9729-2020; Zanella, Janice R/C-3632-2014	Lorusso, Alessio/0000-0001-6156-8212; zanella, janice/0000-0002-6259-6028; Kehrli, Marcus/0000-0003-4850-5211	USDA-ARS; DHHS-CDC	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); DHHS-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by USDA-ARS and DHHS-CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes SM, 2009, VET REC, V164, P760, DOI 10.1136/vr.164.24.760; BROWN IH, 1993, VET REC, V132, P598, DOI 10.1136/vr.132.24.598; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lipatov AS, 2009, J INFECT DIS, V199, P717, DOI 10.1086/596740; ROMIJN PC, 1989, VET REC, V124, P224, DOI 10.1136/vr.124.9.224; Swayne DE, 2005, AVIAN DIS, V49, P81, DOI 10.1637/7260-081104R; Vincent AL, 2009, VET MICROBIOL, V137, P51, DOI 10.1016/j.vetmic.2009.01.003; Weingartl HM, 2009, J VIROL, V83, P4287, DOI 10.1128/JVI.02399-08	9	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8367	10.1371/journal.pone.0008367	http://dx.doi.org/10.1371/journal.pone.0008367			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020048	gold, Green Published			2022-12-25	WOS:000272870600008
J	Cornman, RS				Cornman, R. Scott			Molecular Evolution of Drosophila Cuticular Protein Genes	PLOS ONE			English	Article							CIS-REGULATORY SEQUENCES; ANOPHELES-GAMBIAE; CUTICLE GENE; R CONSENSUS; DEVELOPMENTAL EXPRESSION; CONCERTED EVOLUTION; FAMILY EVOLUTION; PUPAL CUTICLE; GENOMIC DNA; MELANOGASTER	Several multigene families have been described that together encode scores of structural cuticular proteins in Drosophila, although the functional significance of this diversity remains to be explored. Here I investigate the evolutionary histories of several multigene families (CPR, Tweedle, CPLCG, and CPF/CPFL) that vary in age, size, and sequence complexity, using sequenced Drosophila genomes and mosquito outgroups. My objective is to describe the rates and mechanisms of 'cuticleome' divergence, in order to identify conserved and rapidly evolving elements. I also investigate potential examples of interlocus gene conversion and concerted evolution within these families during Drosophila evolution. The absolute rate of change in gene number (per million years) is an order of magnitude lower for cuticular protein families within Drosophila than it is among Drosophila and the two mosquito taxa, implying that major transitions in the cuticle proteome have occurred at higher taxonomic levels. Several hotspots of intergenic conversion and/or gene turnover were identified, e. g. some gene pairs have independently undergone intergenic conversion within different lineages. Some gene conversion hotspots were characterized by conversion tracts initiating near nucleotide repeats within coding regions, and similar repeats were found within concertedly evolving cuticular protein genes in Anopheles gambiae. Rates of amino-acid substitution were generally several fold higher along the branch connecting the Sophophora and Drosophila species groups, and 13 genes have Ka/Ks significantly greater than one along this branch, indicating adaptive divergence. Insect cuticular proteins appear to be a source of adaptive evolution within genera and, at higher taxonomic levels, subject to periods of gene-family expansion and contraction followed by quiescence. However, this relative stasis is belied by hotspots of molecular evolution, particularly concerted evolution, during the diversification of Drosophila. The prominent association between interlocus gene conversion and repeats within the coding sequence of interacting genes suggests that the latter promote strand exchange.	[Cornman, R. Scott] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Cornman, RS (corresponding author), Agr Res Serv, Bee Res Lab, USDA, Beltsville, MD USA.	scott.cornman@gmail.com			National Institutes of Health (NIH) [A155624]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author was supported during the initiation of this work by National Institutes of Health (NIH) grant A155624 to Judith H. Willis, Department of Cellular Biology, University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remainder of the work was completed with no outside funding.	Andersen SO, 1997, INSECT BIOCHEM MOLEC, V27, P121, DOI 10.1016/S0965-1748(96)00076-8; APPLE RT, 1991, DEV BIOL, V146, P569, DOI 10.1016/0012-1606(91)90257-4; AWOLOLA TS, 2008, T R SOC TROP MED HYG; Benedict M.Q., 1993, Insect Molecular Biology, V2, P93, DOI 10.1111/j.1365-2583.1993.tb00130.x; Benedict MQ, 1996, INSECT MOL BIOL, V5, P73, DOI 10.1111/j.1365-2583.1996.tb00042.x; Bettencourt BR, 2002, J MOL EVOL, V54, P569, DOI 10.1007/s00239-001-0044-7; Bruey-Sedano N, 2005, GENESIS, V43, P17, DOI 10.1002/gene.20150; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Charles JP, 1997, GENETICS, V147, P1213; Charles JP, 1998, INSECT BIOCHEM MOLEC, V28, P131, DOI 10.1016/S0965-1748(97)00107-0; CHIHARA CJ, 1982, DEV BIOL, V89, P379, DOI 10.1016/0012-1606(82)90326-8; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Claycomb JM, 2005, TRENDS GENET, V21, P149, DOI 10.1016/j.tig.2005.01.009; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Cui HY, 2009, INSECT MOL BIOL, V18, P421, DOI 10.1111/j.1365-2583.2009.00889.x; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hastings PJ, 2007, CRIT REV BIOCHEM MOL, V42, P271, DOI 10.1080/10409230701507757; Janssens H, 1999, DEV BIOL, V207, P204, DOI 10.1006/dbio.1998.9170; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; KOMORI N, 1992, J CELL SCI, V102, P191; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krzywinski J, 2001, SYST BIOL, V50, P540, DOI 10.1080/106351501750435095; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lestradet M, 2009, INSECT MOL BIOL, V18, P431, DOI 10.1111/j.1365-2583.2009.00893.x; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Neville A.C., 1975, BIOL ARTHROPOD CUTIC; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Steinemann M, 1996, J MOL EVOL, V43, P413; Togawa T, 2004, INSECT BIOCHEM MOLEC, V34, P1059, DOI 10.1016/j.ibmb.2004.06.008; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; WHITE BJ, 2009, GENETICS; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888	49	36	40	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8345	10.1371/journal.pone.0008345	http://dx.doi.org/10.1371/journal.pone.0008345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019874	gold, Green Published, Green Submitted			2022-12-25	WOS:000272834200012
J	Diestra, E; Cayrol, B; Arluison, V; Risco, C				Diestra, Elia; Cayrol, Bastien; Arluison, Veronique; Risco, Cristina			Cellular Electron Microscopy Imaging Reveals the Localization of the Hfq Protein Close to the Bacterial Membrane	PLOS ONE			English	Article							SMALL RNA REGULATORS; ESCHERICHIA-COLI; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; BUNYAMWERA-VIRUS; OUTER-MEMBRANE; ROLES; METALLOTHIONEIN; ORGANIZATION; ARCHITECTURE	Background: Hfq is a bacterial protein involved in several aspects of nucleic acid transactions, but one of its best-characterized functions is to affect the post-transcriptional regulation of mRNA by virtue of its interactions with stress-related small regulatory (sRNA). Methodology and Principal Finding: By using cellular imaging based on the metallothionein clonable tag for electron microscopy, we demonstrate here that in addition to its localization in the cytoplasm and in the nucleoid, a significant amount of Hfq protein is located at the cell periphery. Simultaneous immunogold detection of specific markers strongly suggests that peripheral Hfq is close to the bacterial membrane. Because sRNAs regulate the synthesis of several membrane proteins, our result implies that the sRNA- and Hfq-dependent translational regulation of these proteins takes place in the cytoplasmic region underlying the membrane. Conclusions: This finding supports the proposal that RNA processing and translational machineries dedicated to membrane protein translation may often be located in close proximity to the membrane of the bacterial cell.	[Diestra, Elia; Risco, Cristina] CSIC, Cell Struct Lab, Ctr Nacl Biotecnol, Madrid, Spain; [Cayrol, Bastien; Arluison, Veronique] CNRS Paris 6, FRE 3132, Lab Jean Perrin, Paris, France; [Cayrol, Bastien; Arluison, Veronique] CEA Saclay, CNRS UMR 12, Commissariat Energie Atom, Lab Leon Brillouin, F-91191 Gif Sur Yvette, France; [Arluison, Veronique] Univ Paris Diderot, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Diestra, E (corresponding author), CSIC, Cell Struct Lab, Ctr Nacl Biotecnol, Madrid, Spain.	Veronique.Arluison@univ-paris-diderot.fr; crisco@cnb.csic.es	Risco, Cristina/K-4308-2014; Arluison, Veronique S/F-2714-2019	Risco, Cristina/0000-0001-7501-5934; Arluison, Veronique S/0000-0003-4056-7282	Consejo Superior de Investigaciones Cientificas (CSIC) [PIF06-004/200620F0024]; Ministry of Science and Innovation of Spain [BFU2006-04584/BMC]; University Paris Diderot; CNRS; JAE-CSIC of spain	Consejo Superior de Investigaciones Cientificas (CSIC); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University Paris Diderot; CNRS(Centre National de la Recherche Scientifique (CNRS)); JAE-CSIC of spain	This work was supported by grants PIF06-004/200620F0024 from the Consejo Superior de Investigaciones Cientificas (CSIC) and BFU2006-04584/BMC from the Ministry of Science and Innovation of Spain (to C.R.) and University Paris Diderot and CNRS (to V.A.). E.D. is funded by the JAE-CSIC program of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arluison V, 2002, J MOL BIOL, V320, P705, DOI 10.1016/S0022-2836(02)00548-X; Arluison W, 2006, J MOL BIOL, V356, P86, DOI 10.1016/j.jmb.2005.11.010; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; CASTLEMAN H, 1980, NUCLEIC ACIDS RES, V8, P4485, DOI 10.1093/nar/8.19.4485; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Fontana J, 2007, CELL MICROBIOL, V9, P875, DOI 10.1111/j.1462-5822.2006.00837.x; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jasiecki J, 2005, BIOCHEM BIOPH RES CO, V329, P598, DOI 10.1016/j.bbrc.2005.02.025; Johansen J., 2006, J MOL BIOL; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; Kawamoto H, 2005, GENE DEV, V19, P328, DOI 10.1101/gad.1270605; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497; Mercogliano CP, 2007, J STRUCT BIOL, V160, P70, DOI 10.1016/j.jsb.2007.06.010; Mercogliano CP, 2006, J MOL BIOL, V355, P211, DOI 10.1016/j.jmb.2005.10.026; MICZAK A, 1991, MOL MICROBIOL, V5, P1801, DOI 10.1111/j.1365-2958.1991.tb01929.x; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Perrin C, 2009, APPL ENVIRON MICROB, V75, P1723, DOI 10.1128/AEM.02171-08; PUVIONDUTILLEUL F, 1987, J HISTOCHEM CYTOCHEM, V35, P635, DOI 10.1177/35.6.3033063; PUVIONDUTILLEUL F, 1998, IN SITU HYBRIDIZATIO, P127; Quintana C, 1998, MICRON, V29, P297, DOI 10.1016/S0968-4328(98)00011-0; Quintana C, 2001, MICROSC RES TECHNIQ, V53, P147, DOI 10.1002/jemt.1079; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; Taghbalout A, 2008, J BIOL CHEM, V283, P13850, DOI 10.1074/jbc.M709118200; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Zambrano N, 2009, CELL CYCLE, V8, P2470, DOI 10.4161/cc.8.15.9090; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	50	64	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8301	10.1371/journal.pone.0008301	http://dx.doi.org/10.1371/journal.pone.0008301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011543	Green Published, Green Submitted, gold			2022-12-25	WOS:000272830300048
J	Kayukawa, T; Ishikawa, Y				Kayukawa, Takumi; Ishikawa, Yukio			Chaperonin Contributes to Cold Hardiness of the Onion Maggot Delia antiqua through Repression of Depolymerization of Actin at Low Temperatures	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; T-COMPLEX POLYPEPTIDE-1; SINUSOIDAL ENDOTHELIAL-CELLS; IN-VIVO; FOLDING MACHINE; WINTER DIAPAUSE; THERMAL-STRESS; UP-REGULATION; EXPRESSION; CCT	Winter-diapause and cold-acclimated non-diapause pupae of the onion maggot, Delia antiqua (Diptera: Anthomyiidae), show strong cold hardiness. To obtain insights into the mechanisms involved in the enhancement of cold hardiness, we investigated the expression patterns of genes encoding subunits of chaperonin (CCT) and the morphology of actin, a substrate of CCT, at low temperatures. Quantitative real-time PCR analyses showed the mRNA levels of CCT subunits in pupal tissues to be highly correlated with the cold hardiness of the pupae. While actin in the Malpighian tubules of non-cold-hardy pupae showed extensive depolymerization after a cold treatment, actin in the same tissue of cold-hardy pupae was not depolymerized. Damage to cell membranes became apparent after the depolymerization of actin. Moreover, administration of Latrunculin B, an inhibitor of actin polymerization, to the larvae markedly decreased the cold hardiness of the pupae obtained. These findings suggest that CCT contributes to the cold hardiness of D. antiqua through the repression of depolymerization of actin at low temperatures.	[Kayukawa, Takumi; Ishikawa, Yukio] Univ Tokyo, Appl Entomol Lab, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo	Kayukawa, T (corresponding author), Natl Inst Agrobiol Sci, Ibaraki, Japan.	ayucky@mail.ecc.u-tokyo.ac.jp	Ishikawa, Yukio/J-5676-2019	Ishikawa, Yukio/0000-0003-3067-2513	Japan Society for the Promotion of Science [18-10873]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in- Aid for Young Scientists (No. 18-10873) to TK from the Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Chen B, 2005, INSECT MOL BIOL, V14, P697, DOI 10.1111/j.1365-2583.2005.00602.x; Chen B, 2006, J BIOCHEM MOL BIOL, V39, P749; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Denholm B, 2005, DEVELOPMENT, V132, P2389, DOI 10.1242/dev.01829; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; ISHIKAWA Y, 1983, APPL ENTOMOL ZOOL, V18, P62, DOI 10.1303/aez.18.62; Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650; Kayukawa T, 2005, CELL STRESS CHAPERON, V10, P204, DOI 10.1379/CSC-106R.1; Kayukawa T, 2005, APPL ENTOMOL ZOOL, V40, P193, DOI 10.1303/aez.2005.193; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; Kubota H, 1999, FEBS LETT, V461, P125, DOI 10.1016/S0014-5793(99)01437-4; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; Miyazaki S, 2006, EUR J ENTOMOL, V103, P691, DOI 10.14411/eje.2006.090; Nomura M, 2000, J INSECT PHYSIOL, V46, P373, DOI 10.1016/S0022-1910(99)00120-1; Nomura M, 2001, APPL ENTOMOL ZOOL, V36, P443, DOI 10.1303/aez.2001.443; Ouellet F, 2001, PLANT PHYSIOL, V125, P360, DOI 10.1104/pp.125.1.360; Palmedo G, 1997, EUR J BIOCHEM, V247, P877, DOI 10.1111/j.1432-1033.1997.00877.x; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pokorna J, 2004, PLANT CELL ENVIRON, V27, P641, DOI 10.1111/j.1365-3040.2004.01186.x; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Somer L, 2002, CELL STRESS CHAPERON, V7, P47, DOI 10.1379/1466-1268(2002)007<0047:TECCIA>2.0.CO;2; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Taguchi H, 2005, J BIOCHEM, V137, P543, DOI 10.1093/jb/mvi069; Upadhya GA, 2003, HEPATOLOGY, V37, P313, DOI 10.1053/jhep.2003.50069; Upadhya GA, 1999, HEPATOLOGY, V30, P169, DOI 10.1002/hep.510300130; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0	43	33	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8277	10.1371/journal.pone.0008277	http://dx.doi.org/10.1371/journal.pone.0008277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011606	gold, Green Published, Green Submitted			2022-12-25	WOS:000272830300031
J	Quillard, T; Devalliere, J; Chatelais, M; Coulon, F; Seveno, C; Romagnoli, M; Barille-Nion, S; Charreau, B				Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Seveno, Celine; Romagnoli, Mathilde; Barille-Nion, Sophie; Charreau, Beatrice			Notch2 Signaling Sensitizes Endothelial Cells to Apoptosis by Negatively Regulating the Key Protective Molecule Survivin	PLOS ONE			English	Article							ACTIVATED NOTCH4; EXPRESSION; ANGIOGENESIS; INHIBITION; REQUIRES; PROLIFERATION; NETWORKS; DEFECTS; CANCER	Background: Notch signaling pathway controls key functions in vascular and endothelial cells (ECs) where Notch4 plays a major role. However, little is known about the contribution of other Notch receptors. This study investigated regulation of Notch2 and further examined its implication in EC dysfunction. Methodology/Principal Findings: Here, we provide evidence for a novel link between Notch and TNF signaling, where Notch2 is upregulated and activated in response to TNF. Forced expression of Notch2 intracellular domain in cultured ECs promotes apoptosis and allows the significant downregulation of several cell-death-related transcripts in a dose-dependent manner. In particular, activation of Notch2 led to a rapid decrease in survivin mRNA and protein expression, while survivin upregulation was obtained by the selective knockdown of Notch2 in ECs, indicating that survivin expression is controlled at the Notch level. Moreover, Notch2 silencing and ectopic expression of survivin, but not XIAP or Bcl2, rescued ECs from TNF and Notch2-mediated apoptosis, respectively. Conclusions/Significance: In conclusion, TNF signaling activates Notch2 that sensitizes ECs to apoptosis via modulation of the key apoptosis regulator survivin. Overall, our findings also indicate that specific Notch receptors control distinct functions in vascular cells and inflammatory cytokines contribute to this specificity.	[Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Charreau, Beatrice] INSERM, UMR643, Nantes, France; [Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Charreau, Beatrice] CHU Nantes, Inst Transplantat & Rech Transplantat, ITERT, F-44035 Nantes 01, France; [Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Charreau, Beatrice] Univ Nantes, Fac Med, Nantes, France; [Seveno, Celine; Romagnoli, Mathilde; Barille-Nion, Sophie] INSERM, UMR 892, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Quillard, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.	Beatrice.Charreau@univ-nantes.fr	CHARREAU, Beatrice/AAK-8186-2020; Barille-Nion, sophie/K-8057-2015; Quillard, Thibaut/K-8150-2015; Barille-nion, sophie/W-8103-2019	CHARREAU, Beatrice/0000-0001-5870-4615; Quillard, Thibaut/0000-0002-8096-2597; Barille-nion, sophie/0000-0001-5171-9937	Xenome; European Commission [LSHB-CT-2006-037377]; La Societe Francophone de Transplantation; La Societede Nephrologie; La Fondation Progreffe; la Fondation pour la Recherche Medicale	Xenome; European Commission(European CommissionEuropean Commission Joint Research Centre); La Societe Francophone de Transplantation; La Societede Nephrologie; La Fondation Progreffe; la Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Xenome, a European Commission-funded Integrated Project, Life Sciences, Genomics and Biotechnology for Health LSHB-CT-2006-037377, and by fellowships from La Societe Francophone de Transplantation, La Societede Nephrologie and La Fondation Progreffe. Quillard T was supported by a grant from la Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2006, MOL CANCER THER, V5, P478, DOI 10.1158/1535-7163.MCT-05-0436; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bach FH, 1997, IMMUNOL TODAY, V18, P483, DOI 10.1016/S0167-5699(97)01129-8; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; Boulay JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000576; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Coupel S, 2004, J AM SOC NEPHROL, V15, P2429, DOI 10.1097/01.ASN.0000138237.42675.45; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; FITAU J, 2006, J BIOL CHEM; Florena AM, 2007, PATHOBIOLOGY, V74, P317, DOI 10.1159/000110024; Gridley T, 2007, NATURE, V445, P722, DOI 10.1038/445722a; Hubmann R, 2002, BLOOD, V99, P3742, DOI 10.1182/blood.V99.10.3742; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kirkiles-Smith NC, 2004, J IMMUNOL, V172, P1391, DOI 10.4049/jimmunol.172.3.1391; Krebs LT, 2000, GENE DEV, V14, P1343; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKenzie F, 2004, BLOOD, V104, P1760, DOI 10.1182/blood-2003-12-4244; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Parr C, 2004, INT J MOL MED, V14, P779; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Romagnoli M, 2007, LEUKEMIA, V21, P1070, DOI 10.1038/sj.leu.2404602; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Shawber C, 1996, DEVELOPMENT, V122, P3765; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang GJ, 2005, ARTERIOSCL THROM VAS, V25, P2081, DOI 10.1161/01.ATV.0000183885.66153.8a; Witt CM, 2003, MOL CELL BIOL, V23, P8637, DOI 10.1128/MCB.23.23.8637-8650.2003; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	43	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8244	10.1371/journal.pone.0008244	http://dx.doi.org/10.1371/journal.pone.0008244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011512	Green Submitted, Green Published, gold			2022-12-25	WOS:000272830200003
J	April, C; Klotzle, B; Royce, T; Wickham-Garcia, E; Boyaniwsky, T; Izzo, J; Cox, D; Jones, W; Rubio, R; Holton, K; Matulonis, U; Quackenbush, J; Fan, JB				April, Craig; Klotzle, Brandy; Royce, Thomas; Wickham-Garcia, Eliza; Boyaniwsky, Tanya; Izzo, John; Cox, Donald; Jones, Wendell; Rubio, Renee; Holton, Kristina; Matulonis, Ursula; Quackenbush, John; Fan, Jian-Bing			Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; MICROARRAY ANALYSIS; RNA EXTRACTION; FROZEN TISSUE; SIGNATURES; ASSAY; OLIGONUCLEOTIDE; AMPLIFICATION; OPTIMIZATION	Background: We have developed a gene expression assay (Whole-Genome DASLH), capable of generating whole-genome gene expression profiles from degraded samples such as formalin-fixed, paraffin-embedded (FFPE) specimens. Methodology/Principal Findings: We demonstrated a similar level of sensitivity in gene detection between matched fresh-frozen (FF) and FFPE samples, with the number and overlap of probes detected in the FFPE samples being approximately 88% and 95% of that in the corresponding FF samples, respectively; 74% of the differentially expressed probes overlapped between the FF and FFPE pairs. The WG-DASL assay is also able to detect 1.3-1.5 and 1.5-2-fold changes in intact and FFPE samples, respectively. The dynamic range for the assay is,3 logs. Comparing the WG-DASL assay with an in vitro transcription-based labeling method yielded fold-change correlations of R 2,0.83, while fold-change comparisons with quantitative RT-PCR assays yielded R(2)similar to 0.86 and R(2)similar to 0.55 for intact and FFPE samples, respectively. Additionally, the WG-DASL assay yielded high self-correlations (R(2)> 0.98) with low intact RNA inputs ranging from 1 ng to 100 ng; reproducible expression profiles were also obtained with 250 pg total RNA (R(2)> 0.92), with,71% of the probes detected in 100 ng total RNA also detected at the 250 pg level. When FFPE samples were assayed, 1 ng total RNA yielded self-correlations of R(2)similar to 0.80, while still maintaining a correlation of R(2)similar to 0.75 with standard FFPE inputs (200 ng). Conclusions/Significance: Taken together, these results show that WG-DASL assay provides a reliable platform for genome-wide expression profiling in archived materials. It also possesses utility within clinical settings where only limited quantities of samples may be available (e.g. microdissected material) or when minimally invasive procedures are performed (e.g. biopsied specimens).	[April, Craig; Klotzle, Brandy; Royce, Thomas; Wickham-Garcia, Eliza; Boyaniwsky, Tanya; Izzo, John; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA; [Cox, Donald; Jones, Wendell] Express Anal Inc, Durham, NC USA; [Rubio, Renee; Holton, Kristina; Quackenbush, John] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Matulonis, Ursula] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Illumina; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	April, C (corresponding author), Illumina Inc, San Diego, CA USA.	jfan@illumina.com	Jones, Wendell/AAM-4831-2021	Quackenbush, John/0000-0002-2702-5879; Jones, Wendell/0000-0002-9676-5387	Madeline Franchi Ovarian Cancer Research Fund; Claudia Adams Barr Program; US National Cancer Institute [P50 CA105009]; NATIONAL CANCER INSTITUTE [P50CA105009] Funding Source: NIH RePORTER	Madeline Franchi Ovarian Cancer Research Fund; Claudia Adams Barr Program; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Madeline Franchi Ovarian Cancer Research Fund, the Claudia Adams Barr Program, and a grant from the US National Cancer Institute (P50 CA105009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; Bibikova M, 2004, CLIN CHEM, V50, P2384, DOI 10.1373/clinchem.2004.037432; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bouchie A, 2004, NAT BIOTECHNOL, V22, P1071, DOI 10.1038/nbt0904-1071; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fedorowicz G, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-23; Haller AC, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-9; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Karsten SL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e4; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lassmann S, 2009, J MOL MED, V87, P211, DOI 10.1007/s00109-008-0419-y; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Li HR, 2006, CANCER RES, V66, P4079, DOI 10.1158/0008-5472.CAN-05-4264; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Paik S, 2006, CLIN CANCER RES, V12, p1019S, DOI 10.1158/1078-0432.CCR-05-2296; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529; Ramaswamy S, 2004, NEW ENGL J MED, V350, P1814, DOI 10.1056/NEJMp048059; Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11; Ribeiro-Silva A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-118; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	37	95	100	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8162	10.1371/journal.pone.0008162	http://dx.doi.org/10.1371/journal.pone.0008162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997620	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829000013
J	Madison, G				Madison, Guy			An Auditory Illusion of Infinite Tempo Change Based on Multiple Temporal Levels	PLOS ONE			English	Article							PHASE CORRECTION; SYNCHRONIZATION; PERFORMANCE; INTEGRATION; VOLUNTARY; FIREFLIES; LIMITS	Humans and a few select insect and reptile species synchronise inter-individual behaviour without any time lag by predicting the time of future events rather than reacting to them. This is evident in music performance, dance, and drill. Although repetition of equal time intervals (i.e. isochrony) is the central principle for such prediction, this simple information is used in a flexible and complex way that accommodates both multiples, subdivisions, and gradual changes of intervals. The scope of this flexibility remains largely uncharted, and the underlying mechanisms are a matter for speculation. Here I report an auditory illusion that highlights some aspects of this behaviour and that provides a powerful tool for its future study. A sound pattern is described that affords multiple alternative and concurrent rates of recurrence (temporal levels). An algorithm that systematically controls time intervals and the relative loudness among these levels creates an illusion that the perceived rate speeds up or slows down infinitely. Human participants synchronised hand movements with their perceived rate of events, and exhibited a change in their movement rate that was several times larger than the physical change in the sound pattern. The illusion demonstrates the duality between the external signal and the internal predictive process, such that people's tendency to follow their own subjective pulse overrides the overall properties of the stimulus pattern. Furthermore, accurate synchronisation with sounds separated by more than 8 s demonstrate that multiple temporal levels are employed for facilitating temporal organisation and integration by the human brain. A number of applications of the illusion and the stimulus pattern are suggested.	Umea Univ, Dept Psychol, S-90187 Umea, Sweden	Umea University	Madison, G (corresponding author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.	Guy.Madison@psy.umu.se	Madison, Guy/I-6152-2019	Madison, Guy/0000-0001-5366-1169	The Bank of Sweden Tercentenary Foundation [P2002:0791]	The Bank of Sweden Tercentenary Foundation	Part of this research was supported by The Bank of Sweden Tercentenary Foundation (http://www.rj.se/), through grant P2002:0791; Musical pulse in human timing and coordination. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attenborough D, 1995, PRIVATE LIFE PLANTS; Bolton T.L., 1894, AM J PSYCHOL, V6, P145, DOI [10.2307/1410948, DOI 10.2307/1410948]; BUCK J, 1981, J COMP PHYSIOL, V144, P277, DOI 10.1007/BF00612559; BUCK J, 1981, J COMP PHYSIOL, V144, P287, DOI 10.1007/BF00612560; BUCK J, 1978, AM NAT, V112, P471, DOI 10.1086/283291; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; DIETZE G, 1885, PHILOS STUD, V2, P362; ERMENTROUT B, 1991, J MATH BIOL, V29, P571, DOI 10.1007/BF00164052; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; Freeman W, 2000, ORIGINS OF MUSIC, P411; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; GUTTMAN N, 1963, J ACOUST SOC AM, V35, P610, DOI 10.1121/1.1918551; HARY D, 1987, BRIT J MATH STAT PSY, V40, P109, DOI 10.1111/j.2044-8317.1987.tb00872.x; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Kauranen K, 1996, PERCEPT MOTOR SKILL, V82, P515, DOI 10.2466/pms.1996.82.2.515; KONEN CS, 2007, NAT NEUROSCI, V11, P224; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Madison G, 2005, MUSIC PERCEPT, V22, P441, DOI 10.1525/mp.2005.22.3.441; Madison G, 2004, NEUROSCI LETT, V370, P69, DOI 10.1016/j.neulet.2004.07.094; Madison G, 2002, PSYCHOL RES-PSYCH FO, V66, P201, DOI 10.1007/s00426-001-0085-y; MADISON G, 2000, P 6 INT C MUS PERC C; Madison G, 2009, EXP BRAIN RES, V193, P519, DOI 10.1007/s00221-008-1652-x; MATES J, 1994, J COGNITIVE NEUROSCI, V6, P332, DOI 10.1162/jocn.1994.6.4.332; McNeil W. H., 1995, KEEPING TOGETHER TIM; Merker B, 2000, ORIGINS OF MUSIC, P315; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Meumann Ernst., 1894, PHILOS STUDIEN, V10, P249; Miller G., 2000, MATING MIND; Mithen S., 2005, SINGING NEANDERTHALS; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Repp BH, 2002, HUM MOVEMENT SCI, V21, P1, DOI 10.1016/S0167-9457(02)00076-3; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P410, DOI 10.1037//0096-1523.28.2.410; RISSET JC, 1989, CURRENT DIRECTIONS C, P151; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Thaut MH, 1998, BIOL CYBERN, V79, P241, DOI 10.1007/s004220050474; Toiviainen P, 2003, MUSIC PERCEPT, V21, P43, DOI 10.1525/mp.2003.21.1.43; TUTTLE MD, 1982, BEHAV ECOL SOCIOBIOL, V11, P125, DOI 10.1007/BF00300101; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; 2001, COMPLETE MIDI 1 0 DE; 2007, AUDITORY ILLUSIONS W	45	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8151	10.1371/journal.pone.0008151	http://dx.doi.org/10.1371/journal.pone.0008151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MW	19997635	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829000009
J	Su, ZD; Yuan, YM; Chen, JJ; Cao, L; Zhu, YL; Gao, L; Qiu, Y; He, C				Su, Zhida; Yuan, Yimin; Chen, Jingjing; Cao, Li; Zhu, Yanling; Gao, Liang; Qiu, Yang; He, Cheng			Reactive Astrocytes in Glial Scar Attract Olfactory Ensheathing Cells Migration by Secreted TNF-alpha in Spinal Cord Lesion of Rat	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; SCHWANN-CELLS; DELAYED TRANSPLANTATION; NERVOUS-SYSTEM; CORTICOSPINAL TRACT; AXON REGENERATION; NEUROPATHIC PAIN; EPITHELIAL-CELLS; GROWTH-FACTOR	Background: After spinal cord injury (SCI), the formation of glial scar contributes to the failure of injured adult axons to regenerate past the lesion. Increasing evidence indicates that olfactory ensheathing cells (OECs) implanted into spinal cord are found to migrate into the lesion site and induce axons regeneration beyond glial scar and resumption of functions. However, little is known about the mechanisms of OECs migrating from injection site to glial scar/lesion site. Methods and Findings: In the present study, we identified a link between OECs migration and reactive astrocytes in glial scar that was mediated by the tumor necrosis factor-alpha (TNF-alpha). Initially, the Boyden chamber migration assay showed that both glial scar tissue and reactive astrocyte-conditioned medium promoted OECs migration in vitro. Reactive astrocyte-derived TNF-alpha and its type 1 receptor TNFR1 expressed on OECs were identified to be responsible for the promoting effect on OECs migration. TNF-alpha-induced OECs migration was demonstrated depending on activation of the extracellular signal-regulated kinase (ERK) signaling cascades. Furthermore, TNF-alpha secreted by reactive astrocytes in glial scar was also showed to attract OECs migration in a spinal cord hemisection injury model of rat. Conclusions: These findings showed that TNF-alpha was released by reactive astrocytes in glial scar and attracted OECs migration by interacting with TNFR1 expressed on OECs via regulation of ERK signaling. This migration-attracting effect of reactive astrocytes on OECs may suggest a mechanism for guiding OECs migration into glial scar, which is crucial for OECs-mediated axons regrowth beyond the spinal cord lesion site.	[Su, Zhida] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Key Lab Mol Neurobiol Minister Educ, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Su, ZD (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai, Peoples R China.	chenghe@smmu.edu.cn	Su, Zhida/G-6094-2015		National Natural Science Foundation [30700209, 30530240]; National Key Basic Research Program [2006CB500702]; Ministry of Science and Technology of China [2007CB947100, 2009ZX09311-001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation (30700209, 30530240), National Key Basic Research Program (2006CB500702), Ministry of Science and Technology of China (2007CB947100, 2009ZX09311-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MR, 2007, J NEUROTRAUM, V24, P1773, DOI 10.1089/neu.2007.0353; Boruch AV, 2001, GLIA, V33, P225, DOI 10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.3.CO;2-P; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Broom DC, 2004, NEUROSCIENCE, V124, P891, DOI 10.1016/j.neuroscience.2004.01.003; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cao L, 2006, GLIA, V54, P536, DOI 10.1002/glia.20403; Cervos NJ, 1991, J NEUROL SCI S, V103, pS3; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Dekaris I, 1999, J IMMUNOL, V162, P4235; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Deng C, 2006, J NEUROSCI RES, V83, P1201, DOI 10.1002/jnr.20817; Falchi M, 2001, DRUG EXP CLIN RES, V27, P97; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Graf K, 1997, FEBS LETT, V400, P119, DOI 10.1016/S0014-5793(96)01371-3; HANSEN AB, 1993, VIRCHOWS ARCH B, V63, P107, DOI 10.1007/BF02899249; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Li Y, 2005, GLIA, V52, P245, DOI 10.1002/glia.20241; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2004, EXP NEUROL, V188, P300, DOI 10.1016/j.expneurol.2004.04.021; Li Y, 1998, J NEUROSCI, V18, P10514; Li Y, 2005, J NEUROCYTOL, V34, P343, DOI 10.1007/s11068-005-8361-1; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Montesano R, 2005, J CELL SCI, V118, P3487, DOI 10.1242/jcs.02467; O'Toole DA, 2007, CELL MOL LIFE SCI, V64, P1303, DOI 10.1007/s00018-007-7106-y; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Plant GW, 2003, J NEUROTRAUM, V20, P1, DOI 10.1089/08977150360517146; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Santos-Silva A, 2007, J NEUROSCI, V27, P7154, DOI 10.1523/JNEUROSCI.1184-07.2007; Schafers M, 2003, J NEUROSCI, V23, P2517; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sippy BD, 1996, INVEST OPHTH VIS SCI, V37, P597; Son DS, 2004, ENDOCRINOLOGY, V145, P1218, DOI 10.1210/en.2003-0860; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Teare KA, 2003, NEUROREPORT, V14, P2171, DOI 10.1097/00001756-200312020-00008; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Ubink R, 2003, TRENDS NEUROSCI, V26, P604, DOI 10.1016/j.tins.2003.09.003; Van den Pol AN, 2003, J COMP NEUROL, V458, P175, DOI 10.1002/cne.10577; VIETOR I, 1993, J BIOL CHEM, V268, P18994; Vincent AJ, 2007, GLIA, V55, P905, DOI 10.1002/glia.20512; Vincent AJ, 2005, GLIA, V51, P132, DOI 10.1002/glia.20195; Vouldoukis I, 1996, FEBS LETT, V380, P237, DOI 10.1016/0014-5793(96)00050-6; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	63	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8141	10.1371/journal.pone.0008141	http://dx.doi.org/10.1371/journal.pone.0008141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997621	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829000003
J	Dongari-Bagtzoglou, A; Kashleva, H; Dwivedi, P; Diaz, P; Vasilakos, J				Dongari-Bagtzoglou, Anna; Kashleva, Helena; Dwivedi, Prabhat; Diaz, Patricia; Vasilakos, John			Characterization of Mucosal Candida albicans Biofilms	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; BACTERIAL BIOFILMS; HUMAN NEUTROPHILS; OTITIS-MEDIA; BETA-GLUCAN; ORAL-CAVITY; MODEL; DECTIN-1; INFECTIONS; PATHOGEN	C. albicans triggers recurrent infections of the alimentary tract mucosa that result from biofilm growth. Although the ability of C. albicans to form a biofilm on abiotic surfaces has been well documented in recent years, no information exists on biofilms that form directly on mucosal surfaces. The objectives of this study were to characterize the structure and composition of Candida biofilms forming on the oral mucosa. We found that oral Candida biofilms consist of yeast, hyphae, and commensal bacteria, with keratin dispersed in the intercellular spaces. Neutrophils migrate through the oral mucosa and form nests within the biofilm mass. The cell wall polysaccharide beta-glucan is exposed during mucosal biofilm growth and is more uniformly present on the surface of biofilm organisms invading the oral mucosa. We conclude that C. albicans forms complex mucosal biofilms consisting of both commensal bacterial flora and host components. These discoveries are important since they can prompt a shift of focus for current research in investigating the role of Candida-bacterial interactions in the pathogenesis of mucosal infections as well as the role of beta-glucan mediated signaling in the host response.	[Dongari-Bagtzoglou, Anna; Kashleva, Helena; Diaz, Patricia] Univ Connecticut, Sch Dent Med, Div Periodontol, Farmington, CT 06032 USA; [Dwivedi, Prabhat] Univ Texas Houston, Dept Microbiol, Houston, TX USA; [Vasilakos, John] Biothera, Eagan, MN USA	University of Connecticut; University of Texas System; University of Texas Health Science Center Houston	Dongari-Bagtzoglou, A (corresponding author), Univ Connecticut, Sch Dent Med, Div Periodontol, Farmington, CT 06032 USA.	adongari@uchc.edu		Vasilakos, John/0000-0002-1075-9665	National Institutes of Health/National Institute of Dental and Craniofacial Research [RO1 DE13986]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013986] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health/National Institute of Dental and Craniofacial Research grant RO1 DE13986 to ADB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; CARLSON E, 1983, INFECT IMMUN, V39, P193, DOI 10.1128/IAI.39.1.193-197.1983; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dahlen G, 2009, ORAL DIS, V15, P265, DOI 10.1111/j.1601-0825.2009.01520.x; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Grimoud Anne M, 2003, J Oral Sci, V45, P51; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; HARMSEN HJM, 1999, MICROB ECOL HEALTH D, V14, P165; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Kuhn DM, 2003, J CLIN MICROBIOL, V41, P506, DOI 10.1128/JCM.41.1.506-508.2003; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Milton DK, 2001, APPL ENVIRON MICROB, V67, P5420, DOI 10.1128/AEM.67.12.5420-5424.2001; Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007; ODDS FC, 1988, J ANTIMICROB CHEMOTH, V22, P891, DOI 10.1093/jac/22.6.891; OKSALA E, 1990, ACTA ODONTOL SCAND, V48, P71, DOI 10.3109/00016359009012736; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; Post J Christopher, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P347, DOI 10.1097/MOO.0b013e3282b97327; Scaramuzzino DA, 2000, INFECT IMMUN, V68, P2880, DOI 10.1128/IAI.68.5.2880-2887.2000; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; Southern P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002067; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tampakakis E, 2009, EUKARYOT CELL, V8, P732, DOI 10.1128/EC.00016-09; Trebesius K, 2000, MED MICROBIOL IMMUN, V188, P169, DOI 10.1007/s004300000035; TRUDEL L, 1986, CAN J MICROBIOL, V32, P673, DOI 10.1139/m86-124; TYLDESLEY WR, 1979, J ORAL PATHOL MED, V8, P53, DOI 10.1111/j.1600-0714.1979.tb01622.x; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; Villar CC, 2005, INFECT IMMUN, V73, P4588, DOI 10.1128/IAI.73.8.4588-4595.2005; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Westwater C, 2007, FEMS IMMUNOL MED MIC, V51, P134, DOI 10.1111/j.1574-695X.2007.00287.x; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0	40	146	149	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7967	10.1371/journal.pone.0007967	http://dx.doi.org/10.1371/journal.pone.0007967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956771	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827500004
J	Gupta, S; McGrath, B; Cavener, DR				Gupta, Sounak; McGrath, Barbara; Cavener, Douglas R.			PERK Regulates the Proliferation and Development of Insulin-Secreting Beta-Cell Tumors in the Endocrine Pancreas of Mice	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; KINASE; GROWTH; TUMORIGENESIS; ANGIOGENESIS; EXPRESSION; VIABILITY; HYPOXIA; EIF2AK3; STRESS	Background: PERK eIF2 alpha kinase is required for the proliferation of the insulin-secreting beta-cells as well as insulin synthesis and secretion. In addition, PERK signaling has been found to be an important factor in determining growth and angiogenesis of specific types of tumors, and was attributed to PERK-dependent regulation of the hypoxic stress response. In this report we examine the role of PERK in regulating proliferation and angiogenesis of transformed beta-cells in the development of insulinomas. Methodology: The SV40 Large T-antigen (Tag) was genetically introduced into the insulin secreting beta-cells of Perk KO mice under the control of an inducible promoter. Tumor growth and the related parameters of cell proliferation were measured. In late stage insulinomas the degree of vascularity was determined. Principal Findings: The formation and growth of insulinomas in Perk-deficient mice was dramatically ablated with much fewer tumors, which averaged 38-fold smaller than seen in wild-type control mice. Beta-cell proliferation was ablated in Perk-deficient mice associated with reduced tumor growth. In the small number of large encapsulated insulinomas that developed in Perk-deficient mice, we found a dramatic reduction in tumor vascularity compared to similar sized insulinomas in wild-type mice. Although insulinoma growth in Perk-deficient mice was largely impaired, beta-cell mass was increased sufficiently by T-antigen induction to rescue the hypoinsulinemia and diabetes in these mice. Conclusions: We conclude that PERK has two roles in the development of beta-cell insulinomas, first to support rapid cell proliferation during the initial transition to islet hyperplasia and later to promote angiogenesis during the progression to late-stage encapsulated tumors.	[Gupta, Sounak; McGrath, Barbara; Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Gupta, Sounak; Cavener, Douglas R.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	drc9@psu.edu	Cavener, Douglas R/E-3524-2010		National Institutes of Health [R01-DK062049, R01-GM56957]; Pennsylvania Department of Health TSF; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health TSF; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institutes of Health (R01-DK062049 and R01-GM56957) and the Pennsylvania Department of Health TSF to D. R. C. and from the American Heart Association Fellowship to S. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkovich I, 2001, DIABETES, V50, P2260, DOI 10.2337/diabetes.50.10.2260; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Brown JM, 1998, CANCER RES, V58, P1408; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Martin J, 2003, ONCOGENE, V22, P5261, DOI 10.1038/sj.onc.1206506; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105; Pelengaris S, 2001, ENDOCR-RELAT CANCER, V8, P307, DOI 10.1677/erc.0.0080307; Raught B, 1996, CANCER RES, V56, P4382; Rosenwald IB, 1996, CANCER LETT, V102, P113, DOI 10.1016/0304-3835(96)04171-7; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	21	43	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8008	10.1371/journal.pone.0008008	http://dx.doi.org/10.1371/journal.pone.0008008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956728	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827500031
J	Li, YY; Liu, L; Tollefsbol, TO				Li, Yuanyuan; Liu, Liang; Tollefsbol, Trygve O.			Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression	FASEB JOURNAL			English	Article						cancer; DNA methylation; histone modification; E2F-1; longevity	TELOMERASE ACTIVITY; CANCER-CELLS; TUMOR-CELLS; CALORIC RESTRICTION; GENETIC ELEMENTS; MECHANISMS; DISEASE; CARCINOMA; IMMORTALIZATION; INHIBITION	Cancer cells metabolize glucose at elevated rates and have a higher sensitivity to glucose reduction. However, the precise molecular mechanisms leading to different responses to glucose restriction between normal and cancer cells are not fully understood. We analyzed normal WI-38 and immortalized WI-38/S fetal lung fibroblasts and found that glucose restriction resulted in growth inhibition and apoptosis in WI-38/S cells, whereas it induced lifespan extension in WI-38 cells. Moreover, in WI-38/S cells glucose restriction decreased expression of hTERT (human telomerase reverse transcriptase) and increased expression of p16(INK4a). Opposite effects were found in the gene expression of hTERT and p16 in WI-38 cells in response to glucose restriction. The altered gene expression was partly due to glucose restriction-induced DNA methylation changes and chromatin remodeling of the hTERT and p16 promoters in normal and immortalized WI-38 cells. Furthermore, glucose restriction resulted in altered hTERT and p16 expression in response to epigenetic regulators in WI-38 rather than WI-38/S cells, suggesting that energy stress-induced differential epigenetic regulation may lead to different cellular fates in normal and precancerous cells. Collectively, these results provide new insights into the epigenetic mechanisms of a nutrient control strategy that may contribute to cancer therapy as well as antiaging approaches.-Li, Y., Liu, L., Tollefsbol, T. O. Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J. 24, 1442-1453 (2010). www.fasebj.org	[Li, Yuanyuan; Tollefsbol, Trygve O.] Univ Alabama, Dept Biol, Birmingham, AL 35294 USA; [Liu, Liang; Tollefsbol, Trygve O.] Univ Alabama, Ctr Aging, Birmingham, AL USA; [Liu, Liang] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama, Clin Nutr Res Ctr, Birmingham, AL USA; [Tollefsbol, Trygve O.] Univ Alabama, Comprehens Diabet Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Tollefsbol, TO (corresponding author), CH 175,1300 Univ Blvd, Birmingham, AL 35294 USA.	trygve@uab.edu		Tollefsbol, Trygve/0000-0002-0284-1511	Imperial Cancer Research Fund Laboratories, London, UK; NATIONAL CANCER INSTITUTE [R01CA129415] Funding Source: NIH RePORTER	Imperial Cancer Research Fund Laboratories, London, UK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Gordon Peters (Imperial Cancer Research Fund Laboratories, London, UK) and Dr. Silvia Bacchetti (Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada) for kindly providing the luciferase constructs used in this investigation.	Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Casillas MA, 2003, GENE, V316, P57, DOI 10.1016/S0378-1119(03)00739-X; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Cuezva JM, 2002, CANCER RES, V62, P6674; Del Bufalo D, 2005, CELL DEATH DIFFER, V12, P1429, DOI 10.1038/sj.cdd.4401670; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gupta AK, 1997, MOL CELL BIOCHEM, V170, P23, DOI 10.1023/A:1006890316102; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hammerman PS, 2004, TRENDS BIOCHEM SCI, V29, P586, DOI 10.1016/j.tibs.2004.09.008; Hara E, 1996, MOL CELL BIOL, V16, P859; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kanaya T, 1998, INT J CANCER, V78, P539, DOI 10.1002/(SICI)1097-0215(19981123)78:5<539::AID-IJC2>3.0.CO;2-I; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li YY, 2009, INT J CANCER, V125, P286, DOI 10.1002/ijc.24398; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; RACKER E, AM SCI, V60, P56; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Shin JY, 2000, CANCER RES, V60, P262; Thompson CB, 2005, COLD SH Q B, V70, P357, DOI 10.1101/sqb.2005.70.011; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Willcox BJ, 2007, ANN NY ACAD SCI, V1114, P434, DOI 10.1196/annals.1396.037; Zhu Z, 2007, CANCER RES, V67, P12018, DOI 10.1158/0008-5472.CAN-07-2834	36	89	95	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1442	1453		10.1096/fj.09-149328	http://dx.doi.org/10.1096/fj.09-149328			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20019239	Green Published			2022-12-25	WOS:000277158900017
J	Demonbreun, AR; Posey, AD; Heretis, K; Swaggart, KA; Earley, JU; Pytel, P; McNally, EM				Demonbreun, Alexis R.; Posey, Avery D.; Heretis, Konstantina; Swaggart, Kayleigh A.; Earley, Judy U.; Pytel, Peter; McNally, Elizabeth M.			Myoferlin is required for insulin-like growth factor response and muscle growth	FASEB JOURNAL			English	Article						myoblast fusion; receptor trafficking; lysosome; signaling	DEFECTIVE MEMBRANE REPAIR; ACTIVATED PROTEIN-KINASE; TYPE-1 IGF RECEPTOR; FACTOR-I; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; MYOBLAST FUSION; DEAFNESS FORM; POMPE-DISEASE; STEM-CELLS	Insulin-like growth factor (IGF) is a potent stimulus of muscle growth. Myoferlin is a membrane-associated protein important for muscle development and regeneration. Myoferlin-null mice have smaller muscles and defective myoblast fusion. To understand the mechanism by which myoferlin loss retards muscle growth, we found that myoferlin-null muscle does not respond to IGF1. In vivo after IGF1 infusion, control muscle increased myofiber diameter by 25%, but myoferlin-null muscle was unresponsive. Myoblasts cultured from myoferlin-null muscle and treated with IGF1 also failed to show the expected increase in fusion to multinucleate myotubes. The IGF1 receptor colocalized with myoferlin at sites of myoblast fusion. The lack of IGF1 responsiveness in myoferlin-null myoblasts was linked directly to IGF1 receptor mistrafficking as well as decreased IGF1 signaling. In myoferlin-null myoblasts, the IGF1 receptor accumulated into large vesicular structures. These vesicles colocalized with a marker of late endosomes/lysosomes, LAMP2, specifying redirection from a recycling to a degradative pathway. Furthermore, ultrastructural analysis showed a marked increase in vacuoles in myoferlin-null muscle. These data demonstrate that IGF1 receptor recycling is required for normal myogenesis and that myoferlin is a critical mediator of postnatal muscle growth mediated by IGF1.-Demonbreun, A. R., Posey, A. D., Heretis, K., Swaggart, K. A., Earley, J. U., Pytel, P., McNally, E. M. Myoferlin is required for insulin-like growth factor response and muscle growth. FASEB J. 24, 1284-1295 (2010). www.fasebj.org	[Heretis, Konstantina; Earley, Judy U.; McNally, Elizabeth M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Demonbreun, Alexis R.; McNally, Elizabeth M.] Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; [Posey, Avery D.; McNally, Elizabeth M.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA; [Swaggart, Kayleigh A.; McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	McNally, EM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	emcnally@uchicago.edu	Posey, Avery D./P-4890-2019; McNally, Elizabeth/W-4909-2019	Posey, Avery D./0000-0001-8711-629X; Swaggart, Kayleigh/0000-0001-9856-1014; Demonbreun, Alexis/0000-0001-6823-125X; McNally, Elizabeth/0000-0002-1221-719X	U.S. National Institutes of Health (NIH) [NS047726]; Muscular Dystrophy Association; Jain Foundation; NIH [T32HL007381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047726] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Jain Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) grant NS047726, the Muscular Dystrophy Association, and the Jain Foundation. A. R. D. was supported by NIH grant T32HL007381.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Bakker AC, 1997, J CELL SCI, V110, P2227; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI 10.1139/h06-054; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Cenacchi G, 2005, J CLIN PATHOL, V58, P190, DOI 10.1136/jcp.2004.018978; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; EDWALL D, 1989, ENDOCRINOLOGY, V124, P820, DOI 10.1210/endo-124-2-820; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; FURLANETTO RW, 1988, ENDOCRINOLOGY, V122, P2044, DOI 10.1210/endo-122-5-2044; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Giovannini S, 2008, MECH AGEING DEV, V129, P593, DOI 10.1016/j.mad.2008.08.001; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Heidrych P, 2008, HUM MOL GENET, V17, P3814, DOI 10.1093/hmg/ddn279; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411; LEFAUCHEUR JP, 1995, J NEUROIMMUNOL, V57, P85, DOI 10.1016/0165-5728(94)00166-L; Liao L, 2006, ENDOCRINOLOGY, V147, P3877, DOI 10.1210/en.2005-1537; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lynch GS, 2001, NEUROMUSCULAR DISORD, V11, P260, DOI 10.1016/S0960-8966(00)00192-9; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McNally EM, 1996, HUM MOL GENET, V5, P1841, DOI 10.1093/hmg/5.11.1841; Meikle PJ, 1999, MOL GENET METAB, V66, P179, DOI 10.1006/mgme.1998.2800; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nguyen TT, 2007, REPRODUCTION, V134, P41, DOI 10.1530/REP-06-0087; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; SCHMID C, 1983, FEBS LETT, V161, P117, DOI 10.1016/0014-5793(83)80742-X; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	49	43	44	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1284	1295		10.1096/fj.09-136309	http://dx.doi.org/10.1096/fj.09-136309			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	20008164	Green Published			2022-12-25	WOS:000276462300034
J	Liang, MC; Ma, J; Chen, L; Kozlowski, P; Qin, W; Li, D; Goto, J; Shimamura, T; Hayes, DN; Meyerson, M; Kwiatkowski, DJ; Wong, KK				Liang, M-C; Ma, J.; Chen, L.; Kozlowski, P.; Qin, W.; Li, D.; Goto, J.; Shimamura, T.; Hayes, D. N.; Meyerson, M.; Kwiatkowski, D. J.; Wong, K-K			TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity	ONCOGENE			English	Article						lung cancer; TSC1; KRAS; TSC2; mTOR	TUBEROUS SCLEROSIS COMPLEX; PEUTZ-JEGHERS-SYNDROME; ONCOGENIC K-RAS; TSC1-TSC2 COMPLEX; MAMMALIAN TARGET; MTOR INHIBITORS; BLADDER-CANCER; GENE TSC1; MODEL; LKB1	Germline TSC1 or TSC2 mutations cause tuberous sclerosis complex (TSC), a hamartoma syndrome with lung involvement. To explore the potential interaction between TSC1 and KRAS activation in lung cancer, mice in which Tsc1 loss and KrasG12D expression occur in a small fraction of lung epithelial cells were generated. Mice with a combined Tsc1-KrasG12D mutation had dramatically reduced tumor latency (median survival: 11.6-15.6 weeks) in comparison with KrasG12D alone mutant mice (median survival: 27.5 weeks). Tsc1-KrasG12D tumors showed consistent activation of mTOR (mammalian target of rapamycin) C1 and responded to treatment with rapamycin, leading to significantly improved survival, whereas rapamycin had minor effects on cancers in KrasG12D alone mice. Loss of heterozygosity for TSC1 or TSC2 was found in 22% of 86 human lung cancer specimens. However, none of the 80 lung cancer lines studied showed evidence of the lack of expression of either TSC1 or TSC2 or a signaling pattern corresponding to complete loss. These data indicate that Tsc1 loss synergizes with the Kras mutation to enhance lung tumorigenesis in the mouse, but that this is a rare event in human lung cancer. Rapamycin may have unique benefit for patients with lung cancer, for whom the TSC1/TSC2 function is limited. Oncogene (2010) 29, 1588-1597; doi:10.1038/onc.2009.452; published online 7 December 2009	[Ma, J.; Kozlowski, P.; Qin, W.; Goto, J.; Kwiatkowski, D. J.] Brigham & Womens Hosp, Dept Med, Div Translat Med, Boston, MA 02115 USA; [Liang, M-C; Chen, L.; Li, D.; Wong, K-K] Harvard Canc Ctr, Ludwig Ctr Dana Farber, Boston, MA USA; [Liang, M-C; Chen, L.; Li, D.; Shimamura, T.; Meyerson, M.; Wong, K-K] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hayes, D. N.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC USA; [Meyerson, M.] MIT, Cambridge, MA 02139 USA; [Meyerson, M.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kwiatkowski, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Translat Med, 1 Blackfan Circle,Room 6-216, Boston, MA 02115 USA.	dk@rics.bwh.harvard.edu	Meyerson, Matthew L/E-7123-2012; Kozlowski, Piotr/I-1860-2019	Kozlowski, Piotr/0000-0003-3770-7715; Liang, Mei-Chih/0000-0002-7389-2455; Goto, June/0000-0002-4000-9750; Chen, Liang/0000-0001-7300-6604; Hayes, D. Neil/0000-0001-6203-7771	NIH [R01 AG2400401, R01 CA122794, K08 AG024004, P01 CA120964]; Sidney Kimmel Foundation for Cancer Research; Joan Scarangello Foundation to Conquer Lung Cancer; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [P01CA120964, R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG024004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation for Cancer Research; Joan Scarangello Foundation to Conquer Lung Cancer; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kate McNamara and Sara Zaghlul (Dana-Farber Cancer Institute, Boston), Christine Lam, Iza Malinowska-Kolodziej and Mei Zheng (Brigham and Women's Hospital, Boston) for their technical assistance and Roderick T. Bronson (Harvard Medical School, Boston) and Robert Padera and Lucian Chirieac (Brigham and Women's Hospital, Boston) for assistance with pathology review. This study was supported in part by the NIH Grant nos R01 AG2400401 (K-KW), R01 CA122794 (K-KW), K08 AG024004 (K-KW), P01 CA120964 (DJK), the Sidney Kimmel Foundation for Cancer Research (K-KW), the Joan Scarangello Foundation to Conquer Lung Cancer (K-KW and DJK) and the Flight Attendant Medical Research Institute (K-KW).	Adachi H, 2003, J UROLOGY, V170, P601, DOI 10.1097/01.ju.0000074621.74361.10; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gridelli C, 2008, ONCOLOGIST, V13, P139, DOI 10.1634/theoncologist.2007-0171; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Henske EP, 1996, AM J HUM GENET, V59, P400; Hornigold N, 1999, ONCOGENE, V18, P2657, DOI 10.1038/sj.onc.1202854; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Kozlowski P, 2007, HUM GENET, V121, P389, DOI 10.1007/s00439-006-0308-9; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Milton DT, 2007, CANCER-AM CANCER SOC, V110, P599, DOI 10.1002/cncr.22816; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Muir TE, 1998, AM J SURG PATHOL, V22, P465, DOI 10.1097/00000478-199804000-00012; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Pollizzi K, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-38; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Smilenov LB, 2006, CANCER LETT, V240, P17, DOI 10.1016/j.canlet.2005.08.015; Takamochi K, 2001, AM J PATHOL, V159, P1941, DOI 10.1016/S0002-9440(10)63041-6; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	41	43	44	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1588	1597		10.1038/onc.2009.452	http://dx.doi.org/10.1038/onc.2009.452			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	19966866	Green Submitted, Green Accepted			2022-12-25	WOS:000275694700004
J	Arao, Y; Carpenter, K; Hewitt, S; Korach, KS				Arao, Yukitomo; Carpenter, Karen; Hewitt, Sylvia; Korach, Kenneth S.			Estrogen Down-regulation of the Scx Gene Is Mediated by the Opposing Strand-overlapping Gene Bop1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX TRANSCRIPTION FACTOR; SENSE-ANTISENSE PAIRS; RIBOSOME BIOGENESIS; X-CHROMOSOME; IN-VIVO; RNA; EXPRESSION; SCLERAXIS; INACTIVATION; TENDON	Recent genome-wide transcriptome studies suggest the presence of numerous bidirectional overlapping coding gene pairs in mammalian genomes. Various antisense RNAs are reported as non-coding RNAs that regulate the expression of sense RNA. However, it is still unclear whether the expression of bidirectional overlapping coding genes are regulated by the opposite strand gene transcript acting as a non-coding RNA. Bop1 and Scx are a pair of bidirectional overlapping coding genes related to cellular proliferation and differentiation, respectively. Scx gene is localized in the intron 3 region of the Bop1 gene. The expression of these genes is reciprocally regulated by estrogen (E2) in the mouse uterus. In situ hybridization indicated that both genes are expressed in the uterine endometrial epithelial cells and that the antisense RNA of Scx (Bop1 intronic RNA) accumulates as a stable RNA in these cells. The existence of Bop1 intronic RNA was confirmed by reverse transcription-PCR and was increased after E2 treatment, coinciding with a decrease in Scx mRNA. Murine myoblasts expressing doxycycline-inducible endogenous Bop1 gene showed an increase in Bop1 intronic RNA and a simultaneous decrease in Scx mRNA. Murine fibroblasts expressing Scx mRNA from an exogenous Scx mini-gene indicated that the accumulation of Bop1 intronic RNA impairs the Scx gene expression in a trans-acting manner, which resulted in the reduction of the Scx mRNA level. This study demonstrates a novel example of hormone-stimulated intronic noncoding RNA down-regulating the expression of an opposing strand-overlapping coding gene.	[Arao, Yukitomo; Carpenter, Karen; Hewitt, Sylvia; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021; Hewitt, Sylvia/W-8752-2019	Hewitt, Sylvia/0000-0001-7713-0805; Arao, Yukitomo/0000-0003-1560-351X; Korach, Kenneth/0000-0002-7765-418X	NIEHS [Z01ES70065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01ES70065 (to K. S. K.) through the Division of Intramural Research of the NIEHS.	Brown D, 1999, DEVELOPMENT, V126, P4317; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; Deroo BJ, 2004, ENDOCRINOLOGY, V145, P5485, DOI 10.1210/en.2004-0471; Faghihi MA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r38; Galante PAF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r40; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hyder SM, 1997, CANCER RES, V57, P2547; Jakymiw A, 2007, J CELL SCI, V120, P1317, DOI 10.1242/jcs.03429; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawa-uchi T, 1998, J CELL BIOCHEM, V70, P468, DOI 10.1002/(SICI)1097-4644(19980915)70:4<468::AID-JCB4>3.0.CO;2-H; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liu Y, 1997, J CELL BIOCHEM, V67, P66, DOI 10.1002/(SICI)1097-4644(19971001)67:1<66::AID-JCB7>3.0.CO;2-U; Liu Y, 1997, J BIOL CHEM, V272, P29880, DOI 10.1074/jbc.272.47.29880; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Muir T, 2005, MOL ENDOCRINOL, V19, P2164, DOI 10.1210/me.2004-0473; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; NOGUCHI M, 1994, J BIOL CHEM, V269, P29161; Numata K, 2007, GENE, V392, P134, DOI 10.1016/j.gene.2006.12.005; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Perez AV, 2003, MECH DEVELOP, V120, P1153, DOI 10.1016/j.mod.2003.08.003; Pestov DG, 1998, ONCOGENE, V17, P3187, DOI 10.1038/sj.onc.1202260; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POLLARD JW, 1987, CELL TISSUE RES, V249, P533; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; SILVERMAN TA, 1992, J BIOL CHEM, V267, P9738; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Werner Andreas, 2005, RNA Biol, V2, P53, DOI 10.4161/rna.2.2.1852	41	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4806	4814		10.1074/jbc.M109.036681	http://dx.doi.org/10.1074/jbc.M109.036681			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996321	Green Published, hybrid			2022-12-25	WOS:000275274800059
J	Shinohara, M; Adachi, Y; Mitsushita, J; Kuwabara, M; Nagasawa, A; Harada, S; Furuta, S; Zhang, Y; Seheli, K; Miyazaki, H; Kamata, T				Shinohara, Masahiro; Adachi, Yoshifumi; Mitsushita, Junji; Kuwabara, Mitsuhiro; Nagasawa, Atsushi; Harada, Saori; Furuta, Shuichi; Zhang, Yugen; Seheli, Kajla; Miyazaki, Hitoshi; Kamata, Tohru			Reactive Oxygen Generated by NADPH Oxidase 1 (Nox1) Contributes to Cell Invasion by Regulating Matrix Metalloprotease-9 Production and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SUPEROXIDE-PRODUCTION; EPITHELIAL-CELLS; GENE-EXPRESSION; TUMOR-CELLS; RAS; CANCER; TRANSFORMATION; PHOSPHORYLATION; INVOLVEMENT	A mediating role of the reactive oxygen species-generating enzyme Nox1 has been suggested for Ras oncogene transformation phenotypes including anchorage-independent cell growth, augmented angiogenesis, and tumorigenesis. However, little is known about whether Nox1 signaling regulates cell invasiveness. Here, we report that the cell invasion activity was augmented in K-Ras-transformed normal rat kidney cells and attenuated by transfection of Nox1 small interference RNAs(siRNAs) into the cells. Diphenyleneiodonium (DPI) or Nox1 siRNAs blocked up-regulation of matrix metalloprotease-9 at both protein and mRNA levels in K-Ras-transformed normal rat kidney cells. Furthermore, DPI and Nox1 siRNAs inhibited the activation of IKK alpha kinase and the degradation of I kappa B alpha, suppressing the NF kappa B-dependent matrix metalloprotease-9 promoter activity. Additionally, epidermal growth factor-stimulated migration of CaCO-2 cells was abolished by DPI and Nox1 siRNAs, indicating the requirement of Nox1 activity for the motogenic effect of epidermal growth factor. This Nox1 action was mediated by down-regulation of the Rho activity through the low molecular weight protein-tyrosine phosphatase-p190RhoGAP-dependent mechanism. Taken together, our findings define a mediating role of Nox1-generated reactive oxygen species in cell invasion processes, most notably metalloprotease production and cell motile activity.	[Shinohara, Masahiro; Adachi, Yoshifumi; Mitsushita, Junji; Kuwabara, Mitsuhiro; Nagasawa, Atsushi; Harada, Saori; Furuta, Shuichi; Zhang, Yugen; Seheli, Kajla; Kamata, Tohru] Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, Nagano 3908621, Japan; [Miyazaki, Hitoshi] Univ Tsukuba, Ctr Gene Res, Ibaraki 3058572, Japan	Shinshu University; University of Tsukuba	Kamata, T (corresponding author), Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, 3-1-1 Asahi, Nagano 3908621, Japan.	kamatat@shinshu-u.ac.jp	Mitsushita, Junji/D-7688-2016	Mitsushita, Junji/0000-0001-9402-4318; Shinohara, Masahiro/0000-0002-5532-1042	Ministry of Science and Culture of Japan	Ministry of Science and Culture of Japan	This work was supported by a grant on Cancer Research in Applied Areas from the Ministry of Science and Culture of Japan (to T. K.).	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Aguirre-Ghiso JA, 1999, ONCOGENE, V18, P4718, DOI 10.1038/sj.onc.1202850; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; BERNHARD EJ, 1990, CANCER RES, V50, P3872; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Deng L, 2001, J BIOL CHEM, V276, P413, DOI 10.1074/jbc.M004551200; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; HIROSE K, 1993, FASEB J, V7, P361, DOI 10.1096/fasebj.7.2.8440412; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Klyubin IV, 1996, EUR J CELL BIOL, V70, P347; Komatsu D, 2008, ONCOGENE, V27, P4724, DOI 10.1038/onc.2008.102; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; LIOTTA LA, 1990, JAMA-J AM MED ASSOC, V263, P1123, DOI 10.1001/jama.263.8.1123; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; SATO H, 1993, ONCOGENE, V8, P395; Shimizu H, 2001, BIOCHEM BIOPH RES CO, V289, P602, DOI 10.1006/bbrc.2001.6007; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Shirai H, 1995, ANTICANCER RES, V15, P2889; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Steinbrenner H, 2005, FREE RADICAL RES, V39, P245, DOI 10.1080/10715760500053487; Wilson AJ, 1999, EXP CELL RES, V250, P187, DOI 10.1006/excr.1999.4496; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745	35	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4481	4488		10.1074/jbc.M109.071779	http://dx.doi.org/10.1074/jbc.M109.071779			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018867	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000275274800026
J	Ellisdon, AM; Jani, D; Kohler, A; Hurt, E; Stewart, M				Ellisdon, Andrew M.; Jani, Divyang; Koehler, Alwin; Hurt, Ed; Stewart, Murray			Structural Basis for the Interaction between Yeast Spt-Ada-Gcn5 Acetyltransferase (SAGA) Complex Components Sgf11 and Sus1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE COMPLEX; HISTONE H2B; TRANSCRIPTION ELONGATION; FUNCTIONAL COMPONENT; DEUBIQUITINATION; MACHINERY; ACETYLATION; ASSOCIATION; DROSOPHILA	Sus1 is a central component of the yeast gene gating machinery, the process by which actively transcribing genes such as GAL1 become associated with nuclear pore complexes. Sus1 is a component of both the SAGA transcriptional co-activator complex and the TREX-2 complex that binds to nuclear pore complexes. TREX-2 contains two Sus1 chains that have an articulated helical hairpin fold, enabling them to wrap around an extended alpha-helix in Sac3, following a helical hydrophobic stripe. In SAGA, Sus1 binds to Sgf11 and has been proposed to provide a link between SAGA and TREX-2. We present here the crystal structure of the complex between Sus1 and the N-terminal region of Sgf11 that forms an extended alpha-helix around which Sus1 wraps in a manner that shares some similarities with the Sus1-Sac3 interface in TREX-2. However, the Sus1-binding site on Sgf11 is somewhat shorter than on Sac3 and is based on a narrower hydrophobic stripe. Engineered mutants that disrupt the Sgf11-Sus1 interaction in vitro confirm the importance of the hydrophobic helical stripe in molecular recognition. Helix alpha 1 of the Sus1-articulated hairpin does not bind directly to Sgf11 and adopts a wide range of conformations within and between crystal forms, consistent with the presence of a flexible hinge and also with results from previous extensive mutagenesis studies (Klockner, C., Schneider, M., Lutz, S., Jani, D., Kressler, D., Stewart, M., Hurt, E., and Kohler, A. (2009) J. Biol. Chem. 284, 12049-12056). A single Sus1 molecule cannot bind Sgf11 and Sac3 simultaneously and this, combined with the structure of the Sus1-Sgf11 complex, indicates that Sus1 forms separate subcomplexes within SAGA and TREX-2.	[Ellisdon, Andrew M.; Jani, Divyang; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Koehler, Alwin; Hurt, Ed] Univ Heidelberg, Zentrum Biochem, INF328, D-69120 Heidelberg, Germany	MRC Laboratory Molecular Biology; Ruprecht Karls University Heidelberg	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Ellisdon, Andrew/0000-0002-2248-9914	Wellcome Trust; Deutsche Forschungsgemeinschaft [SBF638]; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Wellcome Trust Program Grant ( to M. S.) and by grants from the Deutsche Forschungsgemeinschaft (SBF638, B3 to E. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Faza MB, 2009, J CELL BIOL, V184, P833, DOI 10.1083/jcb.200810059; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Klockner C, 2009, J BIOL CHEM, V284, P12049, DOI 10.1074/jbc.M900502200; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Kurshakova M, 2007, MOL CELL, V27, P332, DOI 10.1016/j.molcel.2007.05.035; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Luna R, 2009, RNA BIOL, V6, P145, DOI 10.4161/rna.6.2.7803; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Montigiani S, 1996, J MOL BIOL, V258, P6, DOI 10.1006/jmbi.1996.0229; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Wilmes GM, 2009, MOL CELL, V33, P671, DOI 10.1016/j.molcel.2009.03.003; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	39	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3850	3856		10.1074/jbc.M109.070839	http://dx.doi.org/10.1074/jbc.M109.070839			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007317	Green Published, hybrid			2022-12-25	WOS:000275254000038
J	Gutman, O; Walliser, C; Piechulek, T; Gierschik, P; Henis, YI				Gutman, Orit; Walliser, Claudia; Piechulek, Thomas; Gierschik, Peter; Henis, Yoav I.			Differential Regulation of Phospholipase C-beta(2) Activity and Membrane Interaction by G alpha(q), G beta(1)gamma(2), and Rac2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ISOZYME-SPECIFIC STIMULATION; NUCLEOTIDE-BINDING PROTEIN; RHO GTPASES; C-BETA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HUMAN NEUTROPHILS; PLASMA-MEMBRANE; CLEAVAGE FURROW; ACTIVATION	We combined fluorescence recovery after photobleaching (FRAP) beam-size analysis with biochemical assays to investigate the mechanisms of membrane recruitment and activation of phospholipase C-beta(2) (PLC beta(2)) by G protein alpha(q) and beta gamma dimers. We show that activation by alpha(q) and beta gamma differ from activation by Rac2 and from each other. Stimulation by alpha(q) enhanced the plasma membrane association of PLC beta(2), but not of PLC beta(2)Delta, which lacks the alpha(q)-interacting region. Although alpha(q) resembled Rac2 in increasing the contribution of exchange to the FRAP of PLC beta(2) and in enhancing its membrane association, the latter effect was weaker than with Rac2. Moreover, the membrane recruitment of PLC beta(2) by alpha(q) occurred by enhancing PLC beta(2) association with fast-diffusing (lipid-like) membrane components, whereas stimulation by Rac2 led to interactions with slow diffusing membrane sites. On the other hand, activation by beta gamma shifted the FRAP of PLC beta(2) and PLC beta(2)Delta to pure lateral diffusion 3- to 5-fold faster than lipids, suggesting surfing-like diffusion along the membrane. We propose that these different modes of PLC beta(2) membrane recruitment may accommodate contrasting functional needs to hydrolyze phosphatidylinositol 4,5-bisphosphate (PtdInsP(2)) in localized versus dispersed populations. PLC beta(2) activation by Rac2, which leads to slow lateral diffusion and much faster exchange, recruits PLC beta(2) to act locally on PtdInsP2 at specific domains. Activation by alpha(q) leads to lipid-like diffusion of PLC beta(2) accompanied by exchange, enabling the sampling of larger, yet limited, areas prior to dissociation. Finally, activation by beta gamma recruits PLC beta(2) to the membrane by transient interactions, leading to fast "surfing" diffusion along the membrane, sampling large regions for dispersed PtdInsP(2) populations.	[Walliser, Claudia; Piechulek, Thomas; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89081 Ulm, Germany; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Ulm University; Tel Aviv University	Gierschik, P (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	peter.gierschik@uni-ulm.de; henis@tauex.tau.ac.il		Henis, Yoav/0000-0002-1408-3877	German-Israeli Foundation [I-730-46.13/2002]; Deutsche Forschungsgemeinschaft [SFB 497]	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Grant I-730-46.13/2002 from the German-Israeli Foundation for Scientific Research and Development (to Y.I.H. and P. G.) and by the Deutsche Forschungsgemeinschaft (Grant SFB 497, TP C10, to P. G.).	Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; ARKINSTALL S, 1995, FEBS LETT, V364, P45, DOI 10.1016/0014-5793(95)00351-9; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulinski JC, 2001, J CELL SCI, V114, P3885; CAMPS M, 1990, BIOCHEM J, V271, P743, DOI 10.1042/bj2710743; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Coburn RF, 1997, J CELL PHYSIOL, V171, P271, DOI 10.1002/(SICI)1097-4652(199706)171:3<271::AID-JCP5>3.0.CO;2-L; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Efron B, 1993, INTRO BOOTSTRAP, P124; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Illenberger D, 2000, METHOD ENZYMOL, V325, P167; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1997, EUR J BIOCHEM, V246, P71, DOI 10.1111/j.1432-1033.1997.t01-1-00071.x; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; LEE SB, 1993, J BIOL CHEM, V268, P25952; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Lober RM, 2006, J NEUROSCI, V26, P12602, DOI 10.1523/JNEUROSCI.4020-06.2006; de Jesus ML, 2006, NEUROCHEM INT, V49, P72, DOI 10.1016/j.neuint.2005.12.015; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Mason D, 2007, J GEN PHYSIOL, V129, P267, DOI 10.1085/jgp.200609656; Matsuoka S, 2006, J CELL SCI, V119, P1071, DOI 10.1242/jcs.02824; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; PATERSON A, 1995, CELL SIGNAL, V7, P709, DOI 10.1016/0898-6568(95)00039-R; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Rabiet MJ, 2002, BLOOD, V100, P1835, DOI 10.1182/blood-2001-12-0193; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; de Azua IR, 2006, J NEUROSCI RES, V84, P13, DOI 10.1002/jnr.20858; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; Yaradanakul A, 2007, J MEMBRANE BIOL, V220, P53, DOI 10.1007/s00232-007-9074-4	65	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3905	3915		10.1074/jbc.M109.085100	http://dx.doi.org/10.1074/jbc.M109.085100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007712	hybrid, Green Published			2022-12-25	WOS:000275254000044
J	Paratkar, S; Patel, SS				Paratkar, Swaroopa; Patel, Smita S.			Mitochondrial Transcription Factor Mtf1 Traps the Unwound Non-template Strand to Facilitate Open Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; YEAST MITOCHONDRIAL; PROMOTER DNA; SACCHAROMYCES-CEREVISIAE; INITIATION COMPLEX; SPECIFICITY FACTOR; STRUCTURE PREDICTION; PROTEIN STRUCTURES; STRUCTURAL BASIS; MISMATCH BUBBLE	The catalytic subunit of the mitochondrial (mt) RNA polymerase ( RNAP) is highly homologous to the bacteriophage T7/T3 RNAP. Unlike the phage RNAP, however, the mtRNAP relies on accessory proteins to initiate promoter-specific transcription. Rpo41, the catalytic subunit of the Saccharomyces cerevisiae mtRNAP, requires Mtf1 for opening the duplex promoter. To elucidate the role of Mtf1 in promoter-specific DNA opening, we have mapped the structural organization of the mtRNAP using site-specific protein-DNA photo-cross-linking studies. Both Mtf1 and Rpo41 cross-linked to distinct sites on the promoter DNA, but the dominant cross-links were those of the Mtf1, which indicates a direct role of Mtf1 in promoter-specific binding and initiation. Strikingly, Mtf1 cross-linked with a high efficiency to the melted region of the promoter DNA, based on which we suggest that Mtf1 facilitates DNA melting by trapping the non-template strand in the unwound conformation. Additional strong cross-links of the Mtf1 were observed with the -8 to -10 base-paired region of the promoter. The cross-linking results were incorporated into a structural model of the mtRNAP-DNA, created from a homology model of the C-terminal domain of Rpo41 and the available structure of Mtf1. The promoterDNAis sandwiched between Mtf1 and Rpo41 in the structural model, and Mtf1 closely associates mainly with one face of the promoter across the entire nona-nucleotide consensus sequence. Overall, the studies reveal that in many ways the role of Mtf1 is analogous to the transcription factors of the multisubunit RNAPs, which provides an intriguing link between single- and multisubunit RNAPs.	[Paratkar, Swaroopa; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051966, R01GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51966 (to S. S. P.).	AIYAR SE, 1994, BIOCHEMISTRY-US, V33, P11501, DOI 10.1021/bi00204a012; AIYAR SE, 1994, J BIOL CHEM, V269, P13179; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; BISWAS TK, 1985, P NATL ACAD SCI USA, V82, P1954, DOI 10.1073/pnas.82.7.1954; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Brieba LG, 2001, BIOCHEMISTRY-US, V40, P3882, DOI 10.1021/bi002716c; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen BS, 2004, BIOCHEMISTRY-US, V43, P12741, DOI 10.1021/bi048993r; CHEN Y, 1993, J MOL BIOL, V230, P453, DOI 10.1006/jmbi.1993.1162; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Guo Q, 2006, J MOL BIOL, V358, P241, DOI 10.1016/j.jmb.2006.02.001; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; Karlok MA, 2002, J BIOL CHEM, V277, P28143, DOI 10.1074/jbc.M204123200; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mangus D A, 1996, Methods Enzymol, V264, P57, DOI 10.1016/S0076-6879(96)64009-9; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P7993, DOI 10.1093/nar/10.24.7993; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Rykunov Dmitry, 2009, Journal of Structural and Functional Genomics, V10, P95, DOI 10.1007/s10969-008-9044-9; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Stano NM, 2002, J BIOL CHEM, V277, P37292, DOI 10.1074/jbc.M201600200; Stano NM, 2002, J MOL BIOL, V315, P1009, DOI 10.1006/jmbi.2001.5313; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; TICHO BS, 1988, J BIOL CHEM, V263, P10096; Ujvari A, 2000, J MOL BIOL, V295, P1173, DOI 10.1006/jmbi.1999.3418; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WINKLEY CS, 1985, J BIOL CHEM, V260, P4214; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053	65	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3949	3956		10.1074/jbc.M109.050732	http://dx.doi.org/10.1074/jbc.M109.050732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20008320	Green Published, hybrid			2022-12-25	WOS:000275254000048
J	Ham, HJ; Rho, HJ; Shin, SK; Yoon, HJ				Ham, Hye Jin; Rho, Hyun Joo; Shin, Seung Koo; Yoon, Hye-Joo			The TGL2 Gene of Saccharomyces cerevisiae Encodes an Active Acylglycerol Lipase Located in the Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIACYLGLYCEROL LIPASE; DIACYLGLYCEROL KINASE; ESCHERICHIA-COLI; LIPID PARTICLES; YEAST; PURIFICATION; PROTEIN; LIPOLYSIS; MOVEMENT; CLONING	The Saccharomyces cerevisiae Tgl2 protein shows sequence homology to Pseudomonas triacylglycerol (TAG) lipases, but its role in the yeast lipid metabolism is not known. Using hemagglutinin-tagged Tgl2p purified from yeast, we report that this protein carries a significant lipolytic activity toward long-chain TAG. Importantly, mutant hemagglutinin-Tgl2p(S144A), which contains alanine 144 in place of serine 144 in the lipase consensus sequence (G/A)XSXG exhibits no such activity. Although cellular TAG hydrolysis is reduced in the tgl2 deletion mutant, overproduction of Tgl2p in this mutant leads to an increase in TAG degradation in the presence of fatty acid synthesis inhibitor cerulenin, but that of Tgl2p(S144A) does not. This result demonstrates the lipolytic function of Tgl2p in yeast. Although other yeast TAG lipases are localized to lipid particles, Tgl2p is enriched in the mitochondria. The mitochondrial fraction purified from the TGL2-overexpressing yeast shows a strong lipolytic activity, which was absent in the tgl2 deletion mutant. Therefore, we conclude that Tgl2p is a functional lipase of the yeast mitochondria. By analyzing phenotypic effects of TGL2-deficient yeast, we also find that lipolysis-competent Tgl2p is required for the viability of cells treated with antimitotic drug. The addition of oleic acid, the product of Tgl2p-catalyzed lipolysis, fully complements the antimitotic drug sensitivity of the tgl2 null mutation. Thus, we propose that the mitochondrial Tgl2p-dependent lipolysis is crucial for the survival of cells under antimitotic drug treatment.	[Ham, Hye Jin; Rho, Hyun Joo; Shin, Seung Koo; Yoon, Hye-Joo] Pohang Univ Sci & Technol, Dept Chem, Bionanotechnol Ctr, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Shin, SK (corresponding author), Pohang Univ Sci & Technol, Dept Chem, Bionanotechnol Ctr, Pohang 790784, South Korea.	skshin@postech.ac.kr; hjyoon@postech.ac.kr	Shin, Seung Koo/D-2670-2012; Yoon, Hye-Joo/D-4007-2012	Shin, Seung Koo/0000-0002-8294-2119; 	Ministry of Education, Science, and Technology of the Republic of Korea [FPR08A1-040]	Ministry of Education, Science, and Technology of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Functional Proteomics Center Grant FPR08A1-040 established by the Ministry of Education, Science, and Technology of the Republic of Korea.	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; Caron JM, 1997, MOL BIOL CELL, V8, P621, DOI 10.1091/mbc.8.4.621; CLAYCOMB WC, 1971, J BIOL CHEM, V246, P7139; DARTOIS V, 1992, BIOCHIM BIOPHYS ACTA, V1131, P253, DOI 10.1016/0167-4781(92)90023-S; DAUM G, 1982, J BIOL CHEM, V257, P3028; DESNUELLE P, 1963, J LIPID RES, V4, P369; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; MANN JT, 1966, J BIOL CHEM, V241, P3595; Matsufuji Y, 2008, YEAST, V25, P825, DOI 10.1002/yea.1637; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; SchmidtDannert C, 1997, METHOD ENZYMOL, V284, P194; SCHOUSBOE I, 1976, BIOCHIM BIOPHYS ACTA, V450, P165, DOI 10.1016/0005-2760(76)90088-6; SCHOUSBOE I, 1976, BIOCHIM BIOPHYS ACTA, V424, P366, DOI 10.1016/0005-2760(76)90026-6; Seo J, 2008, ANAL CHEM, V80, P6145, DOI 10.1021/ac801007y; SIKORSKI RS, 1989, GENETICS, V122, P19; SOLOMON F, 1991, ANNU REV CELL BIOL, V7, P633, DOI 10.1146/annurev.cellbio.7.1.633; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Van Heusden GPH, 1998, YEAST, V14, P225, DOI 10.1002/(SICI)1097-0061(199802)14:3<225::AID-YEA215>3.0.CO;2-#; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	39	23	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3005	10.1074/jbc.M109.046946	http://dx.doi.org/10.1074/jbc.M109.046946			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19959834	Green Published, hybrid			2022-12-25	WOS:000273829000015
J	Er, F; Nia, AM; Gassanov, N; Caglayan, E; Erdmann, E; Hoppe, UC				Er, Fikret; Nia, Amir M.; Gassanov, Natig; Caglayan, Evren; Erdmann, Erland; Hoppe, Uta C.			Impact of Rescue-Thrombolysis during Cardiopulmonary Resuscitation in Patients with Pulmonary Embolism	PLOS ONE			English	Article							CARDIAC-ARREST; MANAGEMENT; GUIDELINES; ECHOCARDIOGRAPHY; DIAGNOSIS; REGISTRY	Background: Cardiac arrest in patients with pulmonary embolism (PE) is associated with high morbidity and mortality. Thrombolysis is expected to improve the outcome in these patients. However studies evaluating rescue-thrombolysis in patients with PE are missing, mainly due to the difficulties of clinical diagnosis of PE. We aimed to determine the success influencing factors of thrombolysis during resuscitation in patients with PE. Methodology/Principal Findings: We analyzed retrospectively the outcome of 104 consecutive patients with confirmed (n = 63) or highly suspected (n = 41) PE and monitored cardiac arrest. In all patients rtPA was administrated for thrombolysis during cardiopulmonary resuscitation. In 40 of the 104 patients (38.5%) a return of spontaneous circulation (ROSC) could be achieved successfully. Patients with ROSC received thrombolysis significantly earlier after CPR onset compared to patients without ROSC (13.6+/-1.2 min versus 24.6+/-0.8 min; p<0.001). 19 patients (47.5%) out of the 40 patients with initially successful resuscitation survived to hospital discharge. In patients with hospital discharge thrombolysis therapy was begun with a significantly shorter delay after cardiac arrest compared to all other patients (11.0+/-1.3 vs. 22.5+/-0.9 min; p<0.001). Conclusion: Rescue-thrombolysis should be considered and started in patients with PE and cardiac arrest, as soon as possible after cardiac arrest onset.	[Er, Fikret; Nia, Amir M.; Gassanov, Natig; Caglayan, Evren; Erdmann, Erland; Hoppe, Uta C.] Univ Cologne, Dept Internal Med 2, Cologne, Germany; [Hoppe, Uta C.] Univ Cologne, Ctr Mol Med, CMMC, Cologne, Germany	University of Cologne; University of Cologne	Er, F (corresponding author), Univ Cologne, Dept Internal Med 2, Cologne, Germany.	Fikret.Er@uk-koeln.de	Caglayan, Evren/ABB-8674-2020		Center for Molecular Medicine Cologne, Cologne, Germany	Center for Molecular Medicine Cologne, Cologne, Germany	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding source: Center for Molecular Medicine Cologne, Cologne, Germany.	Abu-Laban RB, 2002, NEW ENGL J MED, V346, P1522, DOI 10.1056/NEJMoa012885; Aklog L, 2002, CIRCULATION, V105, P1416, DOI 10.1161/01.CIR.0000012526.21603.25; Bailen MR, 2001, CRIT CARE MED, V29, P2211, DOI 10.1097/00003246-200111000-00027; Bottiger BW, 2008, NEW ENGL J MED, V359, P2651, DOI 10.1056/NEJMoa070570; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goran KP, 2008, EUR HEART J, V29, P3066, DOI 10.1093/eurheartj/ehn474; HOFFMANN B, 2009, THROMB RES; Jardin F, 1997, CHEST, V111, P209, DOI 10.1378/chest.111.1.209; JARDIN F, 1991, PRESSE MED, V20, P2085; JENNETT B, 1975, LANCET, V1, P480; Kasper W, 1997, J AM COLL CARDIOL, V30, P1165, DOI 10.1016/S0735-1097(97)00319-7; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; SOLOFF LA, 1967, AM HEART J, V74, P710, DOI 10.1016/0002-8703(67)90510-8; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; vanderWouw PA, 1997, J AM COLL CARDIOL, V30, P780, DOI 10.1016/S0735-1097(97)00218-0; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; 2000, EUR HEART J, V21, P1301	17	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8323	10.1371/journal.pone.0008323	http://dx.doi.org/10.1371/journal.pone.0008323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016808	Green Submitted, Green Published, gold			2022-12-25	WOS:000272833800017
J	Gellerich, FN; Gizatullina, Z; Arandarcikaite, O; Jerzembek, D; Vielhaber, S; Seppet, E; Striggow, F				Gellerich, Frank Norbert; Gizatullina, Zemfira; Arandarcikaite, Odeta; Jerzembek, Doreen; Vielhaber, Stefan; Seppet, Enn; Striggow, Frank			Extramitochondrial Ca2+ in the Nanomolar Range Regulates Glutamate-Dependent Oxidative Phosphorylation on Demand	PLOS ONE			English	Article							RAT-HEART MITOCHONDRIA; ADENINE-NUCLEOTIDES; LIVER MITOCHONDRIA; RUTHENIUM RED; PERMEABILITY TRANSITION; INTERMEMBRANE SPACE; CREATINE-KINASE; INNER MEMBRANE; CA-2+; TRANSPORT	We present unexpected and novel results revealing that glutamate-dependent oxidative phosphorylation (OXPHOS) of brain mitochondria is exclusively and efficiently activated by extramitochondrial Ca2+ in physiological concentration ranges (S-0.5 = 360 nM Ca2+). This regulation was not affected by RR, an inhibitor of the mitochondrial Ca2+ uniporter. Active respiration is regulated by glutamate supply to mitochondria via aralar, a mitochondrial glutamate/aspartate carrier with regulatory Ca2+-binding sites in the mitochondrial intermembrane space providing full access to cytosolic Ca2+. At micromolar concentrations, Ca2+ can also enter the intramitochondrial matrix and activate specific dehydrogenases. However, the latter mechanism is less efficient than extramitochondrial Ca2+ regulation of respiration/OXPHOS via aralar. These results imply a new mode of glutamate-dependent OXPHOS regulation as a demand-driven regulation of mitochondrial function. This regulation involves the mitochondrial glutamate/aspartate carrier aralar which controls mitochondrial substrate supply according to the level of extramitochondrial Ca2+.	[Gellerich, Frank Norbert; Jerzembek, Doreen; Striggow, Frank] KeyNeurotek Pharmaceut AG, ZENIT Technol Pk, Magdeburg, Germany; [Gizatullina, Zemfira; Vielhaber, Stefan] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Arandarcikaite, Odeta] Kaunas Univ Med, Inst Biomed Res, Kaunas, Lithuania; [Seppet, Enn] Univ Tartu, Dept Pathophysiol, Ctr Mol & Clin Med, EE-50090 Tartu, Estonia	Otto von Guericke University; Lithuanian University of Health Sciences; University of Tartu	Gellerich, FN (corresponding author), KeyNeurotek Pharmaceut AG, ZENIT Technol Pk, Magdeburg, Germany.	frank.gellerich@keyneurotek.de			European Huntington network; DFG [Ge 664/11-2]; German Federal Ministry of Economics and Technology [IWO72052]; Estonian Ministry of Education and Research [SF0180114As08]; Estonian Science Foundation [7117, 7823]	European Huntington network; DFG(German Research Foundation (DFG)); German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This work was supported by the European Huntington network, the DFG (Ge 664/11-2), the German Federal Ministry of Economics and Technology, grant No. IWO72052 (MitoscreenTest), Estonian Ministry of Education and Research (SF0180114As08) and Estonian Science Foundation (grants No. 7117 and 7823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; BUNGER R, 1980, H-S Z PHYSIOL CHEM, V361, P907, DOI 10.1515/bchm2.1980.361.1.907; CHANCE B, 1955, J BIOL CHEM, V217, P409; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Garcia-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932; Gellerich FN, 1998, EUR J BIOCHEM, V254, P172, DOI 10.1046/j.1432-1327.1998.2540172.x; GELLERICH FN, 1987, BIOCHIM BIOPHYS ACTA, V890, P117, DOI 10.1016/0005-2728(87)90012-0; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1140, P327, DOI 10.1016/0005-2728(93)90073-O; Gizatullina ZZ, 2005, BBA-BIOENERGETICS, V1706, P98, DOI 10.1016/j.bbabio.2004.09.013; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; HEINEMAN FW, 1990, J CLIN INVEST, V85, P843, DOI 10.1172/JCI114511; JOHNSTON JD, 1986, BIOCHEM SOC T, V14, P1182, DOI 10.1042/bst0141182; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LANOUE KF, 1974, J BIOL CHEM, V249, P7522; LENZEN S, 1992, BIOCHEM J, V286, P597, DOI 10.1042/bj2860597; MCCORMACK JG, 1989, BIOCHEM J, V264, P167, DOI 10.1042/bj2640167; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROSSI CS, 1973, BIOCHEM BIOPH RES CO, V50, P846, DOI 10.1016/0006-291X(73)91322-3; RUTTER GA, 1988, BIOCHEM J, V252, P181, DOI 10.1042/bj2520181; RUTTER GA, 1989, BIOCHIM BIOPHYS ACTA, V1014, P263, DOI 10.1016/0167-4889(89)90222-X; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Seppet EK, 2001, BBA-BIOENERGETICS, V1504, P379, DOI 10.1016/S0005-2728(00)00269-3; Sharma N, 2005, J PHYSIOL-LONDON, V562, P593, DOI 10.1113/jphysiol.2004.075713; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; UNITT JF, 1989, BIOCHEM J, V262, P293, DOI 10.1042/bj2620293; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1	37	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8181	10.1371/journal.pone.0008181	http://dx.doi.org/10.1371/journal.pone.0008181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011041	gold, Green Published, Green Submitted			2022-12-25	WOS:000272829800004
J	Murphy, DM; Buckley, PG; Bryan, K; Das, S; Alcock, L; Foley, NH; Prenter, S; Bray, I; Watters, KM; Higgins, D; Stallings, RL				Murphy, Derek M.; Buckley, Patrick G.; Bryan, Kenneth; Das, Sudipto; Alcock, Leah; Foley, Niamh H.; Prenter, Suzanne; Bray, Isabella; Watters, Karen M.; Higgins, Desmond; Stallings, Raymond L.			Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; CELL ADHESION MOLECULE; N-MYC; C-MYC; FUNCTIONAL-ANALYSIS; MCM PROTEINS; TARGET GENES; HUMAN GENOME; IN-VIVO; EXPRESSION	Background: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, is a major cause of childhood cancer related deaths. The single most important prognostic indicator of poor clinical outcome in this disease is genomic amplification of MYCN, a member of a family of oncogenic transcription factors. Methodology: We applied MYCN chromatin immunoprecipitation to microarrays (ChIP-chip) using MYCN amplified/non-amplified cell lines as well as a conditional knockdown cell line to determine the distribution of MYCN binding sites within all annotated promoter regions. Conclusion: Assessment of E-box usage within consistently positive MYCN binding sites revealed a predominance for the CATGTG motif (p < 0.0016), with significant enrichment of additional motifs CATTTG, CATCTG, CAACTG in the MYCN amplified state. For cell lines over-expressing MYCN, gene ontology analysis revealed enrichment for the binding of MYCN at promoter regions of numerous molecular functional groups including DNA helicases and mRNA transcriptional regulation. In order to evaluate MYCN binding with respect to other genomic features, we determined the methylation status of all annotated CpG islands and promoter sequences using methylated DNA immunoprecipitation (MeDIP). The integration of MYCN ChIP-chip and MeDIP data revealed a highly significant positive correlation between MYCN binding and DNA hypermethylation. This association was also detected in regions of hemizygous loss, indicating that the observed association occurs on the same homologue. In summary, these findings suggest that MYCN binding occurs more commonly at CATGTG as opposed to the classic CACGTG E-box motif, and that disease associated over expression of MYCN leads to aberrant binding to additional weaker affinity E-box motifs in neuroblastoma. The co-localization of MYCN binding and DNA hypermethylation further supports the dual role of MYCN, namely that of a classical transcription factor affecting the activity of individual genes, and that of a mediator of global chromatin structure.	[Murphy, Derek M.; Buckley, Patrick G.; Bryan, Kenneth; Das, Sudipto; Alcock, Leah; Foley, Niamh H.; Prenter, Suzanne; Bray, Isabella; Watters, Karen M.; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Murphy, Derek M.; Buckley, Patrick G.; Bryan, Kenneth; Das, Sudipto; Alcock, Leah; Foley, Niamh H.; Prenter, Suzanne; Bray, Isabella; Watters, Karen M.; Stallings, Raymond L.] Our Ladys Childrens Hosp, Childrens Res Ctr, Dublin, Ireland; [Higgins, Desmond] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University College Dublin	Murphy, DM (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Murphy, Derek/B-1285-2013; Bray, Isabella/D-6179-2012; Stallings, Raymond/A-7213-2008; Higgins, des g/J-6314-2012	Bryan, Kenneth/0000-0002-9550-8354	Science Foundation Ireland; Children's Medical and Research Foundation; Cancer Research Ireland; National Institutes of Health (NIH) [5R01CA127496]; Government of Ireland Postdoctoral Fellowship in Science, Engineering and Technology; NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; Cancer Research Ireland; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Ireland Postdoctoral Fellowship in Science, Engineering and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from Science Foundation Ireland, Children's Medical and Research Foundation, Cancer Research Ireland, and the National Institutes of Health (NIH) (5R01CA127496). PGB is supported by a Government of Ireland Postdoctoral Fellowship in Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2003, CANCER RES, V63, P4538; ALEX R, 1992, NUCLEIC ACIDS RES, V20, P2257, DOI 10.1093/nar/20.9.2257; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chatrath P, 2003, BRIT J CANCER, V89, P1048, DOI 10.1038/sj.bjc.6601234; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Davidson EJ, 2003, BRIT J CANCER, V88, P257, DOI 10.1038/sj.bjc.6600729; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Koppen A, 2007, CANCER LETT, V256, P218, DOI 10.1016/j.canlet.2007.06.011; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LEDENT V, 2002, GENOME BIOL, V3; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li M, 2008, BIOINFORMATICS, V24, P1745, DOI 10.1093/bioinformatics/btn256; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Lutz W, 1996, ONCOGENE, V13, P803; MA A, 1993, ONCOGENE, V8, P1093; Malynn BA, 2000, GENE DEV, V14, P1390; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morii E, 2004, AM J PATHOL, V165, P491, DOI 10.1016/S0002-9440(10)63314-7; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; PROCHOWNIK EV, 1993, P NATL ACAD SCI USA, V90, P960, DOI 10.1073/pnas.90.3.960; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sirieix PS, 2003, CLIN CANCER RES, V9, P2560; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; STANTON LW, 1986, P NATL ACAD SCI USA, V83, P1772, DOI 10.1073/pnas.83.6.1772; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; You XJ, 2007, ONCOL REP, V18, P691; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	61	59	60	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8154	10.1371/journal.pone.0008154	http://dx.doi.org/10.1371/journal.pone.0008154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997598	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829200004
J	Schoenenberger, P; Gerosa, D; Oertner, TG				Schoenenberger, Philipp; Gerosa, Daniela; Oertner, Thomas G.			Temporal Control of Immediate Early Gene Induction by Light	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHANNELRHODOPSIN-2; EXPRESSION; NEURONS; PHOTOCYCLES; ACTIVATION; CHANNEL; MICE	Background: The light-gated cation channel channelrhodopsin-2 (ChR2) is a powerful tool for the optical induction of action potentials in neurons. Mutations of the cysteine 128 (C128) residue have been shown to greatly extend the lifetime of the conducting state of ChR2. However, until now, only subthreshold depolarizations have been reported from C128 mutants. Methods and Findings: Here we report the induction of long high-frequency spike trains by brief light pulses in ChR2(C128A)-transfected pyramidal cells in hippocampal slice culture. ChR2(C128A)-mediated spike bursts triggered expression of the immediate early gene c-fos in pyramidal neurons. Robust and cell-specific expression of c-Fos protein was detected after a single blue light pulse and depended on action potential firing, but not on synaptic activity. However, photocurrents diminished upon repeated stimulation and limited the number of action potential bursts that could be elicited. Conclusions: We conclude that the C128A mutant is not suitable for chronic stimulation of neurons, but very useful for light-controlled induction of immediate early genes. This property of ChR2( C128A) could be harnessed to control the expression of proteins under control of the c-fos promoter with precise timing and single cell specificity.	[Schoenenberger, Philipp; Gerosa, Daniela; Oertner, Thomas G.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Schoenenberger, P (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	thomas.oertner@fmi.ch	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528	Novartis Research Foundation; SystemsX.ch	Novartis Research Foundation; SystemsX.ch	This work was supported by the Novartis Research Foundation and SystemsX.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMANTIDIS AR, 2007, NATURE; Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; BERNDT A, 2008, NAT NEUROSCI; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cambridge SB, 1997, SCIENCE, V277, P825, DOI 10.1126/science.277.5327.825; Cambridge SB, 2009, NAT METHODS, V6, P527, DOI 10.1038/nmeth.1340; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Nagel G, 1998, BIOPHYS J, V74, P403, DOI 10.1016/S0006-3495(98)77797-5; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; SCHOENENBERGER P, 2008, BRAIN CELL BIOL; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	26	55	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8185	10.1371/journal.pone.0008185	http://dx.doi.org/10.1371/journal.pone.0008185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997631	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829200016
J	Davies, MN; Bayry, J; Tchilian, EZ; Vani, J; Shaila, MS; Forbes, EK; Draper, SJ; Beverley, PCL; Tough, DF; Flower, DR				Davies, Matthew N.; Bayry, Jagadeesh; Tchilian, Elma Z.; Vani, Janakiraman; Shaila, Melkote S.; Forbes, Emily K.; Draper, Simon J.; Beverley, Peter C. L.; Tough, David F.; Flower, Darren R.			Toward the Discovery of Vaccine Adjuvants: Coupling In Silico Screening and In Vitro Analysis of Antagonist Binding to Human and Mouse CCR4 Receptors	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; CONFORMATIONAL-CHANGES; CHEMOKINE RECEPTORS; CRYSTAL-STRUCTURE; HOMOLOGY MODELS; LIGAND-BINDING; DRUG DISCOVERY; SMALL-MOLECULE; PROTEIN	Background: Adjuvants enhance or modify an immune response that is made to an antigen. An antagonist of the chemokine CCR4 receptor can display adjuvant-like properties by diminishing the ability of CD4+CD25+ regulatory T cells (Tregs) to down-regulate immune responses. Methodology: Here, we have used protein modelling to create a plausible chemokine receptor model with the aim of using virtual screening to identify potential small molecule chemokine antagonists. A combination of homology modelling and molecular docking was used to create a model of the CCR4 receptor in order to investigate potential lead compounds that display antagonistic properties. Three-dimensional structure-based virtual screening of the CCR4 receptor identified 116 small molecules that were calculated to have a high affinity for the receptor; these were tested experimentally for CCR4 antagonism. Fifteen of these small molecules were shown to inhibit specifically CCR4-mediated cellmigration, including that of CCR4(+) Tregs. Significance: Our CCR4 antagonists act as adjuvants augmenting human T cell proliferation in an in vitro immune response model and compound SP50 increases T cell and antibody responses in vivo when combined with vaccine antigens of Mycobacterium tuberculosis and Plasmodium yoelii in mice.	[Davies, Matthew N.; Bayry, Jagadeesh; Tough, David F.; Flower, Darren R.] Univ Oxford, Jenner Inst, Newbury, Berks, England; [Bayry, Jagadeesh; Vani, Janakiraman] Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers,Unite Mixte Rech Sante 872,U8, Paris, France; [Shaila, Melkote S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Forbes, Emily K.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore; University of Oxford; Jenner Institute	Davies, MN (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	darren.flower@jenner.ac.uk	Draper, Simon J/F-1758-2011; J, Vani/B-4882-2013; Flower, Darren/F-1263-2010; Tchilian, Elma Z/Q-5976-2017; Bayry, Jagadeesh/A-6589-2011	Draper, Simon J/0000-0002-9415-1357; Flower, Darren/0000-0002-8542-7067; Tchilian, Elma Z/0000-0002-4869-5118; Bayry, Jagadeesh/0000-0003-0498-9808; Beverley, Peter/0000-0003-0481-2180	Edward Jenner Institute for Vaccine Research; Medical Research Council; Biotechnology and Biological Sciences Research Council; Department of Health; GlaxoSmithKline; Wellcome Trust [WT079287MA]	Edward Jenner Institute for Vaccine Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Health; GlaxoSmithKline(GlaxoSmithKline); Wellcome Trust(Wellcome Trust)	This work was core funded by the Edward Jenner Institute for Vaccine Research. The Edward Jenner Institute for Vaccine Research thanks its erstwhile sponsors: the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Department of Health, and GlaxoSmithKline. PCLB and DRF received salary support from Senior Jenner Fellowships, and are both Jenner Institute Investigators. DRF drew additional support from the Wellcome Trust Grant WT079287MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2004, BIOORG MED CHEM LETT, V14, P1619, DOI 10.1016/j.bmcl.2004.01.072; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bayry J, 2008, P NATL ACAD SCI USA, V105, P10221, DOI 10.1073/pnas.0803453105; Bayry J, 2007, J IMMUNOL, V178, P4184, DOI 10.4049/jimmunol.178.7.4184; Bayry J, 2008, NAT REV MICROBIOL, V6, DOI 10.1038/nrmicro1681-c1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bissantz C, 2005, PROTEINS, V61, P938, DOI 10.1002/prot.20651; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Bissantz C, 2003, J RECEPT SIG TRANSD, V23, P123, DOI 10.1081/RRS-120025192; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Byrne B, 2002, CURR OPIN STRUC BIOL, V12, P239, DOI 10.1016/S0959-440X(02)00316-0; CABANIOLS JP, 1994, EUR J IMMUNOL, V24, P1743, DOI 10.1002/eji.1830240804; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaitra MG, 2008, J MED MICROBIOL, V57, P1079, DOI 10.1099/jmm.0.47565-0; Chen JZ, 2007, J CHEM INF MODEL, V47, P1626, DOI 10.1021/ci7000814; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Engel S, 2008, J AM CHEM SOC, V130, P5115, DOI 10.1021/ja077620l; Flower DR, 1998, J MOL GRAPH MODEL, V16, P239, DOI 10.1016/S1093-3263(98)80008-9; Gaulton A, 2003, CURR OPIN PHARMACOL, V3, P114, DOI 10.1016/S1471-4892(03)00005-5; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hattotuwagama CK, 2006, CURR MED CHEM, V13, P1283, DOI 10.2174/092986706776873005; Homer RW, 2008, J CHEM INF MODEL, V48, P2294, DOI 10.1021/ci7004687; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Katou F, 2001, AM J PATHOL, V158, P1263, DOI 10.1016/S0002-9440(10)64077-1; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Lieberam I, 1999, EUR J IMMUNOL, V29, P2684, DOI 10.1002/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.3.CO;2-P; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu SQ, 2007, J MOL MODEL, V13, P411, DOI 10.1007/s00894-006-0158-3; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Newhouse B, 2004, BIOORG MED CHEM LETT, V14, P5537, DOI 10.1016/j.bmcl.2004.09.001; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pandit SA, 2003, BIOPHYS J, V84, P3743, DOI 10.1016/S0006-3495(03)75102-9; Paterlini MG, 2002, BIOPHYS J, V83, P3012, DOI 10.1016/S0006-3495(02)75307-1; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Sadowski J, 1997, J COMPUT AID MOL DES, V11, P53, DOI 10.1023/A:1008023427310; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	60	42	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8084	10.1371/journal.pone.0008084	http://dx.doi.org/10.1371/journal.pone.0008084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	20011659	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000272828400025
J	Flores, LG; Bertolini, S; Yeh, HH; Young, D; Mukhopadhyay, U; Pal, A; Ying, YM; Volgin, A; Shavrin, A; Soghomonyan, S; Tong, W; Bornmann, W; Alauddin, MM; Logsdon, C; Gelovani, JG				Flores, Leo Garcia; Bertolini, Susanna; Yeh, Hsin Hsin; Young, Daniel; Mukhopadhyay, Uday; Pal, Ashutosh; Ying, Yunming; Volgin, Andrei; Shavrin, Aleksandr; Soghomonyan, Suren; Tong, William; Bornmann, William; Alauddin, Mian M.; Logsdon, Craig; Gelovani, Juri G.			Detection of Pancreatic Carcinomas by Imaging Lactose-Binding Protein Expression in Peritumoral Pancreas Using [F-18]Fluoroethyl-Deoxylactose PET/CT	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; DUCTAL ADENOCARCINOMA; FAMILY-HISTORY; HIGH-RISK; CANCER; HIP/PAP; HEPATOCARCINOMA; MANAGEMENT; BIOMARKER; PEPTIDE	Background: Early diagnosis of pancreatic carcinoma with highly sensitive diagnostic imaging methods could save lives of many thousands of patients, because early detection increases resectability and survival rates. Current non-invasive diagnostic imaging techniques have inadequate resolution and sensitivity for detection of small size (similar to 2-3 mm) early pancreatic carcinoma lesions. Therefore, we have assessed the efficacy of positron emission tomography and computer tomography (PET/CT) imaging with beta-O-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[F-18]fluoroethyl-D-glucopyranose ([F-18]FEDL) for detection of less than 3 mm orthotopic xenografts of L3.6pl pancreatic carcinomas in mice. [F-18]FEDL is a novel radioligand of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP), which is overexpressed in peritumoral pancreatic acinar cells. Methodology/Principal Findings: Dynamic PET/CT imaging demonstrated rapid accumulation of [F-18]FEDL in peritumoral pancreatic tissue (4.04+/-2.06%ID/g), bi-exponential blood clearance with half-lives of 1.65+/-0.50 min and 14.14+/-3.60 min, and rapid elimination from other organs and tissues, predominantly by renal clearance. Using model-independent graphical analysis of dynamic PET data, the average distribution volume ratio (DVR) for [F-18]FEDL in peritumoral pancreatic tissue was estimated as 3.57+/-0.60 and 0.94+/-0.72 in sham-operated control pancreas. Comparative analysis of quantitative autoradiographic images and densitometry of immunohistochemically stained and co-registered adjacent tissue sections demonstrated a strong linear correlation between the magnitude of [F-18]FEDL binding and HIP/PAP expression in corresponding regions (r = 0.88). The in situ analysis demonstrated that at least a 2-4 fold apparent lesion size amplification was achieved for submillimeter tumors and to nearly half a murine pancreas for tumors larger than 3 mm. Conclusion/Significance: We have demonstrated the feasibility of detection of early pancreatic tumors by non-invasive imaging with [F-18]FEDL PET/CT of tumor biomarker HIP/PAP over-expressed in peritumoral pancreatic tissue. Non-invasive non-invasive detection of early pancreatic carcinomas with [F-18]FEDL PET/CT imaging should aid the guidance of biopsies and additional imaging procedures, facilitate the resectability and improve the overall prognosis.	[Flores, Leo Garcia; Bertolini, Susanna; Yeh, Hsin Hsin; Young, Daniel; Mukhopadhyay, Uday; Pal, Ashutosh; Volgin, Andrei; Shavrin, Aleksandr; Soghomonyan, Suren; Tong, William; Alauddin, Mian M.; Gelovani, Juri G.] Univ Texas MD Anderson Canc Ctr, CABIR, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Logsdon, Craig] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Ying, Yunming; Bornmann, William] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Flores, LG (corresponding author), Univ Texas MD Anderson Canc Ctr, CABIR, Dept Expt Diagnost Imaging, Houston, TX 77030 USA.	jgelovani@mdanderson.org		Soghomonyan, Suren/0000-0001-5930-9051	NIH [U24 CA126577-01]; University of Texas, MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [U24CA126577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas, MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant U24 CA126577-01 (JG) and new research program development funds of Drs. Juri G. Gelovani and Mian M. Alauddin, provided by the University of Texas, MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormans G, 2001, J LABELLED COMPD RAD, V44, P417, DOI 10.1002/jlcr.471; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cerwenka H, 2001, ANTICANCER RES, V21, P1471; Chakrabarti A, 2007, CANCER BIOL THER, V6, P948, DOI 10.4161/cbt.6.6.4191; Christa L, 1999, AM J PATHOL, V155, P1525, DOI 10.1016/S0002-9440(10)65468-5; CHRISTA L, 1994, FEBS LETT, V337, P114, DOI 10.1016/0014-5793(94)80640-3; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Evans Douglas B., 1997, P1054; Fukushima N, 2005, MODERN PATHOL, V18, P779, DOI 10.1038/modpathol.3800337; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Goggins M, 2000, J SURG ONCOL, V74, P243, DOI 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C; Gold DV, 2008, CANCER RES, V68, P4819, DOI 10.1158/0008-5472.CAN-08-0232; Gold DV, 2006, J CLIN ONCOL, V24, P252, DOI 10.1200/JCO.2005.02.8282; Hervieu V, 2006, HUM PATHOL, V37, P1066, DOI 10.1016/j.humpath.2006.03.005; Honda K, 2005, CANCER RES, V65, P10613, DOI 10.1158/0008-5472.CAN-05-1851; Hruban RH, 2001, DIGEST DIS, V19, P76, DOI 10.1159/000050656; Iovanna JL, 2005, BBA-GEN SUBJECTS, V1723, P8, DOI 10.1016/j.bbagen.2005.01.002; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Lal G, 2000, CANCER RES, V60, P409; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Motoo Y, 2001, PANCREATOLOGY, V1, P43, DOI 10.1159/000055791; Nakashima A, 2009, PANCREAS, V38, P527, DOI 10.1097/MPA.0b013e3181a16d28; *NAT CANC I N, PANCR CANC; Nishii R, 2008, EUR J NUCL MED MOL I, V35, P990, DOI 10.1007/s00259-007-0649-1; Ohuchida K, 2006, CLIN CANCER RES, V12, P2066, DOI 10.1158/1078-0432.CCR-05-1821; Pakzad F, 2006, SEMIN NUCL MED, V36, P248, DOI 10.1053/j.semnuclmed.2006.03.005; Rosty C, 2002, CANCER RES, V62, P1868; Rulyak SJ, 2003, GASTROENTEROLOGY, V124, P1292, DOI 10.1016/S0016-5085(03)00272-5; Simon MT, 2003, FASEB J, V17, P1441, DOI 10.1096/fj.02-1013com; Xie MJ, 2003, DIGEST DIS SCI, V48, P459, DOI 10.1023/A:1022520212447; Yamaguchi K, 2005, WORLD J GASTROENTERO, V11, P5199; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Yeo CJ, 1997, ANN SURG, V226, P257; YING Y, 2009, J MED CHEM IN PRESS; Yokoi K, 2005, INT J ONCOL, V27, P1361	37	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7977	10.1371/journal.pone.0007977	http://dx.doi.org/10.1371/journal.pone.0007977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956730	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827500008
J	Haley, NJ; Mathiason, CK; Zabel, MD; Telling, GC; Hoover, EA				Haley, Nicholas J.; Mathiason, Candace K.; Zabel, Mark D.; Telling, Glenn C.; Hoover, Edward A.			Detection of Sub-Clinical CWD Infection in Conventional Test-Negative Deer Long after Oral Exposure to Urine and Feces from CWD plus Deer	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; ROCKY-MOUNTAIN ELK; BOVINE SPONGIFORM ENCEPHALOPATHY; CERVUS-ELAPHUS-NELSONI; CAPTIVE MULE DEER; ODOCOILEUS-HEMIONUS; PRION PROTEIN; CYCLIC AMPLIFICATION; PRP ACCUMULATION; LYMPHOID-TISSUES	Background: Chronic wasting disease (CWD) of cervids is a prion disease distinguished by high levels of transmissibility, wherein bodily fluids and excretions are thought to play an important role. Using cervid bioassay and established CWD detection methods, we have previously identified infectious prions in saliva and blood but not urine or feces of CWD+ donors. More recently, we identified very low concentrations of CWD prions in urine of deer by cervid PrP transgenic (Tg[CerPrP]) mouse bioassay and serial protein misfolding cyclic amplification (sPMCA). This finding led us to examine further our initial cervid bioassay experiments using sPMCA. Objectives: We sought to investigate whether conventional test-negative deer, previously exposed orally to urine and feces from CWD+ sources, may be harboring low level CWD infection not evident in the 19 month observation period. We further attempted to determine the peripheral PrPCWD distribution in these animals. Methods: Various neural and lymphoid tissues from conventional test-negative deer were reanalyzed for CWD prions by sPMCA and cervid transgenic mouse bioassay in parallel with appropriate tissue-matched positive and negative controls. Results: PrPCWD was detected in the tissues of orally exposed deer by both sPMCA and Tg[CerPrP] mouse bioassay; each assay revealed very low levels of CWD prions previously undetectable by western blot, ELISA, or IHC. Serial PMCA analysis of individual tissues identified that obex alone was positive in 4 of 5 urine/feces exposed deer. PrPCWD was amplified from both lymphoid and neural tissues of positive control deer but not from identical tissues of negative control deer. Discussion: Detection of subclinical infection in deer orally exposed to urine and feces (1) suggests that a prolonged subclinical state can exist, necessitating observation periods in excess of two years to detect CWD infection, and (2) illustrates the sensitive and specific application of sPMCA in the diagnosis of low-level prion infection. Based on these results, it is possible that low doses of prions, e. g. following oral exposure to urine and saliva of CWD-infected deer, bypass significant amplification in the LRS, perhaps utilizing a neural conduit between the alimentary tract and CNS, as has been demonstrated in some other prion diseases.	[Haley, Nicholas J.; Mathiason, Candace K.; Zabel, Mark D.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Telling, Glenn C.] Univ Kentucky, Dept Mol Biol & Genet, Lexington, KY USA	Colorado State University; University of Kentucky	Haley, NJ (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Edward.Hoover@colostate.edu	Telling, Glenn C/G-1217-2019; Mathiason, Candace K/E-7843-2017; Mathiason, Candace/H-9769-2017	Telling, Glenn C/0000-0002-6294-1805; Mathiason, Candace K/0000-0002-5920-4556; Mathiason, Candace/0000-0002-5920-4556	NIH/NCRR [T32 R07072-03]; NIH/NIAID [NO1-AI-25491-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NCRR Ruth L. Kirschstein Institutional T32 R07072-03 and NIH/NIAID NO1-AI-25491-02 (EAH, GCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRIMI U, 2008, PMCA BANK VOLES UPDA; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; [Anonymous], Chronic Wasting Disease; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hibler CP, 2003, J VET DIAGN INVEST, V15, P311, DOI 10.1177/104063870301500402; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Keane DP, 2008, J VET DIAGN INVEST, V20, P58, DOI 10.1177/104063870802000110; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; O'Rourke KI, 2003, J VET DIAGN INVEST, V15, P320, DOI 10.1177/104063870301500403; Peters J, 2000, J VET DIAGN INVEST, V12, P579, DOI 10.1177/104063870001200618; Race BL, 2007, EMERG INFECT DIS, V13, P824, DOI 10.3201/eid1306.070186; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spraker TR, 2006, J VET DIAGN INVEST, V18, P553, DOI 10.1177/104063870601800605; Spraker TR, 2004, VET REC, V155, P295, DOI 10.1136/vr.155.10.295; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Terry LA, 2003, VET REC, V152, P387, DOI 10.1136/vr.152.13.387; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; Wells GAH, 2003, VET RES COMMUN, V27, P25, DOI 10.1023/B:VERC.0000014113.44151.04; Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wolfe LL, 2007, J GEN VIROL, V88, P2078, DOI 10.1099/vir.0.82342-0; MICHIGANS 1 CASE CHR; POSITIVE CASE CWD FO	49	92	94	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7990	10.1371/journal.pone.0007990	http://dx.doi.org/10.1371/journal.pone.0007990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956732	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500020
J	Mavromatis, K; Chu, K; Ivanova, N; Hooper, SD; Markowitz, VM; Kyrpides, NC				Mavromatis, Konstantinos; Chu, Ken; Ivanova, Natalia; Hooper, Sean D.; Markowitz, Victor M.; Kyrpides, Nikos C.			Gene Context Analysis in the Integrated Microbial Genomes (IMG) Data Management System	PLOS ONE			English	Article							PROTEIN FAMILIES; FUSION EVENTS	Computational methods for determining the function of genes in newly sequenced genomes have been traditionally based on sequence similarity to genes whose function has been identified experimentally. Function prediction methods can be extended using gene context analysis approaches such as examining the conservation of chromosomal gene clusters, gene fusion events and co-occurrence profiles across genomes. Context analysis is based on the observation that functionally related genes are often having similar gene context and relies on the identification of such events across phylogenetically diverse collection of genomes. We have used the data management system of the Integrated Microbial Genomes (IMG) as the framework to implement and explore the power of gene context analysis methods because it provides one of the largest available genome integrations. Visualization and search tools to facilitate gene context analysis have been developed and applied across all publicly available archaeal and bacterial genomes in IMG. These computations are now maintained as part of IMG's regular genome content update cycle. IMG is available at: http://img.jgi.doe.gov.	[Mavromatis, Konstantinos; Ivanova, Natalia; Hooper, Sean D.; Kyrpides, Nikos C.] Joint Genome Inst, Dept Energy, Genome Biol Program, Walnut Creek, CA USA; [Chu, Ken; Markowitz, Victor M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mavromatis, K (corresponding author), Joint Genome Inst, Dept Energy, Genome Biol Program, Walnut Creek, CA USA.	KMavrommatis@lbl.gov	Kyrpides, Nikos C./A-6305-2014	Kyrpides, Nikos C./0000-0002-6131-0462; Ivanova, Natalia/0000-0002-5802-9485	US Department of Energy; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]	US Department of Energy(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rogozin IB, 2004, BRIEF BIOINFORM, V5, P131, DOI 10.1093/bib/5.2.131; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pD273, DOI 10.1093/nar/gkh053; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Van Dongen SM, 2000, THESIS U UTRECHT NET; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005	18	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7979	10.1371/journal.pone.0007979	http://dx.doi.org/10.1371/journal.pone.0007979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956731	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500010
J	Schwirtlich, M; Emri, Z; Antal, K; Mate, Z; Katarova, Z; Szabo, G				Schwirtlich, Marija; Emri, Zsuzsa; Antal, Karoly; Mate, Zoltan; Katarova, Zoya; Szabo, Gabor			GABA(A) and GABA(B) receptors of distinct properties affect oppositely the proliferation of mouse embryonic stem cells through synergistic elevation of intracellular Ca2+	FASEB JOURNAL			English	Article						Ca2+ imaging; ES cell self-renewal/differentiation; connexin 43	GAMMA-AMINOBUTYRIC-ACID; SELF-RENEWAL; SIGNAL-TRANSDUCTION; DEVELOPING NEURONS; PROGENITOR CELLS; EPSILON-SUBUNIT; GAP-JUNCTIONS; IN-VITRO; CALCIUM; EXPRESSION	Gamma-amminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system of vertebrates, serves as an autocrine/paracrine signaling molecule during development, modulating a number of calcium (Ca2+)-dependent processes, including proliferation, migration, and differentiation, acting via 2 types of GABA receptors (GABARs): ionotropic GABA(A)Rs and metabotropic GABA(B)Rs. Here, we demonstrate that mouse embryonic stem cells (mESCs), which possess the capacity for virtually unlimited self-renewal and pluripotency, synthesize GABA and express functional GABA(A)Rs and GABA(B)Rs, as well as voltage-gated calcium channels (VGCCs), ryanodine receptors (RyRs), and inwardly rectifying potassium (GIRK) channels. On activation, both GABAR types triggered synergistically intracellular calcium rise. Muscimol (a GABA(A)R agonist) induced single Ca2+ transients involving both VGCC-mediated Ca2+ influx and intracellular stores, while baclofen (a GABA(B)R agonist) evoked Ca2+ transients followed by intercellular Ca2+ waves and oscillations that were resistant to antagonists and entirely dependent on Ca2+ release from intracellular stores. Prolonged treatment with muscimol slightly inhibited, while baclofen or SR95531 (a GABA(A)R antagonist) significantly facilitated, mESC proliferation. GABA(A)R-specific ligands also induced morphological and gene expression changes indicating a differentiation shift. Our data suggest that the interplay between GABARs and downstream (coupled) effectors differentially modulates mESC proliferation/differentiation through selective activation of second messenger signaling cascades.-Schwirtlich, M., Emri, Z., Antal, K., Mate, Z., Katarova, Z., Szabo, G. GABA(A) and GABA(B) receptors of distinct properties affect oppositely the proliferation of mouse embryonic stem cells through synergistic elevation of intracellular Ca2+. FASEB J. 24, 1218-1228 (2010). www.fasebj.org	[Schwirtlich, Marija; Mate, Zoltan; Katarova, Zoya; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Lab Mol Biol & Genet, H-1450 Budapest, Hungary; [Emri, Zsuzsa; Antal, Karoly] Hungarian Acad Sci, Dept Neurochem, Chem Res Ctr, H-1450 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Szabo, G (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Mol Biol & Genet, POB 67, H-1450 Budapest, Hungary.	szabog@koki.hu	Szabo, Gabor/A-5087-2008	Szabo, Gabor/0000-0001-5438-5151; Schwirtlich, Marija/0000-0002-2183-0164				BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BAIN G, 1993, MOL BRAIN RES, V17, P23, DOI 10.1016/0169-328X(93)90068-Z; Balakier H, 2002, HUM REPROD, V17, P2938, DOI 10.1093/humrep/17.11.2938; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Collinson N, 2002, J NEUROSCI, V22, P5572; DEERAUSQUIN G, 1992, MOL PHARMACOL, V42, P407; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; Fiszman ML, 1999, DEV BRAIN RES, V115, P1, DOI 10.1016/S0165-3806(99)00035-8; Fukui M, 2008, J CELL PHYSIOL, V216, P507, DOI 10.1002/jcp.21422; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Goh G, 2005, THROMB HAEMOSTASIS, V94, P728, DOI 10.1160/TH05-04-0268; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; Hisatsune C, 2005, J BIOL CHEM, V280, P11723, DOI 10.1074/jbc.M409535200; Huang ZJ, 2006, NEURON, V50, P521, DOI 10.1016/j.neuron.2006.05.005; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Kanbara K, 2005, J ANDROL, V26, P485, DOI 10.2164/jandrol.04185; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kwakowsky A, 2007, DEV DYNAM, V236, P3532, DOI 10.1002/dvdy.21361; Kwakowsky A, 2008, DEV DYNAM, V237, P3830, DOI 10.1002/dvdy.21768; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lomazzi M, 2008, TRENDS PHARMACOL SCI, V29, P544, DOI 10.1016/j.tips.2008.07.011; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu DP, 2003, BIOL REPROD, V69, P106, DOI 10.1095/biolreprod.102.014696; Luyt K, 2007, J NEUROCHEM, V100, P822, DOI 10.1111/j.1471-4159.2006.04255.x; Magnaghi V, 2004, EUR J NEUROSCI, V19, P2641, DOI 10.1111/j.0953-816X.2004.03368.x; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meier SD, 2008, GLIA, V56, P1127, DOI 10.1002/glia.20684; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mody I, 2008, NEUROCHEM INT, V52, P60, DOI 10.1016/j.neuint.2007.07.010; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Muller E, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.003.2008; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neelands TR, 1999, MOL PHARMACOL, V55, P168, DOI 10.1124/mol.55.1.168; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Obrietan K, 1998, J NEUROPHYSIOL, V79, P1360, DOI 10.1152/jn.1998.79.3.1360; Obrietan K, 1997, J NEUROSCI, V17, P4785; Obrietan K, 2002, J NEUROPHYSIOL, V88, P1005, DOI 10.1152/jn.2002.88.2.1005; Obrietan K, 1999, J NEUROPHYSIOL, V82, P94, DOI 10.1152/jn.1999.82.1.94; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PARRAMON M, 1995, J NEUROSCI RES, V41, P65, DOI 10.1002/jnr.490410108; Ritter B, 2005, CELL TISSUE RES, V319, P181, DOI 10.1007/s00441-004-0991-6; Rosemblit N, 1999, DEV BIOL, V206, P163, DOI 10.1006/dbio.1998.9120; Ross D, 2002, CELL CALCIUM, V32, P307, DOI 10.1016/S0143-4160(02)00198-7; Schuller HM, 2008, CARCINOGENESIS, V29, P1979, DOI 10.1093/carcin/bgn041; Shah BH, 2004, J BIOL CHEM, V279, P414, DOI 10.1074/jbc.M309083200; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Stachecki JJ, 1996, DEVELOPMENT, V122, P2485; Tabata T, 2004, P NATL ACAD SCI USA, V101, P16952, DOI 10.1073/pnas.0405387101; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Tamayama T, 2005, MOL CELL BIOCHEM, V273, P117, DOI 10.1007/s11010-005-8159-6; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200; Tielens S, 2008, IN VITRO CELL DEV-AN, V44, P368, DOI 10.1007/s11626-008-9126-9; Todorova MG, 2008, J CELL PHYSIOL, V214, P354, DOI 10.1002/jcp.21203; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Varju P, 2001, CELL TISSUE RES, V305, P239, DOI 10.1007/s004410100356; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Wang Doris D, 2008, Epilepsy Curr, V8, P137, DOI 10.1111/j.1535-7511.2008.00270.x; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Watanabe M, 2006, HISTOL HISTOPATHOL, V21, P1135, DOI 10.14670/HH-21.1135; Watanabe M, 2002, INT REV CYTOL, V213, P1; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; WISDEN W, 1992, J NEUROSCI, V12, P1040; Worsdorfer P, 2008, STEM CELLS, V26, P431, DOI 10.1634/stemcells.2007-0482; Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	85	34	35	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2010	24	4					1218	1228		10.1096/fj.09-143586	http://dx.doi.org/10.1096/fj.09-143586			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19959723				2022-12-25	WOS:000276462300028
J	Bhatt, TK; Yogavel, M; Wydau, S; Berwal, R; Sharma, A				Bhatt, Tarun Kumar; Yogavel, Manickam; Wydau, Sandra; Berwal, Ritu; Sharma, Amit			Ligand-bound Structures Provide Atomic Snapshots for the Catalytic Mechanism of D-Amino Acid Deacylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA DEACYLASE; D-TYR-TRNA(TYR) DEACYLASE; ESCHERICHIA-COLI; PLASMODIUM-FALCIPARUM; SACCHAROMYCES-CEREVISIAE; BACILLUS SUBTILIS; CRYSTAL-STRUCTURE; ARCHAEA; IDENTIFICATION; SYNTHETASES	D-tyrosyl-tRNATyr deacylase (DTD) is an editing enzyme that removes D-amino acids from mischarged tRNAs. We describe an in-depth analysis of the malaria parasite Plasmodium falciparum DTD here. Our data provide structural insights into DTD complexes with adenosine and D-amino acids. Bound adenosine is proximal to the DTD catalysis site, and it represents the authentic terminal adenosine of charged tRNA. DTD-bound D-amino acids cluster at three different subsites within the overall active site pocket. These subsites, called transition, active, and exit subsites allow docking, re-orientation, chiral selection, catalysis, and exit of the free D-amino acid from DTD. Our studies reveal variable modes of D-amino acid recognition by DTDs, suggesting an inherent plasticity that can accommodate all D-amino acids. An in-depth analysis of native, ADP-bound, and D-amino acid-complexed DTD structures provide the first atomic snapshots of ligand recognition and subsequent catalysis by this enzyme family. We have mapped sites for the deacylation reaction and mark possible routes for entry and egress of all substrates and products. We have also performed structure-based inhibitor discovery and tested lead compounds against the malaria parasite P. falciparum using growth inhibition assays. Our studies provide a comprehensive structural basis for the catalytic mechanism of DTD enzymes and have implications for inhibition of this enzyme in P. falciparum as a route to inhibiting the parasite.	[Bhatt, Tarun Kumar; Yogavel, Manickam; Berwal, Ritu; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Wydau, Sandra] Ecole Polytech, CNRS, UMR7654, Biochim Lab, F-91128 Palaiseau, France	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com	Bhatt, Tarun Kumar/AFD-8503-2022; Manickam, Yogavel/O-4570-2015	Manickam, Yogavel/0000-0002-2119-062X; Wydau-Dematteis, Sandra/0000-0003-2023-3656	European Commission [HEALTH-F3-2009-223024]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been conducted as part of the MEPHITIS project and was supported in part by the European Commission (Grant Agreement HEALTH-F3-2009-223024).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1681, DOI 10.1021/bi00869a033; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; Dwivedi S, 2005, NAT STRUCT MOL BIOL, V12, P556, DOI 10.1038/nsmb943; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferri-Fioni ML, 2006, J BIOL CHEM, V281, P27575, DOI 10.1074/jbc.M605860200; Ferri-Fioni ML, 2001, J BIOL CHEM, V276, P47285, DOI 10.1074/jbc.M106550200; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim K, 2003, J BIOL CHEM, V278, P13496, DOI 10.1074/jbc.M213150200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Soutourina J, 1999, J BIOL CHEM, V274, P19109, DOI 10.1074/jbc.274.27.19109; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Wydau S, 2007, NUCLEIC ACIDS RES, V35, P930, DOI 10.1093/nar/gkl1145; Zheng G, 2009, BIOCHEM J, V417, P85, DOI 10.1042/BJ20080617	28	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5917	5930		10.1074/jbc.M109.038562	http://dx.doi.org/10.1074/jbc.M109.038562			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007323	Green Published, hybrid			2022-12-25	WOS:000275327200082
J	Brzeska, H; Guag, J; Remmert, K; Chacko, S; Korn, ED				Brzeska, Hanna; Guag, Jake; Remmert, Kirsten; Chacko, Susan; Korn, Edward D.			An Experimentally Based Computer Search Identifies Unstructured Membrane-binding Sites in Proteins APPLICATION TO CLASS I MYOSINS, PAKS, AND CARMIL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN KINASE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; ACANTHAMOEBA-CASTELLANII; CAPPING PROTEIN; EFFECTOR DOMAIN; LIPID-BINDING; LOCALIZATION; ACTIN; SEQUENCE	Programs exist for searching protein sequences for potential membrane-penetrating segments (hydrophobic regions) and for lipid-binding sites with highly defined tertiary structures, such as PH, FERM, C2, ENTH, and other domains. However, a rapidly growing number of membrane-associated proteins (including cytoskeletal proteins, kinases, GTP-binding proteins, and their effectors) bind lipids through less structured regions. Here, we describe the development and testing of a simple computer search program that identifies unstructured potential membrane-binding sites. Initially, we found that both basic and hydrophobic amino acids, irrespective of sequence, contribute to the binding to acidic phospholipid vesicles of synthetic peptides that correspond to the putative membrane-binding domains of Acanthamoeba class I myosins. Based on these results, we modified a hydrophobicity scale giving Arg- and Lys-positive, rather than negative, values. Using this basic and hydrophobic scale with a standard search algorithm, we successfully identified previously determined unstructured membrane-binding sites in all 16 proteins tested. Importantly, basic and hydrophobic searches identified previously unknown potential membrane-binding sites in class I myosins, PAKs and CARMIL (capping protein, Arp2/3, myosin I linker; a membrane-associated cytoskeletal scaffold protein), and synthetic peptides and protein domains containing these newly identified sites bound to acidic phospholipids in vitro.	[Brzeska, Hanna; Guag, Jake; Remmert, Kirsten; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Chacko, Susan] NIH, Sci Comp Branch, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Brzeska, H (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50,Rm 2515, Bethesda, MD 20892 USA.	brzeskah@mail.nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; BAINES IC, 1990, J CELL BIOL, V111, P1895, DOI 10.1083/jcb.111.5.1895; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; BRZESKA H, 1990, J BIOL CHEM, V265, P16138; BRZESKA H, 1992, J BIOL CHEM, V267, P23870; BRZESKA H, 1990, J BIOL CHEM, V265, P3591; Brzeska H, 1999, P NATL ACAD SCI USA, V96, P394, DOI 10.1073/pnas.96.2.394; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; DOBERSTEIN SK, 1993, NATURE, V365, P841, DOI 10.1038/365841a0; Feng L, 2001, BIOCHEMISTRY-US, V40, P904, DOI 10.1021/bi000996q; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Ishikawa T, 2004, P NATL ACAD SCI USA, V101, P12189, DOI 10.1073/pnas.0404835101; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1993, J BIOL CHEM, V268, P14981; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; KULESZALIPKA D, 1991, J CELL BIOL, V115, P109, DOI 10.1083/jcb.115.1.109; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee SF, 1998, J BIOL CHEM, V273, P27911, DOI 10.1074/jbc.273.43.27911; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu X, 2000, J BIOL CHEM, V275, P24886, DOI 10.1074/jbc.M004287200; LYNCH TJ, 1989, J BIOL CHEM, V264, P19333; McKenna JMD, 2009, J BIOL CHEM, V284, P28650, DOI 10.1074/jbc.M109.049791; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Morita YS, 1996, EUR J CELL BIOL, V71, P371; Niggli V, 2001, TRENDS BIOCHEM SCI, V26, P604, DOI 10.1016/S0968-0004(01)01927-2; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; Ostap EM, 2003, CELL MOTIL CYTOSKEL, V54, P29, DOI 10.1002/cm.10081; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Scott DL, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-17; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; Sengupta P, 2009, BIOPHYS J, V96, P4887, DOI 10.1016/j.bpj.2009.03.027; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Stock A, 1999, EMBO J, V18, P5274, DOI 10.1093/emboj/18.19.5274; Swanljung-Collins H, 1994, Adv Exp Med Biol, V358, P205; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Van Troys M, 2000, BIOCHEMISTRY-US, V39, P12181, DOI 10.1021/bi000816c; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; WANG ZY, 1995, J BIOL CHEM, V270, P27969, DOI 10.1074/jbc.270.46.27969; Wang ZY, 1997, J MUSCLE RES CELL M, V18, P395, DOI 10.1023/A:1018686428955; Wild AC, 2004, J BIOL CHEM, V279, P17101, DOI 10.1074/jbc.M314035200; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Winteroll S, 2005, TRANSFUS MED HEMOTH, V32, P20, DOI 10.1159/000082126; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; YU FX, 1992, J BIOL CHEM, V267, P14616	56	43	43	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5738	5747		10.1074/jbc.M109.066910	http://dx.doi.org/10.1074/jbc.M109.066910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018884	hybrid, Green Published			2022-12-25	WOS:000275327200066
J	Masuho, I; Celver, J; Kovoor, A; Martemyanov, KA				Masuho, Ikuo; Celver, Jeremy; Kovoor, Abraham; Martemyanov, Kirill A.			Membrane Anchor R9AP Potentiates GTPase-accelerating Protein Activity of RGS11.G beta(5) Complex and Accelerates Inactivation of the mGluR6-G(o) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON-BIPOLAR CELLS; RGS PROTEINS; K+ CHANNELS; R7BP; EXPRESSION; REGULATOR; AFFINITY; SUBUNITS; PHOTORECEPTORS; KINETICS	The R7 subfamily of RGS proteins critically regulates neuronal G protein-signaling pathways that are essential for vision, nociception, motor coordination, and reward processing. A member of the R7 RGS family, RGS11, is a GTPase-accelerating protein specifically expressed in retinal ON-bipolar cells where it forms complexes with the atypical G protein beta subunit, G beta(5), and transmembrane protein R9AP. Association with R9AP has been shown to be critical for the proteolytic stability of the complex in the retina. In this study we report that R9AP can in addition stimulate the GTPase-accelerating protein activity of the RGS11.G beta(5) complex at G alpha(o). Single turnover GTPase assays reveal that R9AP co-localizes RGS11.G beta(5) and G alpha(o) on the membrane and allosterically potentiates the GTPase-accelerating function of RGS11.G beta(5). Reconstitution of mGluR6-G alpha(o) signaling in Xenopus oocytes indicates that RGS11.G beta(5)-mediated GTPase acceleration in this system requires co-expression of R9AP. The results provide new insight into the regulation of mGluR6-G alpha(o) signaling by the RGS11.G beta(5).R9AP complex and establish R9AP as a general GTPase-accelerating protein activity regulator of R7 RGS complexes.	[Masuho, Ikuo; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Celver, Jeremy; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Rhode Island	Kovoor, A (corresponding author), 57 Fogarty Hall,41 Lower Coll Rd, Kingston, RI 02881 USA.	abekovoor@uri.edu; martemyanov@umn.edu	Masuho, Ikuo/J-6115-2014		National Institutes of Health [EY018139, DA026405, R41MH078570]; McKnight Land; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH078570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Land; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants EY018139 (to K. A. M.), DA026405 (to K. A. M.), and R41MH078570 (to J. C. and A. K.). This work was also supported by a McKnight Land Grant award (to K. A. M.).	Andernacht M, 2009, ATW-INT J NUCL POWER, V54, P33; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Cao Y, 2008, J NEUROSCI, V28, P10443, DOI 10.1523/JNEUROSCI.3282-08.2008; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; Dhingra A, 2004, J NEUROSCI, V24, P5684, DOI 10.1523/JNEUROSCI.0492-04.2004; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Garzon J, 2003, NEUROPSYCHOPHARMACOL, V28, P1983, DOI 10.1038/sj.npp.1300263; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Keresztes G, 2003, MOL CELL NEUROSCI, V24, P687, DOI 10.1016/S1044-7431(03)00231-8; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2004, METHOD ENZYMOL, V390, P196; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Vardi Noga, 2002, Keio Journal of Medicine, V51, P154; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	43	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4781	4787		10.1074/jbc.M109.058511	http://dx.doi.org/10.1074/jbc.M109.058511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007977	Green Published, hybrid			2022-12-25	WOS:000275274800056
J	Nishi, H; Ono, K; Iwanaga, Y; Horie, T; Nagao, K; Takemura, G; Kinoshita, M; Kuwabara, Y; Mori, RT; Hasegawa, K; Kita, T; Kimura, T				Nishi, Hitoo; Ono, Koh; Iwanaga, Yoshitaka; Horie, Takahiro; Nagao, Kazuya; Takemura, Genzou; Kinoshita, Minako; Kuwabara, Yasuhide; Mori, Rieko Takanabe; Hasegawa, Koji; Kita, Toru; Kimura, Takeshi			MicroRNA-15b Modulates Cellular ATP Levels and Degenerates Mitochondria via Arl2 in Neonatal Rat Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; HEART; EXPRESSION; HYPERTROPHY; ISOFORM; MUSCLE; ABNORMALITIES; DEFICIENCY; TISSUES; MODELS	MicroRNAs (miRNAs or miRs) are small, non-coding RNAs that modulate mRNA stability and post-transcriptional translation. A growing body of evidence indicates that specific miRNAs can affect the cellular function of cardiomyocytes. In the present study, miRNAs that are highly expressed in the heart were over-expressed in neonatal rat ventricular myocytes, and cellular ATP levels were assessed. As a result, miR-15b, -16, -195, and -424, which have the same seed sequence, the most critical determinant of miRNA targeting, decreased cellular ATP levels. These results suggest that these miRNAs could specifically down-regulate the same target genes and consequently decrease cellular ATP levels. Through a bioinformatics approach, ADP-ribosylation factor-like 2 (Arl2) was identified as a potential target of miR-15b. It has already been shown that Arl2 localizes to adenine nucleotide transporter 1, the exchanger of ADP/ATP in mitochondria. Overexpression of miR-15b, -16, -195, and -424 suppressed the activity of a luciferase reporter construct fused with the 3'-untranslated region of Arl2. In addition, miR-15b overexpression decreased Arl2 mRNA and protein expression levels. The effects of Arl2 siRNA on cellular ATP levels were the same as those of miR-15b, and the expression of Arl2 could restore ATP levels reduced by miR-15b. A loss-of-function study of miR-15b resulted in increased Arl2 protein and cellular ATP levels. Electron microscopic analysis revealed that mitochondria became degenerated in cardiomyocytes that had been transduced with miR-15b and Arl2 siRNA. The present results suggest that miR-15b may decrease mitochondrial integrity by targeting Arl2 in the heart.	[Ono, Koh] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Iwanaga, Yoshitaka] Kinki Univ, Sch Med, Dept Internal Med, Div Cardiol, Osakasayama 5898511, Japan; [Takemura, Genzou] Gifu Univ, Grad Sch Med, Div Cardiol, Gifu 5011194, Japan; [Mori, Rieko Takanabe; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto 6128555, Japan	Kyoto University; Kindai University (Kinki University); Gifu University	Ono, K (corresponding author), Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	kohono@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Science, and Technology [R31-10069]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. O., K. H., T. K., and T. K.) and by Grant R31-10069 (WCU Program) from the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology.	BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Chen XM, 1999, J BIOL CHEM, V274, P37750, DOI 10.1074/jbc.274.53.37750; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; DAS AM, 1990, BIOCHEM J, V266, P355, DOI 10.1042/bj2660355; Dorner A, 2007, TRENDS CARDIOVAS MED, V17, P284, DOI 10.1016/j.tcm.2007.10.001; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Dorner A, 1999, BBA-BIOMEMBRANES, V1417, P16, DOI 10.1016/S0005-2736(98)00245-4; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; HEYLIGER C E, 1985, Canadian Journal of Cardiology, V1, P401; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; Murdock DG, 1999, J BIOL CHEM, V274, P14429, DOI 10.1074/jbc.274.20.14429; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; Ning XH, 2000, J AM COLL CARDIOL, V36, P282, DOI 10.1016/S0735-1097(00)00689-6; PASSARELLA S, 1988, BIOCHEM BIOPH RES CO, V156, P978, DOI 10.1016/S0006-291X(88)80940-9; RUPP H, 1992, FASEB J, V6, P2349, DOI 10.1096/fasebj.6.6.1531968; SABBAH HN, 1992, J MOL CELL CARDIOL, V24, P1333, DOI 10.1016/0022-2828(92)93098-5; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; SCHEUER J, 1982, J CLIN INVEST, V70, P1300, DOI 10.1172/JCI110729; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; SORDAHL LA, 1973, AM J PHYSIOL, V224, P497, DOI 10.1152/ajplegacy.1973.224.3.497; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	38	115	121	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4920	4930		10.1074/jbc.M109.082610	http://dx.doi.org/10.1074/jbc.M109.082610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007690	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000275274800069
J	Altmayr, F; Jusek, G; Holzmann, B				Altmayr, Felicitas; Jusek, Gabriela; Holzmann, Bernhard			The Neuropeptide Calcitonin Gene-related Peptide Causes Repression of Tumor Necrosis Factor-alpha Transcription and Suppression of ATF-2 Promoter Recruitment in Toll-like Receptor-stimulated Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP EARLY REPRESSOR; SIGNAL-TRANSDUCTION; INNATE IMMUNITY; NEGATIVE REGULATION; BINDING-PROTEIN; SENSORY NERVES; MAST-CELLS; T-CELLS; C-JUN; EXPRESSION	Sensory nerves may dampen inflammatory processes through the release of the neuropeptide calcitonin gene-related peptide (CGRP). CGRP mediates immunosuppressive activities through up-regulation of interleukin-10 or, alternatively, through an interleukin-10-independent pathway that is associated with rapid induction of the transcriptional inducible cAMP early repressor (ICER). In this work, we further investigated the molecular mechanisms of immune modulation by CGRP. Using TLR2-stimulated dendritic cells, we show that inhibition of tumor necrosis factor-alpha production by CGRP is dependent on up-regulation of endogenous ICER. Dendritic cell expression of ICER was selectively induced by CGRP and elevation of cellular cAMP levels but not by numerous pro- and anti-inflammatory cytokines. Treatment of dendritic cells with CGRP did not interfere with the induction of Tnfa gene expression but caused premature repression of TLR2-induced transcriptional activity. ATF-2 was rapidly phosphorylated and recruited to the Tnfa promoter following ligation of TLR2. Concomitant administration of CGRP completely prevented binding of ATF-2 to the Tnfa promoter, whereas recruitment of ICER was markedly elevated. In contrast, CGRP did not influence TLR2-stimulated binding of NF-kappa B p65. Together, these results are consistent with a model suggesting that CGRP causes rapid up-regulation of ICER, which in turn competes with ATF-2 for binding to the Tnfa promoter, leading to repression of gene expression.	[Altmayr, Felicitas; Jusek, Gabriela; Holzmann, Bernhard] Tech Univ Munich, Dept Surg, D-81675 Munich, Germany	Technical University of Munich	Holzmann, B (corresponding author), Tech Univ Munich, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.	holzmann@chir.med.tu-muenchen.de						Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; ASAHINA A, 1995, J IMMUNOL, V154, P3056; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; Bodor J, 1998, J BIOL CHEM, V273, P9544, DOI 10.1074/jbc.273.16.9544; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Carucci JA, 2000, J IMMUNOL, V164, P3494, DOI 10.4049/jimmunol.164.7.3494; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Drissi H, 1998, J BIOL CHEM, V273, P20168, DOI 10.1074/jbc.273.32.20168; Dunzendorfer S, 2001, J IMMUNOL, V166, P2167, DOI 10.4049/jimmunol.166.4.2167; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; Fox FE, 1997, J INVEST DERMATOL, V108, P43, DOI 10.1111/1523-1747.ep12285627; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Hussain MA, 2000, DIABETES, V49, P1681, DOI 10.2337/diabetes.49.10.1681; Kameda T, 1999, BBA-GENE STRUCT EXPR, V1445, P31, DOI 10.1016/S0167-4781(99)00018-4; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Levite M, 1998, J IMMUNOL, V160, P993; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mead JR, 2003, J BIOL CHEM, V278, P17741, DOI 10.1074/jbc.M301602200; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Monaco L, 1997, ONCOGENE, V15, P2493, DOI 10.1038/sj.onc.1201636; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Naukkarinen A, 1996, J PATHOL, V180, P200, DOI 10.1002/(SICI)1096-9896(199610)180:2<200::AID-PATH632>3.0.CO;2-Z; NUMAO T, 1992, J IMMUNOL, V149, P3309; Reinshagen M, 2000, GASTROENTEROLOGY, V119, P368, DOI 10.1053/gast.2000.9307; Reinshagen M, 1998, J PHARMACOL EXP THER, V286, P657; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thommesen L, 2000, J BIOL CHEM, V275, P4244, DOI 10.1074/jbc.275.6.4244; Thonberg H, 2001, BIOCHEM J, V354, P169, DOI 10.1042/bj3540169; Torii H, 1997, J LEUKOCYTE BIOL, V61, P216, DOI 10.1002/jlb.61.2.216; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Uyttersprot N, 1999, EUR J BIOCHEM, V259, P370, DOI 10.1046/j.1432-1327.1999.00049.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	49	30	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3525	3531		10.1074/jbc.M109.066787	http://dx.doi.org/10.1074/jbc.M109.066787			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20018859	Green Published, hybrid			2022-12-25	WOS:000275254000001
J	Yang, XM; Wood, PA; Hrushesky, WJM				Yang, Xiaoming; Wood, Patricia A.; Hrushesky, William J. M.			Mammalian TIMELESS Is Required for ATM-dependent CHK2 Activation and G(2)/M Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HISTONE H3; SERINE 10; PHOSPHORYLATION; KINASES; CANCER; P53; PROTEIN; REPAIR	Timeless (Tim), a core circadian clock gene in Drosophila, is retained in mammals but has no apparent mammalian circadian clock function. Mammalian TIM is essential for ATR-dependent Chk1 activation and S-phase arrest. We report that TIM is likewise essential for ATM-dependent Chk2-mediated signaling of doxorubicin-induced DNA double strand breaks. TIM depletion attenuates doxorubicin-induced G(2)/M cell cycle arrest and sensitizes cancer cells to doxorubicin-induced cytotoxicity. TIM is, thereby, a potential novel anticancer drug target whose inhibition may enhance the therapeutic cytotoxicity of agents that activate DNA damage pathways as part of their mechanism.	[Hrushesky, William J. M.] Wm Jennings Bryan Dorn Vet Affairs Med Ctr, Med Chronobiol Lab, Columbia, SC 29209 USA; [Wood, Patricia A.; Hrushesky, William J. M.] Univ S Carolina, Sch Med, Columbia, SC 29209 USA; [Hrushesky, William J. M.] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29209 USA; [Hrushesky, William J. M.] Univ S Carolina, Sch Engn & Comp Sci, Columbia, SC 29209 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hrushesky, WJM (corresponding author), Wm Jennings Bryan Dorn Vet Affairs Med Ctr, Med Chronobiol Lab, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	williamhrushesky@gmail.com		Hrushesky, William/0000-0002-0955-3192				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gotter AL, 2006, NEUROREPORT, V17, P1229, DOI 10.1097/01.wnr.0000233092.90160.92; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kennedy DR, 2007, P NATL ACAD SCI USA, V104, P17632, DOI 10.1073/pnas.0708274104; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perona R, 2008, CLIN TRANSL ONCOL, V10, P538, DOI 10.1007/s12094-008-0248-5; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Prives C, 1999, J PATHOL, V187, P112; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shieh SY, 2000, GENE DEV, V14, P289; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	50	80	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3030	10.1074/jbc.M109.050237	http://dx.doi.org/10.1074/jbc.M109.050237			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996108	hybrid, Green Published			2022-12-25	WOS:000273829000018
J	Chen, GF; Wang, LP; Tsien, JZ				Chen, Guifen; Wang, L. Phillip; Tsien, Joe Z.			Neural Population-Level Memory Traces in the Mouse Hippocampus	PLOS ONE			English	Article							SLEEP SPINDLE DENSITY; LONG-TERM-MEMORY; CONDITIONING REQUIRES; DORSAL HIPPOCAMPUS; EPISODIC MEMORY; PLACE CELLS; GENETIC ENHANCEMENT; PREFRONTAL CORTEX; ENTORHINAL CORTEX; FEAR EXTINCTION	One of the fundamental goals in neurosciences is to elucidate the formation and retrieval of brain's associative memory traces in real-time. Here, we describe real-time neural ensemble transient dynamics in the mouse hippocampal CA1 region and demonstrate their relationships with behavioral performances during both learning and recall. We employed the classic trace fear conditioning paradigm involving a neutral tone followed by a mild foot-shock 20 seconds later. Our large-scale recording and decoding methods revealed that conditioned tone responses and tone-shock association patterns were not present in CA1 during the first pairing, but emerged quickly after multiple pairings. These encoding patterns showed increased immediate-replay, correlating tightly with increased immediate-freezing during learning. Moreover, during contextual recall, these patterns reappeared in tandem six-to-fourteen times per minute, again correlating tightly with behavioral recall. Upon traced tone recall, while various fear memories were retrieved, the shock traces exhibited a unique recall-peak around the 20-second trace interval, further signifying the memory of time for the expected shock. Therefore, our study has revealed various real-time associative memory traces during learning and recall in CA1, and demonstrates that real-time memory traces can be decoded on a moment-to-moment basis over any single trial.	[Chen, Guifen] Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; Med Coll Georgia, Sch Med, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Chen, GF (corresponding author), Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	jtsien@mcg.edu	Chen, Guifen/AAQ-5044-2020	Chen, Guifen/0000-0002-5459-660X	National Institute of Mental Health (NIMH); National Institute of Aging (NIA); MCG; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MCG; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funds from National Institute of Mental Health (NIMH), National Institute of Aging (NIA), MCG fund, and Georgia Research Alliance (All to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; BERGER TW, 1978, P NATL ACAD SCI USA, V75, P1572, DOI 10.1073/pnas.75.3.1572; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; Biedenkapp JC, 2007, LEARN MEMORY, V14, P200, DOI 10.1101/lm.499407; Cho MH, 2007, P NATL ACAD SCI USA, V104, P16317, DOI 10.1073/pnas.0703344104; Chowdhury N, 2005, BEHAV NEUROSCI, V119, P1396, DOI 10.1037/0735-7044.119.5.1396; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Clark RE, 1998, BEHAV NEUROSCI, V112, P1062, DOI 10.1037/0735-7044.112.5.1062; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS M, 1986, BEHAV NEUROSCI, V100, P814, DOI 10.1037/0735-7044.100.6.814; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; DISTERHOFT JF, 1986, P NATL ACAD SCI USA, V83, P2733, DOI 10.1073/pnas.83.8.2733; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P275; Gais S, 2002, J NEUROSCI, V22, P6830; GALLAGHER M, 2000, AMYGDALA; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; HARRISON SA, 2009, NATURE; Hasselmo ME, 2008, EUR J NEUROSCI, V28, P1301, DOI 10.1111/j.1460-9568.2008.06437.x; Hebb Donald O., 1949, ORG BEHAV; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; Kentros C, 2006, HIPPOCAMPUS, V16, P743, DOI 10.1002/hipo.20199; Kholodar-Smith DB, 2008, NEUROBIOL LEARN MEM, V90, P537, DOI 10.1016/j.nlm.2008.06.006; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; Lin LN, 2006, TRENDS NEUROSCI, V29, P48, DOI 10.1016/j.tins.2005.11.004; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2007, P NATL ACAD SCI USA, V104, P6066, DOI 10.1073/pnas.0701106104; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moser EI, 2005, NEUROSCIENCE, V130, P519, DOI 10.1016/j.neuroscience.2004.09.044; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Ohno M, 2005, LEARN MEMORY, V12, P211, DOI 10.1101/lm.90205; OLDS J, 1972, J NEUROPHYSIOL, V35, P202, DOI 10.1152/jn.1972.35.2.202; Osan R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000404; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Ponomarenko AA, 2008, EUR J NEUROSCI, V27, P3035, DOI 10.1111/j.1460-9568.2008.06232.x; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shrager Y, 2008, P NATL ACAD SCI USA, V105, P12034, DOI 10.1073/pnas.0805414105; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; THOMPSON RF, 2005, REV NEUROSCI, V17, P519; Tsien JZ, 2007, SCI AM, V297, P52, DOI 10.1038/scientificamerican0707-52; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tulving E., 1972, ORG MEMORY, P381; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004	67	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8256	10.1371/journal.pone.0008256	http://dx.doi.org/10.1371/journal.pone.0008256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016843	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834000007
J	Pilyugin, M; Demmers, J; Verrijzer, CP; Karch, F; Moshkin, YM				Pilyugin, Maxim; Demmers, Jeroen; Verrijzer, C. Peter; Karch, Francois; Moshkin, Yuri M.			Phosphorylation-Mediated Control of Histone Chaperone ASF1 Levels by Tousled-Like Kinases	PLOS ONE			English	Article							DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; ASSEMBLY PATHWAY; HO PROMOTER; REPAIR; DEPOSITION; MACHINERY; COMPLEX; CAF-1	Histone chaperones are at the hub of a diverse interaction networks integrating a plethora of chromatin modifying activities. Histone H3/H4 chaperone ASF1 is a target for cell-cycle regulated Tousled-like kinases (TLKs) and both proteins cooperate during chromatin replication. However, the precise role of post-translational modification of ASF1 remained unclear. Here, we identify the TLK phosphorylation sites for both Drosophila and human ASF1 proteins. Loss of TLK-mediated phosphorylation triggers hASF1a and dASF1 degradation by proteasome-dependent and independent mechanisms respectively. Consistent with this notion, introduction of phosphorylation-mimicking mutants inhibits hASF1a and dASF1 degradation. Human hASF1b is also targeted for proteasome-dependent degradation, but its stability is not affected by phosphorylation indicating that other mechanisms are likely to be involved in control of hASF1b levels. Together, these results suggest that ASF1 cellular levels are tightly controlled by distinct pathways and provide a molecular mechanism for post-translational regulation of dASF1 and hASF1a by TLK kinases.	[Pilyugin, Maxim; Karch, Francois] Univ Geneva, Dept Zool, Geneva, Switzerland; [Pilyugin, Maxim; Karch, Francois] Univ Geneva, Natl Res Ctr Frontiers Genet, Geneva, Switzerland; [Demmers, Jeroen] Erasmus Univ, Med Ctr, Prote Ctr, Rotterdam, Netherlands; [Verrijzer, C. Peter; Moshkin, Yuri M.] Erasmus Univ, Dept Biochem, Ctr Biomed Genet, NL-3000 DR Rotterdam, Netherlands	University of Geneva; University of Geneva; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam	Pilyugin, M (corresponding author), Univ Geneva, Dept Zool, Geneva, Switzerland.	Francois.Karch@zoo.unige.ch; i.mochkine@erasmusmc.nl	Moshkin, Yuri M./M-3093-2016; Demmers, Jeroen AA/F-4046-2016; Moshkin, Yuri/ABA-3435-2021	Moshkin, Yuri M./0000-0003-2964-8823; Demmers, Jeroen AA/0000-0002-8757-9611; Moshkin, Yuri/0000-0003-2964-8823	Ligue Genevoise Contre Le Cancer [0511]; European Community EuTRACC [LSHG-CT-2007-037445]; EMBO Long Term	Ligue Genevoise Contre Le Cancer; European Community EuTRACC; EMBO Long Term(European Molecular Biology Organization (EMBO))	This work was supported by the grants from Ligue Genevoise Contre Le Cancer N/ref. 0511 (to M. Pilyugin and F. Karch), European Community EuTRACC, LSHG-CT-2007-037445 (to C.P. Verrijzer) and EMBO Long Term Fellowship (Y.M. Moshkin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Bajpe PK, 2008, MOL CELL BIOL, V28, P1606, DOI 10.1128/MCB.01567-07; BERCKMANS B, 2009, TRANSCRIPTIONAL CONT; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Gkikopoulos T, 2009, MOL CELL BIOL, V29, P4057, DOI 10.1128/MCB.00400-09; Goodfellow H, 2007, DEV CELL, V13, P593, DOI 10.1016/j.devcel.2007.08.021; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hayashi R, 2007, DNA CELL BIOL, V26, P91, DOI 10.1089/dna.2006.0515; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Moshkin YM, 2002, GENE DEV, V16, P2621, DOI 10.1101/gad.231202; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; WORBY CA, 2001, SCI STKE 2001; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	31	24	29	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8328	10.1371/journal.pone.0008328	http://dx.doi.org/10.1371/journal.pone.0008328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016786	Green Submitted, gold, Green Published			2022-12-25	WOS:000272834000015
J	Iijima-Ando, K; Hearn, SA; Shenton, C; Gatt, A; Zhao, LJ; Iijima, K				Iijima-Ando, Kanae; Hearn, Stephen A.; Shenton, Christopher; Gatt, Anthony; Zhao, LiJuan; Iijima, Koichi			Mitochondrial Mislocalization Underlies A beta 42-Induced Neuronal Dysfunction in a Drosophila Model of Alzheimer's Disease	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; AMYLOID-BETA; AXONAL-TRANSPORT; A-BETA; DYNAMICS; NEURODEGENERATION; PATHOGENESIS; CALCIUM; OVEREXPRESSION; FRAGMENTATION	The amyloid-beta 42 (A beta 42) is thought to play a central role in the pathogenesis of Alzheimer's disease (AD). However, the molecular mechanisms by which A beta 42 induces neuronal dysfunction and degeneration remain elusive. Mitochondrial dysfunctions are implicated in AD brains. Whether mitochondrial dysfunctions are merely a consequence of AD pathology, or are early seminal events in AD pathogenesis remains to be determined. Here, we show that A beta 42 induces mitochondrial mislocalization, which contributes to A beta 42-induced neuronal dysfunction in a transgenic Drosophila model. In the A beta 42 fly brain, mitochondria were reduced in axons and dendrites, and accumulated in the somata without severe mitochondrial damage or neurodegeneration. In contrast, organization of microtubule or global axonal transport was not significantly altered at this stage. A beta 42-induced behavioral defects were exacerbated by genetic reductions in mitochondrial transport, and were modulated by cAMP levels and PKA activity. Levels of putative PKA substrate phosphoproteins were reduced in the A beta 42 fly brains. Importantly, perturbations in mitochondrial transport in neurons were sufficient to disrupt PKA signaling and induce late-onset behavioral deficits, suggesting a mechanism whereby mitochondrial mislocalization contributes to A beta 42-induced neuronal dysfunction. These results demonstrate that mislocalization of mitochondria underlies the pathogenic effects of A beta 42 in vivo.	[Iijima-Ando, Kanae; Shenton, Christopher; Zhao, LiJuan] Thomas Jefferson Univ, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA; [Shenton, Christopher; Gatt, Anthony; Iijima, Koichi] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Hearn, Stephen A.] Cold Spring Harbor Lab, Microscopy Facil, Cold Spring Harbor, NY 11724 USA	Jefferson University; Jefferson University; Cold Spring Harbor Laboratory	Iijima-Ando, K (corresponding author), Thomas Jefferson Univ, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA.	Kanae.Iijima-Ando@jefferson.edu; Koichi.Iijima@jefferson.edu		Hearn, Stephen/0000-0002-2489-2424	Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation; American Federation for Aging Research; Alzheimer's Association [NIRG-08-91985]; National Institutes of Health [R01AG032279-A1]; NATIONAL INSTITUTE ON AGING [R01AG032279] Funding Source: NIH RePORTER	Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation; American Federation for Aging Research; Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by start-up funds from the Farber Institute for Neurosciences, a pilot research grant from the Thomas Jefferson University, and grants from The Gilbert Foundation, the American Federation for Aging Research (http://www.afar.org/), the Alzheimer's Association (http://www.alz.org/index. asp) (NIRG-08-91985) and the National Institutes of Health (R01AG032279-A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cowburn RF, 2001, BIOCHEM SOC SYMP, V67, P163; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donato AJ, 2009, FASEB J, V23; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; MASLIAH E, 1995, HISTOL HISTOPATHOL, V10, P509; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; YIN JCP, 1995, MOL CELL BIOL, V15, P5123	59	86	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8310	10.1371/journal.pone.0008310	http://dx.doi.org/10.1371/journal.pone.0008310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016833	Green Published, Green Accepted, gold			2022-12-25	WOS:000272833800009
J	Bosch, N; Morell, M; Ponsa, I; Mercader, JM; Armengol, L; Estivill, X				Bosch, Nina; Morell, Marta; Ponsa, Immaculada; Maria Mercader, Josep; Armengol, Lluis; Estivill, Xavier			Nucleotide, Cytogenetic and Expression Impact of the Human Chromosome 8p23.1 Inversion Polymorphism	PLOS ONE			English	Article							COPY-NUMBER-VARIATION; WILLIAMS-BEUREN-SYNDROME; L1 RETROTRANSPOSITION; SOMATIC MOSAICISM; HUMAN GENOME; COMMON-CAUSE; HUMAN DNA; GENE; REARRANGEMENTS; PATIENT	Background: The human chromosome 8p23.1 region contains a 3.8-4.5 Mb segment which can be found in different orientations (defined as genomic inversion) among individuals. The identification of single nucleotide polymorphisms (SNPs) tightly linked to the genomic orientation of a given region should be useful to indirectly evaluate the genotypes of large genomic orientations in the individuals. Results: We have identified 16 SNPs, which are in linkage disequilibrium (LD) with the 8p23.1 inversion as detected by fluorescent in situ hybridization (FISH). The variability of the 8p23.1 orientation in 150 HapMap samples was predicted using this set of SNPs and was verified by FISH in a subset of samples. Four genes (NEIL2, MSRA, CTSB and BLK) were found differentially expressed (p<0.0005) according to the orientation of the 8p23.1 region. Finally, we have found variable levels of mosaicism for the orientation of the 8p23.1 as determined by FISH. Conclusion: By means of dense SNP genotyping of the region, haplotype-based computational analyses and FISH experiments we could infer and verify the orientation status of alleles in the 8p23.1 region by detecting two short haplotype stretches at both ends of the inverted region, which are likely the relic of the chromosome in which the original inversion occurred. Moreover, an impact of 8p23.1 inversion on gene expression levels cannot be ruled out, since four genes from this region have statistically significant different expression levels depending on the inversion status. FISH results in lymphoblastoid cell lines suggest the presence of mosaicism regarding the 8p23.1 inversion.	[Bosch, Nina; Morell, Marta; Ponsa, Immaculada; Maria Mercader, Josep; Armengol, Lluis; Estivill, Xavier] Ctr Genom Regulat CRG UPF, Genes & Dis Programme, Genet Causes Dis Grp, Barcelona, Catalonia, Spain; [Bosch, Nina; Morell, Marta; Maria Mercader, Josep; Armengol, Lluis; Estivill, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Catalonia, Spain; [Ponsa, Immaculada] Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, E-08193 Barcelona, Catalonia, Spain; [Ponsa, Immaculada] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Catalonia, Spain; [Armengol, Lluis] Quantitat Genom Med Labs qGenom, Barcelona, Catalonia, Spain; [Estivill, Xavier] Pompeu Fabra Univ UPF, Dept Hlth & Expt Life Sci, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Pompeu Fabra University	Bosch, N (corresponding author), Ctr Genom Regulat CRG UPF, Genes & Dis Programme, Genet Causes Dis Grp, Barcelona, Catalonia, Spain.	xavier.estivill@crg.cat	Estivill, Xavier/A-3125-2013; Estivill, Xavier/E-2957-2012	Estivill, Xavier/0000-0002-0723-2256; Morell, Marta/0000-0003-1469-2223; Mercader, Josep M/0000-0001-8494-3660; Ponsa, Immaculada/0000-0003-3436-1907	Department of Universities, Research and Information Society [2005SGR00008, 2009SGR1107]; e European Union [037627]; "Ministerio de Ciencia y Innovacion'' [SAF2008-00357]; "Instituto de Salud Carlos III FIS-ISCIII"; Spanish Ministry of Science and Education [SAF2002-00799]; Danone Institute (Spain)	Department of Universities, Research and Information Society; e European Union; "Ministerio de Ciencia y Innovacion''; "Instituto de Salud Carlos III FIS-ISCIII"(Instituto de Salud Carlos III); Spanish Ministry of Science and Education(Spanish Government); Danone Institute (Spain)(Danone Nutricia)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Financial support was received from the Department of Universities, Research and Information Society (2005SGR00008, 2009SGR1107) ("Generalitat de Catalunya''), from the European Union AnEUploidy project (037627) and the "Ministerio de Ciencia y Innovacion'' (SAF2008-00357). N. B. was a recipient of a BEFI fellowship from "Instituto de Salud Carlos III FIS-ISCIII''. J. M. M. was supported by the CRG under project SAF2002-00799 (Spanish Ministry of Science and Education) and by fellowship of the Danone Institute (Spain).	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; ALDRED PM, 2005, HUM MOL GENET; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Antonacci F, 2009, HUM MOL GENET; Ballantyne C, 2007, EUR J CARDIOV PREV R, V14, P3; BANCHS I, 1994, HUM MUTAT, V4, P232; BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; BARBER JC, 2005, EUR J HUM GENET; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Beiraghi S, 2003, GENE, V309, P11, DOI 10.1016/S0378-1119(03)00461-x; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; Bosch N, 2008, GENE, V420, P113, DOI 10.1016/j.gene.2008.05.003; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Chen GK, 2006, AM J HUM GENET, V79, P238, DOI 10.1086/505540; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iida A, 2000, HUM GENET, V106, P277, DOI 10.1007/s004390051038; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; LINZMEIER RM, 2005, GENOMICS; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P3205, DOI 10.1073/pnas.93.8.3205; Navarro A, 2000, GENETICS, V155, P685; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; ROYLE NJ, 1993, GENOMICS, V15, P119, DOI 10.1006/geno.1993.1019; Saito-Ohara F, 2002, AM J HUM GENET, V71, P637, DOI 10.1086/342208; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Sood R, 2004, CYTOGENET GENOME RES, V106, P61, DOI 10.1159/000078563; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Tadin-Strapps M, 2004, CYTOGENET GENOME RES, V107, P68, DOI 10.1159/000079573; Taudien S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-92; Thomas NS, 2008, HUM GENET, V123, P607, DOI 10.1007/s00439-008-0510-z; TUZUN E, 2005, NAT GENET; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	52	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8269	10.1371/journal.pone.0008269	http://dx.doi.org/10.1371/journal.pone.0008269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011547	gold, Green Published			2022-12-25	WOS:000272830300025
J	Dard, N; Louvet-Vallee, S; Maro, B				Dard, Nicolas; Louvet-Vallee, Sophie; Maro, Bernard			Orientation of Mitotic Spindles during the 8-to 16-Cell Stage Transition in Mouse Embryos	PLOS ONE			English	Article							CELL-DIVISION; BLASTOMERES; ALLOCATION; BLASTOCYST; MORULAE; EZRIN; INNER	Background: Asymmetric cell divisions are involved in the divergence of the first two lineages of the pre-implantation mouse embryo. They first take place after cell polarization ( during compaction) at the 8-cell stage. It is thought that, in contrast to many species, spindle orientation is random, although there is no direct evidence for this. Methodology/Principal Findings: Tubulin-GFP and live imaging with a spinning disk confocal microscope were used to directly study spindle orientation in whole embryos undergoing the 8- to 16-cell stage transition. This approach allowed us to determine that there is no predetermined cleavage pattern in 8- cell compacted mouse embryos and that mitotic spindle orientation in live embryo is only modulated by the extent of cell rounding up during mitosis. Conclusions: These results clearly demonstrate that spindle orientation is not controlled at the 8- to 16-cell transition, but influenced by cell bulging during mitosis, thus reinforcing the idea that pre-implantation development is highly regulative and not pre-patterned.	[Dard, Nicolas; Louvet-Vallee, Sophie] CNRS, UMR7622, Lab Biol Cellulaire Dev, Paris, France; [Dard, Nicolas; Louvet-Vallee, Sophie] Univ Paris 06, UMR7622, Lab Biol Cellulaire Dev, Paris, France; [Maro, Bernard] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine	Dard, N (corresponding author), CNRS, UMR7622, Lab Biol Cellulaire Dev, Paris, France.	nicolas.dard@upmc.fr	Maro, Bernard/AAL-2220-2020	Louvet, Sophie/0000-0001-7577-2329; DARD, Nicolas/0000-0001-7036-2275	Association pour la Recherche contre le Cancer [ARC-3871]; Agence Nationale pour la Recherche [ANR-05-BLAN-0120-01]; Ligue Nationale Contre le Cancer	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from Association pour la Recherche contre le Cancer to SLV (ARC-3871), and from Agence Nationale pour la Recherche to BM (ANR-05-BLAN-0120-01). ND was the recipient of fellowship from the Ligue Nationale Contre le Cancer and a post-doctoral contract from Agence Nationale pour la Recherche (ANR-05-BLAN-0120-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Dard N, 2001, DEV BIOL, V233, P161, DOI 10.1006/dbio.2001.0192; Dard N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007117; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; HANDYSIDE AH, 1981, J REPROD IMMUNOL, V2, P339, DOI 10.1016/0165-0378(81)90004-8; JOHNSTON CW, 1986, J CLIN EXP NEUROPSYC, V8, P93, DOI 10.1080/01688638608401299; KELLY SJ, 1978, J EMBRYOL EXP MORPH, V48, P37; Maro B, 1991, Dev Suppl, V1, P17; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; PICKERING SJ, 1988, DEVELOPMENT, V103, P353; SPINDLE AI, 1982, J EXP ZOOL, V235, P361; SURANI MAH, 1984, DEV BIOL, V102, P335, DOI 10.1016/0012-1606(84)90198-2	15	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8171	10.1371/journal.pone.0008171	http://dx.doi.org/10.1371/journal.pone.0008171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997595	Green Published, gold			2022-12-25	WOS:000272829200010
J	Olman, CA; Davachi, L; Inati, S				Olman, Cheryl A.; Davachi, Lila; Inati, Souheil			Distortion and Signal Loss in Medial Temporal Lobe	PLOS ONE			English	Article							ECHO-PLANAR FMRI; GRADIENT-ECHO; HUMAN BRAIN; SPIN-ECHO; PHYSIOLOGICAL NOISE; SPATIAL-RESOLUTION; BOLD FMRI; 7 T; EPI; ARTIFACTS	Background: The medial temporal lobe (MTL) contains subregions that are subject to severe distortion and signal loss in functional MRI. Air/tissue and bone/tissue interfaces in the vicinity of the MTL distort the local magnetic field due to differences in magnetic susceptibility. Fast image acquisition and thin slices can reduce the amount of distortion and signal loss, but at the cost of image signal-to-noise ratio (SNR). Methodology/Principal Findings: In this paper, we quantify the severity of distortion and signal loss in MTL subregions for three different echo planar imaging (EPI) acquisitions at 3 Tesla: a conventional moderate-resolution EPI (36363 mm), a conventional high-resolution EPI (1.5x1.5x2 mm), and a zoomed high-resolution EPI. We also demonstrate the advantage of reversing the phase encode direction to control the direction of distortion and to maximize efficacy of distortion compensation during data post-processing. With the high-resolution zoomed acquisition, distortion is not significant and signal loss is present only in the most anterior regions of the parahippocampal gyrus. Furthermore, we find that the severity of signal loss is variable across subjects, with some subjects showing negligible loss and others showing more dramatic loss. Conclusions/Significance: Although both distortion and signal loss are minimized in a zoomed field of view acquisition with thin slices, this improvement in accuracy comes at the cost of reduced SNR. We quantify this trade-off between distortion and SNR in order to provide a decision tree for design of high-resolution experiments investigating the function of subregions in MTL.	[Olman, Cheryl A.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Olman, Cheryl A.] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA; [Davachi, Lila; Inati, Souheil] NYU, Dept Psychol, New York, NY 10003 USA; [Davachi, Lila; Inati, Souheil] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; New York University; New York University	Olman, CA (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	caolman@umn.edu		Olman, Cheryl/0000-0002-7324-6461; Inati, Souheil/0000-0001-5596-9554; Davachi, Lila/0000-0003-4317-0889	Seaver Foundation; McKnight Foundation; NIH National Institute of Mental Health [MH074692]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	Seaver Foundation; McKnight Foundation; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to acknowledge support from the Seaver Foundation and the McKnight Foundation (http://www.mcknight.org/), as well as an NIH National Institute of Mental Health (http://www.nimh.nih.gov/index.shtml) award MH074692 to L. Davachi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgowan PSF, 2006, NEUROIMAGE, V29, P1244, DOI 10.1016/j.neuroimage.2005.08.042; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Constable RT, 1995, JMRI-J MAGN RESON IM, V5, P746, DOI 10.1002/jmri.1880050622; Cordes D, 2000, MAGN RESON IMAGING, V18, P1055, DOI 10.1016/S0730-725X(00)00199-5; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; De Panfilis C, 2005, NEUROIMAGE, V25, P112, DOI 10.1016/j.neuroimage.2004.11.014; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; FARZANEH F, 1990, MAGNET RESON MED, V14, P123, DOI 10.1002/mrm.1910140112; FLEYSHER L, 2005, P INT SOC MAGN RES M, V13, P2685; FLEYSHER R, 2005, P INT SOC MAGNETIC R, V13; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Heberlein KA, 2004, MAGN RESON MED, V51, P212, DOI 10.1002/mrm.10680; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Merboldt KD, 2000, J MAGN RESON, V145, P184, DOI 10.1006/jmre.2000.2105; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Norris DG, 2002, NEUROIMAGE, V15, P719, DOI 10.1006/nimg.2001.1005; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Parkes LM, 2005, MAGN RESON MED, V54, P1465, DOI 10.1002/mrm.20712; Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103; Pruessmann Klaas P, 2004, Top Magn Reson Imaging, V15, P237, DOI 10.1097/01.rmr.0000139297.66742.4e; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; PRUESSNER JC, 2002, CEREBRAL CORTEX, V12; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Schmidt CF, 2005, NEUROIMAGE, V25, P625, DOI 10.1016/j.neuroimage.2004.12.002; SEKIHARA K, 1987, MED PHYS, V14, P1087, DOI 10.1118/1.595989; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stenger VA, 2000, MAGNET RESON MED, V44, P525, DOI 10.1002/1522-2594(200010)44:4<525::AID-MRM5>3.0.CO;2-L; Thesen S, 2003, P INT SOC MAGN RESON, V11, P1025; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Van de Moortele PF, 2002, MAGNET RESON MED, V47, P888, DOI 10.1002/mrm.10145; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Weiskopf N, 2007, MAGN RESON MATER PHY, V20, P39, DOI 10.1007/s10334-006-0067-6; Weismann August, 1906, Archiv Rassenbiol Berlin, V3; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Zheng J, 1997, JMRI-J MAGN RESON IM, V7, P843, DOI 10.1002/jmri.1880070511	43	77	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8160	10.1371/journal.pone.0008160	http://dx.doi.org/10.1371/journal.pone.0008160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997633	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829000012
J	Hughes, LAE; van den Brandt, PA; de Bruine, AP; Wouters, KAD; Hulsmans, S; Spiertz, A; Goldbohm, RA; de Goeij, AFPM; Herman, JG; Weijenberg, MP; van Engeland, M				Hughes, Laura A. E.; van den Brandt, Piet A.; de Bruine, Adriaan P.; Wouters, Kim A. D.; Hulsmans, Sarah; Spiertz, Angela; Goldbohm, R. Alexandra; de Goeij, Anton F. P. M.; Herman, James G.; Weijenberg, Matty P.; van Engeland, Manon			Early Life Exposure to Famine and Colorectal Cancer Risk: A Role for Epigenetic Mechanisms	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; SCALE PROSPECTIVE COHORT; 1944-1945 DUTCH FAMINE; NETHERLANDS COHORT; BREAST-CANCER; COLON-CANCER; ADULT DISEASE; MICROSATELLITE INSTABILITY; ENERGY RESTRICTION; FOLLOW-UP	Background: Exposure to energy restriction during childhood and adolescence is associated with a lower risk of developing colorectal cancer (CRC). Epigenetic dysregulation during this critical period of growth and development may be a mechanism to explain such observations. Within the Netherlands Cohort Study on diet and cancer, we investigated the association between early life energy restriction and risk of subsequent CRC characterized by the (promoter) CpG island methylation phenotype (CIMP). Methodology/Principal Findings: Information on diet and risk factors was collected by baseline questionnaire (n = 120,856). Three indicators of exposure were assessed: place of residence during the Hunger Winter (1944-45) and World War II years (1940-44), and father's employment status during the Economic Depression (1932-40). Methylation specific PCR (MSP) on DNA from paraffin embedded tumor tissue was performed to determine CIMP status according to the Weisenberger markers. After 7.3 years of follow-up, 603 cases and 4631 sub-cohort members were available for analysis. Cox regression was used to calculate hazard ratios (HR) and 95% confidence intervals for CIMP+ (27.7%) and CIMP- (72.3%) tumors according to the three time periods of energy restriction, adjusted for age and gender. Individuals exposed to severe famine during the Hunger Winter had a decreased risk of developing a tumor characterized by CIMP compared to those not exposed (HR 0.65, 95%CI: 0.45-0.92). Further categorizing individuals by an index of '0-1' '2-3' or '4-7' genes methylated in the promoter region suggested that exposure to the Hunger Winter was associated with the degree of promoter hypermethylation ('0-1 genes methylated' HR = 1.01, 95%CI:0.74-1.37; '2-3 genes methylated' HR = 0.83, 95% CI:0.61-1.15; '4-7 genes methylated' HR = 0.72, 95% CI: 0.49-1.04). No associations were observed with respect to the Economic Depression and WWII years. Conclusions: This is the first study indicating that exposure to a severe, transient environmental condition during adolescence and young adulthood may result in persistent epigenetic changes that later influence CRC development.	[Hughes, Laura A. E.; van den Brandt, Piet A.; Weijenberg, Matty P.] Maastricht Univ, Med Ctr, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [de Bruine, Adriaan P.; Wouters, Kim A. D.; Hulsmans, Sarah; de Goeij, Anton F. P. M.; van Engeland, Manon] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, Maastricht, Netherlands; [Spiertz, Angela; Goldbohm, R. Alexandra] TNO Qual Life, Dept Prevent & Hlth, Leiden, Netherlands; [Herman, James G.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Maastricht University; Maastricht University; Netherlands Organization Applied Science Research; Johns Hopkins University; Johns Hopkins Medicine	Hughes, LAE (corresponding author), Maastricht Univ, Med Ctr, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	manon.van.engeland@mumc.nl	van Engeland, Manon/A-7479-2009	van Engeland, Manon/0000-0002-7952-6843; van den Brandt, Piet/0000-0001-8781-8099	World Cancer Research Fund	World Cancer Research Fund(World Cancer Research Fund International (WCRF))	This work was supported by the World Cancer Research Fund [2007/54 to M. P. W] (http://www.wcrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Burger G, 1948, MALNUTRITION STARV 1; Burger G, 1948, MALNUTRITION STARV 2; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; DENHARTOG AP, 1983, VOEDING, V44, P92; Derks S, 2004, CELL ONCOL, V26, P291; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Dirx MJM, 2001, AM J EPIDEMIOL, V154, P530, DOI 10.1093/aje/154.6.530; Dirx MJM, 2003, CANCER-AM CANCER SOC, V97, P46, DOI 10.1002/cncr.11052; Dirx MJM, 1999, CANCER CAUSE CONTROL, V10, P189, DOI 10.1023/A:1008821524297; DOLS M. J. L., 1946, Voeding, V6, P193; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2004, INT J CANCER, V108, P628, DOI 10.1002/ijc.11584; Ferguson LR, 2004, ENVIRON MOL MUTAGEN, V44, P36, DOI 10.1002/em.20029; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frankel S, 1998, BMJ-BRIT MED J, V316, P499, DOI 10.1136/bmj.316.7130.499; GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HUGHES LAE, 2009, ENERGY RESTRICTION C; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Lumey LH, 1997, AM J EPIDEMIOL, V146, P810, DOI 10.1093/oxfordjournals.aje.a009198; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Okasha M, 2002, BEST PRACT RES CL EN, V16, P225, DOI 10.1053/beem.2002.0204; ROSE G, 1964, BRIT J PREV SOC MED, V18, P75; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Slattery ML, 2009, MUTAT RES-FUND MOL M, V660, P12, DOI 10.1016/j.mrfmmm.2008.10.001; Stein Z., 1975, FAMINE HUM DEV DUTCH; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; VANNOORD PAH, 1991, ANN HUM BIOL, V18, P57, DOI 10.1080/03014469100001402; WACHOLDER S, 1989, BIOMETRIKA, V76, P117, DOI 10.1093/biomet/76.1.117; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Waterland RA, 2006, J PEDIATR-US, V149, pS137, DOI 10.1016/j.jpeds.2006.06.064; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wong JJL, 2007, GUT, V56, P140, DOI 10.1136/gut.2005.088799	54	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7951	10.1371/journal.pone.0007951	http://dx.doi.org/10.1371/journal.pone.0007951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956740	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827300009
J	Hung, CH; Hwang, HJ; Chen, YH; Chiu, YF; Ke, SC; Burnap, RL; Chu, HA				Hung, Chung-Hsien; Hwang, Hong Jin; Chen, Yung-Han; Chiu, Yi-Fang; Ke, Shyue-Chu; Burnap, Robert L.; Chu, Hsiu-An			Spectroscopic and Functional Characterizations of Cyanobacterium Synechocystis PCC 6803 Mutants on and near the Heme Axial Ligand of Cytochrome b(559) in Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING PROPERTIES; SITE-DIRECTED MUTAGENESIS; MOLECULAR-MASS SUBUNITS; DELETION MUTAGENESIS; PLASTOQUINONE-POOL; REDOX PROPERTIES; POTENTIAL FORM; LESS MUTANT; IN-VIVO; PROTEIN	The functional role of cytochrome (cyt) b(559) in photosystem II (PSII) was investigated in H22K alpha and Y18S alpha cyt b(559) mutants of the cyanobacterium Synechocystis sp. PCC6803. H22K alpha and Y18S alpha cyt b(559) mutant carries one amino acid substitution on and near one of heme axial ligands of cyt b(559) in PSII, respectively. Both mutants grew photoautotrophically, assembled stable PSII, and exhibited the normal period-four oscillation in oxygen yield. However, both mutants showed several distinct chlorophyll a fluorescence properties and were more susceptible to photoinhibition than wild type. EPR results indicated the displacement of one of the two axial ligands to the heme of cyt b(559) in H22K alpha mutant reaction centers, at least in isolated reaction centers. The maximum absorption of cyt b(559) in Y18S alpha mutant PSII core complexes was shifted to 561 nm. Y18S alpha and H22K alpha mutant PSII core complexes contained predominately the low potential form of cyt b(559). The findings lend support to the concept that the redox properties of cyt b(559) are strongly influenced by the hydrophobicity and ligation environment of the heme. When the cyt b(559) mutations placed in a D1-D170A genetic background that prevents assembly of the manganese cluster, accumulation of PSII is almost completely abolished. Overall, our data support a functional role of cyt b(559) in protection of PSII under photoinhibition conditions in vivo.	[Hung, Chung-Hsien; Chiu, Yi-Fang; Chu, Hsiu-An] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Chiu, Yi-Fang] Acad Sinica, Mol & Biol Agr Sci Program, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Hung, Chung-Hsien] Natl Taiwan Univ, Coll Life Sci, Inst Plant Biol, Taipei 10617, Taiwan; [Hwang, Hong Jin; Burnap, Robert L.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74075 USA; [Chen, Yung-Han; Ke, Shyue-Chu] Natl Dong Hwa Univ, Dept Phys, Hualien 97401, Taiwan; [Chiu, Yi-Fang] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 402, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Oklahoma State University System; Oklahoma State University - Stillwater; National Dong Hwa University; National Chung Hsing University	Chu, HA (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	chuha@gate.sinica.edu.tw	Chu, Hsiu-An/H-1237-2011	Chu, Hsiu-An/0000-0001-8018-4492	National Science Council [NSC 97-2627-M-001-001, NSC 96-2311-B-001-040-MY3]; Academia Sinica; National Science Foundation [MCB-0818371]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Council Grants NSC 97-2627-M-001-001 and NSC 96-2311-B-001-040-MY3 and by Academia Sinica (to H.-A. C.). Work in the Burnap laboratory was supported by the National Science Foundation Grant MCB-0818371.	AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; BABCOCK GT, 1985, BIOCHEMISTRY-US, V24, P3638, DOI 10.1021/bi00335a036; BARBER J, 1993, P NATL ACAD SCI USA, V90, P10942, DOI 10.1073/pnas.90.23.10942; Bondarava N, 2003, J BIOL CHEM, V278, P13554, DOI 10.1074/jbc.M212842200; BRUCE D, 1989, BIOCHIM BIOPHYS ACTA, V974, P66, DOI 10.1016/S0005-2728(89)80166-5; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; BUSER CA, 1992, BIOCHEMISTRY-US, V31, P11449, DOI 10.1021/bi00161a025; Chiu YF, 2009, BBA-BIOENERGETICS, V1787, P1179, DOI 10.1016/j.bbabio.2009.05.007; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6150, DOI 10.1021/bi00186a014; DZELZKALNS VA, 1989, PLANT PHYSIOL, V90, P617, DOI 10.1104/pp.90.2.617; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HAAG E, 1993, BIOCHEMISTRY-US, V32, P4444, DOI 10.1021/bi00067a037; Hung CH, 2007, BBA-BIOENERGETICS, V1767, P686, DOI 10.1016/j.bbabio.2007.02.016; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Kaminskaya O, 2005, BBA-BIOENERGETICS, V1708, P333, DOI 10.1016/j.bbabio.2005.05.002; Kaminskaya O, 2007, BBA-BIOENERGETICS, V1767, P550, DOI 10.1016/j.bbabio.2007.02.005; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; Kondo K, 2009, PHOTOSYNTH RES, V99, P217, DOI 10.1007/s11120-008-9399-6; Kropacheva TN, 2003, CHEM PHYS, V294, P471, DOI 10.1016/S0301-0104(03)00327-6; Kruk J, 2001, J BIOL CHEM, V276, P86, DOI 10.1074/jbc.M003602200; Kruk J, 1999, PHOTOSYNTH RES, V62, P273, DOI 10.1023/A:1006374319191; LAEMMLI UK, 1970, NATURE, V227, P685; LAVOREL J, 1976, J THEOR BIOL, V57, P171, DOI 10.1016/S0022-5193(76)80011-2; Li J, 2002, BBA-BIOENERGETICS, V1556, P175, DOI 10.1016/S0005-2728(02)00360-2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MEUNIER PC, 1995, PHOTOSYNTH RES, V47, P61; Morais F, 2001, J BIOL CHEM, V276, P31986, DOI 10.1074/jbc.M103935200; Morais F, 1998, J BIOL CHEM, V273, P29315, DOI 10.1074/jbc.273.45.29315; Napoli E, 2007, BBA-MOL BASIS DIS, V1772, P773, DOI 10.1016/j.bbadis.2007.04.001; Ohad I, 2004, BIOCHEMISTRY-US, V43, P2297, DOI 10.1021/bi0348260; PAKRASI HB, 1991, EMBO J, V10, P1619, DOI 10.1002/j.1460-2075.1991.tb07684.x; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; PAKRASI HB, 1990, Z NATURFORSCH C, V45, P423; Qian M, 1999, BIOCHEMISTRY-US, V38, P6070, DOI 10.1021/bi982331i; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; Roncel M, 2001, EUR J BIOCHEM, V268, P4961, DOI 10.1046/j.0014-2956.2001.02427.x; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; Swiatek M, 2003, MOL GENET GENOMICS, V268, P699, DOI 10.1007/s00438-002-0791-1; THOMPSON LK, 1988, BIOCHEMISTRY-US, V27, P6653, DOI 10.1021/bi00418a002; THOMPSON LK, 1989, BIOCHEMISTRY-US, V28, P8048, DOI 10.1021/bi00446a012; WADA K, 1971, P NATL ACAD SCI USA, V68, P3064, DOI 10.1073/pnas.68.12.3064	48	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5653	5663		10.1074/jbc.M109.044719	http://dx.doi.org/10.1074/jbc.M109.044719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007972	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000275327200058
J	Schnaufer, A; Wu, MT; Park, YJ; Nakai, T; Deng, JP; Proff, R; Hol, WGJ; Stuart, KD				Schnaufer, Achim; Wu, Meiting; Park, Young-Jun; Nakai, Tadashi; Deng, Junpeng; Proff, Rose; Hol, Wim G. J.; Stuart, Kenneth D.			A Protein-Protein Interaction Map of Trypanosome similar to 20S Editosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EDITING COMPLEX; STRANDED-DNA-BINDING; ZINC-FINGER MOTIFS; OB-FOLD; STRUCTURAL INTEGRITY; MESSENGER-RNAS; BRUCEI; MITOCHONDRIA; SURVIVAL; GENOME	Mitochondrial mRNA editing in trypanosomatid parasites involves several multiprotein assemblies, including three very similar complexes that contain the key enzymatic editing activities and sediment at similar to 20S on glycerol gradients. These similar to 20S editosomes have a common set of 12 proteins, including enzymes for uridylyl (U) removal and addition, 2 RNA ligases, 2 proteins with RNase III-like domains, and 6 proteins with predicted oligonucleotide binding (OB) folds. In addition, each of the 3 distinct similar to 20S editosomes contains a different RNase III-type endonuclease, 1 of 3 related proteins and, in one case, an additional exonuclease. Here we present a protein-protein interaction map that was obtained through a combination of yeast two-hybrid analysis and subcomplex reconstitution with recombinant protein. This map inter-links ten of the proteins and in several cases localizes the protein region mediating the interaction, which often includes the predicted OB-fold domain. The results indicate that the OB-fold proteins form an extensive protein-protein interaction network that connects the two trimeric subcomplexes that catalyze U removal or addition and RNA ligation. One of these proteins, KREPA6, interacts with the OB-fold zinc finger protein in each subcomplex that interconnects their two catalytic proteins. Another OB-fold protein, KREPA3, appears to link to the putative endonuclease subcomplex. These results reveal a physical organization that underlies the coordination of the various catalytic and substrate binding activities within the similar to 20S editosomes during the editing process.	[Hol, Wim G. J.] Univ Washington, Dept Biochem, Biomol Struct Ctr, Seattle, WA 98195 USA; [Stuart, Kenneth D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Schnaufer, Achim; Wu, Meiting; Proff, Rose; Stuart, Kenneth D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research	Hol, WGJ (corresponding author), Univ Washington, Dept Biochem, Biomol Struct Ctr, 1959 Pacific Ave NE,Box 357742, Seattle, WA 98195 USA.	wghol@u.washington.edu; ken.stuart@sbri.org	Nakai, Tadashi/F-8047-2010; Park, Young-Jun/AAF-6249-2021	Nakai, Tadashi/0000-0001-9770-8168; Park, Young-Jun/0000-0003-2901-6949; Schnaufer, Achim/0000-0003-2132-5560	National Institutes of Health [GM042188, GM077418]; Economic Development Administration; United States Department of Commerce; Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042188, R01GM077418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic Development Administration; United States Department of Commerce; Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM042188 (to K.S.) and GM077418 (to W.H.). Research was conducted using equipment made possible by support from the Economic Development Administration, United States Department of Commerce, and the M. J. Murdock Charitable Trust.	ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, P NATL ACAD SCI USA, V100, P10617, DOI 10.1073/pnas.1833120100; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Babbarwal VK, 2007, RNA, V13, P737, DOI 10.1261/rna.327707; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Deng JP, 2005, EMBO J, V24, P4007, DOI 10.1038/sj.emboj.7600861; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; Ernst NL, 2009, RNA, V15, P947, DOI 10.1261/rna.1373009; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Gao GH, 2005, P NATL ACAD SCI USA, V102, P4712, DOI 10.1073/pnas.0500553102; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Golas MM, 2009, EMBO J, V28, P766, DOI 10.1038/emboj.2009.19; Guo XM, 2008, MOL CELL BIOL, V28, P6939, DOI 10.1128/MCB.01115-08; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; James P, 1996, GENETICS, V144, P1425; Kang XD, 2004, J BIOL CHEM, V279, P3893, DOI 10.1074/jbc.M310185200; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; Law JA, 2007, MOL CELL BIOL, V27, P777, DOI 10.1128/MCB.01460-06; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; MASLOV DA, 1992, CELL, V70, P459, DOI 10.1016/0092-8674(92)90170-H; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Zikova A, 2008, INT J PARASITOL, V38, P901, DOI 10.1016/j.ijpara.2007.12.009	57	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5282	5295		10.1074/jbc.M109.059378	http://dx.doi.org/10.1074/jbc.M109.059378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018860	Green Published, hybrid			2022-12-25	WOS:000275327200022
J	Walker, MR; Brown, SL; Riehl, TE; Stenson, WF; Stappenbeck, TS				Walker, Monica R.; Brown, Sarah L.; Riehl, Terrence E.; Stenson, William F.; Stappenbeck, Thaddeus S.			Growth Factor Regulation of Prostaglandin-Endoperoxide Synthase 2 (Ptgs2) Expression in Colonic Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; CYCLOOXYGENASE-2 EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; STROMAL CELLS; GASTROINTESTINAL-TRACT; MICROBIAL ECOLOGY; RADIATION-INJURY; COX-2 EXPRESSION; EPITHELIAL-CELLS	We previously found that a population of colonic stromal cells that constitutively express high levels of prostaglandin-endoperoxide synthase 2 (Ptgs2, also known as Cox-2) altered their location in the lamina propria in response to injury in a Myd88-dependent manner (Brown, S. L., Riehl, T. E., Walker, M. R., Geske, M. J., Doherty, J. M., Stenson, W. F., and Stappenbeck, T. S. (2007) J. Clin. Invest. 117, 258-269). At the time of this study, the identity of these cells and the mechanism by which they expressed high levels of Ptgs2 were unknown. Here we found that these colonic stromal cells were mesenchymal stem cells (MSCs). These colonic MSCs expressed high Ptgs2 levels not through interaction with bacterial products but instead as a consequence of mRNA stabilization downstream of Fgf9 (fibroblast growth factor 9), a growth factor that is constitutively expressed by the intestinal epithelium. This stabilization was mediated partially through a mechanism involving endogenous CUG-binding protein 2 (CUGbp2). These studies suggest that Fgf9 is an important factor in the regulation of Ptgs2 in colonic MSCs and may be a factor involved in its constitutive expression in vivo.	[Walker, Monica R.; Brown, Sarah L.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Ctr Canc & Stem Cell Biol, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Riehl, Terrence E.; Stenson, William F.] Washington Univ, Sch Med, Ctr Canc & Stem Cell Biol, Div Gastroenterol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Stappenbeck, TS (corresponding author), 660 S Euclid,Box 8118, St Louis, MO 63110 USA.	stappenb@wustl.edu			National Institutes of Health [DK071619, DK07161-90251, DK33165, DK55753, P30-DK52574]; Crohn's Colitis Foundation of America; Pew Scholars Foundation; Cancer Research Institute Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007161, P30DK052574, R01DK071619, R01DK055753, R37DK033165, R01DK033165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's Colitis Foundation of America; Pew Scholars Foundation; Cancer Research Institute Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071619 (to T. S.), DK07161-90251 (to T. S. S.), DK33165 (to W. S.), DK55753 (to W. S.), and P30-DK52574 (to the Washington University Digestive Disease Research Core). This work was also supported by the Crohn's Colitis Foundation of America (to T. S.), the Pew Scholars Foundation (to T. S.), and a Cancer Research Institute Training Grant (Predoctoral Emphasis Pathway in Tumor Immunology) (to M. W.).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ALLGAYER H, 1989, GASTROENTEROLOGY, V96, P1290, DOI 10.1016/S0016-5085(89)80016-2; Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; BONNEY RJ, 1978, BIOCHEM J, V176, P433, DOI 10.1042/bj1760433; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Cao ZX, 2007, CELL SIGNAL, V19, P1542, DOI 10.1016/j.cellsig.2007.01.028; CHANG WWL, 1971, AM J ANAT, V131, P73, DOI 10.1002/aja.1001310105; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Doherty JM, 2008, STEM CELLS, V26, P2124, DOI 10.1634/stemcells.2008-0380; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Estivariz CF, 2000, DIGEST DIS SCI, V45, P736, DOI 10.1023/A:1005447827579; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Ishikawa TO, 2006, MOL IMAGING BIOL, V8, P171, DOI 10.1007/s11307-006-0034-7; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kage K, 1999, BIOCHEM BIOPH RES CO, V254, P259, DOI 10.1006/bbrc.1998.9875; Kiba T, 2006, DIGESTION, V74, P215, DOI 10.1159/000100512; Kim Chang H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P343, DOI 10.2174/1568008043339712; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kwon BS, 1999, J BIOL CHEM, V274, P6056, DOI 10.1074/jbc.274.10.6056; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; LOFTIN CD, 2002, PROTAGLANDINS OTHER, P177; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Pham H, 2008, J CELL PHYSIOL, V214, P96, DOI 10.1002/jcp.21167; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; Sala FG, 2006, DEV BIOL, V299, P373, DOI 10.1016/j.ydbio.2006.08.001; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schadt EE, 2000, J CELL BIOCHEM, V80, P192; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; STANLEY ER, 1976, J EXP MED, V143, P631, DOI 10.1084/jem.143.3.631; Stoeltzing O, 2007, CANCER LETT, V258, P291, DOI 10.1016/j.canlet.2007.09.009; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Walker MR, 2008, CURR OPIN GASTROEN, V24, P115, DOI 10.1097/MOG.0b013e3282f4954f; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wang J, 2007, BRIT J RADIOL, V80, pS41, DOI 10.1259/bjr/33057885; Weaver M, 2000, DEVELOPMENT, V127, P2695; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Xu K, 2009, ONCOGENE, V28, P1410, DOI 10.1038/onc.2008.500; Xu K, 2007, J BIOL CHEM, V282, P32699, DOI 10.1074/jbc.M705272200; Yaksh TL, 2001, J NEUROSCI, V21, P5847, DOI 10.1523/JNEUROSCI.21-16-05847.2001; Zhang XQ, 2006, DEVELOPMENT, V133, P173, DOI 10.1242/dev.02175; Zimmermann KC, 1998, MOL PHARMACOL, V54, P536, DOI 10.1124/mol.54.3.536	72	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5026	5039		10.1074/jbc.M109.032672	http://dx.doi.org/10.1074/jbc.M109.032672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018844	Green Published, hybrid			2022-12-25	WOS:000275274800079
J	Kinander, W; Bruvik, T; Dahle, UR				Kinander, Wibeke; Bruvik, Torbjorn; Dahle, Ulf R.			Dominant Mycobacterium tuberculosis Lineages in Elderly Patients Born in Norway	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; BEIJING STRAINS; CAUSE MORTALITY; HONG-KONG; TRANSMISSION; DIVERSITY; EMERGENCE; VIRULENCE; PATTERNS	Background: During the previous century Norway had a high incidence of tuberculosis, but no molecular epidemiological studies could be performed and these previously epidemic strains have been disappearing during the last decades. Currently, tuberculosis among native Norwegians is in the elimination phase, and it is still not known what type of M. tuberculosis was so efficiently controlled during the second half of the 20th century. However, many elderly Norwegian-born people still develop TB that cannot be clustered to imported or recently transmitted strains of M. tuberculosis. Thus, the majority of these cases are results of reactivation of disease that was transmitted many decades ago. Methodology/Principal Findings: A total of 213 strains of M. tuberculosis isolated during 1998-2005, from patients born in Norway before 1950 were genotyped in the current study. The findings demonstrated a highly homogenous M. tuberculosis population among the patients. A total of 40% belonged to the T-family, were 35% were assigned to T1 sub-family (T2 = 0, 93%, T3 = 1, 4% and T4 = 2, 3%). As many as 35% of the isolates belonged to the Haarlem family, were 15% were assigned to Haarlem1 and 19% to Haarlem3. The remaining 25% belonged to 15 different other families. The RFLP-patterns indicated that the isolates were not a result of recent transmission, but rather represented well established strains that apparently dominated in Norway many decades ago. Conclusions/Significance: The T 1, Haarlem 1, and Haarlem 3 families of M. tuberculosis were abundant among patients born in Norway before 1950. The M. tuberculosis cases represented reactivated disease that had been acquired before 1994 and were likely to have been latent for several decades. Thus, the current study indicated that the T 1, Haarlem 1, and Haarlem 3 families may have been common in Norway, when tuberculosis represented a serious public health threat during the first half of the 20th century.	[Kinander, Wibeke; Bruvik, Torbjorn; Dahle, Ulf R.] Norwegian Inst Publ Hlth, Oslo, Norway	Norwegian Institute of Public Health (NIPH)	Kinander, W (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	ulf.dahle@fhi.no		Dahle, Ulf/0000-0001-5909-7917	Norwegian Institute of Public Health	Norwegian Institute of Public Health	This study was funded by the Norwegian Institute of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chan-Yeung M, 2006, INT J TUBERC LUNG D, V10, P892; Chan-Yeung M, 2003, J CLIN MICROBIOL, V41, P2706, DOI 10.1128/JCM.41.6.2706-2708.2003; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; DRISCOLL JR, 2009, SPOLIGOTYPING MOL EP, P117; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Fletcher HA, 2003, MICROBIOL-SGM, V149, P143, DOI 10.1099/mic.0.25961-0; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Liestol K, 2009, INT J EPIDEMIOL, V38, P427, DOI 10.1093/ije/dyn347; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Tanaka MM, 2006, P NATL ACAD SCI USA, V103, P15266, DOI 10.1073/pnas.0603130103; Tsenova L, 2007, VACCINE, V25, P5126, DOI 10.1016/j.vaccine.2006.11.024; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; VITOL I, 2005, RECOMB 2005; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8373	10.1371/journal.pone.0008373	http://dx.doi.org/10.1371/journal.pone.0008373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020043	Green Published, gold, Green Submitted			2022-12-25	WOS:000272870600012
J	Sakatani, S; Yamada, K; Homma, C; Munesue, S; Yamamoto, Y; Yamamoto, H; Hirase, H				Sakatani, Seiichi; Yamada, Kazuyuki; Homma, Chihiro; Munesue, Seiichi; Yamamoto, Yasuhiko; Yamamoto, Hiroshi; Hirase, Hajime			Deletion of RAGE Causes Hyperactivity and Increased Sensitivity to Auditory Stimuli in Mice	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CELL-SURFACE RECEPTOR; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; IN-VIVO; EXPRESSION; PROTEIN; BRAIN; ENDPRODUCTS	The receptor for advanced glycation end-products (RAGE) is a multi-ligand receptor that belongs to the immunoglobulin superfamily of cell surface receptors. In diabetes and Alzheimer's disease, pathological progression is accelerated by activation of RAGE. However, how RAGE influences gross behavioral activity patterns in basal condition has not been addressed to date. In search for a functional role of RAGE in normal mice, a series of standard behavioral tests were performed on adult RAGE knockout (KO) mice. We observed a solid increase of home cage activity in RAGE KO. In addition, auditory startle response assessment resulted in a higher sensitivity to auditory signal and increased prepulse inhibition in KO mice. There were no significant differences between KO and wild types in behavioral tests for spatial memory and anxiety, as tested by Morris water maze, classical fear conditioning, and elevated plus maze. Our results raise a possibility that systemic therapeutic treatments to occlude RAGE activation may have adverse effects on general activity levels or sensitivity to auditory stimuli.	[Sakatani, Seiichi; Hirase, Hajime] RIKEN, Brain Sci Inst, Hirase Res Unit, Wako, Saitama, Japan; [Yamada, Kazuyuki; Homma, Chihiro] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Munesue, Seiichi; Yamamoto, Yasuhiko; Yamamoto, Hiroshi] Kanazawa Univ, Dept Biochem & Mol Vasc Biol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Hirase, Hajime] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan	RIKEN; RIKEN; Kanazawa University; Saitama University	Sakatani, S (corresponding author), RIKEN, Brain Sci Inst, Hirase Res Unit, Wako, Saitama, Japan.	hirase@brain.riken.jp	Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905	Ministry of Education, Science, Sports and Culture [21700368, 19390085]; RIKEN intramural fundings	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN intramural fundings	Funding was received from the Ministry of Education, Science, Sports and Culture grant-in-aids for Young Scientists (B) (21700368, SS) and Scientific Research (B) (19390085, HY) and RIKEN intramural fundings (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRETT J, 1993, AM J PATHOL, V143, P1699; Chou DKH, 2004, J NEUROCHEM, V90, P1389, DOI 10.1111/j.1471-4159.2004.02609.x; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; GERLAI R, 1995, LEARN MEMORY, V2, P26, DOI 10.1101/lm.2.1.26; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kato T, 2008, NEUROSCI RES, V61, P143, DOI 10.1016/j.neures.2008.02.002; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Ma L, 2003, BRAIN RES, V966, P167, DOI 10.1016/S0006-8993(02)04149-5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Nozaki I, 2007, ARCH HISTOL CYTOL, V70, P279, DOI 10.1679/aohc.70.279; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sakatani S, 2007, EUR J NEUROSCI, V25, P1144, DOI 10.1111/j.1460-9568.2007.05337.x; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2005, J PHARMACOL SCI, V97, P305, DOI 10.1254/jphs.CPJ04005X	30	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8309	10.1371/journal.pone.0008309	http://dx.doi.org/10.1371/journal.pone.0008309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016851	gold, Green Published, Green Submitted			2022-12-25	WOS:000272833800008
J	Kitko, RD; Cleeton, RL; Armentrout, EI; Lee, GE; Noguchi, K; Berkmen, MB; Jones, BD; Slonczewski, JL				Kitko, Ryan D.; Cleeton, Rebecca L.; Armentrout, Erin I.; Lee, Grace E.; Noguchi, Ken; Berkmen, Melanie B.; Jones, Brian D.; Slonczewski, Joan L.			Cytoplasmic Acidification and the Benzoate Transcriptome in Bacillus subtilis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PHENOLIC-ACID DECARBOXYLASE; ESCHERICHIA-COLI; INTRACELLULAR-PH; STRESS-RESPONSE; SIGMA-FACTOR; OXALATE DECARBOXYLASE; FOOD PRESERVATIVES; TOLERANCE RESPONSE; PROTONMOTIVE FORCE	Background: Bacillus subtilis encounters a wide range of environmental pH. The bacteria maintain cytoplasmic pH within a narrow range. Response to acid stress is a poorly understood function of external pH and of permeant acids that conduct protons into the cytoplasm. Methods and Principal Findings: Cytoplasmic acidification and the benzoate transcriptome were observed in Bacillus subtilis. Cytoplasmic pH was measured with 4-s time resolution using GFPmut3b fluorimetry. Rapid external acidification (pH 7.5 to 6.0) acidified the B. subtilis cytoplasm, followed by partial recovery. Benzoate addition up to 60 mM at external pH 7 depressed cytoplasmic pH but left a transmembrane Delta pH permitting growth; this robust adaptation to benzoate exceeds that seen in E. coli. Cytoplasmic pH was depressed by 0.3 units during growth with 30 mM benzoate. The transcriptome of benzoate-adapted cells was determined by comparing 4,095 gene expression indices following growth at pH 7, +/- 30 mM benzoate. 164 ORFs showed >= 2-fold up-regulation by benzoate (30 mM benzoate/0 mM), and 102 ORFs showed >= 2-fold down-regulation. 42% of benzoate-dependent genes are regulated up or down, respectively, at pH 6 versus pH 7; they are candidates for cytoplasmic pH response. Acid-stress genes up-regulated by benzoate included drug resistance genes (yhbI, yhcA, yuxJ, ywoGH); an oligopeptide transporter (opp); glycine catabolism (gcvPA-PB); acetate degradation (acsA); dehydrogenases (ald, fdhD, serA, yrhEFG, yjgCD); the TCA cycle (citZ, icd, mdh, sucD); and oxidative stress (OYE-family yqjM, ohrB). Base-stress genes down-regulated by benzoate included malate metabolism (maeN), sporulation control (spo0M, spo0E), and the SigW alkali shock regulon. Cytoplasmic pH could mediate alkali-shock induction of SigW. Conclusions: B. subtilis maintains partial pH homeostasis during growth, and withstands high concentrations of permeant acid stress, higher than for gram-negative neutralophile E. coli. The benzoate adaptation transcriptome substantially overlaps that of external acid, contributing to a cytoplasmic pH transcriptome.	[Kitko, Ryan D.; Cleeton, Rebecca L.; Armentrout, Erin I.; Lee, Grace E.; Noguchi, Ken; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Berkmen, Melanie B.] Suffolk Univ, Dept Chem & Biochem, Boston, MA 02114 USA; [Jones, Brian D.] Kenyon Coll, Dept Math, Gambier, OH 43022 USA	Kenyon College; Suffolk University; Kenyon College	Kitko, RD (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu		Berkmen, Melanie/0000-0003-0365-6040	National Institutes of Health [R15 GM079731-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM079731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health AREA award no. R15 GM079731-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Browne N, 2002, J APPL MICROBIOL, V92, P404, DOI 10.1046/j.1365-2672.2002.01541.x; Brul S, 1999, INT J FOOD MICROBIOL, V50, P1, DOI 10.1016/S0168-1605(99)00072-0; Cao M, 2002, J MOL BIOL, V316, P443, DOI 10.1006/jmbi.2001.5372; Cavin JF, 1998, APPL ENVIRON MICROB, V64, P1466; Chen JL, 2009, INT J FOOD MICROBIOL, V128, P424, DOI 10.1016/j.ijfoodmicro.2008.09.015; CHENG JB, 1994, J BIOL CHEM, V269, P27365; COLLINS CM, 1993, MOL MICROBIOL, V9, P907, DOI 10.1111/j.1365-2958.1993.tb01220.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Critzer FJ, 2008, J FOOD PROTECT, V71, P1469, DOI 10.4315/0362-028X-71.7.1469; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Debarbouille M, 1999, J BACTERIOL, V181, P2059, DOI 10.1128/JB.181.7.2059-2066.1999; DELL CL, 1994, MOL MICROBIOL, V14, P7, DOI 10.1111/j.1365-2958.1994.tb01262.x; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; EKLUND T, 1985, J GEN MICROBIOL, V131, P73; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; GRUNDY FJ, 1993, MOL MICROBIOL, V10, P259, DOI 10.1111/j.1365-2958.1993.tb01952.x; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Itaya M, 2001, BIOSCI BIOTECH BIOCH, V65, P579, DOI 10.1271/bbb.65.579; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Jobin MP, 2002, INT J FOOD MICROBIOL, V79, P65, DOI 10.1016/S0168-1605(02)00180-0; Kannan G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-37; KHAN S, 1980, J MOL BIOL, V138, P563, DOI 10.1016/S0022-2836(80)80018-0; KHAN S, 1980, J MOL BIOL, V138, P599, DOI 10.1016/S0022-2836(80)80019-2; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Kovacs T, 1998, FEMS MICROBIOL LETT, V165, P323, DOI 10.1111/j.1574-6968.1998.tb13164.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lambert LA, 1997, J BACTERIOL, V179, P7595, DOI 10.1128/jb.179.23.7595-7599.1997; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Lupa B, 2008, CAN J MICROBIOL, V54, P75, DOI [10.1139/W07-113, 10.1139/w07-113]; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; MAGILL NG, 1994, J BACTERIOL, V176, P2252, DOI 10.1128/JB.176.8.2252-2258.1994; Margot P, 1996, MICROBIOL-UK, V142, P3437, DOI 10.1099/13500872-142-12-3437; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mizuno M, 1996, MICROBIOL-UK, V142, P3103, DOI 10.1099/13500872-142-11-3103; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Mols M, 2008, APPL ENVIRON MICROB, V74, P2370, DOI 10.1128/AEM.02737-07; Monteiro SM, 2005, BIOTECHNOL PROGR, V21, P1026, DOI 10.1021/bp050062z; NEELY MN, 1994, J BACTERIOL, V176, P3278, DOI 10.1128/jb.176.11.3278-3285.1994; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Potenski CJ, 2003, FEMS MICROBIOL LETT, V220, P181, DOI 10.1016/S0378-1097(03)00099-5; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; REED PW, 1982, POLYETHER ANTIBIOTIC, V1, P185; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; SETLOW B, 1980, P NATL ACAD SCI-BIOL, V77, P2474, DOI 10.1073/pnas.77.5.2474; SHEU CW, 1975, ANTIMICROB AGENTS CH, V7, P349, DOI 10.1128/AAC.7.3.349; SHIOI J, 1980, J BACTERIOL, V144, P891, DOI 10.1128/JB.144.3.891-897.1980; Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005; Slonczewski J. L, 1996, ESCHERICHIA COLI SAL, P1539; SLONCZEWSKI JL, 1982, J BACTERIOL, V152, P384; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Solomon J, 2003, J BACTERIOL, V185, P6425, DOI 10.1128/JB.185.21.6425-6433.2003; Spilimbergo S, 2005, BIOTECHNOL BIOENG, V92, P447, DOI 10.1002/bit.20606; Ter Beek A, 2008, J BACTERIOL, V190, P1751, DOI 10.1128/JB.01516-07; Thomassin S, 2006, ARCH MICROBIOL, V186, P229, DOI 10.1007/s00203-006-0137-1; Tran NP, 2008, J BACTERIOL, V190, P3213, DOI 10.1128/JB.01936-07; Van Duy N, 2007, PROTEOMICS, V7, P698, DOI 10.1002/pmic.200600706; Wei Y, 2006, J BACTERIOL, V188, P7090, DOI 10.1128/JB.00885-06; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Zellmeier S, 2006, MOL MICROBIOL, V61, P1569, DOI 10.1111/j.1365-2958.2006.05323.x	80	32	32	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8255	10.1371/journal.pone.0008255	http://dx.doi.org/10.1371/journal.pone.0008255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011599	Green Submitted, gold, Green Published			2022-12-25	WOS:000272830300021
J	Linher, K; Dyce, P; Li, JL				Linher, Katja; Dyce, Paul; Li, Julang			Primordial Germ Cell-Like Cells Differentiated In Vitro from Skin-Derived Stem Cells	PLOS ONE			English	Article							OOCYTE-LIKE CELLS; DNA METHYLATION; PREIMPLANTATION EMBRYOS; PATERNAL METHYLATION; OVARIAN STRUCTURES; H19 LOCUS; EXPRESSION; GENE; SPECIFICATION; GENERATION	Background: We have previously demonstrated that stem cells isolated from fetal porcine skin have the potential to form oocyte-like cells (OLCs) in vitro. However, primordial germ cells (PGCs), which must also be specified during the stem cell differentiation to give rise to these putative oocytes at more advanced stages of culture, were not systematically characterized. The current study tested the hypothesis that a morphologically distinct population of cells derived from skin stem cells prior to OLC formation corresponds to putative PGCs, which differentiate further into more mature gametes. Methodology/Principal Findings: When induced to differentiate in an appropriate microenvironment, a subpopulation of morphologically distinct cells, some of which are alkaline phosphatase (AP)-positive, also express Oct4, Fragilis, Stella, Dazl, and Vasa, which are markers indicative of germ cell formation. A known differentially methylated region (DMR) within the H19 gene locus, which is demethylated in oocytes after establishment of the maternal imprint, is hypomethylated in PGC-like cells compared to undifferentiated skin-derived stem cells, suggesting that the putative germ cell population undergoes imprint erasure. Additional evidence supporting the germ cell identity of in vitro-generated PGC-like cells is that, when labeled with a Dazl-GFP reporter, these cells further differentiate into GFP-positive OLCs. Significance: The ability to generate germ cell precursors from somatic stem cells may provide an in vitro model to study some of the unanswered questions surrounding early germ cell formation.	[Linher, Katja; Dyce, Paul; Li, Julang] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Linher, K (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	jli@uoguelph.ca		Dyce, Paul/0000-0002-4574-3321	Canada Institutes for Health Research (CIHR); National Science and Research Engineering Council (NSERC); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); NSERC	Canada Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science and Research Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canada Institutes for Health Research (CIHR), National Science and Research Engineering Council (NSERC), and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA). Katja Linher and Paul Dyce are NSERC Doctoral Scholarship recipients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; Buzina A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000051; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Cauffman G, 2005, MOL HUM REPROD, V11, P405, DOI 10.1093/molehr/gah167; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; CURCHOE CL, 2009, ANIM REPROD SCI; Danner S, 2007, MOL HUM REPROD, V13, P11, DOI 10.1093/molehr/gal096; Dawn B, 2008, STEM CELLS, V26, P1646, DOI 10.1634/stemcells.2007-0715; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; Gebert C, 2006, GENOMICS, V88, P222, DOI 10.1016/j.ygeno.2006.03.011; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GODIN I, 1991, NATURE, V352, P807, DOI 10.1038/352807a0; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kehler J, 2005, SEMIN REPROD MED, V23, P222, DOI 10.1055/s-2005-872450; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia MJ, 2008, STEM CELLS, V26, P2083, DOI 10.1634/stemcells.2007-0922; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee CK, 2000, BIOL REPROD, V63, P887, DOI 10.1095/biolreprod63.3.887; Lee J, 2002, DEVELOPMENT, V129, P1807; Linher KJ, 2007, ENDOCRINOLOGY, V148, P4292, DOI 10.1210/en.2007-0021; Linher K, 2009, DIFFERENTIATION, V77, P335, DOI 10.1016/j.diff.2008.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamura D, 2005, MOL REPROD DEV, V70, P20, DOI 10.1002/mrd.20136; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Petkov SG, 2009, MOL REPROD DEV, V76, P22, DOI 10.1002/mrd.20926; Picton HM, 2001, THERIOGENOLOGY, V55, P1193, DOI 10.1016/S0093-691X(01)00478-2; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; Rajpert-De Meyts E, 2004, HUM REPROD, V19, P1338, DOI 10.1093/humrep/deh265; Ratajczak MZ, 2008, EXP HEMATOL, V36, P742, DOI 10.1016/j.exphem.2008.03.010; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato S, 2003, MOL REPROD DEV, V65, P41, DOI 10.1002/mrd.10264; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Shim H, 1998, THERIOGENOLOGY, V49, P521, DOI 10.1016/S0093-691X(98)00003-X; Thorvaldsen JL, 2006, MOL CELL BIOL, V26, P1245, DOI 10.1128/MCB.26.4.1245-1258.2006; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Wei W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004013; West JA, 2006, NAT PROTOC, V1, P2026, DOI 10.1038/nprot.2006.303; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zuba-Surma EK, 2009, MECH AGEING DEV, V130, P58, DOI 10.1016/j.mad.2008.02.003	65	65	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8263	10.1371/journal.pone.0008263	http://dx.doi.org/10.1371/journal.pone.0008263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011593	Green Published, gold, Green Submitted			2022-12-25	WOS:000272830300024
J	Sasaki, N; Hirano, T; Ichimiya, T; Wakao, M; Hirano, K; Kinoshita-Toyoda, A; Toyoda, H; Suda, Y; Nishihara, S				Sasaki, Norihiko; Hirano, Takuya; Ichimiya, Tomomi; Wakao, Masahiro; Hirano, Kazumi; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Suda, Yasuo; Nishihara, Shoko			The 3 '-Phosphoadenosine 5 '-Phosphosulfate Transporters, PAPST1 and 2, Contribute to the Maintenance and Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							INHIBITS NEURAL DIFFERENTIATION; HEPARAN-SULFATE PROTEOGLYCANS; SELF-RENEWAL; CHONDROITIN SULFATE; MOLECULAR-CLONING; LINEAGE COMMITMENT; RNA INTERFERENCE; ES CELLS; ACTIVATION; PLURIPOTENCY	Recently, we have identified two 3'-phosphoadenosine 5'-phosphosulfate (PAPS) transporters (PAPST1 and PAPST2), which contribute to PAPS transport into the Golgi, in both human and Drosophila. Mutation and RNA interference (RNAi) of the Drosophila PAPST have shown the importance of PAPST-dependent sulfation of carbohydrates and proteins during development. However, the functional roles of PAPST in mammals are largely unknown. Here, we investigated whether PAPST-dependent sulfation is involved in regulating signaling pathways required for the maintenance of mouse embryonic stem cells (mESCs), differentiation into the three germ layers, and neurogenesis. By using a yeast expression system, mouse PAPST1 and PAPST2 proteins were shown to have PAPS transport activity with an apparent K(m) value of 1.54 mu M or 1.49 mu M, respectively. RNAi-mediated knockdown of each PAPST induced the reduction of chondroitin sulfate (CS) chain sulfation as well as heparan sulfate (HS) chain sulfation, and inhibited mESC self-renewal due to defects in several signaling pathways. However, we suggest that these effects were due to reduced HS, not CS, chain sulfation, because knockdown of mouse N-deacetylase/N-sulfotransferase, which catalyzes the first step of HS sulfation, in mESCs gave similar results to those observed in PAPST-knockdown mESCs, but depletion of CS chains did not. On the other hand, during embryoid body formation, PAPST-knockdown mESCs exhibited abnormal differentiation, in particular neurogenesis was promoted, presumably due to the observed defects in BMP, FGF and Wnt signaling. The latter were reduced as a result of the reduction in both HS and CS chain sulfation. We propose that PAPST-dependent sulfation of HS or CS chains, which is regulated developmentally, regulates the extrinsic signaling required for the maintenance and normal differentiation of mESCs.	[Sasaki, Norihiko; Hirano, Takuya; Ichimiya, Tomomi; Hirano, Kazumi; Nishihara, Shoko] Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Tokyo, Japan; [Wakao, Masahiro; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Dept Nanostruct & Adv Mat, Kagoshima 890, Japan; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao] Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Bioanalyt Chem, Shiga, Japan; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Suda, Yasuo; Nishihara, Shoko] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan	Soka University; Kagoshima University; Ritsumeikan University; Japan Science & Technology Agency (JST)	Sasaki, N (corresponding author), Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Tokyo, Japan.	shoko@t.soka.ac.jp	Hirano, Kazumi/L-7031-2018; Hirano, Kazumi/R-5290-2019	Hirano, Kazumi/0000-0001-9717-5904; Hirano, Kazumi/0000-0001-9717-5904; Nishihara, Shoko/0000-0002-1668-2603	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20370051, S0901015]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partially supported by funds from Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Grant-in-Aid for Scientific Research (B) to SN, 20370051, 2008-2010, and from MEXT, the Matching Fund for Private Universities, S0901015, 2009-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; AURELIE C, 2008, PLOS GENET, V7; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dick G, 2008, GLYCOBIOLOGY, V18, P53, DOI 10.1093/glycob/cwm121; Dvorak P, 1998, J CELL SCI, V111, P2945; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Goda E, 2006, J BIOL CHEM, V281, P28508, DOI 10.1074/jbc.M605045200; Gratsch TE, 2002, DEV BIOL, V245, P83, DOI 10.1006/dbio.2002.0629; Haegele L, 2003, MOL CELL NEUROSCI, V24, P696, DOI 10.1016/S1044-7431(03)00232-X; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakayama K, 2003, GLYCOBIOLOGY, V13, P673, DOI 10.1093/glycob/cwg099; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schwartz NB, 1998, CHEM-BIOL INTERACT, V109, P143, DOI 10.1016/S0009-2797(97)00129-4; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tsuiji H, 1998, BIOCHEM BIOPH RES CO, V253, P374, DOI 10.1006/bbrc.1998.9726; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamada T, 2005, BIOINFORMATICS, V21, P1316, DOI 10.1093/bioinformatics/bti155; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009	73	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8262	10.1371/journal.pone.0008262	http://dx.doi.org/10.1371/journal.pone.0008262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011239	Green Submitted, Green Published, gold			2022-12-25	WOS:000272830200009
J	Schisler, JC; Charles, PC; Parker, JS; Hilliard, EG; Mapara, S; Meredith, D; Lineberger, RE; Wu, SS; Alder, BD; Stouffer, GA; Patterson, C				Schisler, Jonathan C.; Charles, Peter C.; Parker, Joel S.; Hilliard, Eleanor G.; Mapara, Sabeen; Meredith, Dane; Lineberger, Robert E.; Wu, Samuel S.; Alder, Brian D.; Stouffer, George A.; Patterson, Cam			Stable Patterns of Gene Expression Regulating Carbohydrate Metabolism Determined by Geographic Ancestry	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; MULTIPLE POPULATIONS; HAPTOGLOBIN GENOTYPE; RACIAL DISPARITIES; ETHNIC-DIFFERENCES; MICROARRAY DATA; RISK-FACTORS	Background: Individuals of African descent in the United States suffer disproportionately from diseases with a metabolic etiology (obesity, metabolic syndrome, and diabetes), and from the pathological consequences of these disorders (hypertension and cardiovascular disease). Methodology/Principal Findings: Using a combination of genetic/genomic and bioinformatics approaches, we identified a large number of genes that were both differentially expressed between American subjects self-identified to be of either African or European ancestry and that also contained single nucleotide polymorphisms that distinguish distantly related ancestral populations. Several of these genes control the metabolism of simple carbohydrates and are direct targets for the SREBP1, a metabolic transcription factor also differentially expressed between our study populations. Conclusions/Significance: These data support the concept of stable patterns of gene transcription unique to a geographic ancestral lineage. Differences in expression of several carbohydrate metabolism genes suggest both genetic and transcriptional mechanisms contribute to these patterns and may play a role in exacerbating the disproportionate levels of obesity, diabetes, and cardiovascular disease observed in Americans with African ancestry.	[Schisler, Jonathan C.; Charles, Peter C.; Hilliard, Eleanor G.; Mapara, Sabeen; Lineberger, Robert E.; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27515 USA; [Charles, Peter C.; Meredith, Dane; Wu, Samuel S.; Stouffer, George A.; Patterson, Cam] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; [Parker, Joel S.] Express Anal, Durham, NC USA; [Alder, Brian D.] Duke Univ, Sch Med, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Schisler, JC (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27515 USA.	cpatters@med.unc.edu	Parker, Joel/AAG-1108-2019; Stouffer, George/AAK-4763-2021; Schisler, Jonathan C./C-1301-2008	Schisler, Jonathan C./0000-0001-7382-2783	American Heart Association [0635100N]; National Institutes of Health [HL072347]; Centers for Disease Control [H75/CCH424675, H75/CCH424677]; University of North Carolina School of Medicine; Doris Duke Charitable Foundation; BurroughsWellcome; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072347, T32HL083828] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of North Carolina School of Medicine; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); BurroughsWellcome(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by an American Heart Association Scientist Development Grant (#0635100N) to PCC, grants from the National Institutes of Health (HL072347), Centers for Disease Control (H75/CCH424675 and H75/CCH424677), and University of North Carolina School of Medicine ("Investments in the Future'' program) to CP, and a Doris Duke Charitable Foundation Fellowship to BDA. CP is an established investigator of the American Heart Association and a BurroughsWellcome Fund Clinician Scientist in Translational Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; BAKER JR, 1983, BRIT MED J, V287, P863, DOI 10.1136/bmj.287.6396.863; Blum S, 2007, J AM COLL CARDIOL, V49, P82, DOI 10.1016/j.jacc.2006.08.044; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Charles PC, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-38; Chen MS, 2005, AM J MED, V118, P1019, DOI 10.1016/j.amjmed.2004.12.035; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; Diraison F, 2008, J LIPID RES, V49, P814, DOI 10.1194/jlr.M700533-JLR200; Drake TA, 2006, MAMM GENOME, V17, P466, DOI 10.1007/s00335-005-0175-z; Duster T, 2005, SCIENCE, V307, P1050, DOI 10.1126/science.1110303; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Felder TK, 2007, INT J OBESITY, V31, P1099, DOI 10.1038/sj.ijo.0803505; Flordellis CS, 2006, CURR TOP MED CHEM, V6, P1791, DOI 10.2174/156802606778194226; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Glinsky GV, 2006, CELL CYCLE, V5, P2613, DOI 10.4161/cc.5.22.3498; Goodman AH, 2000, AM J PUBLIC HEALTH, V90, P1699, DOI 10.2105/AJPH.90.11.1699; Gosmain Y, 2005, J LIPID RES, V46, P697, DOI 10.1194/jlr.M400261-JLR200; Gosmain Y, 2004, DIABETES, V53, P321, DOI 10.2337/diabetes.53.2.321; GRANT DJ, 1993, AM J HUM GENET, V52, P974; Grarup N, 2008, DIABETES, V57, P1136, DOI 10.2337/db07-1534; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Harding AH, 2006, DIABETOLOGIA, V49, P2642, DOI 10.1007/s00125-006-0430-1; Hatada S, 2003, GENE, V319, P55, DOI 10.1016/S0378-1119(03)00791-1; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kim Sung K, 2006, Genome Biol, V7, P310, DOI 10.1186/gb-2006-7-3-310; Kurian AK, 2007, ETHNIC DIS, V17, P143; Laudes M, 2004, DIABETES, V53, P842, DOI 10.2337/diabetes.53.3.842; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Levy AP, 2004, ISRAEL MED ASSOC J, V6, P308; Lindquist CH, 2000, AM J CLIN NUTR, V71, P725, DOI 10.1093/ajcn/71.3.725; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Mingrone G, 2003, ATHEROSCLEROSIS, V170, P155, DOI 10.1016/S0021-9150(03)00254-5; Montgomery Susanne, 2007, Prev Chronic Dis, V4, pA62; Ossorio P, 2005, AM PSYCHOL, V60, P115, DOI 10.1037/0003-066X.60.1.115; Park J, 2007, NUCLEIC ACIDS RES, V35, pD711, DOI 10.1093/nar/gkl962; Qi NR, 2005, HYPERTENSION, V45, P1004, DOI 10.1161/01.HYP.0000161995.64192.2b; Rbo HK, 2005, BIOCHEM BIOPH RES CO, V332, P288, DOI 10.1016/j.bbrc.2005.04.120; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Roguin A, 2003, DIABETES CARE, V26, P2628, DOI 10.2337/diacare.26.9.2628; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Smith SC, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.01.002; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Taillon-Miller P, 2004, GENOMICS, V84, P899, DOI 10.1016/j.ygeno.2004.08.009; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Regenmortel MHV, 2004, EMBO REP, V5, P1016, DOI 10.1038/sj.embor.7400284; Williams JE, 1999, ANN EPIDEMIOL, V9, P472, DOI 10.1016/S1047-2797(99)00029-0; Xing JC, 2008, GENOMICS, V92, P41, DOI 10.1016/j.ygeno.2008.03.011	56	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8183	10.1371/journal.pone.0008183	http://dx.doi.org/10.1371/journal.pone.0008183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20016837	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829800005
J	Huang, J; Hao, P; Chen, H; Hu, W; Yan, Q; Liu, F; Han, ZG				Huang, Jian; Hao, Pei; Chen, Hui; Hu, Wei; Yan, Qing; Liu, Feng; Han, Ze-Guang			Genome-Wide Identification of Schistosoma japonicum MicroRNAs Using a Deep-Sequencing Approach	PLOS ONE			English	Article							GENE-EXPRESSION; EVOLUTION; MANSONI; RNAS; SYSTEM; MPSS	Background: Human schistosomiasis is one of the most prevalent and serious parasitic diseases worldwide. Schistosoma japonicum is one of important pathogens of this disease. MicroRNAs ( miRNAs) are a large group of non-coding RNAs that play important roles in regulating gene expression and protein translation in animals. Genome-wide identification of miRNAs in a given organism is a critical step to facilitating our understanding of genome organization, genome biology, evolution, and posttranscriptional regulation. Methodology/Principal Findings: We sequenced two small RNA libraries prepared from different stages of the life cycle of S. japonicum, immature schistosomula and mature pairing adults, through a deep DNA sequencing approach, which yielded,12 million high-quality short sequence reads containing a total of,2 million non-redundant tags. Based on a bioinformatics pipeline, we identified 176 new S. japonicum miRNAs, of which some exhibited a differential pattern of expression between the two stages. Although 21 S. japonicum miRNAs are orthologs of known miRNAs within the metazoans, some nucleotides at many positions of Schistosoma miRNAs, such as miR-8, let-7, miR-10, miR-31, miR-92, miR-124, and miR-125, are indeed significantly distinct from other bilaterian orthologs. In addition, both miR-71 and some miR-2 family members in tandem are found to be clustered in a reversal direction model on two genomic loci, and two pairs of novel S. japonicum miRNAs were derived from sense and antisense DNA strands at the same genomic loci. Conclusions/Significance: The collection of S. japonicum miRNAs could be used as a new platform to study the genomic structure, gene regulation and networks, evolutionary processes, development, and host-parasite interactions. Some S. japonicum miRNAs and their clusters could represent the ancestral forms of the conserved orthologues and a model for the genesis of novel miRNAs.	[Huang, Jian; Chen, Hui; Yan, Qing; Liu, Feng; Han, Ze-Guang] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Hao, Pei] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Hu, Wei] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention	Huang, J (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China.	hanzg@chgc.sh.cn	HU, Wei/F-1004-2012	Hao, Pei/0000-0002-1498-7059; Han, Ze-Guang/0000-0002-1018-1752	China National Key Project for Basic Research (973) [2010CB529200-04, 2007CB513100, 2006CB910402]; National High-Tech RD Program (863) [2007AA02Z330]; China National Key Projects for Infectious Disease [2008ZX10004-011]; China Postdoctoral Science Foundation [20070420097]; Shanghai Postdoctoral Science Foundation [07R214138]; Shanghai Commission for Science and Technology [08JC1416400]	China National Key Project for Basic Research (973)(National Basic Research Program of China); National High-Tech RD Program (863)(National High Technology Research and Development Program of China); China National Key Projects for Infectious Disease; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Commission for Science and Technology	This work was mainly supported by the China National Key Project for Basic Research (973) (2010CB529200-04, 2007CB513100, and 2006CB910402), National High-Tech R&D Program (863) (2007AA02Z330), China National Key Projects for Infectious Disease (2008ZX10004-011), the China Postdoctoral Science Foundation (20070420097), the Shanghai Postdoctoral Science Foundation (07R214138), and the Shanghai Commission for Science and Technology (08JC1416400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Enright AJ, 2004, GENOME BIOL, V5; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Freitas TC, 2007, PLOS PATHOG, V3, P489, DOI 10.1371/journal.ppat.0030052; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giribet G, 2008, PHILOS T R SOC B, V363, P1513, DOI 10.1098/rstb.2007.2241; Gomes MS, 2009, PARASITOL INT, V58, P61, DOI 10.1016/j.parint.2008.10.002; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Huang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-207; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Krautz-Peterson G, 2008, MOL BIOCHEM PARASIT, V159, P54, DOI 10.1016/j.molbiopara.2007.12.011; Krautz-Peterson G, 2008, EXP PARASITOL, V118, P122, DOI 10.1016/j.exppara.2007.06.013; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MORALES ME, 2003, MOL BIOCHEM PARASIT, V157, P160; NAKAYASHIKI H, 2003, MOL BIOCHEM PARASIT, V128, P205; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Palakodeti D, 2006, RNA, V12, P1640, DOI 10.1261/rna.117206; Pereira TC, 2008, EXP PARASITOL, V118, P619, DOI 10.1016/j.exppara.2007.11.017; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Salzet M, 2000, PARASITOL TODAY, V16, P536, DOI 10.1016/S0169-4758(00)01787-7; Smit A, 1996, REPEATMASKER OPEN 30; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Xue XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004034; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	38	75	83	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8206	10.1371/journal.pone.0008206	http://dx.doi.org/10.1371/journal.pone.0008206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997615	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829700006
J	Matthys, F; Rigouts, L; Sizaire, V; Vezhnina, N; Lecoq, M; Golubeva, V; Portaels, F; Van der Stuyft, P; Kimerling, M				Matthys, Francine; Rigouts, Leen; Sizaire, Vinciane; Vezhnina, Natalia; Lecoq, Maryvonne; Golubeva, Vera; Portaels, Francoise; Van der Stuyft, Patrick; Kimerling, Michael			Outcomes after Chemotherapy with WHO Category II Regimen in a Population with High Prevalence of Drug Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MIXED INFECTION; MDR-TB; OUTBREAK; PATTERNS; STRAINS; GEORGIA; PRISONS; RUSSIA	Standard short course chemotherapy is recommended by the World Health Organization to control tuberculosis worldwide. However, in settings with high drug resistance, first line standard regimens are linked with high treatment failure. We evaluated treatment outcomes after standardized chemotherapy with the WHO recommended category II retreatment regimen in a prison with a high prevalence of drug resistant tuberculosis (TB). A cohort of 233 culture positive TB patients was followed through smear microscopy, culture, drug susceptibility testing and DNA fingerprinting at baseline, after 3 months and at the end of treatment. Overall 172 patients (74%) became culture negative, while 43 (18%) remained positive at the end of treatment. Among those 43 cases, 58% of failures were determined to be due to treatment with an inadequate drug regimen and 42% to either an initial mixed infection or re-infection while under treatment. Overall, drug resistance amplification during treatment occurred in 3.4% of the patient cohort. This study demonstrates that treatment failure is linked to initial drug resistance, that amplification of drug resistance occurs, and that mixed infection and re-infection during standard treatment contribute to treatment failure in confined settings with high prevalence of drug resistance.	[Matthys, Francine; Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Rigouts, Leen; Portaels, Francoise] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Sizaire, Vinciane; Lecoq, Maryvonne] Med Sans Frontieres, Brussels, Belgium; [Vezhnina, Natalia] AIDS Fdn EW, HIV TB Penal Syst Projects Cent Asian Republ, Alma Ata, Kazakhstan; [Golubeva, Vera] Lab Mycobacteriol, Mariinsk, Kemorovo, Russia; [Kimerling, Michael] Univ Alabama, Birmingham, AL USA	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Doctors Without Borders; University of Alabama System; University of Alabama Birmingham	Matthys, F (corresponding author), Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium.	fmatthys@itg.be			Medecins Sans Frontieres, Brussels	Medecins Sans Frontieres, Brussels	Funded by Medecins Sans Frontieres, Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; [Anonymous], 2008, 4 WHO; [Anonymous], 1998, PUBLIC HLTH SERVICE; Behr MA, 2004, AM J RESP CRIT CARE, V169, P554, DOI 10.1164/rccm.2401001; Breathnach AS, 1998, J HOSP INFECT, V39, P111, DOI 10.1016/S0195-6701(98)90324-3; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P48; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Hannan MM, 2001, J HOSP INFECT, V47, P91, DOI 10.1053/jhin.2000.0884; Heersma HF, 1998, METH MOL B, V101, P395, DOI 10.1385/0-89603-471-2:395; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Migliori GB, 2002, INT J TUBERC LUNG D, V6, P858; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Perelman MI, 2000, INT J TUBERC LUNG D, V4, P1097; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Shilova MV, 2001, PHILOS T R SOC B, V356, P1069, DOI 10.1098/rstb.2001.0895; Slavuckij A, 2002, EUR J PUBLIC HEALTH, V12, P94, DOI 10.1093/eurpub/12.2.94; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; *WHO, 2000, GUID EST DOTS PLUS P; *WHO GLOB TASK FOR, 2006, M WHO GLOB TASK FORC; World Health Organization, 1994, WHOTB94179	28	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7954	10.1371/journal.pone.0007954	http://dx.doi.org/10.1371/journal.pone.0007954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956770	Green Published, gold			2022-12-25	WOS:000272827300012
J	Schultsz, C; Nguyen, V; Le, TH; Do, QH; Peiris, JSM; Lim, W; Garcia, JM; Nguyen, DT; Nguyen, THL; Huynh, HT; Phan, XT; van Doorn, HR; Nguyen, VC; Farrar, J; de Jong, MD				Schultsz, Constance; Nguyen Van Dung; Le Thanh Hai; Do Quang Ha; Peiris, J. S. Malik; Lim, Wilina; Garcia, Jean-Michel; Nguyen Dac Tho; Nguyen Thi Hoang Lan; Huynh Huu Tho; Phan Xuan Thao; van Doorn, H. Rogier; Nguyen Van Vinh Chau; Farrar, Jeremy; de Jong, Menno D.			Prevalence of Antibodies against Avian Influenza A (H5N1) Virus among Cullers and Poultry Workers in Ho Chi Minh City, 2005	PLOS ONE			English	Article							LOW-FREQUENCY; INFECTION; TRANSMISSION; CAMBODIA; DUCKS; RISK; ASIA	Background: Between 2003 and 2005, highly pathogenic avian influenza A (H5N1) viruses caused large scale outbreaks in poultry in the Ho Chi Minh City area in Vietnam. We studied the prevalence of antibodies against H5N1 in poultry workers and cullers who were active in the program in Ho Chi Minh City in 2004 and 2005. Methodology/Principal Findings: Single sera from 500 poultry workers and poultry cullers exposed to infected birds were tested for antibodies to avian influenza H5N1, using microneutralization assays and hemagglutination inhibition assay with horse blood. All sera tested negative using microneutralization tests. Three samples showed a 1:80 titer in the hemagglutination inhibition assay. Conclusions/Significance: This study provides additional support for the low transmissibility of clade 1 H5N1 to humans, but limited transmission to highly exposed persons cannot be excluded given the presence of low antibody titers in some individuals.	[Schultsz, Constance; Do Quang Ha; van Doorn, H. Rogier; Nguyen Van Vinh Chau; Farrar, Jeremy; de Jong, Menno D.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Schultsz, Constance; van Doorn, H. Rogier; Farrar, Jeremy; de Jong, Menno D.] Univ Oxford, Dept Clin Med, Ctr Trop Med, Oxford, England; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related & Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Nguyen Van Dung; Huynh Huu Tho; Phan Xuan Thao] Subdept Anim Hlth, Ho Chi Minh City, Vietnam; [Le Thanh Hai; Nguyen Dac Tho; Nguyen Thi Hoang Lan] Prevent Med Ctr, Ho Chi Minh City, Vietnam; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Lim, Wilina] Hong Kong Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Garcia, Jean-Michel] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Hong Kong; University of Hong Kong; University of Amsterdam; Academic Medical Center Amsterdam	Schultsz, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	schultsz@gmail.com	van Doorn, H. Rogier/H-3080-2019; Garcia, Jean-Michel/J-7166-2013; Farrar, Jeremy J./HGA-7610-2022	van Doorn, H. Rogier/0000-0002-9807-1821; Garcia, Jean-Michel/0000-0002-6005-9982; Van Nguyen, Dung/0000-0002-0590-0679; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust, UK; Area of Excellence Scheme of the University Grants Committee, Hong Kong [AoE/M-12/06]	Wellcome Trust, UK(Wellcome Trust); Area of Excellence Scheme of the University Grants Committee, Hong Kong	This study was supported by the Wellcome Trust, UK, and the Area of Excellence Scheme of the University Grants Committee, Hong Kong (Grant AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WHO, 2007, REC LAB PROC DET AV; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P1671, DOI [10.3201/1410.080415, 10.3201/eid1410.080415]	13	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7948	10.1371/journal.pone.0007948	http://dx.doi.org/10.1371/journal.pone.0007948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956765	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827300007
J	Komiya, T; Coxon, A; Park, Y; Chen, WD; Zajac-Kaye, M; Meltzer, P; Karpova, T; Kaye, FJ				Komiya, T.; Coxon, A.; Park, Y.; Chen, W-D; Zajac-Kaye, M.; Meltzer, P.; Karpova, T.; Kaye, F. J.			Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer	ONCOGENE			English	Article						Crtc1; LKB1; lung cancer; Mect1/Torc1; NR4A2	SENSITIVE COINCIDENCE DETECTOR; PEUTZ-JEGHERS-SYNDROME; MUCOEPIDERMOID CARCINOMA; SALIVARY-GLAND; MAMMALIAN-CELLS; WARTHINS TUMORS; GENE-EXPRESSION; RECEPTOR NR4A2; FUSION; ACTIVATION	Activation of Crtc1 (also known as Mect1/Torc1) by a t(11; 19) chromosomal rearrangement underlies the etiology of malignant salivary gland tumors. As LKB1 is a target for mutational inactivation in lung cancer and was recently shown to regulate hepatic Crtc2/CREB transcriptional activity in mice, we now present evidence suggesting disruption of an LKB1/Crtc pathway in cancer. Although Crtc1 is preferentially expressed in adult brain tissues, we observed elevated levels of steady-state Crtc1 in thoracic tumors. In addition, we show that somatic loss of LKB1 is associated with underphosphorylation of endogenous Crtc1, enhanced Crtc1 nuclear localization and enhanced expression of the Crtc prototypic target gene, NR4A2/Nurr1. Inhibition of NR4A2 was associated with growth suppression of LKB1 null tumors, but showed little effect on LKB1-wildtype cells. These data strengthen the role of dysregulated Crtc as a bona. de cancer gene, present a new element to the complex LKB1 tumorigenic axis, and suggest that Crtc genes may be aberrantly activated in a wider range of common adult malignancies. Oncogene (2010) 29, 1672-1680; doi:10.1038/onc.2009.453; published online 14 December 2009	[Komiya, T.; Coxon, A.; Park, Y.; Chen, W-D; Meltzer, P.; Kaye, F. J.] NCI, Genet Branch, Bethesda, MD 20892 USA; [Komiya, T.; Coxon, A.; Park, Y.; Chen, W-D; Zajac-Kaye, M.; Meltzer, P.; Karpova, T.; Kaye, F. J.] Natl Naval Med Ctr, Bethesda, MD USA; [Zajac-Kaye, M.] NCI, Med Oncol Branch, Bethesda, MD 20892 USA; [Karpova, T.] NCI, Lab Receptor Biol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kaye, FJ (corresponding author), Univ Florida Coll, Canc Genet Res Ctr, Dept Med, Rm 364,1376 Mowry Rd, Gainesville, FL 32610 USA.	fkaye@ufl.edu	kaye, frederic/E-2437-2011; CHEN, WEI-DONG/F-4521-2014	CHEN, WEI-DONG/0000-0003-2264-5515; Karpova, Tatiana/0000-0001-6025-2128	NATIONAL CANCER INSTITUTE [ZIASC007256, Z01SC007256, ZIABC011091] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 SC007256-20] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; Behboudi A, 2005, GENE CHROMOSOME CANC, V43, P202, DOI 10.1002/gcc.20168; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Camelo-Piragua SI, 2009, HUM PATHOL, V40, P887, DOI 10.1016/j.humpath.2008.11.004; Carling D, 2006, TRENDS MOL MED, V12, P144, DOI 10.1016/j.molmed.2006.02.003; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Enlund F, 2004, EXP CELL RES, V292, P21, DOI 10.1016/j.yexcr.2003.09.007; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kaye FJ, 2006, CLIN CANCER RES, V12, P3878, DOI 10.1158/1078-0432.CCR-06-0791; Kaye FJ, 2009, MOL CANCER THER, V8, P1399, DOI 10.1158/1535-7163.MCT-09-0135; Kazakov DV, 2007, AM J DERMATOPATH, V29, P457, DOI 10.1097/DAD.0b013e318156d76f; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Lennerz JKM, 2009, AM J SURG PATHOL, V33, P835, DOI 10.1097/PAS.0b013e318190cf5b; Li QX, 2006, HISTOL HISTOPATHOL, V21, P533, DOI 10.14670/HH-21.533; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Shaw RJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286pe55; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tirado Y, 2007, GENE CHROMOSOME CANC, V46, P708, DOI 10.1002/gcc.20458; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	48	37	39	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1672	1680		10.1038/onc.2009.453	http://dx.doi.org/10.1038/onc.2009.453			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	20010869	Green Accepted			2022-12-25	WOS:000275694700012
J	Kajava, AV; Vasselon, T				Kajava, Andrey V.; Vasselon, Thierry			A Network of Hydrogen Bonds on the Surface of TLR2 Controls Ligand Positioning and Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; LEUCINE-RICH REPEAT; MICROBIAL LIPOPROTEINS; BACTERIAL LIPOPROTEINS; PATHOGEN RECOGNITION; CRYSTAL-STRUCTURE; INNATE IMMUNITY; LIPOPEPTIDE; ACTIVATION; BINDING	TLR2 is a pattern recognition receptor that functions in association with TLR1 or TLR6 to mediate innate immune responses to a variety of conserved microbial products. In the present study, the ectodomain of TLR2 was extensively mutated, and the mutants were assessed for their ability to bind and to mediate cellular responses to triacylated lipopeptide Pam(3)CSK(4). This analysis provides evidence that the recently published crystal structure of the TLR2-TLR1-Pam(3)CSK(4) complex represents a functional signal-inducing complex. Furthermore, we report that extended H-bond networks on the surface of TLR2 are critical for signaling in response to Pam(3)CSK(4) and to other di- and tri-acylated TLR2-TLR6 and TLR2-TLR1 ligands. Based on this finding, we suggest a dynamic model for TLR2-mediated recognition of these ligands in which TLR2 fluctuates between a conformation that is more suitable for binding of the fatty acyl moieties of the ligands and a conformation that favors, via a specific orientation of the ligand head group, formation of a signal-inducing ternary complex.	[Vasselon, Thierry] Univ Montpellier 1, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; [Vasselon, Thierry] Univ Montpellier 1, CNRS, Inst Mol Genet, F-34293 Montpellier 5, France; Univ Montpellier 2, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; [Vasselon, Thierry] Univ Montpellier 2, CNRS, Inst Mol Genet Montpellier, F-34293 Montpellier 5, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Vasselon, T (corresponding author), Univ Montpellier 1, Ctr Rech Biochim Macromol, 1919 Route Mende, F-34293 Montpellier 5, France.	thierry.vasselon@igmm.cnrs.fr	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886	Agence Nationale de Recherche sur le Sida et les Hepatites Virales	Agence Nationale de Recherche sur le Sida et les Hepatites Virales(ANRSFrench National Research Agency (ANR))	This work was supported in part by the Agence Nationale de Recherche sur le Sida et les Hepatites Virales (to T. V.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vasselon T, 2004, J IMMUNOL, V173, P7401, DOI 10.4049/jimmunol.173.12.7401; Vasselon T, 2002, J LEUKOCYTE BIOL, V71, P503	28	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6227	6234		10.1074/jbc.M109.063669	http://dx.doi.org/10.1074/jbc.M109.063669			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20007698	hybrid, Green Published			2022-12-25	WOS:000275367500027
J	Wu, JW; Breydo, L; Isas, JM; Lee, J; Kuznetsov, YG; Langen, R; Glabe, C				Wu, Jessica W.; Breydo, Leonid; Isas, J. Mario; Lee, Jerome; Kuznetsov, Yurii G.; Langen, Ralf; Glabe, Charles			Fibrillar Oligomers Nucleate the Oligomerization of Monomeric Amyloid beta but Do Not Seed Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MISFOLDING DISEASES; A-BETA; ALZHEIMERS-DISEASE; MEMBRANE DISRUPTION; COMMON MECHANISM; MEMORY; BRAIN; NEURODEGENERATION; CONFORMATIONS; NEUROTOXICITY	Soluble amyloid oligomers are potent neurotoxins that are involved in a wide range of human degenerative diseases, including Alzheimer disease. In Alzheimer disease, amyloid beta (A beta) oligomers bind to neuronal synapses, inhibit long term potentiation, and induce cell death. Recent evidence indicates that several immunologically distinct structural variants exist as follows: prefibrillar oligomers (PFOs), fibrillar oligomers (FOs), and annular protofibrils. Despite widespread interest, amyloid oligomers are poorly characterized in terms of structural differences and pathological significance. FOs are immunologically related to fibrils because they react with OC, a conformation-dependent, fibril-specific antibody and do not react with antibodies specific for other types of oligomers. However, fibrillar oligomers are much smaller than fibrils. FOs are soluble at 100,000 x g, rich in beta-sheet structures, but yet bind weakly to thioflavin T. EPR spectroscopy indicates that FOs display significantly more spin-spin interaction at multiple labeled sites than PFOs and are more structurally similar to fibrils. Atomic force microscopy indicates that FOs are approximately one-half to one-third the height of mature fibrils. We found that A beta FOs do not seed the formation of thioflavin T-positive fibrils from A beta monomers but instead seed the formation of FOs from A beta monomers that are positive for the OC anti-fibril antibody. These results indicate that the lattice of FOs is distinct from the fibril lattice even though the polypeptide chains are organized in an immunologically identical conformation. The FOs resulting from seeded reactions have the same dimensions and morphology as the initial seeds, suggesting that the seeds replicate by growing to a limiting size and then splitting, indicating that their lattice is less stable than fibrils. We suggest that FOs may represent small pieces of single fibril protofilament and that the addition of monomers to the ends of FOs is kinetically more favorable than the assembly of the oligomers into fibrils via sheet stacking interaction. These studies provide novel structural insight into the relationship between fibrils and FOs and suggest that the increased toxicity of FOs may be due to their ability to replicate and the exposure of hydrophobic sheet surfaces that are otherwise obscured by sheet-sheet interactions between protofilaments in a fibril.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Isas, J. Mario; Langen, Ralf] Univ So Calif, Zilhka Neurogenet Inst, Los Angeles, CA 90033 USA	University of California System; University of California Irvine; University of Southern California		cglabe@uci.edu	Breydo, Leo/AAJ-7996-2020; Breydo, Leonid/E-6119-2010	Breydo, Leonid/0000-0003-4666-2301	National Institutes of Health [38298, AG00538, AG027936]; Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027936, P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 38298 and AG00538 and Grant AG027936 (to R. L.). This work was also supported by the Cure Alzheimer Fund (to C. G.) and a grant from the Larry L. Hillblom Foundation (to C. G. and R. L.).	Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1999, METHOD ENZYMOL, V309, P467; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Vincent VAM, 2002, J NEUROSCI RES, V69, P578, DOI 10.1002/jnr.10329; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	42	123	123	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6071	6079		10.1074/jbc.M109.069542	http://dx.doi.org/10.1074/jbc.M109.069542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018889	Green Published, hybrid			2022-12-25	WOS:000275367500010
J	Blamowska, M; Sichting, M; Mapa, K; Mokranjac, D; Neupert, W; Hell, K				Blamowska, Marta; Sichting, Martin; Mapa, Koyeli; Mokranjac, Dejana; Neupert, Walter; Hell, Kai			ATPase Domain and Interdomain Linker Play a Key Role in Aggregation of Mitochondrial Hsp70 Chaperone Ssc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; STRUCTURAL BASIS; PROTEIN IMPORT; BIOCHEMICAL-PROPERTIES; COCHAPERONE BINDING; PRECURSOR PROTEINS; ESCHERICHIA-COLI; TRANSLOCATION; DNAK	The co-chaperone Hep1 is required to prevent the aggregation of mitochondrial Hsp70 proteins. We have analyzed the interaction of Hep1 with mitochondrial Hsp70 (Ssc1) and the determinants in Ssc1 that make it prone to aggregation. The ATPase and peptide binding domain (PBD) of Hsp70 proteins are connected by a linker segment that mediates interdomain communication between the domains. We show here that the minimal Hep1 binding entity of Ssc1 consists of the ATPase domain and the interdomain linker. In the absence of Hep1, the ATPase domain with the interdomain linker had the tendency to aggregate, in contrast to the ATPase domain with the mutated linker segment or without linker, and in contrast to the PBD. The closest homolog of Ssc1, bacterial DnaK, and a Ssc1 chimera, in which a segment of the ATPase domain of Ssc1 was replaced by the corresponding segment from DnaK, did not aggregate in Delta hep1 mitochondria. The propensity to aggregate appears to be a specific property of the mitochondrial Hsp70 proteins. The ATPase domain in combination with the interdomain linker is crucial for aggregation of Ssc1. In conclusion, our results suggest that interdomain communication makes Ssc1 prone to aggregation. Hep1 counteracts aggregation by binding to this aggregation-prone conformer.	[Blamowska, Marta; Sichting, Martin; Mapa, Koyeli; Mokranjac, Dejana; Neupert, Walter; Hell, Kai] Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Hell, K (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hell@med.uni-muenchen.de		Mokranjac, Dejana/0000-0002-4005-6979	Deutsche Forschungsgemeinschaft [SFB 594 (B13, B3)]; Center for Integrated Protein Science Munich; Elite Netzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Elite Netzwerk Bayern	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 594 (B13, B3), the Center for Integrated Protein Science Munich, and a predoctoral fellowship from the Elite Netzwerk Bayern (to M. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; Becker D, 2009, J BIOL CHEM, V284, P2934, DOI 10.1074/jbc.M803557200; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Deloche O, 1997, J BIOL CHEM, V272, P28539, DOI 10.1074/jbc.272.45.28539; Deloche O, 1996, J BIOL CHEM, V271, P23960, DOI 10.1074/jbc.271.39.23960; Deloche O, 1997, J BACTERIOL, V179, P6066, DOI 10.1128/jb.179.19.6066-6075.1997; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Sherman F., 1986, METHODS YEAST GENETI; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200	44	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4423	4431		10.1074/jbc.M109.061697	http://dx.doi.org/10.1074/jbc.M109.061697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007714	Green Published, hybrid			2022-12-25	WOS:000275274800019
J	Goldman, SDB; Krise, JP				Goldman, Stephen D. B.; Krise, Jeffrey P.			Niemann-Pick C1 Functions Independently of Niemann-Pick C2 in the Initial Stage of Retrograde Transport of Membrane-impermeable Lysosomal Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ISOLATED RAT HEPATOCYTES; DISEASE TYPE-C; LATE ENDOSOMES; CHOLESTEROL HOMEOSTASIS; HYBRID ORGANELLES; LIPID TRANSPORT; ALDEHYDE LOAD; PROTEIN; CELLS	The rare neurodegenerative disease Niemann-Pick Type C (NPC) results from mutations in either NPC1 or NPC2, which are membrane-bound and soluble lysosomal proteins, respectively. Previous studies have shown that mutations in either protein result in biochemically indistinguishable phenotypes, most notably the hyper-accumulation of cholesterol and other cargo in lysosomes. We comparatively evaluated the kinetics of [H-3] dextran release from lysosomes of wild type, NPC1, NPC2, and NPC1/NPC2 pseudo-double mutant cells and found significant differences between all cell types examined. Specifically, NPC1 or NPC2 mutant fibroblasts treated with NPC1 or NPC2 siRNA (to create NPC1/NPC2pseudo-double mutants) secreted dextran less efficiently than did either NPC1 or NPC2 single mutant cell lines, suggesting that the two proteins may work independently of one another in the egress of membrane-impermeable lysosomal cargo. To investigate the basis for these differences, we examined the role of NPC1 and NPC2 in the retrograde fusion of lysosomes with late endosomes to create so-called hybrid organelles, which is believed to be the initial step in the egress of cargo from lysosomes. We show here that cells with mutated NPC1 have significantly reduced rates of late endosome/lysosome fusion relative to wild type cells, whereas cells with mutations in NPC2 have rates that are similar to those observed in wild type cells. Instead of being involved in hybrid organelle formation, we show that NPC2 is required for efficient membrane fission events from nascent hybrid organelles, which is thought to be required for the reformation of lysosomes and the release of lysosomal cargo-containing membrane vesicles. Collectively, these results suggest that NPC1 and NPC2 can function independently of one another in the egress of certain membrane-impermeable lysosomal cargo.	[Goldman, Stephen D. B.; Krise, Jeffrey P.] Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66047 USA	University of Kansas	Krise, JP (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, 2095 Constant Ave, Lawrence, KS 66047 USA.	krise@ku.edu			National Institutes of Health [RO1 CA106655]; NATIONAL CANCER INSTITUTE [R01CA106655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA106655.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BOLHUIS PA, 1987, NEUROLOGY, V37, P75, DOI 10.1212/WNL.37.1.75; Bright NA, 1997, J CELL SCI, V110, P2027; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; JAHRAUS A, 1994, J CELL SCI, V107, P145; JATZKEWI.H, 1965, J NEUROCHEM, V12, P135, DOI 10.1111/j.1471-4159.1965.tb06749.x; Kaufmann AM, 2009, ANAL BIOCHEM, V386, P91, DOI 10.1016/j.ab.2008.11.036; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; KRIEGER M, 1978, J BIOL CHEM, V253, P4093; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Luzio JP, 2005, BIOCHEM SOC SYMP, V72, P77, DOI 10.1042/bss0720077; Luzio JP, 2000, J CELL SCI, V113, P1515; McNeil PL, 2002, J CELL SCI, V115, P873; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; SOLHEIM AE, 1983, BIOCHIM BIOPHYS ACTA, V763, P284, DOI 10.1016/0167-4889(83)90136-2; SOLHEIM AE, 1983, BIOCHEM J, V210, P929, DOI 10.1042/bj2100929; Subramanian K, 2008, P NATL ACAD SCI USA, V105, P15223, DOI 10.1073/pnas.0808256105; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Virgili M, 2006, NEUROCHEM INT, V48, P201, DOI 10.1016/j.neuint.2005.10.004; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Zervas M, 2001, J NEUROPATH EXP NEUR, V60, P49, DOI 10.1093/jnen/60.1.49; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	46	52	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4983	4994		10.1074/jbc.M109.037622	http://dx.doi.org/10.1074/jbc.M109.037622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007703	hybrid, Green Published			2022-12-25	WOS:000275274800075
J	Haweker, H; Rips, S; Koiwa, H; Salomon, S; Saijo, Y; Chinchilla, D; Robatzek, S; von Schaewen, A				Haeweker, Heidrun; Rips, Stephan; Koiwa, Hisashi; Salomon, Susanne; Saijo, Yusuke; Chinchilla, Delphine; Robatzek, Silke; von Schaewen, Antje			Pattern Recognition Receptors Require N-Glycosylation to Mediate Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; ENDOPLASMIC-RETICULUM; INNATE IMMUNITY; FLAGELLIN PERCEPTION; MOLECULAR-PATTERNS; QUALITY-CONTROL; LINKED GLYCANS; ARABIDOPSIS; PROTEIN; KINASE	N-Glycans attached to the ectodomains of plasma membrane pattern recognition receptors constitute likely initial contact sites between plant cells and invading pathogens. To assess the role of N-glycans in receptor-mediated immune responses, we investigated the functionality of Arabidopsis receptor kinases EFR and FLS2, sensing bacterial translation elongation factor Tu (elf18) and flagellin (flg22), respectively, in N-glycosylation mutants. As revealed by binding and responses to elf18 or flg22, both receptors tolerated immature N-glycans induced by mutations in various Golgi modification steps. EFR was specifically impaired by loss-of-function mutations in STT3A, a subunit of the endoplasmic reticulum resident oligosaccharyltransferase complex. FLS2 tolerated mild underglycosylation occurring in stt3a but was sensitive to severe underglycosylation induced by tunicamycin treatment. EFR accumulation was significantly reduced when synthesized without N-glycans but to lesser extent when underglycosylated in stt3a or mutated in single amino acid positions. Interestingly, EFRN143Q lacking a single conserved N-glycosylation site from the EFR ectodomain accumulated to reduced levels and lost the ability to bind its ligand and to mediate elf18-elicited oxidative burst. However, EFR-YFP protein localization and peptide: N-glycosidase F digestion assays support that both EFR produced in stt3a and EFRN143Q in wild type cells correctly targeted to the plasma membrane via the Golgi apparatus. These results indicate that a single N-glycan plays a critical role for receptor abundance and ligand recognition during plant-pathogen interactions at the cell surface.	[Haeweker, Heidrun; Salomon, Susanne; Saijo, Yusuke; Robatzek, Silke; von Schaewen, Antje] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Rips, Stephan] Univ Munster, Inst Bot, D-48149 Munster, Germany; [Koiwa, Hisashi] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, Dept Hort Sci, College Stn, TX 77843 USA; [Koiwa, Hisashi] Texas A&M Univ, Mol & Environm Plant Sci Program, College Stn, TX 77843 USA; [Chinchilla, Delphine] Univ Basel, Basel Zurich Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland	Max Planck Society; University of Munster; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Basel	von Schaewen, A (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	Schaewen@uni-muenster.de	Koiwa, Hisashi/AAO-6512-2020; Koiwa, Hisashi/AAA-8182-2019; Robatzek, Silke/B-6844-2013	Koiwa, Hisashi/0000-0002-7421-340X; 				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Germain H, 2008, PLANTA, V228, P851, DOI 10.1007/s00425-008-0787-0; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kajiura H, 2010, GLYCOBIOLOGY, V20, P235, DOI 10.1093/glycob/cwp170; Kamikubo Y, 2008, BIOCHEM J, V410, P595, DOI 10.1042/BJ20071137; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Lerouxel O, 2005, PLANT J, V42, P455, DOI 10.1111/j.1365-313X.2005.02392.x; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schob H, 1997, MOL GEN GENET, V256, P581, DOI 10.1007/s004380050604; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; Zhu JZ, 2009, MOL IMMUNOL, V46, P978, DOI 10.1016/j.molimm.2008.09.024; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	43	143	147	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4629	4636		10.1074/jbc.M109.063073	http://dx.doi.org/10.1074/jbc.M109.063073			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007973	hybrid, Green Published			2022-12-25	WOS:000275274800041
J	Holland, RA; Wikelski, M; Kummeth, F; Bosque, C				Holland, Richard A.; Wikelski, Martin; Kuemmeth, Franz; Bosque, Carlos			The Secret Life of Oilbirds: New Insights into the Movement Ecology of a Unique Avian Frugivore	PLOS ONE			English	Article							STEATORNIS-CARIPENSIS; PARADIGM; ANIMALS; BIRDS	Background: Steatornis caripensis (the oilbird) is a very unusual bird. It supposedly never sees daylight, roosting in huge aggregations in caves during the day and bringing back fruit to the cave at night. As a consequence a large number of the seeds from the fruit they feed upon germinate in the cave and spoil. Methodology/Principal Findings: Here we use newly developed GPS/acceleration loggers with remote UHF readout to show that several assumptions about the behaviour of Steatornis caripensis need to be revised. On average, they spend only every 3(rd) day in a cave, individuals spent most days sitting quietly in trees in the rainforest where they regurgitate seeds. Conclusions/Significance: This provides new data on the extent of seed dispersal and the movement ecology of Steatornis caripensis. It suggests that Steatornis caripensis is perhaps the most important long-distance seed disperser in Neotropical forests. We also show that colony-living comes with high activity costs to individuals.	[Holland, Richard A.; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Kuemmeth, Franz] E Obs GmbH, Munich, Germany; [Bosque, Carlos] Univ Simon Bolivar, Dept Biol Organismos, Caracas, Venezuela	Max Planck Society; Simon Bolivar University	Holland, RA (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	rholland@orn.mpg.de	Holland, Richard A/A-6107-2010; Bosque, Carlos/AAX-6038-2020	Holland, Richard A/0000-0003-4495-8061; 				Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; BOSQUE C, 1988, WILSON BULL, V100, P675; BOSQUE C, 1992, CONDOR, V94, P557, DOI 10.2307/1369240; Bosque Carlos, 1996, Ornitologia Neotropical, V6, P67; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Damschen EI, 2008, P NATL ACAD SCI USA, V105, P19078, DOI 10.1073/pnas.0802037105; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; HUMBOLDT AV, 1833, OILBIRDS RECUEIL OBS; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Laurance WF, 2007, ENVIRON SCI ENG, P11; Martin G, 2004, NATURWISSENSCHAFTEN, V91, P26, DOI 10.1007/s00114-003-0495-3; Mayr G, 2002, J ORNITHOL, V143, P82, DOI 10.1007/BF02465461; MOERMOND TC, 1985, NEOTROPICAL ORNITHOL; MURRAY DR, 1986, SEED DISPERSAL; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; PIETRI ED, 1979, B SOC VENEZOLANA CIE, V34; Roca RL, 1994, OILBIRDS VENEZUELA E; Rojas LM, 2004, BRAIN BEHAV EVOLUT, V64, P19, DOI 10.1159/000077540; SNOW D. W., 1961, ZOOLOGICA [NEW YORK], V46, P27; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; SNOW DW, 1976, IBIS, V118, P366, DOI 10.1111/j.1474-919X.1976.tb02026.x; SNOW DW, 1965, OIKOS, V15, P275; TANNENBAUM B, 1978, VENEZUELA B ACAD CIE, V38, P83; Tello NS, 2008, J ORNITHOL, V149, P267, DOI 10.1007/s10336-007-0266-6; THOMAS DW, 1993, PHYSIOL ZOOL, V66, P322, DOI 10.1086/physzool.66.3.30163696; WHEELWRIGHT NT, 1982, AM NAT, V119, P402, DOI 10.1086/283918; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064	30	52	53	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8264	10.1371/journal.pone.0008264	http://dx.doi.org/10.1371/journal.pone.0008264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016844	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834000008
J	Beck, Z; Brown, BK; Wieczorek, L; Peachman, KK; Matyas, GR; Polonis, VR; Rao, M; Alving, CR				Beck, Zoltan; Brown, Bruce K.; Wieczorek, Lindsay; Peachman, Kristina K.; Matyas, Gary R.; Polonis, Victoria R.; Rao, Mangala; Alving, Carl R.			Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DUFFY ANTIGEN RECEPTOR; RED-BLOOD-CELLS; HUMORAL IMMUNITY; HEPARAN-SULFATE; TRANS-INFECTION; FC-RECEPTORS; DC-SIGN; COMPLEMENT; PROGRESSION	Although CD4(+) cells represent the major target for HIV infection in blood, claims of complement-independent binding of HIV-1 to erythrocytes and the possible role of Duffy blood group antigen, have generated controversy. To examine the question of binding to erythrocytes, HIV-1 was incubated in vitro with erythrocytes from 30 healthy leukapheresis donors, and binding was determined by p24 analysis and adsorption of HIV-1 with reduction of infectivity for CD4(+) target cells. All of the cells, regardless of blood group type, bound HIV-1 p24. A typical preparation of erythrocytes bound <2.4% of the added p24, but erythrocytes selectively removed essentially all of the viral infectivity as determined by decreased infection of CD4(+) target cells; however, cell-associated HIV-1 was approximately 100-fold more efficient, via trans infection, than unadsorbed virus for infection of CD4(+) cells. All of the bound HIV-1 p24 was released by treatment of the cells with EDTA, and binding was optimized by adding Ca2+ and Mg2+ during the washing of erythrocytes containing bound HIV-1. Although the small number of contaminating leukocytes in the erythrocyte preparation also bound HIV-1 p24, there was no significant binding to CD4, and it thus appears that the binding occurred on leukocytes at non-CD4 sites. Furthermore, binding occurred to erythrocyte ghosts from which contaminating leukocytes had been previously removed. The results demonstrate that erythrocytes incubated in vitro with HIV-1 differentially adsorb all of the infectious HIV-1 virions (as opposed to non-infectious or degraded virions) in the absence of complement and independent of blood group, and binding is dependent on divalent cations. By analogy with HIV-1 bound to DC-SIGN on dendritic cells, erythrocyte-bound HIV-1 might comprise an important surface reservoir for trans infection of permissive cells.	[Beck, Zoltan; Brown, Bruce K.; Wieczorek, Lindsay; Peachman, Kristina K.; Matyas, Gary R.; Polonis, Victoria R.; Rao, Mangala; Alving, Carl R.] Walter Reed Army Inst Res, US Mil HIV Res Program, Div Retrovirol, Rockville, MD USA; [Beck, Zoltan; Brown, Bruce K.; Wieczorek, Lindsay; Peachman, Kristina K.] Henry M Jackson Fdn Advancement Mil Med, Rockville, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Beck, Z (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Div Retrovirol, Rockville, MD USA.	calving@hivresearch.org	Matyas, Gary/AAK-6785-2021		Henry M. Jackson Foundation [W81XWH-07-2-0067]; U.S. Army Medical Research and Material Command [W81XWH-07-2-0067]	Henry M. Jackson Foundation; U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported through Cooperative Agreement contract no. W81XWH-07-2-0067 between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Army Medical Research and Material Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2006, MOL MEMBR BIOL, V23, P453, DOI 10.1080/09687860600935348; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Fierer DS, 2007, J INFECT DIS, V196, P587, DOI 10.1086/519741; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; He WJ, 2009, CELL HOST MICROBE, V5, P418, DOI 10.1016/j.chom.2009.05.007; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Horne KC, 2009, CELL HOST MICROBE, V5, P415, DOI 10.1016/j.chom.2009.04.013; Huber M, 2007, J INTERN MED, V262, P5, DOI 10.1111/j.1365-2796.2007.01819.x; Julg B, 2009, CELL HOST MICROBE, V5, P413, DOI 10.1016/j.chom.2009.04.009; KULKARNI H, 2009, BLOOD IN PRESS; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; Levy JA, 2002, LANCET, V359, P2212, DOI 10.1016/S0140-6736(02)09314-5; LEVY JA, 2007, HIV 1 PATHOGENESIS; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; LIEBER MR, 1982, J BIOL CHEM, V257, P1660; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Montefiori DC, 1997, SPRINGER SEMIN IMMUN, V18, P371, DOI 10.1007/BF00813504; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Olinger GG, 2000, J VIROL, V74, P8550, DOI 10.1128/JVI.74.18.8550-8557.2000; Perez LG, 2009, J VIROL, V83, P7397, DOI 10.1128/JVI.00656-09; Puri A, 1998, BIOCHEM BIOPH RES CO, V242, P219, DOI 10.1006/bbrc.1997.7941; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Terry VH, 2009, VIROLOGY, V388, P294, DOI 10.1016/j.virol.2009.03.022; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Walley NM, 2009, CELL HOST MICROBE, V5, P408, DOI 10.1016/j.chom.2009.04.011; Walton RT, 2008, CELL HOST MICROBE, V4, P3, DOI 10.1016/j.chom.2008.06.006; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008; Winkler CA, 2009, CELL HOST MICROBE, V5, P411, DOI 10.1016/j.chom.2009.04.010	41	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8297	10.1371/journal.pone.0008297	http://dx.doi.org/10.1371/journal.pone.0008297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011536	Green Submitted, Green Published, gold			2022-12-25	WOS:000272830300045
J	Bondar, IV; Leopold, DA; Richmond, BJ; Victor, JD; Logothetis, NK				Bondar, Igor V.; Leopold, David A.; Richmond, Barry J.; Victor, Jonathan D.; Logothetis, Nikos K.			Long-Term Stability of Visual Pattern Selective Responses of Monkey Temporal Lobe Neurons	PLOS ONE			English	Article							TWO-DIMENSIONAL PATTERNS; INFEROTEMPORAL CORTEX; SINGLE NEURONS; CORTICAL-NEURONS; STRIATE CORTEX; MACAQUE; REPRESENTATION; INFORMATION; CELLS; CATEGORIZATION	Many neurons in primate inferotemporal (IT) cortex respond selectively to complex, often meaningful, stimuli such as faces and objects. An important unanswered question is whether such response selectivity, which is thought to arise from experience-dependent plasticity, is maintained from day to day, or whether the roles of individual cells are continually reassigned based on the diet of natural vision. We addressed this question using microwire electrodes that were chronically implanted in the temporal lobe of two monkeys, often allowing us to monitor activity of individual neurons across days. We found that neurons maintained their selectivity in both response magnitude and patterns of spike timing across a large set of visual images throughout periods of stable signal isolation from the same cell that sometimes exceeded two weeks. These results indicate that stimulus-selectivity of responses in IT is stable across days and weeks of visual experience.	[Bondar, Igor V.; Leopold, David A.; Richmond, Barry J.; Victor, Jonathan D.; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Bondar, IV (corresponding author), RAS, Inst Higher Nervous Act & Neurophysiol, Moscow 117901, Russia.	bondar@ihna.ru	Logothetis, Nikos/U-9282-2019; Bondar, Igor V/M-6416-2014; Victor, Jonathan D./D-2931-2009	Bondar, Igor V/0000-0003-1307-5266; Victor, Jonathan D./0000-0002-9293-0111; Leopold, David/0000-0002-1345-6360	Max Planck Society; National Eye Institute [EY9314]; National Institute of Mental Health [MH68012]; NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068012, ZIAMH002898, ZIAMH002032] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Max Planck Society. JV is supported in part by grants EY9314 from the National Eye Institute, and from grant MH68012 (PI: D. Gardner) from the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; AGGLETON JP, 1990, BEHAV BRAIN RES, V39, P262, DOI 10.1016/0166-4328(90)90032-A; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; BAYLIS GC, 1987, J NEUROSCI, V7, P330; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; De Souza WC, 2005, J NEUROPHYSIOL, V94, P1252, DOI 10.1152/jn.00949.2004; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Erickson CA, 1999, J NEUROSCI, V19, P10404; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Jagadeesh B, 2001, J NEUROPHYSIOL, V86, P290, DOI 10.1152/jn.2001.86.1.290; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kayaert G, 2005, EUR J NEUROSCI, V22, P212, DOI 10.1111/j.1460-9568.2005.04202.x; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Nicolelis M.A., 1998, METHODS NEURAL ENSEM; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Porada I, 2000, J NEUROSCI METH, V95, P13, DOI 10.1016/S0165-0270(99)00139-9; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006	45	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8222	10.1371/journal.pone.0008222	http://dx.doi.org/10.1371/journal.pone.0008222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011035	Green Submitted, Green Published, gold			2022-12-25	WOS:000272829800011
J	Hidaka, S; Manaka, Y; Teramoto, W; Sugita, Y; Miyauchi, R; Gyoba, J; Suzuki, Y; Iwaya, Y				Hidaka, Souta; Manaka, Yuko; Teramoto, Wataru; Sugita, Yoichi; Miyauchi, Ryota; Gyoba, Jiro; Suzuki, Yoiti; Iwaya, Yukio			Alternation of Sound Location Induces Visual Motion Perception of a Static Object	PLOS ONE			English	Article							VISION	Background: Audition provides important cues with regard to stimulus motion although vision may provide the most salient information. It has been reported that a sound of fixed intensity tends to be judged as decreasing in intensity after adaptation to looming visual stimuli or as increasing in intensity after adaptation to receding visual stimuli. This audiovisual interaction in motion aftereffects indicates that there are multimodal contributions to motion perception at early levels of sensory processing. However, there has been no report that sounds can induce the perception of visual motion. Methodology/Principal Findings: A visual stimulus blinking at a fixed location was perceived to be moving laterally when the flash onset was synchronized to an alternating left-right sound source. This illusory visual motion was strengthened with an increasing retinal eccentricity (2.5 deg to 20 deg) and occurred more frequently when the onsets of the audio and visual stimuli were synchronized. Conclusions/Significance: We clearly demonstrated that the alternation of sound location induces illusory visual motion when vision cannot provide accurate spatial information. The present findings strongly suggest that the neural representations of auditory and visual motion processing can bias each other, which yields the best estimates of external events in a complementary manner.	[Hidaka, Souta; Teramoto, Wataru; Gyoba, Jiro] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Manaka, Yuko; Sugita, Yoichi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Teramoto, Wataru; Miyauchi, Ryota; Suzuki, Yoiti; Iwaya, Yukio] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST)	Hidaka, S (corresponding author), Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan.	hidaka@sal.tohoku.ac.jp	Hidaka, Souta/L-6393-2019; Suzuki, Yoiti/AAC-3765-2019	Hidaka, Souta/0000-0001-6727-5322; Gyoba, Jiro/0000-0003-4198-6323	JSPS [19001004, 19004400]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aid for Specially Promoted Research (No. 19001004) and by JSPS Research Fellowship for Young Scientists (No. 19004400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DICK M, 1987, SCIENCE, V237, P400, DOI 10.1126/science.3603025; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1987, NATURE, V328, P645, DOI 10.1038/328645a0; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shimojo S, 1997, VISION RES, V37, P1575, DOI 10.1016/S0042-6989(96)00313-6; Soto-Faraco S, 2002, COGNITIVE BRAIN RES, V14, P139, DOI 10.1016/S0926-6410(02)00068-X; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; WELCH RB, 1986, HDB PERCEPTION HUMAN, V1, P25	14	37	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8188	10.1371/journal.pone.0008188	http://dx.doi.org/10.1371/journal.pone.0008188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533NB	19997648	gold, Green Submitted, Green Published			2022-12-25	WOS:000272829500014
J	Su, JJ; Yoon, BJ; Dougherty, ER				Su, Junjie; Yoon, Byung-Jun; Dougherty, Edward R.			Accurate and Reliable Cancer Classification Based on Probabilistic Inference of Pathway Activity	PLOS ONE			English	Article							MICROARRAY DATA; BREAST-CANCER; GENE; METASTASIS; PREDICTION; DISCOVERY; TOOL	With the advent of high-throughput technologies for measuring genome-wide expression profiles, a large number of methods have been proposed for discovering diagnostic markers that can accurately discriminate between different classes of a disease. However, factors such as the small sample size of typical clinical data, the inherent noise in high-throughput measurements, and the heterogeneity across different samples, often make it difficult to find reliable gene markers. To overcome this problem, several studies have proposed the use of pathway-based markers, instead of individual gene markers, for building the classifier. Given a set of known pathways, these methods estimate the activity level of each pathway by summarizing the expression values of its member genes, and use the pathway activities for classification. It has been shown that pathway-based classifiers typically yield more reliable results compared to traditional gene-based classifiers. In this paper, we propose a new classification method based on probabilistic inference of pathway activities. For a given sample, we compute the log-likelihood ratio between different disease phenotypes based on the expression level of each gene. The activity of a given pathway is then inferred by combining the log-likelihood ratios of the constituent genes. We apply the proposed method to the classification of breast cancer metastasis, and show that it achieves higher accuracy and identifies more reproducible pathway markers compared to several existing pathway activity inference methods.	[Su, Junjie; Yoon, Byung-Jun; Dougherty, Edward R.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Dougherty, Edward R.] Translat Genom Res Inst, Computat Biol Div, Phoenix, AZ USA	Texas A&M University System; Texas A&M University College Station; Translational Genomics Research Institute	Su, JJ (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	bjyoon@ece.tamu.edu	Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101	National Science Foundation [CCF-0634794]	National Science Foundation(National Science Foundation (NSF))	Edward R. Dougherty is supported in part by National Science Foundation, CCF-0634794. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Braga-Neto U, 2007, IEEE SIGNAL PROC MAG, V24, P91, DOI 10.1109/MSP.2007.273062; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cowell LG, 2002, GENOME BIOL, V3; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dougherty ER, 2001, COMPAR FUNCT GENOM, V2, P28, DOI 10.1002/cfg.62; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Hua JP, 2009, PATTERN RECOGN, V42, P409, DOI 10.1016/j.patcog.2008.08.001; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lewis D. D., 1998, LECT NOTES COMPUTER, P4, DOI DOI 10.1007/BFB0026666; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Rish I., 2001, P IJCAI 01 WORKSH EM, P41; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	35	90	96	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8161	10.1371/journal.pone.0008161	http://dx.doi.org/10.1371/journal.pone.0008161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997592	gold, Green Published, Green Submitted			2022-12-25	WOS:000272829500013
J	Tortajada, AM; Carmona, MJ; Serra, M				Tortajada, Ana M.; Jose Carmona, Maria; Serra, Manuel			Does Haplodiploidy Purge Inbreeding Depression in Rotifer Populations?	PLOS ONE			English	Article							BRACHIONUS-PLICATILIS ROTIFERA; RESTING EGG BANKS; GENETIC-STRUCTURE; SPECIES COMPLEX; OUTBREEDING DEPRESSION; DAPHNIA METAPOPULATIONS; ZOOPLANKTON POPULATIONS; MICROSATELLITE ANALYSIS; CYCLICAL PARTHENOGEN; PATTERNS	Background: Inbreeding depression is an important evolutionary factor, particularly when new habitats are colonized by few individuals. Then, inbreeding depression by drift could favour the establishment of later immigrants because their hybrid offspring would enjoy higher fitness. Rotifers are the only major zooplanktonic group where information on inbreeding depression is still critically scarce, despite the fact that in cyclical parthenogenetic rotifers males are haploid and could purge deleterious recessive alleles, thereby decreasing inbreeding depression. Methodology/Principal Findings: We studied the effects of inbreeding in two populations of the cyclical parthenogenetic rotifer Brachionus plicatilis. For each population, we compared both the parental fertilization proportion and F1 fitness components from intraclonal (selfed) and interclonal (outcrossed) crosses. The parental fertilization proportion was similar for both types of crosses, suggesting that there is no mechanism to avoid selfing. In the F1 generation of both populations, we found evidence of inbreeding depression for the fitness components associated with asexual reproduction; whereas inbreeding depression was only found for one of the two sexual reproduction fitness components measured. Conclusions/Significance: Our results show that rotifers, like other major zooplanktonic groups, can be affected by inbreeding depression in different stages of their life cycle. These results suggest that haplodiploidy does not purge efficiently deleterious recessive alleles. The inbreeding depression detected here has important implications when a rotifer population is founded and intraclonal crossing is likely to occur. Thus, during the foundation of new populations inbreeding depression may provide opportunities for new immigrants, increasing gene flow between populations, and affecting genetic differentiation.	[Tortajada, Ana M.; Jose Carmona, Maria; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain	University of Valencia	Tortajada, AM (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain.	ana.maria.tortajada@uv.es	Carmona, María José/AAM-4340-2020; Carmona, María José/H-6452-2015; Serra, Manuel/H-7817-2015	Carmona, María José/0000-0002-4835-6933; Carmona, María José/0000-0002-4835-6933; Serra, Manuel/0000-0003-1731-1529	Spanish Ministry of Science and Technology [BOS2003-00755]; Spanish Ministry of Education, Culture and Sport [AP2003-3390]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government)	The work was supported by a grant (BOS2003-00755) for the Spanish Ministry of Science and Technology (http://ciencia.micinn.fecyt.es/ciencia/) and by a fellowship (AP2003-3390) by the Spanish Ministry of Education, Culture and Sport (http://www.educacion.es) to A. M. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRKY CW, 1967, J EXP ZOOL, V164, P105, DOI 10.1002/jez.1401640110; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; BRUCKNER D, 1978, EVOLUTION, V32, P456, DOI [10.2307/2407613, 10.1111/j.1558-5646.1978.tb00661.x]; Caceres CE, 1997, INVERTEBR BIOL, V116, P371, DOI 10.2307/3226870; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Carmona MJ, 1995, HYDROBIOLOGIA, V313, P365, DOI 10.1007/BF00025971; CARMONA MJ, 1993, HYDROBIOLOGIA, V255, P145, DOI 10.1007/BF00025832; CARVALHO GR, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P291; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Ciros-Perez J, 2001, J PLANKTON RES, V23, P1311, DOI 10.1093/plankt/23.12.1311; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Colbourne John K., 1997, P163; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; De Meester L, 1999, P ROY SOC B-BIOL SCI, V266, P2471; De Meester L, 2006, ARCH HYDROBIOL, V167, P217, DOI 10.1127/0003-9136/2006/0167-0217; DEMEESTER L, 1993, OECOLOGIA, V96, P80, DOI 10.1007/BF00318033; DeMeester L, 1996, ECOSCIENCE, V3, P385, DOI 10.1080/11956860.1996.11682356; Deng HW, 1997, HEREDITY, V78, P182; Deng HW, 1997, GENETICS, V147, P147; DESTASIO BT, 1989, ECOLOGY, V70, P1377; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Garcia-Perez A, 2005, METODOS AVANZADOS ES; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Garcia-Roger EM, 2005, J EXP MAR BIOL ECOL, V314, P149, DOI 10.1016/j.jembe.2004.08.023; GARCIAROGER EM, 2006, THESIS U VALENCIA SP; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2002, J EVOLUTION BIOL, V15, P158, DOI 10.1046/j.1420-9101.2002.00368.x; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Gomez A, 1995, HYDROBIOLOGIA, V313, P111, DOI 10.1007/BF00025938; Gomez A, 1996, FUNCT ECOL, V10, P681, DOI 10.2307/2390502; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Haag CR, 2006, HEREDITY, V96, P150, DOI 10.1038/sj.hdy.6800774; Haag CR, 2005, GENETICS, V170, P1809, DOI 10.1534/genetics.104.036814; Haag CR, 2002, EVOLUTION, V56, P518; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; Hairston NG, 1996, HYDROBIOLOGIA, V320, P27, DOI 10.1007/BF00016802; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; Hertel Elmer W., 1942, PHYSIOL ZOOL, V15, P304; INNES DJ, 1993, J EVOLUTION BIOL, V6, P559, DOI 10.1046/j.1420-9101.1993.6040559.x; INNES DJ, 1989, J HERED, V80, P6, DOI 10.1093/oxfordjournals.jhered.a110791; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KING BH, 1995, J INSECT BEHAV, V8, P723, DOI 10.1007/BF01997241; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Louette G, 2007, OIKOS, V116, P728, DOI 10.1111/j.2007.0030-1299.15664.x; LYNCH M, 1983, AM NAT, V122, P745, DOI 10.1086/284169; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Lynch Michael, 1994, P109; Mills S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-225; Ortells R, 2000, ARCH HYDROBIOL, V149, P529; ORTELLS R, 2002, THESIS U VALENCIA SP; Peer K, 2005, EVOLUTION, V59, P317; Quinn GP, 2003, EXPT DESIGN DATA ANA; Schroder T, 2005, HYDROBIOLOGIA, V546, P291, DOI 10.1007/s10750-005-4235-x; SNELL TW, 1987, INT J INVER REP DEV, V12, P103, DOI 10.1080/01688170.1987.10510306; SNELL TW, 1988, J EXP MAR BIOL ECOL, V124, P73, DOI 10.1016/0022-0981(88)90112-8; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Thornhill N.W., 1993, NATURAL HIST INBREED; WALLACE RL, 2006, ROTIFERA, V1; Waller Donald M., 1993, P97; Werren John H., 1993, P42; WILCOX RR, 2009, WRS COMPILED PACKAGE; [No title captured]; [No title captured]; [No title captured]	65	23	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8195	10.1371/journal.pone.0008195	http://dx.doi.org/10.1371/journal.pone.0008195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997616	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829500017
J	Zhang, W; Yang, SX; Ren, LP; Shen, Q; Cui, L; Fan, KZ; Huang, F; Kang, YJ; Shan, TL; Wei, JZ; Xiu, HF; Lou, YF; Liu, JF; Yang, ZB; Zhu, JG; Hua, XG				Zhang, Wen; Yang, Shixing; Ren, Liping; Shen, Quan; Cui, Li; Fan, Kezhang; Huang, Fen; Kang, Yanjun; Shan, Tongling; Wei, Jianzhong; Xiu, Haifeng; Lou, Yifang; Liu, Junfeng; Yang, Zhibiao; Zhu, Jianguo; Hua, Xiuguo			Hepatitis E Virus Infection in Central China Reveals No Evidence of Cross-Species Transmission between Human and Swine in This Area	PLOS ONE			English	Article							NON-B HEPATITIS; NON-A; EASTERN CHINA; STRAINS; SAMPLES; INDIA; IDENTIFICATION; PREVALENCE; ANTIBODIES; EPIDEMIC	Hepatitis E virus (HEV) is a zoonotic pathogen of which several species of animal were reported as reservoirs. Swine stands out as the major reservoir for HEV infection in humans, as suggested by the close genetic relationship of swine and human virus. Since 2000, Genotype 4 HEV has become the dominant cause of hepatitis E disease in China. Recent reports showed that genotype 4 HEV is freely transmitted between humans and swine in eastern and southern China. However, the infection status of HEV in human and swine populations in central China is still unclear. This study was conducted in a rural area of central China, where there are many commercial swine farms. A total of 1476 serum and 554 fecal specimens were collected from the general human and swine populations in this area, respectively. The seroepidemiological study was conducted by enzyme-linked immunosorbent assay. Conserved genomic sequences of open reading frame 2 were detected using reverse transcription-PCR. The results indicated that the overall viral burden of the general human subjects was 0.95% (14/1476), while 7.0% (39/554) of the swine excreted HEV in stool. The positive rate of anti-HEV IgG and IgM in the serum samples was 7.9% (117/1476) and 1.6% (24/1476), respectively. Phylogenetic analysis based on the 150 nt partial sequence of the capsid protein gene showed that the 53 swine and human HEV isolates in the current study all belonged to genotype 4, clustering into three major groups. However, the HEV isolates prevalent in the human and swine populations were classified into known distinct subgenotypes, which suggested that no cross-species transmission between swine and humans had taken place in this area. This result was confirmed by cloning and phylogenetic analysis of the complete capsid protein gene sequence of three representative HEV strains in the three major groups. The cross reactivity between anti-HEV IgG from human sera and the two representative strains from swine in central China was confirmed by Dot-blot assay. In conclusion, although all the HEV strains prevalent in central China belonged to genotype 4, there is no evidence of cross-species transmission between human and swine in this area.	[Zhang, Wen; Yang, Shixing; Shen, Quan; Cui, Li; Huang, Fen; Kang, Yanjun; Shan, Tongling; Liu, Junfeng; Yang, Zhibiao; Zhu, Jianguo; Hua, Xiuguo] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhang, Wen] Jiangsu Univ, Sch Med Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Wen] Jiangsu Univ, Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Ren, Liping; Fan, Kezhang] Fuyang Normal Univ, Sch Life Sci, Fuyang, Peoples R China; [Wei, Jianzhong] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Peoples R China; [Xiu, Haifeng] Fuyang Peoples Hosp, Fuyang, Peoples R China; [Lou, Yifang] First Peoples Hosp Sixian, Sixian, Peoples R China	Shanghai Jiao Tong University; Jiangsu University; Jiangsu University; Fuyang Normal University; Anhui Agricultural University	Zhang, W (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	hxg@sjtu.edu.cn	Shan, Tongling/AFG-8328-2022	Shan, Tongling/0000-0002-5329-6349; Shen, Quan/0000-0001-9041-8475	Key Project of Shanghai Science and Technology Committee of China [063919121]	Key Project of Shanghai Science and Technology Committee of China(Shanghai Science & Technology Committee)	This work was supported by Key Project of Shanghai Science and Technology Committee of China under Grant No. 063919121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Arankalle VA, 2002, J HEPATOL, V36, P417, DOI 10.1016/S0168-8278(01)00297-5; Bendall R, 2008, J MED VIROL, V80, P95, DOI 10.1002/jmv.21033; Boccia D, 2006, CLIN INFECT DIS, V42, P1679, DOI 10.1086/504322; Caron M, 2006, J CLIN MICROBIOL, V44, P3440, DOI 10.1128/JCM.00939-06; Chadha MS, 1999, J VIRAL HEPATITIS, V6, P457, DOI 10.1046/j.1365-2893.1999.00190.x; Fernandez-Barredo S, 2007, CAN J VET RES, V71, P236; Ge ShengXiang, 2005, Chinese Journal of Virology, V21, P181; Goens S. Denise, 2004, Animal Health Research Reviews, V5, P145, DOI 10.1079/AHR200495; HUANG RT, 1995, J MED VIROL, V47, P303, DOI 10.1002/jmv.1890470403; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Li TC, 2005, EMERG INFECT DIS, V11, P1958, DOI 10.3201/eid1112.051041; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Ning HQ, 2007, VET MICROBIOL, V121, P125, DOI 10.1016/j.vetmic.2006.11.006; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Saad MD, 2007, INFECT GENET EVOL, V7, P368, DOI 10.1016/j.meegid.2006.07.007; Schlauder GG, 2001, J MED VIROL, V65, P282, DOI 10.1002/jmv.2031; Shukla P, 2007, J VIRAL HEPATITIS, V14, P310, DOI 10.1111/j.1365-2893.2006.00815.x; Somani SK, 2003, J VIRAL HEPATITIS, V10, P446, DOI 10.1046/j.1365-2893.2003.00458.x; Takahashi M, 2003, J GEN VIROL, V84, P851, DOI 10.1099/vir.0.18918-0; Tanaka E, 2005, J VIRAL HEPATITIS, V12, P439, DOI 10.1111/j.1365-2893.2005.00616.x; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; WONG DC, 1980, LANCET, V2, P876; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhang JZ, 2002, J MED VIROL, V66, P40, DOI 10.1002/jmv.2109; Zhang JZ, 2001, J MED VIROL, V64, P125, DOI 10.1002/jmv.1027; Zhang W, 2008, EPIDEMIOL INFECT, V136, P1020, DOI 10.1017/S095026880700965X; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zheng YJ, 2006, J INFECT DIS, V193, P1643, DOI 10.1086/504293; ZHUANG H, 1991, INT CONGR SER, V895, P277; 王佑春, 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P618	37	27	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8156	10.1371/journal.pone.0008156	http://dx.doi.org/10.1371/journal.pone.0008156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997619	Green Published, Green Submitted, gold			2022-12-25	WOS:000272829500011
J	Gabrielli, E; Pericolini, E; Cenci, E; Ortelli, F; Magliani, W; Ciociola, T; Bistoni, F; Conti, S; Vecchiarelli, A; Polonelli, L				Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Ortelli, Federica; Magliani, Walter; Ciociola, Tecla; Bistoni, Francesco; Conti, Stefania; Vecchiarelli, Anna; Polonelli, Luciano			Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity	PLOS ONE			English	Article							SYNTHETIC KILLER PEPTIDE; BLOOD-GROUP-A; THERAPEUTIC ACTIVITY; MONOCLONAL-ANTIBODY; ANTIIDIOTYPIC ANTIBODY; IN-VITRO; RECEPTOR (TLR)-2; HOST-DEFENSE; CANDIDIASIS; EXPRESSION	Background: It has been documented that, independently from the specificity of the native antibody ( Ab) for a given antigen (Ag), complementarity determining regions (CDR)-related peptides may display differential antimicrobial, antiviral and antitumor activities. Methodology/Principal Findings: In this study we demonstrate that a synthetic peptide with sequence identical to V(H)CDR3 of a mouse monoclonal Ab (mAb) specific for difucosyl human blood group A is easily taken up by macrophages with subsequent stimulation of: i) proinflammatory cytokine production; ii) PI3K-Akt pathway and iii) TLR-4 expression. Significantly, VHCDR3 exerts therapeutic effect against systemic candidiasis without possessing direct candidacidal properties. Conclusions/Significance: These results open a new scenario about the possibility that, beyond the half life of immunoglobulins, Ab fragments may effectively influence the antiinfective cellular immune response in a way reminiscent of regulatory peptides of innate immunity.	[Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Ortelli, Federica; Bistoni, Francesco; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Magliani, Walter; Ciociola, Tecla; Conti, Stefania; Polonelli, Luciano] Univ Parma, Dept Pathol & Lab Med, Microbiol Sect, I-43100 Parma, Italy	University of Perugia; University of Parma; University Hospital of Parma	Gabrielli, E (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	vecchiar@unipg.it	Pericolini, Eva/AAZ-5848-2021; Ciociola, Tecla/HCH-2453-2022; Conti, Stefania/N-3558-2015; Ciociola, Tecla/AFN-5212-2022	Conti, Stefania/0000-0001-9973-8352; Ciociola, Tecla/0000-0001-6499-2545; CENCI, ELIO/0000-0003-0752-7262; Pericolini, Eva/0000-0002-5299-8197; Vecchiarelli, Anna/0000-0002-3185-6720	National Institutes of Health and Investment for Basic Research [AI14209]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014209, R01AI014209] Funding Source: NIH RePORTER	National Institutes of Health and Investment for Basic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI14209 from the National Institutes of Health and Investment for Basic Research, protocol No. RBLA03C9F4_006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; Azuma M, 2006, J PERIODONTAL RES, V41, P361, DOI 10.1111/j.1600-0765.2006.00896.x; Bourgeois C, 1998, J VIROL, V72, P807, DOI 10.1128/JVI.72.1.807-810.1998; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2006, J LEUKOCYTE BIOL, V79, P40, DOI 10.1189/jlb.0205113; Cenci E, 2004, CELL MICROBIOL, V6, P953, DOI 10.1111/j.1462-5822.2004.00413.x; CHEN HT, 1987, J BIOL CHEM, V262, P13579; Conti G, 2008, ANTIMICROB AGENTS CH, V52, P4331, DOI 10.1128/AAC.00506-08; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Fan H, 2007, IMMUNOLOGY, V122, P116, DOI 10.1111/j.1365-2567.2007.02619.x; Fiori PL, 2006, J ANTIMICROB CHEMOTH, V57, P891, DOI 10.1093/jac/dkl051; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Manfredi M, 2005, ORAL MICROBIOL IMMUN, V20, P226, DOI 10.1111/j.1399-302X.2005.00217.x; Monari C, 2005, J IMMUNOL, V174, P3461, DOI 10.4049/jimmunol.174.6.3461; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Moragues MD, 2003, INFECT IMMUN, V71, P5273, DOI 10.1128/IAI.71.9.5273-5279.2003; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; NICKERSON KG, 1995, J BIOL CHEM, V270, P12457, DOI 10.1074/jbc.270.21.12457; PADLAN EA, 1995, FASEB J, V9, P133, DOI 10.1096/fasebj.9.1.7821752; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pertinhez TA, 2009, MOL PHARMACEUT, V6, P1036, DOI 10.1021/mp900024z; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; ROMANI L, 1993, J IMMUNOL, V150, P925; Savoia D, 2006, EXP PARASITOL, V113, P186, DOI 10.1016/j.exppara.2006.01.002; Sevilla MJ, 2006, INFECT IMMUN, V74, P3042, DOI 10.1128/IAI.74.5.3042-3045.2006; Shealy D. J., 2008, V181, P101; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Travassos LR, 2004, J ANTIMICROB CHEMOTH, V54, P956, DOI 10.1093/jac/dkh430; Tuteja R, 1999, IMMUNOLOGY, V97, P1, DOI 10.1046/j.1365-2567.1999.00743.x	43	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8187	10.1371/journal.pone.0008187	http://dx.doi.org/10.1371/journal.pone.0008187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997599	Green Published, gold, Green Submitted			2022-12-25	WOS:000272829200017
J	Hu, HJ; Leppla, SH				Hu, Haijing; Leppla, Stephen H.			Anthrax Toxin Uptake by Primary Immune Cells as Determined with a Lethal Factor-beta-Lactamase Fusion Protein	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; BACILLUS-ANTHRACIS; DENDRITIC CELLS; PROTECTIVE ANTIGEN; INHALATION ANTHRAX; MELANOMA-CELLS; MACROPHAGES; RECEPTOR; SPORES; STRAIN	Background: To initiate infection, Bacillus anthracis needs to overcome the host innate immune system. Anthrax toxin, a major virulence factor of B. anthracis, impairs both the innate and adaptive immune systems and is important in the establishment of anthrax infections. Methodology/Principal Findings: To measure the ability of anthrax toxin to target immune cells, studies were performed using a fusion of the anthrax toxin lethal factor (LF) N-terminal domain (LFn, aa 1-254) with beta-lactamase (LFnBLA). This protein reports on the ability of the anthrax toxin protective antigen (PA) to mediate LF delivery into cells. Primary immune cells prepared from mouse spleens were used in conjunction with flow cytometry to assess cleavage and resulting FRET disruption of a fluorescent b-lactamase substrate, CCF2/AM. In spleen cell suspensions, the macrophages, dendritic cells, and B cells showed about 75% FRET disruption of CCF2/AM due to cleavage by the PA-delivered LFnBLA. LFnBLA delivery into CD4+ and CD8+ T cells was lower, with 40% FRET disruption. When the analyses were done on purified samples of individual cell types, similar results were obtained, with T cells again having lower LFnBLA delivery than macrophages, dendritic cells, and B cells. Relative expression levels of the toxin receptors CMG2 and TEM8 on these cells were determined by real-time PCR. Expression of CMG2 was about 1.5-fold higher in CD8+ cells than in CD4+ and B cells, and 2.5-fold higher than in macrophages. Conclusions/Significance: Anthrax toxin entry and activity differs among immune cells. Macrophages, dendritic cells, and B cells displayed higher LFnBLA activity than CD4+ and CD8+ T cells in both spleen cell suspension and the purified samples of individual cell types. Expression of anthrax toxin receptor CMG2 is higher in CD4+ and CD8+ T cells, which is not correlated to the intracellular LFnBLA activity.	[Hu, Haijing; Leppla, Stephen H.] NIAID, Bacterial Toxins & Therapeut Sect, Lab Bacterial Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hu, HJ (corresponding author), NIAID, Bacterial Toxins & Therapeut Sect, Lab Bacterial Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov			Intramural Research Program of the National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Alfano RW, 2008, MOL CANCER THER, V7, P1218, DOI 10.1158/1535-7163.MCT-08-0024; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Banks DJ, 2005, CELL MICROBIOL, V7, P1173, DOI 10.1111/j.1462-5822.2005.00545.x; Bish SE, 2008, MICROBES INFECT, V10, P1182, DOI 10.1016/j.micinf.2008.06.014; Boyer AE, 2009, INFECT IMMUN, V77, P3432, DOI 10.1128/IAI.00346-09; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; CATALDI A, 1992, FEMS MICROBIOL LETT, V98, P89, DOI 10.1111/j.1574-6968.1992.tb05495.x; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Duesbery N, 1998, SCIENCE, V280, P1673; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; Hobson JP, 2006, NAT METHODS, V3, P259, DOI 10.1038/NMETH862; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; LEPPLA SH, 1986, BACTERIAL PROTEIN TO, P275; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Liu Shihui, 2009, V539, P175, DOI 10.1007/978-1-60327-003-8_10; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mayer-Scholl A, 2006, BERL MUNCH TIERARZTL, V119, P216; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Rono B, 2006, MOL CANCER THER, V5, P89, DOI 10.1158/1535-7163.MCT-05-0163; ROSS JM, 1957, J PATHOL BACTERIOL, V73, P485, DOI 10.1002/path.1700730219; Ruthel G, 2004, J INFECT DIS, V189, P1313, DOI 10.1086/382656; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Tang SX, 2009, CLIN VACCINE IMMUNOL, V16, P408, DOI 10.1128/CVI.00412-08; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; WELKOS SL, 1989, MICROB PATHOGENESIS, V7, P15, DOI 10.1016/0882-4010(89)90108-3; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7946	10.1371/journal.pone.0007946	http://dx.doi.org/10.1371/journal.pone.0007946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956758	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827300005
J	Parsons, KJ; Cooper, WJ; Albertson, RC				Parsons, Kevin J.; Cooper, W. James; Albertson, R. Craig			Limits of Principal Components Analysis for Producing a Common Trait Space: Implications for Inferring Selection, Contingency, and Chance in Evolution	PLOS ONE			English	Article							DEVELOPMENTAL REGULATION; ONTOGENIC DYNAMICS; SKULL MORPHOLOGY; COVARIANCE; VARIANCE	Background: Comparing patterns of divergence among separate lineages or groups has posed an especially difficult challenge for biologists. Recently a new, conceptually simple methodology called the "ordered-axis plot'' approach was introduced for the purpose of comparing patterns of diversity in a common morphospace. This technique involves a combination of principal components analysis (PCA) and linear regression. Given the common use of these statistics the potential for the widespread use of the ordered axis approach is high. However, there are a number of drawbacks to this approach, most notably that lineages with the greatest amount of variance will largely bias interpretations from analyses involving a common morphospace. Therefore, without meeting a set of a priori requirements regarding data structure the ordered-axis plot approach will likely produce misleading results. Methodology/Principal Findings: Morphological data sets from cichlid fishes endemic to Lakes Tanganyika, Malawi, and Victoria were used to statistically demonstrate how separate groups can have differing contributions to a common morphospace produced by a PCA. Through a matrix superimposition of eigenvectors (scale-free trajectories of variation identified by PCA) we show that some groups contribute more to the trajectories of variation identified in a common morphospace. Furthermore, through a set of randomization tests we show that a common morphospace model partitions variation differently than group-specific models. Finally, we demonstrate how these limitations may influence an ordered-axis plot approach by performing a comparison on data sets with known alterations in covariance structure. Using these results we provide a set of criteria that must be met before a common morphospace can be reliably used. Conclusions/Significance: Our results suggest that a common morphospace produced by PCA would not be useful for producing biologically meaningful results unless a restrictive set of criteria are met. We therefore suggest biologists be aware of the limitations of the ordered-axis plot approach before employing it on their own data, and possibly consider other, less restrictive methods for addressing the same question.	[Parsons, Kevin J.; Cooper, W. James; Albertson, R. Craig] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Parsons, KJ (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	kjpars01@syr.edu		Cooper, W. James/0000-0003-4204-4266	National Institute on Aging [RO1AG031922]; National Institute of Dental and Craniofacial Research [1R21DE019223]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031922] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R. C. Albertson's laboratory is supported by grants from the National Institute on Aging (RO1AG031922) and the National Institute of Dental and Craniofacial Research (1R21DE019223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; CHEVERUD JM, 1989, SYST ZOOL, V38, P201, DOI 10.2307/2992282; Flury B, 1988, COMMON PRINCIPAL COM; GOWER JC, 1971, MATH ARCHAEOLOGICAL, P138; Herrera CM, 2002, J EVOLUTION BIOL, V15, P108, DOI 10.1046/j.1420-9101.2002.00365.x; Manly B.F.J., 1994, MULTIVARIATE STAT PR; PERES PR, 2005, MORPHINT AVAILABLE R; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; SHEETS D, 2002, STANDARD6; Young KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004740; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zelditch ML, 2006, EVOL DEV, V8, P46, DOI 10.1111/j.1525-142X.2006.05074.x; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x	14	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7957	10.1371/journal.pone.0007957	http://dx.doi.org/10.1371/journal.pone.0007957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956767	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000272827300014
J	Wegiel, B; Jiborn, T; Abrahamson, M; Helczynski, L; Otterbein, L; Persson, JL; Bjartell, A				Wegiel, Barbara; Jiborn, Thomas; Abrahamson, Magnus; Helczynski, Leszek; Otterbein, Leo; Persson, Jenny Liao; Bjartell, Anders			Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways	PLOS ONE			English	Article							CYSTEINE PROTEASE INHIBITORS; IN-VIVO; GROWTH-FACTOR; CATHEPSIN-B; MATRIX METALLOPROTEINASES; RADICAL PROSTATECTOMY; GENE-EXPRESSION; CYCLIN A1; ACTIVATION; PROGRESSION	Cystatin C is believed to prevent tumor progression by inhibiting the activities of a family of lysosomal cysteine proteases. However, little is known about the precise mechanism of cystatin C function in prostate cancer. In the present study, we examined the expression of cystatin C and its association with matrix metalloproteinases 2 (MMP2) and androgen receptor (AR) in a tissue microarray comparing benign and malignant specimens from 448 patients who underwent radical prostatectomy for localized prostate cancer. Cystatin C expression was significantly lower in cancer specimens than in benign tissues (p<0.001) and there was a statistically significant inverse correlation between expression of cystatin C and MMP2 (r(s)(2) = -0.056, p = 0.05). There was a clear trend that patients with decreased level of cystatin C had lower overall survival. Targeted inhibition of cystatin C using specific siRNA resulted in an increased invasiveness of PC3 cells, whereas induction of cystatin C overexpression greatly reduced invasion rate of PC3 in vitro. The effect of cystatin C on modulating the PC3 cell invasion was provoked by Erk2 inhibitor that specifically inhibited MAPK/Erk2 activity. This suggests that cystatin C may mediate tumor cell invasion by modulating the activity of MAPK/Erk cascades. Consistent with our immunohistochemical findings that patients with low expression of cystatin C and high expression of androgen receptor (AR) tend to have worse overall survival than patients with high expression of cystatin C and high AR expression, induced overexpression of AR in PC3 cells expressing cystatin C siRNA greatly enhanced the invasiveness of PC3 cells. This suggests that there may be a crosstalk between cystatin C and AR-mediated pathways. Our study uncovers a novel role for cystatin C and its associated cellular pathways in prostate cancer invasion and metastasis.	[Wegiel, Barbara; Jiborn, Thomas; Bjartell, Anders] Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Clin Sci,Div Urol Canc, Malmo, Sweden; [Helczynski, Leszek] Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Pathol, Malmo, Sweden; [Persson, Jenny Liao] Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden; [Abrahamson, Magnus] Lund Univ, Univ Lund Hosp, Div Clin Chem & Pharmacol, Dept Lab Med, Lund, Sweden; [Wegiel, Barbara; Otterbein, Leo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wegiel, B (corresponding author), Lund Univ, Malmo Univ Hosp, Clin Res Ctr, Dept Clin Sci,Div Urol Canc, Malmo, Sweden.	jenny_l.persson@med.lu.se	Abrahamson, Magnus/CAG-9507-2022	Persson, Jenny/0000-0001-7682-7678	Swedish Research Council [20760, 09915]; Swedish Cancer Society [07-0458, 02-4573]; Cancer Research Fund of Malmo, University Hospital; Faculty of Medicine, Lund University; Gunnar Nilssons Cancer Foundation; Crafoord STF; Government Health Grant (ALF); A. Oesterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Research Fund of Malmo, University Hospital; Faculty of Medicine, Lund University; Gunnar Nilssons Cancer Foundation; Crafoord STF; Government Health Grant (ALF); A. Oesterlund Foundation	This work was supported by grants from the Swedish Research Council (grant no. 20760 and 09915), the Swedish Cancer Society (Projects No 07-0458 and 02-4573), the Research Fund and the Cancer Research Fund of Malmo, University Hospital, the Faculty of Medicine, Lund University, Gunnar Nilssons Cancer Foundation, and the Crafoord STF, and Government Health Grant (ALF) and A. Oesterlund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23; Aumuller G, 1999, UROLOGY, V53, P1041, DOI 10.1016/S0090-4295(98)00631-1; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P243, DOI 10.1289/ehp.9630; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Bonaccorsi L, 2006, MOL CELL ENDOCRINOL, V246, P157, DOI 10.1016/j.mce.2005.11.006; Buchanan G, 2001, MOL ENDOCRINOL, V15, P46, DOI 10.1210/me.15.1.46; Buchanan G, 2001, CLIN CANCER RES, V7, P1273; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Coleman RE, 2002, AM J CLIN ONCOL-CANC, V25, pS32, DOI 10.1097/00000421-200212001-00006; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; DOSREIS ST, 2008, UROL ONCOL; Ebert E, 1997, ADV EXP MED BIOL, V421, P259; Ellenrieder V, 2001, CANCER RES, V61, P4222; Ervin H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-14; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; Friedrich B, 1999, EUR J CANCER, V35, P138, DOI 10.1016/S0959-8049(98)00273-1; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Gohji K, 1998, INT J CANCER, V79, P96, DOI 10.1002/(SICI)1097-0215(19980220)79:1<96::AID-IJC18>3.0.CO;2-F; Gupta P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004363; Ishimaru H, 2002, ACTA ONCOL, V41, P289, DOI 10.1080/02841860260088845; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jennbacken K, 2006, PROSTATE, V66, P1631, DOI 10.1002/pros.20469; Jiborn T, 2004, J ANDROL, V25, P564; Jiborn T, 2006, BJU INT, V98, P189, DOI 10.1111/j.1464-410X.2006.06345.x; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Konduri SD, 2002, ONCOGENE, V21, P8705, DOI 10.1038/sj.onc.1205949; Kopitz C, 2005, CANCER RES, V65, P8608, DOI 10.1158/0008-5472.CAN-05-1572; Kos J, 2000, INT J BIOL MARKER, V15, P84, DOI 10.1177/172460080001500116; Krishan A, 2000, CLIN CANCER RES, V6, P1922; LAH TT, 1989, CLIN EXP METASTAS, V7, P461, DOI 10.1007/BF01753666; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Moses MA, 1998, CANCER RES, V58, P1395; Nakabayashi H, 2005, HUM PATHOL, V36, P1008, DOI 10.1016/j.humpath.2005.06.021; Nishikawa H, 2004, GYNECOL ONCOL, V92, P881, DOI 10.1016/j.ygyno.2003.11.017; Oka H, 2005, INT J UROL, V12, P899, DOI 10.1111/j.1442-2042.2005.01164.x; Pucci L, 2007, CLIN CHEM, V53, P480, DOI 10.1373/clinchem.2006.076042; Reddy Michael S, 2003, Ann Periodontol, V8, P12, DOI 10.1902/annals.2003.8.1.12; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roos JF, 2007, CLIN BIOCHEM, V40, P383, DOI 10.1016/j.clinbiochem.2006.10.026; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Simon C, 1999, BRIT J CANCER, V80, P1412, DOI 10.1038/sj.bjc.6690537; Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Trudel D, 2003, CANCER RES, V63, P8511; Tummalapalli P, 2007, INT J ONCOL, V31, P5; Tumminello FM, 2009, MED ONCOL, V26, P10, DOI 10.1007/s12032-008-9070-2; van der Poel HG, 2005, EUR UROL, V48, P1051, DOI 10.1016/j.eururo.2005.09.006; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; VOELLER HJ, 1991, MOL ENDOCRINOL, V5, P209, DOI 10.1210/mend-5-2-209; Watts SW, 1998, J PHARMACOL EXP THER, V286, P1431; Watts SW, 1998, ANN NY ACAD SCI, V861, P162; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Wegiel B, 2005, ONCOGENE, V24, P6385, DOI 10.1038/sj.onc.1208795; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214	63	54	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7953	10.1371/journal.pone.0007953	http://dx.doi.org/10.1371/journal.pone.0007953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956729	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827300011
